data_2ksv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ksv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.441 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 5.7 tp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.253 -0.647 . . . . 75.04 109.253 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -145.47 112.85 6.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 73.41 109.312 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -85.84 11.47 11.18 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 63.52 109.987 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.3 t -150.3 149.11 14.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.426 1.079 . . . . 61.31 109.303 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -101.48 143.29 26.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 73.42 109.298 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.99 -33.86 4.27 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 74.34 111.034 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.49 152.52 23.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 70.12 109.294 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.543 HG21 ' CD2' ' A' ' 225' ' ' TYR . 2.1 t -49.54 -36.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 75.22 109.311 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.58 2.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 70.23 109.317 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.527 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -71.53 -36.2 70.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 75.44 110.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.93 -57.4 12.95 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 1.155 . . . . 74.3 109.269 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.514 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 46.8 m-80 -51.08 -33.19 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 74.51 109.29 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -66.9 -56.5 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 74.34 109.943 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.47 ' CD1' HD12 ' A' ' 140' ' ' ILE . 59.8 mt -41.82 -41.9 2.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 73.44 109.3 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.454 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.06 -40.89 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 61.41 111.033 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -51.01 -36.2 38.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 72.05 109.306 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.474 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 65.3 mt-30 -76.52 -56.39 4.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 1.128 . . . . 73.51 110.308 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.464 HG22 ' CG ' ' A' ' 184' ' ' MET . 25.4 mt -50.18 -29.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 74.13 109.296 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -33.44 63.03 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 74.01 109.302 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -61.72 -15.68 42.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 74.3 109.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -84.58 -17.68 38.01 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 73.15 110.301 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.483 ' HA ' ' CE2' ' A' ' 170' ' ' PHE . 16.1 p -38.53 133.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 75.31 110.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -64.59 130.0 41.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 61.14 108.315 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.79 -20.75 10.74 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.495 1.122 . . . . 63.23 110.962 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.43 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 64.2 p -79.24 161.75 26.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 0.791 . . . . 73.13 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.73 -0.84 55.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.43 110.016 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.6 m -116.61 6.19 13.38 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 75.1 110.418 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.43 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -82.66 138.88 34.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.102 . . . . 74.52 109.264 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 73.41 109.977 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.438 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.19 127.24 3.6 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.556 1.16 . . . . 74.43 110.008 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.02 138.02 53.68 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.993 -2.503 . . . . 73.31 111.002 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.03 177.96 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 72.45 108.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.635 ' CG2' ' CZ ' ' A' ' 170' ' ' PHE . 3.5 mp -89.53 125.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.515 1.134 . . . . 64.23 109.276 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.417 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 65.3 p -79.65 88.23 5.16 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.538 1.149 . . . . 75.55 110.387 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.635 ' CZ ' ' CG2' ' A' ' 168' ' ' ILE . 84.8 m-85 -88.01 -26.37 22.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 75.32 111.001 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.77 -1.31 24.44 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 73.33 110.301 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 174' ' ' VAL . 26.4 t80 -128.52 67.6 76.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 71.42 110.986 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 115.58 4.33 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.482 1.78 . . . . 75.3 110.979 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.58 HG22 ' CE1' ' A' ' 172' ' ' TYR . 15.8 t -148.85 -72.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 75.4 109.301 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.02 -45.15 2.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 73.42 109.306 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -42.33 101.54 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.543 1.152 . . . . 60.42 111.006 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 73.9 m -134.3 -48.15 0.78 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.272 -1.01 . . . . 73.44 108.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 38.7 p90 -75.61 -45.55 36.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.22 110.99 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.33 -68.41 0.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 73.14 109.277 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.501 ' NH2' ' N ' ' A' ' 240' ' ' SER . 3.6 ptm180 -50.09 -47.61 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 73.21 110.318 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.454 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.83 -61.2 0.88 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 72.4 109.304 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.697 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.8 OUTLIER -46.37 -39.68 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.145 . . . . 71.31 109.595 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 180' ' ' ARG . 14.1 mmmm -65.25 -61.25 2.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 73.43 109.281 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.464 ' CG ' HG22 ' A' ' 153' ' ' ILE . 13.8 mtm -39.02 -40.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 71.04 110.963 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.454 ' NH1' ' CE ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.546 1.154 . . . . 73.23 110.323 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.411 ' NE2' ' HE2' ' A' ' 183' ' ' LYS . 0.2 OUTLIER -54.48 -35.92 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 71.21 110.31 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.7 mm -71.16 -34.15 53.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 72.11 109.278 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -64.39 -45.78 86.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 74.24 109.273 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.454 ' CE ' ' NH1' ' A' ' 185' ' ' ARG . 3.5 mtt -55.32 -36.8 66.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 74.52 111.006 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.62 -50.3 68.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 73.24 109.305 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.474 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 18.7 t-20 -66.84 -34.23 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 73.43 109.337 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 107.99 53.39 0.66 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.487 1.117 . . . . 54.44 111.012 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 145' ' ' THR . 72.4 m-85 -153.17 134.86 14.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 0.771 . . . . 72.23 111.0 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.446 ' OD1' ' NH2' ' A' ' 185' ' ' ARG . 2.4 t0 -101.43 122.36 43.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 53.35 109.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 29.5 p -100.11 -179.38 4.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 75.34 108.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -126.63 174.47 8.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 73.42 110.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.454 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 18.9 mmtt -110.1 159.01 17.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 74.14 109.301 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.451 ' NE2' ' CD1' ' A' ' 222' ' ' LEU . 7.6 tt0 -151.39 117.59 5.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 75.3 110.282 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.56 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.5 m-85 -110.71 118.59 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 72.44 110.978 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 10.0 p -109.88 146.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 70.31 109.311 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 12.0 m-85 -118.63 160.43 21.82 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 75.31 111.041 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.61 -176.04 16.01 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.509 1.131 . . . . 74.12 110.99 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 263' ' ' SER . 56.7 t-20 -72.39 110.3 6.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 0.781 . . . . 73.14 109.298 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 218' ' ' HIS . 5.2 mt -114.52 94.74 4.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 75.3 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.1 mtpt -92.31 178.75 5.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.145 . . . . 73.41 109.321 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' A' ' 213' ' ' VAL . . . -178.02 163.24 1.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.22 109.316 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.549 1.156 . . . . 73.23 110.007 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.281 -1.007 . . . . 73.53 108.281 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.45 ' N ' ' SG ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -134.07 149.68 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 75.55 109.301 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.34 130.91 27.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 71.43 109.274 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.452 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -137.68 135.82 36.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.979 -1.119 . . . . 75.12 107.979 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 72.7 p -80.05 1.11 29.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 73.53 110.045 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.0 p90 -176.23 129.83 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.093 . . . . 74.43 111.0 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 37.4 t60 -114.43 169.05 9.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 64.55 109.603 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.487 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 2.1 p -146.45 136.37 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 73.35 109.269 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.641 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.13 -168.04 2.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 75.52 109.297 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 28.1 pt -115.75 121.51 67.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 74.53 109.304 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.451 ' CD1' ' NE2' ' A' ' 198' ' ' GLN . 12.9 tp -85.41 109.03 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 73.34 109.313 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.53 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -102.8 146.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 70.22 109.269 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 140' ' ' ILE . 4.0 m -116.78 119.86 36.75 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 74.51 110.024 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.57 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.4 p90 -134.93 143.26 46.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 73.31 111.007 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.419 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -68.61 133.93 49.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 71.45 109.344 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.02 -160.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.122 . . . . 75.52 109.306 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.81 0.05 49.05 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 63.53 109.288 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.4 m -115.12 -8.33 12.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 75.13 110.009 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.73 37.44 7.98 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.483 1.114 . . . . 71.34 111.018 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.37 137.4 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.479 0.752 . . . . 73.44 109.274 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.419 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 6.3 m -71.52 102.66 2.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.484 1.115 . . . . 72.24 110.425 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.409 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 3.0 mm-40 -101.49 -172.24 2.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 72.3 110.298 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.1 mmtm -126.97 144.83 50.9 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 74.15 109.28 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.57 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 5.0 tpt180 -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 75.14 110.282 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.47 HG13 ' CB ' ' A' ' 252' ' ' TRP . 13.8 mm -114.88 127.67 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 64.44 109.296 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.499 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -111.95 41.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 75.32 109.332 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.43 108.05 59.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 73.42 109.289 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.563 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.1 Cg_endo -75.03 -0.54 10.1 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.477 1.777 . . . . 63.15 110.995 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.501 ' N ' ' NH2' ' A' ' 180' ' ' ARG . 1.2 t -67.67 -9.29 42.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.542 1.151 . . . . 71.54 109.944 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.467 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 3.1 mt -135.21 -47.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 74.53 109.287 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.569 ' CD1' HG12 ' A' ' 247' ' ' VAL . 97.5 m-85 -121.0 99.75 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 74.15 110.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.0 -24.04 26.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 74.54 109.999 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 p -61.73 -45.74 92.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 72.43 109.987 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.42 -174.22 41.02 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.496 1.123 . . . . 51.23 111.017 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.425 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.01 169.18 23.2 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.431 1.753 . . . . 75.43 110.973 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 242' ' ' PHE . 4.1 m -152.45 157.21 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 74.22 109.3 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 36.8 p -60.22 137.09 58.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.447 1.092 . . . . 74.45 110.395 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 7.7 p-10 -40.57 -29.67 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.475 1.109 . . . . 72.44 109.334 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.0 m -71.64 -64.91 0.83 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.498 1.124 . . . . 72.34 110.355 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.0 -30.78 11.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 74.34 109.274 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.641 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 15.6 t90 -60.74 -61.9 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 74.22 107.996 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.565 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.44 -40.88 19.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 1.112 . . . . 72.22 110.316 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.85 -50.79 72.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 72.32 109.287 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.79 -23.01 40.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 72.2 109.287 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.447 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.6 m -84.78 -35.84 22.11 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 73.13 108.28 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.481 ' CA ' ' HB1' ' A' ' 264' ' ' ALA . 2.9 m -95.24 21.29 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.551 1.157 . . . . 63.42 109.294 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -50.23 107.27 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 1.1 . . . . 72.32 109.26 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.9 p -72.49 -3.93 27.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 63.21 110.435 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.9 t -46.54 -25.03 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 75.44 110.006 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . 0.44 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 19.7 t -94.34 -35.32 12.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 73.14 108.282 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 162.18 -128.35 1.87 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.489 1.118 . . . . 74.12 110.981 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -71.28 143.91 50.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 0.768 . . . . 73.42 109.953 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.481 ' HB1' ' CA ' ' A' ' 257' ' ' VAL . . . -170.3 144.33 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 73.04 109.297 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.7 t -172.78 154.78 3.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 75.33 110.007 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.27 117.54 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 74.13 109.308 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 20.7 t -73.74 -43.96 57.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 64.1 110.044 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.1 m -165.23 171.92 13.05 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 70.33 110.02 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -154.33 155.81 35.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.34 111.012 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -157.81 160.66 38.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 74.22 109.323 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -121.94 160.64 24.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 75.4 109.303 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.505 HG23 ' CE1' ' A' ' 285' ' ' TYR . 35.0 p -152.62 175.68 12.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 74.51 110.37 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.47 ' CB ' HG21 ' A' ' 276' ' ' VAL . . . -59.13 156.5 11.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 74.53 109.334 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.74 -46.13 62.41 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.486 1.116 . . . . 65.01 110.993 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -52.94 -42.38 65.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 0.771 . . . . 73.14 109.353 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.47 HG21 ' CB ' ' A' ' 273' ' ' ALA . 81.8 t -43.88 101.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.517 1.136 . . . . 74.3 109.325 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.4 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 2.6 t80 -58.67 -59.47 5.35 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 73.32 111.009 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -132.03 150.25 52.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.467 1.104 . . . . 75.52 111.064 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.56 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 60.8 ttt-85 -119.35 147.47 44.29 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 71.3 110.313 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.66 158.2 40.93 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 74.2 110.015 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 0.37 9.0 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.495 1.787 . . . . 63.35 110.976 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 t -100.47 9.88 41.98 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 72.4 109.987 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 72.82 40.8 0.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 72.54 109.336 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -119.18 133.14 55.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.469 1.106 . . . . 74.53 110.022 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.505 ' CE1' HG23 ' A' ' 272' ' ' THR . 18.0 m-30 -114.38 150.12 35.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 73.53 110.985 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -116.44 177.48 4.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 74.21 109.274 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 47.7 m-85 -160.59 115.49 2.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 75.0 111.006 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -115.38 94.87 4.9 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.475 1.109 . . . . 75.2 109.337 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.7 -16.74 53.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 71.14 109.266 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.447 ' CB ' HG12 ' A' ' 292' ' ' ILE . 40.8 m-20 -108.52 5.31 25.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.134 . . . . 64.12 109.321 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.697 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.27 49.7 2.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.553 1.158 . . . . 73.22 109.276 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.447 HG12 ' CB ' ' A' ' 290' ' ' ASN . 40.6 mm -80.03 -29.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.35 109.317 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.486 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.7 t-20 -94.5 -20.59 19.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.13 . . . . 72.01 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.419 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.7 m -87.59 -68.65 0.74 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.133 . . . . 75.34 110.365 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 77.4 m-20 -49.75 -31.2 10.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.1 . . . . 73.22 109.304 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 41.3 t -70.96 -49.36 46.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 72.34 108.302 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.3 t -52.01 -43.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 74.55 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 301' ' ' PHE . 21.0 mt -67.2 -61.12 2.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 75.22 109.3 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -41.4 -31.72 0.27 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.533 1.145 . . . . 72.41 110.382 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -67.14 -51.48 53.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 74.03 109.252 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.6 OUTLIER -94.58 37.72 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 74.44 111.025 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 37.0 t -69.08 -46.82 66.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 72.33 109.953 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.489 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -90.19 -17.55 27.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 72.34 109.31 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.417 ' CD2' ' CD ' ' A' ' 309' ' ' PRO . 16.6 mt -57.81 140.07 52.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.535 1.147 . . . . 74.31 109.297 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.6 p -152.66 140.72 20.29 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.441 1.088 . . . . 75.45 110.002 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.93 -161.66 27.02 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.497 1.123 . . . . 55.51 111.0 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.32 6.2 47.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.344 -0.984 . . . . 73.44 108.344 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.479 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 24.0 p -130.22 151.05 77.79 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 74.03 110.053 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -75.03 145.87 85.08 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.998 -2.501 . . . . 74.51 110.999 0.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.0 p -133.59 135.51 25.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 71.35 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.02 -173.6 12.62 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.047 -2.48 . . . . 70.32 111.002 0.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.01 154.67 18.35 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.532 1.145 . . . . 72.12 109.339 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.506 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -74.96 -162.24 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.482 1.78 . . . . 65.24 111.039 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -85.08 133.83 34.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 73.05 109.295 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.2 m -125.81 25.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 74.1 109.32 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 t -55.12 -31.7 61.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 74.11 110.02 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 28.8 p -49.65 -23.58 1.79 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 74.23 110.026 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 60.12 108.289 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 8.9 tp . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.271 -0.64 . . . . 70.4 109.271 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.549 ' HB2' ' CD2' ' A' ' 193' ' ' TYR . . . -103.92 105.46 15.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 75.45 109.289 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.1 m -83.66 8.46 14.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.129 . . . . 52.01 109.973 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -150.16 147.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 71.51 109.266 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.437 HD13 ' CD1' ' A' ' 149' ' ' LEU . 1.3 mt -97.92 142.14 24.09 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.148 . . . . 70.34 109.304 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.05 -32.37 5.38 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.519 1.8 . . . . 74.11 110.969 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.05 148.36 17.01 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 72.31 109.332 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.564 HG22 ' CD2' ' A' ' 225' ' ' TYR . 2.1 t -46.11 -36.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 73.23 109.286 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.88 -47.39 2.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.112 . . . . 74.32 109.268 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.51 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.55 -36.36 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.54 1.15 . . . . 72.3 110.394 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.483 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.9 -57.23 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 63.54 109.295 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.521 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 47.4 m-80 -51.62 -32.36 28.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 75.34 109.297 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.74 -56.29 8.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.42 110.023 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.469 HD22 ' CD1' ' A' ' 193' ' ' TYR . 56.6 mt -43.69 -42.19 5.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 70.21 109.318 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.452 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.1 t80 -71.87 -44.29 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 72.13 110.987 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -46.4 -35.77 5.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 74.04 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -77.87 -54.89 5.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 61.32 110.278 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.501 ' CD1' ' CD1' ' A' ' 188' ' ' LEU . 10.2 mt -50.63 -24.5 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.113 . . . . 71.11 109.275 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -38.39 46.55 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 72.22 109.31 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.73 -17.04 19.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 74.1 109.288 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -81.91 -26.36 34.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 75.3 110.29 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 13.9 m -42.24 137.75 1.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 73.23 109.972 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.69 113.03 4.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 63.44 108.314 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.58 1.74 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.518 1.136 . . . . 71.44 110.994 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.418 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 72.7 p -93.17 161.66 14.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.538 0.787 . . . . 74.33 110.385 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.7 p -92.52 -1.82 56.67 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 65.02 109.984 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.4 m -114.74 2.54 14.45 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.33 110.396 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.418 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -75.33 133.54 41.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 72.41 109.35 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -170.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 73.13 109.961 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.452 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.4 p -154.11 127.33 4.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 72.44 110.049 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.452 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -75.03 138.04 53.78 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 120.966 -2.514 . . . . 75.14 111.0 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.1 p -72.79 -178.6 2.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.459 1.1 . . . . 72.03 108.328 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.33 132.88 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 64.23 109.295 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.1 p -92.68 73.14 5.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 74.53 110.411 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 12.7 p90 -74.14 -21.3 59.92 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.562 1.164 . . . . 73.35 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 302' ' ' SER . 0.0 OUTLIER -74.73 -1.85 23.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 75.23 110.281 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.579 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 21.9 t80 -131.76 66.97 79.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 72.3 110.976 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.434 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.02 118.79 5.39 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.435 1.755 . . . . 75.2 110.993 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.569 HG22 ' CE1' ' A' ' 172' ' ' TYR . 6.7 t -152.09 -72.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 70.33 109.337 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.6 -44.96 1.5 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 74.22 109.288 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -44.27 110.05 0.32 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.527 1.142 . . . . 65.22 110.999 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.476 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 5.3 p -147.95 -48.47 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.277 -1.009 . . . . 60.34 108.277 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -66.58 -16.96 64.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 75.22 110.984 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.04 -68.11 0.64 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 73.51 109.334 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.471 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 10.0 ptm180 -49.03 -50.62 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.451 1.094 . . . . 75.32 110.314 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.413 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.21 -56.63 3.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 55.34 109.296 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.7 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -45.07 -36.71 3.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 65.14 109.575 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.737 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.0 mmmt -68.89 -59.15 3.27 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.15 . . . . 73.41 109.313 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.423 ' CG ' HG22 ' A' ' 153' ' ' ILE . 11.2 mtm -38.74 -31.45 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.15 111.009 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.437 ' NH2' ' OD2' ' A' ' 194' ' ' ASP . 0.0 OUTLIER -69.32 -54.08 16.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 73.12 110.259 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.737 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.6 OUTLIER -54.15 -32.62 55.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 74.23 110.286 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 153' ' ' ILE . 26.1 mm -71.5 -40.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.459 1.1 . . . . 74.51 109.235 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.501 ' CD1' ' CD1' ' A' ' 153' ' ' ILE . 0.3 OUTLIER -62.18 -42.46 99.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 71.13 109.306 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.0 mtt -57.94 -38.93 76.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 65.44 110.973 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.43 -52.34 54.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 75.23 109.296 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.438 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 7.8 t-20 -64.23 -35.34 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 74.23 109.315 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.58 53.01 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.44 1.088 . . . . 72.32 110.99 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 137' ' ' ALA . 90.0 m-85 -153.28 147.9 26.19 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.541 0.789 . . . . 65.25 111.007 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -110.02 126.88 54.43 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 75.2 109.31 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.474 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 13.4 p -98.8 -179.27 4.24 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.47 1.106 . . . . 65.12 108.312 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -133.38 171.62 13.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.562 1.164 . . . . 75.21 110.357 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.413 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 18.1 mmtt -107.01 161.13 15.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.48 1.113 . . . . 75.41 109.3 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -157.66 117.49 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 73.25 110.323 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 9.1 m-85 -108.49 133.53 52.52 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 75.43 110.967 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.479 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 8.7 p -124.38 148.16 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 74.23 109.301 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.6 m-85 -120.09 156.51 30.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.483 1.114 . . . . 72.23 111.018 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.42 -178.55 16.37 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.542 1.151 . . . . 51.42 111.006 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 263' ' ' SER . 57.2 t-20 -71.02 111.25 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 0.772 . . . . 73.41 109.297 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.468 HD12 ' CB ' ' A' ' 218' ' ' HIS . 5.4 mt -115.27 93.62 4.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 62.34 109.312 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.8 mttp -93.27 165.93 12.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 72.5 109.287 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -171.68 154.07 3.57 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 70.3 109.322 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 75.13 109.995 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 108.295 -1.002 . . . . 65.12 108.295 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.416 ' HB ' ' NE1' ' A' ' 215' ' ' TRP . 0.0 OUTLIER -114.44 153.86 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.541 1.151 . . . . 72.12 109.272 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -137.4 119.02 14.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 73.22 109.276 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.32 134.0 51.23 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.019 -1.104 . . . . 72.34 108.019 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.2 t -79.33 2.32 21.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.485 1.115 . . . . 72.44 109.945 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.484 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.3 p90 -175.33 128.41 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.448 1.092 . . . . 73.42 111.006 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.468 ' CB ' HD12 ' A' ' 204' ' ' LEU . 83.4 t60 -121.75 167.21 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 74.13 109.595 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.476 ' CG1' ' SG ' ' A' ' 177' ' ' CYS . 2.5 p -145.18 149.73 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.459 1.1 . . . . 71.14 109.302 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.501 ' HB2' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.46 -159.43 0.99 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 64.22 109.317 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.469 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 14.4 pt -120.0 122.98 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.462 1.102 . . . . 75.33 109.291 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 11.9 tp -86.71 109.01 18.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 74.41 109.284 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.483 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.51 145.45 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 72.24 109.325 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.4 m -116.56 118.56 32.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 74.33 109.993 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -133.85 144.79 49.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 74.11 111.014 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.435 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -69.83 133.96 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 75.35 109.304 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.12 -159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 75.23 109.313 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 -0.35 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 74.35 109.295 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.0 m -114.87 -7.75 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.451 1.095 . . . . 74.13 109.972 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.57 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.518 1.136 . . . . 55.04 111.033 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.22 137.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 0.777 . . . . 74.32 109.275 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.435 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.4 m -71.53 102.65 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 73.13 110.368 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.407 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 1.9 mm-40 -101.74 -172.68 2.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 74.45 110.259 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -127.03 144.93 50.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 74.44 109.301 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.574 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 1.3 tpt180 -145.48 162.96 36.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 73.41 110.247 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.478 HG13 ' CB ' ' A' ' 252' ' ' TRP . 10.8 mm -116.85 119.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 74.11 109.31 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -105.33 43.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 74.33 109.292 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.436 ' OD1' ' CB ' ' A' ' 240' ' ' SER . 4.2 t70 -101.84 108.13 54.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.457 1.098 . . . . 73.13 109.315 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -4.84 16.01 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.486 1.782 . . . . 70.14 111.032 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 t -72.05 -7.94 51.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 70.34 110.027 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -130.96 -46.59 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 74.34 109.31 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.572 ' CD1' HG12 ' A' ' 247' ' ' VAL . 97.1 m-85 -123.34 106.75 10.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 71.34 110.98 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -26.22 22.25 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.496 1.123 . . . . 72.42 109.985 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.5 m -62.62 -47.74 82.46 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.124 . . . . 73.24 110.034 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.41 -173.78 40.66 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.474 1.109 . . . . 74.01 110.965 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.426 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 169.98 21.41 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.514 1.797 . . . . 72.44 111.017 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.572 HG12 ' CD1' ' A' ' 242' ' ' PHE . 13.7 m -148.61 159.46 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 74.34 109.302 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 43.3 p -61.71 142.08 57.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 72.15 110.427 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 249' ' ' ASP . 1.2 p-10 -45.82 -26.17 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.157 . . . . 75.12 109.333 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 29.1 m -80.88 -61.42 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 74.01 110.387 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.94 -22.01 5.05 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 74.13 109.235 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.57 ' CE3' ' HD3' ' A' ' 253' ' ' ARG . 9.5 t90 -67.05 -59.04 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.48 1.113 . . . . 73.15 108.017 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.06 -43.54 40.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.569 1.168 . . . . 73.44 110.278 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.434 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.2 m-80 -53.74 -52.16 61.04 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 70.42 109.319 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.435 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.4 -18.77 12.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 74.52 109.306 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.8 m -90.34 -35.0 15.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.3 108.287 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.477 ' CA ' ' HB2' ' A' ' 264' ' ' ALA . 3.5 m -94.47 21.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 71.22 109.32 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -51.34 109.24 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 72.51 109.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.0 p -74.71 -3.06 29.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.506 1.129 . . . . 74.44 110.396 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t -44.22 -31.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.508 1.13 . . . . 72.12 110.018 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 46.2 t -88.24 -37.39 16.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 70.11 108.304 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.32 -127.58 1.56 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.45 1.094 . . . . 75.21 111.032 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.1 146.83 39.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 0.784 . . . . 62.32 110.023 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.477 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -168.39 147.83 4.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 1.115 . . . . 71.23 109.286 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 39.0 m -172.83 153.86 2.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.448 1.093 . . . . 72.31 109.985 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.479 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 3.6 p -101.81 115.49 43.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 74.12 109.303 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 9.2 t -70.32 -45.17 66.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.113 . . . . 72.44 110.016 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.6 m -163.73 -174.88 3.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.499 1.124 . . . . 71.41 109.991 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -165.78 156.53 13.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 74.3 110.996 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -153.77 162.49 41.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.464 1.102 . . . . 71.31 109.276 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -121.82 159.88 25.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.32 109.318 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.447 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 2.5 p -154.37 178.12 10.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.146 . . . . 61.53 110.381 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.448 ' CB ' HG21 ' A' ' 276' ' ' VAL . . . -61.3 167.29 3.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 75.32 109.307 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.98 -18.76 66.72 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 71.4 111.015 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.94 -39.15 21.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 0.759 . . . . 73.3 109.319 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.448 HG21 ' CB ' ' A' ' 273' ' ' ALA . 61.7 t -43.6 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.535 1.147 . . . . 74.43 109.32 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.0 t80 -53.92 -54.78 34.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.523 1.139 . . . . 74.52 111.018 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.572 ' CE2' ' O ' ' A' ' 279' ' ' ARG . 66.9 t80 -143.39 159.92 41.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 72.04 110.949 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.575 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.4 ttt-85 -122.73 147.57 46.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 74.5 110.35 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.21 154.32 48.68 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.46 1.1 . . . . 75.01 109.964 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.18 9.22 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.49 1.784 . . . . 74.43 110.972 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 14.2 t -104.62 7.76 35.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.534 1.147 . . . . 73.34 110.013 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 76.7 41.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 72.4 109.275 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.4 t -119.56 118.99 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 74.44 109.997 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -102.78 159.1 15.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 75.5 111.034 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.7 OUTLIER -123.94 176.93 6.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 73.53 109.259 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 94.7 m-85 -161.31 115.37 2.0 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 63.45 111.014 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.408 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.8 t0 -115.3 95.06 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.103 . . . . 75.34 109.279 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.64 -19.45 30.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.469 1.106 . . . . 74.11 109.285 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.455 ' CB ' HG12 ' A' ' 292' ' ' ILE . 50.7 m-20 -105.71 4.18 29.76 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.12 . . . . 73.34 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.7 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.5 mm? 40.41 49.15 2.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 75.34 109.291 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.455 HG12 ' CB ' ' A' ' 290' ' ' ASN . 30.8 mm -78.7 -28.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.539 1.149 . . . . 73.34 109.339 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.7 t-20 -94.71 -24.0 17.32 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.117 . . . . 63.33 109.29 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 4.4 m -83.11 -68.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.537 1.148 . . . . 73.13 110.43 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 56.3 m-20 -51.05 -28.54 10.51 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 73.11 109.323 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 11.5 t -70.9 -66.5 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.133 . . . . 72.44 108.317 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.542 HG11 ' CE2' ' A' ' 301' ' ' PHE . 53.5 t -43.44 -42.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 70.33 109.311 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.13 -58.02 10.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.472 1.108 . . . . 74.22 109.273 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -19.5 52.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 63.32 110.429 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -76.3 -42.39 45.43 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 75.31 109.317 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.579 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 1.7 m-30 -106.02 40.41 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 74.52 111.054 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' SER . . . . . 0.447 ' O ' ' NH1' ' A' ' 171' ' ' ARG . 29.6 t -68.0 -55.28 13.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.145 . . . . 52.24 110.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.501 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -79.39 -18.33 52.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 72.41 109.28 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.552 HD13 ' CE2' ' A' ' 172' ' ' TYR . 13.3 mt -57.42 139.27 53.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.105 . . . . 75.35 109.343 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 90.3 p -149.95 166.13 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 74.33 109.995 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 68.22 -153.05 52.83 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.473 1.108 . . . . 63.42 110.978 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.7 p -103.13 15.53 29.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.283 -1.006 . . . . 70.24 108.283 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.477 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -133.59 150.26 74.39 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 71.03 109.992 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.4 Cg_endo -74.97 146.71 87.41 Favored 'Cis proline' 0 C--N 1.359 1.108 0 C-N-CA 121.052 -2.478 . . . . 64.14 110.994 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -129.75 133.39 24.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 72.5 110.033 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -168.22 6.29 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 121.044 -2.482 . . . . 72.53 110.982 0.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.71 152.08 28.2 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 75.05 109.309 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.56 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.03 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.505 1.792 . . . . 72.13 111.039 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.08 131.24 34.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.533 1.146 . . . . 71.01 109.321 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.48 27.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 73.5 109.306 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 27.0 t -57.37 -24.12 53.38 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 74.23 109.961 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -58.2 -16.8 15.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 75.24 109.984 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 61.7 m . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 72.45 108.346 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.479 ' CD2' ' HB3' ' A' ' 194' ' ' ASP . 6.9 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.267 -0.642 . . . . 74.32 109.267 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.547 ' HB2' ' CD2' ' A' ' 193' ' ' TYR . . . -109.03 111.75 23.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 74.1 109.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.486 ' CB ' ' OD1' ' A' ' 194' ' ' ASP . 0.7 OUTLIER -86.72 6.1 32.99 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 73.4 109.966 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.3 t -145.94 150.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.468 1.105 . . . . 72.01 109.314 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.468 HD11 ' CD1' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -103.28 143.13 26.0 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 71.24 109.33 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -75.05 -33.73 4.31 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.509 1.794 . . . . 54.2 111.02 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.429 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.45 150.36 23.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.114 . . . . 75.22 109.318 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.549 HG22 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -49.06 -33.91 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 54.42 109.286 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.85 -46.28 5.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 72.54 109.327 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.443 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 1.8 m -72.92 -32.16 65.12 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 74.52 110.421 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.6 OUTLIER -61.9 -56.16 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 73.33 109.332 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.509 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 51.3 m-80 -53.64 -31.07 45.87 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.533 1.146 . . . . 73.24 109.3 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -70.26 -55.92 8.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 74.54 109.953 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.468 ' CD1' HD11 ' A' ' 140' ' ' ILE . 70.4 mt -42.63 -42.24 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 1.094 . . . . 73.24 109.32 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.566 ' CE1' ' HD3' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -72.2 -45.11 61.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.141 . . . . 74.34 111.006 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.61 -39.66 17.41 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 64.32 109.271 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.472 HE22 ' ND2' ' A' ' 191' ' ' ASN . 60.9 mt-30 -73.54 -57.07 4.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 71.23 110.292 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.444 ' CD1' HD11 ' A' ' 188' ' ' LEU . 10.7 mt -50.01 -23.27 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 72.52 109.28 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -76.46 -37.58 56.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 72.34 109.285 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -57.03 -18.63 14.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 73.54 109.312 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.409 ' NE2' ' HB2' ' A' ' 164' ' ' SER . 4.8 mm100 -80.24 -27.4 38.69 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.464 1.102 . . . . 73.23 110.341 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' GLN . 15.6 m -39.47 129.59 1.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 74.25 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 7.4 m -58.85 113.31 2.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.43 1.081 . . . . 74.32 108.295 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.36 -17.12 1.68 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.486 1.116 . . . . 61.31 110.982 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 46.0 p -95.33 161.56 14.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 0.76 . . . . 71.43 110.398 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 m -92.9 -3.76 54.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 1.152 . . . . 74.1 109.956 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.0 m -109.5 -1.62 18.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 72.14 110.405 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.08 134.39 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.439 1.087 . . . . 73.31 109.314 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.409 ' HB2' ' NE2' ' A' ' 156' ' ' GLN . 0.4 OUTLIER -55.59 -166.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 74.42 109.996 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.0 m -156.24 127.93 3.84 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 74.31 110.02 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 137.8 52.39 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.944 -2.523 . . . . 71.23 111.027 0.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.0 p -73.0 -179.38 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.103 . . . . 65.32 108.307 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.11 128.31 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 73.44 109.284 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 67.7 p -94.71 84.73 4.29 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 63.41 110.356 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -88.55 -12.7 42.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.522 1.139 . . . . 74.23 110.976 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.77 -4.1 29.41 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.526 1.141 . . . . 73.01 110.324 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.567 ' CE2' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -131.02 70.01 82.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.25 111.011 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.405 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.0 Cg_endo -75.05 113.56 3.82 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.535 1.808 . . . . 75.4 110.957 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.56 HG23 ' CE1' ' A' ' 172' ' ' TYR . 21.7 t -153.41 -67.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 61.42 109.298 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -159.34 112.88 2.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.527 1.142 . . . . 73.01 109.339 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.551 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.68 68.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.515 1.134 . . . . 71.54 111.002 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 42.4 m -107.5 -8.42 16.24 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.28 -1.008 . . . . 74.22 108.28 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.551 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 35.4 p90 -81.16 -23.83 37.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 71.22 110.964 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.08 -68.11 0.52 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 64.2 109.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.475 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 8.0 ptm180 -44.23 -51.12 8.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 73.14 110.309 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -40.35 -62.84 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.42 109.321 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.699 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -42.24 -39.09 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 74.04 109.625 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.666 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 28.0 mmmt -68.69 -54.9 13.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.544 1.152 . . . . 73.14 109.308 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.6 mtm -39.57 -41.72 1.06 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.466 1.104 . . . . 71.35 110.986 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.442 ' CG ' ' SG ' ' A' ' 195' ' ' CYS . 0.6 OUTLIER -62.63 -45.01 94.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 74.15 110.318 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.666 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -50.93 -31.81 18.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 72.2 110.307 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.433 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 10.4 mm -82.95 -39.43 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.13 . . . . 75.11 109.322 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.477 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -57.76 -39.34 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.511 1.132 . . . . 74.31 109.314 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 32.9 mtp -65.84 -45.78 80.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 72.32 110.98 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -42.87 -53.45 4.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 63.11 109.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.472 ' ND2' HE22 ' A' ' 152' ' ' GLN . 5.5 t-20 -62.64 -39.14 92.9 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 75.44 109.354 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 118.74 46.7 0.43 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.518 1.136 . . . . 64.13 111.0 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.547 ' CD2' ' HB2' ' A' ' 137' ' ' ALA . 92.5 m-85 -150.93 129.82 12.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 74.44 111.004 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.486 ' OD1' ' CB ' ' A' ' 138' ' ' SER . 0.3 OUTLIER -96.98 130.76 44.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 75.01 109.358 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 13.9 p -102.65 173.49 6.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 73.25 108.314 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 55.32 110.324 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.413 ' NZ ' ' HA ' ' A' ' 182' ' ' HIS . 7.1 mmtt -100.04 158.39 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 75.12 109.32 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.416 ' OE1' ' CZ3' ' A' ' 252' ' ' TRP . 20.4 tt0 -145.88 117.32 7.99 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 63.31 110.327 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -110.72 126.47 54.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.142 . . . . 74.24 111.032 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.47 ' CG2' HG23 ' A' ' 266' ' ' VAL . 9.1 p -125.92 128.53 72.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.458 1.099 . . . . 74.53 109.334 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.412 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 17.1 m-85 -103.44 158.37 16.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 75.24 111.005 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.94 -176.38 16.41 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.523 1.139 . . . . 44.42 110.97 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -72.18 110.98 7.0 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 0.765 . . . . 54.31 109.273 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.468 HD13 ' CB ' ' A' ' 218' ' ' HIS . 5.1 mt -115.17 94.69 4.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 74.23 109.307 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 4.5 mtpt -92.87 170.92 9.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 73.41 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -172.96 122.53 0.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.11 . . . . 72.04 109.29 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 64.51 109.956 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 108.275 -1.009 . . . . 73.55 108.275 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.07 161.14 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.457 1.098 . . . . 74.32 109.326 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -140.23 137.53 34.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.491 1.119 . . . . 75.31 109.298 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -138.2 134.55 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.479 1.112 . . . . 74.31 108.014 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -78.27 -1.03 31.03 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.46 1.1 . . . . 74.23 110.034 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.454 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 9.4 p90 -173.96 130.42 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 75.42 110.987 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.472 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 48.3 t60 -117.59 165.55 13.44 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.519 1.137 . . . . 71.12 109.588 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.472 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 2.0 p -140.76 135.87 34.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 72.11 109.315 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -136.34 -164.38 1.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 70.23 109.312 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 22.6 pt -119.42 123.28 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 70.22 109.295 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.6 tp -89.77 108.96 20.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 71.1 109.3 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.53 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.97 146.66 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.11 . . . . 75.43 109.27 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 140' ' ' ILE . 9.4 m -116.7 119.42 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.141 . . . . 72.42 109.991 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.6 p90 -134.5 142.89 47.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.21 110.998 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.43 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.8 mmtp -68.28 134.4 50.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 74.13 109.316 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.62 -160.07 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 1.091 . . . . 73.44 109.257 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.39 50.75 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 72.33 109.341 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.0 m -115.02 -7.48 12.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.479 1.112 . . . . 74.15 110.033 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.67 8.45 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.467 1.104 . . . . 62.42 110.95 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.24 137.63 42.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 0.743 . . . . 74.44 109.273 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.43 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 13.4 m -71.52 102.65 2.75 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 74.02 110.416 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.412 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 5.7 mm-40 -101.4 -172.46 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 64.54 110.277 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -127.18 144.98 50.92 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.449 1.093 . . . . 73.25 109.246 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.568 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 4.6 tpt180 -145.02 160.45 41.35 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 72.32 110.316 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.476 HG13 ' CB ' ' A' ' 252' ' ' TRP . 12.7 mm -115.53 118.02 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 74.43 109.336 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.8 mm -102.38 45.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.516 1.135 . . . . 75.31 109.301 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.35 111.27 65.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 74.11 109.301 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -26.59 10.85 Favored 'Trans proline' 0 C--N 1.361 1.202 0 O-C-N 124.47 1.773 . . . . 72.43 111.036 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.408 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.5 t -48.06 -24.19 1.03 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.136 . . . . 74.31 110.001 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 252' ' ' TRP . 25.2 mt -113.56 -54.72 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 73.24 109.316 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.558 ' CD1' HG13 ' A' ' 247' ' ' VAL . 94.9 m-85 -117.88 99.58 7.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.543 1.152 . . . . 62.24 111.025 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -28.34 34.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 75.1 109.947 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.7 t -59.01 -48.77 80.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 75.42 109.991 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.34 -172.83 39.19 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.495 1.122 . . . . 63.23 110.959 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 170.63 20.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.449 1.763 . . . . 61.44 110.976 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.558 HG13 ' CD1' ' A' ' 242' ' ' PHE . 10.7 m -151.01 158.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 72.04 109.297 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.47 HG22 ' CZ ' ' A' ' 235' ' ' ARG . 34.4 p -59.61 142.49 52.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.545 1.153 . . . . 73.22 110.414 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.405 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 18.5 p-10 -46.61 -25.56 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 74.32 109.303 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.411 ' N ' ' C ' ' A' ' 248' ' ' THR . 27.8 m -79.36 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 63.42 110.409 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -49.86 -29.19 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 51.45 109.293 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 12.7 t90 -62.01 -65.88 0.62 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.43 108.022 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.563 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -40.58 -38.23 0.84 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 72.33 110.308 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.452 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.0 m-80 -60.07 -50.74 72.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.555 1.16 . . . . 74.21 109.297 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 252' ' ' TRP . . . -54.08 -29.0 42.74 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.476 1.11 . . . . 65.25 109.255 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 5.6 m -81.14 -36.36 30.34 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.14 108.253 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.476 ' CA ' ' HB2' ' A' ' 264' ' ' ALA . 2.5 m -94.66 23.91 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 72.23 109.301 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -54.52 107.95 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 71.42 109.302 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.1 p -73.03 -3.18 24.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 75.51 110.383 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.6 t -44.99 -25.93 0.37 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 71.52 109.976 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . 0.449 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 52.4 t -94.72 -36.57 11.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 73.44 108.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.14 -128.13 1.63 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.466 1.104 . . . . 65.25 111.032 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.77 148.98 34.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 74.21 110.038 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.476 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -172.5 146.32 1.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.501 1.126 . . . . 74.44 109.302 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.8 p -173.03 156.98 3.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 74.52 109.988 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.47 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.6 p -98.8 124.29 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.496 1.123 . . . . 74.13 109.263 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 39.1 t -86.31 -41.93 14.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 71.22 109.948 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.52 -174.13 4.8 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 50.35 110.007 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 9.5 p90 -170.89 155.7 4.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 73.22 111.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -163.11 173.21 13.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.01 109.319 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.477 ' C ' ' CG2' ' A' ' 272' ' ' THR . 0.8 OUTLIER -146.5 160.72 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 70.14 109.27 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.477 ' CG2' ' C ' ' A' ' 271' ' ' ASN . 6.7 p -151.67 -173.5 4.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.469 1.106 . . . . 74.44 110.415 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.462 ' CB ' HG21 ' A' ' 276' ' ' VAL . . . -67.72 148.95 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 65.52 109.315 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -58.87 -44.55 95.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.516 1.135 . . . . 61.41 111.023 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.434 ' OD1' ' NH1' ' A' ' 185' ' ' ARG . 16.4 m-80 -52.92 -39.6 62.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 0.749 . . . . 44.32 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.462 HG21 ' CB ' ' A' ' 273' ' ' ALA . 21.5 t -47.98 118.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.537 1.148 . . . . 74.3 109.303 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.6 t80 -73.32 -49.43 27.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 72.45 111.043 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 39.5 t80 -148.81 160.32 43.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 64.42 110.99 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.568 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 58.3 ttt-85 -130.34 146.83 51.97 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 75.13 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.42 157.59 40.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 73.11 109.983 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 -0.57 10.13 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 71.51 110.94 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 13.6 m -98.09 5.12 48.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.137 . . . . 71.42 110.004 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 78.27 35.96 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 65.01 109.235 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -117.52 119.32 34.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 1.131 . . . . 63.31 110.004 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -101.56 157.69 16.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.118 . . . . 73.51 111.005 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.44 174.85 6.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 73.43 109.273 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -157.43 115.05 3.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 74.23 111.015 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.446 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.5 t0 -115.37 96.6 5.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 73.21 109.284 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.72 -31.04 22.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 73.21 109.262 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.456 ' CB ' HG12 ' A' ' 292' ' ' ILE . 5.1 m120 -95.01 5.62 51.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 74.41 109.345 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.699 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.3 46.82 2.04 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.5 1.125 . . . . 71.32 109.287 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.456 HG12 ' CB ' ' A' ' 290' ' ' ASN . 26.2 mm -74.83 -33.24 30.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 71.33 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 277' ' ' TYR . 1.8 t-20 -92.73 -20.54 20.68 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.513 1.133 . . . . 71.23 109.27 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.442 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 3.2 m -86.13 -62.55 1.49 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 75.44 110.379 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 76.3 m-20 -56.66 -24.13 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.422 1.076 . . . . 73.31 109.28 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 39.4 t -78.91 -48.2 15.04 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.47 1.106 . . . . 73.22 108.272 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 8.2 t -57.61 -28.06 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 72.2 109.314 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.5 mt -80.05 -59.81 2.58 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.559 1.162 . . . . 73.34 109.29 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -54.01 -19.3 4.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.549 1.156 . . . . 63.2 110.419 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.418 ' NZ ' ' O ' ' A' ' 314' ' ' ASP . 19.4 mmmt -72.14 -44.04 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 75.21 109.266 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.563 ' CD1' HD13 ' A' ' 304' ' ' LEU . 3.6 m-30 -99.67 37.39 1.61 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 71.31 111.05 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.2 t -68.98 -43.09 75.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.095 . . . . 72.52 109.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.501 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -96.35 -17.21 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.112 . . . . 74.21 109.333 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.567 HD13 ' CE2' ' A' ' 172' ' ' TYR . 13.7 mt -57.77 149.19 22.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 74.24 109.324 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -163.94 156.13 17.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.465 1.103 . . . . 71.31 110.017 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.1 -152.99 46.16 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.52 1.138 . . . . 73.13 110.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 17.4 m -99.63 7.33 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.278 -1.008 . . . . 53.32 108.278 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.489 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.8 OUTLIER -125.04 150.67 67.35 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 72.43 110.036 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.3 Cg_endo -74.96 147.36 89.1 Favored 'Cis proline' 0 C--N 1.359 1.111 0 C-N-CA 121.019 -2.492 . . . . 62.11 111.001 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.6 OUTLIER -128.37 133.25 24.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 75.21 110.029 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.96 -168.94 6.89 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 121.024 -2.49 . . . . 75.01 111.028 -0.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.0 154.66 18.33 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 71.35 109.29 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.476 1.777 . . . . 71.21 110.981 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.418 ' O ' ' NZ ' ' A' ' 300' ' ' LYS . 21.7 m-20 -87.77 132.62 34.08 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 75.05 109.337 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.53 27.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.13 . . . . 74.44 109.289 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 318' ' ' CYS . 36.1 t -71.58 -37.07 71.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.477 1.111 . . . . 65.41 110.028 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.6 t -43.11 -27.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 75.35 110.004 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 316' ' ' SER . 3.2 m . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 60.31 108.268 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.292 -0.632 . . . . 73.13 109.292 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.555 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -149.33 110.54 4.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.09 . . . . 74.11 109.329 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -83.5 7.89 15.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.54 1.15 . . . . 74.42 110.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.5 t -150.4 145.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 73.14 109.316 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -96.98 143.28 25.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 75.1 109.314 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -33.38 4.63 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.509 1.794 . . . . 63.4 111.009 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.81 155.41 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 71.45 109.31 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -52.45 -35.72 20.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 74.22 109.311 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.42 -47.49 3.62 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.492 1.12 . . . . 70.55 109.29 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.525 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -71.59 -35.0 70.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 1.116 . . . . 64.22 110.378 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.517 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.5 OUTLIER -58.98 -56.97 15.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 74.12 109.317 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.507 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.3 m-80 -52.31 -31.8 34.74 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.528 1.143 . . . . 71.4 109.257 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -67.56 -56.66 8.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 73.53 110.046 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.459 ' CD1' HD13 ' A' ' 140' ' ' ILE . 92.4 mt -42.29 -41.97 2.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 71.52 109.312 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.474 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.69 -43.11 63.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 71.05 110.972 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -51.94 -34.17 40.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 75.02 109.274 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.497 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 65.0 mt-30 -76.17 -56.33 4.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 73.22 110.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.0 mt -50.27 -29.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 74.14 109.27 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -33.32 63.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 75.44 109.255 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.79 -18.2 59.0 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 75.34 109.31 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.401 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 11.2 mm100 -84.24 -15.47 46.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 73.41 110.274 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -38.7 122.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 71.22 109.982 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.19 130.45 34.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 70.41 108.316 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.95 -30.39 6.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.483 1.114 . . . . 74.32 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.402 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 35.0 p -67.37 161.58 24.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 0.762 . . . . 65.42 110.443 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.1 t -93.63 -0.72 56.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 73.2 109.986 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.9 m -116.84 5.63 13.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.108 . . . . 75.42 110.43 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.402 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -80.85 138.18 36.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.134 . . . . 72.41 109.284 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -164.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.571 1.169 . . . . 74.54 109.955 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.44 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 2.6 m -155.96 126.25 3.37 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.531 1.144 . . . . 74.21 110.023 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.04 141.15 70.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.005 -2.498 . . . . 72.31 110.991 0.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.5 p -72.69 -178.98 2.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 74.11 108.315 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.3 mp -99.16 134.25 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.12 . . . . 74.11 109.3 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.6 p -79.92 71.41 6.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.132 . . . . 73.3 110.402 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.569 ' CE1' ' HG2' ' A' ' 239' ' ' PRO . 30.5 m-85 -75.63 -0.53 20.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 70.02 111.03 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -109.37 8.04 25.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.107 . . . . 75.52 110.275 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.567 ' CE1' HG21 ' A' ' 174' ' ' VAL . 11.6 t80 -125.53 71.79 66.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.545 1.153 . . . . 65.5 110.99 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.442 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 110.13 3.06 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.447 1.761 . . . . 72.45 111.003 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.82 -69.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 73.25 109.341 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -133.77 -48.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 74.23 109.284 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.25 107.5 0.06 OUTLIER Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.488 1.118 . . . . 53.25 111.013 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.479 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 6.9 p -147.86 -48.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 72.53 108.317 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 26.1 p90 -69.98 -29.1 66.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.55 1.156 . . . . 74.55 110.978 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -69.27 -68.1 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.474 1.109 . . . . 72.24 109.328 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.533 ' NH2' ' CD1' ' A' ' 170' ' ' PHE . 0.2 OUTLIER -44.14 -47.26 9.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 61.35 110.3 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -41.41 -60.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 72.23 109.305 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -46.19 -38.03 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.538 1.149 . . . . 74.44 109.616 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.542 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 29.3 mmmt -67.34 -59.69 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.424 1.077 . . . . 73.23 109.296 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.443 ' CE ' HG12 ' A' ' 221' ' ' ILE . 8.4 mtm -39.36 -38.5 0.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.131 . . . . 72.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.47 77.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 74.4 110.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.542 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -51.2 -29.08 12.92 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 75.25 110.292 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.462 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 14.4 mm -81.28 -36.02 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.577 1.173 . . . . 74.3 109.321 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -63.13 -45.54 91.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 74.53 109.296 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 11.5 mtt -58.02 -43.61 86.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.506 1.129 . . . . 74.53 110.999 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -46.21 -52.97 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 70.04 109.311 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.497 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 23.8 t-20 -63.21 -35.47 80.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 75.32 109.342 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 110.88 50.99 0.62 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.464 1.102 . . . . 75.13 111.022 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.555 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 70.3 m-85 -151.04 136.37 17.7 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.531 0.783 . . . . 74.41 111.035 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.485 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -106.96 121.84 45.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 65.44 109.323 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.451 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 26.3 p -102.2 178.4 4.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.088 . . . . 65.13 108.296 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 222' ' ' LEU . 4.9 mp0 -120.23 172.75 7.56 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.494 1.121 . . . . 74.34 110.263 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -104.88 152.91 22.06 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 74.41 109.332 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -139.48 117.73 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.472 1.108 . . . . 64.41 110.273 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.8 m-85 -111.14 122.33 47.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.49 1.119 . . . . 74.24 111.021 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.515 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 13.3 p -118.74 150.38 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 74.33 109.302 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.2 m-85 -123.14 162.17 23.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.54 1.15 . . . . 64.22 111.001 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.2 -177.37 16.37 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.542 1.151 . . . . 75.4 111.04 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 263' ' ' SER . 57.6 t-20 -71.54 109.13 5.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 0.772 . . . . 64.11 109.329 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 218' ' ' HIS . 5.3 mt -112.82 95.09 5.23 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.095 . . . . 74.2 109.328 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.5 mttt -92.29 168.87 11.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 74.43 109.293 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' A' ' 213' ' ' VAL . . . -179.35 165.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 74.51 109.312 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.515 1.134 . . . . 71.13 110.05 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 108.269 -1.011 . . . . 64.24 108.269 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.451 HG21 ' CB ' ' A' ' 206' ' ' ALA . 1.4 m -113.79 134.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.145 . . . . 64.52 109.279 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -127.32 127.56 44.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 64.21 109.307 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -135.68 135.13 39.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 65.55 108.008 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 3.7 20.97 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.105 . . . . 75.04 109.993 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.484 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.7 p90 -177.91 128.1 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 72.13 111.035 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.504 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 31.7 t60 -115.04 159.13 21.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.545 1.153 . . . . 74.33 109.609 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.479 ' CG1' ' SG ' ' A' ' 177' ' ' CYS . 3.4 p -138.85 137.93 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.51 109.331 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.568 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -138.98 -157.25 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.579 1.174 . . . . 74.42 109.317 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.443 HG12 ' CE ' ' A' ' 184' ' ' MET . 18.3 pt -125.8 117.84 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.509 1.131 . . . . 72.13 109.276 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 196' ' ' GLU . 15.6 tp -81.8 110.04 16.74 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.492 1.12 . . . . 73.4 109.294 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.517 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -101.12 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 75.03 109.307 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.8 m -116.73 119.93 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 74.31 110.016 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.562 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 31.4 p90 -135.34 145.55 47.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 75.31 110.993 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -70.3 133.99 47.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.123 . . . . 73.13 109.334 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.36 -159.64 0.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.115 . . . . 73.42 109.323 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.44 51.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.23 109.316 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.9 m -114.58 -8.38 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 65.31 110.01 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.39 37.42 8.19 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.526 1.141 . . . . 60.44 110.981 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 138.09 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.468 0.746 . . . . 73.24 109.301 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.6 m -71.64 102.65 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 74.44 110.407 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.408 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.0 mm-40 -101.99 -172.65 2.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.454 1.096 . . . . 72.53 110.289 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -126.69 145.36 50.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.445 1.091 . . . . 71.32 109.326 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.562 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 5.6 tpt180 -145.66 160.48 41.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.145 . . . . 72.13 110.275 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.523 HG23 ' CD1' ' A' ' 252' ' ' TRP . 12.8 mm -116.53 119.94 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.24 109.285 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -101.38 45.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.105 . . . . 75.14 109.315 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.409 ' HB2' ' CG2' ' A' ' 236' ' ' ILE . 2.1 m-20 -101.17 112.67 65.35 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 62.34 109.274 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.569 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -74.97 -43.57 0.39 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.516 1.798 . . . . 75.52 111.015 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.1 OUTLIER -39.22 -29.9 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 73.1 109.983 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.447 HD11 ' CD1' ' A' ' 252' ' ' TRP . 13.6 mt -101.98 -52.98 3.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 73.34 109.3 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.57 ' CD1' HG12 ' A' ' 247' ' ' VAL . 93.1 m-85 -125.99 99.28 5.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 74.54 111.041 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -79.22 -30.46 43.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 74.24 109.968 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -55.52 -46.15 77.04 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 72.51 109.982 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.48 -170.42 41.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.493 1.12 . . . . 61.25 111.002 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.432 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.06 168.85 23.89 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 75.45 110.992 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.57 HG12 ' CD1' ' A' ' 242' ' ' PHE . 3.9 m -151.66 159.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 73.15 109.291 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.466 HG22 ' CZ ' ' A' ' 235' ' ' ARG . 43.0 p -60.7 139.21 57.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 71.25 110.399 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.438 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER -43.01 -28.1 0.24 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 74.15 109.299 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.428 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.4 m -73.61 -64.76 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 75.43 110.404 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.15 -27.43 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 54.35 109.31 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.568 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 13.0 t90 -62.57 -62.03 2.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 74.45 108.008 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.555 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.24 -42.26 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.503 1.127 . . . . 73.22 110.303 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.435 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 2.9 m-80 -55.8 -51.44 67.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 73.21 109.335 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.03 -20.36 16.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 64.15 109.311 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.58 -36.76 16.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 65.42 108.343 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 264' ' ' ALA . 3.5 m -92.45 20.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.482 1.114 . . . . 62.03 109.288 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -46.61 104.48 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 75.54 109.319 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -76.07 -3.97 38.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 71.43 110.406 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.8 t -49.95 -22.85 1.69 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 65.11 110.023 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 206' ' ' ALA . 30.7 m -90.87 -32.88 15.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 74.24 108.294 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.88 -113.78 0.57 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.484 1.115 . . . . 64.33 111.008 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -90.56 143.45 26.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.78 . . . . 75.13 110.032 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 257' ' ' VAL . . . -167.77 148.27 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.461 1.1 . . . . 60.42 109.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.72 156.58 3.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 63.21 109.982 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.515 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 5.9 p -104.39 113.96 42.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 73.31 109.288 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 4.6 t -68.15 -45.69 72.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 73.31 110.007 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.5 p -163.84 -174.22 3.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 73.15 110.017 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -165.82 155.66 12.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 73.41 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.3 165.23 37.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 74.03 109.302 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -128.29 160.67 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 74.2 109.258 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.434 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 19.1 p -153.96 176.94 11.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 74.01 110.395 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.76 158.32 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 70.03 109.324 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.4 -43.96 76.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.447 1.092 . . . . 53.22 110.993 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -54.87 -42.41 72.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.447 0.733 . . . . 75.22 109.312 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 69.8 t -43.61 101.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 75.54 109.285 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.415 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 7.2 t80 -60.07 -59.22 5.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.34 111.016 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -131.47 156.71 45.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 74.45 111.034 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.565 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 63.6 ttt-85 -126.71 147.45 49.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 71.23 110.275 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.2 m -118.2 158.02 47.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 70.02 110.068 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 0.17 9.21 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.459 1.768 . . . . 73.21 111.005 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 80.1 p -104.27 5.81 34.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 73.52 109.943 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 78.34 39.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 74.35 109.279 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -113.37 120.22 40.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 73.22 110.027 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -107.62 151.78 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 75.33 111.01 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.528 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 1.2 mm? -118.59 177.67 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 74.15 109.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 79.6 m-85 -160.29 115.22 2.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.523 1.139 . . . . 63.11 110.978 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.438 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 0.4 OUTLIER -115.49 97.03 5.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 74.2 109.303 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -85.82 -14.49 44.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 72.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.408 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.0 m-20 -110.75 0.87 17.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 74.43 109.306 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.695 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 42.69 49.58 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.125 . . . . 73.33 109.281 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 290' ' ' ASN . 18.2 mm -78.58 -27.55 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.445 1.09 . . . . 75.41 109.299 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.498 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.9 t-20 -94.18 -27.67 16.07 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.444 1.09 . . . . 62.32 109.286 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.452 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 21.9 m -82.19 -69.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 75.12 110.407 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 44.1 m-20 -47.86 -30.36 4.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 65.23 109.293 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 36.8 t -72.73 -58.41 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 72.42 108.318 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 9.4 t -43.95 -49.54 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 75.43 109.313 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.47 -59.97 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 64.21 109.31 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.35 -31.8 1.78 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.535 1.147 . . . . 61.14 110.411 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -70.13 -49.46 50.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.32 109.283 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.572 ' CE1' ' HD2' ' A' ' 313' ' ' PRO . 3.3 m-30 -91.77 31.39 1.22 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 75.11 110.982 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 26.2 t -63.38 -52.75 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 63.52 110.005 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.426 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.4 -10.41 58.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.432 1.083 . . . . 73.05 109.326 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 172' ' ' TYR . 19.1 mt -76.21 136.63 39.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 74.41 109.289 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.5 p -161.46 147.58 14.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 75.15 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 96.89 -160.14 21.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.498 1.124 . . . . 63.41 110.977 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.403 ' O ' ' OG ' ' A' ' 310' ' ' SER . 0.0 OUTLIER -97.6 25.42 5.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.345 -0.983 . . . . 64.4 108.345 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 93.1 p -156.84 148.62 17.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.1 . . . . 64.14 109.998 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.5 Cg_endo -74.98 145.74 84.76 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 121.007 -2.497 . . . . 73.21 111.024 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 70.0 m -132.21 135.17 26.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 65.3 109.985 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.0 -173.55 12.53 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 120.995 -2.502 . . . . 75.14 110.999 -0.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.89 151.78 31.13 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 53.04 109.295 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.572 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.508 1.794 . . . . 70.32 110.995 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -85.96 135.49 33.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 75.01 109.292 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.4 ' O ' ' SG ' ' A' ' 318' ' ' CYS . 26.8 m -127.77 24.68 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 75.25 109.29 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 35.8 t -54.11 -19.8 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.556 1.16 . . . . 71.41 110.043 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 35.4 p -53.89 -24.84 17.43 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.501 1.126 . . . . 73.35 109.989 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 315' ' ' VAL . 1.8 m . . . . . 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.145 . . . . 55.11 108.257 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.471 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 8.5 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.295 -0.632 . . . . 71.03 109.295 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.56 ' HB1' ' CD1' ' A' ' 193' ' ' TYR . . . -105.74 106.46 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.14 109.277 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -83.45 8.21 14.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.526 1.141 . . . . 74.22 109.946 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.53 145.2 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 73.51 109.264 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 1.1 mt -96.26 142.77 25.03 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 74.31 109.339 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.99 -32.48 5.36 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.551 1.816 . . . . 74.35 111.002 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.71 152.47 21.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 72.32 109.335 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.571 HG23 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -49.96 -35.45 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 74.23 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.5 -47.35 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 73.21 109.3 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.495 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.91 -34.72 69.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.512 1.133 . . . . 73.24 110.403 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.516 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.29 -56.98 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 73.34 109.304 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.519 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 48.9 m-80 -52.27 -32.03 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 72.41 109.307 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.6 -55.5 11.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 73.53 110.008 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.461 ' CD1' HD13 ' A' ' 140' ' ' ILE . 66.5 mt -42.06 -41.83 2.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 71.24 109.315 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.4 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.91 -45.44 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.113 . . . . 73.11 111.017 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -46.52 -38.37 9.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 75.12 109.277 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . 58.4 mt-30 -76.57 -55.38 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 75.02 110.29 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.419 ' N ' HG22 ' A' ' 187' ' ' ILE . 13.6 mt -50.56 -23.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.498 1.124 . . . . 74.44 109.293 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.61 42.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 75.23 109.297 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -58.44 -19.17 34.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 74.24 109.24 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -81.68 -24.64 36.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 61.53 110.324 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.522 ' HA ' ' CE2' ' A' ' 170' ' ' PHE . 23.3 m -41.42 117.35 0.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 55.15 109.982 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 2.4 m -45.27 130.62 8.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.118 . . . . 74.42 108.318 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.39 -24.89 5.51 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.587 1.179 . . . . 64.31 110.976 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.4 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 75.4 p -83.93 161.7 20.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 0.748 . . . . 62.33 110.388 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -93.56 0.76 56.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 63.5 109.959 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.1 m -117.02 3.48 12.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.123 . . . . 74.22 110.381 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.4 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -79.06 133.64 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 75.44 109.278 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.76 -173.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 62.32 109.984 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.3 p -152.39 126.64 4.49 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 74.4 110.001 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.24 49.19 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 121.063 -2.474 . . . . 64.31 110.992 0.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.2 p -73.01 -178.2 2.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 71.35 108.286 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 170' ' ' PHE . 4.3 mp -90.53 137.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 73.45 109.309 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.407 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 74.3 p -90.48 88.62 7.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 73.32 110.426 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.645 ' CE1' ' CG2' ' A' ' 168' ' ' ILE . 19.1 m-85 -88.36 -25.51 22.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 73.54 110.986 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.84 -2.05 28.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.138 . . . . 72.5 110.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.574 ' CE1' HG23 ' A' ' 174' ' ' VAL . 29.4 t80 -128.29 68.22 76.58 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.14 110.998 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.424 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.06 113.39 3.78 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.495 1.787 . . . . 74.11 110.977 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.574 HG23 ' CE1' ' A' ' 172' ' ' TYR . 10.9 t -152.17 -66.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 64.22 109.31 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -163.49 118.16 1.62 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.51 1.131 . . . . 74.13 109.283 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 147.3 48.03 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.516 1.135 . . . . 52.14 110.98 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 74.4 m -88.59 -19.75 25.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.261 -1.014 . . . . 74.13 108.261 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 29.2 p90 -72.55 -40.83 66.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.41 111.018 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.594 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -63.87 -64.63 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 73.33 109.314 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.468 ' NH2' ' CE1' ' A' ' 170' ' ' PHE . 0.2 OUTLIER -43.7 -47.51 7.78 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 74.14 110.288 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.425 ' N ' ' HD3' ' A' ' 180' ' ' ARG . . . -42.17 -55.72 3.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 75.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.692 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.33 -38.99 20.52 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.568 1.168 . . . . 75.21 109.597 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.636 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.8 mmmt -64.32 -61.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.465 1.103 . . . . 74.23 109.268 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.437 ' CE ' HG12 ' A' ' 221' ' ' ILE . 3.4 mtm -38.78 -34.06 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.52 1.138 . . . . 74.03 110.983 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.435 ' NH2' ' OD2' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -63.95 -50.3 69.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 75.25 110.251 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.636 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -52.87 -30.91 36.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.133 . . . . 74.31 110.311 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 153' ' ' ILE . 11.0 mm -82.2 -36.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 75.22 109.277 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.463 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -62.69 -41.8 99.3 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.521 1.138 . . . . 74.11 109.288 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 192' ' ' GLY . 21.8 mtp -63.73 -41.03 98.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 75.32 110.975 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -45.41 -53.28 8.91 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.4 109.341 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -66.02 -27.14 67.89 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.544 1.152 . . . . 64.32 109.279 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.72 55.4 0.74 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.531 1.144 . . . . 73.42 111.025 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.56 ' CD1' ' HB1' ' A' ' 137' ' ' ALA . 77.5 m-85 -154.94 143.63 20.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.571 0.806 . . . . 72.24 111.012 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.471 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.1 t70 -109.55 125.45 52.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 70.15 109.35 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.463 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 17.7 p -94.51 -179.41 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 72.11 108.296 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 171.86 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 74.44 110.294 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -105.72 163.38 12.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 72.25 109.269 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -158.11 117.54 3.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 75.03 110.328 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.9 m-85 -110.75 119.34 38.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.507 1.129 . . . . 75.32 111.013 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.47 ' CG2' HG22 ' A' ' 266' ' ' VAL . 9.9 p -115.08 142.32 28.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 73.02 109.321 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.8 m-85 -117.65 157.25 26.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.24 110.969 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.92 -175.03 16.51 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.536 1.148 . . . . 52.13 110.986 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 263' ' ' SER . 55.1 t-20 -74.39 110.98 9.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.514 0.773 . . . . 74.54 109.297 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.465 HD13 ' CB ' ' A' ' 218' ' ' HIS . 4.7 mt -115.56 94.54 4.74 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.132 . . . . 74.03 109.333 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.4 mttp -92.81 167.12 12.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 74.34 109.255 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.436 ' CB ' HG21 ' A' ' 213' ' ' VAL . . . -170.43 164.41 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 74.43 109.297 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 t . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.11 110.016 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.317 -0.994 . . . . 74.24 108.317 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.436 HG21 ' CB ' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -128.58 142.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 54.11 109.278 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.87 128.78 41.29 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.525 1.141 . . . . 64.33 109.303 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.429 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.0 OUTLIER -134.99 130.84 36.37 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.556 1.16 . . . . 73.51 107.99 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.3 p -76.46 -0.73 24.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.558 1.161 . . . . 75.35 109.966 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.5 p90 -173.72 133.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.125 . . . . 74.43 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 65.5 t60 -119.26 167.79 11.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 75.03 109.604 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.499 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 2.8 p -150.78 136.22 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.126 . . . . 74.51 109.287 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.49 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -135.87 -156.72 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 65.44 109.327 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.437 HG12 ' CE ' ' A' ' 184' ' ' MET . 23.9 pt -123.07 118.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 74.05 109.273 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 11.0 tp -81.55 109.06 15.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 71.3 109.285 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.516 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -100.87 145.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 74.41 109.292 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 17.0 m -117.34 120.29 37.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.502 1.126 . . . . 73.13 110.027 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CD2' HG23 ' A' ' 143' ' ' VAL . 28.1 p90 -135.68 146.62 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.527 1.142 . . . . 75.3 110.974 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -71.52 131.52 43.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 75.05 109.266 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -72.61 -160.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 71.54 109.316 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.02 49.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 64.42 109.291 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.5 m -114.96 -7.81 12.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 61.14 109.993 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.93 37.85 8.26 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.485 1.115 . . . . 74.42 111.005 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.97 137.9 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.532 0.784 . . . . 63.54 109.269 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -72.21 102.63 3.12 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.553 1.158 . . . . 74.53 110.383 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -102.21 -172.78 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.21 110.295 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -126.93 144.78 50.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 73.54 109.32 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.483 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 3.5 tpt180 -145.56 162.07 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 70.12 110.283 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.555 HD13 ' CE3' ' A' ' 252' ' ' TRP . 26.3 mm -117.33 119.66 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 73.34 109.299 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 2.6 mm -101.23 47.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 73.31 109.309 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.501 ' OD1' ' CD1' ' A' ' 241' ' ' LEU . 27.2 p-10 -94.8 111.4 54.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.34 109.289 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -44.79 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 62.22 111.018 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.9 m -39.58 -39.16 0.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.546 1.153 . . . . 72.22 110.005 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.501 ' CD1' ' OD1' ' A' ' 238' ' ' ASP . 5.9 mt -92.93 -56.69 2.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 71.12 109.281 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.569 ' CD2' HG12 ' A' ' 247' ' ' VAL . 95.6 m-85 -121.12 99.5 6.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 73.53 111.001 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -26.01 34.96 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.453 1.096 . . . . 70.53 109.989 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 m -57.24 -45.82 83.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 74.33 109.971 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 179.42 -166.91 36.58 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.447 1.092 . . . . 75.02 111.004 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.437 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.04 164.0 34.14 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.504 1.792 . . . . 62.34 110.982 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.569 HG12 ' CD2' ' A' ' 242' ' ' PHE . 12.3 m -140.99 167.78 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 74.54 109.281 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.449 ' C ' ' N ' ' A' ' 250' ' ' THR . 24.2 p -70.38 136.18 49.44 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.484 1.115 . . . . 73.25 110.384 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 26.6 p-10 -39.86 -30.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 73.54 109.327 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.449 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -78.1 -61.43 2.0 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 74.03 110.409 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.91 -22.79 2.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.486 1.116 . . . . 70.35 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.555 ' CE3' HD13 ' A' ' 236' ' ' ILE . 7.4 t90 -68.68 -60.47 2.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.497 1.123 . . . . 75.45 107.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.513 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -51.29 -41.81 60.71 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 75.02 110.316 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.4 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.8 m-80 -54.66 -51.38 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 73.02 109.253 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.407 ' HB2' ' CE1' ' A' ' 242' ' ' PHE . . . -56.67 -24.45 48.84 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 75.12 109.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -83.97 -35.02 24.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 71.34 108.261 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.482 ' CA ' ' HB1' ' A' ' 264' ' ' ALA . 3.1 m -95.82 21.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.3 109.307 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 39.5 t-20 -51.94 107.88 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 72.53 109.317 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.0 p -73.36 -3.37 26.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 63.32 110.389 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.41 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 0.4 OUTLIER -44.73 -30.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 64.22 109.971 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 42.1 t -88.95 -36.88 15.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 64.45 108.304 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.48 -127.97 1.62 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.473 1.108 . . . . 74.3 110.938 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.56 147.31 37.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 0.778 . . . . 74.02 109.973 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.482 ' HB1' ' CA ' ' A' ' 257' ' ' VAL . . . -168.98 146.22 3.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 72.21 109.289 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -172.73 151.38 2.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.53 110.018 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.47 HG22 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.35 115.08 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.558 1.161 . . . . 72.14 109.28 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 31.7 t -70.11 -45.46 66.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 75.05 109.983 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 m -165.08 177.29 7.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.525 1.14 . . . . 72.21 110.029 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -158.21 156.44 30.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 75.2 110.999 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.34 33.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 73.04 109.282 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -119.14 160.61 21.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 71.4 109.278 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.453 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 2.0 p -154.98 178.89 9.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.524 1.14 . . . . 74.13 110.378 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 276' ' ' VAL . . . -62.67 158.76 17.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.527 1.142 . . . . 73.53 109.301 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.87 -39.25 55.29 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.481 1.113 . . . . 63.32 110.955 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -56.7 -48.06 78.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 0.776 . . . . 71.11 109.273 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.426 HG22 ' CB ' ' A' ' 273' ' ' ALA . 25.3 t -44.7 118.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 70.24 109.332 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -70.41 -53.49 16.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.531 1.144 . . . . 74.42 111.013 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 45.8 t80 -140.22 165.32 27.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 73.14 111.018 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.556 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 55.0 ttt-85 -137.01 147.39 46.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 73.21 110.278 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.6 157.92 44.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 71.35 109.97 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.19 9.2 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 74.33 111.0 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.0 t -97.83 3.92 49.8 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 73.41 110.034 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 77.13 41.37 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.42 109.273 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.8 t -123.07 119.52 30.57 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.461 1.101 . . . . 73.4 109.955 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.5 m-30 -99.92 160.22 14.48 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 73.11 110.957 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.482 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -120.45 177.59 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.468 1.105 . . . . 72.34 109.324 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 94.8 m-85 -160.61 115.57 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 74.0 110.992 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.18 96.11 5.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 74.53 109.241 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -85.57 -30.7 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 72.12 109.274 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.456 ' CB ' HG12 ' A' ' 292' ' ' ILE . 34.3 m-20 -98.3 7.91 45.56 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.139 . . . . 75.51 109.264 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.692 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 3.0 mm? 40.32 47.54 2.19 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.493 1.12 . . . . 71.11 109.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.456 HG12 ' CB ' ' A' ' 290' ' ' ASN . 45.4 mm -78.35 -25.07 13.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.558 1.161 . . . . 72.25 109.305 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.439 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.0 t-20 -94.64 -22.82 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 72.03 109.308 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.438 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.0 m -86.78 -68.97 0.71 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 74.15 110.383 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -50.86 -22.88 2.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.525 1.141 . . . . 75.02 109.333 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 20.5 t -79.03 -62.44 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 65.14 108.312 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 18.2 t -44.09 -43.15 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 71.35 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.42 -58.59 6.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 71.45 109.315 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -38.27 5.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 62.54 110.402 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -57.18 -56.2 24.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.21 109.309 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.5 OUTLIER -89.68 35.22 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 64.02 111.032 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 t -68.07 -49.07 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 75.22 109.962 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.505 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -88.24 -17.94 29.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.439 1.087 . . . . 73.04 109.274 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.467 ' CD2' ' HD2' ' A' ' 309' ' ' PRO . 17.9 mt -57.43 144.26 37.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 54.43 109.26 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.9 p -158.38 136.8 10.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 71.21 109.995 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 93.31 -155.23 22.17 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.519 1.137 . . . . 74.14 111.013 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.7 p -98.87 12.81 34.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.295 -1.002 . . . . 73.01 108.295 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.5 p -135.22 148.61 67.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 74.55 109.968 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.5 Cg_endo -74.95 146.36 86.46 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.023 -2.49 . . . . 74.23 110.998 -0.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.5 p -132.29 135.77 26.94 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 72.42 109.985 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.8 14.76 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.985 -2.506 . . . . 74.12 110.997 -0.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.46 155.91 18.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 74.04 109.291 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.487 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.37 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.5 1.789 . . . . 72.42 111.01 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.99 135.51 33.38 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 74.24 109.277 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 13.3 m -126.49 18.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 73.14 109.285 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.4 -33.06 58.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 72.02 110.013 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.1 p -43.12 -39.93 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.118 . . . . 72.4 110.02 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.467 1.104 . . . . 72.44 108.262 -179.932 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 5.2 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.287 -0.634 . . . . 74.24 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.559 ' HB1' ' CD1' ' A' ' 193' ' ' TYR . . . -149.82 107.76 3.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.543 1.152 . . . . 64.02 109.285 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -81.69 5.88 17.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.164 . . . . 72.33 110.031 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -145.87 148.76 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 63.22 109.331 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.46 HD11 ' CD1' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -100.82 143.72 27.13 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 73.43 109.276 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -74.99 -33.97 4.18 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.509 1.794 . . . . 73.4 110.985 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.82 150.6 22.85 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 74.1 109.314 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.55 HG21 ' CD2' ' A' ' 225' ' ' TYR . 1.8 t -48.83 -36.18 7.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.45 109.286 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.03 -48.55 3.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 74.22 109.302 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.526 HG23 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -70.01 -36.02 74.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.143 . . . . 74.42 110.364 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.529 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.4 OUTLIER -57.95 -57.09 14.32 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.158 . . . . 75.22 109.324 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.483 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.9 m-80 -52.95 -29.4 28.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 75.55 109.304 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.3 -55.57 8.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.515 1.134 . . . . 75.31 109.973 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.46 ' CD1' HD11 ' A' ' 140' ' ' ILE . 65.3 mt -42.2 -41.99 2.88 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.553 1.158 . . . . 75.45 109.259 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.82 -45.37 61.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 73.33 111.003 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -46.12 -35.37 4.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 73.32 109.315 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.449 ' NE2' ' OD1' ' A' ' 191' ' ' ASN . 65.3 mt-30 -77.42 -56.4 4.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 74.44 110.24 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.463 HG21 ' CB ' ' A' ' 184' ' ' MET . 17.3 mt -50.18 -26.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.458 1.099 . . . . 74.1 109.265 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -34.62 57.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 74.14 109.297 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.8 t-20 -61.6 -15.12 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.457 1.098 . . . . 75.24 109.292 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -85.68 -18.72 32.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.135 . . . . 74.52 110.323 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.474 ' HB2' ' CE2' ' A' ' 170' ' ' PHE . 23.7 p -38.68 137.97 0.57 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.553 1.158 . . . . 72.33 109.991 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -68.03 134.16 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 73.33 108.288 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.74 -19.05 19.17 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.469 1.105 . . . . 75.42 111.017 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.486 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 69.8 p -81.24 161.52 23.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.527 0.781 . . . . 74.12 110.414 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.0 p -93.52 -0.5 56.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.138 . . . . 71.52 110.032 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 17.8 m -117.84 6.67 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 63.23 110.368 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.486 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -83.17 138.14 33.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 73.44 109.311 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -164.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 74.04 110.016 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.438 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 14.2 t -156.04 127.47 3.72 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 62.21 109.995 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.03 137.28 49.44 Favored 'Cis proline' 0 C--N 1.361 1.189 0 C-N-CA 120.986 -2.506 . . . . 74.24 111.017 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.0 p -73.08 179.48 3.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 63.13 108.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.467 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.7 mp -88.95 128.94 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 64.43 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 23.8 p -91.14 85.65 5.96 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 64.2 110.41 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 157' ' ' SER . 47.9 p90 -86.34 -18.86 30.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 70.52 110.979 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.448 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.77 -1.78 23.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 75.33 110.273 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.556 ' CE2' HD12 ' A' ' 304' ' ' LEU . 24.8 t80 -129.03 68.29 79.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.44 1.087 . . . . 74.12 110.983 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.409 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 118.8 5.39 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.457 1.767 . . . . 75.34 110.963 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 172' ' ' TYR . 21.2 t -152.47 -74.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.116 . . . . 75.24 109.283 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.68 -43.15 2.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 74.34 109.32 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -43.02 126.66 5.01 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.486 1.117 . . . . 51.21 110.999 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.484 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 4.5 p -165.33 -49.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.266 -1.013 . . . . 74.23 108.266 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -70.08 -18.67 63.27 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 72.03 110.997 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.26 -68.26 0.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.515 1.135 . . . . 72.44 109.313 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.467 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 9.2 ptm180 -48.36 -49.81 33.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.476 1.11 . . . . 71.35 110.302 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.472 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.37 -64.88 0.43 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.118 . . . . 72.31 109.298 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.4 t60 -39.86 -45.03 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 74.41 109.607 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 186' ' ' GLN . 14.3 mmmt -62.3 -58.24 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 74.2 109.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.463 ' CB ' HG21 ' A' ' 153' ' ' ILE . 9.2 mtm -38.96 -36.13 0.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 72.15 110.981 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.409 ' CZ ' ' CE ' ' A' ' 189' ' ' MET . 0.1 OUTLIER -63.47 -48.99 75.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 64.55 110.314 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -53.1 -33.2 51.12 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.447 1.092 . . . . 72.33 110.278 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 153' ' ' ILE . 17.3 mm -75.79 -37.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.145 . . . . 74.0 109.26 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.45 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -61.28 -44.45 97.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.1 109.285 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.409 ' CE ' ' CZ ' ' A' ' 185' ' ' ARG . 3.2 mtt -56.41 -42.28 77.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 75.21 110.992 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -48.45 -52.66 21.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.46 1.1 . . . . 71.35 109.288 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.449 ' OD1' ' NE2' ' A' ' 152' ' ' GLN . 0.4 OUTLIER -62.28 -37.22 84.67 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 74.11 109.274 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.77 48.15 0.69 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.522 1.139 . . . . 75.11 110.971 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.559 ' CD1' ' HB1' ' A' ' 137' ' ' ALA . 61.6 m-85 -147.78 137.62 22.69 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 0.769 . . . . 74.31 111.001 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.466 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.3 t70 -103.17 129.26 50.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 75.44 109.293 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 26.8 p -108.15 -178.79 3.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 74.43 108.286 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.47 174.74 8.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 73.32 110.27 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.472 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 20.5 mmtt -109.73 167.08 10.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 71.14 109.279 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.463 ' O ' ' CG2' ' A' ' 219' ' ' VAL . 0.6 OUTLIER -153.45 144.87 23.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 74.01 110.271 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.527 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.1 m-85 -139.87 112.61 7.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.156 . . . . 75.24 110.992 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 7.4 p -106.68 143.21 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 74.12 109.278 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 6.4 m-85 -113.99 150.49 33.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.11 . . . . 73.43 110.97 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.17 19.53 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.465 1.103 . . . . 64.51 111.003 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 263' ' ' SER . 54.4 t-20 -77.65 111.46 13.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.54 0.788 . . . . 63.12 109.299 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.453 HD12 ' CB ' ' A' ' 218' ' ' HIS . 4.0 mt -114.09 95.97 5.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 74.12 109.251 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.0 mtpt -92.31 165.4 13.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 74.24 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.439 ' CB ' HG21 ' A' ' 213' ' ' VAL . . . -170.6 122.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 62.14 109.325 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.409 ' CB ' ' SG ' ' A' ' 261' ' ' CYS . 3.3 p . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.134 . . . . 72.33 110.017 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.354 -0.98 . . . . 74.41 108.354 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.439 HG21 ' CB ' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -117.56 142.24 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 64.13 109.318 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.31 127.82 28.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 64.42 109.364 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.464 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.6 OUTLIER -132.66 132.9 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 74.23 108.009 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 30.5 t -76.5 -0.76 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.149 . . . . 61.53 109.971 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -176.4 133.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 74.13 111.022 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 32.4 t60 -117.48 168.9 9.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.095 . . . . 72.1 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.507 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 2.8 p -147.75 142.02 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.46 1.1 . . . . 61.24 109.259 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.16 -167.27 2.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 74.14 109.278 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 19.9 pt -115.92 121.95 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 75.42 109.311 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 18.2 tp -84.49 115.55 22.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.463 1.102 . . . . 74.25 109.298 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.529 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -109.07 145.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.487 1.117 . . . . 73.24 109.303 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 140' ' ' ILE . 69.5 m -115.73 121.71 43.32 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 74.53 109.953 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.57 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.3 p90 -136.66 143.32 43.38 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 72.54 111.017 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.423 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.4 mmtp -69.23 132.51 46.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.451 1.094 . . . . 74.42 109.294 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.46 -160.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.34 109.332 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.21 50.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 62.01 109.329 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.6 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 75.35 110.009 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.39 8.16 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.538 1.149 . . . . 71.15 110.982 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.09 137.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 0.767 . . . . 74.51 109.281 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.423 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.5 m -71.91 102.66 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 60.44 110.43 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.8 mm-40 -103.12 -172.86 2.19 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 74.14 110.296 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -126.12 145.56 50.3 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 65.34 109.323 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.57 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 4.8 tpt180 -143.74 159.1 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 71.25 110.325 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.562 HG23 ' CD1' ' A' ' 252' ' ' TRP . 7.7 mm -111.63 124.89 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 72.44 109.331 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 2.8 mm -112.95 44.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 74.31 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.427 ' OD1' ' CG ' ' A' ' 241' ' ' LEU . 10.8 p-10 -94.12 111.67 54.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 51.23 109.322 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -36.33 2.66 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.506 1.793 . . . . 74.34 110.994 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 1.3 p -43.16 -36.47 1.72 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.456 1.097 . . . . 73.31 109.98 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.427 ' CG ' ' OD1' ' A' ' 238' ' ' ASP . 16.5 mt -102.56 -59.52 1.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 72.33 109.284 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.576 ' CD2' HG11 ' A' ' 247' ' ' VAL . 89.6 m-85 -111.3 98.99 7.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 73.13 111.07 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.6 m -91.02 -13.13 33.85 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 71.03 109.985 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 p -74.73 -46.54 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.098 . . . . 72.5 110.001 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -172.0 -179.52 42.98 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.501 1.126 . . . . 73.32 111.005 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.433 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.98 169.29 22.96 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.485 1.782 . . . . 73.51 110.978 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 242' ' ' PHE . 5.0 m -153.13 157.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.121 . . . . 75.33 109.289 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.434 ' C ' ' N ' ' A' ' 250' ' ' THR . 46.7 p -59.28 136.56 58.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 74.4 110.447 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 248' ' ' THR . 1.7 p-10 -40.33 -30.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 74.42 109.316 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.434 ' N ' ' C ' ' A' ' 248' ' ' THR . 3.7 m -70.06 -65.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 73.11 110.365 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.58 -38.4 14.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 71.43 109.31 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 19.4 t90 -54.25 -63.55 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 74.31 108.0 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.571 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -46.49 -45.78 18.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 72.34 110.327 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -53.14 -51.68 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.499 1.124 . . . . 73.0 109.285 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.417 ' CB ' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.78 -21.85 31.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 73.41 109.328 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -84.57 -38.19 20.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 72.2 108.34 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 264' ' ' ALA . 3.3 m -91.19 18.56 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 70.31 109.285 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 260' ' ' SER . 6.8 t30 -40.51 104.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 73.41 109.329 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.8 p -79.89 -4.04 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.461 1.101 . . . . 74.34 110.387 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 258' ' ' ASN . 5.2 t -58.7 -16.13 15.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 71.23 110.033 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 1.3 m -98.76 -20.34 16.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.447 1.092 . . . . 75.25 108.301 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 152.37 -125.88 1.91 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.512 1.132 . . . . 73.32 110.944 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -84.54 144.56 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 75.32 109.993 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 257' ' ' VAL . . . -170.51 146.2 2.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 71.5 109.3 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.26 152.45 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.45 1.094 . . . . 74.14 109.997 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 2.4 p -97.23 111.84 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 75.41 109.303 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.4 t -69.0 -46.95 66.72 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 65.01 110.007 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 200' ' ' VAL . 5.0 m -158.71 -175.04 5.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 71.45 110.013 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -166.5 157.25 12.48 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 74.33 110.977 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -160.34 153.24 21.39 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.55 109.325 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -110.84 160.69 16.52 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.442 1.089 . . . . 74.42 109.325 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.42 177.64 9.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 70.34 110.402 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.29 171.41 3.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 75.05 109.292 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -84.95 -4.53 86.99 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.553 1.158 . . . . 71.54 110.951 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 -44.5 7.73 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.499 0.764 . . . . 73.31 109.326 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' ' 285' ' ' TYR . 87.7 t -43.64 101.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 64.03 109.28 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.448 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 57.4 t80 -62.32 -39.23 92.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.547 1.154 . . . . 75.14 110.979 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -149.48 150.54 32.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 63.43 110.984 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.527 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 74.1 ttt-85 -116.05 147.59 41.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.52 110.288 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 153.4 47.29 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.126 . . . . 74.11 109.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 0.06 9.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.487 1.783 . . . . 71.22 110.999 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 1.7 p -104.12 4.58 34.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 53.34 109.989 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 81.2 41.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 63.2 109.324 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.9 t -121.51 128.72 52.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 75.12 110.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.433 ' CD2' HG21 ' A' ' 276' ' ' VAL . 15.4 m-30 -110.04 155.87 21.27 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.128 . . . . 74.44 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.23 176.95 4.86 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 73.34 109.315 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 95.7 m-85 -162.67 115.62 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 74.15 110.943 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.3 94.97 4.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 71.1 109.315 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -83.19 -39.13 21.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 74.32 109.313 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.465 ' CB ' HG12 ' A' ' 292' ' ' ILE . 28.5 m-20 -90.64 9.95 27.66 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 74.12 109.296 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.517 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.11 46.3 1.83 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.546 1.154 . . . . 73.0 109.304 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.465 HG12 ' CB ' ' A' ' 290' ' ' ASN . 46.3 mm -77.15 -33.95 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 75.44 109.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.488 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.5 t-20 -94.7 -15.25 24.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 74.33 109.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.448 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 24.1 m -87.66 -65.49 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 72.41 110.404 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.415 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 63.3 m-20 -57.95 -22.78 50.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 74.03 109.3 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 12.5 t -75.91 -65.67 0.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 61.24 108.308 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 41.6 t -40.27 -40.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 74.45 109.271 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.93 -57.72 5.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 70.34 109.261 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -56.19 -17.85 8.54 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.488 1.118 . . . . 71.13 110.398 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -76.93 -42.94 37.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 75.1 109.329 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.516 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 1.8 m-30 -105.75 40.33 1.59 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 62.42 111.002 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -67.71 -55.79 11.8 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.542 1.151 . . . . 74.21 110.015 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -81.12 -18.32 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.119 . . . . 73.45 109.299 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.556 HD12 ' CE2' ' A' ' 172' ' ' TYR . 13.5 mt -55.78 134.03 51.4 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.492 1.12 . . . . 74.03 109.274 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 74.5 p -148.61 154.33 39.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 74.42 110.007 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.28 -146.41 29.04 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.463 1.102 . . . . 73.1 110.997 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 12.5 m -108.93 12.99 25.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.301 -0.999 . . . . 64.54 108.301 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.9 OUTLIER -129.8 149.24 72.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 62.34 109.988 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -75.01 147.14 88.55 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.008 -2.497 . . . . 74.55 110.994 0.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.485 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.0 OUTLIER -129.07 133.64 25.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 73.41 110.007 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.04 -169.52 7.44 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.978 -2.509 . . . . 72.41 110.942 0.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.9 151.76 31.33 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.44 1.088 . . . . 74.33 109.295 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.494 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.491 1.785 . . . . 73.33 110.95 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.75 135.01 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 50.14 109.262 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 19.7 m -123.57 24.3 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.137 . . . . 74.04 109.309 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' SER . . . . . 0.429 ' C ' ' N ' ' A' ' 318' ' ' CYS . 3.5 t -53.69 -42.12 67.62 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.093 . . . . 70.42 110.005 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 16.0 m -41.89 -28.26 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 64.14 110.066 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.429 ' N ' ' C ' ' A' ' 316' ' ' SER . 75.4 m . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.551 1.157 . . . . 75.13 108.333 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.301 -0.629 . . . . 73.41 109.301 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -166.73 112.26 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.477 1.111 . . . . 75.31 109.311 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.464 ' CA ' ' OD2' ' A' ' 194' ' ' ASP . 0.5 OUTLIER -83.41 4.03 29.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 70.12 109.974 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -150.4 151.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 71.44 109.286 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.466 HD13 ' CD1' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -104.85 145.0 29.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.43 109.296 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -35.18 3.33 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.493 1.786 . . . . 75.2 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.88 150.06 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 75.33 109.333 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.561 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -46.06 -37.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 72.32 109.291 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.23 -49.32 2.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 64.15 109.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.0 m -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.45 1.094 . . . . 74.13 110.421 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.468 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.78 -57.45 12.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 74.33 109.241 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.5 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.1 m-80 -52.95 -30.41 34.53 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.47 1.106 . . . . 64.02 109.337 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.74 -56.77 7.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.572 1.17 . . . . 60.32 110.038 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.466 ' CD1' HD13 ' A' ' 140' ' ' ILE . 79.2 mt -43.11 -43.03 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 75.42 109.31 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.432 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.69 -45.1 62.92 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 74.44 110.959 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -46.05 -36.92 6.13 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 1.11 . . . . 72.11 109.3 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 62.5 mt-30 -76.41 -55.79 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 74.44 110.284 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.452 ' CD1' HD12 ' A' ' 188' ' ' LEU . 19.9 mt -49.46 -27.46 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 63.2 109.296 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -37.34 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.503 1.127 . . . . 71.45 109.306 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -56.21 -19.33 13.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 73.11 109.324 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' A' ' 156' ' ' GLN . 12.0 mm-40 -80.82 -28.01 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.454 1.096 . . . . 73.53 110.292 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.5 m -39.85 123.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 70.51 109.998 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.1 m -53.24 116.22 2.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.482 1.114 . . . . 73.42 108.303 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 142.03 -14.06 2.6 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.484 1.115 . . . . 75.32 111.011 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.0 p -97.71 161.86 13.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 0.75 . . . . 72.4 110.404 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -93.4 -2.35 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 73.55 109.967 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.2 m -112.03 0.1 15.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 75.43 110.397 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.57 134.09 40.79 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.51 1.131 . . . . 75.11 109.285 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -169.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.55 1.157 . . . . 73.2 110.029 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.456 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 44.0 p -154.75 127.53 4.11 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 64.32 110.026 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.08 137.14 48.56 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 121.019 -2.492 . . . . 71.41 110.981 0.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 9.5 p -72.95 -178.91 2.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 71.51 108.278 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.0 mp -84.5 128.16 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 75.11 109.308 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 p -92.54 76.27 5.08 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.562 1.164 . . . . 73.31 110.399 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -78.76 -14.17 59.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 73.34 110.979 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.46 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -73.74 -3.03 25.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 74.41 110.296 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.558 ' CE2' HD11 ' A' ' 304' ' ' LEU . 24.9 t80 -131.84 66.7 78.43 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 75.44 111.018 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.411 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.2 Cg_endo -74.98 118.46 5.28 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.518 1.799 . . . . 73.22 111.015 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 172' ' ' TYR . 19.0 t -152.84 -64.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 54.1 109.326 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.402 ' O ' ' SG ' ' A' ' 177' ' ' CYS . 2.2 t70 -132.3 -46.68 0.91 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 62.31 109.273 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -45.43 104.15 0.06 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.472 1.107 . . . . 62.25 110.996 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.493 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 3.5 p -138.65 -48.43 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.243 -1.021 . . . . 65.33 108.243 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -68.5 -16.22 63.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 74.45 110.985 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.93 -68.31 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 62.04 109.318 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.475 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 7.2 ptm180 -50.92 -49.03 60.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.12 . . . . 75.44 110.297 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.46 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.58 -56.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 73.3 109.292 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.549 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -47.1 -44.56 21.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.117 . . . . 74.14 109.601 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 180' ' ' ARG . 22.9 mmmt -64.36 -42.25 96.3 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 74.34 109.328 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.453 ' CE ' ' HA ' ' A' ' 181' ' ' ALA . 17.4 mtm -55.5 -33.2 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 75.12 111.003 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -21.33 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 73.44 110.319 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.73 -39.66 69.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.509 1.131 . . . . 74.22 110.304 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 19.0 mm -74.14 -32.48 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 73.11 109.294 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.452 HD12 ' CD1' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -61.65 -44.46 96.94 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.454 1.096 . . . . 74.54 109.324 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.6 mtp -58.51 -42.18 87.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 72.24 111.006 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -50.38 -53.53 28.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.461 1.1 . . . . 64.12 109.303 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.426 ' ND2' HE22 ' A' ' 152' ' ' GLN . 7.1 t-20 -60.55 -29.55 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 73.01 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.71 37.33 2.6 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.517 1.136 . . . . 74.34 110.99 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 73.7 m-85 -138.04 129.05 27.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 0.791 . . . . 73.14 110.988 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.464 ' OD2' ' CA ' ' A' ' 138' ' ' SER . 0.7 OUTLIER -99.27 132.51 44.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 52.04 109.293 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.446 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 25.9 p -112.17 -179.45 3.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 72.25 108.258 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.45 176.02 6.13 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.126 . . . . 62.33 110.285 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.46 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 22.0 mmtt -107.67 174.41 5.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 55.11 109.317 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -160.59 139.17 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.541 1.151 . . . . 75.02 110.263 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.562 ' CE1' HG23 ' A' ' 219' ' ' VAL . 4.1 m-85 -130.27 113.49 14.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 75.14 110.994 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 7.2 p -110.15 148.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 74.23 109.32 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.1 m-85 -121.6 160.44 24.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.478 1.111 . . . . 74.34 111.0 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.44 179.88 17.01 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.551 1.157 . . . . 64.25 111.015 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 263' ' ' SER . 59.3 t-20 -69.23 110.27 4.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.491 0.759 . . . . 62.53 109.324 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 218' ' ' HIS . 5.9 mt -114.56 93.49 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 75.45 109.296 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.8 mttp -93.27 165.35 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 74.13 109.303 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -168.53 143.07 3.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 65.12 109.318 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 62.43 110.015 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 108.329 -0.989 . . . . 62.52 108.329 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.36 155.53 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 72.32 109.247 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.4 119.07 13.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 74.31 109.282 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.33 134.79 51.01 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.155 . . . . 75.15 108.02 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.1 m -80.45 3.78 20.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.458 1.099 . . . . 72.22 109.994 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.8 p90 -176.14 127.75 0.21 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.477 1.111 . . . . 64.11 111.027 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -116.54 168.45 10.16 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.478 1.111 . . . . 64.32 109.619 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.562 HG23 ' CE1' ' A' ' 199' ' ' PHE . 1.3 p -145.57 143.38 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.49 1.119 . . . . 74.32 109.312 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.563 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -142.19 -165.68 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 65.43 109.294 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.463 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 31.1 pt -116.09 122.5 69.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 73.2 109.296 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 19.9 tp -87.1 108.87 19.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 74.0 109.312 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.468 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -102.0 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 71.02 109.3 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ILE . 54.8 m -135.75 120.14 17.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.494 1.121 . . . . 64.52 109.993 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.561 ' CD2' HG23 ' A' ' 143' ' ' VAL . 34.3 p90 -136.15 142.37 44.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 74.42 111.03 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.2 mmtp -68.21 132.84 47.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.504 1.128 . . . . 75.35 109.286 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -73.73 -160.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 73.42 109.321 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 0.09 48.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.481 1.113 . . . . 74.25 109.312 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -115.36 -7.19 12.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 73.33 110.02 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.54 37.66 8.67 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.473 1.108 . . . . 72.51 110.975 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 137.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.455 0.738 . . . . 74.43 109.323 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 8.6 m -71.47 102.58 2.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.05 110.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.414 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 1.8 mm-40 -101.39 -172.47 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 74.31 110.297 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -127.52 145.3 50.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 75.5 109.286 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.495 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 4.3 tpt180 -142.68 161.14 38.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 74.55 110.284 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.564 HD11 ' CE3' ' A' ' 252' ' ' TRP . 15.4 mm -113.7 117.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.52 1.138 . . . . 73.31 109.318 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -105.08 45.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 73.24 109.314 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.9 106.54 53.31 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 62.11 109.309 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -10.02 21.01 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 74.41 111.003 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.7 t -64.5 -11.85 38.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 74.3 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.408 HD12 ' NE2' ' A' ' 218' ' ' HIS . 5.2 mt -127.55 -48.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 74.13 109.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 255' ' ' ALA . 75.9 m-85 -118.54 99.54 6.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.576 1.172 . . . . 74.2 111.017 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 75.6 m -88.14 -6.44 57.88 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.547 1.154 . . . . 74.33 109.982 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.1 m -80.95 -45.77 16.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 75.3 110.012 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.05 -174.23 43.29 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.495 1.122 . . . . 54.4 110.987 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.45 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 164.42 33.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.485 1.781 . . . . 73.23 111.021 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.552 HG12 ' CD1' ' A' ' 242' ' ' PHE . 2.6 m -150.46 161.23 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.113 . . . . 74.12 109.32 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.3 p -64.51 138.21 58.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.523 1.139 . . . . 71.41 110.41 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.425 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 0.4 OUTLIER -40.92 -29.79 0.11 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.51 1.131 . . . . 73.52 109.307 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 6.3 m -71.85 -64.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 72.13 110.384 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.37 -25.55 10.08 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.504 1.127 . . . . 74.23 109.314 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.564 ' CE3' HD11 ' A' ' 236' ' ' ILE . 9.2 t90 -64.36 -59.91 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.995 -1.113 . . . . 72.23 107.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.544 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.26 -41.9 39.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 73.34 110.281 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.448 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 2.9 m-80 -56.56 -50.75 70.97 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.499 1.124 . . . . 74.5 109.275 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.574 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . . . -55.94 -20.99 18.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 51.54 109.32 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.16 -36.2 16.97 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 72.32 108.262 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.47 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.5 m -93.36 21.59 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 74.44 109.271 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -51.06 107.1 0.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 75.14 109.329 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.2 p -73.49 -3.06 25.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 71.32 110.385 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.3 t -44.3 -30.84 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.505 1.128 . . . . 63.53 109.97 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.59 -37.35 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 71.55 108.347 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.72 -128.06 1.66 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.546 1.154 . . . . 73.22 110.993 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.02 145.35 42.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.477 0.751 . . . . 71.32 109.983 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -168.02 148.03 4.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.46 1.1 . . . . 62.02 109.314 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 29.3 m -172.77 155.23 3.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 72.25 110.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 4.9 p -102.65 116.54 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.467 1.104 . . . . 60.23 109.283 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 32.0 t -70.76 -44.89 65.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.505 1.128 . . . . 71.0 109.951 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 50.7 p -165.43 -173.52 2.83 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.151 . . . . 74.23 110.006 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -165.4 156.53 14.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 74.32 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.04 147.84 23.05 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.53 1.144 . . . . 75.12 109.286 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.63 158.93 15.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 70.12 109.31 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 1.3 p -146.44 179.14 7.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.517 1.135 . . . . 72.32 110.386 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -74.57 163.36 27.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 73.21 109.324 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.47 -16.41 80.01 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.492 1.12 . . . . 74.22 111.008 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 276' ' ' VAL . 7.5 p30 -86.29 -43.61 12.78 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 0.782 . . . . 63.42 109.342 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.498 HG23 ' CD1' ' A' ' 285' ' ' TYR . 3.8 t -43.71 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.571 1.169 . . . . 73.24 109.285 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -66.95 -42.8 84.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 75.31 111.022 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 278' ' ' TYR . 0.6 OUTLIER -153.21 121.02 6.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 73.44 111.029 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.469 ' HD2' ' CG2' ' A' ' 272' ' ' THR . 40.8 ttt-85 -106.57 137.19 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.515 1.134 . . . . 75.12 110.334 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.92 158.17 32.62 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 73.04 110.007 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.47 8.88 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.467 1.772 . . . . 74.52 110.974 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 27.9 t -98.18 13.19 32.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.542 1.152 . . . . 73.34 109.99 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 74.87 37.19 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 62.14 109.338 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -112.3 152.94 27.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 75.51 109.951 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.498 ' CD1' HG23 ' A' ' 276' ' ' VAL . 51.9 m-85 -140.54 158.2 44.35 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 73.11 111.022 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -126.08 172.95 9.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.498 1.123 . . . . 74.3 109.281 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.473 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 88.1 m-85 -160.23 114.95 2.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 1.099 . . . . 75.33 111.001 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.428 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 8.0 t0 -115.5 97.04 5.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 64.14 109.273 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -85.83 -39.42 17.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 70.53 109.298 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.476 ' CB ' HG12 ' A' ' 292' ' ' ILE . 4.3 m120 -90.52 9.54 28.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 72.51 109.325 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.549 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.06 46.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 1.125 . . . . 71.33 109.305 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.476 HG12 ' CB ' ' A' ' 290' ' ' ASN . 48.9 mm -77.28 -28.77 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 74.32 109.298 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.489 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.7 t-20 -94.54 -22.53 18.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.42 109.312 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 m -84.52 -64.18 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.478 1.111 . . . . 74.34 110.395 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 82.5 m-20 -57.47 -17.94 15.97 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.119 . . . . 74.02 109.308 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 7.2 t -81.88 -63.95 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 75.03 108.303 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 301' ' ' PHE . 46.2 t -40.38 -51.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.545 1.153 . . . . 75.44 109.27 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 301' ' ' PHE . 47.0 mt -57.14 -59.48 5.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 64.31 109.296 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.22 -34.71 2.92 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.14 110.378 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -68.06 -43.31 78.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.54 109.259 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 1.5 m-30 -99.5 35.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 73.25 111.006 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.2 t -69.41 -43.36 73.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 71.51 110.029 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.45 -12.78 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.43 109.315 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.558 HD11 ' CE2' ' A' ' 172' ' ' TYR . 12.6 mt -60.39 150.28 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 74.21 109.295 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.6 p -161.48 162.92 30.61 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 73.05 109.984 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.68 -152.82 52.78 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.519 1.137 . . . . 74.04 111.018 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 2.1 m -101.64 13.12 35.88 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.292 -1.003 . . . . 64.45 108.292 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.488 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 12.9 p -129.49 150.01 74.45 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 74.13 110.009 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.6 Cg_endo -74.95 147.12 88.51 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.967 -2.514 . . . . 75.54 111.056 -0.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.468 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -128.71 133.69 25.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.531 1.145 . . . . 74.11 109.992 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -74.96 -170.27 8.1 Favored 'Cis proline' 0 C--N 1.36 1.168 0 C-N-CA 120.97 -2.512 . . . . 74.54 111.033 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 152.34 29.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 72.23 109.29 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.413 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.512 1.796 . . . . 73.44 110.996 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -91.4 135.31 33.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.148 . . . . 71.22 109.254 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.7 m -126.59 24.5 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.489 1.118 . . . . 73.13 109.276 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 318' ' ' CYS . 35.6 t -50.73 -44.12 58.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.35 109.952 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.6 m -39.51 -29.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 71.54 110.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 316' ' ' SER . 74.6 m . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.434 1.084 . . . . 64.03 108.304 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.477 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.327 -0.62 . . . . 75.21 109.327 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.568 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -149.04 106.7 3.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.533 1.145 . . . . 62.13 109.327 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m -81.82 5.65 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.33 109.99 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' ' 140' ' ' ILE . 2.3 t -149.35 145.62 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 70.14 109.302 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 1.2 mt -96.88 142.44 24.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.488 1.117 . . . . 62.55 109.27 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -32.44 5.42 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.464 1.77 . . . . 63.11 110.99 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.485 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.49 153.22 22.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.105 . . . . 73.13 109.3 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 225' ' ' TYR . 1.8 t -51.08 -34.31 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.158 . . . . 74.11 109.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.84 -45.86 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 74.05 109.32 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.505 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.6 m -73.21 -32.38 64.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 65.45 110.415 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.47 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.5 OUTLIER -61.84 -56.23 21.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 73.32 109.295 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.512 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 51.6 m-80 -53.62 -31.37 46.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 71.04 109.288 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.39 -55.22 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 73.32 109.987 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' A' ' 140' ' ' ILE . 92.1 mt -44.4 -42.41 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 74.34 109.302 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.463 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.1 t80 -72.35 -44.7 62.22 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 1.117 . . . . 75.13 110.994 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -47.04 -37.32 9.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 75.34 109.262 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.465 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 60.0 mt-30 -74.94 -55.57 5.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 1.139 . . . . 70.24 110.293 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 184' ' ' MET . 23.4 mt -50.45 -28.0 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 54.03 109.308 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -75.07 -33.71 61.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 73.13 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.3 t-20 -61.59 -15.15 36.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 70.01 109.294 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.408 ' HA ' ' NE2' ' A' ' 156' ' ' GLN . 18.6 mm-40 -85.81 -18.47 32.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 74.01 110.302 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.0 p -37.93 134.51 0.75 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 1.13 . . . . 64.12 109.977 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.412 ' HB3' ' NH2' ' A' ' 171' ' ' ARG . 1.3 m -66.18 120.04 12.53 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 61.13 108.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 127.69 -15.82 6.26 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 73.42 110.99 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.492 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 69.6 p -83.39 161.9 21.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 0.758 . . . . 72.31 110.387 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -93.55 0.12 56.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.467 1.104 . . . . 74.5 109.963 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 m -119.45 7.15 11.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 71.33 110.355 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.492 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -81.31 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 62.25 109.308 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -162.03 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 73.25 110.014 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 126.92 3.5 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 74.42 110.039 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 139.85 64.05 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.948 -2.522 . . . . 74.41 110.998 0.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.99 178.46 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.1 . . . . 75.54 108.333 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.49 ' CD1' ' CB ' ' A' ' 183' ' ' LYS . 3.0 mp -86.32 132.95 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 70.21 109.268 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.424 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 51.0 p -90.43 75.24 6.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 60.44 110.403 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -81.64 -24.79 36.13 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 65.11 111.027 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.428 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.97 -1.57 26.28 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 73.45 110.3 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.569 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 25.6 t80 -128.91 67.44 77.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.092 . . . . 62.22 111.012 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.415 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.55 4.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.51 1.795 . . . . 73.3 111.013 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.56 HG22 ' CE1' ' A' ' 172' ' ' TYR . 14.6 t -152.23 -58.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 74.33 109.292 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -138.43 -47.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 63.34 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.19 106.46 0.05 OUTLIER Glycine 0 CA--C 1.529 0.938 0 O-C-N 124.526 1.141 . . . . 61.45 111.044 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.436 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 5.6 p -143.06 -48.41 0.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.307 -0.997 . . . . 72.3 108.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 24.3 p90 -69.99 -33.9 72.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.461 1.101 . . . . 74.13 111.062 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.492 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -62.57 -68.42 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 72.14 109.264 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 240' ' ' SER . 0.4 OUTLIER -46.38 -44.5 17.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 75.24 110.32 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.71 -55.47 5.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.466 1.104 . . . . 73.33 109.267 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.88 -35.83 15.66 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 72.34 109.635 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.49 ' CB ' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER -71.47 -50.55 30.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 75.42 109.286 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.468 ' HA ' ' CG2' ' A' ' 153' ' ' ILE . 5.3 mtm -51.84 -41.2 61.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 63.01 111.01 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.455 ' CZ ' ' HE1' ' A' ' 189' ' ' MET . 0.1 OUTLIER -74.96 -24.47 58.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 75.23 110.305 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.412 ' NE2' ' NZ ' ' A' ' 183' ' ' LYS . 0.7 OUTLIER -69.48 -41.56 75.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.515 1.135 . . . . 75.43 110.305 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 20.8 mm -72.02 -33.0 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.488 1.118 . . . . 74.43 109.274 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -59.56 -47.36 85.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 1.097 . . . . 75.22 109.332 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.455 ' HE1' ' CZ ' ' A' ' 185' ' ' ARG . 2.4 mtt -54.9 -44.35 74.05 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 73.15 111.001 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.0 -53.33 20.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 74.33 109.312 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.41 ' CB ' HD23 ' A' ' 149' ' ' LEU . 9.6 t-20 -58.46 -32.88 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 75.45 109.308 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 108.78 43.86 1.18 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.53 1.144 . . . . 62.31 110.973 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 68.6 m-85 -144.79 133.31 22.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.48 0.753 . . . . 73.32 111.03 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.477 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.5 OUTLIER -99.71 130.07 45.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 75.41 109.31 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.445 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 28.5 p -112.25 -179.44 3.68 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 1.153 . . . . 72.24 108.307 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -125.87 177.41 6.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 65.21 110.286 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -108.87 164.27 12.54 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 73.3 109.292 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -151.5 117.49 5.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.446 1.091 . . . . 73.41 110.277 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 219' ' ' VAL . 3.9 m-85 -108.65 129.74 55.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 64.22 111.056 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 6.3 p -128.49 131.63 68.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 74.42 109.289 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 6.4 m-85 -108.01 159.51 16.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.517 1.135 . . . . 71.23 111.053 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 123.48 -173.19 16.38 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.469 1.105 . . . . 73.14 110.978 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 263' ' ' SER . 58.5 t-20 -76.3 108.19 9.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 73.44 109.321 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 218' ' ' HIS . 4.4 mt -111.13 95.09 5.32 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.118 . . . . 72.24 109.305 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 256' ' ' CYS . 0.2 OUTLIER -92.21 158.35 16.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 73.54 109.294 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 213' ' ' VAL . . . -179.12 162.63 1.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.13 . . . . 73.32 109.318 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.32 110.013 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 108.294 -1.002 . . . . 65.53 108.294 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 206' ' ' ALA . 2.4 m -153.03 129.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.538 1.149 . . . . 72.52 109.3 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.403 ' HB1' ' NZ ' ' A' ' 205' ' ' LYS . . . -124.42 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.433 1.083 . . . . 74.11 109.279 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -132.33 134.87 45.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.988 -1.116 . . . . 75.13 107.988 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 23.8 t -77.36 0.18 23.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 64.01 110.063 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -178.15 136.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 74.22 110.978 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.463 ' HB3' ' CD1' ' A' ' 204' ' ' LEU . 77.6 t60 -129.5 143.31 50.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 74.44 109.61 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 199' ' ' PHE . 7.4 p -124.47 134.27 67.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.475 1.11 . . . . 73.11 109.284 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.35 -152.1 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 72.54 109.371 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.461 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 13.1 pt -128.72 123.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 73.35 109.29 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 15.7 tp -89.78 109.06 20.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 63.44 109.327 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.47 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.04 148.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 74.02 109.301 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.24 121.63 41.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 63.21 109.995 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.563 ' CD2' HG21 ' A' ' 143' ' ' VAL . 32.0 p90 -136.81 144.95 43.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 72.5 111.009 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.439 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.6 mmtp -70.07 133.78 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 75.24 109.322 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.46 -159.67 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 64.23 109.305 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.93 0.07 49.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 74.15 109.243 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.01 -8.59 12.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.133 . . . . 70.21 110.018 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.41 37.59 8.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.478 1.111 . . . . 73.22 111.039 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.54 138.21 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.49 0.759 . . . . 74.1 109.319 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.439 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 23.9 m -71.58 102.67 2.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.152 . . . . 74.32 110.408 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.412 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.0 mm-40 -101.69 -172.61 2.18 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 73.23 110.257 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -126.66 144.91 50.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 75.33 109.257 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.528 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 4.6 tpt180 -143.43 160.57 40.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 75.35 110.32 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.503 HD11 ' CE3' ' A' ' 252' ' ' TRP . 14.3 mm -116.6 119.15 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 63.42 109.313 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -103.37 44.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 75.22 109.284 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -101.26 108.5 55.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.487 1.117 . . . . 63.32 109.283 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -26.9 10.5 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.486 1.782 . . . . 74.54 110.966 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.3 OUTLIER -45.92 -25.46 0.54 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 73.03 110.002 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.1 mt -112.97 -60.71 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 73.33 109.333 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 255' ' ' ALA . 85.3 m-85 -106.5 99.58 9.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 74.24 110.969 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 52.8 m -85.67 -13.47 48.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 65.14 109.992 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.2 m -72.01 -47.85 48.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 72.25 109.944 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.75 -170.97 39.91 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.523 1.14 . . . . 64.42 111.0 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.448 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -74.99 163.84 34.57 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.495 1.787 . . . . 71.43 111.007 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.549 HG12 ' CD1' ' A' ' 242' ' ' PHE . 3.1 m -147.81 162.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 74.03 109.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.431 ' C ' ' N ' ' A' ' 250' ' ' THR . 31.1 p -63.49 139.22 58.75 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.49 1.119 . . . . 73.52 110.428 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 249' ' ' ASP . 0.2 OUTLIER -42.45 -28.56 0.22 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 75.0 109.317 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.431 ' N ' ' C ' ' A' ' 248' ' ' THR . 9.1 m -75.93 -62.57 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.127 . . . . 62.31 110.367 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.07 -28.23 6.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 74.13 109.311 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 220' ' ' ALA . 10.2 t90 -63.25 -63.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 71.53 107.989 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.562 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -46.5 -42.24 15.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 73.21 110.3 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -56.28 -51.29 68.71 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 63.42 109.325 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.69 -28.0 53.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.131 . . . . 73.44 109.276 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.2 m -80.14 -36.89 34.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 71.11 108.309 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.463 ' CG1' HG22 ' A' ' 266' ' ' VAL . 2.6 m -95.37 22.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.49 1.119 . . . . 64.42 109.299 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -50.7 104.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.11 . . . . 74.13 109.286 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -73.34 -4.22 32.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.507 1.129 . . . . 71.4 110.408 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.3 t -51.31 -21.69 2.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.474 1.109 . . . . 65.0 110.004 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . 0.429 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 5.0 m -96.51 -27.3 14.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.541 1.151 . . . . 73.43 108.297 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 156.51 -128.21 2.15 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.436 1.085 . . . . 74.1 111.025 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.449 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -78.54 141.24 38.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 0.753 . . . . 75.2 110.013 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.46 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -171.38 143.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 64.15 109.316 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.65 161.71 4.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.132 . . . . 71.42 109.962 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 257' ' ' VAL . 17.5 t -103.57 128.23 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 55.31 109.342 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.9 t -84.77 -39.44 18.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 75.12 109.991 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.6 m -175.0 144.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 74.1 109.976 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.435 ' CG ' ' NH1' ' A' ' 253' ' ' ARG . 44.5 p90 -130.48 160.13 35.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.42 1.075 . . . . 64.41 111.022 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.96 160.45 41.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.496 1.123 . . . . 74.44 109.341 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.42 ' C ' ' CG2' ' A' ' 272' ' ' THR . 1.2 p-10 -122.7 158.04 30.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.557 1.161 . . . . 71.44 109.283 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.42 ' CG2' ' C ' ' A' ' 271' ' ' ASN . 56.0 p -151.95 175.46 12.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 75.2 110.379 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.36 161.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 70.25 109.373 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.21 -45.38 40.07 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.473 1.108 . . . . 60.31 110.983 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.51 -37.43 49.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 0.768 . . . . 52.32 109.286 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 43.1 t -45.86 118.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.555 1.159 . . . . 75.41 109.277 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -81.34 -52.09 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 72.42 110.995 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -135.89 160.08 39.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.14 . . . . 75.24 111.019 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.514 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.8 ttt-85 -131.11 147.48 52.62 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.437 1.085 . . . . 71.51 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.92 157.45 52.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.1 . . . . 61.34 110.0 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 0.31 9.04 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.482 1.78 . . . . 65.51 111.008 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 11.3 t -99.55 6.21 45.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 73.24 110.018 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.4 t-20 76.21 34.67 0.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 74.24 109.271 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -116.49 123.56 47.76 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 63.54 110.001 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -104.91 157.6 17.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.2 110.987 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.599 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -116.55 171.38 7.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.107 . . . . 72.32 109.323 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.599 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 41.5 m-85 -153.83 115.22 4.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.46 1.1 . . . . 72.24 110.995 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.441 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 3.8 t0 -115.61 97.84 6.37 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.476 1.11 . . . . 73.03 109.305 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -85.66 -26.96 25.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 75.43 109.298 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -101.74 -1.81 31.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 64.3 109.268 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 54.78 46.04 25.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 74.45 109.295 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 16.5 mm -66.69 -42.93 90.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 74.31 109.27 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.488 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.7 t-20 -90.46 -23.6 20.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 62.54 109.304 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.464 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 1.2 m -75.6 -64.21 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 73.52 110.426 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 54.3 m-20 -58.1 -25.56 61.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 75.22 109.315 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 27.2 t -76.24 -60.52 2.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.481 1.113 . . . . 74.15 108.305 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 8.9 t -41.5 -50.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 73.34 109.298 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.05 -60.02 4.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 73.2 109.328 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -41.68 -37.9 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.448 1.093 . . . . 74.41 110.38 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -61.98 -56.67 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 75.11 109.314 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.569 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 0.4 OUTLIER -93.16 37.64 1.04 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 73.32 111.035 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -70.81 -43.89 67.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.46 1.1 . . . . 60.22 110.005 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.28 -12.12 28.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.488 1.117 . . . . 73.32 109.292 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.524 HD12 ' CE2' ' A' ' 172' ' ' TYR . 13.9 mt -61.08 139.45 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.548 1.155 . . . . 74.32 109.294 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 71.0 p -149.39 147.17 27.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 72.02 109.966 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 84.02 -162.0 38.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.128 . . . . 74.04 110.971 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 310' ' ' SER . 4.1 p -91.27 3.67 54.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.296 -1.001 . . . . 64.34 108.296 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.48 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 33.9 p -126.09 150.97 71.04 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 71.01 110.007 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.485 ' CD ' ' CD2' ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.96 146.36 86.45 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.024 -2.49 . . . . 73.15 111.024 -0.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.49 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.1 p -133.77 135.42 24.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 41.24 110.014 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.01 -173.19 11.89 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.996 -2.502 . . . . 61.35 111.004 -0.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.07 154.29 20.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.458 1.099 . . . . 74.01 109.331 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.1 Cg_endo -75.02 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.489 1.783 . . . . 64.35 110.994 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -89.75 130.79 35.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.12 . . . . 75.13 109.269 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.5 m -121.08 27.45 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 71.31 109.276 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 318' ' ' CYS . 9.3 t -50.46 -44.47 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.117 . . . . 74.15 110.005 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 316' ' ' SER . 80.0 p -38.96 -30.55 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.485 1.116 . . . . 74.43 109.973 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 316' ' ' SER . 57.4 m . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 74.34 108.324 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.472 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.301 -0.629 . . . . 71.35 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.543 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -152.74 109.64 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 63.14 109.332 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -83.11 7.52 15.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.536 1.147 . . . . 71.15 110.011 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -147.11 148.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.515 1.134 . . . . 74.12 109.275 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -101.5 143.75 27.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.23 109.303 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -34.12 4.15 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.504 1.791 . . . . 74.02 111.035 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.446 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.37 153.29 25.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 74.24 109.281 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.568 HG21 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -49.94 -36.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 74.32 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.41 -49.27 2.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 71.34 109.335 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.522 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -69.42 -36.88 77.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 73.34 110.38 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.4 OUTLIER -57.16 -57.37 12.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 74.31 109.323 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.502 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.5 m-80 -52.48 -29.6 25.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 73.31 109.329 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.27 -56.13 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 73.42 110.025 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.47 ' CD1' HD13 ' A' ' 140' ' ' ILE . 76.1 mt -42.07 -41.93 2.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 71.14 109.329 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.411 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.45 -45.13 60.97 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 75.21 110.99 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.41 -36.0 9.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 64.52 109.289 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.448 ' NE2' ' OD1' ' A' ' 191' ' ' ASN . 65.0 mt-30 -76.13 -55.49 5.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 74.44 110.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.413 ' N ' HG22 ' A' ' 187' ' ' ILE . 15.7 mt -50.14 -26.87 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.493 1.121 . . . . 71.32 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.402 ' O ' ' OG ' ' A' ' 157' ' ' SER . 0.2 OUTLIER -76.65 -34.56 58.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 73.31 109.288 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -62.33 -14.6 41.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.44 109.259 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -86.44 -17.07 35.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 74.42 110.297 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 154' ' ' LYS . 15.1 p -38.71 122.97 1.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 71.45 109.937 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 131.12 42.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 61.43 108.256 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.46 -25.1 9.36 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.509 1.131 . . . . 74.03 110.993 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.404 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 25.3 p -73.52 162.92 28.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 0.753 . . . . 74.32 110.431 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 -2.45 54.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 72.12 110.029 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.5 m -116.79 8.76 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.453 1.096 . . . . 75.43 110.376 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.404 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -82.81 138.09 34.09 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 75.13 109.3 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -169.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 73.54 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.7 p -153.54 126.78 4.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 71.23 109.999 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -74.97 137.48 50.6 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 75.34 111.002 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.7 p -73.09 -179.7 3.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 73.22 108.322 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.493 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.7 mp -101.93 137.06 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 63.34 109.267 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.1 p -74.37 83.66 1.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 75.12 110.381 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.524 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 3.1 m-85 -80.1 -1.07 38.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.477 1.11 . . . . 75.34 110.991 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -118.02 14.93 14.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 73.32 110.317 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.565 ' CE1' HG23 ' A' ' 174' ' ' VAL . 18.6 t80 -128.86 67.55 77.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 75.24 111.041 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.438 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.5 Cg_endo -74.97 113.19 3.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.521 1.801 . . . . 72.51 111.014 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.565 HG23 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.75 -71.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 72.22 109.24 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -133.53 -46.51 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 62.42 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.93 100.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 54.34 110.988 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.438 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 5.2 p -137.56 -48.53 0.58 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.304 -0.998 . . . . 72.41 108.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -69.92 -25.21 63.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.55 1.156 . . . . 74.44 111.03 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.35 -65.64 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 65.24 109.37 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.493 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 11.4 ptm180 -45.77 -51.86 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.099 . . . . 75.42 110.234 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.441 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -41.37 -63.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 75.44 109.31 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.6 OUTLIER -40.74 -38.71 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 73.51 109.583 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.443 ' HD3' ' CG2' ' A' ' 294' ' ' THR . 13.3 mmmm -68.47 -59.92 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 74.31 109.257 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 25.7 mtm -41.4 -30.67 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 73.04 110.958 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.48 ' CZ ' ' CE ' ' A' ' 189' ' ' MET . 0.1 OUTLIER -68.25 -47.61 67.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.447 1.092 . . . . 70.01 110.293 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -51.4 -33.52 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 74.22 110.306 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.435 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 16.1 mm -75.7 -34.33 28.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.115 . . . . 74.31 109.305 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -60.96 -47.51 86.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 65.53 109.253 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.48 ' CE ' ' CZ ' ' A' ' 185' ' ' ARG . 4.5 mtt -54.93 -44.29 74.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 75.03 110.996 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -47.25 -52.53 15.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 74.23 109.297 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.448 ' OD1' ' NE2' ' A' ' 152' ' ' GLN . 0.5 OUTLIER -63.32 -36.36 83.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 60.0 109.284 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.32 48.71 0.69 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.12 . . . . 63.44 110.987 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.543 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 64.1 m-85 -149.39 137.37 20.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.481 0.754 . . . . 70.14 111.05 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.472 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -103.55 130.31 50.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 71.43 109.333 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 26.4 p -107.52 -179.48 3.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 72.32 108.298 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -127.05 172.62 10.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 75.43 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.441 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 15.9 mmtt -104.98 157.29 17.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.438 1.087 . . . . 74.12 109.321 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -146.52 117.76 7.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 65.44 110.282 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.568 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.2 m-85 -108.27 128.22 54.54 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 73.5 110.977 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.46 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 1.5 t -120.52 161.05 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 70.33 109.328 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 2.3 m-85 -138.84 151.22 46.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 74.11 111.019 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.14 18.24 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.506 1.129 . . . . 71.15 111.027 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 263' ' ' SER . 55.6 t-20 -77.33 111.36 12.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 0.76 . . . . 72.53 109.3 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 218' ' ' HIS . 4.0 mt -113.74 94.12 4.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 74.31 109.299 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 256' ' ' CYS . 1.2 mtpp -92.89 158.31 15.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 74.43 109.294 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 213' ' ' VAL . . . -164.89 162.75 20.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.21 109.313 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.553 1.158 . . . . 73.03 110.017 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 108.283 -1.006 . . . . 74.0 108.283 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -145.08 149.01 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 74.11 109.253 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.401 ' HB1' ' NZ ' ' A' ' 205' ' ' LYS . . . -141.79 120.16 12.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.539 1.15 . . . . 74.23 109.291 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -125.46 136.8 53.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 74.53 108.008 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 p -80.78 1.43 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 72.02 110.007 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 7.9 p90 -178.17 130.8 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 64.32 111.022 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.471 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 80.2 t60 -123.83 166.41 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.568 1.168 . . . . 75.24 109.591 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.471 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 4.8 p -147.94 143.24 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 72.3 109.264 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.605 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.12 -159.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.452 1.095 . . . . 74.51 109.348 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 8.2 pt -118.16 125.17 74.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.542 1.151 . . . . 75.14 109.273 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.19 108.97 19.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 75.54 109.333 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.8 OUTLIER -104.95 147.41 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 72.24 109.32 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 140' ' ' ILE . 5.1 m -117.1 121.52 41.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 62.51 110.02 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CD2' HG21 ' A' ' 143' ' ' VAL . 32.6 p90 -136.45 143.14 43.73 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.471 1.107 . . . . 73.44 110.992 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.0 mmtp -68.73 132.93 47.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 73.53 109.268 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.41 -160.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 74.24 109.349 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.61 0.06 48.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 74.44 109.278 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.8 m -115.15 -7.95 12.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 64.52 110.006 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.97 37.68 8.31 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 72.11 111.005 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.5 138.02 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.511 0.771 . . . . 73.51 109.316 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.0 m -71.72 102.67 2.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 74.55 110.38 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.408 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.9 mm-40 -101.55 -172.58 2.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.468 1.105 . . . . 75.24 110.307 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -127.29 145.08 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.147 . . . . 75.34 109.339 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.51 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 2.7 tpt180 -144.19 161.2 39.47 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.52 110.304 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.554 HD13 ' CE3' ' A' ' 252' ' ' TRP . 15.6 mm -116.75 120.43 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.464 1.102 . . . . 74.41 109.249 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -104.22 44.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 71.35 109.279 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -100.32 108.88 54.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 70.42 109.31 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.524 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.2 Cg_endo -75.05 -27.88 9.56 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.506 1.792 . . . . 75.44 111.019 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.2 t -48.15 -24.2 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 75.14 110.036 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.11 -57.0 2.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 72.55 109.277 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.56 ' CD1' HG13 ' A' ' 247' ' ' VAL . 81.7 m-85 -112.46 99.45 7.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.35 110.996 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.0 m -85.92 -9.1 57.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.094 . . . . 65.51 110.021 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.3 p -77.36 -46.26 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 71.43 110.004 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.76 -171.59 41.35 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.501 1.126 . . . . 72.2 110.958 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.439 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.97 163.35 35.55 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.458 1.767 . . . . 71.32 111.039 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.56 HG13 ' CD1' ' A' ' 242' ' ' PHE . 3.1 m -147.55 160.01 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.502 1.126 . . . . 75.21 109.265 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.9 p -61.53 141.37 57.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 72.44 110.401 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.445 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 8.9 p30 -44.25 -27.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 71.43 109.302 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 15.8 m -77.53 -61.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.133 . . . . 74.53 110.427 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.58 -27.62 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 51.1 109.314 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.605 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 9.9 t90 -63.66 -63.14 1.26 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.47 1.106 . . . . 74.01 108.055 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.543 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.17 -42.04 19.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 75.24 110.311 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.406 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.8 m-80 -55.75 -51.57 66.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 75.41 109.313 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.25 -24.79 29.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.492 1.12 . . . . 71.22 109.322 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.3 m -83.94 -36.5 23.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.144 . . . . 63.14 108.304 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.466 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.0 m -94.63 22.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 63.33 109.311 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -49.28 104.85 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.437 1.086 . . . . 74.44 109.276 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 262' ' ' GLY . 1.8 p -72.33 -4.02 27.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.507 1.13 . . . . 70.44 110.348 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 t -46.32 -27.0 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 64.31 109.967 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 1.7 m -92.11 -35.76 13.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 74.12 108.236 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.15 -126.79 1.68 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.505 1.128 . . . . 74.13 110.973 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -69.64 142.21 53.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 0.768 . . . . 75.12 110.002 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.466 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -173.08 140.84 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 71.24 109.279 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 87.8 p -172.09 156.53 4.04 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.161 . . . . 72.33 109.991 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.438 ' CG2' HG13 ' A' ' 200' ' ' VAL . 6.0 p -103.78 111.15 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.502 1.126 . . . . 74.42 109.3 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 201' ' ' TYR . 16.5 t -61.68 -46.9 87.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 65.42 110.013 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.6 m -159.58 -174.21 4.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.45 1.094 . . . . 75.01 110.009 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -167.0 157.38 11.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.485 1.115 . . . . 75.04 110.986 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.0 169.44 22.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 65.41 109.311 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.44 ' O ' ' CG2' ' A' ' 272' ' ' THR . 1.0 OUTLIER -134.17 160.64 37.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 74.2 109.253 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.488 HG23 ' CZ ' ' A' ' 285' ' ' TYR . 1.7 p -158.24 -177.93 6.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 74.02 110.378 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.97 167.22 3.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 72.15 109.303 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.26 -41.55 10.1 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.489 1.118 . . . . 75.32 110.983 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.446 ' CG ' ' NH2' ' A' ' 185' ' ' ARG . 0.8 OUTLIER -58.58 -45.2 89.57 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.497 0.763 . . . . 75.44 109.321 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 91.3 t -43.76 101.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.431 1.082 . . . . 75.34 109.305 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -52.23 -58.66 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 72.2 110.99 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.9 t80 -139.06 170.17 16.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.109 . . . . 73.12 110.986 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.596 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 66.3 ttt-85 -141.59 147.44 37.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 64.2 110.315 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.61 157.05 43.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 75.24 109.998 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -0.26 9.77 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.525 1.802 . . . . 73.11 111.021 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.408 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.5 p -96.78 9.08 42.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 74.35 110.011 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.3 t-20 74.98 34.67 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.54 1.15 . . . . 73.13 109.294 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.2 t -119.72 119.55 34.0 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 70.44 110.022 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.507 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.3 m-30 -99.59 162.22 13.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.2 110.99 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.3 mm? -116.97 177.57 4.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.517 1.135 . . . . 74.22 109.312 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 97.6 m-85 -160.92 115.4 2.1 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 74.21 111.03 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.465 ' HB3' ' CD1' ' A' ' 291' ' ' LEU . 0.7 OUTLIER -115.31 94.74 4.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 71.21 109.271 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 290' ' ' ASN . 0.7 OUTLIER -80.27 -42.04 23.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 74.21 109.246 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.493 ' N ' ' ND2' ' A' ' 289' ' ' ASN . 11.4 m-20 -95.65 -1.83 49.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 74.21 109.28 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.656 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.0 mm? 52.21 40.34 28.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 75.45 109.32 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.466 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 16.6 mm -69.8 -25.82 29.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 71.33 109.264 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.442 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.7 t-20 -92.97 -31.86 14.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 74.4 109.333 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.443 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 18.0 m -81.42 -66.85 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.515 1.134 . . . . 74.21 110.408 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.8 m-20 -47.33 -29.37 2.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 73.24 109.306 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.5 t -75.23 -52.91 9.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 74.05 108.328 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 4.5 t -46.23 -51.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 73.24 109.307 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 20.9 mt -63.47 -52.69 60.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 75.11 109.309 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -52.2 -26.54 11.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 74.25 110.395 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -76.1 -35.73 59.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 75.53 109.306 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.569 ' CZ ' HG13 ' A' ' 315' ' ' VAL . 3.1 m-30 -101.83 24.88 9.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 72.44 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 14.5 t -57.24 -59.06 5.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 74.5 110.014 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.501 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -74.19 -17.53 60.89 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.441 1.088 . . . . 74.33 109.315 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.464 ' HB2' ' CA ' ' A' ' 301' ' ' PHE . 14.8 mt -67.89 134.43 50.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 75.5 109.317 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.7 p -160.36 135.35 7.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 75.31 110.039 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 109.97 -160.57 13.34 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.477 1.111 . . . . 73.03 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.9 p -95.08 13.5 24.98 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.295 -1.002 . . . . 64.5 108.295 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.468 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.6 p -145.91 152.98 49.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 73.41 110.043 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -74.99 145.59 84.34 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 121.016 -2.493 . . . . 74.42 110.975 0.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.493 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 99.4 p -130.99 134.87 26.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 71.41 109.995 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.08 -173.19 11.91 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.974 -2.511 . . . . 73.01 110.955 0.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.76 153.26 22.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 65.22 109.321 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.564 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.02 -162.38 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.449 1.763 . . . . 71.4 110.99 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -84.52 137.0 33.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 74.41 109.296 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.569 HG13 ' CZ ' ' A' ' 301' ' ' PHE . 21.3 m -144.6 24.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.105 . . . . 74.13 109.326 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 318' ' ' CYS . 28.5 t -69.2 -31.87 70.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.51 109.933 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 26.3 m -44.47 -26.49 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 73.51 109.971 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 316' ' ' SER . 2.4 m . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 62.53 108.293 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 7.3 tp . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.32 -0.622 . . . . 75.21 109.32 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.572 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -105.51 108.78 20.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 73.4 109.326 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -85.7 10.62 12.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 73.11 109.969 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -150.38 144.19 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 63.4 109.286 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 1.3 mt -96.31 141.77 23.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 74.11 109.286 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.08 -30.26 7.24 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.467 1.772 . . . . 74.41 111.015 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.59 152.28 17.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 74.13 109.26 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 225' ' ' TYR . 1.8 t -50.37 -36.0 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 72.33 109.277 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.05 -47.69 3.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.112 . . . . 74.44 109.306 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.488 HG23 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -71.1 -36.05 72.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 75.11 110.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.4 OUTLIER -58.06 -57.08 14.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.517 1.136 . . . . 75.44 109.288 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.509 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.4 m-80 -52.28 -31.36 32.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 72.11 109.281 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.92 -55.03 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 74.24 109.978 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 191' ' ' ASN . 96.2 mt -45.44 -41.88 9.82 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 74.21 109.304 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.47 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.1 t80 -73.54 -43.8 59.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.455 1.097 . . . . 72.2 111.034 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -47.99 -36.4 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 71.41 109.309 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.489 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 61.6 mt-30 -76.4 -56.07 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 72.12 110.321 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 21.6 mt -49.01 -29.41 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 75.25 109.307 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 -37.28 67.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.524 1.14 . . . . 74.54 109.278 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.9 t-20 -58.26 -17.52 20.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 75.55 109.321 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -82.18 -25.3 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.104 . . . . 74.12 110.268 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.527 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 15.5 m -42.14 120.86 1.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 73.02 109.979 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -45.85 131.56 9.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.538 1.149 . . . . 65.15 108.288 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.41 -15.47 9.24 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.542 1.152 . . . . 72.44 111.017 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.456 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 14.5 p -89.3 161.15 16.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.426 0.721 . . . . 75.15 110.381 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.0 m -93.46 -2.03 54.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 74.15 110.031 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 162' ' ' THR . 1.8 m -118.58 8.6 12.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 73.21 110.381 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.456 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -81.68 135.78 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.512 1.133 . . . . 54.32 109.303 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -169.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.47 1.106 . . . . 62.03 110.024 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 54.1 p -153.62 127.05 4.25 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.42 109.978 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.05 137.88 52.86 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.038 -2.484 . . . . 74.11 110.969 0.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.0 p -72.94 -178.63 2.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 44.23 108.315 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.6 mp -86.93 130.76 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.31 109.306 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.1 p -95.85 76.11 3.16 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 74.32 110.432 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.527 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 53.8 p90 -76.88 -16.18 59.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.135 . . . . 75.12 110.994 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -73.46 -3.38 27.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 1.133 . . . . 75.44 110.309 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 24.9 t80 -130.96 66.14 78.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 74.11 111.01 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.61 4.34 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.489 1.783 . . . . 73.01 111.024 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.539 HG23 ' CE1' ' A' ' 172' ' ' TYR . 10.8 t -152.04 -60.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 74.45 109.299 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.4 ' O ' ' SG ' ' A' ' 177' ' ' CYS . 3.3 m-20 -132.1 -46.79 0.93 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.491 1.12 . . . . 73.15 109.277 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -49.15 98.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.545 1.153 . . . . 75.12 111.011 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.488 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 2.5 p -130.09 -46.89 1.11 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.287 -1.005 . . . . 73.33 108.287 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 31.4 p90 -73.8 -44.2 56.59 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 75.22 110.992 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.91 -68.48 0.18 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.13 . . . . 74.3 109.293 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 183' ' ' LYS . 8.8 ptm180 -48.89 -48.71 42.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.436 1.085 . . . . 74.33 110.251 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.437 ' HA ' ' CE ' ' A' ' 184' ' ' MET . . . -42.68 -45.93 4.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.462 1.101 . . . . 74.2 109.307 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -56.98 -41.93 79.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 75.31 109.617 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 180' ' ' ARG . 15.8 mmmt -71.05 -30.22 66.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.122 . . . . 72.3 109.295 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.437 ' CE ' ' HA ' ' A' ' 181' ' ' ALA . 21.7 mtm -66.18 -60.4 2.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 73.23 111.012 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -51.24 -26.88 7.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 75.12 110.279 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.428 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 1.1 tt0 -64.54 -44.28 91.31 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.55 1.156 . . . . 74.55 110.275 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 190' ' ' ASN . 23.8 mm -66.1 -52.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 72.4 109.324 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.3 OUTLIER -40.88 -39.83 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 72.21 109.31 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.421 ' HG2' ' CD2' ' A' ' 136' ' ' LEU . 20.3 mtp -66.62 -45.63 78.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 74.25 110.976 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 187' ' ' ILE . 0.3 OUTLIER -46.35 -47.07 18.63 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.24 109.262 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.489 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 35.0 t-20 -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 73.43 109.282 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' CD2' ' A' ' 193' ' ' TYR . . . 119.85 54.1 0.26 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.516 1.135 . . . . 70.24 110.976 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.572 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 91.1 m-85 -158.67 144.73 16.87 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 73.44 111.026 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.464 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 46.8 t0 -110.72 125.91 53.99 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.563 1.165 . . . . 72.33 109.275 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.461 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 29.6 p -103.17 -179.31 3.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 70.24 108.29 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -127.33 176.72 7.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.446 1.092 . . . . 75.55 110.336 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.421 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 21.3 mmtt -108.57 162.68 13.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 73.43 109.286 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -155.11 117.62 4.26 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.55 1.156 . . . . 75.42 110.34 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.56 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -109.68 124.61 51.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 72.32 110.971 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.468 ' CG2' HG22 ' A' ' 266' ' ' VAL . 8.6 p -115.57 150.8 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 72.52 109.28 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.7 m-85 -122.13 162.96 20.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 74.51 110.982 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 115.59 -179.43 18.05 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.556 1.16 . . . . 74.13 110.98 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 263' ' ' SER . 58.1 t-20 -68.73 109.35 3.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 0.756 . . . . 75.24 109.302 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 218' ' ' HIS . 5.9 mt -113.92 93.42 4.36 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.474 1.109 . . . . 74.0 109.305 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 256' ' ' CYS . 4.5 mttt -93.25 160.3 14.89 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.535 1.147 . . . . 72.24 109.26 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -165.78 162.89 18.82 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.441 1.088 . . . . 75.31 109.269 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.44 110.02 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.33 -0.989 . . . . 72.51 108.33 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.07 161.58 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.525 1.141 . . . . 74.12 109.304 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -146.43 120.48 9.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 63.14 109.291 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.45 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.5 m0 -130.41 132.84 45.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.001 -1.111 . . . . 75.32 108.001 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 54.8 p -79.54 0.61 29.07 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.111 . . . . 72.34 110.014 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 9.1 p90 -170.85 127.82 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 63.44 111.014 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 48.3 t60 -116.47 167.88 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 75.24 109.622 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 2.4 p -143.86 145.16 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 73.45 109.309 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.598 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -146.38 -169.09 3.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 61.14 109.285 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 13.0 pt -114.38 120.8 65.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 74.41 109.311 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 15.8 tp -85.33 108.92 18.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.113 . . . . 74.32 109.314 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.468 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.8 OUTLIER -104.9 149.35 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 72.35 109.292 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 40.2 m -118.26 122.69 43.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 72.21 110.001 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CD2' HG22 ' A' ' 143' ' ' VAL . 33.0 p90 -137.37 145.01 42.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 74.14 111.001 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.428 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.1 mmtp -70.72 132.89 46.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 74.51 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.35 -159.86 0.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.133 . . . . 73.24 109.294 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.83 -0.4 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.549 1.156 . . . . 73.45 109.305 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.78 -7.85 12.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 75.31 110.025 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.96 37.86 8.24 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.509 1.131 . . . . 72.23 111.0 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.76 137.46 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.452 0.736 . . . . 71.43 109.261 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.428 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.6 m -71.59 102.47 2.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.107 . . . . 64.53 110.355 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.4 ' HB2' ' OD1' ' A' ' 227' ' ' ASN . 5.7 mm-40 -102.04 -172.49 2.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.446 1.091 . . . . 73.51 110.276 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -125.66 145.03 50.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.112 . . . . 72.41 109.314 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.562 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 5.8 tpt180 -143.02 159.48 42.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.34 110.354 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.488 HG13 ' CG ' ' A' ' 252' ' ' TRP . 15.0 mm -113.42 117.02 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.118 . . . . 72.15 109.329 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 150' ' ' PHE . 3.2 mm -106.48 46.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 74.43 109.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -104.6 106.12 53.2 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 64.23 109.291 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -1.13 10.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.533 1.807 . . . . 74.14 110.995 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 3.1 t -73.21 -4.14 31.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 75.24 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.6 mt -138.15 -49.12 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 74.14 109.334 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.647 ' CZ ' ' CB ' ' A' ' 255' ' ' ALA . 83.0 m-85 -113.26 99.35 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.548 1.155 . . . . 75.32 111.014 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.5 m -90.63 -5.32 56.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 75.25 109.965 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 12.2 t -83.91 -44.78 13.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.535 1.147 . . . . 53.52 110.021 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.09 -177.43 46.82 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.518 1.136 . . . . 62.45 110.985 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.46 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.98 165.08 32.08 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.478 1.778 . . . . 72.14 111.018 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.573 HG12 ' CD2' ' A' ' 242' ' ' PHE . 4.0 m -148.43 167.8 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.456 1.098 . . . . 71.24 109.32 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.442 ' C ' ' N ' ' A' ' 250' ' ' THR . 66.8 p -70.23 137.78 51.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 75.34 110.4 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -41.23 -29.11 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.24 109.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.442 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -74.7 -63.8 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 74.23 110.362 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.36 -25.78 6.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 63.43 109.359 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.598 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.2 t90 -65.79 -65.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 74.42 108.034 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -42.04 -30.99 0.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 75.52 110.303 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.456 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 2.5 m-80 -67.4 -49.15 65.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.35 109.268 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.647 ' CB ' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.48 -19.36 14.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 70.13 109.278 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 205' ' ' LYS . 6.9 m -90.26 -35.75 15.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 75.34 108.331 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.474 ' CA ' ' HB2' ' A' ' 264' ' ' ALA . 3.4 m -93.53 21.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 74.13 109.284 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -50.48 106.44 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 72.21 109.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 262' ' ' GLY . 14.7 p -73.31 -3.34 26.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 75.34 110.428 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.72 -30.51 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.531 1.145 . . . . 73.5 109.963 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.5 t -88.71 -36.96 15.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 63.31 108.309 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.87 -128.82 1.78 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.512 1.133 . . . . 71.21 110.972 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.89 145.69 42.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 0.775 . . . . 71.15 109.986 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.474 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -167.96 147.61 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 72.3 109.308 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.3 t -172.92 153.61 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 73.23 110.056 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.468 HG22 ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.42 118.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 74.51 109.324 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.0 t -73.78 -43.82 57.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.556 1.16 . . . . 74.32 110.02 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 11.5 p -164.94 -175.15 3.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 74.23 109.994 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -164.77 157.14 16.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 75.25 110.998 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.1 160.49 39.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 74.55 109.27 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -118.41 160.65 21.32 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.093 . . . . 73.45 109.272 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.452 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 2.1 p -153.47 -178.5 7.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 75.25 110.399 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.431 ' CB ' HG22 ' A' ' 276' ' ' VAL . . . -64.75 163.83 13.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 75.41 109.326 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.484 1.115 . . . . 62.12 110.991 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.449 ' OD1' ' NH2' ' A' ' 185' ' ' ARG . 0.2 OUTLIER -85.99 -35.71 20.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 0.778 . . . . 74.32 109.286 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.431 HG22 ' CB ' ' A' ' 273' ' ' ALA . 92.8 t -43.81 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 73.23 109.291 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 6.0 t80 -59.21 -49.83 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 62.51 110.968 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 56.2 t80 -147.9 158.15 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 61.42 110.955 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.56 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 73.0 ttt-85 -123.95 147.47 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 73.24 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.55 154.02 47.8 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.115 . . . . 74.42 109.958 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.21 9.19 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.468 1.772 . . . . 74.33 110.997 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 20.6 t -105.64 10.22 32.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 1.118 . . . . 75.12 109.991 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 75.38 39.55 0.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 73.15 109.278 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.4 t -119.83 120.28 36.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 64.22 110.002 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -101.86 166.65 10.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 73.42 111.03 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -123.34 177.36 5.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 74.32 109.323 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 52.5 m-85 -158.61 115.78 2.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.125 . . . . 73.12 110.984 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -115.26 99.27 7.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 74.23 109.329 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . 0.508 ' H ' ' ND2' ' A' ' 289' ' ' ASN . 0.9 OUTLIER -84.94 -48.54 9.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 75.12 109.34 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.462 ' CB ' HG12 ' A' ' 292' ' ' ILE . 27.0 m-20 -90.33 9.53 28.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 73.42 109.354 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.694 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.32 45.25 1.78 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 75.21 109.299 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.462 HG12 ' CB ' ' A' ' 290' ' ' ASN . 47.6 mm -74.47 -23.79 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 72.3 109.317 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.495 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.7 t-20 -94.5 -29.08 15.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 63.41 109.299 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 7.8 m -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 70.3 110.419 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 39.8 m-20 -48.43 -24.77 1.36 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 73.25 109.288 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 45.7 t -80.8 -47.9 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 65.31 108.297 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.4 t -52.86 -45.47 50.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.521 1.138 . . . . 74.35 109.3 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.4 mt -65.27 -62.9 1.27 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 72.22 109.331 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -24.67 0.85 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.4 110.388 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -73.3 -41.75 63.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 73.42 109.298 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.57 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 3.7 m-30 -100.87 36.77 1.87 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 74.21 111.033 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.72 -44.75 73.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 75.24 110.009 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.415 HD21 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -92.8 -12.09 32.05 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 71.41 109.296 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 301' ' ' PHE . 13.7 mt -68.67 136.69 53.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 74.43 109.33 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 95.2 p -149.39 156.05 41.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.489 1.118 . . . . 65.54 110.014 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.32 -164.68 54.35 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.475 1.109 . . . . 71.44 111.01 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 10.56 22.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.272 -1.01 . . . . 71.33 108.272 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 13.9 p -131.8 149.45 73.44 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.565 1.166 . . . . 74.43 110.022 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.5 Cg_endo -74.92 147.1 88.48 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 75.13 111.047 -0.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.9 p -133.51 135.75 25.71 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.551 1.157 . . . . 64.02 110.005 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.6 Cg_endo -74.94 -173.73 12.81 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 120.98 -2.508 . . . . 71.2 111.032 -0.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.58 154.32 35.39 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 73.45 109.291 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.455 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.99 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.512 1.796 . . . . 73.4 111.011 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -87.92 135.98 33.17 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 71.51 109.263 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.62 23.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.53 109.303 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 17.0 t -54.61 -32.74 59.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.418 1.074 . . . . 62.25 110.039 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.2 m -48.76 -25.37 1.8 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.35 110.002 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 72.35 108.299 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 194' ' ' ASP . 8.6 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.286 -0.635 . . . . 73.11 109.286 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.548 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -116.03 104.37 11.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 75.22 109.314 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.496 ' CB ' ' OD2' ' A' ' 194' ' ' ASP . 0.6 OUTLIER -80.39 3.91 19.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 73.11 109.972 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.415 HG11 ' N ' ' A' ' 140' ' ' ILE . 2.3 t -142.93 147.57 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.13 109.308 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.475 ' CD1' HD11 ' A' ' 149' ' ' LEU . 1.2 mt -98.99 142.55 24.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 72.44 109.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.0 -32.74 5.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.528 1.804 . . . . 73.44 111.025 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.416 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.21 151.47 19.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 74.12 109.295 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -48.51 -35.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.103 . . . . 75.12 109.28 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.56 -46.75 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 73.3 109.303 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.48 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.9 m -72.25 -34.77 68.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.13 . . . . 63.33 110.425 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -59.47 -56.76 17.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.428 1.08 . . . . 74.54 109.254 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.52 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.2 m-80 -52.54 -31.85 37.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 62.5 109.32 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.18 -56.71 6.82 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.473 1.108 . . . . 62.22 109.994 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.475 HD11 ' CD1' ' A' ' 140' ' ' ILE . 60.7 mt -42.97 -42.62 3.83 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.472 1.107 . . . . 75.04 109.307 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.55 -45.1 63.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 74.55 111.037 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.87 -38.15 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 75.24 109.324 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 155' ' ' ASN . 64.6 mt-30 -75.21 -55.31 5.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 73.21 110.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 188' ' ' LEU . 12.4 mt -49.72 -27.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.115 . . . . 74.11 109.306 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -36.07 61.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 73.33 109.289 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -60.75 -15.38 28.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 75.12 109.335 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.403 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 8.9 mm100 -83.09 -21.74 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 74.23 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.402 ' OG ' ' CG2' ' A' ' 160' ' ' THR . 29.8 p -39.09 140.69 0.37 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.25 109.99 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.73 -9.76 52.5 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 74.04 108.274 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -87.87 18.88 36.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.511 1.132 . . . . 60.13 110.999 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.402 ' CG2' ' OG ' ' A' ' 157' ' ' SER . 59.2 p -136.27 160.74 37.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 74.02 110.398 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 p -93.76 -21.55 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.48 1.112 . . . . 72.35 109.991 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.6 m -82.57 -3.65 56.39 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 72.22 110.416 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 156' ' ' GLN . . . -69.38 138.37 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.1 109.303 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.3 t -59.72 -160.14 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.097 . . . . 52.11 109.993 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.446 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -156.45 128.0 3.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 72.21 109.993 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.93 140.7 68.78 Favored 'Cis proline' 0 C--N 1.36 1.132 0 C-N-CA 121.011 -2.495 . . . . 74.43 111.015 -0.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 23.2 p -72.75 177.44 4.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 64.33 108.285 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 2.1 mp -94.51 126.84 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 70.3 109.309 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.4 p -77.56 90.06 3.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 74.2 110.389 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -88.59 -30.2 19.43 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.571 1.169 . . . . 71.42 110.988 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -84.03 9.29 12.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.51 1.131 . . . . 74.12 110.297 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.552 ' CE1' HG22 ' A' ' 174' ' ' VAL . 38.8 t80 -128.56 66.9 75.5 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.494 1.121 . . . . 74.42 111.004 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.448 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -74.97 109.15 2.87 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.463 1.77 . . . . 71.23 110.98 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.552 HG22 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.66 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 75.22 109.271 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -160.52 129.2 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.526 1.141 . . . . 74.25 109.273 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 129.07 52.29 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.505 1.128 . . . . 62.11 111.011 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.4 m -89.14 -18.06 27.93 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.273 -1.01 . . . . 74.42 108.273 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.567 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 34.2 p90 -76.59 -22.62 53.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.527 1.142 . . . . 75.35 110.955 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.17 -68.35 0.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 64.34 109.268 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 183' ' ' LYS . 7.9 ptm180 -46.15 -48.33 17.44 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.498 1.124 . . . . 75.51 110.296 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -40.4 -59.0 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.13 . . . . 61.12 109.327 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.589 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.1 t60 -48.96 -39.69 27.46 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.528 1.142 . . . . 75.42 109.604 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.656 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.6 mmmt -64.61 -61.47 2.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 73.22 109.299 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 15.0 mtm -38.9 -38.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.533 1.146 . . . . 74.23 110.987 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.36 -49.35 78.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 74.15 110.339 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.656 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -54.75 -34.05 62.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.122 . . . . 64.02 110.271 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.469 HD13 ' CG ' ' A' ' 186' ' ' GLN . 31.1 mm -70.3 -43.77 78.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.155 . . . . 75.02 109.341 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 153' ' ' ILE . 0.4 OUTLIER -60.68 -40.77 93.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 73.12 109.28 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.419 ' HG2' ' CD2' ' A' ' 136' ' ' LEU . 52.1 mtp -61.57 -36.04 79.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 73.33 110.994 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.67 -53.63 56.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 74.55 109.293 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 23.6 t30 -62.72 -27.56 69.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 71.22 109.286 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 109.04 53.58 0.61 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.508 1.13 . . . . 73.34 110.988 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.548 ' CD2' ' HB3' ' A' ' 137' ' ' ALA . 92.9 m-85 -156.89 140.74 16.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.45 0.735 . . . . 75.22 111.015 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.496 ' OD2' ' CB ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -106.12 124.86 50.24 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 63.22 109.319 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.474 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 17.1 p -95.92 168.46 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 64.13 108.3 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -117.06 170.91 8.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 62.51 110.295 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.503 ' NZ ' ' N ' ' A' ' 182' ' ' HIS . 17.5 mmtt -100.58 169.34 9.12 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 74.01 109.287 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -167.28 121.85 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.442 1.089 . . . . 75.21 110.27 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -115.9 140.58 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 72.24 111.013 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.495 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 14.0 p -131.71 149.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.0 109.346 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 13.8 m-85 -122.72 156.37 34.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.452 1.095 . . . . 74.01 110.977 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.39 -175.83 16.44 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.508 1.13 . . . . 71.03 111.025 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 263' ' ' SER . 55.5 t-20 -72.63 110.14 6.78 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.782 . . . . 72.42 109.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.461 HD13 ' CB ' ' A' ' 218' ' ' HIS . 5.2 mt -113.19 95.48 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 75.44 109.263 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 256' ' ' CYS . 6.8 mtpt -92.31 165.33 13.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 74.45 109.326 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -169.23 119.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 74.54 109.26 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.157 . . . . 71.4 110.019 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.318 -0.993 . . . . 64.1 108.318 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.87 155.26 9.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.104 . . . . 74.53 109.293 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -147.1 130.05 16.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 53.33 109.315 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.3 135.07 42.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.32 108.015 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.4 m -80.3 3.52 20.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.147 . . . . 73.3 109.991 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.458 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.0 p90 -177.79 130.41 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.459 1.099 . . . . 73.34 111.023 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -120.17 168.03 11.64 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 73.14 109.609 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.506 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 1.5 p -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.13 . . . . 73.11 109.284 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.683 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.0 -165.8 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 74.22 109.291 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 15.9 pt -117.24 123.79 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 72.12 109.273 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.29 108.85 18.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 75.44 109.285 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.8 OUTLIER -102.2 145.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 72.34 109.323 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.3 m -117.75 117.78 30.26 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.467 1.105 . . . . 71.53 110.031 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.561 ' CD2' HG21 ' A' ' 143' ' ' VAL . 29.9 p90 -133.9 144.46 48.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 74.25 110.969 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.1 mmtp -68.87 135.19 50.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 74.34 109.333 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -76.08 -160.18 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 73.31 109.315 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.38 50.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 65.12 109.322 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 -7.49 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 75.51 109.959 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.01 8.23 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.5 1.125 . . . . 44.53 111.031 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.34 138.23 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.442 0.731 . . . . 74.54 109.347 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.436 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 20.4 m -71.93 102.55 2.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.498 1.124 . . . . 73.14 110.394 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.4 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 5.4 mm-40 -101.27 -174.21 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.567 1.167 . . . . 62.15 110.302 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -127.19 144.82 50.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 75.32 109.313 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.462 ' HB3' ' CG2' ' A' ' 223' ' ' VAL . 0.0 OUTLIER -146.7 163.88 34.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 73.44 110.307 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.417 HG13 ' CB ' ' A' ' 252' ' ' TRP . 15.3 mm -117.96 119.11 60.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 72.42 109.328 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -103.42 45.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.488 1.118 . . . . 72.44 109.317 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.41 109.44 61.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 54.04 109.309 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -20.42 16.91 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.448 1.762 . . . . 65.32 111.011 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.439 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.9 t -51.32 -21.72 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.526 1.141 . . . . 73.33 110.009 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 256' ' ' CYS . 7.7 mt -117.97 -57.85 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 73.0 109.272 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.569 ' CD1' HG12 ' A' ' 247' ' ' VAL . 80.7 m-85 -107.65 99.78 9.24 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.146 . . . . 74.35 110.972 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.1 m -86.47 -6.5 58.89 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.101 . . . . 73.23 109.974 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -82.93 -44.45 15.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 75.35 110.005 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.28 -173.96 43.26 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.509 1.131 . . . . 64.34 111.009 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.427 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.5 Cg_endo -74.9 165.42 31.43 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.453 1.765 . . . . 74.05 111.011 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 242' ' ' PHE . 4.8 m -147.23 159.26 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 75.25 109.309 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.432 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.5 p -61.17 139.38 58.13 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 73.11 110.413 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -41.63 -29.81 0.19 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 71.4 109.294 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 248' ' ' THR . 12.6 m -77.26 -61.41 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.118 . . . . 74.13 110.415 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.74 -24.36 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 63.41 109.25 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.683 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 9.7 t90 -66.33 -64.5 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 74.4 108.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.575 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.2 OUTLIER -43.77 -34.8 1.65 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 73.55 110.278 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.451 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.1 m-80 -64.56 -49.4 71.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 74.33 109.347 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.565 ' HB1' ' CE2' ' A' ' 242' ' ' PHE . . . -56.22 -19.08 12.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.45 1.094 . . . . 72.53 109.299 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 205' ' ' LYS . 10.0 m -92.06 -31.91 15.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 72.03 108.28 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.471 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 2.5 m -96.9 21.84 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.555 1.16 . . . . 64.52 109.315 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -49.2 104.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.479 1.112 . . . . 75.22 109.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 262' ' ' GLY . 12.7 p -72.54 -3.89 27.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.138 . . . . 72.13 110.397 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 41.3 t -48.1 -25.15 1.33 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 73.33 110.026 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 5.9 m -90.94 -34.45 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 73.44 108.279 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.01 -118.41 0.82 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.481 1.113 . . . . 51.21 110.979 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.45 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -83.31 142.73 30.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 0.778 . . . . 63.41 110.02 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.471 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -170.97 143.82 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.554 1.159 . . . . 71.32 109.296 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.2 t -172.77 159.24 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.55 1.156 . . . . 75.4 109.983 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.495 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 4.0 p -101.91 118.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 75.45 109.326 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.1 t -77.28 -44.0 31.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 72.34 109.999 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.1 m -149.25 -175.33 4.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 72.3 109.984 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -174.28 152.89 1.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 74.4 110.958 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -159.73 163.59 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.455 1.097 . . . . 62.35 109.312 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.84 160.5 20.74 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 74.15 109.314 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.06 -178.7 6.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 72.33 110.412 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -86.01 158.2 19.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.24 109.302 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.83 93.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.55 1.156 . . . . 71.32 110.987 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -46.28 77.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 0.773 . . . . 73.13 109.312 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.8 t -43.48 127.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 74.2 109.293 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.555 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 3.5 t80 -93.33 -40.7 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 70.42 110.988 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.553 ' CD1' ' C ' ' A' ' 278' ' ' TYR . 0.3 OUTLIER -160.33 115.46 2.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 74.54 111.025 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.419 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 55.1 ttt-85 -94.96 137.87 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.42 110.281 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 157.62 34.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 62.0 109.956 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 0.02 9.41 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.459 1.768 . . . . 61.51 111.033 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 10.2 t -98.42 7.62 45.94 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.093 . . . . 63.32 110.016 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 76.02 34.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 64.34 109.25 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.7 t -117.41 120.73 39.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.565 1.165 . . . . 71.1 110.0 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.95 164.33 12.24 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 73.32 111.009 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.2 mm? -125.32 176.66 6.63 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 75.11 109.288 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 91.2 m-85 -162.62 124.94 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 75.42 110.947 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 294' ' ' THR . 2.0 m-20 -114.91 99.01 7.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 55.13 109.304 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -79.11 -54.79 5.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 74.22 109.332 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.461 ' CB ' HG12 ' A' ' 292' ' ' ILE . 9.5 m-20 -95.1 19.2 10.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 71.04 109.297 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.589 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.5 mm? 40.29 39.38 0.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 65.51 109.324 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.461 HG12 ' CB ' ' A' ' 290' ' ' ASN . 50.2 mm -68.63 -31.94 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 74.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.555 ' HB3' ' CE2' ' A' ' 277' ' ' TYR . 0.1 OUTLIER -88.93 -29.1 19.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.555 1.159 . . . . 72.1 109.302 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.453 ' N ' ' OD1' ' A' ' 288' ' ' ASP . 4.9 m -81.52 -67.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 72.13 110.412 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -45.52 -31.85 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 74.2 109.306 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.85 -55.85 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 65.53 108.288 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.1 t -40.83 -49.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.5 1.125 . . . . 74.32 109.267 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.2 mt -67.76 -57.71 5.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.583 1.177 . . . . 73.24 109.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -44.74 -27.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 75.31 110.382 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -72.99 -44.7 60.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.541 1.151 . . . . 73.3 109.355 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.54 ' CE1' ' HD2' ' A' ' 313' ' ' PRO . 1.9 m-30 -97.65 21.97 9.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.21 111.031 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.0 t -58.27 -57.95 10.61 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.42 109.968 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.463 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -76.36 -15.54 59.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.117 . . . . 65.14 109.254 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.448 ' HB2' ' CA ' ' A' ' 301' ' ' PHE . 17.9 mt -66.38 148.99 51.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 74.13 109.292 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.7 p -168.91 127.2 1.03 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 72.43 109.964 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.28 -163.66 14.22 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.514 1.134 . . . . 72.24 111.006 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.62 15.62 12.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.341 -0.985 . . . . 74.13 108.341 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 84.4 p -139.8 148.27 54.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 74.45 110.033 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.5 Cg_endo -74.95 147.19 88.68 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 121.057 -2.476 . . . . 75.11 111.02 -0.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 6.4 p -129.89 135.28 27.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 74.52 109.99 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.98 -174.49 14.19 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.994 -2.503 . . . . 74.13 110.987 -0.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.2 156.02 23.02 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 54.11 109.317 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.54 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.512 1.796 . . . . 75.32 111.044 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.4 136.4 33.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.23 109.29 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.22 22.92 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 74.24 109.316 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 14.1 t -69.31 -33.27 72.91 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 74.33 109.975 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.8 t -47.55 -24.49 0.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.497 1.123 . . . . 71.14 110.023 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.408 ' HB2' ' ND2' ' A' ' 293' ' ' ASN . 1.8 m . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 71.01 108.279 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.468 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 7.6 tp . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.324 -0.621 . . . . 73.34 109.324 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -104.92 107.69 18.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.458 1.099 . . . . 74.31 109.319 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 t -84.81 9.69 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 73.43 109.996 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -150.25 145.6 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.544 1.152 . . . . 74.25 109.278 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 149' ' ' LEU . 1.2 mt -97.25 142.59 24.77 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 75.45 109.309 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.95 -32.63 5.3 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.497 1.788 . . . . 74.32 111.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.19 151.26 19.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.142 . . . . 63.52 109.318 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.56 HG22 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -48.11 -35.73 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.531 1.145 . . . . 74.11 109.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.33 -47.3 3.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 73.3 109.273 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.468 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.73 -35.35 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.153 . . . . 75.42 110.403 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.521 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.7 OUTLIER -58.72 -56.97 15.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 74.22 109.32 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.516 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.7 m-80 -52.49 -31.7 36.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 73.4 109.348 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.35 -54.05 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 75.54 109.946 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.464 HD22 ' CB ' ' A' ' 191' ' ' ASN . 54.0 mt -44.15 -40.67 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.537 1.148 . . . . 75.1 109.297 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.49 -44.34 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.57 1.169 . . . . 70.3 110.996 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -48.03 -37.25 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 75.01 109.296 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.492 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 61.4 mt-30 -75.67 -55.87 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 65.43 110.294 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.472 HG21 ' CG ' ' A' ' 184' ' ' MET . 12.1 mt -51.13 -23.75 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 75.41 109.367 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.4 ' O ' ' OG ' ' A' ' 157' ' ' SER . 0.1 OUTLIER -79.17 -34.03 43.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.488 1.118 . . . . 71.21 109.305 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.1 t-20 -61.75 -17.63 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 70.01 109.335 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.449 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 4.5 mm100 -84.09 -16.94 41.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 75.31 110.292 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 154' ' ' LYS . 20.6 p -37.94 133.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.21 109.958 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -64.32 125.12 23.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 70.23 108.288 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.85 -18.06 8.62 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.495 1.122 . . . . 55.04 110.96 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.445 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 63.5 p -80.81 161.7 24.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.575 0.809 . . . . 72.2 110.422 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 51.0 p -93.55 -0.8 56.12 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.44 109.998 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.5 m -117.56 7.33 12.63 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 72.01 110.41 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.445 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -82.7 138.93 33.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.526 1.141 . . . . 72.14 109.278 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -162.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 75.23 109.999 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.43 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 41.9 t -156.22 127.47 3.67 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.23 109.982 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.01 139.38 61.44 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.991 -2.504 . . . . 73.43 111.033 -0.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 p -72.73 179.11 3.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 70.5 108.299 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.448 ' CG2' ' HG2' ' A' ' 180' ' ' ARG . 2.2 mp -88.9 124.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 65.22 109.305 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 65.5 p -89.21 83.2 6.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 74.14 110.356 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -88.47 -14.78 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.142 . . . . 75.34 110.999 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.42 -2.21 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.533 1.145 . . . . 75.13 110.302 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.546 ' CE2' HD12 ' A' ' 304' ' ' LEU . 27.1 t80 -127.98 71.15 78.63 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 63.23 110.996 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 114.07 3.94 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.484 1.781 . . . . 74.53 111.005 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.54 HG21 ' CE1' ' A' ' 172' ' ' TYR . 26.2 t -152.59 -75.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.486 1.116 . . . . 71.32 109.246 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -156.51 115.79 3.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 65.21 109.301 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.63 55.84 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.525 1.14 . . . . 71.22 111.043 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 66.8 m -96.68 -0.17 48.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.308 -0.997 . . . . 65.24 108.308 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 12.8 p90 -85.89 -32.65 21.54 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 73.41 111.017 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.6 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -70.93 -49.59 43.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 73.22 109.336 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.448 ' HG2' ' CG2' ' A' ' 168' ' ' ILE . 6.5 mtp85 -57.69 -47.81 81.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 62.03 110.261 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.25 -51.04 8.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.449 1.093 . . . . 71.21 109.329 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.57 ' CD2' HD13 ' A' ' 291' ' ' LEU . 1.6 t60 -56.12 -37.47 69.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.506 1.129 . . . . 73.5 109.646 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.481 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 27.8 mmmt -63.85 -64.33 0.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.564 1.165 . . . . 75.51 109.271 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.472 ' CG ' HG21 ' A' ' 153' ' ' ILE . 9.4 mtm -38.93 -30.24 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 75.02 111.005 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -66.32 -51.02 61.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 73.31 110.289 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.481 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.7 OUTLIER -52.52 -32.32 39.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 73.31 110.282 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.449 ' CD1' ' HG3' ' A' ' 156' ' ' GLN . 11.6 mm -80.97 -34.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 72.52 109.309 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -63.33 -44.6 94.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.54 109.298 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 192' ' ' GLY . 8.5 mtp -60.52 -41.55 94.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 64.5 111.02 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -46.22 -49.53 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 74.11 109.312 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.492 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 24.5 t-20 -68.05 -27.99 66.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 75.12 109.28 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 105.75 56.66 0.67 Allowed Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.512 1.133 . . . . 64.32 110.96 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.558 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 82.0 m-85 -157.52 142.38 16.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 0.776 . . . . 75.33 111.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.468 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.2 t0 -110.02 124.77 52.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.143 . . . . 71.51 109.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.468 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 17.0 p -100.08 171.17 7.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.444 1.09 . . . . 73.13 108.296 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.42 170.23 8.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.086 . . . . 73.4 110.299 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -96.71 159.66 14.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 75.54 109.32 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -151.56 117.47 5.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 73.35 110.298 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.569 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 5.8 m-85 -116.39 128.75 55.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.52 1.137 . . . . 73.31 110.964 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.465 ' CG2' HG22 ' A' ' 266' ' ' VAL . 7.6 p -122.74 149.96 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 70.35 109.311 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 10.0 m-85 -122.88 164.21 18.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 1.15 . . . . 73.13 110.99 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.46 -172.9 14.44 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.516 1.135 . . . . 74.23 111.009 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 263' ' ' SER . 52.4 t-20 -74.12 107.67 6.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 0.786 . . . . 75.32 109.262 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.465 HD12 ' CB ' ' A' ' 218' ' ' HIS . 4.5 mt -111.54 96.26 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 75.1 109.334 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.7 mtpp -90.85 -179.88 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 73.44 109.328 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 258' ' ' ASN . . . -179.46 149.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 1.152 . . . . 74.42 109.321 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 O-C-N 124.49 1.119 . . . . 75.53 109.933 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 4.4 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.277 -1.008 . . . . 72.32 108.277 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.456 HG21 ' CB ' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -138.45 143.43 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 75.21 109.3 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.413 ' HB1' ' NZ ' ' A' ' 205' ' ' LYS . . . -137.88 132.58 32.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 71.14 109.271 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -139.99 136.34 33.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.23 107.993 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.9 t -80.38 -3.65 50.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.499 1.124 . . . . 65.51 110.01 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.4 p90 -169.99 127.45 0.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 72.32 111.03 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CE1' ' O ' ' A' ' 219' ' ' VAL . 28.6 t60 -115.62 167.23 11.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 73.24 109.583 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.542 ' HB ' ' CE1' ' A' ' 199' ' ' PHE . 2.3 p -144.23 140.42 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 71.54 109.313 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.658 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.73 -167.65 2.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 73.3 109.289 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.426 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 21.3 pt -115.17 119.33 61.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.545 1.153 . . . . 73.21 109.267 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 14.7 tp -84.92 108.82 17.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 74.43 109.301 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.521 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -103.02 146.57 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 71.33 109.345 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.9 m -117.17 119.36 34.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 72.14 110.044 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.56 ' CD2' HG22 ' A' ' 143' ' ' VAL . 32.4 p90 -134.63 145.07 48.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 71.12 110.969 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.421 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.0 mmtp -69.86 134.57 48.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 72.41 109.259 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.5 -159.77 0.11 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 71.04 109.334 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.65 52.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.458 1.099 . . . . 64.41 109.261 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.7 m -114.82 -7.88 12.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.123 . . . . 71.35 109.98 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.43 37.64 8.06 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.517 1.136 . . . . 63.31 111.036 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.424 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.35 137.38 44.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.468 0.746 . . . . 65.42 109.298 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.421 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.3 m -71.58 102.73 2.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 62.34 110.388 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.413 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 4.2 mm-40 -101.44 -172.62 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 71.45 110.266 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -126.86 145.22 50.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.1 . . . . 64.23 109.331 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.486 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 0.0 OUTLIER -145.53 162.19 38.0 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 75.25 110.286 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.488 HD11 ' CE3' ' A' ' 252' ' ' TRP . 16.6 mm -115.88 119.34 61.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 71.55 109.311 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.6 mm -105.64 45.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.22 109.248 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.19 108.78 58.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.518 1.136 . . . . 71.01 109.329 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -19.26 18.02 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.473 1.775 . . . . 75.55 110.943 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.433 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.4 OUTLIER -53.06 -20.86 3.95 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 64.12 109.994 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.421 ' CD1' ' SG ' ' A' ' 256' ' ' CYS . 7.3 mt -120.26 -57.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 72.53 109.271 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.57 ' CD1' HG11 ' A' ' 247' ' ' VAL . 96.7 m-85 -110.06 99.62 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 75.54 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -12.63 42.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.23 110.034 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -74.51 -44.83 49.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 1.101 . . . . 73.44 110.041 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -175.88 -174.76 42.7 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.537 1.148 . . . . 75.34 110.978 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.435 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.03 166.57 28.9 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.5 1.79 . . . . 74.54 110.99 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 242' ' ' PHE . 6.0 m -148.09 161.19 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.131 . . . . 72.13 109.322 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.3 p -65.49 137.32 57.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 74.05 110.458 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.415 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 6.4 p-10 -40.03 -30.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.23 109.332 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 7.9 m -76.82 -61.92 1.81 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 75.43 110.394 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.85 -24.01 3.22 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 74.34 109.315 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.658 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 7.7 t90 -68.02 -62.86 1.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.955 -1.128 . . . . 73.22 107.955 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.578 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -48.68 -38.51 21.51 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 74.41 110.32 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.459 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.6 m-80 -58.24 -51.62 68.98 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 72.13 109.302 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . . . -59.87 -17.17 34.77 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 75.22 109.283 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 22.0 m -94.91 -25.81 16.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 63.03 108.28 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.511 ' CA ' ' HB2' ' A' ' 264' ' ' ALA . 3.0 m -106.17 24.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 73.4 109.3 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 206' ' ' ALA . 1.9 p-10 -53.0 129.19 29.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.113 . . . . 75.5 109.314 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 3.1 p -85.81 -3.86 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 74.12 110.403 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.417 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 0.9 OUTLIER -50.71 -30.72 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 63.4 109.999 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . 0.407 ' SG ' ' CE ' ' A' ' 205' ' ' LYS . 16.4 t -88.39 -29.29 20.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.468 1.105 . . . . 73.23 108.31 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 156.76 -120.77 1.01 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.454 1.096 . . . . 55.1 110.978 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -87.5 148.38 24.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 0.743 . . . . 73.02 110.047 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.511 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -169.8 147.69 3.44 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.42 109.306 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.9 m -172.84 156.25 3.37 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 71.43 109.996 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.465 HG22 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.5 118.27 44.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 74.44 109.322 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 8.8 t -74.99 -44.08 50.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.513 1.133 . . . . 63.31 110.007 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.2 m -157.06 -170.11 3.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.428 1.08 . . . . 65.14 110.012 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -170.08 157.36 6.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 73.5 110.982 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -162.26 172.05 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 1.109 . . . . 73.12 109.321 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.412 ' ND2' ' C ' ' A' ' 271' ' ' ASN . 0.7 OUTLIER -145.71 160.73 41.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 1.103 . . . . 72.04 109.288 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.513 HG21 ' CZ ' ' A' ' 285' ' ' TYR . 2.7 p -151.94 -171.92 4.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 72.43 110.387 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.461 ' CB ' HG22 ' A' ' 276' ' ' VAL . . . -68.0 154.39 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.495 1.122 . . . . 65.4 109.242 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -64.56 -46.72 89.34 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.463 1.102 . . . . 72.21 110.992 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -50.96 -38.29 49.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 0.776 . . . . 73.24 109.274 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.461 HG22 ' CB ' ' A' ' 273' ' ' ALA . 33.9 t -46.81 116.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 73.54 109.306 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 2.4 t80 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 72.12 110.999 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.573 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 63.4 t80 -154.77 162.2 41.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 74.42 111.013 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.573 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 75.2 ttt-85 -128.25 147.48 50.59 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.536 1.148 . . . . 71.32 110.254 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.33 154.75 47.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.536 1.148 . . . . 75.32 110.012 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.91 0.22 9.12 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 74.01 111.026 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 27.9 t -101.63 3.35 39.78 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 73.15 110.007 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.6 t-20 81.74 36.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.433 1.083 . . . . 73.2 109.277 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -117.65 119.29 34.52 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.47 1.106 . . . . 64.54 110.013 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 272' ' ' THR . 8.7 m-30 -99.78 160.84 14.0 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 74.33 110.967 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.546 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.9 OUTLIER -119.77 176.55 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 72.53 109.303 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 86.9 m-85 -162.56 130.22 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.531 1.144 . . . . 64.25 111.0 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.439 ' HB2' ' CD2' ' A' ' 182' ' ' HIS . 1.3 m-20 -113.52 111.88 22.64 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 75.1 109.297 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.23 -51.86 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.25 109.319 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.464 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -106.96 18.04 22.32 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 73.23 109.321 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 182' ' ' HIS . 1.3 mm? 50.34 39.36 20.11 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.572 1.17 . . . . 74.03 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 20.0 mm -65.58 -30.63 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 74.5 109.27 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.541 ' HB3' ' CE2' ' A' ' 277' ' ' TYR . 1.2 t-20 -93.94 -29.75 15.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 62.13 109.334 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.453 ' CG2' HD11 ' A' ' 291' ' ' LEU . 1.3 m -76.64 -66.24 0.84 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 72.33 110.397 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -51.01 -25.92 5.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 74.54 109.297 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.41 -53.17 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.47 1.106 . . . . 72.32 108.294 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 10.6 t -49.32 -37.62 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.128 . . . . 74.43 109.315 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 65.9 mt -75.43 -59.62 2.67 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 74.53 109.316 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -51.98 -20.71 2.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 75.34 110.367 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.402 ' HE2' ' CG1' ' A' ' 315' ' ' VAL . 21.4 mmmt -72.58 -42.38 64.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 75.42 109.316 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.528 ' CD1' HD12 ' A' ' 304' ' ' LEU . 5.1 m-30 -102.44 37.82 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 75.22 110.984 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 35.6 t -68.66 -44.37 74.23 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.51 110.003 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.41 HD21 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -95.07 -12.96 25.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 71.11 109.296 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.546 HD12 ' CE2' ' A' ' 172' ' ' TYR . 13.7 mt -65.57 135.65 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 73.42 109.311 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 79.0 p -151.67 152.64 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.105 . . . . 74.41 109.983 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.87 -145.58 27.43 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.478 1.111 . . . . 63.22 111.029 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 59.8 m -109.39 15.41 23.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.341 -0.985 . . . . 74.22 108.341 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 97.8 p -132.82 148.6 70.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 74.11 110.016 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -75.08 146.45 86.59 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 120.959 -2.517 . . . . 72.25 110.992 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.49 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.4 p -128.86 134.46 26.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.498 1.124 . . . . 74.23 109.957 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.5 Cg_endo -74.96 -172.38 10.67 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.985 -2.506 . . . . 73.42 111.006 -0.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.16 153.59 24.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 72.54 109.286 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.491 1.785 . . . . 75.21 110.983 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -86.15 131.13 34.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 73.22 109.335 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.402 ' CG1' ' HE2' ' A' ' 300' ' ' LYS . 30.5 m -134.61 14.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 75.04 109.332 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 30.6 t -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 64.44 110.014 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.0 m -48.1 -24.16 1.04 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.119 . . . . 62.1 109.968 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.128 . . . . 74.02 108.336 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.277 -0.638 . . . . 71.02 109.277 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.486 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -102.69 104.18 14.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 63.52 109.304 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -82.98 7.34 15.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.114 . . . . 55.42 109.985 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.38 142.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.485 1.116 . . . . 64.45 109.319 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.467 HD13 ' CD1' ' A' ' 149' ' ' LEU . 1.4 mt -92.73 141.76 24.82 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.44 109.32 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.02 -31.57 6.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.513 1.796 . . . . 75.14 110.973 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.51 149.63 17.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 1.11 . . . . 64.51 109.348 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.56 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -46.72 -37.19 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.138 . . . . 74.4 109.248 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.18 -50.05 2.67 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.475 1.11 . . . . 73.45 109.325 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.523 HG23 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -68.95 -37.06 78.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 62.13 110.393 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.516 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -56.72 -57.5 12.16 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 75.54 109.287 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.49 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.1 m-80 -52.09 -29.9 23.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 73.23 109.295 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.14 -50.79 44.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 74.51 109.984 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.467 ' CD1' HD13 ' A' ' 140' ' ' ILE . 54.9 mt -48.53 -40.03 25.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 74.24 109.285 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.421 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -75.16 -42.17 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 75.23 110.991 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -48.95 -36.77 18.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 72.2 109.328 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 155' ' ' ASN . 64.2 mt-30 -75.75 -56.0 5.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 73.55 110.269 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.418 ' N ' HG22 ' A' ' 187' ' ' ILE . 13.1 mt -50.71 -26.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.34 109.259 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 -34.21 59.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 75.13 109.304 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.62 -15.15 36.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 70.2 109.309 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -85.75 -18.82 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 73.14 110.29 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.8 p -39.38 136.64 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 73.14 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.33 119.99 13.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 74.05 108.28 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 128.13 -18.74 5.83 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.436 1.085 . . . . 45.13 110.999 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.503 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 82.8 p -80.38 162.33 24.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 0.726 . . . . 72.21 110.407 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.7 m -93.26 -0.59 56.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.46 1.1 . . . . 72.24 110.001 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 162' ' ' THR . 1.3 m -118.84 6.52 11.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 62.14 110.42 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.503 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -79.83 139.27 37.25 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.121 . . . . 72.32 109.263 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -166.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 64.54 110.051 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 60.7 p -152.62 125.84 4.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 70.44 109.976 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 140.16 65.77 Favored 'Cis proline' 0 C--N 1.36 1.183 0 C-N-CA 120.976 -2.51 . . . . 71.45 110.973 0.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.6 p -72.89 -177.82 2.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.153 . . . . 73.15 108.313 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 2.3 mp -91.96 131.4 39.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 64.4 109.327 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.419 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 11.1 p -85.3 85.56 7.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 74.01 110.417 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 170' ' ' PHE . 2.2 p90 -88.56 -28.24 20.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 75.04 111.013 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.426 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -74.12 -2.52 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.495 1.122 . . . . 74.33 110.316 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.568 ' CE1' HG23 ' A' ' 174' ' ' VAL . 24.9 t80 -128.52 68.89 78.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 75.22 111.029 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.03 116.08 4.47 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 70.45 110.972 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.568 HG23 ' CE1' ' A' ' 172' ' ' TYR . 12.2 t -152.08 -74.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.542 1.152 . . . . 62.41 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 177' ' ' CYS . 2.6 p-10 -123.76 -43.41 2.13 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.491 1.12 . . . . 64.32 109.336 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -47.64 92.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.496 1.123 . . . . 74.43 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 175' ' ' ASP . 57.3 m -128.17 -46.86 1.35 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.28 -1.007 . . . . 71.02 108.28 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 21.7 p90 -72.87 -40.95 65.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 72.34 111.008 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.633 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -45.66 -68.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 73.53 109.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.482 ' CZ ' ' OG ' ' A' ' 240' ' ' SER . 9.5 ptm180 -49.94 -47.66 52.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.444 1.09 . . . . 74.24 110.306 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.456 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.4 -57.38 1.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.132 . . . . 70.52 109.318 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -47.79 -44.56 28.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 74.14 109.598 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 180' ' ' ARG . 14.4 mmmm -58.52 -56.58 20.27 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.438 1.086 . . . . 72.44 109.281 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.2 mtm -40.36 -55.41 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 73.32 111.051 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -46.28 -44.09 16.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 73.44 110.316 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.76 -33.19 74.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.12 110.305 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 153' ' ' ILE . 16.2 mm -76.05 -34.41 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 62.32 109.315 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.1 OUTLIER -61.97 -45.66 92.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 73.02 109.306 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.417 ' HE2' ' NH1' ' A' ' 185' ' ' ARG . 7.3 mtt -58.63 -38.58 78.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.437 1.086 . . . . 74.35 111.029 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -44.22 63.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 72.21 109.284 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.464 ' CB ' HD22 ' A' ' 149' ' ' LEU . 41.0 t30 -74.17 -31.96 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.116 . . . . 74.53 109.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.57 58.5 0.73 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.533 1.146 . . . . 64.52 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.523 ' CZ ' HG23 ' A' ' 145' ' ' THR . 68.1 m-85 -153.67 141.42 20.03 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 0.743 . . . . 73.22 110.959 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.427 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -102.89 129.46 49.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 74.25 109.329 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.455 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 30.7 p -120.26 -178.58 3.71 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.547 1.154 . . . . 63.32 108.287 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -131.36 177.5 7.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 72.44 110.248 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.456 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 21.8 mmtt -105.25 153.13 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.139 . . . . 74.5 109.265 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.417 ' NE2' HD13 ' A' ' 222' ' ' LEU . 14.8 tt0 -132.55 117.5 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.14 110.319 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.473 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 2.6 m-85 -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 75.32 111.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.6 p -131.22 142.81 42.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.45 1.094 . . . . 72.1 109.265 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 6.3 m-85 -116.32 156.08 27.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 75.11 111.028 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.53 -173.42 15.67 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.474 1.109 . . . . 75.44 111.061 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 263' ' ' SER . 51.7 t-20 -74.4 110.97 9.12 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.454 0.738 . . . . 75.52 109.252 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.466 HD13 ' CB ' ' A' ' 218' ' ' HIS . 4.6 mt -115.13 94.39 4.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.46 1.1 . . . . 74.11 109.293 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 256' ' ' CYS . 1.9 mtpm? -92.76 175.12 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 74.23 109.306 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -176.04 131.16 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 72.44 109.349 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.9 p . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 74.32 109.972 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 108.313 -0.995 . . . . 62.21 108.313 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.97 162.06 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 74.4 109.285 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.443 ' CB ' ' HE2' ' A' ' 205' ' ' LYS . . . -142.83 135.18 27.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 73.32 109.306 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.7 OUTLIER -138.25 134.32 34.25 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.142 . . . . 72.24 107.998 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 17.9 t -77.03 -0.09 23.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.519 1.137 . . . . 72.15 109.979 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.466 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 7.2 p90 -176.64 129.91 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.432 1.083 . . . . 73.44 110.986 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.495 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 63.0 t60 -115.17 168.44 9.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 63.33 109.603 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.495 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 0.8 OUTLIER -140.38 142.27 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 73.4 109.266 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.631 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.8 -167.14 2.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 73.11 109.349 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.3 pt -120.01 125.19 74.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 63.13 109.337 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.417 HD13 ' NE2' ' A' ' 198' ' ' GLN . 17.1 tp -87.58 110.82 20.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.54 109.272 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.516 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.57 145.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 74.44 109.304 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.47 119.53 35.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 74.22 110.009 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.567 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -134.64 147.1 50.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 71.31 110.979 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.8 mmtp -71.66 134.0 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 75.22 109.332 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -74.87 -160.24 0.11 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 74.44 109.309 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.37 48.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.442 1.089 . . . . 75.24 109.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.68 -7.93 12.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 72.31 109.978 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.5 37.31 8.18 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.521 1.138 . . . . 74.32 110.983 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.02 137.47 43.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 71.54 109.324 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.7 m -71.88 102.69 2.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 65.43 110.34 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.4 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.1 mm-40 -102.23 -172.68 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.551 1.157 . . . . 75.35 110.284 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -126.24 145.68 50.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.447 1.092 . . . . 74.54 109.347 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.567 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 2.6 tpt180 -145.7 161.98 38.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.133 . . . . 71.15 110.32 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.475 HG13 ' CB ' ' A' ' 252' ' ' TRP . 16.1 mm -115.47 116.09 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.1 . . . . 71.14 109.321 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -102.46 46.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.509 1.131 . . . . 75.51 109.286 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -110.28 113.66 56.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.545 1.153 . . . . 64.52 109.232 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 241' ' ' LEU . 18.3 Cg_endo -75.0 -18.13 18.98 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 72.53 111.038 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.482 ' OG ' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 m -45.6 -25.98 0.54 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 74.21 109.976 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.427 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 4.1 mt -119.61 -60.46 1.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 74.35 109.302 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.564 ' CD2' HG23 ' A' ' 247' ' ' VAL . 97.6 m-85 -106.15 101.12 10.62 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 71.51 110.998 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -23.27 26.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 71.33 109.991 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 59.1 m -64.44 -47.8 77.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 65.3 110.008 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.39 -176.1 39.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.522 1.139 . . . . 52.32 111.006 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.424 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -75.03 169.78 21.87 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.475 1.776 . . . . 71.43 110.983 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.564 HG23 ' CD2' ' A' ' 242' ' ' PHE . 6.4 m -150.99 158.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 73.22 109.32 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 38.6 p -58.89 141.95 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 60.53 110.378 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -46.02 -26.1 0.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.541 1.151 . . . . 72.43 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 28.1 m -78.96 -62.43 1.7 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 74.2 110.387 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.32 -27.86 6.89 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 71.24 109.338 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.631 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 14.3 t90 -62.66 -61.43 2.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 72.53 107.971 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.555 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -46.59 -42.69 16.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 73.12 110.249 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.436 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.4 m-80 -55.94 -51.02 69.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 74.03 109.32 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -57.28 -19.46 22.02 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 72.12 109.3 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -90.0 -35.39 15.55 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 74.05 108.281 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.481 ' CA ' ' HB1' ' A' ' 264' ' ' ALA . 3.5 m -94.02 20.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.501 1.126 . . . . 72.32 109.286 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -50.45 106.06 0.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 75.02 109.277 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 262' ' ' GLY . 10.3 p -73.44 -3.2 26.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 71.02 110.375 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 t -44.02 -31.83 1.01 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 73.23 110.002 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . 0.446 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 50.6 t -87.52 -37.5 16.86 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 71.22 108.271 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 170.5 -129.2 1.76 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.497 1.123 . . . . 62.33 110.961 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -76.37 148.21 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 0.726 . . . . 75.01 109.939 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.481 ' HB1' ' CA ' ' A' ' 257' ' ' VAL . . . -169.91 146.99 3.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 70.23 109.284 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.4 t -172.77 152.88 2.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 74.41 109.97 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.465 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.6 p -98.26 114.92 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 72.33 109.285 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.3 t -72.48 -44.77 61.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.511 1.132 . . . . 71.55 110.052 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -158.59 171.37 20.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.22 110.003 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -155.62 156.01 34.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 73.43 111.018 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -166.75 163.58 16.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.438 1.086 . . . . 72.43 109.288 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.45 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.8 OUTLIER -123.58 160.66 26.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.01 109.296 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.45 HG23 ' CD ' ' A' ' 279' ' ' ARG . 21.4 p -147.5 -175.09 4.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 73.05 110.411 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.86 169.69 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 74.2 109.35 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -94.46 -15.96 44.98 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.487 1.117 . . . . 63.23 111.025 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -94.24 -16.95 23.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 0.775 . . . . 74.54 109.294 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.503 ' O ' ' CG1' ' A' ' 276' ' ' VAL . 0.3 OUTLIER -67.45 115.66 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.559 1.162 . . . . 65.21 109.283 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.487 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 16.6 t80 -61.66 -54.76 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 75.34 110.991 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 5.5 t80 -146.54 150.84 36.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 75.01 110.996 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.594 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 22.3 ttt-85 -121.7 142.7 49.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 71.1 110.339 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.48 157.87 34.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 62.14 109.96 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.76 8.51 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.503 1.791 . . . . 73.21 111.014 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 43.2 t -101.72 5.64 41.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.542 1.151 . . . . 70.41 109.961 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.9 t-20 81.66 22.86 0.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.562 1.164 . . . . 73.31 109.309 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.4 t -103.05 119.08 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 72.43 109.984 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.526 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 64.5 m-85 -106.12 156.5 18.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 73.21 111.007 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -113.76 176.1 5.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 75.55 109.279 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 96.5 m-85 -163.55 115.0 1.42 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.496 1.122 . . . . 75.33 110.997 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 11.4 t0 -115.6 95.87 5.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 74.53 109.279 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.55 -27.07 25.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 71.32 109.349 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.459 ' CB ' HG12 ' A' ' 292' ' ' ILE . 43.7 m-20 -99.12 5.76 46.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.13 . . . . 74.02 109.306 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.3 48.4 2.33 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 74.51 109.312 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.459 HG12 ' CB ' ' A' ' 290' ' ' ASN . 39.0 mm -78.32 -29.79 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 70.5 109.274 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.499 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.6 t-20 -94.63 -19.88 20.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.445 1.09 . . . . 73.4 109.348 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.487 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 16.3 m -87.68 -69.05 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 75.42 110.352 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 44.5 m-20 -51.39 -27.03 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 63.42 109.268 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 19.4 t -73.23 -68.8 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 73.43 108.323 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.55 HG12 ' CE2' ' A' ' 301' ' ' PHE . 56.0 t -40.25 -39.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.135 . . . . 73.33 109.296 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.44 -56.98 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.434 1.084 . . . . 74.54 109.273 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -17.95 19.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.42 110.403 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -77.41 -41.71 38.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 72.11 109.315 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.8 OUTLIER -106.08 39.64 1.75 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.521 1.138 . . . . 73.12 111.0 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.7 t -67.89 -53.22 28.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 74.53 109.99 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.492 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.8 -18.09 38.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 72.33 109.281 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 172' ' ' TYR . 14.2 mt -55.98 137.35 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 72.42 109.297 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.8 p -148.68 159.87 43.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 71.34 110.009 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.8 -149.06 40.88 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.475 1.109 . . . . 45.31 110.976 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 1.2 m -106.74 14.24 27.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.303 -0.999 . . . . 72.22 108.303 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -132.06 149.21 72.64 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.433 1.083 . . . . 74.35 110.003 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -74.97 147.08 88.41 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 74.01 110.989 -0.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.6 p -129.99 133.32 24.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 74.24 109.988 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.04 -167.87 6.01 Favored 'Cis proline' 0 C--N 1.359 1.13 0 C-N-CA 121.033 -2.486 . . . . 73.55 110.967 0.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.65 153.8 20.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 73.25 109.315 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.519 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.0 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 73.4 110.993 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.8 135.09 33.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.148 . . . . 54.44 109.278 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.2 24.73 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 74.03 109.274 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 16.5 t -57.04 -18.43 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 74.34 109.975 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -60.28 -26.6 66.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 62.31 109.999 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.515 1.134 . . . . 70.52 108.286 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 194' ' ' ASP . 7.9 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.284 -0.635 . . . . 73.32 109.284 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.577 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -100.39 111.33 23.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 74.53 109.319 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 m -73.29 -43.52 60.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.451 1.094 . . . . 75.14 110.029 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.457 HG21 ' CG2' ' A' ' 232' ' ' THR . 0.4 OUTLIER -112.58 161.22 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 65.1 109.281 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.464 HD11 ' CD1' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -101.84 144.75 29.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 72.22 109.316 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -33.79 4.34 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.493 1.786 . . . . 74.53 110.994 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.19 147.43 19.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.451 1.094 . . . . 72.13 109.306 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.551 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -47.29 -35.18 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 74.14 109.294 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.3 -45.86 4.36 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 65.51 109.322 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.512 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -72.85 -34.11 66.56 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.48 1.112 . . . . 73.43 110.396 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.514 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.6 OUTLIER -59.94 -56.35 22.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.486 1.116 . . . . 73.45 109.31 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.491 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.3 m-80 -53.46 -31.39 45.32 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 72.33 109.3 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.08 -54.08 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.149 . . . . 72.32 109.991 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' A' ' 193' ' ' TYR . 87.5 mt -45.25 -41.6 8.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 75.53 109.262 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.47 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.42 -44.66 57.82 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.423 1.077 . . . . 74.22 110.974 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -46.95 -36.2 7.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.42 1.075 . . . . 64.15 109.306 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . 61.0 mt-30 -77.31 -55.15 5.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 74.25 110.303 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.426 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 17.5 mt -50.35 -27.09 4.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 74.41 109.286 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -37.38 60.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 74.22 109.31 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.4 t-20 -57.74 -17.88 17.97 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 74.34 109.33 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.404 ' NE2' ' H ' ' A' ' 164' ' ' SER . 4.4 mm100 -82.79 -25.72 32.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.42 110.291 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -40.35 114.27 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.15 . . . . 71.42 110.028 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.7 m -42.42 124.4 2.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 70.23 108.3 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.89 -22.04 3.88 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.523 1.14 . . . . 73.44 111.016 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 56.8 p -90.09 158.25 17.39 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 0.747 . . . . 74.31 110.38 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.2 t -89.62 -2.52 58.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 75.13 109.984 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 m -110.27 -1.6 17.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 75.41 110.396 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.75 134.51 41.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.575 1.172 . . . . 62.14 109.288 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.404 ' H ' ' NE2' ' A' ' 156' ' ' GLN . 0.5 OUTLIER -55.14 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 72.33 109.976 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.462 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.6 t -156.27 128.32 3.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 75.12 109.965 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -74.95 136.61 45.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.031 -2.487 . . . . 73.34 111.019 -0.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.9 p -73.19 -179.42 3.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.24 108.269 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.28 124.52 41.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.573 1.171 . . . . 74.02 109.311 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 169' ' ' THR . 12.4 p -90.13 81.16 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 73.14 110.403 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -80.28 -11.18 59.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.128 . . . . 74.12 110.995 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.57 -5.2 35.53 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.519 1.137 . . . . 74.43 110.314 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.569 ' CE2' HD11 ' A' ' 304' ' ' LEU . 26.8 t80 -129.73 69.68 81.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 75.11 111.023 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.403 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 114.19 3.97 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.448 1.762 . . . . 71.11 111.039 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.534 HG22 ' CE1' ' A' ' 172' ' ' TYR . 22.1 t -153.26 -66.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 73.14 109.302 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.91 114.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 75.53 109.28 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.569 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 151.64 46.4 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.476 1.11 . . . . 72.1 111.004 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 180' ' ' ARG . 84.9 m -85.73 -23.12 27.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.3 -1.0 . . . . 74.01 108.3 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.569 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 16.1 p90 -67.13 -35.89 80.71 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.145 . . . . 74.53 110.995 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -68.53 -67.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 44.54 109.271 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 240' ' ' SER . 0.1 OUTLIER -44.05 -46.56 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 73.23 110.319 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.415 ' HB3' ' NZ ' ' A' ' 197' ' ' LYS . . . -44.96 -50.45 10.57 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 73.24 109.285 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.693 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -54.0 -35.39 61.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 73.13 109.579 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 180' ' ' ARG . 17.4 mmmt -73.43 -32.22 64.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 1.143 . . . . 75.23 109.334 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 20.3 mtm -66.21 -55.95 13.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 64.4 110.99 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.492 ' NH2' ' N ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -55.32 -26.86 43.17 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 75.24 110.364 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.419 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 1.2 tt0 -64.05 -43.38 95.69 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.33 110.266 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.426 ' HB ' ' CG1' ' A' ' 153' ' ' ILE . 21.4 mm -70.48 -38.04 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.138 . . . . 74.24 109.281 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -56.43 -31.6 64.09 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 64.43 109.319 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 192' ' ' GLY . 35.7 mtp -72.89 -43.64 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.573 1.171 . . . . 75.42 110.973 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -45.32 -53.37 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 73.33 109.296 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -64.66 -27.86 69.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.21 109.314 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.08 52.33 0.89 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.545 1.153 . . . . 61.41 111.002 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.577 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 60.2 m-85 -150.83 128.13 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.537 0.786 . . . . 70.21 110.981 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.471 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 0.2 OUTLIER -98.38 131.51 44.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 62.2 109.363 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 24.1 p -109.5 -179.3 3.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.5 1.125 . . . . 73.03 108.276 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.71 176.99 5.44 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.55 1.156 . . . . 62.02 110.305 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 181' ' ' ALA . 14.2 mmtt -105.7 171.6 7.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 75.31 109.302 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -166.81 121.02 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 75.14 110.288 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.558 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 8.8 m-85 -116.37 123.93 48.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.466 1.104 . . . . 73.41 110.99 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 8.7 p -115.28 152.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.496 1.122 . . . . 74.32 109.279 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 5.3 m-85 -124.91 162.75 23.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 74.32 111.016 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.57 -179.88 17.76 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.455 1.097 . . . . 70.51 111.005 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 263' ' ' SER . 59.0 t-20 -69.11 109.62 4.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.528 0.781 . . . . 70.33 109.276 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.421 HD13 ' N ' ' A' ' 218' ' ' HIS . 5.9 mt -114.01 93.78 4.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.432 1.083 . . . . 73.24 109.297 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 256' ' ' CYS . 7.1 mttt -93.12 167.19 11.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 63.51 109.349 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -175.53 151.86 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 61.34 109.286 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 64.2 109.962 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.315 -0.995 . . . . 73.31 108.315 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.28 156.61 11.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 75.41 109.287 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -141.34 119.2 11.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 63.52 109.348 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -125.11 137.1 54.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.01 -1.107 . . . . 75.34 108.01 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -81.81 4.6 21.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.508 1.13 . . . . 71.5 110.022 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 9.3 p90 -177.74 126.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.32 110.946 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.514 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 40.5 t60 -112.7 168.71 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 71.12 109.608 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 1.5 p -144.62 142.07 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 72.54 109.314 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.76 -165.13 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 52.32 109.304 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 14.2 pt -119.07 124.93 73.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 74.42 109.305 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.3 tp -85.9 108.99 18.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 72.12 109.293 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.514 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.61 148.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.128 . . . . 71.54 109.301 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 140' ' ' ILE . 49.7 m -116.89 125.39 51.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.01 110.03 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 34.8 p90 -139.48 137.47 35.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 71.34 111.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -64.6 131.1 46.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.568 1.167 . . . . 73.51 109.347 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -72.06 -160.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 72.25 109.277 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.08 49.56 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 71.34 109.324 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.98 -7.85 12.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.497 1.123 . . . . 73.41 110.034 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.42 37.8 8.0 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.495 1.122 . . . . 43.11 111.001 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.62 43.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.501 0.765 . . . . 74.23 109.283 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.457 ' CG2' HG21 ' A' ' 139' ' ' VAL . 2.5 m -71.9 102.75 2.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.54 110.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.409 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 6.8 mm-40 -102.63 -172.58 2.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 75.41 110.303 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.1 mmtm -126.18 145.39 50.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 71.13 109.301 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.571 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 2.2 tpt180 -143.07 161.44 38.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 74.14 110.31 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' A' ' 252' ' ' TRP . 11.2 mm -114.74 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.562 1.163 . . . . 75.25 109.305 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.497 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 4.0 mm -102.58 45.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.115 . . . . 74.44 109.298 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.05 109.47 62.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 75.44 109.263 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -27.3 10.05 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.477 1.777 . . . . 74.13 110.966 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.9 OUTLIER -45.21 -26.37 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 74.45 109.992 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.25 -60.39 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 74.41 109.294 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 255' ' ' ALA . 87.9 m-85 -107.87 99.6 9.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 75.21 111.009 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.96 -6.28 57.36 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 72.02 110.015 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.9 p -80.53 -46.09 16.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.539 1.15 . . . . 71.21 109.97 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.49 -175.76 42.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 74.12 111.034 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.449 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.98 163.57 35.1 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.503 1.791 . . . . 65.14 110.987 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 242' ' ' PHE . 2.4 m -150.35 156.88 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 72.04 109.278 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.423 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.2 p -60.54 140.49 57.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 72.53 110.434 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.42 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 1.1 p-10 -42.97 -28.98 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.33 109.281 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.423 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.0 m -71.34 -65.22 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.116 . . . . 74.41 110.421 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.32 13.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 73.44 109.31 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.577 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 12.5 t90 -59.94 -61.12 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.982 -1.118 . . . . 75.51 107.982 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.566 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.42 -41.61 20.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 71.23 110.275 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.411 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 2.9 m-80 -57.31 -51.11 70.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 74.21 109.3 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.571 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . . . -56.25 -19.51 14.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 62.44 109.297 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -89.08 -35.81 16.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 73.44 108.32 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.472 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.5 m -93.96 21.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 74.4 109.304 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -50.22 106.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 73.04 109.316 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 262' ' ' GLY . 4.6 p -73.48 -3.14 25.74 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 1.129 . . . . 72.44 110.38 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 39.0 t -44.52 -30.76 0.94 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 73.35 110.025 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.51 -37.2 15.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 71.14 108.275 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 166.84 -127.95 1.67 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.53 1.144 . . . . 41.14 110.983 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.61 144.86 43.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 0.778 . . . . 74.15 109.942 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.472 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -168.21 147.53 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.44 109.304 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 84.1 p -172.95 155.56 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.45 109.973 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 3.8 p -101.14 118.86 48.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.145 . . . . 75.35 109.357 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.3 t -73.22 -43.75 60.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 73.14 110.026 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 51.2 p -168.8 -179.35 3.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 75.4 110.029 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -159.22 157.16 30.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 74.34 110.979 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.35 152.22 29.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 62.44 109.295 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.445 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.8 OUTLIER -112.36 160.71 17.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 73.02 109.344 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.478 HG21 ' CZ ' ' A' ' 285' ' ' TYR . 1.7 p -153.83 -178.45 7.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 73.43 110.396 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -68.24 162.15 25.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.461 1.101 . . . . 74.12 109.311 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.9 -44.69 36.37 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.515 1.135 . . . . 73.21 111.015 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.492 ' N ' ' NH2' ' A' ' 185' ' ' ARG . 1.7 p30 -53.18 -41.01 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 0.777 . . . . 72.53 109.299 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 22.8 t -43.56 120.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 74.54 109.247 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -82.2 -53.07 6.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.523 1.139 . . . . 73.23 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -136.92 152.83 50.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 75.24 111.002 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.558 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 78.2 ttt-85 -126.86 147.3 50.06 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 74.31 110.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.96 158.14 50.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.47 1.106 . . . . 72.02 109.936 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 0.25 9.15 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.465 1.771 . . . . 73.41 110.952 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 7.1 t -98.98 4.98 47.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 72.41 110.015 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 75.38 41.56 0.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.35 109.338 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -120.21 120.39 36.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.467 1.104 . . . . 64.05 109.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.478 ' CZ ' HG21 ' A' ' 272' ' ' THR . 11.7 m-30 -103.05 160.65 14.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 73.25 111.035 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -125.42 177.24 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 74.42 109.342 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.7 m-85 -161.03 115.84 2.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.476 1.11 . . . . 75.13 111.016 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.435 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 1.0 OUTLIER -115.36 96.78 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 74.24 109.348 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -85.63 -19.11 31.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 75.44 109.253 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.466 ' CB ' HG12 ' A' ' 292' ' ' ILE . 38.6 m-20 -107.65 6.59 27.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.43 109.297 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.693 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.26 47.22 2.09 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 73.21 109.3 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.466 HG12 ' CB ' ' A' ' 290' ' ' ASN . 47.5 mm -76.51 -31.58 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 73.31 109.296 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.5 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.5 t-20 -94.78 -18.51 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.112 . . . . 74.41 109.27 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.404 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 2.0 m -84.76 -66.51 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 74.23 110.424 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 87.8 m-20 -56.68 -18.71 13.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 75.1 109.278 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 4.9 t -80.49 -63.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.128 . . . . 74.03 108.308 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 65.9 t -46.93 -37.24 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.52 1.138 . . . . 75.3 109.334 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.69 -57.8 5.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.12 . . . . 74.13 109.277 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.85 -20.76 16.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 73.41 110.384 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -72.27 -39.2 68.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 75.02 109.3 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.564 ' CD1' HD11 ' A' ' 304' ' ' LEU . 3.6 m-30 -101.78 35.09 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.498 1.123 . . . . 64.34 110.987 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.3 t -67.96 -43.85 78.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 74.11 110.01 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.496 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -95.62 -17.18 21.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.102 . . . . 71.12 109.278 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 172' ' ' TYR . 14.2 mt -56.58 153.43 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 71.31 109.288 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.1 p -165.55 162.17 18.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.528 1.142 . . . . 75.41 110.039 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 65.69 -153.1 51.48 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.507 1.13 . . . . 75.02 110.979 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 3.0 m -99.38 9.77 42.66 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.294 -1.002 . . . . 73.04 108.294 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -125.06 148.85 61.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 64.4 109.953 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.3 Cg_endo -74.96 147.06 88.37 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.965 -2.515 . . . . 73.41 111.014 -0.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.468 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.1 OUTLIER -128.83 133.33 25.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 63.14 110.006 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.99 -168.73 6.72 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 120.974 -2.511 . . . . 73.22 111.042 -0.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 150.3 40.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.135 . . . . 73.22 109.318 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.525 1.803 . . . . 71.02 111.03 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.47 127.33 39.07 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.143 . . . . 73.24 109.237 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.52 27.22 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 72.35 109.297 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 12.5 t -51.72 -35.55 43.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 70.02 109.993 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 30.8 m -42.3 -28.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.422 1.076 . . . . 73.42 110.025 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 62.0 m . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.42 108.29 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.468 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 12.5 tp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.316 -0.624 . . . . 73.13 109.316 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -102.56 106.91 17.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 64.43 109.302 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 m -69.33 -42.59 75.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.478 1.111 . . . . 61.4 109.972 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.45 HG22 ' CG2' ' A' ' 232' ' ' THR . 0.4 OUTLIER -112.79 159.75 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 74.23 109.298 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.44 ' CD1' HD12 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.07 143.83 26.95 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 72.32 109.316 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -33.23 4.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.514 1.797 . . . . 75.35 110.984 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.37 146.28 16.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 74.12 109.267 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -45.15 -36.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.158 . . . . 73.03 109.271 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.75 2.96 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.546 1.153 . . . . 63.54 109.265 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.528 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.11 -36.26 72.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.546 1.154 . . . . 52.23 110.406 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.529 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.7 -57.26 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 72.24 109.32 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.501 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 48.8 m-80 -51.91 -31.93 30.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 70.52 109.292 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.75 -56.66 7.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 62.23 109.998 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.442 HD11 ' CB ' ' A' ' 193' ' ' TYR . 22.6 mt -43.05 -41.08 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 72.23 109.28 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.469 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.02 -44.48 54.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.544 1.153 . . . . 74.05 111.003 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -48.52 -34.82 11.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.135 . . . . 74.12 109.324 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.436 ' CB ' ' CG2' ' A' ' 187' ' ' ILE . 54.0 mt-30 -77.69 -51.7 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 73.34 110.335 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.421 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 17.6 mt -54.61 -24.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.147 . . . . 74.02 109.327 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -34.73 49.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 72.04 109.26 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -58.64 -20.08 44.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 1.137 . . . . 71.21 109.295 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 157' ' ' SER . 8.9 mm100 -77.63 -24.1 49.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 74.41 110.29 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 156' ' ' GLN . 6.3 m -38.99 113.04 0.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 72.13 109.967 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.9 m -43.05 129.65 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 73.43 108.301 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 125.36 -14.24 7.35 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 71.01 110.989 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.1 p -98.47 154.22 18.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 0.775 . . . . 63.22 110.434 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 p -86.4 -3.61 59.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.548 1.155 . . . . 73.32 109.974 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 -3.98 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 74.42 110.369 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.93 133.6 39.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 71.45 109.285 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -168.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 72.21 109.99 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.465 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -155.91 128.16 4.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 71.25 110.002 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 136.62 46.04 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 120.967 -2.514 . . . . 54.32 111.03 -0.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 13.2 p -73.01 179.66 3.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.13 108.3 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.489 ' HB ' ' CE1' ' A' ' 170' ' ' PHE . 4.4 mp -91.9 135.41 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.094 . . . . 74.14 109.336 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.8 p -96.19 94.53 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.122 . . . . 72.15 110.388 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.517 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 90.2 m-85 -88.48 -15.46 35.3 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.557 1.161 . . . . 72.11 110.993 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.67 -2.02 24.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 74.12 110.285 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.566 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 30.9 t80 -132.38 67.18 78.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 75.03 111.014 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.416 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -75.03 112.53 3.58 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.471 1.774 . . . . 72.25 110.991 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.515 HG23 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.95 -72.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 71.4 109.305 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -152.6 125.12 8.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 62.21 109.325 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 139.34 44.29 0.07 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.467 1.105 . . . . 75.35 111.02 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 218' ' ' HIS . 6.0 t -81.56 -25.42 35.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.329 -0.989 . . . . 74.2 108.329 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.466 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 28.4 p90 -71.47 -28.67 64.11 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 74.44 110.992 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.09 -68.12 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.423 1.077 . . . . 64.12 109.307 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -45.24 -47.69 12.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 73.52 110.298 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.421 ' HB1' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.2 -55.09 4.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.465 1.103 . . . . 72.0 109.28 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.42 -36.61 15.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 74.14 109.582 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 180' ' ' ARG . 9.4 mmmm -77.07 -32.82 57.04 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.149 . . . . 72.12 109.3 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 181' ' ' ALA . 18.3 mtm -63.6 -50.23 70.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 71.14 110.99 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -64.43 -26.34 68.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 75.14 110.316 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -38.92 90.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 73.45 110.301 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.436 ' CG2' ' CB ' ' A' ' 152' ' ' GLN . 21.2 mm -70.7 -37.68 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 72.51 109.336 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.1 OUTLIER -54.69 -44.08 73.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.525 1.141 . . . . 73.41 109.273 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.456 ' HE1' ' CZ ' ' A' ' 185' ' ' ARG . 13.7 mtt -58.85 -43.59 90.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 70.24 111.047 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.08 -51.46 24.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 75.34 109.3 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.421 ' ND2' HE22 ' A' ' 152' ' ' GLN . 6.1 t-20 -68.74 -26.06 65.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.451 1.094 . . . . 75.23 109.257 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.15 57.94 0.84 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.495 1.122 . . . . 61.11 110.982 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 59.6 m-85 -152.13 140.37 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.459 0.741 . . . . 75.14 110.999 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.468 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -105.53 130.8 53.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 72.23 109.301 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.459 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 11.4 p -109.42 -179.52 3.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 71.01 108.258 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.13 175.65 8.25 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.543 1.152 . . . . 75.2 110.279 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.421 ' NZ ' ' HB1' ' A' ' 181' ' ' ALA . 15.8 mmtt -108.9 159.32 16.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 73.43 109.306 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.405 ' NE2' ' CZ3' ' A' ' 252' ' ' TRP . 8.3 tt0 -152.4 117.72 5.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.548 1.155 . . . . 74.51 110.273 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -108.94 136.13 48.98 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.496 1.122 . . . . 71.52 111.047 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.461 ' CG2' HG21 ' A' ' 266' ' ' VAL . 9.4 p -131.81 143.33 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 75.35 109.318 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.3 m-85 -117.7 161.38 19.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 74.32 110.952 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.63 -179.62 17.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.502 1.126 . . . . 74.31 111.023 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 263' ' ' SER . 58.8 t-20 -69.08 110.22 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.43 109.324 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.466 HD12 ' CB ' ' A' ' 218' ' ' HIS . 5.8 mt -114.32 93.98 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 74.12 109.301 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 256' ' ' CYS . 7.0 mttt -93.36 166.14 12.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 73.03 109.297 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -173.28 148.18 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 75.11 109.286 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 74.14 109.953 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 108.314 -0.995 . . . . 64.43 108.314 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.99 157.52 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 73.13 109.27 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -140.76 120.55 13.47 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 70.53 109.26 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m-90 -125.95 135.67 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 74.55 107.995 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.6 t -81.14 1.21 32.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.25 109.969 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 11.2 p90 -172.23 125.62 0.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.467 1.104 . . . . 74.4 111.024 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.6 ' CE1' ' SG ' ' A' ' 177' ' ' CYS . 76.4 t60 -125.41 157.7 36.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.21 109.568 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 220' ' ' ALA . 1.5 p -131.5 163.99 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.548 1.155 . . . . 74.52 109.288 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.65 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -156.19 -167.55 2.47 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.517 1.136 . . . . 64.0 109.292 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.6 pt -117.77 119.79 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 72.35 109.316 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 tp -83.11 109.86 17.52 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.555 1.159 . . . . 75.14 109.304 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.529 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -106.15 147.48 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 75.42 109.313 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 140' ' ' ILE . 37.0 m -116.74 125.4 51.6 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 73.1 109.983 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.572 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -140.52 137.44 33.81 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.54 1.15 . . . . 74.2 110.977 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.406 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 17.9 mmtp -64.08 132.45 50.55 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.153 . . . . 72.21 109.307 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -72.82 -160.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 74.34 109.311 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.86 0.34 48.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.32 109.309 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.32 -8.56 12.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 74.34 109.997 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.45 37.73 7.44 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.469 1.106 . . . . 75.45 110.967 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.65 136.97 46.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.535 0.785 . . . . 74.45 109.28 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.45 ' CG2' HG22 ' A' ' 139' ' ' VAL . 2.5 m -71.23 102.79 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 70.41 110.389 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.43 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.2 mm-40 -102.33 -172.65 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.133 . . . . 74.42 110.32 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -126.1 145.36 50.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 74.2 109.283 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.572 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 4.7 tpt180 -145.88 160.34 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 74.43 110.325 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.476 HG13 ' CB ' ' A' ' 252' ' ' TRP . 9.9 mm -114.24 120.89 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 75.52 109.251 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.507 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 5.5 mm -104.29 44.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 74.33 109.288 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.57 113.62 62.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 1.146 . . . . 75.04 109.271 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.517 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -75.03 -26.61 10.71 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.501 1.79 . . . . 72.44 111.009 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.419 ' HB2' ' NH2' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -41.53 -30.76 0.22 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 74.5 110.049 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.2 mt -110.05 -61.14 1.7 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 72.32 109.317 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.567 ' CD1' HG13 ' A' ' 247' ' ' VAL . 98.3 m-85 -108.78 99.51 8.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 74.33 111.013 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 69.5 m -86.39 -15.98 38.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 64.5 109.998 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.8 t -73.92 -40.05 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.135 . . . . 70.12 110.011 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.6 -177.54 45.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 63.1 111.04 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.438 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.96 170.57 20.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.503 1.791 . . . . 74.42 111.062 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.567 HG13 ' CD1' ' A' ' 242' ' ' PHE . 11.2 m -150.84 158.55 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.506 1.129 . . . . 71.31 109.287 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.47 HG23 ' CZ ' ' A' ' 235' ' ' ARG . 40.6 p -60.64 141.45 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.157 . . . . 64.3 110.379 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -46.3 -25.91 0.71 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 71.32 109.331 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.404 ' N ' ' C ' ' A' ' 248' ' ' THR . 21.4 m -79.37 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.22 110.439 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -54.42 -22.22 11.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 63.21 109.283 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.65 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.6 t90 -66.56 -57.8 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.513 1.133 . . . . 74.2 107.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.556 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -49.22 -42.99 42.16 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 72.13 110.33 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -56.24 -51.04 69.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 75.34 109.31 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.504 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . . . -55.6 -19.36 10.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.444 1.09 . . . . 74.22 109.321 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -89.0 -36.79 15.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.33 108.266 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.469 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.4 m -92.73 20.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 74.21 109.315 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -50.18 105.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.467 1.105 . . . . 74.21 109.266 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.41 -3.26 26.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 75.43 110.352 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 t -44.47 -30.13 0.82 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 71.12 110.01 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.8 t -89.01 -37.3 15.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.115 . . . . 74.0 108.29 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.13 -129.3 1.86 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.481 1.113 . . . . 75.44 111.019 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -73.9 145.18 45.0 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.582 0.813 . . . . 64.25 110.036 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.469 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -168.16 147.68 4.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 62.1 109.281 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 94.7 p -172.9 155.48 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 75.21 110.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.461 HG21 ' CG2' ' A' ' 200' ' ' VAL . 3.7 p -101.42 117.95 47.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 74.24 109.313 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.2 t -73.89 -44.19 56.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 74.42 109.981 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.4 m -166.65 172.97 10.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 63.5 110.002 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -154.64 156.05 35.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 73.23 111.011 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.65 153.34 31.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 1.151 . . . . 65.21 109.311 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.402 ' ND2' ' C ' ' A' ' 271' ' ' ASN . 1.0 OUTLIER -113.49 160.7 18.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 74.14 109.257 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.428 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 2.5 p -154.37 -179.61 8.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.52 1.137 . . . . 75.33 110.41 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.411 ' CB ' HG22 ' A' ' 276' ' ' VAL . . . -66.83 167.76 10.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 71.25 109.307 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.9 -41.77 13.97 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.481 1.113 . . . . 74.01 110.986 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -57.2 -42.59 81.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.509 0.77 . . . . 72.04 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.411 HG22 ' CB ' ' A' ' 273' ' ' ALA . 44.1 t -43.86 118.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.03 109.297 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.582 ' CD2' ' OD2' ' A' ' 288' ' ' ASP . 18.4 t80 -73.74 -53.46 10.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 74.55 111.003 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 279' ' ' ARG . 31.0 t80 -136.31 166.7 22.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 75.31 111.008 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.0 ttt-85 -135.39 147.45 49.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 71.34 110.283 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.85 158.03 50.94 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 61.3 109.997 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 0.32 9.08 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.565 1.823 . . . . 73.24 111.01 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 42.0 p -98.42 4.23 48.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 74.43 109.993 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.3 t-20 77.21 41.74 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 74.24 109.304 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 t -122.66 131.4 53.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 73.03 109.973 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 -111.65 153.13 26.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 73.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.587 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.95 177.44 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.458 1.099 . . . . 73.21 109.334 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 84.9 m-85 -160.25 115.79 2.33 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 75.32 111.044 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.582 ' OD2' ' CD2' ' A' ' 277' ' ' TYR . 0.7 OUTLIER -115.43 94.98 4.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.478 1.111 . . . . 71.51 109.337 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -85.61 -18.34 33.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.483 1.115 . . . . 72.25 109.297 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.441 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.3 m-20 -107.09 3.28 25.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.476 1.11 . . . . 73.41 109.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.56 47.43 2.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.448 1.092 . . . . 74.33 109.27 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.441 HG12 ' CB ' ' A' ' 290' ' ' ASN . 22.5 mm -74.27 -32.63 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 75.22 109.276 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.9 t-20 -90.72 -26.17 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 72.44 109.291 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.458 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 1.3 m -79.37 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.463 1.102 . . . . 62.3 110.409 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -54.59 -20.13 7.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.133 . . . . 72.52 109.272 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 40.4 t -86.32 -62.22 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.477 1.111 . . . . 73.43 108.288 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.9 t -40.29 -41.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 65.4 109.29 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 24.3 mt -69.96 -56.13 7.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 75.33 109.316 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -55.3 -18.46 6.4 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 74.23 110.449 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -75.38 -45.77 37.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 75.42 109.302 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.566 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 1.6 m-30 -99.81 38.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.563 1.165 . . . . 71.21 111.029 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.1 t -69.5 -45.01 69.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.122 . . . . 55.41 110.029 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.67 -17.7 22.95 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 74.51 109.277 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.491 HD13 ' CD1' ' A' ' 301' ' ' PHE . 14.8 mt -59.52 144.91 46.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 73.04 109.34 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.3 p -154.02 158.08 40.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 75.42 110.057 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 70.32 -162.17 53.25 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.505 1.128 . . . . 74.23 110.969 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 310' ' ' SER . 9.4 p -92.1 13.9 17.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.29 -1.004 . . . . 74.5 108.29 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.49 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 3.3 m -132.96 148.1 68.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 74.54 110.009 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -75.01 145.42 83.87 Favored 'Cis proline' 0 C--N 1.361 1.196 0 C-N-CA 120.984 -2.507 . . . . 72.11 111.008 0.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.492 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -131.35 135.6 27.33 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.117 . . . . 74.41 109.996 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.97 -174.96 15.03 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.016 -2.493 . . . . 72.21 111.026 -0.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.43 154.96 21.06 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 73.32 109.296 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.425 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.97 -162.23 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.498 1.788 . . . . 75.43 111.011 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -82.96 131.52 35.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 72.04 109.297 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.39 26.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.512 1.133 . . . . 72.54 109.305 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 6.9 t -70.76 -33.52 70.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 74.41 109.982 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 p -45.75 -25.71 0.54 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 64.53 110.01 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 74.32 108.275 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.479 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 9.0 tp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.348 -0.612 . . . . 73.32 109.348 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.555 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -103.88 105.47 15.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 75.12 109.32 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -83.64 7.89 16.03 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 73.03 110.002 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.4 145.86 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.47 1.106 . . . . 74.33 109.327 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.464 HD11 ' CD1' ' A' ' 149' ' ' LEU . 1.6 mt -97.05 141.67 23.4 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 72.4 109.322 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -30.54 7.09 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.506 1.793 . . . . 75.2 110.968 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.58 150.25 15.71 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.476 1.11 . . . . 72.51 109.293 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -48.54 -36.67 7.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 73.25 109.258 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.99 -47.49 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 72.13 109.242 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.506 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.44 -36.19 71.18 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 61.35 110.375 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -58.1 -57.17 14.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 1.093 . . . . 73.42 109.278 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.517 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 47.6 m-80 -51.71 -32.34 29.82 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 72.21 109.332 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.25 -53.83 17.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 63.43 110.007 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.464 ' CD1' HD11 ' A' ' 140' ' ' ILE . 63.4 mt -45.56 -41.55 10.0 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.53 1.144 . . . . 74.24 109.291 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.41 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.38 -44.7 58.03 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 75.24 110.991 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -47.21 -33.89 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 74.32 109.319 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.451 ' HB2' ' CG2' ' A' ' 187' ' ' ILE . 62.9 mt-30 -78.53 -53.9 6.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 71.14 110.302 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.472 ' CD1' HD11 ' A' ' 188' ' ' LEU . 24.1 mt -51.28 -28.32 7.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 71.22 109.281 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -38.48 63.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 72.11 109.273 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.94 -16.97 20.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.536 1.147 . . . . 71.11 109.283 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -86.83 -26.55 23.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.514 1.134 . . . . 71.13 110.272 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 m -40.04 128.78 2.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 72.12 109.979 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.71 112.43 1.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 75.21 108.326 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.76 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 73.52 110.969 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.4 p -95.47 161.1 14.21 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 0.736 . . . . 70.51 110.383 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.64 -7.59 49.59 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 61.45 110.01 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.4 m -103.53 -4.23 24.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.096 . . . . 64.11 110.396 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.91 136.32 46.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 72.4 109.291 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.05 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 61.01 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.1 m -156.24 127.2 3.57 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 74.51 110.017 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 140.06 65.22 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 120.994 -2.503 . . . . 74.1 111.008 0.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.6 p -72.78 -178.6 2.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 55.14 108.319 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 183' ' ' LYS . 2.2 mp -83.45 128.51 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 75.24 109.275 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 51.3 p -96.56 69.15 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 73.21 110.374 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -81.25 -11.36 59.4 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 73.34 111.023 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.456 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.31 -1.82 25.4 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.545 1.153 . . . . 74.45 110.288 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 174' ' ' VAL . 18.9 t80 -131.47 64.59 73.7 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 74.33 110.984 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.432 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.95 123.09 7.65 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.444 1.76 . . . . 70.21 111.024 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.58 HG22 ' CE1' ' A' ' 172' ' ' TYR . 10.7 t -152.68 -55.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 72.05 109.324 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 177' ' ' CYS . 5.2 m-20 -147.22 -78.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.146 . . . . 72.3 109.313 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.38 92.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.505 1.128 . . . . 63.3 110.978 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.602 ' SG ' ' CE1' ' A' ' 218' ' ' HIS . 13.4 t -115.36 -16.0 11.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 75.52 108.293 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 33.1 p90 -74.99 -45.0 44.99 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.482 1.114 . . . . 73.13 111.02 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -41.58 -68.39 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.529 1.143 . . . . 74.21 109.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -47.67 -47.23 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 74.41 110.333 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -46.86 -55.86 7.27 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.47 1.106 . . . . 75.41 109.289 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.701 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.1 -30.23 4.31 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 74.54 109.604 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.538 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 21.4 mmmt -85.12 -31.99 23.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 74.32 109.275 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.453 ' CE ' HG12 ' A' ' 221' ' ' ILE . 31.2 mtm -62.51 -36.7 83.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 74.22 111.0 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.471 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.0 OUTLIER -78.32 -33.77 49.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 75.22 110.293 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.538 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -53.9 -35.44 61.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 75.34 110.303 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.453 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 21.8 mm -74.67 -48.06 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.529 1.143 . . . . 74.21 109.296 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.472 HD11 ' CD1' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -47.22 -36.87 9.45 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.452 1.095 . . . . 75.53 109.305 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.471 ' HE3' ' CZ ' ' A' ' 185' ' ' ARG . 6.5 mtt -65.72 -46.96 76.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 74.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -46.43 -51.31 15.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 73.25 109.304 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -65.33 -34.81 79.2 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 74.34 109.31 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.93 54.19 0.46 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.473 1.108 . . . . 71.52 110.984 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.555 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 78.1 m-85 -152.24 142.18 22.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 0.772 . . . . 74.01 110.994 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.2 OUTLIER -108.13 128.65 54.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 75.32 109.291 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.469 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 12.5 p -104.45 178.22 4.62 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.49 1.119 . . . . 71.44 108.28 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -127.17 173.81 9.42 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.33 110.322 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 181' ' ' ALA . 21.4 mmtt -108.3 153.78 22.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.544 1.153 . . . . 73.35 109.303 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -147.34 117.42 7.27 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.528 1.142 . . . . 74.44 110.326 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.0 m-85 -110.59 123.29 49.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 70.33 110.973 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.466 ' CG2' HG21 ' A' ' 266' ' ' VAL . 8.0 p -114.99 151.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 73.44 109.313 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.451 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 13.0 m-85 -122.27 161.18 23.77 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 71.15 111.01 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.6 -178.4 16.72 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.478 1.111 . . . . 51.44 111.006 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 263' ' ' SER . 58.8 t-20 -69.96 109.44 4.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.574 0.808 . . . . 64.31 109.328 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.424 HD11 ' N ' ' A' ' 218' ' ' HIS . 5.5 mt -114.26 94.5 4.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.155 . . . . 73.32 109.329 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 256' ' ' CYS . 8.4 mttt -92.96 164.3 13.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 74.23 109.305 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -175.69 170.92 2.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.113 . . . . 62.44 109.321 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.11 110.013 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 108.267 -1.012 . . . . 74.5 108.267 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.417 ' HB ' ' NE1' ' A' ' 215' ' ' TRP . 1.9 m -111.12 128.75 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 64.42 109.314 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 63.12 109.327 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.3 m0 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.119 . . . . 74.33 108.034 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -81.65 -1.31 46.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 75.11 110.007 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.501 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.2 p90 -169.8 127.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 73.41 110.977 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.602 ' CE1' ' SG ' ' A' ' 177' ' ' CYS . 85.8 t60 -124.79 149.24 47.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 71.22 109.597 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 220' ' ' ALA . 1.5 p -118.1 164.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 75.44 109.292 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.644 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.06 -170.53 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.13 . . . . 72.32 109.321 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.471 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 21.1 pt -116.44 118.38 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.546 1.154 . . . . 71.22 109.272 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 11.8 tp -83.99 108.64 17.07 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.461 1.101 . . . . 73.22 109.327 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.9 OUTLIER -102.95 143.89 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 74.55 109.311 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 0.2 OUTLIER -116.32 116.78 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 61.23 109.981 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.5 p90 -131.92 145.83 51.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.121 . . . . 75.51 111.019 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -70.76 132.73 45.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 73.42 109.335 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.28 -160.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 74.24 109.283 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.89 -0.06 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 73.24 109.244 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -114.86 -8.51 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 73.32 109.984 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.86 37.55 7.86 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.494 1.121 . . . . 71.24 111.016 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.41 137.95 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 73.44 109.294 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.0 m -71.87 102.55 2.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 72.24 110.368 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.401 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 6.9 mm-40 -102.12 -172.71 2.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 62.24 110.275 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -127.3 144.63 51.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 73.14 109.304 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.574 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 2.0 tpt180 -143.91 163.31 33.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 70.14 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.474 HG13 ' CB ' ' A' ' 252' ' ' TRP . 22.0 mm -118.82 116.98 52.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 75.21 109.319 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 221' ' ' ILE . 3.4 mm -98.7 50.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 71.31 109.327 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 238' ' ' ASP . 41.2 p-10 -96.6 109.61 48.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 74.15 109.349 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 240' ' ' SER . 18.3 Cg_endo -74.98 -50.55 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.505 1.792 . . . . 73.21 111.002 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.3 OUTLIER -36.51 -34.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 71.13 110.017 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 239' ' ' PRO . 13.9 mt -97.36 -60.97 1.47 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.144 . . . . 74.22 109.302 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.569 ' CE1' HG12 ' A' ' 247' ' ' VAL . 97.2 m-85 -112.02 99.68 8.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.16 . . . . 74.21 111.0 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -22.08 33.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 73.24 109.961 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.1 m -66.49 -47.26 73.57 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.126 . . . . 71.22 109.961 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.18 41.13 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.486 1.116 . . . . 73.14 110.977 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.446 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.94 170.47 20.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.512 1.796 . . . . 73.55 111.019 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.569 HG12 ' CE1' ' A' ' 242' ' ' PHE . 14.6 m -147.74 156.3 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.084 . . . . 75.03 109.318 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.43 ' C ' ' N ' ' A' ' 250' ' ' THR . 41.8 p -59.51 139.01 57.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 74.41 110.398 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.45 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 23.2 p-10 -43.08 -28.19 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 73.22 109.327 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.43 ' N ' ' C ' ' A' ' 248' ' ' THR . 11.5 m -77.12 -62.55 1.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.424 1.077 . . . . 74.45 110.411 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.03 -24.71 4.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 70.13 109.325 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.644 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 11.1 t90 -66.11 -64.66 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 75.35 108.038 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.566 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.2 OUTLIER -43.06 -33.56 0.87 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.112 . . . . 73.23 110.295 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.456 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.5 m-80 -66.25 -48.91 68.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 71.25 109.325 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.447 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -57.45 -18.18 17.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.128 . . . . 70.55 109.26 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.478 ' O ' ' N ' ' A' ' 205' ' ' LYS . 9.6 m -92.53 -33.98 14.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 72.14 108.269 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 264' ' ' ALA . 2.9 m -93.79 20.44 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 73.11 109.258 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.411 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 46.4 t30 -44.4 104.63 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.106 . . . . 65.33 109.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.2 p -74.24 -4.72 37.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 70.32 110.408 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.411 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -47.79 -26.66 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 64.23 110.007 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 18.2 t -91.08 -34.76 14.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 72.32 108.316 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.73 -129.8 2.23 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.517 1.135 . . . . 70.13 111.038 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.441 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -67.0 145.18 55.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 0.741 . . . . 74.34 109.959 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 257' ' ' VAL . . . -173.22 142.23 1.01 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 62.33 109.298 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.9 p -173.08 153.46 2.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 73.13 109.998 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.466 HG21 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.15 120.71 47.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.501 1.125 . . . . 74.41 109.293 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 16.9 t -76.12 -43.07 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.434 1.084 . . . . 74.32 110.007 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.411 ' O ' ' CG2' ' A' ' 200' ' ' VAL . 54.6 m -164.56 -172.52 2.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 71.33 109.971 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -166.75 157.27 11.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 75.42 111.025 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.9 157.55 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 63.43 109.281 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.449 ' O ' ' CG2' ' A' ' 272' ' ' THR . 1.5 p-10 -122.92 160.09 26.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 63.11 109.307 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 271' ' ' ASN . 48.2 p -154.98 176.94 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.096 . . . . 74.43 110.408 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.74 160.91 4.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 75.01 109.291 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.1 -21.65 78.81 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.526 1.141 . . . . 74.34 110.984 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.418 ' HA ' ' NH2' ' A' ' 185' ' ' ARG . 1.5 p-10 -74.19 -35.03 63.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 0.759 . . . . 72.31 109.302 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 53.4 t -43.67 101.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.479 1.112 . . . . 71.35 109.253 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.559 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 4.6 t80 -63.12 -53.63 50.42 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 74.21 111.029 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -146.85 135.04 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.148 . . . . 75.01 110.988 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.57 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 72.8 ttt-85 -106.15 147.44 29.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 74.42 110.294 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.19 157.95 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.439 1.087 . . . . 65.24 110.006 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -0.65 10.19 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.434 1.754 . . . . 70.22 111.004 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 40.5 m -101.12 8.71 42.65 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 72.13 109.959 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 73.03 38.21 0.72 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.563 1.164 . . . . 71.52 109.297 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -119.79 119.17 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.12 110.004 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.423 ' CZ ' HG22 ' A' ' 272' ' ' THR . 9.0 m-30 -99.89 167.06 10.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.491 1.12 . . . . 73.14 111.033 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.562 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -125.89 177.49 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 73.44 109.353 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 37.8 m-85 -158.34 118.98 3.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 73.22 111.036 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.39 99.49 7.42 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.465 1.103 . . . . 72.31 109.305 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -83.48 -52.82 6.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 73.11 109.312 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.472 ' CB ' HG12 ' A' ' 292' ' ' ILE . 24.4 m-20 -88.04 10.63 18.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.146 . . . . 74.54 109.328 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.701 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.5 mm? 40.45 45.15 1.84 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.115 . . . . 71.32 109.287 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.472 HG12 ' CB ' ' A' ' 290' ' ' ASN . 45.5 mm -75.26 -27.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 73.41 109.307 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.494 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.5 t-20 -92.1 -29.32 16.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.478 1.111 . . . . 75.02 109.295 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.559 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 17.9 m -80.02 -68.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 73.33 110.356 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -45.29 -33.64 2.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.56 1.162 . . . . 74.3 109.307 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 53.5 t -72.61 -46.08 55.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 71.54 108.251 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.0 t -55.73 -41.04 63.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 73.24 109.31 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.78 -62.14 1.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.52 1.137 . . . . 73.23 109.32 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -51.89 -23.87 5.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.461 1.101 . . . . 71.34 110.441 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.424 ' HE2' ' CG1' ' A' ' 315' ' ' VAL . 17.7 mmmt -71.19 -40.02 71.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.127 . . . . 75.44 109.318 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.569 ' CD1' HD11 ' A' ' 304' ' ' LEU . 5.2 m-30 -101.5 35.14 2.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 74.02 110.965 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.4 t -67.35 -44.83 78.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.107 . . . . 75.41 110.007 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.414 HD21 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -93.19 -12.25 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 74.43 109.301 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 301' ' ' PHE . 13.2 mt -66.66 141.75 57.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.556 1.16 . . . . 71.45 109.346 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.4 p -159.33 157.46 30.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 44.22 110.026 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.84 -157.65 50.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.525 1.141 . . . . 74.21 110.986 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 29.4 p -96.01 11.41 34.16 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.286 -1.005 . . . . 64.51 108.286 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.478 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -130.07 151.15 77.84 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 75.02 109.98 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -75.01 148.3 91.39 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.02 -2.491 . . . . 74.45 110.967 0.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.475 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.2 p -130.05 134.29 25.96 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 71.12 110.017 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.08 -172.39 10.72 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 120.994 -2.503 . . . . 75.14 110.992 0.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.63 151.38 30.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 63.15 109.36 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -162.42 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.523 1.802 . . . . 71.31 110.985 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.14 135.51 33.62 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 73.44 109.299 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.424 ' CG1' ' HE2' ' A' ' 300' ' ' LYS . 24.4 m -137.48 24.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.527 1.142 . . . . 74.24 109.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' SER . . . . . 0.441 ' C ' ' N ' ' A' ' 318' ' ' CYS . 39.7 t -66.58 -41.07 89.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 75.44 110.041 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -39.72 -29.87 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.443 1.089 . . . . 72.11 109.982 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.441 ' N ' ' C ' ' A' ' 316' ' ' SER . 7.5 m . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.546 1.154 . . . . 63.12 108.3 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.459 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 7.4 tp . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.321 -0.622 . . . . 72.2 109.321 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 193' ' ' TYR . . . -105.17 107.61 18.68 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.551 1.157 . . . . 63.43 109.304 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -85.62 10.64 12.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 72.52 110.001 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -150.37 146.82 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 74.22 109.283 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.13 143.04 25.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 72.25 109.29 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.0 -33.06 4.87 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.489 1.784 . . . . 75.55 111.053 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.435 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.78 152.49 21.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 75.21 109.291 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.557 HG22 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -48.98 -35.87 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 74.24 109.313 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.06 -47.47 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 73.23 109.285 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.499 HG23 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.42 -35.83 71.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 54.5 110.381 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.5 OUTLIER -58.2 -57.03 14.65 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.452 1.095 . . . . 72.54 109.293 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.506 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.4 m-80 -52.51 -31.57 36.04 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 71.32 109.291 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.67 -56.83 6.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.14 . . . . 74.02 109.979 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 140' ' ' ILE . 81.3 mt -42.35 -40.11 2.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 74.3 109.254 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -44.58 49.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 74.45 110.99 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -48.03 -36.8 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 73.32 109.28 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.465 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 63.2 mt-30 -76.05 -55.7 5.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 70.12 110.296 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.425 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 18.3 mt -49.52 -27.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.13 109.304 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 243' ' ' SER . 0.2 OUTLIER -75.07 -36.7 61.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 75.1 109.315 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.2 t-20 -57.52 -20.08 29.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 74.21 109.257 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 157' ' ' SER . 3.0 mm100 -80.53 -25.41 38.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 75.3 110.26 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' GLN . 19.1 m -39.03 116.94 0.63 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.24 110.019 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.6 m -43.39 136.9 2.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 75.11 108.328 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.39 -43.36 1.52 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.561 1.163 . . . . 65.15 110.955 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.406 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 32.2 p -64.84 159.79 21.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.538 0.787 . . . . 62.03 110.434 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 t -91.56 -4.58 55.22 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.555 1.16 . . . . 63.53 110.0 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.5 m -108.86 -1.91 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 71.11 110.423 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.406 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -72.29 133.16 44.86 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 74.42 109.307 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -169.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 70.33 109.971 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 45.9 p -154.61 127.07 3.97 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 62.12 110.013 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.95 138.87 58.56 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.009 -2.496 . . . . 70.44 111.005 -0.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.79 -178.99 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.481 1.113 . . . . 64.12 108.28 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.59 ' CG2' ' CE2' ' A' ' 170' ' ' PHE . 3.1 mp -92.82 137.97 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 75.32 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.423 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 59.7 p -92.03 85.16 5.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 74.4 110.414 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.59 ' CE2' ' CG2' ' A' ' 168' ' ' ILE . 60.0 m-85 -88.75 -25.2 22.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.502 1.126 . . . . 70.2 110.995 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.09 -1.99 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.548 1.155 . . . . 75.02 110.292 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.575 ' CE1' HG23 ' A' ' 174' ' ' VAL . 22.4 t80 -127.25 69.61 74.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 75.04 111.042 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.413 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 111.56 3.35 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.46 1.768 . . . . 75.33 111.026 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.575 HG23 ' CE1' ' A' ' 172' ' ' TYR . 21.3 t -153.0 -75.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 73.22 109.31 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.46 ' HB2' ' CB ' ' A' ' 312' ' ' ALA . 3.9 m-20 -149.09 131.9 16.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.14 109.258 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 121.71 79.26 0.51 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.493 1.121 . . . . 73.34 111.014 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.78 -1.78 10.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.287 -1.005 . . . . 70.34 108.287 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 29.0 p90 -81.9 -43.91 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.539 1.149 . . . . 73.45 111.002 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.605 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -70.09 -45.2 67.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.522 1.139 . . . . 72.42 109.285 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.509 ' NH2' ' CB ' ' A' ' 240' ' ' SER . 7.3 mtm180 -49.76 -58.76 4.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 73.25 110.325 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -43.02 -52.49 5.25 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 75.24 109.303 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -46.91 -39.51 12.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.505 1.128 . . . . 75.31 109.62 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 180' ' ' ARG . 19.0 mmmt -72.92 -33.3 65.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 73.45 109.281 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 181' ' ' ALA . 17.6 mtm -65.99 -59.21 4.05 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.13 . . . . 73.44 110.997 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -26.07 14.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 64.11 110.318 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -43.42 93.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 65.53 110.274 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.425 ' HB ' ' CG1' ' A' ' 153' ' ' ILE . 22.6 mm -69.86 -38.21 75.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 75.24 109.269 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -54.57 -35.54 63.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.495 1.122 . . . . 75.33 109.318 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 192' ' ' GLY . 17.0 mtp -70.12 -42.79 72.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 1.15 . . . . 74.24 111.055 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -44.77 -47.12 10.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.52 109.283 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.465 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 23.8 t-20 -67.81 -34.57 77.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 75.15 109.295 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 113.59 55.29 0.42 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.496 1.123 . . . . 74.32 110.972 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.562 ' CD2' ' HB2' ' A' ' 137' ' ' ALA . 83.7 m-85 -153.61 141.51 20.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 0.738 . . . . 75.44 111.009 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.459 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -108.71 122.87 48.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 73.32 109.308 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.442 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 27.5 p -106.41 -179.28 3.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 74.34 108.301 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -126.77 176.89 6.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 63.24 110.317 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -107.83 164.05 12.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 73.15 109.299 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -151.2 117.36 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 71.03 110.305 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.41 ' CE1' HG23 ' A' ' 219' ' ' VAL . 5.7 m-85 -109.18 125.94 52.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.461 1.101 . . . . 74.42 111.041 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.443 HG23 ' CG2' ' A' ' 266' ' ' VAL . 8.6 p -122.35 121.32 63.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 71.55 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 56.2 m-85 -93.9 151.77 19.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 74.35 111.001 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.42 -172.56 19.3 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.493 1.12 . . . . 62.32 111.021 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 263' ' ' SER . 55.4 t-20 -78.25 111.19 13.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 0.751 . . . . 74.13 109.281 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.468 HD11 ' CB ' ' A' ' 218' ' ' HIS . 3.5 mt -115.33 94.25 4.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 75.42 109.359 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.3 mtpt -93.21 170.52 9.57 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.501 1.125 . . . . 74.41 109.297 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -172.58 129.65 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 74.4 109.338 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.486 1.116 . . . . 75.12 110.007 -179.99 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.314 -0.995 . . . . 72.12 108.314 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.441 ' N ' ' SG ' ' A' ' 212' ' ' CYS . 0.4 OUTLIER -153.59 147.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.095 . . . . 73.31 109.314 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.444 ' CB ' ' HE3' ' A' ' 205' ' ' LYS . . . -133.46 128.43 35.42 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.555 1.159 . . . . 62.32 109.33 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -134.39 131.72 38.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 61.41 107.999 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -74.59 -2.54 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 53.02 109.976 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.43 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.1 p90 -173.74 132.9 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.472 1.108 . . . . 72.31 111.008 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.468 ' CB ' HD11 ' A' ' 204' ' ' LEU . 84.6 t60 -121.61 154.68 36.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 73.45 109.581 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.41 HG23 ' CE1' ' A' ' 199' ' ' PHE . 1.6 p -130.61 130.81 64.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.522 1.139 . . . . 65.35 109.349 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.647 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.4 -164.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 53.13 109.268 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 39.1 pt -122.31 120.26 60.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 72.3 109.296 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.49 109.0 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 73.35 109.282 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.463 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.8 OUTLIER -103.04 147.99 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 74.15 109.267 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 51.6 m -118.15 121.27 40.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.481 1.113 . . . . 74.11 110.021 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.557 ' CD2' HG22 ' A' ' 143' ' ' VAL . 31.3 p90 -136.41 144.24 44.4 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 75.53 110.983 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.438 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.8 mmtp -69.49 133.06 47.25 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 75.15 109.263 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.55 -159.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 74.25 109.293 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.15 48.94 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.499 1.124 . . . . 74.31 109.345 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.7 m -115.22 -8.07 12.37 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.153 . . . . 74.41 110.027 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.14 37.58 8.26 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.471 1.107 . . . . 60.44 111.05 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.46 0.741 . . . . 70.24 109.3 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.438 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.3 m -71.79 102.58 2.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 74.44 110.365 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.403 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.9 mm-40 -101.42 -172.54 2.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 74.42 110.31 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -127.0 145.11 50.83 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.491 1.119 . . . . 75.5 109.311 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.498 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 2.9 tpt180 -144.54 160.84 40.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.11 110.311 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.501 HG22 ' CD1' ' A' ' 252' ' ' TRP . 16.6 mm -115.13 121.73 67.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 75.41 109.317 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -108.09 44.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.529 1.143 . . . . 73.4 109.285 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.98 107.76 59.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 75.04 109.276 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.563 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.3 Cg_endo -75.01 -2.11 12.11 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.549 1.816 . . . . 70.12 111.018 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.509 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.2 OUTLIER -61.3 -22.66 65.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 74.13 109.992 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.74 -50.21 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 71.55 109.272 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.565 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 97.4 m-85 -112.18 99.5 8.09 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 74.04 111.025 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.438 ' O ' ' NZ ' ' A' ' 154' ' ' LYS . 71.0 m -90.14 -8.44 51.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 72.22 109.987 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 30.6 p -77.75 -46.44 21.71 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.543 1.152 . . . . 72.31 110.008 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.11 -174.79 40.45 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.445 1.091 . . . . 62.3 111.036 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.449 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.0 164.68 32.87 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.477 1.777 . . . . 74.32 110.99 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.556 HG13 ' CD1' ' A' ' 242' ' ' PHE . 3.5 m -147.82 164.97 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 74.43 109.317 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.7 p -65.93 141.36 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.455 1.097 . . . . 64.23 110.445 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.437 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 1.3 p30 -45.2 -26.55 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 74.33 109.338 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 10.7 m -77.41 -62.95 1.49 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.469 1.106 . . . . 64.21 110.423 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.69 -27.98 8.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 72.42 109.303 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.647 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 11.0 t90 -63.28 -61.82 2.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 75.43 107.997 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.558 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -46.63 -41.87 15.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 74.44 110.309 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -57.24 -50.8 71.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 61.4 109.298 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.565 ' HB1' ' CE2' ' A' ' 242' ' ' PHE . . . -56.87 -24.41 51.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 42.03 109.317 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -83.42 -36.43 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 74.52 108.304 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.489 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.0 m -94.61 21.47 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 72.51 109.303 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.441 ' ND2' ' CB ' ' A' ' 260' ' ' SER . 38.7 t30 -54.41 109.14 0.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 71.13 109.287 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.3 p -73.79 -2.77 24.92 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 74.13 110.386 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.441 ' CB ' ' ND2' ' A' ' 258' ' ' ASN . 33.7 t -44.0 -27.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.098 . . . . 72.01 109.979 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . 0.45 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 48.5 t -94.27 -37.01 11.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 62.22 108.3 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 171.09 -128.33 1.59 Allowed Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.493 1.121 . . . . 70.22 110.968 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -79.86 149.42 30.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 0.78 . . . . 74.14 110.017 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.489 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -170.69 146.35 2.64 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.501 1.125 . . . . 53.14 109.324 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.3 m -173.08 151.99 2.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.449 1.093 . . . . 72.14 109.99 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.462 HG22 ' CG1' ' A' ' 257' ' ' VAL . 2.3 t -97.84 122.35 49.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.52 109.281 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' SER . . . . . 0.407 ' C ' ' OG ' ' A' ' 268' ' ' SER . 31.1 t -83.81 -34.21 24.77 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.13 . . . . 74.43 109.999 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 267' ' ' SER . 0.7 OUTLIER -174.78 159.32 2.77 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 74.11 109.978 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -147.5 154.66 41.04 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.447 1.092 . . . . 74.45 110.985 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.32 165.7 34.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 70.33 109.32 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.424 ' O ' ' CG2' ' A' ' 272' ' ' THR . 1.4 p-10 -122.68 160.73 25.23 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 62.41 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 271' ' ' ASN . 45.1 p -154.09 179.43 8.94 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 61.13 110.419 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . 0.427 ' CA ' HG22 ' A' ' 276' ' ' VAL . . . -57.5 166.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.127 . . . . 64.22 109.253 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.49 -18.67 63.65 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.52 1.137 . . . . 72.14 111.012 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.433 ' H ' ' ND2' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -83.98 -19.0 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 0.773 . . . . 73.24 109.287 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . 0.427 HG22 ' CA ' ' A' ' 273' ' ' ALA . 12.9 t -60.48 101.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 71.51 109.301 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.415 ' OH ' ' CE1' ' A' ' 178' ' ' TYR . 15.1 t80 -64.41 -44.45 91.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.559 1.162 . . . . 72.55 111.007 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -144.54 155.78 43.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.542 1.151 . . . . 74.11 110.989 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.447 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 68.0 ttt-85 -124.97 147.45 48.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.41 110.318 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.77 154.07 44.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.104 . . . . 71.54 110.006 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -0.03 9.45 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.496 1.787 . . . . 75.52 111.011 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 6.1 t -104.58 10.6 34.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 64.14 109.969 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.0 t-20 76.21 38.5 0.32 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.54 1.15 . . . . 72.33 109.341 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.2 t -117.9 121.03 39.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 74.1 110.001 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -103.86 158.38 16.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 74.25 110.987 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -118.35 177.64 4.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 73.52 109.3 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.0 m-85 -161.84 115.79 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 73.22 111.045 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.3 96.76 5.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.129 . . . . 73.23 109.346 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -85.62 -15.47 42.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 74.52 109.307 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.423 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.6 m-20 -109.88 2.26 19.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.529 1.143 . . . . 73.42 109.302 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.91 47.07 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 74.43 109.293 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.423 HG12 ' CB ' ' A' ' 290' ' ' ASN . 20.4 mm -73.28 -31.74 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.12 . . . . 74.22 109.315 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 318' ' ' CYS . 1.6 t-20 -93.08 -28.41 16.37 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 74.33 109.27 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.421 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 1.8 m -77.07 -65.69 0.92 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.563 1.164 . . . . 73.44 110.407 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 57.3 m-20 -54.61 -20.07 7.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 71.13 109.296 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 297' ' ' VAL . 25.0 t -83.99 -66.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 72.53 108.278 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 296' ' ' CYS . 3.2 t -40.27 -39.54 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 73.43 109.296 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.23 -57.2 5.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 1.142 . . . . 73.32 109.267 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -22.78 2.47 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.454 1.096 . . . . 75.04 110.358 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -71.32 -48.58 49.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 75.54 109.311 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.7 OUTLIER -98.43 38.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.35 111.005 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.0 t -70.07 -48.54 57.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.13 . . . . 52.45 109.971 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.42 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -88.18 -11.36 47.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 75.44 109.284 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.523 HD11 ' CE2' ' A' ' 172' ' ' TYR . 15.1 mt -63.93 142.55 58.37 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 72.25 109.296 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 66.6 p -157.49 148.43 21.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.16 . . . . 75.33 109.964 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.05 -152.12 23.46 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.483 1.114 . . . . 65.13 111.028 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.4 p -103.96 12.87 33.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.309 -0.997 . . . . 53.43 108.309 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.488 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.3 p -134.99 150.99 74.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 74.25 109.992 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.3 Cg_endo -75.01 146.52 86.87 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.001 -2.5 . . . . 73.44 110.992 0.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.488 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 3.3 p -130.06 133.46 25.0 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 71.12 109.968 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.04 -168.16 6.25 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.031 -2.487 . . . . 72.11 110.967 0.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 175' ' ' ASP . . . -56.89 152.73 26.14 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.47 1.106 . . . . 71.11 109.24 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.546 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.06 -162.52 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.5 1.79 . . . . 72.14 110.932 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.65 130.72 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 73.35 109.275 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.85 24.71 2.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 73.14 109.28 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.2 t -68.38 -27.06 65.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 63.43 110.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.5 t -47.19 -24.66 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 74.53 109.961 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.419 ' HB2' ' ND2' ' A' ' 293' ' ' ASN . 1.7 m . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 74.34 108.275 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 194' ' ' ASP . 4.8 tp . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.295 -0.631 . . . . 75.55 109.295 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.571 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -146.99 108.02 4.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 74.2 109.291 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.401 ' OG ' ' OD2' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -81.75 2.74 28.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 75.3 110.026 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -142.23 150.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 74.45 109.243 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.461 HD11 ' CD1' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -102.94 143.31 26.35 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 75.42 109.312 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -33.76 4.33 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.485 1.782 . . . . 74.31 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.44 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.7 151.23 23.75 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.449 1.093 . . . . 75.52 109.288 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.565 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -49.52 -34.81 8.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.485 1.115 . . . . 75.41 109.277 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.48 -46.6 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 74.4 109.255 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.514 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -72.1 -33.22 67.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 72.1 110.36 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.476 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.4 OUTLIER -60.91 -56.44 21.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.511 1.132 . . . . 65.33 109.308 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.497 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 53.6 m-80 -54.05 -30.77 49.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.434 1.084 . . . . 74.13 109.29 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -56.59 7.35 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 63.35 110.032 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 191' ' ' ASN . 84.1 mt -42.18 -42.43 3.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 74.41 109.318 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -71.17 -44.88 64.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 73.31 111.012 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.43 -39.06 6.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 73.42 109.298 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 155' ' ' ASN . 57.1 mt-30 -75.82 -55.51 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 75.22 110.271 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.476 HG23 ' CG ' ' A' ' 184' ' ' MET . 14.3 mt -51.05 -24.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 74.21 109.368 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 243' ' ' SER . 0.0 OUTLIER -78.74 -33.98 46.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 75.45 109.327 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.4 t-20 -61.73 -14.99 37.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 65.31 109.286 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 157' ' ' SER . 3.2 mm100 -84.08 -18.19 37.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.4 110.287 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' GLN . 11.0 p -37.37 147.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 73.55 110.01 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.4 m -82.28 53.54 2.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 75.34 108.335 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -164.34 27.88 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.531 1.145 . . . . 72.45 111.015 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.7 p -132.7 163.19 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 0.754 . . . . 75.1 110.398 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 63.0 m -93.62 0.86 56.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 62.04 110.034 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.0 m -116.68 0.44 12.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 74.11 110.384 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.83 137.99 52.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.13 . . . . 70.21 109.301 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -164.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.132 . . . . 75.04 110.028 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.443 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 15.3 p -155.57 127.39 3.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.476 1.11 . . . . 63.53 110.023 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 139.77 63.61 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.988 -2.505 . . . . 70.33 111.021 -0.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 21.1 p -72.76 -179.53 3.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 64.32 108.312 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.1 mp -92.24 123.24 44.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 74.12 109.344 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.3 p -89.76 80.71 6.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 74.14 110.395 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -80.75 -14.41 58.12 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.24 110.98 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.26 -1.23 22.52 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 74.55 110.278 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.566 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 22.7 t80 -130.9 65.54 76.89 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 73.13 111.001 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.426 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.97 117.24 4.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.486 1.782 . . . . 73.13 110.997 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.558 HG21 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.92 -72.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 70.32 109.301 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.401 ' O ' ' SG ' ' A' ' 177' ' ' CYS . 0.5 OUTLIER -125.37 -44.13 1.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 74.01 109.273 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -53.23 99.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.448 1.093 . . . . 74.52 111.003 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.496 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 3.5 p -134.82 -48.2 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.278 -1.008 . . . . 74.45 108.278 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -69.52 -11.77 61.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.142 . . . . 74.35 110.973 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.41 -68.12 0.53 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 74.5 109.299 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.475 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 11.1 ptm180 -50.64 -49.85 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.157 . . . . 74.25 110.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.463 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.64 -57.63 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 71.51 109.338 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.565 ' CD2' HD13 ' A' ' 291' ' ' LEU . 1.2 t60 -45.86 -43.9 13.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 70.11 109.618 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 180' ' ' ARG . 17.3 mmmt -60.35 -58.58 7.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.125 . . . . 74.53 109.273 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.476 ' CG ' HG23 ' A' ' 153' ' ' ILE . 5.8 mtm -39.01 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 75.11 111.015 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.443 ' NH1' ' SD ' ' A' ' 189' ' ' MET . 2.1 tmt_? -70.57 -50.18 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 74.3 110.3 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 183' ' ' LYS . 0.6 OUTLIER -55.29 -33.97 63.71 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 62.54 110.255 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 153' ' ' ILE . 16.0 mm -77.02 -34.87 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 70.32 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -64.74 -45.12 87.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 65.43 109.338 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.443 ' SD ' ' NH1' ' A' ' 185' ' ' ARG . 63.2 mtp -58.28 -37.2 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.502 1.126 . . . . 72.31 111.064 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -52.29 -52.02 55.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 72.41 109.315 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.471 ' CB ' HD21 ' A' ' 149' ' ' LEU . 7.9 t-20 -63.82 -28.67 70.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 75.32 109.284 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.55 44.94 1.27 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.522 1.139 . . . . 62.24 111.027 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.571 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 80.0 m-85 -147.82 130.3 15.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 0.76 . . . . 73.31 111.018 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.47 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 0.4 OUTLIER -97.07 130.78 44.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 74.41 109.313 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.468 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 30.5 p -104.96 -179.48 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.114 . . . . 73.21 108.311 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -129.54 174.59 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.464 1.103 . . . . 74.35 110.32 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.463 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 16.4 mmtt -108.17 169.49 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.52 1.138 . . . . 74.01 109.303 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -164.11 117.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 73.41 110.299 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.51 ' CE1' HG21 ' A' ' 219' ' ' VAL . 6.0 m-85 -108.28 120.5 42.54 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.511 1.132 . . . . 75.34 111.006 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.469 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 7.5 p -109.77 148.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 74.12 109.29 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.414 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 23.5 m-85 -119.91 158.28 27.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 75.33 111.002 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 120.63 -179.73 16.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.512 1.132 . . . . 73.53 110.979 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 263' ' ' SER . 59.3 t-20 -70.39 110.82 5.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.537 0.787 . . . . 74.05 109.304 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' A' ' 218' ' ' HIS . 5.6 mt -114.93 93.43 4.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 75.41 109.267 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.7 mttp -93.55 166.01 12.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 71.21 109.307 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -169.64 147.98 3.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 71.32 109.298 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 C--N 1.326 -0.451 0 O-C-N 124.509 1.13 . . . . 63.44 109.93 -179.943 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 108.312 -0.996 . . . . 65.11 108.312 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.83 155.69 10.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 75.25 109.303 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.68 119.26 13.1 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 72.3 109.295 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.434 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -128.39 133.1 48.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 74.24 107.958 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.3 m -79.61 2.5 22.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 65.04 109.985 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.9 p90 -174.17 128.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.124 . . . . 74.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 71.2 t60 -116.36 167.6 10.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 73.31 109.612 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.51 HG21 ' CE1' ' A' ' 199' ' ' PHE . 2.6 p -144.79 137.61 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 74.31 109.296 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.651 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.89 -165.7 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 62.12 109.286 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 15.9 pt -115.42 123.54 71.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 74.45 109.295 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.7 tp -87.91 108.83 19.37 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 75.5 109.276 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.476 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.89 146.98 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 71.03 109.275 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 140' ' ' ILE . 75.4 m -117.09 120.18 37.55 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.434 1.084 . . . . 74.12 110.025 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.565 ' CD2' HG23 ' A' ' 143' ' ' VAL . 32.9 p90 -134.96 143.22 46.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.482 1.114 . . . . 74.23 111.007 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.422 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -68.85 132.38 46.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 74.01 109.315 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.36 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.13 . . . . 75.34 109.323 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.66 0.18 48.04 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 74.53 109.32 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -115.27 -7.89 12.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.465 1.103 . . . . 75.35 110.004 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.44 8.34 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.471 1.107 . . . . 75.32 111.004 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.3 137.63 43.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.532 0.784 . . . . 74.22 109.283 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.422 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.1 m -71.82 102.55 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.115 . . . . 74.14 110.369 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.401 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.6 mm-40 -101.79 -172.59 2.18 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 71.3 110.321 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -127.13 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 74.52 109.305 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.507 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 0.9 OUTLIER -142.72 163.95 31.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 75.53 110.252 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.556 HD13 ' CE3' ' A' ' 252' ' ' TRP . 26.6 mm -119.01 117.86 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 75.34 109.294 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.0 mm -102.63 47.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 75.13 109.302 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.48 ' OD1' ' CD1' ' A' ' 241' ' ' LEU . 20.7 p-10 -94.73 111.53 54.56 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.504 1.128 . . . . 74.01 109.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.415 ' HG2' ' NH2' ' A' ' 180' ' ' ARG . 18.3 Cg_endo -75.06 -40.28 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.463 1.77 . . . . 63.41 111.01 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -41.59 -39.09 1.51 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.551 1.157 . . . . 62.4 110.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.48 ' CD1' ' OD1' ' A' ' 238' ' ' ASP . 10.5 mt -95.78 -58.34 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 75.13 109.324 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 247' ' ' VAL . 91.6 m-85 -117.15 99.2 6.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.449 1.093 . . . . 74.32 110.99 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.418 ' O ' ' CE ' ' A' ' 154' ' ' LYS . 35.4 m -90.68 -5.81 55.31 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 73.31 110.0 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 25.3 m -79.42 -47.08 16.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 75.21 109.98 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.13 -175.76 39.84 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.478 1.112 . . . . 75.21 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.449 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 161.7 38.42 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.506 1.793 . . . . 74.03 110.991 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.574 HG13 ' CD2' ' A' ' 242' ' ' PHE . 3.4 m -144.7 157.35 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 73.54 109.314 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.6 p -64.93 137.63 57.87 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 74.4 110.392 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.416 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 0.1 OUTLIER -39.78 -31.12 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 73.32 109.302 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.6 m -71.35 -64.31 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 75.31 110.402 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.42 -24.74 8.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.11 . . . . 72.11 109.282 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.651 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 8.8 t90 -67.33 -59.92 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.478 1.111 . . . . 73.32 108.012 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.566 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -51.95 -41.25 61.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 73.45 110.314 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -54.83 -52.49 62.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.099 . . . . 72.44 109.314 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -55.2 -26.18 37.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 62.23 109.287 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -81.82 -36.36 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 55.33 108.306 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.476 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.0 m -94.69 22.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.137 . . . . 74.51 109.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -52.23 109.21 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 74.3 109.305 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.77 -3.09 26.39 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.153 . . . . 71.32 110.408 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 18.4 t -43.82 -31.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.01 110.001 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.8 -37.7 15.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 62.35 108.301 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.46 -126.97 1.49 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.515 1.134 . . . . 63.3 110.997 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.6 145.03 41.47 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 0.772 . . . . 74.44 109.98 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.476 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -168.2 147.72 4.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 64.12 109.324 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 92.2 p -172.87 156.8 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 71.23 110.004 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.469 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 5.2 p -103.12 117.4 48.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.449 1.093 . . . . 75.24 109.3 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 21.0 t -72.05 -44.7 62.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 73.21 109.965 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.4 m -166.66 -174.67 2.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.137 . . . . 74.22 110.011 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -163.09 156.6 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 74.25 110.968 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.85 149.57 26.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 75.4 109.269 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -107.68 157.81 17.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 73.14 109.282 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.434 HG23 ' CZ ' ' A' ' 285' ' ' TYR . 1.4 p -148.82 179.11 8.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.562 1.164 . . . . 71.32 110.411 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.95 164.44 12.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.118 . . . . 73.52 109.279 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.0 84.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.557 1.16 . . . . 72.32 111.0 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -84.23 -37.1 22.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 0.746 . . . . 74.11 109.347 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 21.1 t -43.73 108.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 74.15 109.265 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.545 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 1.6 t80 -72.01 -41.33 67.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 73.14 110.978 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.565 ' CD1' ' C ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -162.85 115.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.438 1.086 . . . . 75.14 111.011 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.561 ' HG3' ' CE1' ' A' ' 285' ' ' TYR . 62.8 ttt-85 -95.82 141.53 29.17 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.459 1.099 . . . . 70.01 110.297 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.73 158.02 37.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.548 1.155 . . . . 74.23 110.009 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 0.17 9.24 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 62.11 111.026 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 46.3 t -97.51 9.23 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 71.01 109.989 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER 75.37 27.96 1.02 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 75.11 109.334 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 121.51 45.13 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 1.119 . . . . 70.04 109.971 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 3.3 m-85 -104.8 162.42 13.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 64.43 110.974 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.7 OUTLIER -121.21 172.12 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 72.23 109.276 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 78.4 m-85 -160.54 127.86 4.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 73.43 111.022 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.438 ' HB2' ' CD2' ' A' ' 182' ' ' HIS . 1.3 m-20 -115.28 114.21 24.89 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.14 . . . . 74.04 109.331 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -85.65 -51.24 6.6 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 63.33 109.305 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -108.13 14.19 25.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 74.32 109.285 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.565 HD13 ' CD2' ' A' ' 182' ' ' HIS . 1.2 mm? 54.19 39.06 30.39 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 63.12 109.296 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 18.6 mm -66.77 -28.99 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 73.43 109.352 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.545 ' HB3' ' CE2' ' A' ' 277' ' ' TYR . 1.7 t-20 -94.81 -29.25 14.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.456 1.098 . . . . 73.52 109.286 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.9 m -79.03 -65.61 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 71.11 110.381 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -49.13 -34.04 13.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 74.53 109.298 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.06 -49.06 60.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 72.33 108.295 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 8.3 t -47.99 -47.85 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.144 . . . . 71.31 109.329 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 301' ' ' PHE . 15.6 mt -67.2 -61.99 1.65 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.51 1.131 . . . . 74.45 109.33 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.04 -25.6 0.34 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 64.43 110.417 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -72.91 -45.12 59.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.45 1.094 . . . . 73.24 109.314 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.566 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 2.0 m-30 -98.91 37.97 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.524 1.14 . . . . 75.32 111.009 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.97 -44.23 73.36 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 63.14 109.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.506 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.85 -18.16 22.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.12 . . . . 73.04 109.274 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.482 ' CD2' ' CD ' ' A' ' 309' ' ' PRO . 13.9 mt -59.78 142.35 53.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.21 109.315 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 86.9 p -152.64 160.75 43.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 73.13 110.005 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.94 -159.05 51.37 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.535 1.147 . . . . 64.53 110.983 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 27.0 p -95.33 16.52 16.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.308 -0.997 . . . . 72.43 108.308 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.483 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 41.7 p -134.93 148.97 69.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 44.43 110.004 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.3 Cg_endo -75.0 147.28 88.9 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.99 -2.504 . . . . 75.25 110.992 -0.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -131.67 135.56 27.04 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 62.22 109.993 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.94 -174.31 13.86 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.005 -2.498 . . . . 71.44 111.027 -0.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.67 156.03 26.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 61.14 109.327 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -162.3 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.461 1.769 . . . . 73.52 110.993 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -89.29 135.87 33.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 74.33 109.315 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.16 23.17 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 74.02 109.272 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 t -57.61 -35.58 70.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 75.52 110.012 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 43.3 t -49.23 -23.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 64.44 109.985 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.558 1.161 . . . . 72.1 108.282 -179.997 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 2.8 tp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.251 -0.648 . . . . 75.12 109.251 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.546 ' HB1' ' CD1' ' A' ' 193' ' ' TYR . . . -156.25 106.36 2.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 75.34 109.321 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -5.47 54.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 63.02 109.994 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.4 HG11 ' N ' ' A' ' 140' ' ' ILE . 2.3 t -136.38 149.39 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 74.13 109.338 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.46 HD11 ' CD1' ' A' ' 149' ' ' LEU . 0.6 OUTLIER -101.96 143.43 26.59 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.507 1.129 . . . . 74.54 109.299 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -33.77 4.33 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.451 1.764 . . . . 75.14 110.967 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.06 148.0 16.78 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.526 1.142 . . . . 74.35 109.35 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.554 HG21 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -43.68 -36.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 73.35 109.321 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.5 -49.78 2.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 71.2 109.296 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -68.73 -37.06 79.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 74.3 110.415 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.473 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.97 -57.33 12.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 74.13 109.332 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.492 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.2 m-80 -53.12 -29.35 30.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 75.43 109.297 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -57.55 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.428 1.08 . . . . 73.5 109.989 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.46 ' CD1' HD11 ' A' ' 140' ' ' ILE . 92.7 mt -42.63 -42.77 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 74.32 109.29 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.53 -44.81 61.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.415 1.072 . . . . 75.43 110.982 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -47.06 -38.14 10.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 72.43 109.284 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.424 ' CB ' ' CG2' ' A' ' 187' ' ' ILE . 58.7 mt-30 -75.53 -53.37 8.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.24 110.293 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.0 mt -51.95 -24.63 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 72.23 109.317 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 243' ' ' SER . 0.1 OUTLIER -77.41 -35.85 53.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.128 . . . . 74.44 109.247 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -61.78 -15.79 44.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.4 109.317 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.468 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 6.9 mm100 -84.73 -17.48 38.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 75.51 110.316 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.8 p -38.54 133.15 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.455 1.097 . . . . 70.41 110.022 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -62.49 135.33 57.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 75.3 108.312 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 112.21 -22.33 18.27 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.515 1.134 . . . . 73.51 110.987 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.431 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 55.7 p -77.44 161.63 27.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 0.801 . . . . 73.21 110.411 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.2 m -93.56 -2.56 54.07 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.31 110.003 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.5 m -114.98 7.61 15.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.13 . . . . 73.42 110.392 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.431 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -84.19 139.44 32.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 74.31 109.3 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -161.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.48 1.113 . . . . 75.31 109.971 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.434 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 127.64 3.75 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 62.42 110.018 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.06 138.25 54.97 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.028 -2.488 . . . . 74.25 110.968 0.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 15.4 p -73.08 178.88 4.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 71.43 108.269 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.459 ' CG2' ' HG2' ' A' ' 180' ' ' ARG . 2.1 mp -87.41 124.72 40.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 73.21 109.264 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.1 p -92.34 72.58 5.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 54.4 110.423 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.415 ' HA ' ' NH1' ' A' ' 180' ' ' ARG . 26.6 p90 -77.75 -14.24 59.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.529 1.143 . . . . 71.15 110.987 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.439 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.91 -0.57 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 74.32 110.283 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 172' ' ' TYR . 22.0 t80 -129.37 66.3 76.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 74.32 110.999 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.422 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.0 117.76 5.02 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.472 1.775 . . . . 75.21 110.994 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 172' ' ' TYR . 14.0 t -152.28 -54.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.441 1.088 . . . . 62.23 109.254 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.42 -46.71 0.15 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.526 1.141 . . . . 72.34 109.346 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -48.18 103.46 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.526 1.141 . . . . 45.43 110.983 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 42.1 m -138.74 -48.47 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.319 -0.993 . . . . 73.34 108.319 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 13.4 p90 -62.55 -34.52 77.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 75.15 111.01 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.582 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -60.93 -56.88 15.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.46 1.1 . . . . 72.12 109.3 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.459 ' HG2' ' CG2' ' A' ' 168' ' ' ILE . 22.9 mtp180 -53.27 -49.13 67.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 74.15 110.323 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.433 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -41.64 -62.31 0.91 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 73.02 109.347 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.658 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -42.8 -37.02 1.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.512 1.133 . . . . 65.12 109.608 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.632 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 28.0 mmmt -70.67 -55.33 8.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 74.42 109.339 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 20.1 mtm -43.99 -28.73 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 75.41 111.001 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.434 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.3 OUTLIER -75.69 -40.49 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.47 1.106 . . . . 75.32 110.294 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.632 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -51.65 -34.14 36.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 1.132 . . . . 75.23 110.331 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.468 ' CD1' ' HG3' ' A' ' 156' ' ' GLN . 10.9 mm -78.46 -35.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 75.31 109.288 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.449 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.1 OUTLIER -59.83 -40.5 88.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.499 1.124 . . . . 71.41 109.298 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.434 ' HE3' ' CZ ' ' A' ' 185' ' ' ARG . 4.1 mtt -63.75 -42.72 97.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 74.04 110.993 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -47.74 -53.51 14.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.543 1.152 . . . . 74.41 109.289 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.18 -37.48 87.61 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 64.34 109.351 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.48 40.45 1.12 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.517 1.136 . . . . 61.31 111.004 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.546 ' CD1' ' HB1' ' A' ' 137' ' ' ALA . 50.5 m-85 -137.28 134.01 35.64 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 0.766 . . . . 71.01 110.984 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.469 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -101.21 144.91 29.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 71.33 109.27 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 28.7 p -128.57 -179.4 5.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.144 . . . . 73.14 108.282 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 222' ' ' LEU . 19.9 mp0 -125.35 178.09 5.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.467 1.105 . . . . 74.34 110.271 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.433 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 19.0 mmtt -106.01 159.3 16.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 1.107 . . . . 74.43 109.259 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.468 ' HB3' ' CH2' ' A' ' 252' ' ' TRP . 10.2 tt0 -145.18 117.59 8.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 62.23 110.312 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 3.4 m-85 -116.89 128.02 54.83 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.144 . . . . 74.15 110.98 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.482 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 12.3 p -117.37 162.8 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.477 1.111 . . . . 74.25 109.281 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.442 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 76.3 m-85 -133.07 157.97 43.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 73.14 110.99 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.26 -177.19 16.42 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.492 1.12 . . . . 72.32 111.043 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 263' ' ' SER . 62.3 t-20 -70.64 109.77 5.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.479 0.753 . . . . 73.2 109.29 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 218' ' ' HIS . 3.3 mt -113.31 95.74 5.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 74.41 109.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 0.4 OUTLIER -92.09 165.61 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 71.12 109.315 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -174.63 151.6 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.522 1.139 . . . . 74.41 109.302 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.537 1.148 . . . . 75.43 110.027 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.298 -1.001 . . . . 72.31 108.298 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.24 139.29 32.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.509 1.131 . . . . 75.32 109.306 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -133.02 126.14 31.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.12 . . . . 71.21 109.293 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.451 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -132.43 147.8 52.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 74.21 108.024 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -91.59 4.44 52.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 73.53 110.007 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 26.5 p90 -175.66 122.77 0.2 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 74.22 110.981 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.479 ' CD2' HD11 ' A' ' 241' ' ' LEU . 52.1 t60 -106.56 165.69 11.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 62.21 109.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 199' ' ' PHE . 2.1 p -137.2 155.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.55 1.156 . . . . 74.43 109.245 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.652 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.18 -163.24 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 60.03 109.265 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 27.2 pt -123.86 122.48 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.31 109.288 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 196' ' ' GLU . 13.1 tp -86.36 108.85 18.63 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.542 1.151 . . . . 70.24 109.294 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -101.03 166.68 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.576 1.173 . . . . 64.22 109.313 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 140' ' ' ILE . 64.0 m -137.14 118.95 15.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 64.41 109.977 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.554 ' CD2' HG21 ' A' ' 143' ' ' VAL . 33.0 p90 -135.46 143.43 45.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 72.31 110.959 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -68.49 131.73 45.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 74.54 109.316 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.428 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -71.68 -160.21 0.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 74.13 109.318 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -84.26 -0.58 52.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.115 . . . . 63.03 109.254 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.1 m -114.65 -8.17 12.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.133 . . . . 65.34 109.977 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.21 37.78 7.55 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.131 . . . . 73.02 111.028 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.49 138.31 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.512 0.772 . . . . 74.24 109.256 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -72.06 102.71 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.34 110.413 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.428 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 5.4 mm-40 -101.54 -172.62 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.459 1.099 . . . . 71.23 110.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -128.12 145.11 51.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.466 1.104 . . . . 54.32 109.294 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.459 ' HB3' ' CG2' ' A' ' 223' ' ' VAL . 1.9 tpt180 -143.86 161.79 37.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 75.33 110.331 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.548 HD12 ' CE3' ' A' ' 252' ' ' TRP . 17.5 mm -114.47 119.13 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 74.33 109.359 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.2 mm -105.95 45.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 63.13 109.299 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -105.9 107.72 60.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 64.23 109.347 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -0.42 9.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.51 1.795 . . . . 72.44 110.965 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.6 t -72.81 -4.53 32.17 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.504 1.128 . . . . 73.42 110.013 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.479 HD11 ' CD2' ' A' ' 218' ' ' HIS . 10.3 mt -136.21 -47.02 0.64 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.529 1.143 . . . . 74.32 109.264 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.562 ' CD1' HG12 ' A' ' 247' ' ' VAL . 96.5 m-85 -123.23 101.45 7.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 73.12 110.968 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' SER . . . . . 0.436 ' O ' ' NZ ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -85.21 -22.11 28.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 70.15 110.034 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 69.1 m -62.02 -49.56 75.55 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.02 110.014 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.04 -170.77 37.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.478 1.111 . . . . 74.11 110.996 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.444 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.99 164.18 33.89 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.506 1.793 . . . . 73.51 110.987 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.562 HG12 ' CD1' ' A' ' 242' ' ' PHE . 3.0 m -148.36 160.08 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.554 1.159 . . . . 74.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.4 p -64.81 137.6 57.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 74.5 110.392 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 248' ' ' THR . 5.8 p-10 -40.19 -30.29 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 74.12 109.33 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.3 m -71.47 -64.5 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 75.32 110.413 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.98 -26.11 9.85 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.532 1.145 . . . . 74.55 109.281 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.652 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.7 t90 -65.11 -57.87 7.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 74.25 107.993 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.573 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -52.89 -42.12 65.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 74.24 110.293 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.445 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.3 m-80 -55.14 -50.63 68.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 71.5 109.323 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . . . -54.86 -26.59 36.5 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.134 . . . . 63.35 109.312 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -82.56 -37.83 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.108 . . . . 64.32 108.33 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.46 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.1 m -92.77 22.69 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 74.33 109.364 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 47.7 t30 -50.38 104.53 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 43.45 109.328 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.7 p -75.01 -4.03 35.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 73.1 110.37 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.415 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -50.74 -22.26 2.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.549 1.156 . . . . 73.25 110.042 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 5.9 m -93.96 -29.47 15.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.457 1.098 . . . . 71.43 108.255 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 159.9 -122.18 1.1 Allowed Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.483 1.114 . . . . 71.45 111.004 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.3 OUTLIER -83.86 140.12 32.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.572 0.807 . . . . 73.53 110.007 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.46 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -169.21 146.37 3.55 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.486 1.116 . . . . 74.14 109.288 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.7 t -172.87 164.02 5.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 75.52 110.002 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.482 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 6.6 p -105.53 120.54 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 73.53 109.305 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.4 t -80.05 -43.14 22.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.483 1.114 . . . . 75.04 109.984 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.0 m -156.88 176.73 12.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.443 1.089 . . . . 75.11 109.997 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.21 158.77 27.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.574 1.171 . . . . 75.51 110.953 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -172.88 155.37 3.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 65.02 109.345 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.524 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -122.22 159.34 27.48 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.514 1.134 . . . . 74.01 109.344 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.513 HG21 ' CZ ' ' A' ' 285' ' ' TYR . 41.5 p -144.68 167.31 22.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.459 1.1 . . . . 75.45 110.386 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -45.71 158.17 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 1.14 . . . . 63.14 109.289 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -70.24 -46.58 49.26 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.489 1.118 . . . . 73.43 111.026 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -49.5 -37.54 26.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 71.12 109.301 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 98.4 t -45.61 120.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 72.44 109.289 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' A' ' 277' ' ' TYR . 1.0 OUTLIER -75.78 -48.74 20.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 74.35 110.983 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.6 t80 -151.39 154.98 37.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 73.43 111.032 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.561 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 71.1 ttt-85 -118.52 147.53 43.56 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.539 1.149 . . . . 73.35 110.269 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.82 157.4 46.37 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 75.25 109.966 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 0.27 9.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.5 1.79 . . . . 63.52 110.983 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.6 t -105.46 9.13 33.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 74.4 110.003 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.23 40.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.121 . . . . 71.21 109.306 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -119.23 119.81 35.2 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 70.11 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 272' ' ' THR . 10.0 m-30 -100.07 157.96 16.18 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 71.44 111.009 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -118.04 177.64 4.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 73.25 109.244 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.2 m-85 -162.82 132.23 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 74.4 110.98 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.495 ' HB2' ' CD2' ' A' ' 182' ' ' HIS . 0.6 OUTLIER -113.84 112.08 22.8 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.515 1.134 . . . . 72.41 109.334 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -52.17 8.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.461 1.101 . . . . 73.02 109.296 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -115.05 25.08 11.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.518 1.136 . . . . 64.21 109.331 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.658 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 1.9 mm? 48.87 36.59 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 74.01 109.278 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 18.6 mm -66.04 -30.05 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 74.13 109.317 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.477 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.5 t-20 -94.5 -31.35 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.528 1.143 . . . . 73.45 109.245 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.473 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 7.6 m -77.19 -65.89 0.9 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.44 1.087 . . . . 74.32 110.434 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 70.7 m-20 -48.23 -33.17 8.18 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 74.41 109.286 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.4 t -72.72 -40.26 66.27 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 74.31 108.283 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.9 t -59.61 -42.85 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 63.21 109.327 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 301' ' ' PHE . 77.1 mt -71.18 -62.42 1.4 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 71.1 109.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -43.82 -26.38 0.25 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 73.53 110.343 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 314' ' ' ASP . 17.1 mmmt -67.74 -46.77 71.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 65.24 109.255 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.567 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 1.8 m-30 -97.35 36.61 1.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.517 1.136 . . . . 71.25 111.003 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.0 t -67.03 -46.84 73.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.469 1.106 . . . . 71.21 109.978 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -92.13 -18.15 23.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.53 1.144 . . . . 73.13 109.327 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.505 HD12 ' CD1' ' A' ' 301' ' ' PHE . 15.2 mt -59.51 134.17 56.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 75.31 109.303 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 77.3 p -149.67 150.55 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 74.33 109.994 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.6 -162.94 45.79 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.496 1.123 . . . . 73.25 110.986 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 4.6 p -90.17 9.92 26.52 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.295 -1.002 . . . . 71.31 108.295 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.478 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 2.2 p -132.56 150.77 76.75 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 74.11 109.968 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.4 Cg_endo -74.92 146.42 86.63 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 120.984 -2.506 . . . . 73.21 111.046 -0.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.4 p -131.82 136.05 27.74 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 74.31 110.02 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.81 14.78 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.036 -2.485 . . . . 73.04 111.023 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.59 158.2 32.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 72.15 109.324 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.01 -162.4 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.48 1.779 . . . . 55.11 110.976 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.433 ' O ' ' NZ ' ' A' ' 300' ' ' LYS . 4.9 p-10 -91.79 136.24 33.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 75.41 109.279 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.43 17.58 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.13 109.325 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 318' ' ' CYS . 12.4 t -64.9 -33.01 74.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.151 . . . . 72.53 110.014 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -48.33 -23.92 1.06 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.518 1.136 . . . . 74.32 110.0 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 316' ' ' SER . 1.6 m . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 73.13 108.308 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 5.0 tp . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.273 -0.639 . . . . 74.32 109.273 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.566 ' HB1' ' CD1' ' A' ' 193' ' ' TYR . . . -150.06 105.31 3.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 70.44 109.306 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -81.77 5.62 18.03 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 73.32 109.992 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -146.35 147.52 17.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.502 1.126 . . . . 74.22 109.302 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.418 ' CD1' HD12 ' A' ' 149' ' ' LEU . 1.1 mt -100.1 142.54 24.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 75.21 109.315 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -32.73 5.12 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.434 1.755 . . . . 73.11 110.972 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.31 147.7 16.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 64.14 109.266 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -45.45 -36.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 75.2 109.262 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.98 -47.42 3.02 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.476 1.11 . . . . 73.42 109.297 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.519 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.38 -36.16 71.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 71.54 110.395 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.6 OUTLIER -57.91 -56.97 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 74.15 109.303 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.507 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.3 m-80 -52.44 -31.69 35.74 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 75.55 109.299 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.13 -56.13 8.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 74.53 109.98 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.463 ' CD1' ' HG ' ' A' ' 188' ' ' LEU . 45.2 mt -44.08 -42.28 6.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 74.54 109.269 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.1 t80 -72.44 -44.64 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.15 111.037 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -47.05 -34.5 5.86 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.154 . . . . 75.43 109.291 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.485 HE22 ' ND2' ' A' ' 191' ' ' ASN . 55.1 mt-30 -79.35 -50.85 10.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.121 . . . . 70.12 110.281 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.455 ' CD1' HD11 ' A' ' 188' ' ' LEU . 12.7 mt -54.91 -23.19 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.25 109.282 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -38.55 38.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 74.34 109.259 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.21 -17.44 19.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 73.44 109.323 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -82.94 -25.37 32.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.11 110.327 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.574 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 17.4 m -39.87 126.5 2.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 63.23 109.997 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 10.2 m -58.11 109.88 0.83 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 63.22 108.307 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.71 -18.97 1.13 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.483 1.114 . . . . 61.24 111.007 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.4 p -93.25 159.84 15.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 0.762 . . . . 70.14 110.387 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.93 -3.51 58.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 64.42 110.014 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.7 m -110.15 -1.16 17.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 71.35 110.42 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.31 132.82 43.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 72.45 109.294 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -173.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 75.11 109.989 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.429 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.3 p -152.65 126.94 4.5 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.118 . . . . 71.22 109.985 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.88 52.9 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.021 -2.491 . . . . 70.13 110.979 -0.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 9.1 p -72.66 -173.85 1.27 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.125 . . . . 74.22 108.256 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.3 mp -100.82 134.17 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.116 . . . . 75.43 109.351 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.2 p -81.42 86.67 6.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.13 . . . . 74.22 110.377 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 1.6 p90 -88.9 -1.99 58.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 74.52 111.007 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.6 9.88 23.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 71.42 110.258 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.57 ' CE1' HG22 ' A' ' 174' ' ' VAL . 18.0 t80 -129.51 68.09 79.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.476 1.11 . . . . 75.45 110.989 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.45 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -75.03 117.08 4.78 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.528 1.804 . . . . 72.21 111.012 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.57 HG22 ' CE1' ' A' ' 172' ' ' TYR . 2.6 t -151.78 -55.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 71.31 109.262 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.36 -46.77 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 73.45 109.281 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.2 121.22 1.02 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.47 1.106 . . . . 55.11 111.004 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.462 ' HA ' ' CD ' ' A' ' 180' ' ' ARG . 4.3 p -153.02 -47.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.361 -0.978 . . . . 73.15 108.361 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 47.0 p90 -67.53 -44.47 78.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.468 1.105 . . . . 74.23 111.048 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.567 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -54.21 -66.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.472 1.107 . . . . 72.22 109.281 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . 0.5 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 2.0 ptm85 -42.02 -46.96 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 1.155 . . . . 74.31 110.26 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -50.36 -58.96 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.137 . . . . 74.54 109.268 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -46.35 -28.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 74.15 109.613 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.448 ' HG3' ' CG1' ' A' ' 168' ' ' ILE . 24.4 mmmt -81.03 -40.03 24.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 74.31 109.32 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 181' ' ' ALA . 9.8 mtm -60.35 -46.64 89.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 74.02 111.005 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.539 ' NH1' ' CE ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -65.85 -30.67 71.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 64.12 110.303 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.444 ' HG2' ' N ' ' A' ' 187' ' ' ILE . 0.0 OUTLIER -59.85 -33.12 71.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 74.12 110.323 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.444 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 25.1 mm -78.5 -50.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 54.21 109.259 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LEU . . . . . 0.477 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.1 OUTLIER -43.62 -36.89 2.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.454 1.096 . . . . 71.45 109.307 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.539 ' CE ' ' NH1' ' A' ' 185' ' ' ARG . 0.6 OUTLIER -68.54 -46.29 69.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.476 1.11 . . . . 74.15 111.0 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -53.5 12.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.53 1.144 . . . . 70.04 109.251 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ASN . . . . . 0.485 ' ND2' HE22 ' A' ' 152' ' ' GLN . 6.3 t-20 -62.29 -37.47 85.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 70.23 109.31 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.95 51.37 0.33 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.534 1.146 . . . . 70.01 111.002 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.566 ' CD1' ' HB1' ' A' ' 137' ' ' ALA . 74.0 m-85 -151.43 136.92 17.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 0.757 . . . . 74.43 111.028 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.464 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.8 t70 -102.74 131.47 49.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.498 1.123 . . . . 64.03 109.284 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.502 ' SG ' ' CB ' ' A' ' 185' ' ' ARG . 12.8 p -108.38 -179.27 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 74.33 108.323 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.39 177.35 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.05 110.301 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -109.54 171.67 7.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 74.24 109.306 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -168.72 117.4 0.69 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 75.52 110.324 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.4 m-85 -109.09 137.81 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 73.21 111.014 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.47 ' CG2' ' HB3' ' A' ' 269' ' ' TYR . 9.9 p -129.98 125.59 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 75.13 109.289 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -95.97 151.14 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 73.11 110.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 129.44 -171.07 20.21 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.506 1.129 . . . . 71.31 110.995 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 263' ' ' SER . 56.1 t-20 -79.15 111.47 15.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 0.787 . . . . 73.21 109.302 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . 0.472 HD13 ' CB ' ' A' ' 218' ' ' HIS . 3.3 mt -116.53 94.61 4.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 74.22 109.331 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 256' ' ' CYS . 9.3 mttt -93.08 168.18 11.29 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.472 1.107 . . . . 73.31 109.336 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -167.56 125.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.458 1.099 . . . . 72.44 109.296 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.443 1.09 . . . . 71.41 109.966 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.302 -0.999 . . . . 72.12 108.302 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.34 149.19 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 64.41 109.295 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.46 133.37 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 72.35 109.313 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -134.31 132.01 39.06 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.146 . . . . 74.04 108.009 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.5 p -73.66 -3.59 29.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 63.32 109.988 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -173.95 137.46 0.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 74.21 111.013 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 60.2 t60 -125.9 168.83 13.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 75.34 109.546 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 1.8 p -147.44 133.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 74.44 109.327 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.22 -165.03 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 73.22 109.25 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.459 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 18.5 pt -116.99 117.66 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.122 . . . . 72.24 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 14.0 tp -81.83 109.05 15.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.24 109.277 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.468 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.8 OUTLIER -104.85 147.86 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 73.43 109.284 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 67.2 m -117.62 121.74 41.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 74.02 109.991 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.537 ' CD2' HG21 ' A' ' 143' ' ' VAL . 31.7 p90 -136.64 143.23 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 73.2 111.028 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.427 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -69.17 132.28 46.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.529 1.143 . . . . 73.02 109.315 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.476 1.11 . . . . 74.32 109.317 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.68 -0.2 49.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.132 . . . . 73.04 109.337 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.7 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.087 . . . . 73.21 110.052 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.25 37.87 8.06 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.511 1.132 . . . . 64.33 111.001 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.418 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.8 137.33 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 75.13 109.305 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.427 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.3 m -71.45 102.54 2.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 73.11 110.428 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.41 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.7 mm-40 -101.8 -172.58 2.18 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 74.21 110.272 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -126.51 144.89 50.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 75.31 109.3 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.527 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 2.1 tpt180 -144.17 161.59 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 75.14 110.327 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.468 HG13 ' CG ' ' A' ' 252' ' ' TRP . 17.8 mm -115.85 116.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 75.3 109.287 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . 0.502 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -100.42 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 64.12 109.293 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ASP . . . . . 0.419 ' OD1' ' CE ' ' A' ' 184' ' ' MET . 3.1 m-20 -100.1 110.38 59.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 75.44 109.343 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . 0.442 ' C ' ' N ' ' A' ' 241' ' ' LEU . 18.3 Cg_endo -74.99 -42.99 0.43 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.465 1.771 . . . . 73.13 110.987 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 26.5 p -39.28 -29.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 73.52 109.998 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 239' ' ' PRO . 30.0 mt -101.92 -59.49 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.23 109.288 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.569 ' CD1' HG12 ' A' ' 247' ' ' VAL . 79.7 m-85 -112.29 99.39 7.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 71.24 111.025 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.5 m -86.2 -5.18 59.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 64.55 109.968 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 m -82.65 -45.28 14.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 62.32 109.999 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.74 -173.77 45.1 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.512 1.133 . . . . 73.24 110.993 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' PRO . . . . . 0.455 ' CG ' HD21 ' A' ' 146' ' ' LEU . 18.5 Cg_endo -74.95 162.73 36.74 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.501 1.79 . . . . 50.53 111.034 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 242' ' ' PHE . 2.7 m -148.18 159.19 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 73.42 109.329 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' THR . . . . . 0.435 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.2 p -62.23 139.93 58.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 74.34 110.418 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.407 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 2.5 p-10 -42.95 -28.13 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.123 . . . . 73.52 109.328 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.435 ' N ' ' C ' ' A' ' 248' ' ' THR . 17.1 m -72.45 -65.0 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 74.44 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.94 14.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.447 1.092 . . . . 70.12 109.29 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' TRP . . . . . 0.632 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 11.9 t90 -59.47 -66.17 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.953 -1.129 . . . . 70.42 107.953 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.564 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -41.67 -39.18 1.59 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 75.42 110.254 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ASN . . . . . 0.45 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.1 m-80 -60.12 -50.37 73.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 70.33 109.297 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.567 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -55.1 -28.89 55.89 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.41 109.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' LYS . 7.6 m -81.39 -33.52 32.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 73.03 108.309 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.464 ' CA ' ' HB2' ' A' ' 264' ' ' ALA . 2.4 m -98.14 24.18 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 75.23 109.338 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.87 110.93 0.89 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 75.3 109.271 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.8 p -73.32 -3.04 24.61 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 74.3 110.402 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.2 t -44.34 -26.66 0.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 73.44 109.954 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.83 -36.58 11.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.447 1.092 . . . . 75.21 108.253 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.96 -126.55 1.36 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.116 . . . . 72.01 111.028 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -81.24 150.33 28.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 0.759 . . . . 74.34 110.001 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.464 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -172.28 144.68 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 73.42 109.276 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 41.6 p -172.84 153.14 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 74.33 109.992 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.463 HG23 ' CG1' ' A' ' 257' ' ' VAL . 3.1 t -99.75 125.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 74.14 109.295 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.4 t -85.87 -29.35 23.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.124 . . . . 72.43 109.966 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.6 m 178.58 155.64 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 75.11 109.969 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.47 ' HB3' ' CG2' ' A' ' 200' ' ' VAL . 30.2 p90 -144.14 155.94 44.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 75.32 111.014 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -147.79 154.33 40.34 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.556 1.16 . . . . 71.4 109.293 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.426 ' ND2' ' C ' ' A' ' 271' ' ' ASN . 1.0 OUTLIER -107.62 157.71 17.85 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 73.5 109.323 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.436 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 1.8 p -149.47 178.39 8.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 72.32 110.364 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.91 165.93 16.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.425 1.078 . . . . 74.11 109.303 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -75.38 -42.69 27.15 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.545 1.153 . . . . 74.33 110.995 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -55.26 -39.93 70.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 0.767 . . . . 72.41 109.273 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 76.6 t -43.57 101.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 74.31 109.295 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.43 -47.34 84.49 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 74.44 110.978 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -152.12 138.51 18.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.48 1.112 . . . . 71.23 111.036 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.557 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 67.4 ttt-85 -106.84 147.42 29.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 74.53 110.345 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.71 158.12 48.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 63.44 110.011 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 0.25 9.14 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.469 1.773 . . . . 65.14 111.009 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 28.7 t -103.09 7.4 38.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.464 1.103 . . . . 71.52 109.996 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 73.93 41.91 0.39 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.45 109.3 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 t -123.5 121.51 35.85 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.495 1.122 . . . . 74.24 110.04 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -101.27 165.82 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 75.1 110.989 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' LEU . . . . . 0.476 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.1 mm? -124.62 177.37 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 74.32 109.328 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.5 m-85 -160.32 123.21 3.39 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 75.03 110.98 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ASP . . . . . 0.49 ' HB2' ' CD2' ' A' ' 182' ' ' HIS . 2.2 m-20 -115.07 104.01 11.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.099 . . . . 73.41 109.302 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.54 -53.81 4.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 74.4 109.32 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' ASN . . . . . 0.463 ' CB ' HG12 ' A' ' 292' ' ' ILE . 17.0 m-20 -93.04 15.65 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.558 1.161 . . . . 64.52 109.318 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.592 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.4 mm? 40.27 42.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 72.44 109.308 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . 0.463 HG12 ' CB ' ' A' ' 290' ' ' ASN . 26.6 mm -74.04 -28.38 23.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.542 1.151 . . . . 73.44 109.318 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.497 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.4 t-20 -94.64 -26.91 16.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 74.13 109.313 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 297' ' ' VAL . 23.7 m -82.3 -68.96 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 75.33 110.424 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.6 m-20 -47.52 -29.86 3.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 74.44 109.315 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.69 -43.06 57.05 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 1.094 . . . . 53.33 108.333 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.1 t -56.46 -50.59 71.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.13 109.256 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 301' ' ' PHE . 10.4 mt -61.85 -63.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 71.31 109.283 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -41.96 -42.45 2.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 72.35 110.425 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -53.34 -44.66 68.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 72.33 109.305 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' PHE . . . . . 0.562 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 2.5 m-30 -100.42 29.87 4.18 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.541 1.15 . . . . 74.41 110.979 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 27.2 t -62.04 -52.35 64.29 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 72.34 109.989 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' LEU . . . . . 0.427 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -84.05 -10.46 57.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 74.15 109.281 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.548 HD13 ' CE2' ' A' ' 172' ' ' TYR . 17.7 mt -73.82 137.18 43.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 73.52 109.288 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 62.9 p -160.7 137.12 8.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 65.11 110.009 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.89 -158.77 15.53 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.565 1.166 . . . . 64.12 111.019 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 8.4 p -95.76 8.7 42.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.347 -0.983 . . . . 73.32 108.347 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' SER . . . . . 0.472 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 4.0 p -139.14 152.11 69.1 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 73.04 109.985 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.3 Cg_endo -75.02 146.64 87.2 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.002 -2.499 . . . . 74.1 111.028 0.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' SER . . . . . 0.49 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 6.1 t -132.79 135.15 25.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 74.33 109.999 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.1 Cg_endo -75.01 -173.64 12.7 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.986 -2.506 . . . . 73.31 111.0 0.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.99 152.99 25.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 71.54 109.313 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' PRO . . . . . 0.557 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.491 1.785 . . . . 71.41 110.988 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -81.96 133.05 35.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 72.22 109.264 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.19 16.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 63.4 109.27 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 318' ' ' CYS . 1.7 t -64.04 -40.2 95.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.3 109.955 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.1 t -39.5 -29.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 73.11 110.01 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' CYS . . . . . 0.439 ' N ' ' C ' ' A' ' 316' ' ' SER . 5.2 m . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 74.22 108.287 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.441 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 5.7 tp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.253 -0.647 . . . . 75.04 109.253 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -145.47 112.85 6.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 73.41 109.312 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -85.84 11.47 11.18 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 63.52 109.987 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.3 t -150.3 149.11 14.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.426 1.079 . . . . 61.31 109.303 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -101.48 143.29 26.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 73.42 109.298 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.99 -33.86 4.27 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 74.34 111.034 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.49 152.52 23.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 70.12 109.294 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.543 HG21 ' CD2' ' A' ' 225' ' ' TYR . 2.1 t -49.54 -36.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 75.22 109.311 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.58 2.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 70.23 109.317 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.527 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -71.53 -36.2 70.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 75.44 110.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.93 -57.4 12.95 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 1.155 . . . . 74.3 109.269 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.514 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 46.8 m-80 -51.08 -33.19 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 74.51 109.29 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -66.9 -56.5 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 74.34 109.943 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.47 ' CD1' HD12 ' A' ' 140' ' ' ILE . 59.8 mt -41.82 -41.9 2.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 73.44 109.3 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.454 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.06 -40.89 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 61.41 111.033 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -51.01 -36.2 38.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 72.05 109.306 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.474 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 65.3 mt-30 -76.52 -56.39 4.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 1.128 . . . . 73.51 110.308 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.464 HG22 ' CG ' ' A' ' 184' ' ' MET . 25.4 mt -50.18 -29.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 74.13 109.296 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -33.44 63.03 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 74.01 109.302 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -61.72 -15.68 42.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 74.3 109.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -84.58 -17.68 38.01 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 73.15 110.301 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.483 ' HA ' ' CE2' ' A' ' 170' ' ' PHE . 16.1 p -38.53 133.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 75.31 110.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -64.59 130.0 41.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 61.14 108.315 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.79 -20.75 10.74 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.495 1.122 . . . . 63.23 110.962 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.43 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 64.2 p -79.24 161.75 26.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 0.791 . . . . 73.13 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.73 -0.84 55.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.43 110.016 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.6 m -116.61 6.19 13.38 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 75.1 110.418 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.43 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -82.66 138.88 34.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.102 . . . . 74.52 109.264 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 73.41 109.977 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.438 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.19 127.24 3.6 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.556 1.16 . . . . 74.43 110.008 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.02 138.02 53.68 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.993 -2.503 . . . . 73.31 111.002 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.03 177.96 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 72.45 108.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.635 ' CG2' ' CZ ' ' A' ' 170' ' ' PHE . 3.5 mp -89.53 125.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.515 1.134 . . . . 64.23 109.276 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.417 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 65.3 p -79.65 88.23 5.16 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.538 1.149 . . . . 75.55 110.387 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.635 ' CZ ' ' CG2' ' A' ' 168' ' ' ILE . 84.8 m-85 -88.01 -26.37 22.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 75.32 111.001 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.77 -1.31 24.44 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 73.33 110.301 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 174' ' ' VAL . 26.4 t80 -128.52 67.6 76.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 71.42 110.986 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 115.58 4.33 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.482 1.78 . . . . 75.3 110.979 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.58 HG22 ' CE1' ' A' ' 172' ' ' TYR . 15.8 t -148.85 -72.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 75.4 109.301 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.02 -45.15 2.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 73.42 109.306 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -42.33 101.54 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.543 1.152 . . . . 60.42 111.006 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 73.9 m -134.3 -48.15 0.78 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.272 -1.01 . . . . 73.44 108.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 38.7 p90 -75.61 -45.55 36.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.22 110.99 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.33 -68.41 0.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 73.14 109.277 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.501 ' NH2' ' N ' ' A' ' 240' ' ' SER . 3.6 ptm180 -50.09 -47.61 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 73.21 110.318 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.454 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.83 -61.2 0.88 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 72.4 109.304 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.697 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.8 OUTLIER -46.37 -39.68 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.145 . . . . 71.31 109.595 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 180' ' ' ARG . 14.1 mmmm -65.25 -61.25 2.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 73.43 109.281 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.464 ' CG ' HG22 ' A' ' 153' ' ' ILE . 13.8 mtm -39.02 -40.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 71.04 110.963 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.454 ' NH1' ' CE ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.546 1.154 . . . . 73.23 110.323 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.411 ' NE2' ' HE2' ' A' ' 183' ' ' LYS . 0.2 OUTLIER -54.48 -35.92 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 71.21 110.31 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.7 mm -71.16 -34.15 53.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 72.11 109.278 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -64.39 -45.78 86.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 74.24 109.273 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.454 ' CE ' ' NH1' ' A' ' 185' ' ' ARG . 3.5 mtt -55.32 -36.8 66.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 74.52 111.006 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.62 -50.3 68.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 73.24 109.305 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.474 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 18.7 t-20 -66.84 -34.23 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 73.43 109.337 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 107.99 53.39 0.66 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.487 1.117 . . . . 54.44 111.012 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 145' ' ' THR . 72.4 m-85 -153.17 134.86 14.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 0.771 . . . . 72.23 111.0 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.446 ' OD1' ' NH2' ' A' ' 185' ' ' ARG . 2.4 t0 -101.43 122.36 43.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 53.35 109.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 29.5 p -100.11 -179.38 4.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 75.34 108.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -126.63 174.47 8.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 73.42 110.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.454 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 18.9 mmtt -110.1 159.01 17.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 74.14 109.301 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.451 ' NE2' ' CD1' ' A' ' 222' ' ' LEU . 7.6 tt0 -151.39 117.59 5.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 75.3 110.282 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.56 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.5 m-85 -110.71 118.59 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 72.44 110.978 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 10.0 p -109.88 146.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 70.31 109.311 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 12.0 m-85 -118.63 160.43 21.82 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 75.31 111.041 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.61 -176.04 16.01 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.509 1.131 . . . . 74.12 110.99 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 263' ' ' SER . 56.7 t-20 -72.39 110.3 6.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 0.781 . . . . 73.14 109.298 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 218' ' ' HIS . 5.2 mt -114.52 94.74 4.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 75.3 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.1 mtpt -92.31 178.75 5.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.145 . . . . 73.41 109.321 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' A' ' 213' ' ' VAL . . . -178.02 163.24 1.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.22 109.316 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t -141.55 131.07 23.87 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.549 1.156 . . . . 73.23 110.007 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.6 p -108.98 -2.65 18.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 75.43 110.398 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.48 -22.7 25.94 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.529 1.143 . . . . 73.21 110.983 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 t -113.79 -17.29 12.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 0.764 . . . . 73.2 110.427 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 2.2 p -173.96 148.1 1.36 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 73.54 108.263 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -101.85 160.13 14.75 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.423 1.077 . . . . 73.53 108.281 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.45 ' N ' ' SG ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -134.07 149.68 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 75.55 109.301 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.34 130.91 27.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 71.43 109.274 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.452 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -137.68 135.82 36.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.979 -1.119 . . . . 75.12 107.979 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 72.7 p -80.05 1.11 29.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 73.53 110.045 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.0 p90 -176.23 129.83 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.093 . . . . 74.43 111.0 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 37.4 t60 -114.43 169.05 9.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 64.55 109.603 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.487 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 2.1 p -146.45 136.37 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 73.35 109.269 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.641 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.13 -168.04 2.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 75.52 109.297 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 28.1 pt -115.75 121.51 67.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 74.53 109.304 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.451 ' CD1' ' NE2' ' A' ' 198' ' ' GLN . 12.9 tp -85.41 109.03 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 73.34 109.313 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.53 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -102.8 146.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 70.22 109.269 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 140' ' ' ILE . 4.0 m -116.78 119.86 36.75 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 74.51 110.024 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.57 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.4 p90 -134.93 143.26 46.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 73.31 111.007 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.419 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -68.61 133.93 49.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 71.45 109.344 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.02 -160.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.122 . . . . 75.52 109.306 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.81 0.05 49.05 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 63.53 109.288 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.4 m -115.12 -8.33 12.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 75.13 110.009 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.73 37.44 7.98 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.483 1.114 . . . . 71.34 111.018 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.37 137.4 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.479 0.752 . . . . 73.44 109.274 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.419 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 6.3 m -71.52 102.66 2.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.484 1.115 . . . . 72.24 110.425 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.409 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 3.0 mm-40 -101.49 -172.24 2.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 72.3 110.298 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.1 mmtm -126.97 144.83 50.9 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 74.15 109.28 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.57 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 5.0 tpt180 -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 75.14 110.282 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.47 HG13 ' CB ' ' A' ' 252' ' ' TRP . 13.8 mm -114.88 127.67 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 64.44 109.296 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.499 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -111.95 41.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 75.32 109.332 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.43 108.05 59.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 73.42 109.289 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.563 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.1 Cg_endo -75.03 -0.54 10.1 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.477 1.777 . . . . 63.15 110.995 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.501 ' N ' ' NH2' ' A' ' 180' ' ' ARG . 1.2 t -67.67 -9.29 42.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.542 1.151 . . . . 71.54 109.944 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.467 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 3.1 mt -135.21 -47.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 74.53 109.287 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.569 ' CD1' HG12 ' A' ' 247' ' ' VAL . 97.5 m-85 -121.0 99.75 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 74.15 110.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.0 -24.04 26.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 74.54 109.999 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 p -61.73 -45.74 92.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 72.43 109.987 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.42 -174.22 41.02 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.496 1.123 . . . . 51.23 111.017 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.425 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.01 169.18 23.2 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.431 1.753 . . . . 75.43 110.973 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 242' ' ' PHE . 4.1 m -152.45 157.21 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 74.22 109.3 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 36.8 p -60.22 137.09 58.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.447 1.092 . . . . 74.45 110.395 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 7.7 p-10 -40.57 -29.67 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.475 1.109 . . . . 72.44 109.334 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.0 m -71.64 -64.91 0.83 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.498 1.124 . . . . 72.34 110.355 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.0 -30.78 11.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 74.34 109.274 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.641 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 15.6 t90 -60.74 -61.9 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 74.22 107.996 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.565 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.44 -40.88 19.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 1.112 . . . . 72.22 110.316 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.85 -50.79 72.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 72.32 109.287 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.563 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.79 -23.01 40.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 72.2 109.287 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.447 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.6 m -84.78 -35.84 22.11 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 73.13 108.28 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.481 ' CA ' ' HB1' ' A' ' 264' ' ' ALA . 2.9 m -95.24 21.29 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.551 1.157 . . . . 63.42 109.294 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -50.23 107.27 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 1.1 . . . . 72.32 109.26 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.9 p -72.49 -3.93 27.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 63.21 110.435 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.9 t -46.54 -25.03 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 75.44 110.006 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . 0.44 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 19.7 t -94.34 -35.32 12.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 73.14 108.282 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 162.18 -128.35 1.87 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.489 1.118 . . . . 74.12 110.981 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -71.28 143.91 50.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 0.768 . . . . 73.42 109.953 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.481 ' HB1' ' CA ' ' A' ' 257' ' ' VAL . . . -170.3 144.33 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 73.04 109.297 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.7 t -172.78 154.78 3.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 75.33 110.007 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.27 117.54 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 74.13 109.308 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 20.7 t -73.74 -43.96 57.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 64.1 110.044 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.1 m -165.23 171.92 13.05 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 70.33 110.02 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -154.33 155.81 35.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.34 111.012 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -157.81 160.66 38.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 74.22 109.323 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -121.94 160.64 24.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 75.4 109.303 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.505 HG23 ' CE1' ' A' ' 285' ' ' TYR . 35.0 p -152.62 175.68 12.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 74.51 110.37 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.47 ' CB ' HG21 ' A' ' 276' ' ' VAL . . . -59.13 156.5 11.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 74.53 109.334 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.74 -46.13 62.41 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.486 1.116 . . . . 65.01 110.993 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -52.94 -42.38 65.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 0.771 . . . . 73.14 109.353 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.47 HG21 ' CB ' ' A' ' 273' ' ' ALA . 81.8 t -43.88 101.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.517 1.136 . . . . 74.3 109.325 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.4 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 2.6 t80 -58.67 -59.47 5.35 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 73.32 111.009 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -132.03 150.25 52.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.467 1.104 . . . . 75.52 111.064 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.56 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 60.8 ttt-85 -119.35 147.47 44.29 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 71.3 110.313 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.66 158.2 40.93 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 74.2 110.015 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 0.37 9.0 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.495 1.787 . . . . 63.35 110.976 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 t -100.47 9.88 41.98 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 72.4 109.987 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 72.82 40.8 0.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 72.54 109.336 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -119.18 133.14 55.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.469 1.106 . . . . 74.53 110.022 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.505 ' CE1' HG23 ' A' ' 272' ' ' THR . 18.0 m-30 -114.38 150.12 35.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 73.53 110.985 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -116.44 177.48 4.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 74.21 109.274 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 47.7 m-85 -160.59 115.49 2.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 75.0 111.006 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -115.38 94.87 4.9 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.475 1.109 . . . . 75.2 109.337 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.7 -16.74 53.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 71.14 109.266 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.447 ' CB ' HG12 ' A' ' 292' ' ' ILE . 40.8 m-20 -108.52 5.31 25.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.134 . . . . 64.12 109.321 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.697 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.27 49.7 2.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.553 1.158 . . . . 73.22 109.276 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.447 HG12 ' CB ' ' A' ' 290' ' ' ASN . 40.6 mm -80.03 -29.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.35 109.317 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.486 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.7 t-20 -94.5 -20.59 19.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.13 . . . . 72.01 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.419 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.7 m -87.59 -68.65 0.74 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.133 . . . . 75.34 110.365 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 77.4 m-20 -49.75 -31.2 10.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.1 . . . . 73.22 109.304 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 41.3 t -70.96 -49.36 46.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 72.34 108.302 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.3 t -52.01 -43.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 74.55 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 301' ' ' PHE . 21.0 mt -67.2 -61.12 2.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 75.22 109.3 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -41.4 -31.72 0.27 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.533 1.145 . . . . 72.41 110.382 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 17.0 mmmt -67.14 -51.48 53.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 74.03 109.252 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.6 OUTLIER -94.58 37.72 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 74.44 111.025 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 37.0 t -69.08 -46.82 66.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 72.33 109.953 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.489 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -90.19 -17.55 27.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 72.34 109.31 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.417 ' CD2' ' CD ' ' A' ' 309' ' ' PRO . 16.6 mt -57.81 140.07 52.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.535 1.147 . . . . 74.31 109.297 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.6 p -152.66 140.72 20.29 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.441 1.088 . . . . 75.45 110.002 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.93 -161.66 27.02 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.497 1.123 . . . . 55.51 111.0 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.32 6.2 47.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.344 -0.984 . . . . 73.44 108.344 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.479 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 24.0 p -130.22 151.05 77.79 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 74.03 110.053 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -75.03 145.87 85.08 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.998 -2.501 . . . . 74.51 110.999 0.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.491 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.0 p -133.59 135.51 25.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 71.35 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.02 -173.6 12.62 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.047 -2.48 . . . . 70.32 111.002 0.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.01 154.67 18.35 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.532 1.145 . . . . 72.12 109.339 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.506 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -74.96 -162.24 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.482 1.78 . . . . 65.24 111.039 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -85.08 133.83 34.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 73.05 109.295 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.2 m -125.81 25.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 74.1 109.32 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 t -55.12 -31.7 61.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 74.11 110.02 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 28.8 p -49.65 -23.58 1.79 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 74.23 110.026 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.6 m -77.76 175.47 9.93 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 60.12 108.289 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 166.48 100.46 0.14 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.522 1.139 . . . . 75.1 110.982 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 10.6 p90 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.484 0.756 . . . . 75.03 110.966 -179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 8.9 tp . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.271 -0.64 . . . . 70.4 109.271 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.549 ' HB2' ' CD2' ' A' ' 193' ' ' TYR . . . -103.92 105.46 15.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 75.45 109.289 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.1 m -83.66 8.46 14.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.129 . . . . 52.01 109.973 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -150.16 147.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 71.51 109.266 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.437 HD13 ' CD1' ' A' ' 149' ' ' LEU . 1.3 mt -97.92 142.14 24.09 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.148 . . . . 70.34 109.304 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.05 -32.37 5.38 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.519 1.8 . . . . 74.11 110.969 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.05 148.36 17.01 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 72.31 109.332 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.564 HG22 ' CD2' ' A' ' 225' ' ' TYR . 2.1 t -46.11 -36.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 73.23 109.286 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.88 -47.39 2.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.112 . . . . 74.32 109.268 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.51 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.55 -36.36 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.54 1.15 . . . . 72.3 110.394 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.483 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.9 -57.23 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 63.54 109.295 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.521 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 47.4 m-80 -51.62 -32.36 28.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 75.34 109.297 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.74 -56.29 8.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.42 110.023 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.469 HD22 ' CD1' ' A' ' 193' ' ' TYR . 56.6 mt -43.69 -42.19 5.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 70.21 109.318 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.452 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.1 t80 -71.87 -44.29 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 72.13 110.987 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -46.4 -35.77 5.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 74.04 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -77.87 -54.89 5.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 61.32 110.278 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.501 ' CD1' ' CD1' ' A' ' 188' ' ' LEU . 10.2 mt -50.63 -24.5 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.113 . . . . 71.11 109.275 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -38.39 46.55 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 72.22 109.31 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.73 -17.04 19.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 74.1 109.288 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -81.91 -26.36 34.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 75.3 110.29 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 13.9 m -42.24 137.75 1.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 73.23 109.972 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.69 113.03 4.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 63.44 108.314 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.58 1.74 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.518 1.136 . . . . 71.44 110.994 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.418 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 72.7 p -93.17 161.66 14.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.538 0.787 . . . . 74.33 110.385 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.7 p -92.52 -1.82 56.67 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 65.02 109.984 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.4 m -114.74 2.54 14.45 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.33 110.396 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.418 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -75.33 133.54 41.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 72.41 109.35 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -170.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 73.13 109.961 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.452 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.4 p -154.11 127.33 4.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 72.44 110.049 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.452 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -75.03 138.04 53.78 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 120.966 -2.514 . . . . 75.14 111.0 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.1 p -72.79 -178.6 2.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.459 1.1 . . . . 72.03 108.328 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.33 132.88 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 64.23 109.295 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.1 p -92.68 73.14 5.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 74.53 110.411 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 12.7 p90 -74.14 -21.3 59.92 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.562 1.164 . . . . 73.35 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 302' ' ' SER . 0.0 OUTLIER -74.73 -1.85 23.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 75.23 110.281 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.579 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 21.9 t80 -131.76 66.97 79.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 72.3 110.976 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.434 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.02 118.79 5.39 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.435 1.755 . . . . 75.2 110.993 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.569 HG22 ' CE1' ' A' ' 172' ' ' TYR . 6.7 t -152.09 -72.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 70.33 109.337 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.6 -44.96 1.5 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 74.22 109.288 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -44.27 110.05 0.32 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.527 1.142 . . . . 65.22 110.999 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.476 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 5.3 p -147.95 -48.47 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.277 -1.009 . . . . 60.34 108.277 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -66.58 -16.96 64.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 75.22 110.984 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.04 -68.11 0.64 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 73.51 109.334 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.471 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 10.0 ptm180 -49.03 -50.62 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.451 1.094 . . . . 75.32 110.314 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.413 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.21 -56.63 3.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 55.34 109.296 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.7 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -45.07 -36.71 3.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 65.14 109.575 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.737 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.0 mmmt -68.89 -59.15 3.27 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.15 . . . . 73.41 109.313 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.423 ' CG ' HG22 ' A' ' 153' ' ' ILE . 11.2 mtm -38.74 -31.45 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.15 111.009 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.437 ' NH2' ' OD2' ' A' ' 194' ' ' ASP . 0.0 OUTLIER -69.32 -54.08 16.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 73.12 110.259 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.737 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.6 OUTLIER -54.15 -32.62 55.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 74.23 110.286 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 153' ' ' ILE . 26.1 mm -71.5 -40.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.459 1.1 . . . . 74.51 109.235 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.501 ' CD1' ' CD1' ' A' ' 153' ' ' ILE . 0.3 OUTLIER -62.18 -42.46 99.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 71.13 109.306 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.0 mtt -57.94 -38.93 76.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 65.44 110.973 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.43 -52.34 54.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 75.23 109.296 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.438 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 7.8 t-20 -64.23 -35.34 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 74.23 109.315 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.58 53.01 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.44 1.088 . . . . 72.32 110.99 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 137' ' ' ALA . 90.0 m-85 -153.28 147.9 26.19 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.541 0.789 . . . . 65.25 111.007 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -110.02 126.88 54.43 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 75.2 109.31 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.474 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 13.4 p -98.8 -179.27 4.24 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.47 1.106 . . . . 65.12 108.312 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -133.38 171.62 13.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.562 1.164 . . . . 75.21 110.357 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.413 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 18.1 mmtt -107.01 161.13 15.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.48 1.113 . . . . 75.41 109.3 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -157.66 117.49 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 73.25 110.323 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 9.1 m-85 -108.49 133.53 52.52 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 75.43 110.967 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.479 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 8.7 p -124.38 148.16 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 74.23 109.301 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.6 m-85 -120.09 156.51 30.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.483 1.114 . . . . 72.23 111.018 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.42 -178.55 16.37 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.542 1.151 . . . . 51.42 111.006 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 263' ' ' SER . 57.2 t-20 -71.02 111.25 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 0.772 . . . . 73.41 109.297 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.468 HD12 ' CB ' ' A' ' 218' ' ' HIS . 5.4 mt -115.27 93.62 4.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 62.34 109.312 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.8 mttp -93.27 165.93 12.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 72.5 109.287 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -171.68 154.07 3.57 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 70.3 109.322 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t -128.66 129.27 45.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 75.13 109.995 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.0 p -96.85 -7.28 33.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 75.21 110.42 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 107.15 -30.9 8.68 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.542 1.152 . . . . 62.21 110.983 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.4 p -109.08 -16.58 14.08 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.501 0.765 . . . . 74.11 110.435 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -169.07 163.05 11.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.513 1.133 . . . . 74.22 108.312 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.53 145.64 45.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.12 . . . . 65.12 108.295 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.416 ' HB ' ' NE1' ' A' ' 215' ' ' TRP . 0.0 OUTLIER -114.44 153.86 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.541 1.151 . . . . 72.12 109.272 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -137.4 119.02 14.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 73.22 109.276 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.32 134.0 51.23 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.019 -1.104 . . . . 72.34 108.019 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.2 t -79.33 2.32 21.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.485 1.115 . . . . 72.44 109.945 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.484 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.3 p90 -175.33 128.41 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.448 1.092 . . . . 73.42 111.006 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.468 ' CB ' HD12 ' A' ' 204' ' ' LEU . 83.4 t60 -121.75 167.21 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 74.13 109.595 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.476 ' CG1' ' SG ' ' A' ' 177' ' ' CYS . 2.5 p -145.18 149.73 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.459 1.1 . . . . 71.14 109.302 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.501 ' HB2' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.46 -159.43 0.99 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 64.22 109.317 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.469 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 14.4 pt -120.0 122.98 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.462 1.102 . . . . 75.33 109.291 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 11.9 tp -86.71 109.01 18.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 74.41 109.284 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.483 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.51 145.45 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 72.24 109.325 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 45.4 m -116.56 118.56 32.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 74.33 109.993 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -133.85 144.79 49.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 74.11 111.014 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.435 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -69.83 133.96 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 75.35 109.304 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.12 -159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 75.23 109.313 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 -0.35 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 74.35 109.295 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.0 m -114.87 -7.75 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.451 1.095 . . . . 74.13 109.972 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.57 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.518 1.136 . . . . 55.04 111.033 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.22 137.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 0.777 . . . . 74.32 109.275 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.435 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.4 m -71.53 102.65 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 73.13 110.368 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.407 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 1.9 mm-40 -101.74 -172.68 2.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 74.45 110.259 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -127.03 144.93 50.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 74.44 109.301 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.574 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 1.3 tpt180 -145.48 162.96 36.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 73.41 110.247 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.478 HG13 ' CB ' ' A' ' 252' ' ' TRP . 10.8 mm -116.85 119.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 74.11 109.31 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -105.33 43.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 74.33 109.292 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.436 ' OD1' ' CB ' ' A' ' 240' ' ' SER . 4.2 t70 -101.84 108.13 54.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.457 1.098 . . . . 73.13 109.315 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -4.84 16.01 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.486 1.782 . . . . 70.14 111.032 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 t -72.05 -7.94 51.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 70.34 110.027 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -130.96 -46.59 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 74.34 109.31 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.572 ' CD1' HG12 ' A' ' 247' ' ' VAL . 97.1 m-85 -123.34 106.75 10.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 71.34 110.98 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -26.22 22.25 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.496 1.123 . . . . 72.42 109.985 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.5 m -62.62 -47.74 82.46 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.124 . . . . 73.24 110.034 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.41 -173.78 40.66 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.474 1.109 . . . . 74.01 110.965 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.426 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 169.98 21.41 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.514 1.797 . . . . 72.44 111.017 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.572 HG12 ' CD1' ' A' ' 242' ' ' PHE . 13.7 m -148.61 159.46 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 74.34 109.302 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 43.3 p -61.71 142.08 57.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 72.15 110.427 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 249' ' ' ASP . 1.2 p-10 -45.82 -26.17 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.157 . . . . 75.12 109.333 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 29.1 m -80.88 -61.42 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 74.01 110.387 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.94 -22.01 5.05 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 74.13 109.235 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.57 ' CE3' ' HD3' ' A' ' 253' ' ' ARG . 9.5 t90 -67.05 -59.04 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.48 1.113 . . . . 73.15 108.017 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.06 -43.54 40.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.569 1.168 . . . . 73.44 110.278 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.434 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.2 m-80 -53.74 -52.16 61.04 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 70.42 109.319 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.435 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.4 -18.77 12.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 74.52 109.306 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.8 m -90.34 -35.0 15.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.3 108.287 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.477 ' CA ' ' HB2' ' A' ' 264' ' ' ALA . 3.5 m -94.47 21.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 71.22 109.32 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -51.34 109.24 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 72.51 109.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.0 p -74.71 -3.06 29.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.506 1.129 . . . . 74.44 110.396 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t -44.22 -31.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.508 1.13 . . . . 72.12 110.018 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 46.2 t -88.24 -37.39 16.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 70.11 108.304 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.32 -127.58 1.56 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.45 1.094 . . . . 75.21 111.032 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.1 146.83 39.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 0.784 . . . . 62.32 110.023 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.477 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -168.39 147.83 4.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 1.115 . . . . 71.23 109.286 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 39.0 m -172.83 153.86 2.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.448 1.093 . . . . 72.31 109.985 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.479 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 3.6 p -101.81 115.49 43.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 74.12 109.303 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 9.2 t -70.32 -45.17 66.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.113 . . . . 72.44 110.016 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.6 m -163.73 -174.88 3.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.499 1.124 . . . . 71.41 109.991 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -165.78 156.53 13.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 74.3 110.996 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -153.77 162.49 41.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.464 1.102 . . . . 71.31 109.276 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -121.82 159.88 25.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.32 109.318 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.447 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 2.5 p -154.37 178.12 10.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.146 . . . . 61.53 110.381 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.448 ' CB ' HG21 ' A' ' 276' ' ' VAL . . . -61.3 167.29 3.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 75.32 109.307 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.98 -18.76 66.72 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 71.4 111.015 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.94 -39.15 21.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 0.759 . . . . 73.3 109.319 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.448 HG21 ' CB ' ' A' ' 273' ' ' ALA . 61.7 t -43.6 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.535 1.147 . . . . 74.43 109.32 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.0 t80 -53.92 -54.78 34.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.523 1.139 . . . . 74.52 111.018 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.572 ' CE2' ' O ' ' A' ' 279' ' ' ARG . 66.9 t80 -143.39 159.92 41.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 72.04 110.949 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.575 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.4 ttt-85 -122.73 147.57 46.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 74.5 110.35 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.21 154.32 48.68 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.46 1.1 . . . . 75.01 109.964 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.18 9.22 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.49 1.784 . . . . 74.43 110.972 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 14.2 t -104.62 7.76 35.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.534 1.147 . . . . 73.34 110.013 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 76.7 41.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 72.4 109.275 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.4 t -119.56 118.99 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 74.44 109.997 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -102.78 159.1 15.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 75.5 111.034 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.7 OUTLIER -123.94 176.93 6.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 73.53 109.259 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 94.7 m-85 -161.31 115.37 2.0 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 63.45 111.014 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.408 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.8 t0 -115.3 95.06 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.103 . . . . 75.34 109.279 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.64 -19.45 30.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.469 1.106 . . . . 74.11 109.285 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.455 ' CB ' HG12 ' A' ' 292' ' ' ILE . 50.7 m-20 -105.71 4.18 29.76 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.12 . . . . 73.34 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.7 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.5 mm? 40.41 49.15 2.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 75.34 109.291 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.455 HG12 ' CB ' ' A' ' 290' ' ' ASN . 30.8 mm -78.7 -28.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.539 1.149 . . . . 73.34 109.339 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.7 t-20 -94.71 -24.0 17.32 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.117 . . . . 63.33 109.29 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 4.4 m -83.11 -68.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.537 1.148 . . . . 73.13 110.43 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 56.3 m-20 -51.05 -28.54 10.51 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 73.11 109.323 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 11.5 t -70.9 -66.5 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.133 . . . . 72.44 108.317 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.542 HG11 ' CE2' ' A' ' 301' ' ' PHE . 53.5 t -43.44 -42.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 70.33 109.311 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.13 -58.02 10.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.472 1.108 . . . . 74.22 109.273 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -19.5 52.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 63.32 110.429 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -76.3 -42.39 45.43 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 75.31 109.317 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.579 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 1.7 m-30 -106.02 40.41 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 74.52 111.054 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' SER . . . . . 0.447 ' O ' ' NH1' ' A' ' 171' ' ' ARG . 29.6 t -68.0 -55.28 13.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.145 . . . . 52.24 110.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.501 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -79.39 -18.33 52.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 72.41 109.28 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.552 HD13 ' CE2' ' A' ' 172' ' ' TYR . 13.3 mt -57.42 139.27 53.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.105 . . . . 75.35 109.343 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 90.3 p -149.95 166.13 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 74.33 109.995 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 68.22 -153.05 52.83 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.473 1.108 . . . . 63.42 110.978 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.7 p -103.13 15.53 29.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.283 -1.006 . . . . 70.24 108.283 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.477 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -133.59 150.26 74.39 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 71.03 109.992 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.4 Cg_endo -74.97 146.71 87.41 Favored 'Cis proline' 0 C--N 1.359 1.108 0 C-N-CA 121.052 -2.478 . . . . 64.14 110.994 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -129.75 133.39 24.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 72.5 110.033 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -168.22 6.29 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 121.044 -2.482 . . . . 72.53 110.982 0.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.71 152.08 28.2 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 75.05 109.309 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.56 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.03 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.505 1.792 . . . . 72.13 111.039 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.08 131.24 34.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.533 1.146 . . . . 71.01 109.321 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.48 27.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 73.5 109.306 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 27.0 t -57.37 -24.12 53.38 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 74.23 109.961 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -58.2 -16.8 15.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 75.24 109.984 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 61.7 m -67.06 -174.14 0.32 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 72.45 108.346 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.565 ' O ' ' CD2' ' A' ' 320' ' ' PHE . . . -154.6 -118.14 0.64 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.5 1.125 . . . . 71.23 110.99 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 319' ' ' GLY . 14.7 m-85 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.556 0.798 . . . . 62.2 111.015 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.479 ' CD2' ' HB3' ' A' ' 194' ' ' ASP . 6.9 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.267 -0.642 . . . . 74.32 109.267 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.547 ' HB2' ' CD2' ' A' ' 193' ' ' TYR . . . -109.03 111.75 23.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 74.1 109.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.486 ' CB ' ' OD1' ' A' ' 194' ' ' ASP . 0.7 OUTLIER -86.72 6.1 32.99 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 73.4 109.966 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.3 t -145.94 150.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.468 1.105 . . . . 72.01 109.314 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.468 HD11 ' CD1' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -103.28 143.13 26.0 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 71.24 109.33 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -75.05 -33.73 4.31 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.509 1.794 . . . . 54.2 111.02 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.429 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.45 150.36 23.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.114 . . . . 75.22 109.318 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.549 HG22 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -49.06 -33.91 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 54.42 109.286 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.85 -46.28 5.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 72.54 109.327 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.443 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 1.8 m -72.92 -32.16 65.12 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 74.52 110.421 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.53 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.6 OUTLIER -61.9 -56.16 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 73.33 109.332 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.509 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 51.3 m-80 -53.64 -31.07 45.87 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.533 1.146 . . . . 73.24 109.3 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -70.26 -55.92 8.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 74.54 109.953 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.468 ' CD1' HD11 ' A' ' 140' ' ' ILE . 70.4 mt -42.63 -42.24 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 1.094 . . . . 73.24 109.32 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.566 ' CE1' ' HD3' ' A' ' 154' ' ' LYS . 1.0 OUTLIER -72.2 -45.11 61.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.141 . . . . 74.34 111.006 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.61 -39.66 17.41 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 64.32 109.271 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.472 HE22 ' ND2' ' A' ' 191' ' ' ASN . 60.9 mt-30 -73.54 -57.07 4.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 71.23 110.292 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.444 ' CD1' HD11 ' A' ' 188' ' ' LEU . 10.7 mt -50.01 -23.27 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 72.52 109.28 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -76.46 -37.58 56.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 72.34 109.285 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -57.03 -18.63 14.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 73.54 109.312 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.409 ' NE2' ' HB2' ' A' ' 164' ' ' SER . 4.8 mm100 -80.24 -27.4 38.69 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.464 1.102 . . . . 73.23 110.341 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' GLN . 15.6 m -39.47 129.59 1.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 74.25 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 7.4 m -58.85 113.31 2.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.43 1.081 . . . . 74.32 108.295 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.36 -17.12 1.68 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.486 1.116 . . . . 61.31 110.982 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 46.0 p -95.33 161.56 14.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 0.76 . . . . 71.43 110.398 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 m -92.9 -3.76 54.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 1.152 . . . . 74.1 109.956 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.0 m -109.5 -1.62 18.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 72.14 110.405 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.08 134.39 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.439 1.087 . . . . 73.31 109.314 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.409 ' HB2' ' NE2' ' A' ' 156' ' ' GLN . 0.4 OUTLIER -55.59 -166.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 74.42 109.996 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.0 m -156.24 127.93 3.84 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 74.31 110.02 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 137.8 52.39 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.944 -2.523 . . . . 71.23 111.027 0.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.0 p -73.0 -179.38 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.103 . . . . 65.32 108.307 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.11 128.31 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 73.44 109.284 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 67.7 p -94.71 84.73 4.29 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 63.41 110.356 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -88.55 -12.7 42.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.522 1.139 . . . . 74.23 110.976 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.77 -4.1 29.41 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.526 1.141 . . . . 73.01 110.324 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.567 ' CE2' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -131.02 70.01 82.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.25 111.011 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.405 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.0 Cg_endo -75.05 113.56 3.82 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.535 1.808 . . . . 75.4 110.957 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.56 HG23 ' CE1' ' A' ' 172' ' ' TYR . 21.7 t -153.41 -67.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 61.42 109.298 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -159.34 112.88 2.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.527 1.142 . . . . 73.01 109.339 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.551 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.68 68.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.515 1.134 . . . . 71.54 111.002 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 42.4 m -107.5 -8.42 16.24 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.28 -1.008 . . . . 74.22 108.28 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.551 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 35.4 p90 -81.16 -23.83 37.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 71.22 110.964 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.08 -68.11 0.52 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 64.2 109.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.475 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 8.0 ptm180 -44.23 -51.12 8.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 73.14 110.309 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -40.35 -62.84 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.42 109.321 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.699 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -42.24 -39.09 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 74.04 109.625 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.666 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 28.0 mmmt -68.69 -54.9 13.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.544 1.152 . . . . 73.14 109.308 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 8.6 mtm -39.57 -41.72 1.06 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.466 1.104 . . . . 71.35 110.986 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.442 ' CG ' ' SG ' ' A' ' 195' ' ' CYS . 0.6 OUTLIER -62.63 -45.01 94.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 74.15 110.318 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.666 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -50.93 -31.81 18.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 72.2 110.307 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.433 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 10.4 mm -82.95 -39.43 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.13 . . . . 75.11 109.322 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.477 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -57.76 -39.34 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.511 1.132 . . . . 74.31 109.314 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 32.9 mtp -65.84 -45.78 80.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 72.32 110.98 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -42.87 -53.45 4.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 63.11 109.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.472 ' ND2' HE22 ' A' ' 152' ' ' GLN . 5.5 t-20 -62.64 -39.14 92.9 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 75.44 109.354 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 118.74 46.7 0.43 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.518 1.136 . . . . 64.13 111.0 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.547 ' CD2' ' HB2' ' A' ' 137' ' ' ALA . 92.5 m-85 -150.93 129.82 12.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 74.44 111.004 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.486 ' OD1' ' CB ' ' A' ' 138' ' ' SER . 0.3 OUTLIER -96.98 130.76 44.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 75.01 109.358 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 13.9 p -102.65 173.49 6.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 73.25 108.314 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 55.32 110.324 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.413 ' NZ ' ' HA ' ' A' ' 182' ' ' HIS . 7.1 mmtt -100.04 158.39 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 75.12 109.32 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.416 ' OE1' ' CZ3' ' A' ' 252' ' ' TRP . 20.4 tt0 -145.88 117.32 7.99 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 63.31 110.327 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -110.72 126.47 54.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.142 . . . . 74.24 111.032 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.47 ' CG2' HG23 ' A' ' 266' ' ' VAL . 9.1 p -125.92 128.53 72.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.458 1.099 . . . . 74.53 109.334 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.412 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 17.1 m-85 -103.44 158.37 16.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 75.24 111.005 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.94 -176.38 16.41 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.523 1.139 . . . . 44.42 110.97 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -72.18 110.98 7.0 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 0.765 . . . . 54.31 109.273 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.468 HD13 ' CB ' ' A' ' 218' ' ' HIS . 5.1 mt -115.17 94.69 4.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 74.23 109.307 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 4.5 mtpt -92.87 170.92 9.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 73.41 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -172.96 122.53 0.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.11 . . . . 72.04 109.29 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.9 t -109.55 126.44 53.58 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 64.51 109.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 11.2 p -103.58 -3.89 24.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.5 1.125 . . . . 75.22 110.415 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 102.36 -53.38 0.79 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.459 1.1 . . . . 75.23 110.945 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t -81.52 -23.93 36.98 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 0.777 . . . . 74.42 110.387 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 15.9 p -176.69 137.45 0.26 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 70.0 108.274 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.82 -174.64 2.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 73.55 108.275 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.07 161.14 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.457 1.098 . . . . 74.32 109.326 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -140.23 137.53 34.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.491 1.119 . . . . 75.31 109.298 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -138.2 134.55 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.479 1.112 . . . . 74.31 108.014 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -78.27 -1.03 31.03 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.46 1.1 . . . . 74.23 110.034 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.454 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 9.4 p90 -173.96 130.42 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 75.42 110.987 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.472 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 48.3 t60 -117.59 165.55 13.44 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.519 1.137 . . . . 71.12 109.588 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.472 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 2.0 p -140.76 135.87 34.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 72.11 109.315 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -136.34 -164.38 1.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 70.23 109.312 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 22.6 pt -119.42 123.28 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 70.22 109.295 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.6 tp -89.77 108.96 20.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 71.1 109.3 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.53 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.97 146.66 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.11 . . . . 75.43 109.27 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 140' ' ' ILE . 9.4 m -116.7 119.42 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.141 . . . . 72.42 109.991 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.6 p90 -134.5 142.89 47.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.21 110.998 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.43 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.8 mmtp -68.28 134.4 50.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 74.13 109.316 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.62 -160.07 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 1.091 . . . . 73.44 109.257 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.39 50.75 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 72.33 109.341 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.0 m -115.02 -7.48 12.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.479 1.112 . . . . 74.15 110.033 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.67 8.45 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.467 1.104 . . . . 62.42 110.95 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.24 137.63 42.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 0.743 . . . . 74.44 109.273 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.43 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 13.4 m -71.52 102.65 2.75 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 74.02 110.416 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.412 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 5.7 mm-40 -101.4 -172.46 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 64.54 110.277 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -127.18 144.98 50.92 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.449 1.093 . . . . 73.25 109.246 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.568 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 4.6 tpt180 -145.02 160.45 41.35 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 72.32 110.316 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.476 HG13 ' CB ' ' A' ' 252' ' ' TRP . 12.7 mm -115.53 118.02 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 74.43 109.336 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.487 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.8 mm -102.38 45.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.516 1.135 . . . . 75.31 109.301 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.35 111.27 65.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 74.11 109.301 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -26.59 10.85 Favored 'Trans proline' 0 C--N 1.361 1.202 0 O-C-N 124.47 1.773 . . . . 72.43 111.036 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.408 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.5 t -48.06 -24.19 1.03 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.136 . . . . 74.31 110.001 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 252' ' ' TRP . 25.2 mt -113.56 -54.72 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 73.24 109.316 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.558 ' CD1' HG13 ' A' ' 247' ' ' VAL . 94.9 m-85 -117.88 99.58 7.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.543 1.152 . . . . 62.24 111.025 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -28.34 34.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 75.1 109.947 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.7 t -59.01 -48.77 80.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 75.42 109.991 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.34 -172.83 39.19 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.495 1.122 . . . . 63.23 110.959 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 170.63 20.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.449 1.763 . . . . 61.44 110.976 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.558 HG13 ' CD1' ' A' ' 242' ' ' PHE . 10.7 m -151.01 158.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 72.04 109.297 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.47 HG22 ' CZ ' ' A' ' 235' ' ' ARG . 34.4 p -59.61 142.49 52.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.545 1.153 . . . . 73.22 110.414 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.405 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 18.5 p-10 -46.61 -25.56 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 74.32 109.303 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.411 ' N ' ' C ' ' A' ' 248' ' ' THR . 27.8 m -79.36 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 63.42 110.409 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -49.86 -29.19 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 51.45 109.293 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 12.7 t90 -62.01 -65.88 0.62 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.43 108.022 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.563 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -40.58 -38.23 0.84 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 72.33 110.308 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.452 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.0 m-80 -60.07 -50.74 72.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.555 1.16 . . . . 74.21 109.297 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 252' ' ' TRP . . . -54.08 -29.0 42.74 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.476 1.11 . . . . 65.25 109.255 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 5.6 m -81.14 -36.36 30.34 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.14 108.253 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.476 ' CA ' ' HB2' ' A' ' 264' ' ' ALA . 2.5 m -94.66 23.91 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 72.23 109.301 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -54.52 107.95 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 71.42 109.302 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.1 p -73.03 -3.18 24.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 75.51 110.383 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.6 t -44.99 -25.93 0.37 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 71.52 109.976 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . 0.449 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 52.4 t -94.72 -36.57 11.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 73.44 108.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.14 -128.13 1.63 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.466 1.104 . . . . 65.25 111.032 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.77 148.98 34.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 74.21 110.038 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.476 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -172.5 146.32 1.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.501 1.126 . . . . 74.44 109.302 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.8 p -173.03 156.98 3.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 74.52 109.988 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.47 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.6 p -98.8 124.29 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.496 1.123 . . . . 74.13 109.263 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 39.1 t -86.31 -41.93 14.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 71.22 109.948 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.52 -174.13 4.8 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 50.35 110.007 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 269' ' ' TYR . 9.5 p90 -170.89 155.7 4.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 73.22 111.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -163.11 173.21 13.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.01 109.319 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.477 ' C ' ' CG2' ' A' ' 272' ' ' THR . 0.8 OUTLIER -146.5 160.72 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 70.14 109.27 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.477 ' CG2' ' C ' ' A' ' 271' ' ' ASN . 6.7 p -151.67 -173.5 4.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.469 1.106 . . . . 74.44 110.415 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.462 ' CB ' HG21 ' A' ' 276' ' ' VAL . . . -67.72 148.95 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 65.52 109.315 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -58.87 -44.55 95.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.516 1.135 . . . . 61.41 111.023 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.434 ' OD1' ' NH1' ' A' ' 185' ' ' ARG . 16.4 m-80 -52.92 -39.6 62.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 0.749 . . . . 44.32 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.462 HG21 ' CB ' ' A' ' 273' ' ' ALA . 21.5 t -47.98 118.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.537 1.148 . . . . 74.3 109.303 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.6 t80 -73.32 -49.43 27.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 72.45 111.043 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 39.5 t80 -148.81 160.32 43.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 64.42 110.99 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.568 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 58.3 ttt-85 -130.34 146.83 51.97 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 75.13 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.42 157.59 40.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 73.11 109.983 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 -0.57 10.13 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 71.51 110.94 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 13.6 m -98.09 5.12 48.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.137 . . . . 71.42 110.004 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 78.27 35.96 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 65.01 109.235 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -117.52 119.32 34.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 1.131 . . . . 63.31 110.004 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -101.56 157.69 16.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.118 . . . . 73.51 111.005 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.554 HD11 ' CE2' ' A' ' 320' ' ' PHE . 0.8 OUTLIER -119.44 174.85 6.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 73.43 109.273 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -157.43 115.05 3.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 74.23 111.015 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.446 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.5 t0 -115.37 96.6 5.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 73.21 109.284 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.72 -31.04 22.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 73.21 109.262 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.456 ' CB ' HG12 ' A' ' 292' ' ' ILE . 5.1 m120 -95.01 5.62 51.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 74.41 109.345 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.699 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.3 46.82 2.04 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.5 1.125 . . . . 71.32 109.287 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.483 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 26.2 mm -74.83 -33.24 30.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 71.33 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 277' ' ' TYR . 1.8 t-20 -92.73 -20.54 20.68 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.513 1.133 . . . . 71.23 109.27 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.442 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 3.2 m -86.13 -62.55 1.49 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 75.44 110.379 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 76.3 m-20 -56.66 -24.13 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.422 1.076 . . . . 73.31 109.28 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 39.4 t -78.91 -48.2 15.04 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.47 1.106 . . . . 73.22 108.272 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 8.2 t -57.61 -28.06 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 72.2 109.314 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.5 mt -80.05 -59.81 2.58 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.559 1.162 . . . . 73.34 109.29 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -54.01 -19.3 4.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.549 1.156 . . . . 63.2 110.419 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.418 ' NZ ' ' O ' ' A' ' 314' ' ' ASP . 19.4 mmmt -72.14 -44.04 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 75.21 109.266 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.563 ' CD1' HD13 ' A' ' 304' ' ' LEU . 3.6 m-30 -99.67 37.39 1.61 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 71.31 111.05 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.2 t -68.98 -43.09 75.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.095 . . . . 72.52 109.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.501 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -96.35 -17.21 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.112 . . . . 74.21 109.333 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.567 HD13 ' CE2' ' A' ' 172' ' ' TYR . 13.7 mt -57.77 149.19 22.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 74.24 109.324 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -163.94 156.13 17.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.465 1.103 . . . . 71.31 110.017 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.1 -152.99 46.16 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.52 1.138 . . . . 73.13 110.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 17.4 m -99.63 7.33 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.278 -1.008 . . . . 53.32 108.278 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.489 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.8 OUTLIER -125.04 150.67 67.35 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 72.43 110.036 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.3 Cg_endo -74.96 147.36 89.1 Favored 'Cis proline' 0 C--N 1.359 1.111 0 C-N-CA 121.019 -2.492 . . . . 62.11 111.001 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.6 OUTLIER -128.37 133.25 24.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 75.21 110.029 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.96 -168.94 6.89 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 121.024 -2.49 . . . . 75.01 111.028 -0.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.0 154.66 18.33 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 71.35 109.29 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.476 1.777 . . . . 71.21 110.981 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.418 ' O ' ' NZ ' ' A' ' 300' ' ' LYS . 21.7 m-20 -87.77 132.62 34.08 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 75.05 109.337 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.53 27.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.13 . . . . 74.44 109.289 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 318' ' ' CYS . 36.1 t -71.58 -37.07 71.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.477 1.111 . . . . 65.41 110.028 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.6 t -43.11 -27.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 75.35 110.004 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 316' ' ' SER . 3.2 m -66.6 -173.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 60.31 108.268 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.483 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 170.62 94.34 0.09 OUTLIER Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.485 1.116 . . . . 61.21 110.988 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.554 ' CE2' HD11 ' A' ' 286' ' ' LEU . 5.5 p90 . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.459 0.741 . . . . 71.51 110.99 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.292 -0.632 . . . . 73.13 109.292 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.555 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -149.33 110.54 4.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.09 . . . . 74.11 109.329 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -83.5 7.89 15.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.54 1.15 . . . . 74.42 110.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.5 t -150.4 145.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 73.14 109.316 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 1.0 OUTLIER -96.98 143.28 25.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 75.1 109.314 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -33.38 4.63 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.509 1.794 . . . . 63.4 111.009 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.81 155.41 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 71.45 109.31 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.557 HG21 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -52.45 -35.72 20.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 74.22 109.311 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.42 -47.49 3.62 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.492 1.12 . . . . 70.55 109.29 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.525 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -71.59 -35.0 70.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 1.116 . . . . 64.22 110.378 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.517 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.5 OUTLIER -58.98 -56.97 15.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 74.12 109.317 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.507 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.3 m-80 -52.31 -31.8 34.74 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.528 1.143 . . . . 71.4 109.257 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -67.56 -56.66 8.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 73.53 110.046 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.459 ' CD1' HD13 ' A' ' 140' ' ' ILE . 92.4 mt -42.29 -41.97 2.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 71.52 109.312 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.474 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.69 -43.11 63.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 71.05 110.972 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -51.94 -34.17 40.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 75.02 109.274 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.497 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 65.0 mt-30 -76.17 -56.33 4.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 73.22 110.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.0 mt -50.27 -29.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 74.14 109.27 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -33.32 63.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 75.44 109.255 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.79 -18.2 59.0 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 75.34 109.31 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.401 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 11.2 mm100 -84.24 -15.47 46.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 73.41 110.274 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -38.7 122.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 71.22 109.982 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.19 130.45 34.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 70.41 108.316 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.95 -30.39 6.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.483 1.114 . . . . 74.32 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.402 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 35.0 p -67.37 161.58 24.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 0.762 . . . . 65.42 110.443 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.1 t -93.63 -0.72 56.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 73.2 109.986 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.9 m -116.84 5.63 13.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.108 . . . . 75.42 110.43 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.402 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -80.85 138.18 36.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.134 . . . . 72.41 109.284 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -164.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.571 1.169 . . . . 74.54 109.955 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.44 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 2.6 m -155.96 126.25 3.37 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.531 1.144 . . . . 74.21 110.023 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.04 141.15 70.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.005 -2.498 . . . . 72.31 110.991 0.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.5 p -72.69 -178.98 2.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 74.11 108.315 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.46 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.3 mp -99.16 134.25 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.12 . . . . 74.11 109.3 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.6 p -79.92 71.41 6.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.132 . . . . 73.3 110.402 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.569 ' CE1' ' HG2' ' A' ' 239' ' ' PRO . 30.5 m-85 -75.63 -0.53 20.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 70.02 111.03 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -109.37 8.04 25.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.107 . . . . 75.52 110.275 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.567 ' CE1' HG21 ' A' ' 174' ' ' VAL . 11.6 t80 -125.53 71.79 66.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.545 1.153 . . . . 65.5 110.99 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.442 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 110.13 3.06 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.447 1.761 . . . . 72.45 111.003 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.82 -69.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 73.25 109.341 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -133.77 -48.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 74.23 109.284 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.25 107.5 0.06 OUTLIER Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.488 1.118 . . . . 53.25 111.013 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.479 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 6.9 p -147.86 -48.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 72.53 108.317 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 26.1 p90 -69.98 -29.1 66.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.55 1.156 . . . . 74.55 110.978 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -69.27 -68.1 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.474 1.109 . . . . 72.24 109.328 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.533 ' NH2' ' CD1' ' A' ' 170' ' ' PHE . 0.2 OUTLIER -44.14 -47.26 9.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 61.35 110.3 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -41.41 -60.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 72.23 109.305 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -46.19 -38.03 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.538 1.149 . . . . 74.44 109.616 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.542 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 29.3 mmmt -67.34 -59.69 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.424 1.077 . . . . 73.23 109.296 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.443 ' CE ' HG12 ' A' ' 221' ' ' ILE . 8.4 mtm -39.36 -38.5 0.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.131 . . . . 72.0 110.96 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.47 77.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 74.4 110.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.542 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -51.2 -29.08 12.92 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 75.25 110.292 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.462 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 14.4 mm -81.28 -36.02 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.577 1.173 . . . . 74.3 109.321 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -63.13 -45.54 91.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 74.53 109.296 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 11.5 mtt -58.02 -43.61 86.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.506 1.129 . . . . 74.53 110.999 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -46.21 -52.97 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 70.04 109.311 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.497 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 23.8 t-20 -63.21 -35.47 80.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 75.32 109.342 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 110.88 50.99 0.62 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.464 1.102 . . . . 75.13 111.022 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.555 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 70.3 m-85 -151.04 136.37 17.7 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.531 0.783 . . . . 74.41 111.035 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.485 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -106.96 121.84 45.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 65.44 109.323 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.451 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 26.3 p -102.2 178.4 4.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.088 . . . . 65.13 108.296 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 222' ' ' LEU . 4.9 mp0 -120.23 172.75 7.56 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.494 1.121 . . . . 74.34 110.263 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -104.88 152.91 22.06 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 74.41 109.332 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -139.48 117.73 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.472 1.108 . . . . 64.41 110.273 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.8 m-85 -111.14 122.33 47.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.49 1.119 . . . . 74.24 111.021 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.515 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 13.3 p -118.74 150.38 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 74.33 109.302 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.2 m-85 -123.14 162.17 23.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.54 1.15 . . . . 64.22 111.001 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.2 -177.37 16.37 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.542 1.151 . . . . 75.4 111.04 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 263' ' ' SER . 57.6 t-20 -71.54 109.13 5.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 0.772 . . . . 64.11 109.329 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 218' ' ' HIS . 5.3 mt -112.82 95.09 5.23 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.095 . . . . 74.2 109.328 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.5 mttt -92.29 168.87 11.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 74.43 109.293 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.451 ' CB ' HG21 ' A' ' 213' ' ' VAL . . . -179.35 165.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 74.51 109.312 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.86 146.67 39.61 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.515 1.134 . . . . 71.13 110.05 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.4 ' OG1' ' SG ' ' A' ' 211' ' ' CYS . 3.0 p -131.11 5.7 4.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.443 1.089 . . . . 73.04 110.417 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' A' ' 211' ' ' CYS . . . 120.62 118.95 2.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.531 1.145 . . . . 74.24 110.988 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.445 ' O ' ' CG2' ' A' ' 210' ' ' THR . 0.9 OUTLIER 42.01 27.58 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 0.764 . . . . 74.33 110.419 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . 0.405 ' N ' ' C ' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -151.85 173.66 14.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.518 1.136 . . . . 72.0 108.298 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 2.1 m -155.7 136.5 13.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 64.24 108.269 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.451 HG21 ' CB ' ' A' ' 206' ' ' ALA . 1.4 m -113.79 134.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.145 . . . . 64.52 109.279 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -127.32 127.56 44.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 64.21 109.307 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -135.68 135.13 39.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 65.55 108.008 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 3.7 20.97 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.105 . . . . 75.04 109.993 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.484 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.7 p90 -177.91 128.1 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 72.13 111.035 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.504 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 31.7 t60 -115.04 159.13 21.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.545 1.153 . . . . 74.33 109.609 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.479 ' CG1' ' SG ' ' A' ' 177' ' ' CYS . 3.4 p -138.85 137.93 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.51 109.331 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.568 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -138.98 -157.25 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.579 1.174 . . . . 74.42 109.317 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.443 HG12 ' CE ' ' A' ' 184' ' ' MET . 18.3 pt -125.8 117.84 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.509 1.131 . . . . 72.13 109.276 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.411 ' N ' ' O ' ' A' ' 196' ' ' GLU . 15.6 tp -81.8 110.04 16.74 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.492 1.12 . . . . 73.4 109.294 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.517 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -101.12 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 75.03 109.307 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.8 m -116.73 119.93 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 74.31 110.016 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.562 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 31.4 p90 -135.34 145.55 47.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 75.31 110.993 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -70.3 133.99 47.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.123 . . . . 73.13 109.334 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.36 -159.64 0.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.115 . . . . 73.42 109.323 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.44 51.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.23 109.316 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.9 m -114.58 -8.38 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 65.31 110.01 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.39 37.42 8.19 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.526 1.141 . . . . 60.44 110.981 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 138.09 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.468 0.746 . . . . 73.24 109.301 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.6 m -71.64 102.65 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 74.44 110.407 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.408 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.0 mm-40 -101.99 -172.65 2.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.454 1.096 . . . . 72.53 110.289 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -126.69 145.36 50.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.445 1.091 . . . . 71.32 109.326 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.562 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 5.6 tpt180 -145.66 160.48 41.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.145 . . . . 72.13 110.275 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.523 HG23 ' CD1' ' A' ' 252' ' ' TRP . 12.8 mm -116.53 119.94 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.24 109.285 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -101.38 45.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.105 . . . . 75.14 109.315 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.409 ' HB2' ' CG2' ' A' ' 236' ' ' ILE . 2.1 m-20 -101.17 112.67 65.35 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 62.34 109.274 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.569 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -74.97 -43.57 0.39 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.516 1.798 . . . . 75.52 111.015 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.1 OUTLIER -39.22 -29.9 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 73.1 109.983 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.447 HD11 ' CD1' ' A' ' 252' ' ' TRP . 13.6 mt -101.98 -52.98 3.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 73.34 109.3 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.57 ' CD1' HG12 ' A' ' 247' ' ' VAL . 93.1 m-85 -125.99 99.28 5.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 74.54 111.041 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -79.22 -30.46 43.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 74.24 109.968 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -55.52 -46.15 77.04 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 72.51 109.982 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.48 -170.42 41.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.493 1.12 . . . . 61.25 111.002 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.432 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.06 168.85 23.89 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 75.45 110.992 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.57 HG12 ' CD1' ' A' ' 242' ' ' PHE . 3.9 m -151.66 159.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 73.15 109.291 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.466 HG22 ' CZ ' ' A' ' 235' ' ' ARG . 43.0 p -60.7 139.21 57.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 71.25 110.399 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.438 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER -43.01 -28.1 0.24 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 74.15 109.299 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.428 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.4 m -73.61 -64.76 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 75.43 110.404 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.15 -27.43 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 54.35 109.31 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.568 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 13.0 t90 -62.57 -62.03 2.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 74.45 108.008 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.555 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.24 -42.26 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.503 1.127 . . . . 73.22 110.303 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.435 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 2.9 m-80 -55.8 -51.44 67.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 73.21 109.335 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.03 -20.36 16.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 64.15 109.311 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.58 -36.76 16.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 65.42 108.343 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 264' ' ' ALA . 3.5 m -92.45 20.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.482 1.114 . . . . 62.03 109.288 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -46.61 104.48 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 75.54 109.319 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -76.07 -3.97 38.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 71.43 110.406 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.8 t -49.95 -22.85 1.69 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 65.11 110.023 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 206' ' ' ALA . 30.7 m -90.87 -32.88 15.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 74.24 108.294 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.88 -113.78 0.57 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.484 1.115 . . . . 64.33 111.008 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -90.56 143.45 26.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.78 . . . . 75.13 110.032 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 257' ' ' VAL . . . -167.77 148.27 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.461 1.1 . . . . 60.42 109.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.72 156.58 3.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 63.21 109.982 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.515 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 5.9 p -104.39 113.96 42.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 73.31 109.288 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 4.6 t -68.15 -45.69 72.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 73.31 110.007 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 29.5 p -163.84 -174.22 3.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 73.15 110.017 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -165.82 155.66 12.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 73.41 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.3 165.23 37.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 74.03 109.302 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -128.29 160.67 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 74.2 109.258 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.434 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 19.1 p -153.96 176.94 11.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 74.01 110.395 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.76 158.32 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 70.03 109.324 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.4 -43.96 76.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.447 1.092 . . . . 53.22 110.993 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -54.87 -42.41 72.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.447 0.733 . . . . 75.22 109.312 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 69.8 t -43.61 101.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 75.54 109.285 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.415 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 7.2 t80 -60.07 -59.22 5.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.34 111.016 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -131.47 156.71 45.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 74.45 111.034 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.565 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 63.6 ttt-85 -126.71 147.45 49.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 71.23 110.275 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.2 m -118.2 158.02 47.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 70.02 110.068 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 0.17 9.21 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.459 1.768 . . . . 73.21 111.005 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 80.1 p -104.27 5.81 34.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 73.52 109.943 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 78.34 39.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 74.35 109.279 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -113.37 120.22 40.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 73.22 110.027 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -107.62 151.78 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 75.33 111.01 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.528 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 1.2 mm? -118.59 177.67 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 74.15 109.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 79.6 m-85 -160.29 115.22 2.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.523 1.139 . . . . 63.11 110.978 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.438 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 0.4 OUTLIER -115.49 97.03 5.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 74.2 109.303 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -85.82 -14.49 44.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 72.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.408 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.0 m-20 -110.75 0.87 17.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 74.43 109.306 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.695 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 42.69 49.58 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.125 . . . . 73.33 109.281 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 290' ' ' ASN . 18.2 mm -78.58 -27.55 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.445 1.09 . . . . 75.41 109.299 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.498 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.9 t-20 -94.18 -27.67 16.07 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.444 1.09 . . . . 62.32 109.286 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.452 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 21.9 m -82.19 -69.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 75.12 110.407 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 44.1 m-20 -47.86 -30.36 4.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 65.23 109.293 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 36.8 t -72.73 -58.41 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 72.42 108.318 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 9.4 t -43.95 -49.54 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 75.43 109.313 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.47 -59.97 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 64.21 109.31 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.35 -31.8 1.78 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.535 1.147 . . . . 61.14 110.411 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -70.13 -49.46 50.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.32 109.283 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.572 ' CE1' ' HD2' ' A' ' 313' ' ' PRO . 3.3 m-30 -91.77 31.39 1.22 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 75.11 110.982 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 26.2 t -63.38 -52.75 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 63.52 110.005 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.426 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.4 -10.41 58.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.432 1.083 . . . . 73.05 109.326 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 172' ' ' TYR . 19.1 mt -76.21 136.63 39.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 74.41 109.289 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.5 p -161.46 147.58 14.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 75.15 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 96.89 -160.14 21.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.498 1.124 . . . . 63.41 110.977 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.403 ' O ' ' OG ' ' A' ' 310' ' ' SER . 0.0 OUTLIER -97.6 25.42 5.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.345 -0.983 . . . . 64.4 108.345 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 93.1 p -156.84 148.62 17.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.1 . . . . 64.14 109.998 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.5 Cg_endo -74.98 145.74 84.76 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 121.007 -2.497 . . . . 73.21 111.024 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 70.0 m -132.21 135.17 26.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 65.3 109.985 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.0 -173.55 12.53 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 120.995 -2.502 . . . . 75.14 110.999 -0.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.89 151.78 31.13 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 53.04 109.295 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.572 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.508 1.794 . . . . 70.32 110.995 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -85.96 135.49 33.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 75.01 109.292 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.4 ' O ' ' SG ' ' A' ' 318' ' ' CYS . 26.8 m -127.77 24.68 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 75.25 109.29 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 35.8 t -54.11 -19.8 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.556 1.16 . . . . 71.41 110.043 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 35.4 p -53.89 -24.84 17.43 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.501 1.126 . . . . 73.35 109.989 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 315' ' ' VAL . 1.8 m -80.07 -173.37 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.145 . . . . 55.11 108.257 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 162.11 77.85 0.03 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.524 1.14 . . . . 72.3 111.01 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 7.0 p90 . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.484 0.755 . . . . 72.43 110.995 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.471 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 8.5 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.295 -0.632 . . . . 71.03 109.295 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.56 ' HB1' ' CD1' ' A' ' 193' ' ' TYR . . . -105.74 106.46 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.14 109.277 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -83.45 8.21 14.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.526 1.141 . . . . 74.22 109.946 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.53 145.2 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 73.51 109.264 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.465 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 1.1 mt -96.26 142.77 25.03 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 74.31 109.339 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.99 -32.48 5.36 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.551 1.816 . . . . 74.35 111.002 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.71 152.47 21.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 72.32 109.335 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.571 HG23 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -49.96 -35.45 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 74.23 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.5 -47.35 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 73.21 109.3 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.495 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.91 -34.72 69.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.512 1.133 . . . . 73.24 110.403 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.516 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.29 -56.98 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 73.34 109.304 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.519 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 48.9 m-80 -52.27 -32.03 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 72.41 109.307 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.6 -55.5 11.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 73.53 110.008 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.461 ' CD1' HD13 ' A' ' 140' ' ' ILE . 66.5 mt -42.06 -41.83 2.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 71.24 109.315 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.4 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.91 -45.44 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.113 . . . . 73.11 111.017 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -46.52 -38.37 9.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 75.12 109.277 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . 58.4 mt-30 -76.57 -55.38 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 75.02 110.29 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.419 ' N ' HG22 ' A' ' 187' ' ' ILE . 13.6 mt -50.56 -23.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.498 1.124 . . . . 74.44 109.293 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.61 42.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 75.23 109.297 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -58.44 -19.17 34.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 74.24 109.24 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -81.68 -24.64 36.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 61.53 110.324 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.522 ' HA ' ' CE2' ' A' ' 170' ' ' PHE . 23.3 m -41.42 117.35 0.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 55.15 109.982 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 2.4 m -45.27 130.62 8.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.118 . . . . 74.42 108.318 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.39 -24.89 5.51 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.587 1.179 . . . . 64.31 110.976 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.4 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 75.4 p -83.93 161.7 20.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 0.748 . . . . 62.33 110.388 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -93.56 0.76 56.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 63.5 109.959 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.1 m -117.02 3.48 12.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.123 . . . . 74.22 110.381 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.4 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -79.06 133.64 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 75.44 109.278 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.76 -173.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 62.32 109.984 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.3 p -152.39 126.64 4.49 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 74.4 110.001 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.24 49.19 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 121.063 -2.474 . . . . 64.31 110.992 0.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.2 p -73.01 -178.2 2.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 71.35 108.286 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 170' ' ' PHE . 4.3 mp -90.53 137.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 73.45 109.309 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.407 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 74.3 p -90.48 88.62 7.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 73.32 110.426 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.645 ' CE1' ' CG2' ' A' ' 168' ' ' ILE . 19.1 m-85 -88.36 -25.51 22.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 73.54 110.986 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.84 -2.05 28.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.138 . . . . 72.5 110.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.574 ' CE1' HG23 ' A' ' 174' ' ' VAL . 29.4 t80 -128.29 68.22 76.58 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.14 110.998 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.424 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.06 113.39 3.78 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.495 1.787 . . . . 74.11 110.977 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.574 HG23 ' CE1' ' A' ' 172' ' ' TYR . 10.9 t -152.17 -66.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 64.22 109.31 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -163.49 118.16 1.62 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.51 1.131 . . . . 74.13 109.283 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 147.3 48.03 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.516 1.135 . . . . 52.14 110.98 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 74.4 m -88.59 -19.75 25.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.261 -1.014 . . . . 74.13 108.261 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 29.2 p90 -72.55 -40.83 66.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 74.41 111.018 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.594 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -63.87 -64.63 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 73.33 109.314 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.468 ' NH2' ' CE1' ' A' ' 170' ' ' PHE . 0.2 OUTLIER -43.7 -47.51 7.78 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 74.14 110.288 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.425 ' N ' ' HD3' ' A' ' 180' ' ' ARG . . . -42.17 -55.72 3.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 75.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.692 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.33 -38.99 20.52 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.568 1.168 . . . . 75.21 109.597 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.636 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.8 mmmt -64.32 -61.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.465 1.103 . . . . 74.23 109.268 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.437 ' CE ' HG12 ' A' ' 221' ' ' ILE . 3.4 mtm -38.78 -34.06 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.52 1.138 . . . . 74.03 110.983 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.435 ' NH2' ' OD2' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -63.95 -50.3 69.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 75.25 110.251 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.636 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -52.87 -30.91 36.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.133 . . . . 74.31 110.311 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.419 HG22 ' N ' ' A' ' 153' ' ' ILE . 11.0 mm -82.2 -36.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 75.22 109.277 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.463 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -62.69 -41.8 99.3 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.521 1.138 . . . . 74.11 109.288 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 192' ' ' GLY . 21.8 mtp -63.73 -41.03 98.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 75.32 110.975 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -45.41 -53.28 8.91 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.4 109.341 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -66.02 -27.14 67.89 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.544 1.152 . . . . 64.32 109.279 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.72 55.4 0.74 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.531 1.144 . . . . 73.42 111.025 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.56 ' CD1' ' HB1' ' A' ' 137' ' ' ALA . 77.5 m-85 -154.94 143.63 20.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.571 0.806 . . . . 72.24 111.012 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.471 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.1 t70 -109.55 125.45 52.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 70.15 109.35 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.463 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 17.7 p -94.51 -179.41 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 72.11 108.296 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 171.86 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 74.44 110.294 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -105.72 163.38 12.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 72.25 109.269 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -158.11 117.54 3.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 75.03 110.328 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.9 m-85 -110.75 119.34 38.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.507 1.129 . . . . 75.32 111.013 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.47 ' CG2' HG22 ' A' ' 266' ' ' VAL . 9.9 p -115.08 142.32 28.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 73.02 109.321 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.8 m-85 -117.65 157.25 26.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.24 110.969 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.92 -175.03 16.51 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.536 1.148 . . . . 52.13 110.986 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 263' ' ' SER . 55.1 t-20 -74.39 110.98 9.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.514 0.773 . . . . 74.54 109.297 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.465 HD13 ' CB ' ' A' ' 218' ' ' HIS . 4.7 mt -115.56 94.54 4.74 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.132 . . . . 74.03 109.333 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.4 mttp -92.81 167.12 12.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 74.34 109.255 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.436 ' CB ' HG21 ' A' ' 213' ' ' VAL . . . -170.43 164.41 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 74.43 109.297 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 t -142.2 130.19 21.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.11 110.016 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 13.0 p -88.39 -4.62 58.62 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.457 1.098 . . . . 74.4 110.453 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 123.99 -43.18 1.45 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.511 1.132 . . . . 74.3 111.011 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.3 t -128.71 4.98 5.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.468 0.746 . . . . 73.33 110.397 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 6.9 t -140.64 169.96 16.67 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.127 . . . . 73.32 108.289 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -137.09 144.33 43.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 74.24 108.317 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.436 HG21 ' CB ' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -128.58 142.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 54.11 109.278 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.87 128.78 41.29 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.525 1.141 . . . . 64.33 109.303 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.429 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.0 OUTLIER -134.99 130.84 36.37 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.556 1.16 . . . . 73.51 107.99 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.3 p -76.46 -0.73 24.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.558 1.161 . . . . 75.35 109.966 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.5 p90 -173.72 133.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.125 . . . . 74.43 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 65.5 t60 -119.26 167.79 11.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 75.03 109.604 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.499 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 2.8 p -150.78 136.22 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.126 . . . . 74.51 109.287 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.49 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -135.87 -156.72 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 65.44 109.327 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.437 HG12 ' CE ' ' A' ' 184' ' ' MET . 23.9 pt -123.07 118.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 74.05 109.273 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 11.0 tp -81.55 109.06 15.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 71.3 109.285 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.516 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -100.87 145.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 74.41 109.292 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 17.0 m -117.34 120.29 37.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.502 1.126 . . . . 73.13 110.027 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CD2' HG23 ' A' ' 143' ' ' VAL . 28.1 p90 -135.68 146.62 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.527 1.142 . . . . 75.3 110.974 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -71.52 131.52 43.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 75.05 109.266 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -72.61 -160.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 71.54 109.316 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.02 49.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 64.42 109.291 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.5 m -114.96 -7.81 12.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 61.14 109.993 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.93 37.85 8.26 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.485 1.115 . . . . 74.42 111.005 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.97 137.9 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.532 0.784 . . . . 63.54 109.269 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -72.21 102.63 3.12 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.553 1.158 . . . . 74.53 110.383 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -102.21 -172.78 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.21 110.295 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -126.93 144.78 50.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 73.54 109.32 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.483 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 3.5 tpt180 -145.56 162.07 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 70.12 110.283 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.555 HD13 ' CE3' ' A' ' 252' ' ' TRP . 26.3 mm -117.33 119.66 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 73.34 109.299 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 2.6 mm -101.23 47.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 73.31 109.309 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.501 ' OD1' ' CD1' ' A' ' 241' ' ' LEU . 27.2 p-10 -94.8 111.4 54.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.34 109.289 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -44.79 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 62.22 111.018 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.9 m -39.58 -39.16 0.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.546 1.153 . . . . 72.22 110.005 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.501 ' CD1' ' OD1' ' A' ' 238' ' ' ASP . 5.9 mt -92.93 -56.69 2.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 71.12 109.281 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.569 ' CD2' HG12 ' A' ' 247' ' ' VAL . 95.6 m-85 -121.12 99.5 6.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 73.53 111.001 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -26.01 34.96 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.453 1.096 . . . . 70.53 109.989 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 m -57.24 -45.82 83.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 74.33 109.971 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 179.42 -166.91 36.58 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.447 1.092 . . . . 75.02 111.004 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.437 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.04 164.0 34.14 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.504 1.792 . . . . 62.34 110.982 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.569 HG12 ' CD2' ' A' ' 242' ' ' PHE . 12.3 m -140.99 167.78 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 74.54 109.281 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.449 ' C ' ' N ' ' A' ' 250' ' ' THR . 24.2 p -70.38 136.18 49.44 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.484 1.115 . . . . 73.25 110.384 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 26.6 p-10 -39.86 -30.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 73.54 109.327 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.449 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -78.1 -61.43 2.0 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 74.03 110.409 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.91 -22.79 2.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.486 1.116 . . . . 70.35 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.555 ' CE3' HD13 ' A' ' 236' ' ' ILE . 7.4 t90 -68.68 -60.47 2.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.497 1.123 . . . . 75.45 107.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.513 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -51.29 -41.81 60.71 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 75.02 110.316 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.4 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.8 m-80 -54.66 -51.38 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 73.02 109.253 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.407 ' HB2' ' CE1' ' A' ' 242' ' ' PHE . . . -56.67 -24.45 48.84 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 75.12 109.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -83.97 -35.02 24.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 71.34 108.261 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.482 ' CA ' ' HB1' ' A' ' 264' ' ' ALA . 3.1 m -95.82 21.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.3 109.307 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 39.5 t-20 -51.94 107.88 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 72.53 109.317 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.0 p -73.36 -3.37 26.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 63.32 110.389 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.41 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 0.4 OUTLIER -44.73 -30.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 64.22 109.971 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 42.1 t -88.95 -36.88 15.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 64.45 108.304 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.48 -127.97 1.62 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.473 1.108 . . . . 74.3 110.938 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.56 147.31 37.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 0.778 . . . . 74.02 109.973 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.482 ' HB1' ' CA ' ' A' ' 257' ' ' VAL . . . -168.98 146.22 3.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 72.21 109.289 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -172.73 151.38 2.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.53 110.018 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.47 HG22 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.35 115.08 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.558 1.161 . . . . 72.14 109.28 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 31.7 t -70.11 -45.46 66.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 75.05 109.983 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 m -165.08 177.29 7.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.525 1.14 . . . . 72.21 110.029 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -158.21 156.44 30.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 75.2 110.999 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.34 33.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 73.04 109.282 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -119.14 160.61 21.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 71.4 109.278 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.453 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 2.0 p -154.98 178.89 9.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.524 1.14 . . . . 74.13 110.378 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.426 ' CB ' HG22 ' A' ' 276' ' ' VAL . . . -62.67 158.76 17.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.527 1.142 . . . . 73.53 109.301 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.87 -39.25 55.29 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.481 1.113 . . . . 63.32 110.955 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -56.7 -48.06 78.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 0.776 . . . . 71.11 109.273 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.426 HG22 ' CB ' ' A' ' 273' ' ' ALA . 25.3 t -44.7 118.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 70.24 109.332 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -70.41 -53.49 16.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.531 1.144 . . . . 74.42 111.013 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 45.8 t80 -140.22 165.32 27.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 73.14 111.018 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.556 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 55.0 ttt-85 -137.01 147.39 46.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 73.21 110.278 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.6 157.92 44.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 71.35 109.97 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.19 9.2 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 74.33 111.0 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.0 t -97.83 3.92 49.8 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 73.41 110.034 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 77.13 41.37 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.42 109.273 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.8 t -123.07 119.52 30.57 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.461 1.101 . . . . 73.4 109.955 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.5 m-30 -99.92 160.22 14.48 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 73.11 110.957 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.482 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -120.45 177.59 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.468 1.105 . . . . 72.34 109.324 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 94.8 m-85 -160.61 115.57 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 74.0 110.992 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -115.18 96.11 5.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 74.53 109.241 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -85.57 -30.7 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 72.12 109.274 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.456 ' CB ' HG12 ' A' ' 292' ' ' ILE . 34.3 m-20 -98.3 7.91 45.56 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.139 . . . . 75.51 109.264 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.692 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 3.0 mm? 40.32 47.54 2.19 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.493 1.12 . . . . 71.11 109.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.456 HG12 ' CB ' ' A' ' 290' ' ' ASN . 45.4 mm -78.35 -25.07 13.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.558 1.161 . . . . 72.25 109.305 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.439 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.0 t-20 -94.64 -22.82 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 72.03 109.308 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.438 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.0 m -86.78 -68.97 0.71 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 74.15 110.383 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -50.86 -22.88 2.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.525 1.141 . . . . 75.02 109.333 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 20.5 t -79.03 -62.44 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 65.14 108.312 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 18.2 t -44.09 -43.15 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 71.35 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.42 -58.59 6.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 71.45 109.315 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -38.27 5.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 62.54 110.402 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -57.18 -56.2 24.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.21 109.309 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.5 OUTLIER -89.68 35.22 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 64.02 111.032 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 t -68.07 -49.07 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 75.22 109.962 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.505 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -88.24 -17.94 29.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.439 1.087 . . . . 73.04 109.274 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.467 ' CD2' ' HD2' ' A' ' 309' ' ' PRO . 17.9 mt -57.43 144.26 37.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 54.43 109.26 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.9 p -158.38 136.8 10.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 71.21 109.995 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 93.31 -155.23 22.17 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.519 1.137 . . . . 74.14 111.013 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.7 p -98.87 12.81 34.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.295 -1.002 . . . . 73.01 108.295 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.5 p -135.22 148.61 67.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 74.55 109.968 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.5 Cg_endo -74.95 146.36 86.46 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.023 -2.49 . . . . 74.23 110.998 -0.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.499 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.5 p -132.29 135.77 26.94 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 72.42 109.985 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.8 14.76 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.985 -2.506 . . . . 74.12 110.997 -0.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.46 155.91 18.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 74.04 109.291 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.487 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.37 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.5 1.789 . . . . 72.42 111.01 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.99 135.51 33.38 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 74.24 109.277 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 13.3 m -126.49 18.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 73.14 109.285 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.4 -33.06 58.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 72.02 110.013 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.1 p -43.12 -39.93 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.118 . . . . 72.4 110.02 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 6.4 m -52.64 170.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.467 1.104 . . . . 72.44 108.262 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -165.34 73.85 0.17 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.504 1.127 . . . . 64.15 110.991 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.527 ' CD1' ' C ' ' A' ' 320' ' ' PHE . 1.8 p90 . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.481 0.753 . . . . 74.25 110.939 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 5.2 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.287 -0.634 . . . . 74.24 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.559 ' HB1' ' CD1' ' A' ' 193' ' ' TYR . . . -149.82 107.76 3.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.543 1.152 . . . . 64.02 109.285 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -81.69 5.88 17.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.164 . . . . 72.33 110.031 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -145.87 148.76 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 63.22 109.331 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.46 HD11 ' CD1' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -100.82 143.72 27.13 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 73.43 109.276 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -74.99 -33.97 4.18 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.509 1.794 . . . . 73.4 110.985 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.82 150.6 22.85 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 74.1 109.314 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.55 HG21 ' CD2' ' A' ' 225' ' ' TYR . 1.8 t -48.83 -36.18 7.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.45 109.286 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.03 -48.55 3.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 74.22 109.302 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.526 HG23 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -70.01 -36.02 74.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.143 . . . . 74.42 110.364 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.529 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.4 OUTLIER -57.95 -57.09 14.32 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.158 . . . . 75.22 109.324 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.483 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.9 m-80 -52.95 -29.4 28.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 75.55 109.304 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.3 -55.57 8.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.515 1.134 . . . . 75.31 109.973 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.46 ' CD1' HD11 ' A' ' 140' ' ' ILE . 65.3 mt -42.2 -41.99 2.88 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.553 1.158 . . . . 75.45 109.259 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.82 -45.37 61.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 73.33 111.003 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -46.12 -35.37 4.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 73.32 109.315 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.449 ' NE2' ' OD1' ' A' ' 191' ' ' ASN . 65.3 mt-30 -77.42 -56.4 4.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 74.44 110.24 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.463 HG21 ' CB ' ' A' ' 184' ' ' MET . 17.3 mt -50.18 -26.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.458 1.099 . . . . 74.1 109.265 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -34.62 57.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 74.14 109.297 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.8 t-20 -61.6 -15.12 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.457 1.098 . . . . 75.24 109.292 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -85.68 -18.72 32.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.135 . . . . 74.52 110.323 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.474 ' HB2' ' CE2' ' A' ' 170' ' ' PHE . 23.7 p -38.68 137.97 0.57 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.553 1.158 . . . . 72.33 109.991 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -68.03 134.16 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 73.33 108.288 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.74 -19.05 19.17 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.469 1.105 . . . . 75.42 111.017 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.486 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 69.8 p -81.24 161.52 23.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.527 0.781 . . . . 74.12 110.414 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.0 p -93.52 -0.5 56.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.138 . . . . 71.52 110.032 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 17.8 m -117.84 6.67 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 63.23 110.368 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.486 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -83.17 138.14 33.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 73.44 109.311 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -164.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 74.04 110.016 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.438 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 14.2 t -156.04 127.47 3.72 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 62.21 109.995 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.03 137.28 49.44 Favored 'Cis proline' 0 C--N 1.361 1.189 0 C-N-CA 120.986 -2.506 . . . . 74.24 111.017 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.0 p -73.08 179.48 3.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 63.13 108.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.467 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.7 mp -88.95 128.94 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 64.43 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 23.8 p -91.14 85.65 5.96 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 64.2 110.41 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 157' ' ' SER . 47.9 p90 -86.34 -18.86 30.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 70.52 110.979 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.448 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.77 -1.78 23.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 75.33 110.273 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.556 ' CE2' HD12 ' A' ' 304' ' ' LEU . 24.8 t80 -129.03 68.29 79.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.44 1.087 . . . . 74.12 110.983 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.409 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 118.8 5.39 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.457 1.767 . . . . 75.34 110.963 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 172' ' ' TYR . 21.2 t -152.47 -74.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.116 . . . . 75.24 109.283 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.68 -43.15 2.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 74.34 109.32 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -43.02 126.66 5.01 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.486 1.117 . . . . 51.21 110.999 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.484 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 4.5 p -165.33 -49.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.266 -1.013 . . . . 74.23 108.266 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -70.08 -18.67 63.27 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 72.03 110.997 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.26 -68.26 0.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.515 1.135 . . . . 72.44 109.313 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.467 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 9.2 ptm180 -48.36 -49.81 33.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.476 1.11 . . . . 71.35 110.302 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.472 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.37 -64.88 0.43 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.118 . . . . 72.31 109.298 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.4 t60 -39.86 -45.03 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 74.41 109.607 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 186' ' ' GLN . 14.3 mmmt -62.3 -58.24 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 74.2 109.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.463 ' CB ' HG21 ' A' ' 153' ' ' ILE . 9.2 mtm -38.96 -36.13 0.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 72.15 110.981 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.409 ' CZ ' ' CE ' ' A' ' 189' ' ' MET . 0.1 OUTLIER -63.47 -48.99 75.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 64.55 110.314 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -53.1 -33.2 51.12 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.447 1.092 . . . . 72.33 110.278 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 153' ' ' ILE . 17.3 mm -75.79 -37.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.145 . . . . 74.0 109.26 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.45 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -61.28 -44.45 97.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.1 109.285 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.409 ' CE ' ' CZ ' ' A' ' 185' ' ' ARG . 3.2 mtt -56.41 -42.28 77.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 75.21 110.992 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -48.45 -52.66 21.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.46 1.1 . . . . 71.35 109.288 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.449 ' OD1' ' NE2' ' A' ' 152' ' ' GLN . 0.4 OUTLIER -62.28 -37.22 84.67 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 74.11 109.274 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.77 48.15 0.69 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.522 1.139 . . . . 75.11 110.971 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.559 ' CD1' ' HB1' ' A' ' 137' ' ' ALA . 61.6 m-85 -147.78 137.62 22.69 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 0.769 . . . . 74.31 111.001 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.466 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.3 t70 -103.17 129.26 50.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 75.44 109.293 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 26.8 p -108.15 -178.79 3.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 74.43 108.286 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.47 174.74 8.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 73.32 110.27 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.472 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 20.5 mmtt -109.73 167.08 10.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 71.14 109.279 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.463 ' O ' ' CG2' ' A' ' 219' ' ' VAL . 0.6 OUTLIER -153.45 144.87 23.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 74.01 110.271 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.527 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.1 m-85 -139.87 112.61 7.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.156 . . . . 75.24 110.992 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 7.4 p -106.68 143.21 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 74.12 109.278 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 6.4 m-85 -113.99 150.49 33.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.11 . . . . 73.43 110.97 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.17 19.53 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.465 1.103 . . . . 64.51 111.003 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 263' ' ' SER . 54.4 t-20 -77.65 111.46 13.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.54 0.788 . . . . 63.12 109.299 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.453 HD12 ' CB ' ' A' ' 218' ' ' HIS . 4.0 mt -114.09 95.97 5.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 74.12 109.251 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.0 mtpt -92.31 165.4 13.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 74.24 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.439 ' CB ' HG21 ' A' ' 213' ' ' VAL . . . -170.6 122.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 62.14 109.325 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.409 ' CB ' ' SG ' ' A' ' 261' ' ' CYS . 3.3 p -96.24 131.62 42.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.134 . . . . 72.33 110.017 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 15.8 p -107.65 -5.86 17.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.447 1.092 . . . . 74.31 110.421 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 89.28 -22.88 21.07 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.495 1.122 . . . . 55.45 111.014 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.1 m -113.28 -18.85 11.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.443 0.731 . . . . 64.23 110.397 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 1.3 p -169.94 148.33 3.46 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 73.43 108.337 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.5 m -97.78 140.56 31.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.517 1.136 . . . . 74.41 108.354 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.439 HG21 ' CB ' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -117.56 142.24 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 64.13 109.318 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.31 127.82 28.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 64.42 109.364 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.464 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.6 OUTLIER -132.66 132.9 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 74.23 108.009 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 30.5 t -76.5 -0.76 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.149 . . . . 61.53 109.971 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -176.4 133.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 74.13 111.022 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 32.4 t60 -117.48 168.9 9.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.095 . . . . 72.1 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.507 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 2.8 p -147.75 142.02 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.46 1.1 . . . . 61.24 109.259 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.16 -167.27 2.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 74.14 109.278 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 19.9 pt -115.92 121.95 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 75.42 109.311 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 18.2 tp -84.49 115.55 22.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.463 1.102 . . . . 74.25 109.298 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.529 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -109.07 145.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.487 1.117 . . . . 73.24 109.303 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 140' ' ' ILE . 69.5 m -115.73 121.71 43.32 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 74.53 109.953 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.57 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.3 p90 -136.66 143.32 43.38 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 72.54 111.017 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.423 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.4 mmtp -69.23 132.51 46.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.451 1.094 . . . . 74.42 109.294 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.46 -160.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.34 109.332 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.21 50.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 62.01 109.329 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.6 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 75.35 110.009 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.39 8.16 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.538 1.149 . . . . 71.15 110.982 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.09 137.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 0.767 . . . . 74.51 109.281 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.423 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.5 m -71.91 102.66 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 60.44 110.43 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.8 mm-40 -103.12 -172.86 2.19 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 74.14 110.296 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -126.12 145.56 50.3 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 65.34 109.323 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.57 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 4.8 tpt180 -143.74 159.1 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 71.25 110.325 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.562 HG23 ' CD1' ' A' ' 252' ' ' TRP . 7.7 mm -111.63 124.89 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 72.44 109.331 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 2.8 mm -112.95 44.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 74.31 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.427 ' OD1' ' CG ' ' A' ' 241' ' ' LEU . 10.8 p-10 -94.12 111.67 54.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 51.23 109.322 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -36.33 2.66 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.506 1.793 . . . . 74.34 110.994 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 1.3 p -43.16 -36.47 1.72 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.456 1.097 . . . . 73.31 109.98 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.427 ' CG ' ' OD1' ' A' ' 238' ' ' ASP . 16.5 mt -102.56 -59.52 1.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 72.33 109.284 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.576 ' CD2' HG11 ' A' ' 247' ' ' VAL . 89.6 m-85 -111.3 98.99 7.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 73.13 111.07 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.6 m -91.02 -13.13 33.85 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 71.03 109.985 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 p -74.73 -46.54 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.098 . . . . 72.5 110.001 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -172.0 -179.52 42.98 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.501 1.126 . . . . 73.32 111.005 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.433 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.98 169.29 22.96 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.485 1.782 . . . . 73.51 110.978 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 242' ' ' PHE . 5.0 m -153.13 157.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.121 . . . . 75.33 109.289 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.434 ' C ' ' N ' ' A' ' 250' ' ' THR . 46.7 p -59.28 136.56 58.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 74.4 110.447 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 248' ' ' THR . 1.7 p-10 -40.33 -30.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 74.42 109.316 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.434 ' N ' ' C ' ' A' ' 248' ' ' THR . 3.7 m -70.06 -65.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 73.11 110.365 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.58 -38.4 14.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 71.43 109.31 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 19.4 t90 -54.25 -63.55 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 74.31 108.0 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.571 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -46.49 -45.78 18.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 72.34 110.327 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -53.14 -51.68 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.499 1.124 . . . . 73.0 109.285 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.417 ' CB ' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.78 -21.85 31.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 73.41 109.328 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -84.57 -38.19 20.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 72.2 108.34 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 264' ' ' ALA . 3.3 m -91.19 18.56 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 70.31 109.285 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 260' ' ' SER . 6.8 t30 -40.51 104.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 73.41 109.329 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.8 p -79.89 -4.04 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.461 1.101 . . . . 74.34 110.387 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 258' ' ' ASN . 5.2 t -58.7 -16.13 15.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 71.23 110.033 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 1.3 m -98.76 -20.34 16.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.447 1.092 . . . . 75.25 108.301 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 152.37 -125.88 1.91 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.512 1.132 . . . . 73.32 110.944 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -84.54 144.56 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 75.32 109.993 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 257' ' ' VAL . . . -170.51 146.2 2.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 71.5 109.3 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.26 152.45 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.45 1.094 . . . . 74.14 109.997 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 2.4 p -97.23 111.84 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 75.41 109.303 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.4 t -69.0 -46.95 66.72 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 65.01 110.007 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 200' ' ' VAL . 5.0 m -158.71 -175.04 5.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 71.45 110.013 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -166.5 157.25 12.48 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 74.33 110.977 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -160.34 153.24 21.39 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.55 109.325 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -110.84 160.69 16.52 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.442 1.089 . . . . 74.42 109.325 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.42 177.64 9.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 70.34 110.402 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.29 171.41 3.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 75.05 109.292 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -84.95 -4.53 86.99 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.553 1.158 . . . . 71.54 110.951 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 -44.5 7.73 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.499 0.764 . . . . 73.31 109.326 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' ' 285' ' ' TYR . 87.7 t -43.64 101.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 64.03 109.28 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.448 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 57.4 t80 -62.32 -39.23 92.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.547 1.154 . . . . 75.14 110.979 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -149.48 150.54 32.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 63.43 110.984 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.527 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 74.1 ttt-85 -116.05 147.59 41.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.52 110.288 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 153.4 47.29 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.126 . . . . 74.11 109.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 0.06 9.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.487 1.783 . . . . 71.22 110.999 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 1.7 p -104.12 4.58 34.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 53.34 109.989 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 81.2 41.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 63.2 109.324 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.9 t -121.51 128.72 52.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 75.12 110.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.433 ' CD2' HG21 ' A' ' 276' ' ' VAL . 15.4 m-30 -110.04 155.87 21.27 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.128 . . . . 74.44 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.23 176.95 4.86 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 73.34 109.315 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 95.7 m-85 -162.67 115.62 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 74.15 110.943 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.3 94.97 4.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 71.1 109.315 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -83.19 -39.13 21.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 74.32 109.313 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.465 ' CB ' HG12 ' A' ' 292' ' ' ILE . 28.5 m-20 -90.64 9.95 27.66 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 74.12 109.296 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.517 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.11 46.3 1.83 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.546 1.154 . . . . 73.0 109.304 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.465 HG12 ' CB ' ' A' ' 290' ' ' ASN . 46.3 mm -77.15 -33.95 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 75.44 109.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.488 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.5 t-20 -94.7 -15.25 24.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 74.33 109.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.448 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 24.1 m -87.66 -65.49 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 72.41 110.404 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.415 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 63.3 m-20 -57.95 -22.78 50.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 74.03 109.3 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 12.5 t -75.91 -65.67 0.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 61.24 108.308 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 41.6 t -40.27 -40.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 74.45 109.271 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.93 -57.72 5.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 70.34 109.261 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -56.19 -17.85 8.54 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.488 1.118 . . . . 71.13 110.398 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -76.93 -42.94 37.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 75.1 109.329 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.516 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 1.8 m-30 -105.75 40.33 1.59 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 62.42 111.002 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -67.71 -55.79 11.8 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.542 1.151 . . . . 74.21 110.015 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -81.12 -18.32 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.119 . . . . 73.45 109.299 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.556 HD12 ' CE2' ' A' ' 172' ' ' TYR . 13.5 mt -55.78 134.03 51.4 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.492 1.12 . . . . 74.03 109.274 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 74.5 p -148.61 154.33 39.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 74.42 110.007 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.28 -146.41 29.04 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.463 1.102 . . . . 73.1 110.997 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 12.5 m -108.93 12.99 25.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.301 -0.999 . . . . 64.54 108.301 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.9 OUTLIER -129.8 149.24 72.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 62.34 109.988 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -75.01 147.14 88.55 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.008 -2.497 . . . . 74.55 110.994 0.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.485 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.0 OUTLIER -129.07 133.64 25.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 73.41 110.007 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.04 -169.52 7.44 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.978 -2.509 . . . . 72.41 110.942 0.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.9 151.76 31.33 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.44 1.088 . . . . 74.33 109.295 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.494 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.491 1.785 . . . . 73.33 110.95 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.75 135.01 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 50.14 109.262 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 19.7 m -123.57 24.3 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.137 . . . . 74.04 109.309 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.429 ' C ' ' N ' ' A' ' 318' ' ' CYS . 3.5 t -53.69 -42.12 67.62 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.093 . . . . 70.42 110.005 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 16.0 m -41.89 -28.26 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 64.14 110.066 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.429 ' N ' ' C ' ' A' ' 316' ' ' SER . 75.4 m -54.57 -173.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.551 1.157 . . . . 75.13 108.333 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -157.07 -123.69 0.78 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.476 1.11 . . . . 73.41 110.987 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.559 ' CD1' ' C ' ' A' ' 320' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.452 0.736 . . . . 74.32 110.983 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.301 -0.629 . . . . 73.41 109.301 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -166.73 112.26 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.477 1.111 . . . . 75.31 109.311 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.464 ' CA ' ' OD2' ' A' ' 194' ' ' ASP . 0.5 OUTLIER -83.41 4.03 29.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 70.12 109.974 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -150.4 151.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 71.44 109.286 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.466 HD13 ' CD1' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -104.85 145.0 29.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.43 109.296 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -35.18 3.33 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.493 1.786 . . . . 75.2 111.014 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.88 150.06 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 75.33 109.333 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.561 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -46.06 -37.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 72.32 109.291 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.23 -49.32 2.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 64.15 109.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.0 m -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.45 1.094 . . . . 74.13 110.421 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.468 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.78 -57.45 12.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 74.33 109.241 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.5 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.1 m-80 -52.95 -30.41 34.53 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.47 1.106 . . . . 64.02 109.337 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.74 -56.77 7.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.572 1.17 . . . . 60.32 110.038 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.466 ' CD1' HD13 ' A' ' 140' ' ' ILE . 79.2 mt -43.11 -43.03 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 75.42 109.31 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.432 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.69 -45.1 62.92 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 74.44 110.959 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -46.05 -36.92 6.13 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 1.11 . . . . 72.11 109.3 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 62.5 mt-30 -76.41 -55.79 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 74.44 110.284 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.452 ' CD1' HD12 ' A' ' 188' ' ' LEU . 19.9 mt -49.46 -27.46 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 63.2 109.296 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -37.34 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.503 1.127 . . . . 71.45 109.306 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -56.21 -19.33 13.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 73.11 109.324 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' A' ' 156' ' ' GLN . 12.0 mm-40 -80.82 -28.01 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.454 1.096 . . . . 73.53 110.292 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 21.5 m -39.85 123.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 70.51 109.998 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.1 m -53.24 116.22 2.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.482 1.114 . . . . 73.42 108.303 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 142.03 -14.06 2.6 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.484 1.115 . . . . 75.32 111.011 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.0 p -97.71 161.86 13.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 0.75 . . . . 72.4 110.404 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -93.4 -2.35 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 73.55 109.967 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.2 m -112.03 0.1 15.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 75.43 110.397 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -75.57 134.09 40.79 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.51 1.131 . . . . 75.11 109.285 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -169.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.55 1.157 . . . . 73.2 110.029 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.456 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 44.0 p -154.75 127.53 4.11 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 64.32 110.026 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.08 137.14 48.56 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 121.019 -2.492 . . . . 71.41 110.981 0.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 9.5 p -72.95 -178.91 2.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 71.51 108.278 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.0 mp -84.5 128.16 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 75.11 109.308 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 p -92.54 76.27 5.08 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.562 1.164 . . . . 73.31 110.399 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -78.76 -14.17 59.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 73.34 110.979 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.46 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -73.74 -3.03 25.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 74.41 110.296 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.558 ' CE2' HD11 ' A' ' 304' ' ' LEU . 24.9 t80 -131.84 66.7 78.43 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 75.44 111.018 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.411 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.2 Cg_endo -74.98 118.46 5.28 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.518 1.799 . . . . 73.22 111.015 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 172' ' ' TYR . 19.0 t -152.84 -64.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 54.1 109.326 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.402 ' O ' ' SG ' ' A' ' 177' ' ' CYS . 2.2 t70 -132.3 -46.68 0.91 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 62.31 109.273 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -45.43 104.15 0.06 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.472 1.107 . . . . 62.25 110.996 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.493 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 3.5 p -138.65 -48.43 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.243 -1.021 . . . . 65.33 108.243 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -68.5 -16.22 63.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 74.45 110.985 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.93 -68.31 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 62.04 109.318 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.475 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 7.2 ptm180 -50.92 -49.03 60.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.12 . . . . 75.44 110.297 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.46 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.58 -56.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 73.3 109.292 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.549 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -47.1 -44.56 21.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.117 . . . . 74.14 109.601 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 180' ' ' ARG . 22.9 mmmt -64.36 -42.25 96.3 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 74.34 109.328 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.453 ' CE ' ' HA ' ' A' ' 181' ' ' ALA . 17.4 mtm -55.5 -33.2 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 75.12 111.003 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -21.33 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 73.44 110.319 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.73 -39.66 69.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.509 1.131 . . . . 74.22 110.304 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.468 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 19.0 mm -74.14 -32.48 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 73.11 109.294 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.452 HD12 ' CD1' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -61.65 -44.46 96.94 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.454 1.096 . . . . 74.54 109.324 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.6 mtp -58.51 -42.18 87.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 72.24 111.006 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -50.38 -53.53 28.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.461 1.1 . . . . 64.12 109.303 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.426 ' ND2' HE22 ' A' ' 152' ' ' GLN . 7.1 t-20 -60.55 -29.55 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 73.01 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.71 37.33 2.6 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.517 1.136 . . . . 74.34 110.99 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.572 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 73.7 m-85 -138.04 129.05 27.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 0.791 . . . . 73.14 110.988 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.464 ' OD2' ' CA ' ' A' ' 138' ' ' SER . 0.7 OUTLIER -99.27 132.51 44.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 52.04 109.293 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.446 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 25.9 p -112.17 -179.45 3.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 72.25 108.258 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.45 176.02 6.13 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.126 . . . . 62.33 110.285 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.46 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 22.0 mmtt -107.67 174.41 5.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 55.11 109.317 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -160.59 139.17 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.541 1.151 . . . . 75.02 110.263 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.562 ' CE1' HG23 ' A' ' 219' ' ' VAL . 4.1 m-85 -130.27 113.49 14.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 75.14 110.994 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 7.2 p -110.15 148.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 74.23 109.32 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.511 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.1 m-85 -121.6 160.44 24.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.478 1.111 . . . . 74.34 111.0 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.44 179.88 17.01 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.551 1.157 . . . . 64.25 111.015 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 263' ' ' SER . 59.3 t-20 -69.23 110.27 4.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.491 0.759 . . . . 62.53 109.324 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 218' ' ' HIS . 5.9 mt -114.56 93.49 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 75.45 109.296 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.8 mttp -93.27 165.35 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 74.13 109.303 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -168.53 143.07 3.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 65.12 109.318 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 52.6 p -117.69 110.15 17.51 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 62.43 110.015 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.4 p -80.89 -20.08 42.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.492 1.12 . . . . 75.43 110.411 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 122.85 -49.91 0.87 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.539 1.149 . . . . 73.31 111.012 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 75.5 p -91.52 -17.58 25.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.481 0.754 . . . . 74.22 110.413 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -168.0 163.29 13.62 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.487 1.117 . . . . 70.12 108.301 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.478 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.34 145.92 44.75 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.536 1.148 . . . . 62.52 108.329 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.36 155.53 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 72.32 109.247 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.4 119.07 13.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 74.31 109.282 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.33 134.79 51.01 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.155 . . . . 75.15 108.02 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.1 m -80.45 3.78 20.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.458 1.099 . . . . 72.22 109.994 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.8 p90 -176.14 127.75 0.21 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.477 1.111 . . . . 64.11 111.027 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -116.54 168.45 10.16 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.478 1.111 . . . . 64.32 109.619 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.562 HG23 ' CE1' ' A' ' 199' ' ' PHE . 1.3 p -145.57 143.38 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.49 1.119 . . . . 74.32 109.312 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.563 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -142.19 -165.68 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 65.43 109.294 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.463 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 31.1 pt -116.09 122.5 69.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 73.2 109.296 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 19.9 tp -87.1 108.87 19.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 74.0 109.312 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.468 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -102.0 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 71.02 109.3 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ILE . 54.8 m -135.75 120.14 17.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.494 1.121 . . . . 64.52 109.993 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.561 ' CD2' HG23 ' A' ' 143' ' ' VAL . 34.3 p90 -136.15 142.37 44.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 74.42 111.03 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.2 mmtp -68.21 132.84 47.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.504 1.128 . . . . 75.35 109.286 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -73.73 -160.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 73.42 109.321 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 0.09 48.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.481 1.113 . . . . 74.25 109.312 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -115.36 -7.19 12.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 73.33 110.02 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.54 37.66 8.67 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.473 1.108 . . . . 72.51 110.975 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 137.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.455 0.738 . . . . 74.43 109.323 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 8.6 m -71.47 102.58 2.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.05 110.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.414 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 1.8 mm-40 -101.39 -172.47 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 74.31 110.297 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -127.52 145.3 50.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 75.5 109.286 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.495 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 4.3 tpt180 -142.68 161.14 38.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 74.55 110.284 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.564 HD11 ' CE3' ' A' ' 252' ' ' TRP . 15.4 mm -113.7 117.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.52 1.138 . . . . 73.31 109.318 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -105.08 45.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 73.24 109.314 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.9 106.54 53.31 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 62.11 109.309 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -10.02 21.01 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 74.41 111.003 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.7 t -64.5 -11.85 38.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 74.3 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.408 HD12 ' NE2' ' A' ' 218' ' ' HIS . 5.2 mt -127.55 -48.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 74.13 109.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 255' ' ' ALA . 75.9 m-85 -118.54 99.54 6.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.576 1.172 . . . . 74.2 111.017 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 75.6 m -88.14 -6.44 57.88 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.547 1.154 . . . . 74.33 109.982 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.1 m -80.95 -45.77 16.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 75.3 110.012 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.05 -174.23 43.29 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.495 1.122 . . . . 54.4 110.987 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.45 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 164.42 33.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.485 1.781 . . . . 73.23 111.021 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.552 HG12 ' CD1' ' A' ' 242' ' ' PHE . 2.6 m -150.46 161.23 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.113 . . . . 74.12 109.32 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.3 p -64.51 138.21 58.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.523 1.139 . . . . 71.41 110.41 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.425 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 0.4 OUTLIER -40.92 -29.79 0.11 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.51 1.131 . . . . 73.52 109.307 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 6.3 m -71.85 -64.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 72.13 110.384 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.37 -25.55 10.08 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.504 1.127 . . . . 74.23 109.314 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.564 ' CE3' HD11 ' A' ' 236' ' ' ILE . 9.2 t90 -64.36 -59.91 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.995 -1.113 . . . . 72.23 107.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.544 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.26 -41.9 39.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 73.34 110.281 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.448 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 2.9 m-80 -56.56 -50.75 70.97 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.499 1.124 . . . . 74.5 109.275 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.574 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . . . -55.94 -20.99 18.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 51.54 109.32 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.16 -36.2 16.97 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 72.32 108.262 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.47 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.5 m -93.36 21.59 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 74.44 109.271 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -51.06 107.1 0.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 75.14 109.329 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.2 p -73.49 -3.06 25.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 71.32 110.385 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.3 t -44.3 -30.84 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.505 1.128 . . . . 63.53 109.97 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.59 -37.35 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 71.55 108.347 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.72 -128.06 1.66 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.546 1.154 . . . . 73.22 110.993 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.02 145.35 42.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.477 0.751 . . . . 71.32 109.983 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -168.02 148.03 4.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.46 1.1 . . . . 62.02 109.314 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 29.3 m -172.77 155.23 3.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 72.25 110.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.474 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 4.9 p -102.65 116.54 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.467 1.104 . . . . 60.23 109.283 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 32.0 t -70.76 -44.89 65.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.505 1.128 . . . . 71.0 109.951 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 50.7 p -165.43 -173.52 2.83 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.151 . . . . 74.23 110.006 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -165.4 156.53 14.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 74.32 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.04 147.84 23.05 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.53 1.144 . . . . 75.12 109.286 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.63 158.93 15.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 70.12 109.31 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 1.3 p -146.44 179.14 7.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.517 1.135 . . . . 72.32 110.386 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -74.57 163.36 27.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 73.21 109.324 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.47 -16.41 80.01 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.492 1.12 . . . . 74.22 111.008 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 276' ' ' VAL . 7.5 p30 -86.29 -43.61 12.78 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 0.782 . . . . 63.42 109.342 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.498 HG23 ' CD1' ' A' ' 285' ' ' TYR . 3.8 t -43.71 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.571 1.169 . . . . 73.24 109.285 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -66.95 -42.8 84.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 75.31 111.022 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.51 ' CD1' ' C ' ' A' ' 278' ' ' TYR . 0.6 OUTLIER -153.21 121.02 6.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 73.44 111.029 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.469 ' HD2' ' CG2' ' A' ' 272' ' ' THR . 40.8 ttt-85 -106.57 137.19 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.515 1.134 . . . . 75.12 110.334 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.92 158.17 32.62 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 73.04 110.007 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.47 8.88 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.467 1.772 . . . . 74.52 110.974 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 27.9 t -98.18 13.19 32.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.542 1.152 . . . . 73.34 109.99 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 74.87 37.19 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 62.14 109.338 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -112.3 152.94 27.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 75.51 109.951 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.498 ' CD1' HG23 ' A' ' 276' ' ' VAL . 51.9 m-85 -140.54 158.2 44.35 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 73.11 111.022 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -126.08 172.95 9.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.498 1.123 . . . . 74.3 109.281 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.473 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 88.1 m-85 -160.23 114.95 2.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 1.099 . . . . 75.33 111.001 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.428 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 8.0 t0 -115.5 97.04 5.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 64.14 109.273 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -85.83 -39.42 17.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 70.53 109.298 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.476 ' CB ' HG12 ' A' ' 292' ' ' ILE . 4.3 m120 -90.52 9.54 28.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 72.51 109.325 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.549 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.06 46.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 1.125 . . . . 71.33 109.305 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.476 HG12 ' CB ' ' A' ' 290' ' ' ASN . 48.9 mm -77.28 -28.77 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 74.32 109.298 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.489 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.7 t-20 -94.54 -22.53 18.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.42 109.312 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 m -84.52 -64.18 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.478 1.111 . . . . 74.34 110.395 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 82.5 m-20 -57.47 -17.94 15.97 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.119 . . . . 74.02 109.308 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 7.2 t -81.88 -63.95 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 75.03 108.303 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 301' ' ' PHE . 46.2 t -40.38 -51.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.545 1.153 . . . . 75.44 109.27 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 301' ' ' PHE . 47.0 mt -57.14 -59.48 5.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 64.31 109.296 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.22 -34.71 2.92 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.14 110.378 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -68.06 -43.31 78.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.54 109.259 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 1.5 m-30 -99.5 35.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 73.25 111.006 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.2 t -69.41 -43.36 73.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 71.51 110.029 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.45 -12.78 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.43 109.315 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.558 HD11 ' CE2' ' A' ' 172' ' ' TYR . 12.6 mt -60.39 150.28 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 74.21 109.295 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.6 p -161.48 162.92 30.61 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 73.05 109.984 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.68 -152.82 52.78 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.519 1.137 . . . . 74.04 111.018 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 2.1 m -101.64 13.12 35.88 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.292 -1.003 . . . . 64.45 108.292 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.488 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 12.9 p -129.49 150.01 74.45 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 74.13 110.009 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.6 Cg_endo -74.95 147.12 88.51 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.967 -2.514 . . . . 75.54 111.056 -0.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.468 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -128.71 133.69 25.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.531 1.145 . . . . 74.11 109.992 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -74.96 -170.27 8.1 Favored 'Cis proline' 0 C--N 1.36 1.168 0 C-N-CA 120.97 -2.512 . . . . 74.54 111.033 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 152.34 29.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 72.23 109.29 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.413 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.512 1.796 . . . . 73.44 110.996 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -91.4 135.31 33.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.148 . . . . 71.22 109.254 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.7 m -126.59 24.5 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.489 1.118 . . . . 73.13 109.276 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 318' ' ' CYS . 35.6 t -50.73 -44.12 58.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.35 109.952 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.6 m -39.51 -29.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 71.54 110.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 316' ' ' SER . 74.6 m -52.04 -179.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.434 1.084 . . . . 64.03 108.304 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -178.93 66.25 0.08 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.471 1.107 . . . . 70.52 110.959 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 8.3 p90 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.493 0.761 . . . . 74.13 110.966 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.477 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.327 -0.62 . . . . 75.21 109.327 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.568 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -149.04 106.7 3.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.533 1.145 . . . . 62.13 109.327 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m -81.82 5.65 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.33 109.99 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' ' 140' ' ' ILE . 2.3 t -149.35 145.62 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 70.14 109.302 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 1.2 mt -96.88 142.44 24.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.488 1.117 . . . . 62.55 109.27 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -32.44 5.42 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.464 1.77 . . . . 63.11 110.99 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.485 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.49 153.22 22.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.105 . . . . 73.13 109.3 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.563 HG21 ' CD2' ' A' ' 225' ' ' TYR . 1.8 t -51.08 -34.31 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.158 . . . . 74.11 109.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.84 -45.86 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 74.05 109.32 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.505 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.6 m -73.21 -32.38 64.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 65.45 110.415 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.47 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.5 OUTLIER -61.84 -56.23 21.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 73.32 109.295 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.512 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 51.6 m-80 -53.62 -31.37 46.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 71.04 109.288 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.39 -55.22 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 73.32 109.987 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.457 ' CD1' HD11 ' A' ' 140' ' ' ILE . 92.1 mt -44.4 -42.41 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 74.34 109.302 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.463 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.1 t80 -72.35 -44.7 62.22 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 1.117 . . . . 75.13 110.994 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -47.04 -37.32 9.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 75.34 109.262 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.465 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 60.0 mt-30 -74.94 -55.57 5.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 1.139 . . . . 70.24 110.293 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 184' ' ' MET . 23.4 mt -50.45 -28.0 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 54.03 109.308 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.407 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -75.07 -33.71 61.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 73.13 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.3 t-20 -61.59 -15.15 36.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 70.01 109.294 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.408 ' HA ' ' NE2' ' A' ' 156' ' ' GLN . 18.6 mm-40 -85.81 -18.47 32.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 74.01 110.302 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.0 p -37.93 134.51 0.75 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 1.13 . . . . 64.12 109.977 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.412 ' HB3' ' NH2' ' A' ' 171' ' ' ARG . 1.3 m -66.18 120.04 12.53 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 61.13 108.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 127.69 -15.82 6.26 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 73.42 110.99 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.492 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 69.6 p -83.39 161.9 21.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 0.758 . . . . 72.31 110.387 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -93.55 0.12 56.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.467 1.104 . . . . 74.5 109.963 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 m -119.45 7.15 11.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 71.33 110.355 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.492 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -81.31 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 62.25 109.308 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -162.03 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 73.25 110.014 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 126.92 3.5 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 74.42 110.039 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 139.85 64.05 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.948 -2.522 . . . . 74.41 110.998 0.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.99 178.46 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.1 . . . . 75.54 108.333 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.49 ' CD1' ' CB ' ' A' ' 183' ' ' LYS . 3.0 mp -86.32 132.95 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 70.21 109.268 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.424 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 51.0 p -90.43 75.24 6.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 60.44 110.403 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -81.64 -24.79 36.13 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 65.11 111.027 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.428 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.97 -1.57 26.28 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 73.45 110.3 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.569 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 25.6 t80 -128.91 67.44 77.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.092 . . . . 62.22 111.012 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.415 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.55 4.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.51 1.795 . . . . 73.3 111.013 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.56 HG22 ' CE1' ' A' ' 172' ' ' TYR . 14.6 t -152.23 -58.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 74.33 109.292 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -138.43 -47.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 63.34 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.19 106.46 0.05 OUTLIER Glycine 0 CA--C 1.529 0.938 0 O-C-N 124.526 1.141 . . . . 61.45 111.044 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.436 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 5.6 p -143.06 -48.41 0.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.307 -0.997 . . . . 72.3 108.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 24.3 p90 -69.99 -33.9 72.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.461 1.101 . . . . 74.13 111.062 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.492 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -62.57 -68.42 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 72.14 109.264 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 240' ' ' SER . 0.4 OUTLIER -46.38 -44.5 17.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 75.24 110.32 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.71 -55.47 5.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.466 1.104 . . . . 73.33 109.267 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.88 -35.83 15.66 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 72.34 109.635 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.49 ' CB ' ' CD1' ' A' ' 168' ' ' ILE . 0.0 OUTLIER -71.47 -50.55 30.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 75.42 109.286 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.468 ' HA ' ' CG2' ' A' ' 153' ' ' ILE . 5.3 mtm -51.84 -41.2 61.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 63.01 111.01 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.455 ' CZ ' ' HE1' ' A' ' 189' ' ' MET . 0.1 OUTLIER -74.96 -24.47 58.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 75.23 110.305 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.412 ' NE2' ' NZ ' ' A' ' 183' ' ' LYS . 0.7 OUTLIER -69.48 -41.56 75.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.515 1.135 . . . . 75.43 110.305 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 20.8 mm -72.02 -33.0 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.488 1.118 . . . . 74.43 109.274 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -59.56 -47.36 85.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 1.097 . . . . 75.22 109.332 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.455 ' HE1' ' CZ ' ' A' ' 185' ' ' ARG . 2.4 mtt -54.9 -44.35 74.05 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 73.15 111.001 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.0 -53.33 20.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 74.33 109.312 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.41 ' CB ' HD23 ' A' ' 149' ' ' LEU . 9.6 t-20 -58.46 -32.88 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 75.45 109.308 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 108.78 43.86 1.18 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.53 1.144 . . . . 62.31 110.973 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.568 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 68.6 m-85 -144.79 133.31 22.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.48 0.753 . . . . 73.32 111.03 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.477 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.5 OUTLIER -99.71 130.07 45.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 75.41 109.31 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.445 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 28.5 p -112.25 -179.44 3.68 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 1.153 . . . . 72.24 108.307 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -125.87 177.41 6.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 65.21 110.286 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -108.87 164.27 12.54 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 73.3 109.292 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -151.5 117.49 5.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.446 1.091 . . . . 73.41 110.277 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.521 ' CD1' HG22 ' A' ' 219' ' ' VAL . 3.9 m-85 -108.65 129.74 55.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 64.22 111.056 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 6.3 p -128.49 131.63 68.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 74.42 109.289 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 6.4 m-85 -108.01 159.51 16.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.517 1.135 . . . . 71.23 111.053 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 123.48 -173.19 16.38 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.469 1.105 . . . . 73.14 110.978 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 263' ' ' SER . 58.5 t-20 -76.3 108.19 9.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 73.44 109.321 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 218' ' ' HIS . 4.4 mt -111.13 95.09 5.32 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.118 . . . . 72.24 109.305 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 256' ' ' CYS . 0.2 OUTLIER -92.21 158.35 16.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 73.54 109.294 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 213' ' ' VAL . . . -179.12 162.63 1.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.13 . . . . 73.32 109.318 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.0 t -117.75 148.37 42.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.32 110.013 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.453 ' CG2' HG12 ' A' ' 213' ' ' VAL . 1.8 p -124.43 -0.92 8.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 74.32 110.38 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 122.27 115.85 2.33 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.478 1.112 . . . . 64.1 110.981 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.46 ' O ' ' CG2' ' A' ' 210' ' ' THR . 0.6 OUTLIER 46.61 24.56 0.33 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.5 0.765 . . . . 75.51 110.408 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . 0.406 ' SG ' ' OG1' ' A' ' 208' ' ' THR . 0.5 OUTLIER -165.17 157.07 15.19 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 75.44 108.311 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 19.1 m -113.76 176.3 5.09 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 65.53 108.294 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.453 HG12 ' CG2' ' A' ' 208' ' ' THR . 2.4 m -153.03 129.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.538 1.149 . . . . 72.52 109.3 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.403 ' HB1' ' NZ ' ' A' ' 205' ' ' LYS . . . -124.42 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.433 1.083 . . . . 74.11 109.279 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -132.33 134.87 45.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.988 -1.116 . . . . 75.13 107.988 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 23.8 t -77.36 0.18 23.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 64.01 110.063 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -178.15 136.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 74.22 110.978 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.463 ' HB3' ' CD1' ' A' ' 204' ' ' LEU . 77.6 t60 -129.5 143.31 50.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 74.44 109.61 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 199' ' ' PHE . 7.4 p -124.47 134.27 67.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.475 1.11 . . . . 73.11 109.284 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.35 -152.1 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 72.54 109.371 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.461 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 13.1 pt -128.72 123.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 73.35 109.29 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 15.7 tp -89.78 109.06 20.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 63.44 109.327 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.47 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.04 148.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 74.02 109.301 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.24 121.63 41.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 63.21 109.995 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.563 ' CD2' HG21 ' A' ' 143' ' ' VAL . 32.0 p90 -136.81 144.95 43.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 72.5 111.009 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.439 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.6 mmtp -70.07 133.78 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 75.24 109.322 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.46 -159.67 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 64.23 109.305 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.93 0.07 49.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 74.15 109.243 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.01 -8.59 12.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.133 . . . . 70.21 110.018 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.41 37.59 8.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.478 1.111 . . . . 73.22 111.039 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.54 138.21 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.49 0.759 . . . . 74.1 109.319 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.439 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 23.9 m -71.58 102.67 2.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.152 . . . . 74.32 110.408 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.412 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.0 mm-40 -101.69 -172.61 2.18 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 73.23 110.257 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -126.66 144.91 50.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 75.33 109.257 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.528 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 4.6 tpt180 -143.43 160.57 40.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 75.35 110.32 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.503 HD11 ' CE3' ' A' ' 252' ' ' TRP . 14.3 mm -116.6 119.15 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 63.42 109.313 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -103.37 44.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 75.22 109.284 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -101.26 108.5 55.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.487 1.117 . . . . 63.32 109.283 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -26.9 10.5 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.486 1.782 . . . . 74.54 110.966 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.3 OUTLIER -45.92 -25.46 0.54 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 73.03 110.002 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.1 mt -112.97 -60.71 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 73.33 109.333 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 255' ' ' ALA . 85.3 m-85 -106.5 99.58 9.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 74.24 110.969 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 52.8 m -85.67 -13.47 48.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 65.14 109.992 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.2 m -72.01 -47.85 48.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 72.25 109.944 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.75 -170.97 39.91 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.523 1.14 . . . . 64.42 111.0 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.448 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -74.99 163.84 34.57 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.495 1.787 . . . . 71.43 111.007 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.549 HG12 ' CD1' ' A' ' 242' ' ' PHE . 3.1 m -147.81 162.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 74.03 109.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.431 ' C ' ' N ' ' A' ' 250' ' ' THR . 31.1 p -63.49 139.22 58.75 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.49 1.119 . . . . 73.52 110.428 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 249' ' ' ASP . 0.2 OUTLIER -42.45 -28.56 0.22 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 75.0 109.317 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.431 ' N ' ' C ' ' A' ' 248' ' ' THR . 9.1 m -75.93 -62.57 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.127 . . . . 62.31 110.367 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.07 -28.23 6.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 74.13 109.311 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.568 ' CZ2' ' HB2' ' A' ' 220' ' ' ALA . 10.2 t90 -63.25 -63.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 71.53 107.989 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.562 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -46.5 -42.24 15.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 73.21 110.3 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -56.28 -51.29 68.71 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 63.42 109.325 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.69 -28.0 53.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.131 . . . . 73.44 109.276 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.2 m -80.14 -36.89 34.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 71.11 108.309 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.463 ' CG1' HG22 ' A' ' 266' ' ' VAL . 2.6 m -95.37 22.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.49 1.119 . . . . 64.42 109.299 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -50.7 104.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.11 . . . . 74.13 109.286 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -73.34 -4.22 32.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.507 1.129 . . . . 71.4 110.408 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.3 t -51.31 -21.69 2.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.474 1.109 . . . . 65.0 110.004 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . 0.429 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 5.0 m -96.51 -27.3 14.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.541 1.151 . . . . 73.43 108.297 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 156.51 -128.21 2.15 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.436 1.085 . . . . 74.1 111.025 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.449 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -78.54 141.24 38.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 0.753 . . . . 75.2 110.013 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.46 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -171.38 143.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 64.15 109.316 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.65 161.71 4.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.132 . . . . 71.42 109.962 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 257' ' ' VAL . 17.5 t -103.57 128.23 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 55.31 109.342 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.9 t -84.77 -39.44 18.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 75.12 109.991 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.6 m -175.0 144.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 74.1 109.976 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.435 ' CG ' ' NH1' ' A' ' 253' ' ' ARG . 44.5 p90 -130.48 160.13 35.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.42 1.075 . . . . 64.41 111.022 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.96 160.45 41.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.496 1.123 . . . . 74.44 109.341 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.42 ' C ' ' CG2' ' A' ' 272' ' ' THR . 1.2 p-10 -122.7 158.04 30.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.557 1.161 . . . . 71.44 109.283 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.42 ' CG2' ' C ' ' A' ' 271' ' ' ASN . 56.0 p -151.95 175.46 12.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 75.2 110.379 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.36 161.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 70.25 109.373 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.21 -45.38 40.07 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.473 1.108 . . . . 60.31 110.983 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.51 -37.43 49.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 0.768 . . . . 52.32 109.286 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 43.1 t -45.86 118.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.555 1.159 . . . . 75.41 109.277 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -81.34 -52.09 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 72.42 110.995 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -135.89 160.08 39.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.14 . . . . 75.24 111.019 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.514 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.8 ttt-85 -131.11 147.48 52.62 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.437 1.085 . . . . 71.51 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.92 157.45 52.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.1 . . . . 61.34 110.0 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 0.31 9.04 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.482 1.78 . . . . 65.51 111.008 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 11.3 t -99.55 6.21 45.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 73.24 110.018 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.4 t-20 76.21 34.67 0.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 74.24 109.271 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -116.49 123.56 47.76 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 63.54 110.001 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -104.91 157.6 17.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.2 110.987 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.599 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -116.55 171.38 7.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.107 . . . . 72.32 109.323 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.599 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 41.5 m-85 -153.83 115.22 4.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.46 1.1 . . . . 72.24 110.995 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.441 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 3.8 t0 -115.61 97.84 6.37 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.476 1.11 . . . . 73.03 109.305 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -85.66 -26.96 25.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 75.43 109.298 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -101.74 -1.81 31.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 64.3 109.268 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 54.78 46.04 25.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 74.45 109.295 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 16.5 mm -66.69 -42.93 90.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 74.31 109.27 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.488 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.7 t-20 -90.46 -23.6 20.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 62.54 109.304 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.464 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 1.2 m -75.6 -64.21 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 73.52 110.426 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 54.3 m-20 -58.1 -25.56 61.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 75.22 109.315 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 27.2 t -76.24 -60.52 2.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.481 1.113 . . . . 74.15 108.305 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 8.9 t -41.5 -50.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 73.34 109.298 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.05 -60.02 4.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 73.2 109.328 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -41.68 -37.9 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.448 1.093 . . . . 74.41 110.38 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -61.98 -56.67 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 75.11 109.314 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.569 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 0.4 OUTLIER -93.16 37.64 1.04 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 73.32 111.035 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -70.81 -43.89 67.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.46 1.1 . . . . 60.22 110.005 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.28 -12.12 28.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.488 1.117 . . . . 73.32 109.292 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.524 HD12 ' CE2' ' A' ' 172' ' ' TYR . 13.9 mt -61.08 139.45 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.548 1.155 . . . . 74.32 109.294 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 71.0 p -149.39 147.17 27.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 72.02 109.966 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 84.02 -162.0 38.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.128 . . . . 74.04 110.971 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.404 ' O ' ' OG ' ' A' ' 310' ' ' SER . 4.1 p -91.27 3.67 54.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.296 -1.001 . . . . 64.34 108.296 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.48 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 33.9 p -126.09 150.97 71.04 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 71.01 110.007 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.485 ' CD ' ' CD2' ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.96 146.36 86.45 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.024 -2.49 . . . . 73.15 111.024 -0.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.49 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.1 p -133.77 135.42 24.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 41.24 110.014 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.01 -173.19 11.89 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.996 -2.502 . . . . 61.35 111.004 -0.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.07 154.29 20.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.458 1.099 . . . . 74.01 109.331 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.1 Cg_endo -75.02 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.489 1.783 . . . . 64.35 110.994 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -89.75 130.79 35.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.12 . . . . 75.13 109.269 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.5 m -121.08 27.45 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 71.31 109.276 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 318' ' ' CYS . 9.3 t -50.46 -44.47 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.117 . . . . 74.15 110.005 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 316' ' ' SER . 80.0 p -38.96 -30.55 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.485 1.116 . . . . 74.43 109.973 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 316' ' ' SER . 57.4 m -59.65 -173.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 74.34 108.324 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.477 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 163.41 80.23 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.501 1.126 . . . . 71.31 111.028 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.513 ' CG ' HD11 ' A' ' 286' ' ' LEU . 8.0 p90 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.523 0.778 . . . . 74.45 111.042 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.472 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.301 -0.629 . . . . 71.35 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.543 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -152.74 109.64 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 63.14 109.332 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -83.11 7.52 15.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.536 1.147 . . . . 71.15 110.011 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -147.11 148.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.515 1.134 . . . . 74.12 109.275 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -101.5 143.75 27.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.23 109.303 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.94 -34.12 4.15 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.504 1.791 . . . . 74.02 111.035 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.446 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.37 153.29 25.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 74.24 109.281 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.568 HG21 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -49.94 -36.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 74.32 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.41 -49.27 2.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 71.34 109.335 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.522 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -69.42 -36.88 77.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 73.34 110.38 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.4 OUTLIER -57.16 -57.37 12.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 74.31 109.323 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.502 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.5 m-80 -52.48 -29.6 25.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 73.31 109.329 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.27 -56.13 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 73.42 110.025 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.47 ' CD1' HD13 ' A' ' 140' ' ' ILE . 76.1 mt -42.07 -41.93 2.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 71.14 109.329 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.411 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.45 -45.13 60.97 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 75.21 110.99 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.41 -36.0 9.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 64.52 109.289 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.448 ' NE2' ' OD1' ' A' ' 191' ' ' ASN . 65.0 mt-30 -76.13 -55.49 5.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 74.44 110.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.413 ' N ' HG22 ' A' ' 187' ' ' ILE . 15.7 mt -50.14 -26.87 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.493 1.121 . . . . 71.32 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.402 ' O ' ' OG ' ' A' ' 157' ' ' SER . 0.2 OUTLIER -76.65 -34.56 58.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 73.31 109.288 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -62.33 -14.6 41.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.44 109.259 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -86.44 -17.07 35.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 74.42 110.297 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 154' ' ' LYS . 15.1 p -38.71 122.97 1.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 71.45 109.937 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 131.12 42.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 61.43 108.256 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.46 -25.1 9.36 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.509 1.131 . . . . 74.03 110.993 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.404 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 25.3 p -73.52 162.92 28.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 0.753 . . . . 74.32 110.431 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 -2.45 54.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 72.12 110.029 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 7.5 m -116.79 8.76 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.453 1.096 . . . . 75.43 110.376 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.404 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -82.81 138.09 34.09 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 75.13 109.3 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -169.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 73.54 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.7 p -153.54 126.78 4.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 71.23 109.999 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -74.97 137.48 50.6 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 75.34 111.002 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.7 p -73.09 -179.7 3.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 73.22 108.322 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.493 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.7 mp -101.93 137.06 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 63.34 109.267 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.1 p -74.37 83.66 1.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 75.12 110.381 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.524 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 3.1 m-85 -80.1 -1.07 38.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.477 1.11 . . . . 75.34 110.991 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -118.02 14.93 14.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 73.32 110.317 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.565 ' CE1' HG23 ' A' ' 174' ' ' VAL . 18.6 t80 -128.86 67.55 77.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 75.24 111.041 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.438 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.5 Cg_endo -74.97 113.19 3.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.521 1.801 . . . . 72.51 111.014 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.565 HG23 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.75 -71.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 72.22 109.24 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -133.53 -46.51 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 62.42 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.93 100.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 54.34 110.988 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.438 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 5.2 p -137.56 -48.53 0.58 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.304 -0.998 . . . . 72.41 108.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -69.92 -25.21 63.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.55 1.156 . . . . 74.44 111.03 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.35 -65.64 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 65.24 109.37 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.493 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 11.4 ptm180 -45.77 -51.86 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.099 . . . . 75.42 110.234 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.441 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -41.37 -63.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 75.44 109.31 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.6 OUTLIER -40.74 -38.71 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 73.51 109.583 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.443 ' HD3' ' CG2' ' A' ' 294' ' ' THR . 13.3 mmmm -68.47 -59.92 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 74.31 109.257 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 25.7 mtm -41.4 -30.67 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 73.04 110.958 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.48 ' CZ ' ' CE ' ' A' ' 189' ' ' MET . 0.1 OUTLIER -68.25 -47.61 67.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.447 1.092 . . . . 70.01 110.293 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -51.4 -33.52 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 74.22 110.306 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.435 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 16.1 mm -75.7 -34.33 28.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.115 . . . . 74.31 109.305 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.457 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -60.96 -47.51 86.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 65.53 109.253 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.48 ' CE ' ' CZ ' ' A' ' 185' ' ' ARG . 4.5 mtt -54.93 -44.29 74.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 75.03 110.996 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -47.25 -52.53 15.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 74.23 109.297 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.448 ' OD1' ' NE2' ' A' ' 152' ' ' GLN . 0.5 OUTLIER -63.32 -36.36 83.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 60.0 109.284 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.32 48.71 0.69 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.12 . . . . 63.44 110.987 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.543 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 64.1 m-85 -149.39 137.37 20.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.481 0.754 . . . . 70.14 111.05 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.472 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -103.55 130.31 50.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 71.43 109.333 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 26.4 p -107.52 -179.48 3.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 72.32 108.298 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -127.05 172.62 10.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 75.43 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.441 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 15.9 mmtt -104.98 157.29 17.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.438 1.087 . . . . 74.12 109.321 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -146.52 117.76 7.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 65.44 110.282 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.568 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.2 m-85 -108.27 128.22 54.54 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 73.5 110.977 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.46 ' C ' ' CD1' ' A' ' 201' ' ' TYR . 1.5 t -120.52 161.05 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 70.33 109.328 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 2.3 m-85 -138.84 151.22 46.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 74.11 111.019 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.14 18.24 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.506 1.129 . . . . 71.15 111.027 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 263' ' ' SER . 55.6 t-20 -77.33 111.36 12.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 0.76 . . . . 72.53 109.3 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 218' ' ' HIS . 4.0 mt -113.74 94.12 4.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 74.31 109.299 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 256' ' ' CYS . 1.2 mtpp -92.89 158.31 15.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 74.43 109.294 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.419 ' CB ' HG22 ' A' ' 213' ' ' VAL . . . -164.89 162.75 20.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.21 109.313 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t -141.88 130.68 22.92 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.553 1.158 . . . . 73.03 110.017 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 25.6 p -90.58 -2.81 57.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 71.31 110.42 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.15 -39.3 2.95 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.516 1.135 . . . . 75.13 111.003 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.1 p -123.39 7.41 9.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.515 0.773 . . . . 73.43 110.355 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 7.5 t -157.29 170.34 22.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.561 1.163 . . . . 74.44 108.303 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t -133.2 162.35 32.01 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.544 1.153 . . . . 74.0 108.283 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -145.08 149.01 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 74.11 109.253 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.401 ' HB1' ' NZ ' ' A' ' 205' ' ' LYS . . . -141.79 120.16 12.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.539 1.15 . . . . 74.23 109.291 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -125.46 136.8 53.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 74.53 108.008 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 p -80.78 1.43 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 72.02 110.007 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 7.9 p90 -178.17 130.8 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 64.32 111.022 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.471 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 80.2 t60 -123.83 166.41 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.568 1.168 . . . . 75.24 109.591 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.471 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 4.8 p -147.94 143.24 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 72.3 109.264 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.605 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.12 -159.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.452 1.095 . . . . 74.51 109.348 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 8.2 pt -118.16 125.17 74.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.542 1.151 . . . . 75.14 109.273 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.19 108.97 19.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 75.54 109.333 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.8 OUTLIER -104.95 147.41 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 72.24 109.32 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 140' ' ' ILE . 5.1 m -117.1 121.52 41.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 62.51 110.02 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CD2' HG21 ' A' ' 143' ' ' VAL . 32.6 p90 -136.45 143.14 43.73 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.471 1.107 . . . . 73.44 110.992 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.0 mmtp -68.73 132.93 47.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 73.53 109.268 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.41 -160.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 74.24 109.349 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.61 0.06 48.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 74.44 109.278 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.8 m -115.15 -7.95 12.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 64.52 110.006 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.97 37.68 8.31 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 72.11 111.005 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.5 138.02 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.511 0.771 . . . . 73.51 109.316 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.0 m -71.72 102.67 2.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 74.55 110.38 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.408 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.9 mm-40 -101.55 -172.58 2.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.468 1.105 . . . . 75.24 110.307 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -127.29 145.08 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.147 . . . . 75.34 109.339 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.51 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 2.7 tpt180 -144.19 161.2 39.47 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.52 110.304 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.554 HD13 ' CE3' ' A' ' 252' ' ' TRP . 15.6 mm -116.75 120.43 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.464 1.102 . . . . 74.41 109.249 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -104.22 44.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 71.35 109.279 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -100.32 108.88 54.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 70.42 109.31 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.524 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.2 Cg_endo -75.05 -27.88 9.56 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.506 1.792 . . . . 75.44 111.019 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.2 t -48.15 -24.2 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 75.14 110.036 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.11 -57.0 2.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 72.55 109.277 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.56 ' CD1' HG13 ' A' ' 247' ' ' VAL . 81.7 m-85 -112.46 99.45 7.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.35 110.996 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.0 m -85.92 -9.1 57.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.094 . . . . 65.51 110.021 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.3 p -77.36 -46.26 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 71.43 110.004 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.76 -171.59 41.35 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.501 1.126 . . . . 72.2 110.958 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.439 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.97 163.35 35.55 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.458 1.767 . . . . 71.32 111.039 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.56 HG13 ' CD1' ' A' ' 242' ' ' PHE . 3.1 m -147.55 160.01 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.502 1.126 . . . . 75.21 109.265 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.9 p -61.53 141.37 57.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 72.44 110.401 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.445 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 8.9 p30 -44.25 -27.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 71.43 109.302 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 15.8 m -77.53 -61.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.133 . . . . 74.53 110.427 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.58 -27.62 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 51.1 109.314 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.605 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 9.9 t90 -63.66 -63.14 1.26 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.47 1.106 . . . . 74.01 108.055 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.543 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.17 -42.04 19.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 75.24 110.311 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.406 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.8 m-80 -55.75 -51.57 66.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 75.41 109.313 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.25 -24.79 29.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.492 1.12 . . . . 71.22 109.322 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.3 m -83.94 -36.5 23.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.144 . . . . 63.14 108.304 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.466 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.0 m -94.63 22.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 63.33 109.311 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -49.28 104.85 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.437 1.086 . . . . 74.44 109.276 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 262' ' ' GLY . 1.8 p -72.33 -4.02 27.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.507 1.13 . . . . 70.44 110.348 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 t -46.32 -27.0 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 64.31 109.967 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 1.7 m -92.11 -35.76 13.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 74.12 108.236 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.15 -126.79 1.68 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.505 1.128 . . . . 74.13 110.973 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -69.64 142.21 53.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 0.768 . . . . 75.12 110.002 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.466 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -173.08 140.84 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 71.24 109.279 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 87.8 p -172.09 156.53 4.04 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.161 . . . . 72.33 109.991 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.438 ' CG2' HG13 ' A' ' 200' ' ' VAL . 6.0 p -103.78 111.15 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.502 1.126 . . . . 74.42 109.3 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 201' ' ' TYR . 16.5 t -61.68 -46.9 87.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 65.42 110.013 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.6 m -159.58 -174.21 4.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.45 1.094 . . . . 75.01 110.009 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -167.0 157.38 11.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.485 1.115 . . . . 75.04 110.986 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.0 169.44 22.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 65.41 109.311 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.44 ' O ' ' CG2' ' A' ' 272' ' ' THR . 1.0 OUTLIER -134.17 160.64 37.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 74.2 109.253 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.488 HG23 ' CZ ' ' A' ' 285' ' ' TYR . 1.7 p -158.24 -177.93 6.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 74.02 110.378 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -60.97 167.22 3.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 72.15 109.303 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.26 -41.55 10.1 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.489 1.118 . . . . 75.32 110.983 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.446 ' CG ' ' NH2' ' A' ' 185' ' ' ARG . 0.8 OUTLIER -58.58 -45.2 89.57 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.497 0.763 . . . . 75.44 109.321 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 91.3 t -43.76 101.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.431 1.082 . . . . 75.34 109.305 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -52.23 -58.66 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 72.2 110.99 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.9 t80 -139.06 170.17 16.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.109 . . . . 73.12 110.986 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.596 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 66.3 ttt-85 -141.59 147.44 37.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 64.2 110.315 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.61 157.05 43.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 75.24 109.998 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -0.26 9.77 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.525 1.802 . . . . 73.11 111.021 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.408 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.5 p -96.78 9.08 42.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 74.35 110.011 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.3 t-20 74.98 34.67 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.54 1.15 . . . . 73.13 109.294 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.2 t -119.72 119.55 34.0 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 70.44 110.022 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.507 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.3 m-30 -99.59 162.22 13.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.2 110.99 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.3 mm? -116.97 177.57 4.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.517 1.135 . . . . 74.22 109.312 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 97.6 m-85 -160.92 115.4 2.1 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 74.21 111.03 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.465 ' HB3' ' CD1' ' A' ' 291' ' ' LEU . 0.7 OUTLIER -115.31 94.74 4.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 71.21 109.271 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 290' ' ' ASN . 0.7 OUTLIER -80.27 -42.04 23.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 74.21 109.246 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.493 ' N ' ' ND2' ' A' ' 289' ' ' ASN . 11.4 m-20 -95.65 -1.83 49.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 74.21 109.28 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.656 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.0 mm? 52.21 40.34 28.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 75.45 109.32 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 16.6 mm -69.8 -25.82 29.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 71.33 109.264 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.442 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.7 t-20 -92.97 -31.86 14.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 74.4 109.333 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.443 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 18.0 m -81.42 -66.85 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.515 1.134 . . . . 74.21 110.408 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.8 m-20 -47.33 -29.37 2.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 73.24 109.306 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.5 t -75.23 -52.91 9.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 74.05 108.328 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 4.5 t -46.23 -51.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 73.24 109.307 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 20.9 mt -63.47 -52.69 60.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 75.11 109.309 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -52.2 -26.54 11.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 74.25 110.395 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -76.1 -35.73 59.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 75.53 109.306 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.569 ' CZ ' HG13 ' A' ' 315' ' ' VAL . 3.1 m-30 -101.83 24.88 9.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 72.44 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 14.5 t -57.24 -59.06 5.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 74.5 110.014 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.501 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -74.19 -17.53 60.89 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.441 1.088 . . . . 74.33 109.315 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.464 ' HB2' ' CA ' ' A' ' 301' ' ' PHE . 14.8 mt -67.89 134.43 50.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 75.5 109.317 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.7 p -160.36 135.35 7.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 75.31 110.039 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 109.97 -160.57 13.34 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.477 1.111 . . . . 73.03 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.9 p -95.08 13.5 24.98 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.295 -1.002 . . . . 64.5 108.295 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.468 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.6 p -145.91 152.98 49.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 73.41 110.043 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -74.99 145.59 84.34 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 121.016 -2.493 . . . . 74.42 110.975 0.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.493 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 99.4 p -130.99 134.87 26.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 71.41 109.995 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.08 -173.19 11.91 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.974 -2.511 . . . . 73.01 110.955 0.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.76 153.26 22.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 65.22 109.321 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.564 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.02 -162.38 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.449 1.763 . . . . 71.4 110.99 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -84.52 137.0 33.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 74.41 109.296 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.569 HG13 ' CZ ' ' A' ' 301' ' ' PHE . 21.3 m -144.6 24.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.105 . . . . 74.13 109.326 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 318' ' ' CYS . 28.5 t -69.2 -31.87 70.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.51 109.933 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 26.3 m -44.47 -26.49 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 73.51 109.971 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 316' ' ' SER . 2.4 m -71.88 -176.02 1.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 62.53 108.293 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 164.89 119.9 0.5 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.504 1.128 . . . . 75.35 110.972 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 320' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 O-C-N 124.474 0.749 . . . . 74.43 110.982 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 7.3 tp . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.32 -0.622 . . . . 75.21 109.32 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.572 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -105.51 108.78 20.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 73.4 109.326 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -85.7 10.62 12.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 73.11 109.969 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -150.38 144.19 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 63.4 109.286 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 1.3 mt -96.31 141.77 23.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 74.11 109.286 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.08 -30.26 7.24 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.467 1.772 . . . . 74.41 111.015 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.59 152.28 17.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 74.13 109.26 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 225' ' ' TYR . 1.8 t -50.37 -36.0 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 72.33 109.277 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.05 -47.69 3.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.112 . . . . 74.44 109.306 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.488 HG23 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -71.1 -36.05 72.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 75.11 110.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.4 OUTLIER -58.06 -57.08 14.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.517 1.136 . . . . 75.44 109.288 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.509 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.4 m-80 -52.28 -31.36 32.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 72.11 109.281 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.92 -55.03 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 74.24 109.978 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 191' ' ' ASN . 96.2 mt -45.44 -41.88 9.82 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 74.21 109.304 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.47 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.1 t80 -73.54 -43.8 59.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.455 1.097 . . . . 72.2 111.034 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -47.99 -36.4 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 71.41 109.309 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.489 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 61.6 mt-30 -76.4 -56.07 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 72.12 110.321 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 21.6 mt -49.01 -29.41 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 75.25 109.307 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 -37.28 67.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.524 1.14 . . . . 74.54 109.278 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.9 t-20 -58.26 -17.52 20.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 75.55 109.321 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -82.18 -25.3 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.104 . . . . 74.12 110.268 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.527 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 15.5 m -42.14 120.86 1.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 73.02 109.979 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -45.85 131.56 9.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.538 1.149 . . . . 65.15 108.288 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.41 -15.47 9.24 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.542 1.152 . . . . 72.44 111.017 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.456 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 14.5 p -89.3 161.15 16.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.426 0.721 . . . . 75.15 110.381 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.0 m -93.46 -2.03 54.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 74.15 110.031 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 162' ' ' THR . 1.8 m -118.58 8.6 12.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 73.21 110.381 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.456 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -81.68 135.78 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.512 1.133 . . . . 54.32 109.303 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -169.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.47 1.106 . . . . 62.03 110.024 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 54.1 p -153.62 127.05 4.25 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.42 109.978 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.05 137.88 52.86 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.038 -2.484 . . . . 74.11 110.969 0.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.0 p -72.94 -178.63 2.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 44.23 108.315 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.6 mp -86.93 130.76 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.31 109.306 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.1 p -95.85 76.11 3.16 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 74.32 110.432 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.527 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 53.8 p90 -76.88 -16.18 59.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.135 . . . . 75.12 110.994 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -73.46 -3.38 27.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 1.133 . . . . 75.44 110.309 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 24.9 t80 -130.96 66.14 78.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 74.11 111.01 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.61 4.34 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.489 1.783 . . . . 73.01 111.024 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.539 HG23 ' CE1' ' A' ' 172' ' ' TYR . 10.8 t -152.04 -60.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 74.45 109.299 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.4 ' O ' ' SG ' ' A' ' 177' ' ' CYS . 3.3 m-20 -132.1 -46.79 0.93 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.491 1.12 . . . . 73.15 109.277 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -49.15 98.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.545 1.153 . . . . 75.12 111.011 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.488 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 2.5 p -130.09 -46.89 1.11 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.287 -1.005 . . . . 73.33 108.287 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 31.4 p90 -73.8 -44.2 56.59 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 75.22 110.992 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.91 -68.48 0.18 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.13 . . . . 74.3 109.293 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 183' ' ' LYS . 8.8 ptm180 -48.89 -48.71 42.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.436 1.085 . . . . 74.33 110.251 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.437 ' HA ' ' CE ' ' A' ' 184' ' ' MET . . . -42.68 -45.93 4.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.462 1.101 . . . . 74.2 109.307 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -56.98 -41.93 79.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 75.31 109.617 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 180' ' ' ARG . 15.8 mmmt -71.05 -30.22 66.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.122 . . . . 72.3 109.295 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.437 ' CE ' ' HA ' ' A' ' 181' ' ' ALA . 21.7 mtm -66.18 -60.4 2.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 73.23 111.012 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -51.24 -26.88 7.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 75.12 110.279 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.428 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 1.1 tt0 -64.54 -44.28 91.31 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.55 1.156 . . . . 74.55 110.275 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 190' ' ' ASN . 23.8 mm -66.1 -52.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 72.4 109.324 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.3 OUTLIER -40.88 -39.83 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 72.21 109.31 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.421 ' HG2' ' CD2' ' A' ' 136' ' ' LEU . 20.3 mtp -66.62 -45.63 78.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 74.25 110.976 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 187' ' ' ILE . 0.3 OUTLIER -46.35 -47.07 18.63 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.24 109.262 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.489 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 35.0 t-20 -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 73.43 109.282 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' CD2' ' A' ' 193' ' ' TYR . . . 119.85 54.1 0.26 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.516 1.135 . . . . 70.24 110.976 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.572 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 91.1 m-85 -158.67 144.73 16.87 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 73.44 111.026 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.464 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 46.8 t0 -110.72 125.91 53.99 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.563 1.165 . . . . 72.33 109.275 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.461 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 29.6 p -103.17 -179.31 3.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 70.24 108.29 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -127.33 176.72 7.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.446 1.092 . . . . 75.55 110.336 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.421 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 21.3 mmtt -108.57 162.68 13.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 73.43 109.286 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -155.11 117.62 4.26 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.55 1.156 . . . . 75.42 110.34 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.56 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -109.68 124.61 51.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 72.32 110.971 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.468 ' CG2' HG22 ' A' ' 266' ' ' VAL . 8.6 p -115.57 150.8 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 72.52 109.28 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.501 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.7 m-85 -122.13 162.96 20.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 74.51 110.982 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 115.59 -179.43 18.05 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.556 1.16 . . . . 74.13 110.98 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 263' ' ' SER . 58.1 t-20 -68.73 109.35 3.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 0.756 . . . . 75.24 109.302 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 218' ' ' HIS . 5.9 mt -113.92 93.42 4.36 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.474 1.109 . . . . 74.0 109.305 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 256' ' ' CYS . 4.5 mttt -93.25 160.3 14.89 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.535 1.147 . . . . 72.24 109.26 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -165.78 162.89 18.82 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.441 1.088 . . . . 75.31 109.269 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.97 136.92 48.97 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.44 110.02 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.7 p -102.15 -37.06 8.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.508 1.13 . . . . 74.22 110.407 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.6 -26.27 2.79 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.519 1.137 . . . . 75.42 110.994 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.9 t -117.93 -9.01 10.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.538 0.787 . . . . 72.23 110.337 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 1.8 p -176.66 153.42 1.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.147 . . . . 64.04 108.312 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.17 148.37 25.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.532 1.145 . . . . 72.51 108.33 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.07 161.58 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.525 1.141 . . . . 74.12 109.304 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -146.43 120.48 9.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 63.14 109.291 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.45 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.5 m0 -130.41 132.84 45.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.001 -1.111 . . . . 75.32 108.001 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 54.8 p -79.54 0.61 29.07 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.111 . . . . 72.34 110.014 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 9.1 p90 -170.85 127.82 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 63.44 111.014 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 48.3 t60 -116.47 167.88 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 75.24 109.622 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 2.4 p -143.86 145.16 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 73.45 109.309 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.598 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -146.38 -169.09 3.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 61.14 109.285 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 13.0 pt -114.38 120.8 65.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 74.41 109.311 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 15.8 tp -85.33 108.92 18.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.113 . . . . 74.32 109.314 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.468 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.8 OUTLIER -104.9 149.35 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 72.35 109.292 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 40.2 m -118.26 122.69 43.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 72.21 110.001 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CD2' HG22 ' A' ' 143' ' ' VAL . 33.0 p90 -137.37 145.01 42.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 74.14 111.001 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.428 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.1 mmtp -70.72 132.89 46.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 74.51 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.35 -159.86 0.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.133 . . . . 73.24 109.294 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.83 -0.4 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.549 1.156 . . . . 73.45 109.305 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.78 -7.85 12.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 75.31 110.025 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.96 37.86 8.24 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.509 1.131 . . . . 72.23 111.0 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.76 137.46 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.452 0.736 . . . . 71.43 109.261 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.428 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.6 m -71.59 102.47 2.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.107 . . . . 64.53 110.355 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.4 ' HB2' ' OD1' ' A' ' 227' ' ' ASN . 5.7 mm-40 -102.04 -172.49 2.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.446 1.091 . . . . 73.51 110.276 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -125.66 145.03 50.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.112 . . . . 72.41 109.314 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.562 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 5.8 tpt180 -143.02 159.48 42.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.34 110.354 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.488 HG13 ' CG ' ' A' ' 252' ' ' TRP . 15.0 mm -113.42 117.02 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.118 . . . . 72.15 109.329 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 150' ' ' PHE . 3.2 mm -106.48 46.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 74.43 109.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -104.6 106.12 53.2 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 64.23 109.291 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -1.13 10.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.533 1.807 . . . . 74.14 110.995 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 3.1 t -73.21 -4.14 31.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 75.24 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 5.6 mt -138.15 -49.12 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 74.14 109.334 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.647 ' CZ ' ' CB ' ' A' ' 255' ' ' ALA . 83.0 m-85 -113.26 99.35 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.548 1.155 . . . . 75.32 111.014 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.5 m -90.63 -5.32 56.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 75.25 109.965 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 12.2 t -83.91 -44.78 13.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.535 1.147 . . . . 53.52 110.021 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.09 -177.43 46.82 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.518 1.136 . . . . 62.45 110.985 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.46 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.98 165.08 32.08 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.478 1.778 . . . . 72.14 111.018 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.573 HG12 ' CD2' ' A' ' 242' ' ' PHE . 4.0 m -148.43 167.8 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.456 1.098 . . . . 71.24 109.32 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.442 ' C ' ' N ' ' A' ' 250' ' ' THR . 66.8 p -70.23 137.78 51.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 75.34 110.4 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -41.23 -29.11 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.24 109.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.442 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -74.7 -63.8 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 74.23 110.362 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.36 -25.78 6.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 63.43 109.359 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.598 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.2 t90 -65.79 -65.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 74.42 108.034 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -42.04 -30.99 0.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 75.52 110.303 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.456 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 2.5 m-80 -67.4 -49.15 65.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 74.35 109.268 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.647 ' CB ' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.48 -19.36 14.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 70.13 109.278 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 205' ' ' LYS . 6.9 m -90.26 -35.75 15.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 75.34 108.331 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.474 ' CA ' ' HB2' ' A' ' 264' ' ' ALA . 3.4 m -93.53 21.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 74.13 109.284 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -50.48 106.44 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 72.21 109.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 262' ' ' GLY . 14.7 p -73.31 -3.34 26.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 75.34 110.428 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.72 -30.51 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.531 1.145 . . . . 73.5 109.963 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.5 t -88.71 -36.96 15.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 63.31 108.309 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.87 -128.82 1.78 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.512 1.133 . . . . 71.21 110.972 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.89 145.69 42.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 0.775 . . . . 71.15 109.986 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.474 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -167.96 147.61 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 72.3 109.308 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.3 t -172.92 153.61 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 73.23 110.056 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.468 HG22 ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.42 118.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 74.51 109.324 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.0 t -73.78 -43.82 57.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.556 1.16 . . . . 74.32 110.02 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 11.5 p -164.94 -175.15 3.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 74.23 109.994 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -164.77 157.14 16.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 75.25 110.998 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.1 160.49 39.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 74.55 109.27 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -118.41 160.65 21.32 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.093 . . . . 73.45 109.272 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.452 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 2.1 p -153.47 -178.5 7.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 75.25 110.399 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.431 ' CB ' HG22 ' A' ' 276' ' ' VAL . . . -64.75 163.83 13.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 75.41 109.326 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.484 1.115 . . . . 62.12 110.991 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.449 ' OD1' ' NH2' ' A' ' 185' ' ' ARG . 0.2 OUTLIER -85.99 -35.71 20.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 0.778 . . . . 74.32 109.286 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.431 HG22 ' CB ' ' A' ' 273' ' ' ALA . 92.8 t -43.81 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 73.23 109.291 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 6.0 t80 -59.21 -49.83 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 62.51 110.968 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 56.2 t80 -147.9 158.15 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 61.42 110.955 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.56 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 73.0 ttt-85 -123.95 147.47 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 73.24 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.55 154.02 47.8 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.115 . . . . 74.42 109.958 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.21 9.19 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.468 1.772 . . . . 74.33 110.997 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 20.6 t -105.64 10.22 32.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 1.118 . . . . 75.12 109.991 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 75.38 39.55 0.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 73.15 109.278 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.4 t -119.83 120.28 36.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 64.22 110.002 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -101.86 166.65 10.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 73.42 111.03 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -123.34 177.36 5.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 74.32 109.323 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 52.5 m-85 -158.61 115.78 2.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.125 . . . . 73.12 110.984 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.423 ' OD1' ' CB ' ' A' ' 320' ' ' PHE . 3.8 m-20 -115.26 99.27 7.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 74.23 109.329 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . 0.508 ' H ' ' ND2' ' A' ' 289' ' ' ASN . 0.9 OUTLIER -84.94 -48.54 9.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 75.12 109.34 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.462 ' CB ' HG12 ' A' ' 292' ' ' ILE . 27.0 m-20 -90.33 9.53 28.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 73.42 109.354 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.694 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.32 45.25 1.78 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 75.21 109.299 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.462 HG12 ' CB ' ' A' ' 290' ' ' ASN . 47.6 mm -74.47 -23.79 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 72.3 109.317 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.495 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.7 t-20 -94.5 -29.08 15.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 63.41 109.299 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 7.8 m -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 70.3 110.419 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 39.8 m-20 -48.43 -24.77 1.36 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 73.25 109.288 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 45.7 t -80.8 -47.9 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 65.31 108.297 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.4 t -52.86 -45.47 50.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.521 1.138 . . . . 74.35 109.3 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.4 mt -65.27 -62.9 1.27 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 72.22 109.331 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -24.67 0.85 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.4 110.388 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -73.3 -41.75 63.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 73.42 109.298 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.57 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 3.7 m-30 -100.87 36.77 1.87 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 74.21 111.033 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.72 -44.75 73.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 75.24 110.009 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.415 HD21 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -92.8 -12.09 32.05 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 71.41 109.296 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.527 HD13 ' CD1' ' A' ' 301' ' ' PHE . 13.7 mt -68.67 136.69 53.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 74.43 109.33 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 95.2 p -149.39 156.05 41.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.489 1.118 . . . . 65.54 110.014 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.32 -164.68 54.35 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.475 1.109 . . . . 71.44 111.01 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 10.56 22.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.272 -1.01 . . . . 71.33 108.272 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 13.9 p -131.8 149.45 73.44 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.565 1.166 . . . . 74.43 110.022 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.5 Cg_endo -74.92 147.1 88.48 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 75.13 111.047 -0.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.9 p -133.51 135.75 25.71 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.551 1.157 . . . . 64.02 110.005 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.6 Cg_endo -74.94 -173.73 12.81 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 120.98 -2.508 . . . . 71.2 111.032 -0.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.58 154.32 35.39 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 73.45 109.291 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.455 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.99 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.512 1.796 . . . . 73.4 111.011 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -87.92 135.98 33.17 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 71.51 109.263 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.62 23.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.53 109.303 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 17.0 t -54.61 -32.74 59.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.418 1.074 . . . . 62.25 110.039 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.2 m -48.76 -25.37 1.8 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.35 110.002 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.44 170.4 15.99 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 72.35 108.299 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 174.47 110.47 0.25 Allowed Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.478 1.111 . . . . 74.14 111.03 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.558 ' CD1' ' C ' ' A' ' 320' ' ' PHE . 1.3 p90 . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.516 0.774 . . . . 65.24 110.971 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 194' ' ' ASP . 8.6 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.286 -0.635 . . . . 73.11 109.286 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.548 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -116.03 104.37 11.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 75.22 109.314 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.496 ' CB ' ' OD2' ' A' ' 194' ' ' ASP . 0.6 OUTLIER -80.39 3.91 19.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 73.11 109.972 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.415 HG11 ' N ' ' A' ' 140' ' ' ILE . 2.3 t -142.93 147.57 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.13 109.308 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.475 ' CD1' HD11 ' A' ' 149' ' ' LEU . 1.2 mt -98.99 142.55 24.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 72.44 109.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.0 -32.74 5.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.528 1.804 . . . . 73.44 111.025 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.416 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.21 151.47 19.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 74.12 109.295 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -48.51 -35.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.103 . . . . 75.12 109.28 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.56 -46.75 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 73.3 109.303 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.48 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.9 m -72.25 -34.77 68.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.13 . . . . 63.33 110.425 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -59.47 -56.76 17.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.428 1.08 . . . . 74.54 109.254 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.52 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.2 m-80 -52.54 -31.85 37.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 62.5 109.32 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.18 -56.71 6.82 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.473 1.108 . . . . 62.22 109.994 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.475 HD11 ' CD1' ' A' ' 140' ' ' ILE . 60.7 mt -42.97 -42.62 3.83 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.472 1.107 . . . . 75.04 109.307 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -71.55 -45.1 63.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 74.55 111.037 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.87 -38.15 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 75.24 109.324 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 155' ' ' ASN . 64.6 mt-30 -75.21 -55.31 5.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 73.21 110.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 188' ' ' LEU . 12.4 mt -49.72 -27.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.115 . . . . 74.11 109.306 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -36.07 61.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 73.33 109.289 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -60.75 -15.38 28.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 75.12 109.335 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.403 ' O ' ' CB ' ' A' ' 163' ' ' ALA . 8.9 mm100 -83.09 -21.74 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 74.23 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.402 ' OG ' ' CG2' ' A' ' 160' ' ' THR . 29.8 p -39.09 140.69 0.37 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 73.25 109.99 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.73 -9.76 52.5 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 74.04 108.274 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -87.87 18.88 36.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.511 1.132 . . . . 60.13 110.999 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.402 ' CG2' ' OG ' ' A' ' 157' ' ' SER . 59.2 p -136.27 160.74 37.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 74.02 110.398 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 p -93.76 -21.55 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.48 1.112 . . . . 72.35 109.991 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.6 m -82.57 -3.65 56.39 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 72.22 110.416 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 156' ' ' GLN . . . -69.38 138.37 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 74.1 109.303 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.3 t -59.72 -160.14 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.097 . . . . 52.11 109.993 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.446 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -156.45 128.0 3.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 72.21 109.993 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.93 140.7 68.78 Favored 'Cis proline' 0 C--N 1.36 1.132 0 C-N-CA 121.011 -2.495 . . . . 74.43 111.015 -0.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 23.2 p -72.75 177.44 4.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 64.33 108.285 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 2.1 mp -94.51 126.84 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 70.3 109.309 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.4 p -77.56 90.06 3.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 74.2 110.389 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -88.59 -30.2 19.43 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.571 1.169 . . . . 71.42 110.988 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -84.03 9.29 12.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.51 1.131 . . . . 74.12 110.297 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.552 ' CE1' HG22 ' A' ' 174' ' ' VAL . 38.8 t80 -128.56 66.9 75.5 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.494 1.121 . . . . 74.42 111.004 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.448 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -74.97 109.15 2.87 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.463 1.77 . . . . 71.23 110.98 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.552 HG22 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.66 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 75.22 109.271 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -160.52 129.2 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.526 1.141 . . . . 74.25 109.273 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 129.07 52.29 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.505 1.128 . . . . 62.11 111.011 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.4 m -89.14 -18.06 27.93 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.273 -1.01 . . . . 74.42 108.273 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.567 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 34.2 p90 -76.59 -22.62 53.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.527 1.142 . . . . 75.35 110.955 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.17 -68.35 0.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 64.34 109.268 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' A' ' 183' ' ' LYS . 7.9 ptm180 -46.15 -48.33 17.44 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.498 1.124 . . . . 75.51 110.296 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -40.4 -59.0 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.13 . . . . 61.12 109.327 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.589 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.1 t60 -48.96 -39.69 27.46 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.528 1.142 . . . . 75.42 109.604 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.656 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.6 mmmt -64.61 -61.47 2.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 73.22 109.299 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 15.0 mtm -38.9 -38.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.533 1.146 . . . . 74.23 110.987 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.36 -49.35 78.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 74.15 110.339 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.656 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -54.75 -34.05 62.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.122 . . . . 64.02 110.271 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.469 HD13 ' CG ' ' A' ' 186' ' ' GLN . 31.1 mm -70.3 -43.77 78.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.155 . . . . 75.02 109.341 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.479 ' CD1' ' CD1' ' A' ' 153' ' ' ILE . 0.4 OUTLIER -60.68 -40.77 93.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 73.12 109.28 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.419 ' HG2' ' CD2' ' A' ' 136' ' ' LEU . 52.1 mtp -61.57 -36.04 79.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 73.33 110.994 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.67 -53.63 56.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 74.55 109.293 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 23.6 t30 -62.72 -27.56 69.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 71.22 109.286 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 109.04 53.58 0.61 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.508 1.13 . . . . 73.34 110.988 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.548 ' CD2' ' HB3' ' A' ' 137' ' ' ALA . 92.9 m-85 -156.89 140.74 16.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.45 0.735 . . . . 75.22 111.015 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.496 ' OD2' ' CB ' ' A' ' 138' ' ' SER . 0.0 OUTLIER -106.12 124.86 50.24 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 63.22 109.319 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.474 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 17.1 p -95.92 168.46 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 64.13 108.3 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -117.06 170.91 8.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 62.51 110.295 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.503 ' NZ ' ' N ' ' A' ' 182' ' ' HIS . 17.5 mmtt -100.58 169.34 9.12 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 74.01 109.287 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -167.28 121.85 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.442 1.089 . . . . 75.21 110.27 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -115.9 140.58 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 72.24 111.013 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.495 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 14.0 p -131.71 149.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.0 109.346 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 13.8 m-85 -122.72 156.37 34.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.452 1.095 . . . . 74.01 110.977 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.39 -175.83 16.44 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.508 1.13 . . . . 71.03 111.025 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 263' ' ' SER . 55.5 t-20 -72.63 110.14 6.78 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.782 . . . . 72.42 109.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.461 HD13 ' CB ' ' A' ' 218' ' ' HIS . 5.2 mt -113.19 95.48 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 75.44 109.263 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 256' ' ' CYS . 6.8 mtpt -92.31 165.33 13.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 74.45 109.326 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -169.23 119.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 74.54 109.26 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 117.56 30.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.157 . . . . 71.4 110.019 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.7 p -88.63 -3.66 58.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 62.01 110.404 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.76 -24.75 16.08 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.541 1.151 . . . . 75.43 111.024 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.435 ' O ' ' CG2' ' A' ' 210' ' ' THR . 1.1 m -123.38 2.52 9.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.499 0.764 . . . . 75.4 110.427 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.6 156.26 1.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 74.41 108.291 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.71 128.35 55.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 64.1 108.318 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.87 155.26 9.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.104 . . . . 74.53 109.293 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -147.1 130.05 16.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 53.33 109.315 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.3 135.07 42.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.32 108.015 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.4 m -80.3 3.52 20.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.147 . . . . 73.3 109.991 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.458 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.0 p90 -177.79 130.41 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.459 1.099 . . . . 73.34 111.023 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -120.17 168.03 11.64 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 73.14 109.609 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.506 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 1.5 p -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.13 . . . . 73.11 109.284 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.683 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.0 -165.8 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 74.22 109.291 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 15.9 pt -117.24 123.79 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 72.12 109.273 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.29 108.85 18.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 75.44 109.285 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.8 OUTLIER -102.2 145.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 72.34 109.323 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.3 m -117.75 117.78 30.26 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.467 1.105 . . . . 71.53 110.031 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.561 ' CD2' HG21 ' A' ' 143' ' ' VAL . 29.9 p90 -133.9 144.46 48.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 74.25 110.969 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.1 mmtp -68.87 135.19 50.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 74.34 109.333 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -76.08 -160.18 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 73.31 109.315 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.38 50.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 65.12 109.322 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 -7.49 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 75.51 109.959 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.01 8.23 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.5 1.125 . . . . 44.53 111.031 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.34 138.23 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.442 0.731 . . . . 74.54 109.347 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.436 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 20.4 m -71.93 102.55 2.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.498 1.124 . . . . 73.14 110.394 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.4 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 5.4 mm-40 -101.27 -174.21 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.567 1.167 . . . . 62.15 110.302 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -127.19 144.82 50.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 75.32 109.313 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.462 ' HB3' ' CG2' ' A' ' 223' ' ' VAL . 0.0 OUTLIER -146.7 163.88 34.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 73.44 110.307 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.417 HG13 ' CB ' ' A' ' 252' ' ' TRP . 15.3 mm -117.96 119.11 60.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 72.42 109.328 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -103.42 45.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.488 1.118 . . . . 72.44 109.317 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.41 109.44 61.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 54.04 109.309 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -20.42 16.91 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.448 1.762 . . . . 65.32 111.011 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.439 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.9 t -51.32 -21.72 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.526 1.141 . . . . 73.33 110.009 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 256' ' ' CYS . 7.7 mt -117.97 -57.85 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 73.0 109.272 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.569 ' CD1' HG12 ' A' ' 247' ' ' VAL . 80.7 m-85 -107.65 99.78 9.24 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.146 . . . . 74.35 110.972 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.1 m -86.47 -6.5 58.89 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.101 . . . . 73.23 109.974 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -82.93 -44.45 15.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 75.35 110.005 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.28 -173.96 43.26 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.509 1.131 . . . . 64.34 111.009 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.427 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.5 Cg_endo -74.9 165.42 31.43 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.453 1.765 . . . . 74.05 111.011 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 242' ' ' PHE . 4.8 m -147.23 159.26 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 75.25 109.309 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.432 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.5 p -61.17 139.38 58.13 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 73.11 110.413 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -41.63 -29.81 0.19 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 71.4 109.294 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 248' ' ' THR . 12.6 m -77.26 -61.41 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.118 . . . . 74.13 110.415 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.74 -24.36 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 63.41 109.25 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.683 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 9.7 t90 -66.33 -64.5 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 74.4 108.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.575 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.2 OUTLIER -43.77 -34.8 1.65 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 73.55 110.278 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.451 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.1 m-80 -64.56 -49.4 71.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 74.33 109.347 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.565 ' HB1' ' CE2' ' A' ' 242' ' ' PHE . . . -56.22 -19.08 12.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.45 1.094 . . . . 72.53 109.299 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 205' ' ' LYS . 10.0 m -92.06 -31.91 15.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 72.03 108.28 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.471 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 2.5 m -96.9 21.84 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.555 1.16 . . . . 64.52 109.315 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -49.2 104.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.479 1.112 . . . . 75.22 109.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 262' ' ' GLY . 12.7 p -72.54 -3.89 27.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.138 . . . . 72.13 110.397 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 41.3 t -48.1 -25.15 1.33 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 73.33 110.026 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 5.9 m -90.94 -34.45 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 73.44 108.279 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.01 -118.41 0.82 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.481 1.113 . . . . 51.21 110.979 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.45 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -83.31 142.73 30.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 0.778 . . . . 63.41 110.02 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.471 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -170.97 143.82 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.554 1.159 . . . . 71.32 109.296 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.2 t -172.77 159.24 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.55 1.156 . . . . 75.4 109.983 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.495 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 4.0 p -101.91 118.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 75.45 109.326 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.1 t -77.28 -44.0 31.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 72.34 109.999 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.1 m -149.25 -175.33 4.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 72.3 109.984 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -174.28 152.89 1.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 74.4 110.958 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -159.73 163.59 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.455 1.097 . . . . 62.35 109.312 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.84 160.5 20.74 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 74.15 109.314 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.06 -178.7 6.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 72.33 110.412 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -86.01 158.2 19.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.24 109.302 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.83 93.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.55 1.156 . . . . 71.32 110.987 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -46.28 77.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 0.773 . . . . 73.13 109.312 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.8 t -43.48 127.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 74.2 109.293 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.555 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 3.5 t80 -93.33 -40.7 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 70.42 110.988 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.553 ' CD1' ' C ' ' A' ' 278' ' ' TYR . 0.3 OUTLIER -160.33 115.46 2.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 74.54 111.025 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.419 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 55.1 ttt-85 -94.96 137.87 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.42 110.281 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 157.62 34.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 62.0 109.956 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 0.02 9.41 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.459 1.768 . . . . 61.51 111.033 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 10.2 t -98.42 7.62 45.94 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.093 . . . . 63.32 110.016 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 76.02 34.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 64.34 109.25 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.7 t -117.41 120.73 39.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.565 1.165 . . . . 71.1 110.0 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.95 164.33 12.24 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 73.32 111.009 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.2 mm? -125.32 176.66 6.63 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 75.11 109.288 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 91.2 m-85 -162.62 124.94 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 75.42 110.947 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 294' ' ' THR . 2.0 m-20 -114.91 99.01 7.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 55.13 109.304 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -79.11 -54.79 5.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 74.22 109.332 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.461 ' CB ' HG12 ' A' ' 292' ' ' ILE . 9.5 m-20 -95.1 19.2 10.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 71.04 109.297 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.589 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.5 mm? 40.29 39.38 0.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 65.51 109.324 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 50.2 mm -68.63 -31.94 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 74.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.555 ' HB3' ' CE2' ' A' ' 277' ' ' TYR . 0.1 OUTLIER -88.93 -29.1 19.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.555 1.159 . . . . 72.1 109.302 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.453 ' N ' ' OD1' ' A' ' 288' ' ' ASP . 4.9 m -81.52 -67.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 72.13 110.412 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -45.52 -31.85 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 74.2 109.306 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.85 -55.85 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 65.53 108.288 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.1 t -40.83 -49.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.5 1.125 . . . . 74.32 109.267 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.2 mt -67.76 -57.71 5.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.583 1.177 . . . . 73.24 109.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -44.74 -27.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 75.31 110.382 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -72.99 -44.7 60.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.541 1.151 . . . . 73.3 109.355 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.54 ' CE1' ' HD2' ' A' ' 313' ' ' PRO . 1.9 m-30 -97.65 21.97 9.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.21 111.031 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.0 t -58.27 -57.95 10.61 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.42 109.968 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.463 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -76.36 -15.54 59.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.117 . . . . 65.14 109.254 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.448 ' HB2' ' CA ' ' A' ' 301' ' ' PHE . 17.9 mt -66.38 148.99 51.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 74.13 109.292 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.7 p -168.91 127.2 1.03 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 72.43 109.964 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.28 -163.66 14.22 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.514 1.134 . . . . 72.24 111.006 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.62 15.62 12.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.341 -0.985 . . . . 74.13 108.341 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.487 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 84.4 p -139.8 148.27 54.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 74.45 110.033 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.5 Cg_endo -74.95 147.19 88.68 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 121.057 -2.476 . . . . 75.11 111.02 -0.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 6.4 p -129.89 135.28 27.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 74.52 109.99 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.98 -174.49 14.19 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.994 -2.503 . . . . 74.13 110.987 -0.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.2 156.02 23.02 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 54.11 109.317 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.54 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.512 1.796 . . . . 75.32 111.044 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.4 136.4 33.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.23 109.29 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.22 22.92 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 74.24 109.316 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 14.1 t -69.31 -33.27 72.91 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 74.33 109.975 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.8 t -47.55 -24.49 0.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.497 1.123 . . . . 71.14 110.023 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.408 ' HB2' ' ND2' ' A' ' 293' ' ' ASN . 1.8 m -76.19 -175.66 3.24 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 71.01 108.279 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 161.49 119.75 0.52 Allowed Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.496 1.123 . . . . 54.33 111.023 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 320' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 O-C-N 124.508 0.769 . . . . 75.25 110.989 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 7.6 tp . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.324 -0.621 . . . . 73.34 109.324 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.558 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -104.92 107.69 18.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.458 1.099 . . . . 74.31 109.319 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 t -84.81 9.69 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 73.43 109.996 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -150.25 145.6 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.544 1.152 . . . . 74.25 109.278 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 149' ' ' LEU . 1.2 mt -97.25 142.59 24.77 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 75.45 109.309 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.95 -32.63 5.3 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.497 1.788 . . . . 74.32 111.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.19 151.26 19.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.142 . . . . 63.52 109.318 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.56 HG22 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -48.11 -35.73 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.531 1.145 . . . . 74.11 109.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.33 -47.3 3.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 73.3 109.273 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.468 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.73 -35.35 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.153 . . . . 75.42 110.403 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.521 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.7 OUTLIER -58.72 -56.97 15.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 74.22 109.32 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.516 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.7 m-80 -52.49 -31.7 36.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 73.4 109.348 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.35 -54.05 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 75.54 109.946 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.464 HD22 ' CB ' ' A' ' 191' ' ' ASN . 54.0 mt -44.15 -40.67 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.537 1.148 . . . . 75.1 109.297 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.49 -44.34 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.57 1.169 . . . . 70.3 110.996 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -48.03 -37.25 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 75.01 109.296 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.492 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 61.4 mt-30 -75.67 -55.87 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 65.43 110.294 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.472 HG21 ' CG ' ' A' ' 184' ' ' MET . 12.1 mt -51.13 -23.75 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 75.41 109.367 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.4 ' O ' ' OG ' ' A' ' 157' ' ' SER . 0.1 OUTLIER -79.17 -34.03 43.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.488 1.118 . . . . 71.21 109.305 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.1 t-20 -61.75 -17.63 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 70.01 109.335 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.449 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 4.5 mm100 -84.09 -16.94 41.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 75.31 110.292 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 154' ' ' LYS . 20.6 p -37.94 133.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.21 109.958 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -64.32 125.12 23.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 70.23 108.288 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.85 -18.06 8.62 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.495 1.122 . . . . 55.04 110.96 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.445 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 63.5 p -80.81 161.7 24.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.575 0.809 . . . . 72.2 110.422 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 51.0 p -93.55 -0.8 56.12 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.44 109.998 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.5 m -117.56 7.33 12.63 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 72.01 110.41 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.445 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -82.7 138.93 33.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.526 1.141 . . . . 72.14 109.278 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -162.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 75.23 109.999 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.43 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 41.9 t -156.22 127.47 3.67 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.23 109.982 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.01 139.38 61.44 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.991 -2.504 . . . . 73.43 111.033 -0.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 p -72.73 179.11 3.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 70.5 108.299 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.448 ' CG2' ' HG2' ' A' ' 180' ' ' ARG . 2.2 mp -88.9 124.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 65.22 109.305 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 65.5 p -89.21 83.2 6.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 74.14 110.356 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -88.47 -14.78 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.142 . . . . 75.34 110.999 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.42 -2.21 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.533 1.145 . . . . 75.13 110.302 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.546 ' CE2' HD12 ' A' ' 304' ' ' LEU . 27.1 t80 -127.98 71.15 78.63 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 63.23 110.996 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.01 114.07 3.94 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.484 1.781 . . . . 74.53 111.005 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.54 HG21 ' CE1' ' A' ' 172' ' ' TYR . 26.2 t -152.59 -75.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.486 1.116 . . . . 71.32 109.246 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -156.51 115.79 3.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 65.21 109.301 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.63 55.84 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.525 1.14 . . . . 71.22 111.043 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 66.8 m -96.68 -0.17 48.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.308 -0.997 . . . . 65.24 108.308 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.6 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 12.8 p90 -85.89 -32.65 21.54 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 73.41 111.017 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.6 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -70.93 -49.59 43.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 73.22 109.336 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.448 ' HG2' ' CG2' ' A' ' 168' ' ' ILE . 6.5 mtp85 -57.69 -47.81 81.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 62.03 110.261 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.25 -51.04 8.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.449 1.093 . . . . 71.21 109.329 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.57 ' CD2' HD13 ' A' ' 291' ' ' LEU . 1.6 t60 -56.12 -37.47 69.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.506 1.129 . . . . 73.5 109.646 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.481 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 27.8 mmmt -63.85 -64.33 0.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.564 1.165 . . . . 75.51 109.271 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.472 ' CG ' HG21 ' A' ' 153' ' ' ILE . 9.4 mtm -38.93 -30.24 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 75.02 111.005 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -66.32 -51.02 61.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 73.31 110.289 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.481 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.7 OUTLIER -52.52 -32.32 39.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 73.31 110.282 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.449 ' CD1' ' HG3' ' A' ' 156' ' ' GLN . 11.6 mm -80.97 -34.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 72.52 109.309 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -63.33 -44.6 94.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.54 109.298 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.439 ' O ' ' N ' ' A' ' 192' ' ' GLY . 8.5 mtp -60.52 -41.55 94.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 64.5 111.02 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -46.22 -49.53 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 74.11 109.312 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.492 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 24.5 t-20 -68.05 -27.99 66.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 75.12 109.28 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 105.75 56.66 0.67 Allowed Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.512 1.133 . . . . 64.32 110.96 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.558 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 82.0 m-85 -157.52 142.38 16.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 0.776 . . . . 75.33 111.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.468 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 1.2 t0 -110.02 124.77 52.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.143 . . . . 71.51 109.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.468 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 17.0 p -100.08 171.17 7.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.444 1.09 . . . . 73.13 108.296 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.42 170.23 8.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.086 . . . . 73.4 110.299 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -96.71 159.66 14.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 75.54 109.32 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -151.56 117.47 5.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 73.35 110.298 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.569 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 5.8 m-85 -116.39 128.75 55.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.52 1.137 . . . . 73.31 110.964 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.465 ' CG2' HG22 ' A' ' 266' ' ' VAL . 7.6 p -122.74 149.96 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 70.35 109.311 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 10.0 m-85 -122.88 164.21 18.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 1.15 . . . . 73.13 110.99 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.46 -172.9 14.44 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.516 1.135 . . . . 74.23 111.009 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 263' ' ' SER . 52.4 t-20 -74.12 107.67 6.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 0.786 . . . . 75.32 109.262 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.465 HD12 ' CB ' ' A' ' 218' ' ' HIS . 4.5 mt -111.54 96.26 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 75.1 109.334 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.7 mtpp -90.85 -179.88 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 73.44 109.328 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 258' ' ' ASN . . . -179.46 149.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 1.152 . . . . 74.42 109.321 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.05 133.24 45.52 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.49 1.119 . . . . 75.53 109.933 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.4 p -113.54 -5.61 13.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.478 1.111 . . . . 73.13 110.405 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.56 -21.69 31.32 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.482 1.114 . . . . 64.41 111.039 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 t -113.05 -23.47 10.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 0.751 . . . . 75.41 110.371 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 8.6 p -166.71 148.16 6.21 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 75.14 108.291 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 4.4 t -98.17 162.47 13.18 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 72.32 108.277 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.456 HG21 ' CB ' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -138.45 143.43 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 75.21 109.3 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.413 ' HB1' ' NZ ' ' A' ' 205' ' ' LYS . . . -137.88 132.58 32.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 71.14 109.271 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -139.99 136.34 33.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.23 107.993 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.9 t -80.38 -3.65 50.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.499 1.124 . . . . 65.51 110.01 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.4 p90 -169.99 127.45 0.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 72.32 111.03 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CE1' ' O ' ' A' ' 219' ' ' VAL . 28.6 t60 -115.62 167.23 11.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 73.24 109.583 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.542 ' HB ' ' CE1' ' A' ' 199' ' ' PHE . 2.3 p -144.23 140.42 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 71.54 109.313 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.658 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.73 -167.65 2.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 73.3 109.289 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.426 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 21.3 pt -115.17 119.33 61.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.545 1.153 . . . . 73.21 109.267 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 14.7 tp -84.92 108.82 17.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 74.43 109.301 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.521 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -103.02 146.57 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 71.33 109.345 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.9 m -117.17 119.36 34.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 72.14 110.044 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.56 ' CD2' HG22 ' A' ' 143' ' ' VAL . 32.4 p90 -134.63 145.07 48.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 71.12 110.969 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.421 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.0 mmtp -69.86 134.57 48.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 72.41 109.259 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.5 -159.77 0.11 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 71.04 109.334 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.65 52.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.458 1.099 . . . . 64.41 109.261 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.7 m -114.82 -7.88 12.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.123 . . . . 71.35 109.98 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.43 37.64 8.06 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.517 1.136 . . . . 63.31 111.036 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.424 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.35 137.38 44.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.468 0.746 . . . . 65.42 109.298 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.421 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.3 m -71.58 102.73 2.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 62.34 110.388 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.413 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 4.2 mm-40 -101.44 -172.62 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 71.45 110.266 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt -126.86 145.22 50.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.1 . . . . 64.23 109.331 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.486 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 0.0 OUTLIER -145.53 162.19 38.0 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 75.25 110.286 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.488 HD11 ' CE3' ' A' ' 252' ' ' TRP . 16.6 mm -115.88 119.34 61.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 71.55 109.311 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.6 mm -105.64 45.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.22 109.248 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.19 108.78 58.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.518 1.136 . . . . 71.01 109.329 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -19.26 18.02 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.473 1.775 . . . . 75.55 110.943 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.433 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.4 OUTLIER -53.06 -20.86 3.95 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 64.12 109.994 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.421 ' CD1' ' SG ' ' A' ' 256' ' ' CYS . 7.3 mt -120.26 -57.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 72.53 109.271 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.57 ' CD1' HG11 ' A' ' 247' ' ' VAL . 96.7 m-85 -110.06 99.62 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 75.54 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -12.63 42.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.23 110.034 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -74.51 -44.83 49.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 1.101 . . . . 73.44 110.041 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -175.88 -174.76 42.7 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.537 1.148 . . . . 75.34 110.978 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.435 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.03 166.57 28.9 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.5 1.79 . . . . 74.54 110.99 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 242' ' ' PHE . 6.0 m -148.09 161.19 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.131 . . . . 72.13 109.322 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.3 p -65.49 137.32 57.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 74.05 110.458 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.415 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 6.4 p-10 -40.03 -30.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.23 109.332 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 7.9 m -76.82 -61.92 1.81 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 75.43 110.394 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.85 -24.01 3.22 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 74.34 109.315 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.658 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 7.7 t90 -68.02 -62.86 1.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.955 -1.128 . . . . 73.22 107.955 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.578 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -48.68 -38.51 21.51 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 74.41 110.32 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.459 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.6 m-80 -58.24 -51.62 68.98 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 72.13 109.302 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . . . -59.87 -17.17 34.77 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 75.22 109.283 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 22.0 m -94.91 -25.81 16.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 63.03 108.28 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.511 ' CA ' ' HB2' ' A' ' 264' ' ' ALA . 3.0 m -106.17 24.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 73.4 109.3 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 206' ' ' ALA . 1.9 p-10 -53.0 129.19 29.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.113 . . . . 75.5 109.314 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 3.1 p -85.81 -3.86 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 74.12 110.403 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.417 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 0.9 OUTLIER -50.71 -30.72 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 63.4 109.999 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . 0.407 ' SG ' ' CE ' ' A' ' 205' ' ' LYS . 16.4 t -88.39 -29.29 20.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.468 1.105 . . . . 73.23 108.31 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 156.76 -120.77 1.01 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.454 1.096 . . . . 55.1 110.978 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -87.5 148.38 24.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 0.743 . . . . 73.02 110.047 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.511 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -169.8 147.69 3.44 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.42 109.306 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.9 m -172.84 156.25 3.37 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 71.43 109.996 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.465 HG22 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.5 118.27 44.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 74.44 109.322 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 8.8 t -74.99 -44.08 50.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.513 1.133 . . . . 63.31 110.007 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.2 m -157.06 -170.11 3.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.428 1.08 . . . . 65.14 110.012 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -170.08 157.36 6.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 73.5 110.982 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -162.26 172.05 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 1.109 . . . . 73.12 109.321 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.412 ' ND2' ' C ' ' A' ' 271' ' ' ASN . 0.7 OUTLIER -145.71 160.73 41.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 1.103 . . . . 72.04 109.288 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.513 HG21 ' CZ ' ' A' ' 285' ' ' TYR . 2.7 p -151.94 -171.92 4.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 72.43 110.387 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.461 ' CB ' HG22 ' A' ' 276' ' ' VAL . . . -68.0 154.39 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.495 1.122 . . . . 65.4 109.242 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -64.56 -46.72 89.34 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.463 1.102 . . . . 72.21 110.992 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -50.96 -38.29 49.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 0.776 . . . . 73.24 109.274 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.461 HG22 ' CB ' ' A' ' 273' ' ' ALA . 33.9 t -46.81 116.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 73.54 109.306 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 2.4 t80 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 72.12 110.999 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.573 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 63.4 t80 -154.77 162.2 41.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 74.42 111.013 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.573 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 75.2 ttt-85 -128.25 147.48 50.59 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.536 1.148 . . . . 71.32 110.254 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.33 154.75 47.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.536 1.148 . . . . 75.32 110.012 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.91 0.22 9.12 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 74.01 111.026 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 27.9 t -101.63 3.35 39.78 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 73.15 110.007 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.6 t-20 81.74 36.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.433 1.083 . . . . 73.2 109.277 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -117.65 119.29 34.52 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.47 1.106 . . . . 64.54 110.013 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 272' ' ' THR . 8.7 m-30 -99.78 160.84 14.0 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 74.33 110.967 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.546 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.9 OUTLIER -119.77 176.55 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 72.53 109.303 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 86.9 m-85 -162.56 130.22 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.531 1.144 . . . . 64.25 111.0 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.439 ' HB2' ' CD2' ' A' ' 182' ' ' HIS . 1.3 m-20 -113.52 111.88 22.64 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 75.1 109.297 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.23 -51.86 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.25 109.319 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.464 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -106.96 18.04 22.32 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 73.23 109.321 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.57 HD13 ' CD2' ' A' ' 182' ' ' HIS . 1.3 mm? 50.34 39.36 20.11 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.572 1.17 . . . . 74.03 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 20.0 mm -65.58 -30.63 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 74.5 109.27 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.541 ' HB3' ' CE2' ' A' ' 277' ' ' TYR . 1.2 t-20 -93.94 -29.75 15.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 62.13 109.334 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.453 ' CG2' HD11 ' A' ' 291' ' ' LEU . 1.3 m -76.64 -66.24 0.84 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 72.33 110.397 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -51.01 -25.92 5.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 74.54 109.297 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.41 -53.17 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.47 1.106 . . . . 72.32 108.294 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 10.6 t -49.32 -37.62 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.128 . . . . 74.43 109.315 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 65.9 mt -75.43 -59.62 2.67 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 74.53 109.316 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -51.98 -20.71 2.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 75.34 110.367 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.402 ' HE2' ' CG1' ' A' ' 315' ' ' VAL . 21.4 mmmt -72.58 -42.38 64.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 75.42 109.316 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.528 ' CD1' HD12 ' A' ' 304' ' ' LEU . 5.1 m-30 -102.44 37.82 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 75.22 110.984 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 35.6 t -68.66 -44.37 74.23 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.51 110.003 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.41 HD21 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -95.07 -12.96 25.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 71.11 109.296 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.546 HD12 ' CE2' ' A' ' 172' ' ' TYR . 13.7 mt -65.57 135.65 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 73.42 109.311 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 79.0 p -151.67 152.64 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.105 . . . . 74.41 109.983 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.87 -145.58 27.43 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.478 1.111 . . . . 63.22 111.029 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 59.8 m -109.39 15.41 23.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.341 -0.985 . . . . 74.22 108.341 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 97.8 p -132.82 148.6 70.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 74.11 110.016 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -75.08 146.45 86.59 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 120.959 -2.517 . . . . 72.25 110.992 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.49 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.4 p -128.86 134.46 26.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.498 1.124 . . . . 74.23 109.957 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.5 Cg_endo -74.96 -172.38 10.67 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.985 -2.506 . . . . 73.42 111.006 -0.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.16 153.59 24.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 72.54 109.286 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.491 1.785 . . . . 75.21 110.983 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -86.15 131.13 34.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 73.22 109.335 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.402 ' CG1' ' HE2' ' A' ' 300' ' ' LYS . 30.5 m -134.61 14.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 75.04 109.332 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 30.6 t -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 64.44 110.014 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.0 m -48.1 -24.16 1.04 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.119 . . . . 62.1 109.968 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 97.0 m -49.84 169.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.128 . . . . 74.02 108.336 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.4 ' C ' ' CG2' ' A' ' 292' ' ' ILE . . . -124.98 -174.6 14.01 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.484 1.115 . . . . 65.31 110.968 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 286' ' ' LEU . 66.8 m-85 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.502 0.766 . . . . 74.02 110.986 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.277 -0.638 . . . . 71.02 109.277 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.486 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -102.69 104.18 14.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 63.52 109.304 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -82.98 7.34 15.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.114 . . . . 55.42 109.985 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.38 142.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.485 1.116 . . . . 64.45 109.319 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.467 HD13 ' CD1' ' A' ' 149' ' ' LEU . 1.4 mt -92.73 141.76 24.82 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.44 109.32 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.02 -31.57 6.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.513 1.796 . . . . 75.14 110.973 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.51 149.63 17.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 1.11 . . . . 64.51 109.348 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.56 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -46.72 -37.19 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.138 . . . . 74.4 109.248 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.18 -50.05 2.67 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.475 1.11 . . . . 73.45 109.325 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.523 HG23 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -68.95 -37.06 78.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 62.13 110.393 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.516 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.8 OUTLIER -56.72 -57.5 12.16 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 75.54 109.287 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.49 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.1 m-80 -52.09 -29.9 23.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 73.23 109.295 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.14 -50.79 44.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 74.51 109.984 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.467 ' CD1' HD13 ' A' ' 140' ' ' ILE . 54.9 mt -48.53 -40.03 25.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 74.24 109.285 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.421 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -75.16 -42.17 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 75.23 110.991 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -48.95 -36.77 18.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 72.2 109.328 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 155' ' ' ASN . 64.2 mt-30 -75.75 -56.0 5.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 73.55 110.269 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.418 ' N ' HG22 ' A' ' 187' ' ' ILE . 13.1 mt -50.71 -26.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 74.34 109.259 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 -34.21 59.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 75.13 109.304 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.62 -15.15 36.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 70.2 109.309 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -85.75 -18.82 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 73.14 110.29 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.8 p -39.38 136.64 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 73.14 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -68.33 119.99 13.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 74.05 108.28 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 128.13 -18.74 5.83 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.436 1.085 . . . . 45.13 110.999 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.503 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 82.8 p -80.38 162.33 24.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 0.726 . . . . 72.21 110.407 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.7 m -93.26 -0.59 56.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.46 1.1 . . . . 72.24 110.001 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 162' ' ' THR . 1.3 m -118.84 6.52 11.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 62.14 110.42 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.503 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -79.83 139.27 37.25 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.121 . . . . 72.32 109.263 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -166.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 64.54 110.051 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 60.7 p -152.62 125.84 4.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 70.44 109.976 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 140.16 65.77 Favored 'Cis proline' 0 C--N 1.36 1.183 0 C-N-CA 120.976 -2.51 . . . . 71.45 110.973 0.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.6 p -72.89 -177.82 2.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.153 . . . . 73.15 108.313 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 2.3 mp -91.96 131.4 39.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 64.4 109.327 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.419 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 11.1 p -85.3 85.56 7.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 74.01 110.417 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 170' ' ' PHE . 2.2 p90 -88.56 -28.24 20.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 75.04 111.013 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.426 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -74.12 -2.52 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.495 1.122 . . . . 74.33 110.316 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.568 ' CE1' HG23 ' A' ' 174' ' ' VAL . 24.9 t80 -128.52 68.89 78.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 75.22 111.029 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.03 116.08 4.47 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 70.45 110.972 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.568 HG23 ' CE1' ' A' ' 172' ' ' TYR . 12.2 t -152.08 -74.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.542 1.152 . . . . 62.41 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.439 ' O ' ' N ' ' A' ' 177' ' ' CYS . 2.6 p-10 -123.76 -43.41 2.13 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.491 1.12 . . . . 64.32 109.336 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -47.64 92.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.496 1.123 . . . . 74.43 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 175' ' ' ASP . 57.3 m -128.17 -46.86 1.35 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.28 -1.007 . . . . 71.02 108.28 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 21.7 p90 -72.87 -40.95 65.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 72.34 111.008 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.633 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -45.66 -68.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 73.53 109.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.482 ' CZ ' ' OG ' ' A' ' 240' ' ' SER . 9.5 ptm180 -49.94 -47.66 52.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.444 1.09 . . . . 74.24 110.306 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.456 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.4 -57.38 1.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.132 . . . . 70.52 109.318 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -47.79 -44.56 28.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 74.14 109.598 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 180' ' ' ARG . 14.4 mmmm -58.52 -56.58 20.27 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.438 1.086 . . . . 72.44 109.281 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.2 mtm -40.36 -55.41 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 73.32 111.051 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -46.28 -44.09 16.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 73.44 110.316 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.76 -33.19 74.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.12 110.305 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 153' ' ' ILE . 16.2 mm -76.05 -34.41 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 62.32 109.315 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.1 OUTLIER -61.97 -45.66 92.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 73.02 109.306 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.417 ' HE2' ' NH1' ' A' ' 185' ' ' ARG . 7.3 mtt -58.63 -38.58 78.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.437 1.086 . . . . 74.35 111.029 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -44.22 63.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 72.21 109.284 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.464 ' CB ' HD22 ' A' ' 149' ' ' LEU . 41.0 t30 -74.17 -31.96 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.116 . . . . 74.53 109.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.57 58.5 0.73 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.533 1.146 . . . . 64.52 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.523 ' CZ ' HG23 ' A' ' 145' ' ' THR . 68.1 m-85 -153.67 141.42 20.03 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 0.743 . . . . 73.22 110.959 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.427 ' HA ' ' NH1' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -102.89 129.46 49.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 74.25 109.329 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.455 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 30.7 p -120.26 -178.58 3.71 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.547 1.154 . . . . 63.32 108.287 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -131.36 177.5 7.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 72.44 110.248 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.456 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 21.8 mmtt -105.25 153.13 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.139 . . . . 74.5 109.265 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.417 ' NE2' HD13 ' A' ' 222' ' ' LEU . 14.8 tt0 -132.55 117.5 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.14 110.319 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.473 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 2.6 m-85 -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 75.32 111.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.465 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.6 p -131.22 142.81 42.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.45 1.094 . . . . 72.1 109.265 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 6.3 m-85 -116.32 156.08 27.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 75.11 111.028 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.53 -173.42 15.67 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.474 1.109 . . . . 75.44 111.061 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 263' ' ' SER . 51.7 t-20 -74.4 110.97 9.12 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.454 0.738 . . . . 75.52 109.252 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.466 HD13 ' CB ' ' A' ' 218' ' ' HIS . 4.6 mt -115.13 94.39 4.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.46 1.1 . . . . 74.11 109.293 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 256' ' ' CYS . 1.9 mtpm? -92.76 175.12 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 74.23 109.306 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -176.04 131.16 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 72.44 109.349 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.9 p -112.45 107.39 16.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 74.32 109.972 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.8 p -82.26 -16.85 48.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 72.43 110.387 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 114.34 -50.86 0.75 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.464 1.102 . . . . 65.31 110.963 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.1 m -85.38 -20.06 30.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 0.745 . . . . 74.05 110.383 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 1.7 p -176.74 140.05 0.32 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 74.2 108.311 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.69 161.89 13.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 62.21 108.313 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.97 162.06 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 74.4 109.285 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.443 ' CB ' ' HE2' ' A' ' 205' ' ' LYS . . . -142.83 135.18 27.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 73.32 109.306 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.7 OUTLIER -138.25 134.32 34.25 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.142 . . . . 72.24 107.998 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 17.9 t -77.03 -0.09 23.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.519 1.137 . . . . 72.15 109.979 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.466 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 7.2 p90 -176.64 129.91 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.432 1.083 . . . . 73.44 110.986 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.495 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 63.0 t60 -115.17 168.44 9.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 63.33 109.603 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.495 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 0.8 OUTLIER -140.38 142.27 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 73.4 109.266 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.631 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.8 -167.14 2.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 73.11 109.349 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.3 pt -120.01 125.19 74.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 63.13 109.337 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.417 HD13 ' NE2' ' A' ' 198' ' ' GLN . 17.1 tp -87.58 110.82 20.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.54 109.272 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.516 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.57 145.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 74.44 109.304 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.47 119.53 35.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 74.22 110.009 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.567 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -134.64 147.1 50.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 71.31 110.979 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.8 mmtp -71.66 134.0 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 75.22 109.332 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -74.87 -160.24 0.11 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 74.44 109.309 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.37 48.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.442 1.089 . . . . 75.24 109.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.68 -7.93 12.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 72.31 109.978 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.5 37.31 8.18 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.521 1.138 . . . . 74.32 110.983 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.02 137.47 43.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 71.54 109.324 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.7 m -71.88 102.69 2.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 65.43 110.34 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.4 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.1 mm-40 -102.23 -172.68 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.551 1.157 . . . . 75.35 110.284 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -126.24 145.68 50.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.447 1.092 . . . . 74.54 109.347 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.567 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 2.6 tpt180 -145.7 161.98 38.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.133 . . . . 71.15 110.32 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.475 HG13 ' CB ' ' A' ' 252' ' ' TRP . 16.1 mm -115.47 116.09 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.1 . . . . 71.14 109.321 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -102.46 46.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.509 1.131 . . . . 75.51 109.286 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -110.28 113.66 56.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.545 1.153 . . . . 64.52 109.232 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.403 ' C ' ' N ' ' A' ' 241' ' ' LEU . 18.3 Cg_endo -75.0 -18.13 18.98 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 72.53 111.038 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.482 ' OG ' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 m -45.6 -25.98 0.54 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 74.21 109.976 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.427 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 4.1 mt -119.61 -60.46 1.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 74.35 109.302 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.564 ' CD2' HG23 ' A' ' 247' ' ' VAL . 97.6 m-85 -106.15 101.12 10.62 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 71.51 110.998 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -23.27 26.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 71.33 109.991 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 59.1 m -64.44 -47.8 77.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 65.3 110.008 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.39 -176.1 39.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.522 1.139 . . . . 52.32 111.006 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.424 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -75.03 169.78 21.87 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.475 1.776 . . . . 71.43 110.983 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.564 HG23 ' CD2' ' A' ' 242' ' ' PHE . 6.4 m -150.99 158.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 73.22 109.32 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 38.6 p -58.89 141.95 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 60.53 110.378 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -46.02 -26.1 0.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.541 1.151 . . . . 72.43 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 28.1 m -78.96 -62.43 1.7 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 74.2 110.387 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.32 -27.86 6.89 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 71.24 109.338 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.631 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 14.3 t90 -62.66 -61.43 2.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 72.53 107.971 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.555 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -46.59 -42.69 16.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 73.12 110.249 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.436 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.4 m-80 -55.94 -51.02 69.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 74.03 109.32 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -57.28 -19.46 22.02 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 72.12 109.3 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -90.0 -35.39 15.55 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 74.05 108.281 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.481 ' CA ' ' HB1' ' A' ' 264' ' ' ALA . 3.5 m -94.02 20.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.501 1.126 . . . . 72.32 109.286 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -50.45 106.06 0.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 75.02 109.277 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 262' ' ' GLY . 10.3 p -73.44 -3.2 26.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 71.02 110.375 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 t -44.02 -31.83 1.01 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 73.23 110.002 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . 0.446 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 50.6 t -87.52 -37.5 16.86 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 71.22 108.271 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 170.5 -129.2 1.76 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.497 1.123 . . . . 62.33 110.961 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -76.37 148.21 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 0.726 . . . . 75.01 109.939 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.481 ' HB1' ' CA ' ' A' ' 257' ' ' VAL . . . -169.91 146.99 3.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 70.23 109.284 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.4 t -172.77 152.88 2.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 74.41 109.97 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.465 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.6 p -98.26 114.92 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 72.33 109.285 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.3 t -72.48 -44.77 61.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.511 1.132 . . . . 71.55 110.052 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -158.59 171.37 20.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.22 110.003 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -155.62 156.01 34.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 73.43 111.018 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -166.75 163.58 16.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.438 1.086 . . . . 72.43 109.288 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.45 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.8 OUTLIER -123.58 160.66 26.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.01 109.296 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.45 HG23 ' CD ' ' A' ' 279' ' ' ARG . 21.4 p -147.5 -175.09 4.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 73.05 110.411 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -55.86 169.69 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 74.2 109.35 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -94.46 -15.96 44.98 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.487 1.117 . . . . 63.23 111.025 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -94.24 -16.95 23.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 0.775 . . . . 74.54 109.294 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.503 ' O ' ' CG1' ' A' ' 276' ' ' VAL . 0.3 OUTLIER -67.45 115.66 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.559 1.162 . . . . 65.21 109.283 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.487 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 16.6 t80 -61.66 -54.76 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 75.34 110.991 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 5.5 t80 -146.54 150.84 36.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 75.01 110.996 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.594 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 22.3 ttt-85 -121.7 142.7 49.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 71.1 110.339 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.48 157.87 34.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 62.14 109.96 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.76 8.51 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.503 1.791 . . . . 73.21 111.014 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 43.2 t -101.72 5.64 41.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.542 1.151 . . . . 70.41 109.961 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.9 t-20 81.66 22.86 0.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.562 1.164 . . . . 73.31 109.309 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.4 t -103.05 119.08 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 72.43 109.984 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.526 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 64.5 m-85 -106.12 156.5 18.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 73.21 111.007 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -113.76 176.1 5.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 75.55 109.279 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 96.5 m-85 -163.55 115.0 1.42 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.496 1.122 . . . . 75.33 110.997 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 11.4 t0 -115.6 95.87 5.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 74.53 109.279 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.55 -27.07 25.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 71.32 109.349 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.459 ' CB ' HG12 ' A' ' 292' ' ' ILE . 43.7 m-20 -99.12 5.76 46.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.13 . . . . 74.02 109.306 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.3 48.4 2.33 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 74.51 109.312 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.459 HG12 ' CB ' ' A' ' 290' ' ' ASN . 39.0 mm -78.32 -29.79 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 70.5 109.274 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.499 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.6 t-20 -94.63 -19.88 20.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.445 1.09 . . . . 73.4 109.348 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.487 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 16.3 m -87.68 -69.05 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 75.42 110.352 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 44.5 m-20 -51.39 -27.03 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 63.42 109.268 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 19.4 t -73.23 -68.8 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 73.43 108.323 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.55 HG12 ' CE2' ' A' ' 301' ' ' PHE . 56.0 t -40.25 -39.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.135 . . . . 73.33 109.296 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.44 -56.98 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.434 1.084 . . . . 74.54 109.273 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -17.95 19.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.42 110.403 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -77.41 -41.71 38.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 72.11 109.315 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.565 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.8 OUTLIER -106.08 39.64 1.75 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.521 1.138 . . . . 73.12 111.0 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.7 t -67.89 -53.22 28.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 74.53 109.99 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.492 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.8 -18.09 38.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 72.33 109.281 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.551 HD11 ' CE2' ' A' ' 172' ' ' TYR . 14.2 mt -55.98 137.35 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 72.42 109.297 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.8 p -148.68 159.87 43.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 71.34 110.009 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.8 -149.06 40.88 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.475 1.109 . . . . 45.31 110.976 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 1.2 m -106.74 14.24 27.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.303 -0.999 . . . . 72.22 108.303 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.486 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -132.06 149.21 72.64 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.433 1.083 . . . . 74.35 110.003 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -74.97 147.08 88.41 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 74.01 110.989 -0.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.6 p -129.99 133.32 24.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 74.24 109.988 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.04 -167.87 6.01 Favored 'Cis proline' 0 C--N 1.359 1.13 0 C-N-CA 121.033 -2.486 . . . . 73.55 110.967 0.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.65 153.8 20.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 73.25 109.315 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.519 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.0 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 73.4 110.993 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.8 135.09 33.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.148 . . . . 54.44 109.278 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.2 24.73 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 74.03 109.274 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 16.5 t -57.04 -18.43 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 74.34 109.975 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -60.28 -26.6 66.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 62.31 109.999 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.2 m -70.56 -173.44 0.74 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.515 1.134 . . . . 70.52 108.286 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 167.4 81.37 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.513 1.133 . . . . 71.23 110.963 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.44 ' CZ ' HD12 ' A' ' 286' ' ' LEU . 3.6 p90 . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.46 0.741 . . . . 75.25 110.953 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 194' ' ' ASP . 7.9 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.284 -0.635 . . . . 73.32 109.284 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.577 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -100.39 111.33 23.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 74.53 109.319 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 m -73.29 -43.52 60.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.451 1.094 . . . . 75.14 110.029 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.457 HG21 ' CG2' ' A' ' 232' ' ' THR . 0.4 OUTLIER -112.58 161.22 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 65.1 109.281 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.464 HD11 ' CD1' ' A' ' 149' ' ' LEU . 0.7 OUTLIER -101.84 144.75 29.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 72.22 109.316 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.98 -33.79 4.34 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.493 1.786 . . . . 74.53 110.994 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.19 147.43 19.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.451 1.094 . . . . 72.13 109.306 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.551 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -47.29 -35.18 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 74.14 109.294 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.3 -45.86 4.36 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 65.51 109.322 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.512 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -72.85 -34.11 66.56 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.48 1.112 . . . . 73.43 110.396 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.514 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.6 OUTLIER -59.94 -56.35 22.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.486 1.116 . . . . 73.45 109.31 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.491 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.3 m-80 -53.46 -31.39 45.32 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 72.33 109.3 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.08 -54.08 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.149 . . . . 72.32 109.991 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' A' ' 193' ' ' TYR . 87.5 mt -45.25 -41.6 8.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 75.53 109.262 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.47 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.42 -44.66 57.82 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.423 1.077 . . . . 74.22 110.974 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -46.95 -36.2 7.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.42 1.075 . . . . 64.15 109.306 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . 61.0 mt-30 -77.31 -55.15 5.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 74.25 110.303 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.426 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 17.5 mt -50.35 -27.09 4.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 74.41 109.286 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -37.38 60.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 74.22 109.31 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.4 t-20 -57.74 -17.88 17.97 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 74.34 109.33 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.404 ' NE2' ' H ' ' A' ' 164' ' ' SER . 4.4 mm100 -82.79 -25.72 32.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.42 110.291 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -40.35 114.27 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.15 . . . . 71.42 110.028 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.7 m -42.42 124.4 2.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 70.23 108.3 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.89 -22.04 3.88 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.523 1.14 . . . . 73.44 111.016 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 56.8 p -90.09 158.25 17.39 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 0.747 . . . . 74.31 110.38 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.2 t -89.62 -2.52 58.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 75.13 109.984 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 m -110.27 -1.6 17.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 75.41 110.396 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.75 134.51 41.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.575 1.172 . . . . 62.14 109.288 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.404 ' H ' ' NE2' ' A' ' 156' ' ' GLN . 0.5 OUTLIER -55.14 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 72.33 109.976 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.462 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.6 t -156.27 128.32 3.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 75.12 109.965 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -74.95 136.61 45.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.031 -2.487 . . . . 73.34 111.019 -0.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.9 p -73.19 -179.42 3.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.24 108.269 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.28 124.52 41.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.573 1.171 . . . . 74.02 109.311 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 169' ' ' THR . 12.4 p -90.13 81.16 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 73.14 110.403 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -80.28 -11.18 59.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.128 . . . . 74.12 110.995 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.57 -5.2 35.53 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.519 1.137 . . . . 74.43 110.314 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.569 ' CE2' HD11 ' A' ' 304' ' ' LEU . 26.8 t80 -129.73 69.68 81.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 75.11 111.023 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.403 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 114.19 3.97 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.448 1.762 . . . . 71.11 111.039 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.534 HG22 ' CE1' ' A' ' 172' ' ' TYR . 22.1 t -153.26 -66.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 73.14 109.302 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.91 114.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 75.53 109.28 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.569 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 151.64 46.4 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.476 1.11 . . . . 72.1 111.004 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 180' ' ' ARG . 84.9 m -85.73 -23.12 27.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.3 -1.0 . . . . 74.01 108.3 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.569 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 16.1 p90 -67.13 -35.89 80.71 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.145 . . . . 74.53 110.995 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -68.53 -67.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 44.54 109.271 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 240' ' ' SER . 0.1 OUTLIER -44.05 -46.56 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 73.23 110.319 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.415 ' HB3' ' NZ ' ' A' ' 197' ' ' LYS . . . -44.96 -50.45 10.57 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 73.24 109.285 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.693 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -54.0 -35.39 61.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 73.13 109.579 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 180' ' ' ARG . 17.4 mmmt -73.43 -32.22 64.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 1.143 . . . . 75.23 109.334 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 20.3 mtm -66.21 -55.95 13.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 64.4 110.99 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.492 ' NH2' ' N ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -55.32 -26.86 43.17 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 75.24 110.364 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.419 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 1.2 tt0 -64.05 -43.38 95.69 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.33 110.266 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.426 ' HB ' ' CG1' ' A' ' 153' ' ' ILE . 21.4 mm -70.48 -38.04 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.138 . . . . 74.24 109.281 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -56.43 -31.6 64.09 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 64.43 109.319 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 192' ' ' GLY . 35.7 mtp -72.89 -43.64 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.573 1.171 . . . . 75.42 110.973 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -45.32 -53.37 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 73.33 109.296 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -64.66 -27.86 69.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.21 109.314 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.08 52.33 0.89 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.545 1.153 . . . . 61.41 111.002 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.577 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 60.2 m-85 -150.83 128.13 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.537 0.786 . . . . 70.21 110.981 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.471 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 0.2 OUTLIER -98.38 131.51 44.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 62.2 109.363 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 24.1 p -109.5 -179.3 3.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.5 1.125 . . . . 73.03 108.276 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.71 176.99 5.44 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.55 1.156 . . . . 62.02 110.305 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.415 ' NZ ' ' HB3' ' A' ' 181' ' ' ALA . 14.2 mmtt -105.7 171.6 7.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 75.31 109.302 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -166.81 121.02 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 75.14 110.288 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.558 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 8.8 m-85 -116.37 123.93 48.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.466 1.104 . . . . 73.41 110.99 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 8.7 p -115.28 152.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.496 1.122 . . . . 74.32 109.279 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 5.3 m-85 -124.91 162.75 23.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 74.32 111.016 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.57 -179.88 17.76 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.455 1.097 . . . . 70.51 111.005 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 263' ' ' SER . 59.0 t-20 -69.11 109.62 4.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.528 0.781 . . . . 70.33 109.276 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.421 HD13 ' N ' ' A' ' 218' ' ' HIS . 5.9 mt -114.01 93.78 4.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.432 1.083 . . . . 73.24 109.297 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 256' ' ' CYS . 7.1 mttt -93.12 167.19 11.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 63.51 109.349 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -175.53 151.86 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 61.34 109.286 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t -124.32 131.99 53.54 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 64.2 109.962 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 17.3 p -97.29 -14.23 21.47 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 72.02 110.414 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.66 -30.96 5.93 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.503 1.127 . . . . 52.44 110.998 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.5 t -110.95 -22.48 11.49 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.535 0.785 . . . . 65.53 110.396 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -160.98 163.5 31.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.122 . . . . 71.3 108.283 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.482 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.37 143.76 46.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 73.31 108.315 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.28 156.61 11.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 75.41 109.287 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -141.34 119.2 11.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 63.52 109.348 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -125.11 137.1 54.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.01 -1.107 . . . . 75.34 108.01 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -81.81 4.6 21.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.508 1.13 . . . . 71.5 110.022 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 9.3 p90 -177.74 126.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.32 110.946 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.514 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 40.5 t60 -112.7 168.71 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 71.12 109.608 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 1.5 p -144.62 142.07 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 72.54 109.314 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.76 -165.13 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 52.32 109.304 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 14.2 pt -119.07 124.93 73.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 74.42 109.305 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.3 tp -85.9 108.99 18.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 72.12 109.293 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.514 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.61 148.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.128 . . . . 71.54 109.301 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 140' ' ' ILE . 49.7 m -116.89 125.39 51.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.01 110.03 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 34.8 p90 -139.48 137.47 35.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 71.34 111.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -64.6 131.1 46.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.568 1.167 . . . . 73.51 109.347 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -72.06 -160.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 72.25 109.277 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.08 49.56 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 71.34 109.324 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.98 -7.85 12.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.497 1.123 . . . . 73.41 110.034 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.42 37.8 8.0 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.495 1.122 . . . . 43.11 111.001 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.62 43.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.501 0.765 . . . . 74.23 109.283 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.457 ' CG2' HG21 ' A' ' 139' ' ' VAL . 2.5 m -71.9 102.75 2.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.54 110.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.409 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 6.8 mm-40 -102.63 -172.58 2.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 75.41 110.303 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.1 mmtm -126.18 145.39 50.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 71.13 109.301 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.571 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 2.2 tpt180 -143.07 161.44 38.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 74.14 110.31 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' A' ' 252' ' ' TRP . 11.2 mm -114.74 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.562 1.163 . . . . 75.25 109.305 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.497 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 4.0 mm -102.58 45.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.115 . . . . 74.44 109.298 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.05 109.47 62.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 75.44 109.263 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -27.3 10.05 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.477 1.777 . . . . 74.13 110.966 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.9 OUTLIER -45.21 -26.37 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 74.45 109.992 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.25 -60.39 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 74.41 109.294 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 255' ' ' ALA . 87.9 m-85 -107.87 99.6 9.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 75.21 111.009 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.96 -6.28 57.36 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 72.02 110.015 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.9 p -80.53 -46.09 16.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.539 1.15 . . . . 71.21 109.97 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.49 -175.76 42.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 74.12 111.034 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.449 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.98 163.57 35.1 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.503 1.791 . . . . 65.14 110.987 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 242' ' ' PHE . 2.4 m -150.35 156.88 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 72.04 109.278 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.423 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.2 p -60.54 140.49 57.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 72.53 110.434 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.42 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 1.1 p-10 -42.97 -28.98 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.33 109.281 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.423 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.0 m -71.34 -65.22 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.116 . . . . 74.41 110.421 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.32 13.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 73.44 109.31 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.577 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 12.5 t90 -59.94 -61.12 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.982 -1.118 . . . . 75.51 107.982 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.566 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.42 -41.61 20.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 71.23 110.275 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.411 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 2.9 m-80 -57.31 -51.11 70.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 74.21 109.3 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.571 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . . . -56.25 -19.51 14.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 62.44 109.297 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -89.08 -35.81 16.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 73.44 108.32 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.472 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.5 m -93.96 21.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 74.4 109.304 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -50.22 106.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 73.04 109.316 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 262' ' ' GLY . 4.6 p -73.48 -3.14 25.74 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 1.129 . . . . 72.44 110.38 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 39.0 t -44.52 -30.76 0.94 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 73.35 110.025 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.51 -37.2 15.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 71.14 108.275 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 166.84 -127.95 1.67 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.53 1.144 . . . . 41.14 110.983 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.61 144.86 43.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 0.778 . . . . 74.15 109.942 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.472 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -168.21 147.53 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.44 109.304 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 84.1 p -172.95 155.56 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.45 109.973 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.45 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 3.8 p -101.14 118.86 48.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.145 . . . . 75.35 109.357 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.3 t -73.22 -43.75 60.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 73.14 110.026 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 51.2 p -168.8 -179.35 3.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 75.4 110.029 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -159.22 157.16 30.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 74.34 110.979 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.35 152.22 29.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 62.44 109.295 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.445 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.8 OUTLIER -112.36 160.71 17.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 73.02 109.344 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.478 HG21 ' CZ ' ' A' ' 285' ' ' TYR . 1.7 p -153.83 -178.45 7.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 73.43 110.396 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -68.24 162.15 25.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.461 1.101 . . . . 74.12 109.311 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.9 -44.69 36.37 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.515 1.135 . . . . 73.21 111.015 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.492 ' N ' ' NH2' ' A' ' 185' ' ' ARG . 1.7 p30 -53.18 -41.01 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 0.777 . . . . 72.53 109.299 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 22.8 t -43.56 120.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 74.54 109.247 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -82.2 -53.07 6.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.523 1.139 . . . . 73.23 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -136.92 152.83 50.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 75.24 111.002 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.558 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 78.2 ttt-85 -126.86 147.3 50.06 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 74.31 110.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.96 158.14 50.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.47 1.106 . . . . 72.02 109.936 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 0.25 9.15 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.465 1.771 . . . . 73.41 110.952 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 7.1 t -98.98 4.98 47.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 72.41 110.015 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 75.38 41.56 0.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.35 109.338 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -120.21 120.39 36.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.467 1.104 . . . . 64.05 109.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.478 ' CZ ' HG21 ' A' ' 272' ' ' THR . 11.7 m-30 -103.05 160.65 14.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 73.25 111.035 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.671 ' CD1' ' CE2' ' A' ' 320' ' ' PHE . 1.0 OUTLIER -125.42 177.24 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 74.42 109.342 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.7 m-85 -161.03 115.84 2.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.476 1.11 . . . . 75.13 111.016 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.435 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 1.0 OUTLIER -115.36 96.78 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 74.24 109.348 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -85.63 -19.11 31.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 75.44 109.253 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.466 ' CB ' HG12 ' A' ' 292' ' ' ILE . 38.6 m-20 -107.65 6.59 27.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.43 109.297 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.693 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.26 47.22 2.09 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 73.21 109.3 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.481 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 47.5 mm -76.51 -31.58 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 73.31 109.296 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.5 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.5 t-20 -94.78 -18.51 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.112 . . . . 74.41 109.27 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.404 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 2.0 m -84.76 -66.51 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 74.23 110.424 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 87.8 m-20 -56.68 -18.71 13.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 75.1 109.278 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 4.9 t -80.49 -63.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.128 . . . . 74.03 108.308 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 65.9 t -46.93 -37.24 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.52 1.138 . . . . 75.3 109.334 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.69 -57.8 5.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.12 . . . . 74.13 109.277 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.85 -20.76 16.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 73.41 110.384 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -72.27 -39.2 68.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 75.02 109.3 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.564 ' CD1' HD11 ' A' ' 304' ' ' LEU . 3.6 m-30 -101.78 35.09 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.498 1.123 . . . . 64.34 110.987 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.3 t -67.96 -43.85 78.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 74.11 110.01 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.496 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -95.62 -17.18 21.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.102 . . . . 71.12 109.278 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 172' ' ' TYR . 14.2 mt -56.58 153.43 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 71.31 109.288 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.1 p -165.55 162.17 18.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.528 1.142 . . . . 75.41 110.039 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 65.69 -153.1 51.48 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.507 1.13 . . . . 75.02 110.979 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 3.0 m -99.38 9.77 42.66 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.294 -1.002 . . . . 73.04 108.294 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.501 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -125.06 148.85 61.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 64.4 109.953 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.3 Cg_endo -74.96 147.06 88.37 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.965 -2.515 . . . . 73.41 111.014 -0.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.468 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.1 OUTLIER -128.83 133.33 25.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 63.14 110.006 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.99 -168.73 6.72 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 120.974 -2.511 . . . . 73.22 111.042 -0.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 150.3 40.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.135 . . . . 73.22 109.318 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.525 1.803 . . . . 71.02 111.03 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.47 127.33 39.07 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.143 . . . . 73.24 109.237 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.52 27.22 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 72.35 109.297 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 12.5 t -51.72 -35.55 43.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 70.02 109.993 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 30.8 m -42.3 -28.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.422 1.076 . . . . 73.42 110.025 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 62.0 m -56.81 -176.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.42 108.29 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.481 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 179.0 84.31 0.06 OUTLIER Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.527 1.142 . . . . 64.44 111.001 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.671 ' CE2' ' CD1' ' A' ' 286' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.517 0.775 . . . . 73.32 110.976 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.468 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 12.5 tp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.316 -0.624 . . . . 73.13 109.316 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -102.56 106.91 17.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 64.43 109.302 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 m -69.33 -42.59 75.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.478 1.111 . . . . 61.4 109.972 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.45 HG22 ' CG2' ' A' ' 232' ' ' THR . 0.4 OUTLIER -112.79 159.75 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 74.23 109.298 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.44 ' CD1' HD12 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.07 143.83 26.95 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 72.32 109.316 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -33.23 4.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.514 1.797 . . . . 75.35 110.984 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.37 146.28 16.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 74.12 109.267 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.533 HG22 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -45.15 -36.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.158 . . . . 73.03 109.271 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.75 2.96 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.546 1.153 . . . . 63.54 109.265 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.528 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.11 -36.26 72.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.546 1.154 . . . . 52.23 110.406 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.529 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.7 -57.26 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 72.24 109.32 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.501 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 48.8 m-80 -51.91 -31.93 30.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 70.52 109.292 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.75 -56.66 7.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 62.23 109.998 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.442 HD11 ' CB ' ' A' ' 193' ' ' TYR . 22.6 mt -43.05 -41.08 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 72.23 109.28 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.469 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.02 -44.48 54.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.544 1.153 . . . . 74.05 111.003 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -48.52 -34.82 11.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.135 . . . . 74.12 109.324 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.436 ' CB ' ' CG2' ' A' ' 187' ' ' ILE . 54.0 mt-30 -77.69 -51.7 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 73.34 110.335 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.421 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 17.6 mt -54.61 -24.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.147 . . . . 74.02 109.327 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -34.73 49.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 72.04 109.26 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -58.64 -20.08 44.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 1.137 . . . . 71.21 109.295 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 157' ' ' SER . 8.9 mm100 -77.63 -24.1 49.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 74.41 110.29 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 156' ' ' GLN . 6.3 m -38.99 113.04 0.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 72.13 109.967 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.9 m -43.05 129.65 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 73.43 108.301 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 125.36 -14.24 7.35 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 71.01 110.989 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 45.1 p -98.47 154.22 18.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 0.775 . . . . 63.22 110.434 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 p -86.4 -3.61 59.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.548 1.155 . . . . 73.32 109.974 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 -3.98 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 74.42 110.369 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.93 133.6 39.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 71.45 109.285 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -168.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 72.21 109.99 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.465 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -155.91 128.16 4.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 71.25 110.002 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 136.62 46.04 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 120.967 -2.514 . . . . 54.32 111.03 -0.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 13.2 p -73.01 179.66 3.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.13 108.3 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.489 ' HB ' ' CE1' ' A' ' 170' ' ' PHE . 4.4 mp -91.9 135.41 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.094 . . . . 74.14 109.336 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.8 p -96.19 94.53 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.122 . . . . 72.15 110.388 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.517 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 90.2 m-85 -88.48 -15.46 35.3 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.557 1.161 . . . . 72.11 110.993 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.67 -2.02 24.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 74.12 110.285 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.566 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 30.9 t80 -132.38 67.18 78.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 75.03 111.014 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.416 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -75.03 112.53 3.58 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.471 1.774 . . . . 72.25 110.991 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.515 HG23 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.95 -72.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 71.4 109.305 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -152.6 125.12 8.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 62.21 109.325 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 139.34 44.29 0.07 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.467 1.105 . . . . 75.35 111.02 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 218' ' ' HIS . 6.0 t -81.56 -25.42 35.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.329 -0.989 . . . . 74.2 108.329 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.466 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 28.4 p90 -71.47 -28.67 64.11 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 74.44 110.992 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.09 -68.12 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.423 1.077 . . . . 64.12 109.307 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -45.24 -47.69 12.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 73.52 110.298 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.421 ' HB1' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.2 -55.09 4.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.465 1.103 . . . . 72.0 109.28 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.42 -36.61 15.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 74.14 109.582 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 180' ' ' ARG . 9.4 mmmm -77.07 -32.82 57.04 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.149 . . . . 72.12 109.3 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 181' ' ' ALA . 18.3 mtm -63.6 -50.23 70.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 71.14 110.99 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -64.43 -26.34 68.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 75.14 110.316 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -38.92 90.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 73.45 110.301 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.436 ' CG2' ' CB ' ' A' ' 152' ' ' GLN . 21.2 mm -70.7 -37.68 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 72.51 109.336 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.1 OUTLIER -54.69 -44.08 73.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.525 1.141 . . . . 73.41 109.273 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.456 ' HE1' ' CZ ' ' A' ' 185' ' ' ARG . 13.7 mtt -58.85 -43.59 90.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 70.24 111.047 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.08 -51.46 24.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 75.34 109.3 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.421 ' ND2' HE22 ' A' ' 152' ' ' GLN . 6.1 t-20 -68.74 -26.06 65.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.451 1.094 . . . . 75.23 109.257 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.15 57.94 0.84 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.495 1.122 . . . . 61.11 110.982 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 59.6 m-85 -152.13 140.37 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.459 0.741 . . . . 75.14 110.999 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.468 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -105.53 130.8 53.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 72.23 109.301 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.459 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 11.4 p -109.42 -179.52 3.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 71.01 108.258 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.13 175.65 8.25 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.543 1.152 . . . . 75.2 110.279 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.421 ' NZ ' ' HB1' ' A' ' 181' ' ' ALA . 15.8 mmtt -108.9 159.32 16.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 73.43 109.306 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.405 ' NE2' ' CZ3' ' A' ' 252' ' ' TRP . 8.3 tt0 -152.4 117.72 5.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.548 1.155 . . . . 74.51 110.273 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -108.94 136.13 48.98 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.496 1.122 . . . . 71.52 111.047 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.461 ' CG2' HG21 ' A' ' 266' ' ' VAL . 9.4 p -131.81 143.33 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 75.35 109.318 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 201' ' ' TYR . 4.3 m-85 -117.7 161.38 19.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 74.32 110.952 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.63 -179.62 17.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.502 1.126 . . . . 74.31 111.023 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 263' ' ' SER . 58.8 t-20 -69.08 110.22 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.43 109.324 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.466 HD12 ' CB ' ' A' ' 218' ' ' HIS . 5.8 mt -114.32 93.98 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 74.12 109.301 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 256' ' ' CYS . 7.0 mttt -93.36 166.14 12.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 73.03 109.297 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -173.28 148.18 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 75.11 109.286 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.6 t -123.73 131.23 53.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 74.14 109.953 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.6 p -99.96 -4.35 30.3 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.498 1.124 . . . . 71.23 110.368 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 105.36 -35.48 5.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.457 1.098 . . . . 71.15 111.008 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.0 t -102.28 -22.42 14.15 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.508 0.769 . . . . 73.44 110.392 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -166.2 163.52 17.85 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 64.34 108.286 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -119.58 148.57 43.16 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.095 . . . . 64.43 108.314 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.99 157.52 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 73.13 109.27 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -140.76 120.55 13.47 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 70.53 109.26 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m-90 -125.95 135.67 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 74.55 107.995 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.6 t -81.14 1.21 32.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.25 109.969 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 11.2 p90 -172.23 125.62 0.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.467 1.104 . . . . 74.4 111.024 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.6 ' CE1' ' SG ' ' A' ' 177' ' ' CYS . 76.4 t60 -125.41 157.7 36.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.21 109.568 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 220' ' ' ALA . 1.5 p -131.5 163.99 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.548 1.155 . . . . 74.52 109.288 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.65 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -156.19 -167.55 2.47 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.517 1.136 . . . . 64.0 109.292 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.6 pt -117.77 119.79 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 72.35 109.316 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 tp -83.11 109.86 17.52 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.555 1.159 . . . . 75.14 109.304 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.529 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -106.15 147.48 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 75.42 109.313 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 140' ' ' ILE . 37.0 m -116.74 125.4 51.6 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 73.1 109.983 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.572 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -140.52 137.44 33.81 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.54 1.15 . . . . 74.2 110.977 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.406 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 17.9 mmtp -64.08 132.45 50.55 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.153 . . . . 72.21 109.307 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -72.82 -160.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 74.34 109.311 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.86 0.34 48.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.32 109.309 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.32 -8.56 12.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 74.34 109.997 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.45 37.73 7.44 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.469 1.106 . . . . 75.45 110.967 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.65 136.97 46.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.535 0.785 . . . . 74.45 109.28 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.45 ' CG2' HG22 ' A' ' 139' ' ' VAL . 2.5 m -71.23 102.79 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 70.41 110.389 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.43 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.2 mm-40 -102.33 -172.65 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.133 . . . . 74.42 110.32 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -126.1 145.36 50.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 74.2 109.283 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.572 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 4.7 tpt180 -145.88 160.34 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 74.43 110.325 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.476 HG13 ' CB ' ' A' ' 252' ' ' TRP . 9.9 mm -114.24 120.89 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 75.52 109.251 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.507 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 5.5 mm -104.29 44.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 74.33 109.288 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.57 113.62 62.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 1.146 . . . . 75.04 109.271 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.517 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -75.03 -26.61 10.71 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.501 1.79 . . . . 72.44 111.009 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.419 ' HB2' ' NH2' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -41.53 -30.76 0.22 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 74.5 110.049 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.2 mt -110.05 -61.14 1.7 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 72.32 109.317 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.567 ' CD1' HG13 ' A' ' 247' ' ' VAL . 98.3 m-85 -108.78 99.51 8.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 74.33 111.013 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 69.5 m -86.39 -15.98 38.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 64.5 109.998 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.8 t -73.92 -40.05 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.135 . . . . 70.12 110.011 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.6 -177.54 45.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 63.1 111.04 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.438 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.96 170.57 20.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.503 1.791 . . . . 74.42 111.062 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.567 HG13 ' CD1' ' A' ' 242' ' ' PHE . 11.2 m -150.84 158.55 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.506 1.129 . . . . 71.31 109.287 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.47 HG23 ' CZ ' ' A' ' 235' ' ' ARG . 40.6 p -60.64 141.45 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.157 . . . . 64.3 110.379 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -46.3 -25.91 0.71 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 71.32 109.331 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.404 ' N ' ' C ' ' A' ' 248' ' ' THR . 21.4 m -79.37 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.22 110.439 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -54.42 -22.22 11.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 63.21 109.283 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.65 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.6 t90 -66.56 -57.8 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.513 1.133 . . . . 74.2 107.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.556 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -49.22 -42.99 42.16 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 72.13 110.33 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -56.24 -51.04 69.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 75.34 109.31 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.504 ' HB3' ' CE2' ' A' ' 242' ' ' PHE . . . -55.6 -19.36 10.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.444 1.09 . . . . 74.22 109.321 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -89.0 -36.79 15.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.33 108.266 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.469 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.4 m -92.73 20.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 74.21 109.315 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -50.18 105.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.467 1.105 . . . . 74.21 109.266 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.41 -3.26 26.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 75.43 110.352 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 t -44.47 -30.13 0.82 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 71.12 110.01 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.8 t -89.01 -37.3 15.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.115 . . . . 74.0 108.29 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.13 -129.3 1.86 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.481 1.113 . . . . 75.44 111.019 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -73.9 145.18 45.0 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.582 0.813 . . . . 64.25 110.036 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.469 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -168.16 147.68 4.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 62.1 109.281 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 94.7 p -172.9 155.48 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 75.21 110.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.461 HG21 ' CG2' ' A' ' 200' ' ' VAL . 3.7 p -101.42 117.95 47.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 74.24 109.313 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.2 t -73.89 -44.19 56.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 74.42 109.981 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.4 m -166.65 172.97 10.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 63.5 110.002 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -154.64 156.05 35.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 73.23 111.011 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.65 153.34 31.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 1.151 . . . . 65.21 109.311 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.402 ' ND2' ' C ' ' A' ' 271' ' ' ASN . 1.0 OUTLIER -113.49 160.7 18.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 74.14 109.257 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.428 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 2.5 p -154.37 -179.61 8.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.52 1.137 . . . . 75.33 110.41 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.411 ' CB ' HG22 ' A' ' 276' ' ' VAL . . . -66.83 167.76 10.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 71.25 109.307 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.9 -41.77 13.97 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.481 1.113 . . . . 74.01 110.986 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -57.2 -42.59 81.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.509 0.77 . . . . 72.04 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.411 HG22 ' CB ' ' A' ' 273' ' ' ALA . 44.1 t -43.86 118.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.03 109.297 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.582 ' CD2' ' OD2' ' A' ' 288' ' ' ASP . 18.4 t80 -73.74 -53.46 10.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 74.55 111.003 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 279' ' ' ARG . 31.0 t80 -136.31 166.7 22.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 75.31 111.008 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.0 ttt-85 -135.39 147.45 49.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 71.34 110.283 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.85 158.03 50.94 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 61.3 109.997 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 0.32 9.08 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.565 1.823 . . . . 73.24 111.01 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 42.0 p -98.42 4.23 48.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 74.43 109.993 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.3 t-20 77.21 41.74 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 74.24 109.304 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 t -122.66 131.4 53.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 73.03 109.973 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 16.4 m-30 -111.65 153.13 26.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 73.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.587 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.95 177.44 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.458 1.099 . . . . 73.21 109.334 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 84.9 m-85 -160.25 115.79 2.33 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 75.32 111.044 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.582 ' OD2' ' CD2' ' A' ' 277' ' ' TYR . 0.7 OUTLIER -115.43 94.98 4.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.478 1.111 . . . . 71.51 109.337 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -85.61 -18.34 33.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.483 1.115 . . . . 72.25 109.297 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.441 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.3 m-20 -107.09 3.28 25.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.476 1.11 . . . . 73.41 109.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.56 47.43 2.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.448 1.092 . . . . 74.33 109.27 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.454 HG22 ' CA ' ' A' ' 319' ' ' GLY . 22.5 mm -74.27 -32.63 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 75.22 109.276 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.9 t-20 -90.72 -26.17 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 72.44 109.291 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.458 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 1.3 m -79.37 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.463 1.102 . . . . 62.3 110.409 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -54.59 -20.13 7.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.133 . . . . 72.52 109.272 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 40.4 t -86.32 -62.22 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.477 1.111 . . . . 73.43 108.288 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.9 t -40.29 -41.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 65.4 109.29 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 24.3 mt -69.96 -56.13 7.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 75.33 109.316 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -55.3 -18.46 6.4 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 74.23 110.449 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -75.38 -45.77 37.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 75.42 109.302 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.566 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 1.6 m-30 -99.81 38.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.563 1.165 . . . . 71.21 111.029 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.1 t -69.5 -45.01 69.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.122 . . . . 55.41 110.029 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.67 -17.7 22.95 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 74.51 109.277 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.491 HD13 ' CD1' ' A' ' 301' ' ' PHE . 14.8 mt -59.52 144.91 46.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 73.04 109.34 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.3 p -154.02 158.08 40.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 75.42 110.057 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 70.32 -162.17 53.25 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.505 1.128 . . . . 74.23 110.969 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 310' ' ' SER . 9.4 p -92.1 13.9 17.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.29 -1.004 . . . . 74.5 108.29 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.49 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 3.3 m -132.96 148.1 68.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 74.54 110.009 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -75.01 145.42 83.87 Favored 'Cis proline' 0 C--N 1.361 1.196 0 C-N-CA 120.984 -2.507 . . . . 72.11 111.008 0.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.492 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -131.35 135.6 27.33 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.117 . . . . 74.41 109.996 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.97 -174.96 15.03 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.016 -2.493 . . . . 72.21 111.026 -0.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.43 154.96 21.06 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 73.32 109.296 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.425 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.97 -162.23 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.498 1.788 . . . . 75.43 111.011 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -82.96 131.52 35.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 72.04 109.297 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.39 26.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.512 1.133 . . . . 72.54 109.305 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 6.9 t -70.76 -33.52 70.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 74.41 109.982 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 p -45.75 -25.71 0.54 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 64.53 110.01 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.39 -173.83 1.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 74.32 108.275 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.454 ' CA ' HG22 ' A' ' 292' ' ' ILE . . . -164.4 -135.58 1.85 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.475 1.109 . . . . 72.41 110.955 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.566 ' CZ ' HD13 ' A' ' 286' ' ' LEU . 20.5 m-85 . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.516 0.774 . . . . 72.4 110.977 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.479 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 9.0 tp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.348 -0.612 . . . . 73.32 109.348 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.555 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -103.88 105.47 15.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 75.12 109.32 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -83.64 7.89 16.03 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 73.03 110.002 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.4 145.86 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.47 1.106 . . . . 74.33 109.327 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.464 HD11 ' CD1' ' A' ' 149' ' ' LEU . 1.6 mt -97.05 141.67 23.4 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 72.4 109.322 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -30.54 7.09 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.506 1.793 . . . . 75.2 110.968 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.58 150.25 15.71 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.476 1.11 . . . . 72.51 109.293 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -48.54 -36.67 7.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 73.25 109.258 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.99 -47.49 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 72.13 109.242 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.506 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.44 -36.19 71.18 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 61.35 110.375 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -58.1 -57.17 14.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 1.093 . . . . 73.42 109.278 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.517 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 47.6 m-80 -51.71 -32.34 29.82 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 72.21 109.332 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.25 -53.83 17.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 63.43 110.007 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.464 ' CD1' HD11 ' A' ' 140' ' ' ILE . 63.4 mt -45.56 -41.55 10.0 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.53 1.144 . . . . 74.24 109.291 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.41 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.38 -44.7 58.03 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 75.24 110.991 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -47.21 -33.89 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 74.32 109.319 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.451 ' HB2' ' CG2' ' A' ' 187' ' ' ILE . 62.9 mt-30 -78.53 -53.9 6.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 71.14 110.302 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.472 ' CD1' HD11 ' A' ' 188' ' ' LEU . 24.1 mt -51.28 -28.32 7.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 71.22 109.281 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -38.48 63.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 72.11 109.273 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.94 -16.97 20.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.536 1.147 . . . . 71.11 109.283 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -86.83 -26.55 23.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.514 1.134 . . . . 71.13 110.272 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 m -40.04 128.78 2.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 72.12 109.979 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.71 112.43 1.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 75.21 108.326 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.76 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 73.52 110.969 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 37.4 p -95.47 161.1 14.21 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 0.736 . . . . 70.51 110.383 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.64 -7.59 49.59 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 61.45 110.01 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.4 m -103.53 -4.23 24.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.096 . . . . 64.11 110.396 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.91 136.32 46.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 72.4 109.291 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.05 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 61.01 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.1 m -156.24 127.2 3.57 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 74.51 110.017 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 140.06 65.22 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 120.994 -2.503 . . . . 74.1 111.008 0.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.6 p -72.78 -178.6 2.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 55.14 108.319 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 183' ' ' LYS . 2.2 mp -83.45 128.51 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 75.24 109.275 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 51.3 p -96.56 69.15 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 73.21 110.374 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -81.25 -11.36 59.4 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 73.34 111.023 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.456 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.31 -1.82 25.4 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.545 1.153 . . . . 74.45 110.288 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 174' ' ' VAL . 18.9 t80 -131.47 64.59 73.7 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 74.33 110.984 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.432 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.95 123.09 7.65 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.444 1.76 . . . . 70.21 111.024 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.58 HG22 ' CE1' ' A' ' 172' ' ' TYR . 10.7 t -152.68 -55.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 72.05 109.324 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 177' ' ' CYS . 5.2 m-20 -147.22 -78.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.146 . . . . 72.3 109.313 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.38 92.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.505 1.128 . . . . 63.3 110.978 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.602 ' SG ' ' CE1' ' A' ' 218' ' ' HIS . 13.4 t -115.36 -16.0 11.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 75.52 108.293 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 33.1 p90 -74.99 -45.0 44.99 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.482 1.114 . . . . 73.13 111.02 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -41.58 -68.39 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.529 1.143 . . . . 74.21 109.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -47.67 -47.23 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 74.41 110.333 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -46.86 -55.86 7.27 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.47 1.106 . . . . 75.41 109.289 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.701 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.1 -30.23 4.31 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 74.54 109.604 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.538 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 21.4 mmmt -85.12 -31.99 23.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 74.32 109.275 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.453 ' CE ' HG12 ' A' ' 221' ' ' ILE . 31.2 mtm -62.51 -36.7 83.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 74.22 111.0 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.471 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.0 OUTLIER -78.32 -33.77 49.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 75.22 110.293 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.538 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -53.9 -35.44 61.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 75.34 110.303 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.453 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 21.8 mm -74.67 -48.06 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.529 1.143 . . . . 74.21 109.296 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.472 HD11 ' CD1' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -47.22 -36.87 9.45 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.452 1.095 . . . . 75.53 109.305 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.471 ' HE3' ' CZ ' ' A' ' 185' ' ' ARG . 6.5 mtt -65.72 -46.96 76.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 74.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -46.43 -51.31 15.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 73.25 109.304 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -65.33 -34.81 79.2 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 74.34 109.31 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.93 54.19 0.46 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.473 1.108 . . . . 71.52 110.984 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.555 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 78.1 m-85 -152.24 142.18 22.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 0.772 . . . . 74.01 110.994 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.2 OUTLIER -108.13 128.65 54.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 75.32 109.291 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.469 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 12.5 p -104.45 178.22 4.62 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.49 1.119 . . . . 71.44 108.28 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -127.17 173.81 9.42 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.33 110.322 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 181' ' ' ALA . 21.4 mmtt -108.3 153.78 22.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.544 1.153 . . . . 73.35 109.303 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -147.34 117.42 7.27 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.528 1.142 . . . . 74.44 110.326 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.0 m-85 -110.59 123.29 49.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 70.33 110.973 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.466 ' CG2' HG21 ' A' ' 266' ' ' VAL . 8.0 p -114.99 151.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 73.44 109.313 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.451 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 13.0 m-85 -122.27 161.18 23.77 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 71.15 111.01 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.6 -178.4 16.72 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.478 1.111 . . . . 51.44 111.006 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 263' ' ' SER . 58.8 t-20 -69.96 109.44 4.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.574 0.808 . . . . 64.31 109.328 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.424 HD11 ' N ' ' A' ' 218' ' ' HIS . 5.5 mt -114.26 94.5 4.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.155 . . . . 73.32 109.329 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 256' ' ' CYS . 8.4 mttt -92.96 164.3 13.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 74.23 109.305 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -175.69 170.92 2.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.113 . . . . 62.44 109.321 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.24 135.7 54.38 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.11 110.013 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.424 ' CG2' HG23 ' A' ' 213' ' ' VAL . 8.0 p -118.96 0.86 11.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.438 1.086 . . . . 71.1 110.37 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.495 ' O ' ' CG2' ' A' ' 210' ' ' THR . . . 115.3 112.71 2.88 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.496 1.123 . . . . 71.45 111.026 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 209' ' ' GLY . 14.5 t 50.59 21.68 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 0.759 . . . . 74.04 110.402 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.1 OUTLIER -158.42 163.94 36.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.543 1.152 . . . . 70.03 108.319 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.0 OUTLIER -131.24 138.47 49.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.517 1.135 . . . . 74.5 108.267 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.424 HG23 ' CG2' ' A' ' 208' ' ' THR . 1.9 m -111.12 128.75 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 64.42 109.314 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 63.12 109.327 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.3 m0 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.119 . . . . 74.33 108.034 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -81.65 -1.31 46.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 75.11 110.007 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.501 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.2 p90 -169.8 127.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 73.41 110.977 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.602 ' CE1' ' SG ' ' A' ' 177' ' ' CYS . 85.8 t60 -124.79 149.24 47.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 71.22 109.597 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 220' ' ' ALA . 1.5 p -118.1 164.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 75.44 109.292 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.644 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.06 -170.53 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.13 . . . . 72.32 109.321 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.471 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 21.1 pt -116.44 118.38 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.546 1.154 . . . . 71.22 109.272 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 11.8 tp -83.99 108.64 17.07 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.461 1.101 . . . . 73.22 109.327 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.464 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.9 OUTLIER -102.95 143.89 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 74.55 109.311 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 0.2 OUTLIER -116.32 116.78 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 61.23 109.981 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.5 p90 -131.92 145.83 51.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.121 . . . . 75.51 111.019 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -70.76 132.73 45.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 73.42 109.335 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.28 -160.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 74.24 109.283 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.89 -0.06 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 73.24 109.244 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -114.86 -8.51 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 73.32 109.984 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.86 37.55 7.86 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.494 1.121 . . . . 71.24 111.016 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.41 137.95 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 73.44 109.294 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.0 m -71.87 102.55 2.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 72.24 110.368 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.401 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 6.9 mm-40 -102.12 -172.71 2.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 62.24 110.275 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -127.3 144.63 51.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 73.14 109.304 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.574 ' HD3' ' CE1' ' A' ' 225' ' ' TYR . 2.0 tpt180 -143.91 163.31 33.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 70.14 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.474 HG13 ' CB ' ' A' ' 252' ' ' TRP . 22.0 mm -118.82 116.98 52.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 75.21 109.319 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.471 ' HB ' ' CD1' ' A' ' 221' ' ' ILE . 3.4 mm -98.7 50.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 71.31 109.327 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 238' ' ' ASP . 41.2 p-10 -96.6 109.61 48.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 74.15 109.349 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 240' ' ' SER . 18.3 Cg_endo -74.98 -50.55 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.505 1.792 . . . . 73.21 111.002 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.3 OUTLIER -36.51 -34.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 71.13 110.017 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 239' ' ' PRO . 13.9 mt -97.36 -60.97 1.47 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.144 . . . . 74.22 109.302 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.569 ' CE1' HG12 ' A' ' 247' ' ' VAL . 97.2 m-85 -112.02 99.68 8.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.16 . . . . 74.21 111.0 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -22.08 33.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 73.24 109.961 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.1 m -66.49 -47.26 73.57 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.126 . . . . 71.22 109.961 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.18 41.13 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.486 1.116 . . . . 73.14 110.977 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.446 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.94 170.47 20.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.512 1.796 . . . . 73.55 111.019 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.569 HG12 ' CE1' ' A' ' 242' ' ' PHE . 14.6 m -147.74 156.3 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.084 . . . . 75.03 109.318 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.43 ' C ' ' N ' ' A' ' 250' ' ' THR . 41.8 p -59.51 139.01 57.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 74.41 110.398 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.45 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 23.2 p-10 -43.08 -28.19 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 73.22 109.327 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.43 ' N ' ' C ' ' A' ' 248' ' ' THR . 11.5 m -77.12 -62.55 1.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.424 1.077 . . . . 74.45 110.411 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.03 -24.71 4.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 70.13 109.325 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.644 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 11.1 t90 -66.11 -64.66 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 75.35 108.038 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.566 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.2 OUTLIER -43.06 -33.56 0.87 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.112 . . . . 73.23 110.295 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.456 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.5 m-80 -66.25 -48.91 68.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 71.25 109.325 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.447 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -57.45 -18.18 17.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.128 . . . . 70.55 109.26 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.478 ' O ' ' N ' ' A' ' 205' ' ' LYS . 9.6 m -92.53 -33.98 14.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 72.14 108.269 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 264' ' ' ALA . 2.9 m -93.79 20.44 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 73.11 109.258 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.411 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 46.4 t30 -44.4 104.63 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.106 . . . . 65.33 109.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.2 p -74.24 -4.72 37.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 70.32 110.408 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.411 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -47.79 -26.66 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 64.23 110.007 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 18.2 t -91.08 -34.76 14.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 72.32 108.316 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.73 -129.8 2.23 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.517 1.135 . . . . 70.13 111.038 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.441 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -67.0 145.18 55.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 0.741 . . . . 74.34 109.959 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 257' ' ' VAL . . . -173.22 142.23 1.01 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 62.33 109.298 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.9 p -173.08 153.46 2.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 73.13 109.998 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.466 HG21 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.15 120.71 47.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.501 1.125 . . . . 74.41 109.293 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 16.9 t -76.12 -43.07 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.434 1.084 . . . . 74.32 110.007 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.411 ' O ' ' CG2' ' A' ' 200' ' ' VAL . 54.6 m -164.56 -172.52 2.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 71.33 109.971 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -166.75 157.27 11.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 75.42 111.025 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.9 157.55 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 63.43 109.281 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.449 ' O ' ' CG2' ' A' ' 272' ' ' THR . 1.5 p-10 -122.92 160.09 26.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 63.11 109.307 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 271' ' ' ASN . 48.2 p -154.98 176.94 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.096 . . . . 74.43 110.408 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -57.74 160.91 4.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 75.01 109.291 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.1 -21.65 78.81 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.526 1.141 . . . . 74.34 110.984 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.418 ' HA ' ' NH2' ' A' ' 185' ' ' ARG . 1.5 p-10 -74.19 -35.03 63.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 0.759 . . . . 72.31 109.302 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 53.4 t -43.67 101.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.479 1.112 . . . . 71.35 109.253 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.559 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 4.6 t80 -63.12 -53.63 50.42 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 74.21 111.029 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -146.85 135.04 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.148 . . . . 75.01 110.988 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.57 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 72.8 ttt-85 -106.15 147.44 29.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 74.42 110.294 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.19 157.95 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.439 1.087 . . . . 65.24 110.006 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -0.65 10.19 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.434 1.754 . . . . 70.22 111.004 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 40.5 m -101.12 8.71 42.65 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 72.13 109.959 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 73.03 38.21 0.72 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.563 1.164 . . . . 71.52 109.297 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -119.79 119.17 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.12 110.004 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.423 ' CZ ' HG22 ' A' ' 272' ' ' THR . 9.0 m-30 -99.89 167.06 10.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.491 1.12 . . . . 73.14 111.033 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.562 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -125.89 177.49 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 73.44 109.353 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 37.8 m-85 -158.34 118.98 3.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 73.22 111.036 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.39 99.49 7.42 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.465 1.103 . . . . 72.31 109.305 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -83.48 -52.82 6.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 73.11 109.312 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.472 ' CB ' HG12 ' A' ' 292' ' ' ILE . 24.4 m-20 -88.04 10.63 18.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.146 . . . . 74.54 109.328 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.701 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.5 mm? 40.45 45.15 1.84 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.115 . . . . 71.32 109.287 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.472 HG12 ' CB ' ' A' ' 290' ' ' ASN . 45.5 mm -75.26 -27.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 73.41 109.307 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.494 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 2.5 t-20 -92.1 -29.32 16.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.478 1.111 . . . . 75.02 109.295 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.559 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 17.9 m -80.02 -68.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 73.33 110.356 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -45.29 -33.64 2.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.56 1.162 . . . . 74.3 109.307 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 53.5 t -72.61 -46.08 55.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 71.54 108.251 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.0 t -55.73 -41.04 63.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 73.24 109.31 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.78 -62.14 1.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.52 1.137 . . . . 73.23 109.32 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -51.89 -23.87 5.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.461 1.101 . . . . 71.34 110.441 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.424 ' HE2' ' CG1' ' A' ' 315' ' ' VAL . 17.7 mmmt -71.19 -40.02 71.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.127 . . . . 75.44 109.318 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.569 ' CD1' HD11 ' A' ' 304' ' ' LEU . 5.2 m-30 -101.5 35.14 2.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 74.02 110.965 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.4 t -67.35 -44.83 78.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.107 . . . . 75.41 110.007 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.414 HD21 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -93.19 -12.25 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 74.43 109.301 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 301' ' ' PHE . 13.2 mt -66.66 141.75 57.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.556 1.16 . . . . 71.45 109.346 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.4 p -159.33 157.46 30.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 44.22 110.026 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.84 -157.65 50.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.525 1.141 . . . . 74.21 110.986 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 29.4 p -96.01 11.41 34.16 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.286 -1.005 . . . . 64.51 108.286 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.478 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -130.07 151.15 77.84 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 75.02 109.98 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.2 Cg_endo -75.01 148.3 91.39 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.02 -2.491 . . . . 74.45 110.967 0.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.475 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.2 p -130.05 134.29 25.96 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 71.12 110.017 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.08 -172.39 10.72 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 120.994 -2.503 . . . . 75.14 110.992 0.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.63 151.38 30.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 63.15 109.36 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -162.42 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.523 1.802 . . . . 71.31 110.985 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.14 135.51 33.62 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 73.44 109.299 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.424 ' CG1' ' HE2' ' A' ' 300' ' ' LYS . 24.4 m -137.48 24.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.527 1.142 . . . . 74.24 109.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.441 ' C ' ' N ' ' A' ' 318' ' ' CYS . 39.7 t -66.58 -41.07 89.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 75.44 110.041 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -39.72 -29.87 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.443 1.089 . . . . 72.11 109.982 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.441 ' N ' ' C ' ' A' ' 316' ' ' SER . 7.5 m -61.85 -173.9 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.546 1.154 . . . . 63.12 108.3 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 293' ' ' ASN . . . -160.26 -158.82 9.45 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.508 1.13 . . . . 73.44 111.001 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 320' ' ' PHE . 4.4 m-85 . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.503 0.767 . . . . 70.55 111.018 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.459 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 7.4 tp . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.321 -0.622 . . . . 72.2 109.321 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.562 ' HB2' ' CD2' ' A' ' 193' ' ' TYR . . . -105.17 107.61 18.68 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.551 1.157 . . . . 63.43 109.304 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -85.62 10.64 12.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 72.52 110.001 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -150.37 146.82 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 74.22 109.283 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.13 143.04 25.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 72.25 109.29 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.0 -33.06 4.87 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.489 1.784 . . . . 75.55 111.053 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.435 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.78 152.49 21.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 75.21 109.291 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.557 HG22 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -48.98 -35.87 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 74.24 109.313 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.06 -47.47 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 73.23 109.285 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.499 HG23 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.42 -35.83 71.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 54.5 110.381 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.5 OUTLIER -58.2 -57.03 14.65 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.452 1.095 . . . . 72.54 109.293 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.506 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.4 m-80 -52.51 -31.57 36.04 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 71.32 109.291 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.67 -56.83 6.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.14 . . . . 74.02 109.979 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 140' ' ' ILE . 81.3 mt -42.35 -40.11 2.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 74.3 109.254 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -44.58 49.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 74.45 110.99 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -48.03 -36.8 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 73.32 109.28 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.465 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 63.2 mt-30 -76.05 -55.7 5.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 70.12 110.296 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.425 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 18.3 mt -49.52 -27.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 74.13 109.304 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 243' ' ' SER . 0.2 OUTLIER -75.07 -36.7 61.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 75.1 109.315 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.2 t-20 -57.52 -20.08 29.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 74.21 109.257 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 157' ' ' SER . 3.0 mm100 -80.53 -25.41 38.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 75.3 110.26 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 156' ' ' GLN . 19.1 m -39.03 116.94 0.63 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.24 110.019 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.6 m -43.39 136.9 2.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 75.11 108.328 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.39 -43.36 1.52 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.561 1.163 . . . . 65.15 110.955 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.406 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 32.2 p -64.84 159.79 21.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.538 0.787 . . . . 62.03 110.434 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 t -91.56 -4.58 55.22 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.555 1.16 . . . . 63.53 110.0 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.5 m -108.86 -1.91 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 71.11 110.423 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.406 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -72.29 133.16 44.86 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 74.42 109.307 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -169.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 70.33 109.971 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 45.9 p -154.61 127.07 3.97 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 62.12 110.013 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.95 138.87 58.56 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.009 -2.496 . . . . 70.44 111.005 -0.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.79 -178.99 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.481 1.113 . . . . 64.12 108.28 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.59 ' CG2' ' CE2' ' A' ' 170' ' ' PHE . 3.1 mp -92.82 137.97 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 75.32 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.423 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 59.7 p -92.03 85.16 5.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 74.4 110.414 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.59 ' CE2' ' CG2' ' A' ' 168' ' ' ILE . 60.0 m-85 -88.75 -25.2 22.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.502 1.126 . . . . 70.2 110.995 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.09 -1.99 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.548 1.155 . . . . 75.02 110.292 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.575 ' CE1' HG23 ' A' ' 174' ' ' VAL . 22.4 t80 -127.25 69.61 74.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 75.04 111.042 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.413 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 111.56 3.35 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.46 1.768 . . . . 75.33 111.026 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.575 HG23 ' CE1' ' A' ' 172' ' ' TYR . 21.3 t -153.0 -75.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 73.22 109.31 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.46 ' HB2' ' CB ' ' A' ' 312' ' ' ALA . 3.9 m-20 -149.09 131.9 16.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.14 109.258 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 121.71 79.26 0.51 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.493 1.121 . . . . 73.34 111.014 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.78 -1.78 10.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.287 -1.005 . . . . 70.34 108.287 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 29.0 p90 -81.9 -43.91 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.539 1.149 . . . . 73.45 111.002 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.605 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -70.09 -45.2 67.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.522 1.139 . . . . 72.42 109.285 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.509 ' NH2' ' CB ' ' A' ' 240' ' ' SER . 7.3 mtm180 -49.76 -58.76 4.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 73.25 110.325 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -43.02 -52.49 5.25 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 75.24 109.303 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -46.91 -39.51 12.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.505 1.128 . . . . 75.31 109.62 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 180' ' ' ARG . 19.0 mmmt -72.92 -33.3 65.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 73.45 109.281 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 181' ' ' ALA . 17.6 mtm -65.99 -59.21 4.05 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.13 . . . . 73.44 110.997 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -26.07 14.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 64.11 110.318 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -43.42 93.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 65.53 110.274 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.425 ' HB ' ' CG1' ' A' ' 153' ' ' ILE . 22.6 mm -69.86 -38.21 75.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 75.24 109.269 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -54.57 -35.54 63.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.495 1.122 . . . . 75.33 109.318 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.447 ' O ' ' N ' ' A' ' 192' ' ' GLY . 17.0 mtp -70.12 -42.79 72.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 1.15 . . . . 74.24 111.055 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -44.77 -47.12 10.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.52 109.283 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.465 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 23.8 t-20 -67.81 -34.57 77.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 75.15 109.295 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 113.59 55.29 0.42 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.496 1.123 . . . . 74.32 110.972 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.562 ' CD2' ' HB2' ' A' ' 137' ' ' ALA . 83.7 m-85 -153.61 141.51 20.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 0.738 . . . . 75.44 111.009 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.459 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -108.71 122.87 48.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 73.32 109.308 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.442 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 27.5 p -106.41 -179.28 3.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 74.34 108.301 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -126.77 176.89 6.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 63.24 110.317 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -107.83 164.05 12.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 73.15 109.299 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -151.2 117.36 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 71.03 110.305 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.41 ' CE1' HG23 ' A' ' 219' ' ' VAL . 5.7 m-85 -109.18 125.94 52.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.461 1.101 . . . . 74.42 111.041 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.443 HG23 ' CG2' ' A' ' 266' ' ' VAL . 8.6 p -122.35 121.32 63.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 71.55 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 56.2 m-85 -93.9 151.77 19.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 74.35 111.001 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.42 -172.56 19.3 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.493 1.12 . . . . 62.32 111.021 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 263' ' ' SER . 55.4 t-20 -78.25 111.19 13.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 0.751 . . . . 74.13 109.281 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.468 HD11 ' CB ' ' A' ' 218' ' ' HIS . 3.5 mt -115.33 94.25 4.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 75.42 109.359 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.3 mtpt -93.21 170.52 9.57 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.501 1.125 . . . . 74.41 109.297 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -172.58 129.65 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 74.4 109.338 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.6 t -117.89 127.09 53.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.486 1.116 . . . . 75.12 110.007 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 56.4 p -93.28 -26.83 17.16 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.498 1.124 . . . . 64.1 110.408 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 143.03 -63.39 0.5 Allowed Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.518 1.136 . . . . 74.12 110.991 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 53.2 p -99.24 8.07 45.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.546 0.792 . . . . 73.0 110.433 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -173.23 160.95 4.15 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.139 . . . . 73.23 108.288 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.441 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -134.19 -175.64 3.93 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 72.12 108.314 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.441 ' N ' ' SG ' ' A' ' 212' ' ' CYS . 0.4 OUTLIER -153.59 147.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.095 . . . . 73.31 109.314 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.444 ' CB ' ' HE3' ' A' ' 205' ' ' LYS . . . -133.46 128.43 35.42 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.555 1.159 . . . . 62.32 109.33 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -134.39 131.72 38.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 61.41 107.999 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -74.59 -2.54 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 53.02 109.976 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.43 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.1 p90 -173.74 132.9 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.472 1.108 . . . . 72.31 111.008 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.468 ' CB ' HD11 ' A' ' 204' ' ' LEU . 84.6 t60 -121.61 154.68 36.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 73.45 109.581 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.41 HG23 ' CE1' ' A' ' 199' ' ' PHE . 1.6 p -130.61 130.81 64.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.522 1.139 . . . . 65.35 109.349 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.647 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.4 -164.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 53.13 109.268 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 39.1 pt -122.31 120.26 60.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 72.3 109.296 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.49 109.0 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 73.35 109.282 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.463 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.8 OUTLIER -103.04 147.99 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 74.15 109.267 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 51.6 m -118.15 121.27 40.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.481 1.113 . . . . 74.11 110.021 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.557 ' CD2' HG22 ' A' ' 143' ' ' VAL . 31.3 p90 -136.41 144.24 44.4 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 75.53 110.983 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.438 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.8 mmtp -69.49 133.06 47.25 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 75.15 109.263 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.55 -159.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 74.25 109.293 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.15 48.94 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.499 1.124 . . . . 74.31 109.345 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.7 m -115.22 -8.07 12.37 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.153 . . . . 74.41 110.027 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.14 37.58 8.26 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.471 1.107 . . . . 60.44 111.05 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.46 0.741 . . . . 70.24 109.3 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.438 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.3 m -71.79 102.58 2.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 74.44 110.365 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.403 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.9 mm-40 -101.42 -172.54 2.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 74.42 110.31 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -127.0 145.11 50.83 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.491 1.119 . . . . 75.5 109.311 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.498 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 2.9 tpt180 -144.54 160.84 40.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 74.11 110.311 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.501 HG22 ' CD1' ' A' ' 252' ' ' TRP . 16.6 mm -115.13 121.73 67.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 75.41 109.317 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -108.09 44.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.529 1.143 . . . . 73.4 109.285 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.98 107.76 59.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 75.04 109.276 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.563 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.3 Cg_endo -75.01 -2.11 12.11 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.549 1.816 . . . . 70.12 111.018 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.509 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.2 OUTLIER -61.3 -22.66 65.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 74.13 109.992 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.74 -50.21 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 71.55 109.272 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.565 ' CE2' ' HB1' ' A' ' 255' ' ' ALA . 97.4 m-85 -112.18 99.5 8.09 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 74.04 111.025 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.438 ' O ' ' NZ ' ' A' ' 154' ' ' LYS . 71.0 m -90.14 -8.44 51.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 72.22 109.987 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 30.6 p -77.75 -46.44 21.71 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.543 1.152 . . . . 72.31 110.008 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.11 -174.79 40.45 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.445 1.091 . . . . 62.3 111.036 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.449 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.0 164.68 32.87 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.477 1.777 . . . . 74.32 110.99 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.556 HG13 ' CD1' ' A' ' 242' ' ' PHE . 3.5 m -147.82 164.97 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 74.43 109.317 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.7 p -65.93 141.36 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.455 1.097 . . . . 64.23 110.445 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.437 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 1.3 p30 -45.2 -26.55 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 74.33 109.338 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 10.7 m -77.41 -62.95 1.49 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.469 1.106 . . . . 64.21 110.423 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.69 -27.98 8.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 72.42 109.303 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.647 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 11.0 t90 -63.28 -61.82 2.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 75.43 107.997 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.558 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -46.63 -41.87 15.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 74.44 110.309 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -57.24 -50.8 71.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 61.4 109.298 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.565 ' HB1' ' CE2' ' A' ' 242' ' ' PHE . . . -56.87 -24.41 51.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 42.03 109.317 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -83.42 -36.43 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 74.52 108.304 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.489 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.0 m -94.61 21.47 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 72.51 109.303 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.441 ' ND2' ' CB ' ' A' ' 260' ' ' SER . 38.7 t30 -54.41 109.14 0.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 71.13 109.287 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.3 p -73.79 -2.77 24.92 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 74.13 110.386 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.441 ' CB ' ' ND2' ' A' ' 258' ' ' ASN . 33.7 t -44.0 -27.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.098 . . . . 72.01 109.979 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . 0.45 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 48.5 t -94.27 -37.01 11.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 62.22 108.3 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 171.09 -128.33 1.59 Allowed Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.493 1.121 . . . . 70.22 110.968 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -79.86 149.42 30.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 0.78 . . . . 74.14 110.017 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.489 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -170.69 146.35 2.64 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.501 1.125 . . . . 53.14 109.324 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.3 m -173.08 151.99 2.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.449 1.093 . . . . 72.14 109.99 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.462 HG22 ' CG1' ' A' ' 257' ' ' VAL . 2.3 t -97.84 122.35 49.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.52 109.281 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.407 ' C ' ' OG ' ' A' ' 268' ' ' SER . 31.1 t -83.81 -34.21 24.77 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.13 . . . . 74.43 109.999 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 267' ' ' SER . 0.7 OUTLIER -174.78 159.32 2.77 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 74.11 109.978 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -147.5 154.66 41.04 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.447 1.092 . . . . 74.45 110.985 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.32 165.7 34.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 70.33 109.32 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.424 ' O ' ' CG2' ' A' ' 272' ' ' THR . 1.4 p-10 -122.68 160.73 25.23 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 62.41 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 271' ' ' ASN . 45.1 p -154.09 179.43 8.94 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 61.13 110.419 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . 0.427 ' CA ' HG22 ' A' ' 276' ' ' VAL . . . -57.5 166.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.127 . . . . 64.22 109.253 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.49 -18.67 63.65 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.52 1.137 . . . . 72.14 111.012 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.433 ' H ' ' ND2' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -83.98 -19.0 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 0.773 . . . . 73.24 109.287 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . 0.427 HG22 ' CA ' ' A' ' 273' ' ' ALA . 12.9 t -60.48 101.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 71.51 109.301 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.415 ' OH ' ' CE1' ' A' ' 178' ' ' TYR . 15.1 t80 -64.41 -44.45 91.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.559 1.162 . . . . 72.55 111.007 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -144.54 155.78 43.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.542 1.151 . . . . 74.11 110.989 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.447 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 68.0 ttt-85 -124.97 147.45 48.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.41 110.318 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.77 154.07 44.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.104 . . . . 71.54 110.006 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -0.03 9.45 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.496 1.787 . . . . 75.52 111.011 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 6.1 t -104.58 10.6 34.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 64.14 109.969 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.0 t-20 76.21 38.5 0.32 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.54 1.15 . . . . 72.33 109.341 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.2 t -117.9 121.03 39.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 74.1 110.001 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 12.5 m-30 -103.86 158.38 16.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 74.25 110.987 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -118.35 177.64 4.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 73.52 109.3 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.0 m-85 -161.84 115.79 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 73.22 111.045 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.3 96.76 5.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.129 . . . . 73.23 109.346 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -85.62 -15.47 42.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 74.52 109.307 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.423 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.6 m-20 -109.88 2.26 19.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.529 1.143 . . . . 73.42 109.302 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.91 47.07 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 74.43 109.293 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.423 HG12 ' CB ' ' A' ' 290' ' ' ASN . 20.4 mm -73.28 -31.74 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.12 . . . . 74.22 109.315 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 318' ' ' CYS . 1.6 t-20 -93.08 -28.41 16.37 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 74.33 109.27 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.421 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 1.8 m -77.07 -65.69 0.92 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.563 1.164 . . . . 73.44 110.407 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 57.3 m-20 -54.61 -20.07 7.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 71.13 109.296 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 297' ' ' VAL . 25.0 t -83.99 -66.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 72.53 108.278 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 296' ' ' CYS . 3.2 t -40.27 -39.54 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 73.43 109.296 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.23 -57.2 5.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 1.142 . . . . 73.32 109.267 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -22.78 2.47 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.454 1.096 . . . . 75.04 110.358 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -71.32 -48.58 49.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 75.54 109.311 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.7 OUTLIER -98.43 38.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 71.35 111.005 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.0 t -70.07 -48.54 57.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.13 . . . . 52.45 109.971 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.42 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -88.18 -11.36 47.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 75.44 109.284 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.523 HD11 ' CE2' ' A' ' 172' ' ' TYR . 15.1 mt -63.93 142.55 58.37 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 72.25 109.296 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 66.6 p -157.49 148.43 21.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.16 . . . . 75.33 109.964 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.05 -152.12 23.46 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.483 1.114 . . . . 65.13 111.028 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.4 p -103.96 12.87 33.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.309 -0.997 . . . . 53.43 108.309 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.488 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.3 p -134.99 150.99 74.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 74.25 109.992 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.3 Cg_endo -75.01 146.52 86.87 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.001 -2.5 . . . . 73.44 110.992 0.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.488 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 3.3 p -130.06 133.46 25.0 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 71.12 109.968 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.04 -168.16 6.25 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.031 -2.487 . . . . 72.11 110.967 0.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 175' ' ' ASP . . . -56.89 152.73 26.14 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.47 1.106 . . . . 71.11 109.24 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.546 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.06 -162.52 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.5 1.79 . . . . 72.14 110.932 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.65 130.72 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 73.35 109.275 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.85 24.71 2.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 73.14 109.28 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.2 t -68.38 -27.06 65.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 63.43 110.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.5 t -47.19 -24.66 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 74.53 109.961 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.419 ' HB2' ' ND2' ' A' ' 293' ' ' ASN . 1.7 m -76.89 -173.35 2.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 74.34 108.275 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 171.12 83.62 0.06 OUTLIER Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.453 1.095 . . . . 74.34 110.971 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.457 ' CD1' ' C ' ' A' ' 320' ' ' PHE . 2.9 p90 . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.469 0.747 . . . . 75.53 110.969 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.47 ' CD2' ' HB3' ' A' ' 194' ' ' ASP . 4.8 tp . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.295 -0.631 . . . . 75.55 109.295 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.571 ' HB2' ' CD1' ' A' ' 193' ' ' TYR . . . -146.99 108.02 4.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 74.2 109.291 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.401 ' OG ' ' OD2' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -81.75 2.74 28.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 75.3 110.026 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 140' ' ' ILE . 2.4 t -142.23 150.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 74.45 109.243 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.461 HD11 ' CD1' ' A' ' 149' ' ' LEU . 1.0 OUTLIER -102.94 143.31 26.35 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 75.42 109.312 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -33.76 4.33 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.485 1.782 . . . . 74.31 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.44 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.7 151.23 23.75 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.449 1.093 . . . . 75.52 109.288 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.565 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -49.52 -34.81 8.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.485 1.115 . . . . 75.41 109.277 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.48 -46.6 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 74.4 109.255 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.514 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -72.1 -33.22 67.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 72.1 110.36 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.476 ' CD1' ' CG2' ' A' ' 223' ' ' VAL . 0.4 OUTLIER -60.91 -56.44 21.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.511 1.132 . . . . 65.33 109.308 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.497 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 53.6 m-80 -54.05 -30.77 49.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.434 1.084 . . . . 74.13 109.29 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -56.59 7.35 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 63.35 110.032 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.471 HD21 ' CB ' ' A' ' 191' ' ' ASN . 84.1 mt -42.18 -42.43 3.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 74.41 109.318 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -71.17 -44.88 64.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 73.31 111.012 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.43 -39.06 6.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 73.42 109.298 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 155' ' ' ASN . 57.1 mt-30 -75.82 -55.51 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 75.22 110.271 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.476 HG23 ' CG ' ' A' ' 184' ' ' MET . 14.3 mt -51.05 -24.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 74.21 109.368 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 243' ' ' SER . 0.0 OUTLIER -78.74 -33.98 46.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 75.45 109.327 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.4 t-20 -61.73 -14.99 37.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 65.31 109.286 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 157' ' ' SER . 3.2 mm100 -84.08 -18.19 37.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.4 110.287 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' GLN . 11.0 p -37.37 147.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 73.55 110.01 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.4 m -82.28 53.54 2.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 75.34 108.335 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -164.34 27.88 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.531 1.145 . . . . 72.45 111.015 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 60.7 p -132.7 163.19 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 0.754 . . . . 75.1 110.398 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 63.0 m -93.62 0.86 56.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 62.04 110.034 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.0 m -116.68 0.44 12.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 74.11 110.384 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.83 137.99 52.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.13 . . . . 70.21 109.301 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -164.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.132 . . . . 75.04 110.028 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.443 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 15.3 p -155.57 127.39 3.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.476 1.11 . . . . 63.53 110.023 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 139.77 63.61 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.988 -2.505 . . . . 70.33 111.021 -0.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 21.1 p -72.76 -179.53 3.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 64.32 108.312 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.1 mp -92.24 123.24 44.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 74.12 109.344 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.3 p -89.76 80.71 6.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 74.14 110.395 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -80.75 -14.41 58.12 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.24 110.98 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.26 -1.23 22.52 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 74.55 110.278 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.566 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 22.7 t80 -130.9 65.54 76.89 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 73.13 111.001 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.426 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.97 117.24 4.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.486 1.782 . . . . 73.13 110.997 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.558 HG21 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.92 -72.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 70.32 109.301 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.401 ' O ' ' SG ' ' A' ' 177' ' ' CYS . 0.5 OUTLIER -125.37 -44.13 1.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 74.01 109.273 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -53.23 99.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.448 1.093 . . . . 74.52 111.003 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.496 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 3.5 p -134.82 -48.2 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.278 -1.008 . . . . 74.45 108.278 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -69.52 -11.77 61.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.142 . . . . 74.35 110.973 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.41 -68.12 0.53 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 74.5 109.299 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.475 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 11.1 ptm180 -50.64 -49.85 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.157 . . . . 74.25 110.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.463 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.64 -57.63 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 71.51 109.338 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.565 ' CD2' HD13 ' A' ' 291' ' ' LEU . 1.2 t60 -45.86 -43.9 13.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 70.11 109.618 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 180' ' ' ARG . 17.3 mmmt -60.35 -58.58 7.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.125 . . . . 74.53 109.273 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.476 ' CG ' HG23 ' A' ' 153' ' ' ILE . 5.8 mtm -39.01 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 75.11 111.015 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.443 ' NH1' ' SD ' ' A' ' 189' ' ' MET . 2.1 tmt_? -70.57 -50.18 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 74.3 110.3 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 183' ' ' LYS . 0.6 OUTLIER -55.29 -33.97 63.71 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 62.54 110.255 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 153' ' ' ILE . 16.0 mm -77.02 -34.87 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 70.32 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -64.74 -45.12 87.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 65.43 109.338 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.443 ' SD ' ' NH1' ' A' ' 185' ' ' ARG . 63.2 mtp -58.28 -37.2 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.502 1.126 . . . . 72.31 111.064 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -52.29 -52.02 55.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 72.41 109.315 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.471 ' CB ' HD21 ' A' ' 149' ' ' LEU . 7.9 t-20 -63.82 -28.67 70.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 75.32 109.284 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.55 44.94 1.27 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.522 1.139 . . . . 62.24 111.027 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.571 ' CD1' ' HB2' ' A' ' 137' ' ' ALA . 80.0 m-85 -147.82 130.3 15.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 0.76 . . . . 73.31 111.018 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.47 ' HB3' ' CD2' ' A' ' 136' ' ' LEU . 0.4 OUTLIER -97.07 130.78 44.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 74.41 109.313 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.468 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 30.5 p -104.96 -179.48 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.114 . . . . 73.21 108.311 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -129.54 174.59 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.464 1.103 . . . . 74.35 110.32 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.463 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 16.4 mmtt -108.17 169.49 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.52 1.138 . . . . 74.01 109.303 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -164.11 117.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 73.41 110.299 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.51 ' CE1' HG21 ' A' ' 219' ' ' VAL . 6.0 m-85 -108.28 120.5 42.54 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.511 1.132 . . . . 75.34 111.006 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.469 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 7.5 p -109.77 148.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 74.12 109.29 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.414 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 23.5 m-85 -119.91 158.28 27.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 75.33 111.002 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 120.63 -179.73 16.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.512 1.132 . . . . 73.53 110.979 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 263' ' ' SER . 59.3 t-20 -70.39 110.82 5.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.537 0.787 . . . . 74.05 109.304 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' A' ' 218' ' ' HIS . 5.6 mt -114.93 93.43 4.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 75.41 109.267 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.7 mttp -93.55 166.01 12.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 71.21 109.307 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -169.64 147.98 3.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 71.32 109.298 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.2 p -120.84 112.86 19.33 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.509 1.13 . . . . 63.44 109.93 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 27.5 p -82.52 -13.13 57.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 72.32 110.393 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 114.83 -48.15 0.97 Allowed Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.48 1.113 . . . . 72.14 111.013 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.7 t -95.65 -12.55 25.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.494 0.761 . . . . 72.2 110.372 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -170.43 163.36 8.53 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 63.25 108.325 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.479 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.67 144.05 46.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 65.11 108.312 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.83 155.69 10.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 75.25 109.303 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.68 119.26 13.1 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 72.3 109.295 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.434 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -128.39 133.1 48.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 74.24 107.958 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.3 m -79.61 2.5 22.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 65.04 109.985 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 8.9 p90 -174.17 128.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.124 . . . . 74.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 71.2 t60 -116.36 167.6 10.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 73.31 109.612 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.51 HG21 ' CE1' ' A' ' 199' ' ' PHE . 2.6 p -144.79 137.61 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 74.31 109.296 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.651 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.89 -165.7 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 62.12 109.286 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 15.9 pt -115.42 123.54 71.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 74.45 109.295 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.7 tp -87.91 108.83 19.37 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 75.5 109.276 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.476 ' CG2' ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.89 146.98 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 71.03 109.275 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 140' ' ' ILE . 75.4 m -117.09 120.18 37.55 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.434 1.084 . . . . 74.12 110.025 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.565 ' CD2' HG23 ' A' ' 143' ' ' VAL . 32.9 p90 -134.96 143.22 46.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.482 1.114 . . . . 74.23 111.007 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.422 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -68.85 132.38 46.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 74.01 109.315 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.36 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.13 . . . . 75.34 109.323 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.66 0.18 48.04 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 74.53 109.32 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -115.27 -7.89 12.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.465 1.103 . . . . 75.35 110.004 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.44 8.34 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.471 1.107 . . . . 75.32 111.004 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.3 137.63 43.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.532 0.784 . . . . 74.22 109.283 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.422 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.1 m -71.82 102.55 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.115 . . . . 74.14 110.369 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.401 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.6 mm-40 -101.79 -172.59 2.18 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 71.3 110.321 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.3 mmtm -127.13 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 74.52 109.305 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.507 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 0.9 OUTLIER -142.72 163.95 31.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 75.53 110.252 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.556 HD13 ' CE3' ' A' ' 252' ' ' TRP . 26.6 mm -119.01 117.86 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 75.34 109.294 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.0 mm -102.63 47.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 75.13 109.302 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.48 ' OD1' ' CD1' ' A' ' 241' ' ' LEU . 20.7 p-10 -94.73 111.53 54.56 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.504 1.128 . . . . 74.01 109.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.415 ' HG2' ' NH2' ' A' ' 180' ' ' ARG . 18.3 Cg_endo -75.06 -40.28 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.463 1.77 . . . . 63.41 111.01 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -41.59 -39.09 1.51 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.551 1.157 . . . . 62.4 110.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.48 ' CD1' ' OD1' ' A' ' 238' ' ' ASP . 10.5 mt -95.78 -58.34 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 75.13 109.324 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.574 ' CD2' HG13 ' A' ' 247' ' ' VAL . 91.6 m-85 -117.15 99.2 6.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.449 1.093 . . . . 74.32 110.99 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.418 ' O ' ' CE ' ' A' ' 154' ' ' LYS . 35.4 m -90.68 -5.81 55.31 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 73.31 110.0 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 25.3 m -79.42 -47.08 16.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 75.21 109.98 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.13 -175.76 39.84 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.478 1.112 . . . . 75.21 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.449 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 161.7 38.42 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.506 1.793 . . . . 74.03 110.991 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.574 HG13 ' CD2' ' A' ' 242' ' ' PHE . 3.4 m -144.7 157.35 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 73.54 109.314 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.6 p -64.93 137.63 57.87 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 74.4 110.392 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.416 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 0.1 OUTLIER -39.78 -31.12 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 73.32 109.302 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.6 m -71.35 -64.31 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 75.31 110.402 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.42 -24.74 8.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.11 . . . . 72.11 109.282 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.651 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 8.8 t90 -67.33 -59.92 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.478 1.111 . . . . 73.32 108.012 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.566 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -51.95 -41.25 61.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 73.45 110.314 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -54.83 -52.49 62.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.099 . . . . 72.44 109.314 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -55.2 -26.18 37.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 62.23 109.287 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -81.82 -36.36 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 55.33 108.306 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.476 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.0 m -94.69 22.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.137 . . . . 74.51 109.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -52.23 109.21 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 74.3 109.305 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.77 -3.09 26.39 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.153 . . . . 71.32 110.408 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 18.4 t -43.82 -31.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 73.01 110.001 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.8 -37.7 15.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 62.35 108.301 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.46 -126.97 1.49 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.515 1.134 . . . . 63.3 110.997 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.6 145.03 41.47 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 0.772 . . . . 74.44 109.98 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.476 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -168.2 147.72 4.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 64.12 109.324 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 92.2 p -172.87 156.8 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 71.23 110.004 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.469 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 5.2 p -103.12 117.4 48.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.449 1.093 . . . . 75.24 109.3 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 21.0 t -72.05 -44.7 62.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 73.21 109.965 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.4 m -166.66 -174.67 2.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.137 . . . . 74.22 110.011 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -163.09 156.6 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 74.25 110.968 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.85 149.57 26.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 75.4 109.269 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -107.68 157.81 17.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 73.14 109.282 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.434 HG23 ' CZ ' ' A' ' 285' ' ' TYR . 1.4 p -148.82 179.11 8.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.562 1.164 . . . . 71.32 110.411 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -64.95 164.44 12.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.118 . . . . 73.52 109.279 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.0 84.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.557 1.16 . . . . 72.32 111.0 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -84.23 -37.1 22.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 0.746 . . . . 74.11 109.347 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 21.1 t -43.73 108.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 74.15 109.265 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.545 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 1.6 t80 -72.01 -41.33 67.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 73.14 110.978 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.565 ' CD1' ' C ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -162.85 115.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.438 1.086 . . . . 75.14 111.011 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.561 ' HG3' ' CE1' ' A' ' 285' ' ' TYR . 62.8 ttt-85 -95.82 141.53 29.17 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.459 1.099 . . . . 70.01 110.297 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.73 158.02 37.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.548 1.155 . . . . 74.23 110.009 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 0.17 9.24 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 62.11 111.026 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 46.3 t -97.51 9.23 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 71.01 109.989 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER 75.37 27.96 1.02 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 75.11 109.334 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 121.51 45.13 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 1.119 . . . . 70.04 109.971 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 3.3 m-85 -104.8 162.42 13.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 64.43 110.974 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.544 ' CD1' ' CE2' ' A' ' 320' ' ' PHE . 0.7 OUTLIER -121.21 172.12 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 72.23 109.276 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 78.4 m-85 -160.54 127.86 4.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 73.43 111.022 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.438 ' HB2' ' CD2' ' A' ' 182' ' ' HIS . 1.3 m-20 -115.28 114.21 24.89 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.14 . . . . 74.04 109.331 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -85.65 -51.24 6.6 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 63.33 109.305 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -108.13 14.19 25.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 74.32 109.285 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.565 HD13 ' CD2' ' A' ' 182' ' ' HIS . 1.2 mm? 54.19 39.06 30.39 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 63.12 109.296 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 18.6 mm -66.77 -28.99 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 73.43 109.352 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.545 ' HB3' ' CE2' ' A' ' 277' ' ' TYR . 1.7 t-20 -94.81 -29.25 14.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.456 1.098 . . . . 73.52 109.286 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.9 m -79.03 -65.61 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 71.11 110.381 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -49.13 -34.04 13.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 74.53 109.298 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.06 -49.06 60.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 72.33 108.295 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 8.3 t -47.99 -47.85 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.144 . . . . 71.31 109.329 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 301' ' ' PHE . 15.6 mt -67.2 -61.99 1.65 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.51 1.131 . . . . 74.45 109.33 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.04 -25.6 0.34 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 64.43 110.417 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -72.91 -45.12 59.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.45 1.094 . . . . 73.24 109.314 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.566 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 2.0 m-30 -98.91 37.97 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.524 1.14 . . . . 75.32 111.009 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.97 -44.23 73.36 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 63.14 109.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.506 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.85 -18.16 22.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.12 . . . . 73.04 109.274 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.482 ' CD2' ' CD ' ' A' ' 309' ' ' PRO . 13.9 mt -59.78 142.35 53.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.21 109.315 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 86.9 p -152.64 160.75 43.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 73.13 110.005 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.94 -159.05 51.37 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.535 1.147 . . . . 64.53 110.983 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 27.0 p -95.33 16.52 16.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.308 -0.997 . . . . 72.43 108.308 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.483 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 41.7 p -134.93 148.97 69.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 44.43 110.004 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.3 Cg_endo -75.0 147.28 88.9 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.99 -2.504 . . . . 75.25 110.992 -0.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -131.67 135.56 27.04 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 62.22 109.993 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.94 -174.31 13.86 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.005 -2.498 . . . . 71.44 111.027 -0.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.67 156.03 26.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 61.14 109.327 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -162.3 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.461 1.769 . . . . 73.52 110.993 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -89.29 135.87 33.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 74.33 109.315 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.16 23.17 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 74.02 109.272 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 t -57.61 -35.58 70.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 75.52 110.012 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 43.3 t -49.23 -23.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 64.44 109.985 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.5 170.42 15.92 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.558 1.161 . . . . 72.1 108.282 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.427 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . -179.19 104.52 0.19 Allowed Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.459 1.099 . . . . 71.04 110.985 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.544 ' CE2' ' CD1' ' A' ' 286' ' ' LEU . 5.5 p90 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.554 0.796 . . . . 55.43 110.986 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.469 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 2.8 tp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.251 -0.648 . . . . 75.12 109.251 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.546 ' HB1' ' CD1' ' A' ' 193' ' ' TYR . . . -156.25 106.36 2.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 75.34 109.321 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -5.47 54.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 63.02 109.994 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.4 HG11 ' N ' ' A' ' 140' ' ' ILE . 2.3 t -136.38 149.39 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 74.13 109.338 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.46 HD11 ' CD1' ' A' ' 149' ' ' LEU . 0.6 OUTLIER -101.96 143.43 26.59 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.507 1.129 . . . . 74.54 109.299 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 -33.77 4.33 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.451 1.764 . . . . 75.14 110.967 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.06 148.0 16.78 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.526 1.142 . . . . 74.35 109.35 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.554 HG21 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -43.68 -36.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 73.35 109.321 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.5 -49.78 2.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 71.2 109.296 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.45 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -68.73 -37.06 79.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 74.3 110.415 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.473 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.97 -57.33 12.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 74.13 109.332 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.492 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.2 m-80 -53.12 -29.35 30.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 75.43 109.297 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -57.55 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.428 1.08 . . . . 73.5 109.989 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.46 ' CD1' HD11 ' A' ' 140' ' ' ILE . 92.7 mt -42.63 -42.77 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 74.32 109.29 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.53 -44.81 61.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.415 1.072 . . . . 75.43 110.982 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -47.06 -38.14 10.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 72.43 109.284 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.424 ' CB ' ' CG2' ' A' ' 187' ' ' ILE . 58.7 mt-30 -75.53 -53.37 8.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.24 110.293 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.0 mt -51.95 -24.63 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 72.23 109.317 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 243' ' ' SER . 0.1 OUTLIER -77.41 -35.85 53.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.128 . . . . 74.44 109.247 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -61.78 -15.79 44.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.4 109.317 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.468 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 6.9 mm100 -84.73 -17.48 38.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 75.51 110.316 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.8 p -38.54 133.15 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.455 1.097 . . . . 70.41 110.022 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -62.49 135.33 57.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 75.3 108.312 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 112.21 -22.33 18.27 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.515 1.134 . . . . 73.51 110.987 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.431 ' OG1' ' CB ' ' A' ' 163' ' ' ALA . 55.7 p -77.44 161.63 27.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 0.801 . . . . 73.21 110.411 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.2 m -93.56 -2.56 54.07 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.31 110.003 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.5 m -114.98 7.61 15.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.13 . . . . 73.42 110.392 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.431 ' CB ' ' OG1' ' A' ' 160' ' ' THR . . . -84.19 139.44 32.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 74.31 109.3 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -161.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.48 1.113 . . . . 75.31 109.971 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.434 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 127.64 3.75 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 62.42 110.018 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.06 138.25 54.97 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.028 -2.488 . . . . 74.25 110.968 0.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 15.4 p -73.08 178.88 4.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 71.43 108.269 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.459 ' CG2' ' HG2' ' A' ' 180' ' ' ARG . 2.1 mp -87.41 124.72 40.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 73.21 109.264 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.1 p -92.34 72.58 5.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 54.4 110.423 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.415 ' HA ' ' NH1' ' A' ' 180' ' ' ARG . 26.6 p90 -77.75 -14.24 59.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.529 1.143 . . . . 71.15 110.987 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.439 ' HD2' ' N ' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.91 -0.57 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 74.32 110.283 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.568 ' CG ' ' O ' ' A' ' 172' ' ' TYR . 22.0 t80 -129.37 66.3 76.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 74.32 110.999 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.422 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.0 117.76 5.02 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.472 1.775 . . . . 75.21 110.994 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 172' ' ' TYR . 14.0 t -152.28 -54.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.441 1.088 . . . . 62.23 109.254 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.42 -46.71 0.15 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.526 1.141 . . . . 72.34 109.346 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -48.18 103.46 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.526 1.141 . . . . 45.43 110.983 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 42.1 m -138.74 -48.47 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.319 -0.993 . . . . 73.34 108.319 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 13.4 p90 -62.55 -34.52 77.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 75.15 111.01 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.582 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -60.93 -56.88 15.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.46 1.1 . . . . 72.12 109.3 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.459 ' HG2' ' CG2' ' A' ' 168' ' ' ILE . 22.9 mtp180 -53.27 -49.13 67.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 74.15 110.323 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.433 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -41.64 -62.31 0.91 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 73.02 109.347 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.658 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -42.8 -37.02 1.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.512 1.133 . . . . 65.12 109.608 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.632 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 28.0 mmmt -70.67 -55.33 8.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 74.42 109.339 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 20.1 mtm -43.99 -28.73 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 75.41 111.001 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.434 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.3 OUTLIER -75.69 -40.49 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.47 1.106 . . . . 75.32 110.294 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.632 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -51.65 -34.14 36.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 1.132 . . . . 75.23 110.331 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.468 ' CD1' ' HG3' ' A' ' 156' ' ' GLN . 10.9 mm -78.46 -35.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 75.31 109.288 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.449 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.1 OUTLIER -59.83 -40.5 88.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.499 1.124 . . . . 71.41 109.298 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.434 ' HE3' ' CZ ' ' A' ' 185' ' ' ARG . 4.1 mtt -63.75 -42.72 97.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 74.04 110.993 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -47.74 -53.51 14.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.543 1.152 . . . . 74.41 109.289 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.18 -37.48 87.61 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 64.34 109.351 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.48 40.45 1.12 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.517 1.136 . . . . 61.31 111.004 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.546 ' CD1' ' HB1' ' A' ' 137' ' ' ALA . 50.5 m-85 -137.28 134.01 35.64 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 0.766 . . . . 71.01 110.984 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.469 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 0.1 OUTLIER -101.21 144.91 29.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 71.33 109.27 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 188' ' ' LEU . 28.7 p -128.57 -179.4 5.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.144 . . . . 73.14 108.282 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 222' ' ' LEU . 19.9 mp0 -125.35 178.09 5.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.467 1.105 . . . . 74.34 110.271 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.433 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 19.0 mmtt -106.01 159.3 16.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 1.107 . . . . 74.43 109.259 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.468 ' HB3' ' CH2' ' A' ' 252' ' ' TRP . 10.2 tt0 -145.18 117.59 8.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 62.23 110.312 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 3.4 m-85 -116.89 128.02 54.83 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.144 . . . . 74.15 110.98 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.482 ' CG2' ' CG2' ' A' ' 266' ' ' VAL . 12.3 p -117.37 162.8 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.477 1.111 . . . . 74.25 109.281 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.442 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 76.3 m-85 -133.07 157.97 43.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 73.14 110.99 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.26 -177.19 16.42 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.492 1.12 . . . . 72.32 111.043 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 263' ' ' SER . 62.3 t-20 -70.64 109.77 5.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.479 0.753 . . . . 73.2 109.29 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 218' ' ' HIS . 3.3 mt -113.31 95.74 5.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 74.41 109.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 0.4 OUTLIER -92.09 165.61 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 71.12 109.315 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -174.63 151.6 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.522 1.139 . . . . 74.41 109.302 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t -118.1 142.44 47.41 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.537 1.148 . . . . 75.43 110.027 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 7.7 p -129.93 5.43 4.98 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 72.22 110.411 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 210' ' ' THR . . . 108.8 114.41 3.73 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.492 1.12 . . . . 73.02 110.992 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 209' ' ' GLY . 14.7 t 50.48 21.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 0.766 . . . . 63.34 110.413 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 7.5 t -152.37 170.3 20.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 70.03 108.291 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.0 m -154.23 133.29 12.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.133 . . . . 72.31 108.298 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -109.24 139.29 32.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.509 1.131 . . . . 75.32 109.306 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -133.02 126.14 31.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.12 . . . . 71.21 109.293 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.451 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -132.43 147.8 52.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 74.21 108.024 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -91.59 4.44 52.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 73.53 110.007 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 217' ' ' TYR . 26.5 p90 -175.66 122.77 0.2 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 74.22 110.981 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.479 ' CD2' HD11 ' A' ' 241' ' ' LEU . 52.1 t60 -106.56 165.69 11.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 62.21 109.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 199' ' ' PHE . 2.1 p -137.2 155.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.55 1.156 . . . . 74.43 109.245 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.652 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.18 -163.24 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 60.03 109.265 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 27.2 pt -123.86 122.48 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.31 109.288 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 196' ' ' GLU . 13.1 tp -86.36 108.85 18.63 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.542 1.151 . . . . 70.24 109.294 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.9 OUTLIER -101.03 166.68 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.576 1.173 . . . . 64.22 109.313 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 140' ' ' ILE . 64.0 m -137.14 118.95 15.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 64.41 109.977 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.554 ' CD2' HG21 ' A' ' 143' ' ' VAL . 33.0 p90 -135.46 143.43 45.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 72.31 110.959 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -68.49 131.73 45.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 74.54 109.316 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.428 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -71.68 -160.21 0.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 74.13 109.318 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -84.26 -0.58 52.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.115 . . . . 63.03 109.254 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.1 m -114.65 -8.17 12.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.133 . . . . 65.34 109.977 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.21 37.78 7.55 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.131 . . . . 73.02 111.028 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.49 138.31 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.512 0.772 . . . . 74.24 109.256 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -72.06 102.71 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.34 110.413 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.428 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 5.4 mm-40 -101.54 -172.62 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.459 1.099 . . . . 71.23 110.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -128.12 145.11 51.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.466 1.104 . . . . 54.32 109.294 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.459 ' HB3' ' CG2' ' A' ' 223' ' ' VAL . 1.9 tpt180 -143.86 161.79 37.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 75.33 110.331 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.548 HD12 ' CE3' ' A' ' 252' ' ' TRP . 17.5 mm -114.47 119.13 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 74.33 109.359 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.2 mm -105.95 45.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 63.13 109.299 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -105.9 107.72 60.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 64.23 109.347 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -0.42 9.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.51 1.795 . . . . 72.44 110.965 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.6 t -72.81 -4.53 32.17 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.504 1.128 . . . . 73.42 110.013 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.479 HD11 ' CD2' ' A' ' 218' ' ' HIS . 10.3 mt -136.21 -47.02 0.64 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.529 1.143 . . . . 74.32 109.264 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.562 ' CD1' HG12 ' A' ' 247' ' ' VAL . 96.5 m-85 -123.23 101.45 7.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 73.12 110.968 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' SER . . . . . 0.436 ' O ' ' NZ ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -85.21 -22.11 28.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 70.15 110.034 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 69.1 m -62.02 -49.56 75.55 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.02 110.014 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.04 -170.77 37.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.478 1.111 . . . . 74.11 110.996 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.444 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.99 164.18 33.89 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.506 1.793 . . . . 73.51 110.987 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.562 HG12 ' CD1' ' A' ' 242' ' ' PHE . 3.0 m -148.36 160.08 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.554 1.159 . . . . 74.0 109.281 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.4 p -64.81 137.6 57.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 74.5 110.392 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 248' ' ' THR . 5.8 p-10 -40.19 -30.29 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 74.12 109.33 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.3 m -71.47 -64.5 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 75.32 110.413 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.98 -26.11 9.85 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.532 1.145 . . . . 74.55 109.281 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.652 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.7 t90 -65.11 -57.87 7.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 74.25 107.993 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.573 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -52.89 -42.12 65.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 74.24 110.293 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.445 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.3 m-80 -55.14 -50.63 68.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 71.5 109.323 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 242' ' ' PHE . . . -54.86 -26.59 36.5 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.134 . . . . 63.35 109.312 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -82.56 -37.83 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.108 . . . . 64.32 108.33 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.46 ' CA ' ' HB3' ' A' ' 264' ' ' ALA . 3.1 m -92.77 22.69 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 74.33 109.364 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 47.7 t30 -50.38 104.53 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 43.45 109.328 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.7 p -75.01 -4.03 35.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 73.1 110.37 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.415 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -50.74 -22.26 2.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.549 1.156 . . . . 73.25 110.042 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 5.9 m -93.96 -29.47 15.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.457 1.098 . . . . 71.43 108.255 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 159.9 -122.18 1.1 Allowed Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.483 1.114 . . . . 71.45 111.004 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.3 OUTLIER -83.86 140.12 32.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.572 0.807 . . . . 73.53 110.007 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.46 ' HB3' ' CA ' ' A' ' 257' ' ' VAL . . . -169.21 146.37 3.55 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.486 1.116 . . . . 74.14 109.288 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.7 t -172.87 164.02 5.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 75.52 110.002 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.482 ' CG2' ' CG2' ' A' ' 200' ' ' VAL . 6.6 p -105.53 120.54 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 73.53 109.305 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.4 t -80.05 -43.14 22.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.483 1.114 . . . . 75.04 109.984 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.0 m -156.88 176.73 12.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.443 1.089 . . . . 75.11 109.997 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.21 158.77 27.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.574 1.171 . . . . 75.51 110.953 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -172.88 155.37 3.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 65.02 109.345 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.524 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -122.22 159.34 27.48 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.514 1.134 . . . . 74.01 109.344 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.513 HG21 ' CZ ' ' A' ' 285' ' ' TYR . 41.5 p -144.68 167.31 22.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.459 1.1 . . . . 75.45 110.386 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -45.71 158.17 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 1.14 . . . . 63.14 109.289 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -70.24 -46.58 49.26 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.489 1.118 . . . . 73.43 111.026 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -49.5 -37.54 26.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 71.12 109.301 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 98.4 t -45.61 120.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 72.44 109.289 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' A' ' 277' ' ' TYR . 1.0 OUTLIER -75.78 -48.74 20.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 74.35 110.983 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.6 t80 -151.39 154.98 37.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 73.43 111.032 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.561 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 71.1 ttt-85 -118.52 147.53 43.56 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.539 1.149 . . . . 73.35 110.269 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.82 157.4 46.37 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 75.25 109.966 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 0.27 9.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.5 1.79 . . . . 63.52 110.983 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.6 t -105.46 9.13 33.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 74.4 110.003 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.23 40.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.121 . . . . 71.21 109.306 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -119.23 119.81 35.2 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 70.11 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 272' ' ' THR . 10.0 m-30 -100.07 157.96 16.18 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 71.44 111.009 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -118.04 177.64 4.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 73.25 109.244 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.2 m-85 -162.82 132.23 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 74.4 110.98 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.495 ' HB2' ' CD2' ' A' ' 182' ' ' HIS . 0.6 OUTLIER -113.84 112.08 22.8 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.515 1.134 . . . . 72.41 109.334 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -52.17 8.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.461 1.101 . . . . 73.02 109.296 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -115.05 25.08 11.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.518 1.136 . . . . 64.21 109.331 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.658 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 1.9 mm? 48.87 36.59 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 74.01 109.278 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.493 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 18.6 mm -66.04 -30.05 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 74.13 109.317 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.477 ' O ' ' CG2' ' A' ' 297' ' ' VAL . 1.5 t-20 -94.5 -31.35 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.528 1.143 . . . . 73.45 109.245 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.473 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 7.6 m -77.19 -65.89 0.9 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.44 1.087 . . . . 74.32 110.434 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 70.7 m-20 -48.23 -33.17 8.18 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 74.41 109.286 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.4 t -72.72 -40.26 66.27 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 74.31 108.283 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.9 t -59.61 -42.85 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 63.21 109.327 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 301' ' ' PHE . 77.1 mt -71.18 -62.42 1.4 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 71.1 109.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -43.82 -26.38 0.25 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 73.53 110.343 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 314' ' ' ASP . 17.1 mmmt -67.74 -46.77 71.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 65.24 109.255 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.567 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 1.8 m-30 -97.35 36.61 1.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.517 1.136 . . . . 71.25 111.003 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.0 t -67.03 -46.84 73.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.469 1.106 . . . . 71.21 109.978 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -92.13 -18.15 23.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.53 1.144 . . . . 73.13 109.327 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.505 HD12 ' CD1' ' A' ' 301' ' ' PHE . 15.2 mt -59.51 134.17 56.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 75.31 109.303 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 77.3 p -149.67 150.55 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 74.33 109.994 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.6 -162.94 45.79 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.496 1.123 . . . . 73.25 110.986 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 4.6 p -90.17 9.92 26.52 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.295 -1.002 . . . . 71.31 108.295 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.478 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 2.2 p -132.56 150.77 76.75 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 74.11 109.968 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.4 Cg_endo -74.92 146.42 86.63 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 120.984 -2.506 . . . . 73.21 111.046 -0.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.498 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.4 p -131.82 136.05 27.74 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 74.31 110.02 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.81 14.78 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.036 -2.485 . . . . 73.04 111.023 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.59 158.2 32.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 72.15 109.324 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.01 -162.4 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.48 1.779 . . . . 55.11 110.976 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.433 ' O ' ' NZ ' ' A' ' 300' ' ' LYS . 4.9 p-10 -91.79 136.24 33.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 75.41 109.279 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.43 17.58 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.13 109.325 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 318' ' ' CYS . 12.4 t -64.9 -33.01 74.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.151 . . . . 72.53 110.014 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -48.33 -23.92 1.06 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.518 1.136 . . . . 74.32 110.0 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 316' ' ' SER . 1.6 m -79.51 166.51 21.88 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 73.13 108.308 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . -163.15 101.59 0.19 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 64.34 111.009 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 23.9 p90 . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.538 0.787 . . . . 73.52 110.939 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 194' ' ' ASP . 5.0 tp . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.273 -0.639 . . . . 74.32 109.273 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.566 ' HB1' ' CD1' ' A' ' 193' ' ' TYR . . . -150.06 105.31 3.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 70.44 109.306 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -81.77 5.62 18.03 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 73.32 109.992 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -146.35 147.52 17.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.502 1.126 . . . . 74.22 109.302 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.418 ' CD1' HD12 ' A' ' 149' ' ' LEU . 1.1 mt -100.1 142.54 24.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 75.21 109.315 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -32.73 5.12 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.434 1.755 . . . . 73.11 110.972 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.31 147.7 16.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 64.14 109.266 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.537 HG21 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -45.45 -36.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 75.2 109.262 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.98 -47.42 3.02 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.476 1.11 . . . . 73.42 109.297 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.519 HG22 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.38 -36.16 71.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 71.54 110.395 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 143' ' ' VAL . 0.6 OUTLIER -57.91 -56.97 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 74.15 109.303 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.507 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.3 m-80 -52.44 -31.69 35.74 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 75.55 109.299 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.13 -56.13 8.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 74.53 109.98 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.463 ' CD1' ' HG ' ' A' ' 188' ' ' LEU . 45.2 mt -44.08 -42.28 6.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 74.54 109.269 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.468 ' HB2' ' CD1' ' A' ' 237' ' ' ILE . 1.1 t80 -72.44 -44.64 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.15 111.037 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -47.05 -34.5 5.86 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.154 . . . . 75.43 109.291 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.485 HE22 ' ND2' ' A' ' 191' ' ' ASN . 55.1 mt-30 -79.35 -50.85 10.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.121 . . . . 70.12 110.281 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.455 ' CD1' HD11 ' A' ' 188' ' ' LEU . 12.7 mt -54.91 -23.19 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.25 109.282 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -38.55 38.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 74.34 109.259 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.21 -17.44 19.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 73.44 109.323 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -82.94 -25.37 32.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.11 110.327 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.574 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 17.4 m -39.87 126.5 2.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 63.23 109.997 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 10.2 m -58.11 109.88 0.83 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 63.22 108.307 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.71 -18.97 1.13 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.483 1.114 . . . . 61.24 111.007 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 59.4 p -93.25 159.84 15.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 0.762 . . . . 70.14 110.387 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.93 -3.51 58.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 64.42 110.014 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.7 m -110.15 -1.16 17.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 71.35 110.42 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.31 132.82 43.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 72.45 109.294 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -173.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 75.11 109.989 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.429 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.3 p -152.65 126.94 4.5 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.118 . . . . 71.22 109.985 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.88 52.9 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.021 -2.491 . . . . 70.13 110.979 -0.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 9.1 p -72.66 -173.85 1.27 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.125 . . . . 74.22 108.256 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 180' ' ' ARG . 3.3 mp -100.82 134.17 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.116 . . . . 75.43 109.351 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 36.2 p -81.42 86.67 6.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.13 . . . . 74.22 110.377 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 1.6 p90 -88.9 -1.99 58.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 74.52 111.007 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.6 9.88 23.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 71.42 110.258 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.57 ' CE1' HG22 ' A' ' 174' ' ' VAL . 18.0 t80 -129.51 68.09 79.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.476 1.11 . . . . 75.45 110.989 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.45 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -75.03 117.08 4.78 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.528 1.804 . . . . 72.21 111.012 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.57 HG22 ' CE1' ' A' ' 172' ' ' TYR . 2.6 t -151.78 -55.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 71.31 109.262 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.36 -46.77 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 73.45 109.281 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.2 121.22 1.02 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.47 1.106 . . . . 55.11 111.004 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.462 ' HA ' ' CD ' ' A' ' 180' ' ' ARG . 4.3 p -153.02 -47.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.361 -0.978 . . . . 73.15 108.361 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 47.0 p90 -67.53 -44.47 78.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.468 1.105 . . . . 74.23 111.048 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.567 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -54.21 -66.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.472 1.107 . . . . 72.22 109.281 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . 0.5 ' HB3' ' CG2' ' A' ' 168' ' ' ILE . 2.0 ptm85 -42.02 -46.96 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 1.155 . . . . 74.31 110.26 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -50.36 -58.96 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.137 . . . . 74.54 109.268 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -46.35 -28.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 74.15 109.613 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.448 ' HG3' ' CG1' ' A' ' 168' ' ' ILE . 24.4 mmmt -81.03 -40.03 24.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 74.31 109.32 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.449 ' N ' ' O ' ' A' ' 181' ' ' ALA . 9.8 mtm -60.35 -46.64 89.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 74.02 111.005 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.539 ' NH1' ' CE ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -65.85 -30.67 71.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 64.12 110.303 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.444 ' HG2' ' N ' ' A' ' 187' ' ' ILE . 0.0 OUTLIER -59.85 -33.12 71.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 74.12 110.323 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.444 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 25.1 mm -78.5 -50.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 54.21 109.259 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LEU . . . . . 0.477 ' CD2' ' HB3' ' A' ' 195' ' ' CYS . 0.1 OUTLIER -43.62 -36.89 2.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.454 1.096 . . . . 71.45 109.307 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.539 ' CE ' ' NH1' ' A' ' 185' ' ' ARG . 0.6 OUTLIER -68.54 -46.29 69.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.476 1.11 . . . . 74.15 111.0 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -53.5 12.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.53 1.144 . . . . 70.04 109.251 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . 0.485 ' ND2' HE22 ' A' ' 152' ' ' GLN . 6.3 t-20 -62.29 -37.47 85.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 70.23 109.31 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.95 51.37 0.33 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.534 1.146 . . . . 70.01 111.002 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.566 ' CD1' ' HB1' ' A' ' 137' ' ' ALA . 74.0 m-85 -151.43 136.92 17.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 0.757 . . . . 74.43 111.028 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.464 ' HB2' ' CD2' ' A' ' 136' ' ' LEU . 2.8 t70 -102.74 131.47 49.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.498 1.123 . . . . 64.03 109.284 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.502 ' SG ' ' CB ' ' A' ' 185' ' ' ARG . 12.8 p -108.38 -179.27 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 74.33 108.323 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.39 177.35 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.05 110.301 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -109.54 171.67 7.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 74.24 109.306 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -168.72 117.4 0.69 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 75.52 110.324 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.4 m-85 -109.09 137.81 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 73.21 111.014 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.47 ' CG2' ' HB3' ' A' ' 269' ' ' TYR . 9.9 p -129.98 125.59 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 75.13 109.289 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -95.97 151.14 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 73.11 110.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 129.44 -171.07 20.21 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.506 1.129 . . . . 71.31 110.995 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 263' ' ' SER . 56.1 t-20 -79.15 111.47 15.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 0.787 . . . . 73.21 109.302 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.472 HD13 ' CB ' ' A' ' 218' ' ' HIS . 3.3 mt -116.53 94.61 4.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 74.22 109.331 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 256' ' ' CYS . 9.3 mttt -93.08 168.18 11.29 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.472 1.107 . . . . 73.31 109.336 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -167.56 125.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.458 1.099 . . . . 72.44 109.296 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.3 t -116.99 127.05 53.79 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.443 1.09 . . . . 71.41 109.966 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 11.0 p -93.7 -17.8 22.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 74.24 110.4 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 126.25 -48.52 0.96 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.509 1.131 . . . . 73.3 111.024 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -96.61 -20.34 18.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 0.766 . . . . 74.32 110.392 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 5.9 t -156.94 167.61 29.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 74.51 108.343 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.76 178.21 7.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 72.12 108.302 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.34 149.19 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 64.41 109.295 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.46 133.37 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 72.35 109.313 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -134.31 132.01 39.06 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.146 . . . . 74.04 108.009 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.5 p -73.66 -3.59 29.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 63.32 109.988 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -173.95 137.46 0.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 74.21 111.013 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 60.2 t60 -125.9 168.83 13.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 75.34 109.546 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 1.8 p -147.44 133.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 74.44 109.327 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.22 -165.03 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 73.22 109.25 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.459 ' CD1' ' HB ' ' A' ' 237' ' ' ILE . 18.5 pt -116.99 117.66 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.122 . . . . 72.24 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 14.0 tp -81.83 109.05 15.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.24 109.277 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.468 ' CG2' ' HB3' ' A' ' 235' ' ' ARG . 0.8 OUTLIER -104.85 147.86 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 73.43 109.284 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 67.2 m -117.62 121.74 41.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 74.02 109.991 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.537 ' CD2' HG21 ' A' ' 143' ' ' VAL . 31.7 p90 -136.64 143.23 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 73.2 111.028 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.427 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -69.17 132.28 46.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.529 1.143 . . . . 73.02 109.315 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.476 1.11 . . . . 74.32 109.317 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.68 -0.2 49.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.132 . . . . 73.04 109.337 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.7 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.087 . . . . 73.21 110.052 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.25 37.87 8.06 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.511 1.132 . . . . 64.33 111.001 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.418 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.8 137.33 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 75.13 109.305 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.427 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.3 m -71.45 102.54 2.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 73.11 110.428 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.41 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.7 mm-40 -101.8 -172.58 2.18 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 74.21 110.272 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.5 mmtm -126.51 144.89 50.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 75.31 109.3 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.527 ' HB2' ' CE1' ' A' ' 225' ' ' TYR . 2.1 tpt180 -144.17 161.59 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 75.14 110.327 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.468 HG13 ' CG ' ' A' ' 252' ' ' TRP . 17.8 mm -115.85 116.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 75.3 109.287 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . 0.502 ' CG2' ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -100.42 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 64.12 109.293 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.419 ' OD1' ' CE ' ' A' ' 184' ' ' MET . 3.1 m-20 -100.1 110.38 59.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 75.44 109.343 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . 0.442 ' C ' ' N ' ' A' ' 241' ' ' LEU . 18.3 Cg_endo -74.99 -42.99 0.43 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.465 1.771 . . . . 73.13 110.987 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 26.5 p -39.28 -29.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 73.52 109.998 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 239' ' ' PRO . 30.0 mt -101.92 -59.49 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.23 109.288 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.569 ' CD1' HG12 ' A' ' 247' ' ' VAL . 79.7 m-85 -112.29 99.39 7.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 71.24 111.025 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.5 m -86.2 -5.18 59.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 64.55 109.968 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 m -82.65 -45.28 14.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 62.32 109.999 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.74 -173.77 45.1 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.512 1.133 . . . . 73.24 110.993 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.455 ' CG ' HD21 ' A' ' 146' ' ' LEU . 18.5 Cg_endo -74.95 162.73 36.74 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.501 1.79 . . . . 50.53 111.034 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 242' ' ' PHE . 2.7 m -148.18 159.19 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 73.42 109.329 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' THR . . . . . 0.435 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.2 p -62.23 139.93 58.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 74.34 110.418 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.407 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 2.5 p-10 -42.95 -28.13 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.123 . . . . 73.52 109.328 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.435 ' N ' ' C ' ' A' ' 248' ' ' THR . 17.1 m -72.45 -65.0 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 74.44 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.94 14.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.447 1.092 . . . . 70.12 109.29 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' TRP . . . . . 0.632 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 11.9 t90 -59.47 -66.17 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.953 -1.129 . . . . 70.42 107.953 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.564 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -41.67 -39.18 1.59 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 75.42 110.254 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASN . . . . . 0.45 ' HA ' ' CG2' ' A' ' 257' ' ' VAL . 3.1 m-80 -60.12 -50.37 73.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 70.33 109.297 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.567 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -55.1 -28.89 55.89 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.41 109.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' LYS . 7.6 m -81.39 -33.52 32.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 73.03 108.309 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.464 ' CA ' ' HB2' ' A' ' 264' ' ' ALA . 2.4 m -98.14 24.18 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 75.23 109.338 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.87 110.93 0.89 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 75.3 109.271 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.8 p -73.32 -3.04 24.61 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 74.3 110.402 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.2 t -44.34 -26.66 0.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 73.44 109.954 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.83 -36.58 11.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.447 1.092 . . . . 75.21 108.253 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.96 -126.55 1.36 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.116 . . . . 72.01 111.028 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -81.24 150.33 28.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 0.759 . . . . 74.34 110.001 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.464 ' HB2' ' CA ' ' A' ' 257' ' ' VAL . . . -172.28 144.68 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 73.42 109.276 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 41.6 p -172.84 153.14 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 74.33 109.992 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.463 HG23 ' CG1' ' A' ' 257' ' ' VAL . 3.1 t -99.75 125.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 74.14 109.295 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.4 t -85.87 -29.35 23.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.124 . . . . 72.43 109.966 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.6 m 178.58 155.64 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 75.11 109.969 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.47 ' HB3' ' CG2' ' A' ' 200' ' ' VAL . 30.2 p90 -144.14 155.94 44.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 75.32 111.014 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -147.79 154.33 40.34 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.556 1.16 . . . . 71.4 109.293 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.426 ' ND2' ' C ' ' A' ' 271' ' ' ASN . 1.0 OUTLIER -107.62 157.71 17.85 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 73.5 109.323 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.436 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 1.8 p -149.47 178.39 8.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 72.32 110.364 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ALA . . . . . . . . . . . . . . . -67.91 165.93 16.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.425 1.078 . . . . 74.11 109.303 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -75.38 -42.69 27.15 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.545 1.153 . . . . 74.33 110.995 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -55.26 -39.93 70.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 0.767 . . . . 72.41 109.273 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 76.6 t -43.57 101.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 74.31 109.295 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.43 -47.34 84.49 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 74.44 110.978 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -152.12 138.51 18.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.48 1.112 . . . . 71.23 111.036 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.557 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 67.4 ttt-85 -106.84 147.42 29.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 74.53 110.345 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.71 158.12 48.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 63.44 110.011 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 0.25 9.14 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.469 1.773 . . . . 65.14 111.009 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 28.7 t -103.09 7.4 38.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.464 1.103 . . . . 71.52 109.996 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 73.93 41.91 0.39 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.45 109.3 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 t -123.5 121.51 35.85 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.495 1.122 . . . . 74.24 110.04 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 11.5 m-30 -101.27 165.82 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 75.1 110.989 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LEU . . . . . 0.505 HD12 ' CE2' ' A' ' 320' ' ' PHE . 1.1 mm? -124.62 177.37 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 74.32 109.328 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.5 m-85 -160.32 123.21 3.39 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 75.03 110.98 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.49 ' HB2' ' CD2' ' A' ' 182' ' ' HIS . 2.2 m-20 -115.07 104.01 11.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.099 . . . . 73.41 109.302 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.54 -53.81 4.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 74.4 109.32 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ASN . . . . . 0.463 ' CB ' HG12 ' A' ' 292' ' ' ILE . 17.0 m-20 -93.04 15.65 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.558 1.161 . . . . 64.52 109.318 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.592 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.4 mm? 40.27 42.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 72.44 109.308 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . 0.463 HG12 ' CB ' ' A' ' 290' ' ' ASN . 26.6 mm -74.04 -28.38 23.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.542 1.151 . . . . 73.44 109.318 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.538 HD21 ' N ' ' A' ' 319' ' ' GLY . 2.4 t-20 -94.64 -26.91 16.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 74.13 109.313 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 297' ' ' VAL . 23.7 m -82.3 -68.96 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 75.33 110.424 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.6 m-20 -47.52 -29.86 3.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 74.44 109.315 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.69 -43.06 57.05 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 1.094 . . . . 53.33 108.333 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 293' ' ' ASN . 3.1 t -56.46 -50.59 71.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.13 109.256 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 301' ' ' PHE . 10.4 mt -61.85 -63.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 71.31 109.283 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -41.96 -42.45 2.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 72.35 110.425 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -53.34 -44.66 68.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 72.33 109.305 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . 0.562 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 2.5 m-30 -100.42 29.87 4.18 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.541 1.15 . . . . 74.41 110.979 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 27.2 t -62.04 -52.35 64.29 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 72.34 109.989 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' LEU . . . . . 0.427 ' C ' ' CD2' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -84.05 -10.46 57.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 74.15 109.281 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.548 HD13 ' CE2' ' A' ' 172' ' ' TYR . 17.7 mt -73.82 137.18 43.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 73.52 109.288 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 62.9 p -160.7 137.12 8.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 65.11 110.009 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.89 -158.77 15.53 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.565 1.166 . . . . 64.12 111.019 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 8.4 p -95.76 8.7 42.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.347 -0.983 . . . . 73.32 108.347 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' SER . . . . . 0.472 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 4.0 p -139.14 152.11 69.1 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 73.04 109.985 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 308' ' ' SER . 18.3 Cg_endo -75.02 146.64 87.2 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.002 -2.499 . . . . 74.1 111.028 0.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.49 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 6.1 t -132.79 135.15 25.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 74.33 109.999 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.1 Cg_endo -75.01 -173.64 12.7 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.986 -2.506 . . . . 73.31 111.0 0.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.99 152.99 25.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 71.54 109.313 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' PRO . . . . . 0.557 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.491 1.785 . . . . 71.41 110.988 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -81.96 133.05 35.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 72.22 109.264 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.19 16.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 63.4 109.27 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 318' ' ' CYS . 1.7 t -64.04 -40.2 95.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.3 109.955 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.1 t -39.5 -29.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 73.11 110.01 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' CYS . . . . . 0.439 ' N ' ' C ' ' A' ' 316' ' ' SER . 5.2 m -64.84 -174.31 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 74.22 108.287 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.538 ' N ' HD21 ' A' ' 293' ' ' ASN . . . -175.61 167.69 39.7 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.503 1.127 . . . . 54.43 111.046 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.577 ' CD1' ' C ' ' A' ' 320' ' ' PHE . 1.1 p90 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.533 0.784 . . . . 71.43 110.985 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.7 tp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.253 -0.647 . . . . 72.019999999999996 109.253 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.597 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -145.47 112.85 6.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 73.409999999999997 109.312 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -85.84 11.47 11.18 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 63.520000000000003 109.987 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -150.3 149.11 14.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.426 1.079 . . . . 53.329999999999998 109.303 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.024 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -101.48 143.29 26.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 63.5 109.298 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.99 -33.86 4.27 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 62.399999999999999 111.034 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.49 152.52 23.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 61.32 109.294 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.1 t -49.54 -36.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 71.219999999999999 109.311 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.58 2.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 70.230000000000004 109.317 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.701 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -71.53 -36.2 70.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 75.439999999999998 110.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.739 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.93 -57.4 12.95 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 1.155 . . . . 70.049999999999997 109.269 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -51.08 -33.19 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 55.310000000000002 109.29 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -66.9 -56.5 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 74.340000000000003 109.943 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.024 HD12 HD11 ' A' ' 140' ' ' ILE . 59.8 mt -41.82 -41.9 2.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 44.140000000000001 109.3 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.622 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.06 -40.89 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 60.420000000000002 111.033 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -51.01 -36.2 38.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 64.200000000000003 109.306 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 155' ' ' ASN . 20.8 mt-30 -76.52 -56.39 4.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 1.128 . . . . 51.0 110.308 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.633 HG21 ' SD ' ' A' ' 184' ' ' MET . 25.4 mt -50.18 -29.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 71.5 109.296 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -33.44 63.03 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 73.120000000000005 109.302 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -61.72 -15.68 42.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 70.040000000000006 109.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -84.58 -17.68 38.01 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 70.400000000000006 110.301 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.492 ' HA ' ' CD2' ' A' ' 170' ' ' PHE . 16.1 p -38.53 133.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 75.310000000000002 110.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -64.59 130.0 41.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 61.140000000000001 108.315 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.79 -20.75 10.74 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.495 1.122 . . . . 63.229999999999997 110.962 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.803 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 64.2 p -79.24 161.75 26.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 0.791 . . . . 73.129999999999995 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.73 -0.84 55.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.430000000000007 110.016 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 162' ' ' THR . 4.6 m -116.61 6.19 13.38 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 75.030000000000001 110.418 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.803 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.66 138.88 34.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.102 . . . . 74.519999999999996 109.264 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 54.119999999999997 109.977 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.19 127.24 3.6 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.556 1.16 . . . . 74.430000000000007 110.008 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.02 138.02 53.68 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.993 -2.503 . . . . 63.32 111.002 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.03 177.96 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 72.319999999999993 108.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.692 HG21 ' CZ ' ' A' ' 170' ' ' PHE . 3.5 mp -89.53 125.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.515 1.134 . . . . 64.230000000000004 109.276 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.589 HG21 ' O ' ' A' ' 301' ' ' PHE . 65.3 p -79.65 88.23 5.16 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.538 1.149 . . . . 43.130000000000003 110.387 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.692 ' CZ ' HG21 ' A' ' 168' ' ' ILE . 84.8 m-85 -88.01 -26.37 22.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 111.001 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.456 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.77 -1.31 24.44 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 72.510000000000005 110.301 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.689 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 26.4 t80 -128.52 67.6 76.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 71.420000000000002 110.986 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 115.58 4.33 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.482 1.78 . . . . 61.240000000000002 110.979 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.681 HG21 ' CE1' ' A' ' 172' ' ' TYR . 15.8 t -148.85 -72.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 60.140000000000001 109.301 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.02 -45.15 2.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 73.420000000000002 109.306 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -42.33 101.54 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.543 1.152 . . . . 24.23 111.006 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 73.9 m -134.3 -48.15 0.78 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.272 -1.01 . . . . 72.209999999999994 108.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.693 ' HB3' HG11 ' A' ' 219' ' ' VAL . 38.7 p90 -75.61 -45.55 36.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.219999999999999 110.99 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.33 -68.41 0.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 73.140000000000001 109.277 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.834 HH21 ' HD2' ' A' ' 239' ' ' PRO . 3.6 ptm180 -50.09 -47.61 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 73.209999999999994 110.318 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -39.83 -61.2 0.88 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 32.329999999999998 109.304 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.697 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.8 OUTLIER -46.37 -39.68 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.145 . . . . 71.310000000000002 109.595 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.556 ' CB ' HD11 ' A' ' 168' ' ' ILE . 14.1 mmmm -65.25 -61.25 2.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 73.430000000000007 109.281 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.633 ' SD ' HG21 ' A' ' 153' ' ' ILE . 13.8 mtm -39.02 -40.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 61.130000000000003 110.963 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.454 ' NH1' ' CE ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.546 1.154 . . . . 73.230000000000004 110.323 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 183' ' ' LYS . 2.2 pt20 -54.48 -35.92 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 71.209999999999994 110.31 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.7 mm -71.16 -34.15 53.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 63.310000000000002 109.278 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -64.39 -45.78 86.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 74.239999999999995 109.273 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.454 ' CE ' ' NH1' ' A' ' 185' ' ' ARG . 3.5 mtt -55.32 -36.8 66.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 72.109999999999999 111.006 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.62 -50.3 68.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 65.019999999999996 109.305 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -34.23 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 73.430000000000007 109.337 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 107.99 53.39 0.66 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.487 1.117 . . . . 54.439999999999998 111.012 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.701 ' CZ ' HG21 ' A' ' 145' ' ' THR . 72.4 m-85 -153.17 134.86 14.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 0.771 . . . . 72.230000000000004 111.0 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.792 ' HB2' HD23 ' A' ' 136' ' ' LEU . 2.4 t0 -101.43 122.36 43.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 53.350000000000001 109.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.709 ' HB3' HD22 ' A' ' 188' ' ' LEU . 29.5 p -100.11 -179.38 4.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 72.439999999999998 108.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -126.63 174.47 8.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 62.520000000000003 110.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.718 ' HE2' HG22 ' A' ' 221' ' ' ILE . 18.9 mmtt -110.1 159.01 17.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 73.219999999999999 109.301 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.777 ' OE1' HD13 ' A' ' 222' ' ' LEU . 18.3 tt0 -151.39 117.59 5.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 75.299999999999997 110.282 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.559 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.5 m-85 -110.71 118.59 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 61.109999999999999 110.978 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.7 ' CG2' HG23 ' A' ' 266' ' ' VAL . 10.0 p -109.88 146.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 64.200000000000003 109.311 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 12.0 m-85 -118.63 160.43 21.82 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 75.310000000000002 111.041 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.61 -176.04 16.01 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.509 1.131 . . . . 74.120000000000005 110.99 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.768 ' C ' HD23 ' A' ' 204' ' ' LEU . 56.7 t-20 -72.39 110.3 6.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 0.781 . . . . 73.140000000000001 109.298 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.2 mt -114.52 94.74 4.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 70.030000000000001 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.1 mtpt -92.31 178.75 5.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.145 . . . . 61.039999999999999 109.321 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.948 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -178.02 163.24 1.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.219999999999999 109.316 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.549 1.156 . . . . 63.25 110.007 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.281 -1.007 . . . . 73.219999999999999 108.281 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.948 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -134.07 149.68 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 74.109999999999999 109.301 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.34 130.91 27.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 62.049999999999997 109.274 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.452 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -137.68 135.82 36.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.979 -1.119 . . . . 75.120000000000005 107.979 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 72.7 p -80.05 1.11 29.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 73.530000000000001 110.045 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.463 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.0 p90 -176.23 129.83 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.093 . . . . 72.329999999999998 111.0 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 37.4 t60 -114.43 169.05 9.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 62.130000000000003 109.603 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.1 p -146.45 136.37 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 73.349999999999994 109.269 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.641 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.13 -168.04 2.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 75.519999999999996 109.297 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.718 HG22 ' HE2' ' A' ' 197' ' ' LYS . 28.1 pt -115.75 121.51 67.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 74.530000000000001 109.304 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.777 HD13 ' OE1' ' A' ' 198' ' ' GLN . 12.9 tp -85.41 109.03 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 73.340000000000003 109.313 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.739 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -102.8 146.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 62.420000000000002 109.269 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.569 ' HB3' HG22 ' A' ' 139' ' ' VAL . 4.0 m -116.78 119.86 36.75 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 74.510000000000005 110.024 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.57 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.4 p90 -134.93 143.26 46.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 72.420000000000002 111.007 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.419 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -68.61 133.93 49.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 71.450000000000003 109.344 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.02 -160.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.122 . . . . 72.219999999999999 109.306 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.81 0.05 49.05 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 63.210000000000001 109.288 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.4 m -115.12 -8.33 12.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 72.010000000000005 110.009 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.73 37.44 7.98 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.483 1.114 . . . . 71.340000000000003 111.018 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.37 137.4 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.479 0.752 . . . . 71.140000000000001 109.274 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.419 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 6.3 m -71.52 102.66 2.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.484 1.115 . . . . 72.239999999999995 110.425 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 3.0 mm-40 -101.49 -172.24 2.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 71.409999999999997 110.298 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.474 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.1 mmtm -126.97 144.83 50.9 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 62.340000000000003 109.28 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.0 tpt180 -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 72.120000000000005 110.282 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.58 HG21 ' CD1' ' A' ' 252' ' ' TRP . 13.8 mm -114.88 127.67 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 64.439999999999998 109.296 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -111.95 41.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 75.319999999999993 109.332 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.415 ' OD1' ' HE1' ' A' ' 184' ' ' MET . 1.6 m-20 -104.43 108.05 59.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 73.420000000000002 109.289 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.834 ' HD2' HH21 ' A' ' 180' ' ' ARG . 18.1 Cg_endo -75.03 -0.54 10.1 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.477 1.777 . . . . 62.299999999999997 110.995 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.501 ' N ' ' NH2' ' A' ' 180' ' ' ARG . 1.2 t -67.67 -9.29 42.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.542 1.151 . . . . 64.329999999999998 109.944 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.467 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 3.1 mt -135.21 -47.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 71.230000000000004 109.287 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.601 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.5 m-85 -121.0 99.75 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 71.430000000000007 110.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.0 -24.04 26.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 74.540000000000006 109.999 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 p -61.73 -45.74 92.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 72.430000000000007 109.987 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.42 -174.22 41.02 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.496 1.123 . . . . 51.229999999999997 111.017 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.425 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.01 169.18 23.2 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.431 1.753 . . . . 75.430000000000007 110.973 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.601 HG21 ' CE2' ' A' ' 242' ' ' PHE . 4.1 m -152.45 157.21 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 60.439999999999998 109.3 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 36.8 p -60.22 137.09 58.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.447 1.092 . . . . 65.120000000000005 110.395 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 7.7 p-10 -40.57 -29.67 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.475 1.109 . . . . 72.439999999999998 109.334 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.0 m -71.64 -64.91 0.83 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.498 1.124 . . . . 72.340000000000003 110.355 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.0 -30.78 11.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 109.274 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.641 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 15.6 t90 -60.74 -61.9 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 71.430000000000007 107.996 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.611 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -47.44 -40.88 19.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 1.112 . . . . 71.109999999999999 110.316 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.768 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.0 m-80 -57.85 -50.79 72.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 62.350000000000001 109.287 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.79 -23.01 40.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 72.200000000000003 109.287 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.447 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.6 m -84.78 -35.84 22.11 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 73.129999999999995 108.28 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.768 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.9 m -95.24 21.29 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.551 1.157 . . . . 63.009999999999998 109.294 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -50.23 107.27 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 1.1 . . . . 63.130000000000003 109.26 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.9 p -72.49 -3.93 27.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 63.210000000000001 110.435 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.9 t -46.54 -25.03 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 74.030000000000001 110.006 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' CYS . . . . . 0.426 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 19.7 t -94.34 -35.32 12.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 73.140000000000001 108.282 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 162.18 -128.35 1.87 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.489 1.118 . . . . 74.120000000000005 110.981 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -71.28 143.91 50.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 0.768 . . . . 70.120000000000005 109.953 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.3 144.33 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 73.040000000000006 109.297 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.7 t -172.78 154.78 3.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 75.120000000000005 110.007 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.7 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.27 117.54 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 73.299999999999997 109.308 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 20.7 t -73.74 -43.96 57.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 64.099999999999994 110.044 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.1 m -165.23 171.92 13.05 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 70.200000000000003 110.02 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -154.33 155.81 35.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.25 111.012 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -157.81 160.66 38.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 74.219999999999999 109.323 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.432 ' C ' HG23 ' A' ' 272' ' ' THR . 6.7 p30 -121.94 160.64 24.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 71.109999999999999 109.303 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.546 HG21 ' HD2' ' A' ' 279' ' ' ARG . 35.0 p -152.62 175.68 12.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 74.510000000000005 110.37 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.805 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -59.13 156.5 11.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 74.530000000000001 109.334 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.74 -46.13 62.41 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.486 1.116 . . . . 33.43 110.993 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -52.94 -42.38 65.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 0.771 . . . . 73.140000000000001 109.353 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.805 HG23 ' HB3' ' A' ' 273' ' ' ALA . 81.8 t -43.88 101.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.517 1.136 . . . . 74.239999999999995 109.325 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.485 ' HH ' ' HE1' ' A' ' 178' ' ' TYR . 2.6 t80 -58.67 -59.47 5.35 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 63.450000000000003 111.009 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -132.03 150.25 52.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.467 1.104 . . . . 75.519999999999996 111.064 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.559 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 60.8 ttt-85 -119.35 147.47 44.29 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 52.109999999999999 110.313 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.66 158.2 40.93 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 74.200000000000003 110.015 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 0.37 9.0 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.495 1.787 . . . . 63.350000000000001 110.976 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 t -100.47 9.88 41.98 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 71.329999999999998 109.987 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 72.82 40.8 0.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 72.299999999999997 109.336 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -119.18 133.14 55.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.469 1.106 . . . . 74.530000000000001 110.022 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.43 ' OH ' HG22 ' A' ' 272' ' ' THR . 18.0 m-30 -114.38 150.12 35.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 72.5 110.985 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -116.44 177.48 4.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 71.239999999999995 109.274 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 47.7 m-85 -160.59 115.49 2.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 75.0 111.006 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -115.38 94.87 4.9 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.475 1.109 . . . . 75.200000000000003 109.337 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -80.7 -16.74 53.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 71.140000000000001 109.266 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.456 ' HB3' HD11 ' A' ' 292' ' ' ILE . 40.8 m-20 -108.52 5.31 25.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.134 . . . . 64.120000000000005 109.321 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.697 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.27 49.7 2.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.553 1.158 . . . . 73.219999999999999 109.276 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' A' ' 290' ' ' ASN . 40.6 mm -80.03 -29.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.349999999999994 109.317 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.756 ' O ' HG23 ' A' ' 297' ' ' VAL . 11.4 t30 -94.5 -20.59 19.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.13 . . . . 53.229999999999997 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.418 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.7 m -87.59 -68.65 0.74 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.133 . . . . 70.349999999999994 110.365 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 77.4 m-20 -49.75 -31.2 10.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.1 . . . . 73.219999999999999 109.304 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 41.3 t -70.96 -49.36 46.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 72.340000000000003 108.302 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.3 t -52.01 -43.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 64.219999999999999 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 301' ' ' PHE . 21.0 mt -67.2 -61.12 2.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 34.450000000000003 109.3 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -41.4 -31.72 0.27 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.533 1.145 . . . . 45.219999999999999 110.382 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.403 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.0 mmmt -67.14 -51.48 53.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 63.350000000000001 109.252 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.589 ' O ' HG21 ' A' ' 169' ' ' THR . 0.6 OUTLIER -94.58 37.72 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 73.209999999999994 111.025 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 37.0 t -69.08 -46.82 66.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 72.329999999999998 109.953 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.773 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -90.19 -17.55 27.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 72.340000000000003 109.31 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.769 HD22 ' CD ' ' A' ' 309' ' ' PRO . 16.6 mt -57.81 140.07 52.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.535 1.147 . . . . 73.319999999999993 109.297 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.6 p -152.66 140.72 20.29 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.441 1.088 . . . . 72.049999999999997 110.002 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.93 -161.66 27.02 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.497 1.123 . . . . 55.509999999999998 111.0 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.32 6.2 47.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.344 -0.984 . . . . 44.350000000000001 108.344 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 24.0 p -130.22 151.05 77.79 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 64.340000000000003 110.053 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.769 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.03 145.87 85.08 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.998 -2.501 . . . . 74.129999999999995 110.999 0.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.581 ' HB3' HG13 ' A' ' 174' ' ' VAL . 2.0 p -133.59 135.51 25.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 52.409999999999997 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.02 -173.6 12.62 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.047 -2.48 . . . . 70.319999999999993 111.002 0.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.01 154.67 18.35 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.532 1.145 . . . . 52.149999999999999 109.339 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.506 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -74.96 -162.24 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.482 1.78 . . . . 62.200000000000003 111.039 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -85.08 133.83 34.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 73.049999999999997 109.295 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.403 HG12 ' HE2' ' A' ' 300' ' ' LYS . 21.2 m -125.81 25.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 72.109999999999999 109.32 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 t -55.12 -31.7 61.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 72.109999999999999 110.02 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 28.8 p -49.65 -23.58 1.79 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 74.230000000000004 110.026 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 54.109999999999999 108.289 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.898 HD23 ' HB2' ' A' ' 194' ' ' ASP . 8.9 tp . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.271 -0.64 . . . . 63.109999999999999 109.271 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.541 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -103.92 105.46 15.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 75.450000000000003 109.289 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.1 m -83.66 8.46 14.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.129 . . . . 43.340000000000003 109.973 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -150.16 147.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 55.049999999999997 109.266 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.008 HD11 HD12 ' A' ' 149' ' ' LEU . 1.3 mt -97.92 142.14 24.09 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.148 . . . . 64.230000000000004 109.304 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.05 -32.37 5.38 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.519 1.8 . . . . 63.210000000000001 110.969 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.05 148.36 17.01 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 64.510000000000005 109.332 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.1 t -46.11 -36.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 73.230000000000004 109.286 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.88 -47.39 2.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.112 . . . . 72.010000000000005 109.268 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.706 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.55 -36.36 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.54 1.15 . . . . 72.299999999999997 110.394 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.708 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.9 -57.23 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 63.539999999999999 109.295 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -51.62 -32.36 28.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 65.129999999999995 109.297 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.74 -56.29 8.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.420000000000002 110.023 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.008 HD12 HD11 ' A' ' 140' ' ' ILE . 56.6 mt -43.69 -42.19 5.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 63.240000000000002 109.318 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.698 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -71.87 -44.29 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 72.129999999999995 110.987 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -46.4 -35.77 5.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 72.430000000000007 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -77.87 -54.89 5.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 54.340000000000003 110.278 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.044 HD11 HD12 ' A' ' 188' ' ' LEU . 10.2 mt -50.63 -24.5 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.113 . . . . 60.030000000000001 109.275 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -38.39 46.55 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 72.219999999999999 109.31 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.73 -17.04 19.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 62.229999999999997 109.288 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.544 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.9 mm100 -81.91 -26.36 34.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 64.540000000000006 110.29 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 13.9 m -42.24 137.75 1.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 73.230000000000004 109.972 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.69 113.03 4.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 63.439999999999998 108.314 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.58 1.74 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.518 1.136 . . . . 42.5 110.994 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.806 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 72.7 p -93.17 161.66 14.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.538 0.787 . . . . 74.319999999999993 110.385 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.7 p -92.52 -1.82 56.67 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 61.0 109.984 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 162' ' ' THR . 2.4 m -114.74 2.54 14.45 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.329999999999998 110.396 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -75.33 133.54 41.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 71.420000000000002 109.35 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -170.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 73.129999999999995 109.961 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.4 p -154.11 127.33 4.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 72.439999999999998 110.049 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -75.03 138.04 53.78 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 120.966 -2.514 . . . . 75.140000000000001 111.0 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.1 p -72.79 -178.6 2.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.459 1.1 . . . . 44.340000000000003 108.328 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.609 HG23 ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.33 132.88 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 60.140000000000001 109.295 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.1 p -92.68 73.14 5.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 53.310000000000002 110.411 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 12.7 p90 -74.14 -21.3 59.92 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.562 1.164 . . . . 73.140000000000001 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 302' ' ' SER . 0.0 OUTLIER -74.73 -1.85 23.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 71.319999999999993 110.281 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.773 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 21.9 t80 -131.76 66.97 79.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 72.299999999999997 110.976 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.434 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.02 118.79 5.39 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.435 1.755 . . . . 75.200000000000003 110.993 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.578 HG21 ' CE1' ' A' ' 172' ' ' TYR . 6.7 t -152.09 -72.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 63.140000000000001 109.337 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.6 -44.96 1.5 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 63.020000000000003 109.288 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -44.27 110.05 0.32 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.527 1.142 . . . . 64.409999999999997 110.999 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.3 p -147.95 -48.47 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.277 -1.009 . . . . 44.130000000000003 108.277 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -66.58 -16.96 64.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 75.219999999999999 110.984 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.04 -68.11 0.64 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 73.510000000000005 109.334 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.609 ' HB3' HG23 ' A' ' 168' ' ' ILE . 10.0 ptm180 -49.03 -50.62 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.451 1.094 . . . . 75.319999999999993 110.314 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.413 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.21 -56.63 3.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 55.340000000000003 109.296 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.7 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -45.07 -36.71 3.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 55.43 109.575 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 180' ' ' ARG . 30.0 mmmt -68.89 -59.15 3.27 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.15 . . . . 64.409999999999997 109.313 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.471 ' CB ' HD13 ' A' ' 221' ' ' ILE . 11.2 mtm -38.74 -31.45 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.150000000000006 111.009 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.437 ' NH2' ' OD2' ' A' ' 194' ' ' ASP . 0.0 OUTLIER -69.32 -54.08 16.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 73.120000000000005 110.259 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -54.15 -32.62 55.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 73.310000000000002 110.286 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 153' ' ' ILE . 26.1 mm -71.5 -40.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.459 1.1 . . . . 74.510000000000005 109.235 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 1.044 HD12 HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -62.18 -42.46 99.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 60.149999999999999 109.306 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.0 mtt -57.94 -38.93 76.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 43.399999999999999 110.973 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.43 -52.34 54.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 61.0 109.296 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.437 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 7.8 t-20 -64.23 -35.34 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 73.239999999999995 109.315 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.58 53.01 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.44 1.088 . . . . 72.319999999999993 110.99 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.706 ' CZ ' HG21 ' A' ' 145' ' ' THR . 90.0 m-85 -153.28 147.9 26.19 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.541 0.789 . . . . 65.25 111.007 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.898 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -110.02 126.88 54.43 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 70.519999999999996 109.31 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.983 ' HB3' HD22 ' A' ' 188' ' ' LEU . 13.4 p -98.8 -179.27 4.24 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.47 1.106 . . . . 65.120000000000005 108.312 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 27.0 mp0 -133.38 171.62 13.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.562 1.164 . . . . 75.209999999999994 110.357 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.494 ' HZ1' ' HA ' ' A' ' 182' ' ' HIS . 18.1 mmtt -107.01 161.13 15.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.48 1.113 . . . . 62.450000000000003 109.3 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 21.2 tt0 -157.66 117.49 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 73.25 110.323 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 9.1 m-85 -108.49 133.53 52.52 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 75.430000000000007 110.967 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.695 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.7 p -124.38 148.16 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 60.310000000000002 109.301 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.6 m-85 -120.09 156.51 30.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.483 1.114 . . . . 62.539999999999999 111.018 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.42 -178.55 16.37 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.542 1.151 . . . . 25.41 111.006 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.752 ' C ' HD23 ' A' ' 204' ' ' LEU . 57.2 t-20 -71.02 111.25 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 0.772 . . . . 73.409999999999997 109.297 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.752 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.4 mt -115.27 93.62 4.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 62.340000000000003 109.312 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.8 mttp -93.27 165.93 12.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 70.349999999999994 109.287 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.57 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -171.68 154.07 3.57 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 53.219999999999999 109.322 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 75.129999999999995 109.995 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 108.295 -1.002 . . . . 65.120000000000005 108.295 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.57 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -114.44 153.86 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.541 1.151 . . . . 71.239999999999995 109.272 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.467 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -137.4 119.02 14.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 54.340000000000003 109.276 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.32 134.0 51.23 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.019 -1.104 . . . . 72.340000000000003 108.019 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.2 t -79.33 2.32 21.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.485 1.115 . . . . 62.009999999999998 109.945 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.484 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.3 p90 -175.33 128.41 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.448 1.092 . . . . 73.420000000000002 111.006 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.468 ' N ' HD12 ' A' ' 204' ' ' LEU . 83.4 t60 -121.75 167.21 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 74.129999999999995 109.595 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.5 p -145.18 149.73 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.459 1.1 . . . . 45.039999999999999 109.302 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.537 ' CB ' HD12 ' A' ' 236' ' ' ILE . . . -144.46 -159.43 0.99 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 64.219999999999999 109.317 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.487 HG22 ' HE2' ' A' ' 197' ' ' LYS . 14.4 pt -120.0 122.98 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.462 1.102 . . . . 62.409999999999997 109.291 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 234' ' ' LYS . 11.9 tp -86.71 109.01 18.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 74.409999999999997 109.284 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.708 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.51 145.45 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 72.239999999999995 109.325 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.434 ' HB3' HG22 ' A' ' 139' ' ' VAL . 45.4 m -116.56 118.56 32.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 42.100000000000001 109.993 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -133.85 144.79 49.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 73.409999999999997 111.014 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.435 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -69.83 133.96 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 75.299999999999997 109.304 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.12 -159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 75.230000000000004 109.313 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 -0.35 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 64.319999999999993 109.295 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.0 m -114.87 -7.75 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.451 1.095 . . . . 74.129999999999995 109.972 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.57 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.518 1.136 . . . . 52.420000000000002 111.033 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.22 137.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 0.777 . . . . 74.319999999999993 109.275 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.435 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.4 m -71.53 102.65 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 64.010000000000005 110.368 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 1.9 mm-40 -101.74 -172.68 2.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 73.239999999999995 110.259 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.53 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.3 mmtm -127.03 144.93 50.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.400000000000006 109.301 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.589 ' HB3' HG22 ' A' ' 223' ' ' VAL . 1.3 tpt180 -145.48 162.96 36.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 73.409999999999997 110.247 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.537 HD12 ' CB ' ' A' ' 220' ' ' ALA . 10.8 mm -116.85 119.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 64.230000000000004 109.31 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -105.33 43.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 64.329999999999998 109.292 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.436 ' OD1' ' CB ' ' A' ' 240' ' ' SER . 4.2 t70 -101.84 108.13 54.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.457 1.098 . . . . 62.310000000000002 109.315 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -4.84 16.01 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.486 1.782 . . . . 64.120000000000005 111.032 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 t -72.05 -7.94 51.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 62.049999999999997 110.027 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -130.96 -46.59 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 74.340000000000003 109.31 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.79 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.1 m-85 -123.34 106.75 10.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 71.340000000000003 110.98 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -26.22 22.25 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.496 1.123 . . . . 72.420000000000002 109.985 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.5 m -62.62 -47.74 82.46 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.124 . . . . 73.239999999999995 110.034 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.41 -173.78 40.66 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.474 1.109 . . . . 74.010000000000005 110.965 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.425 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 169.98 21.41 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.514 1.797 . . . . 72.439999999999998 111.017 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.79 HG21 ' CE2' ' A' ' 242' ' ' PHE . 13.7 m -148.61 159.46 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 74.340000000000003 109.302 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 43.3 p -61.71 142.08 57.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 63.420000000000002 110.427 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 249' ' ' ASP . 1.2 p-10 -45.82 -26.17 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.157 . . . . 75.120000000000005 109.333 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 29.1 m -80.88 -61.42 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 64.439999999999998 110.387 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.94 -22.01 5.05 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 64.409999999999997 109.235 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.57 ' CE3' ' HD3' ' A' ' 253' ' ' ARG . 9.5 t90 -67.05 -59.04 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.48 1.113 . . . . 71.219999999999999 108.017 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.06 -43.54 40.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.569 1.168 . . . . 72.5 110.278 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.842 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.2 m-80 -53.74 -52.16 61.04 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 70.420000000000002 109.319 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.676 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.4 -18.77 12.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 72.519999999999996 109.306 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.8 m -90.34 -35.0 15.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.299999999999997 108.287 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.842 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -94.47 21.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 71.219999999999999 109.32 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -51.34 109.24 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 61.219999999999999 109.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.0 p -74.71 -3.06 29.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.506 1.129 . . . . 71.540000000000006 110.396 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t -44.22 -31.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.508 1.13 . . . . 45.240000000000002 110.018 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 46.2 t -88.24 -37.39 16.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 70.109999999999999 108.304 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.32 -127.58 1.56 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.45 1.094 . . . . 73.129999999999995 111.032 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.1 146.83 39.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 0.784 . . . . 61.140000000000001 110.023 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.39 147.83 4.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 1.115 . . . . 63.229999999999997 109.286 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 39.0 m -172.83 153.86 2.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.448 1.093 . . . . 63.210000000000001 109.985 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.695 HG23 ' CG2' ' A' ' 200' ' ' VAL . 3.6 p -101.81 115.49 43.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 74.120000000000005 109.303 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 9.2 t -70.32 -45.17 66.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.113 . . . . 71.530000000000001 110.016 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.612 ' O ' HG23 ' A' ' 200' ' ' VAL . 3.6 m -163.73 -174.88 3.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.499 1.124 . . . . 70.310000000000002 109.991 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -165.78 156.53 13.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 73.040000000000006 110.996 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -153.77 162.49 41.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.464 1.102 . . . . 71.310000000000002 109.276 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.491 ' O ' HG23 ' A' ' 272' ' ' THR . 7.8 p30 -121.82 159.88 25.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.319999999999993 109.318 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.601 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.5 p -154.37 178.12 10.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.146 . . . . 61.530000000000001 110.381 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.934 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -61.3 167.29 3.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 75.319999999999993 109.307 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.98 -18.76 66.72 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 71.219999999999999 111.015 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.94 -39.15 21.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 0.759 . . . . 73.299999999999997 109.319 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.934 HG23 ' HB3' ' A' ' 273' ' ' ALA . 61.7 t -43.6 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.535 1.147 . . . . 74.430000000000007 109.32 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.0 t80 -53.92 -54.78 34.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.523 1.139 . . . . 72.340000000000003 111.018 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.572 ' CE2' ' O ' ' A' ' 279' ' ' ARG . 66.9 t80 -143.39 159.92 41.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 72.040000000000006 110.949 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.601 ' HD2' HG21 ' A' ' 272' ' ' THR . 76.4 ttt-85 -122.73 147.57 46.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 72.120000000000005 110.35 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.21 154.32 48.68 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.46 1.1 . . . . 75.010000000000005 109.964 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.18 9.22 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.49 1.784 . . . . 74.430000000000007 110.972 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 14.2 t -104.62 7.76 35.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.534 1.147 . . . . 72.239999999999995 110.013 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 76.7 41.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 72.400000000000006 109.275 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.4 t -119.56 118.99 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 74.439999999999998 109.997 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -102.78 159.1 15.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.219999999999999 111.034 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.7 OUTLIER -123.94 176.93 6.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 70.540000000000006 109.259 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 94.7 m-85 -161.31 115.37 2.0 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 63.450000000000003 111.014 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.408 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.8 t0 -115.3 95.06 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.103 . . . . 51.539999999999999 109.279 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.64 -19.45 30.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.469 1.106 . . . . 74.109999999999999 109.285 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.455 ' CB ' HG12 ' A' ' 292' ' ' ILE . 50.7 m-20 -105.71 4.18 29.76 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.12 . . . . 73.340000000000003 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.7 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.5 mm? 40.41 49.15 2.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 55.43 109.291 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.455 HG12 ' CB ' ' A' ' 290' ' ' ASN . 30.8 mm -78.7 -28.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.539 1.149 . . . . 73.340000000000003 109.339 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.787 ' O ' HG23 ' A' ' 297' ' ' VAL . 8.2 t30 -94.71 -24.0 17.32 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.117 . . . . 54.509999999999998 109.29 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 4.4 m -83.11 -68.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.537 1.148 . . . . 63.509999999999998 110.43 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 56.3 m-20 -51.05 -28.54 10.51 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 62.219999999999999 109.323 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 11.5 t -70.9 -66.5 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.133 . . . . 54.409999999999997 108.317 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 293' ' ' ASN . 53.5 t -43.44 -42.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 62.340000000000003 109.311 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.13 -58.02 10.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.472 1.108 . . . . 62.310000000000002 109.273 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -19.5 52.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 52.229999999999997 110.429 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.493 ' HE2' HG12 ' A' ' 315' ' ' VAL . 18.5 mmmt -76.3 -42.39 45.43 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 75.310000000000002 109.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.712 ' CE2' HG13 ' A' ' 297' ' ' VAL . 1.7 m-30 -106.02 40.41 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 74.519999999999996 111.054 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' SER . . . . . 0.447 ' O ' ' NH1' ' A' ' 171' ' ' ARG . 29.6 t -68.0 -55.28 13.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.145 . . . . 42.399999999999999 110.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.793 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -79.39 -18.33 52.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 64.349999999999994 109.28 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.773 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 13.3 mt -57.42 139.27 53.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.105 . . . . 75.349999999999994 109.343 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 90.3 p -149.95 166.13 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 74.329999999999998 109.995 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 68.22 -153.05 52.83 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.473 1.108 . . . . 51.350000000000001 110.978 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.7 p -103.13 15.53 29.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.283 -1.006 . . . . 50.109999999999999 108.283 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.511 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -133.59 150.26 74.39 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 71.030000000000001 109.992 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.735 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.97 146.71 87.41 Favored 'Cis proline' 0 C--N 1.359 1.108 0 C-N-CA 121.052 -2.478 . . . . 45.530000000000001 110.994 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -129.75 133.39 24.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 64.109999999999999 110.033 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -168.22 6.29 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 121.044 -2.482 . . . . 40.039999999999999 110.982 0.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.71 152.08 28.2 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 65.430000000000007 109.309 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.56 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.03 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.505 1.792 . . . . 54.210000000000001 111.039 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.08 131.24 34.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.533 1.146 . . . . 71.010000000000005 109.321 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.493 HG12 ' HE2' ' A' ' 300' ' ' LYS . 33.4 m -128.48 27.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 73.5 109.306 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 27.0 t -57.37 -24.12 53.38 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 74.230000000000004 109.961 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -58.2 -16.8 15.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 75.239999999999995 109.984 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 61.7 m . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 72.450000000000003 108.346 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' A' ' 194' ' ' ASP . 6.9 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.267 -0.642 . . . . 74.319999999999993 109.267 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.574 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -109.03 111.75 23.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 74.099999999999994 109.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.486 ' CB ' ' OD1' ' A' ' 194' ' ' ASP . 0.7 OUTLIER -86.72 6.1 32.99 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 73.400000000000006 109.966 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -145.94 150.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.468 1.105 . . . . 72.010000000000005 109.314 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.029 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -103.28 143.13 26.0 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 71.239999999999995 109.33 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -75.05 -33.73 4.31 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.509 1.794 . . . . 51.149999999999999 111.02 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.429 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.45 150.36 23.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.114 . . . . 75.219999999999999 109.318 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.505 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -49.06 -33.91 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 54.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.85 -46.28 5.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 62.340000000000003 109.327 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.573 HG22 HG12 ' A' ' 140' ' ' ILE . 1.8 m -72.92 -32.16 65.12 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 74.519999999999996 110.421 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.746 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -61.9 -56.16 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 73.329999999999998 109.332 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -53.64 -31.07 45.87 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.533 1.146 . . . . 65.019999999999996 109.3 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -70.26 -55.92 8.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 42.009999999999998 109.953 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.029 HD12 HD11 ' A' ' 140' ' ' ILE . 70.4 mt -42.63 -42.24 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 1.094 . . . . 64.530000000000001 109.32 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.753 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.2 -45.11 61.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.141 . . . . 64.239999999999995 111.006 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.61 -39.66 17.41 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 64.319999999999993 109.271 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 155' ' ' ASN . 28.0 mt-30 -73.54 -57.07 4.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 43.32 110.292 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.876 HD11 HD12 ' A' ' 188' ' ' LEU . 10.7 mt -50.01 -23.27 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 53.509999999999998 109.28 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -76.46 -37.58 56.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 72.340000000000003 109.285 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -57.03 -18.63 14.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 73.540000000000006 109.312 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.532 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.8 mm100 -80.24 -27.4 38.69 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.464 1.102 . . . . 73.230000000000004 110.341 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' GLN . 15.6 m -39.47 129.59 1.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 73.340000000000003 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 7.4 m -58.85 113.31 2.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.43 1.081 . . . . 71.420000000000002 108.295 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.36 -17.12 1.68 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.486 1.116 . . . . 54.340000000000003 110.982 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.714 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 46.0 p -95.33 161.56 14.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 0.76 . . . . 63.119999999999997 110.398 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 m -92.9 -3.76 54.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 1.152 . . . . 62.310000000000002 109.956 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 162' ' ' THR . 3.0 m -109.5 -1.62 18.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 72.140000000000001 110.405 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.714 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -73.08 134.39 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.439 1.087 . . . . 73.310000000000002 109.314 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.409 ' HB2' ' NE2' ' A' ' 156' ' ' GLN . 0.4 OUTLIER -55.59 -166.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 53.140000000000001 109.996 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.0 m -156.24 127.93 3.84 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 74.310000000000002 110.02 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 137.8 52.39 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.944 -2.523 . . . . 34.229999999999997 111.027 0.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.0 p -73.0 -179.38 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.103 . . . . 65.319999999999993 108.307 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.649 HG23 ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.11 128.31 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 54.329999999999998 109.284 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 67.7 p -94.71 84.73 4.29 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 43.310000000000002 110.356 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -88.55 -12.7 42.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.522 1.139 . . . . 60.310000000000002 110.976 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.77 -4.1 29.41 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.526 1.141 . . . . 73.010000000000005 110.324 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.778 ' CE2' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -131.02 70.01 82.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.25 111.011 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.442 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.0 Cg_endo -75.05 113.56 3.82 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.535 1.808 . . . . 71.430000000000007 110.957 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.589 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.7 t -153.41 -67.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 61.420000000000002 109.298 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -159.34 112.88 2.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.527 1.142 . . . . 73.010000000000005 109.339 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.55 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.68 68.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.515 1.134 . . . . 51.340000000000003 111.002 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 42.4 m -107.5 -8.42 16.24 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.28 -1.008 . . . . 53.200000000000003 108.28 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.57 ' HB3' HG11 ' A' ' 219' ' ' VAL . 35.4 p90 -81.16 -23.83 37.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 55.100000000000001 110.964 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.08 -68.11 0.52 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 62.340000000000003 109.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.649 ' HB3' HG23 ' A' ' 168' ' ' ILE . 8.0 ptm180 -44.23 -51.12 8.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 52.32 110.309 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -40.35 -62.84 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.420000000000002 109.321 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.699 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -42.24 -39.09 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 73.439999999999998 109.625 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.586 ' HE3' HE22 ' A' ' 186' ' ' GLN . 28.0 mmmt -68.69 -54.9 13.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.544 1.152 . . . . 61.530000000000001 109.308 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.478 ' SD ' HG21 ' A' ' 153' ' ' ILE . 8.6 mtm -39.57 -41.72 1.06 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.466 1.104 . . . . 71.349999999999994 110.986 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.442 ' CG ' ' SG ' ' A' ' 195' ' ' CYS . 0.6 OUTLIER -62.63 -45.01 94.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 74.150000000000006 110.318 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.586 HE22 ' HE3' ' A' ' 183' ' ' LYS . 2.5 pt20 -50.93 -31.81 18.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 72.200000000000003 110.307 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.481 HD13 ' HG3' ' A' ' 186' ' ' GLN . 10.4 mm -82.95 -39.43 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.13 . . . . 74.409999999999997 109.322 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.876 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -57.76 -39.34 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.511 1.132 . . . . 74.310000000000002 109.314 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.581 ' HG2' HD21 ' A' ' 136' ' ' LEU . 32.9 mtp -65.84 -45.78 80.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 72.319999999999993 110.98 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -42.87 -53.45 4.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 53.43 109.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -62.64 -39.14 92.9 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 75.439999999999998 109.354 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 118.74 46.7 0.43 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.518 1.136 . . . . 62.5 111.0 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.676 ' O ' HD23 ' A' ' 188' ' ' LEU . 92.5 m-85 -150.93 129.82 12.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 74.439999999999998 111.004 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.777 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -96.98 130.76 44.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 75.010000000000005 109.358 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.829 ' HB3' HD22 ' A' ' 188' ' ' LEU . 13.9 p -102.65 173.49 6.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 62.229999999999997 108.314 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 55.32 110.324 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -100.04 158.39 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 64.099999999999994 109.32 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.534 ' OE1' HD11 ' A' ' 236' ' ' ILE . 20.4 tt0 -145.88 117.32 7.99 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 63.310000000000002 110.327 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -110.72 126.47 54.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.142 . . . . 74.109999999999999 111.032 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.649 HG21 ' CG ' ' A' ' 253' ' ' ARG . 9.1 p -125.92 128.53 72.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.458 1.099 . . . . 74.209999999999994 109.334 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.412 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 17.1 m-85 -103.44 158.37 16.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 111.005 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.94 -176.38 16.41 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.523 1.139 . . . . 43.549999999999997 110.97 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.768 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.5 t-20 -72.18 110.98 7.0 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 0.765 . . . . 54.310000000000002 109.273 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.1 mt -115.17 94.69 4.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 51.100000000000001 109.307 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.766 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 4.5 mtpt -92.87 170.92 9.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 73.409999999999997 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.535 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -172.96 122.53 0.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.11 . . . . 72.040000000000006 109.29 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 54.310000000000002 109.956 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.527 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 108.275 -1.009 . . . . 73.549999999999997 108.275 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.1 OUTLIER -157.07 161.14 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.457 1.098 . . . . 74.219999999999999 109.326 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.766 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -140.23 137.53 34.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.491 1.119 . . . . 75.310000000000002 109.298 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -138.2 134.55 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.479 1.112 . . . . 74.310000000000002 108.014 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -78.27 -1.03 31.03 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.46 1.1 . . . . 74.230000000000004 110.034 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.4 p90 -173.96 130.42 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 75.420000000000002 110.987 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.483 ' N ' HD12 ' A' ' 204' ' ' LEU . 48.3 t60 -117.59 165.55 13.44 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.519 1.137 . . . . 71.120000000000005 109.588 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.0 p -140.76 135.87 34.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 64.209999999999994 109.315 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -136.34 -164.38 1.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 61.119999999999997 109.312 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' A' ' 237' ' ' ILE . 22.6 pt -119.42 123.28 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 70.219999999999999 109.295 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.6 tp -89.77 108.96 20.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 71.099999999999994 109.3 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.97 146.66 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.11 . . . . 73.030000000000001 109.27 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.6 ' HB3' HG22 ' A' ' 139' ' ' VAL . 9.4 m -116.7 119.42 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.141 . . . . 65.030000000000001 109.991 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.6 p90 -134.5 142.89 47.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.209999999999994 110.998 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.43 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.8 mmtp -68.28 134.4 50.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 74.129999999999995 109.316 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.62 -160.07 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 1.091 . . . . 64.329999999999998 109.257 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.39 50.75 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 72.329999999999998 109.341 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.0 m -115.02 -7.48 12.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.479 1.112 . . . . 74.150000000000006 110.033 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.67 8.45 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.467 1.104 . . . . 62.420000000000002 110.95 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.24 137.63 42.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 0.743 . . . . 74.040000000000006 109.273 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.43 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 13.4 m -71.52 102.65 2.75 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 74.019999999999996 110.416 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.7 mm-40 -101.4 -172.46 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 55.43 110.277 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.534 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.9 mmtm -127.18 144.98 50.92 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.449 1.093 . . . . 70.310000000000002 109.246 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.62 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.6 tpt180 -145.02 160.45 41.35 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 65.209999999999994 110.316 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.534 HD11 ' OE1' ' A' ' 198' ' ' GLN . 12.7 mm -115.53 118.02 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 73.219999999999999 109.336 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.753 HD12 ' HB2' ' A' ' 150' ' ' PHE . 3.8 mm -102.38 45.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.516 1.135 . . . . 62.539999999999999 109.301 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.35 111.27 65.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 73.150000000000006 109.301 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.96 -26.59 10.85 Favored 'Trans proline' 0 C--N 1.361 1.202 0 O-C-N 124.47 1.773 . . . . 71.129999999999995 111.036 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.408 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.5 t -48.06 -24.19 1.03 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.136 . . . . 74.310000000000002 110.001 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.404 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 25.2 mt -113.56 -54.72 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 72.230000000000004 109.316 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.725 ' CE2' HG21 ' A' ' 247' ' ' VAL . 94.9 m-85 -117.88 99.58 7.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.543 1.152 . . . . 62.240000000000002 111.025 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -28.34 34.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 75.099999999999994 109.947 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.7 t -59.01 -48.77 80.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 71.530000000000001 109.991 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.34 -172.83 39.19 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.495 1.122 . . . . 55.539999999999999 110.959 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.424 ' HB3' HD13 ' A' ' 237' ' ' ILE . 18.4 Cg_endo -74.97 170.63 20.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.449 1.763 . . . . 41.549999999999997 110.976 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 242' ' ' PHE . 10.7 m -151.01 158.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 72.040000000000006 109.297 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.4 p -59.61 142.49 52.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.545 1.153 . . . . 73.219999999999999 110.414 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.405 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 18.5 p-10 -46.61 -25.56 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 74.319999999999993 109.303 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.411 ' N ' ' C ' ' A' ' 248' ' ' THR . 27.8 m -79.36 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 33.240000000000002 110.409 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -49.86 -29.19 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 51.450000000000003 109.293 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 12.7 t90 -62.01 -65.88 0.62 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.430000000000007 108.022 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.762 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -40.58 -38.23 0.84 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 54.109999999999999 110.308 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.875 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.0 m-80 -60.07 -50.74 72.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.555 1.16 . . . . 74.209999999999994 109.297 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.535 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -54.08 -29.0 42.74 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.476 1.11 . . . . 65.25 109.255 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 5.6 m -81.14 -36.36 30.34 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 54.439999999999998 108.253 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.875 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.5 m -94.66 23.91 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 72.230000000000004 109.301 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -54.52 107.95 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 65.450000000000003 109.302 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.1 p -73.03 -3.18 24.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 45.409999999999997 110.383 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.6 t -44.99 -25.93 0.37 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 54.340000000000003 109.976 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' CYS . . . . . 0.416 ' N ' ' C ' ' A' ' 259' ' ' THR . 52.4 t -94.72 -36.57 11.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 52.219999999999999 108.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.14 -128.13 1.63 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.466 1.104 . . . . 64.120000000000005 111.032 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.77 148.98 34.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 64.439999999999998 110.038 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -172.5 146.32 1.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.501 1.126 . . . . 74.439999999999998 109.302 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.8 p -173.03 156.98 3.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 74.519999999999996 109.988 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.581 HG23 HG22 ' A' ' 200' ' ' VAL . 2.6 p -98.8 124.29 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.496 1.123 . . . . 73.349999999999994 109.263 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 39.1 t -86.31 -41.93 14.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 54.130000000000003 109.948 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.52 -174.13 4.8 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 50.350000000000001 110.007 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 9.5 p90 -170.89 155.7 4.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 73.219999999999999 111.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -163.11 173.21 13.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 64.450000000000003 109.319 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.477 ' C ' ' CG2' ' A' ' 272' ' ' THR . 6.8 p30 -146.5 160.72 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 55.329999999999998 109.27 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.477 ' CG2' ' C ' ' A' ' 271' ' ' ASN . 6.7 p -151.67 -173.5 4.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.469 1.106 . . . . 73.129999999999995 110.415 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.79 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -67.72 148.95 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 65.519999999999996 109.315 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -58.87 -44.55 95.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.516 1.135 . . . . 61.409999999999997 111.023 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.434 ' OD1' ' NH1' ' A' ' 185' ' ' ARG . 16.4 m-80 -52.92 -39.6 62.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 0.749 . . . . 43.539999999999999 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.79 HG23 ' HB3' ' A' ' 273' ' ' ALA . 21.5 t -47.98 118.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.537 1.148 . . . . 74.299999999999997 109.303 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.6 t80 -73.32 -49.43 27.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 72.219999999999999 111.043 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 39.5 t80 -148.81 160.32 43.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 64.420000000000002 110.99 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.568 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 58.3 ttt-85 -130.34 146.83 51.97 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 75.129999999999995 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.42 157.59 40.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 70.549999999999997 109.983 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 -0.57 10.13 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 71.510000000000005 110.94 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 13.6 m -98.09 5.12 48.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.137 . . . . 71.420000000000002 110.004 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 78.27 35.96 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 65.010000000000005 109.235 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -117.52 119.32 34.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 1.131 . . . . 51.329999999999998 110.004 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -101.56 157.69 16.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.118 . . . . 73.510000000000005 111.005 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 286' ' ' LEU . 0.8 OUTLIER -119.44 174.85 6.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 63.219999999999999 109.273 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -157.43 115.05 3.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.120000000000005 111.015 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.446 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.5 t0 -115.37 96.6 5.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 73.209999999999994 109.284 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.72 -31.04 22.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 71.319999999999993 109.262 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.457 ' CB ' HG12 ' A' ' 292' ' ' ILE . 5.1 m120 -95.01 5.62 51.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 62.219999999999999 109.345 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.699 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.3 46.82 2.04 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.5 1.125 . . . . 71.319999999999993 109.287 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.457 HG12 ' CB ' ' A' ' 290' ' ' ASN . 26.2 mm -74.83 -33.24 30.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 71.319999999999993 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.745 ' O ' HG23 ' A' ' 297' ' ' VAL . 4.3 t30 -92.73 -20.54 20.68 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.513 1.133 . . . . 52.130000000000003 109.27 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.433 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 3.2 m -86.13 -62.55 1.49 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 75.439999999999998 110.379 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 76.3 m-20 -56.66 -24.13 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.422 1.076 . . . . 63.549999999999997 109.28 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 39.4 t -78.91 -48.2 15.04 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.47 1.106 . . . . 50.43 108.272 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.2 t -57.61 -28.06 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 72.200000000000003 109.314 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.5 mt -80.05 -59.81 2.58 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.559 1.162 . . . . 72.420000000000002 109.29 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -54.01 -19.3 4.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.549 1.156 . . . . 60.0 110.419 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.748 ' HE2' HG12 ' A' ' 315' ' ' VAL . 19.4 mmmt -72.14 -44.04 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 75.209999999999994 109.266 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.899 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.6 m-30 -99.67 37.39 1.61 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 71.099999999999994 111.05 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.2 t -68.98 -43.09 75.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.095 . . . . 72.519999999999996 109.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.79 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -96.35 -17.21 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.112 . . . . 74.129999999999995 109.333 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.899 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.7 mt -57.77 149.19 22.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 60.140000000000001 109.324 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -163.94 156.13 17.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.465 1.103 . . . . 50.240000000000002 110.017 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.1 -152.99 46.16 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.52 1.138 . . . . 73.129999999999995 110.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 17.4 m -99.63 7.33 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.278 -1.008 . . . . 53.32 108.278 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.8 OUTLIER -125.04 150.67 67.35 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 72.430000000000007 110.036 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.751 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -74.96 147.36 89.1 Favored 'Cis proline' 0 C--N 1.359 1.111 0 C-N-CA 121.019 -2.492 . . . . 62.109999999999999 111.001 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.6 OUTLIER -128.37 133.25 24.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 75.209999999999994 110.029 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.96 -168.94 6.89 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 121.024 -2.49 . . . . 75.010000000000005 111.028 -0.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.0 154.66 18.33 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 60.329999999999998 109.29 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.415 ' HG3' HD11 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.02 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.476 1.777 . . . . 71.209999999999994 110.981 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -87.77 132.62 34.08 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 73.340000000000003 109.337 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.748 HG12 ' HE2' ' A' ' 300' ' ' LYS . 35.3 m -134.53 27.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.13 . . . . 72.150000000000006 109.289 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 318' ' ' CYS . 36.1 t -71.58 -37.07 71.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.477 1.111 . . . . 65.409999999999997 110.028 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.6 t -43.11 -27.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 75.349999999999994 110.004 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 316' ' ' SER . 3.2 m . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 60.310000000000002 108.268 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.696 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.292 -0.632 . . . . 73.120000000000005 109.292 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.33 110.54 4.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.09 . . . . 53.210000000000001 109.329 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -83.5 7.89 15.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.54 1.15 . . . . 73.129999999999995 110.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.4 145.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 63.340000000000003 109.316 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.009 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -96.98 143.28 25.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 72.030000000000001 109.314 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.99 -33.38 4.63 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.509 1.794 . . . . 61.200000000000003 111.009 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.81 155.41 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 71.450000000000003 109.31 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -52.45 -35.72 20.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 74.219999999999999 109.311 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.42 -47.49 3.62 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.492 1.12 . . . . 70.549999999999997 109.29 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.734 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -71.59 -35.0 70.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 1.116 . . . . 64.219999999999999 110.378 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.731 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -58.98 -56.97 15.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 65.030000000000001 109.317 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -52.31 -31.8 34.74 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.528 1.143 . . . . 71.019999999999996 109.257 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -67.56 -56.66 8.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 73.530000000000001 110.046 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.009 HD12 HD11 ' A' ' 140' ' ' ILE . 92.4 mt -42.29 -41.97 2.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 53.43 109.312 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.704 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.69 -43.11 63.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 71.049999999999997 110.972 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -51.94 -34.17 40.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 75.019999999999996 109.274 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 155' ' ' ASN . 19.6 mt-30 -76.17 -56.33 4.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 65.450000000000003 110.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.567 HD11 HD12 ' A' ' 188' ' ' LEU . 23.0 mt -50.27 -29.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 71.349999999999994 109.27 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -33.32 63.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 74.319999999999993 109.255 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.79 -18.2 59.0 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 73.519999999999996 109.31 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.401 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 11.2 mm100 -84.24 -15.47 46.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 72.239999999999995 110.274 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -38.7 122.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 63.210000000000001 109.982 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.19 130.45 34.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 54.229999999999997 108.316 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.95 -30.39 6.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.483 1.114 . . . . 63.310000000000002 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.796 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 35.0 p -67.37 161.58 24.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 0.762 . . . . 65.420000000000002 110.443 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.1 t -93.63 -0.72 56.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 70.420000000000002 109.986 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 162' ' ' THR . 3.9 m -116.84 5.63 13.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.108 . . . . 74.420000000000002 110.43 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.796 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -80.85 138.18 36.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.134 . . . . 64.340000000000003 109.284 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -164.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.571 1.169 . . . . 61.25 109.955 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 166' ' ' PRO . 2.6 m -155.96 126.25 3.37 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.531 1.144 . . . . 70.409999999999997 110.023 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.04 141.15 70.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.005 -2.498 . . . . 65.219999999999999 110.991 0.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.5 p -72.69 -178.98 2.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 74.109999999999999 108.315 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' A' ' 183' ' ' LYS . 3.3 mp -99.16 134.25 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.12 . . . . 74.109999999999999 109.3 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.6 p -79.92 71.41 6.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.132 . . . . 63.409999999999997 110.402 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.646 ' HE1' HH21 ' A' ' 180' ' ' ARG . 30.5 m-85 -75.63 -0.53 20.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 70.019999999999996 111.03 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -109.37 8.04 25.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.107 . . . . 74.219999999999999 110.275 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 174' ' ' VAL . 11.6 t80 -125.53 71.79 66.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.545 1.153 . . . . 65.5 110.99 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.442 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 110.13 3.06 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.447 1.761 . . . . 72.450000000000003 111.003 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.712 HG13 ' OG ' ' A' ' 310' ' ' SER . 2.7 t -151.82 -69.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 64.310000000000002 109.341 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -133.77 -48.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 74.230000000000004 109.284 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.25 107.5 0.06 OUTLIER Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.488 1.118 . . . . 53.25 111.013 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.653 ' SG ' HG12 ' A' ' 219' ' ' VAL . 6.9 p -147.86 -48.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 72.530000000000001 108.317 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.528 ' HB3' HG11 ' A' ' 219' ' ' VAL . 26.1 p90 -69.98 -29.1 66.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.55 1.156 . . . . 74.349999999999994 110.978 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -69.27 -68.1 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.474 1.109 . . . . 72.239999999999995 109.328 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.646 HH21 ' HE1' ' A' ' 170' ' ' PHE . 0.2 OUTLIER -44.14 -47.26 9.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 51.409999999999997 110.3 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -41.41 -60.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 72.230000000000004 109.305 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -46.19 -38.03 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.538 1.149 . . . . 74.439999999999998 109.616 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.884 ' HE3' HE22 ' A' ' 186' ' ' GLN . 29.3 mmmt -67.34 -59.69 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.424 1.077 . . . . 73.230000000000004 109.296 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 153' ' ' ILE . 8.4 mtm -39.36 -38.5 0.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.131 . . . . 62.299999999999997 110.96 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.47 77.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 74.400000000000006 110.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.884 HE22 ' HE3' ' A' ' 183' ' ' LYS . 1.5 pt20 -51.2 -29.08 12.92 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 73.430000000000007 110.292 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.463 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 14.4 mm -81.28 -36.02 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.577 1.173 . . . . 74.299999999999997 109.321 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.567 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -63.13 -45.54 91.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 74.530000000000001 109.296 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.504 ' HG2' HD21 ' A' ' 136' ' ' LEU . 11.5 mtt -58.02 -43.61 86.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.506 1.129 . . . . 71.239999999999995 110.999 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -46.21 -52.97 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 60.100000000000001 109.311 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -35.47 80.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 75.319999999999993 109.342 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 110.88 50.99 0.62 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.464 1.102 . . . . 75.129999999999995 111.022 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.745 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 70.3 m-85 -151.04 136.37 17.7 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.531 0.783 . . . . 74.409999999999997 111.035 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.696 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.7 OUTLIER -106.96 121.84 45.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 65.439999999999998 109.323 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.545 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.3 p -102.2 178.4 4.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.088 . . . . 64.209999999999994 108.296 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 222' ' ' LEU . 4.9 mp0 -120.23 172.75 7.56 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.494 1.121 . . . . 74.340000000000003 110.263 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.68 ' HE2' HG22 ' A' ' 221' ' ' ILE . 19.0 mmtt -104.88 152.91 22.06 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 73.200000000000003 109.332 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.41 ' OE1' HD13 ' A' ' 222' ' ' LEU . 23.4 tt0 -139.48 117.73 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.472 1.108 . . . . 64.409999999999997 110.273 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.8 m-85 -111.14 122.33 47.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.49 1.119 . . . . 64.040000000000006 111.021 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.723 ' CG2' HG23 ' A' ' 266' ' ' VAL . 13.3 p -118.74 150.38 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 74.329999999999998 109.302 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.2 m-85 -123.14 162.17 23.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.54 1.15 . . . . 64.129999999999995 111.001 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.2 -177.37 16.37 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.542 1.151 . . . . 63.310000000000002 111.04 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.747 ' C ' HD23 ' A' ' 204' ' ' LEU . 57.6 t-20 -71.54 109.13 5.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 0.772 . . . . 64.109999999999999 109.329 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.747 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.3 mt -112.82 95.09 5.23 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.095 . . . . 74.200000000000003 109.328 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.5 mttt -92.29 168.87 11.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 70.340000000000003 109.293 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.976 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -179.35 165.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 74.510000000000005 109.312 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.515 1.134 . . . . 71.129999999999995 110.05 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 2.1 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 108.269 -1.011 . . . . 33.439999999999998 108.269 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.976 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.4 m -113.79 134.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.145 . . . . 51.43 109.279 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -127.32 127.56 44.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 64.209999999999994 109.307 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -135.68 135.13 39.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 63.43 108.008 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 3.7 20.97 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.105 . . . . 73.200000000000003 109.993 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.484 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.7 p90 -177.91 128.1 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 72.129999999999995 111.035 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.504 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 31.7 t60 -115.04 159.13 21.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.545 1.153 . . . . 73.420000000000002 109.609 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.653 HG12 ' SG ' ' A' ' 177' ' ' CYS . 3.4 p -138.85 137.93 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.420000000000002 109.331 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.568 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -138.98 -157.25 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.579 1.174 . . . . 74.420000000000002 109.317 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.68 HG22 ' HE2' ' A' ' 197' ' ' LYS . 18.3 pt -125.8 117.84 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.509 1.131 . . . . 72.129999999999995 109.276 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.6 tp -81.8 110.04 16.74 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.492 1.12 . . . . 62.229999999999997 109.294 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -101.12 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 71.439999999999998 109.307 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 24.8 m -116.73 119.93 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 64.430000000000007 110.016 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.563 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 31.4 p90 -135.34 145.55 47.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 75.310000000000002 110.993 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -70.3 133.99 47.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.123 . . . . 73.109999999999999 109.334 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.36 -159.64 0.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.115 . . . . 73.420000000000002 109.323 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.44 51.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.230000000000004 109.316 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.9 m -114.58 -8.38 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 51.549999999999997 110.01 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.39 37.42 8.19 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.526 1.141 . . . . 60.439999999999998 110.981 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 138.09 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.468 0.746 . . . . 51.310000000000002 109.301 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.6 m -71.64 102.65 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 72.439999999999998 110.407 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.0 mm-40 -101.99 -172.65 2.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.454 1.096 . . . . 72.530000000000001 110.289 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.599 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -126.69 145.36 50.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.445 1.091 . . . . 71.040000000000006 109.326 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.6 tpt180 -145.66 160.48 41.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.145 . . . . 62.210000000000001 110.275 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.702 HG21 ' CD1' ' A' ' 252' ' ' TRP . 12.8 mm -116.53 119.94 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.239999999999995 109.285 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -101.38 45.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.105 . . . . 70.219999999999999 109.315 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 236' ' ' ILE . 2.1 m-20 -101.17 112.67 65.35 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 40.509999999999998 109.274 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.568 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -74.97 -43.57 0.39 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.516 1.798 . . . . 54.130000000000003 111.015 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.1 OUTLIER -39.22 -29.9 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 73.099999999999994 109.983 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.582 HD13 ' CD1' ' A' ' 252' ' ' TRP . 13.6 mt -101.98 -52.98 3.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 64.129999999999995 109.3 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 247' ' ' VAL . 93.1 m-85 -125.99 99.28 5.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 72.019999999999996 111.041 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -79.22 -30.46 43.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 74.239999999999995 109.968 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -55.52 -46.15 77.04 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 72.510000000000005 109.982 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.48 -170.42 41.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.493 1.12 . . . . 42.030000000000001 111.002 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.432 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.06 168.85 23.89 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 75.450000000000003 110.992 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.652 HG21 ' CE2' ' A' ' 242' ' ' PHE . 3.9 m -151.66 159.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 50.219999999999999 109.291 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.428 ' C ' ' N ' ' A' ' 250' ' ' THR . 43.0 p -60.7 139.21 57.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 71.25 110.399 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.438 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER -43.01 -28.1 0.24 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 74.150000000000006 109.299 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.428 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.4 m -73.61 -64.76 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 75.430000000000007 110.404 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.15 -27.43 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 50.539999999999999 109.31 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.702 ' CD1' HG21 ' A' ' 236' ' ' ILE . 13.0 t90 -62.57 -62.03 2.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 73.420000000000002 108.008 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.555 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.24 -42.26 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.503 1.127 . . . . 71.310000000000002 110.303 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.836 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -55.8 -51.44 67.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 62.299999999999997 109.335 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.03 -20.36 16.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 62.119999999999997 109.311 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.58 -36.76 16.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 65.420000000000002 108.343 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -92.45 20.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.482 1.114 . . . . 62.030000000000001 109.288 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -46.61 104.48 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 75.540000000000006 109.319 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -76.07 -3.97 38.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 71.430000000000007 110.406 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.8 t -49.95 -22.85 1.69 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 65.109999999999999 110.023 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 206' ' ' ALA . 30.7 m -90.87 -32.88 15.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 74.239999999999995 108.294 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.88 -113.78 0.57 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.484 1.115 . . . . 44.229999999999997 111.008 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -90.56 143.45 26.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.78 . . . . 44.43 110.032 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -167.77 148.27 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.461 1.1 . . . . 54.399999999999999 109.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.72 156.58 3.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 61.109999999999999 109.982 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.723 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.9 p -104.39 113.96 42.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 73.310000000000002 109.288 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 4.6 t -68.15 -45.69 72.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 73.310000000000002 110.007 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 200' ' ' VAL . 29.5 p -163.84 -174.22 3.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 73.150000000000006 110.017 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -165.82 155.66 12.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.3 165.23 37.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 73.109999999999999 109.302 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.437 ' C ' HG23 ' A' ' 272' ' ' THR . 6.8 p30 -128.29 160.67 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 74.200000000000003 109.258 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.598 HG21 ' HD2' ' A' ' 279' ' ' ARG . 19.1 p -153.96 176.94 11.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 74.010000000000005 110.395 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -60.76 158.32 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 54.420000000000002 109.324 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.4 -43.96 76.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.447 1.092 . . . . 53.219999999999999 110.993 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -54.87 -42.41 72.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.447 0.733 . . . . 73.219999999999999 109.312 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' ' 273' ' ' ALA . 69.8 t -43.61 101.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 73.329999999999998 109.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.415 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 7.2 t80 -60.07 -59.22 5.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.209999999999994 111.016 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -131.47 156.71 45.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 74.450000000000003 111.034 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.598 ' HD2' HG21 ' A' ' 272' ' ' THR . 63.6 ttt-85 -126.71 147.45 49.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 63.520000000000003 110.275 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.2 m -118.2 158.02 47.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 70.019999999999996 110.068 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 0.17 9.21 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.459 1.768 . . . . 54.549999999999997 111.005 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 80.1 p -104.27 5.81 34.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 73.519999999999996 109.943 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 78.34 39.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 64.340000000000003 109.279 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -113.37 120.22 40.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 62.240000000000002 110.027 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -107.62 151.78 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 75.329999999999998 111.01 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.528 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 1.2 mm? -118.59 177.67 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 73.530000000000001 109.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 79.6 m-85 -160.29 115.22 2.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.523 1.139 . . . . 63.100000000000001 110.978 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.438 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 0.4 OUTLIER -115.49 97.03 5.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 74.200000000000003 109.303 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -85.82 -14.49 44.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 72.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.408 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.0 m-20 -110.75 0.87 17.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 62.229999999999997 109.306 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.695 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 42.69 49.58 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.125 . . . . 73.329999999999998 109.281 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 290' ' ' ASN . 18.2 mm -78.58 -27.55 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.445 1.09 . . . . 75.409999999999997 109.299 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.798 ' O ' HG23 ' A' ' 297' ' ' VAL . 10.0 t30 -94.18 -27.67 16.07 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.444 1.09 . . . . 62.119999999999997 109.286 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.452 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 21.9 m -82.19 -69.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 73.310000000000002 110.407 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 44.1 m-20 -47.86 -30.36 4.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 65.230000000000004 109.293 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 36.8 t -72.73 -58.41 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 72.420000000000002 108.318 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 293' ' ' ASN . 9.4 t -43.95 -49.54 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 75.430000000000007 109.313 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.692 HD22 ' HA ' ' A' ' 168' ' ' ILE . 9.6 mt -61.47 -59.97 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 64.209999999999994 109.31 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.35 -31.8 1.78 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.535 1.147 . . . . 61.140000000000001 110.411 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -70.13 -49.46 50.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.319999999999993 109.283 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.584 ' CZ ' ' HB1' ' A' ' 312' ' ' ALA . 3.3 m-30 -91.77 31.39 1.22 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 75.109999999999999 110.982 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 26.2 t -63.38 -52.75 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 63.520000000000003 110.005 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.4 -10.41 58.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.432 1.083 . . . . 70.310000000000002 109.326 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.603 ' N ' HD22 ' A' ' 303' ' ' LEU . 19.1 mt -76.21 136.63 39.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 74.409999999999997 109.289 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.5 p -161.46 147.58 14.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 75.150000000000006 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 96.89 -160.14 21.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.498 1.124 . . . . 63.409999999999997 110.977 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 25.42 5.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.345 -0.983 . . . . 50.119999999999997 108.345 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.514 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 93.1 p -156.84 148.62 17.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.1 . . . . 64.140000000000001 109.998 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.588 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.98 145.74 84.76 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 121.007 -2.497 . . . . 73.209999999999994 111.024 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.712 ' OG ' HG13 ' A' ' 174' ' ' VAL . 70.0 m -132.21 135.17 26.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 65.299999999999997 109.985 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.0 -173.55 12.53 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 120.995 -2.502 . . . . 75.140000000000001 110.999 -0.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.584 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.89 151.78 31.13 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 51.32 109.295 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.571 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.508 1.794 . . . . 63.409999999999997 110.995 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -85.96 135.49 33.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 75.010000000000005 109.292 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.4 ' O ' ' SG ' ' A' ' 318' ' ' CYS . 26.8 m -127.77 24.68 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 70.209999999999994 109.29 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 35.8 t -54.11 -19.8 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.556 1.16 . . . . 71.409999999999997 110.043 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 35.4 p -53.89 -24.84 17.43 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.501 1.126 . . . . 73.349999999999994 109.989 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 315' ' ' VAL . 1.8 m . . . . . 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.145 . . . . 55.109999999999999 108.257 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 194' ' ' ASP . 8.5 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.295 -0.632 . . . . 71.030000000000001 109.295 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -105.74 106.46 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.140000000000001 109.277 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -83.45 8.21 14.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.526 1.141 . . . . 55.100000000000001 109.946 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.53 145.2 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 73.510000000000005 109.264 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 149' ' ' LEU . 1.1 mt -96.26 142.77 25.03 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 74.310000000000002 109.339 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.99 -32.48 5.36 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.551 1.816 . . . . 74.349999999999994 111.002 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.71 152.47 21.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 64.239999999999995 109.335 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -49.96 -35.45 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 63.130000000000003 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.5 -47.35 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 73.209999999999994 109.3 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.652 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.91 -34.72 69.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.512 1.133 . . . . 73.239999999999995 110.403 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.741 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.29 -56.98 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 71.25 109.304 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -52.27 -32.03 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 63.520000000000003 109.307 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.6 -55.5 11.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 64.120000000000005 110.008 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 140' ' ' ILE . 66.5 mt -42.06 -41.83 2.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 70.140000000000001 109.315 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.648 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.91 -45.44 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.113 . . . . 73.109999999999999 111.017 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -46.52 -38.37 9.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 75.120000000000005 109.277 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . 19.6 mt-30 -76.57 -55.38 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 73.230000000000004 110.29 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.808 HD11 HD12 ' A' ' 188' ' ' LEU . 13.6 mt -50.56 -23.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.498 1.124 . . . . 74.439999999999998 109.293 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.61 42.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 75.230000000000004 109.297 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -58.44 -19.17 34.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 74.239999999999995 109.24 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 3.3 mm100 -81.68 -24.64 36.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 55.439999999999998 110.324 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.522 ' HA ' ' CD2' ' A' ' 170' ' ' PHE . 23.3 m -41.42 117.35 0.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 53.100000000000001 109.982 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 2.4 m -45.27 130.62 8.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.118 . . . . 74.420000000000002 108.318 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.39 -24.89 5.51 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.587 1.179 . . . . 64.310000000000002 110.976 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.774 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 75.4 p -83.93 161.7 20.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 0.748 . . . . 62.109999999999999 110.388 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -93.56 0.76 56.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 63.5 109.959 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 162' ' ' THR . 2.1 m -117.02 3.48 12.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.123 . . . . 74.219999999999999 110.381 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.774 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -79.06 133.64 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 71.349999999999994 109.278 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.76 -173.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 62.32 109.984 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.3 p -152.39 126.64 4.49 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 74.400000000000006 110.001 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.24 49.19 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 121.063 -2.474 . . . . 64.200000000000003 110.992 0.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.2 p -73.01 -178.2 2.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 71.349999999999994 108.286 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.728 HG21 ' CE1' ' A' ' 170' ' ' PHE . 4.3 mp -90.53 137.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 73.450000000000003 109.309 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.596 HG21 ' O ' ' A' ' 301' ' ' PHE . 74.3 p -90.48 88.62 7.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 72.129999999999995 110.426 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.728 ' CE1' HG21 ' A' ' 168' ' ' ILE . 19.1 m-85 -88.36 -25.51 22.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 64.439999999999998 110.986 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.453 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.84 -2.05 28.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.138 . . . . 72.019999999999996 110.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.675 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 29.4 t80 -128.29 68.22 76.58 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 110.998 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.424 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.06 113.39 3.78 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.495 1.787 . . . . 74.109999999999999 110.977 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.586 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.9 t -152.17 -66.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 34.530000000000001 109.31 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -163.49 118.16 1.62 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.51 1.131 . . . . 64.239999999999995 109.283 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 147.3 48.03 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.516 1.135 . . . . 52.140000000000001 110.98 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 74.4 m -88.59 -19.75 25.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.261 -1.014 . . . . 74.129999999999995 108.261 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.668 ' HB3' HG11 ' A' ' 219' ' ' VAL . 29.2 p90 -72.55 -40.83 66.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 72.519999999999996 111.018 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.594 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -63.87 -64.63 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 73.329999999999998 109.314 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.523 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -43.7 -47.51 7.78 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 74.140000000000001 110.288 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.426 ' N ' ' HD3' ' A' ' 180' ' ' ARG . . . -42.17 -55.72 3.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 75.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.692 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.33 -38.99 20.52 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.568 1.168 . . . . 75.209999999999994 109.597 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 180' ' ' ARG . 30.8 mmmt -64.32 -61.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.465 1.103 . . . . 74.230000000000004 109.268 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.69 ' SD ' HG21 ' A' ' 153' ' ' ILE . 3.4 mtm -38.78 -34.06 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.52 1.138 . . . . 31.02 110.983 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.436 HH21 ' CG ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -63.95 -50.3 69.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 62.450000000000003 110.251 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.516 ' HG3' HD13 ' A' ' 187' ' ' ILE . 3.7 pt20 -52.87 -30.91 36.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.133 . . . . 72.519999999999996 110.311 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.516 HD13 ' HG3' ' A' ' 186' ' ' GLN . 11.0 mm -82.2 -36.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 75.219999999999999 109.277 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.808 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -62.69 -41.8 99.3 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.521 1.138 . . . . 72.120000000000005 109.288 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.439 ' HG2' HD21 ' A' ' 136' ' ' LEU . 21.8 mtp -63.73 -41.03 98.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 71.409999999999997 110.975 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -45.41 -53.28 8.91 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.200000000000003 109.341 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -66.02 -27.14 67.89 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.544 1.152 . . . . 50.509999999999998 109.279 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.72 55.4 0.74 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.531 1.144 . . . . 73.420000000000002 111.025 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.652 ' CZ ' HG21 ' A' ' 145' ' ' THR . 77.5 m-85 -154.94 143.63 20.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.571 0.806 . . . . 64.439999999999998 111.012 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.935 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.1 t70 -109.55 125.45 52.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 70.150000000000006 109.35 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.788 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.7 p -94.51 -179.41 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 44.030000000000001 108.296 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 171.86 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 74.439999999999998 110.294 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.419 ' NZ ' ' HB1' ' A' ' 181' ' ' ALA . 13.0 mmtt -105.72 163.38 12.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 72.25 109.269 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.546 ' OE1' HD13 ' A' ' 222' ' ' LEU . 6.8 tt0 -158.11 117.54 3.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 75.030000000000001 110.328 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.9 m-85 -110.75 119.34 38.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.507 1.129 . . . . 74.209999999999994 111.013 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.659 ' CG2' HG23 ' A' ' 266' ' ' VAL . 9.9 p -115.08 142.32 28.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 71.510000000000005 109.321 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.8 m-85 -117.65 157.25 26.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.239999999999995 110.969 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.92 -175.03 16.51 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.536 1.148 . . . . 51.310000000000002 110.986 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.787 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.1 t-20 -74.39 110.98 9.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.514 0.773 . . . . 73.450000000000003 109.297 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.7 mt -115.56 94.54 4.74 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.132 . . . . 71.340000000000003 109.333 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.4 mttp -92.81 167.12 12.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 109.255 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.923 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -170.43 164.41 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 74.430000000000007 109.297 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 t . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.109999999999999 110.016 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.317 -0.994 . . . . 74.239999999999995 108.317 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.923 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -128.58 142.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 54.109999999999999 109.278 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.87 128.78 41.29 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.525 1.141 . . . . 64.329999999999998 109.303 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.429 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.0 OUTLIER -134.99 130.84 36.37 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.556 1.16 . . . . 70.420000000000002 107.99 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.3 p -76.46 -0.73 24.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.558 1.161 . . . . 75.349999999999994 109.966 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.5 p90 -173.72 133.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.125 . . . . 74.430000000000007 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 65.5 t60 -119.26 167.79 11.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 63.130000000000003 109.604 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.8 p -150.78 136.22 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.126 . . . . 74.510000000000005 109.287 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.545 ' HB3' ' CZ2' ' A' ' 252' ' ' TRP . . . -135.87 -156.72 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 41.109999999999999 109.327 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.436 HG12 ' CE ' ' A' ' 184' ' ' MET . 23.9 pt -123.07 118.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 62.520000000000003 109.273 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 234' ' ' LYS . 11.0 tp -81.55 109.06 15.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 71.299999999999997 109.285 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -100.87 145.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 61.5 109.292 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 17.0 m -117.34 120.29 37.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.502 1.126 . . . . 73.129999999999995 110.027 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 28.1 p90 -135.68 146.62 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.527 1.142 . . . . 73.230000000000004 110.974 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -71.52 131.52 43.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 75.049999999999997 109.266 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -72.61 -160.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 71.540000000000006 109.316 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.02 49.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 62.340000000000003 109.291 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.5 m -114.96 -7.81 12.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 53.509999999999998 109.993 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.93 37.85 8.26 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.485 1.115 . . . . 72.129999999999995 111.005 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.97 137.9 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.532 0.784 . . . . 63.539999999999999 109.269 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -72.21 102.63 3.12 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.553 1.158 . . . . 54.109999999999999 110.383 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 224' ' ' SER . 4.4 mm-40 -102.21 -172.78 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.209999999999994 110.295 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.8 mmtt -126.93 144.78 50.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 73.540000000000006 109.32 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.588 ' HB3' HG22 ' A' ' 223' ' ' VAL . 3.5 tpt180 -145.56 162.07 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 62.439999999999998 110.283 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.627 HG21 ' CD1' ' A' ' 252' ' ' TRP . 26.3 mm -117.33 119.66 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 73.340000000000003 109.299 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 237' ' ' ILE . 2.6 mm -101.23 47.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 70.329999999999998 109.309 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.692 ' OD1' HD12 ' A' ' 241' ' ' LEU . 27.2 p-10 -94.8 111.4 54.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.340000000000003 109.289 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.98 -44.79 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 62.109999999999999 111.018 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.9 m -39.58 -39.16 0.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.546 1.153 . . . . 72.219999999999999 110.005 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.692 HD12 ' OD1' ' A' ' 238' ' ' ASP . 5.9 mt -92.93 -56.69 2.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 71.120000000000005 109.281 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.729 ' CG ' HG11 ' A' ' 247' ' ' VAL . 95.6 m-85 -121.12 99.5 6.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 62.450000000000003 111.001 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -26.01 34.96 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.453 1.096 . . . . 70.530000000000001 109.989 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 m -57.24 -45.82 83.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 62.049999999999997 109.971 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 179.42 -166.91 36.58 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.447 1.092 . . . . 75.019999999999996 111.004 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.493 ' CG ' HD21 ' A' ' 146' ' ' LEU . 18.1 Cg_endo -75.04 164.0 34.14 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.504 1.792 . . . . 61.409999999999997 110.982 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.729 HG11 ' CG ' ' A' ' 242' ' ' PHE . 12.3 m -140.99 167.78 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 62.009999999999998 109.281 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.449 ' C ' ' N ' ' A' ' 250' ' ' THR . 24.2 p -70.38 136.18 49.44 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.484 1.115 . . . . 73.25 110.384 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 26.6 p-10 -39.86 -30.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 73.540000000000006 109.327 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.449 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -78.1 -61.43 2.0 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 40.200000000000003 110.409 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.91 -22.79 2.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.486 1.116 . . . . 70.349999999999994 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.627 ' CD1' HG21 ' A' ' 236' ' ' ILE . 7.4 t90 -68.68 -60.47 2.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.497 1.123 . . . . 75.450000000000003 107.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.568 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -51.29 -41.81 60.71 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.299999999999997 110.316 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.814 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.8 m-80 -54.66 -51.38 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 72.219999999999999 109.253 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.67 -24.45 48.84 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 73.409999999999997 109.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -83.97 -35.02 24.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 55.100000000000001 108.261 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.1 m -95.82 21.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.299999999999997 109.307 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 39.5 t-20 -51.94 107.88 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 72.530000000000001 109.317 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.0 p -73.36 -3.37 26.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 61.210000000000001 110.389 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.41 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 0.4 OUTLIER -44.73 -30.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 54.009999999999998 109.971 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 42.1 t -88.95 -36.88 15.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 50.25 108.304 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.48 -127.97 1.62 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.473 1.108 . . . . 55.439999999999998 110.938 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.56 147.31 37.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 0.778 . . . . 74.019999999999996 109.973 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.98 146.22 3.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 72.209999999999994 109.289 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -172.73 151.38 2.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.530000000000001 110.018 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.659 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.35 115.08 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.558 1.161 . . . . 50.439999999999998 109.28 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 31.7 t -70.11 -45.46 66.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 75.049999999999997 109.983 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 m -165.08 177.29 7.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.525 1.14 . . . . 72.209999999999994 110.029 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -158.21 156.44 30.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 54.43 110.999 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.34 33.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 62.009999999999998 109.282 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.532 ' O ' HG23 ' A' ' 272' ' ' THR . 8.0 p30 -119.14 160.61 21.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 64.420000000000002 109.278 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.685 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.0 p -154.98 178.89 9.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.524 1.14 . . . . 74.129999999999995 110.378 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -62.67 158.76 17.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.527 1.142 . . . . 73.530000000000001 109.301 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.87 -39.25 55.29 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.481 1.113 . . . . 62.100000000000001 110.955 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -56.7 -48.06 78.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 0.776 . . . . 71.109999999999999 109.273 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.771 HG23 ' HB3' ' A' ' 273' ' ' ALA . 25.3 t -44.7 118.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 63.130000000000003 109.332 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.452 ' OH ' ' ND2' ' A' ' 293' ' ' ASN . 27.8 t80 -70.41 -53.49 16.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.531 1.144 . . . . 74.420000000000002 111.013 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 45.8 t80 -140.22 165.32 27.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 71.200000000000003 111.018 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.685 ' HD2' HG21 ' A' ' 272' ' ' THR . 55.0 ttt-85 -137.01 147.39 46.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 64.239999999999995 110.278 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.6 157.92 44.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 71.349999999999994 109.97 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.19 9.2 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 72.510000000000005 111.0 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.0 t -97.83 3.92 49.8 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 73.409999999999997 110.034 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 77.13 41.37 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.420000000000002 109.273 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.8 t -123.07 119.52 30.57 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.461 1.101 . . . . 65.530000000000001 109.955 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.5 m-30 -99.92 160.22 14.48 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 55.229999999999997 110.957 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.482 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -120.45 177.59 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.468 1.105 . . . . 65.030000000000001 109.324 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 94.8 m-85 -160.61 115.57 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 74.0 110.992 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.445 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.7 m-20 -115.18 96.11 5.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 71.200000000000003 109.241 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -85.57 -30.7 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 72.120000000000005 109.274 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.479 ' HB3' HD11 ' A' ' 292' ' ' ILE . 34.3 m-20 -98.3 7.91 45.56 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.139 . . . . 55.32 109.264 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.692 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 3.0 mm? 40.32 47.54 2.19 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.493 1.12 . . . . 65.310000000000002 109.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 290' ' ' ASN . 45.4 mm -78.35 -25.07 13.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.558 1.161 . . . . 72.25 109.305 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.66 ' O ' HG23 ' A' ' 297' ' ' VAL . 8.4 t30 -94.64 -22.82 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 72.030000000000001 109.308 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.438 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.0 m -86.78 -68.97 0.71 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 72.439999999999998 110.383 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -50.86 -22.88 2.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.525 1.141 . . . . 73.030000000000001 109.333 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 20.5 t -79.03 -62.44 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 65.140000000000001 108.312 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 293' ' ' ASN . 18.2 t -44.09 -43.15 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 62.520000000000003 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 168' ' ' ILE . 72.9 mt -63.42 -58.59 6.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 65.530000000000001 109.315 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -38.27 5.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 62.539999999999999 110.402 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -57.18 -56.2 24.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 109.309 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.5 OUTLIER -89.68 35.22 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 63.420000000000002 111.032 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 t -68.07 -49.07 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 54.240000000000002 109.962 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -88.24 -17.94 29.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.439 1.087 . . . . 55.409999999999997 109.274 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.816 HD22 ' CD ' ' A' ' 309' ' ' PRO . 17.9 mt -57.43 144.26 37.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 54.329999999999998 109.26 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.9 p -158.38 136.8 10.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 71.209999999999994 109.995 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 93.31 -155.23 22.17 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.519 1.137 . . . . 74.140000000000001 111.013 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.7 p -98.87 12.81 34.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.295 -1.002 . . . . 31.43 108.295 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.526 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.5 p -135.22 148.61 67.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 74.409999999999997 109.968 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.816 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.95 146.36 86.46 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.023 -2.49 . . . . 74.230000000000004 110.998 -0.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.5 p -132.29 135.77 26.94 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 54.310000000000002 109.985 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.8 14.76 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.985 -2.506 . . . . 63.549999999999997 110.997 -0.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.46 155.91 18.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 44.25 109.291 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.485 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.37 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.5 1.789 . . . . 72.420000000000002 111.01 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.99 135.51 33.38 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 71.319999999999993 109.277 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 13.3 m -126.49 18.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 64.129999999999995 109.285 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.4 -33.06 58.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 72.019999999999996 110.013 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.1 p -43.12 -39.93 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.118 . . . . 72.400000000000006 110.02 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.467 1.104 . . . . 72.439999999999998 108.262 -179.932 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.797 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.2 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.287 -0.634 . . . . 64.010000000000005 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.694 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.82 107.76 3.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.543 1.152 . . . . 64.019999999999996 109.285 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -81.69 5.88 17.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.164 . . . . 65.019999999999996 110.031 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -145.87 148.76 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 62.32 109.331 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.095 HD11 HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -100.82 143.72 27.13 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 52.25 109.276 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.2 Cg_endo -74.99 -33.97 4.18 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.509 1.794 . . . . 73.400000000000006 110.985 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.82 150.6 22.85 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 73.030000000000001 109.314 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.8 t -48.83 -36.18 7.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.450000000000003 109.286 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.03 -48.55 3.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 64.319999999999993 109.302 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.691 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -70.01 -36.02 74.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.143 . . . . 74.420000000000002 110.364 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.746 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -57.95 -57.09 14.32 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.158 . . . . 74.299999999999997 109.324 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -52.95 -29.4 28.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 70.230000000000004 109.304 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.3 -55.57 8.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.515 1.134 . . . . 74.230000000000004 109.973 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.095 HD12 HD11 ' A' ' 140' ' ' ILE . 65.3 mt -42.2 -41.99 2.88 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.553 1.158 . . . . 75.450000000000003 109.259 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.571 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.82 -45.37 61.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 73.329999999999998 111.003 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -46.12 -35.37 4.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 73.319999999999993 109.315 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 155' ' ' ASN . 23.9 mt-30 -77.42 -56.4 4.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.24 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.748 HD11 HD12 ' A' ' 188' ' ' LEU . 17.3 mt -50.18 -26.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.458 1.099 . . . . 71.340000000000003 109.265 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -34.62 57.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 74.140000000000001 109.297 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.8 t-20 -61.6 -15.12 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.457 1.098 . . . . 70.099999999999994 109.292 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.45 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 5.7 mm100 -85.68 -18.72 32.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.135 . . . . 74.519999999999996 110.323 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.474 ' HB2' ' CE2' ' A' ' 170' ' ' PHE . 23.7 p -38.68 137.97 0.57 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.553 1.158 . . . . 61.109999999999999 109.991 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -68.03 134.16 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 73.329999999999998 108.288 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.74 -19.05 19.17 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.469 1.105 . . . . 75.420000000000002 111.017 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.848 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 69.8 p -81.24 161.52 23.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.527 0.781 . . . . 74.120000000000005 110.414 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.0 p -93.52 -0.5 56.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.138 . . . . 71.519999999999996 110.032 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 162' ' ' THR . 17.8 m -117.84 6.67 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 63.229999999999997 110.368 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.848 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -83.17 138.14 33.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 63.409999999999997 109.311 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -164.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 43.240000000000002 110.016 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.44 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 14.2 t -156.04 127.47 3.72 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 62.210000000000001 109.995 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.03 137.28 49.44 Favored 'Cis proline' 0 C--N 1.361 1.189 0 C-N-CA 120.986 -2.506 . . . . 74.239999999999995 111.017 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.0 p -73.08 179.48 3.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 63.130000000000003 108.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.564 HG23 ' HB3' ' A' ' 180' ' ' ARG . 3.7 mp -88.95 128.94 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 62.350000000000001 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 301' ' ' PHE . 23.8 p -91.14 85.65 5.96 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 64.200000000000003 110.41 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 157' ' ' SER . 47.9 p90 -86.34 -18.86 30.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 54.329999999999998 110.979 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.448 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.77 -1.78 23.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 75.329999999999998 110.273 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.78 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.8 t80 -129.03 68.29 79.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.44 1.087 . . . . 64.299999999999997 110.983 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.411 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 118.8 5.39 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.457 1.767 . . . . 74.420000000000002 110.963 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.564 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.2 t -152.47 -74.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.116 . . . . 75.239999999999995 109.283 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.553 ' OD1' ' HB2' ' A' ' 312' ' ' ALA . 1.5 p-10 -123.68 -43.15 2.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 74.340000000000003 109.32 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -43.02 126.66 5.01 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.486 1.117 . . . . 51.210000000000001 110.999 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.627 ' SG ' HG12 ' A' ' 219' ' ' VAL . 4.5 p -165.33 -49.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.266 -1.013 . . . . 72.430000000000007 108.266 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.58 ' HB3' HG11 ' A' ' 219' ' ' VAL . 23.9 p90 -70.08 -18.67 63.27 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 72.030000000000001 110.997 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.26 -68.26 0.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.515 1.135 . . . . 72.439999999999998 109.313 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 168' ' ' ILE . 9.2 ptm180 -48.36 -49.81 33.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.476 1.11 . . . . 71.349999999999994 110.302 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.472 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.37 -64.88 0.43 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.118 . . . . 72.310000000000002 109.298 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.4 t60 -39.86 -45.03 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 74.400000000000006 109.607 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 186' ' ' GLN . 14.3 mmmt -62.3 -58.24 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 72.420000000000002 109.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.642 ' SD ' HG21 ' A' ' 153' ' ' ILE . 9.2 mtm -38.96 -36.13 0.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 60.549999999999997 110.981 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.431 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.1 OUTLIER -63.47 -48.99 75.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 62.43 110.314 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 183' ' ' LYS . 2.9 pt20 -53.1 -33.2 51.12 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.447 1.092 . . . . 72.319999999999993 110.278 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.434 HD13 ' HG3' ' A' ' 186' ' ' GLN . 17.3 mm -75.79 -37.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.145 . . . . 74.0 109.26 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.748 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -61.28 -44.45 97.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.099999999999994 109.285 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.438 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.2 mtt -56.41 -42.28 77.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 75.209999999999994 110.992 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -48.45 -52.66 21.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.46 1.1 . . . . 64.420000000000002 109.288 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -62.28 -37.22 84.67 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 74.109999999999999 109.274 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.77 48.15 0.69 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.522 1.139 . . . . 71.299999999999997 110.971 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.694 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 61.6 m-85 -147.78 137.62 22.69 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 0.769 . . . . 74.310000000000002 111.001 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.797 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.3 t70 -103.17 129.26 50.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 64.109999999999999 109.293 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.712 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.8 p -108.15 -178.79 3.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 74.430000000000007 108.286 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.4 OUTLIER -126.47 174.74 8.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 73.319999999999993 110.27 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.472 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 20.5 mmtt -109.73 167.08 10.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 33.130000000000003 109.279 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 219' ' ' VAL . 0.6 OUTLIER -153.45 144.87 23.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 72.5 110.271 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.527 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.1 m-85 -139.87 112.61 7.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.156 . . . . 64.549999999999997 110.992 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.795 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.4 p -106.68 143.21 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 73.319999999999993 109.278 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.4 m-85 -113.99 150.49 33.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.11 . . . . 73.430000000000007 110.97 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.17 19.53 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.465 1.103 . . . . 64.510000000000005 111.003 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.815 ' C ' HD23 ' A' ' 204' ' ' LEU . 54.4 t-20 -77.65 111.46 13.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.54 0.788 . . . . 63.119999999999997 109.299 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.815 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.0 mt -114.09 95.97 5.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 73.519999999999996 109.251 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.0 mtpt -92.31 165.4 13.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 72.129999999999995 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.877 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -170.6 122.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 52.109999999999999 109.325 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.409 ' CB ' ' SG ' ' A' ' 261' ' ' CYS . 3.3 p . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.134 . . . . 72.120000000000005 110.017 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.354 -0.98 . . . . 74.409999999999997 108.354 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.877 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -117.56 142.24 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 61.149999999999999 109.318 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.31 127.82 28.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 64.420000000000002 109.364 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.464 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.6 OUTLIER -132.66 132.9 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 108.009 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 30.5 t -76.5 -0.76 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.149 . . . . 61.530000000000001 109.971 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 10.3 p90 -176.4 133.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 62.310000000000002 111.022 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 32.4 t60 -117.48 168.9 9.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.095 . . . . 72.099999999999994 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 198' ' ' GLN . 2.8 p -147.75 142.02 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.46 1.1 . . . . 61.240000000000002 109.259 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.16 -167.27 2.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 74.140000000000001 109.278 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 196' ' ' GLU . 19.9 pt -115.92 121.95 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 75.420000000000002 109.311 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.716 HD22 HE22 ' A' ' 198' ' ' GLN . 18.2 tp -84.49 115.55 22.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.463 1.102 . . . . 65.129999999999995 109.298 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -109.07 145.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.487 1.117 . . . . 62.020000000000003 109.303 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 69.5 m -115.73 121.71 43.32 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 73.299999999999997 109.953 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.3 p90 -136.66 143.32 43.38 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 70.409999999999997 111.017 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.423 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.4 mmtp -69.23 132.51 46.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.451 1.094 . . . . 74.420000000000002 109.294 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.46 -160.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.340000000000003 109.332 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.21 50.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 41.409999999999997 109.329 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.6 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 75.349999999999994 110.009 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.39 8.16 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.538 1.149 . . . . 71.019999999999996 110.982 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.09 137.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 0.767 . . . . 73.310000000000002 109.281 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.423 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.5 m -71.91 102.66 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 33.450000000000003 110.43 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.8 mm-40 -103.12 -172.86 2.19 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 71.510000000000005 110.296 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.475 ' HB3' HD11 ' A' ' 222' ' ' LEU . 8.5 mmtm -126.12 145.56 50.3 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 65.340000000000003 109.323 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.8 tpt180 -143.74 159.1 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 63.450000000000003 110.325 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.582 HG21 ' CD1' ' A' ' 252' ' ' TRP . 7.7 mm -111.63 124.89 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 53.130000000000003 109.331 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 237' ' ' ILE . 2.8 mm -112.95 44.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 74.150000000000006 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.545 ' OD1' HD12 ' A' ' 241' ' ' LEU . 10.8 p-10 -94.12 111.67 54.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 51.229999999999997 109.322 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.464 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.4 Cg_endo -74.94 -36.33 2.66 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.506 1.793 . . . . 73.109999999999999 110.994 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 1.3 p -43.16 -36.47 1.72 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.456 1.097 . . . . 73.310000000000002 109.98 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.545 HD12 ' OD1' ' A' ' 238' ' ' ASP . 16.5 mt -102.56 -59.52 1.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 72.109999999999999 109.284 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 255' ' ' ALA . 89.6 m-85 -111.3 98.99 7.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 73.129999999999995 111.07 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.6 m -91.02 -13.13 33.85 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 61.5 109.985 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 p -74.73 -46.54 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.098 . . . . 72.5 110.001 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -172.0 -179.52 42.98 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.501 1.126 . . . . 72.129999999999995 111.005 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 236' ' ' ILE . 18.3 Cg_endo -74.98 169.29 22.96 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.485 1.782 . . . . 73.510000000000005 110.978 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.604 HG11 ' CD2' ' A' ' 242' ' ' PHE . 5.0 m -153.13 157.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.121 . . . . 74.230000000000004 109.289 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.434 ' C ' ' N ' ' A' ' 250' ' ' THR . 46.7 p -59.28 136.56 58.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 73.219999999999999 110.447 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 248' ' ' THR . 1.7 p-10 -40.33 -30.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 74.420000000000002 109.316 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.434 ' N ' ' C ' ' A' ' 248' ' ' THR . 3.7 m -70.06 -65.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 71.230000000000004 110.365 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.58 -38.4 14.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 61.119999999999997 109.31 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 19.4 t90 -54.25 -63.55 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 74.310000000000002 108.0 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.571 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -46.49 -45.78 18.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 60.210000000000001 110.327 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.746 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -53.14 -51.68 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.499 1.124 . . . . 65.349999999999994 109.285 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.78 -21.85 31.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 73.409999999999997 109.328 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -84.57 -38.19 20.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 63.299999999999997 108.34 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.746 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.3 m -91.19 18.56 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 24.350000000000001 109.285 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 260' ' ' SER . 6.8 t30 -40.51 104.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 63.350000000000001 109.329 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.8 p -79.89 -4.04 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.461 1.101 . . . . 53.32 110.387 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 258' ' ' ASN . 5.2 t -58.7 -16.13 15.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 62.509999999999998 110.033 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' CYS . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 1.3 m -98.76 -20.34 16.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.447 1.092 . . . . 70.109999999999999 108.301 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 152.37 -125.88 1.91 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.512 1.132 . . . . 73.319999999999993 110.944 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -84.54 144.56 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 62.240000000000002 109.993 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.51 146.2 2.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 70.150000000000006 109.3 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.26 152.45 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.45 1.094 . . . . 73.019999999999996 109.997 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.795 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.4 p -97.23 111.84 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 71.310000000000002 109.303 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.4 t -69.0 -46.95 66.72 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 64.230000000000004 110.007 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 200' ' ' VAL . 5.0 m -158.71 -175.04 5.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 71.450000000000003 110.013 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -166.5 157.25 12.48 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 71.430000000000007 110.977 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -160.34 153.24 21.39 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.549999999999997 109.325 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -110.84 160.69 16.52 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.442 1.089 . . . . 52.140000000000001 109.325 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.42 177.64 9.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 70.340000000000003 110.402 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.29 171.41 3.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 75.049999999999997 109.292 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -84.95 -4.53 86.99 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.553 1.158 . . . . 71.540000000000006 110.951 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 -44.5 7.73 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.499 0.764 . . . . 73.310000000000002 109.326 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 273' ' ' ALA . 87.7 t -43.64 101.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 60.229999999999997 109.28 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.516 ' HH ' ' HE1' ' A' ' 178' ' ' TYR . 57.4 t80 -62.32 -39.23 92.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.547 1.154 . . . . 75.140000000000001 110.979 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -149.48 150.54 32.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 63.43 110.984 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.527 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 74.1 ttt-85 -116.05 147.59 41.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.519999999999996 110.288 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 153.4 47.29 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.126 . . . . 62.340000000000003 109.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 0.06 9.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.487 1.783 . . . . 53.299999999999997 110.999 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 1.7 p -104.12 4.58 34.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 43.229999999999997 109.989 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 81.2 41.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 45.030000000000001 109.324 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.9 t -121.51 128.72 52.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 64.430000000000007 110.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.438 ' HB3' HG13 ' A' ' 276' ' ' VAL . 15.4 m-30 -110.04 155.87 21.27 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.128 . . . . 74.439999999999998 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.23 176.95 4.86 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 73.340000000000003 109.315 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.622 ' H ' HD13 ' A' ' 286' ' ' LEU . 95.7 m-85 -162.67 115.62 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 71.099999999999994 110.943 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.3 94.97 4.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 61.200000000000003 109.315 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ASN . . . . . 0.421 ' O ' HD22 ' A' ' 291' ' ' LEU . 3.0 m-80 -83.19 -39.13 21.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 73.299999999999997 109.313 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.506 ' HB3' HD11 ' A' ' 292' ' ' ILE . 28.5 m-20 -90.64 9.95 27.66 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 74.120000000000005 109.296 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.517 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.11 46.3 1.83 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.546 1.154 . . . . 53.140000000000001 109.304 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 290' ' ' ASN . 46.3 mm -77.15 -33.95 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 62.340000000000003 109.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.724 ' O ' HG23 ' A' ' 297' ' ' VAL . 3.9 t30 -94.7 -15.25 24.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 63.240000000000002 109.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.448 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 24.1 m -87.66 -65.49 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 63.450000000000003 110.404 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.415 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 63.3 m-20 -57.95 -22.78 50.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 72.230000000000004 109.3 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 12.5 t -75.91 -65.67 0.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 61.240000000000002 108.308 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 293' ' ' ASN . 41.6 t -40.27 -40.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 74.450000000000003 109.271 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.93 -57.72 5.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 70.340000000000003 109.261 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -56.19 -17.85 8.54 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.488 1.118 . . . . 71.129999999999995 110.398 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -76.93 -42.94 37.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 75.099999999999994 109.329 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.8 m-30 -105.75 40.33 1.59 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 62.140000000000001 111.002 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -67.71 -55.79 11.8 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.542 1.151 . . . . 74.209999999999994 110.015 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.796 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -81.12 -18.32 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.119 . . . . 73.120000000000005 109.299 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.78 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 13.5 mt -55.78 134.03 51.4 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.492 1.12 . . . . 72.420000000000002 109.274 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 74.5 p -148.61 154.33 39.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 72.109999999999999 110.007 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.28 -146.41 29.04 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.463 1.102 . . . . 73.099999999999994 110.997 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 12.5 m -108.93 12.99 25.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.301 -0.999 . . . . 64.540000000000006 108.301 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.525 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.9 OUTLIER -129.8 149.24 72.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 51.420000000000002 109.988 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.726 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 147.14 88.55 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.008 -2.497 . . . . 74.420000000000002 110.994 0.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.489 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.0 OUTLIER -129.07 133.64 25.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 73.409999999999997 110.007 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.04 -169.52 7.44 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.978 -2.509 . . . . 64.540000000000006 110.942 0.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.553 ' HB2' ' OD1' ' A' ' 175' ' ' ASP . . . -56.9 151.76 31.33 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.44 1.088 . . . . 61.100000000000001 109.295 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.494 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.491 1.785 . . . . 72.430000000000007 110.95 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.75 135.01 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 43.030000000000001 109.262 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 19.7 m -123.57 24.3 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.137 . . . . 73.329999999999998 109.309 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' SER . . . . . 0.429 ' C ' ' N ' ' A' ' 318' ' ' CYS . 3.5 t -53.69 -42.12 67.62 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.093 . . . . 70.420000000000002 110.005 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 16.0 m -41.89 -28.26 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 63.530000000000001 110.066 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' CYS . . . . . 0.429 ' N ' ' C ' ' A' ' 316' ' ' SER . 75.4 m . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.551 1.157 . . . . 73.530000000000001 108.333 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 136' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.833 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -166.73 112.26 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.477 1.111 . . . . 65.109999999999999 109.311 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.464 ' CA ' ' OD2' ' A' ' 194' ' ' ASP . 0.5 OUTLIER -83.41 4.03 29.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 109.974 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.4 151.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 64.439999999999998 109.286 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -104.85 145.0 29.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.430000000000007 109.296 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.97 -35.18 3.33 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.493 1.786 . . . . 61.009999999999998 111.014 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.413 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.88 150.06 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 73.409999999999997 109.333 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.511 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -46.06 -37.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 72.319999999999993 109.291 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.23 -49.32 2.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 63.219999999999999 109.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.653 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.45 1.094 . . . . 63.329999999999998 110.421 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.78 -57.45 12.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 74.329999999999998 109.241 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -52.95 -30.41 34.53 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.47 1.106 . . . . 62.409999999999997 109.337 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.74 -56.77 7.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.572 1.17 . . . . 54.340000000000003 110.038 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.042 HD12 HD11 ' A' ' 140' ' ' ILE . 79.2 mt -43.11 -43.03 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 75.420000000000002 109.31 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.605 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.69 -45.1 62.92 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 74.439999999999998 110.959 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -46.05 -36.92 6.13 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 1.11 . . . . 72.109999999999999 109.3 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.467 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 28.2 mt-30 -76.41 -55.79 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 74.439999999999998 110.284 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 188' ' ' LEU . 19.9 mt -49.46 -27.46 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 55.439999999999998 109.296 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -37.34 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.503 1.127 . . . . 64.010000000000005 109.306 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -56.21 -19.33 13.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 73.109999999999999 109.324 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.515 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 12.0 mm-40 -80.82 -28.01 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.454 1.096 . . . . 72.120000000000005 110.292 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.4 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 21.5 m -39.85 123.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 61.119999999999997 109.998 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.1 m -53.24 116.22 2.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.482 1.114 . . . . 73.420000000000002 108.303 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 142.03 -14.06 2.6 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.484 1.115 . . . . 23.32 111.011 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.743 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 59.0 p -97.71 161.86 13.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 0.75 . . . . 72.400000000000006 110.404 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -93.4 -2.35 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 63.409999999999997 109.967 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 162' ' ' THR . 2.2 m -112.03 0.1 15.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 75.430000000000007 110.397 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.743 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -75.57 134.09 40.79 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.51 1.131 . . . . 75.109999999999999 109.285 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -169.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.55 1.157 . . . . 73.200000000000003 110.029 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.451 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 44.0 p -154.75 127.53 4.11 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 64.319999999999993 110.026 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.08 137.14 48.56 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 121.019 -2.492 . . . . 65.019999999999996 110.981 0.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.472 ' O ' HD13 ' A' ' 298' ' ' LEU . 9.5 p -72.95 -178.91 2.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 64.120000000000005 108.278 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.845 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.0 mp -84.5 128.16 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 54.32 109.308 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 p -92.54 76.27 5.08 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.562 1.164 . . . . 71.140000000000001 110.399 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 51.2 p90 -78.76 -14.17 59.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 72.420000000000002 110.979 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.46 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -73.74 -3.03 25.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 74.129999999999995 110.296 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.776 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -131.84 66.7 78.43 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 74.340000000000003 111.018 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.547 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.2 Cg_endo -74.98 118.46 5.28 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.518 1.799 . . . . 73.219999999999999 111.015 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 172' ' ' TYR . 19.0 t -152.84 -64.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 54.100000000000001 109.326 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -132.3 -46.68 0.91 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 62.310000000000002 109.273 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -45.43 104.15 0.06 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.472 1.107 . . . . 51.43 110.996 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.493 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 3.5 p -138.65 -48.43 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.243 -1.021 . . . . 31.329999999999998 108.243 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.542 ' HE1' ' HH ' ' A' ' 277' ' ' TYR . 25.7 p90 -68.5 -16.22 63.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 74.450000000000003 110.985 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.93 -68.31 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 62.039999999999999 109.318 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HB3' HG23 ' A' ' 168' ' ' ILE . 7.2 ptm180 -50.92 -49.03 60.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.12 . . . . 75.25 110.297 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB1' ' HZ3' ' A' ' 197' ' ' LYS . . . -39.58 -56.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 71.319999999999993 109.292 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.549 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -47.1 -44.56 21.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.117 . . . . 63.520000000000003 109.601 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.845 ' CB ' HD11 ' A' ' 168' ' ' ILE . 22.9 mmmt -64.36 -42.25 96.3 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 73.549999999999997 109.328 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.516 ' HA ' HG23 ' A' ' 153' ' ' ILE . 17.4 mtm -55.5 -33.2 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 65.420000000000002 111.003 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -21.33 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 65.340000000000003 110.319 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.436 ' HG2' HD13 ' A' ' 187' ' ' ILE . 4.5 tt0 -71.73 -39.66 69.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.509 1.131 . . . . 74.219999999999999 110.304 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.467 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 19.0 mm -74.14 -32.48 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 63.439999999999998 109.294 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.867 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -61.65 -44.46 96.94 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.454 1.096 . . . . 74.030000000000001 109.324 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.6 mtp -58.51 -42.18 87.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 60.200000000000003 111.006 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -50.38 -53.53 28.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.461 1.1 . . . . 64.120000000000005 109.303 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.408 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 7.1 t-20 -60.55 -29.55 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 73.010000000000005 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.71 37.33 2.6 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.517 1.136 . . . . 71.010000000000005 110.99 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.833 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 73.7 m-85 -138.04 129.05 27.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 0.791 . . . . 62.520000000000003 110.988 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.464 ' OD2' ' CA ' ' A' ' 138' ' ' SER . 0.7 OUTLIER -99.27 132.51 44.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 51.240000000000002 109.293 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.695 ' HB3' HD22 ' A' ' 188' ' ' LEU . 25.9 p -112.17 -179.45 3.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 71.129999999999995 108.258 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -122.45 176.02 6.13 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.126 . . . . 62.240000000000002 110.285 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.637 ' HE2' HG22 ' A' ' 221' ' ' ILE . 22.0 mmtt -107.67 174.41 5.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 51.219999999999999 109.317 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.703 ' O ' HG23 ' A' ' 219' ' ' VAL . 17.1 tt0 -160.59 139.17 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.541 1.151 . . . . 74.230000000000004 110.263 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -130.27 113.49 14.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 74.430000000000007 110.994 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.667 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.2 p -110.15 148.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 74.230000000000004 109.32 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.1 m-85 -121.6 160.44 24.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.478 1.111 . . . . 74.340000000000003 111.0 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.44 179.88 17.01 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.551 1.157 . . . . 64.25 111.015 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.728 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.3 t-20 -69.23 110.27 4.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.491 0.759 . . . . 62.530000000000001 109.324 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -114.56 93.49 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 74.450000000000003 109.296 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.8 mttp -93.27 165.35 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 73.0 109.303 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -168.53 143.07 3.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 65.120000000000005 109.318 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 61.140000000000001 110.015 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 108.329 -0.989 . . . . 62.520000000000003 108.329 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -112.36 155.53 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 62.25 109.247 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.52 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -139.4 119.07 13.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 73.25 109.282 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.33 134.79 51.01 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.155 . . . . 75.150000000000006 108.02 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.1 m -80.45 3.78 20.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.458 1.099 . . . . 72.219999999999999 109.994 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.496 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.8 p90 -176.14 127.75 0.21 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.477 1.111 . . . . 55.240000000000002 111.027 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -116.54 168.45 10.16 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.478 1.111 . . . . 62.439999999999998 109.619 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 198' ' ' GLN . 1.3 p -145.57 143.38 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.49 1.119 . . . . 53.219999999999999 109.312 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.563 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -142.19 -165.68 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 45.229999999999997 109.294 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.637 HG22 ' HE2' ' A' ' 197' ' ' LYS . 31.1 pt -116.09 122.5 69.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 73.200000000000003 109.296 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 234' ' ' LYS . 19.9 tp -87.1 108.87 19.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 52.530000000000001 109.312 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.701 HG11 HG13 ' A' ' 237' ' ' ILE . 0.9 OUTLIER -102.0 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 65.140000000000001 109.3 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ILE . 54.8 m -135.75 120.14 17.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.494 1.121 . . . . 64.519999999999996 109.993 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.511 ' CD2' HG23 ' A' ' 143' ' ' VAL . 34.3 p90 -136.15 142.37 44.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.120000000000005 111.03 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.2 mmtp -68.21 132.84 47.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.504 1.128 . . . . 75.349999999999994 109.286 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -73.73 -160.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 53.439999999999998 109.321 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 0.09 48.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.481 1.113 . . . . 71.430000000000007 109.312 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -115.36 -7.19 12.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 73.329999999999998 110.02 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.54 37.66 8.67 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.473 1.108 . . . . 44.350000000000001 110.975 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 137.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.455 0.738 . . . . 74.430000000000007 109.323 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 8.6 m -71.47 102.58 2.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.049999999999997 110.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 224' ' ' SER . 1.8 mm-40 -101.39 -172.47 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 74.310000000000002 110.297 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.511 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -127.52 145.3 50.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 75.5 109.286 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.55 ' NH1' HG22 ' A' ' 248' ' ' THR . 4.3 tpt180 -142.68 161.14 38.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 74.549999999999997 110.284 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.697 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.4 mm -113.7 117.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.52 1.138 . . . . 54.119999999999997 109.318 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -105.08 45.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 64.329999999999998 109.314 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.9 106.54 53.31 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 62.109999999999999 109.309 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -75.01 -10.02 21.01 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 74.409999999999997 111.003 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.7 t -64.5 -11.85 38.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 61.329999999999998 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.472 HD11 ' NE2' ' A' ' 218' ' ' HIS . 5.2 mt -127.55 -48.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 73.140000000000001 109.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' A' ' 255' ' ' ALA . 75.9 m-85 -118.54 99.54 6.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.576 1.172 . . . . 74.200000000000003 111.017 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 75.6 m -88.14 -6.44 57.88 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.547 1.154 . . . . 74.329999999999998 109.982 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.1 m -80.95 -45.77 16.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 74.540000000000006 110.012 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.05 -174.23 43.29 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.495 1.122 . . . . 54.399999999999999 110.987 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.45 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 164.42 33.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.485 1.781 . . . . 63.32 111.021 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.577 HG21 ' CE2' ' A' ' 242' ' ' PHE . 2.6 m -150.46 161.23 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.113 . . . . 72.219999999999999 109.32 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.55 HG22 ' NH1' ' A' ' 235' ' ' ARG . 34.3 p -64.51 138.21 58.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.523 1.139 . . . . 71.010000000000005 110.41 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.409 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 0.4 OUTLIER -40.92 -29.79 0.11 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.51 1.131 . . . . 55.130000000000003 109.307 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 6.3 m -71.85 -64.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 64.5 110.384 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.37 -25.55 10.08 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.504 1.127 . . . . 74.230000000000004 109.314 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.697 ' CD1' HG21 ' A' ' 236' ' ' ILE . 9.2 t90 -64.36 -59.91 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.995 -1.113 . . . . 72.230000000000004 107.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.544 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.26 -41.9 39.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 63.25 110.281 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.852 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -56.56 -50.75 70.97 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.499 1.124 . . . . 74.5 109.275 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.596 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -55.94 -20.99 18.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 40.119999999999997 109.32 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.16 -36.2 16.97 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 72.319999999999993 108.262 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.852 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -93.36 21.59 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 44.420000000000002 109.271 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -51.06 107.1 0.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 73.310000000000002 109.329 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.2 p -73.49 -3.06 25.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 63.210000000000001 110.385 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.3 t -44.3 -30.84 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.505 1.128 . . . . 62.049999999999997 109.97 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.59 -37.35 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 71.219999999999999 108.347 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.72 -128.06 1.66 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.546 1.154 . . . . 23.300000000000001 110.993 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.02 145.35 42.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.477 0.751 . . . . 62.329999999999998 109.983 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.02 148.03 4.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.46 1.1 . . . . 62.020000000000003 109.314 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 29.3 m -172.77 155.23 3.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 44.229999999999997 110.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.667 HG23 ' CG2' ' A' ' 200' ' ' VAL . 4.9 p -102.65 116.54 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.467 1.104 . . . . 41.310000000000002 109.283 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 32.0 t -70.76 -44.89 65.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.505 1.128 . . . . 65.030000000000001 109.951 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 200' ' ' VAL . 50.7 p -165.43 -173.52 2.83 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.151 . . . . 74.230000000000004 110.006 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -165.4 156.53 14.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 63.219999999999999 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.04 147.84 23.05 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.53 1.144 . . . . 75.120000000000005 109.286 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -99.63 158.93 15.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 65.019999999999996 109.31 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 1.3 p -146.44 179.14 7.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.517 1.135 . . . . 71.530000000000001 110.386 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -74.57 163.36 27.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 64.530000000000001 109.324 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.47 -16.41 80.01 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.492 1.12 . . . . 74.219999999999999 111.008 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 276' ' ' VAL . 7.5 p30 -86.29 -43.61 12.78 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 0.782 . . . . 63.420000000000002 109.342 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.445 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 3.8 t -43.71 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.571 1.169 . . . . 64.230000000000004 109.285 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.542 ' HH ' ' HE1' ' A' ' 178' ' ' TYR . 34.0 t80 -66.95 -42.8 84.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 52.549999999999997 111.022 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.6 OUTLIER -153.21 121.02 6.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 64.219999999999999 111.029 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.469 ' HD2' ' CG2' ' A' ' 272' ' ' THR . 40.8 ttt-85 -106.57 137.19 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.515 1.134 . . . . 73.030000000000001 110.334 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.92 158.17 32.62 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 73.040000000000006 110.007 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.47 8.88 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.467 1.772 . . . . 72.409999999999997 110.974 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 27.9 t -98.18 13.19 32.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.542 1.152 . . . . 72.230000000000004 109.99 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 74.87 37.19 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 55.5 109.338 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -112.3 152.94 27.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 64.230000000000004 109.951 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.457 ' CE1' ' HD2' ' A' ' 279' ' ' ARG . 51.9 m-85 -140.54 158.2 44.35 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 73.109999999999999 111.022 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -126.08 172.95 9.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.498 1.123 . . . . 74.299999999999997 109.281 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.473 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 88.1 m-85 -160.23 114.95 2.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 1.099 . . . . 64.329999999999998 111.001 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.426 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 8.0 t0 -115.5 97.04 5.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 64.140000000000001 109.273 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ASN . . . . . 0.434 ' O ' HD22 ' A' ' 291' ' ' LEU . 6.8 m-20 -85.83 -39.42 17.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 65.25 109.298 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.476 ' CB ' HG12 ' A' ' 292' ' ' ILE . 4.3 m120 -90.52 9.54 28.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 72.510000000000005 109.325 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.549 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.06 46.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 1.125 . . . . 65.049999999999997 109.305 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.476 HG12 ' CB ' ' A' ' 290' ' ' ASN . 48.9 mm -77.28 -28.77 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 73.549999999999997 109.298 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.831 ' O ' HG23 ' A' ' 297' ' ' VAL . 4.2 t30 -94.54 -22.53 18.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.420000000000002 109.312 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 m -84.52 -64.18 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.478 1.111 . . . . 53.32 110.395 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 82.5 m-20 -57.47 -17.94 15.97 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.119 . . . . 74.019999999999996 109.308 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 7.2 t -81.88 -63.95 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 55.240000000000002 108.303 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 293' ' ' ASN . 46.2 t -40.38 -51.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.545 1.153 . . . . 75.439999999999998 109.27 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 167' ' ' CYS . 47.0 mt -57.14 -59.48 5.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 64.310000000000002 109.296 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.22 -34.71 2.92 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.140000000000001 110.378 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -68.06 -43.31 78.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 73.109999999999999 109.259 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.738 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.5 m-30 -99.5 35.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 73.25 111.006 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.2 t -69.41 -43.36 73.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 64.109999999999999 110.029 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.45 -12.78 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.430000000000007 109.315 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.776 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 12.6 mt -60.39 150.28 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 74.209999999999994 109.295 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.6 p -161.48 162.92 30.61 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 54.299999999999997 109.984 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.68 -152.82 52.78 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.519 1.137 . . . . 74.040000000000006 111.018 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 2.1 m -101.64 13.12 35.88 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.292 -1.003 . . . . 64.450000000000003 108.292 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.522 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 12.9 p -129.49 150.01 74.45 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.150000000000006 110.009 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.705 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.6 Cg_endo -74.95 147.12 88.51 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.967 -2.514 . . . . 75.540000000000006 111.056 -0.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.465 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -128.71 133.69 25.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.531 1.145 . . . . 74.109999999999999 109.992 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -74.96 -170.27 8.1 Favored 'Cis proline' 0 C--N 1.36 1.168 0 C-N-CA 120.97 -2.512 . . . . 55.109999999999999 111.033 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 152.34 29.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 71.129999999999995 109.29 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.414 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.512 1.796 . . . . 73.439999999999998 110.996 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -91.4 135.31 33.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.148 . . . . 71.219999999999999 109.254 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.7 m -126.59 24.5 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.489 1.118 . . . . 73.129999999999995 109.276 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 318' ' ' CYS . 35.6 t -50.73 -44.12 58.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.349999999999994 109.952 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.6 m -39.51 -29.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 71.25 110.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 316' ' ' SER . 74.6 m . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.434 1.084 . . . . 64.030000000000001 108.304 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.718 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.327 -0.62 . . . . 72.329999999999998 109.327 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.811 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.04 106.7 3.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.533 1.145 . . . . 54.119999999999997 109.327 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m -81.82 5.65 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.329999999999998 109.99 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.3 t -149.35 145.62 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 70.140000000000001 109.302 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.107 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -96.88 142.44 24.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.488 1.117 . . . . 62.549999999999997 109.27 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -32.44 5.42 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.464 1.77 . . . . 63.109999999999999 110.99 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.485 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.49 153.22 22.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.105 . . . . 73.129999999999995 109.3 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 146' ' ' LEU . 1.8 t -51.08 -34.31 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.158 . . . . 74.109999999999999 109.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.84 -45.86 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 74.049999999999997 109.32 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.721 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.6 m -73.21 -32.38 64.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 64.239999999999995 110.415 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -61.84 -56.23 21.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 73.319999999999993 109.295 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -53.62 -31.37 46.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 71.040000000000006 109.288 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.39 -55.22 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 73.319999999999993 109.987 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.107 HD12 HD11 ' A' ' 140' ' ' ILE . 92.1 mt -44.4 -42.41 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 72.010000000000005 109.302 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.654 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -72.35 -44.7 62.22 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 1.117 . . . . 75.129999999999995 110.994 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -47.04 -37.32 9.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 70.450000000000003 109.262 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.465 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 21.9 mt-30 -74.94 -55.57 5.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 1.139 . . . . 62.299999999999997 110.293 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.699 HD11 HD12 ' A' ' 188' ' ' LEU . 23.4 mt -50.45 -28.0 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 54.0 109.308 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.406 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -75.07 -33.71 61.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 62.140000000000001 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.3 t-20 -61.59 -15.15 36.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 70.010000000000005 109.294 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -85.81 -18.47 32.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 71.209999999999994 110.302 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.0 p -37.93 134.51 0.75 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 1.13 . . . . 54.350000000000001 109.977 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.676 ' HB3' HH21 ' A' ' 171' ' ' ARG . 1.3 m -66.18 120.04 12.53 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 60.329999999999998 108.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 127.69 -15.82 6.26 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 51.439999999999998 110.99 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.867 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 69.6 p -83.39 161.9 21.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 0.758 . . . . 72.310000000000002 110.387 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -93.55 0.12 56.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.467 1.104 . . . . 74.5 109.963 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 162' ' ' THR . 2.9 m -119.45 7.15 11.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 50.119999999999997 110.355 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.867 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -81.31 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 62.119999999999997 109.308 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -162.03 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 54.409999999999997 110.014 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 126.92 3.5 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 70.430000000000007 110.039 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 139.85 64.05 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.948 -2.522 . . . . 74.409999999999997 110.998 0.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.99 178.46 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.1 . . . . 75.540000000000006 108.333 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.949 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.0 mp -86.32 132.95 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 70.209999999999994 109.268 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 301' ' ' PHE . 51.0 p -90.43 75.24 6.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 60.439999999999998 110.403 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -81.64 -24.79 36.13 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 62.409999999999997 111.027 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.676 HH21 ' HB3' ' A' ' 158' ' ' CYS . 0.0 OUTLIER -75.97 -1.57 26.28 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 73.450000000000003 110.3 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.796 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 25.6 t80 -128.91 67.44 77.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.092 . . . . 61.240000000000002 111.012 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.415 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.55 4.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.51 1.795 . . . . 50.240000000000002 111.013 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.585 HG21 ' CE1' ' A' ' 172' ' ' TYR . 14.6 t -152.23 -58.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 74.329999999999998 109.292 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -138.43 -47.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 52.43 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.19 106.46 0.05 OUTLIER Glycine 0 CA--C 1.529 0.938 0 O-C-N 124.526 1.141 . . . . 61.450000000000003 111.044 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.786 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.6 p -143.06 -48.41 0.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.307 -0.997 . . . . 52.049999999999997 108.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.604 ' HB3' HG11 ' A' ' 219' ' ' VAL . 24.3 p90 -69.99 -33.9 72.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.461 1.101 . . . . 74.129999999999995 111.062 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.492 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -62.57 -68.42 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 72.140000000000001 109.264 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.669 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -46.38 -44.5 17.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 55.100000000000001 110.32 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.71 -55.47 5.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.466 1.104 . . . . 51.329999999999998 109.267 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.88 -35.83 15.66 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 72.340000000000003 109.635 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.949 ' CB ' HD11 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -71.47 -50.55 30.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 75.420000000000002 109.286 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.555 ' HA ' HG23 ' A' ' 153' ' ' ILE . 5.3 mtm -51.84 -41.2 61.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 62.100000000000001 111.01 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.96 -24.47 58.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 63.530000000000001 110.305 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.425 ' HG2' HD13 ' A' ' 187' ' ' ILE . 5.7 tt0 -69.48 -41.56 75.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.515 1.135 . . . . 72.239999999999995 110.305 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 20.8 mm -72.02 -33.0 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.488 1.118 . . . . 74.430000000000007 109.274 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -59.56 -47.36 85.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 1.097 . . . . 75.219999999999999 109.332 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.482 ' HG2' HD21 ' A' ' 136' ' ' LEU . 2.4 mtt -54.9 -44.35 74.05 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 73.150000000000006 111.001 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.0 -53.33 20.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 74.329999999999998 109.312 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -58.46 -32.88 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 75.450000000000003 109.308 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 108.78 43.86 1.18 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.53 1.144 . . . . 62.310000000000002 110.973 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.811 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 68.6 m-85 -144.79 133.31 22.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.48 0.753 . . . . 73.319999999999993 111.03 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.718 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.5 OUTLIER -99.71 130.07 45.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 75.409999999999997 109.31 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.791 ' HB3' HD22 ' A' ' 188' ' ' LEU . 28.5 p -112.25 -179.44 3.68 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 1.153 . . . . 72.239999999999995 108.307 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -125.87 177.41 6.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 64.209999999999994 110.286 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.654 ' HE2' HG22 ' A' ' 221' ' ' ILE . 16.5 mmtt -108.87 164.27 12.54 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 64.150000000000006 109.292 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.486 ' OE1' HD13 ' A' ' 222' ' ' LEU . 30.5 tt0 -151.5 117.49 5.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.446 1.091 . . . . 73.409999999999997 110.277 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 219' ' ' VAL . 3.9 m-85 -108.65 129.74 55.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 63.299999999999997 111.056 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.795 HG23 ' HB3' ' A' ' 269' ' ' TYR . 6.3 p -128.49 131.63 68.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 64.230000000000004 109.289 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.4 m-85 -108.01 159.51 16.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.517 1.135 . . . . 71.150000000000006 111.053 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 123.48 -173.19 16.38 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.469 1.105 . . . . 51.509999999999998 110.978 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.752 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.5 t-20 -76.3 108.19 9.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 65.319999999999993 109.321 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.752 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.4 mt -111.13 95.09 5.32 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.118 . . . . 72.239999999999995 109.305 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 264' ' ' ALA . 0.2 OUTLIER -92.21 158.35 16.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 73.540000000000006 109.294 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.493 ' O ' HG22 ' A' ' 213' ' ' VAL . . . -179.12 162.63 1.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.13 . . . . 73.319999999999993 109.318 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.140000000000001 110.013 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.455 ' O ' HG13 ' A' ' 213' ' ' VAL . 19.1 m . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 108.294 -1.002 . . . . 65.530000000000001 108.294 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 206' ' ' ALA . 2.4 m -153.03 129.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.538 1.149 . . . . 72.519999999999996 109.3 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 205' ' ' LYS . . . -124.42 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.433 1.083 . . . . 73.519999999999996 109.279 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -132.33 134.87 45.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.988 -1.116 . . . . 75.129999999999995 107.988 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 23.8 t -77.36 0.18 23.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 61.509999999999998 110.063 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 4.7 p90 -178.15 136.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 74.219999999999999 110.978 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.519 ' CB ' HD12 ' A' ' 204' ' ' LEU . 77.6 t60 -129.5 143.31 50.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 74.439999999999998 109.61 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.786 HG12 ' SG ' ' A' ' 177' ' ' CYS . 7.4 p -124.47 134.27 67.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.475 1.11 . . . . 73.109999999999999 109.284 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.552 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.35 -152.1 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 72.540000000000006 109.371 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.654 HG22 ' HE2' ' A' ' 197' ' ' LYS . 13.1 pt -128.72 123.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 63.210000000000001 109.29 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.7 tp -89.78 109.06 20.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 55.229999999999997 109.327 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.7 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.04 148.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 61.530000000000001 109.301 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.611 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -117.24 121.63 41.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 30.239999999999998 109.995 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.0 p90 -136.81 144.95 43.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 64.010000000000005 111.009 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.439 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.6 mmtp -70.07 133.78 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 62.229999999999997 109.322 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.46 -159.67 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 64.230000000000004 109.305 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.93 0.07 49.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 74.150000000000006 109.243 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.01 -8.59 12.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.133 . . . . 62.32 110.018 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.41 37.59 8.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.478 1.111 . . . . 51.210000000000001 111.039 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.54 138.21 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.49 0.759 . . . . 71.540000000000006 109.319 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.439 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 23.9 m -71.58 102.67 2.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.152 . . . . 73.140000000000001 110.408 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.0 mm-40 -101.69 -172.61 2.18 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 60.310000000000002 110.257 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.652 ' HB3' HD11 ' A' ' 222' ' ' LEU . 17.9 mmtt -126.66 144.91 50.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 75.329999999999998 109.257 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.651 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.6 tpt180 -143.43 160.57 40.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 72.420000000000002 110.32 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.644 HG21 ' CD1' ' A' ' 252' ' ' TRP . 14.3 mm -116.6 119.15 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 63.420000000000002 109.313 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -103.37 44.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 75.219999999999999 109.284 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -101.26 108.5 55.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.487 1.117 . . . . 63.32 109.283 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -26.9 10.5 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.486 1.782 . . . . 64.310000000000002 110.966 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.3 OUTLIER -45.92 -25.46 0.54 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 73.030000000000001 110.002 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.1 mt -112.97 -60.71 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 73.329999999999998 109.333 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.596 ' CD1' HG11 ' A' ' 247' ' ' VAL . 85.3 m-85 -106.5 99.58 9.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 74.239999999999995 110.969 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 52.8 m -85.67 -13.47 48.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 43.200000000000003 109.992 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.2 m -72.01 -47.85 48.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 72.25 109.944 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.75 -170.97 39.91 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.523 1.14 . . . . 52.340000000000003 111.0 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.448 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -74.99 163.84 34.57 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.495 1.787 . . . . 71.430000000000007 111.007 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.596 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.1 m -147.81 162.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 74.030000000000001 109.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.453 HG22 ' NH1' ' A' ' 235' ' ' ARG . 31.1 p -63.49 139.22 58.75 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.49 1.119 . . . . 73.519999999999996 110.428 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 249' ' ' ASP . 0.2 OUTLIER -42.45 -28.56 0.22 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 64.219999999999999 109.317 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.431 ' N ' ' C ' ' A' ' 248' ' ' THR . 9.1 m -75.93 -62.57 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.127 . . . . 55.109999999999999 110.367 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.07 -28.23 6.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 74.129999999999995 109.311 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 236' ' ' ILE . 10.2 t90 -63.25 -63.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 71.519999999999996 107.989 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.625 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -46.5 -42.24 15.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 62.409999999999997 110.3 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.781 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -56.28 -51.29 68.71 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 63.420000000000002 109.325 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.69 -28.0 53.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.131 . . . . 73.439999999999998 109.276 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.2 m -80.14 -36.89 34.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 71.109999999999999 108.309 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.802 HG11 HG23 ' A' ' 266' ' ' VAL . 2.6 m -95.37 22.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.49 1.119 . . . . 64.219999999999999 109.299 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -50.7 104.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.11 . . . . 74.129999999999995 109.286 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -73.34 -4.22 32.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.507 1.129 . . . . 71.400000000000006 110.408 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.3 t -51.31 -21.69 2.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.474 1.109 . . . . 43.140000000000001 110.004 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' CYS . . . . . 0.429 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 5.0 m -96.51 -27.3 14.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.541 1.151 . . . . 73.430000000000007 108.297 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 156.51 -128.21 2.15 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.436 1.085 . . . . 73.519999999999996 111.025 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.449 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -78.54 141.24 38.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 0.753 . . . . 75.200000000000003 110.013 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.585 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -171.38 143.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 61.329999999999998 109.316 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.65 161.71 4.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.132 . . . . 71.420000000000002 109.962 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.802 HG23 HG11 ' A' ' 257' ' ' VAL . 17.5 t -103.57 128.23 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 55.310000000000002 109.342 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.9 t -84.77 -39.44 18.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 54.439999999999998 109.991 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.6 m -175.0 144.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 74.099999999999994 109.976 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.795 ' HB3' HG23 ' A' ' 200' ' ' VAL . 44.5 p90 -130.48 160.13 35.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.42 1.075 . . . . 64.409999999999997 111.022 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.96 160.45 41.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.496 1.123 . . . . 74.439999999999998 109.341 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.43 ' C ' HG23 ' A' ' 272' ' ' THR . 8.9 p30 -122.7 158.04 30.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.557 1.161 . . . . 71.439999999999998 109.283 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 271' ' ' ASN . 56.0 p -151.95 175.46 12.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 75.200000000000003 110.379 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.759 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -55.36 161.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 70.25 109.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.21 -45.38 40.07 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.473 1.108 . . . . 54.100000000000001 110.983 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.51 -37.43 49.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 0.768 . . . . 52.32 109.286 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.759 HG23 ' HB3' ' A' ' 273' ' ' ALA . 43.1 t -45.86 118.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.555 1.159 . . . . 75.409999999999997 109.277 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 6.2 t80 -81.34 -52.09 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 61.119999999999997 110.995 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -135.89 160.08 39.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.14 . . . . 71.040000000000006 111.019 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.514 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.8 ttt-85 -131.11 147.48 52.62 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.437 1.085 . . . . 71.510000000000005 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.92 157.45 52.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.1 . . . . 61.340000000000003 110.0 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 0.31 9.04 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.482 1.78 . . . . 51.420000000000002 111.008 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 11.3 t -99.55 6.21 45.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 72.230000000000004 110.018 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.4 t-20 76.21 34.67 0.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 74.140000000000001 109.271 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -116.49 123.56 47.76 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 54.399999999999999 110.001 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -104.91 157.6 17.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.200000000000003 110.987 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -116.55 171.38 7.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.107 . . . . 61.520000000000003 109.323 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.729 ' H ' HD13 ' A' ' 286' ' ' LEU . 41.5 m-85 -153.83 115.22 4.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.46 1.1 . . . . 72.239999999999995 110.995 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.441 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 3.8 t0 -115.61 97.84 6.37 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.476 1.11 . . . . 65.5 109.305 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -85.66 -26.96 25.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 75.430000000000007 109.298 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 2.4 t-20 -101.74 -1.81 31.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 62.119999999999997 109.268 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 54.78 46.04 25.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 74.450000000000003 109.295 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 16.5 mm -66.69 -42.93 90.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 51.219999999999999 109.27 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.75 ' O ' HG23 ' A' ' 297' ' ' VAL . 3.8 t30 -90.46 -23.6 20.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 62.539999999999999 109.304 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.589 HG21 HD12 ' A' ' 291' ' ' LEU . 1.2 m -75.6 -64.21 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 72.150000000000006 110.426 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 54.3 m-20 -58.1 -25.56 61.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 72.430000000000007 109.315 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 27.2 t -76.24 -60.52 2.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.481 1.113 . . . . 74.150000000000006 108.305 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.9 t -41.5 -50.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 64.230000000000004 109.298 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.05 -60.02 4.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 70.329999999999998 109.328 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -41.68 -37.9 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.448 1.093 . . . . 74.349999999999994 110.38 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -61.98 -56.67 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 75.109999999999999 109.314 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.569 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 0.4 OUTLIER -93.16 37.64 1.04 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 73.319999999999993 111.035 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -70.81 -43.89 67.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.46 1.1 . . . . 60.219999999999999 110.005 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.657 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.28 -12.12 28.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.488 1.117 . . . . 72.5 109.292 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.816 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.9 mt -61.08 139.45 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.548 1.155 . . . . 72.340000000000003 109.294 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 71.0 p -149.39 147.17 27.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 72.019999999999996 109.966 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 84.02 -162.0 38.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.128 . . . . 52.030000000000001 110.971 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 4.1 p -91.27 3.67 54.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.296 -1.001 . . . . 64.340000000000003 108.296 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 33.9 p -126.09 150.97 71.04 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 71.010000000000005 110.007 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.816 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.96 146.36 86.45 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.024 -2.49 . . . . 73.150000000000006 111.024 -0.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.493 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.1 p -133.77 135.42 24.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 34.140000000000001 110.014 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.01 -173.19 11.89 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.996 -2.502 . . . . 61.119999999999997 111.004 -0.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.07 154.29 20.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.458 1.099 . . . . 41.520000000000003 109.331 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.562 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.1 Cg_endo -75.02 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.489 1.783 . . . . 61.310000000000002 110.994 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -89.75 130.79 35.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.12 . . . . 70.109999999999999 109.269 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.5 m -121.08 27.45 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 62.229999999999997 109.276 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 318' ' ' CYS . 9.3 t -50.46 -44.47 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.117 . . . . 74.150000000000006 110.005 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 316' ' ' SER . 80.0 p -38.96 -30.55 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.485 1.116 . . . . 43.520000000000003 109.973 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 316' ' ' SER . 57.4 m . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 74.340000000000003 108.324 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.301 -0.629 . . . . 54.119999999999997 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.657 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -152.74 109.64 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 54.219999999999999 109.332 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -83.11 7.52 15.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.536 1.147 . . . . 71.150000000000006 110.011 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -147.11 148.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.515 1.134 . . . . 74.120000000000005 109.275 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.109 HD11 HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -101.5 143.75 27.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.230000000000004 109.303 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.94 -34.12 4.15 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.504 1.791 . . . . 74.019999999999996 111.035 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.446 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.37 153.29 25.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 74.140000000000001 109.281 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -49.94 -36.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 71.219999999999999 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.41 -49.27 2.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 71.340000000000003 109.335 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.677 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -69.42 -36.88 77.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 73.340000000000003 110.38 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.678 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -57.16 -57.37 12.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 74.310000000000002 109.323 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -52.48 -29.6 25.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 73.310000000000002 109.329 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.27 -56.13 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 70.319999999999993 110.025 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.109 HD12 HD11 ' A' ' 140' ' ' ILE . 76.1 mt -42.07 -41.93 2.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 71.140000000000001 109.329 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.612 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.45 -45.13 60.97 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 75.209999999999994 110.99 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.41 -36.0 9.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 63.240000000000002 109.289 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 155' ' ' ASN . 20.3 mt-30 -76.13 -55.49 5.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.481 HD11 HD12 ' A' ' 188' ' ' LEU . 15.7 mt -50.14 -26.87 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -34.56 58.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 63.030000000000001 109.288 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -62.33 -14.6 41.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 109.259 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -86.44 -17.07 35.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 74.420000000000002 110.297 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.1 p -38.71 122.97 1.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 71.450000000000003 109.937 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 131.12 42.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 61.43 108.256 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.46 -25.1 9.36 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.509 1.131 . . . . 74.030000000000001 110.993 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.815 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 25.3 p -73.52 162.92 28.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 0.753 . . . . 73.340000000000003 110.431 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 -2.45 54.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 62.310000000000002 110.029 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 162' ' ' THR . 7.5 m -116.79 8.76 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.453 1.096 . . . . 75.430000000000007 110.376 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.815 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.81 138.09 34.09 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 62.439999999999998 109.3 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -169.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 73.540000000000006 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.437 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.7 p -153.54 126.78 4.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 71.230000000000004 109.999 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -74.97 137.48 50.6 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 64.219999999999999 111.002 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.7 p -73.09 -179.7 3.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 73.219999999999999 108.322 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.722 HG21 ' CB ' ' A' ' 180' ' ' ARG . 3.7 mp -101.93 137.06 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 63.340000000000003 109.267 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 301' ' ' PHE . 34.1 p -74.37 83.66 1.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 64.099999999999994 110.381 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.524 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 3.1 m-85 -80.1 -1.07 38.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.477 1.11 . . . . 75.340000000000003 110.991 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -118.02 14.93 14.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.200000000000003 110.317 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.712 ' OH ' HD13 ' A' ' 304' ' ' LEU . 18.6 t80 -128.86 67.55 77.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 61.409999999999997 111.041 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.438 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.5 Cg_endo -74.97 113.19 3.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.521 1.801 . . . . 72.510000000000005 111.014 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.55 HG21 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.75 -71.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 72.219999999999999 109.24 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -133.53 -46.51 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 54.409999999999997 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.93 100.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 42.43 110.988 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.742 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.2 p -137.56 -48.53 0.58 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.304 -0.998 . . . . 71.430000000000007 108.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.602 ' HB3' HG11 ' A' ' 219' ' ' VAL . 27.4 p90 -69.92 -25.21 63.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.55 1.156 . . . . 62.130000000000003 111.03 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.35 -65.64 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 65.239999999999995 109.37 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.722 ' CB ' HG21 ' A' ' 168' ' ' ILE . 11.4 ptm180 -45.77 -51.86 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.099 . . . . 73.430000000000007 110.234 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.489 ' HB1' ' HZ3' ' A' ' 197' ' ' LYS . . . -41.37 -63.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 75.439999999999998 109.31 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.468 ' HA ' ' HZ1' ' A' ' 197' ' ' LYS . 6.4 t-160 -40.74 -38.71 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 73.219999999999999 109.583 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.629 ' HB3' HD11 ' A' ' 168' ' ' ILE . 13.3 mmmm -68.47 -59.92 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 71.450000000000003 109.257 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.428 ' SD ' HG21 ' A' ' 153' ' ' ILE . 25.7 mtm -41.4 -30.67 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 62.340000000000003 110.958 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.675 HH21 ' CG ' ' A' ' 275' ' ' ASN . 0.1 OUTLIER -68.25 -47.61 67.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.447 1.092 . . . . 53.219999999999999 110.293 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.473 ' HG3' HD13 ' A' ' 187' ' ' ILE . 3.6 pt20 -51.4 -33.52 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 73.319999999999993 110.306 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.473 HD13 ' HG3' ' A' ' 186' ' ' GLN . 16.1 mm -75.7 -34.33 28.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.115 . . . . 63.229999999999997 109.305 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.7 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -60.96 -47.51 86.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 63.340000000000003 109.253 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 136' ' ' LEU . 4.5 mtt -54.93 -44.29 74.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 52.439999999999998 110.996 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -47.25 -52.53 15.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 74.230000000000004 109.297 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -63.32 -36.36 83.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 54.109999999999999 109.284 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.32 48.71 0.69 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.12 . . . . 63.439999999999998 110.987 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.677 ' CZ ' HG21 ' A' ' 145' ' ' THR . 64.1 m-85 -149.39 137.37 20.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.481 0.754 . . . . 62.25 111.05 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -103.55 130.31 50.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 71.430000000000007 109.333 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.7 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.4 p -107.52 -179.48 3.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 50.32 108.298 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -127.05 172.62 10.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 75.430000000000007 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.646 ' HE2' HG22 ' A' ' 221' ' ' ILE . 15.9 mmtt -104.98 157.29 17.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.438 1.087 . . . . 74.120000000000005 109.321 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 219' ' ' VAL . 20.7 tt0 -146.52 117.76 7.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 65.439999999999998 110.282 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.2 m-85 -108.27 128.22 54.54 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 73.5 110.977 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.879 HG13 HG23 ' A' ' 266' ' ' VAL . 1.5 t -120.52 161.05 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 63.43 109.328 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 2.3 m-85 -138.84 151.22 46.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 74.109999999999999 111.019 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.14 18.24 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.506 1.129 . . . . 61.409999999999997 111.027 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.787 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.6 t-20 -77.33 111.36 12.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 0.76 . . . . 72.530000000000001 109.3 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.0 mt -113.74 94.12 4.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 62.509999999999998 109.299 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.7 ' NZ ' ' HB2' ' A' ' 214' ' ' ALA . 1.2 mtpp -92.89 158.31 15.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 73.349999999999994 109.294 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -164.89 162.75 20.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.209999999999994 109.313 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.553 1.158 . . . . 73.030000000000001 110.017 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 108.283 -1.006 . . . . 70.219999999999999 108.283 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.901 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -145.08 149.01 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 64.519999999999996 109.253 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.7 ' HB2' ' NZ ' ' A' ' 205' ' ' LYS . . . -141.79 120.16 12.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.539 1.15 . . . . 41.119999999999997 109.291 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -125.46 136.8 53.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 73.420000000000002 108.008 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 p -80.78 1.43 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 71.510000000000005 110.007 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 7.9 p90 -178.17 130.8 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 51.229999999999997 111.022 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.504 ' CB ' HD12 ' A' ' 204' ' ' LEU . 80.2 t60 -123.83 166.41 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.568 1.168 . . . . 75.239999999999995 109.591 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 198' ' ' GLN . 4.8 p -147.94 143.24 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 72.299999999999997 109.264 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.605 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.12 -159.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.452 1.095 . . . . 74.510000000000005 109.348 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.646 HG22 ' HE2' ' A' ' 197' ' ' LYS . 8.2 pt -118.16 125.17 74.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.542 1.151 . . . . 75.140000000000001 109.273 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 234' ' ' LYS . 12.6 tp -89.19 108.97 19.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 62.5 109.333 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.95 147.41 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 72.239999999999995 109.32 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.563 ' HB3' HG22 ' A' ' 139' ' ' VAL . 5.1 m -117.1 121.52 41.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 62.509999999999998 110.02 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.6 p90 -136.45 143.14 43.73 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.471 1.107 . . . . 73.439999999999998 110.992 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.0 mmtp -68.73 132.93 47.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 51.539999999999999 109.268 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.41 -160.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 74.239999999999995 109.349 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.61 0.06 48.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 74.439999999999998 109.278 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.8 m -115.15 -7.95 12.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 64.519999999999996 110.006 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.97 37.68 8.31 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 72.109999999999999 111.005 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.5 138.02 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.511 0.771 . . . . 72.219999999999999 109.316 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.0 m -71.72 102.67 2.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 74.549999999999997 110.38 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.9 mm-40 -101.55 -172.58 2.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.468 1.105 . . . . 75.129999999999995 110.307 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.497 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.9 mmtm -127.29 145.08 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.147 . . . . 74.430000000000007 109.339 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.7 tpt180 -144.19 161.2 39.47 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.329999999999998 110.304 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.64 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.6 mm -116.75 120.43 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.464 1.102 . . . . 73.439999999999998 109.249 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -104.22 44.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 71.319999999999993 109.279 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -100.32 108.88 54.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 43.240000000000002 109.31 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.524 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.2 Cg_endo -75.05 -27.88 9.56 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.506 1.792 . . . . 75.439999999999998 111.019 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.2 t -48.15 -24.2 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 75.140000000000001 110.036 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.11 -57.0 2.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 72.549999999999997 109.277 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.613 ' CE2' HG21 ' A' ' 247' ' ' VAL . 81.7 m-85 -112.46 99.45 7.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.349999999999994 110.996 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.0 m -85.92 -9.1 57.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.094 . . . . 53.439999999999998 110.021 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.3 p -77.36 -46.26 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 71.430000000000007 110.004 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.76 -171.59 41.35 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.501 1.126 . . . . 72.200000000000003 110.958 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.438 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.97 163.35 35.55 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.458 1.767 . . . . 71.319999999999993 111.039 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.613 HG21 ' CE2' ' A' ' 242' ' ' PHE . 3.1 m -147.55 160.01 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.502 1.126 . . . . 74.450000000000003 109.265 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.9 p -61.53 141.37 57.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 72.430000000000007 110.401 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.445 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 8.9 p30 -44.25 -27.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 71.430000000000007 109.302 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 15.8 m -77.53 -61.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.133 . . . . 74.530000000000001 110.427 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.58 -27.62 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 45.020000000000003 109.314 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 236' ' ' ILE . 9.9 t90 -63.66 -63.14 1.26 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.47 1.106 . . . . 71.239999999999995 108.055 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.569 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -47.17 -42.04 19.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 75.239999999999995 110.311 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.814 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.8 m-80 -55.75 -51.57 66.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 74.340000000000003 109.313 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.25 -24.79 29.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.492 1.12 . . . . 71.219999999999999 109.322 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.3 m -83.94 -36.5 23.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.144 . . . . 63.140000000000001 108.304 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.63 22.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 61.539999999999999 109.311 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -49.28 104.85 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.437 1.086 . . . . 74.439999999999998 109.276 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 262' ' ' GLY . 1.8 p -72.33 -4.02 27.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.507 1.13 . . . . 43.109999999999999 110.348 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 t -46.32 -27.0 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 61.149999999999999 109.967 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' CYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 1.7 m -92.11 -35.76 13.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 74.120000000000005 108.236 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.15 -126.79 1.68 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.505 1.128 . . . . 64.540000000000006 110.973 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -69.64 142.21 53.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 0.768 . . . . 70.209999999999994 110.002 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.559 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -173.08 140.84 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 70.239999999999995 109.279 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 87.8 p -172.09 156.53 4.04 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.161 . . . . 72.329999999999998 109.991 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.879 HG23 HG13 ' A' ' 200' ' ' VAL . 6.0 p -103.78 111.15 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.502 1.126 . . . . 73.120000000000005 109.3 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 201' ' ' TYR . 16.5 t -61.68 -46.9 87.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 65.040000000000006 110.013 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.6 m -159.58 -174.21 4.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.45 1.094 . . . . 75.010000000000005 110.009 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 200' ' ' VAL . 45.6 p90 -167.0 157.38 11.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.485 1.115 . . . . 75.040000000000006 110.986 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.0 169.44 22.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 61.130000000000003 109.311 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 272' ' ' THR . 6.6 p30 -134.17 160.64 37.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 74.200000000000003 109.253 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.743 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.7 p -158.24 -177.93 6.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 74.019999999999996 110.378 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.79 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -60.97 167.22 3.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 54.32 109.303 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.26 -41.55 10.1 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 110.983 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.675 ' CG ' HH21 ' A' ' 185' ' ' ARG . 0.8 OUTLIER -58.58 -45.2 89.57 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.497 0.763 . . . . 75.439999999999998 109.321 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.79 HG23 ' HB3' ' A' ' 273' ' ' ALA . 91.3 t -43.76 101.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.431 1.082 . . . . 74.109999999999999 109.305 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.452 ' HH ' ' HE1' ' A' ' 178' ' ' TYR . 2.9 t80 -52.23 -58.66 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 62.229999999999997 110.99 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.9 t80 -139.06 170.17 16.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.109 . . . . 73.120000000000005 110.986 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.743 ' HD2' HG21 ' A' ' 272' ' ' THR . 66.3 ttt-85 -141.59 147.44 37.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 64.200000000000003 110.315 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.61 157.05 43.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 75.239999999999995 109.998 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -0.26 9.77 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.525 1.802 . . . . 64.540000000000006 111.021 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.408 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.5 p -96.78 9.08 42.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 74.349999999999994 110.011 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.3 t-20 74.98 34.67 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.54 1.15 . . . . 71.209999999999994 109.294 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.2 t -119.72 119.55 34.0 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 70.439999999999998 110.022 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.507 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.3 m-30 -99.59 162.22 13.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.200000000000003 110.99 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.3 mm? -116.97 177.57 4.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.517 1.135 . . . . 74.209999999999994 109.312 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 97.6 m-85 -160.92 115.4 2.1 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 73.25 111.03 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 1.016 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.7 OUTLIER -115.31 94.74 4.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 71.209999999999994 109.271 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' A' ' 290' ' ' ASN . 7.6 p30 -80.27 -42.04 23.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 74.209999999999994 109.246 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.466 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 11.4 m-20 -95.65 -1.83 49.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 74.209999999999994 109.28 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 1.016 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.0 mm? 52.21 40.34 28.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 64.340000000000003 109.32 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.466 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 16.6 mm -69.8 -25.82 29.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 62.210000000000001 109.264 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.805 ' O ' HG23 ' A' ' 297' ' ' VAL . 8.1 t30 -92.97 -31.86 14.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 74.400000000000006 109.333 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.443 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 18.0 m -81.42 -66.85 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.515 1.134 . . . . 73.030000000000001 110.408 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.8 m-20 -47.33 -29.37 2.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 109.306 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.5 t -75.23 -52.91 9.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 74.049999999999997 108.328 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 293' ' ' ASN . 4.5 t -46.23 -51.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 70.319999999999993 109.307 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 168' ' ' ILE . 20.9 mt -63.47 -52.69 60.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 75.109999999999999 109.309 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -52.2 -26.54 11.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 74.25 110.395 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -76.1 -35.73 59.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 75.530000000000001 109.306 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.563 ' CE1' ' HD2' ' A' ' 313' ' ' PRO . 3.1 m-30 -101.83 24.88 9.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 72.439999999999998 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 14.5 t -57.24 -59.06 5.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 72.239999999999995 110.014 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.785 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -74.19 -17.53 60.89 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.441 1.088 . . . . 74.329999999999998 109.315 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.712 HD13 ' OH ' ' A' ' 172' ' ' TYR . 14.8 mt -67.89 134.43 50.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 75.5 109.317 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.7 p -160.36 135.35 7.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 75.310000000000002 110.039 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 109.97 -160.57 13.34 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.477 1.111 . . . . 73.030000000000001 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.9 p -95.08 13.5 24.98 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.295 -1.002 . . . . 64.5 108.295 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.6 p -145.91 152.98 49.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 41.549999999999997 110.043 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.638 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -74.99 145.59 84.34 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 121.016 -2.493 . . . . 73.239999999999995 110.975 0.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 99.4 p -130.99 134.87 26.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 71.409999999999997 109.995 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.08 -173.19 11.91 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.974 -2.511 . . . . 40.130000000000003 110.955 0.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.441 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.76 153.26 22.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 65.219999999999999 109.321 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.563 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.02 -162.38 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.449 1.763 . . . . 70.239999999999995 110.99 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -84.52 137.0 33.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 74.409999999999997 109.296 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.57 HG21 HG22 ' A' ' 297' ' ' VAL . 21.3 m -144.6 24.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.105 . . . . 74.129999999999995 109.326 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 318' ' ' CYS . 28.5 t -69.2 -31.87 70.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.510000000000005 109.933 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 26.3 m -44.47 -26.49 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 73.209999999999994 109.971 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 316' ' ' SER . 2.4 m . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 62.530000000000001 108.293 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.841 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.3 tp . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.32 -0.622 . . . . 75.209999999999994 109.32 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -105.51 108.78 20.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 73.400000000000006 109.326 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -85.7 10.62 12.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 73.109999999999999 109.969 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -150.38 144.19 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 35.299999999999997 109.286 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.071 HD11 HD12 ' A' ' 149' ' ' LEU . 1.3 mt -96.31 141.77 23.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 71.019999999999996 109.286 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.08 -30.26 7.24 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.467 1.772 . . . . 63.229999999999997 111.015 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.59 152.28 17.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 74.129999999999995 109.26 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 146' ' ' LEU . 1.8 t -50.37 -36.0 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 63.009999999999998 109.277 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.05 -47.69 3.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.112 . . . . 74.439999999999998 109.306 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.611 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -71.1 -36.05 72.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 75.109999999999999 110.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.637 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -58.06 -57.08 14.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.517 1.136 . . . . 75.099999999999994 109.288 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -52.28 -31.36 32.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 62.520000000000003 109.281 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.92 -55.03 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 72.319999999999993 109.978 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.071 HD12 HD11 ' A' ' 140' ' ' ILE . 96.2 mt -45.44 -41.88 9.82 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 74.209999999999994 109.304 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.672 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -73.54 -43.8 59.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 111.034 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -47.99 -36.4 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 71.010000000000005 109.309 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 155' ' ' ASN . 26.0 mt-30 -76.4 -56.07 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 71.109999999999999 110.321 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 21.6 mt -49.01 -29.41 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 75.25 109.307 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 -37.28 67.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.524 1.14 . . . . 63.409999999999997 109.278 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.9 t-20 -58.26 -17.52 20.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 74.409999999999997 109.321 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.471 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 21.5 mm-40 -82.18 -25.3 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.104 . . . . 74.120000000000005 110.268 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.528 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 15.5 m -42.14 120.86 1.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 71.230000000000004 109.979 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -45.85 131.56 9.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.538 1.149 . . . . 65.150000000000006 108.288 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.41 -15.47 9.24 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.542 1.152 . . . . 72.439999999999998 111.017 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.875 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 14.5 p -89.3 161.15 16.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.426 0.721 . . . . 75.150000000000006 110.381 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.0 m -93.46 -2.03 54.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 62.130000000000003 110.031 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 162' ' ' THR . 1.8 m -118.58 8.6 12.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 73.209999999999994 110.381 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.875 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -81.68 135.78 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.512 1.133 . . . . 54.32 109.303 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -169.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.47 1.106 . . . . 60.229999999999997 110.024 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 54.1 p -153.62 127.05 4.25 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.420000000000002 109.978 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.05 137.88 52.86 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.038 -2.484 . . . . 74.109999999999999 110.969 0.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.0 p -72.94 -178.63 2.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 43.119999999999997 108.315 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.728 HD11 ' HB2' ' A' ' 183' ' ' LYS . 3.6 mp -86.93 130.76 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.310000000000002 109.306 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.1 p -95.85 76.11 3.16 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 74.319999999999993 110.432 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 53.8 p90 -76.88 -16.18 59.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.135 . . . . 74.540000000000006 110.994 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -73.46 -3.38 27.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 1.133 . . . . 75.439999999999998 110.309 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.613 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -130.96 66.14 78.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 111.01 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.61 4.34 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.489 1.783 . . . . 73.010000000000005 111.024 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.558 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.8 t -152.04 -60.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 62.439999999999998 109.299 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.1 -46.79 0.93 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.491 1.12 . . . . 73.150000000000006 109.277 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -49.15 98.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.545 1.153 . . . . 75.120000000000005 111.011 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.611 ' SG ' HG12 ' A' ' 219' ' ' VAL . 2.5 p -130.09 -46.89 1.11 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.287 -1.005 . . . . 53.399999999999999 108.287 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 31.4 p90 -73.8 -44.2 56.59 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 75.219999999999999 110.992 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.91 -68.48 0.18 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.13 . . . . 44.420000000000002 109.293 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.574 ' HB3' HG23 ' A' ' 168' ' ' ILE . 8.8 ptm180 -48.89 -48.71 42.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.436 1.085 . . . . 74.329999999999998 110.251 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -42.68 -45.93 4.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.462 1.101 . . . . 74.200000000000003 109.307 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.494 ' ND1' ' CD1' ' A' ' 291' ' ' LEU . 1.9 t-160 -56.98 -41.93 79.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 75.310000000000002 109.617 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.728 ' HB2' HD11 ' A' ' 168' ' ' ILE . 15.8 mmmt -71.05 -30.22 66.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.122 . . . . 71.0 109.295 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.489 ' HE3' ' HA ' ' A' ' 181' ' ' ALA . 21.7 mtm -66.18 -60.4 2.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 73.230000000000004 111.012 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -51.24 -26.88 7.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 72.239999999999995 110.279 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.427 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 1.1 tt0 -64.54 -44.28 91.31 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.55 1.156 . . . . 74.549999999999997 110.275 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 190' ' ' ASN . 23.8 mm -66.1 -52.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 72.400000000000006 109.324 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.845 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.3 OUTLIER -40.88 -39.83 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 72.209999999999994 109.31 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.574 ' HG2' HD21 ' A' ' 136' ' ' LEU . 20.3 mtp -66.62 -45.63 78.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 73.540000000000006 110.976 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 187' ' ' ILE . 0.3 OUTLIER -46.35 -47.07 18.63 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 70.310000000000002 109.262 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 73.430000000000007 109.282 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' CD2' ' A' ' 193' ' ' TYR . . . 119.85 54.1 0.26 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.516 1.135 . . . . 70.239999999999995 110.976 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.611 ' CZ ' HG21 ' A' ' 145' ' ' THR . 91.1 m-85 -158.67 144.73 16.87 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 73.439999999999998 111.026 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.841 ' HB2' HD23 ' A' ' 136' ' ' LEU . 46.8 t0 -110.72 125.91 53.99 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.563 1.165 . . . . 54.109999999999999 109.275 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.845 ' HB3' HD22 ' A' ' 188' ' ' LEU . 29.6 p -103.17 -179.31 3.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 63.32 108.29 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 23.1 mp0 -127.33 176.72 7.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.446 1.092 . . . . 75.439999999999998 110.336 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.797 ' HE2' HG22 ' A' ' 221' ' ' ILE . 21.3 mmtt -108.57 162.68 13.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 73.430000000000007 109.286 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 23.8 tt0 -155.11 117.62 4.26 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.55 1.156 . . . . 65.439999999999998 110.34 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -109.68 124.61 51.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 53.200000000000003 110.971 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.666 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.6 p -115.57 150.8 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 62.340000000000003 109.28 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.7 m-85 -122.13 162.96 20.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 73.239999999999995 110.982 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 115.59 -179.43 18.05 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.556 1.16 . . . . 74.129999999999995 110.98 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.72 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.1 t-20 -68.73 109.35 3.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 0.756 . . . . 73.140000000000001 109.302 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -113.92 93.42 4.36 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.474 1.109 . . . . 73.310000000000002 109.305 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.568 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 4.5 mttt -93.25 160.3 14.89 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.535 1.147 . . . . 72.239999999999995 109.26 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.803 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -165.78 162.89 18.82 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.441 1.088 . . . . 42.219999999999999 109.269 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.439999999999998 110.02 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.33 -0.989 . . . . 62.340000000000003 108.33 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.803 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.3 OUTLIER -109.07 161.58 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.525 1.141 . . . . 65.530000000000001 109.304 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.568 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -146.43 120.48 9.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 63.140000000000001 109.291 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.45 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.5 m0 -130.41 132.84 45.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.001 -1.111 . . . . 75.319999999999993 108.001 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 54.8 p -79.54 0.61 29.07 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.111 . . . . 54.149999999999999 110.014 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.495 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.1 p90 -170.85 127.82 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 62.039999999999999 111.014 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 48.3 t60 -116.47 167.88 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 54.030000000000001 109.622 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.611 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.4 p -143.86 145.16 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 65.310000000000002 109.309 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.598 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -146.38 -169.09 3.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 60.329999999999998 109.285 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.797 HG22 ' HE2' ' A' ' 197' ' ' LYS . 13.0 pt -114.38 120.8 65.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 71.540000000000006 109.311 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.8 tp -85.33 108.92 18.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.113 . . . . 74.319999999999993 109.314 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.678 HG11 HG13 ' A' ' 237' ' ' ILE . 0.8 OUTLIER -104.9 149.35 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 71.010000000000005 109.292 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 40.2 m -118.26 122.69 43.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 61.149999999999999 110.001 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 33.0 p90 -137.37 145.01 42.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 71.329999999999998 111.001 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.428 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.1 mmtp -70.72 132.89 46.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 71.299999999999997 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.35 -159.86 0.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.133 . . . . 61.32 109.294 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.83 -0.4 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.549 1.156 . . . . 34.539999999999999 109.305 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.78 -7.85 12.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 75.310000000000002 110.025 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.96 37.86 8.24 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.509 1.131 . . . . 72.230000000000004 111.0 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.76 137.46 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.452 0.736 . . . . 61.039999999999999 109.261 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.428 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.6 m -71.59 102.47 2.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.107 . . . . 64.530000000000001 110.355 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.7 mm-40 -102.04 -172.49 2.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.446 1.091 . . . . 73.510000000000005 110.276 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.523 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.8 mmtm -125.66 145.03 50.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.112 . . . . 72.409999999999997 109.314 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.64 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.8 tpt180 -143.02 159.48 42.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.340000000000003 110.354 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.0 mm -113.42 117.02 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.118 . . . . 64.200000000000003 109.329 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.2 mm -106.48 46.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 54.200000000000003 109.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -104.6 106.12 53.2 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 64.230000000000004 109.291 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -1.13 10.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.533 1.807 . . . . 71.150000000000006 110.995 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 3.1 t -73.21 -4.14 31.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 75.239999999999995 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.485 HD11 ' NE2' ' A' ' 218' ' ' HIS . 5.6 mt -138.15 -49.12 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 74.140000000000001 109.334 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.89 ' CZ ' ' HB2' ' A' ' 255' ' ' ALA . 83.0 m-85 -113.26 99.35 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.548 1.155 . . . . 75.319999999999993 111.014 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.5 m -90.63 -5.32 56.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 70.450000000000003 109.965 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 12.2 t -83.91 -44.78 13.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.535 1.147 . . . . 53.520000000000003 110.021 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.09 -177.43 46.82 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.518 1.136 . . . . 62.450000000000003 110.985 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.98 165.08 32.08 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.478 1.778 . . . . 64.530000000000001 111.018 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.678 HG11 ' CD2' ' A' ' 242' ' ' PHE . 4.0 m -148.43 167.8 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.456 1.098 . . . . 71.239999999999995 109.32 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.442 ' C ' ' N ' ' A' ' 250' ' ' THR . 66.8 p -70.23 137.78 51.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 73.420000000000002 110.4 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -41.23 -29.11 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.239999999999995 109.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.442 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -74.7 -63.8 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 73.349999999999994 110.362 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.36 -25.78 6.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 62.43 109.359 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.598 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.2 t90 -65.79 -65.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 74.420000000000002 108.034 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.764 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -42.04 -30.99 0.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 75.519999999999996 110.303 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.857 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.5 m-80 -67.4 -49.15 65.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 73.040000000000006 109.268 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.89 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.48 -19.36 14.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 70.129999999999995 109.278 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 205' ' ' LYS . 6.9 m -90.26 -35.75 15.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 75.239999999999995 108.331 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.857 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.4 m -93.53 21.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 72.329999999999998 109.284 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -50.48 106.44 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 72.209999999999994 109.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 262' ' ' GLY . 14.7 p -73.31 -3.34 26.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 75.340000000000003 110.428 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.72 -30.51 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.531 1.145 . . . . 73.5 109.963 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.5 t -88.71 -36.96 15.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 61.299999999999997 108.309 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.87 -128.82 1.78 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.512 1.133 . . . . 71.209999999999994 110.972 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.89 145.69 42.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 0.775 . . . . 71.150000000000006 109.986 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -167.96 147.61 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 72.299999999999997 109.308 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.3 t -172.92 153.61 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 73.230000000000004 110.056 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.666 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.42 118.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 74.510000000000005 109.324 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.0 t -73.78 -43.82 57.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.556 1.16 . . . . 74.319999999999993 110.02 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 200' ' ' VAL . 11.5 p -164.94 -175.15 3.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 74.230000000000004 109.994 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -164.77 157.14 16.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 71.319999999999993 110.998 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.1 160.49 39.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 72.040000000000006 109.27 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 272' ' ' THR . 7.4 p30 -118.41 160.65 21.32 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.093 . . . . 50.229999999999997 109.272 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.638 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.1 p -153.47 -178.5 7.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 72.230000000000004 110.399 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.893 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.75 163.83 13.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 64.109999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.484 1.115 . . . . 62.119999999999997 110.991 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.457 ' H ' ' ND2' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -85.99 -35.71 20.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 0.778 . . . . 62.200000000000003 109.286 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' A' ' 273' ' ' ALA . 92.8 t -43.81 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 61.109999999999999 109.291 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 6.0 t80 -59.21 -49.83 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 62.509999999999998 110.968 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 56.2 t80 -147.9 158.15 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 61.420000000000002 110.955 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.638 ' HD2' HG21 ' A' ' 272' ' ' THR . 73.0 ttt-85 -123.95 147.47 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 73.239999999999995 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.55 154.02 47.8 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.115 . . . . 73.530000000000001 109.958 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.21 9.19 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.468 1.772 . . . . 64.109999999999999 110.997 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 20.6 t -105.64 10.22 32.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 1.118 . . . . 74.25 109.991 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 75.38 39.55 0.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 60.310000000000002 109.278 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.4 t -119.83 120.28 36.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 52.409999999999997 110.002 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -101.86 166.65 10.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 65.329999999999998 111.03 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -123.34 177.36 5.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 64.420000000000002 109.323 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 52.5 m-85 -158.61 115.78 2.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.125 . . . . 73.120000000000005 110.984 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.863 ' HB3' HD13 ' A' ' 291' ' ' LEU . 3.8 m-20 -115.26 99.27 7.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 74.230000000000004 109.329 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -84.94 -48.54 9.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.310000000000002 109.34 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.466 ' HB3' HD11 ' A' ' 292' ' ' ILE . 27.0 m-20 -90.33 9.53 28.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 73.420000000000002 109.354 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.863 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.6 mm? 40.32 45.25 1.78 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 109.299 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 290' ' ' ASN . 47.6 mm -74.47 -23.79 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 71.549999999999997 109.317 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.812 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.7 t-20 -94.5 -29.08 15.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 63.409999999999997 109.299 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 7.8 m -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 62.310000000000002 110.419 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 39.8 m-20 -48.43 -24.77 1.36 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 73.25 109.288 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 45.7 t -80.8 -47.9 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 64.340000000000003 108.297 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.4 t -52.86 -45.47 50.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.521 1.138 . . . . 74.349999999999994 109.3 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.4 mt -65.27 -62.9 1.27 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 72.219999999999999 109.331 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -24.67 0.85 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.400000000000006 110.388 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.816 ' HE2' HG12 ' A' ' 315' ' ' VAL . 16.1 mmmt -73.3 -41.75 63.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 52.25 109.298 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.753 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.7 m-30 -100.87 36.77 1.87 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 74.209999999999994 111.033 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.72 -44.75 73.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 110.009 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -92.8 -12.09 32.05 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 53.399999999999999 109.296 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.785 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.7 mt -68.67 136.69 53.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 71.420000000000002 109.33 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 95.2 p -149.39 156.05 41.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.489 1.118 . . . . 62.109999999999999 110.014 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.32 -164.68 54.35 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.475 1.109 . . . . 71.439999999999998 111.01 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 10.56 22.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.272 -1.01 . . . . 42.450000000000003 108.272 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 13.9 p -131.8 149.45 73.44 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.565 1.166 . . . . 73.25 110.022 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.785 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.92 147.1 88.48 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 75.129999999999995 111.047 -0.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.9 p -133.51 135.75 25.71 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.551 1.157 . . . . 64.019999999999996 110.005 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.6 Cg_endo -74.94 -173.73 12.81 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 120.98 -2.508 . . . . 71.200000000000003 111.032 -0.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.58 154.32 35.39 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 73.450000000000003 109.291 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.455 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.99 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.512 1.796 . . . . 73.400000000000006 111.011 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -87.92 135.98 33.17 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 71.510000000000005 109.263 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.816 HG12 ' HE2' ' A' ' 300' ' ' LYS . 27.1 m -129.62 23.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.530000000000001 109.303 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 17.0 t -54.61 -32.74 59.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.418 1.074 . . . . 62.25 110.039 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.2 m -48.76 -25.37 1.8 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.349999999999994 110.002 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 54.539999999999999 108.299 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.83 HD23 ' HB3' ' A' ' 194' ' ' ASP . 8.6 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.286 -0.635 . . . . 61.210000000000001 109.286 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -116.03 104.37 11.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 75.219999999999999 109.314 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.496 ' CB ' ' OD2' ' A' ' 194' ' ' ASP . 0.6 OUTLIER -80.39 3.91 19.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 71.420000000000002 109.972 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -142.93 147.57 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.129999999999995 109.308 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -98.99 142.55 24.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 72.439999999999998 109.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.0 -32.74 5.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.528 1.804 . . . . 43.439999999999998 111.025 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.416 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.21 151.47 19.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 74.120000000000005 109.295 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -48.51 -35.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.103 . . . . 72.0 109.28 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.56 -46.75 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 73.120000000000005 109.303 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.683 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.9 m -72.25 -34.77 68.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.13 . . . . 41.240000000000002 110.425 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.675 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.47 -56.76 17.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.428 1.08 . . . . 74.540000000000006 109.254 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -52.54 -31.85 37.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 62.5 109.32 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.18 -56.71 6.82 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.473 1.108 . . . . 62.219999999999999 109.994 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.053 HD12 HD11 ' A' ' 140' ' ' ILE . 60.7 mt -42.97 -42.62 3.83 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.472 1.107 . . . . 73.099999999999994 109.307 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.648 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.55 -45.1 63.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 73.109999999999999 111.037 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.87 -38.15 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 75.239999999999995 109.324 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 155' ' ' ASN . 24.2 mt-30 -75.21 -55.31 5.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 73.209999999999994 110.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.109 HD11 HD12 ' A' ' 188' ' ' LEU . 12.4 mt -49.72 -27.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.115 . . . . 63.32 109.306 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -36.07 61.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 73.329999999999998 109.289 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -60.75 -15.38 28.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 74.430000000000007 109.335 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.665 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 8.9 mm100 -83.09 -21.74 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 74.0 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.573 ' OG ' HG23 ' A' ' 160' ' ' THR . 29.8 p -39.09 140.69 0.37 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 72.109999999999999 109.99 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.73 -9.76 52.5 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 74.040000000000006 108.274 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -87.87 18.88 36.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.511 1.132 . . . . 60.130000000000003 110.999 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.573 HG23 ' OG ' ' A' ' 157' ' ' SER . 59.2 p -136.27 160.74 37.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 71.439999999999998 110.398 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 p -93.76 -21.55 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.48 1.112 . . . . 52.200000000000003 109.991 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.6 m -82.57 -3.65 56.39 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 64.219999999999999 110.416 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 156' ' ' GLN . . . -69.38 138.37 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 72.120000000000005 109.303 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.3 t -59.72 -160.14 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.097 . . . . 52.109999999999999 109.993 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.448 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -156.45 128.0 3.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 72.209999999999994 109.993 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.93 140.7 68.78 Favored 'Cis proline' 0 C--N 1.36 1.132 0 C-N-CA 121.011 -2.495 . . . . 74.430000000000007 111.015 -0.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 23.2 p -72.75 177.44 4.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 63.450000000000003 108.285 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.612 HD11 ' CB ' ' A' ' 183' ' ' LYS . 2.1 mp -94.51 126.84 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 64.5 109.309 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 301' ' ' PHE . 15.4 p -77.56 90.06 3.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 63.549999999999997 110.389 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -88.59 -30.2 19.43 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.571 1.169 . . . . 71.340000000000003 110.988 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.402 ' C ' ' HD3' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -84.03 9.29 12.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.51 1.131 . . . . 72.25 110.297 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.559 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 38.8 t80 -128.56 66.9 75.5 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.494 1.121 . . . . 73.030000000000001 111.004 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.448 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -74.97 109.15 2.87 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.463 1.77 . . . . 71.230000000000004 110.98 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.66 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 74.329999999999998 109.271 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -160.52 129.2 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.526 1.141 . . . . 74.25 109.273 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 129.07 52.29 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.505 1.128 . . . . 55.049999999999997 111.011 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.4 m -89.14 -18.06 27.93 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.273 -1.01 . . . . 44.520000000000003 108.273 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.622 ' HB3' HG11 ' A' ' 219' ' ' VAL . 34.2 p90 -76.59 -22.62 53.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.527 1.142 . . . . 75.349999999999994 110.955 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.532 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -71.17 -68.35 0.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 64.340000000000003 109.268 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.579 ' HB3' HG23 ' A' ' 168' ' ' ILE . 7.9 ptm180 -46.15 -48.33 17.44 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.498 1.124 . . . . 75.510000000000005 110.296 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.625 ' C ' ' HZ1' ' A' ' 197' ' ' LYS . . . -40.4 -59.0 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.13 . . . . 61.119999999999997 109.327 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.672 ' N ' ' HZ1' ' A' ' 197' ' ' LYS . 1.1 t60 -48.96 -39.69 27.46 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.528 1.142 . . . . 54.25 109.604 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.612 ' CB ' HD11 ' A' ' 168' ' ' ILE . 30.6 mmmt -64.61 -61.47 2.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 72.340000000000003 109.299 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.43 ' HE3' ' HA ' ' A' ' 181' ' ' ALA . 15.0 mtm -38.9 -38.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.533 1.146 . . . . 74.230000000000004 110.987 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.36 -49.35 78.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 74.150000000000006 110.339 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 183' ' ' LYS . 2.8 pt20 -54.75 -34.05 62.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.122 . . . . 50.210000000000001 110.271 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 153' ' ' ILE . 31.1 mm -70.3 -43.77 78.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.155 . . . . 75.019999999999996 109.341 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 1.109 HD12 HD11 ' A' ' 153' ' ' ILE . 0.4 OUTLIER -60.68 -40.77 93.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 73.120000000000005 109.28 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.75 ' HG2' HD21 ' A' ' 136' ' ' LEU . 52.1 mtp -61.57 -36.04 79.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 73.329999999999998 110.994 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.67 -53.63 56.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 64.430000000000007 109.293 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.46 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 5.8 t-20 -62.72 -27.56 69.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 63.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 109.04 53.58 0.61 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.508 1.13 . . . . 73.340000000000003 110.988 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.683 ' CZ ' HG21 ' A' ' 145' ' ' THR . 92.9 m-85 -156.89 140.74 16.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.45 0.735 . . . . 74.510000000000005 111.015 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.83 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -106.12 124.86 50.24 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 62.020000000000003 109.319 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 1.008 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.1 p -95.92 168.46 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 64.129999999999995 108.3 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -117.06 170.91 8.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 54.25 110.295 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.672 ' HZ1' ' N ' ' A' ' 182' ' ' HIS . 17.5 mmtt -100.58 169.34 9.12 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 74.010000000000005 109.287 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 22.8 tt0 -167.28 121.85 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.442 1.089 . . . . 63.420000000000002 110.27 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -115.9 140.58 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 64.510000000000005 111.013 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.697 ' CG2' HG23 ' A' ' 266' ' ' VAL . 14.0 p -131.71 149.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.0 109.346 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 13.8 m-85 -122.72 156.37 34.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.452 1.095 . . . . 72.329999999999998 110.977 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.39 -175.83 16.44 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.508 1.13 . . . . 63.210000000000001 111.025 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.751 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.5 t-20 -72.63 110.14 6.78 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.782 . . . . 65.209999999999994 109.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.751 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.2 mt -113.19 95.48 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 74.450000000000003 109.263 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 256' ' ' CYS . 6.8 mtpt -92.31 165.33 13.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 74.450000000000003 109.326 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.867 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -169.23 119.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 63.140000000000001 109.26 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.157 . . . . 71.400000000000006 110.019 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.318 -0.993 . . . . 61.009999999999998 108.318 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.867 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.5 m -108.87 155.26 9.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.104 . . . . 74.219999999999999 109.293 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -147.1 130.05 16.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 53.329999999999998 109.315 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.3 135.07 42.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.319999999999993 108.015 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.4 m -80.3 3.52 20.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.147 . . . . 73.299999999999997 109.991 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.458 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.0 p90 -177.79 130.41 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.459 1.099 . . . . 73.340000000000003 111.023 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -120.17 168.03 11.64 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 73.140000000000001 109.609 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.622 HG11 ' HB3' ' A' ' 178' ' ' TYR . 1.5 p -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.13 . . . . 63.200000000000003 109.284 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.683 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.0 -165.8 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 74.219999999999999 109.291 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.475 ' O ' HD13 ' A' ' 236' ' ' ILE . 15.9 pt -117.24 123.79 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 64.239999999999995 109.273 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.4 tp -86.29 108.85 18.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 75.439999999999998 109.285 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.675 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -102.2 145.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 63.450000000000003 109.323 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 56.3 m -117.75 117.78 30.26 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.467 1.105 . . . . 53.200000000000003 110.031 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 29.9 p90 -133.9 144.46 48.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 74.25 110.969 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.1 mmtp -68.87 135.19 50.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 73.540000000000006 109.333 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -76.08 -160.18 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 73.239999999999995 109.315 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.38 50.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 65.120000000000005 109.322 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 -7.49 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 75.510000000000005 109.959 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.01 8.23 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.5 1.125 . . . . 44.420000000000002 111.031 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.34 138.23 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.442 0.731 . . . . 74.540000000000006 109.347 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.436 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 20.4 m -71.93 102.55 2.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.498 1.124 . . . . 73.140000000000001 110.394 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.4 mm-40 -101.27 -174.21 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.567 1.167 . . . . 62.149999999999999 110.302 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.535 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.0 mmtm -127.19 144.82 50.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 75.319999999999993 109.313 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.592 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -146.7 163.88 34.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 71.540000000000006 110.307 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.487 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.3 mm -117.96 119.11 60.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 72.420000000000002 109.328 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -103.42 45.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.488 1.118 . . . . 72.439999999999998 109.317 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.41 109.44 61.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 54.039999999999999 109.309 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -20.42 16.91 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.448 1.762 . . . . 61.329999999999998 111.011 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.439 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.9 t -51.32 -21.72 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.526 1.141 . . . . 73.329999999999998 110.009 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 256' ' ' CYS . 7.7 mt -117.97 -57.85 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 64.140000000000001 109.272 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.78 ' CE2' HG21 ' A' ' 247' ' ' VAL . 80.7 m-85 -107.65 99.78 9.24 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.146 . . . . 74.349999999999994 110.972 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.1 m -86.47 -6.5 58.89 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.101 . . . . 73.230000000000004 109.974 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -82.93 -44.45 15.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 52.0 110.005 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.28 -173.96 43.26 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.509 1.131 . . . . 64.340000000000003 111.009 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.427 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.5 Cg_endo -74.9 165.42 31.43 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.453 1.765 . . . . 61.409999999999997 111.011 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.78 HG21 ' CE2' ' A' ' 242' ' ' PHE . 4.8 m -147.23 159.26 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 72.129999999999995 109.309 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.432 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.5 p -61.17 139.38 58.13 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 73.109999999999999 110.413 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -41.63 -29.81 0.19 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 71.400000000000006 109.294 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 248' ' ' THR . 12.6 m -77.26 -61.41 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.118 . . . . 72.329999999999998 110.415 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.74 -24.36 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 43.240000000000002 109.25 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.683 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 9.7 t90 -66.33 -64.5 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 74.400000000000006 108.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.862 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.2 OUTLIER -43.77 -34.8 1.65 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 63.049999999999997 110.278 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.884 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.1 m-80 -64.56 -49.4 71.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 34.130000000000003 109.347 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.648 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.22 -19.08 12.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.45 1.094 . . . . 50.210000000000001 109.299 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 205' ' ' LYS . 10.0 m -92.06 -31.91 15.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 55.210000000000001 108.28 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.884 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.5 m -96.9 21.84 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.555 1.16 . . . . 64.519999999999996 109.315 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -49.2 104.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.479 1.112 . . . . 75.219999999999999 109.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 262' ' ' GLY . 12.7 p -72.54 -3.89 27.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.138 . . . . 72.129999999999995 110.397 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 41.3 t -48.1 -25.15 1.33 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 73.329999999999998 110.026 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' CYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 5.9 m -90.94 -34.45 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 73.439999999999998 108.279 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.01 -118.41 0.82 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.481 1.113 . . . . 45.299999999999997 110.979 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.45 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -83.31 142.73 30.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 0.778 . . . . 63.409999999999997 110.02 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.97 143.82 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.554 1.159 . . . . 71.319999999999993 109.296 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.2 t -172.77 159.24 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.55 1.156 . . . . 63.539999999999999 109.983 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.697 HG23 ' CG2' ' A' ' 200' ' ' VAL . 4.0 p -101.91 118.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 63.009999999999998 109.326 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.1 t -77.28 -44.0 31.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 54.439999999999998 109.999 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 200' ' ' VAL . 4.1 m -149.25 -175.33 4.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 34.5 109.984 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -174.28 152.89 1.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 74.400000000000006 110.958 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -159.73 163.59 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.455 1.097 . . . . 62.350000000000001 109.312 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -116.84 160.5 20.74 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 74.150000000000006 109.314 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.06 -178.7 6.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 70.540000000000006 110.412 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -86.01 158.2 19.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.239999999999995 109.302 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.83 93.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.55 1.156 . . . . 71.319999999999993 110.987 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -46.28 77.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 0.773 . . . . 73.129999999999995 109.312 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.8 t -43.48 127.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 74.200000000000003 109.293 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.555 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 3.5 t80 -93.33 -40.7 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 70.420000000000002 110.988 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.3 OUTLIER -160.33 115.46 2.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 74.540000000000006 111.025 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.419 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 55.1 ttt-85 -94.96 137.87 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.420000000000002 110.281 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 157.62 34.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 60.43 109.956 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 0.02 9.41 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.459 1.768 . . . . 61.32 111.033 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 10.2 t -98.42 7.62 45.94 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.093 . . . . 63.32 110.016 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 76.02 34.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 64.319999999999993 109.25 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.7 t -117.41 120.73 39.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.565 1.165 . . . . 61.039999999999999 110.0 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.95 164.33 12.24 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 73.319999999999993 111.009 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.2 mm? -125.32 176.66 6.63 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 75.109999999999999 109.288 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 91.2 m-85 -162.62 124.94 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 75.109999999999999 110.947 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.948 ' HB3' HD13 ' A' ' 291' ' ' LEU . 2.0 m-20 -114.91 99.01 7.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 50.409999999999997 109.304 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -79.11 -54.79 5.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 74.219999999999999 109.332 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.461 ' CB ' HG12 ' A' ' 292' ' ' ILE . 9.5 m-20 -95.1 19.2 10.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 71.040000000000006 109.297 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.948 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.5 mm? 40.29 39.38 0.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 53.32 109.324 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.461 HG12 ' CB ' ' A' ' 290' ' ' ASN . 50.2 mm -68.63 -31.94 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 73.140000000000001 109.337 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.823 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.1 t-20 -88.93 -29.1 19.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.555 1.159 . . . . 72.099999999999994 109.302 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.453 ' N ' ' OD1' ' A' ' 288' ' ' ASP . 4.9 m -81.52 -67.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 72.030000000000001 110.412 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -45.52 -31.85 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 74.200000000000003 109.306 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.85 -55.85 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 61.329999999999998 108.288 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.1 t -40.83 -49.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.5 1.125 . . . . 74.319999999999993 109.267 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.2 mt -67.76 -57.71 5.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.583 1.177 . . . . 73.239999999999995 109.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -44.74 -27.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 72.340000000000003 110.382 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -72.99 -44.7 60.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.541 1.151 . . . . 73.299999999999997 109.355 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.653 ' HB2' HG21 ' A' ' 169' ' ' THR . 1.9 m-30 -97.65 21.97 9.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.209999999999994 111.031 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.0 t -58.27 -57.95 10.61 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.420000000000002 109.968 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.747 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -76.36 -15.54 59.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.117 . . . . 62.229999999999997 109.254 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.69 HD22 ' CD ' ' A' ' 309' ' ' PRO . 17.9 mt -66.38 148.99 51.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 74.129999999999995 109.292 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.7 p -168.91 127.2 1.03 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 72.430000000000007 109.964 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 172' ' ' TYR . . . 105.28 -163.66 14.22 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.514 1.134 . . . . 54.240000000000002 111.006 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.62 15.62 12.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.341 -0.985 . . . . 74.129999999999995 108.341 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.514 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 84.4 p -139.8 148.27 54.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 74.450000000000003 110.033 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.69 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.95 147.19 88.68 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 121.057 -2.476 . . . . 64.109999999999999 111.02 -0.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 6.4 p -129.89 135.28 27.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 33.210000000000001 109.99 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.98 -174.49 14.19 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.994 -2.503 . . . . 60.140000000000001 110.987 -0.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.2 156.02 23.02 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 50.109999999999999 109.317 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.54 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.512 1.796 . . . . 75.319999999999993 111.044 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.4 136.4 33.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 70.400000000000006 109.29 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.22 22.92 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 109.316 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 14.1 t -69.31 -33.27 72.91 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 51.43 109.975 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.8 t -47.55 -24.49 0.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.497 1.123 . . . . 71.140000000000001 110.023 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 71.010000000000005 108.279 179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.928 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.6 tp . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.324 -0.621 . . . . 50.030000000000001 109.324 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.644 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -104.92 107.69 18.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.458 1.099 . . . . 73.349999999999994 109.319 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 t -84.81 9.69 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 55.039999999999999 109.996 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.25 145.6 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.544 1.152 . . . . 64.540000000000006 109.278 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.031 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -97.25 142.59 24.77 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 75.450000000000003 109.309 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.95 -32.63 5.3 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.497 1.788 . . . . 74.319999999999993 111.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.19 151.26 19.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.142 . . . . 63.520000000000003 109.318 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -48.11 -35.73 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.531 1.145 . . . . 74.109999999999999 109.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.33 -47.3 3.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 70.239999999999995 109.273 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.67 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.73 -35.35 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.153 . . . . 75.420000000000002 110.403 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.768 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -58.72 -56.97 15.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 54.219999999999999 109.32 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -52.49 -31.7 36.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 71.450000000000003 109.348 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.35 -54.05 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 75.540000000000006 109.946 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 140' ' ' ILE . 54.0 mt -44.15 -40.67 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.537 1.148 . . . . 75.099999999999994 109.297 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.611 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.49 -44.34 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.57 1.169 . . . . 70.299999999999997 110.996 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -48.03 -37.25 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 109.296 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 155' ' ' ASN . 18.5 mt-30 -75.67 -55.87 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 61.039999999999999 110.294 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.957 HD11 HD12 ' A' ' 188' ' ' LEU . 12.1 mt -51.13 -23.75 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 75.409999999999997 109.367 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -34.03 43.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.488 1.118 . . . . 71.209999999999994 109.305 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.1 t-20 -61.75 -17.63 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 65.239999999999995 109.335 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.449 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 4.5 mm100 -84.09 -16.94 41.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 75.310000000000002 110.292 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.6 p -37.94 133.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.209999999999994 109.958 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -64.32 125.12 23.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 70.230000000000004 108.288 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.85 -18.06 8.62 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.495 1.122 . . . . 51.509999999999998 110.96 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.823 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 63.5 p -80.81 161.7 24.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.575 0.809 . . . . 71.230000000000004 110.422 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 51.0 p -93.55 -0.8 56.12 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.439999999999998 109.998 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 162' ' ' THR . 4.5 m -117.56 7.33 12.63 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 55.219999999999999 110.41 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.823 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.7 138.93 33.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.526 1.141 . . . . 60.420000000000002 109.278 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -162.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 75.230000000000004 109.999 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.431 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 41.9 t -156.22 127.47 3.67 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.230000000000004 109.982 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.01 139.38 61.44 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.991 -2.504 . . . . 73.430000000000007 111.033 -0.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 p -72.73 179.11 3.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 62.140000000000001 108.299 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.841 HG23 ' HG2' ' A' ' 180' ' ' ARG . 2.2 mp -88.9 124.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 61.329999999999998 109.305 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 301' ' ' PHE . 65.5 p -89.21 83.2 6.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 110.356 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -88.47 -14.78 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.142 . . . . 75.340000000000003 110.999 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.42 -2.21 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.533 1.145 . . . . 70.439999999999998 110.302 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.654 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 27.1 t80 -127.98 71.15 78.63 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 63.039999999999999 110.996 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.433 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.01 114.07 3.94 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.484 1.781 . . . . 74.530000000000001 111.005 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.602 HG21 ' CE1' ' A' ' 172' ' ' TYR . 26.2 t -152.59 -75.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.486 1.116 . . . . 63.43 109.246 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -156.51 115.79 3.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 65.209999999999994 109.301 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.63 55.84 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.525 1.14 . . . . 62.149999999999999 111.043 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 66.8 m -96.68 -0.17 48.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.308 -0.997 . . . . 54.310000000000002 108.308 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.62 ' HE1' HG21 ' A' ' 297' ' ' VAL . 12.8 p90 -85.89 -32.65 21.54 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 73.409999999999997 111.017 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.6 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -70.93 -49.59 43.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 73.219999999999999 109.336 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.841 ' HG2' HG23 ' A' ' 168' ' ' ILE . 6.5 mtp85 -57.69 -47.81 81.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 54.530000000000001 110.261 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.25 -51.04 8.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.449 1.093 . . . . 63.420000000000002 109.329 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -56.12 -37.47 69.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.506 1.129 . . . . 73.5 109.646 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.77 ' HB3' HD11 ' A' ' 168' ' ' ILE . 27.8 mmmt -63.85 -64.33 0.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.564 1.165 . . . . 71.099999999999994 109.271 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 153' ' ' ILE . 9.4 mtm -38.93 -30.24 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 75.019999999999996 111.005 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -66.32 -51.02 61.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 73.310000000000002 110.289 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.56 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.7 pt20 -52.52 -32.32 39.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 73.310000000000002 110.282 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.56 HD13 ' HG3' ' A' ' 186' ' ' GLN . 11.6 mm -80.97 -34.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 72.519999999999996 109.309 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -63.33 -44.6 94.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.540000000000006 109.298 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 136' ' ' LEU . 8.5 mtp -60.52 -41.55 94.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 44.109999999999999 111.02 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -46.22 -49.53 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 74.109999999999999 109.312 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -27.99 66.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 75.120000000000005 109.28 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 105.75 56.66 0.67 Allowed Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.512 1.133 . . . . 64.319999999999993 110.96 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' A' ' 145' ' ' THR . 82.0 m-85 -157.52 142.38 16.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 0.776 . . . . 72.409999999999997 111.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.928 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.2 t0 -110.02 124.77 52.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.143 . . . . 71.510000000000005 109.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.79 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.0 p -100.08 171.17 7.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.444 1.09 . . . . 65.439999999999998 108.296 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.42 170.23 8.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.086 . . . . 71.519999999999996 110.299 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.421 ' HE2' HG22 ' A' ' 221' ' ' ILE . 6.3 mmtt -96.71 159.66 14.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 74.519999999999996 109.32 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.633 ' OE1' HD11 ' A' ' 236' ' ' ILE . 18.9 tt0 -151.56 117.47 5.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 73.349999999999994 110.298 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 5.8 m-85 -116.39 128.75 55.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.52 1.137 . . . . 73.310000000000002 110.964 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.666 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.6 p -122.74 149.96 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 70.349999999999994 109.311 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 10.0 m-85 -122.88 164.21 18.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 1.15 . . . . 73.129999999999995 110.99 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.46 -172.9 14.44 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.516 1.135 . . . . 74.230000000000004 111.009 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.75 ' C ' HD23 ' A' ' 204' ' ' LEU . 52.4 t-20 -74.12 107.67 6.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 0.786 . . . . 73.349999999999994 109.262 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.5 mt -111.54 96.26 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 75.099999999999994 109.334 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.7 mtpp -90.85 -179.88 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 43.439999999999998 109.328 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 1.012 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -179.46 149.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 1.152 . . . . 74.299999999999997 109.321 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 O-C-N 124.49 1.119 . . . . 75.530000000000001 109.933 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 4.4 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.277 -1.008 . . . . 72.319999999999993 108.277 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 1.012 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -138.45 143.43 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 71.140000000000001 109.3 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -137.88 132.58 32.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 70.099999999999994 109.271 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -139.99 136.34 33.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.230000000000004 107.993 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.9 t -80.38 -3.65 50.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.499 1.124 . . . . 65.510000000000005 110.01 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.4 p90 -169.99 127.45 0.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 62.310000000000002 111.03 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CE1' ' O ' ' A' ' 219' ' ' VAL . 28.6 t60 -115.62 167.23 11.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 73.239999999999995 109.583 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.3 p -144.23 140.42 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 52.439999999999998 109.313 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.658 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.73 -167.65 2.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 73.299999999999997 109.289 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.542 HD11 ' HB ' ' A' ' 237' ' ' ILE . 21.3 pt -115.17 119.33 61.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.545 1.153 . . . . 73.209999999999994 109.267 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 234' ' ' LYS . 14.7 tp -84.92 108.82 17.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 34.32 109.301 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.768 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -103.02 146.57 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 71.329999999999998 109.345 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 15.9 m -117.17 119.36 34.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 72.140000000000001 110.044 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.4 p90 -134.63 145.07 48.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 71.120000000000005 110.969 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.421 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.0 mmtp -69.86 134.57 48.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 72.409999999999997 109.259 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.5 -159.77 0.11 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 42.520000000000003 109.334 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.65 52.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.458 1.099 . . . . 64.409999999999997 109.261 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.7 m -114.82 -7.88 12.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.123 . . . . 71.349999999999994 109.98 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.43 37.64 8.06 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.517 1.136 . . . . 44.140000000000001 111.036 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.424 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.35 137.38 44.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.468 0.746 . . . . 54.049999999999997 109.298 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.421 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.3 m -71.58 102.73 2.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 61.25 110.388 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 224' ' ' SER . 4.2 mm-40 -101.44 -172.62 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 64.200000000000003 110.266 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.574 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtt -126.86 145.22 50.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.1 . . . . 61.100000000000001 109.331 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.619 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -145.53 162.19 38.0 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 75.25 110.286 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.633 HD11 ' OE1' ' A' ' 198' ' ' GLN . 16.6 mm -115.88 119.34 61.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 65.150000000000006 109.311 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.6 mm -105.64 45.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.219999999999999 109.248 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.19 108.78 58.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.518 1.136 . . . . 64.549999999999997 109.329 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -75.0 -19.26 18.02 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.473 1.775 . . . . 75.549999999999997 110.943 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.433 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.4 OUTLIER -53.06 -20.86 3.95 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 64.120000000000005 109.994 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.549 HD13 ' SG ' ' A' ' 256' ' ' CYS . 7.3 mt -120.26 -57.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 72.530000000000001 109.271 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.637 ' CD1' HG11 ' A' ' 247' ' ' VAL . 96.7 m-85 -110.06 99.62 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -12.63 42.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.230000000000004 110.034 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -74.51 -44.83 49.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 1.101 . . . . 65.319999999999993 110.041 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -175.88 -174.76 42.7 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.537 1.148 . . . . 74.530000000000001 110.978 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.03 166.57 28.9 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.5 1.79 . . . . 74.540000000000006 110.99 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.637 HG11 ' CD1' ' A' ' 242' ' ' PHE . 6.0 m -148.09 161.19 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.131 . . . . 72.129999999999995 109.322 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.3 p -65.49 137.32 57.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 74.049999999999997 110.458 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.415 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 6.4 p-10 -40.03 -30.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.230000000000004 109.332 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 7.9 m -76.82 -61.92 1.81 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 75.430000000000007 110.394 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.85 -24.01 3.22 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 74.340000000000003 109.315 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.658 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 7.7 t90 -68.02 -62.86 1.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.955 -1.128 . . . . 73.219999999999999 107.955 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.809 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -48.68 -38.51 21.51 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 72.349999999999994 110.32 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.898 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.6 m-80 -58.24 -51.62 68.98 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 72.129999999999995 109.302 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -59.87 -17.17 34.77 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 74.329999999999998 109.283 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.549 ' SG ' HD13 ' A' ' 241' ' ' LEU . 22.0 m -94.91 -25.81 16.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 63.030000000000001 108.28 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.898 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -106.17 24.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 44.43 109.3 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 206' ' ' ALA . 1.9 p-10 -53.0 129.19 29.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.113 . . . . 61.219999999999999 109.314 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 262' ' ' GLY . 3.1 p -85.81 -3.86 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 71.420000000000002 110.403 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.416 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 0.9 OUTLIER -50.71 -30.72 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 42.119999999999997 109.999 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 261' ' ' CYS . . . . . 0.407 ' SG ' ' CE ' ' A' ' 205' ' ' LYS . 16.4 t -88.39 -29.29 20.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.468 1.105 . . . . 73.230000000000004 108.31 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 259' ' ' THR . . . 156.76 -120.77 1.01 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.454 1.096 . . . . 55.100000000000001 110.978 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -87.5 148.38 24.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 0.743 . . . . 73.019999999999996 110.047 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -169.8 147.69 3.44 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.420000000000002 109.306 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.9 m -172.84 156.25 3.37 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 71.430000000000007 109.996 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.666 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.5 118.27 44.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 70.209999999999994 109.322 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 8.8 t -74.99 -44.08 50.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.513 1.133 . . . . 63.310000000000002 110.007 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 200' ' ' VAL . 22.2 m -157.06 -170.11 3.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.428 1.08 . . . . 61.229999999999997 110.012 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -170.08 157.36 6.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 72.230000000000004 110.982 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -162.26 172.05 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 1.109 . . . . 73.120000000000005 109.321 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 272' ' ' THR . 6.0 p30 -145.71 160.73 41.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 1.103 . . . . 72.040000000000006 109.288 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.476 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.7 p -151.94 -171.92 4.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 41.109999999999999 110.387 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.807 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -68.0 154.39 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.495 1.122 . . . . 65.400000000000006 109.242 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -64.56 -46.72 89.34 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.463 1.102 . . . . 72.209999999999994 110.992 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -50.96 -38.29 49.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 0.776 . . . . 73.239999999999995 109.274 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.807 HG23 ' HB3' ' A' ' 273' ' ' ALA . 33.9 t -46.81 116.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 73.540000000000006 109.306 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 2.4 t80 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 72.120000000000005 110.999 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.573 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 63.4 t80 -154.77 162.2 41.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 111.013 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.573 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 75.2 ttt-85 -128.25 147.48 50.59 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.536 1.148 . . . . 54.109999999999999 110.254 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.33 154.75 47.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.536 1.148 . . . . 75.319999999999993 110.012 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.91 0.22 9.12 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 73.040000000000006 111.026 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 27.9 t -101.63 3.35 39.78 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 52.310000000000002 110.007 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.6 t-20 81.74 36.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.433 1.083 . . . . 73.200000000000003 109.277 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -117.65 119.29 34.52 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.47 1.106 . . . . 64.540000000000006 110.013 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 8.7 m-30 -99.78 160.84 14.0 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 74.329999999999998 110.967 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.546 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.9 OUTLIER -119.77 176.55 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 63.149999999999999 109.303 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 86.9 m-85 -162.56 130.22 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.531 1.144 . . . . 64.25 111.0 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.3 m-20 -113.52 111.88 22.64 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 75.099999999999994 109.297 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.23 -51.86 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.25 109.319 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.464 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 3.3 t-20 -106.96 18.04 22.32 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 54.329999999999998 109.321 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.77 HD12 HG21 ' A' ' 294' ' ' THR . 1.3 mm? 50.34 39.36 20.11 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.572 1.17 . . . . 74.030000000000001 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 20.0 mm -65.58 -30.63 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 74.5 109.27 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.737 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.2 t-20 -93.94 -29.75 15.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 60.119999999999997 109.334 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.77 HG21 HD12 ' A' ' 291' ' ' LEU . 1.3 m -76.64 -66.24 0.84 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 63.149999999999999 110.397 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -51.01 -25.92 5.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 74.540000000000006 109.297 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.41 -53.17 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.47 1.106 . . . . 72.319999999999993 108.294 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 293' ' ' ASN . 10.6 t -49.32 -37.62 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.128 . . . . 74.430000000000007 109.315 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.626 HD22 ' HA ' ' A' ' 168' ' ' ILE . 65.9 mt -75.43 -59.62 2.67 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 73.530000000000001 109.316 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -51.98 -20.71 2.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 74.129999999999995 110.367 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.835 ' HE2' HG12 ' A' ' 315' ' ' VAL . 21.4 mmmt -72.58 -42.38 64.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 75.420000000000002 109.316 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.877 ' CD1' HD12 ' A' ' 304' ' ' LEU . 5.1 m-30 -102.44 37.82 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 64.019999999999996 110.984 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 35.6 t -68.66 -44.37 74.23 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.510000000000005 110.003 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.674 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -95.07 -12.96 25.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 62.109999999999999 109.296 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.877 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.7 mt -65.57 135.65 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 61.549999999999997 109.311 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 79.0 p -151.67 152.64 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.105 . . . . 52.219999999999999 109.983 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.87 -145.58 27.43 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.478 1.111 . . . . 63.219999999999999 111.029 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 59.8 m -109.39 15.41 23.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.341 -0.985 . . . . 74.219999999999999 108.341 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.523 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 97.8 p -132.82 148.6 70.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 54.229999999999997 110.016 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.768 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.08 146.45 86.59 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 120.959 -2.517 . . . . 43.229999999999997 110.992 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.4 p -128.86 134.46 26.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.498 1.124 . . . . 74.230000000000004 109.957 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.5 Cg_endo -74.96 -172.38 10.67 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.985 -2.506 . . . . 64.019999999999996 111.006 -0.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.16 153.59 24.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 72.230000000000004 109.286 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.4 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.491 1.785 . . . . 75.209999999999994 110.983 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -86.15 131.13 34.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 72.420000000000002 109.335 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.835 HG12 ' HE2' ' A' ' 300' ' ' LYS . 30.5 m -134.61 14.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 75.040000000000006 109.332 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 30.6 t -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 64.439999999999998 110.014 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.0 m -48.1 -24.16 1.04 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.119 . . . . 62.100000000000001 109.968 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.128 . . . . 74.019999999999996 108.336 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.804 HD23 ' HB2' ' A' ' 194' ' ' ASP . 12.1 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.277 -0.638 . . . . 61.439999999999998 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.605 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -102.69 104.18 14.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 63.210000000000001 109.304 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -82.98 7.34 15.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.114 . . . . 55.420000000000002 109.985 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.585 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.4 t -150.38 142.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.485 1.116 . . . . 64.450000000000003 109.319 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 149' ' ' LEU . 1.4 mt -92.73 141.76 24.82 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.439999999999998 109.32 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.02 -31.57 6.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.513 1.796 . . . . 75.140000000000001 110.973 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.51 149.63 17.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 1.11 . . . . 64.510000000000005 109.348 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 146' ' ' LEU . 1.9 t -46.72 -37.19 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.138 . . . . 74.400000000000006 109.248 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.18 -50.05 2.67 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.475 1.11 . . . . 71.420000000000002 109.325 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.74 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -68.95 -37.06 78.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 55.020000000000003 110.393 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.734 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -56.72 -57.5 12.16 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 61.420000000000002 109.287 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -52.09 -29.9 23.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 73.230000000000004 109.295 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.14 -50.79 44.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 74.510000000000005 109.984 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.034 HD12 HD11 ' A' ' 140' ' ' ILE . 54.9 mt -48.53 -40.03 25.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 72.219999999999999 109.285 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -75.16 -42.17 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 75.230000000000004 110.991 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -48.95 -36.77 18.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 72.109999999999999 109.328 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 155' ' ' ASN . 20.9 mt-30 -75.75 -56.0 5.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 73.109999999999999 110.269 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.589 HD11 HD12 ' A' ' 188' ' ' LEU . 13.1 mt -50.71 -26.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 64.510000000000005 109.259 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 -34.21 59.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 75.129999999999995 109.304 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.62 -15.15 36.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 70.200000000000003 109.309 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -85.75 -18.82 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 73.140000000000001 110.29 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.8 p -39.38 136.64 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 73.140000000000001 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.492 ' HB3' HH21 ' A' ' 171' ' ' ARG . 1.3 m -68.33 119.99 13.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 74.049999999999997 108.28 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 128.13 -18.74 5.83 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.436 1.085 . . . . 45.130000000000003 110.999 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.864 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 82.8 p -80.38 162.33 24.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 0.726 . . . . 61.25 110.407 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.7 m -93.26 -0.59 56.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.46 1.1 . . . . 43.219999999999999 110.001 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 162' ' ' THR . 1.3 m -118.84 6.52 11.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 62.140000000000001 110.42 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.864 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -79.83 139.27 37.25 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.121 . . . . 72.319999999999993 109.263 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -166.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 64.019999999999996 110.051 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 60.7 p -152.62 125.84 4.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 64.019999999999996 109.976 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 140.16 65.77 Favored 'Cis proline' 0 C--N 1.36 1.183 0 C-N-CA 120.976 -2.51 . . . . 71.450000000000003 110.973 0.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.6 p -72.89 -177.82 2.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.153 . . . . 73.150000000000006 108.313 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.687 HD11 ' CB ' ' A' ' 183' ' ' LYS . 2.3 mp -91.96 131.4 39.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 64.400000000000006 109.327 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.458 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 11.1 p -85.3 85.56 7.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 74.010000000000005 110.417 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 170' ' ' PHE . 2.2 p90 -88.56 -28.24 20.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 62.200000000000003 111.013 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.492 HH21 ' HB3' ' A' ' 158' ' ' CYS . 0.0 OUTLIER -74.12 -2.52 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.495 1.122 . . . . 64.219999999999999 110.316 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.749 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -128.52 68.89 78.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 72.109999999999999 111.029 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.03 116.08 4.47 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 64.109999999999999 110.972 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.585 HG21 ' CE1' ' A' ' 172' ' ' TYR . 12.2 t -152.08 -74.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.542 1.152 . . . . 52.240000000000002 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.604 ' OD2' ' HB2' ' A' ' 312' ' ' ALA . 2.6 p-10 -123.76 -43.41 2.13 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.491 1.12 . . . . 51.409999999999997 109.336 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -47.64 92.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.496 1.123 . . . . 74.430000000000007 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 175' ' ' ASP . 57.3 m -128.17 -46.86 1.35 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.28 -1.007 . . . . 63.210000000000001 108.28 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 21.7 p90 -72.87 -40.95 65.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 65.430000000000007 111.008 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.633 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -45.66 -68.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 73.530000000000001 109.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.705 HH21 ' HG2' ' A' ' 239' ' ' PRO . 9.5 ptm180 -49.94 -47.66 52.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.444 1.09 . . . . 74.239999999999995 110.306 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -39.4 -57.38 1.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.132 . . . . 42.240000000000002 109.318 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -47.79 -44.56 28.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 74.140000000000001 109.598 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.687 ' CB ' HD11 ' A' ' 168' ' ' ILE . 14.4 mmmm -58.52 -56.58 20.27 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.438 1.086 . . . . 64.420000000000002 109.281 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.521 ' SD ' HG21 ' A' ' 153' ' ' ILE . 5.2 mtm -40.36 -55.41 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 71.239999999999995 111.051 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.446 ' NH1' ' HA ' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -46.28 -44.09 16.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 73.439999999999998 110.316 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.497 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -62.76 -33.19 74.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.120000000000005 110.305 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.497 HD13 ' HG2' ' A' ' 186' ' ' GLN . 16.2 mm -76.05 -34.41 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 50.219999999999999 109.315 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.589 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -61.97 -45.66 92.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 71.120000000000005 109.306 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 7.3 mtt -58.63 -38.58 78.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.437 1.086 . . . . 73.450000000000003 111.029 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -44.22 63.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 70.310000000000002 109.284 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.446 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 5.4 t-20 -74.17 -31.96 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.116 . . . . 63.409999999999997 109.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.57 58.5 0.73 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.533 1.146 . . . . 64.519999999999996 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.74 ' CZ ' HG21 ' A' ' 145' ' ' THR . 68.1 m-85 -153.67 141.42 20.03 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 0.743 . . . . 61.119999999999997 110.959 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.804 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -102.89 129.46 49.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 74.25 109.329 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.537 ' HB3' HD22 ' A' ' 188' ' ' LEU . 30.7 p -120.26 -178.58 3.71 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.547 1.154 . . . . 42.049999999999997 108.287 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -131.36 177.5 7.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 72.439999999999998 110.248 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.456 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 21.8 mmtt -105.25 153.13 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.139 . . . . 73.409999999999997 109.265 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.855 ' OE1' HD11 ' A' ' 236' ' ' ILE . 14.8 tt0 -132.55 117.5 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.140000000000001 110.319 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.473 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 2.6 m-85 -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 111.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 204' ' ' LEU . 8.6 p -131.22 142.81 42.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.45 1.094 . . . . 72.099999999999994 109.265 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.3 m-85 -116.32 156.08 27.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 75.109999999999999 111.028 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.53 -173.42 15.67 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.474 1.109 . . . . 75.439999999999998 111.061 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.801 ' C ' HD23 ' A' ' 204' ' ' LEU . 51.7 t-20 -74.4 110.97 9.12 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.454 0.738 . . . . 72.230000000000004 109.252 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.801 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.6 mt -115.13 94.39 4.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.46 1.1 . . . . 74.109999999999999 109.293 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.709 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 1.9 mtpm? -92.76 175.12 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 73.319999999999993 109.306 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -176.04 131.16 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 72.439999999999998 109.349 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.9 p . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 74.319999999999993 109.972 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 108.313 -0.995 . . . . 55.119999999999997 108.313 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.2 OUTLIER -132.97 162.06 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 72.549999999999997 109.285 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.709 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -142.83 135.18 27.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 73.319999999999993 109.306 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.7 OUTLIER -138.25 134.32 34.25 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.142 . . . . 65.420000000000002 107.998 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 17.9 t -77.03 -0.09 23.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.519 1.137 . . . . 64.129999999999995 109.979 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.466 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 7.2 p90 -176.64 129.91 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.432 1.083 . . . . 64.510000000000005 110.986 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.495 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 63.0 t60 -115.17 168.44 9.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 63.329999999999998 109.603 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 178' ' ' TYR . 0.8 OUTLIER -140.38 142.27 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 73.109999999999999 109.266 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.631 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.8 -167.14 2.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 72.230000000000004 109.349 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.3 pt -120.01 125.19 74.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 63.130000000000003 109.337 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.598 HD13 ' NE2' ' A' ' 198' ' ' GLN . 17.1 tp -87.58 110.82 20.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.540000000000006 109.272 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.734 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.57 145.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 62.520000000000003 109.304 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.585 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -117.47 119.53 35.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 74.219999999999999 110.009 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -134.64 147.1 50.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 64.530000000000001 110.979 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.8 mmtp -71.66 134.0 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 74.209999999999994 109.332 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -74.87 -160.24 0.11 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 74.439999999999998 109.309 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.37 48.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.442 1.089 . . . . 75.239999999999995 109.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.68 -7.93 12.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 61.43 109.978 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.5 37.31 8.18 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.521 1.138 . . . . 64.319999999999993 110.983 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.02 137.47 43.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 71.540000000000006 109.324 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.7 m -71.88 102.69 2.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 65.430000000000007 110.34 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.1 mm-40 -102.23 -172.68 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.551 1.157 . . . . 72.329999999999998 110.284 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.559 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.3 mmtm -126.24 145.68 50.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.447 1.092 . . . . 74.540000000000006 109.347 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.586 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.6 tpt180 -145.7 161.98 38.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.133 . . . . 71.150000000000006 110.32 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.855 HD11 ' OE1' ' A' ' 198' ' ' GLN . 16.1 mm -115.47 116.09 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.1 . . . . 64.319999999999993 109.321 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -102.46 46.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.509 1.131 . . . . 64.409999999999997 109.286 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -110.28 113.66 56.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.545 1.153 . . . . 64.519999999999996 109.232 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.705 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -75.0 -18.13 18.98 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 72.530000000000001 111.038 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.482 ' OG ' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 m -45.6 -25.98 0.54 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 74.209999999999994 109.976 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.427 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 4.1 mt -119.61 -60.46 1.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 72.329999999999998 109.302 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.6 m-85 -106.15 101.12 10.62 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 53.130000000000003 110.998 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -23.27 26.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 61.140000000000001 109.991 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 59.1 m -64.44 -47.8 77.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 65.299999999999997 110.008 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.39 -176.1 39.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.522 1.139 . . . . 52.32 111.006 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -75.03 169.78 21.87 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.475 1.776 . . . . 71.430000000000007 110.983 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.714 HG21 ' CE2' ' A' ' 242' ' ' PHE . 6.4 m -150.99 158.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 73.219999999999999 109.32 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 38.6 p -58.89 141.95 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 60.530000000000001 110.378 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -46.02 -26.1 0.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.541 1.151 . . . . 72.430000000000007 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 28.1 m -78.96 -62.43 1.7 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 74.200000000000003 110.387 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.32 -27.86 6.89 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 71.239999999999995 109.338 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.631 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 14.3 t90 -62.66 -61.43 2.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 64.219999999999999 107.971 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.56 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.59 -42.69 16.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 73.120000000000005 110.249 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.853 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -55.94 -51.02 69.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 73.109999999999999 109.32 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -57.28 -19.46 22.02 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 65.439999999999998 109.3 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -90.0 -35.39 15.55 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 74.049999999999997 108.281 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.853 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -94.02 20.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.501 1.126 . . . . 51.039999999999999 109.286 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -50.45 106.06 0.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 63.450000000000003 109.277 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 262' ' ' GLY . 10.3 p -73.44 -3.2 26.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 65.409999999999997 110.375 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 t -44.02 -31.83 1.01 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 51.450000000000003 110.002 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 50.6 t -87.52 -37.5 16.86 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 71.219999999999999 108.271 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 170.5 -129.2 1.76 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.497 1.123 . . . . 60.549999999999997 110.961 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -76.37 148.21 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 0.726 . . . . 75.010000000000005 109.939 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -169.91 146.99 3.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 70.230000000000004 109.284 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.4 t -172.77 152.88 2.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 74.409999999999997 109.97 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.683 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.6 p -98.26 114.92 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 51.039999999999999 109.285 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.3 t -72.48 -44.77 61.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.511 1.132 . . . . 71.549999999999997 110.052 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -158.59 171.37 20.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.219999999999999 110.003 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -155.62 156.01 34.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 73.430000000000007 111.018 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -166.75 163.58 16.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.438 1.086 . . . . 72.430000000000007 109.288 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -123.58 160.66 26.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 65.200000000000003 109.296 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.496 HG21 ' CD ' ' A' ' 279' ' ' ARG . 21.4 p -147.5 -175.09 4.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 55.130000000000003 110.411 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 276' ' ' VAL . . . -55.86 169.69 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 74.200000000000003 109.35 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -94.46 -15.96 44.98 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.487 1.117 . . . . 63.229999999999997 111.025 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -94.24 -16.95 23.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 0.775 . . . . 53.549999999999997 109.294 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.674 HG21 ' CD1' ' A' ' 285' ' ' TYR . 0.3 OUTLIER -67.45 115.66 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.559 1.162 . . . . 65.209999999999994 109.283 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.487 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 16.6 t80 -61.66 -54.76 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 74.319999999999993 110.991 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 5.5 t80 -146.54 150.84 36.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 75.010000000000005 110.996 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.594 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 22.3 ttt-85 -121.7 142.7 49.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 65.329999999999998 110.339 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.48 157.87 34.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 61.32 109.96 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.76 8.51 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.503 1.791 . . . . 53.25 111.014 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 43.2 t -101.72 5.64 41.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.542 1.151 . . . . 70.409999999999997 109.961 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.9 t-20 81.66 22.86 0.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.562 1.164 . . . . 72.239999999999995 109.309 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.4 t -103.05 119.08 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 61.409999999999997 109.984 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.674 ' CD1' HG21 ' A' ' 276' ' ' VAL . 64.5 m-85 -106.12 156.5 18.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 73.209999999999994 111.007 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -113.76 176.1 5.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 62.530000000000001 109.279 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 96.5 m-85 -163.55 115.0 1.42 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.496 1.122 . . . . 75.329999999999998 110.997 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 11.4 t0 -115.6 95.87 5.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 54.420000000000002 109.279 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.55 -27.07 25.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 52.340000000000003 109.349 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.459 ' CB ' HG12 ' A' ' 292' ' ' ILE . 43.7 m-20 -99.12 5.76 46.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.13 . . . . 54.009999999999998 109.306 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.3 48.4 2.33 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 74.510000000000005 109.312 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.459 HG12 ' CB ' ' A' ' 290' ' ' ASN . 39.0 mm -78.32 -29.79 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 64.230000000000004 109.274 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.725 ' O ' HG23 ' A' ' 297' ' ' VAL . 11.0 t30 -94.63 -19.88 20.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.445 1.09 . . . . 73.400000000000006 109.348 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.487 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 16.3 m -87.68 -69.05 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 75.420000000000002 110.352 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 44.5 m-20 -51.39 -27.03 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 63.420000000000002 109.268 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 19.4 t -73.23 -68.8 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 72.109999999999999 108.323 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 293' ' ' ASN . 56.0 t -40.25 -39.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.135 . . . . 71.230000000000004 109.296 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.44 -56.98 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.434 1.084 . . . . 64.310000000000002 109.273 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -17.95 19.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.420000000000002 110.403 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.422 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.4 mmmt -77.41 -41.71 38.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 72.109999999999999 109.315 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.719 ' CE2' HG13 ' A' ' 297' ' ' VAL . 0.8 OUTLIER -106.08 39.64 1.75 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.521 1.138 . . . . 73.120000000000005 111.0 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.7 t -67.89 -53.22 28.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 74.530000000000001 109.99 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.786 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.8 -18.09 38.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 65.530000000000001 109.281 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.749 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 14.2 mt -55.98 137.35 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 71.329999999999998 109.297 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.8 p -148.68 159.87 43.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 71.109999999999999 110.009 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.8 -149.06 40.88 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.475 1.109 . . . . 32.350000000000001 110.976 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 1.2 m -106.74 14.24 27.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.303 -0.999 . . . . 60.200000000000003 108.303 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -132.06 149.21 72.64 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.433 1.083 . . . . 74.349999999999994 110.003 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.737 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -74.97 147.08 88.41 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 74.010000000000005 110.989 -0.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.468 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.6 p -129.99 133.32 24.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 109.988 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.04 -167.87 6.01 Favored 'Cis proline' 0 C--N 1.359 1.13 0 C-N-CA 121.033 -2.486 . . . . 70.340000000000003 110.967 0.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.604 ' HB2' ' OD2' ' A' ' 175' ' ' ASP . . . -56.65 153.8 20.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 61.409999999999997 109.315 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.52 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.0 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 73.400000000000006 110.993 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.8 135.09 33.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.148 . . . . 54.439999999999998 109.278 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.422 HG12 ' HE2' ' A' ' 300' ' ' LYS . 17.1 m -127.2 24.73 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 64.120000000000005 109.274 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 16.5 t -57.04 -18.43 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 64.439999999999998 109.975 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -60.28 -26.6 66.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 62.229999999999997 109.999 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.515 1.134 . . . . 61.020000000000003 108.286 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.779 HD23 ' HB3' ' A' ' 194' ' ' ASP . 7.9 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.284 -0.635 . . . . 52.020000000000003 109.284 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -100.39 111.33 23.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 74.530000000000001 109.319 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 m -73.29 -43.52 60.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.451 1.094 . . . . 75.140000000000001 110.029 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.881 HG23 ' HB3' ' A' ' 224' ' ' SER . 0.4 OUTLIER -112.58 161.22 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 65.099999999999994 109.281 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -101.84 144.75 29.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 71.319999999999993 109.316 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.48 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -33.79 4.34 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.493 1.786 . . . . 71.349999999999994 110.994 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.424 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.19 147.43 19.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.451 1.094 . . . . 72.129999999999995 109.306 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -47.29 -35.18 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 74.140000000000001 109.294 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.3 -45.86 4.36 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 65.510000000000005 109.322 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.782 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -72.85 -34.11 66.56 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.48 1.112 . . . . 73.430000000000007 110.396 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.714 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -59.94 -56.35 22.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.486 1.116 . . . . 73.450000000000003 109.31 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -53.46 -31.39 45.32 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 72.329999999999998 109.3 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.08 -54.08 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.149 . . . . 72.319999999999993 109.991 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 140' ' ' ILE . 87.5 mt -45.25 -41.6 8.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 74.140000000000001 109.262 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.656 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.42 -44.66 57.82 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.423 1.077 . . . . 74.049999999999997 110.974 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -46.95 -36.2 7.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.42 1.075 . . . . 54.420000000000002 109.306 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . 18.4 mt-30 -77.31 -55.15 5.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 72.040000000000006 110.303 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.647 HD11 HD12 ' A' ' 188' ' ' LEU . 17.5 mt -50.35 -27.09 4.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 55.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -37.38 60.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 74.219999999999999 109.31 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.4 t-20 -57.74 -17.88 17.97 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 74.340000000000003 109.33 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.452 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.4 mm100 -82.79 -25.72 32.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.420000000000002 110.291 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -40.35 114.27 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.15 . . . . 71.420000000000002 110.028 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.7 m -42.42 124.4 2.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 53.539999999999999 108.3 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.89 -22.04 3.88 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.523 1.14 . . . . 73.439999999999998 111.016 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.709 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 56.8 p -90.09 158.25 17.39 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 0.747 . . . . 65.319999999999993 110.38 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.2 t -89.62 -2.52 58.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 70.349999999999994 109.984 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 162' ' ' THR . 3.2 m -110.27 -1.6 17.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 75.409999999999997 110.396 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.709 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -74.75 134.51 41.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.575 1.172 . . . . 62.140000000000001 109.288 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.423 ' H ' ' NE2' ' A' ' 156' ' ' GLN . 0.5 OUTLIER -55.14 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 72.329999999999998 109.976 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.46 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.6 t -156.27 128.32 3.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 75.120000000000005 109.965 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -74.95 136.61 45.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.031 -2.487 . . . . 73.340000000000003 111.019 -0.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.9 p -73.19 -179.42 3.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.239999999999995 108.269 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.729 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.3 mp -88.28 124.52 41.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.573 1.171 . . . . 74.019999999999996 109.311 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.419 ' HB ' ' NE ' ' A' ' 171' ' ' ARG . 12.4 p -90.13 81.16 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 73.140000000000001 110.403 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -80.28 -11.18 59.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.128 . . . . 74.120000000000005 110.995 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.57 -5.2 35.53 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.519 1.137 . . . . 73.230000000000004 110.314 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.747 ' CE2' HD13 ' A' ' 304' ' ' LEU . 26.8 t80 -129.73 69.68 81.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 75.109999999999999 111.023 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.693 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.4 Cg_endo -74.94 114.19 3.97 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.448 1.762 . . . . 64.329999999999998 111.039 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.566 HG21 ' CE1' ' A' ' 172' ' ' TYR . 22.1 t -153.26 -66.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 61.130000000000003 109.302 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.91 114.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 75.530000000000001 109.28 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 151.64 46.4 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.476 1.11 . . . . 72.099999999999994 111.004 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.455 ' HB2' HG13 ' A' ' 219' ' ' VAL . 84.9 m -85.73 -23.12 27.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.3 -1.0 . . . . 74.010000000000005 108.3 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.57 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 16.1 p90 -67.13 -35.89 80.71 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.145 . . . . 74.530000000000001 110.995 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -68.53 -67.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 44.539999999999999 109.271 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.475 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -44.05 -46.56 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 73.230000000000004 110.319 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.531 ' HB1' ' NZ ' ' A' ' 197' ' ' LYS . . . -44.96 -50.45 10.57 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 73.239999999999995 109.285 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.693 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -54.0 -35.39 61.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 73.129999999999995 109.579 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.729 ' CB ' HD11 ' A' ' 168' ' ' ILE . 17.4 mmmt -73.43 -32.22 64.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 1.143 . . . . 75.230000000000004 109.334 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 20.3 mtm -66.21 -55.95 13.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 63.539999999999999 110.99 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.66 HH21 ' N ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -55.32 -26.86 43.17 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 74.409999999999997 110.364 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.432 ' HG2' HD13 ' A' ' 187' ' ' ILE . 1.2 tt0 -64.05 -43.38 95.69 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 110.266 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.432 HD13 ' HG2' ' A' ' 186' ' ' GLN . 21.4 mm -70.48 -38.04 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.138 . . . . 72.109999999999999 109.281 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.766 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -56.43 -31.6 64.09 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 63.340000000000003 109.319 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.525 ' HG2' HD21 ' A' ' 136' ' ' LEU . 35.7 mtp -72.89 -43.64 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.573 1.171 . . . . 75.420000000000002 110.973 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -45.32 -53.37 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 64.430000000000007 109.296 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -64.66 -27.86 69.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.209999999999994 109.314 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.08 52.33 0.89 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.545 1.153 . . . . 61.409999999999997 111.002 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.782 ' CZ ' HG21 ' A' ' 145' ' ' THR . 60.2 m-85 -150.83 128.13 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.537 0.786 . . . . 63.109999999999999 110.981 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.779 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -98.38 131.51 44.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 61.210000000000001 109.363 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.766 ' HB3' HD22 ' A' ' 188' ' ' LEU . 24.1 p -109.5 -179.3 3.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.5 1.125 . . . . 44.119999999999997 108.276 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.71 176.99 5.44 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.55 1.156 . . . . 62.020000000000003 110.305 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.836 ' HE2' HG22 ' A' ' 221' ' ' ILE . 14.2 mmtt -105.7 171.6 7.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 75.310000000000002 109.302 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 31.8 tt0 -166.81 121.02 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 72.430000000000007 110.288 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 8.8 m-85 -116.37 123.93 48.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.466 1.104 . . . . 64.5 110.99 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.659 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.7 p -115.28 152.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.496 1.122 . . . . 71.209999999999994 109.279 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 5.3 m-85 -124.91 162.75 23.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 73.340000000000003 111.016 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.57 -179.88 17.76 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.455 1.097 . . . . 61.399999999999999 111.005 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.721 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.0 t-20 -69.11 109.62 4.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.528 0.781 . . . . 64.140000000000001 109.276 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.721 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -114.01 93.78 4.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.432 1.083 . . . . 73.239999999999995 109.297 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.52 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 7.1 mttt -93.12 167.19 11.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 34.25 109.349 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.487 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -175.53 151.86 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 61.340000000000003 109.286 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 64.200000000000003 109.962 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.315 -0.995 . . . . 73.310000000000002 108.315 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.693 HG11 ' O ' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -110.28 156.61 11.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 75.409999999999997 109.287 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.52 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -141.34 119.2 11.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 33.240000000000002 109.348 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -125.11 137.1 54.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.01 -1.107 . . . . 75.340000000000003 108.01 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -81.81 4.6 21.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.508 1.13 . . . . 61.539999999999999 110.022 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.505 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.3 p90 -177.74 126.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.319999999999993 110.946 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.514 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 40.5 t60 -112.7 168.71 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 71.120000000000005 109.608 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 1.5 p -144.62 142.07 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 62.520000000000003 109.314 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.76 -165.13 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 52.32 109.304 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.836 HG22 ' HE2' ' A' ' 197' ' ' LYS . 14.2 pt -119.07 124.93 73.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 44.340000000000003 109.305 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.3 tp -85.9 108.99 18.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 70.109999999999999 109.293 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.714 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.61 148.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.128 . . . . 71.439999999999998 109.301 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.881 ' HB3' HG23 ' A' ' 139' ' ' VAL . 49.7 m -116.89 125.39 51.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.010000000000005 110.03 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 34.8 p90 -139.48 137.47 35.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 65.340000000000003 111.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -64.6 131.1 46.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.568 1.167 . . . . 63.539999999999999 109.347 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -72.06 -160.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 65.230000000000004 109.277 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.08 49.56 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 71.340000000000003 109.324 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.98 -7.85 12.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.497 1.123 . . . . 72.239999999999995 110.034 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.42 37.8 8.0 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.495 1.122 . . . . 43.109999999999999 111.001 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.62 43.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.501 0.765 . . . . 72.530000000000001 109.283 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.483 HG23 ' CG2' ' A' ' 139' ' ' VAL . 2.5 m -71.9 102.75 2.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.540000000000006 110.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 224' ' ' SER . 6.8 mm-40 -102.63 -172.58 2.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 75.409999999999997 110.303 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.519 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.1 mmtm -126.18 145.39 50.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 61.420000000000002 109.301 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.636 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.2 tpt180 -143.07 161.44 38.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 74.049999999999997 110.31 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.681 HG21 ' CD1' ' A' ' 252' ' ' TRP . 11.2 mm -114.74 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.562 1.163 . . . . 75.25 109.305 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 237' ' ' ILE . 4.0 mm -102.58 45.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.115 . . . . 74.439999999999998 109.298 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.05 109.47 62.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 75.439999999999998 109.263 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.2 Cg_endo -75.05 -27.3 10.05 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.477 1.777 . . . . 74.129999999999995 110.966 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.9 OUTLIER -45.21 -26.37 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 74.450000000000003 109.992 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.25 -60.39 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 74.409999999999997 109.294 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 255' ' ' ALA . 87.9 m-85 -107.87 99.6 9.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 72.109999999999999 111.009 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.96 -6.28 57.36 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 72.019999999999996 110.015 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.9 p -80.53 -46.09 16.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.539 1.15 . . . . 71.209999999999994 109.97 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.49 -175.76 42.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 74.120000000000005 111.034 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.449 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.98 163.57 35.1 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.503 1.791 . . . . 65.140000000000001 110.987 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 242' ' ' PHE . 2.4 m -150.35 156.88 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 54.229999999999997 109.278 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.423 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.2 p -60.54 140.49 57.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 72.530000000000001 110.434 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.403 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 1.1 p-10 -42.97 -28.98 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.329999999999998 109.281 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.423 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.0 m -71.34 -65.22 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.116 . . . . 73.239999999999995 110.421 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.32 13.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 64.25 109.31 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.681 ' CD1' HG21 ' A' ' 236' ' ' ILE . 12.5 t90 -59.94 -61.12 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.982 -1.118 . . . . 63.240000000000002 107.982 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.566 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.42 -41.61 20.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 61.119999999999997 110.275 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.826 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -57.31 -51.11 70.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 74.209999999999994 109.3 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.588 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.25 -19.51 14.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 62.229999999999997 109.297 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -89.08 -35.81 16.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 73.439999999999998 108.32 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.826 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -93.96 21.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 74.400000000000006 109.304 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -50.22 106.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 64.040000000000006 109.316 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 262' ' ' GLY . 4.6 p -73.48 -3.14 25.74 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 1.129 . . . . 72.049999999999997 110.38 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 39.0 t -44.52 -30.76 0.94 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 73.349999999999994 110.025 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.51 -37.2 15.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 62.219999999999999 108.275 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 166.84 -127.95 1.67 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.53 1.144 . . . . 41.140000000000001 110.983 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.61 144.86 43.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 0.778 . . . . 74.150000000000006 109.942 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.21 147.53 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.439999999999998 109.304 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 84.1 p -172.95 155.56 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.450000000000003 109.973 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.659 HG23 ' CG2' ' A' ' 200' ' ' VAL . 3.8 p -101.14 118.86 48.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.145 . . . . 75.349999999999994 109.357 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.3 t -73.22 -43.75 60.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 73.140000000000001 110.026 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 200' ' ' VAL . 51.2 p -168.8 -179.35 3.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 65.25 110.029 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -159.22 157.16 30.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 73.129999999999995 110.979 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.35 152.22 29.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 62.439999999999998 109.295 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 272' ' ' THR . 8.6 p30 -112.36 160.71 17.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 72.519999999999996 109.344 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.642 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.7 p -153.83 -178.45 7.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 61.240000000000002 110.396 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.829 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -68.24 162.15 25.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.461 1.101 . . . . 63.420000000000002 109.311 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.9 -44.69 36.37 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.515 1.135 . . . . 73.209999999999994 111.015 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.66 ' N ' HH21 ' A' ' 185' ' ' ARG . 1.7 p30 -53.18 -41.01 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 0.777 . . . . 72.510000000000005 109.299 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.829 HG23 ' HB3' ' A' ' 273' ' ' ALA . 22.8 t -43.56 120.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 74.540000000000006 109.247 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -82.2 -53.07 6.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.523 1.139 . . . . 73.209999999999994 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -136.92 152.83 50.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 74.239999999999995 111.002 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.642 ' HD2' HG21 ' A' ' 272' ' ' THR . 78.2 ttt-85 -126.86 147.3 50.06 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 73.230000000000004 110.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.96 158.14 50.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.47 1.106 . . . . 62.420000000000002 109.936 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 0.25 9.15 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.465 1.771 . . . . 73.409999999999997 110.952 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 7.1 t -98.98 4.98 47.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 110.015 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 75.38 41.56 0.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.349999999999994 109.338 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -120.21 120.39 36.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.467 1.104 . . . . 64.049999999999997 109.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.46 ' OH ' HG22 ' A' ' 272' ' ' THR . 11.7 m-30 -103.05 160.65 14.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 61.399999999999999 111.035 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -125.42 177.24 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 54.329999999999998 109.342 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.7 m-85 -161.03 115.84 2.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.476 1.11 . . . . 64.540000000000006 111.016 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.43 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 1.0 OUTLIER -115.36 96.78 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 109.348 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -85.63 -19.11 31.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 75.439999999999998 109.253 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.473 ' HB3' HD11 ' A' ' 292' ' ' ILE . 38.6 m-20 -107.65 6.59 27.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.430000000000007 109.297 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.693 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.26 47.22 2.09 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 73.209999999999994 109.3 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.473 HD11 ' HB3' ' A' ' 290' ' ' ASN . 47.5 mm -76.51 -31.58 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 73.310000000000002 109.296 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.78 ' O ' HG23 ' A' ' 297' ' ' VAL . 3.7 t30 -94.78 -18.51 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.112 . . . . 71.400000000000006 109.27 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.52 HG22 ' HD3' ' A' ' 183' ' ' LYS . 2.0 m -84.76 -66.51 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 60.439999999999998 110.424 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 87.8 m-20 -56.68 -18.71 13.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 52.399999999999999 109.278 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 4.9 t -80.49 -63.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.128 . . . . 74.030000000000001 108.308 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 293' ' ' ASN . 65.9 t -46.93 -37.24 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.52 1.138 . . . . 71.040000000000006 109.334 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.663 HD11 ' HG3' ' A' ' 183' ' ' LYS . 85.2 mt -67.69 -57.8 5.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.12 . . . . 74.129999999999995 109.277 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.85 -20.76 16.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 110.384 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -72.27 -39.2 68.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 70.340000000000003 109.3 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.943 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.6 m-30 -101.78 35.09 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.498 1.123 . . . . 64.340000000000003 110.987 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.3 t -67.96 -43.85 78.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 73.150000000000006 110.01 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.785 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -95.62 -17.18 21.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.102 . . . . 54.439999999999998 109.278 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.943 HD12 ' CD1' ' A' ' 301' ' ' PHE . 14.2 mt -56.58 153.43 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 63.200000000000003 109.288 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.1 p -165.55 162.17 18.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.528 1.142 . . . . 72.0 110.039 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 65.69 -153.1 51.48 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.507 1.13 . . . . 75.019999999999996 110.979 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 3.0 m -99.38 9.77 42.66 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.294 -1.002 . . . . 73.040000000000006 108.294 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.527 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -125.06 148.85 61.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 55.009999999999998 109.953 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.735 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -74.96 147.06 88.37 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.965 -2.515 . . . . 73.409999999999997 111.014 -0.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.467 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.1 OUTLIER -128.83 133.33 25.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 63.140000000000001 110.006 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.99 -168.73 6.72 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 120.974 -2.511 . . . . 73.219999999999999 111.042 -0.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 150.3 40.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.135 . . . . 73.219999999999999 109.318 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.525 1.803 . . . . 71.019999999999996 111.03 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.47 127.33 39.07 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.143 . . . . 73.239999999999995 109.237 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.52 27.22 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 72.099999999999994 109.297 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 12.5 t -51.72 -35.55 43.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 70.019999999999996 109.993 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 30.8 m -42.3 -28.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.422 1.076 . . . . 73.420000000000002 110.025 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 62.0 m . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.420000000000002 108.29 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 194' ' ' ASP . 12.5 tp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.316 -0.624 . . . . 71.420000000000002 109.316 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -102.56 106.91 17.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 64.430000000000007 109.302 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 m -69.33 -42.59 75.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.478 1.111 . . . . 61.399999999999999 109.972 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.845 HG23 ' HB3' ' A' ' 224' ' ' SER . 0.4 OUTLIER -112.79 159.75 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 109.298 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.866 HD11 HD12 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.07 143.83 26.95 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 72.150000000000006 109.316 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.4 Cg_endo -75.02 -33.23 4.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.514 1.797 . . . . 75.349999999999994 110.984 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.41 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.37 146.28 16.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 61.109999999999999 109.267 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -45.15 -36.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.158 . . . . 62.240000000000002 109.271 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.75 2.96 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.546 1.153 . . . . 63.539999999999999 109.265 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.8 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.11 -36.26 72.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.546 1.154 . . . . 34.299999999999997 110.406 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.742 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.7 -57.26 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 72.239999999999995 109.32 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -51.91 -31.93 30.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 62.0 109.292 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.75 -56.66 7.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 62.229999999999997 109.998 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.866 HD12 HD11 ' A' ' 140' ' ' ILE . 22.6 mt -43.05 -41.08 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 63.32 109.28 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.763 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.02 -44.48 54.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.544 1.153 . . . . 73.219999999999999 111.003 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -48.52 -34.82 11.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.135 . . . . 74.120000000000005 109.324 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.436 ' CB ' ' CG2' ' A' ' 187' ' ' ILE . 15.9 mt-30 -77.69 -51.7 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 72.450000000000003 110.335 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 188' ' ' LEU . 17.6 mt -54.61 -24.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.147 . . . . 51.340000000000003 109.327 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -34.73 49.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 72.040000000000006 109.26 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -58.64 -20.08 44.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 1.137 . . . . 62.25 109.295 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.462 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 8.9 mm100 -77.63 -24.1 49.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 74.409999999999997 110.29 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 160' ' ' THR . 6.3 m -38.99 113.04 0.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 70.219999999999999 109.967 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.9 m -43.05 129.65 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 55.32 108.301 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 125.36 -14.24 7.35 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 71.010000000000005 110.989 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.676 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 45.1 p -98.47 154.22 18.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 0.775 . . . . 52.310000000000002 110.434 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 p -86.4 -3.61 59.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.548 1.155 . . . . 73.319999999999993 109.974 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 -3.98 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 71.030000000000001 110.369 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.676 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -76.93 133.6 39.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 71.450000000000003 109.285 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -168.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 63.439999999999998 109.99 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.464 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -155.91 128.16 4.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 61.409999999999997 110.002 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 136.62 46.04 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 120.967 -2.514 . . . . 52.030000000000001 111.03 -0.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 13.2 p -73.01 179.66 3.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.129999999999995 108.3 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 183' ' ' LYS . 4.4 mp -91.9 135.41 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.094 . . . . 74.140000000000001 109.336 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.8 p -96.19 94.53 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.122 . . . . 54.399999999999999 110.388 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.516 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 90.2 m-85 -88.48 -15.46 35.3 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.557 1.161 . . . . 72.109999999999999 110.993 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.67 -2.02 24.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 74.120000000000005 110.285 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.565 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 30.9 t80 -132.38 67.18 78.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 74.040000000000006 111.014 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.416 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -75.03 112.53 3.58 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.471 1.774 . . . . 64.230000000000004 110.991 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.533 HG21 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.95 -72.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 71.400000000000006 109.305 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -152.6 125.12 8.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 62.210000000000001 109.325 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 139.34 44.29 0.07 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.467 1.105 . . . . 72.400000000000006 111.02 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.496 ' HB3' HG13 ' A' ' 219' ' ' VAL . 6.0 t -81.56 -25.42 35.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.329 -0.989 . . . . 64.150000000000006 108.329 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.467 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 28.4 p90 -71.47 -28.67 64.11 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 74.439999999999998 110.992 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.09 -68.12 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.423 1.077 . . . . 63.039999999999999 109.307 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.508 HH21 ' HE2' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -45.24 -47.69 12.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 70.129999999999995 110.298 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB1' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.2 -55.09 4.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.465 1.103 . . . . 71.109999999999999 109.28 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.42 -36.61 15.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 74.140000000000001 109.582 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.834 ' CB ' HD11 ' A' ' 168' ' ' ILE . 9.4 mmmm -77.07 -32.82 57.04 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.149 . . . . 72.120000000000005 109.3 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 181' ' ' ALA . 18.3 mtm -63.6 -50.23 70.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 71.140000000000001 110.99 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.521 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.0 OUTLIER -64.43 -26.34 68.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 72.040000000000006 110.316 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -61.85 -38.92 90.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 73.450000000000003 110.301 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.436 ' CG2' ' CB ' ' A' ' 152' ' ' GLN . 21.2 mm -70.7 -37.68 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 64.409999999999997 109.336 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -54.69 -44.08 73.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.525 1.141 . . . . 73.310000000000002 109.273 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.521 ' HE3' ' CZ ' ' A' ' 185' ' ' ARG . 13.7 mtt -58.85 -43.59 90.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 60.420000000000002 111.047 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.08 -51.46 24.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 75.340000000000003 109.3 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.408 ' HB3' HD21 ' A' ' 149' ' ' LEU . 33.3 t30 -68.74 -26.06 65.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.451 1.094 . . . . 75.230000000000004 109.257 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.15 57.94 0.84 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.495 1.122 . . . . 61.109999999999999 110.982 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.8 ' CZ ' HG21 ' A' ' 145' ' ' THR . 59.6 m-85 -152.13 140.37 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.459 0.741 . . . . 75.140000000000001 110.999 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.967 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -105.53 130.8 53.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 72.230000000000004 109.301 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.915 ' HB3' HD22 ' A' ' 188' ' ' LEU . 11.4 p -109.42 -179.52 3.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 65.430000000000007 108.258 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.13 175.65 8.25 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.543 1.152 . . . . 75.200000000000003 110.279 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.595 ' HE2' HG22 ' A' ' 221' ' ' ILE . 15.8 mmtt -108.9 159.32 16.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 73.430000000000007 109.306 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 34.3 tt0 -152.4 117.72 5.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.548 1.155 . . . . 74.510000000000005 110.273 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -108.94 136.13 48.98 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.496 1.122 . . . . 62.109999999999999 111.047 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.657 HG22 HG23 ' A' ' 266' ' ' VAL . 9.4 p -131.81 143.33 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 75.349999999999994 109.318 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.3 m-85 -117.7 161.38 19.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 71.200000000000003 110.952 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.63 -179.62 17.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.502 1.126 . . . . 53.450000000000003 111.023 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.725 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.8 t-20 -69.08 110.22 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.430000000000007 109.324 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.8 mt -114.32 93.98 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 74.120000000000005 109.301 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.655 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 7.0 mttt -93.36 166.14 12.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 73.030000000000001 109.297 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 212' ' ' CYS . . . -173.28 148.18 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 75.109999999999999 109.286 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 63.240000000000002 109.953 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 108.314 -0.995 . . . . 64.430000000000007 108.314 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -117.99 157.52 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 53.140000000000001 109.27 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.655 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -140.76 120.55 13.47 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 70.530000000000001 109.26 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m-90 -125.95 135.67 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 74.549999999999997 107.995 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.6 t -81.14 1.21 32.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.25 109.969 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.522 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 11.2 p90 -172.23 125.62 0.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.467 1.104 . . . . 74.400000000000006 111.024 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.525 ' O ' HG12 ' A' ' 200' ' ' VAL . 54.0 t-80 -125.41 157.7 36.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.209999999999994 109.568 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 177' ' ' CYS . 1.5 p -131.5 163.99 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.548 1.155 . . . . 54.240000000000002 109.288 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.65 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -156.19 -167.55 2.47 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.517 1.136 . . . . 50.420000000000002 109.292 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.595 HG22 ' HE2' ' A' ' 197' ' ' LYS . 30.6 pt -117.77 119.79 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 63.25 109.316 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 234' ' ' LYS . 10.8 tp -83.11 109.86 17.52 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.555 1.159 . . . . 75.140000000000001 109.304 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.742 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -106.15 147.48 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 71.340000000000003 109.313 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.845 ' HB3' HG23 ' A' ' 139' ' ' VAL . 37.0 m -116.74 125.4 51.6 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 73.099999999999994 109.983 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.572 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -140.52 137.44 33.81 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.54 1.15 . . . . 74.200000000000003 110.977 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.406 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 17.9 mmtp -64.08 132.45 50.55 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.153 . . . . 53.439999999999998 109.307 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -72.82 -160.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 74.340000000000003 109.311 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.86 0.34 48.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.319999999999993 109.309 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.32 -8.56 12.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 109.997 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.45 37.73 7.44 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.469 1.106 . . . . 75.450000000000003 110.967 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.65 136.97 46.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.535 0.785 . . . . 73.540000000000006 109.28 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.493 HG23 ' CG2' ' A' ' 139' ' ' VAL . 2.5 m -71.23 102.79 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 70.409999999999997 110.389 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.43 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.2 mm-40 -102.33 -172.65 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.133 . . . . 73.340000000000003 110.32 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.493 ' HB3' HD11 ' A' ' 222' ' ' LEU . 13.8 mmtm -126.1 145.36 50.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 70.510000000000005 109.283 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.7 tpt180 -145.88 160.34 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 62.409999999999997 110.325 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.547 HG21 ' CD1' ' A' ' 252' ' ' TRP . 9.9 mm -114.24 120.89 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 75.519999999999996 109.251 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 150' ' ' PHE . 5.5 mm -104.29 44.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 74.329999999999998 109.288 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.57 113.62 62.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 1.146 . . . . 75.040000000000006 109.271 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.516 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -75.03 -26.61 10.71 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.501 1.79 . . . . 71.420000000000002 111.009 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.419 ' HB2' ' NH2' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -41.53 -30.76 0.22 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 74.5 110.049 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.2 mt -110.05 -61.14 1.7 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 72.319999999999993 109.317 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 247' ' ' VAL . 98.3 m-85 -108.78 99.51 8.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 74.329999999999998 111.013 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 69.5 m -86.39 -15.98 38.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 64.5 109.998 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.8 t -73.92 -40.05 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.135 . . . . 70.120000000000005 110.011 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.6 -177.54 45.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 51.119999999999997 111.04 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.437 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.96 170.57 20.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.503 1.791 . . . . 74.420000000000002 111.062 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.869 HG21 ' CE2' ' A' ' 242' ' ' PHE . 11.2 m -150.84 158.55 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.506 1.129 . . . . 64.209999999999994 109.287 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.404 ' C ' ' N ' ' A' ' 250' ' ' THR . 40.6 p -60.64 141.45 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.157 . . . . 51.100000000000001 110.379 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -46.3 -25.91 0.71 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 71.319999999999993 109.331 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.404 ' N ' ' C ' ' A' ' 248' ' ' THR . 21.4 m -79.37 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.219999999999999 110.439 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -54.42 -22.22 11.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 63.210000000000001 109.283 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.65 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.6 t90 -66.56 -57.8 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.513 1.133 . . . . 64.439999999999998 107.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.556 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -49.22 -42.99 42.16 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 30.149999999999999 110.33 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.834 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -56.24 -51.04 69.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 75.340000000000003 109.31 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.6 -19.36 10.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.444 1.09 . . . . 73.209999999999994 109.321 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -89.0 -36.79 15.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.329999999999998 108.266 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.834 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.4 m -92.73 20.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 73.420000000000002 109.315 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -50.18 105.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.467 1.105 . . . . 72.019999999999996 109.266 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.41 -3.26 26.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 75.430000000000007 110.352 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 t -44.47 -30.13 0.82 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 52.140000000000001 110.01 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.8 t -89.01 -37.3 15.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.115 . . . . 63.509999999999998 108.29 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.13 -129.3 1.86 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.481 1.113 . . . . 75.439999999999998 111.019 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -73.9 145.18 45.0 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.582 0.813 . . . . 64.209999999999994 110.036 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.16 147.68 4.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 62.100000000000001 109.281 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 94.7 p -172.9 155.48 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 75.099999999999994 110.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.657 HG23 HG22 ' A' ' 200' ' ' VAL . 3.7 p -101.42 117.95 47.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 74.230000000000004 109.313 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.2 t -73.89 -44.19 56.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 74.420000000000002 109.981 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.4 m -166.65 172.97 10.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 63.340000000000003 110.002 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.408 ' HB3' HG23 ' A' ' 200' ' ' VAL . 30.9 p90 -154.64 156.05 35.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 73.230000000000004 111.011 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.65 153.34 31.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 1.151 . . . . 65.209999999999994 109.311 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 272' ' ' THR . 8.4 p30 -113.49 160.7 18.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 72.5 109.257 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 285' ' ' TYR . 2.5 p -154.37 -179.61 8.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.52 1.137 . . . . 75.329999999999998 110.41 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.85 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -66.83 167.76 10.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 60.310000000000002 109.307 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.9 -41.77 13.97 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.481 1.113 . . . . 74.010000000000005 110.986 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -57.2 -42.59 81.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.509 0.77 . . . . 64.409999999999997 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.85 HG23 ' HB3' ' A' ' 273' ' ' ALA . 44.1 t -43.86 118.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.030000000000001 109.297 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.582 ' CD2' ' OD2' ' A' ' 288' ' ' ASP . 18.4 t80 -73.74 -53.46 10.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 74.549999999999997 111.003 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 279' ' ' ARG . 31.0 t80 -136.31 166.7 22.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 70.340000000000003 111.008 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.0 ttt-85 -135.39 147.45 49.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 64.420000000000002 110.283 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.85 158.03 50.94 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 61.299999999999997 109.997 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 0.32 9.08 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.565 1.823 . . . . 70.349999999999994 111.01 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 42.0 p -98.42 4.23 48.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 74.430000000000007 109.993 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.3 t-20 77.21 41.74 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.409999999999997 109.304 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 t -122.66 131.4 53.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 64.430000000000007 109.973 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.552 ' HB3' HG13 ' A' ' 276' ' ' VAL . 16.4 m-30 -111.65 153.13 26.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 73.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.587 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.95 177.44 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.458 1.099 . . . . 73.209999999999994 109.334 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 84.9 m-85 -160.25 115.79 2.33 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 75.319999999999993 111.044 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.582 ' OD2' ' CD2' ' A' ' 277' ' ' TYR . 0.7 OUTLIER -115.43 94.98 4.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.478 1.111 . . . . 70.219999999999999 109.337 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -85.61 -18.34 33.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.483 1.115 . . . . 60.299999999999997 109.297 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.44 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.3 m-20 -107.09 3.28 25.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.476 1.11 . . . . 73.409999999999997 109.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.56 47.43 2.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.448 1.092 . . . . 73.109999999999999 109.27 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.44 HG12 ' CB ' ' A' ' 290' ' ' ASN . 22.5 mm -74.27 -32.63 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 62.219999999999999 109.276 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.659 ' O ' HG23 ' A' ' 297' ' ' VAL . 4.5 t30 -90.72 -26.17 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 72.439999999999998 109.291 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.459 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 1.3 m -79.37 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.463 1.102 . . . . 62.299999999999997 110.409 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -54.59 -20.13 7.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.133 . . . . 62.399999999999999 109.272 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 40.4 t -86.32 -62.22 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.477 1.111 . . . . 73.430000000000007 108.288 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.9 t -40.29 -41.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 55.340000000000003 109.29 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' A' ' 168' ' ' ILE . 24.3 mt -69.96 -56.13 7.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 75.329999999999998 109.316 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -55.3 -18.46 6.4 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 110.449 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.609 ' HE2' HG12 ' A' ' 315' ' ' VAL . 18.6 mmmt -75.38 -45.77 37.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 72.450000000000003 109.302 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.694 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.6 m-30 -99.81 38.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.563 1.165 . . . . 71.209999999999994 111.029 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.1 t -69.5 -45.01 69.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.122 . . . . 55.409999999999997 110.029 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.801 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.67 -17.7 22.95 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 51.530000000000001 109.277 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.767 HD22 ' CD ' ' A' ' 309' ' ' PRO . 14.8 mt -59.52 144.91 46.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 73.040000000000006 109.34 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.3 p -154.02 158.08 40.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 75.420000000000002 110.057 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 70.32 -162.17 53.25 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.505 1.128 . . . . 74.230000000000004 110.969 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 310' ' ' SER . 9.4 p -92.1 13.9 17.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.29 -1.004 . . . . 74.5 108.29 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 3.3 m -132.96 148.1 68.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 62.439999999999998 110.009 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.767 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 145.42 83.87 Favored 'Cis proline' 0 C--N 1.361 1.196 0 C-N-CA 120.984 -2.507 . . . . 64.099999999999994 111.008 0.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -131.35 135.6 27.33 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.117 . . . . 71.310000000000002 109.996 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.97 -174.96 15.03 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.016 -2.493 . . . . 72.209999999999994 111.026 -0.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.43 154.96 21.06 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 73.319999999999993 109.296 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.425 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.97 -162.23 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.498 1.788 . . . . 22.129999999999999 111.011 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -82.96 131.52 35.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 72.040000000000006 109.297 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.609 HG12 ' HE2' ' A' ' 300' ' ' LYS . 34.1 m -129.39 26.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.512 1.133 . . . . 70.340000000000003 109.305 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 6.9 t -70.76 -33.52 70.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 54.409999999999997 109.982 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 p -45.75 -25.71 0.54 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 64.530000000000001 110.01 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 71.439999999999998 108.275 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.98 HD23 ' HB2' ' A' ' 194' ' ' ASP . 9.0 tp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.348 -0.612 . . . . 73.310000000000002 109.348 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.553 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -103.88 105.47 15.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 73.450000000000003 109.32 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -83.64 7.89 16.03 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 73.030000000000001 110.002 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.4 t -150.4 145.86 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.47 1.106 . . . . 41.439999999999998 109.327 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.044 HD11 HD12 ' A' ' 149' ' ' LEU . 1.6 mt -97.05 141.67 23.4 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 60.049999999999997 109.322 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -30.54 7.09 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.506 1.793 . . . . 70.25 110.968 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.58 150.25 15.71 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.476 1.11 . . . . 62.210000000000001 109.293 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -48.54 -36.67 7.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 73.25 109.258 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.99 -47.49 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 72.129999999999995 109.242 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.733 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.44 -36.19 71.18 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 61.350000000000001 110.375 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.728 HD11 HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -58.1 -57.17 14.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 1.093 . . . . 73.420000000000002 109.278 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -51.71 -32.34 29.82 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 72.209999999999994 109.332 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.25 -53.83 17.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 50.340000000000003 110.007 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.044 HD12 HD11 ' A' ' 140' ' ' ILE . 63.4 mt -45.56 -41.55 10.0 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.53 1.144 . . . . 74.239999999999995 109.291 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.677 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.38 -44.7 58.03 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 75.239999999999995 110.991 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -47.21 -33.89 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 74.319999999999993 109.319 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.451 ' HB2' ' CG2' ' A' ' 187' ' ' ILE . 22.6 mt-30 -78.53 -53.9 6.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 71.140000000000001 110.302 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 188' ' ' LEU . 24.1 mt -51.28 -28.32 7.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 71.209999999999994 109.281 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -38.48 63.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 72.109999999999999 109.273 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.94 -16.97 20.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.536 1.147 . . . . 71.109999999999999 109.283 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.485 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 10.0 mm100 -86.83 -26.55 23.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.514 1.134 . . . . 70.129999999999995 110.272 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 m -40.04 128.78 2.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 63.240000000000002 109.979 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.71 112.43 1.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 75.209999999999994 108.326 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.76 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 44.5 110.969 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.68 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 37.4 p -95.47 161.1 14.21 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 0.736 . . . . 70.510000000000005 110.383 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.64 -7.59 49.59 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 54.109999999999999 110.01 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.4 m -103.53 -4.23 24.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.096 . . . . 64.109999999999999 110.396 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.68 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -71.91 136.32 46.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 34.240000000000002 109.291 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.05 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 61.009999999999998 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.421 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.1 m -156.24 127.2 3.57 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 72.239999999999995 110.017 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.421 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 140.06 65.22 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 120.994 -2.503 . . . . 71.340000000000003 111.008 0.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.644 ' O ' HD13 ' A' ' 298' ' ' LEU . 6.6 p -72.78 -178.6 2.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 33.539999999999999 108.319 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 183' ' ' LYS . 2.2 mp -83.45 128.51 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 75.239999999999995 109.275 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 51.3 p -96.56 69.15 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 73.209999999999994 110.374 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -81.25 -11.36 59.4 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 73.340000000000003 111.023 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.456 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.31 -1.82 25.4 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.545 1.153 . . . . 74.450000000000003 110.288 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.793 ' CE2' HD13 ' A' ' 304' ' ' LEU . 18.9 t80 -131.47 64.59 73.7 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 74.329999999999998 110.984 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.432 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.95 123.09 7.65 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.444 1.76 . . . . 63.030000000000001 111.024 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.7 t -152.68 -55.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 65.109999999999999 109.324 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 177' ' ' CYS . 5.2 m-20 -147.22 -78.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.146 . . . . 72.299999999999997 109.313 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.38 92.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.505 1.128 . . . . 63.299999999999997 110.978 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.507 ' N ' ' O ' ' A' ' 175' ' ' ASP . 13.4 t -115.36 -16.0 11.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 75.519999999999996 108.293 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 33.1 p90 -74.99 -45.0 44.99 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.482 1.114 . . . . 73.129999999999995 111.02 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -41.58 -68.39 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.529 1.143 . . . . 72.439999999999998 109.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -47.67 -47.23 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 73.400000000000006 110.333 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -46.86 -55.86 7.27 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.47 1.106 . . . . 73.099999999999994 109.289 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.505 ' ND1' ' CD1' ' A' ' 291' ' ' LEU . 2.4 t-160 -48.1 -30.23 4.31 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 70.409999999999997 109.604 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.755 ' HB2' HD11 ' A' ' 168' ' ' ILE . 21.4 mmmt -85.12 -31.99 23.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 71.030000000000001 109.275 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.57 ' HB3' HD13 ' A' ' 221' ' ' ILE . 31.2 mtm -62.51 -36.7 83.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 53.439999999999998 111.0 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.456 ' CB ' ' SG ' ' A' ' 195' ' ' CYS . 0.0 OUTLIER -78.32 -33.77 49.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 64.299999999999997 110.293 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 187' ' ' ILE . 1.1 pt20 -53.9 -35.44 61.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 75.340000000000003 110.303 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.452 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 21.8 mm -74.67 -48.06 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.529 1.143 . . . . 72.140000000000001 109.296 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -47.22 -36.87 9.45 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.452 1.095 . . . . 73.150000000000006 109.305 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.403 ' SD ' ' CD ' ' A' ' 185' ' ' ARG . 6.5 mtt -65.72 -46.96 76.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 74.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -46.43 -51.31 15.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 73.25 109.304 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -65.33 -34.81 79.2 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 74.340000000000003 109.31 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.93 54.19 0.46 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.473 1.108 . . . . 70.109999999999999 110.984 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.733 ' CZ ' HG21 ' A' ' 145' ' ' THR . 78.1 m-85 -152.24 142.18 22.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 0.772 . . . . 63.450000000000003 110.994 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.98 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -108.13 128.65 54.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 72.5 109.291 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 1.015 ' HB3' HD22 ' A' ' 188' ' ' LEU . 12.5 p -104.45 178.22 4.62 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.49 1.119 . . . . 61.130000000000003 108.28 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -127.17 173.81 9.42 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.329999999999998 110.322 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.456 ' NZ ' ' HB1' ' A' ' 181' ' ' ALA . 21.4 mmtt -108.3 153.78 22.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.544 1.153 . . . . 73.349999999999994 109.303 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 31.7 tt0 -147.34 117.42 7.27 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.528 1.142 . . . . 72.099999999999994 110.326 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.0 m-85 -110.59 123.29 49.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 70.329999999999998 110.973 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.67 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.0 p -114.99 151.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 72.140000000000001 109.313 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.451 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 13.0 m-85 -122.27 161.18 23.77 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 71.150000000000006 111.01 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.6 -178.4 16.72 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.478 1.111 . . . . 50.350000000000001 111.006 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.733 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.8 t-20 -69.96 109.44 4.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.574 0.808 . . . . 62.25 109.328 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.733 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.5 mt -114.26 94.5 4.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.155 . . . . 50.210000000000001 109.329 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.484 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 8.4 mttt -92.96 164.3 13.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 63.240000000000002 109.305 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.748 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -175.69 170.92 2.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.113 . . . . 50.509999999999998 109.321 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.109999999999999 110.013 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 108.267 -1.012 . . . . 74.5 108.267 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.748 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.9 m -111.12 128.75 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 40.130000000000003 109.314 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.484 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 63.119999999999997 109.327 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.3 m0 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.119 . . . . 65.150000000000006 108.034 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -81.65 -1.31 46.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 75.010000000000005 110.007 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.501 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.2 p90 -169.8 127.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 73.409999999999997 110.977 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.54 ' O ' HG12 ' A' ' 200' ' ' VAL . 49.4 t-80 -124.79 149.24 47.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 63.350000000000001 109.597 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 220' ' ' ALA . 1.5 p -118.1 164.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 75.439999999999998 109.292 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.644 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.06 -170.53 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.13 . . . . 65.200000000000003 109.321 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.648 HD11 ' HB ' ' A' ' 237' ' ' ILE . 21.1 pt -116.44 118.38 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.546 1.154 . . . . 71.219999999999999 109.272 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 234' ' ' LYS . 11.8 tp -83.99 108.64 17.07 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.461 1.101 . . . . 73.129999999999995 109.327 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.728 HG21 HD11 ' A' ' 146' ' ' LEU . 0.9 OUTLIER -102.95 143.89 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 74.25 109.311 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.615 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.2 OUTLIER -116.32 116.78 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 52.229999999999997 109.981 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.575 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.5 p90 -131.92 145.83 51.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.121 . . . . 75.510000000000005 111.019 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -70.76 132.73 45.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 64.209999999999994 109.335 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.28 -160.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 63.409999999999997 109.283 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.89 -0.06 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 73.239999999999995 109.244 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -114.86 -8.51 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 73.209999999999994 109.984 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.86 37.55 7.86 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.494 1.121 . . . . 71.239999999999995 111.016 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.41 137.95 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 71.299999999999997 109.294 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.0 m -71.87 102.55 2.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 62.409999999999997 110.368 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 224' ' ' SER . 6.9 mm-40 -102.12 -172.71 2.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 62.240000000000002 110.275 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.544 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.8 mmtt -127.3 144.63 51.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 73.140000000000001 109.304 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.577 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.0 tpt180 -143.91 163.31 33.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 70.140000000000001 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.577 HG21 ' CD1' ' A' ' 252' ' ' TRP . 22.0 mm -118.82 116.98 52.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 73.430000000000007 109.319 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -98.7 50.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 65.120000000000005 109.327 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.443 ' OD1' HG22 ' A' ' 236' ' ' ILE . 41.2 p-10 -96.6 109.61 48.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 74.150000000000006 109.349 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.477 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -74.98 -50.55 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.505 1.792 . . . . 71.239999999999995 111.002 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.3 OUTLIER -36.51 -34.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 51.229999999999997 110.017 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 241' ' ' LEU . 13.9 mt -97.36 -60.97 1.47 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.144 . . . . 64.209999999999994 109.302 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.732 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.2 m-85 -112.02 99.68 8.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.16 . . . . 64.439999999999998 111.0 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -22.08 33.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 73.239999999999995 109.961 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.1 m -66.49 -47.26 73.57 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.126 . . . . 71.219999999999999 109.961 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.18 41.13 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.486 1.116 . . . . 62.240000000000002 110.977 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.446 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.94 170.47 20.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.512 1.796 . . . . 73.549999999999997 111.019 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.732 HG21 ' CE2' ' A' ' 242' ' ' PHE . 14.6 m -147.74 156.3 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.084 . . . . 73.219999999999999 109.318 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.432 ' N ' ' HE ' ' A' ' 235' ' ' ARG . 41.8 p -59.51 139.01 57.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 71.540000000000006 110.398 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.45 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 23.2 p-10 -43.08 -28.19 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 64.150000000000006 109.327 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.43 ' N ' ' C ' ' A' ' 248' ' ' THR . 11.5 m -77.12 -62.55 1.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.424 1.077 . . . . 73.349999999999994 110.411 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.03 -24.71 4.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 64.140000000000001 109.325 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.644 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 11.1 t90 -66.11 -64.66 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 75.349999999999994 108.038 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.886 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.2 OUTLIER -43.06 -33.56 0.87 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.112 . . . . 73.230000000000004 110.295 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.885 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.5 m-80 -66.25 -48.91 68.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 71.25 109.325 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -57.45 -18.18 17.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.128 . . . . 64.219999999999999 109.26 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.478 ' O ' ' N ' ' A' ' 205' ' ' LYS . 9.6 m -92.53 -33.98 14.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 72.140000000000001 108.269 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 253' ' ' ARG . 2.9 m -93.79 20.44 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 64.040000000000006 109.258 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 46.4 t30 -44.4 104.63 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.106 . . . . 65.329999999999998 109.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.2 p -74.24 -4.72 37.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 70.319999999999993 110.408 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.412 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -47.79 -26.66 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 64.230000000000004 110.007 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 18.2 t -91.08 -34.76 14.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 71.040000000000006 108.316 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.73 -129.8 2.23 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.517 1.135 . . . . 63.340000000000003 111.038 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.441 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -67.0 145.18 55.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 0.741 . . . . 74.340000000000003 109.959 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -173.22 142.23 1.01 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 55.32 109.298 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.9 p -173.08 153.46 2.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 73.129999999999995 109.998 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.67 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.15 120.71 47.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.501 1.125 . . . . 61.310000000000002 109.293 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 16.9 t -76.12 -43.07 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.434 1.084 . . . . 64.319999999999993 110.007 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 200' ' ' VAL . 54.6 m -164.56 -172.52 2.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 71.329999999999998 109.971 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -166.75 157.27 11.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 75.420000000000002 111.025 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.9 157.55 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 54.310000000000002 109.281 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.485 ' C ' HG23 ' A' ' 272' ' ' THR . 7.6 p30 -122.92 160.09 26.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 63.109999999999999 109.307 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.582 ' HB ' HG21 ' A' ' 276' ' ' VAL . 48.2 p -154.98 176.94 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.096 . . . . 71.400000000000006 110.408 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.595 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -57.74 160.91 4.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 75.010000000000005 109.291 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.1 -21.65 78.81 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.526 1.141 . . . . 74.340000000000003 110.984 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.44 ' OD1' ' HB1' ' A' ' 273' ' ' ALA . 1.5 p-10 -74.19 -35.03 63.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 0.759 . . . . 64.140000000000001 109.302 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 273' ' ' ALA . 53.4 t -43.67 101.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.479 1.112 . . . . 62.020000000000003 109.253 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.559 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 4.6 t80 -63.12 -53.63 50.42 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 74.209999999999994 111.029 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -146.85 135.04 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.148 . . . . 73.099999999999994 110.988 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.57 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 72.8 ttt-85 -106.15 147.44 29.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 74.420000000000002 110.294 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.19 157.95 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.439 1.087 . . . . 65.239999999999995 110.006 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -0.65 10.19 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.434 1.754 . . . . 70.219999999999999 111.004 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 40.5 m -101.12 8.71 42.65 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 60.450000000000003 109.959 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 73.03 38.21 0.72 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.563 1.164 . . . . 71.519999999999996 109.297 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -119.79 119.17 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.120000000000005 110.004 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -99.89 167.06 10.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.491 1.12 . . . . 73.140000000000001 111.033 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.562 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -125.89 177.49 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 64.430000000000007 109.353 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 37.8 m-85 -158.34 118.98 3.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 73.140000000000001 111.036 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.916 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.9 OUTLIER -115.39 99.49 7.42 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.465 1.103 . . . . 72.310000000000002 109.305 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 289' ' ' ASN . . . . . 0.413 ' O ' HD22 ' A' ' 291' ' ' LEU . 10.3 m-20 -83.48 -52.82 6.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 65.209999999999994 109.312 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.472 ' CB ' HG12 ' A' ' 292' ' ' ILE . 24.4 m-20 -88.04 10.63 18.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.146 . . . . 74.540000000000006 109.328 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.916 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.5 mm? 40.45 45.15 1.84 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.115 . . . . 63.420000000000002 109.287 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.472 HG12 ' CB ' ' A' ' 290' ' ' ASN . 45.5 mm -75.26 -27.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 71.549999999999997 109.307 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 297' ' ' VAL . 6.7 t30 -92.1 -29.32 16.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.478 1.111 . . . . 75.019999999999996 109.295 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.559 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 17.9 m -80.02 -68.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 73.329999999999998 110.356 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -45.29 -33.64 2.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.56 1.162 . . . . 74.299999999999997 109.307 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 53.5 t -72.61 -46.08 55.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 71.540000000000006 108.251 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.0 t -55.73 -41.04 63.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 43.130000000000003 109.31 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 167' ' ' CYS . 84.5 mt -66.78 -62.14 1.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.52 1.137 . . . . 72.420000000000002 109.32 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -51.89 -23.87 5.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.461 1.101 . . . . 71.340000000000003 110.441 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.886 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.7 mmmt -71.19 -40.02 71.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.127 . . . . 72.120000000000005 109.318 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.84 ' CD1' HD12 ' A' ' 304' ' ' LEU . 5.2 m-30 -101.5 35.14 2.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 62.240000000000002 110.965 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.4 t -67.35 -44.83 78.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.107 . . . . 75.409999999999997 110.007 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.656 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -93.19 -12.25 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 72.209999999999994 109.301 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.84 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.2 mt -66.66 141.75 57.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.556 1.16 . . . . 71.450000000000003 109.346 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.4 p -159.33 157.46 30.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 44.219999999999999 110.026 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.84 -157.65 50.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.525 1.141 . . . . 74.209999999999994 110.986 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 29.4 p -96.01 11.41 34.16 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.286 -1.005 . . . . 64.510000000000005 108.286 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -130.07 151.15 77.84 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 75.019999999999996 109.98 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.736 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 148.3 91.39 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.02 -2.491 . . . . 71.310000000000002 110.967 0.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.2 p -130.05 134.29 25.96 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 53.340000000000003 110.017 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.08 -172.39 10.72 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 120.994 -2.503 . . . . 65.329999999999998 110.992 0.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.63 151.38 30.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 44.009999999999998 109.36 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -162.42 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.523 1.802 . . . . 65.5 110.985 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.14 135.51 33.62 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 63.039999999999999 109.299 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.886 HG12 ' HE2' ' A' ' 300' ' ' LYS . 24.4 m -137.48 24.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.527 1.142 . . . . 74.239999999999995 109.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' SER . . . . . 0.441 ' C ' ' N ' ' A' ' 318' ' ' CYS . 39.7 t -66.58 -41.07 89.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 75.140000000000001 110.041 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -39.72 -29.87 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.443 1.089 . . . . 72.109999999999999 109.982 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' CYS . . . . . 0.441 ' N ' ' C ' ' A' ' 316' ' ' SER . 7.5 m . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.546 1.154 . . . . 63.119999999999997 108.3 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.91 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.4 tp . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.321 -0.622 . . . . 70.109999999999999 109.321 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.433 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -105.17 107.61 18.68 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.551 1.157 . . . . 54.340000000000003 109.304 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -85.62 10.64 12.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 71.140000000000001 110.001 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.37 146.82 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 74.219999999999999 109.283 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.071 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.13 143.04 25.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 65.439999999999998 109.29 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.5 Cg_endo -75.0 -33.06 4.87 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.489 1.784 . . . . 75.549999999999997 111.053 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.435 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.78 152.49 21.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 51.200000000000003 109.291 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -48.98 -35.87 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 54.409999999999997 109.313 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.06 -47.47 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 72.439999999999998 109.285 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.675 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.42 -35.83 71.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 54.5 110.381 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -58.2 -57.03 14.65 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.452 1.095 . . . . 72.540000000000006 109.293 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -52.51 -31.57 36.04 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 64.420000000000002 109.291 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.67 -56.83 6.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.14 . . . . 74.019999999999996 109.979 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.071 HD12 HD11 ' A' ' 140' ' ' ILE . 81.3 mt -42.35 -40.11 2.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 54.329999999999998 109.254 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.563 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.69 -44.58 49.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 74.450000000000003 110.99 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -48.03 -36.8 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 61.509999999999998 109.28 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 155' ' ' ASN . 23.9 mt-30 -76.05 -55.7 5.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 110.296 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 188' ' ' LEU . 18.3 mt -49.52 -27.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 64.409999999999997 109.304 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -36.7 61.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 75.099999999999994 109.315 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.2 t-20 -57.52 -20.08 29.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 74.209999999999994 109.257 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.468 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 3.0 mm100 -80.53 -25.41 38.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 75.299999999999997 110.26 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 160' ' ' THR . 19.1 m -39.03 116.94 0.63 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.239999999999995 110.019 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.6 m -43.39 136.9 2.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 75.109999999999999 108.328 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.39 -43.36 1.52 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.561 1.163 . . . . 65.150000000000006 110.955 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.746 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 32.2 p -64.84 159.79 21.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.538 0.787 . . . . 62.030000000000001 110.434 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 t -91.56 -4.58 55.22 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.555 1.16 . . . . 63.530000000000001 110.0 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.5 m -108.86 -1.91 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 71.109999999999999 110.423 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.746 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -72.29 133.16 44.86 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 64.420000000000002 109.307 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -169.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 63.439999999999998 109.971 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.443 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 45.9 p -154.61 127.07 3.97 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 62.119999999999997 110.013 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.95 138.87 58.56 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.009 -2.496 . . . . 70.439999999999998 111.005 -0.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.79 -178.99 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.481 1.113 . . . . 64.120000000000005 108.28 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.803 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.1 mp -92.82 137.97 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 54.219999999999999 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.58 HG21 ' O ' ' A' ' 301' ' ' PHE . 59.7 p -92.03 85.16 5.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 70.150000000000006 110.414 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.7 ' CZ ' HG21 ' A' ' 168' ' ' ILE . 60.0 m-85 -88.75 -25.2 22.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.502 1.126 . . . . 61.039999999999999 110.995 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.471 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.09 -1.99 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.548 1.155 . . . . 75.019999999999996 110.292 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.785 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.4 t80 -127.25 69.61 74.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 64.450000000000003 111.042 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.431 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 111.56 3.35 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.46 1.768 . . . . 70.540000000000006 111.026 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.611 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.3 t -153.0 -75.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 73.219999999999999 109.31 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 312' ' ' ALA . 3.9 m-20 -149.09 131.9 16.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 61.020000000000003 109.258 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 121.71 79.26 0.51 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.493 1.121 . . . . 53.020000000000003 111.014 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.78 -1.78 10.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.287 -1.005 . . . . 70.109999999999999 108.287 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 29.0 p90 -81.9 -43.91 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.539 1.149 . . . . 73.0 111.002 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.625 ' HB1' ' HA ' ' A' ' 294' ' ' THR . . . -70.09 -45.2 67.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.522 1.139 . . . . 71.409999999999997 109.285 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.509 ' NH2' ' CB ' ' A' ' 240' ' ' SER . 7.3 mtm180 -49.76 -58.76 4.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 70.219999999999999 110.325 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -43.02 -52.49 5.25 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 61.409999999999997 109.303 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -46.91 -39.51 12.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.505 1.128 . . . . 74.109999999999999 109.62 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.803 ' CB ' HD11 ' A' ' 168' ' ' ILE . 19.0 mmmt -72.92 -33.3 65.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 65.310000000000002 109.281 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.585 ' HE1' ' OD1' ' A' ' 238' ' ' ASP . 17.6 mtm -65.99 -59.21 4.05 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.13 . . . . 72.140000000000001 110.997 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -26.07 14.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 63.409999999999997 110.318 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.414 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.9 OUTLIER -64.86 -43.42 93.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 65.530000000000001 110.274 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.424 ' HB ' ' CG1' ' A' ' 153' ' ' ILE . 22.6 mm -69.86 -38.21 75.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 74.120000000000005 109.269 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -54.57 -35.54 63.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.495 1.122 . . . . 71.109999999999999 109.318 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.574 ' HG2' HD21 ' A' ' 136' ' ' LEU . 17.0 mtp -70.12 -42.79 72.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 1.15 . . . . 74.239999999999995 111.055 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -44.77 -47.12 10.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 72.010000000000005 109.283 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -34.57 77.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 75.150000000000006 109.295 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 113.59 55.29 0.42 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.496 1.123 . . . . 73.439999999999998 110.972 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.675 ' CZ ' HG21 ' A' ' 145' ' ' THR . 83.7 m-85 -153.61 141.51 20.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 0.738 . . . . 75.439999999999998 111.009 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.91 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -108.71 122.87 48.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 73.319999999999993 109.308 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.817 ' HB3' HD22 ' A' ' 188' ' ' LEU . 27.5 p -106.41 -179.28 3.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 72.129999999999995 108.301 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -126.77 176.89 6.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 53.420000000000002 110.317 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.708 ' HE2' HG22 ' A' ' 221' ' ' ILE . 13.9 mmtt -107.83 164.05 12.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 73.150000000000006 109.299 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 30.4 tt0 -151.2 117.36 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 71.030000000000001 110.305 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -109.18 125.94 52.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.461 1.101 . . . . 73.5 111.041 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.789 HG23 ' HB3' ' A' ' 269' ' ' TYR . 8.6 p -122.35 121.32 63.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 71.549999999999997 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 56.2 m-85 -93.9 151.77 19.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 72.299999999999997 111.001 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.42 -172.56 19.3 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.493 1.12 . . . . 62.32 111.021 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.817 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.4 t-20 -78.25 111.19 13.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 0.751 . . . . 74.129999999999995 109.281 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.817 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.5 mt -115.33 94.25 4.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 64.120000000000005 109.359 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.851 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.3 mtpt -93.21 170.52 9.57 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.501 1.125 . . . . 63.439999999999998 109.297 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.766 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -172.58 129.65 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 64.040000000000006 109.338 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.486 1.116 . . . . 75.120000000000005 110.007 -179.99 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.466 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.314 -0.995 . . . . 72.120000000000005 108.314 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.766 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -153.59 147.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.095 . . . . 73.310000000000002 109.314 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.851 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -133.46 128.43 35.42 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.555 1.159 . . . . 62.32 109.33 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -134.39 131.72 38.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 61.409999999999997 107.999 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -74.59 -2.54 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 53.020000000000003 109.976 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.43 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.1 p90 -173.74 132.9 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.472 1.108 . . . . 72.310000000000002 111.008 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.469 ' N ' HD12 ' A' ' 204' ' ' LEU . 84.6 t60 -121.61 154.68 36.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 65.420000000000002 109.581 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 198' ' ' GLN . 1.6 p -130.61 130.81 64.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.522 1.139 . . . . 65.349999999999994 109.349 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.647 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.4 -164.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 24.41 109.268 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.708 HG22 ' HE2' ' A' ' 197' ' ' LYS . 39.1 pt -122.31 120.26 60.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 72.299999999999997 109.296 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.0 tp -84.49 109.0 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 71.349999999999994 109.282 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.686 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -103.04 147.99 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 70.310000000000002 109.267 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 51.6 m -118.15 121.27 40.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.481 1.113 . . . . 64.299999999999997 110.021 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 31.3 p90 -136.41 144.24 44.4 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 75.530000000000001 110.983 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.438 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.8 mmtp -69.49 133.06 47.25 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 65.0 109.263 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.55 -159.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 74.25 109.293 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.15 48.94 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.499 1.124 . . . . 72.340000000000003 109.345 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.7 m -115.22 -8.07 12.37 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.153 . . . . 43.399999999999999 110.027 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.14 37.58 8.26 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.471 1.107 . . . . 45.450000000000003 111.05 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.46 0.741 . . . . 70.239999999999995 109.3 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.438 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.3 m -71.79 102.58 2.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 61.049999999999997 110.365 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.9 mm-40 -101.42 -172.54 2.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 74.420000000000002 110.31 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.52 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.2 mmtm -127.0 145.11 50.83 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.491 1.119 . . . . 75.5 109.311 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.63 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.9 tpt180 -144.54 160.84 40.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 72.230000000000004 110.311 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 252' ' ' TRP . 16.6 mm -115.13 121.73 67.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 75.219999999999999 109.317 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -108.09 44.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.529 1.143 . . . . 73.400000000000006 109.285 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.585 ' OD1' ' HE1' ' A' ' 184' ' ' MET . 0.7 OUTLIER -104.98 107.76 59.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 74.030000000000001 109.276 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.562 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.3 Cg_endo -75.01 -2.11 12.11 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.549 1.816 . . . . 62.109999999999999 111.018 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.509 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.2 OUTLIER -61.3 -22.66 65.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 74.129999999999995 109.992 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.74 -50.21 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 70.420000000000002 109.272 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.613 ' CD1' HG11 ' A' ' 247' ' ' VAL . 97.4 m-85 -112.18 99.5 8.09 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 74.040000000000006 111.025 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 71.0 m -90.14 -8.44 51.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 72.219999999999999 109.987 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 30.6 p -77.75 -46.44 21.71 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.543 1.152 . . . . 63.399999999999999 110.008 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.11 -174.79 40.45 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.445 1.091 . . . . 62.299999999999997 111.036 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.448 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.0 164.68 32.87 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.477 1.777 . . . . 74.319999999999993 110.99 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.613 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.5 m -147.82 164.97 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 61.210000000000001 109.317 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.7 p -65.93 141.36 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.455 1.097 . . . . 62.439999999999998 110.445 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.437 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 1.3 p30 -45.2 -26.55 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 74.329999999999998 109.338 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 10.7 m -77.41 -62.95 1.49 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.469 1.106 . . . . 64.209999999999994 110.423 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.69 -27.98 8.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 25.52 109.303 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.68 ' CD1' HG21 ' A' ' 236' ' ' ILE . 11.0 t90 -63.28 -61.82 2.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 75.430000000000007 107.997 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.63 -41.87 15.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 63.409999999999997 110.309 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.789 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.3 m-80 -57.24 -50.8 71.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 42.439999999999998 109.298 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.87 -24.41 51.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 33.530000000000001 109.317 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -83.42 -36.43 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 71.310000000000002 108.304 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.61 21.47 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 72.510000000000005 109.303 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -54.41 109.14 0.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 71.129999999999995 109.287 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.3 p -73.79 -2.77 24.92 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 74.129999999999995 110.386 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.7 t -44.0 -27.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.098 . . . . 72.010000000000005 109.979 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 259' ' ' THR . 48.5 t -94.27 -37.01 11.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 61.0 108.3 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 171.09 -128.33 1.59 Allowed Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.493 1.121 . . . . 70.219999999999999 110.968 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -79.86 149.42 30.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 0.78 . . . . 74.140000000000001 110.017 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.573 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -170.69 146.35 2.64 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.501 1.125 . . . . 40.450000000000003 109.324 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.3 m -173.08 151.99 2.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.449 1.093 . . . . 63.5 109.99 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.595 HG23 HG11 ' A' ' 257' ' ' VAL . 2.3 t -97.84 122.35 49.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.519999999999996 109.281 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' SER . . . . . 0.407 ' C ' ' OG ' ' A' ' 268' ' ' SER . 31.1 t -83.81 -34.21 24.77 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.13 . . . . 74.430000000000007 109.999 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 267' ' ' SER . 0.7 OUTLIER -174.78 159.32 2.77 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 74.109999999999999 109.978 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.789 ' HB3' HG23 ' A' ' 200' ' ' VAL . 52.9 p90 -147.5 154.66 41.04 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.447 1.092 . . . . 54.219999999999999 110.985 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.32 165.7 34.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 70.329999999999998 109.32 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.468 ' C ' HG23 ' A' ' 272' ' ' THR . 6.8 p30 -122.68 160.73 25.23 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 62.329999999999998 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.468 HG23 ' C ' ' A' ' 271' ' ' ASN . 45.1 p -154.09 179.43 8.94 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 61.130000000000003 110.419 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.833 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -57.5 166.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.127 . . . . 42.240000000000002 109.253 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.49 -18.67 63.65 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.52 1.137 . . . . 50.130000000000003 111.012 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.448 ' H ' ' ND2' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -83.98 -19.0 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 0.773 . . . . 62.229999999999997 109.287 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.833 HG23 ' HB3' ' A' ' 273' ' ' ALA . 12.9 t -60.48 101.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 71.510000000000005 109.301 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.54 ' OH ' ' ND2' ' A' ' 293' ' ' ASN . 15.1 t80 -64.41 -44.45 91.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.559 1.162 . . . . 64.549999999999997 111.007 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -144.54 155.78 43.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.542 1.151 . . . . 73.099999999999994 110.989 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.447 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 68.0 ttt-85 -124.97 147.45 48.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.409999999999997 110.318 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.77 154.07 44.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.104 . . . . 71.540000000000006 110.006 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -0.03 9.45 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.496 1.787 . . . . 74.019999999999996 111.011 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 6.1 t -104.58 10.6 34.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 44.439999999999998 109.969 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.0 t-20 76.21 38.5 0.32 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.54 1.15 . . . . 72.329999999999998 109.341 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.2 t -117.9 121.03 39.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 63.530000000000001 110.001 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.524 ' HB3' HG13 ' A' ' 276' ' ' VAL . 12.5 m-30 -103.86 158.38 16.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 74.25 110.987 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -118.35 177.64 4.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 73.519999999999996 109.3 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.0 m-85 -161.84 115.79 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 65.120000000000005 111.045 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.3 96.76 5.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.129 . . . . 62.119999999999997 109.346 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -85.62 -15.47 42.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 64.329999999999998 109.307 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.422 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.6 m-20 -109.88 2.26 19.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.529 1.143 . . . . 73.420000000000002 109.302 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.91 47.07 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 45.329999999999998 109.293 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.422 HG12 ' CB ' ' A' ' 290' ' ' ASN . 20.4 mm -73.28 -31.74 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.12 . . . . 65.140000000000001 109.315 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.54 ' ND2' ' OH ' ' A' ' 277' ' ' TYR . 3.5 t30 -93.08 -28.41 16.37 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 74.329999999999998 109.27 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.625 ' HA ' ' HB1' ' A' ' 179' ' ' ALA . 1.8 m -77.07 -65.69 0.92 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.563 1.164 . . . . 73.439999999999998 110.407 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 57.3 m-20 -54.61 -20.07 7.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 53.329999999999998 109.296 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 297' ' ' VAL . 25.0 t -83.99 -66.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 42.399999999999999 108.278 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.523 HG21 ' OH ' ' A' ' 178' ' ' TYR . 3.2 t -40.27 -39.54 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 72.200000000000003 109.296 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.685 HD22 ' HA ' ' A' ' 168' ' ' ILE . 20.4 mt -70.23 -57.2 5.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 1.142 . . . . 73.239999999999995 109.267 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -22.78 2.47 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.454 1.096 . . . . 75.040000000000006 110.358 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -71.32 -48.58 49.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 75.540000000000006 109.311 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.58 ' O ' HG21 ' A' ' 169' ' ' THR . 0.7 OUTLIER -98.43 38.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 61.130000000000003 111.005 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.0 t -70.07 -48.54 57.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.13 . . . . 44.210000000000001 109.971 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -88.18 -11.36 47.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 41.340000000000003 109.284 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.785 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 15.1 mt -63.93 142.55 58.37 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 72.25 109.296 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 66.6 p -157.49 148.43 21.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.16 . . . . 71.430000000000007 109.964 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.05 -152.12 23.46 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.483 1.114 . . . . 41.229999999999997 111.028 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.4 p -103.96 12.87 33.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.309 -0.997 . . . . 52.219999999999999 108.309 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.3 p -134.99 150.99 74.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 64.510000000000005 109.992 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.721 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.01 146.52 86.87 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.001 -2.5 . . . . 73.439999999999998 110.992 0.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.488 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 3.3 p -130.06 133.46 25.0 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 71.120000000000005 109.968 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.04 -168.16 6.25 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.031 -2.487 . . . . 72.109999999999999 110.967 0.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 175' ' ' ASP . . . -56.89 152.73 26.14 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.47 1.106 . . . . 71.109999999999999 109.24 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.548 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.06 -162.52 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.5 1.79 . . . . 64.340000000000003 110.932 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.65 130.72 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 72.329999999999998 109.275 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.486 HG11 ' CZ ' ' A' ' 301' ' ' PHE . 35.4 m -128.85 24.71 2.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 73.140000000000001 109.28 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.2 t -68.38 -27.06 65.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 63.43 110.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.5 t -47.19 -24.66 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 74.530000000000001 109.961 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 74.340000000000003 108.275 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.756 HD23 ' HB3' ' A' ' 194' ' ' ASP . 4.8 tp . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.295 -0.631 . . . . 73.120000000000005 109.295 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.67 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -146.99 108.02 4.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 51.420000000000002 109.291 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.75 2.74 28.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 71.540000000000006 110.026 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -142.23 150.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 72.349999999999994 109.243 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.056 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -102.94 143.31 26.35 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 61.100000000000001 109.312 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -33.76 4.33 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.485 1.782 . . . . 71.129999999999995 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.44 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.7 151.23 23.75 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.449 1.093 . . . . 75.519999999999996 109.288 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.496 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -49.52 -34.81 8.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.485 1.115 . . . . 75.409999999999997 109.277 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.48 -46.6 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 61.350000000000001 109.255 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.702 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -72.1 -33.22 67.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 72.099999999999994 110.36 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -60.91 -56.44 21.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.511 1.132 . . . . 64.540000000000006 109.308 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -54.05 -30.77 49.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.434 1.084 . . . . 72.549999999999997 109.29 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -56.59 7.35 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 63.350000000000001 110.032 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.056 HD12 HD11 ' A' ' 140' ' ' ILE . 84.1 mt -42.18 -42.43 3.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 52.030000000000001 109.318 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.506 ' HB2' HD12 ' A' ' 237' ' ' ILE . 0.8 OUTLIER -71.17 -44.88 64.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 72.450000000000003 111.012 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.43 -39.06 6.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 73.420000000000002 109.298 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 155' ' ' ASN . 20.8 mt-30 -75.82 -55.51 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 74.439999999999998 110.271 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.891 HD11 HD12 ' A' ' 188' ' ' LEU . 14.3 mt -51.05 -24.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 73.430000000000007 109.368 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 243' ' ' SER . 0.0 OUTLIER -78.74 -33.98 46.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 75.450000000000003 109.327 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.4 t-20 -61.73 -14.99 37.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 62.329999999999998 109.286 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 157' ' ' SER . 3.2 mm100 -84.08 -18.19 37.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.400000000000006 110.287 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' GLN . 11.0 p -37.37 147.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 70.409999999999997 110.01 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.4 m -82.28 53.54 2.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 73.400000000000006 108.335 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -164.34 27.88 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.531 1.145 . . . . 72.450000000000003 111.015 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.716 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 60.7 p -132.7 163.19 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 0.754 . . . . 75.099999999999994 110.398 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 63.0 m -93.62 0.86 56.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 62.039999999999999 110.034 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 162' ' ' THR . 3.0 m -116.68 0.44 12.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 74.109999999999999 110.384 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.716 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -69.83 137.99 52.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.13 . . . . 43.109999999999999 109.301 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -164.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.132 . . . . 55.119999999999997 110.028 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 15.3 p -155.57 127.39 3.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.476 1.11 . . . . 63.530000000000001 110.023 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 139.77 63.61 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.988 -2.505 . . . . 52.119999999999997 111.021 -0.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 21.1 p -72.76 -179.53 3.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 64.319999999999993 108.312 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.686 ' HA ' HD22 ' A' ' 298' ' ' LEU . 3.1 mp -92.24 123.24 44.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 72.409999999999997 109.344 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.3 p -89.76 80.71 6.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 65.530000000000001 110.395 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -80.75 -14.41 58.12 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.209999999999994 110.98 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.26 -1.23 22.52 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 71.400000000000006 110.278 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.644 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.7 t80 -130.9 65.54 76.89 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 73.129999999999995 111.001 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.439 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.4 Cg_endo -74.97 117.24 4.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.486 1.782 . . . . 70.510000000000005 110.997 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.578 HG21 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.92 -72.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 70.319999999999993 109.301 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.37 -44.13 1.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 70.540000000000006 109.273 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -53.23 99.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.448 1.093 . . . . 43.340000000000003 111.003 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.63 ' SG ' HG12 ' A' ' 219' ' ' VAL . 3.5 p -134.82 -48.2 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.278 -1.008 . . . . 54.0 108.278 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.569 ' HB3' HG11 ' A' ' 219' ' ' VAL . 8.4 p90 -69.52 -11.77 61.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.142 . . . . 73.409999999999997 110.973 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.494 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -73.41 -68.12 0.53 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 74.5 109.299 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.828 HH21 ' HG2' ' A' ' 239' ' ' PRO . 11.1 ptm180 -50.64 -49.85 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.157 . . . . 74.25 110.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.463 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.64 -57.63 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 71.129999999999995 109.338 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -45.86 -43.9 13.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 70.109999999999999 109.618 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 180' ' ' ARG . 17.3 mmmt -60.35 -58.58 7.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.125 . . . . 74.530000000000001 109.273 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 153' ' ' ILE . 5.8 mtm -39.01 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 75.109999999999999 111.015 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.443 ' NH1' ' SD ' ' A' ' 189' ' ' MET . 2.1 tmt_? -70.57 -50.18 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 71.150000000000006 110.3 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.471 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.2 pt20 -55.29 -33.97 63.71 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 62.539999999999999 110.255 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.471 HD13 ' HG3' ' A' ' 186' ' ' GLN . 16.0 mm -77.02 -34.87 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 64.120000000000005 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.891 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -64.74 -45.12 87.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 63.229999999999997 109.338 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.722 ' HG2' HD21 ' A' ' 136' ' ' LEU . 63.2 mtp -58.28 -37.2 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.502 1.126 . . . . 71.25 111.064 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -52.29 -52.02 55.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 54.210000000000001 109.315 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ASN . . . . . 0.445 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 41.6 t30 -63.82 -28.67 70.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 71.019999999999996 109.284 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.55 44.94 1.27 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.522 1.139 . . . . 62.240000000000002 111.027 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.702 ' CZ ' HG21 ' A' ' 145' ' ' THR . 80.0 m-85 -147.82 130.3 15.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 0.76 . . . . 64.319999999999993 111.018 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.756 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.4 OUTLIER -97.07 130.78 44.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 74.219999999999999 109.313 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.839 ' HB3' HD22 ' A' ' 188' ' ' LEU . 30.5 p -104.96 -179.48 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.114 . . . . 62.100000000000001 108.311 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -129.54 174.59 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.464 1.103 . . . . 74.349999999999994 110.32 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' A' ' 221' ' ' ILE . 16.4 mmtt -108.17 169.49 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.52 1.138 . . . . 64.299999999999997 109.303 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 27.7 tt0 -164.11 117.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 73.0 110.299 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.467 ' CE1' HG21 ' A' ' 219' ' ' VAL . 6.0 m-85 -108.28 120.5 42.54 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.511 1.132 . . . . 75.340000000000003 111.006 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.673 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.5 p -109.77 148.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 74.120000000000005 109.29 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.414 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 23.5 m-85 -119.91 158.28 27.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 75.329999999999998 111.002 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 120.63 -179.73 16.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.512 1.132 . . . . 61.219999999999999 110.979 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.742 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.3 t-20 -70.39 110.82 5.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.537 0.787 . . . . 72.109999999999999 109.304 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.6 mt -114.93 93.43 4.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 75.120000000000005 109.267 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.7 mttp -93.55 166.01 12.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 64.510000000000005 109.307 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -169.64 147.98 3.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 34.399999999999999 109.298 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 C--N 1.326 -0.451 0 O-C-N 124.509 1.13 . . . . 63.439999999999998 109.93 -179.943 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 108.312 -0.996 . . . . 65.109999999999999 108.312 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.1 OUTLIER -109.83 155.69 10.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 70.340000000000003 109.303 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.68 119.26 13.1 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 61.5 109.295 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.434 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -128.39 133.1 48.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 64.310000000000002 107.958 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.3 m -79.61 2.5 22.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 61.0 109.985 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.481 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.9 p90 -174.17 128.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.124 . . . . 74.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 71.2 t60 -116.36 167.6 10.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 73.310000000000002 109.612 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.63 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.6 p -144.79 137.61 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 72.120000000000005 109.296 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.667 ' HB3' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.89 -165.7 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 62.119999999999997 109.286 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.622 HG22 ' HE2' ' A' ' 197' ' ' LYS . 15.9 pt -115.42 123.54 71.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 74.219999999999999 109.295 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.7 tp -87.91 108.83 19.37 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 73.409999999999997 109.276 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.89 146.98 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 71.030000000000001 109.275 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 140' ' ' ILE . 75.4 m -117.09 120.18 37.55 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.434 1.084 . . . . 65.299999999999997 110.025 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.9 p90 -134.96 143.22 46.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.482 1.114 . . . . 74.230000000000004 111.007 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.422 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -68.85 132.38 46.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 63.530000000000001 109.315 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.36 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.13 . . . . 75.340000000000003 109.323 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.66 0.18 48.04 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 71.530000000000001 109.32 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -115.27 -7.89 12.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.465 1.103 . . . . 75.349999999999994 110.004 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.44 8.34 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.471 1.107 . . . . 71.25 111.004 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.3 137.63 43.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.532 0.784 . . . . 74.219999999999999 109.283 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.422 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.1 m -71.82 102.55 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.115 . . . . 74.140000000000001 110.369 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.6 mm-40 -101.79 -172.59 2.18 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 71.299999999999997 110.321 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.523 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.3 mmtm -127.13 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 74.519999999999996 109.305 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.629 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.9 OUTLIER -142.72 163.95 31.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 75.530000000000001 110.252 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.717 HG21 ' CD1' ' A' ' 252' ' ' TRP . 26.6 mm -119.01 117.86 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 74.200000000000003 109.294 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.0 mm -102.63 47.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 75.129999999999995 109.302 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.669 ' OD1' HD12 ' A' ' 241' ' ' LEU . 20.7 p-10 -94.73 111.53 54.56 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.504 1.128 . . . . 74.010000000000005 109.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.828 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -75.06 -40.28 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.463 1.77 . . . . 51.520000000000003 111.01 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -41.59 -39.09 1.51 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.551 1.157 . . . . 51.420000000000002 110.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.669 HD12 ' OD1' ' A' ' 238' ' ' ASP . 10.5 mt -95.78 -58.34 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 74.409999999999997 109.324 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.658 ' CD2' HG11 ' A' ' 247' ' ' VAL . 91.6 m-85 -117.15 99.2 6.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.449 1.093 . . . . 74.319999999999993 110.99 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' SER . . . . . 0.418 ' O ' ' CE ' ' A' ' 154' ' ' LYS . 35.4 m -90.68 -5.81 55.31 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 73.310000000000002 110.0 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 25.3 m -79.42 -47.08 16.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 75.209999999999994 109.98 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.13 -175.76 39.84 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.478 1.112 . . . . 75.209999999999994 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.518 ' CG ' HD21 ' A' ' 146' ' ' LEU . 18.4 Cg_endo -74.97 161.7 38.42 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.506 1.793 . . . . 74.030000000000001 110.991 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.658 HG11 ' CD2' ' A' ' 242' ' ' PHE . 3.4 m -144.7 157.35 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 71.209999999999994 109.314 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.6 p -64.93 137.63 57.87 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 74.400000000000006 110.392 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 248' ' ' THR . 0.1 OUTLIER -39.78 -31.12 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 73.319999999999993 109.302 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.6 m -71.35 -64.31 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 62.020000000000003 110.402 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.42 -24.74 8.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.11 . . . . 72.109999999999999 109.282 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.717 ' CD1' HG21 ' A' ' 236' ' ' ILE . 8.8 t90 -67.33 -59.92 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.478 1.111 . . . . 73.209999999999994 108.012 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.578 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -51.95 -41.25 61.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 73.450000000000003 110.314 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.804 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.3 m-80 -54.83 -52.49 62.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.099 . . . . 72.439999999999998 109.314 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.2 -26.18 37.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 62.229999999999997 109.287 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -81.82 -36.36 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 55.329999999999998 108.306 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.804 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.69 22.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.137 . . . . 62.450000000000003 109.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -52.23 109.21 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 74.299999999999997 109.305 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.77 -3.09 26.39 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.153 . . . . 71.319999999999993 110.408 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 18.4 t -43.82 -31.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 72.239999999999995 110.001 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.8 -37.7 15.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 52.229999999999997 108.301 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.46 -126.97 1.49 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.515 1.134 . . . . 63.299999999999997 110.997 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.6 145.03 41.47 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 0.772 . . . . 74.439999999999998 109.98 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.2 147.72 4.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 64.120000000000005 109.324 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 92.2 p -172.87 156.8 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 60.439999999999998 110.004 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.673 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.2 p -103.12 117.4 48.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.449 1.093 . . . . 75.239999999999995 109.3 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 21.0 t -72.05 -44.7 62.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 63.030000000000001 109.965 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 200' ' ' VAL . 3.4 m -166.66 -174.67 2.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.137 . . . . 74.219999999999999 110.011 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -163.09 156.6 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 74.25 110.968 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 198' ' ' GLN . . . -154.85 149.57 26.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 75.400000000000006 109.269 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -107.68 157.81 17.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 73.140000000000001 109.282 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.582 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.4 p -148.82 179.11 8.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.562 1.164 . . . . 71.319999999999993 110.411 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.95 164.44 12.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.118 . . . . 73.519999999999996 109.279 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.0 84.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.557 1.16 . . . . 71.420000000000002 111.0 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -84.23 -37.1 22.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 0.746 . . . . 74.109999999999999 109.347 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 273' ' ' ALA . 21.1 t -43.73 108.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 65.530000000000001 109.265 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.545 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 1.6 t80 -72.01 -41.33 67.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 73.099999999999994 110.978 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.565 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -162.85 115.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.438 1.086 . . . . 72.510000000000005 111.011 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.582 ' HD2' HG21 ' A' ' 272' ' ' THR . 62.8 ttt-85 -95.82 141.53 29.17 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.459 1.099 . . . . 65.0 110.297 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.73 158.02 37.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.548 1.155 . . . . 64.010000000000005 110.009 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 0.17 9.24 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 43.130000000000003 111.026 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 46.3 t -97.51 9.23 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 71.010000000000005 109.989 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER 75.37 27.96 1.02 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 75.109999999999999 109.334 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 121.51 45.13 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 1.119 . . . . 65.219999999999999 109.971 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 3.3 m-85 -104.8 162.42 13.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 64.430000000000007 110.974 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.7 OUTLIER -121.21 172.12 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 72.230000000000004 109.276 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 78.4 m-85 -160.54 127.86 4.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 73.430000000000007 111.022 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.637 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.3 m-20 -115.28 114.21 24.89 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.14 . . . . 74.040000000000006 109.331 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -85.65 -51.24 6.6 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 54.0 109.305 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 3.3 t-20 -108.13 14.19 25.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 71.549999999999997 109.285 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 288' ' ' ASP . 1.2 mm? 54.19 39.06 30.39 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 62.219999999999999 109.296 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 18.6 mm -66.77 -28.99 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 73.0 109.352 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.915 ' O ' HG23 ' A' ' 297' ' ' VAL . 4.1 t30 -94.81 -29.25 14.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.456 1.098 . . . . 73.519999999999996 109.286 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 291' ' ' LEU . 1.9 m -79.03 -65.61 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 71.109999999999999 110.381 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -49.13 -34.04 13.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 73.209999999999994 109.298 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.06 -49.06 60.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 71.219999999999999 108.295 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.3 t -47.99 -47.85 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.144 . . . . 63.439999999999998 109.329 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 168' ' ' ILE . 15.6 mt -67.2 -61.99 1.65 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.51 1.131 . . . . 63.25 109.33 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.04 -25.6 0.34 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 64.430000000000007 110.417 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.646 ' HE2' HG12 ' A' ' 315' ' ' VAL . 19.6 mmmt -72.91 -45.12 59.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.45 1.094 . . . . 62.229999999999997 109.314 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.731 ' CD1' HD12 ' A' ' 304' ' ' LEU . 2.0 m-30 -98.91 37.97 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.524 1.14 . . . . 75.319999999999993 111.009 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.97 -44.23 73.36 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 63.140000000000001 109.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.799 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.85 -18.16 22.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.12 . . . . 73.040000000000006 109.274 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.818 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.9 mt -59.78 142.35 53.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.209999999999994 109.315 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 86.9 p -152.64 160.75 43.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 61.219999999999999 110.005 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.94 -159.05 51.37 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.535 1.147 . . . . 62.509999999999998 110.983 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 27.0 p -95.33 16.52 16.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.308 -0.997 . . . . 72.430000000000007 108.308 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.51 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 41.7 p -134.93 148.97 69.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 33.340000000000003 110.004 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.818 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.0 147.28 88.9 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.99 -2.504 . . . . 75.25 110.992 -0.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.48 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -131.67 135.56 27.04 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 62.219999999999999 109.993 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.94 -174.31 13.86 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.005 -2.498 . . . . 63.530000000000001 111.027 -0.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.67 156.03 26.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 52.350000000000001 109.327 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -162.3 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.461 1.769 . . . . 34.130000000000003 110.993 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -89.29 135.87 33.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 73.310000000000002 109.315 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.646 HG12 ' HE2' ' A' ' 300' ' ' LYS . 30.0 m -128.16 23.17 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 74.019999999999996 109.272 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 t -57.61 -35.58 70.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 60.200000000000003 110.012 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 43.3 t -49.23 -23.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 64.439999999999998 109.985 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.558 1.161 . . . . 72.099999999999994 108.282 -179.997 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 194' ' ' ASP . 2.8 tp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.251 -0.648 . . . . 75.120000000000005 109.251 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -156.25 106.36 2.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 75.340000000000003 109.321 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -5.47 54.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 63.020000000000003 109.994 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.38 149.39 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 73.540000000000006 109.338 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -101.96 143.43 26.59 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.507 1.129 . . . . 74.540000000000006 109.299 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.0 -33.77 4.33 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.451 1.764 . . . . 74.140000000000001 110.967 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.402 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.06 148.0 16.78 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.526 1.142 . . . . 74.349999999999994 109.35 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.519 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -43.68 -36.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 72.340000000000003 109.321 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.5 -49.78 2.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 71.200000000000003 109.296 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.787 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -68.73 -37.06 79.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 72.420000000000002 110.415 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.625 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.97 -57.33 12.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 74.129999999999995 109.332 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -53.12 -29.35 30.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 75.430000000000007 109.297 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -57.55 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.428 1.08 . . . . 73.5 109.989 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 140' ' ' ILE . 92.7 mt -42.63 -42.77 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 72.439999999999998 109.29 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.53 -44.81 61.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.415 1.072 . . . . 75.430000000000007 110.982 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -47.06 -38.14 10.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 72.430000000000007 109.284 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.424 ' CB ' ' CG2' ' A' ' 187' ' ' ILE . 19.7 mt-30 -75.53 -53.37 8.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.239999999999995 110.293 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 188' ' ' LEU . 16.0 mt -51.95 -24.63 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 41.140000000000001 109.317 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.41 -35.85 53.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.128 . . . . 72.219999999999999 109.247 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -61.78 -15.79 44.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.400000000000006 109.317 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 187' ' ' ILE . 6.9 mm100 -84.73 -17.48 38.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 71.310000000000002 110.316 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.8 p -38.54 133.15 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.455 1.097 . . . . 41.299999999999997 110.022 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -62.49 135.33 57.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 52.210000000000001 108.312 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 112.21 -22.33 18.27 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.515 1.134 . . . . 54.240000000000002 110.987 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.791 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 55.7 p -77.44 161.63 27.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 0.801 . . . . 73.209999999999994 110.411 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.2 m -93.56 -2.56 54.07 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.310000000000002 110.003 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 162' ' ' THR . 3.5 m -114.98 7.61 15.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.13 . . . . 73.420000000000002 110.392 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.791 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -84.19 139.44 32.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 64.239999999999995 109.3 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -161.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.48 1.113 . . . . 75.310000000000002 109.971 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.434 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 127.64 3.75 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 62.25 110.018 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.06 138.25 54.97 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.028 -2.488 . . . . 54.409999999999997 110.968 0.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 15.4 p -73.08 178.88 4.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 64.310000000000002 108.269 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.921 HG23 ' HG2' ' A' ' 180' ' ' ARG . 2.1 mp -87.41 124.72 40.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 71.010000000000005 109.264 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.1 p -92.34 72.58 5.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 54.399999999999999 110.423 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.433 ' HA ' ' NH1' ' A' ' 180' ' ' ARG . 26.6 p90 -77.75 -14.24 59.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.529 1.143 . . . . 61.439999999999998 110.987 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.91 -0.57 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 65.230000000000004 110.283 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.626 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.0 t80 -129.37 66.3 76.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 74.109999999999999 110.999 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.422 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.0 117.76 5.02 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.472 1.775 . . . . 74.519999999999996 110.994 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.596 HG21 ' CE1' ' A' ' 172' ' ' TYR . 14.0 t -152.28 -54.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.441 1.088 . . . . 54.030000000000001 109.254 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.42 -46.71 0.15 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.526 1.141 . . . . 72.340000000000003 109.346 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -48.18 103.46 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.526 1.141 . . . . 45.43 110.983 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.536 ' HB3' HG13 ' A' ' 219' ' ' VAL . 42.1 m -138.74 -48.47 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.319 -0.993 . . . . 73.340000000000003 108.319 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 13.4 p90 -62.55 -34.52 77.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 75.150000000000006 111.01 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.681 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -60.93 -56.88 15.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.46 1.1 . . . . 64.040000000000006 109.3 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.921 ' HG2' HG23 ' A' ' 168' ' ' ILE . 22.9 mtp180 -53.27 -49.13 67.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 74.150000000000006 110.323 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.433 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -41.64 -62.31 0.91 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 73.019999999999996 109.347 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.499 ' HA ' ' HZ1' ' A' ' 197' ' ' LYS . 7.3 t-160 -42.8 -37.02 1.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.512 1.133 . . . . 65.120000000000005 109.608 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.647 ' CB ' HD11 ' A' ' 168' ' ' ILE . 28.0 mmmt -70.67 -55.33 8.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 74.420000000000002 109.339 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.454 ' HA ' HG23 ' A' ' 153' ' ' ILE . 20.1 mtm -43.99 -28.73 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 71.230000000000004 111.001 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.453 ' NH1' ' HE3' ' A' ' 189' ' ' MET . 0.3 OUTLIER -75.69 -40.49 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.47 1.106 . . . . 74.209999999999994 110.294 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.506 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.0 pt20 -51.65 -34.14 36.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 1.132 . . . . 75.230000000000004 110.331 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.506 HD13 ' HG3' ' A' ' 186' ' ' GLN . 10.9 mm -78.46 -35.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 73.109999999999999 109.288 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -59.83 -40.5 88.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.499 1.124 . . . . 54.229999999999997 109.298 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.453 ' HE3' ' NH1' ' A' ' 185' ' ' ARG . 4.1 mtt -63.75 -42.72 97.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 74.040000000000006 110.993 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -47.74 -53.51 14.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.543 1.152 . . . . 74.409999999999997 109.289 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.18 -37.48 87.61 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 64.340000000000003 109.351 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.48 40.45 1.12 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.517 1.136 . . . . 31.32 111.004 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.787 ' CZ ' HG21 ' A' ' 145' ' ' THR . 50.5 m-85 -137.28 134.01 35.64 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 0.766 . . . . 53.229999999999997 110.984 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.635 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -101.21 144.91 29.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 71.329999999999998 109.27 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.61 ' HB3' HD22 ' A' ' 188' ' ' LEU . 28.7 p -128.57 -179.4 5.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.144 . . . . 71.319999999999993 108.282 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 222' ' ' LEU . 19.9 mp0 -125.35 178.09 5.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.467 1.105 . . . . 74.340000000000003 110.271 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.499 ' HZ1' ' HA ' ' A' ' 182' ' ' HIS . 19.0 mmtt -106.01 159.3 16.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 1.107 . . . . 74.430000000000007 109.259 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.795 ' OE1' HD11 ' A' ' 236' ' ' ILE . 10.2 tt0 -145.18 117.59 8.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 51.109999999999999 110.312 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.562 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 3.4 m-85 -116.89 128.02 54.83 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.144 . . . . 73.129999999999995 110.98 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.678 ' CG2' HG23 ' A' ' 266' ' ' VAL . 12.3 p -117.37 162.8 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.477 1.111 . . . . 74.25 109.281 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.442 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 76.3 m-85 -133.07 157.97 43.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 73.140000000000001 110.99 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.26 -177.19 16.42 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.492 1.12 . . . . 50.109999999999999 111.043 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.686 ' C ' HD23 ' A' ' 204' ' ' LEU . 62.3 t-20 -70.64 109.77 5.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.479 0.753 . . . . 73.030000000000001 109.29 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.686 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.3 mt -113.31 95.74 5.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 73.040000000000006 109.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 0.4 OUTLIER -92.09 165.61 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 64.049999999999997 109.315 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.873 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -174.63 151.6 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.522 1.139 . . . . 62.509999999999998 109.302 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.537 1.148 . . . . 75.430000000000007 110.027 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.298 -1.001 . . . . 72.310000000000002 108.298 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.873 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -109.24 139.29 32.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.509 1.131 . . . . 72.25 109.306 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -133.02 126.14 31.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.12 . . . . 71.140000000000001 109.293 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.451 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -132.43 147.8 52.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 108.024 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -91.59 4.44 52.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 71.340000000000003 110.007 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.507 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 26.5 p90 -175.66 122.77 0.2 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 72.219999999999999 110.981 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.544 ' NE2' HD11 ' A' ' 241' ' ' LEU . 52.1 t60 -106.56 165.69 11.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 62.210000000000001 109.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 177' ' ' CYS . 2.1 p -137.2 155.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.55 1.156 . . . . 74.430000000000007 109.245 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.652 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.18 -163.24 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 60.030000000000001 109.265 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.5 HD11 ' HB ' ' A' ' 237' ' ' ILE . 27.2 pt -123.86 122.48 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.310000000000002 109.288 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.1 tp -86.36 108.85 18.63 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.542 1.151 . . . . 70.239999999999995 109.294 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.642 HG11 HG13 ' A' ' 237' ' ' ILE . 0.9 OUTLIER -101.03 166.68 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.576 1.173 . . . . 50.240000000000002 109.313 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 140' ' ' ILE . 64.0 m -137.14 118.95 15.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 64.409999999999997 109.977 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.519 ' CD2' HG23 ' A' ' 143' ' ' VAL . 33.0 p90 -135.46 143.43 45.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 72.310000000000002 110.959 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -68.49 131.73 45.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 73.239999999999995 109.316 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.428 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -71.68 -160.21 0.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 72.409999999999997 109.318 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -84.26 -0.58 52.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.115 . . . . 63.030000000000001 109.254 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.1 m -114.65 -8.17 12.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.133 . . . . 54.009999999999998 109.977 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.21 37.78 7.55 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.131 . . . . 73.019999999999996 111.028 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.49 138.31 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.512 0.772 . . . . 74.239999999999995 109.256 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -72.06 102.71 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.340000000000003 110.413 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.428 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 5.4 mm-40 -101.54 -172.62 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.459 1.099 . . . . 71.230000000000004 110.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.547 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.4 mmtm -128.12 145.11 51.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.466 1.104 . . . . 44.299999999999997 109.294 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.495 ' HB3' HG22 ' A' ' 223' ' ' VAL . 1.9 tpt180 -143.86 161.79 37.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 75.329999999999998 110.331 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.795 HD11 ' OE1' ' A' ' 198' ' ' GLN . 17.5 mm -114.47 119.13 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 72.519999999999996 109.359 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.2 mm -105.95 45.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 44.409999999999997 109.299 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.434 ' HA ' ' HE1' ' A' ' 184' ' ' MET . 12.6 t0 -105.9 107.72 60.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 64.219999999999999 109.347 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -0.42 9.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.51 1.795 . . . . 72.439999999999998 110.965 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.6 t -72.81 -4.53 32.17 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.504 1.128 . . . . 73.420000000000002 110.013 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.544 HD11 ' NE2' ' A' ' 218' ' ' HIS . 10.3 mt -136.21 -47.02 0.64 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.529 1.143 . . . . 71.200000000000003 109.264 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 247' ' ' VAL . 96.5 m-85 -123.23 101.45 7.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 73.120000000000005 110.968 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.21 -22.11 28.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 32.229999999999997 110.034 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 69.1 m -62.02 -49.56 75.55 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.019999999999996 110.014 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.04 -170.77 37.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.478 1.111 . . . . 45.219999999999999 110.996 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.444 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.99 164.18 33.89 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.506 1.793 . . . . 72.409999999999997 110.987 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.594 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.0 m -148.36 160.08 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.554 1.159 . . . . 71.340000000000003 109.281 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.4 p -64.81 137.6 57.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 74.150000000000006 110.392 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 248' ' ' THR . 5.8 p-10 -40.19 -30.29 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 74.120000000000005 109.33 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.3 m -71.47 -64.5 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 74.109999999999999 110.413 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.98 -26.11 9.85 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.532 1.145 . . . . 74.549999999999997 109.281 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.681 ' CD1' HG21 ' A' ' 236' ' ' ILE . 10.7 t90 -65.11 -57.87 7.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 74.25 107.993 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.572 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -52.89 -42.12 65.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 72.430000000000007 110.293 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.858 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.3 m-80 -55.14 -50.63 68.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 70.030000000000001 109.323 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -54.86 -26.59 36.5 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.134 . . . . 52.329999999999998 109.312 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -82.56 -37.83 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.108 . . . . 62.530000000000001 108.33 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.858 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.1 m -92.77 22.69 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 74.329999999999998 109.364 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 47.7 t30 -50.38 104.53 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 41.020000000000003 109.328 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.7 p -75.01 -4.03 35.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 73.099999999999994 110.37 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.414 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -50.74 -22.26 2.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.549 1.156 . . . . 72.420000000000002 110.042 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 5.9 m -93.96 -29.47 15.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.457 1.098 . . . . 71.430000000000007 108.255 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 159.9 -122.18 1.1 Allowed Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.483 1.114 . . . . 71.450000000000003 111.004 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.3 OUTLIER -83.86 140.12 32.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.572 0.807 . . . . 44.020000000000003 110.007 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.543 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -169.21 146.37 3.55 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.486 1.116 . . . . 71.150000000000006 109.288 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.7 t -172.87 164.02 5.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 75.519999999999996 110.002 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.678 HG23 ' CG2' ' A' ' 200' ' ' VAL . 6.6 p -105.53 120.54 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 73.530000000000001 109.305 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.4 t -80.05 -43.14 22.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.483 1.114 . . . . 75.040000000000006 109.984 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.0 m -156.88 176.73 12.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.443 1.089 . . . . 75.109999999999999 109.997 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.21 158.77 27.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.574 1.171 . . . . 75.510000000000005 110.953 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -172.88 155.37 3.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 65.019999999999996 109.345 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.524 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -122.22 159.34 27.48 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.514 1.134 . . . . 73.340000000000003 109.344 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.527 HG21 ' HD2' ' A' ' 279' ' ' ARG . 41.5 p -144.68 167.31 22.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.459 1.1 . . . . 75.450000000000003 110.386 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.696 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -45.71 158.17 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 1.14 . . . . 63.140000000000001 109.289 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -70.24 -46.58 49.26 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.489 1.118 . . . . 73.430000000000007 111.026 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -49.5 -37.54 26.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 71.120000000000005 109.301 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.696 HG23 ' HB3' ' A' ' 273' ' ' ALA . 98.4 t -45.61 120.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 72.109999999999999 109.289 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' A' ' 277' ' ' TYR . 1.0 OUTLIER -75.78 -48.74 20.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 74.349999999999994 110.983 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.6 t80 -151.39 154.98 37.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 51.009999999999998 111.032 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.562 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 71.1 ttt-85 -118.52 147.53 43.56 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.539 1.149 . . . . 73.349999999999994 110.269 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.82 157.4 46.37 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 75.25 109.966 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 0.27 9.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.5 1.79 . . . . 55.43 110.983 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.6 t -105.46 9.13 33.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 74.400000000000006 110.003 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.23 40.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.121 . . . . 71.209999999999994 109.306 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -119.23 119.81 35.2 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 70.109999999999999 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -100.07 157.96 16.18 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 71.439999999999998 111.009 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -118.04 177.64 4.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 63.299999999999997 109.244 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.2 m-85 -162.82 132.23 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 73.430000000000007 110.98 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.888 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.6 OUTLIER -113.84 112.08 22.8 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.515 1.134 . . . . 72.409999999999997 109.334 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -52.17 8.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.461 1.101 . . . . 72.319999999999993 109.296 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 3.3 t-20 -115.05 25.08 11.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.518 1.136 . . . . 63.439999999999998 109.331 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.888 HD13 ' HB3' ' A' ' 288' ' ' ASP . 1.9 mm? 48.87 36.59 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 65.120000000000005 109.278 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 18.6 mm -66.04 -30.05 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 54.310000000000002 109.317 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.886 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.5 t-20 -94.5 -31.35 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.528 1.143 . . . . 73.430000000000007 109.245 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.474 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 7.6 m -77.19 -65.89 0.9 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.44 1.087 . . . . 74.319999999999993 110.434 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 70.7 m-20 -48.23 -33.17 8.18 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 74.409999999999997 109.286 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.4 t -72.72 -40.26 66.27 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 64.349999999999994 108.283 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.9 t -59.61 -42.85 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 63.210000000000001 109.327 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.626 HD11 ' HG3' ' A' ' 183' ' ' LYS . 77.1 mt -71.18 -62.42 1.4 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 70.510000000000005 109.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -43.82 -26.38 0.25 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 73.530000000000001 110.343 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.722 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.1 mmmt -67.74 -46.77 71.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 64.420000000000002 109.255 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.708 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.8 m-30 -97.35 36.61 1.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.517 1.136 . . . . 71.25 111.003 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.0 t -67.03 -46.84 73.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.469 1.106 . . . . 62.219999999999999 109.978 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.796 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -92.13 -18.15 23.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.53 1.144 . . . . 73.129999999999995 109.327 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.793 HD22 ' CD ' ' A' ' 309' ' ' PRO . 15.2 mt -59.51 134.17 56.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 71.209999999999994 109.303 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 77.3 p -149.67 150.55 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 74.329999999999998 109.994 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.6 -162.94 45.79 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.496 1.123 . . . . 73.25 110.986 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 4.6 p -90.17 9.92 26.52 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.295 -1.002 . . . . 61.210000000000001 108.295 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.513 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 2.2 p -132.56 150.77 76.75 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 74.109999999999999 109.968 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.793 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.92 146.42 86.63 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 120.984 -2.506 . . . . 73.209999999999994 111.046 -0.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.4 p -131.82 136.05 27.74 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 71.420000000000002 110.02 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.81 14.78 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.036 -2.485 . . . . 50.399999999999999 111.023 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.59 158.2 32.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 62.119999999999997 109.324 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.01 -162.4 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.48 1.779 . . . . 55.109999999999999 110.976 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -91.79 136.24 33.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 74.329999999999998 109.279 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.722 HG12 ' HE2' ' A' ' 300' ' ' LYS . 17.6 m -130.43 17.58 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.109999999999999 109.325 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 318' ' ' CYS . 12.4 t -64.9 -33.01 74.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.151 . . . . 72.420000000000002 110.014 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -48.33 -23.92 1.06 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.518 1.136 . . . . 62.350000000000001 110.0 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 316' ' ' SER . 1.6 m . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 73.129999999999995 108.308 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.0 tp . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.273 -0.639 . . . . 74.319999999999993 109.273 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -150.06 105.31 3.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 64.530000000000001 109.306 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -81.77 5.62 18.03 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 51.030000000000001 109.992 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -146.35 147.52 17.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.502 1.126 . . . . 74.219999999999999 109.302 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.019 HD11 HD12 ' A' ' 149' ' ' LEU . 1.1 mt -100.1 142.54 24.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 62.520000000000003 109.315 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -32.73 5.12 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.434 1.755 . . . . 73.109999999999999 110.972 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.31 147.7 16.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 64.140000000000001 109.266 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -45.45 -36.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 75.200000000000003 109.262 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.98 -47.42 3.02 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.476 1.11 . . . . 62.240000000000002 109.297 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.777 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.38 -36.16 71.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 53.140000000000001 110.395 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.727 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -57.91 -56.97 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 74.040000000000006 109.303 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -52.44 -31.69 35.74 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 75.549999999999997 109.299 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.13 -56.13 8.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 73.040000000000006 109.98 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 140' ' ' ILE . 45.2 mt -44.08 -42.28 6.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 74.540000000000006 109.269 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.672 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -72.44 -44.64 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.129999999999995 111.037 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -47.05 -34.5 5.86 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.154 . . . . 63.43 109.291 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 187' ' ' ILE . 21.2 mt-30 -79.35 -50.85 10.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.121 . . . . 60.240000000000002 110.281 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 1.132 HD11 HD12 ' A' ' 188' ' ' LEU . 12.7 mt -54.91 -23.19 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.25 109.282 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -38.55 38.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 74.340000000000003 109.259 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.21 -17.44 19.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 63.100000000000001 109.323 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.49 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 12.5 mm-40 -82.94 -25.37 32.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.109999999999999 110.327 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.574 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 17.4 m -39.87 126.5 2.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 55.140000000000001 109.997 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 10.2 m -58.11 109.88 0.83 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 63.219999999999999 108.307 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.71 -18.97 1.13 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.483 1.114 . . . . 61.240000000000002 111.007 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.731 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 59.4 p -93.25 159.84 15.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 0.762 . . . . 70.140000000000001 110.387 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.93 -3.51 58.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 64.420000000000002 110.014 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.7 m -110.15 -1.16 17.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 71.349999999999994 110.42 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.731 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -73.31 132.82 43.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 72.450000000000003 109.294 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -173.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 75.109999999999999 109.989 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.42 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.3 p -152.65 126.94 4.5 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.118 . . . . 62.009999999999998 109.985 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.88 52.9 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.021 -2.491 . . . . 70.129999999999995 110.979 -0.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 9.1 p -72.66 -173.85 1.27 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.125 . . . . 63.539999999999999 108.256 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.94 ' HA ' HD22 ' A' ' 298' ' ' LEU . 3.3 mp -100.82 134.17 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.116 . . . . 75.200000000000003 109.351 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.501 HG21 ' HB2' ' A' ' 301' ' ' PHE . 36.2 p -81.42 86.67 6.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.13 . . . . 74.219999999999999 110.377 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 1.6 p90 -88.9 -1.99 58.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 73.319999999999993 111.007 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.405 HH12 HG22 ' A' ' 169' ' ' THR . 0.1 OUTLIER -110.6 9.88 23.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 55.219999999999999 110.258 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.706 ' OH ' HD13 ' A' ' 304' ' ' LEU . 18.0 t80 -129.51 68.09 79.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.476 1.11 . . . . 75.450000000000003 110.989 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.611 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.3 Cg_endo -75.03 117.08 4.78 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.528 1.804 . . . . 51.310000000000002 111.012 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.637 HG13 ' HB2' ' A' ' 310' ' ' SER . 2.6 t -151.78 -55.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 71.310000000000002 109.262 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.36 -46.77 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 73.450000000000003 109.281 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.2 121.22 1.02 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.47 1.106 . . . . 55.109999999999999 111.004 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.598 ' SG ' HG12 ' A' ' 219' ' ' VAL . 4.3 p -153.02 -47.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.361 -0.978 . . . . 73.150000000000006 108.361 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 47.0 p90 -67.53 -44.47 78.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.468 1.105 . . . . 74.230000000000004 111.048 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.567 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -54.21 -66.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.472 1.107 . . . . 72.219999999999999 109.281 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . 0.529 ' CB ' HG21 ' A' ' 168' ' ' ILE . 2.0 ptm85 -42.02 -46.96 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 1.155 . . . . 72.420000000000002 110.26 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -50.36 -58.96 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.137 . . . . 72.230000000000004 109.268 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -46.35 -28.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 73.349999999999994 109.613 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.843 ' HB3' HD11 ' A' ' 168' ' ' ILE . 24.4 mmmt -81.03 -40.03 24.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 64.150000000000006 109.32 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.553 ' HB3' HD13 ' A' ' 221' ' ' ILE . 9.8 mtm -60.35 -46.64 89.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 70.150000000000006 111.005 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.549 ' NH1' ' HE3' ' A' ' 189' ' ' MET . 0.0 OUTLIER -65.85 -30.67 71.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 64.120000000000005 110.303 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.581 HE22 ' HE3' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -59.85 -33.12 71.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 74.120000000000005 110.323 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.445 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 25.1 mm -78.5 -50.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 52.350000000000001 109.259 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LEU . . . . . 1.132 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -43.62 -36.89 2.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.454 1.096 . . . . 70.519999999999996 109.307 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.69 ' HG2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -68.54 -46.29 69.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.476 1.11 . . . . 62.509999999999998 111.0 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -53.5 12.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.53 1.144 . . . . 70.040000000000006 109.251 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -62.29 -37.47 85.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 62.5 109.31 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.95 51.37 0.33 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.534 1.146 . . . . 70.010000000000005 111.002 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.777 ' CZ ' HG21 ' A' ' 145' ' ' THR . 74.0 m-85 -151.43 136.92 17.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 0.757 . . . . 72.219999999999999 111.028 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.792 ' HB2' HD23 ' A' ' 136' ' ' LEU . 2.8 t70 -102.74 131.47 49.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.498 1.123 . . . . 61.329999999999998 109.284 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 1.012 ' HB3' HD22 ' A' ' 188' ' ' LEU . 12.8 p -108.38 -179.27 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 64.109999999999999 108.323 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER -129.39 177.35 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.049999999999997 110.301 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.653 ' HE2' HG22 ' A' ' 221' ' ' ILE . 13.6 mmtt -109.54 171.67 7.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 73.409999999999997 109.306 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 25.0 tt0 -168.72 117.4 0.69 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 71.109999999999999 110.324 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.4 m-85 -109.09 137.81 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 64.310000000000002 111.014 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.884 HG23 ' HB3' ' A' ' 269' ' ' TYR . 9.9 p -129.98 125.59 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 75.129999999999995 109.289 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -95.97 151.14 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 72.049999999999997 110.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 129.44 -171.07 20.21 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.506 1.129 . . . . 71.310000000000002 110.995 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASN . . . . . 0.837 ' C ' HD23 ' A' ' 204' ' ' LEU . 56.1 t-20 -79.15 111.47 15.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 0.787 . . . . 73.209999999999994 109.302 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.837 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.3 mt -116.53 94.61 4.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 52.109999999999999 109.331 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.777 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 9.3 mttt -93.08 168.18 11.29 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.472 1.107 . . . . 65.430000000000007 109.336 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.586 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -167.56 125.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.458 1.099 . . . . 50.450000000000003 109.296 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.443 1.09 . . . . 71.340000000000003 109.966 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.424 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.302 -0.999 . . . . 70.409999999999997 108.302 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.611 HG11 ' O ' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -153.34 149.19 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 60.409999999999997 109.295 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.777 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -129.46 133.37 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 72.349999999999994 109.313 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -134.31 132.01 39.06 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.146 . . . . 74.040000000000006 108.009 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.5 p -73.66 -3.59 29.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 63.32 109.988 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 6.8 p90 -173.95 137.46 0.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 72.209999999999994 111.013 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 60.2 t60 -125.9 168.83 13.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 75.340000000000003 109.546 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.598 HG12 ' SG ' ' A' ' 177' ' ' CYS . 1.8 p -147.44 133.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 74.439999999999998 109.327 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.22 -165.03 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 73.219999999999999 109.25 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.653 HG22 ' HE2' ' A' ' 197' ' ' LYS . 18.5 pt -116.99 117.66 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.122 . . . . 71.25 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 234' ' ' LYS . 14.0 tp -81.83 109.05 15.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.239999999999995 109.277 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.727 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.85 147.86 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 109.284 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 67.2 m -117.62 121.74 41.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 74.019999999999996 109.991 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.528 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 31.7 p90 -136.64 143.23 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 73.200000000000003 111.028 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.427 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -69.17 132.28 46.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.529 1.143 . . . . 72.409999999999997 109.315 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.476 1.11 . . . . 74.319999999999993 109.317 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.68 -0.2 49.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.132 . . . . 73.040000000000006 109.337 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.7 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.087 . . . . 73.209999999999994 110.052 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.25 37.87 8.06 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.511 1.132 . . . . 54.299999999999997 111.001 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.418 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.8 137.33 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 53.509999999999998 109.305 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.427 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.3 m -71.45 102.54 2.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 54.450000000000003 110.428 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.7 mm-40 -101.8 -172.58 2.18 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 74.209999999999994 110.272 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.497 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -126.51 144.89 50.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 75.310000000000002 109.3 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.627 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.1 tpt180 -144.17 161.59 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 75.140000000000001 110.327 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 252' ' ' TRP . 17.8 mm -115.85 116.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 74.420000000000002 109.287 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -100.42 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 53.439999999999998 109.293 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ASP . . . . . 0.419 ' OD1' ' CE ' ' A' ' 184' ' ' MET . 3.1 m-20 -100.1 110.38 59.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 75.439999999999998 109.343 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -42.99 0.43 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.465 1.771 . . . . 73.129999999999995 110.987 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 26.5 p -39.28 -29.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 73.519999999999996 109.998 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 239' ' ' PRO . 30.0 mt -101.92 -59.49 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.230000000000004 109.288 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.604 ' CD1' HG11 ' A' ' 247' ' ' VAL . 79.7 m-85 -112.29 99.39 7.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 63.049999999999997 111.025 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.5 m -86.2 -5.18 59.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 64.549999999999997 109.968 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 m -82.65 -45.28 14.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 62.32 109.999 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.74 -173.77 45.1 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.512 1.133 . . . . 73.239999999999995 110.993 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' PRO . . . . . 0.441 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.5 Cg_endo -74.95 162.73 36.74 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.501 1.79 . . . . 50.530000000000001 111.034 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.604 HG11 ' CD1' ' A' ' 242' ' ' PHE . 2.7 m -148.18 159.19 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 73.420000000000002 109.329 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.435 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.2 p -62.23 139.93 58.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 71.409999999999997 110.418 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.407 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 2.5 p-10 -42.95 -28.13 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.123 . . . . 63.119999999999997 109.328 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.435 ' N ' ' C ' ' A' ' 248' ' ' THR . 17.1 m -72.45 -65.0 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 74.439999999999998 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.94 14.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.447 1.092 . . . . 70.120000000000005 109.29 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' TRP . . . . . 0.686 ' CD1' HG21 ' A' ' 236' ' ' ILE . 11.9 t90 -59.47 -66.17 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.953 -1.129 . . . . 70.420000000000002 107.953 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.799 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -41.67 -39.18 1.59 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 75.420000000000002 110.254 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ASN . . . . . 0.876 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.1 m-80 -60.12 -50.37 73.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 53.329999999999998 109.297 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.597 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -55.1 -28.89 55.89 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.409999999999997 109.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' LYS . 7.6 m -81.39 -33.52 32.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 73.030000000000001 108.309 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.876 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.4 m -98.14 24.18 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 72.439999999999998 109.338 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.87 110.93 0.89 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 71.200000000000003 109.271 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.8 p -73.32 -3.04 24.61 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 74.299999999999997 110.402 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.2 t -44.34 -26.66 0.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 73.439999999999998 109.954 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.83 -36.58 11.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.447 1.092 . . . . 75.209999999999994 108.253 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.96 -126.55 1.36 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.116 . . . . 71.540000000000006 111.028 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -81.24 150.33 28.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 0.759 . . . . 74.340000000000003 110.001 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.566 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -172.28 144.68 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 61.520000000000003 109.276 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 41.6 p -172.84 153.14 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 74.329999999999998 109.992 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.687 HG23 HG11 ' A' ' 257' ' ' VAL . 3.1 t -99.75 125.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 70.349999999999994 109.295 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.4 t -85.87 -29.35 23.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.124 . . . . 72.430000000000007 109.966 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.6 m 178.58 155.64 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 54.439999999999998 109.969 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.884 ' HB3' HG23 ' A' ' 200' ' ' VAL . 30.2 p90 -144.14 155.94 44.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 75.319999999999993 111.014 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -147.79 154.33 40.34 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.556 1.16 . . . . 62.119999999999997 109.293 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -107.62 157.71 17.85 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 54.420000000000002 109.323 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.705 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.8 p -149.47 178.39 8.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 64.329999999999998 110.364 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ALA . . . . . 0.634 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -67.91 165.93 16.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.425 1.078 . . . . 73.319999999999993 109.303 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -75.38 -42.69 27.15 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.545 1.153 . . . . 74.329999999999998 110.995 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -55.26 -39.93 70.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 0.767 . . . . 72.120000000000005 109.273 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' VAL . . . . . 0.634 HG23 ' HB3' ' A' ' 273' ' ' ALA . 76.6 t -43.57 101.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 74.310000000000002 109.295 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.43 -47.34 84.49 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 74.439999999999998 110.978 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -152.12 138.51 18.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.48 1.112 . . . . 62.009999999999998 111.036 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.705 ' HD2' HG21 ' A' ' 272' ' ' THR . 67.4 ttt-85 -106.84 147.42 29.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 54.43 110.345 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.71 158.12 48.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 63.439999999999998 110.011 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 0.25 9.14 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.469 1.773 . . . . 65.140000000000001 111.009 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 28.7 t -103.09 7.4 38.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.464 1.103 . . . . 53.450000000000003 109.996 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 73.93 41.91 0.39 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.450000000000003 109.3 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 t -123.5 121.51 35.85 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.495 1.122 . . . . 74.239999999999995 110.04 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' TYR . . . . . 0.465 ' OH ' HG22 ' A' ' 272' ' ' THR . 11.5 m-30 -101.27 165.82 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 75.099999999999994 110.989 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' LEU . . . . . 0.476 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.1 mm? -124.62 177.37 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 65.519999999999996 109.328 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.5 m-85 -160.32 123.21 3.39 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 71.430000000000007 110.98 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 291' ' ' LEU . 2.2 m-20 -115.07 104.01 11.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.099 . . . . 73.409999999999997 109.302 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' ASN . . . . . 0.415 ' O ' HD22 ' A' ' 291' ' ' LEU . 3.3 m-80 -85.54 -53.81 4.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 73.329999999999998 109.32 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' ASN . . . . . 0.463 ' CB ' HG12 ' A' ' 292' ' ' ILE . 17.0 m-20 -93.04 15.65 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.558 1.161 . . . . 63.439999999999998 109.318 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.917 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.4 mm? 40.27 42.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 72.439999999999998 109.308 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ILE . . . . . 0.463 HG12 ' CB ' ' A' ' 290' ' ' ASN . 26.6 mm -74.04 -28.38 23.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.542 1.151 . . . . 73.439999999999998 109.318 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.865 ' O ' HG23 ' A' ' 297' ' ' VAL . 9.8 t30 -94.64 -26.91 16.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 71.340000000000003 109.313 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 297' ' ' VAL . 23.7 m -82.3 -68.96 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 75.329999999999998 110.424 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.6 m-20 -47.52 -29.86 3.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 74.439999999999998 109.315 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.69 -43.06 57.05 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 1.094 . . . . 53.329999999999998 108.333 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.1 t -56.46 -50.59 71.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.129999999999995 109.256 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' LEU . . . . . 0.94 HD22 ' HA ' ' A' ' 168' ' ' ILE . 10.4 mt -61.85 -63.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 71.239999999999995 109.283 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -41.96 -42.45 2.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 61.130000000000003 110.425 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' LYS . . . . . 0.564 ' HE2' HG12 ' A' ' 315' ' ' VAL . 14.9 mmmt -53.34 -44.66 68.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 55.130000000000003 109.305 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' PHE . . . . . 0.562 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 2.5 m-30 -100.42 29.87 4.18 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.541 1.15 . . . . 74.409999999999997 110.979 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 27.2 t -62.04 -52.35 64.29 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 52.100000000000001 109.989 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' LEU . . . . . 0.626 HD13 ' H ' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -84.05 -10.46 57.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 72.409999999999997 109.281 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.706 HD13 ' OH ' ' A' ' 172' ' ' TYR . 17.7 mt -73.82 137.18 43.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 71.219999999999999 109.288 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 62.9 p -160.7 137.12 8.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 64.140000000000001 110.009 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.89 -158.77 15.53 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.565 1.166 . . . . 64.120000000000005 111.019 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 8.4 p -95.76 8.7 42.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.347 -0.983 . . . . 71.219999999999999 108.347 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 4.0 p -139.14 152.11 69.1 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 73.040000000000006 109.985 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' PRO . . . . . 0.592 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.02 146.64 87.2 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.002 -2.499 . . . . 61.450000000000003 111.028 0.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' SER . . . . . 0.637 ' HB2' HG13 ' A' ' 174' ' ' VAL . 6.1 t -132.79 135.15 25.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 74.329999999999998 109.999 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.1 Cg_endo -75.01 -173.64 12.7 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.986 -2.506 . . . . 72.129999999999995 111.0 0.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.477 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.99 152.99 25.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 61.219999999999999 109.313 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' PRO . . . . . 0.557 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.491 1.785 . . . . 64.299999999999997 110.988 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -81.96 133.05 35.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 71.109999999999999 109.264 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.564 HG12 ' HE2' ' A' ' 300' ' ' LYS . 27.1 m -136.19 16.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 63.020000000000003 109.27 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 318' ' ' CYS . 1.7 t -64.04 -40.2 95.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.299999999999997 109.955 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.1 t -39.5 -29.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 73.109999999999999 110.01 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' CYS . . . . . 0.439 ' N ' ' C ' ' A' ' 316' ' ' SER . 5.2 m . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 74.219999999999999 108.287 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.7 tp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.253 -0.647 . . . . 72.019999999999996 109.253 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.597 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -145.47 112.85 6.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 73.409999999999997 109.312 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -85.84 11.47 11.18 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 63.520000000000003 109.987 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -150.3 149.11 14.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.426 1.079 . . . . 53.329999999999998 109.303 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.024 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -101.48 143.29 26.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 63.5 109.298 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.99 -33.86 4.27 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 62.399999999999999 111.034 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.49 152.52 23.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 61.32 109.294 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.1 t -49.54 -36.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 71.219999999999999 109.311 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.58 2.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 70.230000000000004 109.317 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.701 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -71.53 -36.2 70.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 75.439999999999998 110.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.739 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.93 -57.4 12.95 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 1.155 . . . . 70.049999999999997 109.269 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -51.08 -33.19 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 55.310000000000002 109.29 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -66.9 -56.5 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 74.340000000000003 109.943 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.024 HD12 HD11 ' A' ' 140' ' ' ILE . 59.8 mt -41.82 -41.9 2.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 44.140000000000001 109.3 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.622 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.06 -40.89 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 60.420000000000002 111.033 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -51.01 -36.2 38.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 64.200000000000003 109.306 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 155' ' ' ASN . 20.8 mt-30 -76.52 -56.39 4.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 1.128 . . . . 51.0 110.308 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.633 HG21 ' SD ' ' A' ' 184' ' ' MET . 25.4 mt -50.18 -29.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 71.5 109.296 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -33.44 63.03 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 73.120000000000005 109.302 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -61.72 -15.68 42.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 70.040000000000006 109.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -84.58 -17.68 38.01 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 70.400000000000006 110.301 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.492 ' HA ' ' CD2' ' A' ' 170' ' ' PHE . 16.1 p -38.53 133.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 75.310000000000002 110.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -64.59 130.0 41.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 61.140000000000001 108.315 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.79 -20.75 10.74 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.495 1.122 . . . . 63.229999999999997 110.962 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.803 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 64.2 p -79.24 161.75 26.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 0.791 . . . . 73.129999999999995 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.73 -0.84 55.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.430000000000007 110.016 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 162' ' ' THR . 4.6 m -116.61 6.19 13.38 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 75.030000000000001 110.418 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.803 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.66 138.88 34.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.102 . . . . 74.519999999999996 109.264 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 54.119999999999997 109.977 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.19 127.24 3.6 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.556 1.16 . . . . 74.430000000000007 110.008 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.02 138.02 53.68 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.993 -2.503 . . . . 63.32 111.002 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.03 177.96 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 72.319999999999993 108.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.692 HG21 ' CZ ' ' A' ' 170' ' ' PHE . 3.5 mp -89.53 125.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.515 1.134 . . . . 64.230000000000004 109.276 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.589 HG21 ' O ' ' A' ' 301' ' ' PHE . 65.3 p -79.65 88.23 5.16 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.538 1.149 . . . . 43.130000000000003 110.387 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.692 ' CZ ' HG21 ' A' ' 168' ' ' ILE . 84.8 m-85 -88.01 -26.37 22.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 111.001 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.456 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.77 -1.31 24.44 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 72.510000000000005 110.301 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.689 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 26.4 t80 -128.52 67.6 76.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 71.420000000000002 110.986 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 115.58 4.33 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.482 1.78 . . . . 61.240000000000002 110.979 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.681 HG21 ' CE1' ' A' ' 172' ' ' TYR . 15.8 t -148.85 -72.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 60.140000000000001 109.301 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.02 -45.15 2.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 73.420000000000002 109.306 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -42.33 101.54 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.543 1.152 . . . . 24.23 111.006 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 73.9 m -134.3 -48.15 0.78 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.272 -1.01 . . . . 72.209999999999994 108.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.693 ' HB3' HG11 ' A' ' 219' ' ' VAL . 38.7 p90 -75.61 -45.55 36.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.219999999999999 110.99 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.33 -68.41 0.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 73.140000000000001 109.277 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.834 HH21 ' HD2' ' A' ' 239' ' ' PRO . 3.6 ptm180 -50.09 -47.61 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 73.209999999999994 110.318 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -39.83 -61.2 0.88 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 32.329999999999998 109.304 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.697 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.8 OUTLIER -46.37 -39.68 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.145 . . . . 71.310000000000002 109.595 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.556 ' CB ' HD11 ' A' ' 168' ' ' ILE . 14.1 mmmm -65.25 -61.25 2.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 73.430000000000007 109.281 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.633 ' SD ' HG21 ' A' ' 153' ' ' ILE . 13.8 mtm -39.02 -40.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 61.130000000000003 110.963 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.454 ' NH1' ' CE ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.546 1.154 . . . . 73.230000000000004 110.323 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 183' ' ' LYS . 2.2 pt20 -54.48 -35.92 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 71.209999999999994 110.31 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.7 mm -71.16 -34.15 53.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 63.310000000000002 109.278 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -64.39 -45.78 86.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 74.239999999999995 109.273 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.454 ' CE ' ' NH1' ' A' ' 185' ' ' ARG . 3.5 mtt -55.32 -36.8 66.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 72.109999999999999 111.006 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.62 -50.3 68.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 65.019999999999996 109.305 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -34.23 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 73.430000000000007 109.337 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 107.99 53.39 0.66 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.487 1.117 . . . . 54.439999999999998 111.012 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.701 ' CZ ' HG21 ' A' ' 145' ' ' THR . 72.4 m-85 -153.17 134.86 14.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 0.771 . . . . 72.230000000000004 111.0 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.792 ' HB2' HD23 ' A' ' 136' ' ' LEU . 2.4 t0 -101.43 122.36 43.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 53.350000000000001 109.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.709 ' HB3' HD22 ' A' ' 188' ' ' LEU . 29.5 p -100.11 -179.38 4.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 72.439999999999998 108.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -126.63 174.47 8.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 62.520000000000003 110.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.718 ' HE2' HG22 ' A' ' 221' ' ' ILE . 18.9 mmtt -110.1 159.01 17.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 73.219999999999999 109.301 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.777 ' OE1' HD13 ' A' ' 222' ' ' LEU . 18.3 tt0 -151.39 117.59 5.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 75.299999999999997 110.282 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.559 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.5 m-85 -110.71 118.59 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 61.109999999999999 110.978 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.7 ' CG2' HG23 ' A' ' 266' ' ' VAL . 10.0 p -109.88 146.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 64.200000000000003 109.311 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 12.0 m-85 -118.63 160.43 21.82 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 75.310000000000002 111.041 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.61 -176.04 16.01 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.509 1.131 . . . . 74.120000000000005 110.99 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.768 ' C ' HD23 ' A' ' 204' ' ' LEU . 56.7 t-20 -72.39 110.3 6.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 0.781 . . . . 73.140000000000001 109.298 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.2 mt -114.52 94.74 4.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 70.030000000000001 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.1 mtpt -92.31 178.75 5.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.145 . . . . 61.039999999999999 109.321 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.948 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -178.02 163.24 1.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.219999999999999 109.316 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t -141.55 131.07 23.87 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.549 1.156 . . . . 63.25 110.007 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.6 p -108.98 -2.65 18.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 60.100000000000001 110.398 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.48 -22.7 25.94 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.529 1.143 . . . . 73.209999999999994 110.983 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 t -113.79 -17.29 12.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 0.764 . . . . 65.349999999999994 110.427 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 2.2 p -173.96 148.1 1.36 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 73.540000000000006 108.263 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -101.85 160.13 14.75 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.423 1.077 . . . . 73.219999999999999 108.281 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.948 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -134.07 149.68 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 74.109999999999999 109.301 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.34 130.91 27.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 62.049999999999997 109.274 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.452 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -137.68 135.82 36.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.979 -1.119 . . . . 75.120000000000005 107.979 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 72.7 p -80.05 1.11 29.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 73.530000000000001 110.045 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.463 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.0 p90 -176.23 129.83 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.093 . . . . 72.329999999999998 111.0 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 37.4 t60 -114.43 169.05 9.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 62.130000000000003 109.603 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.1 p -146.45 136.37 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 73.349999999999994 109.269 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.641 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.13 -168.04 2.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 75.519999999999996 109.297 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.718 HG22 ' HE2' ' A' ' 197' ' ' LYS . 28.1 pt -115.75 121.51 67.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 74.530000000000001 109.304 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.777 HD13 ' OE1' ' A' ' 198' ' ' GLN . 12.9 tp -85.41 109.03 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 73.340000000000003 109.313 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.739 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -102.8 146.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 62.420000000000002 109.269 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.569 ' HB3' HG22 ' A' ' 139' ' ' VAL . 4.0 m -116.78 119.86 36.75 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 74.510000000000005 110.024 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.57 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.4 p90 -134.93 143.26 46.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 72.420000000000002 111.007 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.419 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -68.61 133.93 49.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 71.450000000000003 109.344 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.02 -160.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.122 . . . . 72.219999999999999 109.306 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.81 0.05 49.05 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 63.210000000000001 109.288 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.4 m -115.12 -8.33 12.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 72.010000000000005 110.009 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.73 37.44 7.98 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.483 1.114 . . . . 71.340000000000003 111.018 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.37 137.4 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.479 0.752 . . . . 71.140000000000001 109.274 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.419 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 6.3 m -71.52 102.66 2.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.484 1.115 . . . . 72.239999999999995 110.425 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 3.0 mm-40 -101.49 -172.24 2.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 71.409999999999997 110.298 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.474 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.1 mmtm -126.97 144.83 50.9 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 62.340000000000003 109.28 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.0 tpt180 -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 72.120000000000005 110.282 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.58 HG21 ' CD1' ' A' ' 252' ' ' TRP . 13.8 mm -114.88 127.67 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 64.439999999999998 109.296 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -111.95 41.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 75.319999999999993 109.332 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.415 ' OD1' ' HE1' ' A' ' 184' ' ' MET . 1.6 m-20 -104.43 108.05 59.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 73.420000000000002 109.289 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.834 ' HD2' HH21 ' A' ' 180' ' ' ARG . 18.1 Cg_endo -75.03 -0.54 10.1 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.477 1.777 . . . . 62.299999999999997 110.995 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.501 ' N ' ' NH2' ' A' ' 180' ' ' ARG . 1.2 t -67.67 -9.29 42.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.542 1.151 . . . . 64.329999999999998 109.944 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.467 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 3.1 mt -135.21 -47.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 71.230000000000004 109.287 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.601 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.5 m-85 -121.0 99.75 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 71.430000000000007 110.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.0 -24.04 26.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 74.540000000000006 109.999 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 p -61.73 -45.74 92.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 72.430000000000007 109.987 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.42 -174.22 41.02 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.496 1.123 . . . . 51.229999999999997 111.017 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.425 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.01 169.18 23.2 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.431 1.753 . . . . 75.430000000000007 110.973 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.601 HG21 ' CE2' ' A' ' 242' ' ' PHE . 4.1 m -152.45 157.21 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 60.439999999999998 109.3 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 36.8 p -60.22 137.09 58.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.447 1.092 . . . . 65.120000000000005 110.395 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 7.7 p-10 -40.57 -29.67 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.475 1.109 . . . . 72.439999999999998 109.334 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.0 m -71.64 -64.91 0.83 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.498 1.124 . . . . 72.340000000000003 110.355 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.0 -30.78 11.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 109.274 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.641 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 15.6 t90 -60.74 -61.9 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 71.430000000000007 107.996 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.611 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -47.44 -40.88 19.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 1.112 . . . . 71.109999999999999 110.316 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.768 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.0 m-80 -57.85 -50.79 72.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 62.350000000000001 109.287 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.79 -23.01 40.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 72.200000000000003 109.287 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.447 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.6 m -84.78 -35.84 22.11 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 73.129999999999995 108.28 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.768 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.9 m -95.24 21.29 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.551 1.157 . . . . 63.009999999999998 109.294 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -50.23 107.27 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 1.1 . . . . 63.130000000000003 109.26 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.9 p -72.49 -3.93 27.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 63.210000000000001 110.435 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.9 t -46.54 -25.03 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 74.030000000000001 110.006 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' CYS . . . . . 0.426 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 19.7 t -94.34 -35.32 12.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 73.140000000000001 108.282 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 162.18 -128.35 1.87 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.489 1.118 . . . . 74.120000000000005 110.981 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -71.28 143.91 50.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 0.768 . . . . 70.120000000000005 109.953 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.3 144.33 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 73.040000000000006 109.297 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.7 t -172.78 154.78 3.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 75.120000000000005 110.007 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.7 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.27 117.54 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 73.299999999999997 109.308 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 20.7 t -73.74 -43.96 57.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 64.099999999999994 110.044 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.1 m -165.23 171.92 13.05 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 70.200000000000003 110.02 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -154.33 155.81 35.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.25 111.012 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -157.81 160.66 38.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 74.219999999999999 109.323 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.432 ' C ' HG23 ' A' ' 272' ' ' THR . 6.7 p30 -121.94 160.64 24.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 71.109999999999999 109.303 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.546 HG21 ' HD2' ' A' ' 279' ' ' ARG . 35.0 p -152.62 175.68 12.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 74.510000000000005 110.37 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.805 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -59.13 156.5 11.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 74.530000000000001 109.334 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.74 -46.13 62.41 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.486 1.116 . . . . 33.43 110.993 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -52.94 -42.38 65.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 0.771 . . . . 73.140000000000001 109.353 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.805 HG23 ' HB3' ' A' ' 273' ' ' ALA . 81.8 t -43.88 101.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.517 1.136 . . . . 74.239999999999995 109.325 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.485 ' HH ' ' HE1' ' A' ' 178' ' ' TYR . 2.6 t80 -58.67 -59.47 5.35 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 63.450000000000003 111.009 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -132.03 150.25 52.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.467 1.104 . . . . 75.519999999999996 111.064 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.559 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 60.8 ttt-85 -119.35 147.47 44.29 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 52.109999999999999 110.313 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.66 158.2 40.93 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 74.200000000000003 110.015 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 0.37 9.0 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.495 1.787 . . . . 63.350000000000001 110.976 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 t -100.47 9.88 41.98 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 71.329999999999998 109.987 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 72.82 40.8 0.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 72.299999999999997 109.336 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -119.18 133.14 55.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.469 1.106 . . . . 74.530000000000001 110.022 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.43 ' OH ' HG22 ' A' ' 272' ' ' THR . 18.0 m-30 -114.38 150.12 35.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 72.5 110.985 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.559 HD11 ' CZ ' ' A' ' 320' ' ' PHE . 1.1 mm? -116.44 177.48 4.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 71.239999999999995 109.274 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 47.7 m-85 -160.59 115.49 2.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 75.0 111.006 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -115.38 94.87 4.9 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.475 1.109 . . . . 75.200000000000003 109.337 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -80.7 -16.74 53.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 71.140000000000001 109.266 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.456 ' HB3' HD11 ' A' ' 292' ' ' ILE . 40.8 m-20 -108.52 5.31 25.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.134 . . . . 64.120000000000005 109.321 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.697 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.27 49.7 2.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.553 1.158 . . . . 73.219999999999999 109.276 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' A' ' 290' ' ' ASN . 40.6 mm -80.03 -29.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.349999999999994 109.317 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.756 ' O ' HG23 ' A' ' 297' ' ' VAL . 11.4 t30 -94.5 -20.59 19.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.13 . . . . 53.229999999999997 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.418 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.7 m -87.59 -68.65 0.74 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.133 . . . . 70.349999999999994 110.365 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 77.4 m-20 -49.75 -31.2 10.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.1 . . . . 73.219999999999999 109.304 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 41.3 t -70.96 -49.36 46.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 72.340000000000003 108.302 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.3 t -52.01 -43.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 64.219999999999999 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 301' ' ' PHE . 21.0 mt -67.2 -61.12 2.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 34.450000000000003 109.3 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -41.4 -31.72 0.27 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.533 1.145 . . . . 45.219999999999999 110.382 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.403 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.0 mmmt -67.14 -51.48 53.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 63.350000000000001 109.252 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.589 ' O ' HG21 ' A' ' 169' ' ' THR . 0.6 OUTLIER -94.58 37.72 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 73.209999999999994 111.025 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 37.0 t -69.08 -46.82 66.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 72.329999999999998 109.953 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.773 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -90.19 -17.55 27.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 72.340000000000003 109.31 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.769 HD22 ' CD ' ' A' ' 309' ' ' PRO . 16.6 mt -57.81 140.07 52.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.535 1.147 . . . . 73.319999999999993 109.297 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.6 p -152.66 140.72 20.29 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.441 1.088 . . . . 72.049999999999997 110.002 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.93 -161.66 27.02 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.497 1.123 . . . . 55.509999999999998 111.0 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.32 6.2 47.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.344 -0.984 . . . . 44.350000000000001 108.344 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 24.0 p -130.22 151.05 77.79 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 64.340000000000003 110.053 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.769 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.03 145.87 85.08 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.998 -2.501 . . . . 74.129999999999995 110.999 0.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.581 ' HB3' HG13 ' A' ' 174' ' ' VAL . 2.0 p -133.59 135.51 25.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 52.409999999999997 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.02 -173.6 12.62 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.047 -2.48 . . . . 70.319999999999993 111.002 0.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.01 154.67 18.35 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.532 1.145 . . . . 52.149999999999999 109.339 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.506 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -74.96 -162.24 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.482 1.78 . . . . 62.200000000000003 111.039 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -85.08 133.83 34.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 73.049999999999997 109.295 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.403 HG12 ' HE2' ' A' ' 300' ' ' LYS . 21.2 m -125.81 25.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 72.109999999999999 109.32 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 t -55.12 -31.7 61.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 72.109999999999999 110.02 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 28.8 p -49.65 -23.58 1.79 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 74.230000000000004 110.026 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.6 m -77.76 175.47 9.93 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 54.109999999999999 108.289 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 166.48 100.46 0.14 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.522 1.139 . . . . 75.099999999999994 110.982 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.559 ' CZ ' HD11 ' A' ' 286' ' ' LEU . 10.6 p90 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.484 0.756 . . . . 72.319999999999993 110.966 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.898 HD23 ' HB2' ' A' ' 194' ' ' ASP . 8.9 tp . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.271 -0.64 . . . . 63.109999999999999 109.271 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.541 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -103.92 105.46 15.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 75.450000000000003 109.289 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.1 m -83.66 8.46 14.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.129 . . . . 43.340000000000003 109.973 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -150.16 147.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 55.049999999999997 109.266 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.008 HD11 HD12 ' A' ' 149' ' ' LEU . 1.3 mt -97.92 142.14 24.09 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.148 . . . . 64.230000000000004 109.304 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.05 -32.37 5.38 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.519 1.8 . . . . 63.210000000000001 110.969 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.05 148.36 17.01 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 64.510000000000005 109.332 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.1 t -46.11 -36.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 73.230000000000004 109.286 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.88 -47.39 2.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.112 . . . . 72.010000000000005 109.268 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.706 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.55 -36.36 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.54 1.15 . . . . 72.299999999999997 110.394 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.708 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.9 -57.23 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 63.539999999999999 109.295 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -51.62 -32.36 28.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 65.129999999999995 109.297 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.74 -56.29 8.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.420000000000002 110.023 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.008 HD12 HD11 ' A' ' 140' ' ' ILE . 56.6 mt -43.69 -42.19 5.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 63.240000000000002 109.318 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.698 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -71.87 -44.29 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 72.129999999999995 110.987 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -46.4 -35.77 5.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 72.430000000000007 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -77.87 -54.89 5.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 54.340000000000003 110.278 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.044 HD11 HD12 ' A' ' 188' ' ' LEU . 10.2 mt -50.63 -24.5 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.113 . . . . 60.030000000000001 109.275 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -38.39 46.55 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 72.219999999999999 109.31 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.73 -17.04 19.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 62.229999999999997 109.288 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.544 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.9 mm100 -81.91 -26.36 34.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 64.540000000000006 110.29 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 13.9 m -42.24 137.75 1.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 73.230000000000004 109.972 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.69 113.03 4.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 63.439999999999998 108.314 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.58 1.74 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.518 1.136 . . . . 42.5 110.994 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.806 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 72.7 p -93.17 161.66 14.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.538 0.787 . . . . 74.319999999999993 110.385 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.7 p -92.52 -1.82 56.67 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 61.0 109.984 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 162' ' ' THR . 2.4 m -114.74 2.54 14.45 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.329999999999998 110.396 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -75.33 133.54 41.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 71.420000000000002 109.35 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -170.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 73.129999999999995 109.961 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.4 p -154.11 127.33 4.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 72.439999999999998 110.049 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -75.03 138.04 53.78 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 120.966 -2.514 . . . . 75.140000000000001 111.0 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.1 p -72.79 -178.6 2.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.459 1.1 . . . . 44.340000000000003 108.328 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.609 HG23 ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.33 132.88 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 60.140000000000001 109.295 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.1 p -92.68 73.14 5.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 53.310000000000002 110.411 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 12.7 p90 -74.14 -21.3 59.92 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.562 1.164 . . . . 73.140000000000001 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 302' ' ' SER . 0.0 OUTLIER -74.73 -1.85 23.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 71.319999999999993 110.281 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.773 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 21.9 t80 -131.76 66.97 79.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 72.299999999999997 110.976 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.434 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.02 118.79 5.39 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.435 1.755 . . . . 75.200000000000003 110.993 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.578 HG21 ' CE1' ' A' ' 172' ' ' TYR . 6.7 t -152.09 -72.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 63.140000000000001 109.337 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.6 -44.96 1.5 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 63.020000000000003 109.288 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -44.27 110.05 0.32 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.527 1.142 . . . . 64.409999999999997 110.999 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.3 p -147.95 -48.47 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.277 -1.009 . . . . 44.130000000000003 108.277 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -66.58 -16.96 64.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 75.219999999999999 110.984 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.04 -68.11 0.64 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 73.510000000000005 109.334 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.609 ' HB3' HG23 ' A' ' 168' ' ' ILE . 10.0 ptm180 -49.03 -50.62 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.451 1.094 . . . . 75.319999999999993 110.314 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.413 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.21 -56.63 3.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 55.340000000000003 109.296 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.7 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -45.07 -36.71 3.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 55.43 109.575 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 180' ' ' ARG . 30.0 mmmt -68.89 -59.15 3.27 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.15 . . . . 64.409999999999997 109.313 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.471 ' CB ' HD13 ' A' ' 221' ' ' ILE . 11.2 mtm -38.74 -31.45 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.150000000000006 111.009 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.437 ' NH2' ' OD2' ' A' ' 194' ' ' ASP . 0.0 OUTLIER -69.32 -54.08 16.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 73.120000000000005 110.259 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -54.15 -32.62 55.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 73.310000000000002 110.286 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 153' ' ' ILE . 26.1 mm -71.5 -40.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.459 1.1 . . . . 74.510000000000005 109.235 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 1.044 HD12 HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -62.18 -42.46 99.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 60.149999999999999 109.306 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.0 mtt -57.94 -38.93 76.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 43.399999999999999 110.973 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.43 -52.34 54.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 61.0 109.296 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.437 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 7.8 t-20 -64.23 -35.34 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 73.239999999999995 109.315 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.58 53.01 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.44 1.088 . . . . 72.319999999999993 110.99 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.706 ' CZ ' HG21 ' A' ' 145' ' ' THR . 90.0 m-85 -153.28 147.9 26.19 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.541 0.789 . . . . 65.25 111.007 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.898 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -110.02 126.88 54.43 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 70.519999999999996 109.31 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.983 ' HB3' HD22 ' A' ' 188' ' ' LEU . 13.4 p -98.8 -179.27 4.24 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.47 1.106 . . . . 65.120000000000005 108.312 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 27.0 mp0 -133.38 171.62 13.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.562 1.164 . . . . 75.209999999999994 110.357 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.494 ' HZ1' ' HA ' ' A' ' 182' ' ' HIS . 18.1 mmtt -107.01 161.13 15.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.48 1.113 . . . . 62.450000000000003 109.3 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 21.2 tt0 -157.66 117.49 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 73.25 110.323 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 9.1 m-85 -108.49 133.53 52.52 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 75.430000000000007 110.967 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.695 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.7 p -124.38 148.16 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 60.310000000000002 109.301 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.6 m-85 -120.09 156.51 30.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.483 1.114 . . . . 62.539999999999999 111.018 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.42 -178.55 16.37 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.542 1.151 . . . . 25.41 111.006 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.752 ' C ' HD23 ' A' ' 204' ' ' LEU . 57.2 t-20 -71.02 111.25 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 0.772 . . . . 73.409999999999997 109.297 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.752 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.4 mt -115.27 93.62 4.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 62.340000000000003 109.312 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.8 mttp -93.27 165.93 12.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 70.349999999999994 109.287 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.57 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -171.68 154.07 3.57 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 53.219999999999999 109.322 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t -128.66 129.27 45.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 75.129999999999995 109.995 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.0 p -96.85 -7.28 33.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 45.219999999999999 110.42 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 107.15 -30.9 8.68 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.542 1.152 . . . . 52.219999999999999 110.983 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.4 p -109.08 -16.58 14.08 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.501 0.765 . . . . 74.109999999999999 110.435 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -169.07 163.05 11.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.513 1.133 . . . . 74.219999999999999 108.312 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.53 145.64 45.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.12 . . . . 65.120000000000005 108.295 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.57 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -114.44 153.86 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.541 1.151 . . . . 71.239999999999995 109.272 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.467 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -137.4 119.02 14.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 54.340000000000003 109.276 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.32 134.0 51.23 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.019 -1.104 . . . . 72.340000000000003 108.019 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.2 t -79.33 2.32 21.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.485 1.115 . . . . 62.009999999999998 109.945 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.484 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.3 p90 -175.33 128.41 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.448 1.092 . . . . 73.420000000000002 111.006 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.468 ' N ' HD12 ' A' ' 204' ' ' LEU . 83.4 t60 -121.75 167.21 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 74.129999999999995 109.595 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.5 p -145.18 149.73 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.459 1.1 . . . . 45.039999999999999 109.302 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.537 ' CB ' HD12 ' A' ' 236' ' ' ILE . . . -144.46 -159.43 0.99 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 64.219999999999999 109.317 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.487 HG22 ' HE2' ' A' ' 197' ' ' LYS . 14.4 pt -120.0 122.98 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.462 1.102 . . . . 62.409999999999997 109.291 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 234' ' ' LYS . 11.9 tp -86.71 109.01 18.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 74.409999999999997 109.284 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.708 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.51 145.45 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 72.239999999999995 109.325 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.434 ' HB3' HG22 ' A' ' 139' ' ' VAL . 45.4 m -116.56 118.56 32.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 42.100000000000001 109.993 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -133.85 144.79 49.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 73.409999999999997 111.014 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.435 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -69.83 133.96 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 75.299999999999997 109.304 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.12 -159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 75.230000000000004 109.313 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 -0.35 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 64.319999999999993 109.295 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.0 m -114.87 -7.75 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.451 1.095 . . . . 74.129999999999995 109.972 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.57 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.518 1.136 . . . . 52.420000000000002 111.033 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.22 137.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 0.777 . . . . 74.319999999999993 109.275 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.435 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.4 m -71.53 102.65 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 64.010000000000005 110.368 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 1.9 mm-40 -101.74 -172.68 2.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 73.239999999999995 110.259 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.53 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.3 mmtm -127.03 144.93 50.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.400000000000006 109.301 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.589 ' HB3' HG22 ' A' ' 223' ' ' VAL . 1.3 tpt180 -145.48 162.96 36.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 73.409999999999997 110.247 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.537 HD12 ' CB ' ' A' ' 220' ' ' ALA . 10.8 mm -116.85 119.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 64.230000000000004 109.31 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -105.33 43.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 64.329999999999998 109.292 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.436 ' OD1' ' CB ' ' A' ' 240' ' ' SER . 4.2 t70 -101.84 108.13 54.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.457 1.098 . . . . 62.310000000000002 109.315 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -4.84 16.01 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.486 1.782 . . . . 64.120000000000005 111.032 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 t -72.05 -7.94 51.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 62.049999999999997 110.027 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -130.96 -46.59 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 74.340000000000003 109.31 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.79 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.1 m-85 -123.34 106.75 10.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 71.340000000000003 110.98 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -26.22 22.25 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.496 1.123 . . . . 72.420000000000002 109.985 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.5 m -62.62 -47.74 82.46 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.124 . . . . 73.239999999999995 110.034 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.41 -173.78 40.66 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.474 1.109 . . . . 74.010000000000005 110.965 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.425 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 169.98 21.41 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.514 1.797 . . . . 72.439999999999998 111.017 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.79 HG21 ' CE2' ' A' ' 242' ' ' PHE . 13.7 m -148.61 159.46 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 74.340000000000003 109.302 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 43.3 p -61.71 142.08 57.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 63.420000000000002 110.427 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 249' ' ' ASP . 1.2 p-10 -45.82 -26.17 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.157 . . . . 75.120000000000005 109.333 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 29.1 m -80.88 -61.42 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 64.439999999999998 110.387 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.94 -22.01 5.05 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 64.409999999999997 109.235 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.57 ' CE3' ' HD3' ' A' ' 253' ' ' ARG . 9.5 t90 -67.05 -59.04 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.48 1.113 . . . . 71.219999999999999 108.017 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.06 -43.54 40.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.569 1.168 . . . . 72.5 110.278 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.842 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.2 m-80 -53.74 -52.16 61.04 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 70.420000000000002 109.319 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.676 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.4 -18.77 12.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 72.519999999999996 109.306 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.8 m -90.34 -35.0 15.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.299999999999997 108.287 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.842 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -94.47 21.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 71.219999999999999 109.32 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -51.34 109.24 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 61.219999999999999 109.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.0 p -74.71 -3.06 29.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.506 1.129 . . . . 71.540000000000006 110.396 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t -44.22 -31.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.508 1.13 . . . . 45.240000000000002 110.018 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 46.2 t -88.24 -37.39 16.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 70.109999999999999 108.304 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.32 -127.58 1.56 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.45 1.094 . . . . 73.129999999999995 111.032 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.1 146.83 39.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 0.784 . . . . 61.140000000000001 110.023 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.39 147.83 4.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 1.115 . . . . 63.229999999999997 109.286 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 39.0 m -172.83 153.86 2.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.448 1.093 . . . . 63.210000000000001 109.985 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.695 HG23 ' CG2' ' A' ' 200' ' ' VAL . 3.6 p -101.81 115.49 43.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 74.120000000000005 109.303 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 9.2 t -70.32 -45.17 66.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.113 . . . . 71.530000000000001 110.016 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.612 ' O ' HG23 ' A' ' 200' ' ' VAL . 3.6 m -163.73 -174.88 3.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.499 1.124 . . . . 70.310000000000002 109.991 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -165.78 156.53 13.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 73.040000000000006 110.996 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -153.77 162.49 41.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.464 1.102 . . . . 71.310000000000002 109.276 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.491 ' O ' HG23 ' A' ' 272' ' ' THR . 7.8 p30 -121.82 159.88 25.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.319999999999993 109.318 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.601 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.5 p -154.37 178.12 10.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.146 . . . . 61.530000000000001 110.381 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.934 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -61.3 167.29 3.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 75.319999999999993 109.307 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.98 -18.76 66.72 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 71.219999999999999 111.015 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.94 -39.15 21.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 0.759 . . . . 73.299999999999997 109.319 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.934 HG23 ' HB3' ' A' ' 273' ' ' ALA . 61.7 t -43.6 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.535 1.147 . . . . 74.430000000000007 109.32 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.0 t80 -53.92 -54.78 34.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.523 1.139 . . . . 72.340000000000003 111.018 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.572 ' CE2' ' O ' ' A' ' 279' ' ' ARG . 66.9 t80 -143.39 159.92 41.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 72.040000000000006 110.949 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.601 ' HD2' HG21 ' A' ' 272' ' ' THR . 76.4 ttt-85 -122.73 147.57 46.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 72.120000000000005 110.35 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.21 154.32 48.68 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.46 1.1 . . . . 75.010000000000005 109.964 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.18 9.22 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.49 1.784 . . . . 74.430000000000007 110.972 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 14.2 t -104.62 7.76 35.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.534 1.147 . . . . 72.239999999999995 110.013 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 76.7 41.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 72.400000000000006 109.275 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.4 t -119.56 118.99 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 74.439999999999998 109.997 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -102.78 159.1 15.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.219999999999999 111.034 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.7 OUTLIER -123.94 176.93 6.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 70.540000000000006 109.259 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 94.7 m-85 -161.31 115.37 2.0 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 63.450000000000003 111.014 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.408 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.8 t0 -115.3 95.06 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.103 . . . . 51.539999999999999 109.279 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.64 -19.45 30.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.469 1.106 . . . . 74.109999999999999 109.285 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.455 ' CB ' HG12 ' A' ' 292' ' ' ILE . 50.7 m-20 -105.71 4.18 29.76 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.12 . . . . 73.340000000000003 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.7 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.5 mm? 40.41 49.15 2.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 55.43 109.291 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.455 HG12 ' CB ' ' A' ' 290' ' ' ASN . 30.8 mm -78.7 -28.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.539 1.149 . . . . 73.340000000000003 109.339 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.787 ' O ' HG23 ' A' ' 297' ' ' VAL . 8.2 t30 -94.71 -24.0 17.32 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.117 . . . . 54.509999999999998 109.29 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 4.4 m -83.11 -68.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.537 1.148 . . . . 63.509999999999998 110.43 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 56.3 m-20 -51.05 -28.54 10.51 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 62.219999999999999 109.323 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 11.5 t -70.9 -66.5 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.133 . . . . 54.409999999999997 108.317 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 293' ' ' ASN . 53.5 t -43.44 -42.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 62.340000000000003 109.311 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.13 -58.02 10.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.472 1.108 . . . . 62.310000000000002 109.273 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -19.5 52.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 52.229999999999997 110.429 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.493 ' HE2' HG12 ' A' ' 315' ' ' VAL . 18.5 mmmt -76.3 -42.39 45.43 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 75.310000000000002 109.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.712 ' CE2' HG13 ' A' ' 297' ' ' VAL . 1.7 m-30 -106.02 40.41 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 74.519999999999996 111.054 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' SER . . . . . 0.447 ' O ' ' NH1' ' A' ' 171' ' ' ARG . 29.6 t -68.0 -55.28 13.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.145 . . . . 42.399999999999999 110.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.793 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -79.39 -18.33 52.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 64.349999999999994 109.28 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.773 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 13.3 mt -57.42 139.27 53.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.105 . . . . 75.349999999999994 109.343 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 90.3 p -149.95 166.13 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 74.329999999999998 109.995 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 68.22 -153.05 52.83 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.473 1.108 . . . . 51.350000000000001 110.978 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.7 p -103.13 15.53 29.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.283 -1.006 . . . . 50.109999999999999 108.283 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.511 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -133.59 150.26 74.39 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 71.030000000000001 109.992 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.735 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.97 146.71 87.41 Favored 'Cis proline' 0 C--N 1.359 1.108 0 C-N-CA 121.052 -2.478 . . . . 45.530000000000001 110.994 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -129.75 133.39 24.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 64.109999999999999 110.033 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -168.22 6.29 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 121.044 -2.482 . . . . 40.039999999999999 110.982 0.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.71 152.08 28.2 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 65.430000000000007 109.309 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.56 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.03 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.505 1.792 . . . . 54.210000000000001 111.039 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.08 131.24 34.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.533 1.146 . . . . 71.010000000000005 109.321 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.493 HG12 ' HE2' ' A' ' 300' ' ' LYS . 33.4 m -128.48 27.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 73.5 109.306 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 27.0 t -57.37 -24.12 53.38 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 74.230000000000004 109.961 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -58.2 -16.8 15.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 75.239999999999995 109.984 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 61.7 m -67.06 -174.14 0.32 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 72.450000000000003 108.346 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.565 ' O ' ' CD2' ' A' ' 320' ' ' PHE . . . -154.6 -118.14 0.64 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.5 1.125 . . . . 53.350000000000001 110.99 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 319' ' ' GLY . 14.7 m-85 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.556 0.798 . . . . 62.200000000000003 111.015 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' A' ' 194' ' ' ASP . 6.9 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.267 -0.642 . . . . 74.319999999999993 109.267 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.574 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -109.03 111.75 23.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 74.099999999999994 109.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.486 ' CB ' ' OD1' ' A' ' 194' ' ' ASP . 0.7 OUTLIER -86.72 6.1 32.99 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 73.400000000000006 109.966 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -145.94 150.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.468 1.105 . . . . 72.010000000000005 109.314 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.029 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -103.28 143.13 26.0 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 71.239999999999995 109.33 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -75.05 -33.73 4.31 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.509 1.794 . . . . 51.149999999999999 111.02 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.429 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.45 150.36 23.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.114 . . . . 75.219999999999999 109.318 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.505 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -49.06 -33.91 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 54.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.85 -46.28 5.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 62.340000000000003 109.327 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.573 HG22 HG12 ' A' ' 140' ' ' ILE . 1.8 m -72.92 -32.16 65.12 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 74.519999999999996 110.421 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.746 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -61.9 -56.16 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 73.329999999999998 109.332 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -53.64 -31.07 45.87 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.533 1.146 . . . . 65.019999999999996 109.3 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -70.26 -55.92 8.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 42.009999999999998 109.953 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.029 HD12 HD11 ' A' ' 140' ' ' ILE . 70.4 mt -42.63 -42.24 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 1.094 . . . . 64.530000000000001 109.32 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.753 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.2 -45.11 61.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.141 . . . . 64.239999999999995 111.006 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.61 -39.66 17.41 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 64.319999999999993 109.271 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 155' ' ' ASN . 28.0 mt-30 -73.54 -57.07 4.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 43.32 110.292 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.876 HD11 HD12 ' A' ' 188' ' ' LEU . 10.7 mt -50.01 -23.27 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 53.509999999999998 109.28 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -76.46 -37.58 56.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 72.340000000000003 109.285 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -57.03 -18.63 14.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 73.540000000000006 109.312 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.532 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.8 mm100 -80.24 -27.4 38.69 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.464 1.102 . . . . 73.230000000000004 110.341 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' GLN . 15.6 m -39.47 129.59 1.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 73.340000000000003 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 7.4 m -58.85 113.31 2.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.43 1.081 . . . . 71.420000000000002 108.295 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.36 -17.12 1.68 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.486 1.116 . . . . 54.340000000000003 110.982 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.714 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 46.0 p -95.33 161.56 14.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 0.76 . . . . 63.119999999999997 110.398 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 m -92.9 -3.76 54.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 1.152 . . . . 62.310000000000002 109.956 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 162' ' ' THR . 3.0 m -109.5 -1.62 18.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 72.140000000000001 110.405 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.714 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -73.08 134.39 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.439 1.087 . . . . 73.310000000000002 109.314 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.409 ' HB2' ' NE2' ' A' ' 156' ' ' GLN . 0.4 OUTLIER -55.59 -166.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 53.140000000000001 109.996 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.0 m -156.24 127.93 3.84 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 74.310000000000002 110.02 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 137.8 52.39 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.944 -2.523 . . . . 34.229999999999997 111.027 0.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.0 p -73.0 -179.38 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.103 . . . . 65.319999999999993 108.307 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.649 HG23 ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.11 128.31 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 54.329999999999998 109.284 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 67.7 p -94.71 84.73 4.29 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 43.310000000000002 110.356 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -88.55 -12.7 42.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.522 1.139 . . . . 60.310000000000002 110.976 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.77 -4.1 29.41 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.526 1.141 . . . . 73.010000000000005 110.324 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.778 ' CE2' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -131.02 70.01 82.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.25 111.011 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.442 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.0 Cg_endo -75.05 113.56 3.82 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.535 1.808 . . . . 71.430000000000007 110.957 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.589 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.7 t -153.41 -67.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 61.420000000000002 109.298 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -159.34 112.88 2.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.527 1.142 . . . . 73.010000000000005 109.339 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.55 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.68 68.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.515 1.134 . . . . 51.340000000000003 111.002 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 42.4 m -107.5 -8.42 16.24 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.28 -1.008 . . . . 53.200000000000003 108.28 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.57 ' HB3' HG11 ' A' ' 219' ' ' VAL . 35.4 p90 -81.16 -23.83 37.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 55.100000000000001 110.964 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.08 -68.11 0.52 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 62.340000000000003 109.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.649 ' HB3' HG23 ' A' ' 168' ' ' ILE . 8.0 ptm180 -44.23 -51.12 8.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 52.32 110.309 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -40.35 -62.84 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.420000000000002 109.321 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.699 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -42.24 -39.09 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 73.439999999999998 109.625 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.586 ' HE3' HE22 ' A' ' 186' ' ' GLN . 28.0 mmmt -68.69 -54.9 13.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.544 1.152 . . . . 61.530000000000001 109.308 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.478 ' SD ' HG21 ' A' ' 153' ' ' ILE . 8.6 mtm -39.57 -41.72 1.06 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.466 1.104 . . . . 71.349999999999994 110.986 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.442 ' CG ' ' SG ' ' A' ' 195' ' ' CYS . 0.6 OUTLIER -62.63 -45.01 94.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 74.150000000000006 110.318 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.586 HE22 ' HE3' ' A' ' 183' ' ' LYS . 2.5 pt20 -50.93 -31.81 18.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 72.200000000000003 110.307 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.481 HD13 ' HG3' ' A' ' 186' ' ' GLN . 10.4 mm -82.95 -39.43 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.13 . . . . 74.409999999999997 109.322 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.876 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -57.76 -39.34 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.511 1.132 . . . . 74.310000000000002 109.314 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.581 ' HG2' HD21 ' A' ' 136' ' ' LEU . 32.9 mtp -65.84 -45.78 80.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 72.319999999999993 110.98 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -42.87 -53.45 4.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 53.43 109.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -62.64 -39.14 92.9 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 75.439999999999998 109.354 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 118.74 46.7 0.43 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.518 1.136 . . . . 62.5 111.0 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.676 ' O ' HD23 ' A' ' 188' ' ' LEU . 92.5 m-85 -150.93 129.82 12.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 74.439999999999998 111.004 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.777 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -96.98 130.76 44.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 75.010000000000005 109.358 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.829 ' HB3' HD22 ' A' ' 188' ' ' LEU . 13.9 p -102.65 173.49 6.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 62.229999999999997 108.314 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 55.32 110.324 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -100.04 158.39 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 64.099999999999994 109.32 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.534 ' OE1' HD11 ' A' ' 236' ' ' ILE . 20.4 tt0 -145.88 117.32 7.99 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 63.310000000000002 110.327 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -110.72 126.47 54.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.142 . . . . 74.109999999999999 111.032 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.649 HG21 ' CG ' ' A' ' 253' ' ' ARG . 9.1 p -125.92 128.53 72.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.458 1.099 . . . . 74.209999999999994 109.334 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.412 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 17.1 m-85 -103.44 158.37 16.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 111.005 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.94 -176.38 16.41 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.523 1.139 . . . . 43.549999999999997 110.97 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.768 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.5 t-20 -72.18 110.98 7.0 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 0.765 . . . . 54.310000000000002 109.273 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.1 mt -115.17 94.69 4.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 51.100000000000001 109.307 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.766 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 4.5 mtpt -92.87 170.92 9.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 73.409999999999997 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.535 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -172.96 122.53 0.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.11 . . . . 72.040000000000006 109.29 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.9 t -109.55 126.44 53.58 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 54.310000000000002 109.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 11.2 p -103.58 -3.89 24.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.5 1.125 . . . . 75.219999999999999 110.415 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 102.36 -53.38 0.79 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.459 1.1 . . . . 73.319999999999993 110.945 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t -81.52 -23.93 36.98 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 0.777 . . . . 74.420000000000002 110.387 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 15.9 p -176.69 137.45 0.26 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 70.0 108.274 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.527 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -97.82 -174.64 2.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 73.549999999999997 108.275 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.1 OUTLIER -157.07 161.14 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.457 1.098 . . . . 74.219999999999999 109.326 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.766 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -140.23 137.53 34.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.491 1.119 . . . . 75.310000000000002 109.298 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -138.2 134.55 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.479 1.112 . . . . 74.310000000000002 108.014 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -78.27 -1.03 31.03 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.46 1.1 . . . . 74.230000000000004 110.034 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.4 p90 -173.96 130.42 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 75.420000000000002 110.987 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.483 ' N ' HD12 ' A' ' 204' ' ' LEU . 48.3 t60 -117.59 165.55 13.44 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.519 1.137 . . . . 71.120000000000005 109.588 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.0 p -140.76 135.87 34.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 64.209999999999994 109.315 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -136.34 -164.38 1.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 61.119999999999997 109.312 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' A' ' 237' ' ' ILE . 22.6 pt -119.42 123.28 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 70.219999999999999 109.295 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.6 tp -89.77 108.96 20.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 71.099999999999994 109.3 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.97 146.66 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.11 . . . . 73.030000000000001 109.27 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.6 ' HB3' HG22 ' A' ' 139' ' ' VAL . 9.4 m -116.7 119.42 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.141 . . . . 65.030000000000001 109.991 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.6 p90 -134.5 142.89 47.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.209999999999994 110.998 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.43 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.8 mmtp -68.28 134.4 50.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 74.129999999999995 109.316 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.62 -160.07 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 1.091 . . . . 64.329999999999998 109.257 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.39 50.75 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 72.329999999999998 109.341 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.0 m -115.02 -7.48 12.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.479 1.112 . . . . 74.150000000000006 110.033 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.67 8.45 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.467 1.104 . . . . 62.420000000000002 110.95 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.24 137.63 42.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 0.743 . . . . 74.040000000000006 109.273 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.43 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 13.4 m -71.52 102.65 2.75 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 74.019999999999996 110.416 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.7 mm-40 -101.4 -172.46 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 55.43 110.277 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.534 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.9 mmtm -127.18 144.98 50.92 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.449 1.093 . . . . 70.310000000000002 109.246 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.62 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.6 tpt180 -145.02 160.45 41.35 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 65.209999999999994 110.316 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.534 HD11 ' OE1' ' A' ' 198' ' ' GLN . 12.7 mm -115.53 118.02 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 73.219999999999999 109.336 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.753 HD12 ' HB2' ' A' ' 150' ' ' PHE . 3.8 mm -102.38 45.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.516 1.135 . . . . 62.539999999999999 109.301 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.35 111.27 65.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 73.150000000000006 109.301 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.96 -26.59 10.85 Favored 'Trans proline' 0 C--N 1.361 1.202 0 O-C-N 124.47 1.773 . . . . 71.129999999999995 111.036 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.408 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.5 t -48.06 -24.19 1.03 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.136 . . . . 74.310000000000002 110.001 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.404 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 25.2 mt -113.56 -54.72 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 72.230000000000004 109.316 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.725 ' CE2' HG21 ' A' ' 247' ' ' VAL . 94.9 m-85 -117.88 99.58 7.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.543 1.152 . . . . 62.240000000000002 111.025 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -28.34 34.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 75.099999999999994 109.947 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.7 t -59.01 -48.77 80.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 71.530000000000001 109.991 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.34 -172.83 39.19 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.495 1.122 . . . . 55.539999999999999 110.959 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.424 ' HB3' HD13 ' A' ' 237' ' ' ILE . 18.4 Cg_endo -74.97 170.63 20.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.449 1.763 . . . . 41.549999999999997 110.976 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 242' ' ' PHE . 10.7 m -151.01 158.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 72.040000000000006 109.297 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.4 p -59.61 142.49 52.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.545 1.153 . . . . 73.219999999999999 110.414 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.405 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 18.5 p-10 -46.61 -25.56 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 74.319999999999993 109.303 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.411 ' N ' ' C ' ' A' ' 248' ' ' THR . 27.8 m -79.36 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 33.240000000000002 110.409 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -49.86 -29.19 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 51.450000000000003 109.293 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 12.7 t90 -62.01 -65.88 0.62 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.430000000000007 108.022 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.762 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -40.58 -38.23 0.84 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 54.109999999999999 110.308 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.875 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.0 m-80 -60.07 -50.74 72.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.555 1.16 . . . . 74.209999999999994 109.297 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.535 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -54.08 -29.0 42.74 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.476 1.11 . . . . 65.25 109.255 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 5.6 m -81.14 -36.36 30.34 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 54.439999999999998 108.253 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.875 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.5 m -94.66 23.91 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 72.230000000000004 109.301 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -54.52 107.95 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 65.450000000000003 109.302 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.1 p -73.03 -3.18 24.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 45.409999999999997 110.383 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.6 t -44.99 -25.93 0.37 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 54.340000000000003 109.976 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' CYS . . . . . 0.416 ' N ' ' C ' ' A' ' 259' ' ' THR . 52.4 t -94.72 -36.57 11.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 52.219999999999999 108.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.14 -128.13 1.63 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.466 1.104 . . . . 64.120000000000005 111.032 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.77 148.98 34.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 64.439999999999998 110.038 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -172.5 146.32 1.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.501 1.126 . . . . 74.439999999999998 109.302 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.8 p -173.03 156.98 3.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 74.519999999999996 109.988 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.581 HG23 HG22 ' A' ' 200' ' ' VAL . 2.6 p -98.8 124.29 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.496 1.123 . . . . 73.349999999999994 109.263 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 39.1 t -86.31 -41.93 14.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 54.130000000000003 109.948 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.52 -174.13 4.8 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 50.350000000000001 110.007 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 9.5 p90 -170.89 155.7 4.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 73.219999999999999 111.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -163.11 173.21 13.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 64.450000000000003 109.319 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.477 ' C ' ' CG2' ' A' ' 272' ' ' THR . 6.8 p30 -146.5 160.72 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 55.329999999999998 109.27 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.477 ' CG2' ' C ' ' A' ' 271' ' ' ASN . 6.7 p -151.67 -173.5 4.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.469 1.106 . . . . 73.129999999999995 110.415 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.79 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -67.72 148.95 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 65.519999999999996 109.315 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -58.87 -44.55 95.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.516 1.135 . . . . 61.409999999999997 111.023 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.434 ' OD1' ' NH1' ' A' ' 185' ' ' ARG . 16.4 m-80 -52.92 -39.6 62.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 0.749 . . . . 43.539999999999999 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.79 HG23 ' HB3' ' A' ' 273' ' ' ALA . 21.5 t -47.98 118.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.537 1.148 . . . . 74.299999999999997 109.303 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.6 t80 -73.32 -49.43 27.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 72.219999999999999 111.043 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 39.5 t80 -148.81 160.32 43.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 64.420000000000002 110.99 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.568 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 58.3 ttt-85 -130.34 146.83 51.97 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 75.129999999999995 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.42 157.59 40.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 70.549999999999997 109.983 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 -0.57 10.13 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 71.510000000000005 110.94 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 13.6 m -98.09 5.12 48.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.137 . . . . 71.420000000000002 110.004 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 78.27 35.96 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 65.010000000000005 109.235 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -117.52 119.32 34.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 1.131 . . . . 51.329999999999998 110.004 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -101.56 157.69 16.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.118 . . . . 73.510000000000005 111.005 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 320' ' ' PHE . 0.8 OUTLIER -119.44 174.85 6.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 63.219999999999999 109.273 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -157.43 115.05 3.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.120000000000005 111.015 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.446 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.5 t0 -115.37 96.6 5.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 73.209999999999994 109.284 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.72 -31.04 22.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 71.319999999999993 109.262 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.457 ' CB ' HG12 ' A' ' 292' ' ' ILE . 5.1 m120 -95.01 5.62 51.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 62.219999999999999 109.345 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.699 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.3 46.82 2.04 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.5 1.125 . . . . 71.319999999999993 109.287 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.483 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 26.2 mm -74.83 -33.24 30.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 71.319999999999993 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.745 ' O ' HG23 ' A' ' 297' ' ' VAL . 4.3 t30 -92.73 -20.54 20.68 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.513 1.133 . . . . 52.130000000000003 109.27 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.433 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 3.2 m -86.13 -62.55 1.49 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 75.439999999999998 110.379 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 76.3 m-20 -56.66 -24.13 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.422 1.076 . . . . 63.549999999999997 109.28 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 39.4 t -78.91 -48.2 15.04 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.47 1.106 . . . . 50.43 108.272 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.2 t -57.61 -28.06 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 72.200000000000003 109.314 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.5 mt -80.05 -59.81 2.58 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.559 1.162 . . . . 72.420000000000002 109.29 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -54.01 -19.3 4.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.549 1.156 . . . . 60.0 110.419 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.748 ' HE2' HG12 ' A' ' 315' ' ' VAL . 19.4 mmmt -72.14 -44.04 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 75.209999999999994 109.266 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.899 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.6 m-30 -99.67 37.39 1.61 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 71.099999999999994 111.05 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.2 t -68.98 -43.09 75.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.095 . . . . 72.519999999999996 109.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.79 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -96.35 -17.21 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.112 . . . . 74.129999999999995 109.333 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.899 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.7 mt -57.77 149.19 22.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 60.140000000000001 109.324 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -163.94 156.13 17.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.465 1.103 . . . . 50.240000000000002 110.017 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.1 -152.99 46.16 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.52 1.138 . . . . 73.129999999999995 110.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 17.4 m -99.63 7.33 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.278 -1.008 . . . . 53.32 108.278 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.8 OUTLIER -125.04 150.67 67.35 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 72.430000000000007 110.036 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.751 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -74.96 147.36 89.1 Favored 'Cis proline' 0 C--N 1.359 1.111 0 C-N-CA 121.019 -2.492 . . . . 62.109999999999999 111.001 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.6 OUTLIER -128.37 133.25 24.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 75.209999999999994 110.029 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.96 -168.94 6.89 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 121.024 -2.49 . . . . 75.010000000000005 111.028 -0.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.0 154.66 18.33 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 60.329999999999998 109.29 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.415 ' HG3' HD11 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.02 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.476 1.777 . . . . 71.209999999999994 110.981 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -87.77 132.62 34.08 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 73.340000000000003 109.337 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.748 HG12 ' HE2' ' A' ' 300' ' ' LYS . 35.3 m -134.53 27.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.13 . . . . 72.150000000000006 109.289 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 318' ' ' CYS . 36.1 t -71.58 -37.07 71.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.477 1.111 . . . . 65.409999999999997 110.028 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.6 t -43.11 -27.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 75.349999999999994 110.004 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 316' ' ' SER . 3.2 m -66.6 -173.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 60.310000000000002 108.268 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.483 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 170.62 94.34 0.09 OUTLIER Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.485 1.116 . . . . 61.210000000000001 110.988 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 320' ' ' PHE . 5.5 p90 . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.459 0.741 . . . . 71.510000000000005 110.99 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.696 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.292 -0.632 . . . . 73.120000000000005 109.292 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.33 110.54 4.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.09 . . . . 53.210000000000001 109.329 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -83.5 7.89 15.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.54 1.15 . . . . 73.129999999999995 110.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.4 145.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 63.340000000000003 109.316 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.009 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -96.98 143.28 25.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 72.030000000000001 109.314 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.99 -33.38 4.63 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.509 1.794 . . . . 61.200000000000003 111.009 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.81 155.41 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 71.450000000000003 109.31 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -52.45 -35.72 20.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 74.219999999999999 109.311 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.42 -47.49 3.62 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.492 1.12 . . . . 70.549999999999997 109.29 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.734 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -71.59 -35.0 70.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 1.116 . . . . 64.219999999999999 110.378 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.731 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -58.98 -56.97 15.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 65.030000000000001 109.317 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -52.31 -31.8 34.74 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.528 1.143 . . . . 71.019999999999996 109.257 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -67.56 -56.66 8.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 73.530000000000001 110.046 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.009 HD12 HD11 ' A' ' 140' ' ' ILE . 92.4 mt -42.29 -41.97 2.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 53.43 109.312 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.704 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.69 -43.11 63.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 71.049999999999997 110.972 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -51.94 -34.17 40.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 75.019999999999996 109.274 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 155' ' ' ASN . 19.6 mt-30 -76.17 -56.33 4.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 65.450000000000003 110.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.567 HD11 HD12 ' A' ' 188' ' ' LEU . 23.0 mt -50.27 -29.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 71.349999999999994 109.27 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -33.32 63.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 74.319999999999993 109.255 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.79 -18.2 59.0 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 73.519999999999996 109.31 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.401 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 11.2 mm100 -84.24 -15.47 46.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 72.239999999999995 110.274 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -38.7 122.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 63.210000000000001 109.982 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.19 130.45 34.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 54.229999999999997 108.316 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.95 -30.39 6.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.483 1.114 . . . . 63.310000000000002 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.796 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 35.0 p -67.37 161.58 24.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 0.762 . . . . 65.420000000000002 110.443 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.1 t -93.63 -0.72 56.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 70.420000000000002 109.986 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 162' ' ' THR . 3.9 m -116.84 5.63 13.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.108 . . . . 74.420000000000002 110.43 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.796 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -80.85 138.18 36.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.134 . . . . 64.340000000000003 109.284 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -164.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.571 1.169 . . . . 61.25 109.955 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 166' ' ' PRO . 2.6 m -155.96 126.25 3.37 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.531 1.144 . . . . 70.409999999999997 110.023 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.04 141.15 70.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.005 -2.498 . . . . 65.219999999999999 110.991 0.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.5 p -72.69 -178.98 2.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 74.109999999999999 108.315 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' A' ' 183' ' ' LYS . 3.3 mp -99.16 134.25 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.12 . . . . 74.109999999999999 109.3 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.6 p -79.92 71.41 6.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.132 . . . . 63.409999999999997 110.402 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.646 ' HE1' HH21 ' A' ' 180' ' ' ARG . 30.5 m-85 -75.63 -0.53 20.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 70.019999999999996 111.03 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -109.37 8.04 25.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.107 . . . . 74.219999999999999 110.275 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 174' ' ' VAL . 11.6 t80 -125.53 71.79 66.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.545 1.153 . . . . 65.5 110.99 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.442 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 110.13 3.06 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.447 1.761 . . . . 72.450000000000003 111.003 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.712 HG13 ' OG ' ' A' ' 310' ' ' SER . 2.7 t -151.82 -69.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 64.310000000000002 109.341 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -133.77 -48.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 74.230000000000004 109.284 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.25 107.5 0.06 OUTLIER Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.488 1.118 . . . . 53.25 111.013 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.653 ' SG ' HG12 ' A' ' 219' ' ' VAL . 6.9 p -147.86 -48.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 72.530000000000001 108.317 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.528 ' HB3' HG11 ' A' ' 219' ' ' VAL . 26.1 p90 -69.98 -29.1 66.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.55 1.156 . . . . 74.349999999999994 110.978 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -69.27 -68.1 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.474 1.109 . . . . 72.239999999999995 109.328 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.646 HH21 ' HE1' ' A' ' 170' ' ' PHE . 0.2 OUTLIER -44.14 -47.26 9.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 51.409999999999997 110.3 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -41.41 -60.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 72.230000000000004 109.305 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -46.19 -38.03 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.538 1.149 . . . . 74.439999999999998 109.616 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.884 ' HE3' HE22 ' A' ' 186' ' ' GLN . 29.3 mmmt -67.34 -59.69 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.424 1.077 . . . . 73.230000000000004 109.296 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 153' ' ' ILE . 8.4 mtm -39.36 -38.5 0.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.131 . . . . 62.299999999999997 110.96 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.47 77.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 74.400000000000006 110.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.884 HE22 ' HE3' ' A' ' 183' ' ' LYS . 1.5 pt20 -51.2 -29.08 12.92 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 73.430000000000007 110.292 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.463 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 14.4 mm -81.28 -36.02 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.577 1.173 . . . . 74.299999999999997 109.321 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.567 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -63.13 -45.54 91.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 74.530000000000001 109.296 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.504 ' HG2' HD21 ' A' ' 136' ' ' LEU . 11.5 mtt -58.02 -43.61 86.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.506 1.129 . . . . 71.239999999999995 110.999 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -46.21 -52.97 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 60.100000000000001 109.311 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -35.47 80.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 75.319999999999993 109.342 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 110.88 50.99 0.62 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.464 1.102 . . . . 75.129999999999995 111.022 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.745 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 70.3 m-85 -151.04 136.37 17.7 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.531 0.783 . . . . 74.409999999999997 111.035 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.696 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.7 OUTLIER -106.96 121.84 45.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 65.439999999999998 109.323 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.545 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.3 p -102.2 178.4 4.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.088 . . . . 64.209999999999994 108.296 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 222' ' ' LEU . 4.9 mp0 -120.23 172.75 7.56 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.494 1.121 . . . . 74.340000000000003 110.263 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.68 ' HE2' HG22 ' A' ' 221' ' ' ILE . 19.0 mmtt -104.88 152.91 22.06 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 73.200000000000003 109.332 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.41 ' OE1' HD13 ' A' ' 222' ' ' LEU . 23.4 tt0 -139.48 117.73 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.472 1.108 . . . . 64.409999999999997 110.273 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.8 m-85 -111.14 122.33 47.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.49 1.119 . . . . 64.040000000000006 111.021 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.723 ' CG2' HG23 ' A' ' 266' ' ' VAL . 13.3 p -118.74 150.38 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 74.329999999999998 109.302 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.2 m-85 -123.14 162.17 23.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.54 1.15 . . . . 64.129999999999995 111.001 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.2 -177.37 16.37 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.542 1.151 . . . . 63.310000000000002 111.04 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.747 ' C ' HD23 ' A' ' 204' ' ' LEU . 57.6 t-20 -71.54 109.13 5.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 0.772 . . . . 64.109999999999999 109.329 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.747 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.3 mt -112.82 95.09 5.23 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.095 . . . . 74.200000000000003 109.328 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.5 mttt -92.29 168.87 11.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 70.340000000000003 109.293 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.976 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -179.35 165.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 74.510000000000005 109.312 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.86 146.67 39.61 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.515 1.134 . . . . 71.129999999999995 110.05 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.0 p -131.11 5.7 4.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.443 1.089 . . . . 73.040000000000006 110.417 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' A' ' 211' ' ' CYS . . . 120.62 118.95 2.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.531 1.145 . . . . 74.239999999999995 110.988 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 210' ' ' THR . 0.9 OUTLIER 42.01 27.58 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 0.764 . . . . 74.329999999999998 110.419 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' CYS . . . . . 0.405 ' N ' ' C ' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -151.85 173.66 14.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.518 1.136 . . . . 50.409999999999997 108.298 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 2.1 m -155.7 136.5 13.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 33.439999999999998 108.269 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.976 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.4 m -113.79 134.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.145 . . . . 51.43 109.279 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -127.32 127.56 44.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 64.209999999999994 109.307 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -135.68 135.13 39.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 63.43 108.008 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 3.7 20.97 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.105 . . . . 73.200000000000003 109.993 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.484 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.7 p90 -177.91 128.1 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 72.129999999999995 111.035 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.504 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 31.7 t60 -115.04 159.13 21.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.545 1.153 . . . . 73.420000000000002 109.609 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.653 HG12 ' SG ' ' A' ' 177' ' ' CYS . 3.4 p -138.85 137.93 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.420000000000002 109.331 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.568 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -138.98 -157.25 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.579 1.174 . . . . 74.420000000000002 109.317 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.68 HG22 ' HE2' ' A' ' 197' ' ' LYS . 18.3 pt -125.8 117.84 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.509 1.131 . . . . 72.129999999999995 109.276 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.6 tp -81.8 110.04 16.74 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.492 1.12 . . . . 62.229999999999997 109.294 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -101.12 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 71.439999999999998 109.307 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 24.8 m -116.73 119.93 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 64.430000000000007 110.016 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.563 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 31.4 p90 -135.34 145.55 47.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 75.310000000000002 110.993 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -70.3 133.99 47.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.123 . . . . 73.109999999999999 109.334 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.36 -159.64 0.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.115 . . . . 73.420000000000002 109.323 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.44 51.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.230000000000004 109.316 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.9 m -114.58 -8.38 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 51.549999999999997 110.01 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.39 37.42 8.19 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.526 1.141 . . . . 60.439999999999998 110.981 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 138.09 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.468 0.746 . . . . 51.310000000000002 109.301 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.6 m -71.64 102.65 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 72.439999999999998 110.407 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.0 mm-40 -101.99 -172.65 2.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.454 1.096 . . . . 72.530000000000001 110.289 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.599 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -126.69 145.36 50.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.445 1.091 . . . . 71.040000000000006 109.326 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.6 tpt180 -145.66 160.48 41.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.145 . . . . 62.210000000000001 110.275 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.702 HG21 ' CD1' ' A' ' 252' ' ' TRP . 12.8 mm -116.53 119.94 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.239999999999995 109.285 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -101.38 45.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.105 . . . . 70.219999999999999 109.315 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 236' ' ' ILE . 2.1 m-20 -101.17 112.67 65.35 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 40.509999999999998 109.274 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.568 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -74.97 -43.57 0.39 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.516 1.798 . . . . 54.130000000000003 111.015 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.1 OUTLIER -39.22 -29.9 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 73.099999999999994 109.983 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.582 HD13 ' CD1' ' A' ' 252' ' ' TRP . 13.6 mt -101.98 -52.98 3.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 64.129999999999995 109.3 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 247' ' ' VAL . 93.1 m-85 -125.99 99.28 5.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 72.019999999999996 111.041 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -79.22 -30.46 43.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 74.239999999999995 109.968 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -55.52 -46.15 77.04 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 72.510000000000005 109.982 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.48 -170.42 41.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.493 1.12 . . . . 42.030000000000001 111.002 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.432 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.06 168.85 23.89 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 75.450000000000003 110.992 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.652 HG21 ' CE2' ' A' ' 242' ' ' PHE . 3.9 m -151.66 159.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 50.219999999999999 109.291 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.428 ' C ' ' N ' ' A' ' 250' ' ' THR . 43.0 p -60.7 139.21 57.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 71.25 110.399 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.438 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER -43.01 -28.1 0.24 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 74.150000000000006 109.299 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.428 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.4 m -73.61 -64.76 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 75.430000000000007 110.404 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.15 -27.43 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 50.539999999999999 109.31 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.702 ' CD1' HG21 ' A' ' 236' ' ' ILE . 13.0 t90 -62.57 -62.03 2.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 73.420000000000002 108.008 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.555 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.24 -42.26 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.503 1.127 . . . . 71.310000000000002 110.303 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.836 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -55.8 -51.44 67.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 62.299999999999997 109.335 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.03 -20.36 16.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 62.119999999999997 109.311 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.58 -36.76 16.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 65.420000000000002 108.343 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -92.45 20.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.482 1.114 . . . . 62.030000000000001 109.288 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -46.61 104.48 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 75.540000000000006 109.319 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -76.07 -3.97 38.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 71.430000000000007 110.406 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.8 t -49.95 -22.85 1.69 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 65.109999999999999 110.023 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 206' ' ' ALA . 30.7 m -90.87 -32.88 15.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 74.239999999999995 108.294 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.88 -113.78 0.57 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.484 1.115 . . . . 44.229999999999997 111.008 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -90.56 143.45 26.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.78 . . . . 44.43 110.032 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -167.77 148.27 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.461 1.1 . . . . 54.399999999999999 109.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.72 156.58 3.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 61.109999999999999 109.982 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.723 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.9 p -104.39 113.96 42.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 73.310000000000002 109.288 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 4.6 t -68.15 -45.69 72.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 73.310000000000002 110.007 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 200' ' ' VAL . 29.5 p -163.84 -174.22 3.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 73.150000000000006 110.017 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -165.82 155.66 12.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.3 165.23 37.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 73.109999999999999 109.302 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.437 ' C ' HG23 ' A' ' 272' ' ' THR . 6.8 p30 -128.29 160.67 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 74.200000000000003 109.258 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.598 HG21 ' HD2' ' A' ' 279' ' ' ARG . 19.1 p -153.96 176.94 11.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 74.010000000000005 110.395 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -60.76 158.32 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 54.420000000000002 109.324 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.4 -43.96 76.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.447 1.092 . . . . 53.219999999999999 110.993 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -54.87 -42.41 72.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.447 0.733 . . . . 73.219999999999999 109.312 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' ' 273' ' ' ALA . 69.8 t -43.61 101.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 73.329999999999998 109.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.415 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 7.2 t80 -60.07 -59.22 5.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.209999999999994 111.016 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -131.47 156.71 45.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 74.450000000000003 111.034 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.598 ' HD2' HG21 ' A' ' 272' ' ' THR . 63.6 ttt-85 -126.71 147.45 49.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 63.520000000000003 110.275 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.2 m -118.2 158.02 47.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 70.019999999999996 110.068 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 0.17 9.21 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.459 1.768 . . . . 54.549999999999997 111.005 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 80.1 p -104.27 5.81 34.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 73.519999999999996 109.943 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 78.34 39.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 64.340000000000003 109.279 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -113.37 120.22 40.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 62.240000000000002 110.027 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -107.62 151.78 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 75.329999999999998 111.01 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.59 HD11 ' CZ ' ' A' ' 320' ' ' PHE . 1.2 mm? -118.59 177.67 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 73.530000000000001 109.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 79.6 m-85 -160.29 115.22 2.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.523 1.139 . . . . 63.100000000000001 110.978 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.438 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 0.4 OUTLIER -115.49 97.03 5.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 74.200000000000003 109.303 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -85.82 -14.49 44.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 72.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.408 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.0 m-20 -110.75 0.87 17.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 62.229999999999997 109.306 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.695 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 42.69 49.58 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.125 . . . . 73.329999999999998 109.281 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 290' ' ' ASN . 18.2 mm -78.58 -27.55 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.445 1.09 . . . . 75.409999999999997 109.299 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.798 ' O ' HG23 ' A' ' 297' ' ' VAL . 10.0 t30 -94.18 -27.67 16.07 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.444 1.09 . . . . 62.119999999999997 109.286 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.452 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 21.9 m -82.19 -69.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 73.310000000000002 110.407 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 44.1 m-20 -47.86 -30.36 4.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 65.230000000000004 109.293 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 36.8 t -72.73 -58.41 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 72.420000000000002 108.318 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 293' ' ' ASN . 9.4 t -43.95 -49.54 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 75.430000000000007 109.313 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.692 HD22 ' HA ' ' A' ' 168' ' ' ILE . 9.6 mt -61.47 -59.97 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 64.209999999999994 109.31 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.35 -31.8 1.78 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.535 1.147 . . . . 61.140000000000001 110.411 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -70.13 -49.46 50.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.319999999999993 109.283 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.584 ' CZ ' ' HB1' ' A' ' 312' ' ' ALA . 3.3 m-30 -91.77 31.39 1.22 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 75.109999999999999 110.982 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 26.2 t -63.38 -52.75 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 63.520000000000003 110.005 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.4 -10.41 58.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.432 1.083 . . . . 70.310000000000002 109.326 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.603 ' N ' HD22 ' A' ' 303' ' ' LEU . 19.1 mt -76.21 136.63 39.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 74.409999999999997 109.289 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.5 p -161.46 147.58 14.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 75.150000000000006 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 96.89 -160.14 21.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.498 1.124 . . . . 63.409999999999997 110.977 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 25.42 5.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.345 -0.983 . . . . 50.119999999999997 108.345 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.514 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 93.1 p -156.84 148.62 17.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.1 . . . . 64.140000000000001 109.998 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.588 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.98 145.74 84.76 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 121.007 -2.497 . . . . 73.209999999999994 111.024 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.712 ' OG ' HG13 ' A' ' 174' ' ' VAL . 70.0 m -132.21 135.17 26.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 65.299999999999997 109.985 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.0 -173.55 12.53 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 120.995 -2.502 . . . . 75.140000000000001 110.999 -0.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.584 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.89 151.78 31.13 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 51.32 109.295 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.571 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.508 1.794 . . . . 63.409999999999997 110.995 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -85.96 135.49 33.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 75.010000000000005 109.292 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.4 ' O ' ' SG ' ' A' ' 318' ' ' CYS . 26.8 m -127.77 24.68 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 70.209999999999994 109.29 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 35.8 t -54.11 -19.8 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.556 1.16 . . . . 71.409999999999997 110.043 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 35.4 p -53.89 -24.84 17.43 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.501 1.126 . . . . 73.349999999999994 109.989 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 315' ' ' VAL . 1.8 m -80.07 -173.37 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.145 . . . . 55.109999999999999 108.257 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 162.11 77.85 0.03 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.524 1.14 . . . . 72.299999999999997 111.01 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.59 ' CZ ' HD11 ' A' ' 286' ' ' LEU . 7.0 p90 . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.484 0.755 . . . . 72.430000000000007 110.995 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 194' ' ' ASP . 8.5 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.295 -0.632 . . . . 71.030000000000001 109.295 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -105.74 106.46 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.140000000000001 109.277 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -83.45 8.21 14.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.526 1.141 . . . . 55.100000000000001 109.946 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.53 145.2 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 73.510000000000005 109.264 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 149' ' ' LEU . 1.1 mt -96.26 142.77 25.03 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 74.310000000000002 109.339 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.99 -32.48 5.36 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.551 1.816 . . . . 74.349999999999994 111.002 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.71 152.47 21.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 64.239999999999995 109.335 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -49.96 -35.45 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 63.130000000000003 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.5 -47.35 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 73.209999999999994 109.3 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.652 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.91 -34.72 69.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.512 1.133 . . . . 73.239999999999995 110.403 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.741 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.29 -56.98 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 71.25 109.304 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -52.27 -32.03 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 63.520000000000003 109.307 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.6 -55.5 11.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 64.120000000000005 110.008 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 140' ' ' ILE . 66.5 mt -42.06 -41.83 2.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 70.140000000000001 109.315 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.648 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.91 -45.44 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.113 . . . . 73.109999999999999 111.017 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -46.52 -38.37 9.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 75.120000000000005 109.277 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . 19.6 mt-30 -76.57 -55.38 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 73.230000000000004 110.29 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.808 HD11 HD12 ' A' ' 188' ' ' LEU . 13.6 mt -50.56 -23.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.498 1.124 . . . . 74.439999999999998 109.293 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.61 42.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 75.230000000000004 109.297 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -58.44 -19.17 34.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 74.239999999999995 109.24 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 3.3 mm100 -81.68 -24.64 36.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 55.439999999999998 110.324 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.522 ' HA ' ' CD2' ' A' ' 170' ' ' PHE . 23.3 m -41.42 117.35 0.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 53.100000000000001 109.982 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 2.4 m -45.27 130.62 8.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.118 . . . . 74.420000000000002 108.318 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.39 -24.89 5.51 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.587 1.179 . . . . 64.310000000000002 110.976 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.774 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 75.4 p -83.93 161.7 20.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 0.748 . . . . 62.109999999999999 110.388 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -93.56 0.76 56.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 63.5 109.959 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 162' ' ' THR . 2.1 m -117.02 3.48 12.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.123 . . . . 74.219999999999999 110.381 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.774 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -79.06 133.64 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 71.349999999999994 109.278 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.76 -173.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 62.32 109.984 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.3 p -152.39 126.64 4.49 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 74.400000000000006 110.001 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.24 49.19 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 121.063 -2.474 . . . . 64.200000000000003 110.992 0.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.2 p -73.01 -178.2 2.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 71.349999999999994 108.286 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.728 HG21 ' CE1' ' A' ' 170' ' ' PHE . 4.3 mp -90.53 137.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 73.450000000000003 109.309 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.596 HG21 ' O ' ' A' ' 301' ' ' PHE . 74.3 p -90.48 88.62 7.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 72.129999999999995 110.426 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.728 ' CE1' HG21 ' A' ' 168' ' ' ILE . 19.1 m-85 -88.36 -25.51 22.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 64.439999999999998 110.986 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.453 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.84 -2.05 28.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.138 . . . . 72.019999999999996 110.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.675 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 29.4 t80 -128.29 68.22 76.58 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 110.998 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.424 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.06 113.39 3.78 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.495 1.787 . . . . 74.109999999999999 110.977 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.586 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.9 t -152.17 -66.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 34.530000000000001 109.31 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -163.49 118.16 1.62 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.51 1.131 . . . . 64.239999999999995 109.283 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 147.3 48.03 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.516 1.135 . . . . 52.140000000000001 110.98 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 74.4 m -88.59 -19.75 25.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.261 -1.014 . . . . 74.129999999999995 108.261 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.668 ' HB3' HG11 ' A' ' 219' ' ' VAL . 29.2 p90 -72.55 -40.83 66.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 72.519999999999996 111.018 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.594 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -63.87 -64.63 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 73.329999999999998 109.314 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.523 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -43.7 -47.51 7.78 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 74.140000000000001 110.288 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.426 ' N ' ' HD3' ' A' ' 180' ' ' ARG . . . -42.17 -55.72 3.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 75.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.692 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.33 -38.99 20.52 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.568 1.168 . . . . 75.209999999999994 109.597 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 180' ' ' ARG . 30.8 mmmt -64.32 -61.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.465 1.103 . . . . 74.230000000000004 109.268 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.69 ' SD ' HG21 ' A' ' 153' ' ' ILE . 3.4 mtm -38.78 -34.06 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.52 1.138 . . . . 31.02 110.983 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.436 HH21 ' CG ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -63.95 -50.3 69.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 62.450000000000003 110.251 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.516 ' HG3' HD13 ' A' ' 187' ' ' ILE . 3.7 pt20 -52.87 -30.91 36.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.133 . . . . 72.519999999999996 110.311 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.516 HD13 ' HG3' ' A' ' 186' ' ' GLN . 11.0 mm -82.2 -36.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 75.219999999999999 109.277 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.808 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -62.69 -41.8 99.3 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.521 1.138 . . . . 72.120000000000005 109.288 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.439 ' HG2' HD21 ' A' ' 136' ' ' LEU . 21.8 mtp -63.73 -41.03 98.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 71.409999999999997 110.975 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -45.41 -53.28 8.91 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.200000000000003 109.341 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -66.02 -27.14 67.89 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.544 1.152 . . . . 50.509999999999998 109.279 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.72 55.4 0.74 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.531 1.144 . . . . 73.420000000000002 111.025 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.652 ' CZ ' HG21 ' A' ' 145' ' ' THR . 77.5 m-85 -154.94 143.63 20.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.571 0.806 . . . . 64.439999999999998 111.012 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.935 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.1 t70 -109.55 125.45 52.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 70.150000000000006 109.35 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.788 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.7 p -94.51 -179.41 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 44.030000000000001 108.296 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 171.86 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 74.439999999999998 110.294 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.419 ' NZ ' ' HB1' ' A' ' 181' ' ' ALA . 13.0 mmtt -105.72 163.38 12.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 72.25 109.269 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.546 ' OE1' HD13 ' A' ' 222' ' ' LEU . 6.8 tt0 -158.11 117.54 3.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 75.030000000000001 110.328 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.9 m-85 -110.75 119.34 38.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.507 1.129 . . . . 74.209999999999994 111.013 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.659 ' CG2' HG23 ' A' ' 266' ' ' VAL . 9.9 p -115.08 142.32 28.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 71.510000000000005 109.321 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.8 m-85 -117.65 157.25 26.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.239999999999995 110.969 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.92 -175.03 16.51 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.536 1.148 . . . . 51.310000000000002 110.986 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.787 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.1 t-20 -74.39 110.98 9.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.514 0.773 . . . . 73.450000000000003 109.297 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.7 mt -115.56 94.54 4.74 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.132 . . . . 71.340000000000003 109.333 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.4 mttp -92.81 167.12 12.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 109.255 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.923 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -170.43 164.41 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 74.430000000000007 109.297 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 t -142.2 130.19 21.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.109999999999999 110.016 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 13.0 p -88.39 -4.62 58.62 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.457 1.098 . . . . 44.350000000000001 110.453 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 123.99 -43.18 1.45 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.511 1.132 . . . . 74.299999999999997 111.011 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.3 t -128.71 4.98 5.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.468 0.746 . . . . 73.329999999999998 110.397 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 6.9 t -140.64 169.96 16.67 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.127 . . . . 54.210000000000001 108.289 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -137.09 144.33 43.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 74.239999999999995 108.317 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.923 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -128.58 142.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 54.109999999999999 109.278 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.87 128.78 41.29 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.525 1.141 . . . . 64.329999999999998 109.303 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.429 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.0 OUTLIER -134.99 130.84 36.37 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.556 1.16 . . . . 70.420000000000002 107.99 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.3 p -76.46 -0.73 24.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.558 1.161 . . . . 75.349999999999994 109.966 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.5 p90 -173.72 133.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.125 . . . . 74.430000000000007 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 65.5 t60 -119.26 167.79 11.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 63.130000000000003 109.604 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.8 p -150.78 136.22 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.126 . . . . 74.510000000000005 109.287 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.545 ' HB3' ' CZ2' ' A' ' 252' ' ' TRP . . . -135.87 -156.72 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 41.109999999999999 109.327 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.436 HG12 ' CE ' ' A' ' 184' ' ' MET . 23.9 pt -123.07 118.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 62.520000000000003 109.273 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 234' ' ' LYS . 11.0 tp -81.55 109.06 15.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 71.299999999999997 109.285 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -100.87 145.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 61.5 109.292 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 17.0 m -117.34 120.29 37.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.502 1.126 . . . . 73.129999999999995 110.027 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 28.1 p90 -135.68 146.62 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.527 1.142 . . . . 73.230000000000004 110.974 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -71.52 131.52 43.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 75.049999999999997 109.266 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -72.61 -160.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 71.540000000000006 109.316 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.02 49.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 62.340000000000003 109.291 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.5 m -114.96 -7.81 12.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 53.509999999999998 109.993 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.93 37.85 8.26 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.485 1.115 . . . . 72.129999999999995 111.005 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.97 137.9 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.532 0.784 . . . . 63.539999999999999 109.269 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -72.21 102.63 3.12 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.553 1.158 . . . . 54.109999999999999 110.383 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 224' ' ' SER . 4.4 mm-40 -102.21 -172.78 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.209999999999994 110.295 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.8 mmtt -126.93 144.78 50.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 73.540000000000006 109.32 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.588 ' HB3' HG22 ' A' ' 223' ' ' VAL . 3.5 tpt180 -145.56 162.07 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 62.439999999999998 110.283 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.627 HG21 ' CD1' ' A' ' 252' ' ' TRP . 26.3 mm -117.33 119.66 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 73.340000000000003 109.299 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 237' ' ' ILE . 2.6 mm -101.23 47.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 70.329999999999998 109.309 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.692 ' OD1' HD12 ' A' ' 241' ' ' LEU . 27.2 p-10 -94.8 111.4 54.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.340000000000003 109.289 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.98 -44.79 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 62.109999999999999 111.018 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.9 m -39.58 -39.16 0.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.546 1.153 . . . . 72.219999999999999 110.005 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.692 HD12 ' OD1' ' A' ' 238' ' ' ASP . 5.9 mt -92.93 -56.69 2.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 71.120000000000005 109.281 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.729 ' CG ' HG11 ' A' ' 247' ' ' VAL . 95.6 m-85 -121.12 99.5 6.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 62.450000000000003 111.001 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -26.01 34.96 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.453 1.096 . . . . 70.530000000000001 109.989 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 m -57.24 -45.82 83.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 62.049999999999997 109.971 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 179.42 -166.91 36.58 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.447 1.092 . . . . 75.019999999999996 111.004 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.493 ' CG ' HD21 ' A' ' 146' ' ' LEU . 18.1 Cg_endo -75.04 164.0 34.14 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.504 1.792 . . . . 61.409999999999997 110.982 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.729 HG11 ' CG ' ' A' ' 242' ' ' PHE . 12.3 m -140.99 167.78 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 62.009999999999998 109.281 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.449 ' C ' ' N ' ' A' ' 250' ' ' THR . 24.2 p -70.38 136.18 49.44 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.484 1.115 . . . . 73.25 110.384 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 26.6 p-10 -39.86 -30.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 73.540000000000006 109.327 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.449 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -78.1 -61.43 2.0 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 40.200000000000003 110.409 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.91 -22.79 2.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.486 1.116 . . . . 70.349999999999994 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.627 ' CD1' HG21 ' A' ' 236' ' ' ILE . 7.4 t90 -68.68 -60.47 2.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.497 1.123 . . . . 75.450000000000003 107.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.568 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -51.29 -41.81 60.71 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.299999999999997 110.316 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.814 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.8 m-80 -54.66 -51.38 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 72.219999999999999 109.253 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.67 -24.45 48.84 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 73.409999999999997 109.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -83.97 -35.02 24.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 55.100000000000001 108.261 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.1 m -95.82 21.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.299999999999997 109.307 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 39.5 t-20 -51.94 107.88 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 72.530000000000001 109.317 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.0 p -73.36 -3.37 26.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 61.210000000000001 110.389 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.41 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 0.4 OUTLIER -44.73 -30.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 54.009999999999998 109.971 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 42.1 t -88.95 -36.88 15.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 50.25 108.304 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.48 -127.97 1.62 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.473 1.108 . . . . 55.439999999999998 110.938 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.56 147.31 37.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 0.778 . . . . 74.019999999999996 109.973 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.98 146.22 3.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 72.209999999999994 109.289 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -172.73 151.38 2.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.530000000000001 110.018 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.659 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.35 115.08 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.558 1.161 . . . . 50.439999999999998 109.28 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 31.7 t -70.11 -45.46 66.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 75.049999999999997 109.983 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 m -165.08 177.29 7.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.525 1.14 . . . . 72.209999999999994 110.029 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -158.21 156.44 30.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 54.43 110.999 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.34 33.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 62.009999999999998 109.282 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.532 ' O ' HG23 ' A' ' 272' ' ' THR . 8.0 p30 -119.14 160.61 21.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 64.420000000000002 109.278 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.685 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.0 p -154.98 178.89 9.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.524 1.14 . . . . 74.129999999999995 110.378 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -62.67 158.76 17.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.527 1.142 . . . . 73.530000000000001 109.301 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.87 -39.25 55.29 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.481 1.113 . . . . 62.100000000000001 110.955 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -56.7 -48.06 78.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 0.776 . . . . 71.109999999999999 109.273 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.771 HG23 ' HB3' ' A' ' 273' ' ' ALA . 25.3 t -44.7 118.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 63.130000000000003 109.332 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.452 ' OH ' ' ND2' ' A' ' 293' ' ' ASN . 27.8 t80 -70.41 -53.49 16.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.531 1.144 . . . . 74.420000000000002 111.013 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 45.8 t80 -140.22 165.32 27.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 71.200000000000003 111.018 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.685 ' HD2' HG21 ' A' ' 272' ' ' THR . 55.0 ttt-85 -137.01 147.39 46.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 64.239999999999995 110.278 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.6 157.92 44.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 71.349999999999994 109.97 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.19 9.2 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 72.510000000000005 111.0 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.0 t -97.83 3.92 49.8 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 73.409999999999997 110.034 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 77.13 41.37 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.420000000000002 109.273 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.8 t -123.07 119.52 30.57 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.461 1.101 . . . . 65.530000000000001 109.955 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.5 m-30 -99.92 160.22 14.48 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 55.229999999999997 110.957 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.671 HD11 ' CZ ' ' A' ' 320' ' ' PHE . 1.0 OUTLIER -120.45 177.59 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.468 1.105 . . . . 65.030000000000001 109.324 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 94.8 m-85 -160.61 115.57 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 74.0 110.992 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.445 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.7 m-20 -115.18 96.11 5.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 71.200000000000003 109.241 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -85.57 -30.7 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 72.120000000000005 109.274 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.479 ' HB3' HD11 ' A' ' 292' ' ' ILE . 34.3 m-20 -98.3 7.91 45.56 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.139 . . . . 55.32 109.264 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.692 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 3.0 mm? 40.32 47.54 2.19 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.493 1.12 . . . . 65.310000000000002 109.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 290' ' ' ASN . 45.4 mm -78.35 -25.07 13.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.558 1.161 . . . . 72.25 109.305 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.66 ' O ' HG23 ' A' ' 297' ' ' VAL . 8.4 t30 -94.64 -22.82 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 72.030000000000001 109.308 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.438 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.0 m -86.78 -68.97 0.71 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 72.439999999999998 110.383 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -50.86 -22.88 2.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.525 1.141 . . . . 73.030000000000001 109.333 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 20.5 t -79.03 -62.44 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 65.140000000000001 108.312 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 293' ' ' ASN . 18.2 t -44.09 -43.15 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 62.520000000000003 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 168' ' ' ILE . 72.9 mt -63.42 -58.59 6.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 65.530000000000001 109.315 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -38.27 5.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 62.539999999999999 110.402 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -57.18 -56.2 24.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 109.309 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.5 OUTLIER -89.68 35.22 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 63.420000000000002 111.032 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 t -68.07 -49.07 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 54.240000000000002 109.962 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -88.24 -17.94 29.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.439 1.087 . . . . 55.409999999999997 109.274 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.816 HD22 ' CD ' ' A' ' 309' ' ' PRO . 17.9 mt -57.43 144.26 37.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 54.329999999999998 109.26 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.9 p -158.38 136.8 10.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 71.209999999999994 109.995 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 93.31 -155.23 22.17 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.519 1.137 . . . . 74.140000000000001 111.013 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.7 p -98.87 12.81 34.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.295 -1.002 . . . . 31.43 108.295 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.526 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.5 p -135.22 148.61 67.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 74.409999999999997 109.968 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.816 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.95 146.36 86.46 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.023 -2.49 . . . . 74.230000000000004 110.998 -0.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.5 p -132.29 135.77 26.94 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 54.310000000000002 109.985 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.8 14.76 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.985 -2.506 . . . . 63.549999999999997 110.997 -0.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.46 155.91 18.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 44.25 109.291 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.485 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.37 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.5 1.789 . . . . 72.420000000000002 111.01 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.99 135.51 33.38 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 71.319999999999993 109.277 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 13.3 m -126.49 18.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 64.129999999999995 109.285 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.4 -33.06 58.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 72.019999999999996 110.013 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.1 p -43.12 -39.93 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.118 . . . . 72.400000000000006 110.02 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 6.4 m -52.64 170.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.467 1.104 . . . . 72.439999999999998 108.262 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -165.34 73.85 0.17 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.504 1.127 . . . . 64.150000000000006 110.991 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.671 ' CZ ' HD11 ' A' ' 286' ' ' LEU . 1.8 p90 . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.481 0.753 . . . . 74.25 110.939 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.797 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.2 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.287 -0.634 . . . . 64.010000000000005 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.694 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.82 107.76 3.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.543 1.152 . . . . 64.019999999999996 109.285 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -81.69 5.88 17.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.164 . . . . 65.019999999999996 110.031 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -145.87 148.76 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 62.32 109.331 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.095 HD11 HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -100.82 143.72 27.13 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 52.25 109.276 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.2 Cg_endo -74.99 -33.97 4.18 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.509 1.794 . . . . 73.400000000000006 110.985 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.82 150.6 22.85 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 73.030000000000001 109.314 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.8 t -48.83 -36.18 7.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.450000000000003 109.286 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.03 -48.55 3.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 64.319999999999993 109.302 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.691 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -70.01 -36.02 74.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.143 . . . . 74.420000000000002 110.364 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.746 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -57.95 -57.09 14.32 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.158 . . . . 74.299999999999997 109.324 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -52.95 -29.4 28.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 70.230000000000004 109.304 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.3 -55.57 8.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.515 1.134 . . . . 74.230000000000004 109.973 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.095 HD12 HD11 ' A' ' 140' ' ' ILE . 65.3 mt -42.2 -41.99 2.88 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.553 1.158 . . . . 75.450000000000003 109.259 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.571 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.82 -45.37 61.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 73.329999999999998 111.003 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -46.12 -35.37 4.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 73.319999999999993 109.315 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 155' ' ' ASN . 23.9 mt-30 -77.42 -56.4 4.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.24 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.748 HD11 HD12 ' A' ' 188' ' ' LEU . 17.3 mt -50.18 -26.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.458 1.099 . . . . 71.340000000000003 109.265 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -34.62 57.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 74.140000000000001 109.297 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.8 t-20 -61.6 -15.12 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.457 1.098 . . . . 70.099999999999994 109.292 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.45 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 5.7 mm100 -85.68 -18.72 32.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.135 . . . . 74.519999999999996 110.323 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.474 ' HB2' ' CE2' ' A' ' 170' ' ' PHE . 23.7 p -38.68 137.97 0.57 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.553 1.158 . . . . 61.109999999999999 109.991 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -68.03 134.16 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 73.329999999999998 108.288 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.74 -19.05 19.17 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.469 1.105 . . . . 75.420000000000002 111.017 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.848 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 69.8 p -81.24 161.52 23.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.527 0.781 . . . . 74.120000000000005 110.414 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.0 p -93.52 -0.5 56.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.138 . . . . 71.519999999999996 110.032 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 162' ' ' THR . 17.8 m -117.84 6.67 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 63.229999999999997 110.368 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.848 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -83.17 138.14 33.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 63.409999999999997 109.311 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -164.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 43.240000000000002 110.016 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.44 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 14.2 t -156.04 127.47 3.72 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 62.210000000000001 109.995 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.03 137.28 49.44 Favored 'Cis proline' 0 C--N 1.361 1.189 0 C-N-CA 120.986 -2.506 . . . . 74.239999999999995 111.017 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.0 p -73.08 179.48 3.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 63.130000000000003 108.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.564 HG23 ' HB3' ' A' ' 180' ' ' ARG . 3.7 mp -88.95 128.94 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 62.350000000000001 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 301' ' ' PHE . 23.8 p -91.14 85.65 5.96 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 64.200000000000003 110.41 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 157' ' ' SER . 47.9 p90 -86.34 -18.86 30.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 54.329999999999998 110.979 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.448 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.77 -1.78 23.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 75.329999999999998 110.273 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.78 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.8 t80 -129.03 68.29 79.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.44 1.087 . . . . 64.299999999999997 110.983 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.411 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 118.8 5.39 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.457 1.767 . . . . 74.420000000000002 110.963 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.564 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.2 t -152.47 -74.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.116 . . . . 75.239999999999995 109.283 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.553 ' OD1' ' HB2' ' A' ' 312' ' ' ALA . 1.5 p-10 -123.68 -43.15 2.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 74.340000000000003 109.32 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -43.02 126.66 5.01 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.486 1.117 . . . . 51.210000000000001 110.999 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.627 ' SG ' HG12 ' A' ' 219' ' ' VAL . 4.5 p -165.33 -49.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.266 -1.013 . . . . 72.430000000000007 108.266 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.58 ' HB3' HG11 ' A' ' 219' ' ' VAL . 23.9 p90 -70.08 -18.67 63.27 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 72.030000000000001 110.997 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.26 -68.26 0.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.515 1.135 . . . . 72.439999999999998 109.313 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 168' ' ' ILE . 9.2 ptm180 -48.36 -49.81 33.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.476 1.11 . . . . 71.349999999999994 110.302 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.472 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.37 -64.88 0.43 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.118 . . . . 72.310000000000002 109.298 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.4 t60 -39.86 -45.03 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 74.400000000000006 109.607 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 186' ' ' GLN . 14.3 mmmt -62.3 -58.24 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 72.420000000000002 109.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.642 ' SD ' HG21 ' A' ' 153' ' ' ILE . 9.2 mtm -38.96 -36.13 0.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 60.549999999999997 110.981 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.431 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.1 OUTLIER -63.47 -48.99 75.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 62.43 110.314 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 183' ' ' LYS . 2.9 pt20 -53.1 -33.2 51.12 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.447 1.092 . . . . 72.319999999999993 110.278 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.434 HD13 ' HG3' ' A' ' 186' ' ' GLN . 17.3 mm -75.79 -37.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.145 . . . . 74.0 109.26 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.748 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -61.28 -44.45 97.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.099999999999994 109.285 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.438 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.2 mtt -56.41 -42.28 77.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 75.209999999999994 110.992 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -48.45 -52.66 21.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.46 1.1 . . . . 64.420000000000002 109.288 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -62.28 -37.22 84.67 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 74.109999999999999 109.274 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.77 48.15 0.69 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.522 1.139 . . . . 71.299999999999997 110.971 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.694 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 61.6 m-85 -147.78 137.62 22.69 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 0.769 . . . . 74.310000000000002 111.001 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.797 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.3 t70 -103.17 129.26 50.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 64.109999999999999 109.293 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.712 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.8 p -108.15 -178.79 3.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 74.430000000000007 108.286 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.4 OUTLIER -126.47 174.74 8.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 73.319999999999993 110.27 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.472 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 20.5 mmtt -109.73 167.08 10.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 33.130000000000003 109.279 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 219' ' ' VAL . 0.6 OUTLIER -153.45 144.87 23.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 72.5 110.271 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.527 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.1 m-85 -139.87 112.61 7.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.156 . . . . 64.549999999999997 110.992 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.795 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.4 p -106.68 143.21 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 73.319999999999993 109.278 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.4 m-85 -113.99 150.49 33.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.11 . . . . 73.430000000000007 110.97 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.17 19.53 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.465 1.103 . . . . 64.510000000000005 111.003 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.815 ' C ' HD23 ' A' ' 204' ' ' LEU . 54.4 t-20 -77.65 111.46 13.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.54 0.788 . . . . 63.119999999999997 109.299 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.815 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.0 mt -114.09 95.97 5.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 73.519999999999996 109.251 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.0 mtpt -92.31 165.4 13.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 72.129999999999995 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.877 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -170.6 122.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 52.109999999999999 109.325 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.409 ' CB ' ' SG ' ' A' ' 261' ' ' CYS . 3.3 p -96.24 131.62 42.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.134 . . . . 72.120000000000005 110.017 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 15.8 p -107.65 -5.86 17.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.447 1.092 . . . . 74.310000000000002 110.421 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 89.28 -22.88 21.07 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.495 1.122 . . . . 55.450000000000003 111.014 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.1 m -113.28 -18.85 11.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.443 0.731 . . . . 64.230000000000004 110.397 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 1.3 p -169.94 148.33 3.46 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 73.430000000000007 108.337 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.5 m -97.78 140.56 31.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.517 1.136 . . . . 74.409999999999997 108.354 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.877 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -117.56 142.24 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 61.149999999999999 109.318 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.31 127.82 28.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 64.420000000000002 109.364 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.464 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.6 OUTLIER -132.66 132.9 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 108.009 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 30.5 t -76.5 -0.76 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.149 . . . . 61.530000000000001 109.971 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 10.3 p90 -176.4 133.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 62.310000000000002 111.022 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 32.4 t60 -117.48 168.9 9.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.095 . . . . 72.099999999999994 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 198' ' ' GLN . 2.8 p -147.75 142.02 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.46 1.1 . . . . 61.240000000000002 109.259 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.16 -167.27 2.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 74.140000000000001 109.278 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 196' ' ' GLU . 19.9 pt -115.92 121.95 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 75.420000000000002 109.311 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.716 HD22 HE22 ' A' ' 198' ' ' GLN . 18.2 tp -84.49 115.55 22.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.463 1.102 . . . . 65.129999999999995 109.298 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -109.07 145.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.487 1.117 . . . . 62.020000000000003 109.303 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 69.5 m -115.73 121.71 43.32 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 73.299999999999997 109.953 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.3 p90 -136.66 143.32 43.38 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 70.409999999999997 111.017 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.423 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.4 mmtp -69.23 132.51 46.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.451 1.094 . . . . 74.420000000000002 109.294 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.46 -160.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.340000000000003 109.332 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.21 50.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 41.409999999999997 109.329 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.6 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 75.349999999999994 110.009 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.39 8.16 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.538 1.149 . . . . 71.019999999999996 110.982 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.09 137.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 0.767 . . . . 73.310000000000002 109.281 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.423 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.5 m -71.91 102.66 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 33.450000000000003 110.43 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.8 mm-40 -103.12 -172.86 2.19 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 71.510000000000005 110.296 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.475 ' HB3' HD11 ' A' ' 222' ' ' LEU . 8.5 mmtm -126.12 145.56 50.3 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 65.340000000000003 109.323 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.8 tpt180 -143.74 159.1 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 63.450000000000003 110.325 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.582 HG21 ' CD1' ' A' ' 252' ' ' TRP . 7.7 mm -111.63 124.89 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 53.130000000000003 109.331 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 237' ' ' ILE . 2.8 mm -112.95 44.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 74.150000000000006 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.545 ' OD1' HD12 ' A' ' 241' ' ' LEU . 10.8 p-10 -94.12 111.67 54.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 51.229999999999997 109.322 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.464 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.4 Cg_endo -74.94 -36.33 2.66 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.506 1.793 . . . . 73.109999999999999 110.994 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 1.3 p -43.16 -36.47 1.72 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.456 1.097 . . . . 73.310000000000002 109.98 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.545 HD12 ' OD1' ' A' ' 238' ' ' ASP . 16.5 mt -102.56 -59.52 1.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 72.109999999999999 109.284 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 255' ' ' ALA . 89.6 m-85 -111.3 98.99 7.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 73.129999999999995 111.07 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.6 m -91.02 -13.13 33.85 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 61.5 109.985 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 p -74.73 -46.54 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.098 . . . . 72.5 110.001 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -172.0 -179.52 42.98 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.501 1.126 . . . . 72.129999999999995 111.005 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 236' ' ' ILE . 18.3 Cg_endo -74.98 169.29 22.96 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.485 1.782 . . . . 73.510000000000005 110.978 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.604 HG11 ' CD2' ' A' ' 242' ' ' PHE . 5.0 m -153.13 157.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.121 . . . . 74.230000000000004 109.289 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.434 ' C ' ' N ' ' A' ' 250' ' ' THR . 46.7 p -59.28 136.56 58.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 73.219999999999999 110.447 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 248' ' ' THR . 1.7 p-10 -40.33 -30.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 74.420000000000002 109.316 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.434 ' N ' ' C ' ' A' ' 248' ' ' THR . 3.7 m -70.06 -65.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 71.230000000000004 110.365 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.58 -38.4 14.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 61.119999999999997 109.31 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 19.4 t90 -54.25 -63.55 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 74.310000000000002 108.0 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.571 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -46.49 -45.78 18.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 60.210000000000001 110.327 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.746 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -53.14 -51.68 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.499 1.124 . . . . 65.349999999999994 109.285 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.78 -21.85 31.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 73.409999999999997 109.328 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -84.57 -38.19 20.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 63.299999999999997 108.34 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.746 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.3 m -91.19 18.56 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 24.350000000000001 109.285 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 260' ' ' SER . 6.8 t30 -40.51 104.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 63.350000000000001 109.329 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.8 p -79.89 -4.04 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.461 1.101 . . . . 53.32 110.387 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 258' ' ' ASN . 5.2 t -58.7 -16.13 15.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 62.509999999999998 110.033 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' CYS . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 1.3 m -98.76 -20.34 16.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.447 1.092 . . . . 70.109999999999999 108.301 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 152.37 -125.88 1.91 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.512 1.132 . . . . 73.319999999999993 110.944 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -84.54 144.56 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 62.240000000000002 109.993 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.51 146.2 2.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 70.150000000000006 109.3 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.26 152.45 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.45 1.094 . . . . 73.019999999999996 109.997 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.795 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.4 p -97.23 111.84 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 71.310000000000002 109.303 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.4 t -69.0 -46.95 66.72 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 64.230000000000004 110.007 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 200' ' ' VAL . 5.0 m -158.71 -175.04 5.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 71.450000000000003 110.013 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -166.5 157.25 12.48 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 71.430000000000007 110.977 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -160.34 153.24 21.39 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.549999999999997 109.325 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -110.84 160.69 16.52 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.442 1.089 . . . . 52.140000000000001 109.325 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.42 177.64 9.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 70.340000000000003 110.402 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.29 171.41 3.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 75.049999999999997 109.292 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -84.95 -4.53 86.99 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.553 1.158 . . . . 71.540000000000006 110.951 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 -44.5 7.73 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.499 0.764 . . . . 73.310000000000002 109.326 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 273' ' ' ALA . 87.7 t -43.64 101.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 60.229999999999997 109.28 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.516 ' HH ' ' HE1' ' A' ' 178' ' ' TYR . 57.4 t80 -62.32 -39.23 92.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.547 1.154 . . . . 75.140000000000001 110.979 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -149.48 150.54 32.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 63.43 110.984 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.527 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 74.1 ttt-85 -116.05 147.59 41.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.519999999999996 110.288 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 153.4 47.29 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.126 . . . . 62.340000000000003 109.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 0.06 9.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.487 1.783 . . . . 53.299999999999997 110.999 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 1.7 p -104.12 4.58 34.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 43.229999999999997 109.989 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 81.2 41.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 45.030000000000001 109.324 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.9 t -121.51 128.72 52.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 64.430000000000007 110.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.438 ' HB3' HG13 ' A' ' 276' ' ' VAL . 15.4 m-30 -110.04 155.87 21.27 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.128 . . . . 74.439999999999998 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.23 176.95 4.86 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 73.340000000000003 109.315 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.622 ' H ' HD13 ' A' ' 286' ' ' LEU . 95.7 m-85 -162.67 115.62 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 71.099999999999994 110.943 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.3 94.97 4.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 61.200000000000003 109.315 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.421 ' O ' HD22 ' A' ' 291' ' ' LEU . 3.0 m-80 -83.19 -39.13 21.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 73.299999999999997 109.313 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.506 ' HB3' HD11 ' A' ' 292' ' ' ILE . 28.5 m-20 -90.64 9.95 27.66 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 74.120000000000005 109.296 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.517 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.11 46.3 1.83 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.546 1.154 . . . . 53.140000000000001 109.304 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 290' ' ' ASN . 46.3 mm -77.15 -33.95 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 62.340000000000003 109.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.724 ' O ' HG23 ' A' ' 297' ' ' VAL . 3.9 t30 -94.7 -15.25 24.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 63.240000000000002 109.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.448 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 24.1 m -87.66 -65.49 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 63.450000000000003 110.404 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.415 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 63.3 m-20 -57.95 -22.78 50.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 72.230000000000004 109.3 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 12.5 t -75.91 -65.67 0.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 61.240000000000002 108.308 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 293' ' ' ASN . 41.6 t -40.27 -40.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 74.450000000000003 109.271 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.93 -57.72 5.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 70.340000000000003 109.261 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -56.19 -17.85 8.54 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.488 1.118 . . . . 71.129999999999995 110.398 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -76.93 -42.94 37.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 75.099999999999994 109.329 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.8 m-30 -105.75 40.33 1.59 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 62.140000000000001 111.002 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -67.71 -55.79 11.8 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.542 1.151 . . . . 74.209999999999994 110.015 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.796 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -81.12 -18.32 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.119 . . . . 73.120000000000005 109.299 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.78 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 13.5 mt -55.78 134.03 51.4 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.492 1.12 . . . . 72.420000000000002 109.274 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 74.5 p -148.61 154.33 39.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 72.109999999999999 110.007 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.28 -146.41 29.04 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.463 1.102 . . . . 73.099999999999994 110.997 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 12.5 m -108.93 12.99 25.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.301 -0.999 . . . . 64.540000000000006 108.301 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.525 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.9 OUTLIER -129.8 149.24 72.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 51.420000000000002 109.988 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.726 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 147.14 88.55 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.008 -2.497 . . . . 74.420000000000002 110.994 0.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.489 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.0 OUTLIER -129.07 133.64 25.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 73.409999999999997 110.007 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.04 -169.52 7.44 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.978 -2.509 . . . . 64.540000000000006 110.942 0.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.553 ' HB2' ' OD1' ' A' ' 175' ' ' ASP . . . -56.9 151.76 31.33 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.44 1.088 . . . . 61.100000000000001 109.295 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.494 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.491 1.785 . . . . 72.430000000000007 110.95 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.75 135.01 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 43.030000000000001 109.262 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 19.7 m -123.57 24.3 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.137 . . . . 73.329999999999998 109.309 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.429 ' C ' ' N ' ' A' ' 318' ' ' CYS . 3.5 t -53.69 -42.12 67.62 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.093 . . . . 70.420000000000002 110.005 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 16.0 m -41.89 -28.26 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 63.530000000000001 110.066 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' CYS . . . . . 0.429 ' N ' ' C ' ' A' ' 316' ' ' SER . 75.4 m -54.57 -173.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.551 1.157 . . . . 73.530000000000001 108.333 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -157.07 -123.69 0.78 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.476 1.11 . . . . 73.409999999999997 110.987 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' A' ' 320' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.452 0.736 . . . . 64.319999999999993 110.983 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 136' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.833 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -166.73 112.26 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.477 1.111 . . . . 65.109999999999999 109.311 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.464 ' CA ' ' OD2' ' A' ' 194' ' ' ASP . 0.5 OUTLIER -83.41 4.03 29.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 109.974 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.4 151.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 64.439999999999998 109.286 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -104.85 145.0 29.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.430000000000007 109.296 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.97 -35.18 3.33 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.493 1.786 . . . . 61.009999999999998 111.014 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.413 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.88 150.06 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 73.409999999999997 109.333 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.511 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -46.06 -37.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 72.319999999999993 109.291 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.23 -49.32 2.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 63.219999999999999 109.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.653 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.45 1.094 . . . . 63.329999999999998 110.421 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.78 -57.45 12.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 74.329999999999998 109.241 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -52.95 -30.41 34.53 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.47 1.106 . . . . 62.409999999999997 109.337 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.74 -56.77 7.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.572 1.17 . . . . 54.340000000000003 110.038 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.042 HD12 HD11 ' A' ' 140' ' ' ILE . 79.2 mt -43.11 -43.03 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 75.420000000000002 109.31 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.605 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.69 -45.1 62.92 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 74.439999999999998 110.959 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -46.05 -36.92 6.13 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 1.11 . . . . 72.109999999999999 109.3 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.467 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 28.2 mt-30 -76.41 -55.79 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 74.439999999999998 110.284 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 188' ' ' LEU . 19.9 mt -49.46 -27.46 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 55.439999999999998 109.296 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -37.34 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.503 1.127 . . . . 64.010000000000005 109.306 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -56.21 -19.33 13.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 73.109999999999999 109.324 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.515 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 12.0 mm-40 -80.82 -28.01 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.454 1.096 . . . . 72.120000000000005 110.292 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.4 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 21.5 m -39.85 123.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 61.119999999999997 109.998 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.1 m -53.24 116.22 2.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.482 1.114 . . . . 73.420000000000002 108.303 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 142.03 -14.06 2.6 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.484 1.115 . . . . 23.32 111.011 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.743 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 59.0 p -97.71 161.86 13.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 0.75 . . . . 72.400000000000006 110.404 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -93.4 -2.35 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 63.409999999999997 109.967 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 162' ' ' THR . 2.2 m -112.03 0.1 15.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 75.430000000000007 110.397 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.743 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -75.57 134.09 40.79 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.51 1.131 . . . . 75.109999999999999 109.285 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -169.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.55 1.157 . . . . 73.200000000000003 110.029 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.451 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 44.0 p -154.75 127.53 4.11 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 64.319999999999993 110.026 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.08 137.14 48.56 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 121.019 -2.492 . . . . 65.019999999999996 110.981 0.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.472 ' O ' HD13 ' A' ' 298' ' ' LEU . 9.5 p -72.95 -178.91 2.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 64.120000000000005 108.278 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.845 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.0 mp -84.5 128.16 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 54.32 109.308 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 p -92.54 76.27 5.08 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.562 1.164 . . . . 71.140000000000001 110.399 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 51.2 p90 -78.76 -14.17 59.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 72.420000000000002 110.979 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.46 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -73.74 -3.03 25.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 74.129999999999995 110.296 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.776 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -131.84 66.7 78.43 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 74.340000000000003 111.018 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.547 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.2 Cg_endo -74.98 118.46 5.28 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.518 1.799 . . . . 73.219999999999999 111.015 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 172' ' ' TYR . 19.0 t -152.84 -64.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 54.100000000000001 109.326 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -132.3 -46.68 0.91 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 62.310000000000002 109.273 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -45.43 104.15 0.06 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.472 1.107 . . . . 51.43 110.996 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.493 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 3.5 p -138.65 -48.43 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.243 -1.021 . . . . 31.329999999999998 108.243 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.542 ' HE1' ' HH ' ' A' ' 277' ' ' TYR . 25.7 p90 -68.5 -16.22 63.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 74.450000000000003 110.985 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.93 -68.31 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 62.039999999999999 109.318 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HB3' HG23 ' A' ' 168' ' ' ILE . 7.2 ptm180 -50.92 -49.03 60.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.12 . . . . 75.25 110.297 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB1' ' HZ3' ' A' ' 197' ' ' LYS . . . -39.58 -56.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 71.319999999999993 109.292 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.549 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -47.1 -44.56 21.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.117 . . . . 63.520000000000003 109.601 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.845 ' CB ' HD11 ' A' ' 168' ' ' ILE . 22.9 mmmt -64.36 -42.25 96.3 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 73.549999999999997 109.328 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.516 ' HA ' HG23 ' A' ' 153' ' ' ILE . 17.4 mtm -55.5 -33.2 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 65.420000000000002 111.003 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -21.33 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 65.340000000000003 110.319 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.436 ' HG2' HD13 ' A' ' 187' ' ' ILE . 4.5 tt0 -71.73 -39.66 69.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.509 1.131 . . . . 74.219999999999999 110.304 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.467 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 19.0 mm -74.14 -32.48 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 63.439999999999998 109.294 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.867 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -61.65 -44.46 96.94 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.454 1.096 . . . . 74.030000000000001 109.324 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.6 mtp -58.51 -42.18 87.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 60.200000000000003 111.006 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -50.38 -53.53 28.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.461 1.1 . . . . 64.120000000000005 109.303 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.408 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 7.1 t-20 -60.55 -29.55 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 73.010000000000005 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.71 37.33 2.6 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.517 1.136 . . . . 71.010000000000005 110.99 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.833 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 73.7 m-85 -138.04 129.05 27.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 0.791 . . . . 62.520000000000003 110.988 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.464 ' OD2' ' CA ' ' A' ' 138' ' ' SER . 0.7 OUTLIER -99.27 132.51 44.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 51.240000000000002 109.293 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.695 ' HB3' HD22 ' A' ' 188' ' ' LEU . 25.9 p -112.17 -179.45 3.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 71.129999999999995 108.258 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -122.45 176.02 6.13 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.126 . . . . 62.240000000000002 110.285 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.637 ' HE2' HG22 ' A' ' 221' ' ' ILE . 22.0 mmtt -107.67 174.41 5.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 51.219999999999999 109.317 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.703 ' O ' HG23 ' A' ' 219' ' ' VAL . 17.1 tt0 -160.59 139.17 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.541 1.151 . . . . 74.230000000000004 110.263 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -130.27 113.49 14.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 74.430000000000007 110.994 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.667 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.2 p -110.15 148.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 74.230000000000004 109.32 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.1 m-85 -121.6 160.44 24.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.478 1.111 . . . . 74.340000000000003 111.0 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.44 179.88 17.01 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.551 1.157 . . . . 64.25 111.015 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.728 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.3 t-20 -69.23 110.27 4.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.491 0.759 . . . . 62.530000000000001 109.324 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -114.56 93.49 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 74.450000000000003 109.296 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.8 mttp -93.27 165.35 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 73.0 109.303 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -168.53 143.07 3.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 65.120000000000005 109.318 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 52.6 p -117.69 110.15 17.51 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 61.140000000000001 110.015 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.4 p -80.89 -20.08 42.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.492 1.12 . . . . 74.430000000000007 110.411 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 122.85 -49.91 0.87 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.539 1.149 . . . . 73.310000000000002 111.012 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 75.5 p -91.52 -17.58 25.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.481 0.754 . . . . 22.120000000000001 110.413 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -168.0 163.29 13.62 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.487 1.117 . . . . 70.120000000000005 108.301 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.478 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.34 145.92 44.75 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.536 1.148 . . . . 62.520000000000003 108.329 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -112.36 155.53 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 62.25 109.247 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.52 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -139.4 119.07 13.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 73.25 109.282 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.33 134.79 51.01 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.155 . . . . 75.150000000000006 108.02 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.1 m -80.45 3.78 20.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.458 1.099 . . . . 72.219999999999999 109.994 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.496 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.8 p90 -176.14 127.75 0.21 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.477 1.111 . . . . 55.240000000000002 111.027 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -116.54 168.45 10.16 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.478 1.111 . . . . 62.439999999999998 109.619 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 198' ' ' GLN . 1.3 p -145.57 143.38 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.49 1.119 . . . . 53.219999999999999 109.312 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.563 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -142.19 -165.68 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 45.229999999999997 109.294 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.637 HG22 ' HE2' ' A' ' 197' ' ' LYS . 31.1 pt -116.09 122.5 69.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 73.200000000000003 109.296 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 234' ' ' LYS . 19.9 tp -87.1 108.87 19.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 52.530000000000001 109.312 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.701 HG11 HG13 ' A' ' 237' ' ' ILE . 0.9 OUTLIER -102.0 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 65.140000000000001 109.3 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ILE . 54.8 m -135.75 120.14 17.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.494 1.121 . . . . 64.519999999999996 109.993 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.511 ' CD2' HG23 ' A' ' 143' ' ' VAL . 34.3 p90 -136.15 142.37 44.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.120000000000005 111.03 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.2 mmtp -68.21 132.84 47.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.504 1.128 . . . . 75.349999999999994 109.286 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -73.73 -160.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 53.439999999999998 109.321 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 0.09 48.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.481 1.113 . . . . 71.430000000000007 109.312 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -115.36 -7.19 12.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 73.329999999999998 110.02 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.54 37.66 8.67 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.473 1.108 . . . . 44.350000000000001 110.975 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 137.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.455 0.738 . . . . 74.430000000000007 109.323 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 8.6 m -71.47 102.58 2.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.049999999999997 110.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 224' ' ' SER . 1.8 mm-40 -101.39 -172.47 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 74.310000000000002 110.297 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.511 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -127.52 145.3 50.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 75.5 109.286 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.55 ' NH1' HG22 ' A' ' 248' ' ' THR . 4.3 tpt180 -142.68 161.14 38.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 74.549999999999997 110.284 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.697 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.4 mm -113.7 117.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.52 1.138 . . . . 54.119999999999997 109.318 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -105.08 45.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 64.329999999999998 109.314 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.9 106.54 53.31 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 62.109999999999999 109.309 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -75.01 -10.02 21.01 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 74.409999999999997 111.003 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.7 t -64.5 -11.85 38.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 61.329999999999998 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.472 HD11 ' NE2' ' A' ' 218' ' ' HIS . 5.2 mt -127.55 -48.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 73.140000000000001 109.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' A' ' 255' ' ' ALA . 75.9 m-85 -118.54 99.54 6.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.576 1.172 . . . . 74.200000000000003 111.017 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 75.6 m -88.14 -6.44 57.88 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.547 1.154 . . . . 74.329999999999998 109.982 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.1 m -80.95 -45.77 16.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 74.540000000000006 110.012 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.05 -174.23 43.29 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.495 1.122 . . . . 54.399999999999999 110.987 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.45 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 164.42 33.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.485 1.781 . . . . 63.32 111.021 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.577 HG21 ' CE2' ' A' ' 242' ' ' PHE . 2.6 m -150.46 161.23 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.113 . . . . 72.219999999999999 109.32 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.55 HG22 ' NH1' ' A' ' 235' ' ' ARG . 34.3 p -64.51 138.21 58.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.523 1.139 . . . . 71.010000000000005 110.41 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.409 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 0.4 OUTLIER -40.92 -29.79 0.11 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.51 1.131 . . . . 55.130000000000003 109.307 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 6.3 m -71.85 -64.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 64.5 110.384 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.37 -25.55 10.08 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.504 1.127 . . . . 74.230000000000004 109.314 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.697 ' CD1' HG21 ' A' ' 236' ' ' ILE . 9.2 t90 -64.36 -59.91 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.995 -1.113 . . . . 72.230000000000004 107.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.544 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.26 -41.9 39.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 63.25 110.281 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.852 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -56.56 -50.75 70.97 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.499 1.124 . . . . 74.5 109.275 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.596 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -55.94 -20.99 18.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 40.119999999999997 109.32 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.16 -36.2 16.97 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 72.319999999999993 108.262 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.852 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -93.36 21.59 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 44.420000000000002 109.271 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -51.06 107.1 0.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 73.310000000000002 109.329 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.2 p -73.49 -3.06 25.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 63.210000000000001 110.385 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.3 t -44.3 -30.84 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.505 1.128 . . . . 62.049999999999997 109.97 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.59 -37.35 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 71.219999999999999 108.347 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.72 -128.06 1.66 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.546 1.154 . . . . 23.300000000000001 110.993 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.02 145.35 42.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.477 0.751 . . . . 62.329999999999998 109.983 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.02 148.03 4.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.46 1.1 . . . . 62.020000000000003 109.314 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 29.3 m -172.77 155.23 3.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 44.229999999999997 110.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.667 HG23 ' CG2' ' A' ' 200' ' ' VAL . 4.9 p -102.65 116.54 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.467 1.104 . . . . 41.310000000000002 109.283 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 32.0 t -70.76 -44.89 65.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.505 1.128 . . . . 65.030000000000001 109.951 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 200' ' ' VAL . 50.7 p -165.43 -173.52 2.83 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.151 . . . . 74.230000000000004 110.006 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -165.4 156.53 14.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 63.219999999999999 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.04 147.84 23.05 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.53 1.144 . . . . 75.120000000000005 109.286 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -99.63 158.93 15.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 65.019999999999996 109.31 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 1.3 p -146.44 179.14 7.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.517 1.135 . . . . 71.530000000000001 110.386 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -74.57 163.36 27.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 64.530000000000001 109.324 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.47 -16.41 80.01 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.492 1.12 . . . . 74.219999999999999 111.008 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 276' ' ' VAL . 7.5 p30 -86.29 -43.61 12.78 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 0.782 . . . . 63.420000000000002 109.342 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.445 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 3.8 t -43.71 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.571 1.169 . . . . 64.230000000000004 109.285 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.542 ' HH ' ' HE1' ' A' ' 178' ' ' TYR . 34.0 t80 -66.95 -42.8 84.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 52.549999999999997 111.022 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.6 OUTLIER -153.21 121.02 6.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 64.219999999999999 111.029 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.469 ' HD2' ' CG2' ' A' ' 272' ' ' THR . 40.8 ttt-85 -106.57 137.19 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.515 1.134 . . . . 73.030000000000001 110.334 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.92 158.17 32.62 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 73.040000000000006 110.007 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.47 8.88 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.467 1.772 . . . . 72.409999999999997 110.974 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 27.9 t -98.18 13.19 32.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.542 1.152 . . . . 72.230000000000004 109.99 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 74.87 37.19 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 55.5 109.338 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -112.3 152.94 27.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 64.230000000000004 109.951 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.457 ' CE1' ' HD2' ' A' ' 279' ' ' ARG . 51.9 m-85 -140.54 158.2 44.35 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 73.109999999999999 111.022 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -126.08 172.95 9.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.498 1.123 . . . . 74.299999999999997 109.281 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.473 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 88.1 m-85 -160.23 114.95 2.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 1.099 . . . . 64.329999999999998 111.001 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.426 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 8.0 t0 -115.5 97.04 5.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 64.140000000000001 109.273 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.434 ' O ' HD22 ' A' ' 291' ' ' LEU . 6.8 m-20 -85.83 -39.42 17.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 65.25 109.298 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.476 ' CB ' HG12 ' A' ' 292' ' ' ILE . 4.3 m120 -90.52 9.54 28.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 72.510000000000005 109.325 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.549 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.06 46.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 1.125 . . . . 65.049999999999997 109.305 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.485 HG21 ' O ' ' A' ' 319' ' ' GLY . 48.9 mm -77.28 -28.77 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 73.549999999999997 109.298 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.831 ' O ' HG23 ' A' ' 297' ' ' VAL . 4.2 t30 -94.54 -22.53 18.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.420000000000002 109.312 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 m -84.52 -64.18 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.478 1.111 . . . . 53.32 110.395 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 82.5 m-20 -57.47 -17.94 15.97 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.119 . . . . 74.019999999999996 109.308 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 7.2 t -81.88 -63.95 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 55.240000000000002 108.303 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 293' ' ' ASN . 46.2 t -40.38 -51.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.545 1.153 . . . . 75.439999999999998 109.27 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 167' ' ' CYS . 47.0 mt -57.14 -59.48 5.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 64.310000000000002 109.296 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.22 -34.71 2.92 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.140000000000001 110.378 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -68.06 -43.31 78.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 73.109999999999999 109.259 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.738 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.5 m-30 -99.5 35.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 73.25 111.006 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.2 t -69.41 -43.36 73.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 64.109999999999999 110.029 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.45 -12.78 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.430000000000007 109.315 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.776 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 12.6 mt -60.39 150.28 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 74.209999999999994 109.295 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.6 p -161.48 162.92 30.61 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 54.299999999999997 109.984 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.68 -152.82 52.78 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.519 1.137 . . . . 74.040000000000006 111.018 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 2.1 m -101.64 13.12 35.88 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.292 -1.003 . . . . 64.450000000000003 108.292 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.522 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 12.9 p -129.49 150.01 74.45 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.150000000000006 110.009 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.705 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.6 Cg_endo -74.95 147.12 88.51 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.967 -2.514 . . . . 75.540000000000006 111.056 -0.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.465 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -128.71 133.69 25.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.531 1.145 . . . . 74.109999999999999 109.992 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -74.96 -170.27 8.1 Favored 'Cis proline' 0 C--N 1.36 1.168 0 C-N-CA 120.97 -2.512 . . . . 55.109999999999999 111.033 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 152.34 29.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 71.129999999999995 109.29 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.414 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.512 1.796 . . . . 73.439999999999998 110.996 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -91.4 135.31 33.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.148 . . . . 71.219999999999999 109.254 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.7 m -126.59 24.5 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.489 1.118 . . . . 73.129999999999995 109.276 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 318' ' ' CYS . 35.6 t -50.73 -44.12 58.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.349999999999994 109.952 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.6 m -39.51 -29.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 71.25 110.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 316' ' ' SER . 74.6 m -52.04 -179.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.434 1.084 . . . . 64.030000000000001 108.304 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.485 ' O ' HG21 ' A' ' 292' ' ' ILE . . . -178.93 66.25 0.08 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.471 1.107 . . . . 70.519999999999996 110.959 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 8.3 p90 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.493 0.761 . . . . 74.129999999999995 110.966 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.718 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.327 -0.62 . . . . 72.329999999999998 109.327 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.811 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.04 106.7 3.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.533 1.145 . . . . 54.119999999999997 109.327 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m -81.82 5.65 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.329999999999998 109.99 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.3 t -149.35 145.62 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 70.140000000000001 109.302 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.107 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -96.88 142.44 24.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.488 1.117 . . . . 62.549999999999997 109.27 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -32.44 5.42 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.464 1.77 . . . . 63.109999999999999 110.99 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.485 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.49 153.22 22.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.105 . . . . 73.129999999999995 109.3 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 146' ' ' LEU . 1.8 t -51.08 -34.31 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.158 . . . . 74.109999999999999 109.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.84 -45.86 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 74.049999999999997 109.32 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.721 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.6 m -73.21 -32.38 64.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 64.239999999999995 110.415 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -61.84 -56.23 21.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 73.319999999999993 109.295 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -53.62 -31.37 46.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 71.040000000000006 109.288 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.39 -55.22 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 73.319999999999993 109.987 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.107 HD12 HD11 ' A' ' 140' ' ' ILE . 92.1 mt -44.4 -42.41 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 72.010000000000005 109.302 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.654 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -72.35 -44.7 62.22 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 1.117 . . . . 75.129999999999995 110.994 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -47.04 -37.32 9.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 70.450000000000003 109.262 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.465 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 21.9 mt-30 -74.94 -55.57 5.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 1.139 . . . . 62.299999999999997 110.293 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.699 HD11 HD12 ' A' ' 188' ' ' LEU . 23.4 mt -50.45 -28.0 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 54.0 109.308 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.406 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -75.07 -33.71 61.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 62.140000000000001 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.3 t-20 -61.59 -15.15 36.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 70.010000000000005 109.294 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -85.81 -18.47 32.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 71.209999999999994 110.302 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.0 p -37.93 134.51 0.75 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 1.13 . . . . 54.350000000000001 109.977 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.676 ' HB3' HH21 ' A' ' 171' ' ' ARG . 1.3 m -66.18 120.04 12.53 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 60.329999999999998 108.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 127.69 -15.82 6.26 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 51.439999999999998 110.99 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.867 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 69.6 p -83.39 161.9 21.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 0.758 . . . . 72.310000000000002 110.387 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -93.55 0.12 56.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.467 1.104 . . . . 74.5 109.963 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 162' ' ' THR . 2.9 m -119.45 7.15 11.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 50.119999999999997 110.355 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.867 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -81.31 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 62.119999999999997 109.308 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -162.03 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 54.409999999999997 110.014 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 126.92 3.5 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 70.430000000000007 110.039 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 139.85 64.05 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.948 -2.522 . . . . 74.409999999999997 110.998 0.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.99 178.46 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.1 . . . . 75.540000000000006 108.333 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.949 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.0 mp -86.32 132.95 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 70.209999999999994 109.268 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 301' ' ' PHE . 51.0 p -90.43 75.24 6.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 60.439999999999998 110.403 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -81.64 -24.79 36.13 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 62.409999999999997 111.027 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.676 HH21 ' HB3' ' A' ' 158' ' ' CYS . 0.0 OUTLIER -75.97 -1.57 26.28 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 73.450000000000003 110.3 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.796 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 25.6 t80 -128.91 67.44 77.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.092 . . . . 61.240000000000002 111.012 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.415 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.55 4.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.51 1.795 . . . . 50.240000000000002 111.013 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.585 HG21 ' CE1' ' A' ' 172' ' ' TYR . 14.6 t -152.23 -58.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 74.329999999999998 109.292 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -138.43 -47.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 52.43 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.19 106.46 0.05 OUTLIER Glycine 0 CA--C 1.529 0.938 0 O-C-N 124.526 1.141 . . . . 61.450000000000003 111.044 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.786 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.6 p -143.06 -48.41 0.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.307 -0.997 . . . . 52.049999999999997 108.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.604 ' HB3' HG11 ' A' ' 219' ' ' VAL . 24.3 p90 -69.99 -33.9 72.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.461 1.101 . . . . 74.129999999999995 111.062 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.492 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -62.57 -68.42 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 72.140000000000001 109.264 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.669 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -46.38 -44.5 17.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 55.100000000000001 110.32 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.71 -55.47 5.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.466 1.104 . . . . 51.329999999999998 109.267 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.88 -35.83 15.66 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 72.340000000000003 109.635 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.949 ' CB ' HD11 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -71.47 -50.55 30.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 75.420000000000002 109.286 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.555 ' HA ' HG23 ' A' ' 153' ' ' ILE . 5.3 mtm -51.84 -41.2 61.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 62.100000000000001 111.01 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.96 -24.47 58.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 63.530000000000001 110.305 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.425 ' HG2' HD13 ' A' ' 187' ' ' ILE . 5.7 tt0 -69.48 -41.56 75.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.515 1.135 . . . . 72.239999999999995 110.305 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 20.8 mm -72.02 -33.0 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.488 1.118 . . . . 74.430000000000007 109.274 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -59.56 -47.36 85.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 1.097 . . . . 75.219999999999999 109.332 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.482 ' HG2' HD21 ' A' ' 136' ' ' LEU . 2.4 mtt -54.9 -44.35 74.05 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 73.150000000000006 111.001 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.0 -53.33 20.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 74.329999999999998 109.312 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -58.46 -32.88 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 75.450000000000003 109.308 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 108.78 43.86 1.18 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.53 1.144 . . . . 62.310000000000002 110.973 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.811 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 68.6 m-85 -144.79 133.31 22.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.48 0.753 . . . . 73.319999999999993 111.03 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.718 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.5 OUTLIER -99.71 130.07 45.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 75.409999999999997 109.31 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.791 ' HB3' HD22 ' A' ' 188' ' ' LEU . 28.5 p -112.25 -179.44 3.68 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 1.153 . . . . 72.239999999999995 108.307 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -125.87 177.41 6.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 64.209999999999994 110.286 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.654 ' HE2' HG22 ' A' ' 221' ' ' ILE . 16.5 mmtt -108.87 164.27 12.54 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 64.150000000000006 109.292 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.486 ' OE1' HD13 ' A' ' 222' ' ' LEU . 30.5 tt0 -151.5 117.49 5.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.446 1.091 . . . . 73.409999999999997 110.277 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 219' ' ' VAL . 3.9 m-85 -108.65 129.74 55.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 63.299999999999997 111.056 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.795 HG23 ' HB3' ' A' ' 269' ' ' TYR . 6.3 p -128.49 131.63 68.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 64.230000000000004 109.289 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.4 m-85 -108.01 159.51 16.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.517 1.135 . . . . 71.150000000000006 111.053 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 123.48 -173.19 16.38 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.469 1.105 . . . . 51.509999999999998 110.978 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.752 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.5 t-20 -76.3 108.19 9.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 65.319999999999993 109.321 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.752 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.4 mt -111.13 95.09 5.32 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.118 . . . . 72.239999999999995 109.305 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 264' ' ' ALA . 0.2 OUTLIER -92.21 158.35 16.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 73.540000000000006 109.294 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.493 ' O ' HG22 ' A' ' 213' ' ' VAL . . . -179.12 162.63 1.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.13 . . . . 73.319999999999993 109.318 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.0 t -117.75 148.37 42.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.140000000000001 110.013 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.8 p -124.43 -0.92 8.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 74.319999999999993 110.38 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 122.27 115.85 2.33 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.478 1.112 . . . . 64.099999999999994 110.981 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 210' ' ' THR . 0.6 OUTLIER 46.61 24.56 0.33 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.5 0.765 . . . . 71.200000000000003 110.408 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.17 157.07 15.19 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 70.430000000000007 108.311 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.455 ' O ' HG13 ' A' ' 213' ' ' VAL . 19.1 m -113.76 176.3 5.09 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 65.530000000000001 108.294 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 206' ' ' ALA . 2.4 m -153.03 129.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.538 1.149 . . . . 72.519999999999996 109.3 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 205' ' ' LYS . . . -124.42 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.433 1.083 . . . . 73.519999999999996 109.279 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -132.33 134.87 45.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.988 -1.116 . . . . 75.129999999999995 107.988 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 23.8 t -77.36 0.18 23.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 61.509999999999998 110.063 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 4.7 p90 -178.15 136.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 74.219999999999999 110.978 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.519 ' CB ' HD12 ' A' ' 204' ' ' LEU . 77.6 t60 -129.5 143.31 50.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 74.439999999999998 109.61 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.786 HG12 ' SG ' ' A' ' 177' ' ' CYS . 7.4 p -124.47 134.27 67.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.475 1.11 . . . . 73.109999999999999 109.284 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.552 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.35 -152.1 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 72.540000000000006 109.371 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.654 HG22 ' HE2' ' A' ' 197' ' ' LYS . 13.1 pt -128.72 123.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 63.210000000000001 109.29 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.7 tp -89.78 109.06 20.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 55.229999999999997 109.327 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.7 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.04 148.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 61.530000000000001 109.301 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.611 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -117.24 121.63 41.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 30.239999999999998 109.995 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.0 p90 -136.81 144.95 43.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 64.010000000000005 111.009 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.439 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.6 mmtp -70.07 133.78 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 62.229999999999997 109.322 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.46 -159.67 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 64.230000000000004 109.305 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.93 0.07 49.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 74.150000000000006 109.243 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.01 -8.59 12.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.133 . . . . 62.32 110.018 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.41 37.59 8.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.478 1.111 . . . . 51.210000000000001 111.039 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.54 138.21 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.49 0.759 . . . . 71.540000000000006 109.319 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.439 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 23.9 m -71.58 102.67 2.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.152 . . . . 73.140000000000001 110.408 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.0 mm-40 -101.69 -172.61 2.18 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 60.310000000000002 110.257 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.652 ' HB3' HD11 ' A' ' 222' ' ' LEU . 17.9 mmtt -126.66 144.91 50.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 75.329999999999998 109.257 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.651 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.6 tpt180 -143.43 160.57 40.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 72.420000000000002 110.32 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.644 HG21 ' CD1' ' A' ' 252' ' ' TRP . 14.3 mm -116.6 119.15 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 63.420000000000002 109.313 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -103.37 44.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 75.219999999999999 109.284 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -101.26 108.5 55.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.487 1.117 . . . . 63.32 109.283 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -26.9 10.5 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.486 1.782 . . . . 64.310000000000002 110.966 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.3 OUTLIER -45.92 -25.46 0.54 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 73.030000000000001 110.002 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.1 mt -112.97 -60.71 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 73.329999999999998 109.333 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.596 ' CD1' HG11 ' A' ' 247' ' ' VAL . 85.3 m-85 -106.5 99.58 9.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 74.239999999999995 110.969 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 52.8 m -85.67 -13.47 48.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 43.200000000000003 109.992 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.2 m -72.01 -47.85 48.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 72.25 109.944 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.75 -170.97 39.91 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.523 1.14 . . . . 52.340000000000003 111.0 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.448 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -74.99 163.84 34.57 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.495 1.787 . . . . 71.430000000000007 111.007 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.596 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.1 m -147.81 162.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 74.030000000000001 109.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.453 HG22 ' NH1' ' A' ' 235' ' ' ARG . 31.1 p -63.49 139.22 58.75 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.49 1.119 . . . . 73.519999999999996 110.428 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 249' ' ' ASP . 0.2 OUTLIER -42.45 -28.56 0.22 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 64.219999999999999 109.317 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.431 ' N ' ' C ' ' A' ' 248' ' ' THR . 9.1 m -75.93 -62.57 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.127 . . . . 55.109999999999999 110.367 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.07 -28.23 6.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 74.129999999999995 109.311 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 236' ' ' ILE . 10.2 t90 -63.25 -63.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 71.519999999999996 107.989 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.625 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -46.5 -42.24 15.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 62.409999999999997 110.3 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.781 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -56.28 -51.29 68.71 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 63.420000000000002 109.325 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.69 -28.0 53.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.131 . . . . 73.439999999999998 109.276 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.2 m -80.14 -36.89 34.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 71.109999999999999 108.309 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.802 HG11 HG23 ' A' ' 266' ' ' VAL . 2.6 m -95.37 22.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.49 1.119 . . . . 64.219999999999999 109.299 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -50.7 104.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.11 . . . . 74.129999999999995 109.286 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -73.34 -4.22 32.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.507 1.129 . . . . 71.400000000000006 110.408 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.3 t -51.31 -21.69 2.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.474 1.109 . . . . 43.140000000000001 110.004 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' CYS . . . . . 0.429 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 5.0 m -96.51 -27.3 14.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.541 1.151 . . . . 73.430000000000007 108.297 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 156.51 -128.21 2.15 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.436 1.085 . . . . 73.519999999999996 111.025 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.449 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -78.54 141.24 38.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 0.753 . . . . 75.200000000000003 110.013 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.585 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -171.38 143.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 61.329999999999998 109.316 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.65 161.71 4.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.132 . . . . 71.420000000000002 109.962 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.802 HG23 HG11 ' A' ' 257' ' ' VAL . 17.5 t -103.57 128.23 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 55.310000000000002 109.342 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.9 t -84.77 -39.44 18.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 54.439999999999998 109.991 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.6 m -175.0 144.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 74.099999999999994 109.976 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.795 ' HB3' HG23 ' A' ' 200' ' ' VAL . 44.5 p90 -130.48 160.13 35.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.42 1.075 . . . . 64.409999999999997 111.022 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.96 160.45 41.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.496 1.123 . . . . 74.439999999999998 109.341 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.43 ' C ' HG23 ' A' ' 272' ' ' THR . 8.9 p30 -122.7 158.04 30.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.557 1.161 . . . . 71.439999999999998 109.283 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 271' ' ' ASN . 56.0 p -151.95 175.46 12.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 75.200000000000003 110.379 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.759 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -55.36 161.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 70.25 109.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.21 -45.38 40.07 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.473 1.108 . . . . 54.100000000000001 110.983 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.51 -37.43 49.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 0.768 . . . . 52.32 109.286 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.759 HG23 ' HB3' ' A' ' 273' ' ' ALA . 43.1 t -45.86 118.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.555 1.159 . . . . 75.409999999999997 109.277 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 6.2 t80 -81.34 -52.09 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 61.119999999999997 110.995 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -135.89 160.08 39.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.14 . . . . 71.040000000000006 111.019 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.514 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.8 ttt-85 -131.11 147.48 52.62 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.437 1.085 . . . . 71.510000000000005 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.92 157.45 52.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.1 . . . . 61.340000000000003 110.0 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 0.31 9.04 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.482 1.78 . . . . 51.420000000000002 111.008 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 11.3 t -99.55 6.21 45.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 72.230000000000004 110.018 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.4 t-20 76.21 34.67 0.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 74.140000000000001 109.271 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -116.49 123.56 47.76 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 54.399999999999999 110.001 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -104.91 157.6 17.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.200000000000003 110.987 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -116.55 171.38 7.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.107 . . . . 61.520000000000003 109.323 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.729 ' H ' HD13 ' A' ' 286' ' ' LEU . 41.5 m-85 -153.83 115.22 4.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.46 1.1 . . . . 72.239999999999995 110.995 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.441 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 3.8 t0 -115.61 97.84 6.37 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.476 1.11 . . . . 65.5 109.305 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -85.66 -26.96 25.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 75.430000000000007 109.298 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 2.4 t-20 -101.74 -1.81 31.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 62.119999999999997 109.268 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 54.78 46.04 25.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 74.450000000000003 109.295 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.709 HG21 ' O ' ' A' ' 319' ' ' GLY . 16.5 mm -66.69 -42.93 90.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 51.219999999999999 109.27 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.75 ' O ' HG23 ' A' ' 297' ' ' VAL . 3.8 t30 -90.46 -23.6 20.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 62.539999999999999 109.304 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.589 HG21 HD12 ' A' ' 291' ' ' LEU . 1.2 m -75.6 -64.21 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 72.150000000000006 110.426 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 54.3 m-20 -58.1 -25.56 61.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 72.430000000000007 109.315 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 27.2 t -76.24 -60.52 2.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.481 1.113 . . . . 74.150000000000006 108.305 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.9 t -41.5 -50.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 64.230000000000004 109.298 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.05 -60.02 4.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 70.329999999999998 109.328 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -41.68 -37.9 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.448 1.093 . . . . 74.349999999999994 110.38 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -61.98 -56.67 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 75.109999999999999 109.314 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.569 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 0.4 OUTLIER -93.16 37.64 1.04 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 73.319999999999993 111.035 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -70.81 -43.89 67.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.46 1.1 . . . . 60.219999999999999 110.005 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.657 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.28 -12.12 28.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.488 1.117 . . . . 72.5 109.292 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.816 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.9 mt -61.08 139.45 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.548 1.155 . . . . 72.340000000000003 109.294 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 71.0 p -149.39 147.17 27.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 72.019999999999996 109.966 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 84.02 -162.0 38.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.128 . . . . 52.030000000000001 110.971 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 4.1 p -91.27 3.67 54.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.296 -1.001 . . . . 64.340000000000003 108.296 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 33.9 p -126.09 150.97 71.04 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 71.010000000000005 110.007 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.816 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.96 146.36 86.45 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.024 -2.49 . . . . 73.150000000000006 111.024 -0.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.493 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.1 p -133.77 135.42 24.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 34.140000000000001 110.014 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.01 -173.19 11.89 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.996 -2.502 . . . . 61.119999999999997 111.004 -0.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.07 154.29 20.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.458 1.099 . . . . 41.520000000000003 109.331 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.562 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.1 Cg_endo -75.02 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.489 1.783 . . . . 61.310000000000002 110.994 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -89.75 130.79 35.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.12 . . . . 70.109999999999999 109.269 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.5 m -121.08 27.45 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 62.229999999999997 109.276 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 318' ' ' CYS . 9.3 t -50.46 -44.47 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.117 . . . . 74.150000000000006 110.005 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 316' ' ' SER . 80.0 p -38.96 -30.55 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.485 1.116 . . . . 43.520000000000003 109.973 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 316' ' ' SER . 57.4 m -59.65 -173.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 74.340000000000003 108.324 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.709 ' O ' HG21 ' A' ' 292' ' ' ILE . . . 163.41 80.23 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.501 1.126 . . . . 53.210000000000001 111.028 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.636 ' CD2' HD11 ' A' ' 286' ' ' LEU . 8.0 p90 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.523 0.778 . . . . 74.450000000000003 111.042 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.301 -0.629 . . . . 54.119999999999997 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.657 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -152.74 109.64 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 54.219999999999999 109.332 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -83.11 7.52 15.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.536 1.147 . . . . 71.150000000000006 110.011 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -147.11 148.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.515 1.134 . . . . 74.120000000000005 109.275 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.109 HD11 HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -101.5 143.75 27.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.230000000000004 109.303 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.94 -34.12 4.15 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.504 1.791 . . . . 74.019999999999996 111.035 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.446 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.37 153.29 25.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 74.140000000000001 109.281 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -49.94 -36.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 71.219999999999999 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.41 -49.27 2.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 71.340000000000003 109.335 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.677 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -69.42 -36.88 77.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 73.340000000000003 110.38 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.678 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -57.16 -57.37 12.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 74.310000000000002 109.323 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -52.48 -29.6 25.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 73.310000000000002 109.329 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.27 -56.13 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 70.319999999999993 110.025 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.109 HD12 HD11 ' A' ' 140' ' ' ILE . 76.1 mt -42.07 -41.93 2.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 71.140000000000001 109.329 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.612 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.45 -45.13 60.97 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 75.209999999999994 110.99 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.41 -36.0 9.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 63.240000000000002 109.289 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 155' ' ' ASN . 20.3 mt-30 -76.13 -55.49 5.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.481 HD11 HD12 ' A' ' 188' ' ' LEU . 15.7 mt -50.14 -26.87 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -34.56 58.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 63.030000000000001 109.288 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -62.33 -14.6 41.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 109.259 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -86.44 -17.07 35.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 74.420000000000002 110.297 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.1 p -38.71 122.97 1.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 71.450000000000003 109.937 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 131.12 42.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 61.43 108.256 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.46 -25.1 9.36 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.509 1.131 . . . . 74.030000000000001 110.993 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.815 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 25.3 p -73.52 162.92 28.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 0.753 . . . . 73.340000000000003 110.431 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 -2.45 54.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 62.310000000000002 110.029 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 162' ' ' THR . 7.5 m -116.79 8.76 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.453 1.096 . . . . 75.430000000000007 110.376 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.815 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.81 138.09 34.09 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 62.439999999999998 109.3 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -169.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 73.540000000000006 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.437 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.7 p -153.54 126.78 4.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 71.230000000000004 109.999 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -74.97 137.48 50.6 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 64.219999999999999 111.002 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.7 p -73.09 -179.7 3.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 73.219999999999999 108.322 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.722 HG21 ' CB ' ' A' ' 180' ' ' ARG . 3.7 mp -101.93 137.06 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 63.340000000000003 109.267 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 301' ' ' PHE . 34.1 p -74.37 83.66 1.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 64.099999999999994 110.381 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.524 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 3.1 m-85 -80.1 -1.07 38.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.477 1.11 . . . . 75.340000000000003 110.991 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -118.02 14.93 14.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.200000000000003 110.317 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.712 ' OH ' HD13 ' A' ' 304' ' ' LEU . 18.6 t80 -128.86 67.55 77.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 61.409999999999997 111.041 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.438 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.5 Cg_endo -74.97 113.19 3.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.521 1.801 . . . . 72.510000000000005 111.014 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.55 HG21 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.75 -71.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 72.219999999999999 109.24 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -133.53 -46.51 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 54.409999999999997 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.93 100.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 42.43 110.988 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.742 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.2 p -137.56 -48.53 0.58 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.304 -0.998 . . . . 71.430000000000007 108.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.602 ' HB3' HG11 ' A' ' 219' ' ' VAL . 27.4 p90 -69.92 -25.21 63.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.55 1.156 . . . . 62.130000000000003 111.03 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.35 -65.64 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 65.239999999999995 109.37 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.722 ' CB ' HG21 ' A' ' 168' ' ' ILE . 11.4 ptm180 -45.77 -51.86 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.099 . . . . 73.430000000000007 110.234 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.489 ' HB1' ' HZ3' ' A' ' 197' ' ' LYS . . . -41.37 -63.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 75.439999999999998 109.31 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.468 ' HA ' ' HZ1' ' A' ' 197' ' ' LYS . 6.4 t-160 -40.74 -38.71 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 73.219999999999999 109.583 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.629 ' HB3' HD11 ' A' ' 168' ' ' ILE . 13.3 mmmm -68.47 -59.92 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 71.450000000000003 109.257 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.428 ' SD ' HG21 ' A' ' 153' ' ' ILE . 25.7 mtm -41.4 -30.67 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 62.340000000000003 110.958 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.675 HH21 ' CG ' ' A' ' 275' ' ' ASN . 0.1 OUTLIER -68.25 -47.61 67.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.447 1.092 . . . . 53.219999999999999 110.293 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.473 ' HG3' HD13 ' A' ' 187' ' ' ILE . 3.6 pt20 -51.4 -33.52 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 73.319999999999993 110.306 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.473 HD13 ' HG3' ' A' ' 186' ' ' GLN . 16.1 mm -75.7 -34.33 28.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.115 . . . . 63.229999999999997 109.305 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.7 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -60.96 -47.51 86.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 63.340000000000003 109.253 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 136' ' ' LEU . 4.5 mtt -54.93 -44.29 74.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 52.439999999999998 110.996 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -47.25 -52.53 15.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 74.230000000000004 109.297 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -63.32 -36.36 83.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 54.109999999999999 109.284 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.32 48.71 0.69 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.12 . . . . 63.439999999999998 110.987 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.677 ' CZ ' HG21 ' A' ' 145' ' ' THR . 64.1 m-85 -149.39 137.37 20.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.481 0.754 . . . . 62.25 111.05 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -103.55 130.31 50.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 71.430000000000007 109.333 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.7 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.4 p -107.52 -179.48 3.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 50.32 108.298 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -127.05 172.62 10.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 75.430000000000007 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.646 ' HE2' HG22 ' A' ' 221' ' ' ILE . 15.9 mmtt -104.98 157.29 17.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.438 1.087 . . . . 74.120000000000005 109.321 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 219' ' ' VAL . 20.7 tt0 -146.52 117.76 7.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 65.439999999999998 110.282 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.2 m-85 -108.27 128.22 54.54 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 73.5 110.977 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.879 HG13 HG23 ' A' ' 266' ' ' VAL . 1.5 t -120.52 161.05 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 63.43 109.328 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 2.3 m-85 -138.84 151.22 46.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 74.109999999999999 111.019 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.14 18.24 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.506 1.129 . . . . 61.409999999999997 111.027 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.787 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.6 t-20 -77.33 111.36 12.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 0.76 . . . . 72.530000000000001 109.3 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.0 mt -113.74 94.12 4.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 62.509999999999998 109.299 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.7 ' NZ ' ' HB2' ' A' ' 214' ' ' ALA . 1.2 mtpp -92.89 158.31 15.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 73.349999999999994 109.294 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -164.89 162.75 20.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.209999999999994 109.313 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t -141.88 130.68 22.92 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.553 1.158 . . . . 73.030000000000001 110.017 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 25.6 p -90.58 -2.81 57.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 71.310000000000002 110.42 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.15 -39.3 2.95 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.516 1.135 . . . . 75.129999999999995 111.003 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.1 p -123.39 7.41 9.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.515 0.773 . . . . 73.430000000000007 110.355 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 7.5 t -157.29 170.34 22.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.561 1.163 . . . . 72.120000000000005 108.303 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t -133.2 162.35 32.01 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.544 1.153 . . . . 70.219999999999999 108.283 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.901 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -145.08 149.01 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 64.519999999999996 109.253 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.7 ' HB2' ' NZ ' ' A' ' 205' ' ' LYS . . . -141.79 120.16 12.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.539 1.15 . . . . 41.119999999999997 109.291 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -125.46 136.8 53.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 73.420000000000002 108.008 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 p -80.78 1.43 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 71.510000000000005 110.007 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 7.9 p90 -178.17 130.8 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 51.229999999999997 111.022 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.504 ' CB ' HD12 ' A' ' 204' ' ' LEU . 80.2 t60 -123.83 166.41 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.568 1.168 . . . . 75.239999999999995 109.591 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 198' ' ' GLN . 4.8 p -147.94 143.24 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 72.299999999999997 109.264 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.605 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.12 -159.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.452 1.095 . . . . 74.510000000000005 109.348 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.646 HG22 ' HE2' ' A' ' 197' ' ' LYS . 8.2 pt -118.16 125.17 74.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.542 1.151 . . . . 75.140000000000001 109.273 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 234' ' ' LYS . 12.6 tp -89.19 108.97 19.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 62.5 109.333 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.95 147.41 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 72.239999999999995 109.32 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.563 ' HB3' HG22 ' A' ' 139' ' ' VAL . 5.1 m -117.1 121.52 41.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 62.509999999999998 110.02 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.6 p90 -136.45 143.14 43.73 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.471 1.107 . . . . 73.439999999999998 110.992 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.0 mmtp -68.73 132.93 47.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 51.539999999999999 109.268 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.41 -160.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 74.239999999999995 109.349 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.61 0.06 48.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 74.439999999999998 109.278 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.8 m -115.15 -7.95 12.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 64.519999999999996 110.006 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.97 37.68 8.31 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 72.109999999999999 111.005 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.5 138.02 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.511 0.771 . . . . 72.219999999999999 109.316 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.0 m -71.72 102.67 2.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 74.549999999999997 110.38 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.9 mm-40 -101.55 -172.58 2.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.468 1.105 . . . . 75.129999999999995 110.307 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.497 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.9 mmtm -127.29 145.08 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.147 . . . . 74.430000000000007 109.339 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.7 tpt180 -144.19 161.2 39.47 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.329999999999998 110.304 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.64 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.6 mm -116.75 120.43 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.464 1.102 . . . . 73.439999999999998 109.249 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -104.22 44.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 71.319999999999993 109.279 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -100.32 108.88 54.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 43.240000000000002 109.31 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.524 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.2 Cg_endo -75.05 -27.88 9.56 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.506 1.792 . . . . 75.439999999999998 111.019 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.2 t -48.15 -24.2 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 75.140000000000001 110.036 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.11 -57.0 2.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 72.549999999999997 109.277 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.613 ' CE2' HG21 ' A' ' 247' ' ' VAL . 81.7 m-85 -112.46 99.45 7.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.349999999999994 110.996 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.0 m -85.92 -9.1 57.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.094 . . . . 53.439999999999998 110.021 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.3 p -77.36 -46.26 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 71.430000000000007 110.004 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.76 -171.59 41.35 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.501 1.126 . . . . 72.200000000000003 110.958 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.438 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.97 163.35 35.55 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.458 1.767 . . . . 71.319999999999993 111.039 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.613 HG21 ' CE2' ' A' ' 242' ' ' PHE . 3.1 m -147.55 160.01 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.502 1.126 . . . . 74.450000000000003 109.265 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.9 p -61.53 141.37 57.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 72.430000000000007 110.401 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.445 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 8.9 p30 -44.25 -27.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 71.430000000000007 109.302 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 15.8 m -77.53 -61.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.133 . . . . 74.530000000000001 110.427 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.58 -27.62 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 45.020000000000003 109.314 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 236' ' ' ILE . 9.9 t90 -63.66 -63.14 1.26 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.47 1.106 . . . . 71.239999999999995 108.055 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.569 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -47.17 -42.04 19.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 75.239999999999995 110.311 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.814 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.8 m-80 -55.75 -51.57 66.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 74.340000000000003 109.313 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.25 -24.79 29.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.492 1.12 . . . . 71.219999999999999 109.322 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.3 m -83.94 -36.5 23.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.144 . . . . 63.140000000000001 108.304 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.63 22.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 61.539999999999999 109.311 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -49.28 104.85 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.437 1.086 . . . . 74.439999999999998 109.276 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 262' ' ' GLY . 1.8 p -72.33 -4.02 27.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.507 1.13 . . . . 43.109999999999999 110.348 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 t -46.32 -27.0 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 61.149999999999999 109.967 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' CYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 1.7 m -92.11 -35.76 13.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 74.120000000000005 108.236 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.15 -126.79 1.68 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.505 1.128 . . . . 64.540000000000006 110.973 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -69.64 142.21 53.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 0.768 . . . . 70.209999999999994 110.002 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.559 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -173.08 140.84 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 70.239999999999995 109.279 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 87.8 p -172.09 156.53 4.04 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.161 . . . . 72.329999999999998 109.991 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.879 HG23 HG13 ' A' ' 200' ' ' VAL . 6.0 p -103.78 111.15 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.502 1.126 . . . . 73.120000000000005 109.3 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 201' ' ' TYR . 16.5 t -61.68 -46.9 87.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 65.040000000000006 110.013 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.6 m -159.58 -174.21 4.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.45 1.094 . . . . 75.010000000000005 110.009 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 200' ' ' VAL . 45.6 p90 -167.0 157.38 11.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.485 1.115 . . . . 75.040000000000006 110.986 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.0 169.44 22.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 61.130000000000003 109.311 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 272' ' ' THR . 6.6 p30 -134.17 160.64 37.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 74.200000000000003 109.253 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.743 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.7 p -158.24 -177.93 6.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 74.019999999999996 110.378 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.79 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -60.97 167.22 3.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 54.32 109.303 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.26 -41.55 10.1 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 110.983 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.675 ' CG ' HH21 ' A' ' 185' ' ' ARG . 0.8 OUTLIER -58.58 -45.2 89.57 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.497 0.763 . . . . 75.439999999999998 109.321 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.79 HG23 ' HB3' ' A' ' 273' ' ' ALA . 91.3 t -43.76 101.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.431 1.082 . . . . 74.109999999999999 109.305 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.452 ' HH ' ' HE1' ' A' ' 178' ' ' TYR . 2.9 t80 -52.23 -58.66 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 62.229999999999997 110.99 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.9 t80 -139.06 170.17 16.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.109 . . . . 73.120000000000005 110.986 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.743 ' HD2' HG21 ' A' ' 272' ' ' THR . 66.3 ttt-85 -141.59 147.44 37.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 64.200000000000003 110.315 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.61 157.05 43.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 75.239999999999995 109.998 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -0.26 9.77 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.525 1.802 . . . . 64.540000000000006 111.021 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.408 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.5 p -96.78 9.08 42.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 74.349999999999994 110.011 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.3 t-20 74.98 34.67 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.54 1.15 . . . . 71.209999999999994 109.294 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.2 t -119.72 119.55 34.0 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 70.439999999999998 110.022 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.507 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.3 m-30 -99.59 162.22 13.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.200000000000003 110.99 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.3 mm? -116.97 177.57 4.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.517 1.135 . . . . 74.209999999999994 109.312 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 97.6 m-85 -160.92 115.4 2.1 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 73.25 111.03 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 1.016 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.7 OUTLIER -115.31 94.74 4.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 71.209999999999994 109.271 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.446 ' CG ' ' N ' ' A' ' 290' ' ' ASN . 7.6 p30 -80.27 -42.04 23.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 74.209999999999994 109.246 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.466 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 11.4 m-20 -95.65 -1.83 49.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 74.209999999999994 109.28 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 1.016 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.0 mm? 52.21 40.34 28.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 64.340000000000003 109.32 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 16.6 mm -69.8 -25.82 29.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 62.210000000000001 109.264 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.805 ' O ' HG23 ' A' ' 297' ' ' VAL . 8.1 t30 -92.97 -31.86 14.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 74.400000000000006 109.333 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.443 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 18.0 m -81.42 -66.85 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.515 1.134 . . . . 73.030000000000001 110.408 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.8 m-20 -47.33 -29.37 2.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 109.306 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.5 t -75.23 -52.91 9.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 74.049999999999997 108.328 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 293' ' ' ASN . 4.5 t -46.23 -51.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 70.319999999999993 109.307 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 168' ' ' ILE . 20.9 mt -63.47 -52.69 60.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 75.109999999999999 109.309 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -52.2 -26.54 11.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 74.25 110.395 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -76.1 -35.73 59.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 75.530000000000001 109.306 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.563 ' CE1' ' HD2' ' A' ' 313' ' ' PRO . 3.1 m-30 -101.83 24.88 9.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 72.439999999999998 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 14.5 t -57.24 -59.06 5.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 72.239999999999995 110.014 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.785 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -74.19 -17.53 60.89 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.441 1.088 . . . . 74.329999999999998 109.315 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.712 HD13 ' OH ' ' A' ' 172' ' ' TYR . 14.8 mt -67.89 134.43 50.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 75.5 109.317 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.7 p -160.36 135.35 7.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 75.310000000000002 110.039 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 109.97 -160.57 13.34 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.477 1.111 . . . . 73.030000000000001 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.9 p -95.08 13.5 24.98 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.295 -1.002 . . . . 64.5 108.295 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.6 p -145.91 152.98 49.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 41.549999999999997 110.043 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.638 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -74.99 145.59 84.34 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 121.016 -2.493 . . . . 73.239999999999995 110.975 0.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 99.4 p -130.99 134.87 26.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 71.409999999999997 109.995 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.08 -173.19 11.91 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.974 -2.511 . . . . 40.130000000000003 110.955 0.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.441 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.76 153.26 22.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 65.219999999999999 109.321 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.563 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.02 -162.38 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.449 1.763 . . . . 70.239999999999995 110.99 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -84.52 137.0 33.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 74.409999999999997 109.296 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.57 HG21 HG22 ' A' ' 297' ' ' VAL . 21.3 m -144.6 24.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.105 . . . . 74.129999999999995 109.326 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 318' ' ' CYS . 28.5 t -69.2 -31.87 70.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.510000000000005 109.933 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 26.3 m -44.47 -26.49 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 73.209999999999994 109.971 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 316' ' ' SER . 2.4 m -71.88 -176.02 1.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 62.530000000000001 108.293 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 164.89 119.9 0.5 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.504 1.128 . . . . 60.420000000000002 110.972 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 320' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 O-C-N 124.474 0.749 . . . . 54.229999999999997 110.982 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.841 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.3 tp . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.32 -0.622 . . . . 75.209999999999994 109.32 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -105.51 108.78 20.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 73.400000000000006 109.326 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -85.7 10.62 12.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 73.109999999999999 109.969 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -150.38 144.19 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 35.299999999999997 109.286 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.071 HD11 HD12 ' A' ' 149' ' ' LEU . 1.3 mt -96.31 141.77 23.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 71.019999999999996 109.286 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.08 -30.26 7.24 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.467 1.772 . . . . 63.229999999999997 111.015 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.59 152.28 17.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 74.129999999999995 109.26 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 146' ' ' LEU . 1.8 t -50.37 -36.0 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 63.009999999999998 109.277 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.05 -47.69 3.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.112 . . . . 74.439999999999998 109.306 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.611 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -71.1 -36.05 72.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 75.109999999999999 110.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.637 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -58.06 -57.08 14.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.517 1.136 . . . . 75.099999999999994 109.288 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -52.28 -31.36 32.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 62.520000000000003 109.281 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.92 -55.03 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 72.319999999999993 109.978 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.071 HD12 HD11 ' A' ' 140' ' ' ILE . 96.2 mt -45.44 -41.88 9.82 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 74.209999999999994 109.304 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.672 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -73.54 -43.8 59.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 111.034 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -47.99 -36.4 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 71.010000000000005 109.309 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 155' ' ' ASN . 26.0 mt-30 -76.4 -56.07 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 71.109999999999999 110.321 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 21.6 mt -49.01 -29.41 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 75.25 109.307 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 -37.28 67.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.524 1.14 . . . . 63.409999999999997 109.278 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.9 t-20 -58.26 -17.52 20.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 74.409999999999997 109.321 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.471 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 21.5 mm-40 -82.18 -25.3 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.104 . . . . 74.120000000000005 110.268 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.528 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 15.5 m -42.14 120.86 1.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 71.230000000000004 109.979 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -45.85 131.56 9.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.538 1.149 . . . . 65.150000000000006 108.288 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.41 -15.47 9.24 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.542 1.152 . . . . 72.439999999999998 111.017 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.875 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 14.5 p -89.3 161.15 16.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.426 0.721 . . . . 75.150000000000006 110.381 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.0 m -93.46 -2.03 54.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 62.130000000000003 110.031 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 162' ' ' THR . 1.8 m -118.58 8.6 12.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 73.209999999999994 110.381 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.875 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -81.68 135.78 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.512 1.133 . . . . 54.32 109.303 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -169.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.47 1.106 . . . . 60.229999999999997 110.024 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 54.1 p -153.62 127.05 4.25 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.420000000000002 109.978 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.05 137.88 52.86 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.038 -2.484 . . . . 74.109999999999999 110.969 0.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.0 p -72.94 -178.63 2.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 43.119999999999997 108.315 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.728 HD11 ' HB2' ' A' ' 183' ' ' LYS . 3.6 mp -86.93 130.76 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.310000000000002 109.306 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.1 p -95.85 76.11 3.16 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 74.319999999999993 110.432 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 53.8 p90 -76.88 -16.18 59.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.135 . . . . 74.540000000000006 110.994 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -73.46 -3.38 27.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 1.133 . . . . 75.439999999999998 110.309 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.613 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -130.96 66.14 78.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 111.01 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.61 4.34 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.489 1.783 . . . . 73.010000000000005 111.024 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.558 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.8 t -152.04 -60.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 62.439999999999998 109.299 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.1 -46.79 0.93 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.491 1.12 . . . . 73.150000000000006 109.277 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -49.15 98.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.545 1.153 . . . . 75.120000000000005 111.011 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.611 ' SG ' HG12 ' A' ' 219' ' ' VAL . 2.5 p -130.09 -46.89 1.11 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.287 -1.005 . . . . 53.399999999999999 108.287 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 31.4 p90 -73.8 -44.2 56.59 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 75.219999999999999 110.992 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.91 -68.48 0.18 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.13 . . . . 44.420000000000002 109.293 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.574 ' HB3' HG23 ' A' ' 168' ' ' ILE . 8.8 ptm180 -48.89 -48.71 42.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.436 1.085 . . . . 74.329999999999998 110.251 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -42.68 -45.93 4.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.462 1.101 . . . . 74.200000000000003 109.307 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.494 ' ND1' ' CD1' ' A' ' 291' ' ' LEU . 1.9 t-160 -56.98 -41.93 79.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 75.310000000000002 109.617 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.728 ' HB2' HD11 ' A' ' 168' ' ' ILE . 15.8 mmmt -71.05 -30.22 66.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.122 . . . . 71.0 109.295 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.489 ' HE3' ' HA ' ' A' ' 181' ' ' ALA . 21.7 mtm -66.18 -60.4 2.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 73.230000000000004 111.012 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -51.24 -26.88 7.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 72.239999999999995 110.279 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.427 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 1.1 tt0 -64.54 -44.28 91.31 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.55 1.156 . . . . 74.549999999999997 110.275 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 190' ' ' ASN . 23.8 mm -66.1 -52.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 72.400000000000006 109.324 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.845 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.3 OUTLIER -40.88 -39.83 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 72.209999999999994 109.31 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.574 ' HG2' HD21 ' A' ' 136' ' ' LEU . 20.3 mtp -66.62 -45.63 78.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 73.540000000000006 110.976 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 187' ' ' ILE . 0.3 OUTLIER -46.35 -47.07 18.63 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 70.310000000000002 109.262 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 73.430000000000007 109.282 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' CD2' ' A' ' 193' ' ' TYR . . . 119.85 54.1 0.26 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.516 1.135 . . . . 70.239999999999995 110.976 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.611 ' CZ ' HG21 ' A' ' 145' ' ' THR . 91.1 m-85 -158.67 144.73 16.87 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 73.439999999999998 111.026 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.841 ' HB2' HD23 ' A' ' 136' ' ' LEU . 46.8 t0 -110.72 125.91 53.99 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.563 1.165 . . . . 54.109999999999999 109.275 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.845 ' HB3' HD22 ' A' ' 188' ' ' LEU . 29.6 p -103.17 -179.31 3.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 63.32 108.29 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 23.1 mp0 -127.33 176.72 7.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.446 1.092 . . . . 75.439999999999998 110.336 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.797 ' HE2' HG22 ' A' ' 221' ' ' ILE . 21.3 mmtt -108.57 162.68 13.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 73.430000000000007 109.286 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 23.8 tt0 -155.11 117.62 4.26 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.55 1.156 . . . . 65.439999999999998 110.34 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -109.68 124.61 51.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 53.200000000000003 110.971 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.666 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.6 p -115.57 150.8 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 62.340000000000003 109.28 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.7 m-85 -122.13 162.96 20.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 73.239999999999995 110.982 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 115.59 -179.43 18.05 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.556 1.16 . . . . 74.129999999999995 110.98 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.72 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.1 t-20 -68.73 109.35 3.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 0.756 . . . . 73.140000000000001 109.302 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -113.92 93.42 4.36 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.474 1.109 . . . . 73.310000000000002 109.305 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.568 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 4.5 mttt -93.25 160.3 14.89 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.535 1.147 . . . . 72.239999999999995 109.26 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.803 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -165.78 162.89 18.82 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.441 1.088 . . . . 42.219999999999999 109.269 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.97 136.92 48.97 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.439999999999998 110.02 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.7 p -102.15 -37.06 8.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.508 1.13 . . . . 74.219999999999999 110.407 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.6 -26.27 2.79 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.519 1.137 . . . . 75.420000000000002 110.994 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.498 HG23 ' SG ' ' A' ' 211' ' ' CYS . 11.9 t -117.93 -9.01 10.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.538 0.787 . . . . 72.230000000000004 110.337 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' A' ' 210' ' ' THR . 1.8 p -176.66 153.42 1.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.147 . . . . 54.100000000000001 108.312 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.17 148.37 25.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.532 1.145 . . . . 62.340000000000003 108.33 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.803 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.3 OUTLIER -109.07 161.58 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.525 1.141 . . . . 65.530000000000001 109.304 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.568 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -146.43 120.48 9.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 63.140000000000001 109.291 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.45 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.5 m0 -130.41 132.84 45.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.001 -1.111 . . . . 75.319999999999993 108.001 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 54.8 p -79.54 0.61 29.07 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.111 . . . . 54.149999999999999 110.014 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.495 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.1 p90 -170.85 127.82 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 62.039999999999999 111.014 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 48.3 t60 -116.47 167.88 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 54.030000000000001 109.622 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.611 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.4 p -143.86 145.16 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 65.310000000000002 109.309 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.598 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -146.38 -169.09 3.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 60.329999999999998 109.285 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.797 HG22 ' HE2' ' A' ' 197' ' ' LYS . 13.0 pt -114.38 120.8 65.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 71.540000000000006 109.311 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.8 tp -85.33 108.92 18.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.113 . . . . 74.319999999999993 109.314 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.678 HG11 HG13 ' A' ' 237' ' ' ILE . 0.8 OUTLIER -104.9 149.35 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 71.010000000000005 109.292 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 40.2 m -118.26 122.69 43.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 61.149999999999999 110.001 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 33.0 p90 -137.37 145.01 42.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 71.329999999999998 111.001 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.428 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.1 mmtp -70.72 132.89 46.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 71.299999999999997 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.35 -159.86 0.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.133 . . . . 61.32 109.294 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.83 -0.4 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.549 1.156 . . . . 34.539999999999999 109.305 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.78 -7.85 12.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 75.310000000000002 110.025 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.96 37.86 8.24 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.509 1.131 . . . . 72.230000000000004 111.0 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.76 137.46 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.452 0.736 . . . . 61.039999999999999 109.261 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.428 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.6 m -71.59 102.47 2.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.107 . . . . 64.530000000000001 110.355 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.7 mm-40 -102.04 -172.49 2.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.446 1.091 . . . . 73.510000000000005 110.276 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.523 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.8 mmtm -125.66 145.03 50.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.112 . . . . 72.409999999999997 109.314 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.64 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.8 tpt180 -143.02 159.48 42.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.340000000000003 110.354 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.0 mm -113.42 117.02 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.118 . . . . 64.200000000000003 109.329 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.2 mm -106.48 46.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 54.200000000000003 109.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -104.6 106.12 53.2 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 64.230000000000004 109.291 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -1.13 10.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.533 1.807 . . . . 71.150000000000006 110.995 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 3.1 t -73.21 -4.14 31.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 75.239999999999995 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.485 HD11 ' NE2' ' A' ' 218' ' ' HIS . 5.6 mt -138.15 -49.12 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 74.140000000000001 109.334 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.89 ' CZ ' ' HB2' ' A' ' 255' ' ' ALA . 83.0 m-85 -113.26 99.35 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.548 1.155 . . . . 75.319999999999993 111.014 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.5 m -90.63 -5.32 56.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 70.450000000000003 109.965 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 12.2 t -83.91 -44.78 13.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.535 1.147 . . . . 53.520000000000003 110.021 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.09 -177.43 46.82 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.518 1.136 . . . . 62.450000000000003 110.985 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.98 165.08 32.08 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.478 1.778 . . . . 64.530000000000001 111.018 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.678 HG11 ' CD2' ' A' ' 242' ' ' PHE . 4.0 m -148.43 167.8 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.456 1.098 . . . . 71.239999999999995 109.32 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.442 ' C ' ' N ' ' A' ' 250' ' ' THR . 66.8 p -70.23 137.78 51.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 73.420000000000002 110.4 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -41.23 -29.11 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.239999999999995 109.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.442 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -74.7 -63.8 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 73.349999999999994 110.362 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.36 -25.78 6.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 62.43 109.359 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.598 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.2 t90 -65.79 -65.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 74.420000000000002 108.034 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.764 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -42.04 -30.99 0.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 75.519999999999996 110.303 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.857 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.5 m-80 -67.4 -49.15 65.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 73.040000000000006 109.268 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.89 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.48 -19.36 14.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 70.129999999999995 109.278 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 205' ' ' LYS . 6.9 m -90.26 -35.75 15.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 75.239999999999995 108.331 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.857 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.4 m -93.53 21.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 72.329999999999998 109.284 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -50.48 106.44 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 72.209999999999994 109.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 262' ' ' GLY . 14.7 p -73.31 -3.34 26.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 75.340000000000003 110.428 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.72 -30.51 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.531 1.145 . . . . 73.5 109.963 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.5 t -88.71 -36.96 15.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 61.299999999999997 108.309 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.87 -128.82 1.78 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.512 1.133 . . . . 71.209999999999994 110.972 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.89 145.69 42.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 0.775 . . . . 71.150000000000006 109.986 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -167.96 147.61 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 72.299999999999997 109.308 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.3 t -172.92 153.61 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 73.230000000000004 110.056 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.666 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.42 118.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 74.510000000000005 109.324 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.0 t -73.78 -43.82 57.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.556 1.16 . . . . 74.319999999999993 110.02 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 200' ' ' VAL . 11.5 p -164.94 -175.15 3.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 74.230000000000004 109.994 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -164.77 157.14 16.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 71.319999999999993 110.998 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.1 160.49 39.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 72.040000000000006 109.27 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 272' ' ' THR . 7.4 p30 -118.41 160.65 21.32 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.093 . . . . 50.229999999999997 109.272 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.638 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.1 p -153.47 -178.5 7.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 72.230000000000004 110.399 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.893 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.75 163.83 13.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 64.109999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.484 1.115 . . . . 62.119999999999997 110.991 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.457 ' H ' ' ND2' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -85.99 -35.71 20.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 0.778 . . . . 62.200000000000003 109.286 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' A' ' 273' ' ' ALA . 92.8 t -43.81 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 61.109999999999999 109.291 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 6.0 t80 -59.21 -49.83 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 62.509999999999998 110.968 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 56.2 t80 -147.9 158.15 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 61.420000000000002 110.955 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.638 ' HD2' HG21 ' A' ' 272' ' ' THR . 73.0 ttt-85 -123.95 147.47 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 73.239999999999995 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.55 154.02 47.8 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.115 . . . . 73.530000000000001 109.958 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.21 9.19 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.468 1.772 . . . . 64.109999999999999 110.997 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 20.6 t -105.64 10.22 32.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 1.118 . . . . 74.25 109.991 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 75.38 39.55 0.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 60.310000000000002 109.278 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.4 t -119.83 120.28 36.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 52.409999999999997 110.002 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -101.86 166.65 10.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 65.329999999999998 111.03 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -123.34 177.36 5.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 64.420000000000002 109.323 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 52.5 m-85 -158.61 115.78 2.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.125 . . . . 73.120000000000005 110.984 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.863 ' HB3' HD13 ' A' ' 291' ' ' LEU . 3.8 m-20 -115.26 99.27 7.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 74.230000000000004 109.329 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -84.94 -48.54 9.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.310000000000002 109.34 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.466 ' HB3' HD11 ' A' ' 292' ' ' ILE . 27.0 m-20 -90.33 9.53 28.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 73.420000000000002 109.354 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.863 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.6 mm? 40.32 45.25 1.78 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 109.299 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 290' ' ' ASN . 47.6 mm -74.47 -23.79 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 71.549999999999997 109.317 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.812 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.7 t-20 -94.5 -29.08 15.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 63.409999999999997 109.299 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 7.8 m -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 62.310000000000002 110.419 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 39.8 m-20 -48.43 -24.77 1.36 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 73.25 109.288 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 45.7 t -80.8 -47.9 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 64.340000000000003 108.297 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.4 t -52.86 -45.47 50.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.521 1.138 . . . . 74.349999999999994 109.3 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.4 mt -65.27 -62.9 1.27 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 72.219999999999999 109.331 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -24.67 0.85 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.400000000000006 110.388 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.816 ' HE2' HG12 ' A' ' 315' ' ' VAL . 16.1 mmmt -73.3 -41.75 63.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 52.25 109.298 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.753 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.7 m-30 -100.87 36.77 1.87 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 74.209999999999994 111.033 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.72 -44.75 73.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 110.009 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -92.8 -12.09 32.05 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 53.399999999999999 109.296 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.785 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.7 mt -68.67 136.69 53.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 71.420000000000002 109.33 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 95.2 p -149.39 156.05 41.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.489 1.118 . . . . 62.109999999999999 110.014 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.32 -164.68 54.35 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.475 1.109 . . . . 71.439999999999998 111.01 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 10.56 22.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.272 -1.01 . . . . 42.450000000000003 108.272 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 13.9 p -131.8 149.45 73.44 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.565 1.166 . . . . 73.25 110.022 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.785 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.92 147.1 88.48 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 75.129999999999995 111.047 -0.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.9 p -133.51 135.75 25.71 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.551 1.157 . . . . 64.019999999999996 110.005 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.6 Cg_endo -74.94 -173.73 12.81 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 120.98 -2.508 . . . . 71.200000000000003 111.032 -0.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.58 154.32 35.39 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 73.450000000000003 109.291 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.455 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.99 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.512 1.796 . . . . 73.400000000000006 111.011 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -87.92 135.98 33.17 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 71.510000000000005 109.263 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.816 HG12 ' HE2' ' A' ' 300' ' ' LYS . 27.1 m -129.62 23.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.530000000000001 109.303 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 17.0 t -54.61 -32.74 59.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.418 1.074 . . . . 62.25 110.039 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.2 m -48.76 -25.37 1.8 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.349999999999994 110.002 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.44 170.4 15.99 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 54.539999999999999 108.299 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 174.47 110.47 0.25 Allowed Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.478 1.111 . . . . 74.140000000000001 111.03 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.558 ' C ' ' CD1' ' A' ' 320' ' ' PHE . 1.3 p90 . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.516 0.774 . . . . 62.109999999999999 110.971 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.83 HD23 ' HB3' ' A' ' 194' ' ' ASP . 8.6 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.286 -0.635 . . . . 61.210000000000001 109.286 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -116.03 104.37 11.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 75.219999999999999 109.314 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.496 ' CB ' ' OD2' ' A' ' 194' ' ' ASP . 0.6 OUTLIER -80.39 3.91 19.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 71.420000000000002 109.972 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -142.93 147.57 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.129999999999995 109.308 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -98.99 142.55 24.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 72.439999999999998 109.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.0 -32.74 5.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.528 1.804 . . . . 43.439999999999998 111.025 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.416 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.21 151.47 19.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 74.120000000000005 109.295 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -48.51 -35.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.103 . . . . 72.0 109.28 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.56 -46.75 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 73.120000000000005 109.303 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.683 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.9 m -72.25 -34.77 68.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.13 . . . . 41.240000000000002 110.425 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.675 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.47 -56.76 17.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.428 1.08 . . . . 74.540000000000006 109.254 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -52.54 -31.85 37.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 62.5 109.32 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.18 -56.71 6.82 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.473 1.108 . . . . 62.219999999999999 109.994 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.053 HD12 HD11 ' A' ' 140' ' ' ILE . 60.7 mt -42.97 -42.62 3.83 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.472 1.107 . . . . 73.099999999999994 109.307 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.648 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.55 -45.1 63.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 73.109999999999999 111.037 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.87 -38.15 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 75.239999999999995 109.324 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 155' ' ' ASN . 24.2 mt-30 -75.21 -55.31 5.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 73.209999999999994 110.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.109 HD11 HD12 ' A' ' 188' ' ' LEU . 12.4 mt -49.72 -27.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.115 . . . . 63.32 109.306 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -36.07 61.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 73.329999999999998 109.289 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -60.75 -15.38 28.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 74.430000000000007 109.335 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.665 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 8.9 mm100 -83.09 -21.74 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 74.0 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.573 ' OG ' HG23 ' A' ' 160' ' ' THR . 29.8 p -39.09 140.69 0.37 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 72.109999999999999 109.99 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.73 -9.76 52.5 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 74.040000000000006 108.274 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -87.87 18.88 36.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.511 1.132 . . . . 60.130000000000003 110.999 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.573 HG23 ' OG ' ' A' ' 157' ' ' SER . 59.2 p -136.27 160.74 37.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 71.439999999999998 110.398 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 p -93.76 -21.55 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.48 1.112 . . . . 52.200000000000003 109.991 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.6 m -82.57 -3.65 56.39 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 64.219999999999999 110.416 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 156' ' ' GLN . . . -69.38 138.37 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 72.120000000000005 109.303 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.3 t -59.72 -160.14 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.097 . . . . 52.109999999999999 109.993 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.448 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -156.45 128.0 3.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 72.209999999999994 109.993 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.93 140.7 68.78 Favored 'Cis proline' 0 C--N 1.36 1.132 0 C-N-CA 121.011 -2.495 . . . . 74.430000000000007 111.015 -0.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 23.2 p -72.75 177.44 4.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 63.450000000000003 108.285 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.612 HD11 ' CB ' ' A' ' 183' ' ' LYS . 2.1 mp -94.51 126.84 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 64.5 109.309 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 301' ' ' PHE . 15.4 p -77.56 90.06 3.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 63.549999999999997 110.389 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -88.59 -30.2 19.43 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.571 1.169 . . . . 71.340000000000003 110.988 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.402 ' C ' ' HD3' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -84.03 9.29 12.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.51 1.131 . . . . 72.25 110.297 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.559 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 38.8 t80 -128.56 66.9 75.5 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.494 1.121 . . . . 73.030000000000001 111.004 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.448 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -74.97 109.15 2.87 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.463 1.77 . . . . 71.230000000000004 110.98 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.66 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 74.329999999999998 109.271 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -160.52 129.2 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.526 1.141 . . . . 74.25 109.273 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 129.07 52.29 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.505 1.128 . . . . 55.049999999999997 111.011 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.4 m -89.14 -18.06 27.93 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.273 -1.01 . . . . 44.520000000000003 108.273 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.622 ' HB3' HG11 ' A' ' 219' ' ' VAL . 34.2 p90 -76.59 -22.62 53.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.527 1.142 . . . . 75.349999999999994 110.955 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.532 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -71.17 -68.35 0.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 64.340000000000003 109.268 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.579 ' HB3' HG23 ' A' ' 168' ' ' ILE . 7.9 ptm180 -46.15 -48.33 17.44 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.498 1.124 . . . . 75.510000000000005 110.296 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.625 ' C ' ' HZ1' ' A' ' 197' ' ' LYS . . . -40.4 -59.0 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.13 . . . . 61.119999999999997 109.327 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.672 ' N ' ' HZ1' ' A' ' 197' ' ' LYS . 1.1 t60 -48.96 -39.69 27.46 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.528 1.142 . . . . 54.25 109.604 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.612 ' CB ' HD11 ' A' ' 168' ' ' ILE . 30.6 mmmt -64.61 -61.47 2.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 72.340000000000003 109.299 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.43 ' HE3' ' HA ' ' A' ' 181' ' ' ALA . 15.0 mtm -38.9 -38.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.533 1.146 . . . . 74.230000000000004 110.987 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.36 -49.35 78.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 74.150000000000006 110.339 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 183' ' ' LYS . 2.8 pt20 -54.75 -34.05 62.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.122 . . . . 50.210000000000001 110.271 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 153' ' ' ILE . 31.1 mm -70.3 -43.77 78.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.155 . . . . 75.019999999999996 109.341 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 1.109 HD12 HD11 ' A' ' 153' ' ' ILE . 0.4 OUTLIER -60.68 -40.77 93.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 73.120000000000005 109.28 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.75 ' HG2' HD21 ' A' ' 136' ' ' LEU . 52.1 mtp -61.57 -36.04 79.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 73.329999999999998 110.994 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.67 -53.63 56.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 64.430000000000007 109.293 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.46 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 5.8 t-20 -62.72 -27.56 69.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 63.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 109.04 53.58 0.61 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.508 1.13 . . . . 73.340000000000003 110.988 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.683 ' CZ ' HG21 ' A' ' 145' ' ' THR . 92.9 m-85 -156.89 140.74 16.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.45 0.735 . . . . 74.510000000000005 111.015 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.83 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -106.12 124.86 50.24 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 62.020000000000003 109.319 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 1.008 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.1 p -95.92 168.46 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 64.129999999999995 108.3 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -117.06 170.91 8.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 54.25 110.295 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.672 ' HZ1' ' N ' ' A' ' 182' ' ' HIS . 17.5 mmtt -100.58 169.34 9.12 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 74.010000000000005 109.287 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 22.8 tt0 -167.28 121.85 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.442 1.089 . . . . 63.420000000000002 110.27 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -115.9 140.58 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 64.510000000000005 111.013 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.697 ' CG2' HG23 ' A' ' 266' ' ' VAL . 14.0 p -131.71 149.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.0 109.346 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 13.8 m-85 -122.72 156.37 34.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.452 1.095 . . . . 72.329999999999998 110.977 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.39 -175.83 16.44 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.508 1.13 . . . . 63.210000000000001 111.025 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.751 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.5 t-20 -72.63 110.14 6.78 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.782 . . . . 65.209999999999994 109.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.751 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.2 mt -113.19 95.48 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 74.450000000000003 109.263 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 256' ' ' CYS . 6.8 mtpt -92.31 165.33 13.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 74.450000000000003 109.326 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.867 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -169.23 119.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 63.140000000000001 109.26 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 117.56 30.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.157 . . . . 71.400000000000006 110.019 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.7 p -88.63 -3.66 58.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 62.009999999999998 110.404 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.76 -24.75 16.08 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.541 1.151 . . . . 75.430000000000007 111.024 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.435 ' O ' ' CG2' ' A' ' 210' ' ' THR . 1.1 m -123.38 2.52 9.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.499 0.764 . . . . 75.400000000000006 110.427 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.6 156.26 1.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 74.409999999999997 108.291 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.71 128.35 55.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 61.009999999999998 108.318 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.867 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.5 m -108.87 155.26 9.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.104 . . . . 74.219999999999999 109.293 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -147.1 130.05 16.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 53.329999999999998 109.315 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.3 135.07 42.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.319999999999993 108.015 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.4 m -80.3 3.52 20.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.147 . . . . 73.299999999999997 109.991 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.458 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.0 p90 -177.79 130.41 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.459 1.099 . . . . 73.340000000000003 111.023 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -120.17 168.03 11.64 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 73.140000000000001 109.609 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.622 HG11 ' HB3' ' A' ' 178' ' ' TYR . 1.5 p -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.13 . . . . 63.200000000000003 109.284 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.683 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.0 -165.8 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 74.219999999999999 109.291 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.475 ' O ' HD13 ' A' ' 236' ' ' ILE . 15.9 pt -117.24 123.79 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 64.239999999999995 109.273 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.4 tp -86.29 108.85 18.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 75.439999999999998 109.285 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.675 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -102.2 145.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 63.450000000000003 109.323 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 56.3 m -117.75 117.78 30.26 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.467 1.105 . . . . 53.200000000000003 110.031 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 29.9 p90 -133.9 144.46 48.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 74.25 110.969 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.1 mmtp -68.87 135.19 50.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 73.540000000000006 109.333 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -76.08 -160.18 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 73.239999999999995 109.315 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.38 50.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 65.120000000000005 109.322 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 -7.49 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 75.510000000000005 109.959 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.01 8.23 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.5 1.125 . . . . 44.420000000000002 111.031 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.34 138.23 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.442 0.731 . . . . 74.540000000000006 109.347 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.436 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 20.4 m -71.93 102.55 2.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.498 1.124 . . . . 73.140000000000001 110.394 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.4 mm-40 -101.27 -174.21 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.567 1.167 . . . . 62.149999999999999 110.302 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.535 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.0 mmtm -127.19 144.82 50.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 75.319999999999993 109.313 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.592 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -146.7 163.88 34.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 71.540000000000006 110.307 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.487 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.3 mm -117.96 119.11 60.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 72.420000000000002 109.328 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -103.42 45.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.488 1.118 . . . . 72.439999999999998 109.317 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.41 109.44 61.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 54.039999999999999 109.309 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -20.42 16.91 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.448 1.762 . . . . 61.329999999999998 111.011 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.439 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.9 t -51.32 -21.72 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.526 1.141 . . . . 73.329999999999998 110.009 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 256' ' ' CYS . 7.7 mt -117.97 -57.85 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 64.140000000000001 109.272 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.78 ' CE2' HG21 ' A' ' 247' ' ' VAL . 80.7 m-85 -107.65 99.78 9.24 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.146 . . . . 74.349999999999994 110.972 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.1 m -86.47 -6.5 58.89 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.101 . . . . 73.230000000000004 109.974 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -82.93 -44.45 15.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 52.0 110.005 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.28 -173.96 43.26 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.509 1.131 . . . . 64.340000000000003 111.009 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.427 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.5 Cg_endo -74.9 165.42 31.43 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.453 1.765 . . . . 61.409999999999997 111.011 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.78 HG21 ' CE2' ' A' ' 242' ' ' PHE . 4.8 m -147.23 159.26 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 72.129999999999995 109.309 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.432 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.5 p -61.17 139.38 58.13 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 73.109999999999999 110.413 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -41.63 -29.81 0.19 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 71.400000000000006 109.294 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 248' ' ' THR . 12.6 m -77.26 -61.41 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.118 . . . . 72.329999999999998 110.415 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.74 -24.36 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 43.240000000000002 109.25 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.683 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 9.7 t90 -66.33 -64.5 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 74.400000000000006 108.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.862 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.2 OUTLIER -43.77 -34.8 1.65 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 63.049999999999997 110.278 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.884 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.1 m-80 -64.56 -49.4 71.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 34.130000000000003 109.347 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.648 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.22 -19.08 12.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.45 1.094 . . . . 50.210000000000001 109.299 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 205' ' ' LYS . 10.0 m -92.06 -31.91 15.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 55.210000000000001 108.28 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.884 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.5 m -96.9 21.84 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.555 1.16 . . . . 64.519999999999996 109.315 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -49.2 104.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.479 1.112 . . . . 75.219999999999999 109.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 262' ' ' GLY . 12.7 p -72.54 -3.89 27.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.138 . . . . 72.129999999999995 110.397 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 41.3 t -48.1 -25.15 1.33 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 73.329999999999998 110.026 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' CYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 5.9 m -90.94 -34.45 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 73.439999999999998 108.279 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.01 -118.41 0.82 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.481 1.113 . . . . 45.299999999999997 110.979 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.45 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -83.31 142.73 30.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 0.778 . . . . 63.409999999999997 110.02 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.97 143.82 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.554 1.159 . . . . 71.319999999999993 109.296 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.2 t -172.77 159.24 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.55 1.156 . . . . 63.539999999999999 109.983 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.697 HG23 ' CG2' ' A' ' 200' ' ' VAL . 4.0 p -101.91 118.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 63.009999999999998 109.326 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.1 t -77.28 -44.0 31.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 54.439999999999998 109.999 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 200' ' ' VAL . 4.1 m -149.25 -175.33 4.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 34.5 109.984 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -174.28 152.89 1.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 74.400000000000006 110.958 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -159.73 163.59 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.455 1.097 . . . . 62.350000000000001 109.312 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -116.84 160.5 20.74 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 74.150000000000006 109.314 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.06 -178.7 6.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 70.540000000000006 110.412 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -86.01 158.2 19.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.239999999999995 109.302 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.83 93.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.55 1.156 . . . . 71.319999999999993 110.987 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -46.28 77.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 0.773 . . . . 73.129999999999995 109.312 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.8 t -43.48 127.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 74.200000000000003 109.293 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.555 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 3.5 t80 -93.33 -40.7 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 70.420000000000002 110.988 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.3 OUTLIER -160.33 115.46 2.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 74.540000000000006 111.025 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.419 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 55.1 ttt-85 -94.96 137.87 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.420000000000002 110.281 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 157.62 34.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 60.43 109.956 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 0.02 9.41 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.459 1.768 . . . . 61.32 111.033 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 10.2 t -98.42 7.62 45.94 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.093 . . . . 63.32 110.016 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 76.02 34.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 64.319999999999993 109.25 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.7 t -117.41 120.73 39.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.565 1.165 . . . . 61.039999999999999 110.0 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.95 164.33 12.24 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 73.319999999999993 111.009 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.2 mm? -125.32 176.66 6.63 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 75.109999999999999 109.288 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 91.2 m-85 -162.62 124.94 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 75.109999999999999 110.947 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.948 ' HB3' HD13 ' A' ' 291' ' ' LEU . 2.0 m-20 -114.91 99.01 7.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 50.409999999999997 109.304 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -79.11 -54.79 5.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 74.219999999999999 109.332 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.461 ' CB ' HG12 ' A' ' 292' ' ' ILE . 9.5 m-20 -95.1 19.2 10.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 71.040000000000006 109.297 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.948 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.5 mm? 40.29 39.38 0.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 53.32 109.324 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 50.2 mm -68.63 -31.94 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 73.140000000000001 109.337 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.823 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.1 t-20 -88.93 -29.1 19.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.555 1.159 . . . . 72.099999999999994 109.302 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.453 ' N ' ' OD1' ' A' ' 288' ' ' ASP . 4.9 m -81.52 -67.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 72.030000000000001 110.412 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -45.52 -31.85 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 74.200000000000003 109.306 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.85 -55.85 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 61.329999999999998 108.288 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.1 t -40.83 -49.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.5 1.125 . . . . 74.319999999999993 109.267 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.2 mt -67.76 -57.71 5.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.583 1.177 . . . . 73.239999999999995 109.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -44.74 -27.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 72.340000000000003 110.382 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -72.99 -44.7 60.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.541 1.151 . . . . 73.299999999999997 109.355 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.653 ' HB2' HG21 ' A' ' 169' ' ' THR . 1.9 m-30 -97.65 21.97 9.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.209999999999994 111.031 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.0 t -58.27 -57.95 10.61 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.420000000000002 109.968 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.747 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -76.36 -15.54 59.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.117 . . . . 62.229999999999997 109.254 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.69 HD22 ' CD ' ' A' ' 309' ' ' PRO . 17.9 mt -66.38 148.99 51.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 74.129999999999995 109.292 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.7 p -168.91 127.2 1.03 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 72.430000000000007 109.964 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 172' ' ' TYR . . . 105.28 -163.66 14.22 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.514 1.134 . . . . 54.240000000000002 111.006 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.62 15.62 12.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.341 -0.985 . . . . 74.129999999999995 108.341 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.514 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 84.4 p -139.8 148.27 54.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 74.450000000000003 110.033 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.69 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.95 147.19 88.68 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 121.057 -2.476 . . . . 64.109999999999999 111.02 -0.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 6.4 p -129.89 135.28 27.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 33.210000000000001 109.99 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.98 -174.49 14.19 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.994 -2.503 . . . . 60.140000000000001 110.987 -0.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.2 156.02 23.02 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 50.109999999999999 109.317 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.54 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.512 1.796 . . . . 75.319999999999993 111.044 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.4 136.4 33.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 70.400000000000006 109.29 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.22 22.92 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 109.316 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 14.1 t -69.31 -33.27 72.91 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 51.43 109.975 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.8 t -47.55 -24.49 0.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.497 1.123 . . . . 71.140000000000001 110.023 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.19 -175.66 3.24 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 71.010000000000005 108.279 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 161.49 119.75 0.52 Allowed Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.496 1.123 . . . . 43.229999999999997 111.023 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 320' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 O-C-N 124.508 0.769 . . . . 75.25 110.989 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.928 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.6 tp . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.324 -0.621 . . . . 50.030000000000001 109.324 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.644 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -104.92 107.69 18.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.458 1.099 . . . . 73.349999999999994 109.319 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 t -84.81 9.69 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 55.039999999999999 109.996 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.25 145.6 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.544 1.152 . . . . 64.540000000000006 109.278 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.031 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -97.25 142.59 24.77 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 75.450000000000003 109.309 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.95 -32.63 5.3 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.497 1.788 . . . . 74.319999999999993 111.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.19 151.26 19.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.142 . . . . 63.520000000000003 109.318 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -48.11 -35.73 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.531 1.145 . . . . 74.109999999999999 109.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.33 -47.3 3.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 70.239999999999995 109.273 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.67 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.73 -35.35 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.153 . . . . 75.420000000000002 110.403 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.768 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -58.72 -56.97 15.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 54.219999999999999 109.32 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -52.49 -31.7 36.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 71.450000000000003 109.348 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.35 -54.05 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 75.540000000000006 109.946 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 140' ' ' ILE . 54.0 mt -44.15 -40.67 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.537 1.148 . . . . 75.099999999999994 109.297 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.611 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.49 -44.34 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.57 1.169 . . . . 70.299999999999997 110.996 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -48.03 -37.25 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 109.296 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.43 ' O ' ' N ' ' A' ' 155' ' ' ASN . 18.5 mt-30 -75.67 -55.87 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 61.039999999999999 110.294 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.957 HD11 HD12 ' A' ' 188' ' ' LEU . 12.1 mt -51.13 -23.75 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 75.409999999999997 109.367 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -34.03 43.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.488 1.118 . . . . 71.209999999999994 109.305 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.1 t-20 -61.75 -17.63 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 65.239999999999995 109.335 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.449 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 4.5 mm100 -84.09 -16.94 41.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 75.310000000000002 110.292 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.6 p -37.94 133.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.209999999999994 109.958 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -64.32 125.12 23.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 70.230000000000004 108.288 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.85 -18.06 8.62 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.495 1.122 . . . . 51.509999999999998 110.96 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.823 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 63.5 p -80.81 161.7 24.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.575 0.809 . . . . 71.230000000000004 110.422 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 51.0 p -93.55 -0.8 56.12 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.439999999999998 109.998 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 162' ' ' THR . 4.5 m -117.56 7.33 12.63 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 55.219999999999999 110.41 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.823 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.7 138.93 33.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.526 1.141 . . . . 60.420000000000002 109.278 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -162.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 75.230000000000004 109.999 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.431 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 41.9 t -156.22 127.47 3.67 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.230000000000004 109.982 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.01 139.38 61.44 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.991 -2.504 . . . . 73.430000000000007 111.033 -0.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 p -72.73 179.11 3.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 62.140000000000001 108.299 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.841 HG23 ' HG2' ' A' ' 180' ' ' ARG . 2.2 mp -88.9 124.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 61.329999999999998 109.305 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 301' ' ' PHE . 65.5 p -89.21 83.2 6.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 110.356 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -88.47 -14.78 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.142 . . . . 75.340000000000003 110.999 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.42 -2.21 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.533 1.145 . . . . 70.439999999999998 110.302 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.654 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 27.1 t80 -127.98 71.15 78.63 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 63.039999999999999 110.996 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.433 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.01 114.07 3.94 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.484 1.781 . . . . 74.530000000000001 111.005 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.602 HG21 ' CE1' ' A' ' 172' ' ' TYR . 26.2 t -152.59 -75.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.486 1.116 . . . . 63.43 109.246 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -156.51 115.79 3.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 65.209999999999994 109.301 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.63 55.84 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.525 1.14 . . . . 62.149999999999999 111.043 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 66.8 m -96.68 -0.17 48.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.308 -0.997 . . . . 54.310000000000002 108.308 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.62 ' HE1' HG21 ' A' ' 297' ' ' VAL . 12.8 p90 -85.89 -32.65 21.54 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 73.409999999999997 111.017 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.6 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -70.93 -49.59 43.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 73.219999999999999 109.336 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.841 ' HG2' HG23 ' A' ' 168' ' ' ILE . 6.5 mtp85 -57.69 -47.81 81.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 54.530000000000001 110.261 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.25 -51.04 8.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.449 1.093 . . . . 63.420000000000002 109.329 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -56.12 -37.47 69.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.506 1.129 . . . . 73.5 109.646 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.77 ' HB3' HD11 ' A' ' 168' ' ' ILE . 27.8 mmmt -63.85 -64.33 0.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.564 1.165 . . . . 71.099999999999994 109.271 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 153' ' ' ILE . 9.4 mtm -38.93 -30.24 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 75.019999999999996 111.005 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -66.32 -51.02 61.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 73.310000000000002 110.289 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.56 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.7 pt20 -52.52 -32.32 39.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 73.310000000000002 110.282 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.56 HD13 ' HG3' ' A' ' 186' ' ' GLN . 11.6 mm -80.97 -34.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 72.519999999999996 109.309 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -63.33 -44.6 94.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.540000000000006 109.298 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 136' ' ' LEU . 8.5 mtp -60.52 -41.55 94.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 44.109999999999999 111.02 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -46.22 -49.53 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 74.109999999999999 109.312 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -27.99 66.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 75.120000000000005 109.28 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 105.75 56.66 0.67 Allowed Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.512 1.133 . . . . 64.319999999999993 110.96 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' A' ' 145' ' ' THR . 82.0 m-85 -157.52 142.38 16.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 0.776 . . . . 72.409999999999997 111.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.928 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.2 t0 -110.02 124.77 52.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.143 . . . . 71.510000000000005 109.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.79 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.0 p -100.08 171.17 7.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.444 1.09 . . . . 65.439999999999998 108.296 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.42 170.23 8.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.086 . . . . 71.519999999999996 110.299 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.421 ' HE2' HG22 ' A' ' 221' ' ' ILE . 6.3 mmtt -96.71 159.66 14.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 74.519999999999996 109.32 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.633 ' OE1' HD11 ' A' ' 236' ' ' ILE . 18.9 tt0 -151.56 117.47 5.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 73.349999999999994 110.298 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 5.8 m-85 -116.39 128.75 55.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.52 1.137 . . . . 73.310000000000002 110.964 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.666 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.6 p -122.74 149.96 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 70.349999999999994 109.311 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 10.0 m-85 -122.88 164.21 18.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 1.15 . . . . 73.129999999999995 110.99 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.46 -172.9 14.44 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.516 1.135 . . . . 74.230000000000004 111.009 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.75 ' C ' HD23 ' A' ' 204' ' ' LEU . 52.4 t-20 -74.12 107.67 6.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 0.786 . . . . 73.349999999999994 109.262 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.5 mt -111.54 96.26 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 75.099999999999994 109.334 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.7 mtpp -90.85 -179.88 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 43.439999999999998 109.328 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 1.012 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -179.46 149.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 1.152 . . . . 74.299999999999997 109.321 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.05 133.24 45.52 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.49 1.119 . . . . 75.530000000000001 109.933 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.4 p -113.54 -5.61 13.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.478 1.111 . . . . 73.129999999999995 110.405 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.56 -21.69 31.32 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.482 1.114 . . . . 44.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 t -113.05 -23.47 10.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 0.751 . . . . 71.209999999999994 110.371 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 8.6 p -166.71 148.16 6.21 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 75.140000000000001 108.291 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 4.4 t -98.17 162.47 13.18 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 72.319999999999993 108.277 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 1.012 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -138.45 143.43 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 71.140000000000001 109.3 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -137.88 132.58 32.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 70.099999999999994 109.271 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -139.99 136.34 33.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.230000000000004 107.993 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.9 t -80.38 -3.65 50.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.499 1.124 . . . . 65.510000000000005 110.01 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.4 p90 -169.99 127.45 0.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 62.310000000000002 111.03 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CE1' ' O ' ' A' ' 219' ' ' VAL . 28.6 t60 -115.62 167.23 11.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 73.239999999999995 109.583 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.3 p -144.23 140.42 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 52.439999999999998 109.313 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.658 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.73 -167.65 2.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 73.299999999999997 109.289 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.542 HD11 ' HB ' ' A' ' 237' ' ' ILE . 21.3 pt -115.17 119.33 61.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.545 1.153 . . . . 73.209999999999994 109.267 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 234' ' ' LYS . 14.7 tp -84.92 108.82 17.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 34.32 109.301 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.768 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -103.02 146.57 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 71.329999999999998 109.345 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 15.9 m -117.17 119.36 34.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 72.140000000000001 110.044 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.4 p90 -134.63 145.07 48.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 71.120000000000005 110.969 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.421 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.0 mmtp -69.86 134.57 48.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 72.409999999999997 109.259 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.5 -159.77 0.11 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 42.520000000000003 109.334 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.65 52.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.458 1.099 . . . . 64.409999999999997 109.261 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.7 m -114.82 -7.88 12.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.123 . . . . 71.349999999999994 109.98 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.43 37.64 8.06 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.517 1.136 . . . . 44.140000000000001 111.036 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.424 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.35 137.38 44.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.468 0.746 . . . . 54.049999999999997 109.298 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.421 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.3 m -71.58 102.73 2.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 61.25 110.388 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 224' ' ' SER . 4.2 mm-40 -101.44 -172.62 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 64.200000000000003 110.266 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.574 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtt -126.86 145.22 50.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.1 . . . . 61.100000000000001 109.331 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.619 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -145.53 162.19 38.0 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 75.25 110.286 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.633 HD11 ' OE1' ' A' ' 198' ' ' GLN . 16.6 mm -115.88 119.34 61.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 65.150000000000006 109.311 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.6 mm -105.64 45.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.219999999999999 109.248 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.19 108.78 58.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.518 1.136 . . . . 64.549999999999997 109.329 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -75.0 -19.26 18.02 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.473 1.775 . . . . 75.549999999999997 110.943 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.433 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.4 OUTLIER -53.06 -20.86 3.95 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 64.120000000000005 109.994 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.549 HD13 ' SG ' ' A' ' 256' ' ' CYS . 7.3 mt -120.26 -57.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 72.530000000000001 109.271 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.637 ' CD1' HG11 ' A' ' 247' ' ' VAL . 96.7 m-85 -110.06 99.62 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -12.63 42.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.230000000000004 110.034 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -74.51 -44.83 49.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 1.101 . . . . 65.319999999999993 110.041 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -175.88 -174.76 42.7 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.537 1.148 . . . . 74.530000000000001 110.978 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.03 166.57 28.9 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.5 1.79 . . . . 74.540000000000006 110.99 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.637 HG11 ' CD1' ' A' ' 242' ' ' PHE . 6.0 m -148.09 161.19 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.131 . . . . 72.129999999999995 109.322 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.3 p -65.49 137.32 57.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 74.049999999999997 110.458 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.415 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 6.4 p-10 -40.03 -30.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.230000000000004 109.332 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 7.9 m -76.82 -61.92 1.81 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 75.430000000000007 110.394 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.85 -24.01 3.22 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 74.340000000000003 109.315 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.658 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 7.7 t90 -68.02 -62.86 1.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.955 -1.128 . . . . 73.219999999999999 107.955 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.809 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -48.68 -38.51 21.51 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 72.349999999999994 110.32 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.898 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.6 m-80 -58.24 -51.62 68.98 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 72.129999999999995 109.302 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -59.87 -17.17 34.77 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 74.329999999999998 109.283 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.549 ' SG ' HD13 ' A' ' 241' ' ' LEU . 22.0 m -94.91 -25.81 16.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 63.030000000000001 108.28 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.898 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -106.17 24.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 44.43 109.3 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 206' ' ' ALA . 1.9 p-10 -53.0 129.19 29.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.113 . . . . 61.219999999999999 109.314 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 262' ' ' GLY . 3.1 p -85.81 -3.86 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 71.420000000000002 110.403 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.416 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 0.9 OUTLIER -50.71 -30.72 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 42.119999999999997 109.999 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 261' ' ' CYS . . . . . 0.407 ' SG ' ' CE ' ' A' ' 205' ' ' LYS . 16.4 t -88.39 -29.29 20.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.468 1.105 . . . . 73.230000000000004 108.31 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 259' ' ' THR . . . 156.76 -120.77 1.01 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.454 1.096 . . . . 55.100000000000001 110.978 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -87.5 148.38 24.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 0.743 . . . . 73.019999999999996 110.047 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -169.8 147.69 3.44 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.420000000000002 109.306 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.9 m -172.84 156.25 3.37 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 71.430000000000007 109.996 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.666 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.5 118.27 44.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 70.209999999999994 109.322 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 8.8 t -74.99 -44.08 50.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.513 1.133 . . . . 63.310000000000002 110.007 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 200' ' ' VAL . 22.2 m -157.06 -170.11 3.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.428 1.08 . . . . 61.229999999999997 110.012 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -170.08 157.36 6.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 72.230000000000004 110.982 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -162.26 172.05 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 1.109 . . . . 73.120000000000005 109.321 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 272' ' ' THR . 6.0 p30 -145.71 160.73 41.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 1.103 . . . . 72.040000000000006 109.288 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.476 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.7 p -151.94 -171.92 4.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 41.109999999999999 110.387 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.807 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -68.0 154.39 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.495 1.122 . . . . 65.400000000000006 109.242 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -64.56 -46.72 89.34 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.463 1.102 . . . . 72.209999999999994 110.992 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -50.96 -38.29 49.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 0.776 . . . . 73.239999999999995 109.274 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.807 HG23 ' HB3' ' A' ' 273' ' ' ALA . 33.9 t -46.81 116.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 73.540000000000006 109.306 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 2.4 t80 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 72.120000000000005 110.999 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.573 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 63.4 t80 -154.77 162.2 41.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 111.013 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.573 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 75.2 ttt-85 -128.25 147.48 50.59 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.536 1.148 . . . . 54.109999999999999 110.254 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.33 154.75 47.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.536 1.148 . . . . 75.319999999999993 110.012 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.91 0.22 9.12 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 73.040000000000006 111.026 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 27.9 t -101.63 3.35 39.78 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 52.310000000000002 110.007 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.6 t-20 81.74 36.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.433 1.083 . . . . 73.200000000000003 109.277 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -117.65 119.29 34.52 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.47 1.106 . . . . 64.540000000000006 110.013 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 8.7 m-30 -99.78 160.84 14.0 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 74.329999999999998 110.967 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.546 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.9 OUTLIER -119.77 176.55 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 63.149999999999999 109.303 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 86.9 m-85 -162.56 130.22 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.531 1.144 . . . . 64.25 111.0 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.3 m-20 -113.52 111.88 22.64 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 75.099999999999994 109.297 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.23 -51.86 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.25 109.319 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.464 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 3.3 t-20 -106.96 18.04 22.32 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 54.329999999999998 109.321 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.77 HD12 HG21 ' A' ' 294' ' ' THR . 1.3 mm? 50.34 39.36 20.11 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.572 1.17 . . . . 74.030000000000001 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.562 HG22 ' C ' ' A' ' 319' ' ' GLY . 20.0 mm -65.58 -30.63 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 74.5 109.27 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.737 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.2 t-20 -93.94 -29.75 15.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 60.119999999999997 109.334 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.77 HG21 HD12 ' A' ' 291' ' ' LEU . 1.3 m -76.64 -66.24 0.84 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 63.149999999999999 110.397 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -51.01 -25.92 5.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 74.540000000000006 109.297 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.41 -53.17 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.47 1.106 . . . . 72.319999999999993 108.294 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 293' ' ' ASN . 10.6 t -49.32 -37.62 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.128 . . . . 74.430000000000007 109.315 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.626 HD22 ' HA ' ' A' ' 168' ' ' ILE . 65.9 mt -75.43 -59.62 2.67 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 73.530000000000001 109.316 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -51.98 -20.71 2.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 74.129999999999995 110.367 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.835 ' HE2' HG12 ' A' ' 315' ' ' VAL . 21.4 mmmt -72.58 -42.38 64.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 75.420000000000002 109.316 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.877 ' CD1' HD12 ' A' ' 304' ' ' LEU . 5.1 m-30 -102.44 37.82 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 64.019999999999996 110.984 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 35.6 t -68.66 -44.37 74.23 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.510000000000005 110.003 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.674 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -95.07 -12.96 25.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 62.109999999999999 109.296 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.877 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.7 mt -65.57 135.65 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 61.549999999999997 109.311 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 79.0 p -151.67 152.64 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.105 . . . . 52.219999999999999 109.983 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.87 -145.58 27.43 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.478 1.111 . . . . 63.219999999999999 111.029 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 59.8 m -109.39 15.41 23.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.341 -0.985 . . . . 74.219999999999999 108.341 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.523 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 97.8 p -132.82 148.6 70.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 54.229999999999997 110.016 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.768 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.08 146.45 86.59 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 120.959 -2.517 . . . . 43.229999999999997 110.992 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.4 p -128.86 134.46 26.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.498 1.124 . . . . 74.230000000000004 109.957 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.5 Cg_endo -74.96 -172.38 10.67 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.985 -2.506 . . . . 64.019999999999996 111.006 -0.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.16 153.59 24.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 72.230000000000004 109.286 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.4 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.491 1.785 . . . . 75.209999999999994 110.983 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -86.15 131.13 34.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 72.420000000000002 109.335 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.835 HG12 ' HE2' ' A' ' 300' ' ' LYS . 30.5 m -134.61 14.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 75.040000000000006 109.332 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 30.6 t -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 64.439999999999998 110.014 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.0 m -48.1 -24.16 1.04 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.119 . . . . 62.100000000000001 109.968 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 97.0 m -49.84 169.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.128 . . . . 74.019999999999996 108.336 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.562 ' C ' HG22 ' A' ' 292' ' ' ILE . . . -124.98 -174.6 14.01 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.484 1.115 . . . . 65.310000000000002 110.968 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.502 0.766 . . . . 73.239999999999995 110.986 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.804 HD23 ' HB2' ' A' ' 194' ' ' ASP . 12.1 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.277 -0.638 . . . . 61.439999999999998 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.605 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -102.69 104.18 14.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 63.210000000000001 109.304 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -82.98 7.34 15.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.114 . . . . 55.420000000000002 109.985 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.585 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.4 t -150.38 142.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.485 1.116 . . . . 64.450000000000003 109.319 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 149' ' ' LEU . 1.4 mt -92.73 141.76 24.82 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.439999999999998 109.32 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.02 -31.57 6.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.513 1.796 . . . . 75.140000000000001 110.973 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.51 149.63 17.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 1.11 . . . . 64.510000000000005 109.348 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 146' ' ' LEU . 1.9 t -46.72 -37.19 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.138 . . . . 74.400000000000006 109.248 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.18 -50.05 2.67 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.475 1.11 . . . . 71.420000000000002 109.325 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.74 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -68.95 -37.06 78.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 55.020000000000003 110.393 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.734 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -56.72 -57.5 12.16 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 61.420000000000002 109.287 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -52.09 -29.9 23.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 73.230000000000004 109.295 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.14 -50.79 44.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 74.510000000000005 109.984 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.034 HD12 HD11 ' A' ' 140' ' ' ILE . 54.9 mt -48.53 -40.03 25.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 72.219999999999999 109.285 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -75.16 -42.17 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 75.230000000000004 110.991 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -48.95 -36.77 18.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 72.109999999999999 109.328 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 155' ' ' ASN . 20.9 mt-30 -75.75 -56.0 5.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 73.109999999999999 110.269 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.589 HD11 HD12 ' A' ' 188' ' ' LEU . 13.1 mt -50.71 -26.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 64.510000000000005 109.259 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 -34.21 59.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 75.129999999999995 109.304 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.62 -15.15 36.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 70.200000000000003 109.309 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -85.75 -18.82 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 73.140000000000001 110.29 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.8 p -39.38 136.64 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 73.140000000000001 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.492 ' HB3' HH21 ' A' ' 171' ' ' ARG . 1.3 m -68.33 119.99 13.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 74.049999999999997 108.28 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 128.13 -18.74 5.83 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.436 1.085 . . . . 45.130000000000003 110.999 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.864 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 82.8 p -80.38 162.33 24.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 0.726 . . . . 61.25 110.407 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.7 m -93.26 -0.59 56.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.46 1.1 . . . . 43.219999999999999 110.001 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 162' ' ' THR . 1.3 m -118.84 6.52 11.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 62.140000000000001 110.42 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.864 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -79.83 139.27 37.25 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.121 . . . . 72.319999999999993 109.263 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -166.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 64.019999999999996 110.051 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 60.7 p -152.62 125.84 4.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 64.019999999999996 109.976 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 140.16 65.77 Favored 'Cis proline' 0 C--N 1.36 1.183 0 C-N-CA 120.976 -2.51 . . . . 71.450000000000003 110.973 0.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.6 p -72.89 -177.82 2.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.153 . . . . 73.150000000000006 108.313 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.687 HD11 ' CB ' ' A' ' 183' ' ' LYS . 2.3 mp -91.96 131.4 39.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 64.400000000000006 109.327 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.458 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 11.1 p -85.3 85.56 7.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 74.010000000000005 110.417 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 170' ' ' PHE . 2.2 p90 -88.56 -28.24 20.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 62.200000000000003 111.013 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.492 HH21 ' HB3' ' A' ' 158' ' ' CYS . 0.0 OUTLIER -74.12 -2.52 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.495 1.122 . . . . 64.219999999999999 110.316 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.749 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -128.52 68.89 78.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 72.109999999999999 111.029 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.03 116.08 4.47 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 64.109999999999999 110.972 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.585 HG21 ' CE1' ' A' ' 172' ' ' TYR . 12.2 t -152.08 -74.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.542 1.152 . . . . 52.240000000000002 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.604 ' OD2' ' HB2' ' A' ' 312' ' ' ALA . 2.6 p-10 -123.76 -43.41 2.13 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.491 1.12 . . . . 51.409999999999997 109.336 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -47.64 92.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.496 1.123 . . . . 74.430000000000007 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 175' ' ' ASP . 57.3 m -128.17 -46.86 1.35 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.28 -1.007 . . . . 63.210000000000001 108.28 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 21.7 p90 -72.87 -40.95 65.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 65.430000000000007 111.008 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.633 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -45.66 -68.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 73.530000000000001 109.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.705 HH21 ' HG2' ' A' ' 239' ' ' PRO . 9.5 ptm180 -49.94 -47.66 52.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.444 1.09 . . . . 74.239999999999995 110.306 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -39.4 -57.38 1.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.132 . . . . 42.240000000000002 109.318 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -47.79 -44.56 28.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 74.140000000000001 109.598 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.687 ' CB ' HD11 ' A' ' 168' ' ' ILE . 14.4 mmmm -58.52 -56.58 20.27 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.438 1.086 . . . . 64.420000000000002 109.281 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.521 ' SD ' HG21 ' A' ' 153' ' ' ILE . 5.2 mtm -40.36 -55.41 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 71.239999999999995 111.051 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.446 ' NH1' ' HA ' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -46.28 -44.09 16.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 73.439999999999998 110.316 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.497 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -62.76 -33.19 74.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.120000000000005 110.305 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.497 HD13 ' HG2' ' A' ' 186' ' ' GLN . 16.2 mm -76.05 -34.41 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 50.219999999999999 109.315 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.589 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -61.97 -45.66 92.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 71.120000000000005 109.306 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 7.3 mtt -58.63 -38.58 78.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.437 1.086 . . . . 73.450000000000003 111.029 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -44.22 63.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 70.310000000000002 109.284 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.446 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 5.4 t-20 -74.17 -31.96 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.116 . . . . 63.409999999999997 109.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.57 58.5 0.73 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.533 1.146 . . . . 64.519999999999996 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.74 ' CZ ' HG21 ' A' ' 145' ' ' THR . 68.1 m-85 -153.67 141.42 20.03 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 0.743 . . . . 61.119999999999997 110.959 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.804 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -102.89 129.46 49.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 74.25 109.329 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.537 ' HB3' HD22 ' A' ' 188' ' ' LEU . 30.7 p -120.26 -178.58 3.71 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.547 1.154 . . . . 42.049999999999997 108.287 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -131.36 177.5 7.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 72.439999999999998 110.248 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.456 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 21.8 mmtt -105.25 153.13 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.139 . . . . 73.409999999999997 109.265 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.855 ' OE1' HD11 ' A' ' 236' ' ' ILE . 14.8 tt0 -132.55 117.5 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.140000000000001 110.319 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.473 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 2.6 m-85 -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 111.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 204' ' ' LEU . 8.6 p -131.22 142.81 42.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.45 1.094 . . . . 72.099999999999994 109.265 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.3 m-85 -116.32 156.08 27.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 75.109999999999999 111.028 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.53 -173.42 15.67 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.474 1.109 . . . . 75.439999999999998 111.061 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.801 ' C ' HD23 ' A' ' 204' ' ' LEU . 51.7 t-20 -74.4 110.97 9.12 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.454 0.738 . . . . 72.230000000000004 109.252 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.801 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.6 mt -115.13 94.39 4.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.46 1.1 . . . . 74.109999999999999 109.293 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.709 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 1.9 mtpm? -92.76 175.12 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 73.319999999999993 109.306 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -176.04 131.16 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 72.439999999999998 109.349 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.9 p -112.45 107.39 16.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 74.319999999999993 109.972 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.8 p -82.26 -16.85 48.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 72.430000000000007 110.387 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 114.34 -50.86 0.75 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.464 1.102 . . . . 65.310000000000002 110.963 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.1 m -85.38 -20.06 30.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 0.745 . . . . 63.340000000000003 110.383 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 1.7 p -176.74 140.05 0.32 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 64.120000000000005 108.311 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER -97.69 161.89 13.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 55.119999999999997 108.313 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.2 OUTLIER -132.97 162.06 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 72.549999999999997 109.285 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.709 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -142.83 135.18 27.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 73.319999999999993 109.306 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.7 OUTLIER -138.25 134.32 34.25 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.142 . . . . 65.420000000000002 107.998 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 17.9 t -77.03 -0.09 23.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.519 1.137 . . . . 64.129999999999995 109.979 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.466 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 7.2 p90 -176.64 129.91 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.432 1.083 . . . . 64.510000000000005 110.986 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.495 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 63.0 t60 -115.17 168.44 9.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 63.329999999999998 109.603 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 178' ' ' TYR . 0.8 OUTLIER -140.38 142.27 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 73.109999999999999 109.266 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.631 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.8 -167.14 2.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 72.230000000000004 109.349 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.3 pt -120.01 125.19 74.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 63.130000000000003 109.337 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.598 HD13 ' NE2' ' A' ' 198' ' ' GLN . 17.1 tp -87.58 110.82 20.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.540000000000006 109.272 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.734 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.57 145.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 62.520000000000003 109.304 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.585 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -117.47 119.53 35.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 74.219999999999999 110.009 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -134.64 147.1 50.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 64.530000000000001 110.979 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.8 mmtp -71.66 134.0 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 74.209999999999994 109.332 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -74.87 -160.24 0.11 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 74.439999999999998 109.309 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.37 48.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.442 1.089 . . . . 75.239999999999995 109.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.68 -7.93 12.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 61.43 109.978 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.5 37.31 8.18 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.521 1.138 . . . . 64.319999999999993 110.983 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.02 137.47 43.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 71.540000000000006 109.324 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.7 m -71.88 102.69 2.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 65.430000000000007 110.34 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.1 mm-40 -102.23 -172.68 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.551 1.157 . . . . 72.329999999999998 110.284 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.559 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.3 mmtm -126.24 145.68 50.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.447 1.092 . . . . 74.540000000000006 109.347 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.586 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.6 tpt180 -145.7 161.98 38.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.133 . . . . 71.150000000000006 110.32 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.855 HD11 ' OE1' ' A' ' 198' ' ' GLN . 16.1 mm -115.47 116.09 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.1 . . . . 64.319999999999993 109.321 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -102.46 46.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.509 1.131 . . . . 64.409999999999997 109.286 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -110.28 113.66 56.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.545 1.153 . . . . 64.519999999999996 109.232 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.705 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -75.0 -18.13 18.98 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 72.530000000000001 111.038 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.482 ' OG ' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 m -45.6 -25.98 0.54 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 74.209999999999994 109.976 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.427 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 4.1 mt -119.61 -60.46 1.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 72.329999999999998 109.302 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.6 m-85 -106.15 101.12 10.62 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 53.130000000000003 110.998 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -23.27 26.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 61.140000000000001 109.991 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 59.1 m -64.44 -47.8 77.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 65.299999999999997 110.008 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.39 -176.1 39.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.522 1.139 . . . . 52.32 111.006 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -75.03 169.78 21.87 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.475 1.776 . . . . 71.430000000000007 110.983 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.714 HG21 ' CE2' ' A' ' 242' ' ' PHE . 6.4 m -150.99 158.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 73.219999999999999 109.32 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 38.6 p -58.89 141.95 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 60.530000000000001 110.378 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -46.02 -26.1 0.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.541 1.151 . . . . 72.430000000000007 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 28.1 m -78.96 -62.43 1.7 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 74.200000000000003 110.387 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.32 -27.86 6.89 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 71.239999999999995 109.338 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.631 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 14.3 t90 -62.66 -61.43 2.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 64.219999999999999 107.971 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.56 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.59 -42.69 16.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 73.120000000000005 110.249 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.853 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -55.94 -51.02 69.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 73.109999999999999 109.32 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -57.28 -19.46 22.02 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 65.439999999999998 109.3 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -90.0 -35.39 15.55 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 74.049999999999997 108.281 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.853 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -94.02 20.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.501 1.126 . . . . 51.039999999999999 109.286 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -50.45 106.06 0.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 63.450000000000003 109.277 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 262' ' ' GLY . 10.3 p -73.44 -3.2 26.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 65.409999999999997 110.375 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 t -44.02 -31.83 1.01 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 51.450000000000003 110.002 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 50.6 t -87.52 -37.5 16.86 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 71.219999999999999 108.271 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 170.5 -129.2 1.76 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.497 1.123 . . . . 60.549999999999997 110.961 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -76.37 148.21 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 0.726 . . . . 75.010000000000005 109.939 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -169.91 146.99 3.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 70.230000000000004 109.284 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.4 t -172.77 152.88 2.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 74.409999999999997 109.97 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.683 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.6 p -98.26 114.92 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 51.039999999999999 109.285 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.3 t -72.48 -44.77 61.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.511 1.132 . . . . 71.549999999999997 110.052 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -158.59 171.37 20.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.219999999999999 110.003 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -155.62 156.01 34.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 73.430000000000007 111.018 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -166.75 163.58 16.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.438 1.086 . . . . 72.430000000000007 109.288 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -123.58 160.66 26.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 65.200000000000003 109.296 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.496 HG21 ' CD ' ' A' ' 279' ' ' ARG . 21.4 p -147.5 -175.09 4.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 55.130000000000003 110.411 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 276' ' ' VAL . . . -55.86 169.69 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 74.200000000000003 109.35 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -94.46 -15.96 44.98 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.487 1.117 . . . . 63.229999999999997 111.025 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -94.24 -16.95 23.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 0.775 . . . . 53.549999999999997 109.294 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.674 HG21 ' CD1' ' A' ' 285' ' ' TYR . 0.3 OUTLIER -67.45 115.66 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.559 1.162 . . . . 65.209999999999994 109.283 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.487 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 16.6 t80 -61.66 -54.76 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 74.319999999999993 110.991 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 5.5 t80 -146.54 150.84 36.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 75.010000000000005 110.996 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.594 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 22.3 ttt-85 -121.7 142.7 49.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 65.329999999999998 110.339 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.48 157.87 34.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 61.32 109.96 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.76 8.51 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.503 1.791 . . . . 53.25 111.014 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 43.2 t -101.72 5.64 41.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.542 1.151 . . . . 70.409999999999997 109.961 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.9 t-20 81.66 22.86 0.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.562 1.164 . . . . 72.239999999999995 109.309 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.4 t -103.05 119.08 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 61.409999999999997 109.984 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.674 ' CD1' HG21 ' A' ' 276' ' ' VAL . 64.5 m-85 -106.12 156.5 18.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 73.209999999999994 111.007 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.647 HD11 ' CZ ' ' A' ' 320' ' ' PHE . 1.0 OUTLIER -113.76 176.1 5.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 62.530000000000001 109.279 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 96.5 m-85 -163.55 115.0 1.42 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.496 1.122 . . . . 75.329999999999998 110.997 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 11.4 t0 -115.6 95.87 5.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 54.420000000000002 109.279 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.55 -27.07 25.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 52.340000000000003 109.349 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.459 ' CB ' HG12 ' A' ' 292' ' ' ILE . 43.7 m-20 -99.12 5.76 46.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.13 . . . . 54.009999999999998 109.306 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.3 48.4 2.33 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 74.510000000000005 109.312 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.459 HG12 ' CB ' ' A' ' 290' ' ' ASN . 39.0 mm -78.32 -29.79 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 64.230000000000004 109.274 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.725 ' O ' HG23 ' A' ' 297' ' ' VAL . 11.0 t30 -94.63 -19.88 20.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.445 1.09 . . . . 73.400000000000006 109.348 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.487 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 16.3 m -87.68 -69.05 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 75.420000000000002 110.352 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 44.5 m-20 -51.39 -27.03 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 63.420000000000002 109.268 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 19.4 t -73.23 -68.8 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 72.109999999999999 108.323 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 293' ' ' ASN . 56.0 t -40.25 -39.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.135 . . . . 71.230000000000004 109.296 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.44 -56.98 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.434 1.084 . . . . 64.310000000000002 109.273 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -17.95 19.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.420000000000002 110.403 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.422 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.4 mmmt -77.41 -41.71 38.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 72.109999999999999 109.315 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.719 ' CE2' HG13 ' A' ' 297' ' ' VAL . 0.8 OUTLIER -106.08 39.64 1.75 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.521 1.138 . . . . 73.120000000000005 111.0 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.7 t -67.89 -53.22 28.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 74.530000000000001 109.99 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.786 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.8 -18.09 38.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 65.530000000000001 109.281 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.749 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 14.2 mt -55.98 137.35 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 71.329999999999998 109.297 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.8 p -148.68 159.87 43.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 71.109999999999999 110.009 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.8 -149.06 40.88 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.475 1.109 . . . . 32.350000000000001 110.976 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 1.2 m -106.74 14.24 27.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.303 -0.999 . . . . 60.200000000000003 108.303 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -132.06 149.21 72.64 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.433 1.083 . . . . 74.349999999999994 110.003 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.737 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -74.97 147.08 88.41 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 74.010000000000005 110.989 -0.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.468 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.6 p -129.99 133.32 24.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 109.988 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.04 -167.87 6.01 Favored 'Cis proline' 0 C--N 1.359 1.13 0 C-N-CA 121.033 -2.486 . . . . 70.340000000000003 110.967 0.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.604 ' HB2' ' OD2' ' A' ' 175' ' ' ASP . . . -56.65 153.8 20.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 61.409999999999997 109.315 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.52 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.0 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 73.400000000000006 110.993 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.8 135.09 33.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.148 . . . . 54.439999999999998 109.278 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.422 HG12 ' HE2' ' A' ' 300' ' ' LYS . 17.1 m -127.2 24.73 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 64.120000000000005 109.274 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 16.5 t -57.04 -18.43 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 64.439999999999998 109.975 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -60.28 -26.6 66.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 62.229999999999997 109.999 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.2 m -70.56 -173.44 0.74 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.515 1.134 . . . . 61.020000000000003 108.286 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 167.4 81.37 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.513 1.133 . . . . 71.230000000000004 110.963 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.647 ' CZ ' HD11 ' A' ' 286' ' ' LEU . 3.6 p90 . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.46 0.741 . . . . 75.25 110.953 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.779 HD23 ' HB3' ' A' ' 194' ' ' ASP . 7.9 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.284 -0.635 . . . . 52.020000000000003 109.284 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -100.39 111.33 23.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 74.530000000000001 109.319 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 m -73.29 -43.52 60.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.451 1.094 . . . . 75.140000000000001 110.029 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.881 HG23 ' HB3' ' A' ' 224' ' ' SER . 0.4 OUTLIER -112.58 161.22 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 65.099999999999994 109.281 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -101.84 144.75 29.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 71.319999999999993 109.316 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.48 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -33.79 4.34 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.493 1.786 . . . . 71.349999999999994 110.994 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.424 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.19 147.43 19.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.451 1.094 . . . . 72.129999999999995 109.306 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -47.29 -35.18 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 74.140000000000001 109.294 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.3 -45.86 4.36 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 65.510000000000005 109.322 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.782 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -72.85 -34.11 66.56 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.48 1.112 . . . . 73.430000000000007 110.396 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.714 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -59.94 -56.35 22.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.486 1.116 . . . . 73.450000000000003 109.31 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -53.46 -31.39 45.32 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 72.329999999999998 109.3 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.08 -54.08 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.149 . . . . 72.319999999999993 109.991 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 140' ' ' ILE . 87.5 mt -45.25 -41.6 8.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 74.140000000000001 109.262 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.656 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.42 -44.66 57.82 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.423 1.077 . . . . 74.049999999999997 110.974 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -46.95 -36.2 7.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.42 1.075 . . . . 54.420000000000002 109.306 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . 18.4 mt-30 -77.31 -55.15 5.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 72.040000000000006 110.303 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.647 HD11 HD12 ' A' ' 188' ' ' LEU . 17.5 mt -50.35 -27.09 4.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 55.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -37.38 60.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 74.219999999999999 109.31 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.4 t-20 -57.74 -17.88 17.97 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 74.340000000000003 109.33 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.452 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.4 mm100 -82.79 -25.72 32.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.420000000000002 110.291 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -40.35 114.27 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.15 . . . . 71.420000000000002 110.028 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.7 m -42.42 124.4 2.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 53.539999999999999 108.3 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.89 -22.04 3.88 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.523 1.14 . . . . 73.439999999999998 111.016 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.709 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 56.8 p -90.09 158.25 17.39 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 0.747 . . . . 65.319999999999993 110.38 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.2 t -89.62 -2.52 58.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 70.349999999999994 109.984 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 162' ' ' THR . 3.2 m -110.27 -1.6 17.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 75.409999999999997 110.396 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.709 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -74.75 134.51 41.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.575 1.172 . . . . 62.140000000000001 109.288 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.423 ' H ' ' NE2' ' A' ' 156' ' ' GLN . 0.5 OUTLIER -55.14 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 72.329999999999998 109.976 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.46 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.6 t -156.27 128.32 3.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 75.120000000000005 109.965 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -74.95 136.61 45.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.031 -2.487 . . . . 73.340000000000003 111.019 -0.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.9 p -73.19 -179.42 3.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.239999999999995 108.269 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.729 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.3 mp -88.28 124.52 41.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.573 1.171 . . . . 74.019999999999996 109.311 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.419 ' HB ' ' NE ' ' A' ' 171' ' ' ARG . 12.4 p -90.13 81.16 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 73.140000000000001 110.403 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -80.28 -11.18 59.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.128 . . . . 74.120000000000005 110.995 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.57 -5.2 35.53 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.519 1.137 . . . . 73.230000000000004 110.314 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.747 ' CE2' HD13 ' A' ' 304' ' ' LEU . 26.8 t80 -129.73 69.68 81.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 75.109999999999999 111.023 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.693 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.4 Cg_endo -74.94 114.19 3.97 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.448 1.762 . . . . 64.329999999999998 111.039 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.566 HG21 ' CE1' ' A' ' 172' ' ' TYR . 22.1 t -153.26 -66.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 61.130000000000003 109.302 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.91 114.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 75.530000000000001 109.28 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 151.64 46.4 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.476 1.11 . . . . 72.099999999999994 111.004 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.455 ' HB2' HG13 ' A' ' 219' ' ' VAL . 84.9 m -85.73 -23.12 27.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.3 -1.0 . . . . 74.010000000000005 108.3 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.57 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 16.1 p90 -67.13 -35.89 80.71 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.145 . . . . 74.530000000000001 110.995 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -68.53 -67.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 44.539999999999999 109.271 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.475 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -44.05 -46.56 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 73.230000000000004 110.319 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.531 ' HB1' ' NZ ' ' A' ' 197' ' ' LYS . . . -44.96 -50.45 10.57 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 73.239999999999995 109.285 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.693 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -54.0 -35.39 61.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 73.129999999999995 109.579 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.729 ' CB ' HD11 ' A' ' 168' ' ' ILE . 17.4 mmmt -73.43 -32.22 64.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 1.143 . . . . 75.230000000000004 109.334 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 20.3 mtm -66.21 -55.95 13.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 63.539999999999999 110.99 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.66 HH21 ' N ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -55.32 -26.86 43.17 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 74.409999999999997 110.364 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.432 ' HG2' HD13 ' A' ' 187' ' ' ILE . 1.2 tt0 -64.05 -43.38 95.69 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 110.266 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.432 HD13 ' HG2' ' A' ' 186' ' ' GLN . 21.4 mm -70.48 -38.04 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.138 . . . . 72.109999999999999 109.281 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.766 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -56.43 -31.6 64.09 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 63.340000000000003 109.319 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.525 ' HG2' HD21 ' A' ' 136' ' ' LEU . 35.7 mtp -72.89 -43.64 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.573 1.171 . . . . 75.420000000000002 110.973 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -45.32 -53.37 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 64.430000000000007 109.296 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -64.66 -27.86 69.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.209999999999994 109.314 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.08 52.33 0.89 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.545 1.153 . . . . 61.409999999999997 111.002 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.782 ' CZ ' HG21 ' A' ' 145' ' ' THR . 60.2 m-85 -150.83 128.13 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.537 0.786 . . . . 63.109999999999999 110.981 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.779 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -98.38 131.51 44.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 61.210000000000001 109.363 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.766 ' HB3' HD22 ' A' ' 188' ' ' LEU . 24.1 p -109.5 -179.3 3.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.5 1.125 . . . . 44.119999999999997 108.276 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.71 176.99 5.44 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.55 1.156 . . . . 62.020000000000003 110.305 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.836 ' HE2' HG22 ' A' ' 221' ' ' ILE . 14.2 mmtt -105.7 171.6 7.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 75.310000000000002 109.302 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 31.8 tt0 -166.81 121.02 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 72.430000000000007 110.288 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 8.8 m-85 -116.37 123.93 48.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.466 1.104 . . . . 64.5 110.99 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.659 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.7 p -115.28 152.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.496 1.122 . . . . 71.209999999999994 109.279 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 5.3 m-85 -124.91 162.75 23.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 73.340000000000003 111.016 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.57 -179.88 17.76 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.455 1.097 . . . . 61.399999999999999 111.005 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.721 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.0 t-20 -69.11 109.62 4.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.528 0.781 . . . . 64.140000000000001 109.276 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.721 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -114.01 93.78 4.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.432 1.083 . . . . 73.239999999999995 109.297 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.52 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 7.1 mttt -93.12 167.19 11.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 34.25 109.349 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.487 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -175.53 151.86 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 61.340000000000003 109.286 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t -124.32 131.99 53.54 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 64.200000000000003 109.962 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 17.3 p -97.29 -14.23 21.47 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 62.109999999999999 110.414 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.66 -30.96 5.93 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.503 1.127 . . . . 15.529999999999999 110.998 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.5 t -110.95 -22.48 11.49 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.535 0.785 . . . . 65.530000000000001 110.396 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -160.98 163.5 31.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.122 . . . . 70.430000000000007 108.283 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.482 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.37 143.76 46.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 73.310000000000002 108.315 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.693 HG11 ' O ' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -110.28 156.61 11.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 75.409999999999997 109.287 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.52 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -141.34 119.2 11.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 33.240000000000002 109.348 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -125.11 137.1 54.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.01 -1.107 . . . . 75.340000000000003 108.01 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -81.81 4.6 21.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.508 1.13 . . . . 61.539999999999999 110.022 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.505 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.3 p90 -177.74 126.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.319999999999993 110.946 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.514 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 40.5 t60 -112.7 168.71 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 71.120000000000005 109.608 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 1.5 p -144.62 142.07 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 62.520000000000003 109.314 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.76 -165.13 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 52.32 109.304 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.836 HG22 ' HE2' ' A' ' 197' ' ' LYS . 14.2 pt -119.07 124.93 73.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 44.340000000000003 109.305 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.3 tp -85.9 108.99 18.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 70.109999999999999 109.293 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.714 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.61 148.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.128 . . . . 71.439999999999998 109.301 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.881 ' HB3' HG23 ' A' ' 139' ' ' VAL . 49.7 m -116.89 125.39 51.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.010000000000005 110.03 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 34.8 p90 -139.48 137.47 35.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 65.340000000000003 111.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -64.6 131.1 46.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.568 1.167 . . . . 63.539999999999999 109.347 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -72.06 -160.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 65.230000000000004 109.277 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.08 49.56 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 71.340000000000003 109.324 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.98 -7.85 12.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.497 1.123 . . . . 72.239999999999995 110.034 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.42 37.8 8.0 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.495 1.122 . . . . 43.109999999999999 111.001 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.62 43.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.501 0.765 . . . . 72.530000000000001 109.283 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.483 HG23 ' CG2' ' A' ' 139' ' ' VAL . 2.5 m -71.9 102.75 2.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.540000000000006 110.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 224' ' ' SER . 6.8 mm-40 -102.63 -172.58 2.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 75.409999999999997 110.303 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.519 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.1 mmtm -126.18 145.39 50.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 61.420000000000002 109.301 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.636 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.2 tpt180 -143.07 161.44 38.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 74.049999999999997 110.31 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.681 HG21 ' CD1' ' A' ' 252' ' ' TRP . 11.2 mm -114.74 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.562 1.163 . . . . 75.25 109.305 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 237' ' ' ILE . 4.0 mm -102.58 45.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.115 . . . . 74.439999999999998 109.298 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.05 109.47 62.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 75.439999999999998 109.263 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.2 Cg_endo -75.05 -27.3 10.05 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.477 1.777 . . . . 74.129999999999995 110.966 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.9 OUTLIER -45.21 -26.37 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 74.450000000000003 109.992 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.25 -60.39 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 74.409999999999997 109.294 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 255' ' ' ALA . 87.9 m-85 -107.87 99.6 9.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 72.109999999999999 111.009 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.96 -6.28 57.36 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 72.019999999999996 110.015 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.9 p -80.53 -46.09 16.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.539 1.15 . . . . 71.209999999999994 109.97 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.49 -175.76 42.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 74.120000000000005 111.034 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.449 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.98 163.57 35.1 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.503 1.791 . . . . 65.140000000000001 110.987 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 242' ' ' PHE . 2.4 m -150.35 156.88 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 54.229999999999997 109.278 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.423 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.2 p -60.54 140.49 57.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 72.530000000000001 110.434 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.403 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 1.1 p-10 -42.97 -28.98 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.329999999999998 109.281 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.423 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.0 m -71.34 -65.22 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.116 . . . . 73.239999999999995 110.421 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.32 13.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 64.25 109.31 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.681 ' CD1' HG21 ' A' ' 236' ' ' ILE . 12.5 t90 -59.94 -61.12 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.982 -1.118 . . . . 63.240000000000002 107.982 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.566 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.42 -41.61 20.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 61.119999999999997 110.275 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.826 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -57.31 -51.11 70.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 74.209999999999994 109.3 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.588 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.25 -19.51 14.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 62.229999999999997 109.297 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -89.08 -35.81 16.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 73.439999999999998 108.32 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.826 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -93.96 21.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 74.400000000000006 109.304 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -50.22 106.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 64.040000000000006 109.316 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 262' ' ' GLY . 4.6 p -73.48 -3.14 25.74 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 1.129 . . . . 72.049999999999997 110.38 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 39.0 t -44.52 -30.76 0.94 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 73.349999999999994 110.025 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.51 -37.2 15.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 62.219999999999999 108.275 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 166.84 -127.95 1.67 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.53 1.144 . . . . 41.140000000000001 110.983 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.61 144.86 43.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 0.778 . . . . 74.150000000000006 109.942 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.21 147.53 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.439999999999998 109.304 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 84.1 p -172.95 155.56 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.450000000000003 109.973 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.659 HG23 ' CG2' ' A' ' 200' ' ' VAL . 3.8 p -101.14 118.86 48.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.145 . . . . 75.349999999999994 109.357 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.3 t -73.22 -43.75 60.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 73.140000000000001 110.026 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 200' ' ' VAL . 51.2 p -168.8 -179.35 3.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 65.25 110.029 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -159.22 157.16 30.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 73.129999999999995 110.979 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.35 152.22 29.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 62.439999999999998 109.295 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 272' ' ' THR . 8.6 p30 -112.36 160.71 17.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 72.519999999999996 109.344 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.642 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.7 p -153.83 -178.45 7.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 61.240000000000002 110.396 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.829 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -68.24 162.15 25.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.461 1.101 . . . . 63.420000000000002 109.311 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.9 -44.69 36.37 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.515 1.135 . . . . 73.209999999999994 111.015 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.66 ' N ' HH21 ' A' ' 185' ' ' ARG . 1.7 p30 -53.18 -41.01 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 0.777 . . . . 72.510000000000005 109.299 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.829 HG23 ' HB3' ' A' ' 273' ' ' ALA . 22.8 t -43.56 120.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 74.540000000000006 109.247 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -82.2 -53.07 6.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.523 1.139 . . . . 73.209999999999994 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -136.92 152.83 50.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 74.239999999999995 111.002 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.642 ' HD2' HG21 ' A' ' 272' ' ' THR . 78.2 ttt-85 -126.86 147.3 50.06 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 73.230000000000004 110.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.96 158.14 50.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.47 1.106 . . . . 62.420000000000002 109.936 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 0.25 9.15 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.465 1.771 . . . . 73.409999999999997 110.952 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 7.1 t -98.98 4.98 47.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 110.015 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 75.38 41.56 0.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.349999999999994 109.338 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -120.21 120.39 36.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.467 1.104 . . . . 64.049999999999997 109.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.46 ' OH ' HG22 ' A' ' 272' ' ' THR . 11.7 m-30 -103.05 160.65 14.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 61.399999999999999 111.035 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.671 ' CD1' ' CE2' ' A' ' 320' ' ' PHE . 1.0 OUTLIER -125.42 177.24 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 54.329999999999998 109.342 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.7 m-85 -161.03 115.84 2.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.476 1.11 . . . . 64.540000000000006 111.016 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.43 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 1.0 OUTLIER -115.36 96.78 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 109.348 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -85.63 -19.11 31.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 75.439999999999998 109.253 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.473 ' HB3' HD11 ' A' ' 292' ' ' ILE . 38.6 m-20 -107.65 6.59 27.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.430000000000007 109.297 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.693 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.26 47.22 2.09 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 73.209999999999994 109.3 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.703 HG21 ' O ' ' A' ' 319' ' ' GLY . 47.5 mm -76.51 -31.58 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 73.310000000000002 109.296 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.78 ' O ' HG23 ' A' ' 297' ' ' VAL . 3.7 t30 -94.78 -18.51 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.112 . . . . 71.400000000000006 109.27 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.52 HG22 ' HD3' ' A' ' 183' ' ' LYS . 2.0 m -84.76 -66.51 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 60.439999999999998 110.424 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 87.8 m-20 -56.68 -18.71 13.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 52.399999999999999 109.278 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 4.9 t -80.49 -63.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.128 . . . . 74.030000000000001 108.308 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 293' ' ' ASN . 65.9 t -46.93 -37.24 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.52 1.138 . . . . 71.040000000000006 109.334 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.663 HD11 ' HG3' ' A' ' 183' ' ' LYS . 85.2 mt -67.69 -57.8 5.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.12 . . . . 74.129999999999995 109.277 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.85 -20.76 16.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 110.384 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -72.27 -39.2 68.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 70.340000000000003 109.3 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.943 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.6 m-30 -101.78 35.09 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.498 1.123 . . . . 64.340000000000003 110.987 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.3 t -67.96 -43.85 78.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 73.150000000000006 110.01 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.785 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -95.62 -17.18 21.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.102 . . . . 54.439999999999998 109.278 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.943 HD12 ' CD1' ' A' ' 301' ' ' PHE . 14.2 mt -56.58 153.43 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 63.200000000000003 109.288 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.1 p -165.55 162.17 18.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.528 1.142 . . . . 72.0 110.039 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 65.69 -153.1 51.48 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.507 1.13 . . . . 75.019999999999996 110.979 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 3.0 m -99.38 9.77 42.66 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.294 -1.002 . . . . 73.040000000000006 108.294 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.527 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -125.06 148.85 61.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 55.009999999999998 109.953 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.735 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -74.96 147.06 88.37 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.965 -2.515 . . . . 73.409999999999997 111.014 -0.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.467 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.1 OUTLIER -128.83 133.33 25.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 63.140000000000001 110.006 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.99 -168.73 6.72 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 120.974 -2.511 . . . . 73.219999999999999 111.042 -0.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 150.3 40.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.135 . . . . 73.219999999999999 109.318 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.525 1.803 . . . . 71.019999999999996 111.03 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.47 127.33 39.07 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.143 . . . . 73.239999999999995 109.237 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.52 27.22 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 72.099999999999994 109.297 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 12.5 t -51.72 -35.55 43.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 70.019999999999996 109.993 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 30.8 m -42.3 -28.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.422 1.076 . . . . 73.420000000000002 110.025 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 62.0 m -56.81 -176.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.420000000000002 108.29 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.703 ' O ' HG21 ' A' ' 292' ' ' ILE . . . 179.0 84.31 0.06 OUTLIER Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.527 1.142 . . . . 43.039999999999999 111.001 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.671 ' CE2' ' CD1' ' A' ' 286' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.517 0.775 . . . . 73.319999999999993 110.976 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 194' ' ' ASP . 12.5 tp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.316 -0.624 . . . . 71.420000000000002 109.316 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -102.56 106.91 17.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 64.430000000000007 109.302 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 m -69.33 -42.59 75.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.478 1.111 . . . . 61.399999999999999 109.972 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.845 HG23 ' HB3' ' A' ' 224' ' ' SER . 0.4 OUTLIER -112.79 159.75 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 109.298 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.866 HD11 HD12 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.07 143.83 26.95 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 72.150000000000006 109.316 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.4 Cg_endo -75.02 -33.23 4.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.514 1.797 . . . . 75.349999999999994 110.984 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.41 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.37 146.28 16.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 61.109999999999999 109.267 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -45.15 -36.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.158 . . . . 62.240000000000002 109.271 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.75 2.96 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.546 1.153 . . . . 63.539999999999999 109.265 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.8 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.11 -36.26 72.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.546 1.154 . . . . 34.299999999999997 110.406 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.742 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.7 -57.26 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 72.239999999999995 109.32 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -51.91 -31.93 30.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 62.0 109.292 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.75 -56.66 7.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 62.229999999999997 109.998 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.866 HD12 HD11 ' A' ' 140' ' ' ILE . 22.6 mt -43.05 -41.08 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 63.32 109.28 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.763 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.02 -44.48 54.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.544 1.153 . . . . 73.219999999999999 111.003 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -48.52 -34.82 11.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.135 . . . . 74.120000000000005 109.324 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.436 ' CB ' ' CG2' ' A' ' 187' ' ' ILE . 15.9 mt-30 -77.69 -51.7 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 72.450000000000003 110.335 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 188' ' ' LEU . 17.6 mt -54.61 -24.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.147 . . . . 51.340000000000003 109.327 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -34.73 49.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 72.040000000000006 109.26 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -58.64 -20.08 44.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 1.137 . . . . 62.25 109.295 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.462 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 8.9 mm100 -77.63 -24.1 49.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 74.409999999999997 110.29 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 160' ' ' THR . 6.3 m -38.99 113.04 0.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 70.219999999999999 109.967 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.9 m -43.05 129.65 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 55.32 108.301 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 125.36 -14.24 7.35 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 71.010000000000005 110.989 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.676 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 45.1 p -98.47 154.22 18.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 0.775 . . . . 52.310000000000002 110.434 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 p -86.4 -3.61 59.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.548 1.155 . . . . 73.319999999999993 109.974 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 -3.98 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 71.030000000000001 110.369 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.676 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -76.93 133.6 39.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 71.450000000000003 109.285 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -168.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 63.439999999999998 109.99 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.464 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -155.91 128.16 4.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 61.409999999999997 110.002 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 136.62 46.04 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 120.967 -2.514 . . . . 52.030000000000001 111.03 -0.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 13.2 p -73.01 179.66 3.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.129999999999995 108.3 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 183' ' ' LYS . 4.4 mp -91.9 135.41 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.094 . . . . 74.140000000000001 109.336 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.8 p -96.19 94.53 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.122 . . . . 54.399999999999999 110.388 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.516 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 90.2 m-85 -88.48 -15.46 35.3 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.557 1.161 . . . . 72.109999999999999 110.993 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.67 -2.02 24.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 74.120000000000005 110.285 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.565 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 30.9 t80 -132.38 67.18 78.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 74.040000000000006 111.014 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.416 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -75.03 112.53 3.58 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.471 1.774 . . . . 64.230000000000004 110.991 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.533 HG21 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.95 -72.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 71.400000000000006 109.305 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -152.6 125.12 8.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 62.210000000000001 109.325 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 139.34 44.29 0.07 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.467 1.105 . . . . 72.400000000000006 111.02 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.496 ' HB3' HG13 ' A' ' 219' ' ' VAL . 6.0 t -81.56 -25.42 35.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.329 -0.989 . . . . 64.150000000000006 108.329 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.467 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 28.4 p90 -71.47 -28.67 64.11 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 74.439999999999998 110.992 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.09 -68.12 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.423 1.077 . . . . 63.039999999999999 109.307 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.508 HH21 ' HE2' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -45.24 -47.69 12.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 70.129999999999995 110.298 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB1' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.2 -55.09 4.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.465 1.103 . . . . 71.109999999999999 109.28 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.42 -36.61 15.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 74.140000000000001 109.582 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.834 ' CB ' HD11 ' A' ' 168' ' ' ILE . 9.4 mmmm -77.07 -32.82 57.04 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.149 . . . . 72.120000000000005 109.3 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 181' ' ' ALA . 18.3 mtm -63.6 -50.23 70.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 71.140000000000001 110.99 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.521 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.0 OUTLIER -64.43 -26.34 68.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 72.040000000000006 110.316 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -61.85 -38.92 90.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 73.450000000000003 110.301 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.436 ' CG2' ' CB ' ' A' ' 152' ' ' GLN . 21.2 mm -70.7 -37.68 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 64.409999999999997 109.336 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -54.69 -44.08 73.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.525 1.141 . . . . 73.310000000000002 109.273 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.521 ' HE3' ' CZ ' ' A' ' 185' ' ' ARG . 13.7 mtt -58.85 -43.59 90.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 60.420000000000002 111.047 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.08 -51.46 24.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 75.340000000000003 109.3 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.408 ' HB3' HD21 ' A' ' 149' ' ' LEU . 33.3 t30 -68.74 -26.06 65.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.451 1.094 . . . . 75.230000000000004 109.257 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.15 57.94 0.84 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.495 1.122 . . . . 61.109999999999999 110.982 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.8 ' CZ ' HG21 ' A' ' 145' ' ' THR . 59.6 m-85 -152.13 140.37 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.459 0.741 . . . . 75.140000000000001 110.999 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.967 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -105.53 130.8 53.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 72.230000000000004 109.301 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.915 ' HB3' HD22 ' A' ' 188' ' ' LEU . 11.4 p -109.42 -179.52 3.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 65.430000000000007 108.258 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.13 175.65 8.25 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.543 1.152 . . . . 75.200000000000003 110.279 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.595 ' HE2' HG22 ' A' ' 221' ' ' ILE . 15.8 mmtt -108.9 159.32 16.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 73.430000000000007 109.306 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 34.3 tt0 -152.4 117.72 5.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.548 1.155 . . . . 74.510000000000005 110.273 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -108.94 136.13 48.98 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.496 1.122 . . . . 62.109999999999999 111.047 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.657 HG22 HG23 ' A' ' 266' ' ' VAL . 9.4 p -131.81 143.33 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 75.349999999999994 109.318 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.3 m-85 -117.7 161.38 19.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 71.200000000000003 110.952 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.63 -179.62 17.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.502 1.126 . . . . 53.450000000000003 111.023 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.725 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.8 t-20 -69.08 110.22 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.430000000000007 109.324 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.8 mt -114.32 93.98 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 74.120000000000005 109.301 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.655 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 7.0 mttt -93.36 166.14 12.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 73.030000000000001 109.297 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 212' ' ' CYS . . . -173.28 148.18 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 75.109999999999999 109.286 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.6 t -123.73 131.23 53.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 63.240000000000002 109.953 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.6 p -99.96 -4.35 30.3 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.498 1.124 . . . . 62.409999999999997 110.368 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 105.36 -35.48 5.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.457 1.098 . . . . 30.129999999999999 111.008 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.0 t -102.28 -22.42 14.15 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.508 0.769 . . . . 63.030000000000001 110.392 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -166.2 163.52 17.85 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 52.409999999999997 108.286 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -119.58 148.57 43.16 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.095 . . . . 64.430000000000007 108.314 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -117.99 157.52 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 53.140000000000001 109.27 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.655 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -140.76 120.55 13.47 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 70.530000000000001 109.26 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m-90 -125.95 135.67 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 74.549999999999997 107.995 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.6 t -81.14 1.21 32.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.25 109.969 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.522 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 11.2 p90 -172.23 125.62 0.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.467 1.104 . . . . 74.400000000000006 111.024 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.525 ' O ' HG12 ' A' ' 200' ' ' VAL . 54.0 t-80 -125.41 157.7 36.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.209999999999994 109.568 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 177' ' ' CYS . 1.5 p -131.5 163.99 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.548 1.155 . . . . 54.240000000000002 109.288 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.65 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -156.19 -167.55 2.47 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.517 1.136 . . . . 50.420000000000002 109.292 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.595 HG22 ' HE2' ' A' ' 197' ' ' LYS . 30.6 pt -117.77 119.79 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 63.25 109.316 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 234' ' ' LYS . 10.8 tp -83.11 109.86 17.52 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.555 1.159 . . . . 75.140000000000001 109.304 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.742 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -106.15 147.48 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 71.340000000000003 109.313 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.845 ' HB3' HG23 ' A' ' 139' ' ' VAL . 37.0 m -116.74 125.4 51.6 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 73.099999999999994 109.983 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.572 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -140.52 137.44 33.81 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.54 1.15 . . . . 74.200000000000003 110.977 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.406 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 17.9 mmtp -64.08 132.45 50.55 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.153 . . . . 53.439999999999998 109.307 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -72.82 -160.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 74.340000000000003 109.311 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.86 0.34 48.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.319999999999993 109.309 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.32 -8.56 12.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 109.997 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.45 37.73 7.44 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.469 1.106 . . . . 75.450000000000003 110.967 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.65 136.97 46.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.535 0.785 . . . . 73.540000000000006 109.28 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.493 HG23 ' CG2' ' A' ' 139' ' ' VAL . 2.5 m -71.23 102.79 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 70.409999999999997 110.389 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.43 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.2 mm-40 -102.33 -172.65 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.133 . . . . 73.340000000000003 110.32 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.493 ' HB3' HD11 ' A' ' 222' ' ' LEU . 13.8 mmtm -126.1 145.36 50.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 70.510000000000005 109.283 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.7 tpt180 -145.88 160.34 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 62.409999999999997 110.325 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.547 HG21 ' CD1' ' A' ' 252' ' ' TRP . 9.9 mm -114.24 120.89 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 75.519999999999996 109.251 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 150' ' ' PHE . 5.5 mm -104.29 44.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 74.329999999999998 109.288 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.57 113.62 62.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 1.146 . . . . 75.040000000000006 109.271 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.516 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -75.03 -26.61 10.71 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.501 1.79 . . . . 71.420000000000002 111.009 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.419 ' HB2' ' NH2' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -41.53 -30.76 0.22 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 74.5 110.049 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.2 mt -110.05 -61.14 1.7 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 72.319999999999993 109.317 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 247' ' ' VAL . 98.3 m-85 -108.78 99.51 8.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 74.329999999999998 111.013 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 69.5 m -86.39 -15.98 38.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 64.5 109.998 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.8 t -73.92 -40.05 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.135 . . . . 70.120000000000005 110.011 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.6 -177.54 45.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 51.119999999999997 111.04 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.437 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.96 170.57 20.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.503 1.791 . . . . 74.420000000000002 111.062 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.869 HG21 ' CE2' ' A' ' 242' ' ' PHE . 11.2 m -150.84 158.55 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.506 1.129 . . . . 64.209999999999994 109.287 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.404 ' C ' ' N ' ' A' ' 250' ' ' THR . 40.6 p -60.64 141.45 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.157 . . . . 51.100000000000001 110.379 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -46.3 -25.91 0.71 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 71.319999999999993 109.331 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.404 ' N ' ' C ' ' A' ' 248' ' ' THR . 21.4 m -79.37 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.219999999999999 110.439 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -54.42 -22.22 11.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 63.210000000000001 109.283 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.65 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.6 t90 -66.56 -57.8 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.513 1.133 . . . . 64.439999999999998 107.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.556 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -49.22 -42.99 42.16 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 30.149999999999999 110.33 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.834 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -56.24 -51.04 69.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 75.340000000000003 109.31 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.6 -19.36 10.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.444 1.09 . . . . 73.209999999999994 109.321 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -89.0 -36.79 15.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.329999999999998 108.266 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.834 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.4 m -92.73 20.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 73.420000000000002 109.315 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -50.18 105.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.467 1.105 . . . . 72.019999999999996 109.266 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.41 -3.26 26.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 75.430000000000007 110.352 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 t -44.47 -30.13 0.82 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 52.140000000000001 110.01 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.8 t -89.01 -37.3 15.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.115 . . . . 63.509999999999998 108.29 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.13 -129.3 1.86 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.481 1.113 . . . . 75.439999999999998 111.019 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -73.9 145.18 45.0 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.582 0.813 . . . . 64.209999999999994 110.036 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.16 147.68 4.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 62.100000000000001 109.281 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 94.7 p -172.9 155.48 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 75.099999999999994 110.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.657 HG23 HG22 ' A' ' 200' ' ' VAL . 3.7 p -101.42 117.95 47.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 74.230000000000004 109.313 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.2 t -73.89 -44.19 56.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 74.420000000000002 109.981 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.4 m -166.65 172.97 10.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 63.340000000000003 110.002 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.408 ' HB3' HG23 ' A' ' 200' ' ' VAL . 30.9 p90 -154.64 156.05 35.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 73.230000000000004 111.011 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.65 153.34 31.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 1.151 . . . . 65.209999999999994 109.311 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 272' ' ' THR . 8.4 p30 -113.49 160.7 18.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 72.5 109.257 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 285' ' ' TYR . 2.5 p -154.37 -179.61 8.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.52 1.137 . . . . 75.329999999999998 110.41 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.85 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -66.83 167.76 10.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 60.310000000000002 109.307 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.9 -41.77 13.97 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.481 1.113 . . . . 74.010000000000005 110.986 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -57.2 -42.59 81.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.509 0.77 . . . . 64.409999999999997 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.85 HG23 ' HB3' ' A' ' 273' ' ' ALA . 44.1 t -43.86 118.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.030000000000001 109.297 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.582 ' CD2' ' OD2' ' A' ' 288' ' ' ASP . 18.4 t80 -73.74 -53.46 10.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 74.549999999999997 111.003 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 279' ' ' ARG . 31.0 t80 -136.31 166.7 22.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 70.340000000000003 111.008 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.0 ttt-85 -135.39 147.45 49.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 64.420000000000002 110.283 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.85 158.03 50.94 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 61.299999999999997 109.997 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 0.32 9.08 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.565 1.823 . . . . 70.349999999999994 111.01 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 42.0 p -98.42 4.23 48.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 74.430000000000007 109.993 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.3 t-20 77.21 41.74 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.409999999999997 109.304 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 t -122.66 131.4 53.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 64.430000000000007 109.973 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.552 ' HB3' HG13 ' A' ' 276' ' ' VAL . 16.4 m-30 -111.65 153.13 26.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 73.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.587 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.95 177.44 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.458 1.099 . . . . 73.209999999999994 109.334 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 84.9 m-85 -160.25 115.79 2.33 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 75.319999999999993 111.044 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.582 ' OD2' ' CD2' ' A' ' 277' ' ' TYR . 0.7 OUTLIER -115.43 94.98 4.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.478 1.111 . . . . 70.219999999999999 109.337 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -85.61 -18.34 33.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.483 1.115 . . . . 60.299999999999997 109.297 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.44 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.3 m-20 -107.09 3.28 25.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.476 1.11 . . . . 73.409999999999997 109.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.56 47.43 2.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.448 1.092 . . . . 73.109999999999999 109.27 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.722 HG22 ' H ' ' A' ' 319' ' ' GLY . 22.5 mm -74.27 -32.63 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 62.219999999999999 109.276 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.659 ' O ' HG23 ' A' ' 297' ' ' VAL . 4.5 t30 -90.72 -26.17 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 72.439999999999998 109.291 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.459 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 1.3 m -79.37 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.463 1.102 . . . . 62.299999999999997 110.409 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -54.59 -20.13 7.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.133 . . . . 62.399999999999999 109.272 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 40.4 t -86.32 -62.22 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.477 1.111 . . . . 73.430000000000007 108.288 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.9 t -40.29 -41.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 55.340000000000003 109.29 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' A' ' 168' ' ' ILE . 24.3 mt -69.96 -56.13 7.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 75.329999999999998 109.316 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -55.3 -18.46 6.4 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 110.449 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.609 ' HE2' HG12 ' A' ' 315' ' ' VAL . 18.6 mmmt -75.38 -45.77 37.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 72.450000000000003 109.302 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.694 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.6 m-30 -99.81 38.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.563 1.165 . . . . 71.209999999999994 111.029 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.1 t -69.5 -45.01 69.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.122 . . . . 55.409999999999997 110.029 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.801 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.67 -17.7 22.95 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 51.530000000000001 109.277 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.767 HD22 ' CD ' ' A' ' 309' ' ' PRO . 14.8 mt -59.52 144.91 46.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 73.040000000000006 109.34 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.3 p -154.02 158.08 40.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 75.420000000000002 110.057 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 70.32 -162.17 53.25 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.505 1.128 . . . . 74.230000000000004 110.969 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 310' ' ' SER . 9.4 p -92.1 13.9 17.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.29 -1.004 . . . . 74.5 108.29 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 3.3 m -132.96 148.1 68.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 62.439999999999998 110.009 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.767 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 145.42 83.87 Favored 'Cis proline' 0 C--N 1.361 1.196 0 C-N-CA 120.984 -2.507 . . . . 64.099999999999994 111.008 0.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -131.35 135.6 27.33 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.117 . . . . 71.310000000000002 109.996 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.97 -174.96 15.03 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.016 -2.493 . . . . 72.209999999999994 111.026 -0.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.43 154.96 21.06 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 73.319999999999993 109.296 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.425 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.97 -162.23 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.498 1.788 . . . . 22.129999999999999 111.011 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -82.96 131.52 35.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 72.040000000000006 109.297 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.609 HG12 ' HE2' ' A' ' 300' ' ' LYS . 34.1 m -129.39 26.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.512 1.133 . . . . 70.340000000000003 109.305 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 6.9 t -70.76 -33.52 70.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 54.409999999999997 109.982 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 p -45.75 -25.71 0.54 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 64.530000000000001 110.01 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.39 -173.83 1.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 71.439999999999998 108.275 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.722 ' H ' HG22 ' A' ' 292' ' ' ILE . . . -164.4 -135.58 1.85 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.475 1.109 . . . . 72.409999999999997 110.955 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.445 ' CA ' ' HB ' ' A' ' 292' ' ' ILE . 20.5 m-85 . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.516 0.774 . . . . 72.400000000000006 110.977 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.98 HD23 ' HB2' ' A' ' 194' ' ' ASP . 9.0 tp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.348 -0.612 . . . . 73.310000000000002 109.348 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.553 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -103.88 105.47 15.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 73.450000000000003 109.32 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -83.64 7.89 16.03 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 73.030000000000001 110.002 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.4 t -150.4 145.86 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.47 1.106 . . . . 41.439999999999998 109.327 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.044 HD11 HD12 ' A' ' 149' ' ' LEU . 1.6 mt -97.05 141.67 23.4 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 60.049999999999997 109.322 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -30.54 7.09 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.506 1.793 . . . . 70.25 110.968 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.58 150.25 15.71 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.476 1.11 . . . . 62.210000000000001 109.293 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -48.54 -36.67 7.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 73.25 109.258 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.99 -47.49 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 72.129999999999995 109.242 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.733 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.44 -36.19 71.18 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 61.350000000000001 110.375 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.728 HD11 HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -58.1 -57.17 14.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 1.093 . . . . 73.420000000000002 109.278 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -51.71 -32.34 29.82 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 72.209999999999994 109.332 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.25 -53.83 17.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 50.340000000000003 110.007 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.044 HD12 HD11 ' A' ' 140' ' ' ILE . 63.4 mt -45.56 -41.55 10.0 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.53 1.144 . . . . 74.239999999999995 109.291 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.677 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.38 -44.7 58.03 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 75.239999999999995 110.991 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -47.21 -33.89 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 74.319999999999993 109.319 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.451 ' HB2' ' CG2' ' A' ' 187' ' ' ILE . 22.6 mt-30 -78.53 -53.9 6.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 71.140000000000001 110.302 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 188' ' ' LEU . 24.1 mt -51.28 -28.32 7.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 71.209999999999994 109.281 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -38.48 63.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 72.109999999999999 109.273 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.94 -16.97 20.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.536 1.147 . . . . 71.109999999999999 109.283 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.485 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 10.0 mm100 -86.83 -26.55 23.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.514 1.134 . . . . 70.129999999999995 110.272 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 m -40.04 128.78 2.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 63.240000000000002 109.979 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.71 112.43 1.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 75.209999999999994 108.326 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.76 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 44.5 110.969 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.68 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 37.4 p -95.47 161.1 14.21 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 0.736 . . . . 70.510000000000005 110.383 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.64 -7.59 49.59 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 54.109999999999999 110.01 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.4 m -103.53 -4.23 24.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.096 . . . . 64.109999999999999 110.396 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.68 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -71.91 136.32 46.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 34.240000000000002 109.291 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.05 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 61.009999999999998 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.421 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.1 m -156.24 127.2 3.57 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 72.239999999999995 110.017 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.421 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 140.06 65.22 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 120.994 -2.503 . . . . 71.340000000000003 111.008 0.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.644 ' O ' HD13 ' A' ' 298' ' ' LEU . 6.6 p -72.78 -178.6 2.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 33.539999999999999 108.319 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 183' ' ' LYS . 2.2 mp -83.45 128.51 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 75.239999999999995 109.275 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 51.3 p -96.56 69.15 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 73.209999999999994 110.374 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -81.25 -11.36 59.4 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 73.340000000000003 111.023 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.456 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.31 -1.82 25.4 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.545 1.153 . . . . 74.450000000000003 110.288 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.793 ' CE2' HD13 ' A' ' 304' ' ' LEU . 18.9 t80 -131.47 64.59 73.7 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 74.329999999999998 110.984 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.432 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.95 123.09 7.65 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.444 1.76 . . . . 63.030000000000001 111.024 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.7 t -152.68 -55.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 65.109999999999999 109.324 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 177' ' ' CYS . 5.2 m-20 -147.22 -78.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.146 . . . . 72.299999999999997 109.313 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.38 92.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.505 1.128 . . . . 63.299999999999997 110.978 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.507 ' N ' ' O ' ' A' ' 175' ' ' ASP . 13.4 t -115.36 -16.0 11.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 75.519999999999996 108.293 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 33.1 p90 -74.99 -45.0 44.99 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.482 1.114 . . . . 73.129999999999995 111.02 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -41.58 -68.39 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.529 1.143 . . . . 72.439999999999998 109.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -47.67 -47.23 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 73.400000000000006 110.333 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -46.86 -55.86 7.27 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.47 1.106 . . . . 73.099999999999994 109.289 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.505 ' ND1' ' CD1' ' A' ' 291' ' ' LEU . 2.4 t-160 -48.1 -30.23 4.31 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 70.409999999999997 109.604 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.755 ' HB2' HD11 ' A' ' 168' ' ' ILE . 21.4 mmmt -85.12 -31.99 23.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 71.030000000000001 109.275 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.57 ' HB3' HD13 ' A' ' 221' ' ' ILE . 31.2 mtm -62.51 -36.7 83.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 53.439999999999998 111.0 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.456 ' CB ' ' SG ' ' A' ' 195' ' ' CYS . 0.0 OUTLIER -78.32 -33.77 49.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 64.299999999999997 110.293 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 187' ' ' ILE . 1.1 pt20 -53.9 -35.44 61.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 75.340000000000003 110.303 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.452 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 21.8 mm -74.67 -48.06 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.529 1.143 . . . . 72.140000000000001 109.296 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -47.22 -36.87 9.45 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.452 1.095 . . . . 73.150000000000006 109.305 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.403 ' SD ' ' CD ' ' A' ' 185' ' ' ARG . 6.5 mtt -65.72 -46.96 76.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 74.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -46.43 -51.31 15.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 73.25 109.304 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -65.33 -34.81 79.2 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 74.340000000000003 109.31 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.93 54.19 0.46 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.473 1.108 . . . . 70.109999999999999 110.984 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.733 ' CZ ' HG21 ' A' ' 145' ' ' THR . 78.1 m-85 -152.24 142.18 22.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 0.772 . . . . 63.450000000000003 110.994 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.98 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -108.13 128.65 54.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 72.5 109.291 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 1.015 ' HB3' HD22 ' A' ' 188' ' ' LEU . 12.5 p -104.45 178.22 4.62 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.49 1.119 . . . . 61.130000000000003 108.28 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -127.17 173.81 9.42 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.329999999999998 110.322 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.456 ' NZ ' ' HB1' ' A' ' 181' ' ' ALA . 21.4 mmtt -108.3 153.78 22.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.544 1.153 . . . . 73.349999999999994 109.303 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 31.7 tt0 -147.34 117.42 7.27 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.528 1.142 . . . . 72.099999999999994 110.326 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.0 m-85 -110.59 123.29 49.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 70.329999999999998 110.973 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.67 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.0 p -114.99 151.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 72.140000000000001 109.313 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.451 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 13.0 m-85 -122.27 161.18 23.77 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 71.150000000000006 111.01 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.6 -178.4 16.72 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.478 1.111 . . . . 50.350000000000001 111.006 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.733 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.8 t-20 -69.96 109.44 4.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.574 0.808 . . . . 62.25 109.328 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.733 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.5 mt -114.26 94.5 4.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.155 . . . . 50.210000000000001 109.329 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.484 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 8.4 mttt -92.96 164.3 13.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 63.240000000000002 109.305 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.748 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -175.69 170.92 2.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.113 . . . . 50.509999999999998 109.321 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.24 135.7 54.38 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.109999999999999 110.013 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.0 p -118.96 0.86 11.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.438 1.086 . . . . 71.099999999999994 110.37 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 210' ' ' THR . . . 115.3 112.71 2.88 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.496 1.123 . . . . 71.450000000000003 111.026 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 209' ' ' GLY . 14.5 t 50.59 21.68 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 0.759 . . . . 74.040000000000006 110.402 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.1 OUTLIER -158.42 163.94 36.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.543 1.152 . . . . 62.350000000000001 108.319 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.0 OUTLIER -131.24 138.47 49.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.517 1.135 . . . . 74.5 108.267 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.748 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.9 m -111.12 128.75 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 40.130000000000003 109.314 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.484 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 63.119999999999997 109.327 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.3 m0 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.119 . . . . 65.150000000000006 108.034 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -81.65 -1.31 46.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 75.010000000000005 110.007 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.501 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.2 p90 -169.8 127.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 73.409999999999997 110.977 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.54 ' O ' HG12 ' A' ' 200' ' ' VAL . 49.4 t-80 -124.79 149.24 47.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 63.350000000000001 109.597 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 220' ' ' ALA . 1.5 p -118.1 164.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 75.439999999999998 109.292 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.644 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.06 -170.53 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.13 . . . . 65.200000000000003 109.321 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.648 HD11 ' HB ' ' A' ' 237' ' ' ILE . 21.1 pt -116.44 118.38 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.546 1.154 . . . . 71.219999999999999 109.272 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 234' ' ' LYS . 11.8 tp -83.99 108.64 17.07 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.461 1.101 . . . . 73.129999999999995 109.327 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.728 HG21 HD11 ' A' ' 146' ' ' LEU . 0.9 OUTLIER -102.95 143.89 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 74.25 109.311 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.615 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.2 OUTLIER -116.32 116.78 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 52.229999999999997 109.981 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.575 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.5 p90 -131.92 145.83 51.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.121 . . . . 75.510000000000005 111.019 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -70.76 132.73 45.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 64.209999999999994 109.335 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.28 -160.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 63.409999999999997 109.283 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.89 -0.06 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 73.239999999999995 109.244 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -114.86 -8.51 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 73.209999999999994 109.984 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.86 37.55 7.86 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.494 1.121 . . . . 71.239999999999995 111.016 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.41 137.95 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 71.299999999999997 109.294 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.0 m -71.87 102.55 2.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 62.409999999999997 110.368 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 224' ' ' SER . 6.9 mm-40 -102.12 -172.71 2.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 62.240000000000002 110.275 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.544 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.8 mmtt -127.3 144.63 51.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 73.140000000000001 109.304 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.577 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.0 tpt180 -143.91 163.31 33.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 70.140000000000001 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.577 HG21 ' CD1' ' A' ' 252' ' ' TRP . 22.0 mm -118.82 116.98 52.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 73.430000000000007 109.319 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -98.7 50.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 65.120000000000005 109.327 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.443 ' OD1' HG22 ' A' ' 236' ' ' ILE . 41.2 p-10 -96.6 109.61 48.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 74.150000000000006 109.349 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.477 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -74.98 -50.55 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.505 1.792 . . . . 71.239999999999995 111.002 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.3 OUTLIER -36.51 -34.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 51.229999999999997 110.017 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 241' ' ' LEU . 13.9 mt -97.36 -60.97 1.47 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.144 . . . . 64.209999999999994 109.302 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.732 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.2 m-85 -112.02 99.68 8.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.16 . . . . 64.439999999999998 111.0 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -22.08 33.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 73.239999999999995 109.961 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.1 m -66.49 -47.26 73.57 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.126 . . . . 71.219999999999999 109.961 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.18 41.13 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.486 1.116 . . . . 62.240000000000002 110.977 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.446 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.94 170.47 20.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.512 1.796 . . . . 73.549999999999997 111.019 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.732 HG21 ' CE2' ' A' ' 242' ' ' PHE . 14.6 m -147.74 156.3 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.084 . . . . 73.219999999999999 109.318 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.432 ' N ' ' HE ' ' A' ' 235' ' ' ARG . 41.8 p -59.51 139.01 57.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 71.540000000000006 110.398 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.45 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 23.2 p-10 -43.08 -28.19 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 64.150000000000006 109.327 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.43 ' N ' ' C ' ' A' ' 248' ' ' THR . 11.5 m -77.12 -62.55 1.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.424 1.077 . . . . 73.349999999999994 110.411 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.03 -24.71 4.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 64.140000000000001 109.325 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.644 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 11.1 t90 -66.11 -64.66 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 75.349999999999994 108.038 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.886 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.2 OUTLIER -43.06 -33.56 0.87 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.112 . . . . 73.230000000000004 110.295 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.885 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.5 m-80 -66.25 -48.91 68.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 71.25 109.325 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -57.45 -18.18 17.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.128 . . . . 64.219999999999999 109.26 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.478 ' O ' ' N ' ' A' ' 205' ' ' LYS . 9.6 m -92.53 -33.98 14.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 72.140000000000001 108.269 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 253' ' ' ARG . 2.9 m -93.79 20.44 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 64.040000000000006 109.258 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 46.4 t30 -44.4 104.63 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.106 . . . . 65.329999999999998 109.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.2 p -74.24 -4.72 37.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 70.319999999999993 110.408 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.412 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -47.79 -26.66 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 64.230000000000004 110.007 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 18.2 t -91.08 -34.76 14.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 71.040000000000006 108.316 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.73 -129.8 2.23 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.517 1.135 . . . . 63.340000000000003 111.038 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.441 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -67.0 145.18 55.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 0.741 . . . . 74.340000000000003 109.959 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -173.22 142.23 1.01 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 55.32 109.298 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.9 p -173.08 153.46 2.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 73.129999999999995 109.998 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.67 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.15 120.71 47.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.501 1.125 . . . . 61.310000000000002 109.293 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 16.9 t -76.12 -43.07 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.434 1.084 . . . . 64.319999999999993 110.007 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 200' ' ' VAL . 54.6 m -164.56 -172.52 2.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 71.329999999999998 109.971 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -166.75 157.27 11.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 75.420000000000002 111.025 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.9 157.55 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 54.310000000000002 109.281 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.485 ' C ' HG23 ' A' ' 272' ' ' THR . 7.6 p30 -122.92 160.09 26.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 63.109999999999999 109.307 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.582 ' HB ' HG21 ' A' ' 276' ' ' VAL . 48.2 p -154.98 176.94 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.096 . . . . 71.400000000000006 110.408 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.595 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -57.74 160.91 4.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 75.010000000000005 109.291 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.1 -21.65 78.81 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.526 1.141 . . . . 74.340000000000003 110.984 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.44 ' OD1' ' HB1' ' A' ' 273' ' ' ALA . 1.5 p-10 -74.19 -35.03 63.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 0.759 . . . . 64.140000000000001 109.302 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 273' ' ' ALA . 53.4 t -43.67 101.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.479 1.112 . . . . 62.020000000000003 109.253 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.559 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 4.6 t80 -63.12 -53.63 50.42 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 74.209999999999994 111.029 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -146.85 135.04 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.148 . . . . 73.099999999999994 110.988 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.57 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 72.8 ttt-85 -106.15 147.44 29.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 74.420000000000002 110.294 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.19 157.95 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.439 1.087 . . . . 65.239999999999995 110.006 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -0.65 10.19 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.434 1.754 . . . . 70.219999999999999 111.004 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 40.5 m -101.12 8.71 42.65 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 60.450000000000003 109.959 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 73.03 38.21 0.72 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.563 1.164 . . . . 71.519999999999996 109.297 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -119.79 119.17 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.120000000000005 110.004 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -99.89 167.06 10.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.491 1.12 . . . . 73.140000000000001 111.033 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.562 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -125.89 177.49 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 64.430000000000007 109.353 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 37.8 m-85 -158.34 118.98 3.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 73.140000000000001 111.036 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.916 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.9 OUTLIER -115.39 99.49 7.42 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.465 1.103 . . . . 72.310000000000002 109.305 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.413 ' O ' HD22 ' A' ' 291' ' ' LEU . 10.3 m-20 -83.48 -52.82 6.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 65.209999999999994 109.312 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.472 ' CB ' HG12 ' A' ' 292' ' ' ILE . 24.4 m-20 -88.04 10.63 18.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.146 . . . . 74.540000000000006 109.328 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.916 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.5 mm? 40.45 45.15 1.84 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.115 . . . . 63.420000000000002 109.287 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.472 HG12 ' CB ' ' A' ' 290' ' ' ASN . 45.5 mm -75.26 -27.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 71.549999999999997 109.307 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 297' ' ' VAL . 6.7 t30 -92.1 -29.32 16.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.478 1.111 . . . . 75.019999999999996 109.295 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.559 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 17.9 m -80.02 -68.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 73.329999999999998 110.356 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -45.29 -33.64 2.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.56 1.162 . . . . 74.299999999999997 109.307 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 53.5 t -72.61 -46.08 55.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 71.540000000000006 108.251 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.0 t -55.73 -41.04 63.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 43.130000000000003 109.31 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 167' ' ' CYS . 84.5 mt -66.78 -62.14 1.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.52 1.137 . . . . 72.420000000000002 109.32 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -51.89 -23.87 5.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.461 1.101 . . . . 71.340000000000003 110.441 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.886 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.7 mmmt -71.19 -40.02 71.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.127 . . . . 72.120000000000005 109.318 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.84 ' CD1' HD12 ' A' ' 304' ' ' LEU . 5.2 m-30 -101.5 35.14 2.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 62.240000000000002 110.965 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.4 t -67.35 -44.83 78.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.107 . . . . 75.409999999999997 110.007 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.656 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -93.19 -12.25 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 72.209999999999994 109.301 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.84 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.2 mt -66.66 141.75 57.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.556 1.16 . . . . 71.450000000000003 109.346 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.4 p -159.33 157.46 30.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 44.219999999999999 110.026 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.84 -157.65 50.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.525 1.141 . . . . 74.209999999999994 110.986 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 29.4 p -96.01 11.41 34.16 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.286 -1.005 . . . . 64.510000000000005 108.286 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -130.07 151.15 77.84 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 75.019999999999996 109.98 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.736 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 148.3 91.39 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.02 -2.491 . . . . 71.310000000000002 110.967 0.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.2 p -130.05 134.29 25.96 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 53.340000000000003 110.017 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.08 -172.39 10.72 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 120.994 -2.503 . . . . 65.329999999999998 110.992 0.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.63 151.38 30.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 44.009999999999998 109.36 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -162.42 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.523 1.802 . . . . 65.5 110.985 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.14 135.51 33.62 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 63.039999999999999 109.299 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.886 HG12 ' HE2' ' A' ' 300' ' ' LYS . 24.4 m -137.48 24.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.527 1.142 . . . . 74.239999999999995 109.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.441 ' C ' ' N ' ' A' ' 318' ' ' CYS . 39.7 t -66.58 -41.07 89.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 75.140000000000001 110.041 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -39.72 -29.87 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.443 1.089 . . . . 72.109999999999999 109.982 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' CYS . . . . . 0.441 ' N ' ' C ' ' A' ' 316' ' ' SER . 7.5 m -61.85 -173.9 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.546 1.154 . . . . 63.119999999999997 108.3 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 293' ' ' ASN . . . -160.26 -158.82 9.45 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.508 1.13 . . . . 52.229999999999997 111.001 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 320' ' ' PHE . 4.4 m-85 . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.503 0.767 . . . . 70.549999999999997 111.018 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.91 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.4 tp . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.321 -0.622 . . . . 70.109999999999999 109.321 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.433 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -105.17 107.61 18.68 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.551 1.157 . . . . 54.340000000000003 109.304 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -85.62 10.64 12.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 71.140000000000001 110.001 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.37 146.82 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 74.219999999999999 109.283 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.071 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.13 143.04 25.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 65.439999999999998 109.29 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.5 Cg_endo -75.0 -33.06 4.87 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.489 1.784 . . . . 75.549999999999997 111.053 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.435 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.78 152.49 21.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 51.200000000000003 109.291 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 146' ' ' LEU . 2.0 t -48.98 -35.87 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 54.409999999999997 109.313 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.06 -47.47 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 72.439999999999998 109.285 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.675 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.42 -35.83 71.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 54.5 110.381 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -58.2 -57.03 14.65 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.452 1.095 . . . . 72.540000000000006 109.293 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -52.51 -31.57 36.04 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 64.420000000000002 109.291 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.67 -56.83 6.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.14 . . . . 74.019999999999996 109.979 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.071 HD12 HD11 ' A' ' 140' ' ' ILE . 81.3 mt -42.35 -40.11 2.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 54.329999999999998 109.254 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.563 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.69 -44.58 49.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 74.450000000000003 110.99 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -48.03 -36.8 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 61.509999999999998 109.28 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 155' ' ' ASN . 23.9 mt-30 -76.05 -55.7 5.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 110.296 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 188' ' ' LEU . 18.3 mt -49.52 -27.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 64.409999999999997 109.304 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -36.7 61.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 75.099999999999994 109.315 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.2 t-20 -57.52 -20.08 29.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 74.209999999999994 109.257 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.468 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 3.0 mm100 -80.53 -25.41 38.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 75.299999999999997 110.26 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 160' ' ' THR . 19.1 m -39.03 116.94 0.63 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.239999999999995 110.019 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.6 m -43.39 136.9 2.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 75.109999999999999 108.328 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.39 -43.36 1.52 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.561 1.163 . . . . 65.150000000000006 110.955 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.746 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 32.2 p -64.84 159.79 21.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.538 0.787 . . . . 62.030000000000001 110.434 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 t -91.56 -4.58 55.22 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.555 1.16 . . . . 63.530000000000001 110.0 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.5 m -108.86 -1.91 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 71.109999999999999 110.423 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.746 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -72.29 133.16 44.86 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 64.420000000000002 109.307 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -169.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 63.439999999999998 109.971 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.443 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 45.9 p -154.61 127.07 3.97 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 62.119999999999997 110.013 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.95 138.87 58.56 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.009 -2.496 . . . . 70.439999999999998 111.005 -0.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.79 -178.99 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.481 1.113 . . . . 64.120000000000005 108.28 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.803 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.1 mp -92.82 137.97 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 54.219999999999999 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.58 HG21 ' O ' ' A' ' 301' ' ' PHE . 59.7 p -92.03 85.16 5.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 70.150000000000006 110.414 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.7 ' CZ ' HG21 ' A' ' 168' ' ' ILE . 60.0 m-85 -88.75 -25.2 22.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.502 1.126 . . . . 61.039999999999999 110.995 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.471 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.09 -1.99 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.548 1.155 . . . . 75.019999999999996 110.292 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.785 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.4 t80 -127.25 69.61 74.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 64.450000000000003 111.042 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.431 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 111.56 3.35 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.46 1.768 . . . . 70.540000000000006 111.026 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.611 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.3 t -153.0 -75.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 73.219999999999999 109.31 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 312' ' ' ALA . 3.9 m-20 -149.09 131.9 16.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 61.020000000000003 109.258 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 121.71 79.26 0.51 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.493 1.121 . . . . 53.020000000000003 111.014 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.78 -1.78 10.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.287 -1.005 . . . . 70.109999999999999 108.287 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 29.0 p90 -81.9 -43.91 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.539 1.149 . . . . 73.0 111.002 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.625 ' HB1' ' HA ' ' A' ' 294' ' ' THR . . . -70.09 -45.2 67.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.522 1.139 . . . . 71.409999999999997 109.285 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.509 ' NH2' ' CB ' ' A' ' 240' ' ' SER . 7.3 mtm180 -49.76 -58.76 4.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 70.219999999999999 110.325 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -43.02 -52.49 5.25 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 61.409999999999997 109.303 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -46.91 -39.51 12.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.505 1.128 . . . . 74.109999999999999 109.62 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.803 ' CB ' HD11 ' A' ' 168' ' ' ILE . 19.0 mmmt -72.92 -33.3 65.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 65.310000000000002 109.281 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.585 ' HE1' ' OD1' ' A' ' 238' ' ' ASP . 17.6 mtm -65.99 -59.21 4.05 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.13 . . . . 72.140000000000001 110.997 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -26.07 14.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 63.409999999999997 110.318 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.414 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.9 OUTLIER -64.86 -43.42 93.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 65.530000000000001 110.274 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.424 ' HB ' ' CG1' ' A' ' 153' ' ' ILE . 22.6 mm -69.86 -38.21 75.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 74.120000000000005 109.269 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -54.57 -35.54 63.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.495 1.122 . . . . 71.109999999999999 109.318 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.574 ' HG2' HD21 ' A' ' 136' ' ' LEU . 17.0 mtp -70.12 -42.79 72.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 1.15 . . . . 74.239999999999995 111.055 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -44.77 -47.12 10.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 72.010000000000005 109.283 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -34.57 77.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 75.150000000000006 109.295 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 113.59 55.29 0.42 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.496 1.123 . . . . 73.439999999999998 110.972 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.675 ' CZ ' HG21 ' A' ' 145' ' ' THR . 83.7 m-85 -153.61 141.51 20.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 0.738 . . . . 75.439999999999998 111.009 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.91 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -108.71 122.87 48.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 73.319999999999993 109.308 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.817 ' HB3' HD22 ' A' ' 188' ' ' LEU . 27.5 p -106.41 -179.28 3.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 72.129999999999995 108.301 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -126.77 176.89 6.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 53.420000000000002 110.317 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.708 ' HE2' HG22 ' A' ' 221' ' ' ILE . 13.9 mmtt -107.83 164.05 12.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 73.150000000000006 109.299 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 30.4 tt0 -151.2 117.36 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 71.030000000000001 110.305 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -109.18 125.94 52.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.461 1.101 . . . . 73.5 111.041 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.789 HG23 ' HB3' ' A' ' 269' ' ' TYR . 8.6 p -122.35 121.32 63.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 71.549999999999997 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 56.2 m-85 -93.9 151.77 19.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 72.299999999999997 111.001 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.42 -172.56 19.3 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.493 1.12 . . . . 62.32 111.021 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.817 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.4 t-20 -78.25 111.19 13.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 0.751 . . . . 74.129999999999995 109.281 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.817 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.5 mt -115.33 94.25 4.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 64.120000000000005 109.359 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.851 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.3 mtpt -93.21 170.52 9.57 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.501 1.125 . . . . 63.439999999999998 109.297 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.766 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -172.58 129.65 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 64.040000000000006 109.338 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.6 t -117.89 127.09 53.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.486 1.116 . . . . 75.120000000000005 110.007 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 56.4 p -93.28 -26.83 17.16 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.498 1.124 . . . . 33.43 110.408 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 143.03 -63.39 0.5 Allowed Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.518 1.136 . . . . 65.109999999999999 110.991 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 53.2 p -99.24 8.07 45.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.546 0.792 . . . . 72.209999999999994 110.433 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -173.23 160.95 4.15 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.139 . . . . 73.230000000000004 108.288 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.466 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -134.19 -175.64 3.93 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 72.120000000000005 108.314 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.766 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -153.59 147.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.095 . . . . 73.310000000000002 109.314 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.851 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -133.46 128.43 35.42 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.555 1.159 . . . . 62.32 109.33 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -134.39 131.72 38.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 61.409999999999997 107.999 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -74.59 -2.54 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 53.020000000000003 109.976 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.43 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.1 p90 -173.74 132.9 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.472 1.108 . . . . 72.310000000000002 111.008 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.469 ' N ' HD12 ' A' ' 204' ' ' LEU . 84.6 t60 -121.61 154.68 36.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 65.420000000000002 109.581 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 198' ' ' GLN . 1.6 p -130.61 130.81 64.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.522 1.139 . . . . 65.349999999999994 109.349 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.647 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.4 -164.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 24.41 109.268 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.708 HG22 ' HE2' ' A' ' 197' ' ' LYS . 39.1 pt -122.31 120.26 60.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 72.299999999999997 109.296 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.0 tp -84.49 109.0 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 71.349999999999994 109.282 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.686 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -103.04 147.99 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 70.310000000000002 109.267 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 51.6 m -118.15 121.27 40.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.481 1.113 . . . . 64.299999999999997 110.021 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 31.3 p90 -136.41 144.24 44.4 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 75.530000000000001 110.983 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.438 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.8 mmtp -69.49 133.06 47.25 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 65.0 109.263 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.55 -159.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 74.25 109.293 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.15 48.94 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.499 1.124 . . . . 72.340000000000003 109.345 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.7 m -115.22 -8.07 12.37 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.153 . . . . 43.399999999999999 110.027 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.14 37.58 8.26 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.471 1.107 . . . . 45.450000000000003 111.05 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.46 0.741 . . . . 70.239999999999995 109.3 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.438 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.3 m -71.79 102.58 2.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 61.049999999999997 110.365 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.9 mm-40 -101.42 -172.54 2.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 74.420000000000002 110.31 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.52 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.2 mmtm -127.0 145.11 50.83 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.491 1.119 . . . . 75.5 109.311 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.63 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.9 tpt180 -144.54 160.84 40.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 72.230000000000004 110.311 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 252' ' ' TRP . 16.6 mm -115.13 121.73 67.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 75.219999999999999 109.317 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -108.09 44.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.529 1.143 . . . . 73.400000000000006 109.285 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.585 ' OD1' ' HE1' ' A' ' 184' ' ' MET . 0.7 OUTLIER -104.98 107.76 59.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 74.030000000000001 109.276 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.562 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.3 Cg_endo -75.01 -2.11 12.11 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.549 1.816 . . . . 62.109999999999999 111.018 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.509 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.2 OUTLIER -61.3 -22.66 65.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 74.129999999999995 109.992 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.74 -50.21 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 70.420000000000002 109.272 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.613 ' CD1' HG11 ' A' ' 247' ' ' VAL . 97.4 m-85 -112.18 99.5 8.09 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 74.040000000000006 111.025 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 71.0 m -90.14 -8.44 51.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 72.219999999999999 109.987 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 30.6 p -77.75 -46.44 21.71 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.543 1.152 . . . . 63.399999999999999 110.008 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.11 -174.79 40.45 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.445 1.091 . . . . 62.299999999999997 111.036 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.448 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.0 164.68 32.87 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.477 1.777 . . . . 74.319999999999993 110.99 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.613 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.5 m -147.82 164.97 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 61.210000000000001 109.317 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.7 p -65.93 141.36 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.455 1.097 . . . . 62.439999999999998 110.445 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.437 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 1.3 p30 -45.2 -26.55 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 74.329999999999998 109.338 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 10.7 m -77.41 -62.95 1.49 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.469 1.106 . . . . 64.209999999999994 110.423 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.69 -27.98 8.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 25.52 109.303 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.68 ' CD1' HG21 ' A' ' 236' ' ' ILE . 11.0 t90 -63.28 -61.82 2.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 75.430000000000007 107.997 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.63 -41.87 15.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 63.409999999999997 110.309 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.789 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.3 m-80 -57.24 -50.8 71.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 42.439999999999998 109.298 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.87 -24.41 51.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 33.530000000000001 109.317 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -83.42 -36.43 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 71.310000000000002 108.304 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.61 21.47 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 72.510000000000005 109.303 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -54.41 109.14 0.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 71.129999999999995 109.287 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.3 p -73.79 -2.77 24.92 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 74.129999999999995 110.386 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.7 t -44.0 -27.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.098 . . . . 72.010000000000005 109.979 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 259' ' ' THR . 48.5 t -94.27 -37.01 11.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 61.0 108.3 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 171.09 -128.33 1.59 Allowed Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.493 1.121 . . . . 70.219999999999999 110.968 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -79.86 149.42 30.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 0.78 . . . . 74.140000000000001 110.017 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.573 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -170.69 146.35 2.64 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.501 1.125 . . . . 40.450000000000003 109.324 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.3 m -173.08 151.99 2.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.449 1.093 . . . . 63.5 109.99 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.595 HG23 HG11 ' A' ' 257' ' ' VAL . 2.3 t -97.84 122.35 49.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.519999999999996 109.281 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' SER . . . . . 0.407 ' C ' ' OG ' ' A' ' 268' ' ' SER . 31.1 t -83.81 -34.21 24.77 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.13 . . . . 74.430000000000007 109.999 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 267' ' ' SER . 0.7 OUTLIER -174.78 159.32 2.77 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 74.109999999999999 109.978 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.789 ' HB3' HG23 ' A' ' 200' ' ' VAL . 52.9 p90 -147.5 154.66 41.04 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.447 1.092 . . . . 54.219999999999999 110.985 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.32 165.7 34.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 70.329999999999998 109.32 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.468 ' C ' HG23 ' A' ' 272' ' ' THR . 6.8 p30 -122.68 160.73 25.23 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 62.329999999999998 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.468 HG23 ' C ' ' A' ' 271' ' ' ASN . 45.1 p -154.09 179.43 8.94 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 61.130000000000003 110.419 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.833 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -57.5 166.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.127 . . . . 42.240000000000002 109.253 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.49 -18.67 63.65 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.52 1.137 . . . . 50.130000000000003 111.012 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.448 ' H ' ' ND2' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -83.98 -19.0 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 0.773 . . . . 62.229999999999997 109.287 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.833 HG23 ' HB3' ' A' ' 273' ' ' ALA . 12.9 t -60.48 101.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 71.510000000000005 109.301 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.54 ' OH ' ' ND2' ' A' ' 293' ' ' ASN . 15.1 t80 -64.41 -44.45 91.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.559 1.162 . . . . 64.549999999999997 111.007 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -144.54 155.78 43.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.542 1.151 . . . . 73.099999999999994 110.989 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.447 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 68.0 ttt-85 -124.97 147.45 48.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.409999999999997 110.318 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.77 154.07 44.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.104 . . . . 71.540000000000006 110.006 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -0.03 9.45 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.496 1.787 . . . . 74.019999999999996 111.011 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 6.1 t -104.58 10.6 34.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 44.439999999999998 109.969 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.0 t-20 76.21 38.5 0.32 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.54 1.15 . . . . 72.329999999999998 109.341 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.2 t -117.9 121.03 39.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 63.530000000000001 110.001 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.524 ' HB3' HG13 ' A' ' 276' ' ' VAL . 12.5 m-30 -103.86 158.38 16.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 74.25 110.987 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.742 HD11 ' CZ ' ' A' ' 320' ' ' PHE . 1.0 OUTLIER -118.35 177.64 4.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 73.519999999999996 109.3 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.0 m-85 -161.84 115.79 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 65.120000000000005 111.045 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.3 96.76 5.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.129 . . . . 62.119999999999997 109.346 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -85.62 -15.47 42.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 64.329999999999998 109.307 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.422 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.6 m-20 -109.88 2.26 19.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.529 1.143 . . . . 73.420000000000002 109.302 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.91 47.07 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 45.329999999999998 109.293 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.422 HG12 ' CB ' ' A' ' 290' ' ' ASN . 20.4 mm -73.28 -31.74 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.12 . . . . 65.140000000000001 109.315 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.54 ' ND2' ' OH ' ' A' ' 277' ' ' TYR . 3.5 t30 -93.08 -28.41 16.37 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 74.329999999999998 109.27 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.625 ' HA ' ' HB1' ' A' ' 179' ' ' ALA . 1.8 m -77.07 -65.69 0.92 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.563 1.164 . . . . 73.439999999999998 110.407 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 57.3 m-20 -54.61 -20.07 7.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 53.329999999999998 109.296 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 297' ' ' VAL . 25.0 t -83.99 -66.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 42.399999999999999 108.278 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.523 HG21 ' OH ' ' A' ' 178' ' ' TYR . 3.2 t -40.27 -39.54 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 72.200000000000003 109.296 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.685 HD22 ' HA ' ' A' ' 168' ' ' ILE . 20.4 mt -70.23 -57.2 5.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 1.142 . . . . 73.239999999999995 109.267 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -22.78 2.47 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.454 1.096 . . . . 75.040000000000006 110.358 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -71.32 -48.58 49.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 75.540000000000006 109.311 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.58 ' O ' HG21 ' A' ' 169' ' ' THR . 0.7 OUTLIER -98.43 38.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 61.130000000000003 111.005 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.0 t -70.07 -48.54 57.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.13 . . . . 44.210000000000001 109.971 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -88.18 -11.36 47.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 41.340000000000003 109.284 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.785 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 15.1 mt -63.93 142.55 58.37 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 72.25 109.296 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 66.6 p -157.49 148.43 21.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.16 . . . . 71.430000000000007 109.964 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.05 -152.12 23.46 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.483 1.114 . . . . 41.229999999999997 111.028 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.4 p -103.96 12.87 33.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.309 -0.997 . . . . 52.219999999999999 108.309 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.3 p -134.99 150.99 74.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 64.510000000000005 109.992 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.721 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.01 146.52 86.87 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.001 -2.5 . . . . 73.439999999999998 110.992 0.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.488 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 3.3 p -130.06 133.46 25.0 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 71.120000000000005 109.968 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.04 -168.16 6.25 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.031 -2.487 . . . . 72.109999999999999 110.967 0.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 175' ' ' ASP . . . -56.89 152.73 26.14 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.47 1.106 . . . . 71.109999999999999 109.24 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.548 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.06 -162.52 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.5 1.79 . . . . 64.340000000000003 110.932 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.65 130.72 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 72.329999999999998 109.275 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.486 HG11 ' CZ ' ' A' ' 301' ' ' PHE . 35.4 m -128.85 24.71 2.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 73.140000000000001 109.28 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.2 t -68.38 -27.06 65.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 63.43 110.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.5 t -47.19 -24.66 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 74.530000000000001 109.961 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.89 -173.35 2.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 74.340000000000003 108.275 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 171.12 83.62 0.06 OUTLIER Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.453 1.095 . . . . 74.099999999999994 110.971 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.742 ' CZ ' HD11 ' A' ' 286' ' ' LEU . 2.9 p90 . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.469 0.747 . . . . 63.219999999999999 110.969 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.756 HD23 ' HB3' ' A' ' 194' ' ' ASP . 4.8 tp . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.295 -0.631 . . . . 73.120000000000005 109.295 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.67 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -146.99 108.02 4.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 51.420000000000002 109.291 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.75 2.74 28.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 71.540000000000006 110.026 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -142.23 150.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 72.349999999999994 109.243 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.056 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -102.94 143.31 26.35 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 61.100000000000001 109.312 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -33.76 4.33 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.485 1.782 . . . . 71.129999999999995 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.44 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.7 151.23 23.75 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.449 1.093 . . . . 75.519999999999996 109.288 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.496 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -49.52 -34.81 8.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.485 1.115 . . . . 75.409999999999997 109.277 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.48 -46.6 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 61.350000000000001 109.255 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.702 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -72.1 -33.22 67.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 72.099999999999994 110.36 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -60.91 -56.44 21.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.511 1.132 . . . . 64.540000000000006 109.308 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -54.05 -30.77 49.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.434 1.084 . . . . 72.549999999999997 109.29 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -56.59 7.35 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 63.350000000000001 110.032 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.056 HD12 HD11 ' A' ' 140' ' ' ILE . 84.1 mt -42.18 -42.43 3.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 52.030000000000001 109.318 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.506 ' HB2' HD12 ' A' ' 237' ' ' ILE . 0.8 OUTLIER -71.17 -44.88 64.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 72.450000000000003 111.012 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.43 -39.06 6.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 73.420000000000002 109.298 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 155' ' ' ASN . 20.8 mt-30 -75.82 -55.51 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 74.439999999999998 110.271 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.891 HD11 HD12 ' A' ' 188' ' ' LEU . 14.3 mt -51.05 -24.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 73.430000000000007 109.368 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 243' ' ' SER . 0.0 OUTLIER -78.74 -33.98 46.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 75.450000000000003 109.327 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.4 t-20 -61.73 -14.99 37.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 62.329999999999998 109.286 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 157' ' ' SER . 3.2 mm100 -84.08 -18.19 37.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.400000000000006 110.287 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' GLN . 11.0 p -37.37 147.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 70.409999999999997 110.01 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.4 m -82.28 53.54 2.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 73.400000000000006 108.335 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -164.34 27.88 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.531 1.145 . . . . 72.450000000000003 111.015 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.716 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 60.7 p -132.7 163.19 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 0.754 . . . . 75.099999999999994 110.398 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 63.0 m -93.62 0.86 56.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 62.039999999999999 110.034 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 162' ' ' THR . 3.0 m -116.68 0.44 12.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 74.109999999999999 110.384 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.716 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -69.83 137.99 52.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.13 . . . . 43.109999999999999 109.301 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -164.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.132 . . . . 55.119999999999997 110.028 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 15.3 p -155.57 127.39 3.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.476 1.11 . . . . 63.530000000000001 110.023 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 139.77 63.61 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.988 -2.505 . . . . 52.119999999999997 111.021 -0.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 21.1 p -72.76 -179.53 3.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 64.319999999999993 108.312 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.686 ' HA ' HD22 ' A' ' 298' ' ' LEU . 3.1 mp -92.24 123.24 44.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 72.409999999999997 109.344 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.3 p -89.76 80.71 6.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 65.530000000000001 110.395 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -80.75 -14.41 58.12 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.209999999999994 110.98 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.26 -1.23 22.52 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 71.400000000000006 110.278 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.644 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.7 t80 -130.9 65.54 76.89 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 73.129999999999995 111.001 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.439 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.4 Cg_endo -74.97 117.24 4.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.486 1.782 . . . . 70.510000000000005 110.997 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.578 HG21 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.92 -72.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 70.319999999999993 109.301 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.37 -44.13 1.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 70.540000000000006 109.273 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -53.23 99.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.448 1.093 . . . . 43.340000000000003 111.003 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.63 ' SG ' HG12 ' A' ' 219' ' ' VAL . 3.5 p -134.82 -48.2 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.278 -1.008 . . . . 54.0 108.278 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.569 ' HB3' HG11 ' A' ' 219' ' ' VAL . 8.4 p90 -69.52 -11.77 61.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.142 . . . . 73.409999999999997 110.973 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.494 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -73.41 -68.12 0.53 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 74.5 109.299 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.828 HH21 ' HG2' ' A' ' 239' ' ' PRO . 11.1 ptm180 -50.64 -49.85 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.157 . . . . 74.25 110.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.463 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.64 -57.63 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 71.129999999999995 109.338 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -45.86 -43.9 13.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 70.109999999999999 109.618 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 180' ' ' ARG . 17.3 mmmt -60.35 -58.58 7.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.125 . . . . 74.530000000000001 109.273 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 153' ' ' ILE . 5.8 mtm -39.01 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 75.109999999999999 111.015 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.443 ' NH1' ' SD ' ' A' ' 189' ' ' MET . 2.1 tmt_? -70.57 -50.18 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 71.150000000000006 110.3 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.471 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.2 pt20 -55.29 -33.97 63.71 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 62.539999999999999 110.255 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.471 HD13 ' HG3' ' A' ' 186' ' ' GLN . 16.0 mm -77.02 -34.87 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 64.120000000000005 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.891 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -64.74 -45.12 87.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 63.229999999999997 109.338 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.722 ' HG2' HD21 ' A' ' 136' ' ' LEU . 63.2 mtp -58.28 -37.2 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.502 1.126 . . . . 71.25 111.064 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -52.29 -52.02 55.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 54.210000000000001 109.315 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASN . . . . . 0.445 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 41.6 t30 -63.82 -28.67 70.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 71.019999999999996 109.284 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.55 44.94 1.27 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.522 1.139 . . . . 62.240000000000002 111.027 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.702 ' CZ ' HG21 ' A' ' 145' ' ' THR . 80.0 m-85 -147.82 130.3 15.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 0.76 . . . . 64.319999999999993 111.018 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.756 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.4 OUTLIER -97.07 130.78 44.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 74.219999999999999 109.313 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.839 ' HB3' HD22 ' A' ' 188' ' ' LEU . 30.5 p -104.96 -179.48 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.114 . . . . 62.100000000000001 108.311 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -129.54 174.59 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.464 1.103 . . . . 74.349999999999994 110.32 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' A' ' 221' ' ' ILE . 16.4 mmtt -108.17 169.49 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.52 1.138 . . . . 64.299999999999997 109.303 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 27.7 tt0 -164.11 117.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 73.0 110.299 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.467 ' CE1' HG21 ' A' ' 219' ' ' VAL . 6.0 m-85 -108.28 120.5 42.54 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.511 1.132 . . . . 75.340000000000003 111.006 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.673 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.5 p -109.77 148.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 74.120000000000005 109.29 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.414 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 23.5 m-85 -119.91 158.28 27.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 75.329999999999998 111.002 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 120.63 -179.73 16.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.512 1.132 . . . . 61.219999999999999 110.979 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.742 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.3 t-20 -70.39 110.82 5.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.537 0.787 . . . . 72.109999999999999 109.304 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.6 mt -114.93 93.43 4.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 75.120000000000005 109.267 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.7 mttp -93.55 166.01 12.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 64.510000000000005 109.307 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -169.64 147.98 3.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 34.399999999999999 109.298 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.2 p -120.84 112.86 19.33 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.509 1.13 . . . . 63.439999999999998 109.93 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 27.5 p -82.52 -13.13 57.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 72.319999999999993 110.393 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 114.83 -48.15 0.97 Allowed Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.48 1.113 . . . . 60.030000000000001 111.013 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.7 t -95.65 -12.55 25.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.494 0.761 . . . . 72.200000000000003 110.372 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -170.43 163.36 8.53 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 55.5 108.325 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.479 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.67 144.05 46.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 65.109999999999999 108.312 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.1 OUTLIER -109.83 155.69 10.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 70.340000000000003 109.303 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.68 119.26 13.1 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 61.5 109.295 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.434 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -128.39 133.1 48.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 64.310000000000002 107.958 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.3 m -79.61 2.5 22.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 61.0 109.985 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.481 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.9 p90 -174.17 128.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.124 . . . . 74.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 71.2 t60 -116.36 167.6 10.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 73.310000000000002 109.612 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.63 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.6 p -144.79 137.61 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 72.120000000000005 109.296 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.667 ' HB3' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.89 -165.7 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 62.119999999999997 109.286 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.622 HG22 ' HE2' ' A' ' 197' ' ' LYS . 15.9 pt -115.42 123.54 71.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 74.219999999999999 109.295 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.7 tp -87.91 108.83 19.37 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 73.409999999999997 109.276 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.89 146.98 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 71.030000000000001 109.275 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 140' ' ' ILE . 75.4 m -117.09 120.18 37.55 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.434 1.084 . . . . 65.299999999999997 110.025 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.9 p90 -134.96 143.22 46.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.482 1.114 . . . . 74.230000000000004 111.007 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.422 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -68.85 132.38 46.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 63.530000000000001 109.315 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.36 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.13 . . . . 75.340000000000003 109.323 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.66 0.18 48.04 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 71.530000000000001 109.32 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -115.27 -7.89 12.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.465 1.103 . . . . 75.349999999999994 110.004 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.44 8.34 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.471 1.107 . . . . 71.25 111.004 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.3 137.63 43.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.532 0.784 . . . . 74.219999999999999 109.283 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.422 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.1 m -71.82 102.55 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.115 . . . . 74.140000000000001 110.369 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.6 mm-40 -101.79 -172.59 2.18 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 71.299999999999997 110.321 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.523 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.3 mmtm -127.13 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 74.519999999999996 109.305 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.629 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.9 OUTLIER -142.72 163.95 31.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 75.530000000000001 110.252 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.717 HG21 ' CD1' ' A' ' 252' ' ' TRP . 26.6 mm -119.01 117.86 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 74.200000000000003 109.294 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.0 mm -102.63 47.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 75.129999999999995 109.302 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.669 ' OD1' HD12 ' A' ' 241' ' ' LEU . 20.7 p-10 -94.73 111.53 54.56 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.504 1.128 . . . . 74.010000000000005 109.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.828 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -75.06 -40.28 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.463 1.77 . . . . 51.520000000000003 111.01 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -41.59 -39.09 1.51 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.551 1.157 . . . . 51.420000000000002 110.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.669 HD12 ' OD1' ' A' ' 238' ' ' ASP . 10.5 mt -95.78 -58.34 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 74.409999999999997 109.324 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.658 ' CD2' HG11 ' A' ' 247' ' ' VAL . 91.6 m-85 -117.15 99.2 6.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.449 1.093 . . . . 74.319999999999993 110.99 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' SER . . . . . 0.418 ' O ' ' CE ' ' A' ' 154' ' ' LYS . 35.4 m -90.68 -5.81 55.31 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 73.310000000000002 110.0 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 25.3 m -79.42 -47.08 16.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 75.209999999999994 109.98 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.13 -175.76 39.84 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.478 1.112 . . . . 75.209999999999994 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.518 ' CG ' HD21 ' A' ' 146' ' ' LEU . 18.4 Cg_endo -74.97 161.7 38.42 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.506 1.793 . . . . 74.030000000000001 110.991 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.658 HG11 ' CD2' ' A' ' 242' ' ' PHE . 3.4 m -144.7 157.35 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 71.209999999999994 109.314 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.6 p -64.93 137.63 57.87 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 74.400000000000006 110.392 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 248' ' ' THR . 0.1 OUTLIER -39.78 -31.12 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 73.319999999999993 109.302 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.6 m -71.35 -64.31 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 62.020000000000003 110.402 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.42 -24.74 8.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.11 . . . . 72.109999999999999 109.282 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.717 ' CD1' HG21 ' A' ' 236' ' ' ILE . 8.8 t90 -67.33 -59.92 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.478 1.111 . . . . 73.209999999999994 108.012 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.578 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -51.95 -41.25 61.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 73.450000000000003 110.314 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.804 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.3 m-80 -54.83 -52.49 62.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.099 . . . . 72.439999999999998 109.314 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.2 -26.18 37.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 62.229999999999997 109.287 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -81.82 -36.36 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 55.329999999999998 108.306 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.804 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.69 22.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.137 . . . . 62.450000000000003 109.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -52.23 109.21 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 74.299999999999997 109.305 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.77 -3.09 26.39 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.153 . . . . 71.319999999999993 110.408 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 18.4 t -43.82 -31.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 72.239999999999995 110.001 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.8 -37.7 15.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 52.229999999999997 108.301 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.46 -126.97 1.49 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.515 1.134 . . . . 63.299999999999997 110.997 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.6 145.03 41.47 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 0.772 . . . . 74.439999999999998 109.98 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.2 147.72 4.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 64.120000000000005 109.324 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 92.2 p -172.87 156.8 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 60.439999999999998 110.004 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.673 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.2 p -103.12 117.4 48.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.449 1.093 . . . . 75.239999999999995 109.3 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 21.0 t -72.05 -44.7 62.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 63.030000000000001 109.965 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 200' ' ' VAL . 3.4 m -166.66 -174.67 2.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.137 . . . . 74.219999999999999 110.011 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -163.09 156.6 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 74.25 110.968 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 198' ' ' GLN . . . -154.85 149.57 26.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 75.400000000000006 109.269 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -107.68 157.81 17.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 73.140000000000001 109.282 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.582 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.4 p -148.82 179.11 8.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.562 1.164 . . . . 71.319999999999993 110.411 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.95 164.44 12.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.118 . . . . 73.519999999999996 109.279 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.0 84.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.557 1.16 . . . . 71.420000000000002 111.0 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -84.23 -37.1 22.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 0.746 . . . . 74.109999999999999 109.347 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 273' ' ' ALA . 21.1 t -43.73 108.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 65.530000000000001 109.265 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.545 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 1.6 t80 -72.01 -41.33 67.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 73.099999999999994 110.978 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.565 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -162.85 115.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.438 1.086 . . . . 72.510000000000005 111.011 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.582 ' HD2' HG21 ' A' ' 272' ' ' THR . 62.8 ttt-85 -95.82 141.53 29.17 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.459 1.099 . . . . 65.0 110.297 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.73 158.02 37.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.548 1.155 . . . . 64.010000000000005 110.009 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 0.17 9.24 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 43.130000000000003 111.026 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 46.3 t -97.51 9.23 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 71.010000000000005 109.989 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER 75.37 27.96 1.02 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 75.109999999999999 109.334 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 121.51 45.13 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 1.119 . . . . 65.219999999999999 109.971 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 3.3 m-85 -104.8 162.42 13.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 64.430000000000007 110.974 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.544 ' CD1' ' CE2' ' A' ' 320' ' ' PHE . 0.7 OUTLIER -121.21 172.12 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 72.230000000000004 109.276 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 78.4 m-85 -160.54 127.86 4.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 73.430000000000007 111.022 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.637 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.3 m-20 -115.28 114.21 24.89 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.14 . . . . 74.040000000000006 109.331 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -85.65 -51.24 6.6 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 54.0 109.305 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 3.3 t-20 -108.13 14.19 25.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 71.549999999999997 109.285 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 288' ' ' ASP . 1.2 mm? 54.19 39.06 30.39 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 62.219999999999999 109.296 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 18.6 mm -66.77 -28.99 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 73.0 109.352 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.915 ' O ' HG23 ' A' ' 297' ' ' VAL . 4.1 t30 -94.81 -29.25 14.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.456 1.098 . . . . 73.519999999999996 109.286 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 291' ' ' LEU . 1.9 m -79.03 -65.61 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 71.109999999999999 110.381 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -49.13 -34.04 13.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 73.209999999999994 109.298 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.06 -49.06 60.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 71.219999999999999 108.295 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.3 t -47.99 -47.85 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.144 . . . . 63.439999999999998 109.329 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 168' ' ' ILE . 15.6 mt -67.2 -61.99 1.65 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.51 1.131 . . . . 63.25 109.33 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.04 -25.6 0.34 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 64.430000000000007 110.417 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.646 ' HE2' HG12 ' A' ' 315' ' ' VAL . 19.6 mmmt -72.91 -45.12 59.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.45 1.094 . . . . 62.229999999999997 109.314 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.731 ' CD1' HD12 ' A' ' 304' ' ' LEU . 2.0 m-30 -98.91 37.97 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.524 1.14 . . . . 75.319999999999993 111.009 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.97 -44.23 73.36 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 63.140000000000001 109.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.799 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.85 -18.16 22.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.12 . . . . 73.040000000000006 109.274 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.818 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.9 mt -59.78 142.35 53.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.209999999999994 109.315 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 86.9 p -152.64 160.75 43.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 61.219999999999999 110.005 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.94 -159.05 51.37 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.535 1.147 . . . . 62.509999999999998 110.983 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 27.0 p -95.33 16.52 16.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.308 -0.997 . . . . 72.430000000000007 108.308 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.51 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 41.7 p -134.93 148.97 69.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 33.340000000000003 110.004 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.818 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.0 147.28 88.9 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.99 -2.504 . . . . 75.25 110.992 -0.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.48 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -131.67 135.56 27.04 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 62.219999999999999 109.993 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.94 -174.31 13.86 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.005 -2.498 . . . . 63.530000000000001 111.027 -0.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.67 156.03 26.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 52.350000000000001 109.327 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -162.3 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.461 1.769 . . . . 34.130000000000003 110.993 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -89.29 135.87 33.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 73.310000000000002 109.315 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.646 HG12 ' HE2' ' A' ' 300' ' ' LYS . 30.0 m -128.16 23.17 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 74.019999999999996 109.272 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 t -57.61 -35.58 70.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 60.200000000000003 110.012 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 43.3 t -49.23 -23.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 64.439999999999998 109.985 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.5 170.42 15.92 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.558 1.161 . . . . 72.099999999999994 108.282 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.427 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . -179.19 104.52 0.19 Allowed Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.459 1.099 . . . . 71.040000000000006 110.985 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.544 ' CE2' ' CD1' ' A' ' 286' ' ' LEU . 5.5 p90 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.554 0.796 . . . . 52.350000000000001 110.986 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 194' ' ' ASP . 2.8 tp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.251 -0.648 . . . . 75.120000000000005 109.251 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -156.25 106.36 2.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 75.340000000000003 109.321 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -5.47 54.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 63.020000000000003 109.994 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.38 149.39 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 73.540000000000006 109.338 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -101.96 143.43 26.59 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.507 1.129 . . . . 74.540000000000006 109.299 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.0 -33.77 4.33 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.451 1.764 . . . . 74.140000000000001 110.967 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.402 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.06 148.0 16.78 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.526 1.142 . . . . 74.349999999999994 109.35 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.519 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -43.68 -36.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 72.340000000000003 109.321 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.5 -49.78 2.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 71.200000000000003 109.296 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.787 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -68.73 -37.06 79.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 72.420000000000002 110.415 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.625 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.97 -57.33 12.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 74.129999999999995 109.332 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -53.12 -29.35 30.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 75.430000000000007 109.297 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -57.55 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.428 1.08 . . . . 73.5 109.989 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 140' ' ' ILE . 92.7 mt -42.63 -42.77 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 72.439999999999998 109.29 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.53 -44.81 61.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.415 1.072 . . . . 75.430000000000007 110.982 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -47.06 -38.14 10.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 72.430000000000007 109.284 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.424 ' CB ' ' CG2' ' A' ' 187' ' ' ILE . 19.7 mt-30 -75.53 -53.37 8.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.239999999999995 110.293 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 188' ' ' LEU . 16.0 mt -51.95 -24.63 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 41.140000000000001 109.317 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.41 -35.85 53.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.128 . . . . 72.219999999999999 109.247 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -61.78 -15.79 44.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.400000000000006 109.317 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 187' ' ' ILE . 6.9 mm100 -84.73 -17.48 38.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 71.310000000000002 110.316 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.8 p -38.54 133.15 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.455 1.097 . . . . 41.299999999999997 110.022 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -62.49 135.33 57.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 52.210000000000001 108.312 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 112.21 -22.33 18.27 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.515 1.134 . . . . 54.240000000000002 110.987 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.791 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 55.7 p -77.44 161.63 27.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 0.801 . . . . 73.209999999999994 110.411 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.2 m -93.56 -2.56 54.07 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.310000000000002 110.003 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 162' ' ' THR . 3.5 m -114.98 7.61 15.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.13 . . . . 73.420000000000002 110.392 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.791 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -84.19 139.44 32.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 64.239999999999995 109.3 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -161.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.48 1.113 . . . . 75.310000000000002 109.971 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.434 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 127.64 3.75 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 62.25 110.018 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.06 138.25 54.97 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.028 -2.488 . . . . 54.409999999999997 110.968 0.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 15.4 p -73.08 178.88 4.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 64.310000000000002 108.269 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.921 HG23 ' HG2' ' A' ' 180' ' ' ARG . 2.1 mp -87.41 124.72 40.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 71.010000000000005 109.264 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.1 p -92.34 72.58 5.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 54.399999999999999 110.423 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.433 ' HA ' ' NH1' ' A' ' 180' ' ' ARG . 26.6 p90 -77.75 -14.24 59.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.529 1.143 . . . . 61.439999999999998 110.987 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.91 -0.57 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 65.230000000000004 110.283 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.626 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.0 t80 -129.37 66.3 76.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 74.109999999999999 110.999 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.422 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.0 117.76 5.02 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.472 1.775 . . . . 74.519999999999996 110.994 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.596 HG21 ' CE1' ' A' ' 172' ' ' TYR . 14.0 t -152.28 -54.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.441 1.088 . . . . 54.030000000000001 109.254 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.42 -46.71 0.15 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.526 1.141 . . . . 72.340000000000003 109.346 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -48.18 103.46 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.526 1.141 . . . . 45.43 110.983 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.536 ' HB3' HG13 ' A' ' 219' ' ' VAL . 42.1 m -138.74 -48.47 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.319 -0.993 . . . . 73.340000000000003 108.319 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 13.4 p90 -62.55 -34.52 77.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 75.150000000000006 111.01 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.681 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -60.93 -56.88 15.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.46 1.1 . . . . 64.040000000000006 109.3 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.921 ' HG2' HG23 ' A' ' 168' ' ' ILE . 22.9 mtp180 -53.27 -49.13 67.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 74.150000000000006 110.323 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.433 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -41.64 -62.31 0.91 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 73.019999999999996 109.347 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.499 ' HA ' ' HZ1' ' A' ' 197' ' ' LYS . 7.3 t-160 -42.8 -37.02 1.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.512 1.133 . . . . 65.120000000000005 109.608 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.647 ' CB ' HD11 ' A' ' 168' ' ' ILE . 28.0 mmmt -70.67 -55.33 8.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 74.420000000000002 109.339 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.454 ' HA ' HG23 ' A' ' 153' ' ' ILE . 20.1 mtm -43.99 -28.73 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 71.230000000000004 111.001 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.453 ' NH1' ' HE3' ' A' ' 189' ' ' MET . 0.3 OUTLIER -75.69 -40.49 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.47 1.106 . . . . 74.209999999999994 110.294 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.506 ' HG3' HD13 ' A' ' 187' ' ' ILE . 4.0 pt20 -51.65 -34.14 36.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 1.132 . . . . 75.230000000000004 110.331 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.506 HD13 ' HG3' ' A' ' 186' ' ' GLN . 10.9 mm -78.46 -35.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 73.109999999999999 109.288 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -59.83 -40.5 88.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.499 1.124 . . . . 54.229999999999997 109.298 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.453 ' HE3' ' NH1' ' A' ' 185' ' ' ARG . 4.1 mtt -63.75 -42.72 97.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 74.040000000000006 110.993 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -47.74 -53.51 14.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.543 1.152 . . . . 74.409999999999997 109.289 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.18 -37.48 87.61 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 64.340000000000003 109.351 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.48 40.45 1.12 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.517 1.136 . . . . 31.32 111.004 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.787 ' CZ ' HG21 ' A' ' 145' ' ' THR . 50.5 m-85 -137.28 134.01 35.64 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 0.766 . . . . 53.229999999999997 110.984 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.635 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -101.21 144.91 29.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 71.329999999999998 109.27 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.61 ' HB3' HD22 ' A' ' 188' ' ' LEU . 28.7 p -128.57 -179.4 5.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.144 . . . . 71.319999999999993 108.282 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 222' ' ' LEU . 19.9 mp0 -125.35 178.09 5.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.467 1.105 . . . . 74.340000000000003 110.271 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.499 ' HZ1' ' HA ' ' A' ' 182' ' ' HIS . 19.0 mmtt -106.01 159.3 16.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 1.107 . . . . 74.430000000000007 109.259 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.795 ' OE1' HD11 ' A' ' 236' ' ' ILE . 10.2 tt0 -145.18 117.59 8.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 51.109999999999999 110.312 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.562 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 3.4 m-85 -116.89 128.02 54.83 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.144 . . . . 73.129999999999995 110.98 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.678 ' CG2' HG23 ' A' ' 266' ' ' VAL . 12.3 p -117.37 162.8 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.477 1.111 . . . . 74.25 109.281 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.442 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 76.3 m-85 -133.07 157.97 43.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 73.140000000000001 110.99 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.26 -177.19 16.42 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.492 1.12 . . . . 50.109999999999999 111.043 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.686 ' C ' HD23 ' A' ' 204' ' ' LEU . 62.3 t-20 -70.64 109.77 5.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.479 0.753 . . . . 73.030000000000001 109.29 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.686 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.3 mt -113.31 95.74 5.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 73.040000000000006 109.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 0.4 OUTLIER -92.09 165.61 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 64.049999999999997 109.315 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.873 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -174.63 151.6 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.522 1.139 . . . . 62.509999999999998 109.302 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t -118.1 142.44 47.41 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.537 1.148 . . . . 75.430000000000007 110.027 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 7.7 p -129.93 5.43 4.98 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 53.140000000000001 110.411 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.751 ' O ' HG22 ' A' ' 210' ' ' THR . . . 108.8 114.41 3.73 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.492 1.12 . . . . 73.019999999999996 110.992 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 209' ' ' GLY . 14.7 t 50.48 21.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 0.766 . . . . 61.409999999999997 110.413 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 7.5 t -152.37 170.3 20.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 70.030000000000001 108.291 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.0 m -154.23 133.29 12.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.133 . . . . 72.310000000000002 108.298 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.873 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -109.24 139.29 32.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.509 1.131 . . . . 72.25 109.306 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -133.02 126.14 31.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.12 . . . . 71.140000000000001 109.293 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.451 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -132.43 147.8 52.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 108.024 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -91.59 4.44 52.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 71.340000000000003 110.007 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.507 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 26.5 p90 -175.66 122.77 0.2 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 72.219999999999999 110.981 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.544 ' NE2' HD11 ' A' ' 241' ' ' LEU . 52.1 t60 -106.56 165.69 11.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 62.210000000000001 109.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 177' ' ' CYS . 2.1 p -137.2 155.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.55 1.156 . . . . 74.430000000000007 109.245 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.652 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.18 -163.24 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 60.030000000000001 109.265 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.5 HD11 ' HB ' ' A' ' 237' ' ' ILE . 27.2 pt -123.86 122.48 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.310000000000002 109.288 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.1 tp -86.36 108.85 18.63 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.542 1.151 . . . . 70.239999999999995 109.294 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.642 HG11 HG13 ' A' ' 237' ' ' ILE . 0.9 OUTLIER -101.03 166.68 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.576 1.173 . . . . 50.240000000000002 109.313 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 140' ' ' ILE . 64.0 m -137.14 118.95 15.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 64.409999999999997 109.977 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.519 ' CD2' HG23 ' A' ' 143' ' ' VAL . 33.0 p90 -135.46 143.43 45.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 72.310000000000002 110.959 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -68.49 131.73 45.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 73.239999999999995 109.316 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.428 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -71.68 -160.21 0.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 72.409999999999997 109.318 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -84.26 -0.58 52.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.115 . . . . 63.030000000000001 109.254 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.1 m -114.65 -8.17 12.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.133 . . . . 54.009999999999998 109.977 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.21 37.78 7.55 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.131 . . . . 73.019999999999996 111.028 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.49 138.31 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.512 0.772 . . . . 74.239999999999995 109.256 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -72.06 102.71 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.340000000000003 110.413 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.428 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 5.4 mm-40 -101.54 -172.62 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.459 1.099 . . . . 71.230000000000004 110.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.547 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.4 mmtm -128.12 145.11 51.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.466 1.104 . . . . 44.299999999999997 109.294 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.495 ' HB3' HG22 ' A' ' 223' ' ' VAL . 1.9 tpt180 -143.86 161.79 37.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 75.329999999999998 110.331 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.795 HD11 ' OE1' ' A' ' 198' ' ' GLN . 17.5 mm -114.47 119.13 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 72.519999999999996 109.359 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.2 mm -105.95 45.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 44.409999999999997 109.299 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.434 ' HA ' ' HE1' ' A' ' 184' ' ' MET . 12.6 t0 -105.9 107.72 60.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 64.219999999999999 109.347 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -0.42 9.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.51 1.795 . . . . 72.439999999999998 110.965 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.6 t -72.81 -4.53 32.17 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.504 1.128 . . . . 73.420000000000002 110.013 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.544 HD11 ' NE2' ' A' ' 218' ' ' HIS . 10.3 mt -136.21 -47.02 0.64 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.529 1.143 . . . . 71.200000000000003 109.264 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 247' ' ' VAL . 96.5 m-85 -123.23 101.45 7.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 73.120000000000005 110.968 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.21 -22.11 28.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 32.229999999999997 110.034 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 69.1 m -62.02 -49.56 75.55 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.019999999999996 110.014 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.04 -170.77 37.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.478 1.111 . . . . 45.219999999999999 110.996 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.444 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.99 164.18 33.89 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.506 1.793 . . . . 72.409999999999997 110.987 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.594 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.0 m -148.36 160.08 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.554 1.159 . . . . 71.340000000000003 109.281 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.4 p -64.81 137.6 57.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 74.150000000000006 110.392 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 248' ' ' THR . 5.8 p-10 -40.19 -30.29 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 74.120000000000005 109.33 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.3 m -71.47 -64.5 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 74.109999999999999 110.413 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.98 -26.11 9.85 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.532 1.145 . . . . 74.549999999999997 109.281 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.681 ' CD1' HG21 ' A' ' 236' ' ' ILE . 10.7 t90 -65.11 -57.87 7.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 74.25 107.993 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.572 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -52.89 -42.12 65.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 72.430000000000007 110.293 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.858 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.3 m-80 -55.14 -50.63 68.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 70.030000000000001 109.323 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -54.86 -26.59 36.5 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.134 . . . . 52.329999999999998 109.312 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -82.56 -37.83 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.108 . . . . 62.530000000000001 108.33 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.858 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.1 m -92.77 22.69 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 74.329999999999998 109.364 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 47.7 t30 -50.38 104.53 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 41.020000000000003 109.328 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.7 p -75.01 -4.03 35.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 73.099999999999994 110.37 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.414 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -50.74 -22.26 2.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.549 1.156 . . . . 72.420000000000002 110.042 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 5.9 m -93.96 -29.47 15.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.457 1.098 . . . . 71.430000000000007 108.255 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 159.9 -122.18 1.1 Allowed Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.483 1.114 . . . . 71.450000000000003 111.004 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.3 OUTLIER -83.86 140.12 32.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.572 0.807 . . . . 44.020000000000003 110.007 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.543 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -169.21 146.37 3.55 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.486 1.116 . . . . 71.150000000000006 109.288 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.7 t -172.87 164.02 5.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 75.519999999999996 110.002 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.678 HG23 ' CG2' ' A' ' 200' ' ' VAL . 6.6 p -105.53 120.54 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 73.530000000000001 109.305 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.4 t -80.05 -43.14 22.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.483 1.114 . . . . 75.040000000000006 109.984 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.0 m -156.88 176.73 12.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.443 1.089 . . . . 75.109999999999999 109.997 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.21 158.77 27.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.574 1.171 . . . . 75.510000000000005 110.953 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -172.88 155.37 3.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 65.019999999999996 109.345 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.524 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -122.22 159.34 27.48 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.514 1.134 . . . . 73.340000000000003 109.344 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.527 HG21 ' HD2' ' A' ' 279' ' ' ARG . 41.5 p -144.68 167.31 22.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.459 1.1 . . . . 75.450000000000003 110.386 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.696 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -45.71 158.17 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 1.14 . . . . 63.140000000000001 109.289 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -70.24 -46.58 49.26 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.489 1.118 . . . . 73.430000000000007 111.026 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -49.5 -37.54 26.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 71.120000000000005 109.301 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.696 HG23 ' HB3' ' A' ' 273' ' ' ALA . 98.4 t -45.61 120.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 72.109999999999999 109.289 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' A' ' 277' ' ' TYR . 1.0 OUTLIER -75.78 -48.74 20.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 74.349999999999994 110.983 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.6 t80 -151.39 154.98 37.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 51.009999999999998 111.032 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.562 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 71.1 ttt-85 -118.52 147.53 43.56 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.539 1.149 . . . . 73.349999999999994 110.269 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.82 157.4 46.37 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 75.25 109.966 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 0.27 9.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.5 1.79 . . . . 55.43 110.983 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.6 t -105.46 9.13 33.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 74.400000000000006 110.003 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.23 40.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.121 . . . . 71.209999999999994 109.306 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -119.23 119.81 35.2 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 70.109999999999999 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -100.07 157.96 16.18 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 71.439999999999998 111.009 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -118.04 177.64 4.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 63.299999999999997 109.244 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.2 m-85 -162.82 132.23 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 73.430000000000007 110.98 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.888 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.6 OUTLIER -113.84 112.08 22.8 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.515 1.134 . . . . 72.409999999999997 109.334 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -52.17 8.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.461 1.101 . . . . 72.319999999999993 109.296 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 3.3 t-20 -115.05 25.08 11.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.518 1.136 . . . . 63.439999999999998 109.331 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.888 HD13 ' HB3' ' A' ' 288' ' ' ASP . 1.9 mm? 48.87 36.59 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 65.120000000000005 109.278 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.493 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 18.6 mm -66.04 -30.05 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 54.310000000000002 109.317 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.886 ' O ' HG23 ' A' ' 297' ' ' VAL . 3.8 t30 -94.5 -31.35 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.528 1.143 . . . . 73.430000000000007 109.245 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.474 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 7.6 m -77.19 -65.89 0.9 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.44 1.087 . . . . 74.319999999999993 110.434 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 70.7 m-20 -48.23 -33.17 8.18 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 74.409999999999997 109.286 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.4 t -72.72 -40.26 66.27 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 64.349999999999994 108.283 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.9 t -59.61 -42.85 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 63.210000000000001 109.327 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.626 HD11 ' HG3' ' A' ' 183' ' ' LYS . 77.1 mt -71.18 -62.42 1.4 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 70.510000000000005 109.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -43.82 -26.38 0.25 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 73.530000000000001 110.343 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.722 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.1 mmmt -67.74 -46.77 71.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 64.420000000000002 109.255 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.708 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.8 m-30 -97.35 36.61 1.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.517 1.136 . . . . 71.25 111.003 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.0 t -67.03 -46.84 73.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.469 1.106 . . . . 62.219999999999999 109.978 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.796 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -92.13 -18.15 23.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.53 1.144 . . . . 73.129999999999995 109.327 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.793 HD22 ' CD ' ' A' ' 309' ' ' PRO . 15.2 mt -59.51 134.17 56.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 71.209999999999994 109.303 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 77.3 p -149.67 150.55 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 74.329999999999998 109.994 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.6 -162.94 45.79 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.496 1.123 . . . . 73.25 110.986 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 4.6 p -90.17 9.92 26.52 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.295 -1.002 . . . . 61.210000000000001 108.295 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.513 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 2.2 p -132.56 150.77 76.75 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 74.109999999999999 109.968 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.793 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.92 146.42 86.63 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 120.984 -2.506 . . . . 73.209999999999994 111.046 -0.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.4 p -131.82 136.05 27.74 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 71.420000000000002 110.02 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.81 14.78 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.036 -2.485 . . . . 50.399999999999999 111.023 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.59 158.2 32.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 62.119999999999997 109.324 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.01 -162.4 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.48 1.779 . . . . 55.109999999999999 110.976 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -91.79 136.24 33.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 74.329999999999998 109.279 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.722 HG12 ' HE2' ' A' ' 300' ' ' LYS . 17.6 m -130.43 17.58 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.109999999999999 109.325 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 318' ' ' CYS . 12.4 t -64.9 -33.01 74.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.151 . . . . 72.420000000000002 110.014 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -48.33 -23.92 1.06 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.518 1.136 . . . . 62.350000000000001 110.0 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 316' ' ' SER . 1.6 m -79.51 166.51 21.88 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 73.129999999999995 108.308 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . -163.15 101.59 0.19 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 64.340000000000003 111.009 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 23.9 p90 . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.538 0.787 . . . . 73.519999999999996 110.939 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.0 tp . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.273 -0.639 . . . . 74.319999999999993 109.273 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -150.06 105.31 3.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 64.530000000000001 109.306 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -81.77 5.62 18.03 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 51.030000000000001 109.992 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -146.35 147.52 17.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.502 1.126 . . . . 74.219999999999999 109.302 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.019 HD11 HD12 ' A' ' 149' ' ' LEU . 1.1 mt -100.1 142.54 24.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 62.520000000000003 109.315 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -32.73 5.12 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.434 1.755 . . . . 73.109999999999999 110.972 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.31 147.7 16.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 64.140000000000001 109.266 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 225' ' ' TYR . 2.0 t -45.45 -36.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 75.200000000000003 109.262 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.98 -47.42 3.02 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.476 1.11 . . . . 62.240000000000002 109.297 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.777 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.38 -36.16 71.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 53.140000000000001 110.395 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.727 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -57.91 -56.97 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 74.040000000000006 109.303 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -52.44 -31.69 35.74 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 75.549999999999997 109.299 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.13 -56.13 8.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 73.040000000000006 109.98 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 140' ' ' ILE . 45.2 mt -44.08 -42.28 6.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 74.540000000000006 109.269 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.672 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -72.44 -44.64 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.129999999999995 111.037 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -47.05 -34.5 5.86 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.154 . . . . 63.43 109.291 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 187' ' ' ILE . 21.2 mt-30 -79.35 -50.85 10.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.121 . . . . 60.240000000000002 110.281 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 1.132 HD11 HD12 ' A' ' 188' ' ' LEU . 12.7 mt -54.91 -23.19 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.25 109.282 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -38.55 38.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 74.340000000000003 109.259 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.21 -17.44 19.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 63.100000000000001 109.323 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.49 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 12.5 mm-40 -82.94 -25.37 32.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.109999999999999 110.327 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.574 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 17.4 m -39.87 126.5 2.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 55.140000000000001 109.997 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 10.2 m -58.11 109.88 0.83 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 63.219999999999999 108.307 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.71 -18.97 1.13 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.483 1.114 . . . . 61.240000000000002 111.007 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.731 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 59.4 p -93.25 159.84 15.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 0.762 . . . . 70.140000000000001 110.387 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.93 -3.51 58.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 64.420000000000002 110.014 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.7 m -110.15 -1.16 17.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 71.349999999999994 110.42 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.731 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -73.31 132.82 43.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 72.450000000000003 109.294 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -173.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 75.109999999999999 109.989 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.42 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.3 p -152.65 126.94 4.5 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.118 . . . . 62.009999999999998 109.985 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.88 52.9 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.021 -2.491 . . . . 70.129999999999995 110.979 -0.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 9.1 p -72.66 -173.85 1.27 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.125 . . . . 63.539999999999999 108.256 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.94 ' HA ' HD22 ' A' ' 298' ' ' LEU . 3.3 mp -100.82 134.17 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.116 . . . . 75.200000000000003 109.351 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.501 HG21 ' HB2' ' A' ' 301' ' ' PHE . 36.2 p -81.42 86.67 6.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.13 . . . . 74.219999999999999 110.377 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 1.6 p90 -88.9 -1.99 58.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 73.319999999999993 111.007 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.405 HH12 HG22 ' A' ' 169' ' ' THR . 0.1 OUTLIER -110.6 9.88 23.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 55.219999999999999 110.258 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.706 ' OH ' HD13 ' A' ' 304' ' ' LEU . 18.0 t80 -129.51 68.09 79.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.476 1.11 . . . . 75.450000000000003 110.989 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.611 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.3 Cg_endo -75.03 117.08 4.78 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.528 1.804 . . . . 51.310000000000002 111.012 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.637 HG13 ' HB2' ' A' ' 310' ' ' SER . 2.6 t -151.78 -55.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 71.310000000000002 109.262 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.36 -46.77 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 73.450000000000003 109.281 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.2 121.22 1.02 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.47 1.106 . . . . 55.109999999999999 111.004 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.598 ' SG ' HG12 ' A' ' 219' ' ' VAL . 4.3 p -153.02 -47.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.361 -0.978 . . . . 73.150000000000006 108.361 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 47.0 p90 -67.53 -44.47 78.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.468 1.105 . . . . 74.230000000000004 111.048 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.567 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -54.21 -66.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.472 1.107 . . . . 72.219999999999999 109.281 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.529 ' CB ' HG21 ' A' ' 168' ' ' ILE . 2.0 ptm85 -42.02 -46.96 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 1.155 . . . . 72.420000000000002 110.26 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -50.36 -58.96 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.137 . . . . 72.230000000000004 109.268 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -46.35 -28.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 73.349999999999994 109.613 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.843 ' HB3' HD11 ' A' ' 168' ' ' ILE . 24.4 mmmt -81.03 -40.03 24.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 64.150000000000006 109.32 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.553 ' HB3' HD13 ' A' ' 221' ' ' ILE . 9.8 mtm -60.35 -46.64 89.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 70.150000000000006 111.005 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.549 ' NH1' ' HE3' ' A' ' 189' ' ' MET . 0.0 OUTLIER -65.85 -30.67 71.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 64.120000000000005 110.303 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.581 HE22 ' HE3' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -59.85 -33.12 71.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 74.120000000000005 110.323 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.445 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 25.1 mm -78.5 -50.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 52.350000000000001 109.259 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LEU . . . . . 1.132 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -43.62 -36.89 2.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.454 1.096 . . . . 70.519999999999996 109.307 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.69 ' HG2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -68.54 -46.29 69.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.476 1.11 . . . . 62.509999999999998 111.0 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -53.5 12.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.53 1.144 . . . . 70.040000000000006 109.251 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -62.29 -37.47 85.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 62.5 109.31 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.95 51.37 0.33 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.534 1.146 . . . . 70.010000000000005 111.002 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.777 ' CZ ' HG21 ' A' ' 145' ' ' THR . 74.0 m-85 -151.43 136.92 17.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 0.757 . . . . 72.219999999999999 111.028 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.792 ' HB2' HD23 ' A' ' 136' ' ' LEU . 2.8 t70 -102.74 131.47 49.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.498 1.123 . . . . 61.329999999999998 109.284 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 1.012 ' HB3' HD22 ' A' ' 188' ' ' LEU . 12.8 p -108.38 -179.27 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 64.109999999999999 108.323 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER -129.39 177.35 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.049999999999997 110.301 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.653 ' HE2' HG22 ' A' ' 221' ' ' ILE . 13.6 mmtt -109.54 171.67 7.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 73.409999999999997 109.306 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 25.0 tt0 -168.72 117.4 0.69 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 71.109999999999999 110.324 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.4 m-85 -109.09 137.81 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 64.310000000000002 111.014 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.884 HG23 ' HB3' ' A' ' 269' ' ' TYR . 9.9 p -129.98 125.59 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 75.129999999999995 109.289 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -95.97 151.14 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 72.049999999999997 110.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 129.44 -171.07 20.21 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.506 1.129 . . . . 71.310000000000002 110.995 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASN . . . . . 0.837 ' C ' HD23 ' A' ' 204' ' ' LEU . 56.1 t-20 -79.15 111.47 15.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 0.787 . . . . 73.209999999999994 109.302 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.837 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.3 mt -116.53 94.61 4.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 52.109999999999999 109.331 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.777 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 9.3 mttt -93.08 168.18 11.29 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.472 1.107 . . . . 65.430000000000007 109.336 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.586 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -167.56 125.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.458 1.099 . . . . 50.450000000000003 109.296 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.3 t -116.99 127.05 53.79 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.443 1.09 . . . . 71.340000000000003 109.966 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 11.0 p -93.7 -17.8 22.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 62.520000000000003 110.4 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 126.25 -48.52 0.96 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.509 1.131 . . . . 73.299999999999997 111.024 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -96.61 -20.34 18.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 0.766 . . . . 74.109999999999999 110.392 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 5.9 t -156.94 167.61 29.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 74.510000000000005 108.343 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.424 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -135.76 178.21 7.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 70.409999999999997 108.302 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.611 HG11 ' O ' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -153.34 149.19 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 60.409999999999997 109.295 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.777 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -129.46 133.37 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 72.349999999999994 109.313 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -134.31 132.01 39.06 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.146 . . . . 74.040000000000006 108.009 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.5 p -73.66 -3.59 29.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 63.32 109.988 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 6.8 p90 -173.95 137.46 0.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 72.209999999999994 111.013 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 60.2 t60 -125.9 168.83 13.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 75.340000000000003 109.546 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.598 HG12 ' SG ' ' A' ' 177' ' ' CYS . 1.8 p -147.44 133.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 74.439999999999998 109.327 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.22 -165.03 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 73.219999999999999 109.25 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.653 HG22 ' HE2' ' A' ' 197' ' ' LYS . 18.5 pt -116.99 117.66 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.122 . . . . 71.25 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 234' ' ' LYS . 14.0 tp -81.83 109.05 15.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.239999999999995 109.277 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.727 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.85 147.86 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 109.284 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 67.2 m -117.62 121.74 41.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 74.019999999999996 109.991 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.528 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 31.7 p90 -136.64 143.23 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 73.200000000000003 111.028 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.427 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -69.17 132.28 46.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.529 1.143 . . . . 72.409999999999997 109.315 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.476 1.11 . . . . 74.319999999999993 109.317 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.68 -0.2 49.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.132 . . . . 73.040000000000006 109.337 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.7 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.087 . . . . 73.209999999999994 110.052 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.25 37.87 8.06 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.511 1.132 . . . . 54.299999999999997 111.001 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.418 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.8 137.33 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 53.509999999999998 109.305 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.427 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.3 m -71.45 102.54 2.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 54.450000000000003 110.428 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.7 mm-40 -101.8 -172.58 2.18 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 74.209999999999994 110.272 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.497 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -126.51 144.89 50.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 75.310000000000002 109.3 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.627 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.1 tpt180 -144.17 161.59 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 75.140000000000001 110.327 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 252' ' ' TRP . 17.8 mm -115.85 116.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 74.420000000000002 109.287 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -100.42 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 53.439999999999998 109.293 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.419 ' OD1' ' CE ' ' A' ' 184' ' ' MET . 3.1 m-20 -100.1 110.38 59.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 75.439999999999998 109.343 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -42.99 0.43 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.465 1.771 . . . . 73.129999999999995 110.987 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 26.5 p -39.28 -29.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 73.519999999999996 109.998 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 239' ' ' PRO . 30.0 mt -101.92 -59.49 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.230000000000004 109.288 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.604 ' CD1' HG11 ' A' ' 247' ' ' VAL . 79.7 m-85 -112.29 99.39 7.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 63.049999999999997 111.025 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.5 m -86.2 -5.18 59.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 64.549999999999997 109.968 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 m -82.65 -45.28 14.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 62.32 109.999 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.74 -173.77 45.1 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.512 1.133 . . . . 73.239999999999995 110.993 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.441 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.5 Cg_endo -74.95 162.73 36.74 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.501 1.79 . . . . 50.530000000000001 111.034 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.604 HG11 ' CD1' ' A' ' 242' ' ' PHE . 2.7 m -148.18 159.19 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 73.420000000000002 109.329 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.435 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.2 p -62.23 139.93 58.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 71.409999999999997 110.418 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.407 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 2.5 p-10 -42.95 -28.13 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.123 . . . . 63.119999999999997 109.328 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.435 ' N ' ' C ' ' A' ' 248' ' ' THR . 17.1 m -72.45 -65.0 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 74.439999999999998 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.94 14.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.447 1.092 . . . . 70.120000000000005 109.29 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' TRP . . . . . 0.686 ' CD1' HG21 ' A' ' 236' ' ' ILE . 11.9 t90 -59.47 -66.17 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.953 -1.129 . . . . 70.420000000000002 107.953 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.799 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -41.67 -39.18 1.59 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 75.420000000000002 110.254 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASN . . . . . 0.876 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.1 m-80 -60.12 -50.37 73.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 53.329999999999998 109.297 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.597 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -55.1 -28.89 55.89 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.409999999999997 109.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' LYS . 7.6 m -81.39 -33.52 32.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 73.030000000000001 108.309 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.876 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.4 m -98.14 24.18 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 72.439999999999998 109.338 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.87 110.93 0.89 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 71.200000000000003 109.271 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.8 p -73.32 -3.04 24.61 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 74.299999999999997 110.402 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.2 t -44.34 -26.66 0.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 73.439999999999998 109.954 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.83 -36.58 11.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.447 1.092 . . . . 75.209999999999994 108.253 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.96 -126.55 1.36 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.116 . . . . 71.540000000000006 111.028 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -81.24 150.33 28.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 0.759 . . . . 74.340000000000003 110.001 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.566 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -172.28 144.68 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 61.520000000000003 109.276 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 41.6 p -172.84 153.14 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 74.329999999999998 109.992 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.687 HG23 HG11 ' A' ' 257' ' ' VAL . 3.1 t -99.75 125.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 70.349999999999994 109.295 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.4 t -85.87 -29.35 23.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.124 . . . . 72.430000000000007 109.966 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.6 m 178.58 155.64 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 54.439999999999998 109.969 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.884 ' HB3' HG23 ' A' ' 200' ' ' VAL . 30.2 p90 -144.14 155.94 44.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 75.319999999999993 111.014 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -147.79 154.33 40.34 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.556 1.16 . . . . 62.119999999999997 109.293 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -107.62 157.71 17.85 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 54.420000000000002 109.323 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.705 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.8 p -149.47 178.39 8.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 64.329999999999998 110.364 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ALA . . . . . 0.634 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -67.91 165.93 16.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.425 1.078 . . . . 73.319999999999993 109.303 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -75.38 -42.69 27.15 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.545 1.153 . . . . 74.329999999999998 110.995 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -55.26 -39.93 70.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 0.767 . . . . 72.120000000000005 109.273 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' VAL . . . . . 0.634 HG23 ' HB3' ' A' ' 273' ' ' ALA . 76.6 t -43.57 101.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 74.310000000000002 109.295 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.43 -47.34 84.49 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 74.439999999999998 110.978 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -152.12 138.51 18.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.48 1.112 . . . . 62.009999999999998 111.036 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.705 ' HD2' HG21 ' A' ' 272' ' ' THR . 67.4 ttt-85 -106.84 147.42 29.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 54.43 110.345 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.71 158.12 48.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 63.439999999999998 110.011 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 0.25 9.14 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.469 1.773 . . . . 65.140000000000001 111.009 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 28.7 t -103.09 7.4 38.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.464 1.103 . . . . 53.450000000000003 109.996 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 73.93 41.91 0.39 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.450000000000003 109.3 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 t -123.5 121.51 35.85 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.495 1.122 . . . . 74.239999999999995 110.04 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' TYR . . . . . 0.465 ' OH ' HG22 ' A' ' 272' ' ' THR . 11.5 m-30 -101.27 165.82 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 75.099999999999994 110.989 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LEU . . . . . 0.656 HD11 ' CE2' ' A' ' 320' ' ' PHE . 1.1 mm? -124.62 177.37 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 65.519999999999996 109.328 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.5 m-85 -160.32 123.21 3.39 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 71.430000000000007 110.98 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 291' ' ' LEU . 2.2 m-20 -115.07 104.01 11.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.099 . . . . 73.409999999999997 109.302 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.415 ' O ' HD22 ' A' ' 291' ' ' LEU . 3.3 m-80 -85.54 -53.81 4.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 73.329999999999998 109.32 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ASN . . . . . 0.463 ' CB ' HG12 ' A' ' 292' ' ' ILE . 17.0 m-20 -93.04 15.65 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.558 1.161 . . . . 63.439999999999998 109.318 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.917 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.4 mm? 40.27 42.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 72.439999999999998 109.308 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ILE . . . . . 0.463 HG12 ' CB ' ' A' ' 290' ' ' ASN . 26.6 mm -74.04 -28.38 23.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.542 1.151 . . . . 73.439999999999998 109.318 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.865 ' O ' HG23 ' A' ' 297' ' ' VAL . 9.8 t30 -94.64 -26.91 16.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 71.340000000000003 109.313 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 297' ' ' VAL . 23.7 m -82.3 -68.96 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 75.329999999999998 110.424 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.6 m-20 -47.52 -29.86 3.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 74.439999999999998 109.315 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.69 -43.06 57.05 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 1.094 . . . . 53.329999999999998 108.333 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.1 t -56.46 -50.59 71.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.129999999999995 109.256 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' LEU . . . . . 0.94 HD22 ' HA ' ' A' ' 168' ' ' ILE . 10.4 mt -61.85 -63.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 71.239999999999995 109.283 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -41.96 -42.45 2.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 61.130000000000003 110.425 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.564 ' HE2' HG12 ' A' ' 315' ' ' VAL . 14.9 mmmt -53.34 -44.66 68.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 55.130000000000003 109.305 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.562 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 2.5 m-30 -100.42 29.87 4.18 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.541 1.15 . . . . 74.409999999999997 110.979 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 27.2 t -62.04 -52.35 64.29 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 52.100000000000001 109.989 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' LEU . . . . . 0.626 HD13 ' H ' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -84.05 -10.46 57.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 72.409999999999997 109.281 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.706 HD13 ' OH ' ' A' ' 172' ' ' TYR . 17.7 mt -73.82 137.18 43.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 71.219999999999999 109.288 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 62.9 p -160.7 137.12 8.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 64.140000000000001 110.009 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.89 -158.77 15.53 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.565 1.166 . . . . 64.120000000000005 111.019 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 8.4 p -95.76 8.7 42.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.347 -0.983 . . . . 71.219999999999999 108.347 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 4.0 p -139.14 152.11 69.1 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 73.040000000000006 109.985 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' PRO . . . . . 0.592 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.02 146.64 87.2 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.002 -2.499 . . . . 61.450000000000003 111.028 0.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.637 ' HB2' HG13 ' A' ' 174' ' ' VAL . 6.1 t -132.79 135.15 25.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 74.329999999999998 109.999 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.1 Cg_endo -75.01 -173.64 12.7 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.986 -2.506 . . . . 72.129999999999995 111.0 0.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.477 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.99 152.99 25.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 61.219999999999999 109.313 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' PRO . . . . . 0.557 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.491 1.785 . . . . 64.299999999999997 110.988 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -81.96 133.05 35.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 71.109999999999999 109.264 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.564 HG12 ' HE2' ' A' ' 300' ' ' LYS . 27.1 m -136.19 16.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 63.020000000000003 109.27 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 318' ' ' CYS . 1.7 t -64.04 -40.2 95.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.299999999999997 109.955 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.1 t -39.5 -29.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 73.109999999999999 110.01 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' CYS . . . . . 0.439 ' N ' ' C ' ' A' ' 316' ' ' SER . 5.2 m -64.84 -174.31 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 74.219999999999999 108.287 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -175.61 167.69 39.7 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.503 1.127 . . . . 54.43 111.046 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 286' ' ' LEU . 1.1 p90 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.533 0.784 . . . . 70.430000000000007 110.985 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.7 tp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.253 -0.647 . . . . 72.019999999999996 109.253 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.597 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -145.47 112.85 6.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 73.409999999999997 109.312 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -85.84 11.47 11.18 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 63.520000000000003 109.987 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -150.3 149.11 14.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.426 1.079 . . . . 53.329999999999998 109.303 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.024 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -101.48 143.29 26.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 63.5 109.298 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.99 -33.86 4.27 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 62.399999999999999 111.034 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.49 152.52 23.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 61.32 109.294 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.514 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.1 t -49.54 -36.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 71.219999999999999 109.311 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.58 2.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 70.230000000000004 109.317 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.701 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -71.53 -36.2 70.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 75.439999999999998 110.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.739 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.93 -57.4 12.95 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 1.155 . . . . 70.049999999999997 109.269 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.514 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 46.8 m-80 -51.08 -33.19 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 55.310000000000002 109.29 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -66.9 -56.5 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 74.340000000000003 109.943 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.024 HD12 HD11 ' A' ' 140' ' ' ILE . 59.8 mt -41.82 -41.9 2.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 44.140000000000001 109.3 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.622 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.06 -40.89 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 60.420000000000002 111.033 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -51.01 -36.2 38.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 64.200000000000003 109.306 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.474 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 65.3 mt-30 -76.52 -56.39 4.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 1.128 . . . . 51.0 110.308 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.633 HG21 ' SD ' ' A' ' 184' ' ' MET . 25.4 mt -50.18 -29.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 71.5 109.296 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -33.44 63.03 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 73.120000000000005 109.302 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -61.72 -15.68 42.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 70.040000000000006 109.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -84.58 -17.68 38.01 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 70.400000000000006 110.301 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.492 ' HA ' ' CD2' ' A' ' 170' ' ' PHE . 16.1 p -38.53 133.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 75.310000000000002 110.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -64.59 130.0 41.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 61.140000000000001 108.315 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.79 -20.75 10.74 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.495 1.122 . . . . 63.229999999999997 110.962 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.803 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 64.2 p -79.24 161.75 26.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 0.791 . . . . 73.129999999999995 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.73 -0.84 55.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.430000000000007 110.016 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 162' ' ' THR . 4.6 m -116.61 6.19 13.38 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 75.030000000000001 110.418 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.803 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.66 138.88 34.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.102 . . . . 74.519999999999996 109.264 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 54.119999999999997 109.977 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.19 127.24 3.6 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.556 1.16 . . . . 74.430000000000007 110.008 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.02 138.02 53.68 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.993 -2.503 . . . . 63.32 111.002 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.03 177.96 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 72.319999999999993 108.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.692 HG21 ' CZ ' ' A' ' 170' ' ' PHE . 3.5 mp -89.53 125.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.515 1.134 . . . . 64.230000000000004 109.276 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.589 HG21 ' O ' ' A' ' 301' ' ' PHE . 65.3 p -79.65 88.23 5.16 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.538 1.149 . . . . 43.130000000000003 110.387 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.692 ' CZ ' HG21 ' A' ' 168' ' ' ILE . 84.8 m-85 -88.01 -26.37 22.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 111.001 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.456 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.77 -1.31 24.44 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 72.510000000000005 110.301 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.689 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 26.4 t80 -128.52 67.6 76.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 71.420000000000002 110.986 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 115.58 4.33 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.482 1.78 . . . . 61.240000000000002 110.979 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.681 HG21 ' CE1' ' A' ' 172' ' ' TYR . 15.8 t -148.85 -72.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 60.140000000000001 109.301 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.02 -45.15 2.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 73.420000000000002 109.306 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -42.33 101.54 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.543 1.152 . . . . 24.23 111.006 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 73.9 m -134.3 -48.15 0.78 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.272 -1.01 . . . . 72.209999999999994 108.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.693 ' HB3' HG11 ' A' ' 219' ' ' VAL . 38.7 p90 -75.61 -45.55 36.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.219999999999999 110.99 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.33 -68.41 0.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 73.140000000000001 109.277 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.834 HH21 ' HD2' ' A' ' 239' ' ' PRO . 3.6 ptm180 -50.09 -47.61 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 73.209999999999994 110.318 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -39.83 -61.2 0.88 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 32.329999999999998 109.304 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.697 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.8 OUTLIER -46.37 -39.68 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.145 . . . . 71.310000000000002 109.595 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.556 ' CB ' HD11 ' A' ' 168' ' ' ILE . 14.1 mmmm -65.25 -61.25 2.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 73.430000000000007 109.281 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.633 ' SD ' HG21 ' A' ' 153' ' ' ILE . 13.8 mtm -39.02 -40.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 61.130000000000003 110.963 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.454 ' NH1' ' CE ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.546 1.154 . . . . 73.230000000000004 110.323 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.412 ' NE2' ' HE2' ' A' ' 183' ' ' LYS . 0.2 OUTLIER -54.48 -35.92 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 71.209999999999994 110.31 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.7 mm -71.16 -34.15 53.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 63.310000000000002 109.278 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -64.39 -45.78 86.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 74.239999999999995 109.273 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.454 ' CE ' ' NH1' ' A' ' 185' ' ' ARG . 3.5 mtt -55.32 -36.8 66.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 72.109999999999999 111.006 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.62 -50.3 68.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 65.019999999999996 109.305 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.474 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 18.7 t-20 -66.84 -34.23 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 73.430000000000007 109.337 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 107.99 53.39 0.66 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.487 1.117 . . . . 54.439999999999998 111.012 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.701 ' CZ ' HG21 ' A' ' 145' ' ' THR . 72.4 m-85 -153.17 134.86 14.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 0.771 . . . . 72.230000000000004 111.0 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.792 ' HB2' HD23 ' A' ' 136' ' ' LEU . 2.4 t0 -101.43 122.36 43.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 53.350000000000001 109.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.709 ' HB3' HD22 ' A' ' 188' ' ' LEU . 29.5 p -100.11 -179.38 4.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 72.439999999999998 108.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -126.63 174.47 8.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 62.520000000000003 110.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.718 ' HE2' HG22 ' A' ' 221' ' ' ILE . 18.9 mmtt -110.1 159.01 17.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 73.219999999999999 109.301 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.926 ' NE2' HD13 ' A' ' 222' ' ' LEU . 7.6 tt0 -151.39 117.59 5.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 75.299999999999997 110.282 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.559 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.5 m-85 -110.71 118.59 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 61.109999999999999 110.978 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.7 ' CG2' HG23 ' A' ' 266' ' ' VAL . 10.0 p -109.88 146.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 64.200000000000003 109.311 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 12.0 m-85 -118.63 160.43 21.82 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 75.310000000000002 111.041 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.61 -176.04 16.01 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.509 1.131 . . . . 74.120000000000005 110.99 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.768 ' C ' HD23 ' A' ' 204' ' ' LEU . 56.7 t-20 -72.39 110.3 6.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 0.781 . . . . 73.140000000000001 109.298 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.2 mt -114.52 94.74 4.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 70.030000000000001 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.1 mtpt -92.31 178.75 5.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.145 . . . . 61.039999999999999 109.321 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.948 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -178.02 163.24 1.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.219999999999999 109.316 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.549 1.156 . . . . 63.25 110.007 -179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.281 -1.007 . . . . 73.219999999999999 108.281 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.948 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -134.07 149.68 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 74.109999999999999 109.301 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.34 130.91 27.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 62.049999999999997 109.274 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.452 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -137.68 135.82 36.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.979 -1.119 . . . . 75.120000000000005 107.979 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 72.7 p -80.05 1.11 29.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 73.530000000000001 110.045 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.463 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.0 p90 -176.23 129.83 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.093 . . . . 72.329999999999998 111.0 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 37.4 t60 -114.43 169.05 9.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 62.130000000000003 109.603 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.1 p -146.45 136.37 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 73.349999999999994 109.269 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.641 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.13 -168.04 2.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 75.519999999999996 109.297 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.718 HG22 ' HE2' ' A' ' 197' ' ' LYS . 28.1 pt -115.75 121.51 67.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 74.530000000000001 109.304 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.926 HD13 ' NE2' ' A' ' 198' ' ' GLN . 12.9 tp -85.41 109.03 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 73.340000000000003 109.313 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.739 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -102.8 146.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 62.420000000000002 109.269 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.569 ' HB3' HG22 ' A' ' 139' ' ' VAL . 4.0 m -116.78 119.86 36.75 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 74.510000000000005 110.024 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.57 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.4 p90 -134.93 143.26 46.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 72.420000000000002 111.007 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.419 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -68.61 133.93 49.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 71.450000000000003 109.344 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.02 -160.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.122 . . . . 72.219999999999999 109.306 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.81 0.05 49.05 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 63.210000000000001 109.288 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.4 m -115.12 -8.33 12.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 72.010000000000005 110.009 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.73 37.44 7.98 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.483 1.114 . . . . 71.340000000000003 111.018 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.37 137.4 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.479 0.752 . . . . 71.140000000000001 109.274 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.419 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 6.3 m -71.52 102.66 2.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.484 1.115 . . . . 72.239999999999995 110.425 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 3.0 mm-40 -101.49 -172.24 2.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 71.409999999999997 110.298 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.474 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.1 mmtm -126.97 144.83 50.9 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 62.340000000000003 109.28 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.0 tpt180 -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 72.120000000000005 110.282 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.58 HG21 ' CD1' ' A' ' 252' ' ' TRP . 13.8 mm -114.88 127.67 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 64.439999999999998 109.296 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -111.95 41.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 75.319999999999993 109.332 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.415 ' OD1' ' HE1' ' A' ' 184' ' ' MET . 1.6 m-20 -104.43 108.05 59.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 73.420000000000002 109.289 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.834 ' HD2' HH21 ' A' ' 180' ' ' ARG . 18.1 Cg_endo -75.03 -0.54 10.1 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.477 1.777 . . . . 62.299999999999997 110.995 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.501 ' N ' ' NH2' ' A' ' 180' ' ' ARG . 1.2 t -67.67 -9.29 42.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.542 1.151 . . . . 64.329999999999998 109.944 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.467 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 3.1 mt -135.21 -47.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 71.230000000000004 109.287 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.601 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.5 m-85 -121.0 99.75 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 71.430000000000007 110.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.0 -24.04 26.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 74.540000000000006 109.999 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 p -61.73 -45.74 92.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 72.430000000000007 109.987 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.42 -174.22 41.02 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.496 1.123 . . . . 51.229999999999997 111.017 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.425 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.01 169.18 23.2 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.431 1.753 . . . . 75.430000000000007 110.973 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.601 HG21 ' CE2' ' A' ' 242' ' ' PHE . 4.1 m -152.45 157.21 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 60.439999999999998 109.3 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 36.8 p -60.22 137.09 58.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.447 1.092 . . . . 65.120000000000005 110.395 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 7.7 p-10 -40.57 -29.67 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.475 1.109 . . . . 72.439999999999998 109.334 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.0 m -71.64 -64.91 0.83 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.498 1.124 . . . . 72.340000000000003 110.355 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.0 -30.78 11.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 109.274 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.641 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 15.6 t90 -60.74 -61.9 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 71.430000000000007 107.996 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.611 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -47.44 -40.88 19.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 1.112 . . . . 71.109999999999999 110.316 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.768 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.0 m-80 -57.85 -50.79 72.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 62.350000000000001 109.287 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.79 -23.01 40.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 72.200000000000003 109.287 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.447 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.6 m -84.78 -35.84 22.11 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 73.129999999999995 108.28 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.768 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.9 m -95.24 21.29 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.551 1.157 . . . . 63.009999999999998 109.294 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -50.23 107.27 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 1.1 . . . . 63.130000000000003 109.26 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.9 p -72.49 -3.93 27.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 63.210000000000001 110.435 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.9 t -46.54 -25.03 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 74.030000000000001 110.006 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . 0.426 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 19.7 t -94.34 -35.32 12.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 73.140000000000001 108.282 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 162.18 -128.35 1.87 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.489 1.118 . . . . 74.120000000000005 110.981 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -71.28 143.91 50.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 0.768 . . . . 70.120000000000005 109.953 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.3 144.33 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 73.040000000000006 109.297 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.7 t -172.78 154.78 3.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 75.120000000000005 110.007 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.7 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.27 117.54 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 73.299999999999997 109.308 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 20.7 t -73.74 -43.96 57.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 64.099999999999994 110.044 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.1 m -165.23 171.92 13.05 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 70.200000000000003 110.02 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -154.33 155.81 35.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.25 111.012 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -157.81 160.66 38.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 74.219999999999999 109.323 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.432 ' C ' HG23 ' A' ' 272' ' ' THR . 1.9 p-10 -121.94 160.64 24.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 71.109999999999999 109.303 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.546 HG21 ' HD2' ' A' ' 279' ' ' ARG . 35.0 p -152.62 175.68 12.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 74.510000000000005 110.37 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.805 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -59.13 156.5 11.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 74.530000000000001 109.334 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.74 -46.13 62.41 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.486 1.116 . . . . 33.43 110.993 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -52.94 -42.38 65.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 0.771 . . . . 73.140000000000001 109.353 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.805 HG23 ' HB3' ' A' ' 273' ' ' ALA . 81.8 t -43.88 101.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.517 1.136 . . . . 74.239999999999995 109.325 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.4 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 2.6 t80 -58.67 -59.47 5.35 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 63.450000000000003 111.009 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -132.03 150.25 52.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.467 1.104 . . . . 75.519999999999996 111.064 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.559 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 60.8 ttt-85 -119.35 147.47 44.29 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 52.109999999999999 110.313 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.66 158.2 40.93 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 74.200000000000003 110.015 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 0.37 9.0 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.495 1.787 . . . . 63.350000000000001 110.976 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 t -100.47 9.88 41.98 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 71.329999999999998 109.987 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 72.82 40.8 0.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 72.299999999999997 109.336 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -119.18 133.14 55.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.469 1.106 . . . . 74.530000000000001 110.022 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.43 ' OH ' HG22 ' A' ' 272' ' ' THR . 18.0 m-30 -114.38 150.12 35.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 72.5 110.985 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -116.44 177.48 4.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 71.239999999999995 109.274 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 47.7 m-85 -160.59 115.49 2.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 75.0 111.006 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -115.38 94.87 4.9 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.475 1.109 . . . . 75.200000000000003 109.337 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.7 -16.74 53.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 71.140000000000001 109.266 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.456 ' HB3' HD11 ' A' ' 292' ' ' ILE . 40.8 m-20 -108.52 5.31 25.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.134 . . . . 64.120000000000005 109.321 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.697 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.27 49.7 2.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.553 1.158 . . . . 73.219999999999999 109.276 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' A' ' 290' ' ' ASN . 40.6 mm -80.03 -29.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.349999999999994 109.317 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.756 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.7 t-20 -94.5 -20.59 19.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.13 . . . . 53.229999999999997 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.418 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.7 m -87.59 -68.65 0.74 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.133 . . . . 70.349999999999994 110.365 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 77.4 m-20 -49.75 -31.2 10.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.1 . . . . 73.219999999999999 109.304 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 41.3 t -70.96 -49.36 46.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 72.340000000000003 108.302 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.3 t -52.01 -43.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 64.219999999999999 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 301' ' ' PHE . 21.0 mt -67.2 -61.12 2.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 34.450000000000003 109.3 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -41.4 -31.72 0.27 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.533 1.145 . . . . 45.219999999999999 110.382 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.403 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.0 mmmt -67.14 -51.48 53.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 63.350000000000001 109.252 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.589 ' O ' HG21 ' A' ' 169' ' ' THR . 0.6 OUTLIER -94.58 37.72 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 73.209999999999994 111.025 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 37.0 t -69.08 -46.82 66.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 72.329999999999998 109.953 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.773 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -90.19 -17.55 27.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 72.340000000000003 109.31 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.769 HD22 ' CD ' ' A' ' 309' ' ' PRO . 16.6 mt -57.81 140.07 52.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.535 1.147 . . . . 73.319999999999993 109.297 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.6 p -152.66 140.72 20.29 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.441 1.088 . . . . 72.049999999999997 110.002 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.93 -161.66 27.02 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.497 1.123 . . . . 55.509999999999998 111.0 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.32 6.2 47.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.344 -0.984 . . . . 44.350000000000001 108.344 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 24.0 p -130.22 151.05 77.79 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 64.340000000000003 110.053 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.769 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.03 145.87 85.08 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.998 -2.501 . . . . 74.129999999999995 110.999 0.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.581 ' HB3' HG13 ' A' ' 174' ' ' VAL . 2.0 p -133.59 135.51 25.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 52.409999999999997 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.02 -173.6 12.62 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.047 -2.48 . . . . 70.319999999999993 111.002 0.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.01 154.67 18.35 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.532 1.145 . . . . 52.149999999999999 109.339 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.506 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -74.96 -162.24 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.482 1.78 . . . . 62.200000000000003 111.039 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -85.08 133.83 34.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 73.049999999999997 109.295 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.403 HG12 ' HE2' ' A' ' 300' ' ' LYS . 21.2 m -125.81 25.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 72.109999999999999 109.32 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 t -55.12 -31.7 61.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 72.109999999999999 110.02 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 28.8 p -49.65 -23.58 1.79 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 74.230000000000004 110.026 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 54.109999999999999 108.289 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.898 HD23 ' HB2' ' A' ' 194' ' ' ASP . 8.9 tp . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.271 -0.64 . . . . 63.109999999999999 109.271 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.541 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -103.92 105.46 15.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 75.450000000000003 109.289 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.1 m -83.66 8.46 14.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.129 . . . . 43.340000000000003 109.973 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -150.16 147.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 55.049999999999997 109.266 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.008 HD11 HD12 ' A' ' 149' ' ' LEU . 1.3 mt -97.92 142.14 24.09 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.148 . . . . 64.230000000000004 109.304 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.05 -32.37 5.38 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.519 1.8 . . . . 63.210000000000001 110.969 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.05 148.36 17.01 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 64.510000000000005 109.332 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.521 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.1 t -46.11 -36.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 73.230000000000004 109.286 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.88 -47.39 2.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.112 . . . . 72.010000000000005 109.268 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.706 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.55 -36.36 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.54 1.15 . . . . 72.299999999999997 110.394 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.708 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.9 -57.23 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 63.539999999999999 109.295 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.521 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 47.4 m-80 -51.62 -32.36 28.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 65.129999999999995 109.297 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.74 -56.29 8.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.420000000000002 110.023 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.008 HD12 HD11 ' A' ' 140' ' ' ILE . 56.6 mt -43.69 -42.19 5.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 63.240000000000002 109.318 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.698 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -71.87 -44.29 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 72.129999999999995 110.987 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -46.4 -35.77 5.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 72.430000000000007 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -77.87 -54.89 5.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 54.340000000000003 110.278 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.044 HD11 HD12 ' A' ' 188' ' ' LEU . 10.2 mt -50.63 -24.5 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.113 . . . . 60.030000000000001 109.275 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -38.39 46.55 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 72.219999999999999 109.31 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.73 -17.04 19.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 62.229999999999997 109.288 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.544 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.9 mm100 -81.91 -26.36 34.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 64.540000000000006 110.29 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 13.9 m -42.24 137.75 1.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 73.230000000000004 109.972 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.69 113.03 4.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 63.439999999999998 108.314 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.58 1.74 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.518 1.136 . . . . 42.5 110.994 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.806 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 72.7 p -93.17 161.66 14.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.538 0.787 . . . . 74.319999999999993 110.385 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.7 p -92.52 -1.82 56.67 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 61.0 109.984 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 162' ' ' THR . 2.4 m -114.74 2.54 14.45 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.329999999999998 110.396 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -75.33 133.54 41.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 71.420000000000002 109.35 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -170.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 73.129999999999995 109.961 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.4 p -154.11 127.33 4.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 72.439999999999998 110.049 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -75.03 138.04 53.78 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 120.966 -2.514 . . . . 75.140000000000001 111.0 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.1 p -72.79 -178.6 2.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.459 1.1 . . . . 44.340000000000003 108.328 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.609 HG23 ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.33 132.88 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 60.140000000000001 109.295 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.1 p -92.68 73.14 5.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 53.310000000000002 110.411 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 12.7 p90 -74.14 -21.3 59.92 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.562 1.164 . . . . 73.140000000000001 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 302' ' ' SER . 0.0 OUTLIER -74.73 -1.85 23.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 71.319999999999993 110.281 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.773 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 21.9 t80 -131.76 66.97 79.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 72.299999999999997 110.976 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.434 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.02 118.79 5.39 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.435 1.755 . . . . 75.200000000000003 110.993 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.578 HG21 ' CE1' ' A' ' 172' ' ' TYR . 6.7 t -152.09 -72.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 63.140000000000001 109.337 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.6 -44.96 1.5 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 63.020000000000003 109.288 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -44.27 110.05 0.32 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.527 1.142 . . . . 64.409999999999997 110.999 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.3 p -147.95 -48.47 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.277 -1.009 . . . . 44.130000000000003 108.277 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -66.58 -16.96 64.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 75.219999999999999 110.984 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.04 -68.11 0.64 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 73.510000000000005 109.334 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.609 ' HB3' HG23 ' A' ' 168' ' ' ILE . 10.0 ptm180 -49.03 -50.62 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.451 1.094 . . . . 75.319999999999993 110.314 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.413 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.21 -56.63 3.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 55.340000000000003 109.296 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.7 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -45.07 -36.71 3.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 55.43 109.575 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.753 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.0 mmmt -68.89 -59.15 3.27 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.15 . . . . 64.409999999999997 109.313 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.471 ' CB ' HD13 ' A' ' 221' ' ' ILE . 11.2 mtm -38.74 -31.45 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.150000000000006 111.009 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.437 ' NH2' ' OD2' ' A' ' 194' ' ' ASP . 0.0 OUTLIER -69.32 -54.08 16.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 73.120000000000005 110.259 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.753 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.6 OUTLIER -54.15 -32.62 55.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 73.310000000000002 110.286 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 153' ' ' ILE . 26.1 mm -71.5 -40.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.459 1.1 . . . . 74.510000000000005 109.235 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 1.044 HD12 HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -62.18 -42.46 99.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 60.149999999999999 109.306 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.0 mtt -57.94 -38.93 76.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 43.399999999999999 110.973 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.43 -52.34 54.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 61.0 109.296 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.437 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 7.8 t-20 -64.23 -35.34 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 73.239999999999995 109.315 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.58 53.01 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.44 1.088 . . . . 72.319999999999993 110.99 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.706 ' CZ ' HG21 ' A' ' 145' ' ' THR . 90.0 m-85 -153.28 147.9 26.19 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.541 0.789 . . . . 65.25 111.007 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.898 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -110.02 126.88 54.43 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 70.519999999999996 109.31 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.983 ' HB3' HD22 ' A' ' 188' ' ' LEU . 13.4 p -98.8 -179.27 4.24 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.47 1.106 . . . . 65.120000000000005 108.312 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 27.0 mp0 -133.38 171.62 13.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.562 1.164 . . . . 75.209999999999994 110.357 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.494 ' HZ1' ' HA ' ' A' ' 182' ' ' HIS . 18.1 mmtt -107.01 161.13 15.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.48 1.113 . . . . 62.450000000000003 109.3 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 21.2 tt0 -157.66 117.49 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 73.25 110.323 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 9.1 m-85 -108.49 133.53 52.52 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 75.430000000000007 110.967 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.695 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.7 p -124.38 148.16 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 60.310000000000002 109.301 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.6 m-85 -120.09 156.51 30.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.483 1.114 . . . . 62.539999999999999 111.018 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.42 -178.55 16.37 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.542 1.151 . . . . 25.41 111.006 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.752 ' C ' HD23 ' A' ' 204' ' ' LEU . 57.2 t-20 -71.02 111.25 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 0.772 . . . . 73.409999999999997 109.297 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.752 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.4 mt -115.27 93.62 4.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 62.340000000000003 109.312 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.8 mttp -93.27 165.93 12.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 70.349999999999994 109.287 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.57 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -171.68 154.07 3.57 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 53.219999999999999 109.322 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 75.129999999999995 109.995 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 108.295 -1.002 . . . . 65.120000000000005 108.295 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.57 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -114.44 153.86 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.541 1.151 . . . . 71.239999999999995 109.272 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.467 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -137.4 119.02 14.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 54.340000000000003 109.276 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.32 134.0 51.23 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.019 -1.104 . . . . 72.340000000000003 108.019 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.2 t -79.33 2.32 21.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.485 1.115 . . . . 62.009999999999998 109.945 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.484 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.3 p90 -175.33 128.41 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.448 1.092 . . . . 73.420000000000002 111.006 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.468 ' N ' HD12 ' A' ' 204' ' ' LEU . 83.4 t60 -121.75 167.21 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 74.129999999999995 109.595 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.5 p -145.18 149.73 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.459 1.1 . . . . 45.039999999999999 109.302 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.537 ' CB ' HD12 ' A' ' 236' ' ' ILE . . . -144.46 -159.43 0.99 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 64.219999999999999 109.317 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.487 HG22 ' HE2' ' A' ' 197' ' ' LYS . 14.4 pt -120.0 122.98 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.462 1.102 . . . . 62.409999999999997 109.291 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 234' ' ' LYS . 11.9 tp -86.71 109.01 18.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 74.409999999999997 109.284 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.708 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.51 145.45 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 72.239999999999995 109.325 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.434 ' HB3' HG22 ' A' ' 139' ' ' VAL . 45.4 m -116.56 118.56 32.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 42.100000000000001 109.993 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -133.85 144.79 49.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 73.409999999999997 111.014 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.435 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -69.83 133.96 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 75.299999999999997 109.304 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.12 -159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 75.230000000000004 109.313 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 -0.35 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 64.319999999999993 109.295 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.0 m -114.87 -7.75 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.451 1.095 . . . . 74.129999999999995 109.972 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.57 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.518 1.136 . . . . 52.420000000000002 111.033 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.22 137.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 0.777 . . . . 74.319999999999993 109.275 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.435 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.4 m -71.53 102.65 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 64.010000000000005 110.368 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 1.9 mm-40 -101.74 -172.68 2.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 73.239999999999995 110.259 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.53 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.3 mmtm -127.03 144.93 50.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.400000000000006 109.301 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.589 ' HB3' HG22 ' A' ' 223' ' ' VAL . 1.3 tpt180 -145.48 162.96 36.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 73.409999999999997 110.247 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.537 HD12 ' CB ' ' A' ' 220' ' ' ALA . 10.8 mm -116.85 119.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 64.230000000000004 109.31 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -105.33 43.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 64.329999999999998 109.292 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.436 ' OD1' ' CB ' ' A' ' 240' ' ' SER . 4.2 t70 -101.84 108.13 54.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.457 1.098 . . . . 62.310000000000002 109.315 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -4.84 16.01 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.486 1.782 . . . . 64.120000000000005 111.032 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 t -72.05 -7.94 51.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 62.049999999999997 110.027 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -130.96 -46.59 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 74.340000000000003 109.31 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.79 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.1 m-85 -123.34 106.75 10.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 71.340000000000003 110.98 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -26.22 22.25 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.496 1.123 . . . . 72.420000000000002 109.985 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.5 m -62.62 -47.74 82.46 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.124 . . . . 73.239999999999995 110.034 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.41 -173.78 40.66 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.474 1.109 . . . . 74.010000000000005 110.965 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.425 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 169.98 21.41 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.514 1.797 . . . . 72.439999999999998 111.017 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.79 HG21 ' CE2' ' A' ' 242' ' ' PHE . 13.7 m -148.61 159.46 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 74.340000000000003 109.302 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 43.3 p -61.71 142.08 57.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 63.420000000000002 110.427 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 249' ' ' ASP . 1.2 p-10 -45.82 -26.17 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.157 . . . . 75.120000000000005 109.333 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 29.1 m -80.88 -61.42 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 64.439999999999998 110.387 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.94 -22.01 5.05 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 64.409999999999997 109.235 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.57 ' CE3' ' HD3' ' A' ' 253' ' ' ARG . 9.5 t90 -67.05 -59.04 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.48 1.113 . . . . 71.219999999999999 108.017 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.06 -43.54 40.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.569 1.168 . . . . 72.5 110.278 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.842 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.2 m-80 -53.74 -52.16 61.04 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 70.420000000000002 109.319 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.676 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.4 -18.77 12.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 72.519999999999996 109.306 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.8 m -90.34 -35.0 15.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.299999999999997 108.287 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.842 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -94.47 21.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 71.219999999999999 109.32 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -51.34 109.24 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 61.219999999999999 109.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.0 p -74.71 -3.06 29.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.506 1.129 . . . . 71.540000000000006 110.396 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t -44.22 -31.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.508 1.13 . . . . 45.240000000000002 110.018 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 46.2 t -88.24 -37.39 16.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 70.109999999999999 108.304 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.32 -127.58 1.56 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.45 1.094 . . . . 73.129999999999995 111.032 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.1 146.83 39.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 0.784 . . . . 61.140000000000001 110.023 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.39 147.83 4.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 1.115 . . . . 63.229999999999997 109.286 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 39.0 m -172.83 153.86 2.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.448 1.093 . . . . 63.210000000000001 109.985 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.695 HG23 ' CG2' ' A' ' 200' ' ' VAL . 3.6 p -101.81 115.49 43.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 74.120000000000005 109.303 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 9.2 t -70.32 -45.17 66.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.113 . . . . 71.530000000000001 110.016 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.612 ' O ' HG23 ' A' ' 200' ' ' VAL . 3.6 m -163.73 -174.88 3.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.499 1.124 . . . . 70.310000000000002 109.991 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -165.78 156.53 13.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 73.040000000000006 110.996 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -153.77 162.49 41.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.464 1.102 . . . . 71.310000000000002 109.276 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.491 ' O ' HG23 ' A' ' 272' ' ' THR . 1.3 p-10 -121.82 159.88 25.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.319999999999993 109.318 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.601 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.5 p -154.37 178.12 10.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.146 . . . . 61.530000000000001 110.381 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.934 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -61.3 167.29 3.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 75.319999999999993 109.307 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.98 -18.76 66.72 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 71.219999999999999 111.015 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.94 -39.15 21.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 0.759 . . . . 73.299999999999997 109.319 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.934 HG23 ' HB3' ' A' ' 273' ' ' ALA . 61.7 t -43.6 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.535 1.147 . . . . 74.430000000000007 109.32 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.0 t80 -53.92 -54.78 34.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.523 1.139 . . . . 72.340000000000003 111.018 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.572 ' CE2' ' O ' ' A' ' 279' ' ' ARG . 66.9 t80 -143.39 159.92 41.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 72.040000000000006 110.949 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.601 ' HD2' HG21 ' A' ' 272' ' ' THR . 76.4 ttt-85 -122.73 147.57 46.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 72.120000000000005 110.35 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.21 154.32 48.68 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.46 1.1 . . . . 75.010000000000005 109.964 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.18 9.22 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.49 1.784 . . . . 74.430000000000007 110.972 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 14.2 t -104.62 7.76 35.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.534 1.147 . . . . 72.239999999999995 110.013 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 76.7 41.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 72.400000000000006 109.275 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.4 t -119.56 118.99 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 74.439999999999998 109.997 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -102.78 159.1 15.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.219999999999999 111.034 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.7 OUTLIER -123.94 176.93 6.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 70.540000000000006 109.259 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 94.7 m-85 -161.31 115.37 2.0 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 63.450000000000003 111.014 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.408 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.8 t0 -115.3 95.06 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.103 . . . . 51.539999999999999 109.279 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.64 -19.45 30.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.469 1.106 . . . . 74.109999999999999 109.285 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.455 ' CB ' HG12 ' A' ' 292' ' ' ILE . 50.7 m-20 -105.71 4.18 29.76 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.12 . . . . 73.340000000000003 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.7 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.5 mm? 40.41 49.15 2.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 55.43 109.291 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.455 HG12 ' CB ' ' A' ' 290' ' ' ASN . 30.8 mm -78.7 -28.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.539 1.149 . . . . 73.340000000000003 109.339 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.787 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.7 t-20 -94.71 -24.0 17.32 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.117 . . . . 54.509999999999998 109.29 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 4.4 m -83.11 -68.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.537 1.148 . . . . 63.509999999999998 110.43 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 56.3 m-20 -51.05 -28.54 10.51 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 62.219999999999999 109.323 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 11.5 t -70.9 -66.5 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.133 . . . . 54.409999999999997 108.317 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 293' ' ' ASN . 53.5 t -43.44 -42.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 62.340000000000003 109.311 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.13 -58.02 10.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.472 1.108 . . . . 62.310000000000002 109.273 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -19.5 52.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 52.229999999999997 110.429 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.493 ' HE2' HG12 ' A' ' 315' ' ' VAL . 18.5 mmmt -76.3 -42.39 45.43 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 75.310000000000002 109.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.712 ' CE2' HG13 ' A' ' 297' ' ' VAL . 1.7 m-30 -106.02 40.41 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 74.519999999999996 111.054 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . 0.447 ' O ' ' NH1' ' A' ' 171' ' ' ARG . 29.6 t -68.0 -55.28 13.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.145 . . . . 42.399999999999999 110.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.793 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -79.39 -18.33 52.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 64.349999999999994 109.28 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.773 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 13.3 mt -57.42 139.27 53.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.105 . . . . 75.349999999999994 109.343 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 90.3 p -149.95 166.13 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 74.329999999999998 109.995 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 68.22 -153.05 52.83 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.473 1.108 . . . . 51.350000000000001 110.978 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.7 p -103.13 15.53 29.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.283 -1.006 . . . . 50.109999999999999 108.283 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.511 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -133.59 150.26 74.39 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 71.030000000000001 109.992 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.735 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.97 146.71 87.41 Favored 'Cis proline' 0 C--N 1.359 1.108 0 C-N-CA 121.052 -2.478 . . . . 45.530000000000001 110.994 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -129.75 133.39 24.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 64.109999999999999 110.033 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -168.22 6.29 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 121.044 -2.482 . . . . 40.039999999999999 110.982 0.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.71 152.08 28.2 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 65.430000000000007 109.309 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.56 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.03 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.505 1.792 . . . . 54.210000000000001 111.039 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.08 131.24 34.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.533 1.146 . . . . 71.010000000000005 109.321 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.493 HG12 ' HE2' ' A' ' 300' ' ' LYS . 33.4 m -128.48 27.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 73.5 109.306 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 27.0 t -57.37 -24.12 53.38 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 74.230000000000004 109.961 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -58.2 -16.8 15.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 75.239999999999995 109.984 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 61.7 m . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 72.450000000000003 108.346 179.949 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' A' ' 194' ' ' ASP . 6.9 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.267 -0.642 . . . . 74.319999999999993 109.267 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.574 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -109.03 111.75 23.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 74.099999999999994 109.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.486 ' CB ' ' OD1' ' A' ' 194' ' ' ASP . 0.7 OUTLIER -86.72 6.1 32.99 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 73.400000000000006 109.966 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -145.94 150.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.468 1.105 . . . . 72.010000000000005 109.314 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.029 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -103.28 143.13 26.0 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 71.239999999999995 109.33 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -75.05 -33.73 4.31 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.509 1.794 . . . . 51.149999999999999 111.02 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.429 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.45 150.36 23.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.114 . . . . 75.219999999999999 109.318 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.509 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.7 t -49.06 -33.91 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 54.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.85 -46.28 5.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 62.340000000000003 109.327 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.573 HG22 HG12 ' A' ' 140' ' ' ILE . 1.8 m -72.92 -32.16 65.12 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 74.519999999999996 110.421 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.746 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -61.9 -56.16 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 73.329999999999998 109.332 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.509 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 51.3 m-80 -53.64 -31.07 45.87 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.533 1.146 . . . . 65.019999999999996 109.3 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -70.26 -55.92 8.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 42.009999999999998 109.953 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.029 HD12 HD11 ' A' ' 140' ' ' ILE . 70.4 mt -42.63 -42.24 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 1.094 . . . . 64.530000000000001 109.32 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.753 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.2 -45.11 61.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.141 . . . . 64.239999999999995 111.006 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.61 -39.66 17.41 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 64.319999999999993 109.271 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.487 HE22 ' ND2' ' A' ' 191' ' ' ASN . 60.9 mt-30 -73.54 -57.07 4.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 43.32 110.292 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.876 HD11 HD12 ' A' ' 188' ' ' LEU . 10.7 mt -50.01 -23.27 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 53.509999999999998 109.28 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -76.46 -37.58 56.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 72.340000000000003 109.285 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -57.03 -18.63 14.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 73.540000000000006 109.312 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.532 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.8 mm100 -80.24 -27.4 38.69 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.464 1.102 . . . . 73.230000000000004 110.341 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' GLN . 15.6 m -39.47 129.59 1.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 73.340000000000003 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 7.4 m -58.85 113.31 2.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.43 1.081 . . . . 71.420000000000002 108.295 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.36 -17.12 1.68 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.486 1.116 . . . . 54.340000000000003 110.982 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.714 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 46.0 p -95.33 161.56 14.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 0.76 . . . . 63.119999999999997 110.398 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 m -92.9 -3.76 54.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 1.152 . . . . 62.310000000000002 109.956 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 162' ' ' THR . 3.0 m -109.5 -1.62 18.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 72.140000000000001 110.405 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.714 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -73.08 134.39 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.439 1.087 . . . . 73.310000000000002 109.314 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.409 ' HB2' ' NE2' ' A' ' 156' ' ' GLN . 0.4 OUTLIER -55.59 -166.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 53.140000000000001 109.996 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.0 m -156.24 127.93 3.84 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 74.310000000000002 110.02 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 137.8 52.39 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.944 -2.523 . . . . 34.229999999999997 111.027 0.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.0 p -73.0 -179.38 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.103 . . . . 65.319999999999993 108.307 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.649 HG23 ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.11 128.31 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 54.329999999999998 109.284 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 67.7 p -94.71 84.73 4.29 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 43.310000000000002 110.356 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -88.55 -12.7 42.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.522 1.139 . . . . 60.310000000000002 110.976 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.77 -4.1 29.41 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.526 1.141 . . . . 73.010000000000005 110.324 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.778 ' CE2' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -131.02 70.01 82.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.25 111.011 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.442 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.0 Cg_endo -75.05 113.56 3.82 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.535 1.808 . . . . 71.430000000000007 110.957 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.589 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.7 t -153.41 -67.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 61.420000000000002 109.298 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -159.34 112.88 2.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.527 1.142 . . . . 73.010000000000005 109.339 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.55 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.68 68.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.515 1.134 . . . . 51.340000000000003 111.002 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 42.4 m -107.5 -8.42 16.24 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.28 -1.008 . . . . 53.200000000000003 108.28 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.57 ' HB3' HG11 ' A' ' 219' ' ' VAL . 35.4 p90 -81.16 -23.83 37.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 55.100000000000001 110.964 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.08 -68.11 0.52 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 62.340000000000003 109.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.649 ' HB3' HG23 ' A' ' 168' ' ' ILE . 8.0 ptm180 -44.23 -51.12 8.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 52.32 110.309 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -40.35 -62.84 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.420000000000002 109.321 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.699 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -42.24 -39.09 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 73.439999999999998 109.625 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.685 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 28.0 mmmt -68.69 -54.9 13.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.544 1.152 . . . . 61.530000000000001 109.308 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.478 ' SD ' HG21 ' A' ' 153' ' ' ILE . 8.6 mtm -39.57 -41.72 1.06 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.466 1.104 . . . . 71.349999999999994 110.986 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.442 ' CG ' ' SG ' ' A' ' 195' ' ' CYS . 0.6 OUTLIER -62.63 -45.01 94.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 74.150000000000006 110.318 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.685 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -50.93 -31.81 18.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 72.200000000000003 110.307 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.481 HD13 ' HG3' ' A' ' 186' ' ' GLN . 10.4 mm -82.95 -39.43 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.13 . . . . 74.409999999999997 109.322 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.876 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -57.76 -39.34 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.511 1.132 . . . . 74.310000000000002 109.314 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.581 ' HG2' HD21 ' A' ' 136' ' ' LEU . 32.9 mtp -65.84 -45.78 80.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 72.319999999999993 110.98 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -42.87 -53.45 4.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 53.43 109.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.487 ' ND2' HE22 ' A' ' 152' ' ' GLN . 5.5 t-20 -62.64 -39.14 92.9 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 75.439999999999998 109.354 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 118.74 46.7 0.43 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.518 1.136 . . . . 62.5 111.0 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.676 ' O ' HD23 ' A' ' 188' ' ' LEU . 92.5 m-85 -150.93 129.82 12.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 74.439999999999998 111.004 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.777 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -96.98 130.76 44.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 75.010000000000005 109.358 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.829 ' HB3' HD22 ' A' ' 188' ' ' LEU . 13.9 p -102.65 173.49 6.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 62.229999999999997 108.314 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 55.32 110.324 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -100.04 158.39 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 64.099999999999994 109.32 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.534 ' OE1' HD11 ' A' ' 236' ' ' ILE . 20.4 tt0 -145.88 117.32 7.99 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 63.310000000000002 110.327 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -110.72 126.47 54.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.142 . . . . 74.109999999999999 111.032 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.649 HG21 ' CG ' ' A' ' 253' ' ' ARG . 9.1 p -125.92 128.53 72.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.458 1.099 . . . . 74.209999999999994 109.334 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.412 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 17.1 m-85 -103.44 158.37 16.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 111.005 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.94 -176.38 16.41 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.523 1.139 . . . . 43.549999999999997 110.97 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.768 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.5 t-20 -72.18 110.98 7.0 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 0.765 . . . . 54.310000000000002 109.273 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.1 mt -115.17 94.69 4.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 51.100000000000001 109.307 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.766 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 4.5 mtpt -92.87 170.92 9.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 73.409999999999997 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.535 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -172.96 122.53 0.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.11 . . . . 72.040000000000006 109.29 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 54.310000000000002 109.956 179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.527 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 108.275 -1.009 . . . . 73.549999999999997 108.275 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.1 OUTLIER -157.07 161.14 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.457 1.098 . . . . 74.219999999999999 109.326 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.766 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -140.23 137.53 34.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.491 1.119 . . . . 75.310000000000002 109.298 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -138.2 134.55 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.479 1.112 . . . . 74.310000000000002 108.014 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -78.27 -1.03 31.03 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.46 1.1 . . . . 74.230000000000004 110.034 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.4 p90 -173.96 130.42 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 75.420000000000002 110.987 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.483 ' N ' HD12 ' A' ' 204' ' ' LEU . 48.3 t60 -117.59 165.55 13.44 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.519 1.137 . . . . 71.120000000000005 109.588 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.0 p -140.76 135.87 34.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 64.209999999999994 109.315 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -136.34 -164.38 1.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 61.119999999999997 109.312 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' A' ' 237' ' ' ILE . 22.6 pt -119.42 123.28 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 70.219999999999999 109.295 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.6 tp -89.77 108.96 20.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 71.099999999999994 109.3 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.97 146.66 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.11 . . . . 73.030000000000001 109.27 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.6 ' HB3' HG22 ' A' ' 139' ' ' VAL . 9.4 m -116.7 119.42 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.141 . . . . 65.030000000000001 109.991 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.6 p90 -134.5 142.89 47.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.209999999999994 110.998 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.43 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.8 mmtp -68.28 134.4 50.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 74.129999999999995 109.316 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.62 -160.07 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 1.091 . . . . 64.329999999999998 109.257 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.39 50.75 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 72.329999999999998 109.341 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.0 m -115.02 -7.48 12.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.479 1.112 . . . . 74.150000000000006 110.033 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.67 8.45 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.467 1.104 . . . . 62.420000000000002 110.95 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.24 137.63 42.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 0.743 . . . . 74.040000000000006 109.273 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.43 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 13.4 m -71.52 102.65 2.75 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 74.019999999999996 110.416 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.7 mm-40 -101.4 -172.46 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 55.43 110.277 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.534 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.9 mmtm -127.18 144.98 50.92 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.449 1.093 . . . . 70.310000000000002 109.246 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.62 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.6 tpt180 -145.02 160.45 41.35 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 65.209999999999994 110.316 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.534 HD11 ' OE1' ' A' ' 198' ' ' GLN . 12.7 mm -115.53 118.02 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 73.219999999999999 109.336 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.753 HD12 ' HB2' ' A' ' 150' ' ' PHE . 3.8 mm -102.38 45.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.516 1.135 . . . . 62.539999999999999 109.301 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.35 111.27 65.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 73.150000000000006 109.301 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.96 -26.59 10.85 Favored 'Trans proline' 0 C--N 1.361 1.202 0 O-C-N 124.47 1.773 . . . . 71.129999999999995 111.036 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.408 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.5 t -48.06 -24.19 1.03 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.136 . . . . 74.310000000000002 110.001 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.404 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 25.2 mt -113.56 -54.72 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 72.230000000000004 109.316 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.725 ' CE2' HG21 ' A' ' 247' ' ' VAL . 94.9 m-85 -117.88 99.58 7.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.543 1.152 . . . . 62.240000000000002 111.025 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -28.34 34.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 75.099999999999994 109.947 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.7 t -59.01 -48.77 80.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 71.530000000000001 109.991 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.34 -172.83 39.19 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.495 1.122 . . . . 55.539999999999999 110.959 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.424 ' HB3' HD13 ' A' ' 237' ' ' ILE . 18.4 Cg_endo -74.97 170.63 20.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.449 1.763 . . . . 41.549999999999997 110.976 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 242' ' ' PHE . 10.7 m -151.01 158.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 72.040000000000006 109.297 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.4 p -59.61 142.49 52.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.545 1.153 . . . . 73.219999999999999 110.414 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.405 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 18.5 p-10 -46.61 -25.56 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 74.319999999999993 109.303 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.411 ' N ' ' C ' ' A' ' 248' ' ' THR . 27.8 m -79.36 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 33.240000000000002 110.409 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -49.86 -29.19 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 51.450000000000003 109.293 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 12.7 t90 -62.01 -65.88 0.62 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.430000000000007 108.022 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.762 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -40.58 -38.23 0.84 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 54.109999999999999 110.308 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.875 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.0 m-80 -60.07 -50.74 72.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.555 1.16 . . . . 74.209999999999994 109.297 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.535 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -54.08 -29.0 42.74 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.476 1.11 . . . . 65.25 109.255 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 5.6 m -81.14 -36.36 30.34 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 54.439999999999998 108.253 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.875 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.5 m -94.66 23.91 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 72.230000000000004 109.301 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -54.52 107.95 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 65.450000000000003 109.302 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.1 p -73.03 -3.18 24.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 45.409999999999997 110.383 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.6 t -44.99 -25.93 0.37 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 54.340000000000003 109.976 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . 0.416 ' N ' ' C ' ' A' ' 259' ' ' THR . 52.4 t -94.72 -36.57 11.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 52.219999999999999 108.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.14 -128.13 1.63 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.466 1.104 . . . . 64.120000000000005 111.032 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.77 148.98 34.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 64.439999999999998 110.038 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -172.5 146.32 1.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.501 1.126 . . . . 74.439999999999998 109.302 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.8 p -173.03 156.98 3.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 74.519999999999996 109.988 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.581 HG23 HG22 ' A' ' 200' ' ' VAL . 2.6 p -98.8 124.29 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.496 1.123 . . . . 73.349999999999994 109.263 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 39.1 t -86.31 -41.93 14.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 54.130000000000003 109.948 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.52 -174.13 4.8 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 50.350000000000001 110.007 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 9.5 p90 -170.89 155.7 4.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 73.219999999999999 111.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -163.11 173.21 13.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 64.450000000000003 109.319 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.477 ' C ' ' CG2' ' A' ' 272' ' ' THR . 0.8 OUTLIER -146.5 160.72 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 55.329999999999998 109.27 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.477 ' CG2' ' C ' ' A' ' 271' ' ' ASN . 6.7 p -151.67 -173.5 4.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.469 1.106 . . . . 73.129999999999995 110.415 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.79 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -67.72 148.95 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 65.519999999999996 109.315 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -58.87 -44.55 95.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.516 1.135 . . . . 61.409999999999997 111.023 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.434 ' OD1' ' NH1' ' A' ' 185' ' ' ARG . 16.4 m-80 -52.92 -39.6 62.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 0.749 . . . . 43.539999999999999 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.79 HG23 ' HB3' ' A' ' 273' ' ' ALA . 21.5 t -47.98 118.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.537 1.148 . . . . 74.299999999999997 109.303 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.6 t80 -73.32 -49.43 27.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 72.219999999999999 111.043 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 39.5 t80 -148.81 160.32 43.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 64.420000000000002 110.99 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.568 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 58.3 ttt-85 -130.34 146.83 51.97 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 75.129999999999995 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.42 157.59 40.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 70.549999999999997 109.983 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 -0.57 10.13 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 71.510000000000005 110.94 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 13.6 m -98.09 5.12 48.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.137 . . . . 71.420000000000002 110.004 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 78.27 35.96 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 65.010000000000005 109.235 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -117.52 119.32 34.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 1.131 . . . . 51.329999999999998 110.004 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -101.56 157.69 16.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.118 . . . . 73.510000000000005 111.005 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 286' ' ' LEU . 0.8 OUTLIER -119.44 174.85 6.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 63.219999999999999 109.273 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -157.43 115.05 3.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.120000000000005 111.015 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.446 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.5 t0 -115.37 96.6 5.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 73.209999999999994 109.284 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.72 -31.04 22.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 71.319999999999993 109.262 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.457 ' CB ' HG12 ' A' ' 292' ' ' ILE . 5.1 m120 -95.01 5.62 51.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 62.219999999999999 109.345 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.699 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.3 46.82 2.04 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.5 1.125 . . . . 71.319999999999993 109.287 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.457 HG12 ' CB ' ' A' ' 290' ' ' ASN . 26.2 mm -74.83 -33.24 30.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 71.319999999999993 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.745 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.8 t-20 -92.73 -20.54 20.68 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.513 1.133 . . . . 52.130000000000003 109.27 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.433 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 3.2 m -86.13 -62.55 1.49 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 75.439999999999998 110.379 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 76.3 m-20 -56.66 -24.13 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.422 1.076 . . . . 63.549999999999997 109.28 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 39.4 t -78.91 -48.2 15.04 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.47 1.106 . . . . 50.43 108.272 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.2 t -57.61 -28.06 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 72.200000000000003 109.314 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.5 mt -80.05 -59.81 2.58 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.559 1.162 . . . . 72.420000000000002 109.29 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -54.01 -19.3 4.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.549 1.156 . . . . 60.0 110.419 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.748 ' HE2' HG12 ' A' ' 315' ' ' VAL . 19.4 mmmt -72.14 -44.04 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 75.209999999999994 109.266 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.899 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.6 m-30 -99.67 37.39 1.61 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 71.099999999999994 111.05 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.2 t -68.98 -43.09 75.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.095 . . . . 72.519999999999996 109.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.79 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -96.35 -17.21 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.112 . . . . 74.129999999999995 109.333 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.899 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.7 mt -57.77 149.19 22.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 60.140000000000001 109.324 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -163.94 156.13 17.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.465 1.103 . . . . 50.240000000000002 110.017 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.1 -152.99 46.16 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.52 1.138 . . . . 73.129999999999995 110.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 17.4 m -99.63 7.33 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.278 -1.008 . . . . 53.32 108.278 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.8 OUTLIER -125.04 150.67 67.35 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 72.430000000000007 110.036 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.751 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -74.96 147.36 89.1 Favored 'Cis proline' 0 C--N 1.359 1.111 0 C-N-CA 121.019 -2.492 . . . . 62.109999999999999 111.001 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.6 OUTLIER -128.37 133.25 24.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 75.209999999999994 110.029 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.96 -168.94 6.89 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 121.024 -2.49 . . . . 75.010000000000005 111.028 -0.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.0 154.66 18.33 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 60.329999999999998 109.29 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.415 ' HG3' HD11 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.02 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.476 1.777 . . . . 71.209999999999994 110.981 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -87.77 132.62 34.08 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 73.340000000000003 109.337 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.748 HG12 ' HE2' ' A' ' 300' ' ' LYS . 35.3 m -134.53 27.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.13 . . . . 72.150000000000006 109.289 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 318' ' ' CYS . 36.1 t -71.58 -37.07 71.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.477 1.111 . . . . 65.409999999999997 110.028 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.6 t -43.11 -27.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 75.349999999999994 110.004 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 316' ' ' SER . 3.2 m . . . . . 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 60.310000000000002 108.268 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.696 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.292 -0.632 . . . . 73.120000000000005 109.292 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.33 110.54 4.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.09 . . . . 53.210000000000001 109.329 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -83.5 7.89 15.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.54 1.15 . . . . 73.129999999999995 110.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.4 145.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 63.340000000000003 109.316 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.009 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -96.98 143.28 25.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 72.030000000000001 109.314 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.99 -33.38 4.63 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.509 1.794 . . . . 61.200000000000003 111.009 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.81 155.41 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 71.450000000000003 109.31 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.507 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -52.45 -35.72 20.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 74.219999999999999 109.311 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.42 -47.49 3.62 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.492 1.12 . . . . 70.549999999999997 109.29 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.734 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -71.59 -35.0 70.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 1.116 . . . . 64.219999999999999 110.378 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.731 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -58.98 -56.97 15.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 65.030000000000001 109.317 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.507 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.3 m-80 -52.31 -31.8 34.74 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.528 1.143 . . . . 71.019999999999996 109.257 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -67.56 -56.66 8.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 73.530000000000001 110.046 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.009 HD12 HD11 ' A' ' 140' ' ' ILE . 92.4 mt -42.29 -41.97 2.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 53.43 109.312 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.704 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.69 -43.11 63.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 71.049999999999997 110.972 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -51.94 -34.17 40.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 75.019999999999996 109.274 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.497 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 65.0 mt-30 -76.17 -56.33 4.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 65.450000000000003 110.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.567 HD11 HD12 ' A' ' 188' ' ' LEU . 23.0 mt -50.27 -29.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 71.349999999999994 109.27 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -33.32 63.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 74.319999999999993 109.255 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.79 -18.2 59.0 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 73.519999999999996 109.31 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.401 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 11.2 mm100 -84.24 -15.47 46.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 72.239999999999995 110.274 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -38.7 122.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 63.210000000000001 109.982 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.19 130.45 34.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 54.229999999999997 108.316 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.95 -30.39 6.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.483 1.114 . . . . 63.310000000000002 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.796 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 35.0 p -67.37 161.58 24.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 0.762 . . . . 65.420000000000002 110.443 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.1 t -93.63 -0.72 56.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 70.420000000000002 109.986 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 162' ' ' THR . 3.9 m -116.84 5.63 13.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.108 . . . . 74.420000000000002 110.43 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.796 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -80.85 138.18 36.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.134 . . . . 64.340000000000003 109.284 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -164.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.571 1.169 . . . . 61.25 109.955 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 166' ' ' PRO . 2.6 m -155.96 126.25 3.37 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.531 1.144 . . . . 70.409999999999997 110.023 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.04 141.15 70.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.005 -2.498 . . . . 65.219999999999999 110.991 0.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.5 p -72.69 -178.98 2.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 74.109999999999999 108.315 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' A' ' 183' ' ' LYS . 3.3 mp -99.16 134.25 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.12 . . . . 74.109999999999999 109.3 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.6 p -79.92 71.41 6.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.132 . . . . 63.409999999999997 110.402 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.646 ' HE1' HH21 ' A' ' 180' ' ' ARG . 30.5 m-85 -75.63 -0.53 20.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 70.019999999999996 111.03 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -109.37 8.04 25.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.107 . . . . 74.219999999999999 110.275 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 174' ' ' VAL . 11.6 t80 -125.53 71.79 66.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.545 1.153 . . . . 65.5 110.99 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.442 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 110.13 3.06 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.447 1.761 . . . . 72.450000000000003 111.003 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.712 HG13 ' OG ' ' A' ' 310' ' ' SER . 2.7 t -151.82 -69.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 64.310000000000002 109.341 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -133.77 -48.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 74.230000000000004 109.284 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.25 107.5 0.06 OUTLIER Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.488 1.118 . . . . 53.25 111.013 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.653 ' SG ' HG12 ' A' ' 219' ' ' VAL . 6.9 p -147.86 -48.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 72.530000000000001 108.317 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.528 ' HB3' HG11 ' A' ' 219' ' ' VAL . 26.1 p90 -69.98 -29.1 66.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.55 1.156 . . . . 74.349999999999994 110.978 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -69.27 -68.1 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.474 1.109 . . . . 72.239999999999995 109.328 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.646 HH21 ' HE1' ' A' ' 170' ' ' PHE . 0.2 OUTLIER -44.14 -47.26 9.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 51.409999999999997 110.3 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -41.41 -60.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 72.230000000000004 109.305 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -46.19 -38.03 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.538 1.149 . . . . 74.439999999999998 109.616 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.768 ' HB3' HD11 ' A' ' 168' ' ' ILE . 29.3 mmmt -67.34 -59.69 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.424 1.077 . . . . 73.230000000000004 109.296 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 153' ' ' ILE . 8.4 mtm -39.36 -38.5 0.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.131 . . . . 62.299999999999997 110.96 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.47 77.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 74.400000000000006 110.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.562 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -51.2 -29.08 12.92 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 73.430000000000007 110.292 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.463 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 14.4 mm -81.28 -36.02 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.577 1.173 . . . . 74.299999999999997 109.321 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.567 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -63.13 -45.54 91.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 74.530000000000001 109.296 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.504 ' HG2' HD21 ' A' ' 136' ' ' LEU . 11.5 mtt -58.02 -43.61 86.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.506 1.129 . . . . 71.239999999999995 110.999 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -46.21 -52.97 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 60.100000000000001 109.311 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.497 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 23.8 t-20 -63.21 -35.47 80.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 75.319999999999993 109.342 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 110.88 50.99 0.62 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.464 1.102 . . . . 75.129999999999995 111.022 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.745 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 70.3 m-85 -151.04 136.37 17.7 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.531 0.783 . . . . 74.409999999999997 111.035 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.696 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.7 OUTLIER -106.96 121.84 45.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 65.439999999999998 109.323 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.545 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.3 p -102.2 178.4 4.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.088 . . . . 64.209999999999994 108.296 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 222' ' ' LEU . 4.9 mp0 -120.23 172.75 7.56 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.494 1.121 . . . . 74.340000000000003 110.263 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.68 ' HE2' HG22 ' A' ' 221' ' ' ILE . 19.0 mmtt -104.88 152.91 22.06 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 73.200000000000003 109.332 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.41 ' OE1' HD13 ' A' ' 222' ' ' LEU . 23.4 tt0 -139.48 117.73 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.472 1.108 . . . . 64.409999999999997 110.273 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.8 m-85 -111.14 122.33 47.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.49 1.119 . . . . 64.040000000000006 111.021 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.723 ' CG2' HG23 ' A' ' 266' ' ' VAL . 13.3 p -118.74 150.38 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 74.329999999999998 109.302 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.2 m-85 -123.14 162.17 23.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.54 1.15 . . . . 64.129999999999995 111.001 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.2 -177.37 16.37 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.542 1.151 . . . . 63.310000000000002 111.04 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.747 ' C ' HD23 ' A' ' 204' ' ' LEU . 57.6 t-20 -71.54 109.13 5.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 0.772 . . . . 64.109999999999999 109.329 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.747 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.3 mt -112.82 95.09 5.23 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.095 . . . . 74.200000000000003 109.328 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.5 mttt -92.29 168.87 11.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 70.340000000000003 109.293 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.976 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -179.35 165.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 74.510000000000005 109.312 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.515 1.134 . . . . 71.129999999999995 110.05 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 2.1 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 108.269 -1.011 . . . . 33.439999999999998 108.269 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.976 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.4 m -113.79 134.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.145 . . . . 51.43 109.279 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -127.32 127.56 44.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 64.209999999999994 109.307 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -135.68 135.13 39.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 63.43 108.008 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 3.7 20.97 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.105 . . . . 73.200000000000003 109.993 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.484 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.7 p90 -177.91 128.1 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 72.129999999999995 111.035 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.504 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 31.7 t60 -115.04 159.13 21.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.545 1.153 . . . . 73.420000000000002 109.609 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.653 HG12 ' SG ' ' A' ' 177' ' ' CYS . 3.4 p -138.85 137.93 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.420000000000002 109.331 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.568 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -138.98 -157.25 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.579 1.174 . . . . 74.420000000000002 109.317 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.68 HG22 ' HE2' ' A' ' 197' ' ' LYS . 18.3 pt -125.8 117.84 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.509 1.131 . . . . 72.129999999999995 109.276 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.6 tp -81.8 110.04 16.74 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.492 1.12 . . . . 62.229999999999997 109.294 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -101.12 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 71.439999999999998 109.307 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 24.8 m -116.73 119.93 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 64.430000000000007 110.016 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.563 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 31.4 p90 -135.34 145.55 47.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 75.310000000000002 110.993 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -70.3 133.99 47.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.123 . . . . 73.109999999999999 109.334 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.36 -159.64 0.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.115 . . . . 73.420000000000002 109.323 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.44 51.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.230000000000004 109.316 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.9 m -114.58 -8.38 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 51.549999999999997 110.01 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.39 37.42 8.19 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.526 1.141 . . . . 60.439999999999998 110.981 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 138.09 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.468 0.746 . . . . 51.310000000000002 109.301 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.6 m -71.64 102.65 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 72.439999999999998 110.407 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.0 mm-40 -101.99 -172.65 2.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.454 1.096 . . . . 72.530000000000001 110.289 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.599 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -126.69 145.36 50.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.445 1.091 . . . . 71.040000000000006 109.326 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.6 tpt180 -145.66 160.48 41.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.145 . . . . 62.210000000000001 110.275 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.702 HG21 ' CD1' ' A' ' 252' ' ' TRP . 12.8 mm -116.53 119.94 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.239999999999995 109.285 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -101.38 45.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.105 . . . . 70.219999999999999 109.315 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 236' ' ' ILE . 2.1 m-20 -101.17 112.67 65.35 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 40.509999999999998 109.274 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.568 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -74.97 -43.57 0.39 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.516 1.798 . . . . 54.130000000000003 111.015 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.1 OUTLIER -39.22 -29.9 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 73.099999999999994 109.983 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.582 HD13 ' CD1' ' A' ' 252' ' ' TRP . 13.6 mt -101.98 -52.98 3.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 64.129999999999995 109.3 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 247' ' ' VAL . 93.1 m-85 -125.99 99.28 5.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 72.019999999999996 111.041 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -79.22 -30.46 43.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 74.239999999999995 109.968 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -55.52 -46.15 77.04 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 72.510000000000005 109.982 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.48 -170.42 41.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.493 1.12 . . . . 42.030000000000001 111.002 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.432 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.06 168.85 23.89 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 75.450000000000003 110.992 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.652 HG21 ' CE2' ' A' ' 242' ' ' PHE . 3.9 m -151.66 159.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 50.219999999999999 109.291 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.428 ' C ' ' N ' ' A' ' 250' ' ' THR . 43.0 p -60.7 139.21 57.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 71.25 110.399 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.438 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER -43.01 -28.1 0.24 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 74.150000000000006 109.299 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.428 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.4 m -73.61 -64.76 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 75.430000000000007 110.404 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.15 -27.43 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 50.539999999999999 109.31 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.702 ' CD1' HG21 ' A' ' 236' ' ' ILE . 13.0 t90 -62.57 -62.03 2.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 73.420000000000002 108.008 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.555 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.24 -42.26 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.503 1.127 . . . . 71.310000000000002 110.303 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.836 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -55.8 -51.44 67.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 62.299999999999997 109.335 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.03 -20.36 16.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 62.119999999999997 109.311 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.58 -36.76 16.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 65.420000000000002 108.343 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -92.45 20.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.482 1.114 . . . . 62.030000000000001 109.288 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -46.61 104.48 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 75.540000000000006 109.319 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -76.07 -3.97 38.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 71.430000000000007 110.406 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.8 t -49.95 -22.85 1.69 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 65.109999999999999 110.023 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 206' ' ' ALA . 30.7 m -90.87 -32.88 15.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 74.239999999999995 108.294 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.88 -113.78 0.57 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.484 1.115 . . . . 44.229999999999997 111.008 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -90.56 143.45 26.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.78 . . . . 44.43 110.032 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -167.77 148.27 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.461 1.1 . . . . 54.399999999999999 109.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.72 156.58 3.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 61.109999999999999 109.982 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.723 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.9 p -104.39 113.96 42.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 73.310000000000002 109.288 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 4.6 t -68.15 -45.69 72.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 73.310000000000002 110.007 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 200' ' ' VAL . 29.5 p -163.84 -174.22 3.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 73.150000000000006 110.017 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -165.82 155.66 12.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.3 165.23 37.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 73.109999999999999 109.302 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.437 ' C ' HG23 ' A' ' 272' ' ' THR . 1.7 p-10 -128.29 160.67 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 74.200000000000003 109.258 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.598 HG21 ' HD2' ' A' ' 279' ' ' ARG . 19.1 p -153.96 176.94 11.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 74.010000000000005 110.395 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -60.76 158.32 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 54.420000000000002 109.324 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.4 -43.96 76.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.447 1.092 . . . . 53.219999999999999 110.993 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -54.87 -42.41 72.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.447 0.733 . . . . 73.219999999999999 109.312 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' ' 273' ' ' ALA . 69.8 t -43.61 101.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 73.329999999999998 109.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.415 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 7.2 t80 -60.07 -59.22 5.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.209999999999994 111.016 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -131.47 156.71 45.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 74.450000000000003 111.034 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.598 ' HD2' HG21 ' A' ' 272' ' ' THR . 63.6 ttt-85 -126.71 147.45 49.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 63.520000000000003 110.275 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.2 m -118.2 158.02 47.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 70.019999999999996 110.068 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 0.17 9.21 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.459 1.768 . . . . 54.549999999999997 111.005 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 80.1 p -104.27 5.81 34.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 73.519999999999996 109.943 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 78.34 39.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 64.340000000000003 109.279 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -113.37 120.22 40.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 62.240000000000002 110.027 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -107.62 151.78 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 75.329999999999998 111.01 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.528 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 1.2 mm? -118.59 177.67 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 73.530000000000001 109.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 79.6 m-85 -160.29 115.22 2.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.523 1.139 . . . . 63.100000000000001 110.978 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.438 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 0.4 OUTLIER -115.49 97.03 5.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 74.200000000000003 109.303 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -85.82 -14.49 44.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 72.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.408 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.0 m-20 -110.75 0.87 17.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 62.229999999999997 109.306 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.695 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 42.69 49.58 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.125 . . . . 73.329999999999998 109.281 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 290' ' ' ASN . 18.2 mm -78.58 -27.55 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.445 1.09 . . . . 75.409999999999997 109.299 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.798 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.9 t-20 -94.18 -27.67 16.07 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.444 1.09 . . . . 62.119999999999997 109.286 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.452 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 21.9 m -82.19 -69.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 73.310000000000002 110.407 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 44.1 m-20 -47.86 -30.36 4.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 65.230000000000004 109.293 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 36.8 t -72.73 -58.41 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 72.420000000000002 108.318 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 293' ' ' ASN . 9.4 t -43.95 -49.54 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 75.430000000000007 109.313 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.692 HD22 ' HA ' ' A' ' 168' ' ' ILE . 9.6 mt -61.47 -59.97 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 64.209999999999994 109.31 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.35 -31.8 1.78 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.535 1.147 . . . . 61.140000000000001 110.411 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -70.13 -49.46 50.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.319999999999993 109.283 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.584 ' CZ ' ' HB1' ' A' ' 312' ' ' ALA . 3.3 m-30 -91.77 31.39 1.22 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 75.109999999999999 110.982 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 26.2 t -63.38 -52.75 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 63.520000000000003 110.005 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.4 -10.41 58.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.432 1.083 . . . . 70.310000000000002 109.326 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.603 ' N ' HD22 ' A' ' 303' ' ' LEU . 19.1 mt -76.21 136.63 39.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 74.409999999999997 109.289 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.5 p -161.46 147.58 14.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 75.150000000000006 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 96.89 -160.14 21.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.498 1.124 . . . . 63.409999999999997 110.977 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 25.42 5.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.345 -0.983 . . . . 50.119999999999997 108.345 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.514 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 93.1 p -156.84 148.62 17.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.1 . . . . 64.140000000000001 109.998 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.588 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.98 145.74 84.76 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 121.007 -2.497 . . . . 73.209999999999994 111.024 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.712 ' OG ' HG13 ' A' ' 174' ' ' VAL . 70.0 m -132.21 135.17 26.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 65.299999999999997 109.985 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.0 -173.55 12.53 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 120.995 -2.502 . . . . 75.140000000000001 110.999 -0.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.584 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.89 151.78 31.13 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 51.32 109.295 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.571 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.508 1.794 . . . . 63.409999999999997 110.995 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -85.96 135.49 33.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 75.010000000000005 109.292 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.4 ' O ' ' SG ' ' A' ' 318' ' ' CYS . 26.8 m -127.77 24.68 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 70.209999999999994 109.29 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 35.8 t -54.11 -19.8 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.556 1.16 . . . . 71.409999999999997 110.043 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 35.4 p -53.89 -24.84 17.43 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.501 1.126 . . . . 73.349999999999994 109.989 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 315' ' ' VAL . 1.8 m . . . . . 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.145 . . . . 55.109999999999999 108.257 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 194' ' ' ASP . 8.5 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.295 -0.632 . . . . 71.030000000000001 109.295 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -105.74 106.46 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.140000000000001 109.277 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -83.45 8.21 14.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.526 1.141 . . . . 55.100000000000001 109.946 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.53 145.2 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 73.510000000000005 109.264 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 149' ' ' LEU . 1.1 mt -96.26 142.77 25.03 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 74.310000000000002 109.339 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.99 -32.48 5.36 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.551 1.816 . . . . 74.349999999999994 111.002 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.71 152.47 21.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 64.239999999999995 109.335 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.519 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -49.96 -35.45 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 63.130000000000003 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.5 -47.35 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 73.209999999999994 109.3 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.652 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.91 -34.72 69.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.512 1.133 . . . . 73.239999999999995 110.403 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.741 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.29 -56.98 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 71.25 109.304 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.519 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 48.9 m-80 -52.27 -32.03 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 63.520000000000003 109.307 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.6 -55.5 11.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 64.120000000000005 110.008 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 140' ' ' ILE . 66.5 mt -42.06 -41.83 2.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 70.140000000000001 109.315 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.648 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.91 -45.44 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.113 . . . . 73.109999999999999 111.017 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -46.52 -38.37 9.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 75.120000000000005 109.277 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . 58.4 mt-30 -76.57 -55.38 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 73.230000000000004 110.29 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.808 HD11 HD12 ' A' ' 188' ' ' LEU . 13.6 mt -50.56 -23.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.498 1.124 . . . . 74.439999999999998 109.293 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.61 42.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 75.230000000000004 109.297 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -58.44 -19.17 34.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 74.239999999999995 109.24 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 3.3 mm100 -81.68 -24.64 36.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 55.439999999999998 110.324 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.522 ' HA ' ' CD2' ' A' ' 170' ' ' PHE . 23.3 m -41.42 117.35 0.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 53.100000000000001 109.982 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 2.4 m -45.27 130.62 8.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.118 . . . . 74.420000000000002 108.318 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.39 -24.89 5.51 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.587 1.179 . . . . 64.310000000000002 110.976 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.774 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 75.4 p -83.93 161.7 20.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 0.748 . . . . 62.109999999999999 110.388 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -93.56 0.76 56.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 63.5 109.959 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 162' ' ' THR . 2.1 m -117.02 3.48 12.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.123 . . . . 74.219999999999999 110.381 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.774 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -79.06 133.64 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 71.349999999999994 109.278 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.76 -173.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 62.32 109.984 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.3 p -152.39 126.64 4.49 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 74.400000000000006 110.001 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.24 49.19 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 121.063 -2.474 . . . . 64.200000000000003 110.992 0.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.2 p -73.01 -178.2 2.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 71.349999999999994 108.286 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.728 HG21 ' CE1' ' A' ' 170' ' ' PHE . 4.3 mp -90.53 137.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 73.450000000000003 109.309 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.596 HG21 ' O ' ' A' ' 301' ' ' PHE . 74.3 p -90.48 88.62 7.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 72.129999999999995 110.426 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.728 ' CE1' HG21 ' A' ' 168' ' ' ILE . 19.1 m-85 -88.36 -25.51 22.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 64.439999999999998 110.986 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.453 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.84 -2.05 28.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.138 . . . . 72.019999999999996 110.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.675 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 29.4 t80 -128.29 68.22 76.58 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 110.998 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.424 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.06 113.39 3.78 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.495 1.787 . . . . 74.109999999999999 110.977 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.586 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.9 t -152.17 -66.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 34.530000000000001 109.31 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -163.49 118.16 1.62 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.51 1.131 . . . . 64.239999999999995 109.283 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 147.3 48.03 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.516 1.135 . . . . 52.140000000000001 110.98 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 74.4 m -88.59 -19.75 25.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.261 -1.014 . . . . 74.129999999999995 108.261 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.668 ' HB3' HG11 ' A' ' 219' ' ' VAL . 29.2 p90 -72.55 -40.83 66.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 72.519999999999996 111.018 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.594 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -63.87 -64.63 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 73.329999999999998 109.314 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.523 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -43.7 -47.51 7.78 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 74.140000000000001 110.288 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.426 ' N ' ' HD3' ' A' ' 180' ' ' ARG . . . -42.17 -55.72 3.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 75.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.692 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.33 -38.99 20.52 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.568 1.168 . . . . 75.209999999999994 109.597 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.656 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.8 mmmt -64.32 -61.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.465 1.103 . . . . 74.230000000000004 109.268 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.69 ' SD ' HG21 ' A' ' 153' ' ' ILE . 3.4 mtm -38.78 -34.06 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.52 1.138 . . . . 31.02 110.983 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.436 HH21 ' CG ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -63.95 -50.3 69.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 62.450000000000003 110.251 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.656 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -52.87 -30.91 36.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.133 . . . . 72.519999999999996 110.311 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.516 HD13 ' HG3' ' A' ' 186' ' ' GLN . 11.0 mm -82.2 -36.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 75.219999999999999 109.277 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.808 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -62.69 -41.8 99.3 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.521 1.138 . . . . 72.120000000000005 109.288 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.439 ' HG2' HD21 ' A' ' 136' ' ' LEU . 21.8 mtp -63.73 -41.03 98.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 71.409999999999997 110.975 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -45.41 -53.28 8.91 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.200000000000003 109.341 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -66.02 -27.14 67.89 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.544 1.152 . . . . 50.509999999999998 109.279 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.72 55.4 0.74 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.531 1.144 . . . . 73.420000000000002 111.025 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.652 ' CZ ' HG21 ' A' ' 145' ' ' THR . 77.5 m-85 -154.94 143.63 20.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.571 0.806 . . . . 64.439999999999998 111.012 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.935 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.1 t70 -109.55 125.45 52.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 70.150000000000006 109.35 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.788 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.7 p -94.51 -179.41 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 44.030000000000001 108.296 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 171.86 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 74.439999999999998 110.294 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.419 ' NZ ' ' HB1' ' A' ' 181' ' ' ALA . 13.0 mmtt -105.72 163.38 12.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 72.25 109.269 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.737 HE22 HD13 ' A' ' 222' ' ' LEU . 3.3 tt0 -158.11 117.54 3.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 75.030000000000001 110.328 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.9 m-85 -110.75 119.34 38.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.507 1.129 . . . . 74.209999999999994 111.013 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.659 ' CG2' HG23 ' A' ' 266' ' ' VAL . 9.9 p -115.08 142.32 28.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 71.510000000000005 109.321 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.504 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.8 m-85 -117.65 157.25 26.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.239999999999995 110.969 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.92 -175.03 16.51 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.536 1.148 . . . . 51.310000000000002 110.986 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.787 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.1 t-20 -74.39 110.98 9.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.514 0.773 . . . . 73.450000000000003 109.297 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.7 mt -115.56 94.54 4.74 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.132 . . . . 71.340000000000003 109.333 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.4 mttp -92.81 167.12 12.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 109.255 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.923 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -170.43 164.41 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 74.430000000000007 109.297 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 t . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.109999999999999 110.016 -179.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.317 -0.994 . . . . 74.239999999999995 108.317 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.923 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -128.58 142.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 54.109999999999999 109.278 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.87 128.78 41.29 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.525 1.141 . . . . 64.329999999999998 109.303 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.429 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.0 OUTLIER -134.99 130.84 36.37 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.556 1.16 . . . . 70.420000000000002 107.99 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.3 p -76.46 -0.73 24.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.558 1.161 . . . . 75.349999999999994 109.966 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.5 p90 -173.72 133.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.125 . . . . 74.430000000000007 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 65.5 t60 -119.26 167.79 11.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 63.130000000000003 109.604 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.8 p -150.78 136.22 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.126 . . . . 74.510000000000005 109.287 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.545 ' HB3' ' CZ2' ' A' ' 252' ' ' TRP . . . -135.87 -156.72 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 41.109999999999999 109.327 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.436 HG12 ' CE ' ' A' ' 184' ' ' MET . 23.9 pt -123.07 118.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 62.520000000000003 109.273 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.737 HD13 HE22 ' A' ' 198' ' ' GLN . 11.0 tp -81.55 109.06 15.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 71.299999999999997 109.285 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -100.87 145.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 61.5 109.292 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 17.0 m -117.34 120.29 37.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.502 1.126 . . . . 73.129999999999995 110.027 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 28.1 p90 -135.68 146.62 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.527 1.142 . . . . 73.230000000000004 110.974 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -71.52 131.52 43.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 75.049999999999997 109.266 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -72.61 -160.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 71.540000000000006 109.316 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.02 49.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 62.340000000000003 109.291 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.5 m -114.96 -7.81 12.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 53.509999999999998 109.993 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.93 37.85 8.26 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.485 1.115 . . . . 72.129999999999995 111.005 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.97 137.9 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.532 0.784 . . . . 63.539999999999999 109.269 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -72.21 102.63 3.12 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.553 1.158 . . . . 54.109999999999999 110.383 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 224' ' ' SER . 4.4 mm-40 -102.21 -172.78 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.209999999999994 110.295 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.8 mmtt -126.93 144.78 50.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 73.540000000000006 109.32 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.588 ' HB3' HG22 ' A' ' 223' ' ' VAL . 3.5 tpt180 -145.56 162.07 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 62.439999999999998 110.283 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.627 HG21 ' CD1' ' A' ' 252' ' ' TRP . 26.3 mm -117.33 119.66 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 73.340000000000003 109.299 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 237' ' ' ILE . 2.6 mm -101.23 47.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 70.329999999999998 109.309 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.692 ' OD1' HD12 ' A' ' 241' ' ' LEU . 27.2 p-10 -94.8 111.4 54.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.340000000000003 109.289 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.98 -44.79 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 62.109999999999999 111.018 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.9 m -39.58 -39.16 0.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.546 1.153 . . . . 72.219999999999999 110.005 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.692 HD12 ' OD1' ' A' ' 238' ' ' ASP . 5.9 mt -92.93 -56.69 2.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 71.120000000000005 109.281 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.729 ' CG ' HG11 ' A' ' 247' ' ' VAL . 95.6 m-85 -121.12 99.5 6.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 62.450000000000003 111.001 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -26.01 34.96 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.453 1.096 . . . . 70.530000000000001 109.989 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 m -57.24 -45.82 83.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 62.049999999999997 109.971 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 179.42 -166.91 36.58 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.447 1.092 . . . . 75.019999999999996 111.004 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.493 ' CG ' HD21 ' A' ' 146' ' ' LEU . 18.1 Cg_endo -75.04 164.0 34.14 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.504 1.792 . . . . 61.409999999999997 110.982 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.729 HG11 ' CG ' ' A' ' 242' ' ' PHE . 12.3 m -140.99 167.78 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 62.009999999999998 109.281 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.449 ' C ' ' N ' ' A' ' 250' ' ' THR . 24.2 p -70.38 136.18 49.44 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.484 1.115 . . . . 73.25 110.384 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 26.6 p-10 -39.86 -30.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 73.540000000000006 109.327 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.449 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -78.1 -61.43 2.0 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 40.200000000000003 110.409 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.91 -22.79 2.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.486 1.116 . . . . 70.349999999999994 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.627 ' CD1' HG21 ' A' ' 236' ' ' ILE . 7.4 t90 -68.68 -60.47 2.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.497 1.123 . . . . 75.450000000000003 107.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.568 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -51.29 -41.81 60.71 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.299999999999997 110.316 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.814 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.8 m-80 -54.66 -51.38 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 72.219999999999999 109.253 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.67 -24.45 48.84 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 73.409999999999997 109.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -83.97 -35.02 24.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 55.100000000000001 108.261 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.1 m -95.82 21.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.299999999999997 109.307 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 39.5 t-20 -51.94 107.88 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 72.530000000000001 109.317 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.0 p -73.36 -3.37 26.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 61.210000000000001 110.389 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.41 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 0.4 OUTLIER -44.73 -30.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 54.009999999999998 109.971 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 42.1 t -88.95 -36.88 15.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 50.25 108.304 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.48 -127.97 1.62 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.473 1.108 . . . . 55.439999999999998 110.938 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.56 147.31 37.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 0.778 . . . . 74.019999999999996 109.973 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.98 146.22 3.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 72.209999999999994 109.289 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -172.73 151.38 2.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.530000000000001 110.018 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.659 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.35 115.08 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.558 1.161 . . . . 50.439999999999998 109.28 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 31.7 t -70.11 -45.46 66.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 75.049999999999997 109.983 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 m -165.08 177.29 7.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.525 1.14 . . . . 72.209999999999994 110.029 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -158.21 156.44 30.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 54.43 110.999 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.34 33.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 62.009999999999998 109.282 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.532 ' O ' HG23 ' A' ' 272' ' ' THR . 1.2 p-10 -119.14 160.61 21.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 64.420000000000002 109.278 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.685 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.0 p -154.98 178.89 9.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.524 1.14 . . . . 74.129999999999995 110.378 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -62.67 158.76 17.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.527 1.142 . . . . 73.530000000000001 109.301 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.87 -39.25 55.29 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.481 1.113 . . . . 62.100000000000001 110.955 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -56.7 -48.06 78.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 0.776 . . . . 71.109999999999999 109.273 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.771 HG23 ' HB3' ' A' ' 273' ' ' ALA . 25.3 t -44.7 118.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 63.130000000000003 109.332 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -70.41 -53.49 16.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.531 1.144 . . . . 74.420000000000002 111.013 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 45.8 t80 -140.22 165.32 27.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 71.200000000000003 111.018 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.685 ' HD2' HG21 ' A' ' 272' ' ' THR . 55.0 ttt-85 -137.01 147.39 46.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 64.239999999999995 110.278 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.6 157.92 44.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 71.349999999999994 109.97 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.19 9.2 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 72.510000000000005 111.0 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.0 t -97.83 3.92 49.8 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 73.409999999999997 110.034 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 77.13 41.37 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.420000000000002 109.273 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.8 t -123.07 119.52 30.57 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.461 1.101 . . . . 65.530000000000001 109.955 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.5 m-30 -99.92 160.22 14.48 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 55.229999999999997 110.957 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.482 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -120.45 177.59 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.468 1.105 . . . . 65.030000000000001 109.324 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 94.8 m-85 -160.61 115.57 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 74.0 110.992 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.445 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.7 m-20 -115.18 96.11 5.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 71.200000000000003 109.241 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -85.57 -30.7 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 72.120000000000005 109.274 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.479 ' HB3' HD11 ' A' ' 292' ' ' ILE . 34.3 m-20 -98.3 7.91 45.56 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.139 . . . . 55.32 109.264 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.692 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 3.0 mm? 40.32 47.54 2.19 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.493 1.12 . . . . 65.310000000000002 109.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 290' ' ' ASN . 45.4 mm -78.35 -25.07 13.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.558 1.161 . . . . 72.25 109.305 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.66 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.0 t-20 -94.64 -22.82 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 72.030000000000001 109.308 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.438 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.0 m -86.78 -68.97 0.71 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 72.439999999999998 110.383 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -50.86 -22.88 2.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.525 1.141 . . . . 73.030000000000001 109.333 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 20.5 t -79.03 -62.44 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 65.140000000000001 108.312 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 293' ' ' ASN . 18.2 t -44.09 -43.15 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 62.520000000000003 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 168' ' ' ILE . 72.9 mt -63.42 -58.59 6.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 65.530000000000001 109.315 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -38.27 5.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 62.539999999999999 110.402 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -57.18 -56.2 24.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 109.309 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.5 OUTLIER -89.68 35.22 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 63.420000000000002 111.032 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 t -68.07 -49.07 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 54.240000000000002 109.962 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -88.24 -17.94 29.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.439 1.087 . . . . 55.409999999999997 109.274 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.816 HD22 ' CD ' ' A' ' 309' ' ' PRO . 17.9 mt -57.43 144.26 37.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 54.329999999999998 109.26 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.9 p -158.38 136.8 10.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 71.209999999999994 109.995 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 93.31 -155.23 22.17 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.519 1.137 . . . . 74.140000000000001 111.013 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.7 p -98.87 12.81 34.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.295 -1.002 . . . . 31.43 108.295 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.526 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.5 p -135.22 148.61 67.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 74.409999999999997 109.968 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.816 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.95 146.36 86.46 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.023 -2.49 . . . . 74.230000000000004 110.998 -0.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.5 p -132.29 135.77 26.94 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 54.310000000000002 109.985 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.8 14.76 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.985 -2.506 . . . . 63.549999999999997 110.997 -0.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.46 155.91 18.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 44.25 109.291 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.485 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.37 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.5 1.789 . . . . 72.420000000000002 111.01 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.99 135.51 33.38 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 71.319999999999993 109.277 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 13.3 m -126.49 18.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 64.129999999999995 109.285 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.4 -33.06 58.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 72.019999999999996 110.013 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.1 p -43.12 -39.93 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.118 . . . . 72.400000000000006 110.02 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.467 1.104 . . . . 72.439999999999998 108.262 -179.932 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.797 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.2 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.287 -0.634 . . . . 64.010000000000005 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.694 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.82 107.76 3.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.543 1.152 . . . . 64.019999999999996 109.285 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -81.69 5.88 17.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.164 . . . . 65.019999999999996 110.031 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -145.87 148.76 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 62.32 109.331 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.095 HD11 HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -100.82 143.72 27.13 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 52.25 109.276 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.2 Cg_endo -74.99 -33.97 4.18 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.509 1.794 . . . . 73.400000000000006 110.985 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.82 150.6 22.85 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 73.030000000000001 109.314 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.8 t -48.83 -36.18 7.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.450000000000003 109.286 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.03 -48.55 3.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 64.319999999999993 109.302 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.691 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -70.01 -36.02 74.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.143 . . . . 74.420000000000002 110.364 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.746 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -57.95 -57.09 14.32 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.158 . . . . 74.299999999999997 109.324 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.483 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.9 m-80 -52.95 -29.4 28.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 70.230000000000004 109.304 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.3 -55.57 8.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.515 1.134 . . . . 74.230000000000004 109.973 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.095 HD12 HD11 ' A' ' 140' ' ' ILE . 65.3 mt -42.2 -41.99 2.88 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.553 1.158 . . . . 75.450000000000003 109.259 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.571 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.82 -45.37 61.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 73.329999999999998 111.003 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -46.12 -35.37 4.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 73.319999999999993 109.315 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.449 ' NE2' ' OD1' ' A' ' 191' ' ' ASN . 65.3 mt-30 -77.42 -56.4 4.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.24 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.748 HD11 HD12 ' A' ' 188' ' ' LEU . 17.3 mt -50.18 -26.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.458 1.099 . . . . 71.340000000000003 109.265 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -34.62 57.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 74.140000000000001 109.297 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.8 t-20 -61.6 -15.12 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.457 1.098 . . . . 70.099999999999994 109.292 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.45 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 5.7 mm100 -85.68 -18.72 32.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.135 . . . . 74.519999999999996 110.323 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.474 ' HB2' ' CE2' ' A' ' 170' ' ' PHE . 23.7 p -38.68 137.97 0.57 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.553 1.158 . . . . 61.109999999999999 109.991 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -68.03 134.16 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 73.329999999999998 108.288 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.74 -19.05 19.17 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.469 1.105 . . . . 75.420000000000002 111.017 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.848 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 69.8 p -81.24 161.52 23.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.527 0.781 . . . . 74.120000000000005 110.414 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.0 p -93.52 -0.5 56.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.138 . . . . 71.519999999999996 110.032 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 162' ' ' THR . 17.8 m -117.84 6.67 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 63.229999999999997 110.368 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.848 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -83.17 138.14 33.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 63.409999999999997 109.311 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -164.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 43.240000000000002 110.016 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.44 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 14.2 t -156.04 127.47 3.72 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 62.210000000000001 109.995 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.03 137.28 49.44 Favored 'Cis proline' 0 C--N 1.361 1.189 0 C-N-CA 120.986 -2.506 . . . . 74.239999999999995 111.017 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.0 p -73.08 179.48 3.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 63.130000000000003 108.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.564 HG23 ' HB3' ' A' ' 180' ' ' ARG . 3.7 mp -88.95 128.94 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 62.350000000000001 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 301' ' ' PHE . 23.8 p -91.14 85.65 5.96 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 64.200000000000003 110.41 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 157' ' ' SER . 47.9 p90 -86.34 -18.86 30.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 54.329999999999998 110.979 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.448 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.77 -1.78 23.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 75.329999999999998 110.273 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.78 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.8 t80 -129.03 68.29 79.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.44 1.087 . . . . 64.299999999999997 110.983 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.411 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 118.8 5.39 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.457 1.767 . . . . 74.420000000000002 110.963 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.564 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.2 t -152.47 -74.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.116 . . . . 75.239999999999995 109.283 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.553 ' OD1' ' HB2' ' A' ' 312' ' ' ALA . 1.5 p-10 -123.68 -43.15 2.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 74.340000000000003 109.32 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -43.02 126.66 5.01 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.486 1.117 . . . . 51.210000000000001 110.999 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.627 ' SG ' HG12 ' A' ' 219' ' ' VAL . 4.5 p -165.33 -49.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.266 -1.013 . . . . 72.430000000000007 108.266 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.58 ' HB3' HG11 ' A' ' 219' ' ' VAL . 23.9 p90 -70.08 -18.67 63.27 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 72.030000000000001 110.997 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.26 -68.26 0.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.515 1.135 . . . . 72.439999999999998 109.313 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 168' ' ' ILE . 9.2 ptm180 -48.36 -49.81 33.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.476 1.11 . . . . 71.349999999999994 110.302 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.472 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.37 -64.88 0.43 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.118 . . . . 72.310000000000002 109.298 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.4 t60 -39.86 -45.03 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 74.400000000000006 109.607 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 186' ' ' GLN . 14.3 mmmt -62.3 -58.24 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 72.420000000000002 109.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.642 ' SD ' HG21 ' A' ' 153' ' ' ILE . 9.2 mtm -38.96 -36.13 0.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 60.549999999999997 110.981 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.431 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.1 OUTLIER -63.47 -48.99 75.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 62.43 110.314 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -53.1 -33.2 51.12 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.447 1.092 . . . . 72.319999999999993 110.278 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.434 HD13 ' HG3' ' A' ' 186' ' ' GLN . 17.3 mm -75.79 -37.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.145 . . . . 74.0 109.26 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.748 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -61.28 -44.45 97.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.099999999999994 109.285 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.438 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.2 mtt -56.41 -42.28 77.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 75.209999999999994 110.992 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -48.45 -52.66 21.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.46 1.1 . . . . 64.420000000000002 109.288 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.449 ' OD1' ' NE2' ' A' ' 152' ' ' GLN . 0.4 OUTLIER -62.28 -37.22 84.67 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 74.109999999999999 109.274 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.77 48.15 0.69 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.522 1.139 . . . . 71.299999999999997 110.971 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.694 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 61.6 m-85 -147.78 137.62 22.69 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 0.769 . . . . 74.310000000000002 111.001 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.797 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.3 t70 -103.17 129.26 50.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 64.109999999999999 109.293 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.712 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.8 p -108.15 -178.79 3.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 74.430000000000007 108.286 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.4 OUTLIER -126.47 174.74 8.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 73.319999999999993 110.27 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.472 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 20.5 mmtt -109.73 167.08 10.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 33.130000000000003 109.279 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 219' ' ' VAL . 0.6 OUTLIER -153.45 144.87 23.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 72.5 110.271 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.527 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.1 m-85 -139.87 112.61 7.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.156 . . . . 64.549999999999997 110.992 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.795 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.4 p -106.68 143.21 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 73.319999999999993 109.278 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.4 m-85 -113.99 150.49 33.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.11 . . . . 73.430000000000007 110.97 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.17 19.53 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.465 1.103 . . . . 64.510000000000005 111.003 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.815 ' C ' HD23 ' A' ' 204' ' ' LEU . 54.4 t-20 -77.65 111.46 13.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.54 0.788 . . . . 63.119999999999997 109.299 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.815 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.0 mt -114.09 95.97 5.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 73.519999999999996 109.251 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.0 mtpt -92.31 165.4 13.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 72.129999999999995 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.877 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -170.6 122.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 52.109999999999999 109.325 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.409 ' CB ' ' SG ' ' A' ' 261' ' ' CYS . 3.3 p . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.134 . . . . 72.120000000000005 110.017 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.354 -0.98 . . . . 74.409999999999997 108.354 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.877 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -117.56 142.24 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 61.149999999999999 109.318 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.31 127.82 28.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 64.420000000000002 109.364 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.464 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.6 OUTLIER -132.66 132.9 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 108.009 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 30.5 t -76.5 -0.76 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.149 . . . . 61.530000000000001 109.971 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 10.3 p90 -176.4 133.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 62.310000000000002 111.022 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 32.4 t60 -117.48 168.9 9.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.095 . . . . 72.099999999999994 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 198' ' ' GLN . 2.8 p -147.75 142.02 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.46 1.1 . . . . 61.240000000000002 109.259 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.16 -167.27 2.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 74.140000000000001 109.278 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 196' ' ' GLU . 19.9 pt -115.92 121.95 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 75.420000000000002 109.311 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.716 HD22 HE22 ' A' ' 198' ' ' GLN . 18.2 tp -84.49 115.55 22.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.463 1.102 . . . . 65.129999999999995 109.298 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -109.07 145.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.487 1.117 . . . . 62.020000000000003 109.303 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 69.5 m -115.73 121.71 43.32 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 73.299999999999997 109.953 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.3 p90 -136.66 143.32 43.38 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 70.409999999999997 111.017 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.423 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.4 mmtp -69.23 132.51 46.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.451 1.094 . . . . 74.420000000000002 109.294 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.46 -160.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.340000000000003 109.332 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.21 50.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 41.409999999999997 109.329 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.6 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 75.349999999999994 110.009 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.39 8.16 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.538 1.149 . . . . 71.019999999999996 110.982 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.09 137.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 0.767 . . . . 73.310000000000002 109.281 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.423 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.5 m -71.91 102.66 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 33.450000000000003 110.43 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.8 mm-40 -103.12 -172.86 2.19 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 71.510000000000005 110.296 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.475 ' HB3' HD11 ' A' ' 222' ' ' LEU . 8.5 mmtm -126.12 145.56 50.3 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 65.340000000000003 109.323 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.8 tpt180 -143.74 159.1 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 63.450000000000003 110.325 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.582 HG21 ' CD1' ' A' ' 252' ' ' TRP . 7.7 mm -111.63 124.89 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 53.130000000000003 109.331 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 237' ' ' ILE . 2.8 mm -112.95 44.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 74.150000000000006 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.545 ' OD1' HD12 ' A' ' 241' ' ' LEU . 10.8 p-10 -94.12 111.67 54.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 51.229999999999997 109.322 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.464 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.4 Cg_endo -74.94 -36.33 2.66 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.506 1.793 . . . . 73.109999999999999 110.994 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 1.3 p -43.16 -36.47 1.72 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.456 1.097 . . . . 73.310000000000002 109.98 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.545 HD12 ' OD1' ' A' ' 238' ' ' ASP . 16.5 mt -102.56 -59.52 1.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 72.109999999999999 109.284 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 255' ' ' ALA . 89.6 m-85 -111.3 98.99 7.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 73.129999999999995 111.07 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.6 m -91.02 -13.13 33.85 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 61.5 109.985 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 p -74.73 -46.54 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.098 . . . . 72.5 110.001 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -172.0 -179.52 42.98 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.501 1.126 . . . . 72.129999999999995 111.005 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 236' ' ' ILE . 18.3 Cg_endo -74.98 169.29 22.96 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.485 1.782 . . . . 73.510000000000005 110.978 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.604 HG11 ' CD2' ' A' ' 242' ' ' PHE . 5.0 m -153.13 157.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.121 . . . . 74.230000000000004 109.289 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.434 ' C ' ' N ' ' A' ' 250' ' ' THR . 46.7 p -59.28 136.56 58.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 73.219999999999999 110.447 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 248' ' ' THR . 1.7 p-10 -40.33 -30.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 74.420000000000002 109.316 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.434 ' N ' ' C ' ' A' ' 248' ' ' THR . 3.7 m -70.06 -65.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 71.230000000000004 110.365 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.58 -38.4 14.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 61.119999999999997 109.31 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 19.4 t90 -54.25 -63.55 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 74.310000000000002 108.0 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.571 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -46.49 -45.78 18.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 60.210000000000001 110.327 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.746 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -53.14 -51.68 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.499 1.124 . . . . 65.349999999999994 109.285 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.78 -21.85 31.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 73.409999999999997 109.328 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -84.57 -38.19 20.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 63.299999999999997 108.34 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.746 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.3 m -91.19 18.56 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 24.350000000000001 109.285 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 260' ' ' SER . 6.8 t30 -40.51 104.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 63.350000000000001 109.329 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.8 p -79.89 -4.04 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.461 1.101 . . . . 53.32 110.387 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 258' ' ' ASN . 5.2 t -58.7 -16.13 15.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 62.509999999999998 110.033 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 1.3 m -98.76 -20.34 16.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.447 1.092 . . . . 70.109999999999999 108.301 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 152.37 -125.88 1.91 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.512 1.132 . . . . 73.319999999999993 110.944 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -84.54 144.56 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 62.240000000000002 109.993 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.51 146.2 2.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 70.150000000000006 109.3 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.26 152.45 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.45 1.094 . . . . 73.019999999999996 109.997 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.795 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.4 p -97.23 111.84 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 71.310000000000002 109.303 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.4 t -69.0 -46.95 66.72 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 64.230000000000004 110.007 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 200' ' ' VAL . 5.0 m -158.71 -175.04 5.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 71.450000000000003 110.013 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -166.5 157.25 12.48 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 71.430000000000007 110.977 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -160.34 153.24 21.39 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.549999999999997 109.325 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -110.84 160.69 16.52 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.442 1.089 . . . . 52.140000000000001 109.325 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.42 177.64 9.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 70.340000000000003 110.402 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.29 171.41 3.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 75.049999999999997 109.292 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -84.95 -4.53 86.99 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.553 1.158 . . . . 71.540000000000006 110.951 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 -44.5 7.73 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.499 0.764 . . . . 73.310000000000002 109.326 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 273' ' ' ALA . 87.7 t -43.64 101.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 60.229999999999997 109.28 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.516 ' HH ' ' HE1' ' A' ' 178' ' ' TYR . 57.4 t80 -62.32 -39.23 92.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.547 1.154 . . . . 75.140000000000001 110.979 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -149.48 150.54 32.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 63.43 110.984 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.527 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 74.1 ttt-85 -116.05 147.59 41.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.519999999999996 110.288 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 153.4 47.29 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.126 . . . . 62.340000000000003 109.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 0.06 9.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.487 1.783 . . . . 53.299999999999997 110.999 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 1.7 p -104.12 4.58 34.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 43.229999999999997 109.989 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 81.2 41.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 45.030000000000001 109.324 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.9 t -121.51 128.72 52.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 64.430000000000007 110.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.438 ' HB3' HG13 ' A' ' 276' ' ' VAL . 15.4 m-30 -110.04 155.87 21.27 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.128 . . . . 74.439999999999998 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.23 176.95 4.86 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 73.340000000000003 109.315 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.622 ' H ' HD13 ' A' ' 286' ' ' LEU . 95.7 m-85 -162.67 115.62 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 71.099999999999994 110.943 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.3 94.97 4.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 61.200000000000003 109.315 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . 0.421 ' O ' HD22 ' A' ' 291' ' ' LEU . 3.0 m-80 -83.19 -39.13 21.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 73.299999999999997 109.313 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.506 ' HB3' HD11 ' A' ' 292' ' ' ILE . 28.5 m-20 -90.64 9.95 27.66 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 74.120000000000005 109.296 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.517 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.11 46.3 1.83 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.546 1.154 . . . . 53.140000000000001 109.304 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 290' ' ' ASN . 46.3 mm -77.15 -33.95 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 62.340000000000003 109.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.724 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.5 t-20 -94.7 -15.25 24.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 63.240000000000002 109.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.448 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 24.1 m -87.66 -65.49 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 63.450000000000003 110.404 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.415 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 63.3 m-20 -57.95 -22.78 50.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 72.230000000000004 109.3 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 12.5 t -75.91 -65.67 0.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 61.240000000000002 108.308 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 293' ' ' ASN . 41.6 t -40.27 -40.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 74.450000000000003 109.271 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.93 -57.72 5.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 70.340000000000003 109.261 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -56.19 -17.85 8.54 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.488 1.118 . . . . 71.129999999999995 110.398 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -76.93 -42.94 37.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 75.099999999999994 109.329 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.8 m-30 -105.75 40.33 1.59 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 62.140000000000001 111.002 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -67.71 -55.79 11.8 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.542 1.151 . . . . 74.209999999999994 110.015 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.796 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -81.12 -18.32 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.119 . . . . 73.120000000000005 109.299 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.78 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 13.5 mt -55.78 134.03 51.4 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.492 1.12 . . . . 72.420000000000002 109.274 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 74.5 p -148.61 154.33 39.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 72.109999999999999 110.007 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.28 -146.41 29.04 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.463 1.102 . . . . 73.099999999999994 110.997 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 12.5 m -108.93 12.99 25.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.301 -0.999 . . . . 64.540000000000006 108.301 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.525 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.9 OUTLIER -129.8 149.24 72.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 51.420000000000002 109.988 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.726 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 147.14 88.55 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.008 -2.497 . . . . 74.420000000000002 110.994 0.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.489 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.0 OUTLIER -129.07 133.64 25.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 73.409999999999997 110.007 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.04 -169.52 7.44 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.978 -2.509 . . . . 64.540000000000006 110.942 0.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.553 ' HB2' ' OD1' ' A' ' 175' ' ' ASP . . . -56.9 151.76 31.33 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.44 1.088 . . . . 61.100000000000001 109.295 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.494 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.491 1.785 . . . . 72.430000000000007 110.95 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.75 135.01 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 43.030000000000001 109.262 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 19.7 m -123.57 24.3 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.137 . . . . 73.329999999999998 109.309 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . 0.429 ' C ' ' N ' ' A' ' 318' ' ' CYS . 3.5 t -53.69 -42.12 67.62 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.093 . . . . 70.420000000000002 110.005 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 16.0 m -41.89 -28.26 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 63.530000000000001 110.066 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.429 ' N ' ' C ' ' A' ' 316' ' ' SER . 75.4 m . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.551 1.157 . . . . 73.530000000000001 108.333 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 136' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.833 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -166.73 112.26 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.477 1.111 . . . . 65.109999999999999 109.311 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.464 ' CA ' ' OD2' ' A' ' 194' ' ' ASP . 0.5 OUTLIER -83.41 4.03 29.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 109.974 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.4 151.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 64.439999999999998 109.286 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -104.85 145.0 29.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.430000000000007 109.296 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.97 -35.18 3.33 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.493 1.786 . . . . 61.009999999999998 111.014 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.413 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.88 150.06 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 73.409999999999997 109.333 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.511 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -46.06 -37.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 72.319999999999993 109.291 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.23 -49.32 2.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 63.219999999999999 109.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.653 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.45 1.094 . . . . 63.329999999999998 110.421 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.78 -57.45 12.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 74.329999999999998 109.241 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.5 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.1 m-80 -52.95 -30.41 34.53 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.47 1.106 . . . . 62.409999999999997 109.337 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.74 -56.77 7.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.572 1.17 . . . . 54.340000000000003 110.038 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.042 HD12 HD11 ' A' ' 140' ' ' ILE . 79.2 mt -43.11 -43.03 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 75.420000000000002 109.31 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.605 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.69 -45.1 62.92 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 74.439999999999998 110.959 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -46.05 -36.92 6.13 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 1.11 . . . . 72.109999999999999 109.3 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.467 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 62.5 mt-30 -76.41 -55.79 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 74.439999999999998 110.284 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 188' ' ' LEU . 19.9 mt -49.46 -27.46 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 55.439999999999998 109.296 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -37.34 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.503 1.127 . . . . 64.010000000000005 109.306 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -56.21 -19.33 13.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 73.109999999999999 109.324 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.515 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 12.0 mm-40 -80.82 -28.01 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.454 1.096 . . . . 72.120000000000005 110.292 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.4 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 21.5 m -39.85 123.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 61.119999999999997 109.998 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.1 m -53.24 116.22 2.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.482 1.114 . . . . 73.420000000000002 108.303 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 142.03 -14.06 2.6 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.484 1.115 . . . . 23.32 111.011 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.743 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 59.0 p -97.71 161.86 13.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 0.75 . . . . 72.400000000000006 110.404 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -93.4 -2.35 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 63.409999999999997 109.967 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 162' ' ' THR . 2.2 m -112.03 0.1 15.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 75.430000000000007 110.397 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.743 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -75.57 134.09 40.79 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.51 1.131 . . . . 75.109999999999999 109.285 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -169.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.55 1.157 . . . . 73.200000000000003 110.029 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.451 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 44.0 p -154.75 127.53 4.11 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 64.319999999999993 110.026 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.08 137.14 48.56 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 121.019 -2.492 . . . . 65.019999999999996 110.981 0.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.472 ' O ' HD13 ' A' ' 298' ' ' LEU . 9.5 p -72.95 -178.91 2.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 64.120000000000005 108.278 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.845 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.0 mp -84.5 128.16 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 54.32 109.308 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 p -92.54 76.27 5.08 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.562 1.164 . . . . 71.140000000000001 110.399 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 51.2 p90 -78.76 -14.17 59.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 72.420000000000002 110.979 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.46 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -73.74 -3.03 25.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 74.129999999999995 110.296 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.776 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -131.84 66.7 78.43 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 74.340000000000003 111.018 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.547 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.2 Cg_endo -74.98 118.46 5.28 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.518 1.799 . . . . 73.219999999999999 111.015 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 172' ' ' TYR . 19.0 t -152.84 -64.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 54.100000000000001 109.326 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -132.3 -46.68 0.91 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 62.310000000000002 109.273 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -45.43 104.15 0.06 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.472 1.107 . . . . 51.43 110.996 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.493 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 3.5 p -138.65 -48.43 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.243 -1.021 . . . . 31.329999999999998 108.243 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -68.5 -16.22 63.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 74.450000000000003 110.985 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.93 -68.31 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 62.039999999999999 109.318 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HB3' HG23 ' A' ' 168' ' ' ILE . 7.2 ptm180 -50.92 -49.03 60.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.12 . . . . 75.25 110.297 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB1' ' HZ3' ' A' ' 197' ' ' LYS . . . -39.58 -56.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 71.319999999999993 109.292 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.549 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -47.1 -44.56 21.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.117 . . . . 63.520000000000003 109.601 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.845 ' CB ' HD11 ' A' ' 168' ' ' ILE . 22.9 mmmt -64.36 -42.25 96.3 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 73.549999999999997 109.328 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.516 ' HA ' HG23 ' A' ' 153' ' ' ILE . 17.4 mtm -55.5 -33.2 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 65.420000000000002 111.003 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -21.33 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 65.340000000000003 110.319 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.436 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.9 OUTLIER -71.73 -39.66 69.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.509 1.131 . . . . 74.219999999999999 110.304 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.467 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 19.0 mm -74.14 -32.48 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 63.439999999999998 109.294 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.867 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -61.65 -44.46 96.94 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.454 1.096 . . . . 74.030000000000001 109.324 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.6 mtp -58.51 -42.18 87.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 60.200000000000003 111.006 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -50.38 -53.53 28.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.461 1.1 . . . . 64.120000000000005 109.303 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.443 ' ND2' HE22 ' A' ' 152' ' ' GLN . 7.1 t-20 -60.55 -29.55 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 73.010000000000005 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.71 37.33 2.6 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.517 1.136 . . . . 71.010000000000005 110.99 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.833 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 73.7 m-85 -138.04 129.05 27.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 0.791 . . . . 62.520000000000003 110.988 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.464 ' OD2' ' CA ' ' A' ' 138' ' ' SER . 0.7 OUTLIER -99.27 132.51 44.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 51.240000000000002 109.293 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.695 ' HB3' HD22 ' A' ' 188' ' ' LEU . 25.9 p -112.17 -179.45 3.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 71.129999999999995 108.258 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -122.45 176.02 6.13 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.126 . . . . 62.240000000000002 110.285 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.637 ' HE2' HG22 ' A' ' 221' ' ' ILE . 22.0 mmtt -107.67 174.41 5.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 51.219999999999999 109.317 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.703 ' O ' HG23 ' A' ' 219' ' ' VAL . 17.1 tt0 -160.59 139.17 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.541 1.151 . . . . 74.230000000000004 110.263 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -130.27 113.49 14.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 74.430000000000007 110.994 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.667 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.2 p -110.15 148.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 74.230000000000004 109.32 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.1 m-85 -121.6 160.44 24.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.478 1.111 . . . . 74.340000000000003 111.0 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.44 179.88 17.01 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.551 1.157 . . . . 64.25 111.015 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.728 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.3 t-20 -69.23 110.27 4.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.491 0.759 . . . . 62.530000000000001 109.324 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -114.56 93.49 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 74.450000000000003 109.296 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.8 mttp -93.27 165.35 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 73.0 109.303 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -168.53 143.07 3.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 65.120000000000005 109.318 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 61.140000000000001 110.015 -180.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 108.329 -0.989 . . . . 62.520000000000003 108.329 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -112.36 155.53 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 62.25 109.247 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.52 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -139.4 119.07 13.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 73.25 109.282 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.33 134.79 51.01 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.155 . . . . 75.150000000000006 108.02 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.1 m -80.45 3.78 20.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.458 1.099 . . . . 72.219999999999999 109.994 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.496 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.8 p90 -176.14 127.75 0.21 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.477 1.111 . . . . 55.240000000000002 111.027 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -116.54 168.45 10.16 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.478 1.111 . . . . 62.439999999999998 109.619 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 198' ' ' GLN . 1.3 p -145.57 143.38 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.49 1.119 . . . . 53.219999999999999 109.312 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.563 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -142.19 -165.68 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 45.229999999999997 109.294 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.637 HG22 ' HE2' ' A' ' 197' ' ' LYS . 31.1 pt -116.09 122.5 69.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 73.200000000000003 109.296 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 234' ' ' LYS . 19.9 tp -87.1 108.87 19.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 52.530000000000001 109.312 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.701 HG11 HG13 ' A' ' 237' ' ' ILE . 0.9 OUTLIER -102.0 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 65.140000000000001 109.3 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ILE . 54.8 m -135.75 120.14 17.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.494 1.121 . . . . 64.519999999999996 109.993 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.511 ' CD2' HG23 ' A' ' 143' ' ' VAL . 34.3 p90 -136.15 142.37 44.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.120000000000005 111.03 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.2 mmtp -68.21 132.84 47.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.504 1.128 . . . . 75.349999999999994 109.286 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -73.73 -160.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 53.439999999999998 109.321 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 0.09 48.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.481 1.113 . . . . 71.430000000000007 109.312 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -115.36 -7.19 12.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 73.329999999999998 110.02 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.54 37.66 8.67 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.473 1.108 . . . . 44.350000000000001 110.975 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 137.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.455 0.738 . . . . 74.430000000000007 109.323 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 8.6 m -71.47 102.58 2.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.049999999999997 110.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 224' ' ' SER . 1.8 mm-40 -101.39 -172.47 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 74.310000000000002 110.297 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.511 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -127.52 145.3 50.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 75.5 109.286 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.55 ' NH1' HG22 ' A' ' 248' ' ' THR . 4.3 tpt180 -142.68 161.14 38.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 74.549999999999997 110.284 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.697 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.4 mm -113.7 117.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.52 1.138 . . . . 54.119999999999997 109.318 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -105.08 45.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 64.329999999999998 109.314 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.9 106.54 53.31 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 62.109999999999999 109.309 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -75.01 -10.02 21.01 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 74.409999999999997 111.003 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.7 t -64.5 -11.85 38.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 61.329999999999998 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.472 HD11 ' NE2' ' A' ' 218' ' ' HIS . 5.2 mt -127.55 -48.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 73.140000000000001 109.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' A' ' 255' ' ' ALA . 75.9 m-85 -118.54 99.54 6.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.576 1.172 . . . . 74.200000000000003 111.017 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 75.6 m -88.14 -6.44 57.88 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.547 1.154 . . . . 74.329999999999998 109.982 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.1 m -80.95 -45.77 16.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 74.540000000000006 110.012 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.05 -174.23 43.29 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.495 1.122 . . . . 54.399999999999999 110.987 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.45 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 164.42 33.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.485 1.781 . . . . 63.32 111.021 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.577 HG21 ' CE2' ' A' ' 242' ' ' PHE . 2.6 m -150.46 161.23 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.113 . . . . 72.219999999999999 109.32 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.55 HG22 ' NH1' ' A' ' 235' ' ' ARG . 34.3 p -64.51 138.21 58.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.523 1.139 . . . . 71.010000000000005 110.41 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.409 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 0.4 OUTLIER -40.92 -29.79 0.11 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.51 1.131 . . . . 55.130000000000003 109.307 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 6.3 m -71.85 -64.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 64.5 110.384 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.37 -25.55 10.08 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.504 1.127 . . . . 74.230000000000004 109.314 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.697 ' CD1' HG21 ' A' ' 236' ' ' ILE . 9.2 t90 -64.36 -59.91 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.995 -1.113 . . . . 72.230000000000004 107.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.544 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.26 -41.9 39.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 63.25 110.281 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.852 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -56.56 -50.75 70.97 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.499 1.124 . . . . 74.5 109.275 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.596 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -55.94 -20.99 18.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 40.119999999999997 109.32 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.16 -36.2 16.97 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 72.319999999999993 108.262 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.852 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -93.36 21.59 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 44.420000000000002 109.271 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -51.06 107.1 0.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 73.310000000000002 109.329 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.2 p -73.49 -3.06 25.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 63.210000000000001 110.385 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.3 t -44.3 -30.84 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.505 1.128 . . . . 62.049999999999997 109.97 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.59 -37.35 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 71.219999999999999 108.347 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.72 -128.06 1.66 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.546 1.154 . . . . 23.300000000000001 110.993 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.02 145.35 42.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.477 0.751 . . . . 62.329999999999998 109.983 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.02 148.03 4.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.46 1.1 . . . . 62.020000000000003 109.314 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 29.3 m -172.77 155.23 3.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 44.229999999999997 110.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.667 HG23 ' CG2' ' A' ' 200' ' ' VAL . 4.9 p -102.65 116.54 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.467 1.104 . . . . 41.310000000000002 109.283 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 32.0 t -70.76 -44.89 65.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.505 1.128 . . . . 65.030000000000001 109.951 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 200' ' ' VAL . 50.7 p -165.43 -173.52 2.83 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.151 . . . . 74.230000000000004 110.006 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -165.4 156.53 14.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 63.219999999999999 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.04 147.84 23.05 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.53 1.144 . . . . 75.120000000000005 109.286 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.63 158.93 15.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 65.019999999999996 109.31 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 1.3 p -146.44 179.14 7.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.517 1.135 . . . . 71.530000000000001 110.386 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -74.57 163.36 27.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 64.530000000000001 109.324 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.47 -16.41 80.01 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.492 1.12 . . . . 74.219999999999999 111.008 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 276' ' ' VAL . 7.5 p30 -86.29 -43.61 12.78 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 0.782 . . . . 63.420000000000002 109.342 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.445 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 3.8 t -43.71 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.571 1.169 . . . . 64.230000000000004 109.285 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -66.95 -42.8 84.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 52.549999999999997 111.022 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.6 OUTLIER -153.21 121.02 6.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 64.219999999999999 111.029 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.469 ' HD2' ' CG2' ' A' ' 272' ' ' THR . 40.8 ttt-85 -106.57 137.19 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.515 1.134 . . . . 73.030000000000001 110.334 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.92 158.17 32.62 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 73.040000000000006 110.007 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.47 8.88 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.467 1.772 . . . . 72.409999999999997 110.974 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 27.9 t -98.18 13.19 32.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.542 1.152 . . . . 72.230000000000004 109.99 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 74.87 37.19 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 55.5 109.338 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -112.3 152.94 27.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 64.230000000000004 109.951 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.457 ' CE1' ' HD2' ' A' ' 279' ' ' ARG . 51.9 m-85 -140.54 158.2 44.35 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 73.109999999999999 111.022 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -126.08 172.95 9.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.498 1.123 . . . . 74.299999999999997 109.281 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.473 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 88.1 m-85 -160.23 114.95 2.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 1.099 . . . . 64.329999999999998 111.001 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.426 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 8.0 t0 -115.5 97.04 5.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 64.140000000000001 109.273 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . 0.434 ' O ' HD22 ' A' ' 291' ' ' LEU . 6.8 m-20 -85.83 -39.42 17.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 65.25 109.298 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.476 ' CB ' HG12 ' A' ' 292' ' ' ILE . 4.3 m120 -90.52 9.54 28.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 72.510000000000005 109.325 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.549 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.06 46.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 1.125 . . . . 65.049999999999997 109.305 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.476 HG12 ' CB ' ' A' ' 290' ' ' ASN . 48.9 mm -77.28 -28.77 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 73.549999999999997 109.298 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.831 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.7 t-20 -94.54 -22.53 18.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.420000000000002 109.312 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 m -84.52 -64.18 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.478 1.111 . . . . 53.32 110.395 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 82.5 m-20 -57.47 -17.94 15.97 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.119 . . . . 74.019999999999996 109.308 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 7.2 t -81.88 -63.95 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 55.240000000000002 108.303 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 293' ' ' ASN . 46.2 t -40.38 -51.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.545 1.153 . . . . 75.439999999999998 109.27 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 167' ' ' CYS . 47.0 mt -57.14 -59.48 5.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 64.310000000000002 109.296 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.22 -34.71 2.92 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.140000000000001 110.378 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -68.06 -43.31 78.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 73.109999999999999 109.259 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.738 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.5 m-30 -99.5 35.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 73.25 111.006 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.2 t -69.41 -43.36 73.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 64.109999999999999 110.029 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.45 -12.78 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.430000000000007 109.315 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.776 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 12.6 mt -60.39 150.28 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 74.209999999999994 109.295 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.6 p -161.48 162.92 30.61 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 54.299999999999997 109.984 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.68 -152.82 52.78 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.519 1.137 . . . . 74.040000000000006 111.018 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 2.1 m -101.64 13.12 35.88 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.292 -1.003 . . . . 64.450000000000003 108.292 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.522 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 12.9 p -129.49 150.01 74.45 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.150000000000006 110.009 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.705 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.6 Cg_endo -74.95 147.12 88.51 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.967 -2.514 . . . . 75.540000000000006 111.056 -0.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.465 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -128.71 133.69 25.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.531 1.145 . . . . 74.109999999999999 109.992 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -74.96 -170.27 8.1 Favored 'Cis proline' 0 C--N 1.36 1.168 0 C-N-CA 120.97 -2.512 . . . . 55.109999999999999 111.033 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 152.34 29.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 71.129999999999995 109.29 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.414 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.512 1.796 . . . . 73.439999999999998 110.996 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -91.4 135.31 33.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.148 . . . . 71.219999999999999 109.254 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.7 m -126.59 24.5 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.489 1.118 . . . . 73.129999999999995 109.276 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 318' ' ' CYS . 35.6 t -50.73 -44.12 58.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.349999999999994 109.952 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.6 m -39.51 -29.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 71.25 110.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 316' ' ' SER . 74.6 m . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.434 1.084 . . . . 64.030000000000001 108.304 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.718 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.327 -0.62 . . . . 72.329999999999998 109.327 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.811 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.04 106.7 3.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.533 1.145 . . . . 54.119999999999997 109.327 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m -81.82 5.65 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.329999999999998 109.99 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.3 t -149.35 145.62 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 70.140000000000001 109.302 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.107 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -96.88 142.44 24.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.488 1.117 . . . . 62.549999999999997 109.27 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -32.44 5.42 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.464 1.77 . . . . 63.109999999999999 110.99 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.485 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.49 153.22 22.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.105 . . . . 73.129999999999995 109.3 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.512 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.8 t -51.08 -34.31 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.158 . . . . 74.109999999999999 109.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.84 -45.86 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 74.049999999999997 109.32 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.721 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.6 m -73.21 -32.38 64.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 64.239999999999995 110.415 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -61.84 -56.23 21.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 73.319999999999993 109.295 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.512 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 51.6 m-80 -53.62 -31.37 46.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 71.040000000000006 109.288 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.39 -55.22 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 73.319999999999993 109.987 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.107 HD12 HD11 ' A' ' 140' ' ' ILE . 92.1 mt -44.4 -42.41 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 72.010000000000005 109.302 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.654 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -72.35 -44.7 62.22 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 1.117 . . . . 75.129999999999995 110.994 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -47.04 -37.32 9.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 70.450000000000003 109.262 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.465 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 60.0 mt-30 -74.94 -55.57 5.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 1.139 . . . . 62.299999999999997 110.293 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.699 HD11 HD12 ' A' ' 188' ' ' LEU . 23.4 mt -50.45 -28.0 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 54.0 109.308 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.406 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -75.07 -33.71 61.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 62.140000000000001 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.3 t-20 -61.59 -15.15 36.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 70.010000000000005 109.294 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -85.81 -18.47 32.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 71.209999999999994 110.302 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.0 p -37.93 134.51 0.75 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 1.13 . . . . 54.350000000000001 109.977 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.676 ' HB3' HH21 ' A' ' 171' ' ' ARG . 1.3 m -66.18 120.04 12.53 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 60.329999999999998 108.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 127.69 -15.82 6.26 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 51.439999999999998 110.99 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.867 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 69.6 p -83.39 161.9 21.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 0.758 . . . . 72.310000000000002 110.387 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -93.55 0.12 56.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.467 1.104 . . . . 74.5 109.963 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 162' ' ' THR . 2.9 m -119.45 7.15 11.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 50.119999999999997 110.355 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.867 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -81.31 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 62.119999999999997 109.308 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -162.03 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 54.409999999999997 110.014 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 126.92 3.5 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 70.430000000000007 110.039 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 139.85 64.05 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.948 -2.522 . . . . 74.409999999999997 110.998 0.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.99 178.46 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.1 . . . . 75.540000000000006 108.333 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.949 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.0 mp -86.32 132.95 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 70.209999999999994 109.268 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 301' ' ' PHE . 51.0 p -90.43 75.24 6.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 60.439999999999998 110.403 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -81.64 -24.79 36.13 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 62.409999999999997 111.027 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.676 HH21 ' HB3' ' A' ' 158' ' ' CYS . 0.0 OUTLIER -75.97 -1.57 26.28 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 73.450000000000003 110.3 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.796 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 25.6 t80 -128.91 67.44 77.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.092 . . . . 61.240000000000002 111.012 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.415 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.55 4.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.51 1.795 . . . . 50.240000000000002 111.013 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.585 HG21 ' CE1' ' A' ' 172' ' ' TYR . 14.6 t -152.23 -58.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 74.329999999999998 109.292 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -138.43 -47.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 52.43 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.19 106.46 0.05 OUTLIER Glycine 0 CA--C 1.529 0.938 0 O-C-N 124.526 1.141 . . . . 61.450000000000003 111.044 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.786 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.6 p -143.06 -48.41 0.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.307 -0.997 . . . . 52.049999999999997 108.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.604 ' HB3' HG11 ' A' ' 219' ' ' VAL . 24.3 p90 -69.99 -33.9 72.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.461 1.101 . . . . 74.129999999999995 111.062 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.492 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -62.57 -68.42 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 72.140000000000001 109.264 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.669 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -46.38 -44.5 17.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 55.100000000000001 110.32 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.71 -55.47 5.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.466 1.104 . . . . 51.329999999999998 109.267 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.88 -35.83 15.66 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 72.340000000000003 109.635 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.949 ' CB ' HD11 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -71.47 -50.55 30.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 75.420000000000002 109.286 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.555 ' HA ' HG23 ' A' ' 153' ' ' ILE . 5.3 mtm -51.84 -41.2 61.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 62.100000000000001 111.01 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.96 -24.47 58.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 63.530000000000001 110.305 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.425 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -69.48 -41.56 75.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.515 1.135 . . . . 72.239999999999995 110.305 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 20.8 mm -72.02 -33.0 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.488 1.118 . . . . 74.430000000000007 109.274 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -59.56 -47.36 85.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 1.097 . . . . 75.219999999999999 109.332 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.482 ' HG2' HD21 ' A' ' 136' ' ' LEU . 2.4 mtt -54.9 -44.35 74.05 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 73.150000000000006 111.001 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.0 -53.33 20.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 74.329999999999998 109.312 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -58.46 -32.88 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 75.450000000000003 109.308 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 108.78 43.86 1.18 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.53 1.144 . . . . 62.310000000000002 110.973 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.811 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 68.6 m-85 -144.79 133.31 22.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.48 0.753 . . . . 73.319999999999993 111.03 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.718 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.5 OUTLIER -99.71 130.07 45.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 75.409999999999997 109.31 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.791 ' HB3' HD22 ' A' ' 188' ' ' LEU . 28.5 p -112.25 -179.44 3.68 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 1.153 . . . . 72.239999999999995 108.307 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -125.87 177.41 6.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 64.209999999999994 110.286 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.654 ' HE2' HG22 ' A' ' 221' ' ' ILE . 16.5 mmtt -108.87 164.27 12.54 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 64.150000000000006 109.292 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.486 ' OE1' HD13 ' A' ' 222' ' ' LEU . 30.5 tt0 -151.5 117.49 5.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.446 1.091 . . . . 73.409999999999997 110.277 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 219' ' ' VAL . 3.9 m-85 -108.65 129.74 55.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 63.299999999999997 111.056 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.795 HG23 ' HB3' ' A' ' 269' ' ' TYR . 6.3 p -128.49 131.63 68.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 64.230000000000004 109.289 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.4 m-85 -108.01 159.51 16.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.517 1.135 . . . . 71.150000000000006 111.053 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 123.48 -173.19 16.38 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.469 1.105 . . . . 51.509999999999998 110.978 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.752 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.5 t-20 -76.3 108.19 9.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 65.319999999999993 109.321 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.752 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.4 mt -111.13 95.09 5.32 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.118 . . . . 72.239999999999995 109.305 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 264' ' ' ALA . 0.2 OUTLIER -92.21 158.35 16.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 73.540000000000006 109.294 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.493 ' O ' HG22 ' A' ' 213' ' ' VAL . . . -179.12 162.63 1.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.13 . . . . 73.319999999999993 109.318 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.140000000000001 110.013 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.455 ' O ' HG13 ' A' ' 213' ' ' VAL . 19.1 m . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 108.294 -1.002 . . . . 65.530000000000001 108.294 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 206' ' ' ALA . 2.4 m -153.03 129.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.538 1.149 . . . . 72.519999999999996 109.3 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 205' ' ' LYS . . . -124.42 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.433 1.083 . . . . 73.519999999999996 109.279 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -132.33 134.87 45.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.988 -1.116 . . . . 75.129999999999995 107.988 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 23.8 t -77.36 0.18 23.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 61.509999999999998 110.063 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 4.7 p90 -178.15 136.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 74.219999999999999 110.978 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.519 ' CB ' HD12 ' A' ' 204' ' ' LEU . 77.6 t60 -129.5 143.31 50.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 74.439999999999998 109.61 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.786 HG12 ' SG ' ' A' ' 177' ' ' CYS . 7.4 p -124.47 134.27 67.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.475 1.11 . . . . 73.109999999999999 109.284 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.552 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.35 -152.1 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 72.540000000000006 109.371 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.654 HG22 ' HE2' ' A' ' 197' ' ' LYS . 13.1 pt -128.72 123.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 63.210000000000001 109.29 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.7 tp -89.78 109.06 20.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 55.229999999999997 109.327 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.7 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.04 148.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 61.530000000000001 109.301 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.611 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -117.24 121.63 41.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 30.239999999999998 109.995 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.0 p90 -136.81 144.95 43.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 64.010000000000005 111.009 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.439 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.6 mmtp -70.07 133.78 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 62.229999999999997 109.322 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.46 -159.67 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 64.230000000000004 109.305 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.93 0.07 49.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 74.150000000000006 109.243 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.01 -8.59 12.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.133 . . . . 62.32 110.018 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.41 37.59 8.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.478 1.111 . . . . 51.210000000000001 111.039 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.54 138.21 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.49 0.759 . . . . 71.540000000000006 109.319 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.439 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 23.9 m -71.58 102.67 2.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.152 . . . . 73.140000000000001 110.408 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.0 mm-40 -101.69 -172.61 2.18 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 60.310000000000002 110.257 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.652 ' HB3' HD11 ' A' ' 222' ' ' LEU . 17.9 mmtt -126.66 144.91 50.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 75.329999999999998 109.257 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.651 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.6 tpt180 -143.43 160.57 40.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 72.420000000000002 110.32 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.644 HG21 ' CD1' ' A' ' 252' ' ' TRP . 14.3 mm -116.6 119.15 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 63.420000000000002 109.313 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -103.37 44.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 75.219999999999999 109.284 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -101.26 108.5 55.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.487 1.117 . . . . 63.32 109.283 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -26.9 10.5 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.486 1.782 . . . . 64.310000000000002 110.966 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.3 OUTLIER -45.92 -25.46 0.54 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 73.030000000000001 110.002 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.1 mt -112.97 -60.71 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 73.329999999999998 109.333 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.596 ' CD1' HG11 ' A' ' 247' ' ' VAL . 85.3 m-85 -106.5 99.58 9.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 74.239999999999995 110.969 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 52.8 m -85.67 -13.47 48.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 43.200000000000003 109.992 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.2 m -72.01 -47.85 48.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 72.25 109.944 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.75 -170.97 39.91 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.523 1.14 . . . . 52.340000000000003 111.0 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.448 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -74.99 163.84 34.57 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.495 1.787 . . . . 71.430000000000007 111.007 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.596 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.1 m -147.81 162.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 74.030000000000001 109.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.453 HG22 ' NH1' ' A' ' 235' ' ' ARG . 31.1 p -63.49 139.22 58.75 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.49 1.119 . . . . 73.519999999999996 110.428 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 249' ' ' ASP . 0.2 OUTLIER -42.45 -28.56 0.22 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 64.219999999999999 109.317 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.431 ' N ' ' C ' ' A' ' 248' ' ' THR . 9.1 m -75.93 -62.57 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.127 . . . . 55.109999999999999 110.367 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.07 -28.23 6.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 74.129999999999995 109.311 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 236' ' ' ILE . 10.2 t90 -63.25 -63.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 71.519999999999996 107.989 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.625 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -46.5 -42.24 15.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 62.409999999999997 110.3 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.781 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -56.28 -51.29 68.71 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 63.420000000000002 109.325 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.69 -28.0 53.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.131 . . . . 73.439999999999998 109.276 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.2 m -80.14 -36.89 34.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 71.109999999999999 108.309 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.802 HG11 HG23 ' A' ' 266' ' ' VAL . 2.6 m -95.37 22.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.49 1.119 . . . . 64.219999999999999 109.299 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -50.7 104.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.11 . . . . 74.129999999999995 109.286 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -73.34 -4.22 32.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.507 1.129 . . . . 71.400000000000006 110.408 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.3 t -51.31 -21.69 2.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.474 1.109 . . . . 43.140000000000001 110.004 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . 0.429 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 5.0 m -96.51 -27.3 14.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.541 1.151 . . . . 73.430000000000007 108.297 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 156.51 -128.21 2.15 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.436 1.085 . . . . 73.519999999999996 111.025 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.449 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -78.54 141.24 38.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 0.753 . . . . 75.200000000000003 110.013 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.585 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -171.38 143.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 61.329999999999998 109.316 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.65 161.71 4.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.132 . . . . 71.420000000000002 109.962 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.802 HG23 HG11 ' A' ' 257' ' ' VAL . 17.5 t -103.57 128.23 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 55.310000000000002 109.342 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.9 t -84.77 -39.44 18.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 54.439999999999998 109.991 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.6 m -175.0 144.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 74.099999999999994 109.976 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.795 ' HB3' HG23 ' A' ' 200' ' ' VAL . 44.5 p90 -130.48 160.13 35.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.42 1.075 . . . . 64.409999999999997 111.022 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.96 160.45 41.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.496 1.123 . . . . 74.439999999999998 109.341 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.43 ' C ' HG23 ' A' ' 272' ' ' THR . 1.2 p-10 -122.7 158.04 30.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.557 1.161 . . . . 71.439999999999998 109.283 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 271' ' ' ASN . 56.0 p -151.95 175.46 12.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 75.200000000000003 110.379 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.759 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -55.36 161.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 70.25 109.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.21 -45.38 40.07 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.473 1.108 . . . . 54.100000000000001 110.983 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.51 -37.43 49.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 0.768 . . . . 52.32 109.286 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.759 HG23 ' HB3' ' A' ' 273' ' ' ALA . 43.1 t -45.86 118.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.555 1.159 . . . . 75.409999999999997 109.277 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 6.2 t80 -81.34 -52.09 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 61.119999999999997 110.995 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -135.89 160.08 39.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.14 . . . . 71.040000000000006 111.019 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.514 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.8 ttt-85 -131.11 147.48 52.62 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.437 1.085 . . . . 71.510000000000005 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.92 157.45 52.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.1 . . . . 61.340000000000003 110.0 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 0.31 9.04 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.482 1.78 . . . . 51.420000000000002 111.008 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 11.3 t -99.55 6.21 45.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 72.230000000000004 110.018 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.4 t-20 76.21 34.67 0.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 74.140000000000001 109.271 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -116.49 123.56 47.76 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 54.399999999999999 110.001 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -104.91 157.6 17.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.200000000000003 110.987 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -116.55 171.38 7.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.107 . . . . 61.520000000000003 109.323 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.729 ' H ' HD13 ' A' ' 286' ' ' LEU . 41.5 m-85 -153.83 115.22 4.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.46 1.1 . . . . 72.239999999999995 110.995 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.441 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 3.8 t0 -115.61 97.84 6.37 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.476 1.11 . . . . 65.5 109.305 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -85.66 -26.96 25.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 75.430000000000007 109.298 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -101.74 -1.81 31.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 62.119999999999997 109.268 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 54.78 46.04 25.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 74.450000000000003 109.295 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 16.5 mm -66.69 -42.93 90.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 51.219999999999999 109.27 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.75 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.7 t-20 -90.46 -23.6 20.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 62.539999999999999 109.304 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.589 HG21 HD12 ' A' ' 291' ' ' LEU . 1.2 m -75.6 -64.21 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 72.150000000000006 110.426 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 54.3 m-20 -58.1 -25.56 61.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 72.430000000000007 109.315 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 27.2 t -76.24 -60.52 2.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.481 1.113 . . . . 74.150000000000006 108.305 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.9 t -41.5 -50.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 64.230000000000004 109.298 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.05 -60.02 4.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 70.329999999999998 109.328 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -41.68 -37.9 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.448 1.093 . . . . 74.349999999999994 110.38 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -61.98 -56.67 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 75.109999999999999 109.314 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.569 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 0.4 OUTLIER -93.16 37.64 1.04 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 73.319999999999993 111.035 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -70.81 -43.89 67.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.46 1.1 . . . . 60.219999999999999 110.005 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.657 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.28 -12.12 28.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.488 1.117 . . . . 72.5 109.292 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.816 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.9 mt -61.08 139.45 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.548 1.155 . . . . 72.340000000000003 109.294 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 71.0 p -149.39 147.17 27.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 72.019999999999996 109.966 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 84.02 -162.0 38.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.128 . . . . 52.030000000000001 110.971 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 4.1 p -91.27 3.67 54.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.296 -1.001 . . . . 64.340000000000003 108.296 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 33.9 p -126.09 150.97 71.04 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 71.010000000000005 110.007 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.816 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.96 146.36 86.45 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.024 -2.49 . . . . 73.150000000000006 111.024 -0.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.493 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.1 p -133.77 135.42 24.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 34.140000000000001 110.014 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.01 -173.19 11.89 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.996 -2.502 . . . . 61.119999999999997 111.004 -0.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.07 154.29 20.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.458 1.099 . . . . 41.520000000000003 109.331 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.562 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.1 Cg_endo -75.02 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.489 1.783 . . . . 61.310000000000002 110.994 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -89.75 130.79 35.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.12 . . . . 70.109999999999999 109.269 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.5 m -121.08 27.45 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 62.229999999999997 109.276 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 318' ' ' CYS . 9.3 t -50.46 -44.47 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.117 . . . . 74.150000000000006 110.005 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 316' ' ' SER . 80.0 p -38.96 -30.55 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.485 1.116 . . . . 43.520000000000003 109.973 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 316' ' ' SER . 57.4 m . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 74.340000000000003 108.324 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.301 -0.629 . . . . 54.119999999999997 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.657 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -152.74 109.64 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 54.219999999999999 109.332 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -83.11 7.52 15.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.536 1.147 . . . . 71.150000000000006 110.011 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -147.11 148.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.515 1.134 . . . . 74.120000000000005 109.275 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.109 HD11 HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -101.5 143.75 27.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.230000000000004 109.303 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.94 -34.12 4.15 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.504 1.791 . . . . 74.019999999999996 111.035 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.446 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.37 153.29 25.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 74.140000000000001 109.281 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.502 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -49.94 -36.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 71.219999999999999 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.41 -49.27 2.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 71.340000000000003 109.335 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.677 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -69.42 -36.88 77.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 73.340000000000003 110.38 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.678 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -57.16 -57.37 12.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 74.310000000000002 109.323 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.502 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.5 m-80 -52.48 -29.6 25.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 73.310000000000002 109.329 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.27 -56.13 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 70.319999999999993 110.025 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.109 HD12 HD11 ' A' ' 140' ' ' ILE . 76.1 mt -42.07 -41.93 2.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 71.140000000000001 109.329 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.612 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.45 -45.13 60.97 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 75.209999999999994 110.99 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.41 -36.0 9.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 63.240000000000002 109.289 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.448 ' NE2' ' OD1' ' A' ' 191' ' ' ASN . 65.0 mt-30 -76.13 -55.49 5.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.481 HD11 HD12 ' A' ' 188' ' ' LEU . 15.7 mt -50.14 -26.87 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -34.56 58.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 63.030000000000001 109.288 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -62.33 -14.6 41.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 109.259 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -86.44 -17.07 35.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 74.420000000000002 110.297 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.1 p -38.71 122.97 1.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 71.450000000000003 109.937 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 131.12 42.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 61.43 108.256 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.46 -25.1 9.36 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.509 1.131 . . . . 74.030000000000001 110.993 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.815 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 25.3 p -73.52 162.92 28.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 0.753 . . . . 73.340000000000003 110.431 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 -2.45 54.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 62.310000000000002 110.029 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 162' ' ' THR . 7.5 m -116.79 8.76 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.453 1.096 . . . . 75.430000000000007 110.376 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.815 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.81 138.09 34.09 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 62.439999999999998 109.3 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -169.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 73.540000000000006 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.437 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.7 p -153.54 126.78 4.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 71.230000000000004 109.999 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -74.97 137.48 50.6 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 64.219999999999999 111.002 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.7 p -73.09 -179.7 3.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 73.219999999999999 108.322 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.722 HG21 ' CB ' ' A' ' 180' ' ' ARG . 3.7 mp -101.93 137.06 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 63.340000000000003 109.267 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 301' ' ' PHE . 34.1 p -74.37 83.66 1.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 64.099999999999994 110.381 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.524 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 3.1 m-85 -80.1 -1.07 38.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.477 1.11 . . . . 75.340000000000003 110.991 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -118.02 14.93 14.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.200000000000003 110.317 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.712 ' OH ' HD13 ' A' ' 304' ' ' LEU . 18.6 t80 -128.86 67.55 77.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 61.409999999999997 111.041 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.438 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.5 Cg_endo -74.97 113.19 3.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.521 1.801 . . . . 72.510000000000005 111.014 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.55 HG21 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.75 -71.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 72.219999999999999 109.24 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -133.53 -46.51 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 54.409999999999997 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.93 100.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 42.43 110.988 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.742 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.2 p -137.56 -48.53 0.58 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.304 -0.998 . . . . 71.430000000000007 108.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.602 ' HB3' HG11 ' A' ' 219' ' ' VAL . 27.4 p90 -69.92 -25.21 63.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.55 1.156 . . . . 62.130000000000003 111.03 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.35 -65.64 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 65.239999999999995 109.37 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.722 ' CB ' HG21 ' A' ' 168' ' ' ILE . 11.4 ptm180 -45.77 -51.86 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.099 . . . . 73.430000000000007 110.234 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.489 ' HB1' ' HZ3' ' A' ' 197' ' ' LYS . . . -41.37 -63.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 75.439999999999998 109.31 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.6 OUTLIER -40.74 -38.71 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 73.219999999999999 109.583 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.629 ' HB3' HD11 ' A' ' 168' ' ' ILE . 13.3 mmmm -68.47 -59.92 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 71.450000000000003 109.257 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.428 ' SD ' HG21 ' A' ' 153' ' ' ILE . 25.7 mtm -41.4 -30.67 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 62.340000000000003 110.958 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.675 HH21 ' CG ' ' A' ' 275' ' ' ASN . 0.1 OUTLIER -68.25 -47.61 67.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.447 1.092 . . . . 53.219999999999999 110.293 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.473 ' HG3' HD13 ' A' ' 187' ' ' ILE . 0.5 OUTLIER -51.4 -33.52 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 73.319999999999993 110.306 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.473 HD13 ' HG3' ' A' ' 186' ' ' GLN . 16.1 mm -75.7 -34.33 28.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.115 . . . . 63.229999999999997 109.305 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.7 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -60.96 -47.51 86.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 63.340000000000003 109.253 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 136' ' ' LEU . 4.5 mtt -54.93 -44.29 74.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 52.439999999999998 110.996 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -47.25 -52.53 15.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 74.230000000000004 109.297 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.448 ' OD1' ' NE2' ' A' ' 152' ' ' GLN . 0.5 OUTLIER -63.32 -36.36 83.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 54.109999999999999 109.284 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.32 48.71 0.69 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.12 . . . . 63.439999999999998 110.987 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.677 ' CZ ' HG21 ' A' ' 145' ' ' THR . 64.1 m-85 -149.39 137.37 20.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.481 0.754 . . . . 62.25 111.05 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -103.55 130.31 50.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 71.430000000000007 109.333 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.7 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.4 p -107.52 -179.48 3.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 50.32 108.298 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -127.05 172.62 10.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 75.430000000000007 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.646 ' HE2' HG22 ' A' ' 221' ' ' ILE . 15.9 mmtt -104.98 157.29 17.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.438 1.087 . . . . 74.120000000000005 109.321 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 219' ' ' VAL . 20.7 tt0 -146.52 117.76 7.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 65.439999999999998 110.282 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.2 m-85 -108.27 128.22 54.54 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 73.5 110.977 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.879 HG13 HG23 ' A' ' 266' ' ' VAL . 1.5 t -120.52 161.05 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 63.43 109.328 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 2.3 m-85 -138.84 151.22 46.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 74.109999999999999 111.019 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.14 18.24 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.506 1.129 . . . . 61.409999999999997 111.027 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.787 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.6 t-20 -77.33 111.36 12.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 0.76 . . . . 72.530000000000001 109.3 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.0 mt -113.74 94.12 4.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 62.509999999999998 109.299 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.7 ' NZ ' ' HB2' ' A' ' 214' ' ' ALA . 1.2 mtpp -92.89 158.31 15.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 73.349999999999994 109.294 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -164.89 162.75 20.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.209999999999994 109.313 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 C--N 1.326 -0.456 0 O-C-N 124.553 1.158 . . . . 73.030000000000001 110.017 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t . . . . . 0 N--CA 1.454 -0.263 0 N-CA-C 108.283 -1.006 . . . . 70.219999999999999 108.283 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.901 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -145.08 149.01 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 64.519999999999996 109.253 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.7 ' HB2' ' NZ ' ' A' ' 205' ' ' LYS . . . -141.79 120.16 12.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.539 1.15 . . . . 41.119999999999997 109.291 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -125.46 136.8 53.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 73.420000000000002 108.008 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 p -80.78 1.43 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 71.510000000000005 110.007 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 7.9 p90 -178.17 130.8 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 51.229999999999997 111.022 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.504 ' CB ' HD12 ' A' ' 204' ' ' LEU . 80.2 t60 -123.83 166.41 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.568 1.168 . . . . 75.239999999999995 109.591 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 198' ' ' GLN . 4.8 p -147.94 143.24 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 72.299999999999997 109.264 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.605 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.12 -159.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.452 1.095 . . . . 74.510000000000005 109.348 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.646 HG22 ' HE2' ' A' ' 197' ' ' LYS . 8.2 pt -118.16 125.17 74.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.542 1.151 . . . . 75.140000000000001 109.273 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 234' ' ' LYS . 12.6 tp -89.19 108.97 19.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 62.5 109.333 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.95 147.41 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 72.239999999999995 109.32 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.563 ' HB3' HG22 ' A' ' 139' ' ' VAL . 5.1 m -117.1 121.52 41.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 62.509999999999998 110.02 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.6 p90 -136.45 143.14 43.73 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.471 1.107 . . . . 73.439999999999998 110.992 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.0 mmtp -68.73 132.93 47.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 51.539999999999999 109.268 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.41 -160.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 74.239999999999995 109.349 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.61 0.06 48.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 74.439999999999998 109.278 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.8 m -115.15 -7.95 12.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 64.519999999999996 110.006 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.97 37.68 8.31 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 72.109999999999999 111.005 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.5 138.02 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.511 0.771 . . . . 72.219999999999999 109.316 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.0 m -71.72 102.67 2.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 74.549999999999997 110.38 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.9 mm-40 -101.55 -172.58 2.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.468 1.105 . . . . 75.129999999999995 110.307 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.497 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.9 mmtm -127.29 145.08 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.147 . . . . 74.430000000000007 109.339 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.7 tpt180 -144.19 161.2 39.47 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.329999999999998 110.304 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.64 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.6 mm -116.75 120.43 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.464 1.102 . . . . 73.439999999999998 109.249 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -104.22 44.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 71.319999999999993 109.279 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -100.32 108.88 54.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 43.240000000000002 109.31 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.524 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.2 Cg_endo -75.05 -27.88 9.56 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.506 1.792 . . . . 75.439999999999998 111.019 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.2 t -48.15 -24.2 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 75.140000000000001 110.036 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.11 -57.0 2.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 72.549999999999997 109.277 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.613 ' CE2' HG21 ' A' ' 247' ' ' VAL . 81.7 m-85 -112.46 99.45 7.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.349999999999994 110.996 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.0 m -85.92 -9.1 57.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.094 . . . . 53.439999999999998 110.021 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.3 p -77.36 -46.26 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 71.430000000000007 110.004 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.76 -171.59 41.35 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.501 1.126 . . . . 72.200000000000003 110.958 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.438 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.97 163.35 35.55 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.458 1.767 . . . . 71.319999999999993 111.039 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.613 HG21 ' CE2' ' A' ' 242' ' ' PHE . 3.1 m -147.55 160.01 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.502 1.126 . . . . 74.450000000000003 109.265 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.9 p -61.53 141.37 57.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 72.430000000000007 110.401 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.445 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 8.9 p30 -44.25 -27.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 71.430000000000007 109.302 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 15.8 m -77.53 -61.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.133 . . . . 74.530000000000001 110.427 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.58 -27.62 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 45.020000000000003 109.314 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 236' ' ' ILE . 9.9 t90 -63.66 -63.14 1.26 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.47 1.106 . . . . 71.239999999999995 108.055 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.569 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -47.17 -42.04 19.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 75.239999999999995 110.311 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.814 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.8 m-80 -55.75 -51.57 66.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 74.340000000000003 109.313 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.25 -24.79 29.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.492 1.12 . . . . 71.219999999999999 109.322 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.3 m -83.94 -36.5 23.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.144 . . . . 63.140000000000001 108.304 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.63 22.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 61.539999999999999 109.311 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -49.28 104.85 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.437 1.086 . . . . 74.439999999999998 109.276 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 262' ' ' GLY . 1.8 p -72.33 -4.02 27.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.507 1.13 . . . . 43.109999999999999 110.348 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 t -46.32 -27.0 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 61.149999999999999 109.967 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 1.7 m -92.11 -35.76 13.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 74.120000000000005 108.236 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.15 -126.79 1.68 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.505 1.128 . . . . 64.540000000000006 110.973 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -69.64 142.21 53.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 0.768 . . . . 70.209999999999994 110.002 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.559 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -173.08 140.84 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 70.239999999999995 109.279 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 87.8 p -172.09 156.53 4.04 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.161 . . . . 72.329999999999998 109.991 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.879 HG23 HG13 ' A' ' 200' ' ' VAL . 6.0 p -103.78 111.15 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.502 1.126 . . . . 73.120000000000005 109.3 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 201' ' ' TYR . 16.5 t -61.68 -46.9 87.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 65.040000000000006 110.013 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.6 m -159.58 -174.21 4.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.45 1.094 . . . . 75.010000000000005 110.009 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 200' ' ' VAL . 45.6 p90 -167.0 157.38 11.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.485 1.115 . . . . 75.040000000000006 110.986 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.0 169.44 22.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 61.130000000000003 109.311 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 272' ' ' THR . 1.0 OUTLIER -134.17 160.64 37.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 74.200000000000003 109.253 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.743 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.7 p -158.24 -177.93 6.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 74.019999999999996 110.378 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.79 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -60.97 167.22 3.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 54.32 109.303 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.26 -41.55 10.1 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 110.983 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.675 ' CG ' HH21 ' A' ' 185' ' ' ARG . 0.8 OUTLIER -58.58 -45.2 89.57 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.497 0.763 . . . . 75.439999999999998 109.321 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.79 HG23 ' HB3' ' A' ' 273' ' ' ALA . 91.3 t -43.76 101.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.431 1.082 . . . . 74.109999999999999 109.305 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -52.23 -58.66 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 62.229999999999997 110.99 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.9 t80 -139.06 170.17 16.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.109 . . . . 73.120000000000005 110.986 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.743 ' HD2' HG21 ' A' ' 272' ' ' THR . 66.3 ttt-85 -141.59 147.44 37.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 64.200000000000003 110.315 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.61 157.05 43.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 75.239999999999995 109.998 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -0.26 9.77 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.525 1.802 . . . . 64.540000000000006 111.021 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.408 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.5 p -96.78 9.08 42.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 74.349999999999994 110.011 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.3 t-20 74.98 34.67 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.54 1.15 . . . . 71.209999999999994 109.294 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.2 t -119.72 119.55 34.0 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 70.439999999999998 110.022 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.507 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.3 m-30 -99.59 162.22 13.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.200000000000003 110.99 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.3 mm? -116.97 177.57 4.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.517 1.135 . . . . 74.209999999999994 109.312 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 97.6 m-85 -160.92 115.4 2.1 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 73.25 111.03 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 1.016 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.7 OUTLIER -115.31 94.74 4.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 71.209999999999994 109.271 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 290' ' ' ASN . 0.7 OUTLIER -80.27 -42.04 23.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 74.209999999999994 109.246 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.493 ' N ' ' ND2' ' A' ' 289' ' ' ASN . 11.4 m-20 -95.65 -1.83 49.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 74.209999999999994 109.28 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 1.016 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.0 mm? 52.21 40.34 28.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 64.340000000000003 109.32 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.466 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 16.6 mm -69.8 -25.82 29.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 62.210000000000001 109.264 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.805 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.7 t-20 -92.97 -31.86 14.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 74.400000000000006 109.333 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.443 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 18.0 m -81.42 -66.85 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.515 1.134 . . . . 73.030000000000001 110.408 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.8 m-20 -47.33 -29.37 2.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 109.306 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.5 t -75.23 -52.91 9.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 74.049999999999997 108.328 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 293' ' ' ASN . 4.5 t -46.23 -51.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 70.319999999999993 109.307 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 168' ' ' ILE . 20.9 mt -63.47 -52.69 60.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 75.109999999999999 109.309 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -52.2 -26.54 11.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 74.25 110.395 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -76.1 -35.73 59.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 75.530000000000001 109.306 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.563 ' CE1' ' HD2' ' A' ' 313' ' ' PRO . 3.1 m-30 -101.83 24.88 9.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 72.439999999999998 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 14.5 t -57.24 -59.06 5.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 72.239999999999995 110.014 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.785 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -74.19 -17.53 60.89 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.441 1.088 . . . . 74.329999999999998 109.315 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.712 HD13 ' OH ' ' A' ' 172' ' ' TYR . 14.8 mt -67.89 134.43 50.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 75.5 109.317 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.7 p -160.36 135.35 7.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 75.310000000000002 110.039 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 109.97 -160.57 13.34 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.477 1.111 . . . . 73.030000000000001 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.9 p -95.08 13.5 24.98 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.295 -1.002 . . . . 64.5 108.295 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.6 p -145.91 152.98 49.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 41.549999999999997 110.043 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.638 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -74.99 145.59 84.34 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 121.016 -2.493 . . . . 73.239999999999995 110.975 0.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 99.4 p -130.99 134.87 26.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 71.409999999999997 109.995 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.08 -173.19 11.91 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.974 -2.511 . . . . 40.130000000000003 110.955 0.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.441 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.76 153.26 22.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 65.219999999999999 109.321 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.563 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.02 -162.38 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.449 1.763 . . . . 70.239999999999995 110.99 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -84.52 137.0 33.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 74.409999999999997 109.296 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.57 HG21 HG22 ' A' ' 297' ' ' VAL . 21.3 m -144.6 24.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.105 . . . . 74.129999999999995 109.326 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 318' ' ' CYS . 28.5 t -69.2 -31.87 70.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.510000000000005 109.933 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 26.3 m -44.47 -26.49 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 73.209999999999994 109.971 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 316' ' ' SER . 2.4 m . . . . . 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 62.530000000000001 108.293 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.841 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.3 tp . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.32 -0.622 . . . . 75.209999999999994 109.32 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -105.51 108.78 20.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 73.400000000000006 109.326 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -85.7 10.62 12.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 73.109999999999999 109.969 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -150.38 144.19 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 35.299999999999997 109.286 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.071 HD11 HD12 ' A' ' 149' ' ' LEU . 1.3 mt -96.31 141.77 23.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 71.019999999999996 109.286 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.08 -30.26 7.24 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.467 1.772 . . . . 63.229999999999997 111.015 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.59 152.28 17.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 74.129999999999995 109.26 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.509 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.8 t -50.37 -36.0 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 63.009999999999998 109.277 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.05 -47.69 3.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.112 . . . . 74.439999999999998 109.306 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.611 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -71.1 -36.05 72.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 75.109999999999999 110.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.637 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -58.06 -57.08 14.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.517 1.136 . . . . 75.099999999999994 109.288 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.509 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.4 m-80 -52.28 -31.36 32.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 62.520000000000003 109.281 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.92 -55.03 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 72.319999999999993 109.978 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.071 HD12 HD11 ' A' ' 140' ' ' ILE . 96.2 mt -45.44 -41.88 9.82 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 74.209999999999994 109.304 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.672 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -73.54 -43.8 59.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 111.034 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -47.99 -36.4 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 71.010000000000005 109.309 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.489 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 61.6 mt-30 -76.4 -56.07 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 71.109999999999999 110.321 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 21.6 mt -49.01 -29.41 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 75.25 109.307 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 -37.28 67.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.524 1.14 . . . . 63.409999999999997 109.278 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.9 t-20 -58.26 -17.52 20.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 74.409999999999997 109.321 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.471 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 21.5 mm-40 -82.18 -25.3 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.104 . . . . 74.120000000000005 110.268 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.528 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 15.5 m -42.14 120.86 1.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 71.230000000000004 109.979 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -45.85 131.56 9.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.538 1.149 . . . . 65.150000000000006 108.288 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.41 -15.47 9.24 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.542 1.152 . . . . 72.439999999999998 111.017 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.875 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 14.5 p -89.3 161.15 16.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.426 0.721 . . . . 75.150000000000006 110.381 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.0 m -93.46 -2.03 54.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 62.130000000000003 110.031 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 162' ' ' THR . 1.8 m -118.58 8.6 12.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 73.209999999999994 110.381 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.875 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -81.68 135.78 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.512 1.133 . . . . 54.32 109.303 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -169.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.47 1.106 . . . . 60.229999999999997 110.024 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 54.1 p -153.62 127.05 4.25 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.420000000000002 109.978 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.05 137.88 52.86 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.038 -2.484 . . . . 74.109999999999999 110.969 0.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.0 p -72.94 -178.63 2.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 43.119999999999997 108.315 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.728 HD11 ' HB2' ' A' ' 183' ' ' LYS . 3.6 mp -86.93 130.76 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.310000000000002 109.306 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.1 p -95.85 76.11 3.16 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 74.319999999999993 110.432 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 53.8 p90 -76.88 -16.18 59.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.135 . . . . 74.540000000000006 110.994 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -73.46 -3.38 27.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 1.133 . . . . 75.439999999999998 110.309 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.613 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -130.96 66.14 78.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 111.01 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.61 4.34 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.489 1.783 . . . . 73.010000000000005 111.024 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.558 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.8 t -152.04 -60.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 62.439999999999998 109.299 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.1 -46.79 0.93 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.491 1.12 . . . . 73.150000000000006 109.277 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -49.15 98.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.545 1.153 . . . . 75.120000000000005 111.011 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.611 ' SG ' HG12 ' A' ' 219' ' ' VAL . 2.5 p -130.09 -46.89 1.11 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.287 -1.005 . . . . 53.399999999999999 108.287 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 31.4 p90 -73.8 -44.2 56.59 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 75.219999999999999 110.992 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.91 -68.48 0.18 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.13 . . . . 44.420000000000002 109.293 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.574 ' HB3' HG23 ' A' ' 168' ' ' ILE . 8.8 ptm180 -48.89 -48.71 42.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.436 1.085 . . . . 74.329999999999998 110.251 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -42.68 -45.93 4.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.462 1.101 . . . . 74.200000000000003 109.307 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -56.98 -41.93 79.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 75.310000000000002 109.617 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.728 ' HB2' HD11 ' A' ' 168' ' ' ILE . 15.8 mmmt -71.05 -30.22 66.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.122 . . . . 71.0 109.295 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.489 ' HE3' ' HA ' ' A' ' 181' ' ' ALA . 21.7 mtm -66.18 -60.4 2.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 73.230000000000004 111.012 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -51.24 -26.88 7.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 72.239999999999995 110.279 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.427 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 1.1 tt0 -64.54 -44.28 91.31 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.55 1.156 . . . . 74.549999999999997 110.275 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 190' ' ' ASN . 23.8 mm -66.1 -52.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 72.400000000000006 109.324 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.845 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.3 OUTLIER -40.88 -39.83 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 72.209999999999994 109.31 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.574 ' HG2' HD21 ' A' ' 136' ' ' LEU . 20.3 mtp -66.62 -45.63 78.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 73.540000000000006 110.976 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 187' ' ' ILE . 0.3 OUTLIER -46.35 -47.07 18.63 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 70.310000000000002 109.262 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.489 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 35.0 t-20 -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 73.430000000000007 109.282 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' CD2' ' A' ' 193' ' ' TYR . . . 119.85 54.1 0.26 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.516 1.135 . . . . 70.239999999999995 110.976 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.611 ' CZ ' HG21 ' A' ' 145' ' ' THR . 91.1 m-85 -158.67 144.73 16.87 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 73.439999999999998 111.026 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.841 ' HB2' HD23 ' A' ' 136' ' ' LEU . 46.8 t0 -110.72 125.91 53.99 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.563 1.165 . . . . 54.109999999999999 109.275 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.845 ' HB3' HD22 ' A' ' 188' ' ' LEU . 29.6 p -103.17 -179.31 3.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 63.32 108.29 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 23.1 mp0 -127.33 176.72 7.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.446 1.092 . . . . 75.439999999999998 110.336 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.797 ' HE2' HG22 ' A' ' 221' ' ' ILE . 21.3 mmtt -108.57 162.68 13.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 73.430000000000007 109.286 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 23.8 tt0 -155.11 117.62 4.26 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.55 1.156 . . . . 65.439999999999998 110.34 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -109.68 124.61 51.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 53.200000000000003 110.971 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.666 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.6 p -115.57 150.8 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 62.340000000000003 109.28 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.7 m-85 -122.13 162.96 20.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 73.239999999999995 110.982 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 115.59 -179.43 18.05 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.556 1.16 . . . . 74.129999999999995 110.98 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.72 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.1 t-20 -68.73 109.35 3.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 0.756 . . . . 73.140000000000001 109.302 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -113.92 93.42 4.36 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.474 1.109 . . . . 73.310000000000002 109.305 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.568 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 4.5 mttt -93.25 160.3 14.89 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.535 1.147 . . . . 72.239999999999995 109.26 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.803 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -165.78 162.89 18.82 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.441 1.088 . . . . 42.219999999999999 109.269 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.439999999999998 110.02 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.33 -0.989 . . . . 62.340000000000003 108.33 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.803 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.3 OUTLIER -109.07 161.58 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.525 1.141 . . . . 65.530000000000001 109.304 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.568 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -146.43 120.48 9.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 63.140000000000001 109.291 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.45 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.5 m0 -130.41 132.84 45.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.001 -1.111 . . . . 75.319999999999993 108.001 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 54.8 p -79.54 0.61 29.07 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.111 . . . . 54.149999999999999 110.014 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.495 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.1 p90 -170.85 127.82 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 62.039999999999999 111.014 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 48.3 t60 -116.47 167.88 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 54.030000000000001 109.622 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.611 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.4 p -143.86 145.16 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 65.310000000000002 109.309 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.598 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -146.38 -169.09 3.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 60.329999999999998 109.285 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.797 HG22 ' HE2' ' A' ' 197' ' ' LYS . 13.0 pt -114.38 120.8 65.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 71.540000000000006 109.311 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.8 tp -85.33 108.92 18.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.113 . . . . 74.319999999999993 109.314 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.678 HG11 HG13 ' A' ' 237' ' ' ILE . 0.8 OUTLIER -104.9 149.35 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 71.010000000000005 109.292 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 40.2 m -118.26 122.69 43.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 61.149999999999999 110.001 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 33.0 p90 -137.37 145.01 42.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 71.329999999999998 111.001 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.428 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.1 mmtp -70.72 132.89 46.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 71.299999999999997 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.35 -159.86 0.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.133 . . . . 61.32 109.294 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.83 -0.4 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.549 1.156 . . . . 34.539999999999999 109.305 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.78 -7.85 12.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 75.310000000000002 110.025 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.96 37.86 8.24 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.509 1.131 . . . . 72.230000000000004 111.0 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.76 137.46 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.452 0.736 . . . . 61.039999999999999 109.261 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.428 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.6 m -71.59 102.47 2.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.107 . . . . 64.530000000000001 110.355 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.7 mm-40 -102.04 -172.49 2.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.446 1.091 . . . . 73.510000000000005 110.276 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.523 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.8 mmtm -125.66 145.03 50.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.112 . . . . 72.409999999999997 109.314 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.64 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.8 tpt180 -143.02 159.48 42.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.340000000000003 110.354 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.0 mm -113.42 117.02 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.118 . . . . 64.200000000000003 109.329 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.2 mm -106.48 46.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 54.200000000000003 109.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -104.6 106.12 53.2 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 64.230000000000004 109.291 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -1.13 10.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.533 1.807 . . . . 71.150000000000006 110.995 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 3.1 t -73.21 -4.14 31.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 75.239999999999995 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.485 HD11 ' NE2' ' A' ' 218' ' ' HIS . 5.6 mt -138.15 -49.12 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 74.140000000000001 109.334 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.89 ' CZ ' ' HB2' ' A' ' 255' ' ' ALA . 83.0 m-85 -113.26 99.35 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.548 1.155 . . . . 75.319999999999993 111.014 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.5 m -90.63 -5.32 56.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 70.450000000000003 109.965 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 12.2 t -83.91 -44.78 13.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.535 1.147 . . . . 53.520000000000003 110.021 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.09 -177.43 46.82 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.518 1.136 . . . . 62.450000000000003 110.985 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.98 165.08 32.08 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.478 1.778 . . . . 64.530000000000001 111.018 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.678 HG11 ' CD2' ' A' ' 242' ' ' PHE . 4.0 m -148.43 167.8 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.456 1.098 . . . . 71.239999999999995 109.32 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.442 ' C ' ' N ' ' A' ' 250' ' ' THR . 66.8 p -70.23 137.78 51.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 73.420000000000002 110.4 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -41.23 -29.11 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.239999999999995 109.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.442 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -74.7 -63.8 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 73.349999999999994 110.362 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.36 -25.78 6.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 62.43 109.359 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.598 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.2 t90 -65.79 -65.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 74.420000000000002 108.034 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.764 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -42.04 -30.99 0.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 75.519999999999996 110.303 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.857 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.5 m-80 -67.4 -49.15 65.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 73.040000000000006 109.268 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.89 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.48 -19.36 14.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 70.129999999999995 109.278 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 205' ' ' LYS . 6.9 m -90.26 -35.75 15.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 75.239999999999995 108.331 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.857 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.4 m -93.53 21.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 72.329999999999998 109.284 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -50.48 106.44 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 72.209999999999994 109.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 262' ' ' GLY . 14.7 p -73.31 -3.34 26.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 75.340000000000003 110.428 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.72 -30.51 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.531 1.145 . . . . 73.5 109.963 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.5 t -88.71 -36.96 15.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 61.299999999999997 108.309 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.87 -128.82 1.78 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.512 1.133 . . . . 71.209999999999994 110.972 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.89 145.69 42.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 0.775 . . . . 71.150000000000006 109.986 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -167.96 147.61 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 72.299999999999997 109.308 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.3 t -172.92 153.61 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 73.230000000000004 110.056 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.666 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.42 118.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 74.510000000000005 109.324 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.0 t -73.78 -43.82 57.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.556 1.16 . . . . 74.319999999999993 110.02 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 200' ' ' VAL . 11.5 p -164.94 -175.15 3.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 74.230000000000004 109.994 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -164.77 157.14 16.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 71.319999999999993 110.998 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.1 160.49 39.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 72.040000000000006 109.27 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 272' ' ' THR . 1.1 p-10 -118.41 160.65 21.32 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.093 . . . . 50.229999999999997 109.272 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.638 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.1 p -153.47 -178.5 7.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 72.230000000000004 110.399 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.893 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.75 163.83 13.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 64.109999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.484 1.115 . . . . 62.119999999999997 110.991 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.457 ' H ' ' ND2' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -85.99 -35.71 20.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 0.778 . . . . 62.200000000000003 109.286 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' A' ' 273' ' ' ALA . 92.8 t -43.81 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 61.109999999999999 109.291 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 6.0 t80 -59.21 -49.83 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 62.509999999999998 110.968 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 56.2 t80 -147.9 158.15 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 61.420000000000002 110.955 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.638 ' HD2' HG21 ' A' ' 272' ' ' THR . 73.0 ttt-85 -123.95 147.47 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 73.239999999999995 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.55 154.02 47.8 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.115 . . . . 73.530000000000001 109.958 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.21 9.19 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.468 1.772 . . . . 64.109999999999999 110.997 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 20.6 t -105.64 10.22 32.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 1.118 . . . . 74.25 109.991 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 75.38 39.55 0.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 60.310000000000002 109.278 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.4 t -119.83 120.28 36.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 52.409999999999997 110.002 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -101.86 166.65 10.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 65.329999999999998 111.03 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -123.34 177.36 5.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 64.420000000000002 109.323 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 52.5 m-85 -158.61 115.78 2.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.125 . . . . 73.120000000000005 110.984 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.863 ' HB3' HD13 ' A' ' 291' ' ' LEU . 3.8 m-20 -115.26 99.27 7.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 74.230000000000004 109.329 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . 0.525 ' H ' ' ND2' ' A' ' 289' ' ' ASN . 0.9 OUTLIER -84.94 -48.54 9.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.310000000000002 109.34 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.466 ' HB3' HD11 ' A' ' 292' ' ' ILE . 27.0 m-20 -90.33 9.53 28.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 73.420000000000002 109.354 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.863 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.6 mm? 40.32 45.25 1.78 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 109.299 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 290' ' ' ASN . 47.6 mm -74.47 -23.79 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 71.549999999999997 109.317 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.812 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.7 t-20 -94.5 -29.08 15.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 63.409999999999997 109.299 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 7.8 m -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 62.310000000000002 110.419 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 39.8 m-20 -48.43 -24.77 1.36 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 73.25 109.288 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 45.7 t -80.8 -47.9 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 64.340000000000003 108.297 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.4 t -52.86 -45.47 50.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.521 1.138 . . . . 74.349999999999994 109.3 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.4 mt -65.27 -62.9 1.27 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 72.219999999999999 109.331 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -24.67 0.85 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.400000000000006 110.388 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.816 ' HE2' HG12 ' A' ' 315' ' ' VAL . 16.1 mmmt -73.3 -41.75 63.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 52.25 109.298 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.753 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.7 m-30 -100.87 36.77 1.87 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 74.209999999999994 111.033 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.72 -44.75 73.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 110.009 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -92.8 -12.09 32.05 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 53.399999999999999 109.296 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.785 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.7 mt -68.67 136.69 53.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 71.420000000000002 109.33 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 95.2 p -149.39 156.05 41.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.489 1.118 . . . . 62.109999999999999 110.014 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.32 -164.68 54.35 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.475 1.109 . . . . 71.439999999999998 111.01 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 10.56 22.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.272 -1.01 . . . . 42.450000000000003 108.272 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 13.9 p -131.8 149.45 73.44 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.565 1.166 . . . . 73.25 110.022 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.785 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.92 147.1 88.48 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 75.129999999999995 111.047 -0.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.9 p -133.51 135.75 25.71 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.551 1.157 . . . . 64.019999999999996 110.005 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.6 Cg_endo -74.94 -173.73 12.81 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 120.98 -2.508 . . . . 71.200000000000003 111.032 -0.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.58 154.32 35.39 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 73.450000000000003 109.291 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.455 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.99 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.512 1.796 . . . . 73.400000000000006 111.011 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -87.92 135.98 33.17 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 71.510000000000005 109.263 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.816 HG12 ' HE2' ' A' ' 300' ' ' LYS . 27.1 m -129.62 23.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.530000000000001 109.303 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 17.0 t -54.61 -32.74 59.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.418 1.074 . . . . 62.25 110.039 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.2 m -48.76 -25.37 1.8 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.349999999999994 110.002 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 54.539999999999999 108.299 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.83 HD23 ' HB3' ' A' ' 194' ' ' ASP . 8.6 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.286 -0.635 . . . . 61.210000000000001 109.286 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -116.03 104.37 11.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 75.219999999999999 109.314 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.496 ' CB ' ' OD2' ' A' ' 194' ' ' ASP . 0.6 OUTLIER -80.39 3.91 19.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 71.420000000000002 109.972 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -142.93 147.57 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.129999999999995 109.308 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -98.99 142.55 24.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 72.439999999999998 109.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.0 -32.74 5.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.528 1.804 . . . . 43.439999999999998 111.025 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.416 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.21 151.47 19.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 74.120000000000005 109.295 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.52 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -48.51 -35.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.103 . . . . 72.0 109.28 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.56 -46.75 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 73.120000000000005 109.303 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.683 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.9 m -72.25 -34.77 68.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.13 . . . . 41.240000000000002 110.425 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.675 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.47 -56.76 17.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.428 1.08 . . . . 74.540000000000006 109.254 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.52 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.2 m-80 -52.54 -31.85 37.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 62.5 109.32 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.18 -56.71 6.82 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.473 1.108 . . . . 62.219999999999999 109.994 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.053 HD12 HD11 ' A' ' 140' ' ' ILE . 60.7 mt -42.97 -42.62 3.83 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.472 1.107 . . . . 73.099999999999994 109.307 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.648 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.55 -45.1 63.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 73.109999999999999 111.037 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.87 -38.15 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 75.239999999999995 109.324 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 155' ' ' ASN . 64.6 mt-30 -75.21 -55.31 5.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 73.209999999999994 110.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.109 HD11 HD12 ' A' ' 188' ' ' LEU . 12.4 mt -49.72 -27.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.115 . . . . 63.32 109.306 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -36.07 61.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 73.329999999999998 109.289 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -60.75 -15.38 28.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 74.430000000000007 109.335 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.665 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 8.9 mm100 -83.09 -21.74 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 74.0 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.573 ' OG ' HG23 ' A' ' 160' ' ' THR . 29.8 p -39.09 140.69 0.37 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 72.109999999999999 109.99 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.73 -9.76 52.5 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 74.040000000000006 108.274 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -87.87 18.88 36.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.511 1.132 . . . . 60.130000000000003 110.999 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.573 HG23 ' OG ' ' A' ' 157' ' ' SER . 59.2 p -136.27 160.74 37.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 71.439999999999998 110.398 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 p -93.76 -21.55 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.48 1.112 . . . . 52.200000000000003 109.991 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.6 m -82.57 -3.65 56.39 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 64.219999999999999 110.416 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 156' ' ' GLN . . . -69.38 138.37 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 72.120000000000005 109.303 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.3 t -59.72 -160.14 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.097 . . . . 52.109999999999999 109.993 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.448 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -156.45 128.0 3.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 72.209999999999994 109.993 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.93 140.7 68.78 Favored 'Cis proline' 0 C--N 1.36 1.132 0 C-N-CA 121.011 -2.495 . . . . 74.430000000000007 111.015 -0.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 23.2 p -72.75 177.44 4.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 63.450000000000003 108.285 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.612 HD11 ' CB ' ' A' ' 183' ' ' LYS . 2.1 mp -94.51 126.84 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 64.5 109.309 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 301' ' ' PHE . 15.4 p -77.56 90.06 3.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 63.549999999999997 110.389 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -88.59 -30.2 19.43 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.571 1.169 . . . . 71.340000000000003 110.988 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.402 ' C ' ' HD3' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -84.03 9.29 12.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.51 1.131 . . . . 72.25 110.297 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.559 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 38.8 t80 -128.56 66.9 75.5 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.494 1.121 . . . . 73.030000000000001 111.004 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.448 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -74.97 109.15 2.87 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.463 1.77 . . . . 71.230000000000004 110.98 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.66 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 74.329999999999998 109.271 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -160.52 129.2 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.526 1.141 . . . . 74.25 109.273 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 129.07 52.29 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.505 1.128 . . . . 55.049999999999997 111.011 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.4 m -89.14 -18.06 27.93 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.273 -1.01 . . . . 44.520000000000003 108.273 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.622 ' HB3' HG11 ' A' ' 219' ' ' VAL . 34.2 p90 -76.59 -22.62 53.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.527 1.142 . . . . 75.349999999999994 110.955 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.532 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -71.17 -68.35 0.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 64.340000000000003 109.268 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.579 ' HB3' HG23 ' A' ' 168' ' ' ILE . 7.9 ptm180 -46.15 -48.33 17.44 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.498 1.124 . . . . 75.510000000000005 110.296 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.625 ' C ' ' HZ1' ' A' ' 197' ' ' LYS . . . -40.4 -59.0 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.13 . . . . 61.119999999999997 109.327 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.672 ' N ' ' HZ1' ' A' ' 197' ' ' LYS . 1.1 t60 -48.96 -39.69 27.46 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.528 1.142 . . . . 54.25 109.604 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.674 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.6 mmmt -64.61 -61.47 2.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 72.340000000000003 109.299 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.43 ' HE3' ' HA ' ' A' ' 181' ' ' ALA . 15.0 mtm -38.9 -38.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.533 1.146 . . . . 74.230000000000004 110.987 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.36 -49.35 78.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 74.150000000000006 110.339 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.674 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -54.75 -34.05 62.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.122 . . . . 50.210000000000001 110.271 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 153' ' ' ILE . 31.1 mm -70.3 -43.77 78.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.155 . . . . 75.019999999999996 109.341 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 1.109 HD12 HD11 ' A' ' 153' ' ' ILE . 0.4 OUTLIER -60.68 -40.77 93.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 73.120000000000005 109.28 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.75 ' HG2' HD21 ' A' ' 136' ' ' LEU . 52.1 mtp -61.57 -36.04 79.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 73.329999999999998 110.994 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.67 -53.63 56.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 64.430000000000007 109.293 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.51 HD22 HD21 ' A' ' 149' ' ' LEU . 23.6 t30 -62.72 -27.56 69.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 63.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 109.04 53.58 0.61 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.508 1.13 . . . . 73.340000000000003 110.988 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.683 ' CZ ' HG21 ' A' ' 145' ' ' THR . 92.9 m-85 -156.89 140.74 16.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.45 0.735 . . . . 74.510000000000005 111.015 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.83 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -106.12 124.86 50.24 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 62.020000000000003 109.319 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 1.008 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.1 p -95.92 168.46 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 64.129999999999995 108.3 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -117.06 170.91 8.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 54.25 110.295 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.672 ' HZ1' ' N ' ' A' ' 182' ' ' HIS . 17.5 mmtt -100.58 169.34 9.12 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 74.010000000000005 109.287 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 22.8 tt0 -167.28 121.85 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.442 1.089 . . . . 63.420000000000002 110.27 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -115.9 140.58 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 64.510000000000005 111.013 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.697 ' CG2' HG23 ' A' ' 266' ' ' VAL . 14.0 p -131.71 149.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.0 109.346 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 13.8 m-85 -122.72 156.37 34.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.452 1.095 . . . . 72.329999999999998 110.977 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.39 -175.83 16.44 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.508 1.13 . . . . 63.210000000000001 111.025 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.751 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.5 t-20 -72.63 110.14 6.78 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.782 . . . . 65.209999999999994 109.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.751 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.2 mt -113.19 95.48 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 74.450000000000003 109.263 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 256' ' ' CYS . 6.8 mtpt -92.31 165.33 13.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 74.450000000000003 109.326 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.867 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -169.23 119.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 63.140000000000001 109.26 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.157 . . . . 71.400000000000006 110.019 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.318 -0.993 . . . . 61.009999999999998 108.318 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.867 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.5 m -108.87 155.26 9.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.104 . . . . 74.219999999999999 109.293 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -147.1 130.05 16.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 53.329999999999998 109.315 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.3 135.07 42.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.319999999999993 108.015 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.4 m -80.3 3.52 20.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.147 . . . . 73.299999999999997 109.991 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.458 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.0 p90 -177.79 130.41 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.459 1.099 . . . . 73.340000000000003 111.023 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -120.17 168.03 11.64 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 73.140000000000001 109.609 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.622 HG11 ' HB3' ' A' ' 178' ' ' TYR . 1.5 p -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.13 . . . . 63.200000000000003 109.284 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.683 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.0 -165.8 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 74.219999999999999 109.291 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.475 ' O ' HD13 ' A' ' 236' ' ' ILE . 15.9 pt -117.24 123.79 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 64.239999999999995 109.273 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.4 tp -86.29 108.85 18.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 75.439999999999998 109.285 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.675 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -102.2 145.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 63.450000000000003 109.323 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 56.3 m -117.75 117.78 30.26 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.467 1.105 . . . . 53.200000000000003 110.031 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 29.9 p90 -133.9 144.46 48.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 74.25 110.969 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.1 mmtp -68.87 135.19 50.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 73.540000000000006 109.333 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -76.08 -160.18 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 73.239999999999995 109.315 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.38 50.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 65.120000000000005 109.322 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 -7.49 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 75.510000000000005 109.959 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.01 8.23 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.5 1.125 . . . . 44.420000000000002 111.031 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.34 138.23 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.442 0.731 . . . . 74.540000000000006 109.347 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.436 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 20.4 m -71.93 102.55 2.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.498 1.124 . . . . 73.140000000000001 110.394 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.4 mm-40 -101.27 -174.21 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.567 1.167 . . . . 62.149999999999999 110.302 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.535 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.0 mmtm -127.19 144.82 50.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 75.319999999999993 109.313 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.592 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -146.7 163.88 34.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 71.540000000000006 110.307 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.487 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.3 mm -117.96 119.11 60.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 72.420000000000002 109.328 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -103.42 45.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.488 1.118 . . . . 72.439999999999998 109.317 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.41 109.44 61.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 54.039999999999999 109.309 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -20.42 16.91 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.448 1.762 . . . . 61.329999999999998 111.011 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.439 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.9 t -51.32 -21.72 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.526 1.141 . . . . 73.329999999999998 110.009 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 256' ' ' CYS . 7.7 mt -117.97 -57.85 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 64.140000000000001 109.272 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.78 ' CE2' HG21 ' A' ' 247' ' ' VAL . 80.7 m-85 -107.65 99.78 9.24 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.146 . . . . 74.349999999999994 110.972 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.1 m -86.47 -6.5 58.89 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.101 . . . . 73.230000000000004 109.974 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -82.93 -44.45 15.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 52.0 110.005 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.28 -173.96 43.26 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.509 1.131 . . . . 64.340000000000003 111.009 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.427 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.5 Cg_endo -74.9 165.42 31.43 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.453 1.765 . . . . 61.409999999999997 111.011 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.78 HG21 ' CE2' ' A' ' 242' ' ' PHE . 4.8 m -147.23 159.26 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 72.129999999999995 109.309 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.432 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.5 p -61.17 139.38 58.13 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 73.109999999999999 110.413 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -41.63 -29.81 0.19 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 71.400000000000006 109.294 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 248' ' ' THR . 12.6 m -77.26 -61.41 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.118 . . . . 72.329999999999998 110.415 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.74 -24.36 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 43.240000000000002 109.25 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.683 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 9.7 t90 -66.33 -64.5 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 74.400000000000006 108.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.862 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.2 OUTLIER -43.77 -34.8 1.65 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 63.049999999999997 110.278 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.884 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.1 m-80 -64.56 -49.4 71.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 34.130000000000003 109.347 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.648 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.22 -19.08 12.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.45 1.094 . . . . 50.210000000000001 109.299 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 205' ' ' LYS . 10.0 m -92.06 -31.91 15.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 55.210000000000001 108.28 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.884 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.5 m -96.9 21.84 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.555 1.16 . . . . 64.519999999999996 109.315 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -49.2 104.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.479 1.112 . . . . 75.219999999999999 109.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 262' ' ' GLY . 12.7 p -72.54 -3.89 27.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.138 . . . . 72.129999999999995 110.397 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 41.3 t -48.1 -25.15 1.33 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 73.329999999999998 110.026 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 5.9 m -90.94 -34.45 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 73.439999999999998 108.279 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.01 -118.41 0.82 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.481 1.113 . . . . 45.299999999999997 110.979 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.45 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -83.31 142.73 30.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 0.778 . . . . 63.409999999999997 110.02 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.97 143.82 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.554 1.159 . . . . 71.319999999999993 109.296 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.2 t -172.77 159.24 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.55 1.156 . . . . 63.539999999999999 109.983 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.697 HG23 ' CG2' ' A' ' 200' ' ' VAL . 4.0 p -101.91 118.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 63.009999999999998 109.326 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.1 t -77.28 -44.0 31.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 54.439999999999998 109.999 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 200' ' ' VAL . 4.1 m -149.25 -175.33 4.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 34.5 109.984 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -174.28 152.89 1.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 74.400000000000006 110.958 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -159.73 163.59 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.455 1.097 . . . . 62.350000000000001 109.312 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.84 160.5 20.74 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 74.150000000000006 109.314 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.06 -178.7 6.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 70.540000000000006 110.412 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -86.01 158.2 19.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.239999999999995 109.302 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.83 93.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.55 1.156 . . . . 71.319999999999993 110.987 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -46.28 77.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 0.773 . . . . 73.129999999999995 109.312 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.8 t -43.48 127.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 74.200000000000003 109.293 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.555 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 3.5 t80 -93.33 -40.7 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 70.420000000000002 110.988 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.3 OUTLIER -160.33 115.46 2.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 74.540000000000006 111.025 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.419 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 55.1 ttt-85 -94.96 137.87 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.420000000000002 110.281 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 157.62 34.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 60.43 109.956 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 0.02 9.41 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.459 1.768 . . . . 61.32 111.033 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 10.2 t -98.42 7.62 45.94 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.093 . . . . 63.32 110.016 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 76.02 34.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 64.319999999999993 109.25 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.7 t -117.41 120.73 39.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.565 1.165 . . . . 61.039999999999999 110.0 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.95 164.33 12.24 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 73.319999999999993 111.009 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.2 mm? -125.32 176.66 6.63 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 75.109999999999999 109.288 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 91.2 m-85 -162.62 124.94 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 75.109999999999999 110.947 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.948 ' HB3' HD13 ' A' ' 291' ' ' LEU . 2.0 m-20 -114.91 99.01 7.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 50.409999999999997 109.304 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -79.11 -54.79 5.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 74.219999999999999 109.332 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.461 ' CB ' HG12 ' A' ' 292' ' ' ILE . 9.5 m-20 -95.1 19.2 10.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 71.040000000000006 109.297 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.948 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.5 mm? 40.29 39.38 0.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 53.32 109.324 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.461 HG12 ' CB ' ' A' ' 290' ' ' ASN . 50.2 mm -68.63 -31.94 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 73.140000000000001 109.337 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.823 ' O ' HG23 ' A' ' 297' ' ' VAL . 0.1 OUTLIER -88.93 -29.1 19.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.555 1.159 . . . . 72.099999999999994 109.302 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.453 ' N ' ' OD1' ' A' ' 288' ' ' ASP . 4.9 m -81.52 -67.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 72.030000000000001 110.412 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -45.52 -31.85 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 74.200000000000003 109.306 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.85 -55.85 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 61.329999999999998 108.288 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.1 t -40.83 -49.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.5 1.125 . . . . 74.319999999999993 109.267 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.2 mt -67.76 -57.71 5.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.583 1.177 . . . . 73.239999999999995 109.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -44.74 -27.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 72.340000000000003 110.382 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -72.99 -44.7 60.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.541 1.151 . . . . 73.299999999999997 109.355 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.653 ' HB2' HG21 ' A' ' 169' ' ' THR . 1.9 m-30 -97.65 21.97 9.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.209999999999994 111.031 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.0 t -58.27 -57.95 10.61 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.420000000000002 109.968 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.747 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -76.36 -15.54 59.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.117 . . . . 62.229999999999997 109.254 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.69 HD22 ' CD ' ' A' ' 309' ' ' PRO . 17.9 mt -66.38 148.99 51.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 74.129999999999995 109.292 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.7 p -168.91 127.2 1.03 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 72.430000000000007 109.964 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 172' ' ' TYR . . . 105.28 -163.66 14.22 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.514 1.134 . . . . 54.240000000000002 111.006 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.62 15.62 12.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.341 -0.985 . . . . 74.129999999999995 108.341 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.514 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 84.4 p -139.8 148.27 54.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 74.450000000000003 110.033 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.69 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.95 147.19 88.68 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 121.057 -2.476 . . . . 64.109999999999999 111.02 -0.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 6.4 p -129.89 135.28 27.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 33.210000000000001 109.99 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.98 -174.49 14.19 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.994 -2.503 . . . . 60.140000000000001 110.987 -0.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.2 156.02 23.02 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 50.109999999999999 109.317 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.54 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.512 1.796 . . . . 75.319999999999993 111.044 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.4 136.4 33.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 70.400000000000006 109.29 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.22 22.92 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 109.316 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 14.1 t -69.31 -33.27 72.91 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 51.43 109.975 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.8 t -47.55 -24.49 0.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.497 1.123 . . . . 71.140000000000001 110.023 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.408 ' HB2' ' ND2' ' A' ' 293' ' ' ASN . 1.8 m . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 71.010000000000005 108.279 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.928 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.6 tp . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.324 -0.621 . . . . 50.030000000000001 109.324 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.644 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -104.92 107.69 18.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.458 1.099 . . . . 73.349999999999994 109.319 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 t -84.81 9.69 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 55.039999999999999 109.996 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.25 145.6 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.544 1.152 . . . . 64.540000000000006 109.278 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.031 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -97.25 142.59 24.77 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 75.450000000000003 109.309 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.95 -32.63 5.3 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.497 1.788 . . . . 74.319999999999993 111.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.19 151.26 19.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.142 . . . . 63.520000000000003 109.318 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.516 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.9 t -48.11 -35.73 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.531 1.145 . . . . 74.109999999999999 109.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.33 -47.3 3.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 70.239999999999995 109.273 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.67 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.73 -35.35 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.153 . . . . 75.420000000000002 110.403 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.768 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -58.72 -56.97 15.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 54.219999999999999 109.32 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.516 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.7 m-80 -52.49 -31.7 36.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 71.450000000000003 109.348 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.35 -54.05 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 75.540000000000006 109.946 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 140' ' ' ILE . 54.0 mt -44.15 -40.67 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.537 1.148 . . . . 75.099999999999994 109.297 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.611 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.49 -44.34 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.57 1.169 . . . . 70.299999999999997 110.996 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -48.03 -37.25 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 109.296 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.492 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 61.4 mt-30 -75.67 -55.87 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 61.039999999999999 110.294 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.957 HD11 HD12 ' A' ' 188' ' ' LEU . 12.1 mt -51.13 -23.75 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 75.409999999999997 109.367 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -34.03 43.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.488 1.118 . . . . 71.209999999999994 109.305 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.1 t-20 -61.75 -17.63 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 65.239999999999995 109.335 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.449 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 4.5 mm100 -84.09 -16.94 41.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 75.310000000000002 110.292 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.6 p -37.94 133.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.209999999999994 109.958 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -64.32 125.12 23.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 70.230000000000004 108.288 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.85 -18.06 8.62 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.495 1.122 . . . . 51.509999999999998 110.96 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.823 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 63.5 p -80.81 161.7 24.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.575 0.809 . . . . 71.230000000000004 110.422 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 51.0 p -93.55 -0.8 56.12 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.439999999999998 109.998 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 162' ' ' THR . 4.5 m -117.56 7.33 12.63 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 55.219999999999999 110.41 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.823 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.7 138.93 33.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.526 1.141 . . . . 60.420000000000002 109.278 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -162.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 75.230000000000004 109.999 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.431 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 41.9 t -156.22 127.47 3.67 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.230000000000004 109.982 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.01 139.38 61.44 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.991 -2.504 . . . . 73.430000000000007 111.033 -0.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 p -72.73 179.11 3.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 62.140000000000001 108.299 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.841 HG23 ' HG2' ' A' ' 180' ' ' ARG . 2.2 mp -88.9 124.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 61.329999999999998 109.305 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 301' ' ' PHE . 65.5 p -89.21 83.2 6.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 110.356 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -88.47 -14.78 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.142 . . . . 75.340000000000003 110.999 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.42 -2.21 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.533 1.145 . . . . 70.439999999999998 110.302 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.654 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 27.1 t80 -127.98 71.15 78.63 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 63.039999999999999 110.996 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.433 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.01 114.07 3.94 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.484 1.781 . . . . 74.530000000000001 111.005 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.602 HG21 ' CE1' ' A' ' 172' ' ' TYR . 26.2 t -152.59 -75.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.486 1.116 . . . . 63.43 109.246 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -156.51 115.79 3.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 65.209999999999994 109.301 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.63 55.84 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.525 1.14 . . . . 62.149999999999999 111.043 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 66.8 m -96.68 -0.17 48.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.308 -0.997 . . . . 54.310000000000002 108.308 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.62 ' HE1' HG21 ' A' ' 297' ' ' VAL . 12.8 p90 -85.89 -32.65 21.54 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 73.409999999999997 111.017 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.6 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -70.93 -49.59 43.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 73.219999999999999 109.336 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.841 ' HG2' HG23 ' A' ' 168' ' ' ILE . 6.5 mtp85 -57.69 -47.81 81.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 54.530000000000001 110.261 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.25 -51.04 8.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.449 1.093 . . . . 63.420000000000002 109.329 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.489 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -56.12 -37.47 69.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.506 1.129 . . . . 73.5 109.646 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.77 ' HB3' HD11 ' A' ' 168' ' ' ILE . 27.8 mmmt -63.85 -64.33 0.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.564 1.165 . . . . 71.099999999999994 109.271 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 153' ' ' ILE . 9.4 mtm -38.93 -30.24 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 75.019999999999996 111.005 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -66.32 -51.02 61.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 73.310000000000002 110.289 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.56 ' HG3' HD13 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -52.52 -32.32 39.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 73.310000000000002 110.282 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.56 HD13 ' HG3' ' A' ' 186' ' ' GLN . 11.6 mm -80.97 -34.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 72.519999999999996 109.309 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -63.33 -44.6 94.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.540000000000006 109.298 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 136' ' ' LEU . 8.5 mtp -60.52 -41.55 94.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 44.109999999999999 111.02 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -46.22 -49.53 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 74.109999999999999 109.312 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.492 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 24.5 t-20 -68.05 -27.99 66.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 75.120000000000005 109.28 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 105.75 56.66 0.67 Allowed Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.512 1.133 . . . . 64.319999999999993 110.96 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' A' ' 145' ' ' THR . 82.0 m-85 -157.52 142.38 16.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 0.776 . . . . 72.409999999999997 111.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.928 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.2 t0 -110.02 124.77 52.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.143 . . . . 71.510000000000005 109.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.79 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.0 p -100.08 171.17 7.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.444 1.09 . . . . 65.439999999999998 108.296 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.42 170.23 8.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.086 . . . . 71.519999999999996 110.299 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.421 ' HE2' HG22 ' A' ' 221' ' ' ILE . 6.3 mmtt -96.71 159.66 14.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 74.519999999999996 109.32 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.633 ' OE1' HD11 ' A' ' 236' ' ' ILE . 18.9 tt0 -151.56 117.47 5.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 73.349999999999994 110.298 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 5.8 m-85 -116.39 128.75 55.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.52 1.137 . . . . 73.310000000000002 110.964 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.666 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.6 p -122.74 149.96 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 70.349999999999994 109.311 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 10.0 m-85 -122.88 164.21 18.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 1.15 . . . . 73.129999999999995 110.99 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.46 -172.9 14.44 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.516 1.135 . . . . 74.230000000000004 111.009 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.75 ' C ' HD23 ' A' ' 204' ' ' LEU . 52.4 t-20 -74.12 107.67 6.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 0.786 . . . . 73.349999999999994 109.262 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.5 mt -111.54 96.26 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 75.099999999999994 109.334 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.7 mtpp -90.85 -179.88 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 43.439999999999998 109.328 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 1.012 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -179.46 149.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 1.152 . . . . 74.299999999999997 109.321 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.45 0 O-C-N 124.49 1.119 . . . . 75.530000000000001 109.933 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 4.4 t . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.277 -1.008 . . . . 72.319999999999993 108.277 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 1.012 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -138.45 143.43 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 71.140000000000001 109.3 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -137.88 132.58 32.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 70.099999999999994 109.271 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -139.99 136.34 33.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.230000000000004 107.993 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.9 t -80.38 -3.65 50.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.499 1.124 . . . . 65.510000000000005 110.01 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.4 p90 -169.99 127.45 0.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 62.310000000000002 111.03 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CE1' ' O ' ' A' ' 219' ' ' VAL . 28.6 t60 -115.62 167.23 11.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 73.239999999999995 109.583 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.3 p -144.23 140.42 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 52.439999999999998 109.313 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.658 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.73 -167.65 2.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 73.299999999999997 109.289 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.542 HD11 ' HB ' ' A' ' 237' ' ' ILE . 21.3 pt -115.17 119.33 61.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.545 1.153 . . . . 73.209999999999994 109.267 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 234' ' ' LYS . 14.7 tp -84.92 108.82 17.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 34.32 109.301 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.768 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -103.02 146.57 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 71.329999999999998 109.345 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 15.9 m -117.17 119.36 34.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 72.140000000000001 110.044 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.4 p90 -134.63 145.07 48.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 71.120000000000005 110.969 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.421 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.0 mmtp -69.86 134.57 48.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 72.409999999999997 109.259 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.5 -159.77 0.11 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 42.520000000000003 109.334 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.65 52.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.458 1.099 . . . . 64.409999999999997 109.261 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.7 m -114.82 -7.88 12.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.123 . . . . 71.349999999999994 109.98 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.43 37.64 8.06 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.517 1.136 . . . . 44.140000000000001 111.036 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.424 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.35 137.38 44.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.468 0.746 . . . . 54.049999999999997 109.298 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.421 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.3 m -71.58 102.73 2.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 61.25 110.388 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 224' ' ' SER . 4.2 mm-40 -101.44 -172.62 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 64.200000000000003 110.266 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.574 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtt -126.86 145.22 50.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.1 . . . . 61.100000000000001 109.331 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.619 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -145.53 162.19 38.0 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 75.25 110.286 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.633 HD11 ' OE1' ' A' ' 198' ' ' GLN . 16.6 mm -115.88 119.34 61.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 65.150000000000006 109.311 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.6 mm -105.64 45.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.219999999999999 109.248 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.19 108.78 58.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.518 1.136 . . . . 64.549999999999997 109.329 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -75.0 -19.26 18.02 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.473 1.775 . . . . 75.549999999999997 110.943 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.433 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.4 OUTLIER -53.06 -20.86 3.95 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 64.120000000000005 109.994 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.549 HD13 ' SG ' ' A' ' 256' ' ' CYS . 7.3 mt -120.26 -57.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 72.530000000000001 109.271 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.637 ' CD1' HG11 ' A' ' 247' ' ' VAL . 96.7 m-85 -110.06 99.62 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -12.63 42.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.230000000000004 110.034 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -74.51 -44.83 49.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 1.101 . . . . 65.319999999999993 110.041 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -175.88 -174.76 42.7 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.537 1.148 . . . . 74.530000000000001 110.978 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.03 166.57 28.9 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.5 1.79 . . . . 74.540000000000006 110.99 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.637 HG11 ' CD1' ' A' ' 242' ' ' PHE . 6.0 m -148.09 161.19 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.131 . . . . 72.129999999999995 109.322 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.3 p -65.49 137.32 57.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 74.049999999999997 110.458 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.415 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 6.4 p-10 -40.03 -30.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.230000000000004 109.332 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 7.9 m -76.82 -61.92 1.81 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 75.430000000000007 110.394 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.85 -24.01 3.22 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 74.340000000000003 109.315 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.658 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 7.7 t90 -68.02 -62.86 1.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.955 -1.128 . . . . 73.219999999999999 107.955 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.809 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -48.68 -38.51 21.51 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 72.349999999999994 110.32 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.898 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.6 m-80 -58.24 -51.62 68.98 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 72.129999999999995 109.302 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -59.87 -17.17 34.77 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 74.329999999999998 109.283 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.549 ' SG ' HD13 ' A' ' 241' ' ' LEU . 22.0 m -94.91 -25.81 16.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 63.030000000000001 108.28 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.898 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -106.17 24.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 44.43 109.3 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 206' ' ' ALA . 1.9 p-10 -53.0 129.19 29.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.113 . . . . 61.219999999999999 109.314 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 262' ' ' GLY . 3.1 p -85.81 -3.86 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 71.420000000000002 110.403 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.416 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 0.9 OUTLIER -50.71 -30.72 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 42.119999999999997 109.999 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . 0.407 ' SG ' ' CE ' ' A' ' 205' ' ' LYS . 16.4 t -88.39 -29.29 20.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.468 1.105 . . . . 73.230000000000004 108.31 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 259' ' ' THR . . . 156.76 -120.77 1.01 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.454 1.096 . . . . 55.100000000000001 110.978 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -87.5 148.38 24.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 0.743 . . . . 73.019999999999996 110.047 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -169.8 147.69 3.44 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.420000000000002 109.306 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.9 m -172.84 156.25 3.37 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 71.430000000000007 109.996 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.666 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.5 118.27 44.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 70.209999999999994 109.322 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 8.8 t -74.99 -44.08 50.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.513 1.133 . . . . 63.310000000000002 110.007 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 200' ' ' VAL . 22.2 m -157.06 -170.11 3.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.428 1.08 . . . . 61.229999999999997 110.012 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -170.08 157.36 6.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 72.230000000000004 110.982 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -162.26 172.05 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 1.109 . . . . 73.120000000000005 109.321 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 272' ' ' THR . 0.7 OUTLIER -145.71 160.73 41.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 1.103 . . . . 72.040000000000006 109.288 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.476 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.7 p -151.94 -171.92 4.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 41.109999999999999 110.387 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.807 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -68.0 154.39 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.495 1.122 . . . . 65.400000000000006 109.242 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -64.56 -46.72 89.34 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.463 1.102 . . . . 72.209999999999994 110.992 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -50.96 -38.29 49.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 0.776 . . . . 73.239999999999995 109.274 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.807 HG23 ' HB3' ' A' ' 273' ' ' ALA . 33.9 t -46.81 116.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 73.540000000000006 109.306 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 2.4 t80 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 72.120000000000005 110.999 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.573 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 63.4 t80 -154.77 162.2 41.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 111.013 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.573 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 75.2 ttt-85 -128.25 147.48 50.59 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.536 1.148 . . . . 54.109999999999999 110.254 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.33 154.75 47.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.536 1.148 . . . . 75.319999999999993 110.012 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.91 0.22 9.12 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 73.040000000000006 111.026 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 27.9 t -101.63 3.35 39.78 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 52.310000000000002 110.007 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.6 t-20 81.74 36.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.433 1.083 . . . . 73.200000000000003 109.277 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -117.65 119.29 34.52 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.47 1.106 . . . . 64.540000000000006 110.013 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 8.7 m-30 -99.78 160.84 14.0 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 74.329999999999998 110.967 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.546 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.9 OUTLIER -119.77 176.55 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 63.149999999999999 109.303 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 86.9 m-85 -162.56 130.22 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.531 1.144 . . . . 64.25 111.0 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.3 m-20 -113.52 111.88 22.64 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 75.099999999999994 109.297 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.23 -51.86 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.25 109.319 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.464 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -106.96 18.04 22.32 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 54.329999999999998 109.321 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.77 HD12 HG21 ' A' ' 294' ' ' THR . 1.3 mm? 50.34 39.36 20.11 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.572 1.17 . . . . 74.030000000000001 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.464 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 20.0 mm -65.58 -30.63 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 74.5 109.27 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.737 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.2 t-20 -93.94 -29.75 15.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 60.119999999999997 109.334 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.77 HG21 HD12 ' A' ' 291' ' ' LEU . 1.3 m -76.64 -66.24 0.84 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 63.149999999999999 110.397 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -51.01 -25.92 5.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 74.540000000000006 109.297 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.41 -53.17 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.47 1.106 . . . . 72.319999999999993 108.294 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 293' ' ' ASN . 10.6 t -49.32 -37.62 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.128 . . . . 74.430000000000007 109.315 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.626 HD22 ' HA ' ' A' ' 168' ' ' ILE . 65.9 mt -75.43 -59.62 2.67 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 73.530000000000001 109.316 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -51.98 -20.71 2.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 74.129999999999995 110.367 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.835 ' HE2' HG12 ' A' ' 315' ' ' VAL . 21.4 mmmt -72.58 -42.38 64.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 75.420000000000002 109.316 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.877 ' CD1' HD12 ' A' ' 304' ' ' LEU . 5.1 m-30 -102.44 37.82 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 64.019999999999996 110.984 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 35.6 t -68.66 -44.37 74.23 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.510000000000005 110.003 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.674 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -95.07 -12.96 25.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 62.109999999999999 109.296 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.877 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.7 mt -65.57 135.65 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 61.549999999999997 109.311 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 79.0 p -151.67 152.64 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.105 . . . . 52.219999999999999 109.983 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.87 -145.58 27.43 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.478 1.111 . . . . 63.219999999999999 111.029 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 59.8 m -109.39 15.41 23.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.341 -0.985 . . . . 74.219999999999999 108.341 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.523 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 97.8 p -132.82 148.6 70.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 54.229999999999997 110.016 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.768 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.08 146.45 86.59 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 120.959 -2.517 . . . . 43.229999999999997 110.992 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.4 p -128.86 134.46 26.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.498 1.124 . . . . 74.230000000000004 109.957 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.5 Cg_endo -74.96 -172.38 10.67 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.985 -2.506 . . . . 64.019999999999996 111.006 -0.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.16 153.59 24.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 72.230000000000004 109.286 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.4 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.491 1.785 . . . . 75.209999999999994 110.983 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -86.15 131.13 34.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 72.420000000000002 109.335 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.835 HG12 ' HE2' ' A' ' 300' ' ' LYS . 30.5 m -134.61 14.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 75.040000000000006 109.332 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 30.6 t -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 64.439999999999998 110.014 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.0 m -48.1 -24.16 1.04 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.119 . . . . 62.100000000000001 109.968 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.128 . . . . 74.019999999999996 108.336 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.804 HD23 ' HB2' ' A' ' 194' ' ' ASP . 12.1 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.277 -0.638 . . . . 61.439999999999998 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.605 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -102.69 104.18 14.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 63.210000000000001 109.304 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -82.98 7.34 15.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.114 . . . . 55.420000000000002 109.985 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.585 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.4 t -150.38 142.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.485 1.116 . . . . 64.450000000000003 109.319 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 149' ' ' LEU . 1.4 mt -92.73 141.76 24.82 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.439999999999998 109.32 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.02 -31.57 6.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.513 1.796 . . . . 75.140000000000001 110.973 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.51 149.63 17.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 1.11 . . . . 64.510000000000005 109.348 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.49 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.9 t -46.72 -37.19 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.138 . . . . 74.400000000000006 109.248 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.18 -50.05 2.67 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.475 1.11 . . . . 71.420000000000002 109.325 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.74 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -68.95 -37.06 78.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 55.020000000000003 110.393 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.734 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -56.72 -57.5 12.16 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 61.420000000000002 109.287 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.49 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.1 m-80 -52.09 -29.9 23.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 73.230000000000004 109.295 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.14 -50.79 44.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 74.510000000000005 109.984 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.034 HD12 HD11 ' A' ' 140' ' ' ILE . 54.9 mt -48.53 -40.03 25.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 72.219999999999999 109.285 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -75.16 -42.17 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 75.230000000000004 110.991 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -48.95 -36.77 18.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 72.109999999999999 109.328 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 155' ' ' ASN . 64.2 mt-30 -75.75 -56.0 5.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 73.109999999999999 110.269 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.589 HD11 HD12 ' A' ' 188' ' ' LEU . 13.1 mt -50.71 -26.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 64.510000000000005 109.259 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 -34.21 59.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 75.129999999999995 109.304 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.62 -15.15 36.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 70.200000000000003 109.309 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -85.75 -18.82 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 73.140000000000001 110.29 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.8 p -39.38 136.64 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 73.140000000000001 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.492 ' HB3' HH21 ' A' ' 171' ' ' ARG . 1.3 m -68.33 119.99 13.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 74.049999999999997 108.28 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 128.13 -18.74 5.83 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.436 1.085 . . . . 45.130000000000003 110.999 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.864 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 82.8 p -80.38 162.33 24.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 0.726 . . . . 61.25 110.407 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.7 m -93.26 -0.59 56.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.46 1.1 . . . . 43.219999999999999 110.001 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 162' ' ' THR . 1.3 m -118.84 6.52 11.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 62.140000000000001 110.42 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.864 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -79.83 139.27 37.25 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.121 . . . . 72.319999999999993 109.263 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -166.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 64.019999999999996 110.051 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 60.7 p -152.62 125.84 4.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 64.019999999999996 109.976 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 140.16 65.77 Favored 'Cis proline' 0 C--N 1.36 1.183 0 C-N-CA 120.976 -2.51 . . . . 71.450000000000003 110.973 0.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.6 p -72.89 -177.82 2.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.153 . . . . 73.150000000000006 108.313 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.687 HD11 ' CB ' ' A' ' 183' ' ' LYS . 2.3 mp -91.96 131.4 39.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 64.400000000000006 109.327 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.458 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 11.1 p -85.3 85.56 7.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 74.010000000000005 110.417 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 170' ' ' PHE . 2.2 p90 -88.56 -28.24 20.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 62.200000000000003 111.013 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.492 HH21 ' HB3' ' A' ' 158' ' ' CYS . 0.0 OUTLIER -74.12 -2.52 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.495 1.122 . . . . 64.219999999999999 110.316 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.749 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -128.52 68.89 78.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 72.109999999999999 111.029 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.03 116.08 4.47 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 64.109999999999999 110.972 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.585 HG21 ' CE1' ' A' ' 172' ' ' TYR . 12.2 t -152.08 -74.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.542 1.152 . . . . 52.240000000000002 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.604 ' OD2' ' HB2' ' A' ' 312' ' ' ALA . 2.6 p-10 -123.76 -43.41 2.13 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.491 1.12 . . . . 51.409999999999997 109.336 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -47.64 92.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.496 1.123 . . . . 74.430000000000007 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 175' ' ' ASP . 57.3 m -128.17 -46.86 1.35 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.28 -1.007 . . . . 63.210000000000001 108.28 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 21.7 p90 -72.87 -40.95 65.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 65.430000000000007 111.008 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.633 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -45.66 -68.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 73.530000000000001 109.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.705 HH21 ' HG2' ' A' ' 239' ' ' PRO . 9.5 ptm180 -49.94 -47.66 52.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.444 1.09 . . . . 74.239999999999995 110.306 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -39.4 -57.38 1.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.132 . . . . 42.240000000000002 109.318 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -47.79 -44.56 28.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 74.140000000000001 109.598 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.687 ' CB ' HD11 ' A' ' 168' ' ' ILE . 14.4 mmmm -58.52 -56.58 20.27 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.438 1.086 . . . . 64.420000000000002 109.281 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.521 ' SD ' HG21 ' A' ' 153' ' ' ILE . 5.2 mtm -40.36 -55.41 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 71.239999999999995 111.051 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.446 ' NH1' ' HA ' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -46.28 -44.09 16.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 73.439999999999998 110.316 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.497 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -62.76 -33.19 74.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.120000000000005 110.305 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.497 HD13 ' HG2' ' A' ' 186' ' ' GLN . 16.2 mm -76.05 -34.41 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 50.219999999999999 109.315 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.589 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -61.97 -45.66 92.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 71.120000000000005 109.306 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 7.3 mtt -58.63 -38.58 78.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.437 1.086 . . . . 73.450000000000003 111.029 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -44.22 63.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 70.310000000000002 109.284 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.557 HD22 HD21 ' A' ' 149' ' ' LEU . 41.0 t30 -74.17 -31.96 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.116 . . . . 63.409999999999997 109.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.57 58.5 0.73 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.533 1.146 . . . . 64.519999999999996 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.74 ' CZ ' HG21 ' A' ' 145' ' ' THR . 68.1 m-85 -153.67 141.42 20.03 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 0.743 . . . . 61.119999999999997 110.959 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.804 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -102.89 129.46 49.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 74.25 109.329 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.537 ' HB3' HD22 ' A' ' 188' ' ' LEU . 30.7 p -120.26 -178.58 3.71 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.547 1.154 . . . . 42.049999999999997 108.287 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -131.36 177.5 7.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 72.439999999999998 110.248 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.456 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 21.8 mmtt -105.25 153.13 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.139 . . . . 73.409999999999997 109.265 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.855 ' OE1' HD11 ' A' ' 236' ' ' ILE . 14.8 tt0 -132.55 117.5 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.140000000000001 110.319 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.473 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 2.6 m-85 -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 111.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 204' ' ' LEU . 8.6 p -131.22 142.81 42.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.45 1.094 . . . . 72.099999999999994 109.265 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.3 m-85 -116.32 156.08 27.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 75.109999999999999 111.028 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.53 -173.42 15.67 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.474 1.109 . . . . 75.439999999999998 111.061 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.801 ' C ' HD23 ' A' ' 204' ' ' LEU . 51.7 t-20 -74.4 110.97 9.12 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.454 0.738 . . . . 72.230000000000004 109.252 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.801 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.6 mt -115.13 94.39 4.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.46 1.1 . . . . 74.109999999999999 109.293 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.709 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 1.9 mtpm? -92.76 175.12 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 73.319999999999993 109.306 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -176.04 131.16 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 72.439999999999998 109.349 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.9 p . . . . . 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 74.319999999999993 109.972 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 108.313 -0.995 . . . . 55.119999999999997 108.313 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.2 OUTLIER -132.97 162.06 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 72.549999999999997 109.285 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.709 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -142.83 135.18 27.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 73.319999999999993 109.306 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.7 OUTLIER -138.25 134.32 34.25 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.142 . . . . 65.420000000000002 107.998 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 17.9 t -77.03 -0.09 23.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.519 1.137 . . . . 64.129999999999995 109.979 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.466 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 7.2 p90 -176.64 129.91 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.432 1.083 . . . . 64.510000000000005 110.986 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.495 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 63.0 t60 -115.17 168.44 9.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 63.329999999999998 109.603 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 178' ' ' TYR . 0.8 OUTLIER -140.38 142.27 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 73.109999999999999 109.266 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.631 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.8 -167.14 2.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 72.230000000000004 109.349 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.3 pt -120.01 125.19 74.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 63.130000000000003 109.337 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.598 HD13 ' NE2' ' A' ' 198' ' ' GLN . 17.1 tp -87.58 110.82 20.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.540000000000006 109.272 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.734 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.57 145.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 62.520000000000003 109.304 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.585 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -117.47 119.53 35.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 74.219999999999999 110.009 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -134.64 147.1 50.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 64.530000000000001 110.979 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.8 mmtp -71.66 134.0 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 74.209999999999994 109.332 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -74.87 -160.24 0.11 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 74.439999999999998 109.309 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.37 48.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.442 1.089 . . . . 75.239999999999995 109.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.68 -7.93 12.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 61.43 109.978 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.5 37.31 8.18 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.521 1.138 . . . . 64.319999999999993 110.983 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.02 137.47 43.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 71.540000000000006 109.324 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.7 m -71.88 102.69 2.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 65.430000000000007 110.34 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.1 mm-40 -102.23 -172.68 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.551 1.157 . . . . 72.329999999999998 110.284 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.559 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.3 mmtm -126.24 145.68 50.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.447 1.092 . . . . 74.540000000000006 109.347 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.586 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.6 tpt180 -145.7 161.98 38.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.133 . . . . 71.150000000000006 110.32 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.855 HD11 ' OE1' ' A' ' 198' ' ' GLN . 16.1 mm -115.47 116.09 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.1 . . . . 64.319999999999993 109.321 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -102.46 46.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.509 1.131 . . . . 64.409999999999997 109.286 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -110.28 113.66 56.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.545 1.153 . . . . 64.519999999999996 109.232 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.705 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -75.0 -18.13 18.98 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 72.530000000000001 111.038 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.482 ' OG ' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 m -45.6 -25.98 0.54 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 74.209999999999994 109.976 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.427 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 4.1 mt -119.61 -60.46 1.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 72.329999999999998 109.302 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.6 m-85 -106.15 101.12 10.62 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 53.130000000000003 110.998 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -23.27 26.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 61.140000000000001 109.991 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 59.1 m -64.44 -47.8 77.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 65.299999999999997 110.008 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.39 -176.1 39.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.522 1.139 . . . . 52.32 111.006 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -75.03 169.78 21.87 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.475 1.776 . . . . 71.430000000000007 110.983 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.714 HG21 ' CE2' ' A' ' 242' ' ' PHE . 6.4 m -150.99 158.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 73.219999999999999 109.32 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 38.6 p -58.89 141.95 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 60.530000000000001 110.378 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -46.02 -26.1 0.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.541 1.151 . . . . 72.430000000000007 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 28.1 m -78.96 -62.43 1.7 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 74.200000000000003 110.387 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.32 -27.86 6.89 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 71.239999999999995 109.338 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.631 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 14.3 t90 -62.66 -61.43 2.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 64.219999999999999 107.971 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.56 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.59 -42.69 16.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 73.120000000000005 110.249 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.853 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -55.94 -51.02 69.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 73.109999999999999 109.32 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -57.28 -19.46 22.02 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 65.439999999999998 109.3 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -90.0 -35.39 15.55 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 74.049999999999997 108.281 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.853 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -94.02 20.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.501 1.126 . . . . 51.039999999999999 109.286 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -50.45 106.06 0.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 63.450000000000003 109.277 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 262' ' ' GLY . 10.3 p -73.44 -3.2 26.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 65.409999999999997 110.375 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 t -44.02 -31.83 1.01 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 51.450000000000003 110.002 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 50.6 t -87.52 -37.5 16.86 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 71.219999999999999 108.271 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 170.5 -129.2 1.76 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.497 1.123 . . . . 60.549999999999997 110.961 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -76.37 148.21 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 0.726 . . . . 75.010000000000005 109.939 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -169.91 146.99 3.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 70.230000000000004 109.284 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.4 t -172.77 152.88 2.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 74.409999999999997 109.97 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.683 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.6 p -98.26 114.92 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 51.039999999999999 109.285 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.3 t -72.48 -44.77 61.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.511 1.132 . . . . 71.549999999999997 110.052 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -158.59 171.37 20.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.219999999999999 110.003 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -155.62 156.01 34.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 73.430000000000007 111.018 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -166.75 163.58 16.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.438 1.086 . . . . 72.430000000000007 109.288 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.45 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.8 OUTLIER -123.58 160.66 26.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 65.200000000000003 109.296 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.496 HG21 ' CD ' ' A' ' 279' ' ' ARG . 21.4 p -147.5 -175.09 4.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 55.130000000000003 110.411 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 276' ' ' VAL . . . -55.86 169.69 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 74.200000000000003 109.35 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -94.46 -15.96 44.98 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.487 1.117 . . . . 63.229999999999997 111.025 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -94.24 -16.95 23.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 0.775 . . . . 53.549999999999997 109.294 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.674 HG21 ' CD1' ' A' ' 285' ' ' TYR . 0.3 OUTLIER -67.45 115.66 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.559 1.162 . . . . 65.209999999999994 109.283 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.487 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 16.6 t80 -61.66 -54.76 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 74.319999999999993 110.991 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 5.5 t80 -146.54 150.84 36.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 75.010000000000005 110.996 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.594 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 22.3 ttt-85 -121.7 142.7 49.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 65.329999999999998 110.339 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.48 157.87 34.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 61.32 109.96 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.76 8.51 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.503 1.791 . . . . 53.25 111.014 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 43.2 t -101.72 5.64 41.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.542 1.151 . . . . 70.409999999999997 109.961 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.9 t-20 81.66 22.86 0.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.562 1.164 . . . . 72.239999999999995 109.309 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.4 t -103.05 119.08 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 61.409999999999997 109.984 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.674 ' CD1' HG21 ' A' ' 276' ' ' VAL . 64.5 m-85 -106.12 156.5 18.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 73.209999999999994 111.007 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.574 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -113.76 176.1 5.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 62.530000000000001 109.279 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 96.5 m-85 -163.55 115.0 1.42 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.496 1.122 . . . . 75.329999999999998 110.997 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 11.4 t0 -115.6 95.87 5.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 54.420000000000002 109.279 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.55 -27.07 25.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 52.340000000000003 109.349 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.459 ' CB ' HG12 ' A' ' 292' ' ' ILE . 43.7 m-20 -99.12 5.76 46.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.13 . . . . 54.009999999999998 109.306 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.3 48.4 2.33 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 74.510000000000005 109.312 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.459 HG12 ' CB ' ' A' ' 290' ' ' ASN . 39.0 mm -78.32 -29.79 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 64.230000000000004 109.274 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.725 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.6 t-20 -94.63 -19.88 20.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.445 1.09 . . . . 73.400000000000006 109.348 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.487 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 16.3 m -87.68 -69.05 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 75.420000000000002 110.352 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 44.5 m-20 -51.39 -27.03 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 63.420000000000002 109.268 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 19.4 t -73.23 -68.8 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 72.109999999999999 108.323 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 293' ' ' ASN . 56.0 t -40.25 -39.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.135 . . . . 71.230000000000004 109.296 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.44 -56.98 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.434 1.084 . . . . 64.310000000000002 109.273 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -17.95 19.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.420000000000002 110.403 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.422 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.4 mmmt -77.41 -41.71 38.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 72.109999999999999 109.315 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.719 ' CE2' HG13 ' A' ' 297' ' ' VAL . 0.8 OUTLIER -106.08 39.64 1.75 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.521 1.138 . . . . 73.120000000000005 111.0 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.7 t -67.89 -53.22 28.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 74.530000000000001 109.99 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.786 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.8 -18.09 38.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 65.530000000000001 109.281 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.749 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 14.2 mt -55.98 137.35 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 71.329999999999998 109.297 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.8 p -148.68 159.87 43.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 71.109999999999999 110.009 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.8 -149.06 40.88 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.475 1.109 . . . . 32.350000000000001 110.976 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 1.2 m -106.74 14.24 27.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.303 -0.999 . . . . 60.200000000000003 108.303 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -132.06 149.21 72.64 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.433 1.083 . . . . 74.349999999999994 110.003 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.737 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -74.97 147.08 88.41 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 74.010000000000005 110.989 -0.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.468 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.6 p -129.99 133.32 24.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 109.988 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.04 -167.87 6.01 Favored 'Cis proline' 0 C--N 1.359 1.13 0 C-N-CA 121.033 -2.486 . . . . 70.340000000000003 110.967 0.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.604 ' HB2' ' OD2' ' A' ' 175' ' ' ASP . . . -56.65 153.8 20.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 61.409999999999997 109.315 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.52 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.0 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 73.400000000000006 110.993 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.8 135.09 33.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.148 . . . . 54.439999999999998 109.278 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.422 HG12 ' HE2' ' A' ' 300' ' ' LYS . 17.1 m -127.2 24.73 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 64.120000000000005 109.274 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 16.5 t -57.04 -18.43 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 64.439999999999998 109.975 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -60.28 -26.6 66.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 62.229999999999997 109.999 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.515 1.134 . . . . 61.020000000000003 108.286 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.779 HD23 ' HB3' ' A' ' 194' ' ' ASP . 7.9 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.284 -0.635 . . . . 52.020000000000003 109.284 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -100.39 111.33 23.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 74.530000000000001 109.319 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 m -73.29 -43.52 60.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.451 1.094 . . . . 75.140000000000001 110.029 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.881 HG23 ' HB3' ' A' ' 224' ' ' SER . 0.4 OUTLIER -112.58 161.22 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 65.099999999999994 109.281 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -101.84 144.75 29.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 71.319999999999993 109.316 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.48 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -33.79 4.34 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.493 1.786 . . . . 71.349999999999994 110.994 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.424 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.19 147.43 19.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.451 1.094 . . . . 72.129999999999995 109.306 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -47.29 -35.18 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 74.140000000000001 109.294 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.3 -45.86 4.36 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 65.510000000000005 109.322 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.782 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -72.85 -34.11 66.56 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.48 1.112 . . . . 73.430000000000007 110.396 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.714 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -59.94 -56.35 22.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.486 1.116 . . . . 73.450000000000003 109.31 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.491 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.3 m-80 -53.46 -31.39 45.32 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 72.329999999999998 109.3 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.08 -54.08 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.149 . . . . 72.319999999999993 109.991 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 140' ' ' ILE . 87.5 mt -45.25 -41.6 8.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 74.140000000000001 109.262 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.656 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.42 -44.66 57.82 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.423 1.077 . . . . 74.049999999999997 110.974 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -46.95 -36.2 7.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.42 1.075 . . . . 54.420000000000002 109.306 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . 61.0 mt-30 -77.31 -55.15 5.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 72.040000000000006 110.303 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.647 HD11 HD12 ' A' ' 188' ' ' LEU . 17.5 mt -50.35 -27.09 4.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 55.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -37.38 60.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 74.219999999999999 109.31 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.4 t-20 -57.74 -17.88 17.97 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 74.340000000000003 109.33 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.452 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.4 mm100 -82.79 -25.72 32.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.420000000000002 110.291 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -40.35 114.27 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.15 . . . . 71.420000000000002 110.028 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.7 m -42.42 124.4 2.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 53.539999999999999 108.3 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.89 -22.04 3.88 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.523 1.14 . . . . 73.439999999999998 111.016 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.709 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 56.8 p -90.09 158.25 17.39 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 0.747 . . . . 65.319999999999993 110.38 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.2 t -89.62 -2.52 58.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 70.349999999999994 109.984 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 162' ' ' THR . 3.2 m -110.27 -1.6 17.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 75.409999999999997 110.396 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.709 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -74.75 134.51 41.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.575 1.172 . . . . 62.140000000000001 109.288 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.423 ' H ' ' NE2' ' A' ' 156' ' ' GLN . 0.5 OUTLIER -55.14 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 72.329999999999998 109.976 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.46 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.6 t -156.27 128.32 3.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 75.120000000000005 109.965 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -74.95 136.61 45.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.031 -2.487 . . . . 73.340000000000003 111.019 -0.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.9 p -73.19 -179.42 3.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.239999999999995 108.269 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.729 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.3 mp -88.28 124.52 41.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.573 1.171 . . . . 74.019999999999996 109.311 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.419 ' HB ' ' NE ' ' A' ' 171' ' ' ARG . 12.4 p -90.13 81.16 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 73.140000000000001 110.403 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -80.28 -11.18 59.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.128 . . . . 74.120000000000005 110.995 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.57 -5.2 35.53 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.519 1.137 . . . . 73.230000000000004 110.314 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.747 ' CE2' HD13 ' A' ' 304' ' ' LEU . 26.8 t80 -129.73 69.68 81.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 75.109999999999999 111.023 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.693 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.4 Cg_endo -74.94 114.19 3.97 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.448 1.762 . . . . 64.329999999999998 111.039 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.566 HG21 ' CE1' ' A' ' 172' ' ' TYR . 22.1 t -153.26 -66.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 61.130000000000003 109.302 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.91 114.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 75.530000000000001 109.28 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 151.64 46.4 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.476 1.11 . . . . 72.099999999999994 111.004 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.455 ' HB2' HG13 ' A' ' 219' ' ' VAL . 84.9 m -85.73 -23.12 27.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.3 -1.0 . . . . 74.010000000000005 108.3 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.57 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 16.1 p90 -67.13 -35.89 80.71 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.145 . . . . 74.530000000000001 110.995 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -68.53 -67.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 44.539999999999999 109.271 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.475 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -44.05 -46.56 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 73.230000000000004 110.319 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.531 ' HB1' ' NZ ' ' A' ' 197' ' ' LYS . . . -44.96 -50.45 10.57 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 73.239999999999995 109.285 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.693 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -54.0 -35.39 61.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 73.129999999999995 109.579 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.729 ' CB ' HD11 ' A' ' 168' ' ' ILE . 17.4 mmmt -73.43 -32.22 64.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 1.143 . . . . 75.230000000000004 109.334 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 20.3 mtm -66.21 -55.95 13.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 63.539999999999999 110.99 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.66 HH21 ' N ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -55.32 -26.86 43.17 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 74.409999999999997 110.364 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.432 ' HG2' HD13 ' A' ' 187' ' ' ILE . 1.2 tt0 -64.05 -43.38 95.69 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 110.266 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.432 HD13 ' HG2' ' A' ' 186' ' ' GLN . 21.4 mm -70.48 -38.04 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.138 . . . . 72.109999999999999 109.281 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.766 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -56.43 -31.6 64.09 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 63.340000000000003 109.319 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.525 ' HG2' HD21 ' A' ' 136' ' ' LEU . 35.7 mtp -72.89 -43.64 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.573 1.171 . . . . 75.420000000000002 110.973 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -45.32 -53.37 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 64.430000000000007 109.296 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -64.66 -27.86 69.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.209999999999994 109.314 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.08 52.33 0.89 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.545 1.153 . . . . 61.409999999999997 111.002 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.782 ' CZ ' HG21 ' A' ' 145' ' ' THR . 60.2 m-85 -150.83 128.13 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.537 0.786 . . . . 63.109999999999999 110.981 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.779 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -98.38 131.51 44.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 61.210000000000001 109.363 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.766 ' HB3' HD22 ' A' ' 188' ' ' LEU . 24.1 p -109.5 -179.3 3.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.5 1.125 . . . . 44.119999999999997 108.276 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.71 176.99 5.44 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.55 1.156 . . . . 62.020000000000003 110.305 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.836 ' HE2' HG22 ' A' ' 221' ' ' ILE . 14.2 mmtt -105.7 171.6 7.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 75.310000000000002 109.302 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 31.8 tt0 -166.81 121.02 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 72.430000000000007 110.288 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 8.8 m-85 -116.37 123.93 48.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.466 1.104 . . . . 64.5 110.99 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.659 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.7 p -115.28 152.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.496 1.122 . . . . 71.209999999999994 109.279 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 5.3 m-85 -124.91 162.75 23.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 73.340000000000003 111.016 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.57 -179.88 17.76 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.455 1.097 . . . . 61.399999999999999 111.005 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.721 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.0 t-20 -69.11 109.62 4.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.528 0.781 . . . . 64.140000000000001 109.276 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.721 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -114.01 93.78 4.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.432 1.083 . . . . 73.239999999999995 109.297 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.52 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 7.1 mttt -93.12 167.19 11.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 34.25 109.349 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.487 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -175.53 151.86 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 61.340000000000003 109.286 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 64.200000000000003 109.962 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.315 -0.995 . . . . 73.310000000000002 108.315 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.693 HG11 ' O ' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -110.28 156.61 11.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 75.409999999999997 109.287 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.52 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -141.34 119.2 11.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 33.240000000000002 109.348 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -125.11 137.1 54.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.01 -1.107 . . . . 75.340000000000003 108.01 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -81.81 4.6 21.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.508 1.13 . . . . 61.539999999999999 110.022 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.505 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.3 p90 -177.74 126.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.319999999999993 110.946 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.514 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 40.5 t60 -112.7 168.71 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 71.120000000000005 109.608 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 1.5 p -144.62 142.07 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 62.520000000000003 109.314 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.76 -165.13 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 52.32 109.304 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.836 HG22 ' HE2' ' A' ' 197' ' ' LYS . 14.2 pt -119.07 124.93 73.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 44.340000000000003 109.305 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.3 tp -85.9 108.99 18.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 70.109999999999999 109.293 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.714 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.61 148.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.128 . . . . 71.439999999999998 109.301 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.881 ' HB3' HG23 ' A' ' 139' ' ' VAL . 49.7 m -116.89 125.39 51.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.010000000000005 110.03 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 34.8 p90 -139.48 137.47 35.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 65.340000000000003 111.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -64.6 131.1 46.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.568 1.167 . . . . 63.539999999999999 109.347 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -72.06 -160.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 65.230000000000004 109.277 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.08 49.56 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 71.340000000000003 109.324 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.98 -7.85 12.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.497 1.123 . . . . 72.239999999999995 110.034 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.42 37.8 8.0 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.495 1.122 . . . . 43.109999999999999 111.001 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.62 43.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.501 0.765 . . . . 72.530000000000001 109.283 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.483 HG23 ' CG2' ' A' ' 139' ' ' VAL . 2.5 m -71.9 102.75 2.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.540000000000006 110.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 224' ' ' SER . 6.8 mm-40 -102.63 -172.58 2.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 75.409999999999997 110.303 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.519 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.1 mmtm -126.18 145.39 50.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 61.420000000000002 109.301 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.636 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.2 tpt180 -143.07 161.44 38.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 74.049999999999997 110.31 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.681 HG21 ' CD1' ' A' ' 252' ' ' TRP . 11.2 mm -114.74 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.562 1.163 . . . . 75.25 109.305 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 237' ' ' ILE . 4.0 mm -102.58 45.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.115 . . . . 74.439999999999998 109.298 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.05 109.47 62.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 75.439999999999998 109.263 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.2 Cg_endo -75.05 -27.3 10.05 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.477 1.777 . . . . 74.129999999999995 110.966 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.9 OUTLIER -45.21 -26.37 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 74.450000000000003 109.992 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.25 -60.39 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 74.409999999999997 109.294 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 255' ' ' ALA . 87.9 m-85 -107.87 99.6 9.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 72.109999999999999 111.009 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.96 -6.28 57.36 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 72.019999999999996 110.015 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.9 p -80.53 -46.09 16.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.539 1.15 . . . . 71.209999999999994 109.97 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.49 -175.76 42.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 74.120000000000005 111.034 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.449 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.98 163.57 35.1 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.503 1.791 . . . . 65.140000000000001 110.987 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 242' ' ' PHE . 2.4 m -150.35 156.88 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 54.229999999999997 109.278 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.423 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.2 p -60.54 140.49 57.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 72.530000000000001 110.434 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.403 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 1.1 p-10 -42.97 -28.98 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.329999999999998 109.281 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.423 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.0 m -71.34 -65.22 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.116 . . . . 73.239999999999995 110.421 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.32 13.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 64.25 109.31 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.681 ' CD1' HG21 ' A' ' 236' ' ' ILE . 12.5 t90 -59.94 -61.12 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.982 -1.118 . . . . 63.240000000000002 107.982 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.566 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.42 -41.61 20.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 61.119999999999997 110.275 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.826 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -57.31 -51.11 70.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 74.209999999999994 109.3 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.588 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.25 -19.51 14.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 62.229999999999997 109.297 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -89.08 -35.81 16.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 73.439999999999998 108.32 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.826 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -93.96 21.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 74.400000000000006 109.304 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -50.22 106.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 64.040000000000006 109.316 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 262' ' ' GLY . 4.6 p -73.48 -3.14 25.74 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 1.129 . . . . 72.049999999999997 110.38 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 39.0 t -44.52 -30.76 0.94 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 73.349999999999994 110.025 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.51 -37.2 15.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 62.219999999999999 108.275 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 166.84 -127.95 1.67 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.53 1.144 . . . . 41.140000000000001 110.983 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.61 144.86 43.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 0.778 . . . . 74.150000000000006 109.942 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.21 147.53 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.439999999999998 109.304 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 84.1 p -172.95 155.56 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.450000000000003 109.973 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.659 HG23 ' CG2' ' A' ' 200' ' ' VAL . 3.8 p -101.14 118.86 48.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.145 . . . . 75.349999999999994 109.357 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.3 t -73.22 -43.75 60.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 73.140000000000001 110.026 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 200' ' ' VAL . 51.2 p -168.8 -179.35 3.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 65.25 110.029 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -159.22 157.16 30.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 73.129999999999995 110.979 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.35 152.22 29.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 62.439999999999998 109.295 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 272' ' ' THR . 0.8 OUTLIER -112.36 160.71 17.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 72.519999999999996 109.344 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.642 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.7 p -153.83 -178.45 7.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 61.240000000000002 110.396 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.829 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -68.24 162.15 25.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.461 1.101 . . . . 63.420000000000002 109.311 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.9 -44.69 36.37 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.515 1.135 . . . . 73.209999999999994 111.015 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.66 ' N ' HH21 ' A' ' 185' ' ' ARG . 1.7 p30 -53.18 -41.01 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 0.777 . . . . 72.510000000000005 109.299 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.829 HG23 ' HB3' ' A' ' 273' ' ' ALA . 22.8 t -43.56 120.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 74.540000000000006 109.247 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -82.2 -53.07 6.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.523 1.139 . . . . 73.209999999999994 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -136.92 152.83 50.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 74.239999999999995 111.002 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.642 ' HD2' HG21 ' A' ' 272' ' ' THR . 78.2 ttt-85 -126.86 147.3 50.06 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 73.230000000000004 110.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.96 158.14 50.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.47 1.106 . . . . 62.420000000000002 109.936 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 0.25 9.15 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.465 1.771 . . . . 73.409999999999997 110.952 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 7.1 t -98.98 4.98 47.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 110.015 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 75.38 41.56 0.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.349999999999994 109.338 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -120.21 120.39 36.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.467 1.104 . . . . 64.049999999999997 109.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.46 ' OH ' HG22 ' A' ' 272' ' ' THR . 11.7 m-30 -103.05 160.65 14.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 61.399999999999999 111.035 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.498 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -125.42 177.24 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 54.329999999999998 109.342 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.7 m-85 -161.03 115.84 2.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.476 1.11 . . . . 64.540000000000006 111.016 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.43 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 1.0 OUTLIER -115.36 96.78 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 109.348 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -85.63 -19.11 31.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 75.439999999999998 109.253 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.473 ' HB3' HD11 ' A' ' 292' ' ' ILE . 38.6 m-20 -107.65 6.59 27.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.430000000000007 109.297 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.693 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.26 47.22 2.09 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 73.209999999999994 109.3 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.473 HD11 ' HB3' ' A' ' 290' ' ' ASN . 47.5 mm -76.51 -31.58 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 73.310000000000002 109.296 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.78 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.5 t-20 -94.78 -18.51 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.112 . . . . 71.400000000000006 109.27 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.52 HG22 ' HD3' ' A' ' 183' ' ' LYS . 2.0 m -84.76 -66.51 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 60.439999999999998 110.424 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 87.8 m-20 -56.68 -18.71 13.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 52.399999999999999 109.278 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 4.9 t -80.49 -63.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.128 . . . . 74.030000000000001 108.308 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 293' ' ' ASN . 65.9 t -46.93 -37.24 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.52 1.138 . . . . 71.040000000000006 109.334 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.663 HD11 ' HG3' ' A' ' 183' ' ' LYS . 85.2 mt -67.69 -57.8 5.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.12 . . . . 74.129999999999995 109.277 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.85 -20.76 16.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 110.384 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -72.27 -39.2 68.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 70.340000000000003 109.3 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.943 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.6 m-30 -101.78 35.09 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.498 1.123 . . . . 64.340000000000003 110.987 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.3 t -67.96 -43.85 78.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 73.150000000000006 110.01 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.785 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -95.62 -17.18 21.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.102 . . . . 54.439999999999998 109.278 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.943 HD12 ' CD1' ' A' ' 301' ' ' PHE . 14.2 mt -56.58 153.43 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 63.200000000000003 109.288 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.1 p -165.55 162.17 18.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.528 1.142 . . . . 72.0 110.039 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 65.69 -153.1 51.48 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.507 1.13 . . . . 75.019999999999996 110.979 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 3.0 m -99.38 9.77 42.66 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.294 -1.002 . . . . 73.040000000000006 108.294 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.527 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -125.06 148.85 61.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 55.009999999999998 109.953 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.735 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -74.96 147.06 88.37 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.965 -2.515 . . . . 73.409999999999997 111.014 -0.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.467 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.1 OUTLIER -128.83 133.33 25.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 63.140000000000001 110.006 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.99 -168.73 6.72 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 120.974 -2.511 . . . . 73.219999999999999 111.042 -0.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 150.3 40.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.135 . . . . 73.219999999999999 109.318 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.525 1.803 . . . . 71.019999999999996 111.03 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.47 127.33 39.07 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.143 . . . . 73.239999999999995 109.237 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.52 27.22 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 72.099999999999994 109.297 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 12.5 t -51.72 -35.55 43.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 70.019999999999996 109.993 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 30.8 m -42.3 -28.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.422 1.076 . . . . 73.420000000000002 110.025 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 62.0 m . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.420000000000002 108.29 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 194' ' ' ASP . 12.5 tp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.316 -0.624 . . . . 71.420000000000002 109.316 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -102.56 106.91 17.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 64.430000000000007 109.302 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 m -69.33 -42.59 75.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.478 1.111 . . . . 61.399999999999999 109.972 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.845 HG23 ' HB3' ' A' ' 224' ' ' SER . 0.4 OUTLIER -112.79 159.75 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 109.298 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.866 HD11 HD12 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.07 143.83 26.95 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 72.150000000000006 109.316 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.4 Cg_endo -75.02 -33.23 4.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.514 1.797 . . . . 75.349999999999994 110.984 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.41 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.37 146.28 16.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 61.109999999999999 109.267 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -45.15 -36.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.158 . . . . 62.240000000000002 109.271 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.75 2.96 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.546 1.153 . . . . 63.539999999999999 109.265 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.8 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.11 -36.26 72.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.546 1.154 . . . . 34.299999999999997 110.406 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.742 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.7 -57.26 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 72.239999999999995 109.32 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.501 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 48.8 m-80 -51.91 -31.93 30.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 62.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.75 -56.66 7.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 62.229999999999997 109.998 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.866 HD12 HD11 ' A' ' 140' ' ' ILE . 22.6 mt -43.05 -41.08 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 63.32 109.28 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.763 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.02 -44.48 54.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.544 1.153 . . . . 73.219999999999999 111.003 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -48.52 -34.82 11.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.135 . . . . 74.120000000000005 109.324 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.438 HE22 ' ND2' ' A' ' 191' ' ' ASN . 54.0 mt-30 -77.69 -51.7 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 72.450000000000003 110.335 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 188' ' ' LEU . 17.6 mt -54.61 -24.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.147 . . . . 51.340000000000003 109.327 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -34.73 49.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 72.040000000000006 109.26 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -58.64 -20.08 44.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 1.137 . . . . 62.25 109.295 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.462 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 8.9 mm100 -77.63 -24.1 49.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 74.409999999999997 110.29 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 160' ' ' THR . 6.3 m -38.99 113.04 0.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 70.219999999999999 109.967 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.9 m -43.05 129.65 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 55.32 108.301 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 125.36 -14.24 7.35 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 71.010000000000005 110.989 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.676 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 45.1 p -98.47 154.22 18.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 0.775 . . . . 52.310000000000002 110.434 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 p -86.4 -3.61 59.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.548 1.155 . . . . 73.319999999999993 109.974 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 -3.98 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 71.030000000000001 110.369 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.676 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -76.93 133.6 39.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 71.450000000000003 109.285 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -168.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 63.439999999999998 109.99 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.464 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -155.91 128.16 4.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 61.409999999999997 110.002 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 136.62 46.04 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 120.967 -2.514 . . . . 52.030000000000001 111.03 -0.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 13.2 p -73.01 179.66 3.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.129999999999995 108.3 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 183' ' ' LYS . 4.4 mp -91.9 135.41 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.094 . . . . 74.140000000000001 109.336 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.8 p -96.19 94.53 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.122 . . . . 54.399999999999999 110.388 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.516 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 90.2 m-85 -88.48 -15.46 35.3 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.557 1.161 . . . . 72.109999999999999 110.993 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.67 -2.02 24.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 74.120000000000005 110.285 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.565 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 30.9 t80 -132.38 67.18 78.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 74.040000000000006 111.014 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.416 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -75.03 112.53 3.58 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.471 1.774 . . . . 64.230000000000004 110.991 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.533 HG21 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.95 -72.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 71.400000000000006 109.305 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -152.6 125.12 8.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 62.210000000000001 109.325 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 139.34 44.29 0.07 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.467 1.105 . . . . 72.400000000000006 111.02 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 218' ' ' HIS . 6.0 t -81.56 -25.42 35.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.329 -0.989 . . . . 64.150000000000006 108.329 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.467 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 28.4 p90 -71.47 -28.67 64.11 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 74.439999999999998 110.992 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.09 -68.12 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.423 1.077 . . . . 63.039999999999999 109.307 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.508 HH21 ' HE2' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -45.24 -47.69 12.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 70.129999999999995 110.298 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB1' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.2 -55.09 4.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.465 1.103 . . . . 71.109999999999999 109.28 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.42 -36.61 15.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 74.140000000000001 109.582 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.834 ' CB ' HD11 ' A' ' 168' ' ' ILE . 9.4 mmmm -77.07 -32.82 57.04 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.149 . . . . 72.120000000000005 109.3 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 181' ' ' ALA . 18.3 mtm -63.6 -50.23 70.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 71.140000000000001 110.99 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.521 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.0 OUTLIER -64.43 -26.34 68.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 72.040000000000006 110.316 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -38.92 90.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 73.450000000000003 110.301 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.436 ' CG2' ' CB ' ' A' ' 152' ' ' GLN . 21.2 mm -70.7 -37.68 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 64.409999999999997 109.336 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -54.69 -44.08 73.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.525 1.141 . . . . 73.310000000000002 109.273 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.521 ' HE3' ' CZ ' ' A' ' 185' ' ' ARG . 13.7 mtt -58.85 -43.59 90.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 60.420000000000002 111.047 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.08 -51.46 24.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 75.340000000000003 109.3 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.438 ' ND2' HE22 ' A' ' 152' ' ' GLN . 6.1 t-20 -68.74 -26.06 65.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.451 1.094 . . . . 75.230000000000004 109.257 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.15 57.94 0.84 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.495 1.122 . . . . 61.109999999999999 110.982 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.8 ' CZ ' HG21 ' A' ' 145' ' ' THR . 59.6 m-85 -152.13 140.37 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.459 0.741 . . . . 75.140000000000001 110.999 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.967 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -105.53 130.8 53.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 72.230000000000004 109.301 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.915 ' HB3' HD22 ' A' ' 188' ' ' LEU . 11.4 p -109.42 -179.52 3.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 65.430000000000007 108.258 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.13 175.65 8.25 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.543 1.152 . . . . 75.200000000000003 110.279 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.595 ' HE2' HG22 ' A' ' 221' ' ' ILE . 15.8 mmtt -108.9 159.32 16.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 73.430000000000007 109.306 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 8.3 tt0 -152.4 117.72 5.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.548 1.155 . . . . 74.510000000000005 110.273 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -108.94 136.13 48.98 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.496 1.122 . . . . 62.109999999999999 111.047 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.657 HG22 HG23 ' A' ' 266' ' ' VAL . 9.4 p -131.81 143.33 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 75.349999999999994 109.318 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.3 m-85 -117.7 161.38 19.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 71.200000000000003 110.952 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.63 -179.62 17.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.502 1.126 . . . . 53.450000000000003 111.023 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.725 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.8 t-20 -69.08 110.22 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.430000000000007 109.324 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.8 mt -114.32 93.98 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 74.120000000000005 109.301 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.655 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 7.0 mttt -93.36 166.14 12.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 73.030000000000001 109.297 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 212' ' ' CYS . . . -173.28 148.18 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 75.109999999999999 109.286 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 63.240000000000002 109.953 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 108.314 -0.995 . . . . 64.430000000000007 108.314 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -117.99 157.52 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 53.140000000000001 109.27 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.655 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -140.76 120.55 13.47 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 70.530000000000001 109.26 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m-90 -125.95 135.67 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 74.549999999999997 107.995 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.6 t -81.14 1.21 32.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.25 109.969 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.522 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 11.2 p90 -172.23 125.62 0.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.467 1.104 . . . . 74.400000000000006 111.024 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.6 ' CE1' ' SG ' ' A' ' 177' ' ' CYS . 76.4 t60 -125.41 157.7 36.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.209999999999994 109.568 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 177' ' ' CYS . 1.5 p -131.5 163.99 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.548 1.155 . . . . 54.240000000000002 109.288 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.65 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -156.19 -167.55 2.47 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.517 1.136 . . . . 50.420000000000002 109.292 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.595 HG22 ' HE2' ' A' ' 197' ' ' LYS . 30.6 pt -117.77 119.79 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 63.25 109.316 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 234' ' ' LYS . 10.8 tp -83.11 109.86 17.52 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.555 1.159 . . . . 75.140000000000001 109.304 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.742 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -106.15 147.48 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 71.340000000000003 109.313 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.845 ' HB3' HG23 ' A' ' 139' ' ' VAL . 37.0 m -116.74 125.4 51.6 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 73.099999999999994 109.983 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.572 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -140.52 137.44 33.81 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.54 1.15 . . . . 74.200000000000003 110.977 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.406 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 17.9 mmtp -64.08 132.45 50.55 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.153 . . . . 53.439999999999998 109.307 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -72.82 -160.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 74.340000000000003 109.311 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.86 0.34 48.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.319999999999993 109.309 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.32 -8.56 12.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 109.997 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.45 37.73 7.44 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.469 1.106 . . . . 75.450000000000003 110.967 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.65 136.97 46.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.535 0.785 . . . . 73.540000000000006 109.28 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.493 HG23 ' CG2' ' A' ' 139' ' ' VAL . 2.5 m -71.23 102.79 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 70.409999999999997 110.389 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.43 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.2 mm-40 -102.33 -172.65 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.133 . . . . 73.340000000000003 110.32 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.493 ' HB3' HD11 ' A' ' 222' ' ' LEU . 13.8 mmtm -126.1 145.36 50.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 70.510000000000005 109.283 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.7 tpt180 -145.88 160.34 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 62.409999999999997 110.325 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.547 HG21 ' CD1' ' A' ' 252' ' ' TRP . 9.9 mm -114.24 120.89 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 75.519999999999996 109.251 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 150' ' ' PHE . 5.5 mm -104.29 44.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 74.329999999999998 109.288 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.57 113.62 62.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 1.146 . . . . 75.040000000000006 109.271 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.516 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -75.03 -26.61 10.71 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.501 1.79 . . . . 71.420000000000002 111.009 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.419 ' HB2' ' NH2' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -41.53 -30.76 0.22 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 74.5 110.049 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.2 mt -110.05 -61.14 1.7 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 72.319999999999993 109.317 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 247' ' ' VAL . 98.3 m-85 -108.78 99.51 8.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 74.329999999999998 111.013 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 69.5 m -86.39 -15.98 38.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 64.5 109.998 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.8 t -73.92 -40.05 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.135 . . . . 70.120000000000005 110.011 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.6 -177.54 45.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 51.119999999999997 111.04 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.437 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.96 170.57 20.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.503 1.791 . . . . 74.420000000000002 111.062 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.869 HG21 ' CE2' ' A' ' 242' ' ' PHE . 11.2 m -150.84 158.55 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.506 1.129 . . . . 64.209999999999994 109.287 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.404 ' C ' ' N ' ' A' ' 250' ' ' THR . 40.6 p -60.64 141.45 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.157 . . . . 51.100000000000001 110.379 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -46.3 -25.91 0.71 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 71.319999999999993 109.331 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.404 ' N ' ' C ' ' A' ' 248' ' ' THR . 21.4 m -79.37 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.219999999999999 110.439 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -54.42 -22.22 11.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 63.210000000000001 109.283 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.65 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.6 t90 -66.56 -57.8 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.513 1.133 . . . . 64.439999999999998 107.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.556 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -49.22 -42.99 42.16 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 30.149999999999999 110.33 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.834 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -56.24 -51.04 69.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 75.340000000000003 109.31 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.6 -19.36 10.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.444 1.09 . . . . 73.209999999999994 109.321 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -89.0 -36.79 15.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.329999999999998 108.266 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.834 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.4 m -92.73 20.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 73.420000000000002 109.315 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -50.18 105.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.467 1.105 . . . . 72.019999999999996 109.266 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.41 -3.26 26.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 75.430000000000007 110.352 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 t -44.47 -30.13 0.82 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 52.140000000000001 110.01 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.8 t -89.01 -37.3 15.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.115 . . . . 63.509999999999998 108.29 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.13 -129.3 1.86 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.481 1.113 . . . . 75.439999999999998 111.019 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -73.9 145.18 45.0 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.582 0.813 . . . . 64.209999999999994 110.036 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.16 147.68 4.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 62.100000000000001 109.281 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 94.7 p -172.9 155.48 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 75.099999999999994 110.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.657 HG23 HG22 ' A' ' 200' ' ' VAL . 3.7 p -101.42 117.95 47.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 74.230000000000004 109.313 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.2 t -73.89 -44.19 56.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 74.420000000000002 109.981 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.4 m -166.65 172.97 10.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 63.340000000000003 110.002 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.408 ' HB3' HG23 ' A' ' 200' ' ' VAL . 30.9 p90 -154.64 156.05 35.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 73.230000000000004 111.011 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.65 153.34 31.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 1.151 . . . . 65.209999999999994 109.311 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 272' ' ' THR . 1.0 OUTLIER -113.49 160.7 18.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 72.5 109.257 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 285' ' ' TYR . 2.5 p -154.37 -179.61 8.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.52 1.137 . . . . 75.329999999999998 110.41 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.85 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -66.83 167.76 10.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 60.310000000000002 109.307 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.9 -41.77 13.97 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.481 1.113 . . . . 74.010000000000005 110.986 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -57.2 -42.59 81.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.509 0.77 . . . . 64.409999999999997 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.85 HG23 ' HB3' ' A' ' 273' ' ' ALA . 44.1 t -43.86 118.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.030000000000001 109.297 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.582 ' CD2' ' OD2' ' A' ' 288' ' ' ASP . 18.4 t80 -73.74 -53.46 10.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 74.549999999999997 111.003 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 279' ' ' ARG . 31.0 t80 -136.31 166.7 22.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 70.340000000000003 111.008 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.0 ttt-85 -135.39 147.45 49.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 64.420000000000002 110.283 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.85 158.03 50.94 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 61.299999999999997 109.997 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 0.32 9.08 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.565 1.823 . . . . 70.349999999999994 111.01 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 42.0 p -98.42 4.23 48.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 74.430000000000007 109.993 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.3 t-20 77.21 41.74 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.409999999999997 109.304 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 t -122.66 131.4 53.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 64.430000000000007 109.973 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.552 ' HB3' HG13 ' A' ' 276' ' ' VAL . 16.4 m-30 -111.65 153.13 26.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 73.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.587 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.95 177.44 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.458 1.099 . . . . 73.209999999999994 109.334 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 84.9 m-85 -160.25 115.79 2.33 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 75.319999999999993 111.044 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.582 ' OD2' ' CD2' ' A' ' 277' ' ' TYR . 0.7 OUTLIER -115.43 94.98 4.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.478 1.111 . . . . 70.219999999999999 109.337 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -85.61 -18.34 33.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.483 1.115 . . . . 60.299999999999997 109.297 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.44 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.3 m-20 -107.09 3.28 25.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.476 1.11 . . . . 73.409999999999997 109.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.56 47.43 2.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.448 1.092 . . . . 73.109999999999999 109.27 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.44 HG12 ' CB ' ' A' ' 290' ' ' ASN . 22.5 mm -74.27 -32.63 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 62.219999999999999 109.276 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.659 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.9 t-20 -90.72 -26.17 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 72.439999999999998 109.291 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.459 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 1.3 m -79.37 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.463 1.102 . . . . 62.299999999999997 110.409 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -54.59 -20.13 7.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.133 . . . . 62.399999999999999 109.272 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 40.4 t -86.32 -62.22 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.477 1.111 . . . . 73.430000000000007 108.288 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.9 t -40.29 -41.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 55.340000000000003 109.29 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' A' ' 168' ' ' ILE . 24.3 mt -69.96 -56.13 7.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 75.329999999999998 109.316 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -55.3 -18.46 6.4 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 110.449 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.609 ' HE2' HG12 ' A' ' 315' ' ' VAL . 18.6 mmmt -75.38 -45.77 37.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 72.450000000000003 109.302 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.694 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.6 m-30 -99.81 38.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.563 1.165 . . . . 71.209999999999994 111.029 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.1 t -69.5 -45.01 69.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.122 . . . . 55.409999999999997 110.029 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.801 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.67 -17.7 22.95 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 51.530000000000001 109.277 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.767 HD22 ' CD ' ' A' ' 309' ' ' PRO . 14.8 mt -59.52 144.91 46.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 73.040000000000006 109.34 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.3 p -154.02 158.08 40.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 75.420000000000002 110.057 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 70.32 -162.17 53.25 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.505 1.128 . . . . 74.230000000000004 110.969 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 310' ' ' SER . 9.4 p -92.1 13.9 17.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.29 -1.004 . . . . 74.5 108.29 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 3.3 m -132.96 148.1 68.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 62.439999999999998 110.009 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.767 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 145.42 83.87 Favored 'Cis proline' 0 C--N 1.361 1.196 0 C-N-CA 120.984 -2.507 . . . . 64.099999999999994 111.008 0.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -131.35 135.6 27.33 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.117 . . . . 71.310000000000002 109.996 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.97 -174.96 15.03 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.016 -2.493 . . . . 72.209999999999994 111.026 -0.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.43 154.96 21.06 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 73.319999999999993 109.296 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.425 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.97 -162.23 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.498 1.788 . . . . 22.129999999999999 111.011 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -82.96 131.52 35.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 72.040000000000006 109.297 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.609 HG12 ' HE2' ' A' ' 300' ' ' LYS . 34.1 m -129.39 26.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.512 1.133 . . . . 70.340000000000003 109.305 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 6.9 t -70.76 -33.52 70.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 54.409999999999997 109.982 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 p -45.75 -25.71 0.54 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 64.530000000000001 110.01 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 71.439999999999998 108.275 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.98 HD23 ' HB2' ' A' ' 194' ' ' ASP . 9.0 tp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.348 -0.612 . . . . 73.310000000000002 109.348 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.553 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -103.88 105.47 15.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 73.450000000000003 109.32 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -83.64 7.89 16.03 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 73.030000000000001 110.002 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.4 t -150.4 145.86 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.47 1.106 . . . . 41.439999999999998 109.327 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.044 HD11 HD12 ' A' ' 149' ' ' LEU . 1.6 mt -97.05 141.67 23.4 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 60.049999999999997 109.322 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -30.54 7.09 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.506 1.793 . . . . 70.25 110.968 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.58 150.25 15.71 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.476 1.11 . . . . 62.210000000000001 109.293 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.517 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -48.54 -36.67 7.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 73.25 109.258 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.99 -47.49 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 72.129999999999995 109.242 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.733 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.44 -36.19 71.18 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 61.350000000000001 110.375 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.728 HD11 HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -58.1 -57.17 14.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 1.093 . . . . 73.420000000000002 109.278 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.517 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 47.6 m-80 -51.71 -32.34 29.82 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 72.209999999999994 109.332 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.25 -53.83 17.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 50.340000000000003 110.007 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.044 HD12 HD11 ' A' ' 140' ' ' ILE . 63.4 mt -45.56 -41.55 10.0 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.53 1.144 . . . . 74.239999999999995 109.291 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.677 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.38 -44.7 58.03 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 75.239999999999995 110.991 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -47.21 -33.89 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 74.319999999999993 109.319 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.451 ' HB2' ' CG2' ' A' ' 187' ' ' ILE . 62.9 mt-30 -78.53 -53.9 6.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 71.140000000000001 110.302 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 188' ' ' LEU . 24.1 mt -51.28 -28.32 7.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 71.209999999999994 109.281 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -38.48 63.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 72.109999999999999 109.273 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.94 -16.97 20.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.536 1.147 . . . . 71.109999999999999 109.283 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.485 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 10.0 mm100 -86.83 -26.55 23.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.514 1.134 . . . . 70.129999999999995 110.272 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 m -40.04 128.78 2.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 63.240000000000002 109.979 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.71 112.43 1.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 75.209999999999994 108.326 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.76 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 44.5 110.969 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.68 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 37.4 p -95.47 161.1 14.21 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 0.736 . . . . 70.510000000000005 110.383 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.64 -7.59 49.59 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 54.109999999999999 110.01 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.4 m -103.53 -4.23 24.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.096 . . . . 64.109999999999999 110.396 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.68 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -71.91 136.32 46.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 34.240000000000002 109.291 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.05 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 61.009999999999998 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.421 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.1 m -156.24 127.2 3.57 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 72.239999999999995 110.017 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.421 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 140.06 65.22 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 120.994 -2.503 . . . . 71.340000000000003 111.008 0.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.644 ' O ' HD13 ' A' ' 298' ' ' LEU . 6.6 p -72.78 -178.6 2.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 33.539999999999999 108.319 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 183' ' ' LYS . 2.2 mp -83.45 128.51 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 75.239999999999995 109.275 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 51.3 p -96.56 69.15 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 73.209999999999994 110.374 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -81.25 -11.36 59.4 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 73.340000000000003 111.023 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.456 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.31 -1.82 25.4 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.545 1.153 . . . . 74.450000000000003 110.288 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.793 ' CE2' HD13 ' A' ' 304' ' ' LEU . 18.9 t80 -131.47 64.59 73.7 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 74.329999999999998 110.984 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.432 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.95 123.09 7.65 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.444 1.76 . . . . 63.030000000000001 111.024 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.7 t -152.68 -55.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 65.109999999999999 109.324 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 177' ' ' CYS . 5.2 m-20 -147.22 -78.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.146 . . . . 72.299999999999997 109.313 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.38 92.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.505 1.128 . . . . 63.299999999999997 110.978 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.602 ' SG ' ' CE1' ' A' ' 218' ' ' HIS . 13.4 t -115.36 -16.0 11.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 75.519999999999996 108.293 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 33.1 p90 -74.99 -45.0 44.99 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.482 1.114 . . . . 73.129999999999995 111.02 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -41.58 -68.39 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.529 1.143 . . . . 72.439999999999998 109.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -47.67 -47.23 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 73.400000000000006 110.333 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -46.86 -55.86 7.27 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.47 1.106 . . . . 73.099999999999994 109.289 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.701 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.1 -30.23 4.31 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 70.409999999999997 109.604 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.755 ' HB2' HD11 ' A' ' 168' ' ' ILE . 21.4 mmmt -85.12 -31.99 23.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 71.030000000000001 109.275 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.57 ' HB3' HD13 ' A' ' 221' ' ' ILE . 31.2 mtm -62.51 -36.7 83.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 53.439999999999998 111.0 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.456 ' CB ' ' SG ' ' A' ' 195' ' ' CYS . 0.0 OUTLIER -78.32 -33.77 49.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 64.299999999999997 110.293 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.553 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -53.9 -35.44 61.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 75.340000000000003 110.303 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.452 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 21.8 mm -74.67 -48.06 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.529 1.143 . . . . 72.140000000000001 109.296 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -47.22 -36.87 9.45 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.452 1.095 . . . . 73.150000000000006 109.305 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.403 ' SD ' ' CD ' ' A' ' 185' ' ' ARG . 6.5 mtt -65.72 -46.96 76.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 74.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -46.43 -51.31 15.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 73.25 109.304 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.408 ' ND2' HE22 ' A' ' 152' ' ' GLN . 7.0 t-20 -65.33 -34.81 79.2 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 74.340000000000003 109.31 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.93 54.19 0.46 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.473 1.108 . . . . 70.109999999999999 110.984 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.733 ' CZ ' HG21 ' A' ' 145' ' ' THR . 78.1 m-85 -152.24 142.18 22.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 0.772 . . . . 63.450000000000003 110.994 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.98 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -108.13 128.65 54.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 72.5 109.291 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 1.015 ' HB3' HD22 ' A' ' 188' ' ' LEU . 12.5 p -104.45 178.22 4.62 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.49 1.119 . . . . 61.130000000000003 108.28 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -127.17 173.81 9.42 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.329999999999998 110.322 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.456 ' NZ ' ' HB1' ' A' ' 181' ' ' ALA . 21.4 mmtt -108.3 153.78 22.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.544 1.153 . . . . 73.349999999999994 109.303 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.474 ' NE2' HD13 ' A' ' 222' ' ' LEU . 9.2 tt0 -147.34 117.42 7.27 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.528 1.142 . . . . 72.099999999999994 110.326 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.0 m-85 -110.59 123.29 49.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 70.329999999999998 110.973 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.67 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.0 p -114.99 151.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 72.140000000000001 109.313 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.451 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 13.0 m-85 -122.27 161.18 23.77 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 71.150000000000006 111.01 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.6 -178.4 16.72 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.478 1.111 . . . . 50.350000000000001 111.006 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.733 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.8 t-20 -69.96 109.44 4.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.574 0.808 . . . . 62.25 109.328 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.733 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.5 mt -114.26 94.5 4.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.155 . . . . 50.210000000000001 109.329 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.484 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 8.4 mttt -92.96 164.3 13.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 63.240000000000002 109.305 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.748 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -175.69 170.92 2.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.113 . . . . 50.509999999999998 109.321 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.109999999999999 110.013 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 108.267 -1.012 . . . . 74.5 108.267 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.748 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.9 m -111.12 128.75 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 40.130000000000003 109.314 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.484 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 63.119999999999997 109.327 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.3 m0 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.119 . . . . 65.150000000000006 108.034 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -81.65 -1.31 46.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 75.010000000000005 110.007 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.501 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.2 p90 -169.8 127.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 73.409999999999997 110.977 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.602 ' CE1' ' SG ' ' A' ' 177' ' ' CYS . 85.8 t60 -124.79 149.24 47.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 63.350000000000001 109.597 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 220' ' ' ALA . 1.5 p -118.1 164.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 75.439999999999998 109.292 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.644 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.06 -170.53 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.13 . . . . 65.200000000000003 109.321 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.648 HD11 ' HB ' ' A' ' 237' ' ' ILE . 21.1 pt -116.44 118.38 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.546 1.154 . . . . 71.219999999999999 109.272 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 234' ' ' LYS . 11.8 tp -83.99 108.64 17.07 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.461 1.101 . . . . 73.129999999999995 109.327 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.728 HG21 HD11 ' A' ' 146' ' ' LEU . 0.9 OUTLIER -102.95 143.89 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 74.25 109.311 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.615 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.2 OUTLIER -116.32 116.78 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 52.229999999999997 109.981 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.575 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.5 p90 -131.92 145.83 51.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.121 . . . . 75.510000000000005 111.019 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -70.76 132.73 45.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 64.209999999999994 109.335 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.28 -160.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 63.409999999999997 109.283 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.89 -0.06 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 73.239999999999995 109.244 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -114.86 -8.51 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 73.209999999999994 109.984 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.86 37.55 7.86 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.494 1.121 . . . . 71.239999999999995 111.016 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.41 137.95 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 71.299999999999997 109.294 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.0 m -71.87 102.55 2.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 62.409999999999997 110.368 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 224' ' ' SER . 6.9 mm-40 -102.12 -172.71 2.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 62.240000000000002 110.275 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.544 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.8 mmtt -127.3 144.63 51.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 73.140000000000001 109.304 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.577 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.0 tpt180 -143.91 163.31 33.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 70.140000000000001 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.577 HG21 ' CD1' ' A' ' 252' ' ' TRP . 22.0 mm -118.82 116.98 52.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 73.430000000000007 109.319 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -98.7 50.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 65.120000000000005 109.327 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.443 ' OD1' HG22 ' A' ' 236' ' ' ILE . 41.2 p-10 -96.6 109.61 48.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 74.150000000000006 109.349 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.477 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -74.98 -50.55 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.505 1.792 . . . . 71.239999999999995 111.002 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.3 OUTLIER -36.51 -34.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 51.229999999999997 110.017 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 241' ' ' LEU . 13.9 mt -97.36 -60.97 1.47 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.144 . . . . 64.209999999999994 109.302 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.732 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.2 m-85 -112.02 99.68 8.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.16 . . . . 64.439999999999998 111.0 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -22.08 33.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 73.239999999999995 109.961 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.1 m -66.49 -47.26 73.57 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.126 . . . . 71.219999999999999 109.961 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.18 41.13 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.486 1.116 . . . . 62.240000000000002 110.977 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.446 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.94 170.47 20.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.512 1.796 . . . . 73.549999999999997 111.019 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.732 HG21 ' CE2' ' A' ' 242' ' ' PHE . 14.6 m -147.74 156.3 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.084 . . . . 73.219999999999999 109.318 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.432 ' N ' ' HE ' ' A' ' 235' ' ' ARG . 41.8 p -59.51 139.01 57.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 71.540000000000006 110.398 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.45 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 23.2 p-10 -43.08 -28.19 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 64.150000000000006 109.327 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.43 ' N ' ' C ' ' A' ' 248' ' ' THR . 11.5 m -77.12 -62.55 1.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.424 1.077 . . . . 73.349999999999994 110.411 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.03 -24.71 4.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 64.140000000000001 109.325 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.644 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 11.1 t90 -66.11 -64.66 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 75.349999999999994 108.038 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.886 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.2 OUTLIER -43.06 -33.56 0.87 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.112 . . . . 73.230000000000004 110.295 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.885 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.5 m-80 -66.25 -48.91 68.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 71.25 109.325 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -57.45 -18.18 17.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.128 . . . . 64.219999999999999 109.26 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.478 ' O ' ' N ' ' A' ' 205' ' ' LYS . 9.6 m -92.53 -33.98 14.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 72.140000000000001 108.269 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 253' ' ' ARG . 2.9 m -93.79 20.44 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 64.040000000000006 109.258 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 46.4 t30 -44.4 104.63 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.106 . . . . 65.329999999999998 109.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.2 p -74.24 -4.72 37.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 70.319999999999993 110.408 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.412 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -47.79 -26.66 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 64.230000000000004 110.007 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 18.2 t -91.08 -34.76 14.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 71.040000000000006 108.316 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.73 -129.8 2.23 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.517 1.135 . . . . 63.340000000000003 111.038 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.441 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -67.0 145.18 55.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 0.741 . . . . 74.340000000000003 109.959 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -173.22 142.23 1.01 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 55.32 109.298 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.9 p -173.08 153.46 2.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 73.129999999999995 109.998 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.67 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.15 120.71 47.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.501 1.125 . . . . 61.310000000000002 109.293 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 16.9 t -76.12 -43.07 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.434 1.084 . . . . 64.319999999999993 110.007 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 200' ' ' VAL . 54.6 m -164.56 -172.52 2.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 71.329999999999998 109.971 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -166.75 157.27 11.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 75.420000000000002 111.025 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.9 157.55 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 54.310000000000002 109.281 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.485 ' C ' HG23 ' A' ' 272' ' ' THR . 1.5 p-10 -122.92 160.09 26.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 63.109999999999999 109.307 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.582 ' HB ' HG21 ' A' ' 276' ' ' VAL . 48.2 p -154.98 176.94 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.096 . . . . 71.400000000000006 110.408 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.595 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -57.74 160.91 4.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 75.010000000000005 109.291 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.1 -21.65 78.81 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.526 1.141 . . . . 74.340000000000003 110.984 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.44 ' OD1' ' HB1' ' A' ' 273' ' ' ALA . 1.5 p-10 -74.19 -35.03 63.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 0.759 . . . . 64.140000000000001 109.302 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 273' ' ' ALA . 53.4 t -43.67 101.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.479 1.112 . . . . 62.020000000000003 109.253 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.559 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 4.6 t80 -63.12 -53.63 50.42 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 74.209999999999994 111.029 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -146.85 135.04 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.148 . . . . 73.099999999999994 110.988 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.57 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 72.8 ttt-85 -106.15 147.44 29.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 74.420000000000002 110.294 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.19 157.95 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.439 1.087 . . . . 65.239999999999995 110.006 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -0.65 10.19 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.434 1.754 . . . . 70.219999999999999 111.004 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 40.5 m -101.12 8.71 42.65 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 60.450000000000003 109.959 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 73.03 38.21 0.72 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.563 1.164 . . . . 71.519999999999996 109.297 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -119.79 119.17 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.120000000000005 110.004 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -99.89 167.06 10.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.491 1.12 . . . . 73.140000000000001 111.033 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.562 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -125.89 177.49 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 64.430000000000007 109.353 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 37.8 m-85 -158.34 118.98 3.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 73.140000000000001 111.036 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.916 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.9 OUTLIER -115.39 99.49 7.42 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.465 1.103 . . . . 72.310000000000002 109.305 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . 0.413 ' O ' HD22 ' A' ' 291' ' ' LEU . 10.3 m-20 -83.48 -52.82 6.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 65.209999999999994 109.312 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.472 ' CB ' HG12 ' A' ' 292' ' ' ILE . 24.4 m-20 -88.04 10.63 18.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.146 . . . . 74.540000000000006 109.328 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.916 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.5 mm? 40.45 45.15 1.84 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.115 . . . . 63.420000000000002 109.287 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.472 HG12 ' CB ' ' A' ' 290' ' ' ASN . 45.5 mm -75.26 -27.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 71.549999999999997 109.307 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.5 t-20 -92.1 -29.32 16.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.478 1.111 . . . . 75.019999999999996 109.295 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.559 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 17.9 m -80.02 -68.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 73.329999999999998 110.356 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -45.29 -33.64 2.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.56 1.162 . . . . 74.299999999999997 109.307 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 53.5 t -72.61 -46.08 55.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 71.540000000000006 108.251 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.0 t -55.73 -41.04 63.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 43.130000000000003 109.31 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 167' ' ' CYS . 84.5 mt -66.78 -62.14 1.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.52 1.137 . . . . 72.420000000000002 109.32 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -51.89 -23.87 5.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.461 1.101 . . . . 71.340000000000003 110.441 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.886 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.7 mmmt -71.19 -40.02 71.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.127 . . . . 72.120000000000005 109.318 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.84 ' CD1' HD12 ' A' ' 304' ' ' LEU . 5.2 m-30 -101.5 35.14 2.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 62.240000000000002 110.965 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.4 t -67.35 -44.83 78.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.107 . . . . 75.409999999999997 110.007 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.656 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -93.19 -12.25 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 72.209999999999994 109.301 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.84 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.2 mt -66.66 141.75 57.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.556 1.16 . . . . 71.450000000000003 109.346 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.4 p -159.33 157.46 30.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 44.219999999999999 110.026 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.84 -157.65 50.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.525 1.141 . . . . 74.209999999999994 110.986 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 29.4 p -96.01 11.41 34.16 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.286 -1.005 . . . . 64.510000000000005 108.286 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -130.07 151.15 77.84 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 75.019999999999996 109.98 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.736 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 148.3 91.39 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.02 -2.491 . . . . 71.310000000000002 110.967 0.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.2 p -130.05 134.29 25.96 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 53.340000000000003 110.017 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.08 -172.39 10.72 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 120.994 -2.503 . . . . 65.329999999999998 110.992 0.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.63 151.38 30.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 44.009999999999998 109.36 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -162.42 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.523 1.802 . . . . 65.5 110.985 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.14 135.51 33.62 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 63.039999999999999 109.299 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.886 HG12 ' HE2' ' A' ' 300' ' ' LYS . 24.4 m -137.48 24.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.527 1.142 . . . . 74.239999999999995 109.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . 0.441 ' C ' ' N ' ' A' ' 318' ' ' CYS . 39.7 t -66.58 -41.07 89.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 75.140000000000001 110.041 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -39.72 -29.87 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.443 1.089 . . . . 72.109999999999999 109.982 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.441 ' N ' ' C ' ' A' ' 316' ' ' SER . 7.5 m . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.546 1.154 . . . . 63.119999999999997 108.3 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.91 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.4 tp . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.321 -0.622 . . . . 70.109999999999999 109.321 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.433 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -105.17 107.61 18.68 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.551 1.157 . . . . 54.340000000000003 109.304 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -85.62 10.64 12.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 71.140000000000001 110.001 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.37 146.82 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 74.219999999999999 109.283 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.071 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.13 143.04 25.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 65.439999999999998 109.29 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.5 Cg_endo -75.0 -33.06 4.87 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.489 1.784 . . . . 75.549999999999997 111.053 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.435 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.78 152.49 21.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 51.200000000000003 109.291 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.506 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -48.98 -35.87 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 54.409999999999997 109.313 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.06 -47.47 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 72.439999999999998 109.285 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.675 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.42 -35.83 71.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 54.5 110.381 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -58.2 -57.03 14.65 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.452 1.095 . . . . 72.540000000000006 109.293 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.506 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.4 m-80 -52.51 -31.57 36.04 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 64.420000000000002 109.291 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.67 -56.83 6.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.14 . . . . 74.019999999999996 109.979 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.071 HD12 HD11 ' A' ' 140' ' ' ILE . 81.3 mt -42.35 -40.11 2.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 54.329999999999998 109.254 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.563 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.69 -44.58 49.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 74.450000000000003 110.99 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -48.03 -36.8 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 61.509999999999998 109.28 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.465 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 63.2 mt-30 -76.05 -55.7 5.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 110.296 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 188' ' ' LEU . 18.3 mt -49.52 -27.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 64.409999999999997 109.304 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -36.7 61.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 75.099999999999994 109.315 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.2 t-20 -57.52 -20.08 29.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 74.209999999999994 109.257 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.468 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 3.0 mm100 -80.53 -25.41 38.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 75.299999999999997 110.26 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 160' ' ' THR . 19.1 m -39.03 116.94 0.63 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.239999999999995 110.019 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.6 m -43.39 136.9 2.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 75.109999999999999 108.328 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.39 -43.36 1.52 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.561 1.163 . . . . 65.150000000000006 110.955 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.746 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 32.2 p -64.84 159.79 21.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.538 0.787 . . . . 62.030000000000001 110.434 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 t -91.56 -4.58 55.22 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.555 1.16 . . . . 63.530000000000001 110.0 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.5 m -108.86 -1.91 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 71.109999999999999 110.423 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.746 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -72.29 133.16 44.86 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 64.420000000000002 109.307 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -169.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 63.439999999999998 109.971 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.443 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 45.9 p -154.61 127.07 3.97 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 62.119999999999997 110.013 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.95 138.87 58.56 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.009 -2.496 . . . . 70.439999999999998 111.005 -0.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.79 -178.99 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.481 1.113 . . . . 64.120000000000005 108.28 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.803 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.1 mp -92.82 137.97 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 54.219999999999999 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.58 HG21 ' O ' ' A' ' 301' ' ' PHE . 59.7 p -92.03 85.16 5.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 70.150000000000006 110.414 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.7 ' CZ ' HG21 ' A' ' 168' ' ' ILE . 60.0 m-85 -88.75 -25.2 22.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.502 1.126 . . . . 61.039999999999999 110.995 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.471 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.09 -1.99 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.548 1.155 . . . . 75.019999999999996 110.292 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.785 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.4 t80 -127.25 69.61 74.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 64.450000000000003 111.042 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.431 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 111.56 3.35 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.46 1.768 . . . . 70.540000000000006 111.026 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.611 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.3 t -153.0 -75.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 73.219999999999999 109.31 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 312' ' ' ALA . 3.9 m-20 -149.09 131.9 16.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 61.020000000000003 109.258 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 121.71 79.26 0.51 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.493 1.121 . . . . 53.020000000000003 111.014 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.78 -1.78 10.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.287 -1.005 . . . . 70.109999999999999 108.287 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 29.0 p90 -81.9 -43.91 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.539 1.149 . . . . 73.0 111.002 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.625 ' HB1' ' HA ' ' A' ' 294' ' ' THR . . . -70.09 -45.2 67.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.522 1.139 . . . . 71.409999999999997 109.285 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.509 ' NH2' ' CB ' ' A' ' 240' ' ' SER . 7.3 mtm180 -49.76 -58.76 4.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 70.219999999999999 110.325 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -43.02 -52.49 5.25 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 61.409999999999997 109.303 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -46.91 -39.51 12.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.505 1.128 . . . . 74.109999999999999 109.62 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.803 ' CB ' HD11 ' A' ' 168' ' ' ILE . 19.0 mmmt -72.92 -33.3 65.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 65.310000000000002 109.281 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.585 ' HE1' ' OD1' ' A' ' 238' ' ' ASP . 17.6 mtm -65.99 -59.21 4.05 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.13 . . . . 72.140000000000001 110.997 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -26.07 14.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 63.409999999999997 110.318 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.414 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.9 OUTLIER -64.86 -43.42 93.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 65.530000000000001 110.274 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.424 ' HB ' ' CG1' ' A' ' 153' ' ' ILE . 22.6 mm -69.86 -38.21 75.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 74.120000000000005 109.269 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -54.57 -35.54 63.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.495 1.122 . . . . 71.109999999999999 109.318 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.574 ' HG2' HD21 ' A' ' 136' ' ' LEU . 17.0 mtp -70.12 -42.79 72.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 1.15 . . . . 74.239999999999995 111.055 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -44.77 -47.12 10.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 72.010000000000005 109.283 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.465 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 23.8 t-20 -67.81 -34.57 77.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 75.150000000000006 109.295 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 113.59 55.29 0.42 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.496 1.123 . . . . 73.439999999999998 110.972 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.675 ' CZ ' HG21 ' A' ' 145' ' ' THR . 83.7 m-85 -153.61 141.51 20.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 0.738 . . . . 75.439999999999998 111.009 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.91 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -108.71 122.87 48.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 73.319999999999993 109.308 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.817 ' HB3' HD22 ' A' ' 188' ' ' LEU . 27.5 p -106.41 -179.28 3.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 72.129999999999995 108.301 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -126.77 176.89 6.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 53.420000000000002 110.317 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.708 ' HE2' HG22 ' A' ' 221' ' ' ILE . 13.9 mmtt -107.83 164.05 12.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 73.150000000000006 109.299 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 30.4 tt0 -151.2 117.36 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 71.030000000000001 110.305 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -109.18 125.94 52.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.461 1.101 . . . . 73.5 111.041 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.789 HG23 ' HB3' ' A' ' 269' ' ' TYR . 8.6 p -122.35 121.32 63.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 71.549999999999997 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 56.2 m-85 -93.9 151.77 19.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 72.299999999999997 111.001 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.42 -172.56 19.3 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.493 1.12 . . . . 62.32 111.021 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.817 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.4 t-20 -78.25 111.19 13.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 0.751 . . . . 74.129999999999995 109.281 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.817 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.5 mt -115.33 94.25 4.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 64.120000000000005 109.359 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.851 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.3 mtpt -93.21 170.52 9.57 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.501 1.125 . . . . 63.439999999999998 109.297 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.766 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -172.58 129.65 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 64.040000000000006 109.338 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.486 1.116 . . . . 75.120000000000005 110.007 -179.99 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.466 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 108.314 -0.995 . . . . 72.120000000000005 108.314 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.766 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -153.59 147.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.095 . . . . 73.310000000000002 109.314 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.851 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -133.46 128.43 35.42 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.555 1.159 . . . . 62.32 109.33 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -134.39 131.72 38.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 61.409999999999997 107.999 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -74.59 -2.54 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 53.020000000000003 109.976 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.43 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.1 p90 -173.74 132.9 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.472 1.108 . . . . 72.310000000000002 111.008 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.469 ' N ' HD12 ' A' ' 204' ' ' LEU . 84.6 t60 -121.61 154.68 36.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 65.420000000000002 109.581 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 198' ' ' GLN . 1.6 p -130.61 130.81 64.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.522 1.139 . . . . 65.349999999999994 109.349 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.647 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.4 -164.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 24.41 109.268 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.708 HG22 ' HE2' ' A' ' 197' ' ' LYS . 39.1 pt -122.31 120.26 60.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 72.299999999999997 109.296 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.0 tp -84.49 109.0 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 71.349999999999994 109.282 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.686 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -103.04 147.99 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 70.310000000000002 109.267 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 51.6 m -118.15 121.27 40.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.481 1.113 . . . . 64.299999999999997 110.021 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 31.3 p90 -136.41 144.24 44.4 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 75.530000000000001 110.983 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.438 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.8 mmtp -69.49 133.06 47.25 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 65.0 109.263 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.55 -159.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 74.25 109.293 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.15 48.94 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.499 1.124 . . . . 72.340000000000003 109.345 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.7 m -115.22 -8.07 12.37 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.153 . . . . 43.399999999999999 110.027 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.14 37.58 8.26 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.471 1.107 . . . . 45.450000000000003 111.05 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.46 0.741 . . . . 70.239999999999995 109.3 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.438 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.3 m -71.79 102.58 2.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 61.049999999999997 110.365 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.9 mm-40 -101.42 -172.54 2.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 74.420000000000002 110.31 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.52 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.2 mmtm -127.0 145.11 50.83 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.491 1.119 . . . . 75.5 109.311 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.63 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.9 tpt180 -144.54 160.84 40.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 72.230000000000004 110.311 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 252' ' ' TRP . 16.6 mm -115.13 121.73 67.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 75.219999999999999 109.317 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -108.09 44.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.529 1.143 . . . . 73.400000000000006 109.285 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.585 ' OD1' ' HE1' ' A' ' 184' ' ' MET . 0.7 OUTLIER -104.98 107.76 59.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 74.030000000000001 109.276 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.562 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.3 Cg_endo -75.01 -2.11 12.11 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.549 1.816 . . . . 62.109999999999999 111.018 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.509 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.2 OUTLIER -61.3 -22.66 65.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 74.129999999999995 109.992 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.74 -50.21 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 70.420000000000002 109.272 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.613 ' CD1' HG11 ' A' ' 247' ' ' VAL . 97.4 m-85 -112.18 99.5 8.09 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 74.040000000000006 111.025 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 71.0 m -90.14 -8.44 51.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 72.219999999999999 109.987 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 30.6 p -77.75 -46.44 21.71 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.543 1.152 . . . . 63.399999999999999 110.008 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.11 -174.79 40.45 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.445 1.091 . . . . 62.299999999999997 111.036 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.448 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.0 164.68 32.87 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.477 1.777 . . . . 74.319999999999993 110.99 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.613 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.5 m -147.82 164.97 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 61.210000000000001 109.317 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.7 p -65.93 141.36 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.455 1.097 . . . . 62.439999999999998 110.445 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.437 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 1.3 p30 -45.2 -26.55 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 74.329999999999998 109.338 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 10.7 m -77.41 -62.95 1.49 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.469 1.106 . . . . 64.209999999999994 110.423 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.69 -27.98 8.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 25.52 109.303 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.68 ' CD1' HG21 ' A' ' 236' ' ' ILE . 11.0 t90 -63.28 -61.82 2.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 75.430000000000007 107.997 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.63 -41.87 15.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 63.409999999999997 110.309 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.789 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.3 m-80 -57.24 -50.8 71.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 42.439999999999998 109.298 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.87 -24.41 51.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 33.530000000000001 109.317 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -83.42 -36.43 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 71.310000000000002 108.304 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.61 21.47 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 72.510000000000005 109.303 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.441 ' ND2' ' CB ' ' A' ' 260' ' ' SER . 38.7 t30 -54.41 109.14 0.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 71.129999999999995 109.287 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.3 p -73.79 -2.77 24.92 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 74.129999999999995 110.386 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.441 ' CB ' ' ND2' ' A' ' 258' ' ' ASN . 33.7 t -44.0 -27.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.098 . . . . 72.010000000000005 109.979 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 259' ' ' THR . 48.5 t -94.27 -37.01 11.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 61.0 108.3 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 171.09 -128.33 1.59 Allowed Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.493 1.121 . . . . 70.219999999999999 110.968 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -79.86 149.42 30.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 0.78 . . . . 74.140000000000001 110.017 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.573 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -170.69 146.35 2.64 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.501 1.125 . . . . 40.450000000000003 109.324 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.3 m -173.08 151.99 2.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.449 1.093 . . . . 63.5 109.99 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.595 HG23 HG11 ' A' ' 257' ' ' VAL . 2.3 t -97.84 122.35 49.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.519999999999996 109.281 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . 0.407 ' C ' ' OG ' ' A' ' 268' ' ' SER . 31.1 t -83.81 -34.21 24.77 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.13 . . . . 74.430000000000007 109.999 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 267' ' ' SER . 0.7 OUTLIER -174.78 159.32 2.77 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 74.109999999999999 109.978 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.789 ' HB3' HG23 ' A' ' 200' ' ' VAL . 52.9 p90 -147.5 154.66 41.04 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.447 1.092 . . . . 54.219999999999999 110.985 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.32 165.7 34.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 70.329999999999998 109.32 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.468 ' C ' HG23 ' A' ' 272' ' ' THR . 1.4 p-10 -122.68 160.73 25.23 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 62.329999999999998 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.468 HG23 ' C ' ' A' ' 271' ' ' ASN . 45.1 p -154.09 179.43 8.94 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 61.130000000000003 110.419 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.833 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -57.5 166.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.127 . . . . 42.240000000000002 109.253 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.49 -18.67 63.65 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.52 1.137 . . . . 50.130000000000003 111.012 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.448 ' H ' ' ND2' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -83.98 -19.0 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 0.773 . . . . 62.229999999999997 109.287 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.833 HG23 ' HB3' ' A' ' 273' ' ' ALA . 12.9 t -60.48 101.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 71.510000000000005 109.301 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.415 ' OH ' ' CE1' ' A' ' 178' ' ' TYR . 15.1 t80 -64.41 -44.45 91.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.559 1.162 . . . . 64.549999999999997 111.007 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -144.54 155.78 43.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.542 1.151 . . . . 73.099999999999994 110.989 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.447 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 68.0 ttt-85 -124.97 147.45 48.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.409999999999997 110.318 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.77 154.07 44.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.104 . . . . 71.540000000000006 110.006 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -0.03 9.45 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.496 1.787 . . . . 74.019999999999996 111.011 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 6.1 t -104.58 10.6 34.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 44.439999999999998 109.969 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.0 t-20 76.21 38.5 0.32 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.54 1.15 . . . . 72.329999999999998 109.341 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.2 t -117.9 121.03 39.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 63.530000000000001 110.001 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.524 ' HB3' HG13 ' A' ' 276' ' ' VAL . 12.5 m-30 -103.86 158.38 16.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 74.25 110.987 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.5 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -118.35 177.64 4.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 73.519999999999996 109.3 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.0 m-85 -161.84 115.79 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 65.120000000000005 111.045 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.3 96.76 5.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.129 . . . . 62.119999999999997 109.346 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -85.62 -15.47 42.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 64.329999999999998 109.307 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.422 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.6 m-20 -109.88 2.26 19.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.529 1.143 . . . . 73.420000000000002 109.302 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.91 47.07 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 45.329999999999998 109.293 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.422 HG12 ' CB ' ' A' ' 290' ' ' ASN . 20.4 mm -73.28 -31.74 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.12 . . . . 65.140000000000001 109.315 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 318' ' ' CYS . 1.6 t-20 -93.08 -28.41 16.37 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 74.329999999999998 109.27 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.625 ' HA ' ' HB1' ' A' ' 179' ' ' ALA . 1.8 m -77.07 -65.69 0.92 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.563 1.164 . . . . 73.439999999999998 110.407 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 57.3 m-20 -54.61 -20.07 7.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 53.329999999999998 109.296 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 297' ' ' VAL . 25.0 t -83.99 -66.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 42.399999999999999 108.278 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.523 HG21 ' OH ' ' A' ' 178' ' ' TYR . 3.2 t -40.27 -39.54 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 72.200000000000003 109.296 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.685 HD22 ' HA ' ' A' ' 168' ' ' ILE . 20.4 mt -70.23 -57.2 5.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 1.142 . . . . 73.239999999999995 109.267 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -22.78 2.47 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.454 1.096 . . . . 75.040000000000006 110.358 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -71.32 -48.58 49.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 75.540000000000006 109.311 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.58 ' O ' HG21 ' A' ' 169' ' ' THR . 0.7 OUTLIER -98.43 38.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 61.130000000000003 111.005 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.0 t -70.07 -48.54 57.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.13 . . . . 44.210000000000001 109.971 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -88.18 -11.36 47.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 41.340000000000003 109.284 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.785 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 15.1 mt -63.93 142.55 58.37 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 72.25 109.296 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 66.6 p -157.49 148.43 21.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.16 . . . . 71.430000000000007 109.964 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.05 -152.12 23.46 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.483 1.114 . . . . 41.229999999999997 111.028 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.4 p -103.96 12.87 33.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.309 -0.997 . . . . 52.219999999999999 108.309 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.3 p -134.99 150.99 74.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 64.510000000000005 109.992 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.721 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.01 146.52 86.87 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.001 -2.5 . . . . 73.439999999999998 110.992 0.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.488 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 3.3 p -130.06 133.46 25.0 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 71.120000000000005 109.968 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.04 -168.16 6.25 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.031 -2.487 . . . . 72.109999999999999 110.967 0.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 175' ' ' ASP . . . -56.89 152.73 26.14 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.47 1.106 . . . . 71.109999999999999 109.24 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.548 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.06 -162.52 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.5 1.79 . . . . 64.340000000000003 110.932 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.65 130.72 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 72.329999999999998 109.275 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.486 HG11 ' CZ ' ' A' ' 301' ' ' PHE . 35.4 m -128.85 24.71 2.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 73.140000000000001 109.28 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.2 t -68.38 -27.06 65.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 63.43 110.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.5 t -47.19 -24.66 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 74.530000000000001 109.961 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.418 ' HB2' ' ND2' ' A' ' 293' ' ' ASN . 1.7 m . . . . . 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 74.340000000000003 108.275 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.756 HD23 ' HB3' ' A' ' 194' ' ' ASP . 4.8 tp . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.295 -0.631 . . . . 73.120000000000005 109.295 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.67 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -146.99 108.02 4.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 51.420000000000002 109.291 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.75 2.74 28.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 71.540000000000006 110.026 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -142.23 150.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 72.349999999999994 109.243 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.056 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -102.94 143.31 26.35 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 61.100000000000001 109.312 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -33.76 4.33 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.485 1.782 . . . . 71.129999999999995 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.44 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.7 151.23 23.75 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.449 1.093 . . . . 75.519999999999996 109.288 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.497 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.7 t -49.52 -34.81 8.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.485 1.115 . . . . 75.409999999999997 109.277 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.48 -46.6 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 61.350000000000001 109.255 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.702 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -72.1 -33.22 67.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 72.099999999999994 110.36 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -60.91 -56.44 21.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.511 1.132 . . . . 64.540000000000006 109.308 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.497 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 53.6 m-80 -54.05 -30.77 49.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.434 1.084 . . . . 72.549999999999997 109.29 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -56.59 7.35 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 63.350000000000001 110.032 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.056 HD12 HD11 ' A' ' 140' ' ' ILE . 84.1 mt -42.18 -42.43 3.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 52.030000000000001 109.318 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.506 ' HB2' HD12 ' A' ' 237' ' ' ILE . 0.8 OUTLIER -71.17 -44.88 64.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 72.450000000000003 111.012 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.43 -39.06 6.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 73.420000000000002 109.298 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 155' ' ' ASN . 57.1 mt-30 -75.82 -55.51 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 74.439999999999998 110.271 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.891 HD11 HD12 ' A' ' 188' ' ' LEU . 14.3 mt -51.05 -24.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 73.430000000000007 109.368 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 243' ' ' SER . 0.0 OUTLIER -78.74 -33.98 46.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 75.450000000000003 109.327 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.4 t-20 -61.73 -14.99 37.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 62.329999999999998 109.286 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 157' ' ' SER . 3.2 mm100 -84.08 -18.19 37.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.400000000000006 110.287 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' GLN . 11.0 p -37.37 147.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 70.409999999999997 110.01 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.4 m -82.28 53.54 2.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 73.400000000000006 108.335 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -164.34 27.88 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.531 1.145 . . . . 72.450000000000003 111.015 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.716 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 60.7 p -132.7 163.19 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 0.754 . . . . 75.099999999999994 110.398 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 63.0 m -93.62 0.86 56.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 62.039999999999999 110.034 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 162' ' ' THR . 3.0 m -116.68 0.44 12.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 74.109999999999999 110.384 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.716 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -69.83 137.99 52.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.13 . . . . 43.109999999999999 109.301 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -164.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.132 . . . . 55.119999999999997 110.028 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 15.3 p -155.57 127.39 3.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.476 1.11 . . . . 63.530000000000001 110.023 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 139.77 63.61 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.988 -2.505 . . . . 52.119999999999997 111.021 -0.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 21.1 p -72.76 -179.53 3.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 64.319999999999993 108.312 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.686 ' HA ' HD22 ' A' ' 298' ' ' LEU . 3.1 mp -92.24 123.24 44.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 72.409999999999997 109.344 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.3 p -89.76 80.71 6.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 65.530000000000001 110.395 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -80.75 -14.41 58.12 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.209999999999994 110.98 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.26 -1.23 22.52 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 71.400000000000006 110.278 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.644 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.7 t80 -130.9 65.54 76.89 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 73.129999999999995 111.001 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.439 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.4 Cg_endo -74.97 117.24 4.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.486 1.782 . . . . 70.510000000000005 110.997 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.578 HG21 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.92 -72.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 70.319999999999993 109.301 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.37 -44.13 1.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 70.540000000000006 109.273 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -53.23 99.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.448 1.093 . . . . 43.340000000000003 111.003 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.63 ' SG ' HG12 ' A' ' 219' ' ' VAL . 3.5 p -134.82 -48.2 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.278 -1.008 . . . . 54.0 108.278 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.569 ' HB3' HG11 ' A' ' 219' ' ' VAL . 8.4 p90 -69.52 -11.77 61.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.142 . . . . 73.409999999999997 110.973 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.494 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -73.41 -68.12 0.53 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 74.5 109.299 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.828 HH21 ' HG2' ' A' ' 239' ' ' PRO . 11.1 ptm180 -50.64 -49.85 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.157 . . . . 74.25 110.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.463 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.64 -57.63 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 71.129999999999995 109.338 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.505 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.2 t60 -45.86 -43.9 13.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 70.109999999999999 109.618 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 180' ' ' ARG . 17.3 mmmt -60.35 -58.58 7.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.125 . . . . 74.530000000000001 109.273 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 153' ' ' ILE . 5.8 mtm -39.01 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 75.109999999999999 111.015 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.443 ' NH1' ' SD ' ' A' ' 189' ' ' MET . 2.1 tmt_? -70.57 -50.18 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 71.150000000000006 110.3 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.471 ' HG3' HD13 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -55.29 -33.97 63.71 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 62.539999999999999 110.255 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.471 HD13 ' HG3' ' A' ' 186' ' ' GLN . 16.0 mm -77.02 -34.87 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 64.120000000000005 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.891 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -64.74 -45.12 87.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 63.229999999999997 109.338 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.722 ' HG2' HD21 ' A' ' 136' ' ' LEU . 63.2 mtp -58.28 -37.2 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.502 1.126 . . . . 71.25 111.064 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -52.29 -52.02 55.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 54.210000000000001 109.315 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.445 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 7.9 t-20 -63.82 -28.67 70.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 71.019999999999996 109.284 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.55 44.94 1.27 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.522 1.139 . . . . 62.240000000000002 111.027 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.702 ' CZ ' HG21 ' A' ' 145' ' ' THR . 80.0 m-85 -147.82 130.3 15.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 0.76 . . . . 64.319999999999993 111.018 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.756 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.4 OUTLIER -97.07 130.78 44.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 74.219999999999999 109.313 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.839 ' HB3' HD22 ' A' ' 188' ' ' LEU . 30.5 p -104.96 -179.48 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.114 . . . . 62.100000000000001 108.311 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -129.54 174.59 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.464 1.103 . . . . 74.349999999999994 110.32 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' A' ' 221' ' ' ILE . 16.4 mmtt -108.17 169.49 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.52 1.138 . . . . 64.299999999999997 109.303 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 27.7 tt0 -164.11 117.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 73.0 110.299 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.467 ' CE1' HG21 ' A' ' 219' ' ' VAL . 6.0 m-85 -108.28 120.5 42.54 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.511 1.132 . . . . 75.340000000000003 111.006 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.673 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.5 p -109.77 148.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 74.120000000000005 109.29 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.414 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 23.5 m-85 -119.91 158.28 27.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 75.329999999999998 111.002 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 120.63 -179.73 16.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.512 1.132 . . . . 61.219999999999999 110.979 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.742 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.3 t-20 -70.39 110.82 5.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.537 0.787 . . . . 72.109999999999999 109.304 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.6 mt -114.93 93.43 4.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 75.120000000000005 109.267 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.7 mttp -93.55 166.01 12.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 64.510000000000005 109.307 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -169.64 147.98 3.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 34.399999999999999 109.298 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.2 p . . . . . 0 C--N 1.326 -0.451 0 O-C-N 124.509 1.13 . . . . 63.439999999999998 109.93 -179.943 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 108.312 -0.996 . . . . 65.109999999999999 108.312 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.1 OUTLIER -109.83 155.69 10.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 70.340000000000003 109.303 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.68 119.26 13.1 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 61.5 109.295 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.434 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -128.39 133.1 48.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 64.310000000000002 107.958 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.3 m -79.61 2.5 22.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 61.0 109.985 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.481 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.9 p90 -174.17 128.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.124 . . . . 74.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 71.2 t60 -116.36 167.6 10.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 73.310000000000002 109.612 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.63 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.6 p -144.79 137.61 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 72.120000000000005 109.296 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.667 ' HB3' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.89 -165.7 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 62.119999999999997 109.286 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.622 HG22 ' HE2' ' A' ' 197' ' ' LYS . 15.9 pt -115.42 123.54 71.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 74.219999999999999 109.295 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.7 tp -87.91 108.83 19.37 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 73.409999999999997 109.276 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.89 146.98 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 71.030000000000001 109.275 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 140' ' ' ILE . 75.4 m -117.09 120.18 37.55 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.434 1.084 . . . . 65.299999999999997 110.025 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.9 p90 -134.96 143.22 46.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.482 1.114 . . . . 74.230000000000004 111.007 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.422 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -68.85 132.38 46.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 63.530000000000001 109.315 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.36 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.13 . . . . 75.340000000000003 109.323 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.66 0.18 48.04 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 71.530000000000001 109.32 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -115.27 -7.89 12.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.465 1.103 . . . . 75.349999999999994 110.004 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.44 8.34 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.471 1.107 . . . . 71.25 111.004 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.3 137.63 43.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.532 0.784 . . . . 74.219999999999999 109.283 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.422 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.1 m -71.82 102.55 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.115 . . . . 74.140000000000001 110.369 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.6 mm-40 -101.79 -172.59 2.18 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 71.299999999999997 110.321 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.523 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.3 mmtm -127.13 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 74.519999999999996 109.305 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.629 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.9 OUTLIER -142.72 163.95 31.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 75.530000000000001 110.252 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.717 HG21 ' CD1' ' A' ' 252' ' ' TRP . 26.6 mm -119.01 117.86 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 74.200000000000003 109.294 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.0 mm -102.63 47.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 75.129999999999995 109.302 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.669 ' OD1' HD12 ' A' ' 241' ' ' LEU . 20.7 p-10 -94.73 111.53 54.56 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.504 1.128 . . . . 74.010000000000005 109.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.828 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -75.06 -40.28 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.463 1.77 . . . . 51.520000000000003 111.01 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -41.59 -39.09 1.51 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.551 1.157 . . . . 51.420000000000002 110.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.669 HD12 ' OD1' ' A' ' 238' ' ' ASP . 10.5 mt -95.78 -58.34 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 74.409999999999997 109.324 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.658 ' CD2' HG11 ' A' ' 247' ' ' VAL . 91.6 m-85 -117.15 99.2 6.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.449 1.093 . . . . 74.319999999999993 110.99 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . 0.418 ' O ' ' CE ' ' A' ' 154' ' ' LYS . 35.4 m -90.68 -5.81 55.31 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 73.310000000000002 110.0 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 25.3 m -79.42 -47.08 16.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 75.209999999999994 109.98 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.13 -175.76 39.84 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.478 1.112 . . . . 75.209999999999994 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.518 ' CG ' HD21 ' A' ' 146' ' ' LEU . 18.4 Cg_endo -74.97 161.7 38.42 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.506 1.793 . . . . 74.030000000000001 110.991 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.658 HG11 ' CD2' ' A' ' 242' ' ' PHE . 3.4 m -144.7 157.35 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 71.209999999999994 109.314 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.6 p -64.93 137.63 57.87 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 74.400000000000006 110.392 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 248' ' ' THR . 0.1 OUTLIER -39.78 -31.12 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 73.319999999999993 109.302 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.6 m -71.35 -64.31 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 62.020000000000003 110.402 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.42 -24.74 8.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.11 . . . . 72.109999999999999 109.282 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.717 ' CD1' HG21 ' A' ' 236' ' ' ILE . 8.8 t90 -67.33 -59.92 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.478 1.111 . . . . 73.209999999999994 108.012 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.578 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -51.95 -41.25 61.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 73.450000000000003 110.314 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.804 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.3 m-80 -54.83 -52.49 62.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.099 . . . . 72.439999999999998 109.314 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.2 -26.18 37.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 62.229999999999997 109.287 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -81.82 -36.36 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 55.329999999999998 108.306 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.804 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.69 22.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.137 . . . . 62.450000000000003 109.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -52.23 109.21 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 74.299999999999997 109.305 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.77 -3.09 26.39 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.153 . . . . 71.319999999999993 110.408 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 18.4 t -43.82 -31.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 72.239999999999995 110.001 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.8 -37.7 15.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 52.229999999999997 108.301 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.46 -126.97 1.49 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.515 1.134 . . . . 63.299999999999997 110.997 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.6 145.03 41.47 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 0.772 . . . . 74.439999999999998 109.98 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.2 147.72 4.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 64.120000000000005 109.324 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 92.2 p -172.87 156.8 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 60.439999999999998 110.004 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.673 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.2 p -103.12 117.4 48.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.449 1.093 . . . . 75.239999999999995 109.3 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 21.0 t -72.05 -44.7 62.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 63.030000000000001 109.965 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 200' ' ' VAL . 3.4 m -166.66 -174.67 2.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.137 . . . . 74.219999999999999 110.011 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -163.09 156.6 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 74.25 110.968 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 198' ' ' GLN . . . -154.85 149.57 26.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 75.400000000000006 109.269 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -107.68 157.81 17.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 73.140000000000001 109.282 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.582 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.4 p -148.82 179.11 8.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.562 1.164 . . . . 71.319999999999993 110.411 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.95 164.44 12.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.118 . . . . 73.519999999999996 109.279 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.0 84.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.557 1.16 . . . . 71.420000000000002 111.0 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -84.23 -37.1 22.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 0.746 . . . . 74.109999999999999 109.347 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 273' ' ' ALA . 21.1 t -43.73 108.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 65.530000000000001 109.265 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.545 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 1.6 t80 -72.01 -41.33 67.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 73.099999999999994 110.978 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.565 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -162.85 115.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.438 1.086 . . . . 72.510000000000005 111.011 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.582 ' HD2' HG21 ' A' ' 272' ' ' THR . 62.8 ttt-85 -95.82 141.53 29.17 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.459 1.099 . . . . 65.0 110.297 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.73 158.02 37.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.548 1.155 . . . . 64.010000000000005 110.009 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 0.17 9.24 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 43.130000000000003 111.026 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 46.3 t -97.51 9.23 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 71.010000000000005 109.989 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER 75.37 27.96 1.02 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 75.109999999999999 109.334 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 121.51 45.13 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 1.119 . . . . 65.219999999999999 109.971 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 3.3 m-85 -104.8 162.42 13.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 64.430000000000007 110.974 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.7 OUTLIER -121.21 172.12 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 72.230000000000004 109.276 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 78.4 m-85 -160.54 127.86 4.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 73.430000000000007 111.022 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.637 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.3 m-20 -115.28 114.21 24.89 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.14 . . . . 74.040000000000006 109.331 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -85.65 -51.24 6.6 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 54.0 109.305 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -108.13 14.19 25.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 71.549999999999997 109.285 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 288' ' ' ASP . 1.2 mm? 54.19 39.06 30.39 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 62.219999999999999 109.296 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 18.6 mm -66.77 -28.99 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 73.0 109.352 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.915 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.7 t-20 -94.81 -29.25 14.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.456 1.098 . . . . 73.519999999999996 109.286 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 291' ' ' LEU . 1.9 m -79.03 -65.61 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 71.109999999999999 110.381 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -49.13 -34.04 13.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 73.209999999999994 109.298 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.06 -49.06 60.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 71.219999999999999 108.295 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.3 t -47.99 -47.85 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.144 . . . . 63.439999999999998 109.329 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 168' ' ' ILE . 15.6 mt -67.2 -61.99 1.65 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.51 1.131 . . . . 63.25 109.33 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.04 -25.6 0.34 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 64.430000000000007 110.417 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.646 ' HE2' HG12 ' A' ' 315' ' ' VAL . 19.6 mmmt -72.91 -45.12 59.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.45 1.094 . . . . 62.229999999999997 109.314 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.731 ' CD1' HD12 ' A' ' 304' ' ' LEU . 2.0 m-30 -98.91 37.97 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.524 1.14 . . . . 75.319999999999993 111.009 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.97 -44.23 73.36 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 63.140000000000001 109.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.799 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.85 -18.16 22.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.12 . . . . 73.040000000000006 109.274 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.818 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.9 mt -59.78 142.35 53.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.209999999999994 109.315 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 86.9 p -152.64 160.75 43.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 61.219999999999999 110.005 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.94 -159.05 51.37 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.535 1.147 . . . . 62.509999999999998 110.983 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 27.0 p -95.33 16.52 16.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.308 -0.997 . . . . 72.430000000000007 108.308 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.51 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 41.7 p -134.93 148.97 69.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 33.340000000000003 110.004 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.818 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.0 147.28 88.9 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.99 -2.504 . . . . 75.25 110.992 -0.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.48 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -131.67 135.56 27.04 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 62.219999999999999 109.993 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.94 -174.31 13.86 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.005 -2.498 . . . . 63.530000000000001 111.027 -0.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.67 156.03 26.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 52.350000000000001 109.327 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -162.3 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.461 1.769 . . . . 34.130000000000003 110.993 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -89.29 135.87 33.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 73.310000000000002 109.315 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.646 HG12 ' HE2' ' A' ' 300' ' ' LYS . 30.0 m -128.16 23.17 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 74.019999999999996 109.272 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 t -57.61 -35.58 70.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 60.200000000000003 110.012 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 43.3 t -49.23 -23.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 64.439999999999998 109.985 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.558 1.161 . . . . 72.099999999999994 108.282 -179.997 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 194' ' ' ASP . 2.8 tp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.251 -0.648 . . . . 75.120000000000005 109.251 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -156.25 106.36 2.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 75.340000000000003 109.321 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -5.47 54.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 63.020000000000003 109.994 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.38 149.39 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 73.540000000000006 109.338 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -101.96 143.43 26.59 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.507 1.129 . . . . 74.540000000000006 109.299 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.0 -33.77 4.33 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.451 1.764 . . . . 74.140000000000001 110.967 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.402 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.06 148.0 16.78 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.526 1.142 . . . . 74.349999999999994 109.35 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.519 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -43.68 -36.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 72.340000000000003 109.321 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.5 -49.78 2.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 71.200000000000003 109.296 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.787 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -68.73 -37.06 79.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 72.420000000000002 110.415 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.625 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.97 -57.33 12.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 74.129999999999995 109.332 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.492 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.2 m-80 -53.12 -29.35 30.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 75.430000000000007 109.297 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -57.55 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.428 1.08 . . . . 73.5 109.989 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 140' ' ' ILE . 92.7 mt -42.63 -42.77 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 72.439999999999998 109.29 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.53 -44.81 61.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.415 1.072 . . . . 75.430000000000007 110.982 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -47.06 -38.14 10.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 72.430000000000007 109.284 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.424 ' CB ' ' CG2' ' A' ' 187' ' ' ILE . 58.7 mt-30 -75.53 -53.37 8.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.239999999999995 110.293 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 188' ' ' LEU . 16.0 mt -51.95 -24.63 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 41.140000000000001 109.317 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.41 -35.85 53.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.128 . . . . 72.219999999999999 109.247 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -61.78 -15.79 44.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.400000000000006 109.317 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 187' ' ' ILE . 6.9 mm100 -84.73 -17.48 38.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 71.310000000000002 110.316 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.8 p -38.54 133.15 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.455 1.097 . . . . 41.299999999999997 110.022 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -62.49 135.33 57.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 52.210000000000001 108.312 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 112.21 -22.33 18.27 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.515 1.134 . . . . 54.240000000000002 110.987 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.791 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 55.7 p -77.44 161.63 27.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 0.801 . . . . 73.209999999999994 110.411 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.2 m -93.56 -2.56 54.07 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.310000000000002 110.003 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 162' ' ' THR . 3.5 m -114.98 7.61 15.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.13 . . . . 73.420000000000002 110.392 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.791 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -84.19 139.44 32.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 64.239999999999995 109.3 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -161.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.48 1.113 . . . . 75.310000000000002 109.971 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.434 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 127.64 3.75 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 62.25 110.018 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.06 138.25 54.97 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.028 -2.488 . . . . 54.409999999999997 110.968 0.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 15.4 p -73.08 178.88 4.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 64.310000000000002 108.269 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.921 HG23 ' HG2' ' A' ' 180' ' ' ARG . 2.1 mp -87.41 124.72 40.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 71.010000000000005 109.264 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.1 p -92.34 72.58 5.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 54.399999999999999 110.423 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.433 ' HA ' ' NH1' ' A' ' 180' ' ' ARG . 26.6 p90 -77.75 -14.24 59.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.529 1.143 . . . . 61.439999999999998 110.987 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.91 -0.57 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 65.230000000000004 110.283 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.626 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.0 t80 -129.37 66.3 76.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 74.109999999999999 110.999 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.422 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.0 117.76 5.02 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.472 1.775 . . . . 74.519999999999996 110.994 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.596 HG21 ' CE1' ' A' ' 172' ' ' TYR . 14.0 t -152.28 -54.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.441 1.088 . . . . 54.030000000000001 109.254 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.42 -46.71 0.15 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.526 1.141 . . . . 72.340000000000003 109.346 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -48.18 103.46 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.526 1.141 . . . . 45.43 110.983 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.536 ' HB3' HG13 ' A' ' 219' ' ' VAL . 42.1 m -138.74 -48.47 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.319 -0.993 . . . . 73.340000000000003 108.319 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 13.4 p90 -62.55 -34.52 77.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 75.150000000000006 111.01 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.681 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -60.93 -56.88 15.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.46 1.1 . . . . 64.040000000000006 109.3 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.921 ' HG2' HG23 ' A' ' 168' ' ' ILE . 22.9 mtp180 -53.27 -49.13 67.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 74.150000000000006 110.323 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.433 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -41.64 -62.31 0.91 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 73.019999999999996 109.347 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.658 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -42.8 -37.02 1.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.512 1.133 . . . . 65.120000000000005 109.608 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.647 ' CB ' HD11 ' A' ' 168' ' ' ILE . 28.0 mmmt -70.67 -55.33 8.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 74.420000000000002 109.339 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.454 ' HA ' HG23 ' A' ' 153' ' ' ILE . 20.1 mtm -43.99 -28.73 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 71.230000000000004 111.001 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.453 ' NH1' ' HE3' ' A' ' 189' ' ' MET . 0.3 OUTLIER -75.69 -40.49 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.47 1.106 . . . . 74.209999999999994 110.294 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.647 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -51.65 -34.14 36.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 1.132 . . . . 75.230000000000004 110.331 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.506 HD13 ' HG3' ' A' ' 186' ' ' GLN . 10.9 mm -78.46 -35.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 73.109999999999999 109.288 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -59.83 -40.5 88.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.499 1.124 . . . . 54.229999999999997 109.298 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.453 ' HE3' ' NH1' ' A' ' 185' ' ' ARG . 4.1 mtt -63.75 -42.72 97.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 74.040000000000006 110.993 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -47.74 -53.51 14.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.543 1.152 . . . . 74.409999999999997 109.289 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.18 -37.48 87.61 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 64.340000000000003 109.351 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.48 40.45 1.12 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.517 1.136 . . . . 31.32 111.004 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.787 ' CZ ' HG21 ' A' ' 145' ' ' THR . 50.5 m-85 -137.28 134.01 35.64 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 0.766 . . . . 53.229999999999997 110.984 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.635 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -101.21 144.91 29.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 71.329999999999998 109.27 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.61 ' HB3' HD22 ' A' ' 188' ' ' LEU . 28.7 p -128.57 -179.4 5.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.144 . . . . 71.319999999999993 108.282 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 222' ' ' LEU . 19.9 mp0 -125.35 178.09 5.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.467 1.105 . . . . 74.340000000000003 110.271 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.499 ' HZ1' ' HA ' ' A' ' 182' ' ' HIS . 19.0 mmtt -106.01 159.3 16.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 1.107 . . . . 74.430000000000007 109.259 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.795 ' OE1' HD11 ' A' ' 236' ' ' ILE . 10.2 tt0 -145.18 117.59 8.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 51.109999999999999 110.312 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.562 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 3.4 m-85 -116.89 128.02 54.83 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.144 . . . . 73.129999999999995 110.98 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.678 ' CG2' HG23 ' A' ' 266' ' ' VAL . 12.3 p -117.37 162.8 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.477 1.111 . . . . 74.25 109.281 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.442 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 76.3 m-85 -133.07 157.97 43.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 73.140000000000001 110.99 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.26 -177.19 16.42 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.492 1.12 . . . . 50.109999999999999 111.043 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.686 ' C ' HD23 ' A' ' 204' ' ' LEU . 62.3 t-20 -70.64 109.77 5.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.479 0.753 . . . . 73.030000000000001 109.29 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.686 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.3 mt -113.31 95.74 5.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 73.040000000000006 109.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 0.4 OUTLIER -92.09 165.61 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 64.049999999999997 109.315 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.873 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -174.63 151.6 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.522 1.139 . . . . 62.509999999999998 109.302 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.537 1.148 . . . . 75.430000000000007 110.027 -179.973 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.298 -1.001 . . . . 72.310000000000002 108.298 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.873 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -109.24 139.29 32.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.509 1.131 . . . . 72.25 109.306 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -133.02 126.14 31.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.12 . . . . 71.140000000000001 109.293 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.451 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -132.43 147.8 52.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 108.024 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -91.59 4.44 52.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 71.340000000000003 110.007 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.507 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 26.5 p90 -175.66 122.77 0.2 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 72.219999999999999 110.981 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.544 ' NE2' HD11 ' A' ' 241' ' ' LEU . 52.1 t60 -106.56 165.69 11.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 62.210000000000001 109.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 177' ' ' CYS . 2.1 p -137.2 155.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.55 1.156 . . . . 74.430000000000007 109.245 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.652 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.18 -163.24 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 60.030000000000001 109.265 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.5 HD11 ' HB ' ' A' ' 237' ' ' ILE . 27.2 pt -123.86 122.48 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.310000000000002 109.288 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.1 tp -86.36 108.85 18.63 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.542 1.151 . . . . 70.239999999999995 109.294 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.642 HG11 HG13 ' A' ' 237' ' ' ILE . 0.9 OUTLIER -101.03 166.68 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.576 1.173 . . . . 50.240000000000002 109.313 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 140' ' ' ILE . 64.0 m -137.14 118.95 15.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 64.409999999999997 109.977 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.519 ' CD2' HG23 ' A' ' 143' ' ' VAL . 33.0 p90 -135.46 143.43 45.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 72.310000000000002 110.959 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -68.49 131.73 45.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 73.239999999999995 109.316 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.428 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -71.68 -160.21 0.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 72.409999999999997 109.318 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -84.26 -0.58 52.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.115 . . . . 63.030000000000001 109.254 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.1 m -114.65 -8.17 12.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.133 . . . . 54.009999999999998 109.977 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.21 37.78 7.55 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.131 . . . . 73.019999999999996 111.028 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.49 138.31 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.512 0.772 . . . . 74.239999999999995 109.256 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -72.06 102.71 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.340000000000003 110.413 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.428 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 5.4 mm-40 -101.54 -172.62 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.459 1.099 . . . . 71.230000000000004 110.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.547 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.4 mmtm -128.12 145.11 51.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.466 1.104 . . . . 44.299999999999997 109.294 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.495 ' HB3' HG22 ' A' ' 223' ' ' VAL . 1.9 tpt180 -143.86 161.79 37.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 75.329999999999998 110.331 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.795 HD11 ' OE1' ' A' ' 198' ' ' GLN . 17.5 mm -114.47 119.13 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 72.519999999999996 109.359 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.2 mm -105.95 45.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 44.409999999999997 109.299 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.434 ' HA ' ' HE1' ' A' ' 184' ' ' MET . 12.6 t0 -105.9 107.72 60.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 64.219999999999999 109.347 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -0.42 9.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.51 1.795 . . . . 72.439999999999998 110.965 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.6 t -72.81 -4.53 32.17 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.504 1.128 . . . . 73.420000000000002 110.013 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.544 HD11 ' NE2' ' A' ' 218' ' ' HIS . 10.3 mt -136.21 -47.02 0.64 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.529 1.143 . . . . 71.200000000000003 109.264 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 247' ' ' VAL . 96.5 m-85 -123.23 101.45 7.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 73.120000000000005 110.968 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.21 -22.11 28.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 32.229999999999997 110.034 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 69.1 m -62.02 -49.56 75.55 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.019999999999996 110.014 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.04 -170.77 37.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.478 1.111 . . . . 45.219999999999999 110.996 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.444 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.99 164.18 33.89 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.506 1.793 . . . . 72.409999999999997 110.987 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.594 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.0 m -148.36 160.08 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.554 1.159 . . . . 71.340000000000003 109.281 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.4 p -64.81 137.6 57.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 74.150000000000006 110.392 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 248' ' ' THR . 5.8 p-10 -40.19 -30.29 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 74.120000000000005 109.33 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.3 m -71.47 -64.5 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 74.109999999999999 110.413 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.98 -26.11 9.85 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.532 1.145 . . . . 74.549999999999997 109.281 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.681 ' CD1' HG21 ' A' ' 236' ' ' ILE . 10.7 t90 -65.11 -57.87 7.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 74.25 107.993 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.572 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -52.89 -42.12 65.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 72.430000000000007 110.293 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.858 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.3 m-80 -55.14 -50.63 68.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 70.030000000000001 109.323 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -54.86 -26.59 36.5 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.134 . . . . 52.329999999999998 109.312 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -82.56 -37.83 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.108 . . . . 62.530000000000001 108.33 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.858 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.1 m -92.77 22.69 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 74.329999999999998 109.364 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 47.7 t30 -50.38 104.53 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 41.020000000000003 109.328 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.7 p -75.01 -4.03 35.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 73.099999999999994 110.37 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.414 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -50.74 -22.26 2.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.549 1.156 . . . . 72.420000000000002 110.042 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 5.9 m -93.96 -29.47 15.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.457 1.098 . . . . 71.430000000000007 108.255 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 159.9 -122.18 1.1 Allowed Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.483 1.114 . . . . 71.450000000000003 111.004 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.3 OUTLIER -83.86 140.12 32.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.572 0.807 . . . . 44.020000000000003 110.007 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.543 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -169.21 146.37 3.55 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.486 1.116 . . . . 71.150000000000006 109.288 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.7 t -172.87 164.02 5.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 75.519999999999996 110.002 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.678 HG23 ' CG2' ' A' ' 200' ' ' VAL . 6.6 p -105.53 120.54 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 73.530000000000001 109.305 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.4 t -80.05 -43.14 22.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.483 1.114 . . . . 75.040000000000006 109.984 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.0 m -156.88 176.73 12.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.443 1.089 . . . . 75.109999999999999 109.997 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.21 158.77 27.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.574 1.171 . . . . 75.510000000000005 110.953 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -172.88 155.37 3.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 65.019999999999996 109.345 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.524 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -122.22 159.34 27.48 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.514 1.134 . . . . 73.340000000000003 109.344 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.527 HG21 ' HD2' ' A' ' 279' ' ' ARG . 41.5 p -144.68 167.31 22.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.459 1.1 . . . . 75.450000000000003 110.386 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.696 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -45.71 158.17 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 1.14 . . . . 63.140000000000001 109.289 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -70.24 -46.58 49.26 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.489 1.118 . . . . 73.430000000000007 111.026 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -49.5 -37.54 26.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 71.120000000000005 109.301 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.696 HG23 ' HB3' ' A' ' 273' ' ' ALA . 98.4 t -45.61 120.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 72.109999999999999 109.289 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' A' ' 277' ' ' TYR . 1.0 OUTLIER -75.78 -48.74 20.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 74.349999999999994 110.983 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.6 t80 -151.39 154.98 37.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 51.009999999999998 111.032 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.562 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 71.1 ttt-85 -118.52 147.53 43.56 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.539 1.149 . . . . 73.349999999999994 110.269 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.82 157.4 46.37 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 75.25 109.966 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 0.27 9.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.5 1.79 . . . . 55.43 110.983 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.6 t -105.46 9.13 33.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 74.400000000000006 110.003 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.23 40.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.121 . . . . 71.209999999999994 109.306 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -119.23 119.81 35.2 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 70.109999999999999 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -100.07 157.96 16.18 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 71.439999999999998 111.009 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -118.04 177.64 4.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 63.299999999999997 109.244 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.2 m-85 -162.82 132.23 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 73.430000000000007 110.98 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.888 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.6 OUTLIER -113.84 112.08 22.8 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.515 1.134 . . . . 72.409999999999997 109.334 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -52.17 8.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.461 1.101 . . . . 72.319999999999993 109.296 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -115.05 25.08 11.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.518 1.136 . . . . 63.439999999999998 109.331 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.888 HD13 ' HB3' ' A' ' 288' ' ' ASP . 1.9 mm? 48.87 36.59 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 65.120000000000005 109.278 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 18.6 mm -66.04 -30.05 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 54.310000000000002 109.317 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.886 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.5 t-20 -94.5 -31.35 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.528 1.143 . . . . 73.430000000000007 109.245 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.474 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 7.6 m -77.19 -65.89 0.9 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.44 1.087 . . . . 74.319999999999993 110.434 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 70.7 m-20 -48.23 -33.17 8.18 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 74.409999999999997 109.286 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.4 t -72.72 -40.26 66.27 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 64.349999999999994 108.283 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.9 t -59.61 -42.85 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 63.210000000000001 109.327 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.626 HD11 ' HG3' ' A' ' 183' ' ' LYS . 77.1 mt -71.18 -62.42 1.4 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 70.510000000000005 109.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -43.82 -26.38 0.25 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 73.530000000000001 110.343 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.722 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.1 mmmt -67.74 -46.77 71.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 64.420000000000002 109.255 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.708 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.8 m-30 -97.35 36.61 1.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.517 1.136 . . . . 71.25 111.003 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.0 t -67.03 -46.84 73.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.469 1.106 . . . . 62.219999999999999 109.978 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.796 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -92.13 -18.15 23.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.53 1.144 . . . . 73.129999999999995 109.327 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.793 HD22 ' CD ' ' A' ' 309' ' ' PRO . 15.2 mt -59.51 134.17 56.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 71.209999999999994 109.303 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 77.3 p -149.67 150.55 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 74.329999999999998 109.994 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.6 -162.94 45.79 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.496 1.123 . . . . 73.25 110.986 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 4.6 p -90.17 9.92 26.52 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.295 -1.002 . . . . 61.210000000000001 108.295 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.513 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 2.2 p -132.56 150.77 76.75 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 74.109999999999999 109.968 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.793 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.92 146.42 86.63 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 120.984 -2.506 . . . . 73.209999999999994 111.046 -0.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.4 p -131.82 136.05 27.74 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 71.420000000000002 110.02 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.81 14.78 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.036 -2.485 . . . . 50.399999999999999 111.023 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.59 158.2 32.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 62.119999999999997 109.324 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.01 -162.4 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.48 1.779 . . . . 55.109999999999999 110.976 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -91.79 136.24 33.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 74.329999999999998 109.279 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.722 HG12 ' HE2' ' A' ' 300' ' ' LYS . 17.6 m -130.43 17.58 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.109999999999999 109.325 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 318' ' ' CYS . 12.4 t -64.9 -33.01 74.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.151 . . . . 72.420000000000002 110.014 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -48.33 -23.92 1.06 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.518 1.136 . . . . 62.350000000000001 110.0 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 316' ' ' SER . 1.6 m . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 73.129999999999995 108.308 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.0 tp . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.273 -0.639 . . . . 74.319999999999993 109.273 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -150.06 105.31 3.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 64.530000000000001 109.306 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -81.77 5.62 18.03 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 51.030000000000001 109.992 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -146.35 147.52 17.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.502 1.126 . . . . 74.219999999999999 109.302 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.019 HD11 HD12 ' A' ' 149' ' ' LEU . 1.1 mt -100.1 142.54 24.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 62.520000000000003 109.315 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -32.73 5.12 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.434 1.755 . . . . 73.109999999999999 110.972 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.31 147.7 16.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 64.140000000000001 109.266 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.507 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -45.45 -36.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 75.200000000000003 109.262 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.98 -47.42 3.02 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.476 1.11 . . . . 62.240000000000002 109.297 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.777 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.38 -36.16 71.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 53.140000000000001 110.395 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.727 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -57.91 -56.97 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 74.040000000000006 109.303 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.507 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.3 m-80 -52.44 -31.69 35.74 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 75.549999999999997 109.299 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.13 -56.13 8.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 73.040000000000006 109.98 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 140' ' ' ILE . 45.2 mt -44.08 -42.28 6.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 74.540000000000006 109.269 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.672 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -72.44 -44.64 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.129999999999995 111.037 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -47.05 -34.5 5.86 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.154 . . . . 63.43 109.291 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.502 HE22 ' ND2' ' A' ' 191' ' ' ASN . 55.1 mt-30 -79.35 -50.85 10.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.121 . . . . 60.240000000000002 110.281 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 1.132 HD11 HD12 ' A' ' 188' ' ' LEU . 12.7 mt -54.91 -23.19 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.25 109.282 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -38.55 38.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 74.340000000000003 109.259 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.21 -17.44 19.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 63.100000000000001 109.323 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.49 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 12.5 mm-40 -82.94 -25.37 32.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.109999999999999 110.327 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.574 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 17.4 m -39.87 126.5 2.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 55.140000000000001 109.997 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 10.2 m -58.11 109.88 0.83 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 63.219999999999999 108.307 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.71 -18.97 1.13 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.483 1.114 . . . . 61.240000000000002 111.007 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.731 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 59.4 p -93.25 159.84 15.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 0.762 . . . . 70.140000000000001 110.387 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.93 -3.51 58.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 64.420000000000002 110.014 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.7 m -110.15 -1.16 17.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 71.349999999999994 110.42 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.731 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -73.31 132.82 43.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 72.450000000000003 109.294 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -173.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 75.109999999999999 109.989 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.42 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.3 p -152.65 126.94 4.5 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.118 . . . . 62.009999999999998 109.985 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.88 52.9 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.021 -2.491 . . . . 70.129999999999995 110.979 -0.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 9.1 p -72.66 -173.85 1.27 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.125 . . . . 63.539999999999999 108.256 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.94 ' HA ' HD22 ' A' ' 298' ' ' LEU . 3.3 mp -100.82 134.17 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.116 . . . . 75.200000000000003 109.351 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.501 HG21 ' HB2' ' A' ' 301' ' ' PHE . 36.2 p -81.42 86.67 6.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.13 . . . . 74.219999999999999 110.377 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 1.6 p90 -88.9 -1.99 58.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 73.319999999999993 111.007 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.405 HH12 HG22 ' A' ' 169' ' ' THR . 0.1 OUTLIER -110.6 9.88 23.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 55.219999999999999 110.258 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.706 ' OH ' HD13 ' A' ' 304' ' ' LEU . 18.0 t80 -129.51 68.09 79.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.476 1.11 . . . . 75.450000000000003 110.989 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.611 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.3 Cg_endo -75.03 117.08 4.78 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.528 1.804 . . . . 51.310000000000002 111.012 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.637 HG13 ' HB2' ' A' ' 310' ' ' SER . 2.6 t -151.78 -55.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 71.310000000000002 109.262 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.36 -46.77 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 73.450000000000003 109.281 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.2 121.22 1.02 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.47 1.106 . . . . 55.109999999999999 111.004 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.598 ' SG ' HG12 ' A' ' 219' ' ' VAL . 4.3 p -153.02 -47.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.361 -0.978 . . . . 73.150000000000006 108.361 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 47.0 p90 -67.53 -44.47 78.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.468 1.105 . . . . 74.230000000000004 111.048 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.567 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -54.21 -66.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.472 1.107 . . . . 72.219999999999999 109.281 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . 0.529 ' CB ' HG21 ' A' ' 168' ' ' ILE . 2.0 ptm85 -42.02 -46.96 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 1.155 . . . . 72.420000000000002 110.26 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -50.36 -58.96 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.137 . . . . 72.230000000000004 109.268 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -46.35 -28.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 73.349999999999994 109.613 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.843 ' HB3' HD11 ' A' ' 168' ' ' ILE . 24.4 mmmt -81.03 -40.03 24.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 64.150000000000006 109.32 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.553 ' HB3' HD13 ' A' ' 221' ' ' ILE . 9.8 mtm -60.35 -46.64 89.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 70.150000000000006 111.005 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.549 ' NH1' ' HE3' ' A' ' 189' ' ' MET . 0.0 OUTLIER -65.85 -30.67 71.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 64.120000000000005 110.303 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.445 ' HG2' ' N ' ' A' ' 187' ' ' ILE . 0.0 OUTLIER -59.85 -33.12 71.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 74.120000000000005 110.323 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.445 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 25.1 mm -78.5 -50.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 52.350000000000001 109.259 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LEU . . . . . 1.132 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -43.62 -36.89 2.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.454 1.096 . . . . 70.519999999999996 109.307 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.69 ' HG2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -68.54 -46.29 69.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.476 1.11 . . . . 62.509999999999998 111.0 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -53.5 12.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.53 1.144 . . . . 70.040000000000006 109.251 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ASN . . . . . 0.502 ' ND2' HE22 ' A' ' 152' ' ' GLN . 6.3 t-20 -62.29 -37.47 85.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 62.5 109.31 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.95 51.37 0.33 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.534 1.146 . . . . 70.010000000000005 111.002 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.777 ' CZ ' HG21 ' A' ' 145' ' ' THR . 74.0 m-85 -151.43 136.92 17.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 0.757 . . . . 72.219999999999999 111.028 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.792 ' HB2' HD23 ' A' ' 136' ' ' LEU . 2.8 t70 -102.74 131.47 49.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.498 1.123 . . . . 61.329999999999998 109.284 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 1.012 ' HB3' HD22 ' A' ' 188' ' ' LEU . 12.8 p -108.38 -179.27 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 64.109999999999999 108.323 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER -129.39 177.35 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.049999999999997 110.301 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.653 ' HE2' HG22 ' A' ' 221' ' ' ILE . 13.6 mmtt -109.54 171.67 7.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 73.409999999999997 109.306 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.429 ' NE2' HD13 ' A' ' 222' ' ' LEU . 9.9 tt0 -168.72 117.4 0.69 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 71.109999999999999 110.324 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.4 m-85 -109.09 137.81 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 64.310000000000002 111.014 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.884 HG23 ' HB3' ' A' ' 269' ' ' TYR . 9.9 p -129.98 125.59 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 75.129999999999995 109.289 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -95.97 151.14 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 72.049999999999997 110.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 129.44 -171.07 20.21 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.506 1.129 . . . . 71.310000000000002 110.995 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . 0.837 ' C ' HD23 ' A' ' 204' ' ' LEU . 56.1 t-20 -79.15 111.47 15.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 0.787 . . . . 73.209999999999994 109.302 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.837 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.3 mt -116.53 94.61 4.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 52.109999999999999 109.331 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.777 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 9.3 mttt -93.08 168.18 11.29 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.472 1.107 . . . . 65.430000000000007 109.336 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.586 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -167.56 125.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.458 1.099 . . . . 50.450000000000003 109.296 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 C--N 1.325 -0.484 0 O-C-N 124.443 1.09 . . . . 71.340000000000003 109.966 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.424 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.302 -0.999 . . . . 70.409999999999997 108.302 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.611 HG11 ' O ' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -153.34 149.19 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 60.409999999999997 109.295 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.777 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -129.46 133.37 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 72.349999999999994 109.313 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -134.31 132.01 39.06 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.146 . . . . 74.040000000000006 108.009 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.5 p -73.66 -3.59 29.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 63.32 109.988 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 6.8 p90 -173.95 137.46 0.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 72.209999999999994 111.013 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 60.2 t60 -125.9 168.83 13.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 75.340000000000003 109.546 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.598 HG12 ' SG ' ' A' ' 177' ' ' CYS . 1.8 p -147.44 133.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 74.439999999999998 109.327 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.22 -165.03 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 73.219999999999999 109.25 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.653 HG22 ' HE2' ' A' ' 197' ' ' LYS . 18.5 pt -116.99 117.66 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.122 . . . . 71.25 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 234' ' ' LYS . 14.0 tp -81.83 109.05 15.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.239999999999995 109.277 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.727 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.85 147.86 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 109.284 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 67.2 m -117.62 121.74 41.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 74.019999999999996 109.991 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.528 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 31.7 p90 -136.64 143.23 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 73.200000000000003 111.028 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.427 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -69.17 132.28 46.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.529 1.143 . . . . 72.409999999999997 109.315 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.476 1.11 . . . . 74.319999999999993 109.317 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.68 -0.2 49.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.132 . . . . 73.040000000000006 109.337 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.7 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.087 . . . . 73.209999999999994 110.052 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.25 37.87 8.06 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.511 1.132 . . . . 54.299999999999997 111.001 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.418 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.8 137.33 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 53.509999999999998 109.305 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.427 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.3 m -71.45 102.54 2.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 54.450000000000003 110.428 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.7 mm-40 -101.8 -172.58 2.18 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 74.209999999999994 110.272 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.497 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -126.51 144.89 50.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 75.310000000000002 109.3 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.627 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.1 tpt180 -144.17 161.59 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 75.140000000000001 110.327 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 252' ' ' TRP . 17.8 mm -115.85 116.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 74.420000000000002 109.287 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -100.42 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 53.439999999999998 109.293 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ASP . . . . . 0.419 ' OD1' ' CE ' ' A' ' 184' ' ' MET . 3.1 m-20 -100.1 110.38 59.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 75.439999999999998 109.343 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -42.99 0.43 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.465 1.771 . . . . 73.129999999999995 110.987 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 26.5 p -39.28 -29.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 73.519999999999996 109.998 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 239' ' ' PRO . 30.0 mt -101.92 -59.49 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.230000000000004 109.288 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.604 ' CD1' HG11 ' A' ' 247' ' ' VAL . 79.7 m-85 -112.29 99.39 7.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 63.049999999999997 111.025 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.5 m -86.2 -5.18 59.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 64.549999999999997 109.968 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 m -82.65 -45.28 14.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 62.32 109.999 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.74 -173.77 45.1 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.512 1.133 . . . . 73.239999999999995 110.993 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' PRO . . . . . 0.441 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.5 Cg_endo -74.95 162.73 36.74 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.501 1.79 . . . . 50.530000000000001 111.034 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.604 HG11 ' CD1' ' A' ' 242' ' ' PHE . 2.7 m -148.18 159.19 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 73.420000000000002 109.329 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.435 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.2 p -62.23 139.93 58.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 71.409999999999997 110.418 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.407 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 2.5 p-10 -42.95 -28.13 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.123 . . . . 63.119999999999997 109.328 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.435 ' N ' ' C ' ' A' ' 248' ' ' THR . 17.1 m -72.45 -65.0 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 74.439999999999998 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.94 14.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.447 1.092 . . . . 70.120000000000005 109.29 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' TRP . . . . . 0.686 ' CD1' HG21 ' A' ' 236' ' ' ILE . 11.9 t90 -59.47 -66.17 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.953 -1.129 . . . . 70.420000000000002 107.953 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.799 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -41.67 -39.18 1.59 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 75.420000000000002 110.254 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ASN . . . . . 0.876 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.1 m-80 -60.12 -50.37 73.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 53.329999999999998 109.297 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.597 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -55.1 -28.89 55.89 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.409999999999997 109.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' LYS . 7.6 m -81.39 -33.52 32.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 73.030000000000001 108.309 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.876 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.4 m -98.14 24.18 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 72.439999999999998 109.338 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.87 110.93 0.89 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 71.200000000000003 109.271 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.8 p -73.32 -3.04 24.61 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 74.299999999999997 110.402 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.2 t -44.34 -26.66 0.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 73.439999999999998 109.954 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.83 -36.58 11.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.447 1.092 . . . . 75.209999999999994 108.253 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.96 -126.55 1.36 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.116 . . . . 71.540000000000006 111.028 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -81.24 150.33 28.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 0.759 . . . . 74.340000000000003 110.001 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.566 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -172.28 144.68 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 61.520000000000003 109.276 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 41.6 p -172.84 153.14 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 74.329999999999998 109.992 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.687 HG23 HG11 ' A' ' 257' ' ' VAL . 3.1 t -99.75 125.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 70.349999999999994 109.295 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.4 t -85.87 -29.35 23.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.124 . . . . 72.430000000000007 109.966 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.6 m 178.58 155.64 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 54.439999999999998 109.969 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.884 ' HB3' HG23 ' A' ' 200' ' ' VAL . 30.2 p90 -144.14 155.94 44.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 75.319999999999993 111.014 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -147.79 154.33 40.34 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.556 1.16 . . . . 62.119999999999997 109.293 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.426 ' ND2' ' C ' ' A' ' 271' ' ' ASN . 1.0 OUTLIER -107.62 157.71 17.85 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 54.420000000000002 109.323 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.705 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.8 p -149.47 178.39 8.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 64.329999999999998 110.364 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ALA . . . . . 0.634 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -67.91 165.93 16.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.425 1.078 . . . . 73.319999999999993 109.303 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -75.38 -42.69 27.15 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.545 1.153 . . . . 74.329999999999998 110.995 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -55.26 -39.93 70.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 0.767 . . . . 72.120000000000005 109.273 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' VAL . . . . . 0.634 HG23 ' HB3' ' A' ' 273' ' ' ALA . 76.6 t -43.57 101.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 74.310000000000002 109.295 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.43 -47.34 84.49 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 74.439999999999998 110.978 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -152.12 138.51 18.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.48 1.112 . . . . 62.009999999999998 111.036 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.705 ' HD2' HG21 ' A' ' 272' ' ' THR . 67.4 ttt-85 -106.84 147.42 29.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 54.43 110.345 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.71 158.12 48.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 63.439999999999998 110.011 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 0.25 9.14 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.469 1.773 . . . . 65.140000000000001 111.009 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 28.7 t -103.09 7.4 38.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.464 1.103 . . . . 53.450000000000003 109.996 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 73.93 41.91 0.39 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.450000000000003 109.3 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 t -123.5 121.51 35.85 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.495 1.122 . . . . 74.239999999999995 110.04 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' TYR . . . . . 0.465 ' OH ' HG22 ' A' ' 272' ' ' THR . 11.5 m-30 -101.27 165.82 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 75.099999999999994 110.989 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' LEU . . . . . 0.476 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.1 mm? -124.62 177.37 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 65.519999999999996 109.328 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.5 m-85 -160.32 123.21 3.39 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 71.430000000000007 110.98 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 291' ' ' LEU . 2.2 m-20 -115.07 104.01 11.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.099 . . . . 73.409999999999997 109.302 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' ASN . . . . . 0.415 ' O ' HD22 ' A' ' 291' ' ' LEU . 3.3 m-80 -85.54 -53.81 4.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 73.329999999999998 109.32 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' ASN . . . . . 0.463 ' CB ' HG12 ' A' ' 292' ' ' ILE . 17.0 m-20 -93.04 15.65 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.558 1.161 . . . . 63.439999999999998 109.318 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.917 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.4 mm? 40.27 42.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 72.439999999999998 109.308 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . 0.463 HG12 ' CB ' ' A' ' 290' ' ' ASN . 26.6 mm -74.04 -28.38 23.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.542 1.151 . . . . 73.439999999999998 109.318 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.865 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.4 t-20 -94.64 -26.91 16.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 71.340000000000003 109.313 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 297' ' ' VAL . 23.7 m -82.3 -68.96 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 75.329999999999998 110.424 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.6 m-20 -47.52 -29.86 3.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 74.439999999999998 109.315 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.69 -43.06 57.05 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 1.094 . . . . 53.329999999999998 108.333 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.1 t -56.46 -50.59 71.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.129999999999995 109.256 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' LEU . . . . . 0.94 HD22 ' HA ' ' A' ' 168' ' ' ILE . 10.4 mt -61.85 -63.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 71.239999999999995 109.283 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -41.96 -42.45 2.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 61.130000000000003 110.425 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' LYS . . . . . 0.564 ' HE2' HG12 ' A' ' 315' ' ' VAL . 14.9 mmmt -53.34 -44.66 68.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 55.130000000000003 109.305 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' PHE . . . . . 0.562 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 2.5 m-30 -100.42 29.87 4.18 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.541 1.15 . . . . 74.409999999999997 110.979 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 27.2 t -62.04 -52.35 64.29 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 52.100000000000001 109.989 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' LEU . . . . . 0.626 HD13 ' H ' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -84.05 -10.46 57.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 72.409999999999997 109.281 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.706 HD13 ' OH ' ' A' ' 172' ' ' TYR . 17.7 mt -73.82 137.18 43.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 71.219999999999999 109.288 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 62.9 p -160.7 137.12 8.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 64.140000000000001 110.009 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.89 -158.77 15.53 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.565 1.166 . . . . 64.120000000000005 111.019 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 8.4 p -95.76 8.7 42.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.347 -0.983 . . . . 71.219999999999999 108.347 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 4.0 p -139.14 152.11 69.1 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 73.040000000000006 109.985 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' PRO . . . . . 0.592 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.02 146.64 87.2 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.002 -2.499 . . . . 61.450000000000003 111.028 0.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' SER . . . . . 0.637 ' HB2' HG13 ' A' ' 174' ' ' VAL . 6.1 t -132.79 135.15 25.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 74.329999999999998 109.999 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.1 Cg_endo -75.01 -173.64 12.7 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.986 -2.506 . . . . 72.129999999999995 111.0 0.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.477 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.99 152.99 25.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 61.219999999999999 109.313 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' PRO . . . . . 0.557 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.491 1.785 . . . . 64.299999999999997 110.988 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -81.96 133.05 35.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 71.109999999999999 109.264 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.564 HG12 ' HE2' ' A' ' 300' ' ' LYS . 27.1 m -136.19 16.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 63.020000000000003 109.27 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 318' ' ' CYS . 1.7 t -64.04 -40.2 95.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.299999999999997 109.955 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.1 t -39.5 -29.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 73.109999999999999 110.01 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' CYS . . . . . 0.439 ' N ' ' C ' ' A' ' 316' ' ' SER . 5.2 m . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 74.219999999999999 108.287 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.7 tp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.253 -0.647 . . . . 72.019999999999996 109.253 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.597 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -145.47 112.85 6.2 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.119 . . . . 73.409999999999997 109.312 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -85.84 11.47 11.18 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 63.520000000000003 109.987 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -150.3 149.11 14.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.426 1.079 . . . . 53.329999999999998 109.303 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.024 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -101.48 143.29 26.31 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 63.5 109.298 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.99 -33.86 4.27 Favored 'Trans proline' 0 C--N 1.36 1.176 0 O-C-N 124.469 1.773 . . . . 62.399999999999999 111.034 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.432 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.49 152.52 23.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 61.32 109.294 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.514 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.1 t -49.54 -36.09 9.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.147 . . . . 71.219999999999999 109.311 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.58 2.93 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 70.230000000000004 109.317 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.701 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -71.53 -36.2 70.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 75.439999999999998 110.391 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.739 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.93 -57.4 12.95 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.548 1.155 . . . . 70.049999999999997 109.269 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.514 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 46.8 m-80 -51.08 -33.19 24.9 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 55.310000000000002 109.29 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -66.9 -56.5 10.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 74.340000000000003 109.943 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.024 HD12 HD11 ' A' ' 140' ' ' ILE . 59.8 mt -41.82 -41.9 2.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 44.140000000000001 109.3 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.622 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.06 -40.89 62.48 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 60.420000000000002 111.033 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -51.01 -36.2 38.11 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.513 1.133 . . . . 64.200000000000003 109.306 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.474 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 65.3 mt-30 -76.52 -56.39 4.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 1.128 . . . . 51.0 110.308 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.633 HG21 ' SD ' ' A' ' 184' ' ' MET . 25.4 mt -50.18 -29.38 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.492 1.12 . . . . 71.5 109.296 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -33.44 63.03 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.127 . . . . 73.120000000000005 109.302 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -61.72 -15.68 42.69 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 70.040000000000006 109.305 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -84.58 -17.68 38.01 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 70.400000000000006 110.301 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.492 ' HA ' ' CD2' ' A' ' 170' ' ' PHE . 16.1 p -38.53 133.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.536 1.147 . . . . 75.310000000000002 110.007 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -64.59 130.0 41.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 61.140000000000001 108.315 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 117.79 -20.75 10.74 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.495 1.122 . . . . 63.229999999999997 110.962 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.803 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 64.2 p -79.24 161.75 26.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 0.791 . . . . 73.129999999999995 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.73 -0.84 55.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.458 1.099 . . . . 64.430000000000007 110.016 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 162' ' ' THR . 4.6 m -116.61 6.19 13.38 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 75.030000000000001 110.418 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.803 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.66 138.88 34.0 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.464 1.102 . . . . 74.519999999999996 109.264 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.59 -163.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.487 1.117 . . . . 54.119999999999997 109.977 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.19 127.24 3.6 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.556 1.16 . . . . 74.430000000000007 110.008 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.02 138.02 53.68 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 120.993 -2.503 . . . . 63.32 111.002 0.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.1 p -73.03 177.96 4.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 72.319999999999993 108.319 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.692 HG21 ' CZ ' ' A' ' 170' ' ' PHE . 3.5 mp -89.53 125.09 42.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.515 1.134 . . . . 64.230000000000004 109.276 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.589 HG21 ' O ' ' A' ' 301' ' ' PHE . 65.3 p -79.65 88.23 5.16 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.538 1.149 . . . . 43.130000000000003 110.387 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.692 ' CZ ' HG21 ' A' ' 168' ' ' ILE . 84.8 m-85 -88.01 -26.37 22.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 111.001 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.456 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.77 -1.31 24.44 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 72.510000000000005 110.301 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.689 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 26.4 t80 -128.52 67.6 76.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 71.420000000000002 110.986 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 115.58 4.33 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.482 1.78 . . . . 61.240000000000002 110.979 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.681 HG21 ' CE1' ' A' ' 172' ' ' TYR . 15.8 t -148.85 -72.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.484 1.115 . . . . 60.140000000000001 109.301 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.02 -45.15 2.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 73.420000000000002 109.306 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -42.33 101.54 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.543 1.152 . . . . 24.23 111.006 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 73.9 m -134.3 -48.15 0.78 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.272 -1.01 . . . . 72.209999999999994 108.272 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.693 ' HB3' HG11 ' A' ' 219' ' ' VAL . 38.7 p90 -75.61 -45.55 36.78 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.219999999999999 110.99 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.626 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.33 -68.41 0.18 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.495 1.122 . . . . 73.140000000000001 109.277 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.834 HH21 ' HD2' ' A' ' 239' ' ' PRO . 3.6 ptm180 -50.09 -47.61 53.68 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 73.209999999999994 110.318 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -39.83 -61.2 0.88 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.505 1.128 . . . . 32.329999999999998 109.304 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.697 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.8 OUTLIER -46.37 -39.68 10.75 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.145 . . . . 71.310000000000002 109.595 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.556 ' CB ' HD11 ' A' ' 168' ' ' ILE . 14.1 mmmm -65.25 -61.25 2.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.152 . . . . 73.430000000000007 109.281 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.633 ' SD ' HG21 ' A' ' 153' ' ' ILE . 13.8 mtm -39.02 -40.96 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.432 1.082 . . . . 61.130000000000003 110.963 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.454 ' NH1' ' CE ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -56.76 -49.89 73.92 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.546 1.154 . . . . 73.230000000000004 110.323 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.412 ' NE2' ' HE2' ' A' ' 183' ' ' LYS . 0.2 OUTLIER -54.48 -35.92 63.58 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 71.209999999999994 110.31 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 21.7 mm -71.16 -34.15 53.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 63.310000000000002 109.278 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -64.39 -45.78 86.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 74.239999999999995 109.273 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.454 ' CE ' ' NH1' ' A' ' 185' ' ' ARG . 3.5 mtt -55.32 -36.8 66.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 72.109999999999999 111.006 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.62 -50.3 68.42 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.495 1.122 . . . . 65.019999999999996 109.305 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.474 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 18.7 t-20 -66.84 -34.23 77.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.538 1.149 . . . . 73.430000000000007 109.337 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 107.99 53.39 0.66 Allowed Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.487 1.117 . . . . 54.439999999999998 111.012 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.701 ' CZ ' HG21 ' A' ' 145' ' ' THR . 72.4 m-85 -153.17 134.86 14.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 0.771 . . . . 72.230000000000004 111.0 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.792 ' HB2' HD23 ' A' ' 136' ' ' LEU . 2.4 t0 -101.43 122.36 43.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.475 1.109 . . . . 53.350000000000001 109.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.709 ' HB3' HD22 ' A' ' 188' ' ' LEU . 29.5 p -100.11 -179.38 4.13 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 72.439999999999998 108.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -126.63 174.47 8.67 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 1.113 . . . . 62.520000000000003 110.312 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.718 ' HE2' HG22 ' A' ' 221' ' ' ILE . 18.9 mmtt -110.1 159.01 17.7 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 73.219999999999999 109.301 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.926 ' NE2' HD13 ' A' ' 222' ' ' LEU . 7.6 tt0 -151.39 117.59 5.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.481 1.113 . . . . 75.299999999999997 110.282 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.559 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.5 m-85 -110.71 118.59 36.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 61.109999999999999 110.978 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.7 ' CG2' HG23 ' A' ' 266' ' ' VAL . 10.0 p -109.88 146.71 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 64.200000000000003 109.311 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 12.0 m-85 -118.63 160.43 21.82 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 75.310000000000002 111.041 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.61 -176.04 16.01 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.509 1.131 . . . . 74.120000000000005 110.99 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.768 ' C ' HD23 ' A' ' 204' ' ' LEU . 56.7 t-20 -72.39 110.3 6.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 0.781 . . . . 73.140000000000001 109.298 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.2 mt -114.52 94.74 4.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.543 1.152 . . . . 70.030000000000001 109.314 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.1 mtpt -92.31 178.75 5.75 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.531 1.145 . . . . 61.039999999999999 109.321 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.948 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -178.02 163.24 1.72 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.219999999999999 109.316 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t -141.55 131.07 23.87 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.549 1.156 . . . . 63.25 110.007 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.6 p -108.98 -2.65 18.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.507 1.129 . . . . 60.100000000000001 110.398 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.48 -22.7 25.94 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.529 1.143 . . . . 73.209999999999994 110.983 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 t -113.79 -17.29 12.1 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 0.764 . . . . 65.349999999999994 110.427 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 2.2 p -173.96 148.1 1.36 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 73.540000000000006 108.263 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.45 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 0.5 OUTLIER -101.85 160.13 14.75 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.423 1.077 . . . . 73.219999999999999 108.281 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.948 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -134.07 149.68 30.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.479 1.112 . . . . 74.109999999999999 109.301 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.34 130.91 27.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 62.049999999999997 109.274 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.452 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -137.68 135.82 36.84 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.979 -1.119 . . . . 75.120000000000005 107.979 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 72.7 p -80.05 1.11 29.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 73.530000000000001 110.045 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.463 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.0 p90 -176.23 129.83 0.22 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.448 1.093 . . . . 72.329999999999998 111.0 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 37.4 t60 -114.43 169.05 9.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 62.130000000000003 109.603 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.1 p -146.45 136.37 17.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 73.349999999999994 109.269 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.641 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.13 -168.04 2.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.51 1.131 . . . . 75.519999999999996 109.297 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.718 HG22 ' HE2' ' A' ' 197' ' ' LYS . 28.1 pt -115.75 121.51 67.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.485 1.116 . . . . 74.530000000000001 109.304 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.926 HD13 ' NE2' ' A' ' 198' ' ' GLN . 12.9 tp -85.41 109.03 18.15 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 73.340000000000003 109.313 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.739 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -102.8 146.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.503 1.127 . . . . 62.420000000000002 109.269 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.569 ' HB3' HG22 ' A' ' 139' ' ' VAL . 4.0 m -116.78 119.86 36.75 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 74.510000000000005 110.024 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.57 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.4 p90 -134.93 143.26 46.81 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.124 . . . . 72.420000000000002 111.007 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.419 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -68.61 133.93 49.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 71.450000000000003 109.344 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.02 -160.22 0.11 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.496 1.122 . . . . 72.219999999999999 109.306 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.81 0.05 49.05 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 63.210000000000001 109.288 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.4 m -115.12 -8.33 12.41 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 72.010000000000005 110.009 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.73 37.44 7.98 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.483 1.114 . . . . 71.340000000000003 111.018 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.37 137.4 44.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.479 0.752 . . . . 71.140000000000001 109.274 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.419 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 6.3 m -71.52 102.66 2.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.484 1.115 . . . . 72.239999999999995 110.425 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 3.0 mm-40 -101.49 -172.24 2.13 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.496 1.123 . . . . 71.409999999999997 110.298 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.474 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.1 mmtm -126.97 144.83 50.9 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.5 1.125 . . . . 62.340000000000003 109.28 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.0 tpt180 -144.47 160.46 41.06 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.543 1.152 . . . . 72.120000000000005 110.282 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.58 HG21 ' CD1' ' A' ' 252' ' ' TRP . 13.8 mm -114.88 127.67 72.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 64.439999999999998 109.296 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -111.95 41.82 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.49 1.119 . . . . 75.319999999999993 109.332 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.415 ' OD1' ' HE1' ' A' ' 184' ' ' MET . 1.6 m-20 -104.43 108.05 59.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.468 1.105 . . . . 73.420000000000002 109.289 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.834 ' HD2' HH21 ' A' ' 180' ' ' ARG . 18.1 Cg_endo -75.03 -0.54 10.1 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.477 1.777 . . . . 62.299999999999997 110.995 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.501 ' N ' ' NH2' ' A' ' 180' ' ' ARG . 1.2 t -67.67 -9.29 42.18 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.542 1.151 . . . . 64.329999999999998 109.944 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.467 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 3.1 mt -135.21 -47.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 71.230000000000004 109.287 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.601 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.5 m-85 -121.0 99.75 6.68 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 71.430000000000007 110.966 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.0 -24.04 26.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 74.540000000000006 109.999 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.7 p -61.73 -45.74 92.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.543 1.152 . . . . 72.430000000000007 109.987 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.42 -174.22 41.02 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.496 1.123 . . . . 51.229999999999997 111.017 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.425 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.01 169.18 23.2 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.431 1.753 . . . . 75.430000000000007 110.973 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.601 HG21 ' CE2' ' A' ' 242' ' ' PHE . 4.1 m -152.45 157.21 5.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.497 1.123 . . . . 60.439999999999998 109.3 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 36.8 p -60.22 137.09 58.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.447 1.092 . . . . 65.120000000000005 110.395 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 7.7 p-10 -40.57 -29.67 0.1 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.475 1.109 . . . . 72.439999999999998 109.334 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.0 m -71.64 -64.91 0.83 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.498 1.124 . . . . 72.340000000000003 110.355 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.0 -30.78 11.26 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 109.274 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.641 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 15.6 t90 -60.74 -61.9 2.25 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 71.430000000000007 107.996 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.611 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -47.44 -40.88 19.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.48 1.112 . . . . 71.109999999999999 110.316 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.768 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.0 m-80 -57.85 -50.79 72.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.491 1.119 . . . . 62.350000000000001 109.287 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.79 -23.01 40.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.491 1.119 . . . . 72.200000000000003 109.287 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.447 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.6 m -84.78 -35.84 22.11 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 73.129999999999995 108.28 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.768 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.9 m -95.24 21.29 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.551 1.157 . . . . 63.009999999999998 109.294 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -50.23 107.27 0.15 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.46 1.1 . . . . 63.130000000000003 109.26 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.9 p -72.49 -3.93 27.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.561 1.163 . . . . 63.210000000000001 110.435 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.9 t -46.54 -25.03 0.61 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.539 1.149 . . . . 74.030000000000001 110.006 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . 0.426 ' SG ' ' NZ ' ' A' ' 205' ' ' LYS . 19.7 t -94.34 -35.32 12.45 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 73.140000000000001 108.282 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 162.18 -128.35 1.87 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.489 1.118 . . . . 74.120000000000005 110.981 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -71.28 143.91 50.19 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 0.768 . . . . 70.120000000000005 109.953 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.3 144.33 2.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.493 1.121 . . . . 73.040000000000006 109.297 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.7 t -172.78 154.78 3.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.498 1.124 . . . . 75.120000000000005 110.007 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.7 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.27 117.54 44.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 73.299999999999997 109.308 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 20.7 t -73.74 -43.96 57.61 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.131 . . . . 64.099999999999994 110.044 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.1 m -165.23 171.92 13.05 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 70.200000000000003 110.02 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -154.33 155.81 35.77 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.481 1.113 . . . . 73.25 111.012 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -157.81 160.66 38.0 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 74.219999999999999 109.323 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.432 ' C ' HG23 ' A' ' 272' ' ' THR . 1.9 p-10 -121.94 160.64 24.41 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.504 1.128 . . . . 71.109999999999999 109.303 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.546 HG21 ' HD2' ' A' ' 279' ' ' ARG . 35.0 p -152.62 175.68 12.54 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 74.510000000000005 110.37 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.805 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -59.13 156.5 11.97 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 74.530000000000001 109.334 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.74 -46.13 62.41 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.486 1.116 . . . . 33.43 110.993 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -52.94 -42.38 65.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.511 0.771 . . . . 73.140000000000001 109.353 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.805 HG23 ' HB3' ' A' ' 273' ' ' ALA . 81.8 t -43.88 101.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.517 1.136 . . . . 74.239999999999995 109.325 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.4 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 2.6 t80 -58.67 -59.47 5.35 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 63.450000000000003 111.009 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -132.03 150.25 52.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.467 1.104 . . . . 75.519999999999996 111.064 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.559 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 60.8 ttt-85 -119.35 147.47 44.29 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 52.109999999999999 110.313 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.66 158.2 40.93 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.44 1.087 . . . . 74.200000000000003 110.015 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 0.37 9.0 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.495 1.787 . . . . 63.350000000000001 110.976 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.9 t -100.47 9.88 41.98 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 71.329999999999998 109.987 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 72.82 40.8 0.57 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 72.299999999999997 109.336 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -119.18 133.14 55.94 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.469 1.106 . . . . 74.530000000000001 110.022 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.43 ' OH ' HG22 ' A' ' 272' ' ' THR . 18.0 m-30 -114.38 150.12 35.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.54 1.15 . . . . 72.5 110.985 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.559 HD11 ' CZ ' ' A' ' 320' ' ' PHE . 1.1 mm? -116.44 177.48 4.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 71.239999999999995 109.274 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 47.7 m-85 -160.59 115.49 2.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 75.0 111.006 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -115.38 94.87 4.9 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.475 1.109 . . . . 75.200000000000003 109.337 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.7 -16.74 53.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.511 1.132 . . . . 71.140000000000001 109.266 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.456 ' HB3' HD11 ' A' ' 292' ' ' ILE . 40.8 m-20 -108.52 5.31 25.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.134 . . . . 64.120000000000005 109.321 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.697 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.27 49.7 2.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.553 1.158 . . . . 73.219999999999999 109.276 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' A' ' 290' ' ' ASN . 40.6 mm -80.03 -29.26 12.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.532 1.145 . . . . 75.349999999999994 109.317 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.756 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.7 t-20 -94.5 -20.59 19.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.509 1.13 . . . . 53.229999999999997 109.281 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.418 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.7 m -87.59 -68.65 0.74 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.133 . . . . 70.349999999999994 110.365 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 77.4 m-20 -49.75 -31.2 10.92 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.459 1.1 . . . . 73.219999999999999 109.304 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 41.3 t -70.96 -49.36 46.31 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 72.340000000000003 108.302 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.3 t -52.01 -43.84 37.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 64.219999999999999 109.331 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 301' ' ' PHE . 21.0 mt -67.2 -61.12 2.08 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.505 1.128 . . . . 34.450000000000003 109.3 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -41.4 -31.72 0.27 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.533 1.145 . . . . 45.219999999999999 110.382 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.403 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.0 mmmt -67.14 -51.48 53.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 63.350000000000001 109.252 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.589 ' O ' HG21 ' A' ' 169' ' ' THR . 0.6 OUTLIER -94.58 37.72 1.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 73.209999999999994 111.025 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 37.0 t -69.08 -46.82 66.85 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.484 1.115 . . . . 72.329999999999998 109.953 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.773 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -90.19 -17.55 27.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 72.340000000000003 109.31 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.769 HD22 ' CD ' ' A' ' 309' ' ' PRO . 16.6 mt -57.81 140.07 52.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.535 1.147 . . . . 73.319999999999993 109.297 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.6 p -152.66 140.72 20.29 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.441 1.088 . . . . 72.049999999999997 110.002 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.93 -161.66 27.02 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.497 1.123 . . . . 55.509999999999998 111.0 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.8 m -92.32 6.2 47.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.344 -0.984 . . . . 44.350000000000001 108.344 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 24.0 p -130.22 151.05 77.79 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 64.340000000000003 110.053 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.769 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.03 145.87 85.08 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.998 -2.501 . . . . 74.129999999999995 110.999 0.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.581 ' HB3' HG13 ' A' ' 174' ' ' VAL . 2.0 p -133.59 135.51 25.16 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 52.409999999999997 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.02 -173.6 12.62 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.047 -2.48 . . . . 70.319999999999993 111.002 0.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.01 154.67 18.35 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.532 1.145 . . . . 52.149999999999999 109.339 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.506 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -74.96 -162.24 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.482 1.78 . . . . 62.200000000000003 111.039 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -85.08 133.83 34.21 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 73.049999999999997 109.295 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.403 HG12 ' HE2' ' A' ' 300' ' ' LYS . 21.2 m -125.81 25.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.52 1.137 . . . . 72.109999999999999 109.32 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 t -55.12 -31.7 61.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.463 1.102 . . . . 72.109999999999999 110.02 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 28.8 p -49.65 -23.58 1.79 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 74.230000000000004 110.026 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.6 m -77.76 175.47 9.93 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 54.109999999999999 108.289 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 166.48 100.46 0.14 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.522 1.139 . . . . 75.099999999999994 110.982 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.559 ' CZ ' HD11 ' A' ' 286' ' ' LEU . 10.6 p90 . . . . . 0 C--N 1.324 -0.503 0 O-C-N 124.484 0.756 . . . . 72.319999999999993 110.966 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.898 HD23 ' HB2' ' A' ' 194' ' ' ASP . 8.9 tp . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.271 -0.64 . . . . 63.109999999999999 109.271 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.541 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -103.92 105.46 15.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 75.450000000000003 109.289 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.1 m -83.66 8.46 14.32 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.129 . . . . 43.340000000000003 109.973 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -150.16 147.01 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.456 1.098 . . . . 55.049999999999997 109.266 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.008 HD11 HD12 ' A' ' 149' ' ' LEU . 1.3 mt -97.92 142.14 24.09 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.148 . . . . 64.230000000000004 109.304 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.05 -32.37 5.38 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.519 1.8 . . . . 63.210000000000001 110.969 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.05 148.36 17.01 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.487 1.117 . . . . 64.510000000000005 109.332 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.521 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.1 t -46.11 -36.35 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.14 . . . . 73.230000000000004 109.286 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.88 -47.39 2.94 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.478 1.112 . . . . 72.010000000000005 109.268 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.706 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.55 -36.36 70.93 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.54 1.15 . . . . 72.299999999999997 110.394 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.708 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.9 -57.23 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 63.539999999999999 109.295 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.521 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 47.4 m-80 -51.62 -32.36 28.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 65.129999999999995 109.297 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.74 -56.29 8.57 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 73.420000000000002 110.023 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.008 HD12 HD11 ' A' ' 140' ' ' ILE . 56.6 mt -43.69 -42.19 5.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 63.240000000000002 109.318 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.698 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -71.87 -44.29 64.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 72.129999999999995 110.987 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -46.4 -35.77 5.84 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 72.430000000000007 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -77.87 -54.89 5.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.461 1.101 . . . . 54.340000000000003 110.278 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.044 HD11 HD12 ' A' ' 188' ' ' LEU . 10.2 mt -50.63 -24.5 2.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.48 1.113 . . . . 60.030000000000001 109.275 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -38.39 46.55 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 72.219999999999999 109.31 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -58.73 -17.04 19.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.52 1.137 . . . . 62.229999999999997 109.288 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.544 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.9 mm100 -81.91 -26.36 34.16 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.558 1.161 . . . . 64.540000000000006 110.29 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 13.9 m -42.24 137.75 1.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 73.230000000000004 109.972 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.69 113.03 4.51 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.521 1.138 . . . . 63.439999999999998 108.314 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.1 -17.58 1.74 Allowed Glycine 0 CA--C 1.531 1.033 0 O-C-N 124.518 1.136 . . . . 42.5 110.994 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.806 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 72.7 p -93.17 161.66 14.33 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.538 0.787 . . . . 74.319999999999993 110.385 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 85.7 p -92.52 -1.82 56.67 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 61.0 109.984 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 162' ' ' THR . 2.4 m -114.74 2.54 14.45 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.521 1.138 . . . . 74.329999999999998 110.396 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.806 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -75.33 133.54 41.23 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 71.420000000000002 109.35 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -170.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 73.129999999999995 109.961 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.4 p -154.11 127.33 4.22 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 72.439999999999998 110.049 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -75.03 138.04 53.78 Favored 'Cis proline' 0 C--N 1.36 1.137 0 C-N-CA 120.966 -2.514 . . . . 75.140000000000001 111.0 0.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.1 p -72.79 -178.6 2.78 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.459 1.1 . . . . 44.340000000000003 108.328 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.609 HG23 ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.33 132.88 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.134 . . . . 60.140000000000001 109.295 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 18.1 p -92.68 73.14 5.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.525 1.14 . . . . 53.310000000000002 110.411 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 12.7 p90 -74.14 -21.3 59.92 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.562 1.164 . . . . 73.140000000000001 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 302' ' ' SER . 0.0 OUTLIER -74.73 -1.85 23.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.461 1.101 . . . . 71.319999999999993 110.281 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.773 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 21.9 t80 -131.76 66.97 79.16 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.514 1.134 . . . . 72.299999999999997 110.976 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.434 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.02 118.79 5.39 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.435 1.755 . . . . 75.200000000000003 110.993 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.578 HG21 ' CE1' ' A' ' 172' ' ' TYR . 6.7 t -152.09 -72.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 63.140000000000001 109.337 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -127.6 -44.96 1.5 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.529 1.143 . . . . 63.020000000000003 109.288 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -44.27 110.05 0.32 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.527 1.142 . . . . 64.409999999999997 110.999 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.544 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.3 p -147.95 -48.47 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.277 -1.009 . . . . 44.130000000000003 108.277 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -66.58 -16.96 64.55 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.538 1.149 . . . . 75.219999999999999 110.984 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -77.04 -68.11 0.64 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 1.121 . . . . 73.510000000000005 109.334 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.609 ' HB3' HG23 ' A' ' 168' ' ' ILE . 10.0 ptm180 -49.03 -50.62 35.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.451 1.094 . . . . 75.319999999999993 110.314 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.413 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.21 -56.63 3.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.507 1.129 . . . . 55.340000000000003 109.296 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.7 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -45.07 -36.71 3.72 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 55.43 109.575 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.753 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.0 mmmt -68.89 -59.15 3.27 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.15 . . . . 64.409999999999997 109.313 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.471 ' CB ' HD13 ' A' ' 221' ' ' ILE . 11.2 mtm -38.74 -31.45 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.150000000000006 111.009 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.437 ' NH2' ' OD2' ' A' ' 194' ' ' ASP . 0.0 OUTLIER -69.32 -54.08 16.38 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.458 1.099 . . . . 73.120000000000005 110.259 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.753 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.6 OUTLIER -54.15 -32.62 55.8 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 73.310000000000002 110.286 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 153' ' ' ILE . 26.1 mm -71.5 -40.14 71.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.459 1.1 . . . . 74.510000000000005 109.235 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 1.044 HD12 HD11 ' A' ' 153' ' ' ILE . 0.3 OUTLIER -62.18 -42.46 99.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.496 1.122 . . . . 60.149999999999999 109.306 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.0 mtt -57.94 -38.93 76.84 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.522 1.139 . . . . 43.399999999999999 110.973 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.43 -52.34 54.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.48 1.112 . . . . 61.0 109.296 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.437 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 7.8 t-20 -64.23 -35.34 80.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.123 . . . . 73.239999999999995 109.315 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 114.58 53.01 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.44 1.088 . . . . 72.319999999999993 110.99 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.706 ' CZ ' HG21 ' A' ' 145' ' ' THR . 90.0 m-85 -153.28 147.9 26.19 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.541 0.789 . . . . 65.25 111.007 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.898 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -110.02 126.88 54.43 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 70.519999999999996 109.31 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.983 ' HB3' HD22 ' A' ' 188' ' ' LEU . 13.4 p -98.8 -179.27 4.24 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.47 1.106 . . . . 65.120000000000005 108.312 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 27.0 mp0 -133.38 171.62 13.8 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.562 1.164 . . . . 75.209999999999994 110.357 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.494 ' HZ1' ' HA ' ' A' ' 182' ' ' HIS . 18.1 mmtt -107.01 161.13 15.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.48 1.113 . . . . 62.450000000000003 109.3 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 21.2 tt0 -157.66 117.49 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.525 1.141 . . . . 73.25 110.323 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.575 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 9.1 m-85 -108.49 133.53 52.52 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 75.430000000000007 110.967 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.695 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.7 p -124.38 148.16 28.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 60.310000000000002 109.301 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.6 m-85 -120.09 156.51 30.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.483 1.114 . . . . 62.539999999999999 111.018 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.42 -178.55 16.37 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.542 1.151 . . . . 25.41 111.006 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.752 ' C ' HD23 ' A' ' 204' ' ' LEU . 57.2 t-20 -71.02 111.25 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 0.772 . . . . 73.409999999999997 109.297 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.752 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.4 mt -115.27 93.62 4.37 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 62.340000000000003 109.312 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.8 mttp -93.27 165.93 12.56 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 70.349999999999994 109.287 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.57 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -171.68 154.07 3.57 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.517 1.135 . . . . 53.219999999999999 109.322 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.9 t -128.66 129.27 45.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 75.129999999999995 109.995 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.0 p -96.85 -7.28 33.9 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.471 1.107 . . . . 45.219999999999999 110.42 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 107.15 -30.9 8.68 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.542 1.152 . . . . 52.219999999999999 110.983 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.4 p -109.08 -16.58 14.08 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.501 0.765 . . . . 74.109999999999999 110.435 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -169.07 163.05 11.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.513 1.133 . . . . 74.219999999999999 108.312 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.48 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.53 145.64 45.17 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.493 1.12 . . . . 65.120000000000005 108.295 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.57 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -114.44 153.86 15.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.541 1.151 . . . . 71.239999999999995 109.272 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.467 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -137.4 119.02 14.95 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 54.340000000000003 109.276 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.32 134.0 51.23 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.019 -1.104 . . . . 72.340000000000003 108.019 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.2 t -79.33 2.32 21.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.485 1.115 . . . . 62.009999999999998 109.945 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.484 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.3 p90 -175.33 128.41 0.27 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.448 1.092 . . . . 73.420000000000002 111.006 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.468 ' N ' HD12 ' A' ' 204' ' ' LEU . 83.4 t60 -121.75 167.21 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.467 1.104 . . . . 74.129999999999995 109.595 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.544 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.5 p -145.18 149.73 16.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.459 1.1 . . . . 45.039999999999999 109.302 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.537 ' CB ' HD12 ' A' ' 236' ' ' ILE . . . -144.46 -159.43 0.99 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.449 1.093 . . . . 64.219999999999999 109.317 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.487 HG22 ' HE2' ' A' ' 197' ' ' LYS . 14.4 pt -120.0 122.98 69.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.462 1.102 . . . . 62.409999999999997 109.291 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.53 HD11 ' HB3' ' A' ' 234' ' ' LYS . 11.9 tp -86.71 109.01 18.93 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.498 1.124 . . . . 74.409999999999997 109.284 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.708 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.51 145.45 13.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.529 1.143 . . . . 72.239999999999995 109.325 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.434 ' HB3' HG22 ' A' ' 139' ' ' VAL . 45.4 m -116.56 118.56 32.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.505 1.128 . . . . 42.100000000000001 109.993 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -133.85 144.79 49.15 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.461 1.101 . . . . 73.409999999999997 111.014 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.435 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -69.83 133.96 47.97 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.53 1.144 . . . . 75.299999999999997 109.304 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.12 -159.91 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.129 . . . . 75.230000000000004 109.313 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 -0.35 50.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.102 . . . . 64.319999999999993 109.295 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.0 m -114.87 -7.75 12.59 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.451 1.095 . . . . 74.129999999999995 109.972 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.57 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.518 1.136 . . . . 52.420000000000002 111.033 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.22 137.94 41.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.521 0.777 . . . . 74.319999999999993 109.275 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.435 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.4 m -71.53 102.65 2.76 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.497 1.123 . . . . 64.010000000000005 110.368 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 1.9 mm-40 -101.74 -172.68 2.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.492 1.12 . . . . 73.239999999999995 110.259 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.53 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.3 mmtm -127.03 144.93 50.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.400000000000006 109.301 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.589 ' HB3' HG22 ' A' ' 223' ' ' VAL . 1.3 tpt180 -145.48 162.96 36.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.457 1.098 . . . . 73.409999999999997 110.247 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.537 HD12 ' CB ' ' A' ' 220' ' ' ALA . 10.8 mm -116.85 119.68 62.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.486 1.117 . . . . 64.230000000000004 109.31 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -105.33 43.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 64.329999999999998 109.292 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.436 ' OD1' ' CB ' ' A' ' 240' ' ' SER . 4.2 t70 -101.84 108.13 54.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.457 1.098 . . . . 62.310000000000002 109.315 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.93 -4.84 16.01 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.486 1.782 . . . . 64.120000000000005 111.032 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 t -72.05 -7.94 51.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 62.049999999999997 110.027 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -130.96 -46.59 1.02 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.54 1.15 . . . . 74.340000000000003 109.31 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.79 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.1 m-85 -123.34 106.75 10.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.111 . . . . 71.340000000000003 110.98 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -26.22 22.25 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.496 1.123 . . . . 72.420000000000002 109.985 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 3.5 m -62.62 -47.74 82.46 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.124 . . . . 73.239999999999995 110.034 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.41 -173.78 40.66 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.474 1.109 . . . . 74.010000000000005 110.965 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.425 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 169.98 21.41 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.514 1.797 . . . . 72.439999999999998 111.017 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.79 HG21 ' CE2' ' A' ' 242' ' ' PHE . 13.7 m -148.61 159.46 6.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.528 1.143 . . . . 74.340000000000003 109.302 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 43.3 p -61.71 142.08 57.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 63.420000000000002 110.427 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 249' ' ' ASP . 1.2 p-10 -45.82 -26.17 0.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.552 1.157 . . . . 75.120000000000005 109.333 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 29.1 m -80.88 -61.42 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.503 1.127 . . . . 64.439999999999998 110.387 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.94 -22.01 5.05 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 64.409999999999997 109.235 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.57 ' CE3' ' HD3' ' A' ' 253' ' ' ARG . 9.5 t90 -67.05 -59.04 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.48 1.113 . . . . 71.219999999999999 108.017 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.57 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.06 -43.54 40.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.569 1.168 . . . . 72.5 110.278 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.842 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.2 m-80 -53.74 -52.16 61.04 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.5 1.125 . . . . 70.420000000000002 109.319 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.676 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.4 -18.77 12.11 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.523 1.14 . . . . 72.519999999999996 109.306 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.8 m -90.34 -35.0 15.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 1.139 . . . . 74.299999999999997 108.287 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.842 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -94.47 21.47 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 71.219999999999999 109.32 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -51.34 109.24 0.32 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.45 1.094 . . . . 61.219999999999999 109.267 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.0 p -74.71 -3.06 29.23 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.506 1.129 . . . . 71.540000000000006 110.396 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.1 t -44.22 -31.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.508 1.13 . . . . 45.240000000000002 110.018 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 46.2 t -88.24 -37.39 16.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 70.109999999999999 108.304 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.32 -127.58 1.56 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.45 1.094 . . . . 73.129999999999995 111.032 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.1 146.83 39.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.533 0.784 . . . . 61.140000000000001 110.023 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.39 147.83 4.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 1.115 . . . . 63.229999999999997 109.286 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 39.0 m -172.83 153.86 2.77 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.448 1.093 . . . . 63.210000000000001 109.985 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.695 HG23 ' CG2' ' A' ' 200' ' ' VAL . 3.6 p -101.81 115.49 43.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 74.120000000000005 109.303 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 9.2 t -70.32 -45.17 66.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.113 . . . . 71.530000000000001 110.016 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.612 ' O ' HG23 ' A' ' 200' ' ' VAL . 3.6 m -163.73 -174.88 3.86 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.499 1.124 . . . . 70.310000000000002 109.991 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -165.78 156.53 13.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 73.040000000000006 110.996 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -153.77 162.49 41.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.464 1.102 . . . . 71.310000000000002 109.276 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.491 ' O ' HG23 ' A' ' 272' ' ' THR . 1.3 p-10 -121.82 159.88 25.82 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.319999999999993 109.318 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.601 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.5 p -154.37 178.12 10.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.533 1.146 . . . . 61.530000000000001 110.381 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.934 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -61.3 167.29 3.28 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.117 . . . . 75.319999999999993 109.307 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.98 -18.76 66.72 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.476 1.11 . . . . 71.219999999999999 111.015 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.94 -39.15 21.8 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 0.759 . . . . 73.299999999999997 109.319 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.934 HG23 ' HB3' ' A' ' 273' ' ' ALA . 61.7 t -43.6 101.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.535 1.147 . . . . 74.430000000000007 109.32 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.0 t80 -53.92 -54.78 34.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.523 1.139 . . . . 72.340000000000003 111.018 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.572 ' CE2' ' O ' ' A' ' 279' ' ' ARG . 66.9 t80 -143.39 159.92 41.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.134 . . . . 72.040000000000006 110.949 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.601 ' HD2' HG21 ' A' ' 272' ' ' THR . 76.4 ttt-85 -122.73 147.57 46.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 72.120000000000005 110.35 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.21 154.32 48.68 Favored Pre-proline 0 C--N 1.326 -0.451 0 O-C-N 124.46 1.1 . . . . 75.010000000000005 109.964 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.18 9.22 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.49 1.784 . . . . 74.430000000000007 110.972 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 14.2 t -104.62 7.76 35.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.534 1.147 . . . . 72.239999999999995 110.013 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 76.7 41.57 0.18 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.12 . . . . 72.400000000000006 109.275 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.4 t -119.56 118.99 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 74.439999999999998 109.997 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -102.78 159.1 15.78 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.529 1.143 . . . . 74.219999999999999 111.034 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.551 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.7 OUTLIER -123.94 176.93 6.02 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.477 1.111 . . . . 70.540000000000006 109.259 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 94.7 m-85 -161.31 115.37 2.0 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 63.450000000000003 111.014 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.408 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.8 t0 -115.3 95.06 4.99 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.466 1.103 . . . . 51.539999999999999 109.279 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -85.64 -19.45 30.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.469 1.106 . . . . 74.109999999999999 109.285 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.455 ' CB ' HG12 ' A' ' 292' ' ' ILE . 50.7 m-20 -105.71 4.18 29.76 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.493 1.12 . . . . 73.340000000000003 109.322 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.7 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.5 mm? 40.41 49.15 2.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 55.43 109.291 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.455 HG12 ' CB ' ' A' ' 290' ' ' ASN . 30.8 mm -78.7 -28.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.539 1.149 . . . . 73.340000000000003 109.339 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.787 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.7 t-20 -94.71 -24.0 17.32 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.117 . . . . 54.509999999999998 109.29 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 4.4 m -83.11 -68.99 0.66 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.537 1.148 . . . . 63.509999999999998 110.43 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 56.3 m-20 -51.05 -28.54 10.51 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.134 . . . . 62.219999999999999 109.323 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 11.5 t -70.9 -66.5 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.514 1.133 . . . . 54.409999999999997 108.317 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 293' ' ' ASN . 53.5 t -43.44 -42.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 62.340000000000003 109.311 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.13 -58.02 10.1 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.472 1.108 . . . . 62.310000000000002 109.273 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -19.5 52.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.509 1.131 . . . . 52.229999999999997 110.429 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.493 ' HE2' HG12 ' A' ' 315' ' ' VAL . 18.5 mmmt -76.3 -42.39 45.43 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 75.310000000000002 109.317 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.712 ' CE2' HG13 ' A' ' 297' ' ' VAL . 1.7 m-30 -106.02 40.41 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.503 1.127 . . . . 74.519999999999996 111.054 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . 0.447 ' O ' ' NH1' ' A' ' 171' ' ' ARG . 29.6 t -68.0 -55.28 13.22 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.145 . . . . 42.399999999999999 110.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.793 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -79.39 -18.33 52.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 64.349999999999994 109.28 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.773 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 13.3 mt -57.42 139.27 53.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.105 . . . . 75.349999999999994 109.343 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 90.3 p -149.95 166.13 30.56 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.51 1.131 . . . . 74.329999999999998 109.995 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 68.22 -153.05 52.83 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.473 1.108 . . . . 51.350000000000001 110.978 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.7 p -103.13 15.53 29.05 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.283 -1.006 . . . . 50.109999999999999 108.283 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.511 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -133.59 150.26 74.39 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 71.030000000000001 109.992 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.735 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.97 146.71 87.41 Favored 'Cis proline' 0 C--N 1.359 1.108 0 C-N-CA 121.052 -2.478 . . . . 45.530000000000001 110.994 -0.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -129.75 133.39 24.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.484 1.115 . . . . 64.109999999999999 110.033 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -168.22 6.29 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 121.044 -2.482 . . . . 40.039999999999999 110.982 0.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.71 152.08 28.2 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 65.430000000000007 109.309 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.56 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.03 -162.39 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.505 1.792 . . . . 54.210000000000001 111.039 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.08 131.24 34.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.533 1.146 . . . . 71.010000000000005 109.321 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.493 HG12 ' HE2' ' A' ' 300' ' ' LYS . 33.4 m -128.48 27.48 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.523 1.139 . . . . 73.5 109.306 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 27.0 t -57.37 -24.12 53.38 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 74.230000000000004 109.961 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -58.2 -16.8 15.05 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.539 1.149 . . . . 75.239999999999995 109.984 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 61.7 m -67.06 -174.14 0.32 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 72.450000000000003 108.346 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.565 ' O ' ' CD2' ' A' ' 320' ' ' PHE . . . -154.6 -118.14 0.64 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.5 1.125 . . . . 53.350000000000001 110.99 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.565 ' CD2' ' O ' ' A' ' 319' ' ' GLY . 14.7 m-85 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.556 0.798 . . . . 62.200000000000003 111.015 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.777 HD23 ' HB3' ' A' ' 194' ' ' ASP . 6.9 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.267 -0.642 . . . . 74.319999999999993 109.267 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.574 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -109.03 111.75 23.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 74.099999999999994 109.286 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.486 ' CB ' ' OD1' ' A' ' 194' ' ' ASP . 0.7 OUTLIER -86.72 6.1 32.99 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.473 1.108 . . . . 73.400000000000006 109.966 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.6 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.3 t -145.94 150.85 15.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.468 1.105 . . . . 72.010000000000005 109.314 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.029 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -103.28 143.13 26.0 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 71.239999999999995 109.33 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -75.05 -33.73 4.31 Favored 'Trans proline' 0 C--N 1.359 1.11 0 O-C-N 124.509 1.794 . . . . 51.149999999999999 111.02 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.429 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.45 150.36 23.31 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.114 . . . . 75.219999999999999 109.318 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.509 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.7 t -49.06 -33.91 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.484 1.115 . . . . 54.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.85 -46.28 5.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.123 . . . . 62.340000000000003 109.327 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.573 HG22 HG12 ' A' ' 140' ' ' ILE . 1.8 m -72.92 -32.16 65.12 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.505 1.128 . . . . 74.519999999999996 110.421 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.746 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -61.9 -56.16 22.15 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 73.329999999999998 109.332 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.509 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 51.3 m-80 -53.64 -31.07 45.87 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.533 1.146 . . . . 65.019999999999996 109.3 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -70.26 -55.92 8.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.455 1.097 . . . . 42.009999999999998 109.953 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.029 HD12 HD11 ' A' ' 140' ' ' ILE . 70.4 mt -42.63 -42.24 3.37 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 1.094 . . . . 64.530000000000001 109.32 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.753 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.2 -45.11 61.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.525 1.141 . . . . 64.239999999999995 111.006 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.61 -39.66 17.41 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 64.319999999999993 109.271 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.487 HE22 ' ND2' ' A' ' 191' ' ' ASN . 60.9 mt-30 -73.54 -57.07 4.25 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 43.32 110.292 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.876 HD11 HD12 ' A' ' 188' ' ' LEU . 10.7 mt -50.01 -23.27 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 53.509999999999998 109.28 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.566 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.2 OUTLIER -76.46 -37.58 56.72 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.439 1.087 . . . . 72.340000000000003 109.285 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -57.03 -18.63 14.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 73.540000000000006 109.312 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.532 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.8 mm100 -80.24 -27.4 38.69 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.464 1.102 . . . . 73.230000000000004 110.341 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 156' ' ' GLN . 15.6 m -39.47 129.59 1.84 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 73.340000000000003 109.98 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 7.4 m -58.85 113.31 2.0 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.43 1.081 . . . . 71.420000000000002 108.295 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.36 -17.12 1.68 Allowed Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.486 1.116 . . . . 54.340000000000003 110.982 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.714 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 46.0 p -95.33 161.56 14.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 0.76 . . . . 63.119999999999997 110.398 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.5 m -92.9 -3.76 54.02 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.543 1.152 . . . . 62.310000000000002 109.956 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 162' ' ' THR . 3.0 m -109.5 -1.62 18.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.524 1.14 . . . . 72.140000000000001 110.405 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.714 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -73.08 134.39 44.53 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.439 1.087 . . . . 73.310000000000002 109.314 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.409 ' HB2' ' NE2' ' A' ' 156' ' ' GLN . 0.4 OUTLIER -55.59 -166.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.534 1.146 . . . . 53.140000000000001 109.996 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.0 m -156.24 127.93 3.84 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 74.310000000000002 110.02 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 137.8 52.39 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.944 -2.523 . . . . 34.229999999999997 111.027 0.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 12.0 p -73.0 -179.38 3.2 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.103 . . . . 65.319999999999993 108.307 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.649 HG23 ' HB3' ' A' ' 180' ' ' ARG . 4.2 mp -86.11 128.31 39.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 54.329999999999998 109.284 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 67.7 p -94.71 84.73 4.29 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 43.310000000000002 110.356 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -88.55 -12.7 42.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.522 1.139 . . . . 60.310000000000002 110.976 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.444 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.77 -4.1 29.41 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.526 1.141 . . . . 73.010000000000005 110.324 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.778 ' CE2' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -131.02 70.01 82.58 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.468 1.105 . . . . 74.25 111.011 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.442 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.0 Cg_endo -75.05 113.56 3.82 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.535 1.808 . . . . 71.430000000000007 110.957 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.589 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.7 t -153.41 -67.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 61.420000000000002 109.298 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -159.34 112.88 2.29 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.527 1.142 . . . . 73.010000000000005 109.339 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.55 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.68 68.8 0.02 OUTLIER Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.515 1.134 . . . . 51.340000000000003 111.002 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 42.4 m -107.5 -8.42 16.24 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.28 -1.008 . . . . 53.200000000000003 108.28 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.57 ' HB3' HG11 ' A' ' 219' ' ' VAL . 35.4 p90 -81.16 -23.83 37.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 55.100000000000001 110.964 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.08 -68.11 0.52 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 62.340000000000003 109.338 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.649 ' HB3' HG23 ' A' ' 168' ' ' ILE . 8.0 ptm180 -44.23 -51.12 8.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 52.32 110.309 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -40.35 -62.84 0.7 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.420000000000002 109.321 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.699 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -42.24 -39.09 1.96 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 73.439999999999998 109.625 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.685 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 28.0 mmmt -68.69 -54.9 13.43 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.544 1.152 . . . . 61.530000000000001 109.308 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.478 ' SD ' HG21 ' A' ' 153' ' ' ILE . 8.6 mtm -39.57 -41.72 1.06 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.466 1.104 . . . . 71.349999999999994 110.986 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.442 ' CG ' ' SG ' ' A' ' 195' ' ' CYS . 0.6 OUTLIER -62.63 -45.01 94.81 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 74.150000000000006 110.318 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.685 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.1 OUTLIER -50.93 -31.81 18.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 72.200000000000003 110.307 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.481 HD13 ' HG3' ' A' ' 186' ' ' GLN . 10.4 mm -82.95 -39.43 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.507 1.13 . . . . 74.409999999999997 109.322 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.876 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -57.76 -39.34 77.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.511 1.132 . . . . 74.310000000000002 109.314 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.581 ' HG2' HD21 ' A' ' 136' ' ' LEU . 32.9 mtp -65.84 -45.78 80.96 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 72.319999999999993 110.98 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -42.87 -53.45 4.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.483 1.114 . . . . 53.43 109.291 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.487 ' ND2' HE22 ' A' ' 152' ' ' GLN . 5.5 t-20 -62.64 -39.14 92.9 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.527 1.142 . . . . 75.439999999999998 109.354 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 118.74 46.7 0.43 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.518 1.136 . . . . 62.5 111.0 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.676 ' O ' HD23 ' A' ' 188' ' ' LEU . 92.5 m-85 -150.93 129.82 12.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.486 0.756 . . . . 74.439999999999998 111.004 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.777 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.3 OUTLIER -96.98 130.76 44.26 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 75.010000000000005 109.358 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.829 ' HB3' HD22 ' A' ' 188' ' ' LEU . 13.9 p -102.65 173.49 6.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 62.229999999999997 108.314 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.486 1.116 . . . . 55.32 110.324 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -100.04 158.39 15.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 64.099999999999994 109.32 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.534 ' OE1' HD11 ' A' ' 236' ' ' ILE . 20.4 tt0 -145.88 117.32 7.99 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.549 1.156 . . . . 63.310000000000002 110.327 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -110.72 126.47 54.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.142 . . . . 74.109999999999999 111.032 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.649 HG21 ' CG ' ' A' ' 253' ' ' ARG . 9.1 p -125.92 128.53 72.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.458 1.099 . . . . 74.209999999999994 109.334 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.412 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 17.1 m-85 -103.44 158.37 16.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 111.005 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.94 -176.38 16.41 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.523 1.139 . . . . 43.549999999999997 110.97 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.768 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.5 t-20 -72.18 110.98 7.0 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 0.765 . . . . 54.310000000000002 109.273 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.768 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.1 mt -115.17 94.69 4.84 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.504 1.128 . . . . 51.100000000000001 109.307 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.766 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 4.5 mtpt -92.87 170.92 9.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.134 . . . . 73.409999999999997 109.321 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.535 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -172.96 122.53 0.4 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.477 1.11 . . . . 72.040000000000006 109.29 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.9 t -109.55 126.44 53.58 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 54.310000000000002 109.956 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 11.2 p -103.58 -3.89 24.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.5 1.125 . . . . 75.219999999999999 110.415 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 102.36 -53.38 0.79 Allowed Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.459 1.1 . . . . 73.319999999999993 110.945 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 t -81.52 -23.93 36.98 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.522 0.777 . . . . 74.420000000000002 110.387 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 15.9 p -176.69 137.45 0.26 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 70.0 108.274 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.527 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -97.82 -174.64 2.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.529 1.143 . . . . 73.549999999999997 108.275 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.1 OUTLIER -157.07 161.14 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.457 1.098 . . . . 74.219999999999999 109.326 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.766 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -140.23 137.53 34.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.491 1.119 . . . . 75.310000000000002 109.298 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -138.2 134.55 34.62 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.479 1.112 . . . . 74.310000000000002 108.014 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 51.0 m -78.27 -1.03 31.03 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.46 1.1 . . . . 74.230000000000004 110.034 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.4 p90 -173.96 130.42 0.4 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 75.420000000000002 110.987 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.483 ' N ' HD12 ' A' ' 204' ' ' LEU . 48.3 t60 -117.59 165.55 13.44 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.519 1.137 . . . . 71.120000000000005 109.588 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.57 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.0 p -140.76 135.87 34.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.528 1.142 . . . . 64.209999999999994 109.315 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -136.34 -164.38 1.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.469 1.106 . . . . 61.119999999999997 109.312 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' A' ' 237' ' ' ILE . 22.6 pt -119.42 123.28 70.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.499 1.124 . . . . 70.219999999999999 109.295 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.6 tp -89.77 108.96 20.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.521 1.138 . . . . 71.099999999999994 109.3 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.97 146.66 11.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.475 1.11 . . . . 73.030000000000001 109.27 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.6 ' HB3' HG22 ' A' ' 139' ' ' VAL . 9.4 m -116.7 119.42 35.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.525 1.141 . . . . 65.030000000000001 109.991 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 33.6 p90 -134.5 142.89 47.18 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 74.209999999999994 110.998 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.43 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.8 mmtp -68.28 134.4 50.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 74.129999999999995 109.316 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.62 -160.07 0.12 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.446 1.091 . . . . 64.329999999999998 109.257 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.39 50.75 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 72.329999999999998 109.341 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.0 m -115.02 -7.48 12.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.479 1.112 . . . . 74.150000000000006 110.033 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.81 37.67 8.45 Favored Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.467 1.104 . . . . 62.420000000000002 110.95 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.24 137.63 42.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.463 0.743 . . . . 74.040000000000006 109.273 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.43 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 13.4 m -71.52 102.65 2.75 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 74.019999999999996 110.416 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.7 mm-40 -101.4 -172.46 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 55.43 110.277 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.534 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.9 mmtm -127.18 144.98 50.92 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.449 1.093 . . . . 70.310000000000002 109.246 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.62 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.6 tpt180 -145.02 160.45 41.35 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 65.209999999999994 110.316 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.534 HD11 ' OE1' ' A' ' 198' ' ' GLN . 12.7 mm -115.53 118.02 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.496 1.123 . . . . 73.219999999999999 109.336 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.753 HD12 ' HB2' ' A' ' 150' ' ' PHE . 3.8 mm -102.38 45.02 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.516 1.135 . . . . 62.539999999999999 109.301 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.35 111.27 65.14 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 73.150000000000006 109.301 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.96 -26.59 10.85 Favored 'Trans proline' 0 C--N 1.361 1.202 0 O-C-N 124.47 1.773 . . . . 71.129999999999995 111.036 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.408 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.5 t -48.06 -24.19 1.03 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.136 . . . . 74.310000000000002 110.001 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.404 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 25.2 mt -113.56 -54.72 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.471 1.107 . . . . 72.230000000000004 109.316 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.725 ' CE2' HG21 ' A' ' 247' ' ' VAL . 94.9 m-85 -117.88 99.58 7.01 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.543 1.152 . . . . 62.240000000000002 111.025 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -28.34 34.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.53 1.144 . . . . 75.099999999999994 109.947 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.7 t -59.01 -48.77 80.41 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.473 1.108 . . . . 71.530000000000001 109.991 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.34 -172.83 39.19 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.495 1.122 . . . . 55.539999999999999 110.959 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.424 ' HB3' HD13 ' A' ' 237' ' ' ILE . 18.4 Cg_endo -74.97 170.63 20.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.449 1.763 . . . . 41.549999999999997 110.976 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 242' ' ' PHE . 10.7 m -151.01 158.0 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 72.040000000000006 109.297 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.4 p -59.61 142.49 52.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.545 1.153 . . . . 73.219999999999999 110.414 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.405 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 18.5 p-10 -46.61 -25.56 0.73 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 74.319999999999993 109.303 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.411 ' N ' ' C ' ' A' ' 248' ' ' THR . 27.8 m -79.36 -62.49 1.68 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 33.240000000000002 110.409 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -49.86 -29.19 7.64 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 51.450000000000003 109.293 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 12.7 t90 -62.01 -65.88 0.62 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 74.430000000000007 108.022 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.762 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -40.58 -38.23 0.84 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.534 1.146 . . . . 54.109999999999999 110.308 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.875 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.0 m-80 -60.07 -50.74 72.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.555 1.16 . . . . 74.209999999999994 109.297 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.535 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -54.08 -29.0 42.74 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.476 1.11 . . . . 65.25 109.255 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 5.6 m -81.14 -36.36 30.34 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 54.439999999999998 108.253 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.875 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.5 m -94.66 23.91 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.522 1.139 . . . . 72.230000000000004 109.301 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -54.52 107.95 0.33 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 65.450000000000003 109.302 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.1 p -73.03 -3.18 24.55 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 45.409999999999997 110.383 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 30.6 t -44.99 -25.93 0.37 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.498 1.124 . . . . 54.340000000000003 109.976 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . 0.416 ' N ' ' C ' ' A' ' 259' ' ' THR . 52.4 t -94.72 -36.57 11.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 52.219999999999999 108.308 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.14 -128.13 1.63 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.466 1.104 . . . . 64.120000000000005 111.032 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.77 148.98 34.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 64.439999999999998 110.038 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -172.5 146.32 1.73 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.501 1.126 . . . . 74.439999999999998 109.302 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.8 p -173.03 156.98 3.41 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.467 1.104 . . . . 74.519999999999996 109.988 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.581 HG23 HG22 ' A' ' 200' ' ' VAL . 2.6 p -98.8 124.29 51.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.496 1.123 . . . . 73.349999999999994 109.263 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 39.1 t -86.31 -41.93 14.14 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.529 1.143 . . . . 54.130000000000003 109.948 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.52 -174.13 4.8 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 50.350000000000001 110.007 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 269' ' ' TYR . 9.5 p90 -170.89 155.7 4.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 73.219999999999999 111.001 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -163.11 173.21 13.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 64.450000000000003 109.319 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.477 ' C ' ' CG2' ' A' ' 272' ' ' THR . 0.8 OUTLIER -146.5 160.72 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.11 . . . . 55.329999999999998 109.27 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.477 ' CG2' ' C ' ' A' ' 271' ' ' ASN . 6.7 p -151.67 -173.5 4.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.469 1.106 . . . . 73.129999999999995 110.415 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.79 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -67.72 148.95 50.61 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 65.519999999999996 109.315 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -58.87 -44.55 95.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.516 1.135 . . . . 61.409999999999997 111.023 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.434 ' OD1' ' NH1' ' A' ' 185' ' ' ARG . 16.4 m-80 -52.92 -39.6 62.92 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.473 0.749 . . . . 43.539999999999999 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.79 HG23 ' HB3' ' A' ' 273' ' ' ALA . 21.5 t -47.98 118.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.537 1.148 . . . . 74.299999999999997 109.303 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 9.6 t80 -73.32 -49.43 27.51 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 72.219999999999999 111.043 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.568 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 39.5 t80 -148.81 160.32 43.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 64.420000000000002 110.99 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.568 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 58.3 ttt-85 -130.34 146.83 51.97 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.495 1.122 . . . . 75.129999999999995 110.298 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.42 157.59 40.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 70.549999999999997 109.983 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.98 -0.57 10.13 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.489 1.784 . . . . 71.510000000000005 110.94 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 13.6 m -98.09 5.12 48.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.137 . . . . 71.420000000000002 110.004 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 78.27 35.96 0.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.512 1.133 . . . . 65.010000000000005 109.235 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -117.52 119.32 34.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.509 1.131 . . . . 51.329999999999998 110.004 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -101.56 157.69 16.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.49 1.118 . . . . 73.510000000000005 111.005 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.452 HD11 ' CE2' ' A' ' 320' ' ' PHE . 0.8 OUTLIER -119.44 174.85 6.13 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 63.219999999999999 109.273 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -157.43 115.05 3.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.502 1.126 . . . . 72.120000000000005 111.015 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.446 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 12.5 t0 -115.37 96.6 5.73 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 73.209999999999994 109.284 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -85.72 -31.04 22.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 71.319999999999993 109.262 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.457 ' CB ' HG12 ' A' ' 292' ' ' ILE . 5.1 m120 -95.01 5.62 51.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.464 1.102 . . . . 62.219999999999999 109.345 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.699 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.6 mm? 40.3 46.82 2.04 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.5 1.125 . . . . 71.319999999999993 109.287 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.483 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 26.2 mm -74.83 -33.24 30.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 71.319999999999993 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.745 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.8 t-20 -92.73 -20.54 20.68 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.513 1.133 . . . . 52.130000000000003 109.27 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.433 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 3.2 m -86.13 -62.55 1.49 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 75.439999999999998 110.379 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 76.3 m-20 -56.66 -24.13 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.422 1.076 . . . . 63.549999999999997 109.28 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 39.4 t -78.91 -48.2 15.04 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.47 1.106 . . . . 50.43 108.272 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.2 t -57.61 -28.06 31.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.499 1.125 . . . . 72.200000000000003 109.314 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 93.5 mt -80.05 -59.81 2.58 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.559 1.162 . . . . 72.420000000000002 109.29 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -54.01 -19.3 4.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.549 1.156 . . . . 60.0 110.419 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.748 ' HE2' HG12 ' A' ' 315' ' ' VAL . 19.4 mmmt -72.14 -44.04 63.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 75.209999999999994 109.266 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.899 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.6 m-30 -99.67 37.39 1.61 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.445 1.091 . . . . 71.099999999999994 111.05 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.2 t -68.98 -43.09 75.62 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.453 1.095 . . . . 72.519999999999996 109.925 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.79 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -96.35 -17.21 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.478 1.112 . . . . 74.129999999999995 109.333 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.899 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.7 mt -57.77 149.19 22.83 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.491 1.119 . . . . 60.140000000000001 109.324 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -163.94 156.13 17.14 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.465 1.103 . . . . 50.240000000000002 110.017 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.1 -152.99 46.16 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.52 1.138 . . . . 73.129999999999995 110.956 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 17.4 m -99.63 7.33 45.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.278 -1.008 . . . . 53.32 108.278 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.8 OUTLIER -125.04 150.67 67.35 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 72.430000000000007 110.036 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.751 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -74.96 147.36 89.1 Favored 'Cis proline' 0 C--N 1.359 1.111 0 C-N-CA 121.019 -2.492 . . . . 62.109999999999999 111.001 -0.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.481 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.6 OUTLIER -128.37 133.25 24.96 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 75.209999999999994 110.029 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.96 -168.94 6.89 Favored 'Cis proline' 0 C--N 1.359 1.112 0 C-N-CA 121.024 -2.49 . . . . 75.010000000000005 111.028 -0.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.0 154.66 18.33 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 60.329999999999998 109.29 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.415 ' HG3' HD11 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.02 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.476 1.777 . . . . 71.209999999999994 110.981 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -87.77 132.62 34.08 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 73.340000000000003 109.337 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.748 HG12 ' HE2' ' A' ' 300' ' ' LYS . 35.3 m -134.53 27.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.507 1.13 . . . . 72.150000000000006 109.289 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 318' ' ' CYS . 36.1 t -71.58 -37.07 71.07 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.477 1.111 . . . . 65.409999999999997 110.028 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.6 t -43.11 -27.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 75.349999999999994 110.004 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.42 ' N ' ' C ' ' A' ' 316' ' ' SER . 3.2 m -66.6 -173.31 0.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 60.310000000000002 108.268 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.483 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 170.62 94.34 0.09 OUTLIER Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.485 1.116 . . . . 61.210000000000001 110.988 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' A' ' 320' ' ' PHE . 5.5 p90 . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.459 0.741 . . . . 71.510000000000005 110.99 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.696 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.292 -0.632 . . . . 73.120000000000005 109.292 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.33 110.54 4.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.09 . . . . 53.210000000000001 109.329 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -83.5 7.89 15.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.54 1.15 . . . . 73.129999999999995 110.011 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 t -150.4 145.87 16.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.126 . . . . 63.340000000000003 109.316 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.009 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -96.98 143.28 25.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.487 1.117 . . . . 72.030000000000001 109.314 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.99 -33.38 4.63 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.509 1.794 . . . . 61.200000000000003 111.009 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.81 155.41 27.82 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.534 1.146 . . . . 71.450000000000003 109.31 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.507 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -52.45 -35.72 20.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 74.219999999999999 109.311 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.42 -47.49 3.62 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.492 1.12 . . . . 70.549999999999997 109.29 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.734 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -71.59 -35.0 70.38 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 1.116 . . . . 64.219999999999999 110.378 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.731 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -58.98 -56.97 15.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.498 1.124 . . . . 65.030000000000001 109.317 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.507 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.3 m-80 -52.31 -31.8 34.74 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.528 1.143 . . . . 71.019999999999996 109.257 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -67.56 -56.66 8.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 73.530000000000001 110.046 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.009 HD12 HD11 ' A' ' 140' ' ' ILE . 92.4 mt -42.29 -41.97 2.96 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.503 1.127 . . . . 53.43 109.312 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.704 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.69 -43.11 63.5 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 71.049999999999997 110.972 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -51.94 -34.17 40.75 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.111 . . . . 75.019999999999996 109.274 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.497 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 65.0 mt-30 -76.17 -56.33 4.75 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.497 1.123 . . . . 65.450000000000003 110.297 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.567 HD11 HD12 ' A' ' 188' ' ' LEU . 23.0 mt -50.27 -29.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.491 1.119 . . . . 71.349999999999994 109.27 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -33.32 63.63 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.512 1.133 . . . . 74.319999999999993 109.255 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.79 -18.2 59.0 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.494 1.121 . . . . 73.519999999999996 109.31 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.401 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 11.2 mm100 -84.24 -15.47 46.73 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 72.239999999999995 110.274 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.9 p -38.7 122.57 1.16 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 63.210000000000001 109.982 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -53.19 130.45 34.56 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.129 . . . . 54.229999999999997 108.316 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.95 -30.39 6.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.483 1.114 . . . . 63.310000000000002 110.975 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.796 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 35.0 p -67.37 161.58 24.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 0.762 . . . . 65.420000000000002 110.443 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 5.1 t -93.63 -0.72 56.01 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.481 1.113 . . . . 70.420000000000002 109.986 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 162' ' ' THR . 3.9 m -116.84 5.63 13.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 1.108 . . . . 74.420000000000002 110.43 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.796 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -80.85 138.18 36.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.515 1.134 . . . . 64.340000000000003 109.284 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -164.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.571 1.169 . . . . 61.25 109.955 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 166' ' ' PRO . 2.6 m -155.96 126.25 3.37 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.531 1.144 . . . . 70.409999999999997 110.023 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.04 141.15 70.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.005 -2.498 . . . . 65.219999999999999 110.991 0.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 16.5 p -72.69 -178.98 2.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.468 1.105 . . . . 74.109999999999999 108.315 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.768 HD11 ' HB3' ' A' ' 183' ' ' LYS . 3.3 mp -99.16 134.25 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.12 . . . . 74.109999999999999 109.3 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.6 p -79.92 71.41 6.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.51 1.132 . . . . 63.409999999999997 110.402 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.646 ' HE1' HH21 ' A' ' 180' ' ' ARG . 30.5 m-85 -75.63 -0.53 20.9 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 70.019999999999996 111.03 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -109.37 8.04 25.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.47 1.107 . . . . 74.219999999999999 110.275 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 174' ' ' VAL . 11.6 t80 -125.53 71.79 66.36 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.545 1.153 . . . . 65.5 110.99 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.442 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 110.13 3.06 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.447 1.761 . . . . 72.450000000000003 111.003 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.712 HG13 ' OG ' ' A' ' 310' ' ' SER . 2.7 t -151.82 -69.52 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.56 1.162 . . . . 64.310000000000002 109.341 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -133.77 -48.19 0.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 74.230000000000004 109.284 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.25 107.5 0.06 OUTLIER Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.488 1.118 . . . . 53.25 111.013 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.653 ' SG ' HG12 ' A' ' 219' ' ' VAL . 6.9 p -147.86 -48.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 72.530000000000001 108.317 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.528 ' HB3' HG11 ' A' ' 219' ' ' VAL . 26.1 p90 -69.98 -29.1 66.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.55 1.156 . . . . 74.349999999999994 110.978 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.457 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -69.27 -68.1 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.474 1.109 . . . . 72.239999999999995 109.328 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.646 HH21 ' HE1' ' A' ' 170' ' ' PHE . 0.2 OUTLIER -44.14 -47.26 9.02 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 51.409999999999997 110.3 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -41.41 -60.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.14 . . . . 72.230000000000004 109.305 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.695 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -46.19 -38.03 7.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.538 1.149 . . . . 74.439999999999998 109.616 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.768 ' HB3' HD11 ' A' ' 168' ' ' ILE . 29.3 mmmt -67.34 -59.69 3.2 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.424 1.077 . . . . 73.230000000000004 109.296 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.529 ' SD ' HG21 ' A' ' 153' ' ' ILE . 8.4 mtm -39.36 -38.5 0.55 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.509 1.131 . . . . 62.299999999999997 110.96 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -49.47 77.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 74.400000000000006 110.281 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.562 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -51.2 -29.08 12.92 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 73.430000000000007 110.292 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.463 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 14.4 mm -81.28 -36.02 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.577 1.173 . . . . 74.299999999999997 109.321 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.567 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -63.13 -45.54 91.49 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.527 1.142 . . . . 74.530000000000001 109.296 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.504 ' HG2' HD21 ' A' ' 136' ' ' LEU . 11.5 mtt -58.02 -43.61 86.83 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.506 1.129 . . . . 71.239999999999995 110.999 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -46.21 -52.97 11.42 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 60.100000000000001 109.311 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.497 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 23.8 t-20 -63.21 -35.47 80.43 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.48 1.113 . . . . 75.319999999999993 109.342 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 110.88 50.99 0.62 Allowed Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.464 1.102 . . . . 75.129999999999995 111.022 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.745 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 70.3 m-85 -151.04 136.37 17.7 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.531 0.783 . . . . 74.409999999999997 111.035 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.696 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.7 OUTLIER -106.96 121.84 45.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.479 1.112 . . . . 65.439999999999998 109.323 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.545 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.3 p -102.2 178.4 4.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.44 1.088 . . . . 64.209999999999994 108.296 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 222' ' ' LEU . 4.9 mp0 -120.23 172.75 7.56 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.494 1.121 . . . . 74.340000000000003 110.263 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.68 ' HE2' HG22 ' A' ' 221' ' ' ILE . 19.0 mmtt -104.88 152.91 22.06 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.462 1.101 . . . . 73.200000000000003 109.332 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.41 ' OE1' HD13 ' A' ' 222' ' ' LEU . 23.4 tt0 -139.48 117.73 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.472 1.108 . . . . 64.409999999999997 110.273 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.8 m-85 -111.14 122.33 47.59 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.49 1.119 . . . . 64.040000000000006 111.021 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.723 ' CG2' HG23 ' A' ' 266' ' ' VAL . 13.3 p -118.74 150.38 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.548 1.155 . . . . 74.329999999999998 109.302 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.2 m-85 -123.14 162.17 23.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.54 1.15 . . . . 64.129999999999995 111.001 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 119.2 -177.37 16.37 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.542 1.151 . . . . 63.310000000000002 111.04 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.747 ' C ' HD23 ' A' ' 204' ' ' LEU . 57.6 t-20 -71.54 109.13 5.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.513 0.772 . . . . 64.109999999999999 109.329 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.747 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.3 mt -112.82 95.09 5.23 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.095 . . . . 74.200000000000003 109.328 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.5 mttt -92.29 168.87 11.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 70.340000000000003 109.293 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.976 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -179.35 165.08 1.4 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.546 1.154 . . . . 74.510000000000005 109.312 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.86 146.67 39.61 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.515 1.134 . . . . 71.129999999999995 110.05 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.0 p -131.11 5.7 4.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.443 1.089 . . . . 73.040000000000006 110.417 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.405 ' C ' ' N ' ' A' ' 211' ' ' CYS . . . 120.62 118.95 2.66 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.531 1.145 . . . . 74.239999999999995 110.988 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 210' ' ' THR . 0.9 OUTLIER 42.01 27.58 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.498 0.764 . . . . 74.329999999999998 110.419 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . 0.405 ' N ' ' C ' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -151.85 173.66 14.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.518 1.136 . . . . 50.409999999999997 108.298 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 2.1 m -155.7 136.5 13.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.535 1.147 . . . . 33.439999999999998 108.269 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.976 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.4 m -113.79 134.37 56.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.145 . . . . 51.43 109.279 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -127.32 127.56 44.5 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 64.209999999999994 109.307 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -135.68 135.13 39.85 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 63.43 108.008 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 3.7 20.97 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.467 1.105 . . . . 73.200000000000003 109.993 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.484 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.7 p90 -177.91 128.1 0.13 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 1.104 . . . . 72.129999999999995 111.035 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.504 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 31.7 t60 -115.04 159.13 21.17 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.545 1.153 . . . . 73.420000000000002 109.609 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.653 HG12 ' SG ' ' A' ' 177' ' ' CYS . 3.4 p -138.85 137.93 42.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.117 . . . . 71.420000000000002 109.331 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.568 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -138.98 -157.25 0.75 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.579 1.174 . . . . 74.420000000000002 109.317 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.68 HG22 ' HE2' ' A' ' 197' ' ' LYS . 18.3 pt -125.8 117.84 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.509 1.131 . . . . 72.129999999999995 109.276 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.6 tp -81.8 110.04 16.74 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.492 1.12 . . . . 62.229999999999997 109.294 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.731 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -101.12 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 71.439999999999998 109.307 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 24.8 m -116.73 119.93 37.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.476 1.11 . . . . 64.430000000000007 110.016 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.563 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 31.4 p90 -135.34 145.55 47.53 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.157 . . . . 75.310000000000002 110.993 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.2 mmtp -70.3 133.99 47.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.496 1.123 . . . . 73.109999999999999 109.334 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.36 -159.64 0.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.483 1.115 . . . . 73.420000000000002 109.323 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.44 51.52 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.230000000000004 109.316 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.9 m -114.58 -8.38 12.73 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.52 1.138 . . . . 51.549999999999997 110.01 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.39 37.42 8.19 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.526 1.141 . . . . 60.439999999999998 110.981 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 138.09 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.468 0.746 . . . . 51.310000000000002 109.301 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 17.6 m -71.64 102.65 2.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.498 1.123 . . . . 72.439999999999998 110.407 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.0 mm-40 -101.99 -172.65 2.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.454 1.096 . . . . 72.530000000000001 110.289 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.599 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -126.69 145.36 50.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.445 1.091 . . . . 71.040000000000006 109.326 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.6 tpt180 -145.66 160.48 41.63 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.145 . . . . 62.210000000000001 110.275 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.702 HG21 ' CD1' ' A' ' 252' ' ' TRP . 12.8 mm -116.53 119.94 63.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.506 1.129 . . . . 74.239999999999995 109.285 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -101.38 45.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.467 1.105 . . . . 70.219999999999999 109.315 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 236' ' ' ILE . 2.1 m-20 -101.17 112.67 65.35 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 40.509999999999998 109.274 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.568 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -74.97 -43.57 0.39 Allowed 'Trans proline' 0 C--N 1.359 1.117 0 O-C-N 124.516 1.798 . . . . 54.130000000000003 111.015 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.1 OUTLIER -39.22 -29.9 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 73.099999999999994 109.983 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.582 HD13 ' CD1' ' A' ' 252' ' ' TRP . 13.6 mt -101.98 -52.98 3.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.54 1.15 . . . . 64.129999999999995 109.3 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.652 ' CE2' HG21 ' A' ' 247' ' ' VAL . 93.1 m-85 -125.99 99.28 5.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.494 1.121 . . . . 72.019999999999996 111.041 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 49.4 m -79.22 -30.46 43.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.494 1.121 . . . . 74.239999999999995 109.968 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.9 t -55.52 -46.15 77.04 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 72.510000000000005 109.982 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.48 -170.42 41.22 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.493 1.12 . . . . 42.030000000000001 111.002 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.432 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.06 168.85 23.89 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 75.450000000000003 110.992 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.652 HG21 ' CE2' ' A' ' 242' ' ' PHE . 3.9 m -151.66 159.45 4.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.526 1.141 . . . . 50.219999999999999 109.291 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.428 ' C ' ' N ' ' A' ' 250' ' ' THR . 43.0 p -60.7 139.21 57.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 71.25 110.399 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.438 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER -43.01 -28.1 0.24 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 74.150000000000006 109.299 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.428 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.4 m -73.61 -64.76 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 75.430000000000007 110.404 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.15 -27.43 8.58 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 50.539999999999999 109.31 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.702 ' CD1' HG21 ' A' ' 236' ' ' ILE . 13.0 t90 -62.57 -62.03 2.03 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.496 1.123 . . . . 73.420000000000002 108.008 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.555 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.24 -42.26 20.09 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.503 1.127 . . . . 71.310000000000002 110.303 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.836 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -55.8 -51.44 67.44 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 62.299999999999997 109.335 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.03 -20.36 16.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.505 1.128 . . . . 62.119999999999997 109.311 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.58 -36.76 16.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 65.420000000000002 108.343 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.836 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -92.45 20.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.482 1.114 . . . . 62.030000000000001 109.288 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -46.61 104.48 0.05 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 75.540000000000006 109.319 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -76.07 -3.97 38.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.513 1.133 . . . . 71.430000000000007 110.406 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.8 t -49.95 -22.85 1.69 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 65.109999999999999 110.023 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 206' ' ' ALA . 30.7 m -90.87 -32.88 15.86 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 74.239999999999995 108.294 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.88 -113.78 0.57 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.484 1.115 . . . . 44.229999999999997 111.008 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -90.56 143.45 26.73 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.527 0.78 . . . . 44.43 110.032 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -167.77 148.27 5.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.461 1.1 . . . . 54.399999999999999 109.273 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.72 156.58 3.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.485 1.116 . . . . 61.109999999999999 109.982 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.723 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.9 p -104.39 113.96 42.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.115 . . . . 73.310000000000002 109.288 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 4.6 t -68.15 -45.69 72.84 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.514 1.134 . . . . 73.310000000000002 110.007 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 200' ' ' VAL . 29.5 p -163.84 -174.22 3.55 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 73.150000000000006 110.017 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -165.82 155.66 12.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 110.999 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.3 165.23 37.29 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.509 1.131 . . . . 73.109999999999999 109.302 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.437 ' C ' HG23 ' A' ' 272' ' ' THR . 1.7 p-10 -128.29 160.67 31.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 74.200000000000003 109.258 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.598 HG21 ' HD2' ' A' ' 279' ' ' ARG . 19.1 p -153.96 176.94 11.6 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.474 1.109 . . . . 74.010000000000005 110.395 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -60.76 158.32 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 54.420000000000002 109.324 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -68.4 -43.96 76.01 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.447 1.092 . . . . 53.219999999999999 110.993 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -54.87 -42.41 72.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.447 0.733 . . . . 73.219999999999999 109.312 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' ' 273' ' ' ALA . 69.8 t -43.61 101.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 73.329999999999998 109.285 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.415 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 7.2 t80 -60.07 -59.22 5.77 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.519 1.137 . . . . 74.209999999999994 111.016 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -131.47 156.71 45.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 74.450000000000003 111.034 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.598 ' HD2' HG21 ' A' ' 272' ' ' THR . 63.6 ttt-85 -126.71 147.45 49.96 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.52 1.138 . . . . 63.520000000000003 110.275 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 1.2 m -118.2 158.02 47.48 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.108 . . . . 70.019999999999996 110.068 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 0.17 9.21 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.459 1.768 . . . . 54.549999999999997 111.005 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.436 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 80.1 p -104.27 5.81 34.93 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.095 . . . . 73.519999999999996 109.943 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 78.34 39.46 0.15 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.524 1.14 . . . . 64.340000000000003 109.279 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -113.37 120.22 40.36 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 62.240000000000002 110.027 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -107.62 151.78 25.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 75.329999999999998 111.01 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.59 HD11 ' CZ ' ' A' ' 320' ' ' PHE . 1.2 mm? -118.59 177.67 4.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 73.530000000000001 109.323 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.528 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 79.6 m-85 -160.29 115.22 2.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.523 1.139 . . . . 63.100000000000001 110.978 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.438 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 0.4 OUTLIER -115.49 97.03 5.93 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.101 . . . . 74.200000000000003 109.303 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -85.82 -14.49 44.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 72.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.408 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.0 m-20 -110.75 0.87 17.52 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 62.229999999999997 109.306 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.695 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 42.69 49.58 4.93 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.125 . . . . 73.329999999999998 109.281 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 290' ' ' ASN . 18.2 mm -78.58 -27.55 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.445 1.09 . . . . 75.409999999999997 109.299 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.798 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.9 t-20 -94.18 -27.67 16.07 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.444 1.09 . . . . 62.119999999999997 109.286 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.452 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 21.9 m -82.19 -69.01 0.65 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.47 1.106 . . . . 73.310000000000002 110.407 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 44.1 m-20 -47.86 -30.36 4.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.523 1.14 . . . . 65.230000000000004 109.293 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 36.8 t -72.73 -58.41 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 72.420000000000002 108.318 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 293' ' ' ASN . 9.4 t -43.95 -49.54 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 75.430000000000007 109.313 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.692 HD22 ' HA ' ' A' ' 168' ' ' ILE . 9.6 mt -61.47 -59.97 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 64.209999999999994 109.31 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.35 -31.8 1.78 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.535 1.147 . . . . 61.140000000000001 110.411 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -70.13 -49.46 50.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.502 1.126 . . . . 73.319999999999993 109.283 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.584 ' CZ ' ' HB1' ' A' ' 312' ' ' ALA . 3.3 m-30 -91.77 31.39 1.22 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 75.109999999999999 110.982 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 26.2 t -63.38 -52.75 60.39 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.484 1.115 . . . . 63.520000000000003 110.005 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.4 -10.41 58.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.432 1.083 . . . . 70.310000000000002 109.326 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.603 ' N ' HD22 ' A' ' 303' ' ' LEU . 19.1 mt -76.21 136.63 39.71 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.46 1.1 . . . . 74.409999999999997 109.289 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.5 p -161.46 147.58 14.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 75.150000000000006 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 96.89 -160.14 21.6 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.498 1.124 . . . . 63.409999999999997 110.977 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 25.42 5.79 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.345 -0.983 . . . . 50.119999999999997 108.345 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.514 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 93.1 p -156.84 148.62 17.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.461 1.1 . . . . 64.140000000000001 109.998 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.588 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.98 145.74 84.76 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 121.007 -2.497 . . . . 73.209999999999994 111.024 -0.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.712 ' OG ' HG13 ' A' ' 174' ' ' VAL . 70.0 m -132.21 135.17 26.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.534 1.146 . . . . 65.299999999999997 109.985 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.0 -173.55 12.53 Favored 'Cis proline' 0 C--N 1.359 1.122 0 C-N-CA 120.995 -2.502 . . . . 75.140000000000001 110.999 -0.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.584 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.89 151.78 31.13 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 51.32 109.295 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.571 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.5 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.508 1.794 . . . . 63.409999999999997 110.995 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -85.96 135.49 33.65 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 75.010000000000005 109.292 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.4 ' O ' ' SG ' ' A' ' 318' ' ' CYS . 26.8 m -127.77 24.68 2.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 70.209999999999994 109.29 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 35.8 t -54.11 -19.8 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.556 1.16 . . . . 71.409999999999997 110.043 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 35.4 p -53.89 -24.84 17.43 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.501 1.126 . . . . 73.349999999999994 109.989 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 315' ' ' VAL . 1.8 m -80.07 -173.37 3.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.533 1.145 . . . . 55.109999999999999 108.257 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 162.11 77.85 0.03 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.524 1.14 . . . . 72.299999999999997 111.01 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.59 ' CZ ' HD11 ' A' ' 286' ' ' LEU . 7.0 p90 . . . . . 0 C--N 1.325 -0.467 0 O-C-N 124.484 0.755 . . . . 72.430000000000007 110.995 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.935 HD23 ' HB2' ' A' ' 194' ' ' ASP . 8.5 tp . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 109.295 -0.632 . . . . 71.030000000000001 109.295 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.612 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -105.74 106.46 16.97 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 74.140000000000001 109.277 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -83.45 8.21 14.56 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.526 1.141 . . . . 55.100000000000001 109.946 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.5 t -149.53 145.2 17.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 73.510000000000005 109.264 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 149' ' ' LEU . 1.1 mt -96.26 142.77 25.03 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.511 1.132 . . . . 74.310000000000002 109.339 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.99 -32.48 5.36 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.551 1.816 . . . . 74.349999999999994 111.002 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.71 152.47 21.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.48 1.112 . . . . 64.239999999999995 109.335 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.519 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -49.96 -35.45 10.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 63.130000000000003 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.5 -47.35 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.493 1.121 . . . . 73.209999999999994 109.3 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.652 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.91 -34.72 69.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.512 1.133 . . . . 73.239999999999995 110.403 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.741 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.29 -56.98 15.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.482 1.114 . . . . 71.25 109.304 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.519 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 48.9 m-80 -52.27 -32.03 35.32 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.507 1.129 . . . . 63.520000000000003 109.307 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.6 -55.5 11.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.483 1.114 . . . . 64.120000000000005 110.008 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 140' ' ' ILE . 66.5 mt -42.06 -41.83 2.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 70.140000000000001 109.315 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.648 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.91 -45.44 61.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.48 1.113 . . . . 73.109999999999999 111.017 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -46.52 -38.37 9.24 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.467 1.105 . . . . 75.120000000000005 109.277 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 155' ' ' ASN . 58.4 mt-30 -76.57 -55.38 5.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 73.230000000000004 110.29 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.808 HD11 HD12 ' A' ' 188' ' ' LEU . 13.6 mt -50.56 -23.77 2.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.498 1.124 . . . . 74.439999999999998 109.293 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.61 42.59 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 75.230000000000004 109.297 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.6 t-20 -58.44 -19.17 34.25 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.55 1.156 . . . . 74.239999999999995 109.24 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 3.3 mm100 -81.68 -24.64 36.11 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.52 1.137 . . . . 55.439999999999998 110.324 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.522 ' HA ' ' CD2' ' A' ' 170' ' ' PHE . 23.3 m -41.42 117.35 0.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 53.100000000000001 109.982 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 2.4 m -45.27 130.62 8.12 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.49 1.118 . . . . 74.420000000000002 108.318 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.39 -24.89 5.51 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.587 1.179 . . . . 64.310000000000002 110.976 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.774 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 75.4 p -83.93 161.7 20.73 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 0.748 . . . . 62.109999999999999 110.388 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.2 p -93.56 0.76 56.76 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 63.5 109.959 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 162' ' ' THR . 2.1 m -117.02 3.48 12.76 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.123 . . . . 74.219999999999999 110.381 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.774 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -79.06 133.64 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.487 1.117 . . . . 71.349999999999994 109.278 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.76 -173.06 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 62.32 109.984 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.3 p -152.39 126.64 4.49 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.541 1.151 . . . . 74.400000000000006 110.001 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.24 49.19 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 121.063 -2.474 . . . . 64.200000000000003 110.992 0.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 6.2 p -73.01 -178.2 2.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.514 1.134 . . . . 71.349999999999994 108.286 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.728 HG21 ' CE1' ' A' ' 170' ' ' PHE . 4.3 mp -90.53 137.63 21.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.446 1.091 . . . . 73.450000000000003 109.309 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.596 HG21 ' O ' ' A' ' 301' ' ' PHE . 74.3 p -90.48 88.62 7.23 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.462 1.101 . . . . 72.129999999999995 110.426 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.728 ' CE1' HG21 ' A' ' 168' ' ' ILE . 19.1 m-85 -88.36 -25.51 22.69 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.509 1.131 . . . . 64.439999999999998 110.986 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.453 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.84 -2.05 28.16 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 1.138 . . . . 72.019999999999996 110.32 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.675 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 29.4 t80 -128.29 68.22 76.58 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 110.998 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.424 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.06 113.39 3.78 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.495 1.787 . . . . 74.109999999999999 110.977 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.586 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.9 t -152.17 -66.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.467 1.104 . . . . 34.530000000000001 109.31 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -163.49 118.16 1.62 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.51 1.131 . . . . 64.239999999999995 109.283 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 147.3 48.03 0.03 OUTLIER Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.516 1.135 . . . . 52.140000000000001 110.98 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 74.4 m -88.59 -19.75 25.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.261 -1.014 . . . . 74.129999999999995 108.261 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.668 ' HB3' HG11 ' A' ' 219' ' ' VAL . 29.2 p90 -72.55 -40.83 66.4 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.545 1.153 . . . . 72.519999999999996 111.018 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.594 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -63.87 -64.63 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.534 1.146 . . . . 73.329999999999998 109.314 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.523 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -43.7 -47.51 7.78 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 74.140000000000001 110.288 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.426 ' N ' ' HD3' ' A' ' 180' ' ' ARG . . . -42.17 -55.72 3.16 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.507 1.13 . . . . 75.0 109.277 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.692 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.33 -38.99 20.52 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.568 1.168 . . . . 75.209999999999994 109.597 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.656 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.8 mmmt -64.32 -61.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.465 1.103 . . . . 74.230000000000004 109.268 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.69 ' SD ' HG21 ' A' ' 153' ' ' ILE . 3.4 mtm -38.78 -34.06 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.52 1.138 . . . . 31.02 110.983 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.436 HH21 ' CG ' ' A' ' 194' ' ' ASP . 0.4 OUTLIER -63.95 -50.3 69.19 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.495 1.122 . . . . 62.450000000000003 110.251 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.656 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -52.87 -30.91 36.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.514 1.133 . . . . 72.519999999999996 110.311 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.516 HD13 ' HG3' ' A' ' 186' ' ' GLN . 11.0 mm -82.2 -36.02 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 75.219999999999999 109.277 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.808 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -62.69 -41.8 99.3 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.521 1.138 . . . . 72.120000000000005 109.288 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.439 ' HG2' HD21 ' A' ' 136' ' ' LEU . 21.8 mtp -63.73 -41.03 98.11 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 71.409999999999997 110.975 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -45.41 -53.28 8.91 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.469 1.106 . . . . 73.200000000000003 109.341 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -66.02 -27.14 67.89 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.544 1.152 . . . . 50.509999999999998 109.279 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.72 55.4 0.74 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.531 1.144 . . . . 73.420000000000002 111.025 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.652 ' CZ ' HG21 ' A' ' 145' ' ' THR . 77.5 m-85 -154.94 143.63 20.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.571 0.806 . . . . 64.439999999999998 111.012 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.935 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.1 t70 -109.55 125.45 52.53 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 70.150000000000006 109.35 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.788 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.7 p -94.51 -179.41 4.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 44.030000000000001 108.296 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.59 171.86 10.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.454 1.096 . . . . 74.439999999999998 110.294 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.419 ' NZ ' ' HB1' ' A' ' 181' ' ' ALA . 13.0 mmtt -105.72 163.38 12.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 72.25 109.269 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.737 HE22 HD13 ' A' ' 222' ' ' LEU . 3.3 tt0 -158.11 117.54 3.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.517 1.136 . . . . 75.030000000000001 110.328 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.551 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.9 m-85 -110.75 119.34 38.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.507 1.129 . . . . 74.209999999999994 111.013 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.659 ' CG2' HG23 ' A' ' 266' ' ' VAL . 9.9 p -115.08 142.32 28.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.522 1.139 . . . . 71.510000000000005 109.321 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.504 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.8 m-85 -117.65 157.25 26.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 74.239999999999995 110.969 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.92 -175.03 16.51 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.536 1.148 . . . . 51.310000000000002 110.986 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.787 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.1 t-20 -74.39 110.98 9.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.514 0.773 . . . . 73.450000000000003 109.297 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.7 mt -115.56 94.54 4.74 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.132 . . . . 71.340000000000003 109.333 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.4 mttp -92.81 167.12 12.07 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 74.340000000000003 109.255 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.923 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -170.43 164.41 8.64 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 74.430000000000007 109.297 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 16.2 t -142.2 130.19 21.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.454 1.096 . . . . 74.109999999999999 110.016 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 13.0 p -88.39 -4.62 58.62 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.457 1.098 . . . . 44.350000000000001 110.453 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 123.99 -43.18 1.45 Allowed Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.511 1.132 . . . . 74.299999999999997 111.011 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.3 t -128.71 4.98 5.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.468 0.746 . . . . 73.329999999999998 110.397 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 6.9 t -140.64 169.96 16.67 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.127 . . . . 54.210000000000001 108.289 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -137.09 144.33 43.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.502 1.126 . . . . 74.239999999999995 108.317 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.923 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -128.58 142.49 43.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.471 1.107 . . . . 54.109999999999999 109.278 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.87 128.78 41.29 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.525 1.141 . . . . 64.329999999999998 109.303 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.429 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.0 OUTLIER -134.99 130.84 36.37 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.556 1.16 . . . . 70.420000000000002 107.99 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 96.3 p -76.46 -0.73 24.02 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.558 1.161 . . . . 75.349999999999994 109.966 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.425 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.5 p90 -173.72 133.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.125 . . . . 74.430000000000007 111.02 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.499 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 65.5 t60 -119.26 167.79 11.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.517 1.136 . . . . 63.130000000000003 109.604 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.8 p -150.78 136.22 10.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.502 1.126 . . . . 74.510000000000005 109.287 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.545 ' HB3' ' CZ2' ' A' ' 252' ' ' TRP . . . -135.87 -156.72 0.73 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 41.109999999999999 109.327 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.436 HG12 ' CE ' ' A' ' 184' ' ' MET . 23.9 pt -123.07 118.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 62.520000000000003 109.273 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.737 HD13 HE22 ' A' ' 198' ' ' GLN . 11.0 tp -81.55 109.06 15.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.489 1.118 . . . . 71.299999999999997 109.285 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -100.87 145.01 11.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 61.5 109.292 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 17.0 m -117.34 120.29 37.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.502 1.126 . . . . 73.129999999999995 110.027 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 28.1 p90 -135.68 146.62 47.97 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.527 1.142 . . . . 73.230000000000004 110.974 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -71.52 131.52 43.4 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.476 1.11 . . . . 75.049999999999997 109.266 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -72.61 -160.43 0.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.523 1.14 . . . . 71.540000000000006 109.316 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.02 49.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.445 1.091 . . . . 62.340000000000003 109.291 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 12.5 m -114.96 -7.81 12.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.509 1.131 . . . . 53.509999999999998 109.993 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.93 37.85 8.26 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.485 1.115 . . . . 72.129999999999995 111.005 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.97 137.9 42.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.532 0.784 . . . . 63.539999999999999 109.269 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -72.21 102.63 3.12 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.553 1.158 . . . . 54.109999999999999 110.383 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 224' ' ' SER . 4.4 mm-40 -102.21 -172.78 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 75.209999999999994 110.295 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.611 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.8 mmtt -126.93 144.78 50.9 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 73.540000000000006 109.32 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.588 ' HB3' HG22 ' A' ' 223' ' ' VAL . 3.5 tpt180 -145.56 162.07 38.3 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.512 1.132 . . . . 62.439999999999998 110.283 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.627 HG21 ' CD1' ' A' ' 252' ' ' TRP . 26.3 mm -117.33 119.66 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.529 1.143 . . . . 73.340000000000003 109.299 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 237' ' ' ILE . 2.6 mm -101.23 47.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.497 1.123 . . . . 70.329999999999998 109.309 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.692 ' OD1' HD12 ' A' ' 241' ' ' LEU . 27.2 p-10 -94.8 111.4 54.18 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.340000000000003 109.289 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.98 -44.79 0.32 Allowed 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 62.109999999999999 111.018 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 5.9 m -39.58 -39.16 0.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.546 1.153 . . . . 72.219999999999999 110.005 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.692 HD12 ' OD1' ' A' ' 238' ' ' ASP . 5.9 mt -92.93 -56.69 2.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 71.120000000000005 109.281 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.729 ' CG ' HG11 ' A' ' 247' ' ' VAL . 95.6 m-85 -121.12 99.5 6.53 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.481 1.113 . . . . 62.450000000000003 111.001 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -26.01 34.96 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.453 1.096 . . . . 70.530000000000001 109.989 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.8 m -57.24 -45.82 83.59 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.441 1.088 . . . . 62.049999999999997 109.971 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 179.42 -166.91 36.58 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.447 1.092 . . . . 75.019999999999996 111.004 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.493 ' CG ' HD21 ' A' ' 146' ' ' LEU . 18.1 Cg_endo -75.04 164.0 34.14 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.504 1.792 . . . . 61.409999999999997 110.982 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.729 HG11 ' CG ' ' A' ' 242' ' ' PHE . 12.3 m -140.99 167.78 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.516 1.135 . . . . 62.009999999999998 109.281 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.449 ' C ' ' N ' ' A' ' 250' ' ' THR . 24.2 p -70.38 136.18 49.44 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.484 1.115 . . . . 73.25 110.384 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 248' ' ' THR . 26.6 p-10 -39.86 -30.24 0.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.129 . . . . 73.540000000000006 109.327 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.449 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -78.1 -61.43 2.0 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 40.200000000000003 110.409 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.91 -22.79 2.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.486 1.116 . . . . 70.349999999999994 109.259 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.627 ' CD1' HG21 ' A' ' 236' ' ' ILE . 7.4 t90 -68.68 -60.47 2.38 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.497 1.123 . . . . 75.450000000000003 107.998 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.568 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -51.29 -41.81 60.71 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 74.299999999999997 110.316 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.814 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.8 m-80 -54.66 -51.38 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 72.219999999999999 109.253 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.67 -24.45 48.84 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 73.409999999999997 109.291 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -83.97 -35.02 24.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 55.100000000000001 108.261 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.1 m -95.82 21.47 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.299999999999997 109.307 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.41 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 39.5 t-20 -51.94 107.88 0.23 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.526 1.141 . . . . 72.530000000000001 109.317 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.0 p -73.36 -3.37 26.8 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.529 1.143 . . . . 61.210000000000001 110.389 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.41 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 0.4 OUTLIER -44.73 -30.48 0.95 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.526 1.141 . . . . 54.009999999999998 109.971 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 42.1 t -88.95 -36.88 15.64 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 50.25 108.304 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.48 -127.97 1.62 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.473 1.108 . . . . 55.439999999999998 110.938 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -76.56 147.31 37.77 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 0.778 . . . . 74.019999999999996 109.973 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.98 146.22 3.67 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.503 1.127 . . . . 72.209999999999994 109.289 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -172.73 151.38 2.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.530000000000001 110.018 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.659 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.35 115.08 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.558 1.161 . . . . 50.439999999999998 109.28 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 31.7 t -70.11 -45.46 66.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.495 1.122 . . . . 75.049999999999997 109.983 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.2 m -165.08 177.29 7.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.525 1.14 . . . . 72.209999999999994 110.029 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -158.21 156.44 30.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.54 1.15 . . . . 54.43 110.999 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.2 155.34 33.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 62.009999999999998 109.282 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.532 ' O ' HG23 ' A' ' 272' ' ' THR . 1.2 p-10 -119.14 160.61 21.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.503 1.127 . . . . 64.420000000000002 109.278 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.685 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.0 p -154.98 178.89 9.67 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.524 1.14 . . . . 74.129999999999995 110.378 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -62.67 158.76 17.61 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.527 1.142 . . . . 73.530000000000001 109.301 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.87 -39.25 55.29 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.481 1.113 . . . . 62.100000000000001 110.955 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -56.7 -48.06 78.52 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 0.776 . . . . 71.109999999999999 109.273 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.771 HG23 ' HB3' ' A' ' 273' ' ' ALA . 25.3 t -44.7 118.51 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.456 1.097 . . . . 63.130000000000003 109.332 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -70.41 -53.49 16.28 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.531 1.144 . . . . 74.420000000000002 111.013 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.556 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 45.8 t80 -140.22 165.32 27.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 71.200000000000003 111.018 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.685 ' HD2' HG21 ' A' ' 272' ' ' THR . 55.0 ttt-85 -137.01 147.39 46.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 1.124 . . . . 64.239999999999995 110.278 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.6 157.92 44.71 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 71.349999999999994 109.97 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.19 9.2 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.485 1.781 . . . . 72.510000000000005 111.0 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.0 t -97.83 3.92 49.8 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 73.409999999999997 110.034 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 77.13 41.37 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.491 1.119 . . . . 75.420000000000002 109.273 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.8 t -123.07 119.52 30.57 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.461 1.101 . . . . 65.530000000000001 109.955 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.5 m-30 -99.92 160.22 14.48 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.518 1.136 . . . . 55.229999999999997 110.957 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.671 HD11 ' CZ ' ' A' ' 320' ' ' PHE . 1.0 OUTLIER -120.45 177.59 4.99 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.468 1.105 . . . . 65.030000000000001 109.324 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.482 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 94.8 m-85 -160.61 115.57 2.21 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 74.0 110.992 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.445 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.7 m-20 -115.18 96.11 5.51 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.439 1.087 . . . . 71.200000000000003 109.241 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -85.57 -30.7 23.14 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.46 1.1 . . . . 72.120000000000005 109.274 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.479 ' HB3' HD11 ' A' ' 292' ' ' ILE . 34.3 m-20 -98.3 7.91 45.56 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.523 1.139 . . . . 55.32 109.264 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.692 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 3.0 mm? 40.32 47.54 2.19 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.493 1.12 . . . . 65.310000000000002 109.321 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.479 HD11 ' HB3' ' A' ' 290' ' ' ASN . 45.4 mm -78.35 -25.07 13.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.558 1.161 . . . . 72.25 109.305 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.66 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.0 t-20 -94.64 -22.82 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 72.030000000000001 109.308 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.438 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 17.0 m -86.78 -68.97 0.71 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.45 1.094 . . . . 72.439999999999998 110.383 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -50.86 -22.88 2.41 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.525 1.141 . . . . 73.030000000000001 109.333 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 20.5 t -79.03 -62.44 1.7 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.5 1.125 . . . . 65.140000000000001 108.312 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 293' ' ' ASN . 18.2 t -44.09 -43.15 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 62.520000000000003 109.307 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 168' ' ' ILE . 72.9 mt -63.42 -58.59 6.56 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 65.530000000000001 109.315 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -38.27 5.1 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 62.539999999999999 110.402 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -57.18 -56.2 24.87 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 109.309 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' A' ' 301' ' ' PHE . 0.5 OUTLIER -89.68 35.22 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 63.420000000000002 111.032 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 44.8 t -68.07 -49.07 63.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 54.240000000000002 109.962 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -88.24 -17.94 29.69 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.439 1.087 . . . . 55.409999999999997 109.274 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.816 HD22 ' CD ' ' A' ' 309' ' ' PRO . 17.9 mt -57.43 144.26 37.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.458 1.099 . . . . 54.329999999999998 109.26 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 52.9 p -158.38 136.8 10.95 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 71.209999999999994 109.995 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 93.31 -155.23 22.17 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.519 1.137 . . . . 74.140000000000001 111.013 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.7 p -98.87 12.81 34.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.295 -1.002 . . . . 31.43 108.295 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.526 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.5 p -135.22 148.61 67.14 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 74.409999999999997 109.968 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.816 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.95 146.36 86.46 Favored 'Cis proline' 0 C--N 1.36 1.157 0 C-N-CA 121.023 -2.49 . . . . 74.230000000000004 110.998 -0.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.508 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.5 p -132.29 135.77 26.94 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.546 1.154 . . . . 54.310000000000002 109.985 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.8 14.76 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.985 -2.506 . . . . 63.549999999999997 110.997 -0.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.46 155.91 18.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.489 1.118 . . . . 44.25 109.291 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.485 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.03 -162.37 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.5 1.789 . . . . 72.420000000000002 111.01 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -87.99 135.51 33.38 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 71.319999999999993 109.277 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 13.3 m -126.49 18.04 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.483 1.114 . . . . 64.129999999999995 109.285 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.4 -33.06 58.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 72.019999999999996 110.013 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 83.1 p -43.12 -39.93 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.49 1.118 . . . . 72.400000000000006 110.02 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 6.4 m -52.64 170.97 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.467 1.104 . . . . 72.439999999999998 108.262 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -165.34 73.85 0.17 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.504 1.127 . . . . 64.150000000000006 110.991 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.671 ' CZ ' HD11 ' A' ' 286' ' ' LEU . 1.8 p90 . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.481 0.753 . . . . 74.25 110.939 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.797 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.2 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.287 -0.634 . . . . 64.010000000000005 109.287 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.694 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.82 107.76 3.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.543 1.152 . . . . 64.019999999999996 109.285 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.2 m -81.69 5.88 17.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.562 1.164 . . . . 65.019999999999996 110.031 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -145.87 148.76 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.455 1.097 . . . . 62.32 109.331 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.095 HD11 HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -100.82 143.72 27.13 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.5 1.125 . . . . 52.25 109.276 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.2 Cg_endo -74.99 -33.97 4.18 Favored 'Trans proline' 0 C--N 1.359 1.127 0 O-C-N 124.509 1.794 . . . . 73.400000000000006 110.985 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.82 150.6 22.85 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 73.030000000000001 109.314 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.8 t -48.83 -36.18 7.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 75.450000000000003 109.286 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.03 -48.55 3.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 64.319999999999993 109.302 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.691 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -70.01 -36.02 74.79 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.143 . . . . 74.420000000000002 110.364 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.746 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -57.95 -57.09 14.32 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.552 1.158 . . . . 74.299999999999997 109.324 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.483 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.9 m-80 -52.95 -29.4 28.6 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 70.230000000000004 109.304 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.3 -55.57 8.86 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.515 1.134 . . . . 74.230000000000004 109.973 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.095 HD12 HD11 ' A' ' 140' ' ' ILE . 65.3 mt -42.2 -41.99 2.88 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.553 1.158 . . . . 75.450000000000003 109.259 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.571 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.82 -45.37 61.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.521 1.138 . . . . 73.329999999999998 111.003 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -46.12 -35.37 4.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 73.319999999999993 109.315 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.449 ' NE2' ' OD1' ' A' ' 191' ' ' ASN . 65.3 mt-30 -77.42 -56.4 4.58 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.24 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.748 HD11 HD12 ' A' ' 188' ' ' LEU . 17.3 mt -50.18 -26.58 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.458 1.099 . . . . 71.340000000000003 109.265 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -34.62 57.62 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.144 . . . . 74.140000000000001 109.297 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.439 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.8 t-20 -61.6 -15.12 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.457 1.098 . . . . 70.099999999999994 109.292 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.45 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 5.7 mm100 -85.68 -18.72 32.35 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 1.135 . . . . 74.519999999999996 110.323 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.474 ' HB2' ' CE2' ' A' ' 170' ' ' PHE . 23.7 p -38.68 137.97 0.57 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.553 1.158 . . . . 61.109999999999999 109.991 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -68.03 134.16 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 73.329999999999998 108.288 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 113.74 -19.05 19.17 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.469 1.105 . . . . 75.420000000000002 111.017 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.848 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 69.8 p -81.24 161.52 23.91 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.527 0.781 . . . . 74.120000000000005 110.414 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 9.0 p -93.52 -0.5 56.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.138 . . . . 71.519999999999996 110.032 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 162' ' ' THR . 17.8 m -117.84 6.67 12.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.474 1.109 . . . . 63.229999999999997 110.368 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.848 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -83.17 138.14 33.76 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 63.409999999999997 109.311 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.74 -164.49 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 43.240000000000002 110.016 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.44 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 14.2 t -156.04 127.47 3.72 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 62.210000000000001 109.995 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.03 137.28 49.44 Favored 'Cis proline' 0 C--N 1.361 1.189 0 C-N-CA 120.986 -2.506 . . . . 74.239999999999995 111.017 0.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.0 p -73.08 179.48 3.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 1.136 . . . . 63.130000000000003 108.263 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.564 HG23 ' HB3' ' A' ' 180' ' ' ARG . 3.7 mp -88.95 128.94 40.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.505 1.128 . . . . 62.350000000000001 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 301' ' ' PHE . 23.8 p -91.14 85.65 5.96 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.484 1.115 . . . . 64.200000000000003 110.41 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 157' ' ' SER . 47.9 p90 -86.34 -18.86 30.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 54.329999999999998 110.979 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.448 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.77 -1.78 23.56 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 75.329999999999998 110.273 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.78 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.8 t80 -129.03 68.29 79.6 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.44 1.087 . . . . 64.299999999999997 110.983 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.411 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.2 Cg_endo -75.04 118.8 5.39 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.457 1.767 . . . . 74.420000000000002 110.963 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.564 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.2 t -152.47 -74.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.116 . . . . 75.239999999999995 109.283 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.553 ' OD1' ' HB2' ' A' ' 312' ' ' ALA . 1.5 p-10 -123.68 -43.15 2.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.513 1.133 . . . . 74.340000000000003 109.32 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -43.02 126.66 5.01 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.486 1.117 . . . . 51.210000000000001 110.999 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.627 ' SG ' HG12 ' A' ' 219' ' ' VAL . 4.5 p -165.33 -49.96 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.266 -1.013 . . . . 72.430000000000007 108.266 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.58 ' HB3' HG11 ' A' ' 219' ' ' VAL . 23.9 p90 -70.08 -18.67 63.27 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.527 1.142 . . . . 72.030000000000001 110.997 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.26 -68.26 0.51 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.515 1.135 . . . . 72.439999999999998 109.313 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 168' ' ' ILE . 9.2 ptm180 -48.36 -49.81 33.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.476 1.11 . . . . 71.349999999999994 110.302 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.472 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.37 -64.88 0.43 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.49 1.118 . . . . 72.310000000000002 109.298 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.517 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.4 t60 -39.86 -45.03 1.74 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.508 1.13 . . . . 74.400000000000006 109.607 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 186' ' ' GLN . 14.3 mmmt -62.3 -58.24 8.44 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.55 1.156 . . . . 72.420000000000002 109.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.642 ' SD ' HG21 ' A' ' 153' ' ' ILE . 9.2 mtm -38.96 -36.13 0.26 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.514 1.134 . . . . 60.549999999999997 110.981 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.431 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.1 OUTLIER -63.47 -48.99 75.39 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 62.43 110.314 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -53.1 -33.2 51.12 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.447 1.092 . . . . 72.319999999999993 110.278 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.434 HD13 ' HG3' ' A' ' 186' ' ' GLN . 17.3 mm -75.79 -37.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.145 . . . . 74.0 109.26 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.748 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -61.28 -44.45 97.22 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.533 1.146 . . . . 74.099999999999994 109.285 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.438 ' HG2' HD21 ' A' ' 136' ' ' LEU . 3.2 mtt -56.41 -42.28 77.73 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.498 1.124 . . . . 75.209999999999994 110.992 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -48.45 -52.66 21.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.46 1.1 . . . . 64.420000000000002 109.288 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.449 ' OD1' ' NE2' ' A' ' 152' ' ' GLN . 0.4 OUTLIER -62.28 -37.22 84.67 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.504 1.128 . . . . 74.109999999999999 109.274 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.77 48.15 0.69 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.522 1.139 . . . . 71.299999999999997 110.971 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.694 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 61.6 m-85 -147.78 137.62 22.69 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.508 0.769 . . . . 74.310000000000002 111.001 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.797 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.3 t70 -103.17 129.26 50.02 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 64.109999999999999 109.293 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.712 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.8 p -108.15 -178.79 3.71 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 1.129 . . . . 74.430000000000007 108.286 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.4 OUTLIER -126.47 174.74 8.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 73.319999999999993 110.27 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.472 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 20.5 mmtt -109.73 167.08 10.41 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.491 1.119 . . . . 33.130000000000003 109.279 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 219' ' ' VAL . 0.6 OUTLIER -153.45 144.87 23.18 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.44 1.087 . . . . 72.5 110.271 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.527 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.1 m-85 -139.87 112.61 7.98 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.549 1.156 . . . . 64.549999999999997 110.992 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.795 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.4 p -106.68 143.21 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.498 1.124 . . . . 73.319999999999993 109.278 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.4 m-85 -113.99 150.49 33.77 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.477 1.11 . . . . 73.430000000000007 110.97 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.7 -172.17 19.53 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.465 1.103 . . . . 64.510000000000005 111.003 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.815 ' C ' HD23 ' A' ' 204' ' ' LEU . 54.4 t-20 -77.65 111.46 13.44 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.54 0.788 . . . . 63.119999999999997 109.299 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.815 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.0 mt -114.09 95.97 5.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.512 1.133 . . . . 73.519999999999996 109.251 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.0 mtpt -92.31 165.4 13.11 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.467 1.104 . . . . 72.129999999999995 109.312 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.877 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -170.6 122.02 0.61 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 52.109999999999999 109.325 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.409 ' CB ' ' SG ' ' A' ' 261' ' ' CYS . 3.3 p -96.24 131.62 42.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.134 . . . . 72.120000000000005 110.017 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 15.8 p -107.65 -5.86 17.22 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.447 1.092 . . . . 74.310000000000002 110.421 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 89.28 -22.88 21.07 Favored Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.495 1.122 . . . . 55.450000000000003 111.014 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.1 m -113.28 -18.85 11.97 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.443 0.731 . . . . 64.230000000000004 110.397 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 1.3 p -169.94 148.33 3.46 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 73.430000000000007 108.337 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.5 m -97.78 140.56 31.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.517 1.136 . . . . 74.409999999999997 108.354 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.877 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -117.56 142.24 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 61.149999999999999 109.318 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -136.31 127.82 28.65 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.469 1.106 . . . . 64.420000000000002 109.364 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.464 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.6 OUTLIER -132.66 132.9 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.489 1.118 . . . . 74.230000000000004 108.009 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 30.5 t -76.5 -0.76 24.23 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.539 1.149 . . . . 61.530000000000001 109.971 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 10.3 p90 -176.4 133.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.486 1.116 . . . . 62.310000000000002 111.022 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 32.4 t60 -117.48 168.9 9.97 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.453 1.095 . . . . 72.099999999999994 109.602 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 198' ' ' GLN . 2.8 p -147.75 142.02 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.46 1.1 . . . . 61.240000000000002 109.259 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.624 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.16 -167.27 2.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.132 . . . . 74.140000000000001 109.278 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 196' ' ' GLU . 19.9 pt -115.92 121.95 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.514 1.134 . . . . 75.420000000000002 109.311 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.716 HD22 HE22 ' A' ' 198' ' ' GLN . 18.2 tp -84.49 115.55 22.63 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.463 1.102 . . . . 65.129999999999995 109.298 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.746 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -109.07 145.81 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.487 1.117 . . . . 62.020000000000003 109.303 180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 69.5 m -115.73 121.71 43.32 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.5 1.125 . . . . 73.299999999999997 109.953 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.3 p90 -136.66 143.32 43.38 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.484 1.115 . . . . 70.409999999999997 111.017 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.423 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.4 mmtp -69.23 132.51 46.6 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.451 1.094 . . . . 74.420000000000002 109.294 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.46 -160.33 0.08 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.526 1.141 . . . . 73.340000000000003 109.332 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.21 50.08 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.489 1.118 . . . . 41.409999999999997 109.329 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.6 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.497 1.123 . . . . 75.349999999999994 110.009 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.46 37.39 8.16 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.538 1.149 . . . . 71.019999999999996 110.982 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.09 137.76 42.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.504 0.767 . . . . 73.310000000000002 109.281 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.423 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.5 m -71.91 102.66 2.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 33.450000000000003 110.43 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.8 mm-40 -103.12 -172.86 2.19 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.458 1.099 . . . . 71.510000000000005 110.296 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.475 ' HB3' HD11 ' A' ' 222' ' ' LEU . 8.5 mmtm -126.12 145.56 50.3 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 65.340000000000003 109.323 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.8 tpt180 -143.74 159.1 43.11 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 63.450000000000003 110.325 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.582 HG21 ' CD1' ' A' ' 252' ' ' TRP . 7.7 mm -111.63 124.89 68.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.477 1.111 . . . . 53.130000000000003 109.331 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 237' ' ' ILE . 2.8 mm -112.95 44.89 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.535 1.147 . . . . 74.150000000000006 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.545 ' OD1' HD12 ' A' ' 241' ' ' LEU . 10.8 p-10 -94.12 111.67 54.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.106 . . . . 51.229999999999997 109.322 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.464 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.4 Cg_endo -74.94 -36.33 2.66 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.506 1.793 . . . . 73.109999999999999 110.994 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 1.3 p -43.16 -36.47 1.72 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.456 1.097 . . . . 73.310000000000002 109.98 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.545 HD12 ' OD1' ' A' ' 238' ' ' ASP . 16.5 mt -102.56 -59.52 1.69 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 72.109999999999999 109.284 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.611 ' CZ ' ' HB2' ' A' ' 255' ' ' ALA . 89.6 m-85 -111.3 98.99 7.88 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 73.129999999999995 111.07 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 70.6 m -91.02 -13.13 33.85 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.524 1.14 . . . . 61.5 109.985 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.9 p -74.73 -46.54 36.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.458 1.098 . . . . 72.5 110.001 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -172.0 -179.52 42.98 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.501 1.126 . . . . 72.129999999999995 111.005 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 236' ' ' ILE . 18.3 Cg_endo -74.98 169.29 22.96 Favored 'Trans proline' 0 C--N 1.359 1.119 0 O-C-N 124.485 1.782 . . . . 73.510000000000005 110.978 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.604 HG11 ' CD2' ' A' ' 242' ' ' PHE . 5.0 m -153.13 157.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.494 1.121 . . . . 74.230000000000004 109.289 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.434 ' C ' ' N ' ' A' ' 250' ' ' THR . 46.7 p -59.28 136.56 58.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.487 1.117 . . . . 73.219999999999999 110.447 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 248' ' ' THR . 1.7 p-10 -40.33 -30.65 0.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 74.420000000000002 109.316 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.434 ' N ' ' C ' ' A' ' 248' ' ' THR . 3.7 m -70.06 -65.36 0.73 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.524 1.14 . . . . 71.230000000000004 110.365 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -47.58 -38.4 14.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.487 1.117 . . . . 61.119999999999997 109.31 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.624 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 19.4 t90 -54.25 -63.55 1.12 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 74.310000000000002 108.0 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.571 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -46.49 -45.78 18.58 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.547 1.154 . . . . 60.210000000000001 110.327 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.746 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -53.14 -51.68 61.18 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.499 1.124 . . . . 65.349999999999994 109.285 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.611 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.78 -21.85 31.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 73.409999999999997 109.328 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -84.57 -38.19 20.25 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 63.299999999999997 108.34 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.746 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.3 m -91.19 18.56 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 24.350000000000001 109.285 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.419 ' OD1' ' CB ' ' A' ' 260' ' ' SER . 6.8 t30 -40.51 104.64 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 63.350000000000001 109.329 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . . . . . . . . . 2.8 p -79.89 -4.04 50.61 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.461 1.101 . . . . 53.32 110.387 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.419 ' CB ' ' OD1' ' A' ' 258' ' ' ASN . 5.2 t -58.7 -16.13 15.07 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 62.509999999999998 110.033 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 1.3 m -98.76 -20.34 16.96 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.447 1.092 . . . . 70.109999999999999 108.301 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . 152.37 -125.88 1.91 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.512 1.132 . . . . 73.319999999999993 110.944 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -84.54 144.56 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 62.240000000000002 109.993 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.51 146.2 2.72 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.503 1.127 . . . . 70.150000000000006 109.3 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -171.26 152.45 3.37 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.45 1.094 . . . . 73.019999999999996 109.997 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.795 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.4 p -97.23 111.84 27.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.492 1.12 . . . . 71.310000000000002 109.303 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 22.4 t -69.0 -46.95 66.72 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 64.230000000000004 110.007 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 200' ' ' VAL . 5.0 m -158.71 -175.04 5.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 71.450000000000003 110.013 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -166.5 157.25 12.48 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 71.430000000000007 110.977 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -160.34 153.24 21.39 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.471 1.107 . . . . 75.549999999999997 109.325 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -110.84 160.69 16.52 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.442 1.089 . . . . 52.140000000000001 109.325 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.42 177.64 9.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 70.340000000000003 110.402 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.29 171.41 3.09 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.541 1.151 . . . . 75.049999999999997 109.292 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -84.95 -4.53 86.99 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.553 1.158 . . . . 71.540000000000006 110.951 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.82 -44.5 7.73 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.499 0.764 . . . . 73.310000000000002 109.326 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 273' ' ' ALA . 87.7 t -43.64 101.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.53 1.144 . . . . 60.229999999999997 109.28 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.516 ' HH ' ' HE1' ' A' ' 178' ' ' TYR . 57.4 t80 -62.32 -39.23 92.36 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.547 1.154 . . . . 75.140000000000001 110.979 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -149.48 150.54 32.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 63.43 110.984 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.527 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 74.1 ttt-85 -116.05 147.59 41.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 74.519999999999996 110.288 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.15 153.4 47.29 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.126 . . . . 62.340000000000003 109.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 0.06 9.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.487 1.783 . . . . 53.299999999999997 110.999 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 1.7 p -104.12 4.58 34.33 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.534 1.146 . . . . 43.229999999999997 109.989 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.0 t-20 81.2 41.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.492 1.12 . . . . 45.030000000000001 109.324 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.9 t -121.51 128.72 52.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 64.430000000000007 110.012 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.438 ' HB3' HG13 ' A' ' 276' ' ' VAL . 15.4 m-30 -110.04 155.87 21.27 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.506 1.128 . . . . 74.439999999999998 110.979 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.23 176.95 4.86 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.124 . . . . 73.340000000000003 109.315 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.622 ' H ' HD13 ' A' ' 286' ' ' LEU . 95.7 m-85 -162.67 115.62 1.66 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.14 . . . . 71.099999999999994 110.943 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -115.3 94.97 4.95 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.516 1.135 . . . . 61.200000000000003 109.315 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.421 ' O ' HD22 ' A' ' 291' ' ' LEU . 3.0 m-80 -83.19 -39.13 21.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 73.299999999999997 109.313 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.506 ' HB3' HD11 ' A' ' 292' ' ' ILE . 28.5 m-20 -90.64 9.95 27.66 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.493 1.121 . . . . 74.120000000000005 109.296 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.517 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.11 46.3 1.83 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.546 1.154 . . . . 53.140000000000001 109.304 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.506 HD11 ' HB3' ' A' ' 290' ' ' ASN . 46.3 mm -77.15 -33.95 20.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 62.340000000000003 109.324 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.724 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.5 t-20 -94.7 -15.25 24.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.513 1.133 . . . . 63.240000000000002 109.289 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.448 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 24.1 m -87.66 -65.49 1.01 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 63.450000000000003 110.404 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.415 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 63.3 m-20 -57.95 -22.78 50.75 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.471 1.107 . . . . 72.230000000000004 109.3 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 12.5 t -75.91 -65.67 0.88 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 61.240000000000002 108.308 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 293' ' ' ASN . 41.6 t -40.27 -40.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.471 1.107 . . . . 74.450000000000003 109.271 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.93 -57.72 5.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.486 1.116 . . . . 70.340000000000003 109.261 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -56.19 -17.85 8.54 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.488 1.118 . . . . 71.129999999999995 110.398 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -76.93 -42.94 37.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.528 1.142 . . . . 75.099999999999994 109.329 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.8 m-30 -105.75 40.33 1.59 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.522 1.139 . . . . 62.140000000000001 111.002 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -67.71 -55.79 11.8 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.542 1.151 . . . . 74.209999999999994 110.015 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.796 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -81.12 -18.32 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.119 . . . . 73.120000000000005 109.299 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.78 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 13.5 mt -55.78 134.03 51.4 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.492 1.12 . . . . 72.420000000000002 109.274 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 74.5 p -148.61 154.33 39.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 72.109999999999999 110.007 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.28 -146.41 29.04 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.463 1.102 . . . . 73.099999999999994 110.997 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 12.5 m -108.93 12.99 25.05 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.301 -0.999 . . . . 64.540000000000006 108.301 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.525 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 0.9 OUTLIER -129.8 149.24 72.47 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.555 1.159 . . . . 51.420000000000002 109.988 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.726 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 147.14 88.55 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.008 -2.497 . . . . 74.420000000000002 110.994 0.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.489 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.0 OUTLIER -129.07 133.64 25.42 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.503 1.127 . . . . 73.409999999999997 110.007 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.04 -169.52 7.44 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.978 -2.509 . . . . 64.540000000000006 110.942 0.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.553 ' HB2' ' OD1' ' A' ' 175' ' ' ASP . . . -56.9 151.76 31.33 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.44 1.088 . . . . 61.100000000000001 109.295 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.494 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.491 1.785 . . . . 72.430000000000007 110.95 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -89.75 135.01 33.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.473 1.108 . . . . 43.030000000000001 109.262 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 19.7 m -123.57 24.3 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.137 . . . . 73.329999999999998 109.309 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.429 ' C ' ' N ' ' A' ' 318' ' ' CYS . 3.5 t -53.69 -42.12 67.62 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.093 . . . . 70.420000000000002 110.005 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 16.0 m -41.89 -28.26 0.15 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 63.530000000000001 110.066 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.429 ' N ' ' C ' ' A' ' 316' ' ' SER . 75.4 m -54.57 -173.24 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.551 1.157 . . . . 73.530000000000001 108.333 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -157.07 -123.69 0.78 Allowed Glycine 0 CA--C 1.53 0.992 0 O-C-N 124.476 1.11 . . . . 73.409999999999997 110.987 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.559 ' C ' ' CD1' ' A' ' 320' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.452 0.736 . . . . 64.319999999999993 110.983 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 136' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.833 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -166.73 112.26 0.79 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.477 1.111 . . . . 65.109999999999999 109.311 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.464 ' CA ' ' OD2' ' A' ' 194' ' ' ASP . 0.5 OUTLIER -83.41 4.03 29.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 109.974 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.4 151.35 12.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.436 1.085 . . . . 64.439999999999998 109.286 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.042 HD11 HD12 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -104.85 145.0 29.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.482 1.114 . . . . 74.430000000000007 109.296 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.97 -35.18 3.33 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.493 1.786 . . . . 61.009999999999998 111.014 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.413 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.88 150.06 20.37 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 73.409999999999997 109.333 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.511 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -46.06 -37.41 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.555 1.159 . . . . 72.319999999999993 109.291 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.23 -49.32 2.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.111 . . . . 63.219999999999999 109.305 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.653 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -69.34 -37.21 77.57 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.45 1.094 . . . . 63.329999999999998 110.421 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.78 -57.45 12.42 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.444 1.09 . . . . 74.329999999999998 109.241 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.5 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.1 m-80 -52.95 -30.41 34.53 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.47 1.106 . . . . 62.409999999999997 109.337 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.74 -56.77 7.02 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.572 1.17 . . . . 54.340000000000003 110.038 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.042 HD12 HD11 ' A' ' 140' ' ' ILE . 79.2 mt -43.11 -43.03 4.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 75.420000000000002 109.31 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.605 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.69 -45.1 62.92 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 74.439999999999998 110.959 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -46.05 -36.92 6.13 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.476 1.11 . . . . 72.109999999999999 109.3 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.467 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 62.5 mt-30 -76.41 -55.79 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.471 1.107 . . . . 74.439999999999998 110.284 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 188' ' ' LEU . 19.9 mt -49.46 -27.46 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.561 1.163 . . . . 55.439999999999998 109.296 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -37.34 62.68 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.503 1.127 . . . . 64.010000000000005 109.306 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -56.21 -19.33 13.32 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.451 1.094 . . . . 73.109999999999999 109.324 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.515 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 12.0 mm-40 -80.82 -28.01 36.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.454 1.096 . . . . 72.120000000000005 110.292 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.4 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 21.5 m -39.85 123.69 1.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.449 1.093 . . . . 61.119999999999997 109.998 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 8.1 m -53.24 116.22 2.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.482 1.114 . . . . 73.420000000000002 108.303 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 142.03 -14.06 2.6 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.484 1.115 . . . . 23.32 111.011 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.743 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 59.0 p -97.71 161.86 13.55 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.475 0.75 . . . . 72.400000000000006 110.404 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.1 m -93.4 -2.35 54.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 63.409999999999997 109.967 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 162' ' ' THR . 2.2 m -112.03 0.1 15.87 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.522 1.139 . . . . 75.430000000000007 110.397 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.743 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -75.57 134.09 40.79 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.51 1.131 . . . . 75.109999999999999 109.285 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.01 -169.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.55 1.157 . . . . 73.200000000000003 110.029 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.451 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 44.0 p -154.75 127.53 4.11 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.468 1.105 . . . . 64.319999999999993 110.026 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.08 137.14 48.56 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 121.019 -2.492 . . . . 65.019999999999996 110.981 0.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.472 ' O ' HD13 ' A' ' 298' ' ' LEU . 9.5 p -72.95 -178.91 2.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 64.120000000000005 108.278 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.845 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.0 mp -84.5 128.16 39.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.497 1.123 . . . . 54.32 109.308 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.4 p -92.54 76.27 5.08 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.562 1.164 . . . . 71.140000000000001 110.399 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 51.2 p90 -78.76 -14.17 59.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.537 1.148 . . . . 72.420000000000002 110.979 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.46 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -73.74 -3.03 25.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 74.129999999999995 110.296 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.776 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -131.84 66.7 78.43 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.446 1.091 . . . . 74.340000000000003 111.018 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.547 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.2 Cg_endo -74.98 118.46 5.28 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.518 1.799 . . . . 73.219999999999999 111.015 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.531 HG21 ' CE1' ' A' ' 172' ' ' TYR . 19.0 t -152.84 -64.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 54.100000000000001 109.326 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -132.3 -46.68 0.91 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.472 1.108 . . . . 62.310000000000002 109.273 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -45.43 104.15 0.06 OUTLIER Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.472 1.107 . . . . 51.43 110.996 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.493 ' SG ' ' CG1' ' A' ' 219' ' ' VAL . 3.5 p -138.65 -48.43 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.243 -1.021 . . . . 31.329999999999998 108.243 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -68.5 -16.22 63.81 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.5 1.125 . . . . 74.450000000000003 110.985 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.93 -68.31 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.53 1.144 . . . . 62.039999999999999 109.318 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.57 ' HB3' HG23 ' A' ' 168' ' ' ILE . 7.2 ptm180 -50.92 -49.03 60.51 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.12 . . . . 75.25 110.297 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.516 ' HB1' ' HZ3' ' A' ' 197' ' ' LYS . . . -39.58 -56.63 1.63 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.464 1.102 . . . . 71.319999999999993 109.292 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.549 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.4 OUTLIER -47.1 -44.56 21.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.117 . . . . 63.520000000000003 109.601 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.845 ' CB ' HD11 ' A' ' 168' ' ' ILE . 22.9 mmmt -64.36 -42.25 96.3 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.496 1.122 . . . . 73.549999999999997 109.328 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.516 ' HA ' HG23 ' A' ' 153' ' ' ILE . 17.4 mtm -55.5 -33.2 63.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 65.420000000000002 111.003 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -21.33 41.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.479 1.112 . . . . 65.340000000000003 110.319 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.436 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.9 OUTLIER -71.73 -39.66 69.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.509 1.131 . . . . 74.219999999999999 110.304 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.467 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 19.0 mm -74.14 -32.48 32.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 63.439999999999998 109.294 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.867 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -61.65 -44.46 96.94 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.454 1.096 . . . . 74.030000000000001 109.324 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 30.6 mtp -58.51 -42.18 87.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.539 1.149 . . . . 60.200000000000003 111.006 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -50.38 -53.53 28.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.461 1.1 . . . . 64.120000000000005 109.303 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.443 ' ND2' HE22 ' A' ' 152' ' ' GLN . 7.1 t-20 -60.55 -29.55 69.21 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 73.010000000000005 109.309 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 105.71 37.33 2.6 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.517 1.136 . . . . 71.010000000000005 110.99 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.833 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 73.7 m-85 -138.04 129.05 27.21 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 0.791 . . . . 62.520000000000003 110.988 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.464 ' OD2' ' CA ' ' A' ' 138' ' ' SER . 0.7 OUTLIER -99.27 132.51 44.54 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.505 1.128 . . . . 51.240000000000002 109.293 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.695 ' HB3' HD22 ' A' ' 188' ' ' LEU . 25.9 p -112.17 -179.45 3.68 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.511 1.132 . . . . 71.129999999999995 108.258 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -122.45 176.02 6.13 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.501 1.126 . . . . 62.240000000000002 110.285 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.637 ' HE2' HG22 ' A' ' 221' ' ' ILE . 22.0 mmtt -107.67 174.41 5.9 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 51.219999999999999 109.317 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.703 ' O ' HG23 ' A' ' 219' ' ' VAL . 17.1 tt0 -160.59 139.17 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.541 1.151 . . . . 74.230000000000004 110.263 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -130.27 113.49 14.47 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 74.430000000000007 110.994 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.667 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.2 p -110.15 148.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.51 1.131 . . . . 74.230000000000004 109.32 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.1 m-85 -121.6 160.44 24.36 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.478 1.111 . . . . 74.340000000000003 111.0 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.44 179.88 17.01 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.551 1.157 . . . . 64.25 111.015 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.728 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.3 t-20 -69.23 110.27 4.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.491 0.759 . . . . 62.530000000000001 109.324 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -114.56 93.49 4.36 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 74.450000000000003 109.296 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.8 mttp -93.27 165.35 12.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 73.0 109.303 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.631 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -168.53 143.07 3.31 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.513 1.133 . . . . 65.120000000000005 109.318 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 52.6 p -117.69 110.15 17.51 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.499 1.124 . . . . 61.140000000000001 110.015 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 19.4 p -80.89 -20.08 42.99 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.492 1.12 . . . . 74.430000000000007 110.411 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 122.85 -49.91 0.87 Allowed Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.539 1.149 . . . . 73.310000000000002 111.012 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 75.5 p -91.52 -17.58 25.45 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.481 0.754 . . . . 22.120000000000001 110.413 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -168.0 163.29 13.62 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.487 1.117 . . . . 70.120000000000005 108.301 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.478 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.34 145.92 44.75 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.536 1.148 . . . . 62.520000000000003 108.329 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -112.36 155.53 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 62.25 109.247 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.52 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -139.4 119.07 13.12 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.507 1.129 . . . . 73.25 109.282 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.481 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -126.33 134.79 51.01 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.155 . . . . 75.150000000000006 108.02 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 4.1 m -80.45 3.78 20.34 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.458 1.099 . . . . 72.219999999999999 109.994 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.496 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.8 p90 -176.14 127.75 0.21 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.477 1.111 . . . . 55.240000000000002 111.027 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -116.54 168.45 10.16 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.478 1.111 . . . . 62.439999999999998 109.619 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 198' ' ' GLN . 1.3 p -145.57 143.38 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.49 1.119 . . . . 53.219999999999999 109.312 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.563 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -142.19 -165.68 2.07 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.12 . . . . 45.229999999999997 109.294 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.637 HG22 ' HE2' ' A' ' 197' ' ' LYS . 31.1 pt -116.09 122.5 69.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 73.200000000000003 109.296 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 234' ' ' LYS . 19.9 tp -87.1 108.87 19.08 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.446 1.091 . . . . 52.530000000000001 109.312 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.701 HG11 HG13 ' A' ' 237' ' ' ILE . 0.9 OUTLIER -102.0 167.6 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 65.140000000000001 109.3 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 140' ' ' ILE . 54.8 m -135.75 120.14 17.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.494 1.121 . . . . 64.519999999999996 109.993 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.511 ' CD2' HG23 ' A' ' 143' ' ' VAL . 34.3 p90 -136.15 142.37 44.19 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.120000000000005 111.03 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.2 mmtp -68.21 132.84 47.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.504 1.128 . . . . 75.349999999999994 109.286 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -73.73 -160.36 0.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.496 1.122 . . . . 53.439999999999998 109.321 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.84 0.09 48.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.481 1.113 . . . . 71.430000000000007 109.312 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.3 m -115.36 -7.19 12.33 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.506 1.129 . . . . 73.329999999999998 110.02 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.54 37.66 8.67 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.473 1.108 . . . . 44.350000000000001 110.975 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.28 137.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.455 0.738 . . . . 74.430000000000007 109.323 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 8.6 m -71.47 102.58 2.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.495 1.122 . . . . 74.049999999999997 110.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 224' ' ' SER . 1.8 mm-40 -101.39 -172.47 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.535 1.147 . . . . 74.310000000000002 110.297 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.511 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -127.52 145.3 50.9 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.524 1.14 . . . . 75.5 109.286 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.55 ' NH1' HG22 ' A' ' 248' ' ' THR . 4.3 tpt180 -142.68 161.14 38.85 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.493 1.121 . . . . 74.549999999999997 110.284 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.697 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.4 mm -113.7 117.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.52 1.138 . . . . 54.119999999999997 109.318 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.724 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -105.08 45.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 64.329999999999998 109.314 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.9 106.54 53.31 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 62.109999999999999 109.309 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -75.01 -10.02 21.01 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.517 1.799 . . . . 74.409999999999997 111.003 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.7 t -64.5 -11.85 38.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.545 1.153 . . . . 61.329999999999998 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.472 HD11 ' NE2' ' A' ' 218' ' ' HIS . 5.2 mt -127.55 -48.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.547 1.154 . . . . 73.140000000000001 109.281 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.596 ' CE2' ' HB2' ' A' ' 255' ' ' ALA . 75.9 m-85 -118.54 99.54 6.88 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.576 1.172 . . . . 74.200000000000003 111.017 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 75.6 m -88.14 -6.44 57.88 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.547 1.154 . . . . 74.329999999999998 109.982 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.1 m -80.95 -45.77 16.17 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.537 1.148 . . . . 74.540000000000006 110.012 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.05 -174.23 43.29 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.495 1.122 . . . . 54.399999999999999 110.987 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.45 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.97 164.42 33.42 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.485 1.781 . . . . 63.32 111.021 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.577 HG21 ' CE2' ' A' ' 242' ' ' PHE . 2.6 m -150.46 161.23 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.48 1.113 . . . . 72.219999999999999 109.32 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.55 HG22 ' NH1' ' A' ' 235' ' ' ARG . 34.3 p -64.51 138.21 58.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.523 1.139 . . . . 71.010000000000005 110.41 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.409 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 0.4 OUTLIER -40.92 -29.79 0.11 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.51 1.131 . . . . 55.130000000000003 109.307 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 6.3 m -71.85 -64.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.54 1.15 . . . . 64.5 110.384 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.37 -25.55 10.08 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.504 1.127 . . . . 74.230000000000004 109.314 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.697 ' CD1' HG21 ' A' ' 236' ' ' ILE . 9.2 t90 -64.36 -59.91 3.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.995 -1.113 . . . . 72.230000000000004 107.995 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.544 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -49.26 -41.9 39.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 63.25 110.281 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.852 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -56.56 -50.75 70.97 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.499 1.124 . . . . 74.5 109.275 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.596 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -55.94 -20.99 18.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 40.119999999999997 109.32 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -88.16 -36.2 16.97 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 1.136 . . . . 72.319999999999993 108.262 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.852 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -93.36 21.59 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.485 1.115 . . . . 44.420000000000002 109.271 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -51.06 107.1 0.15 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 73.310000000000002 109.329 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 5.2 p -73.49 -3.06 25.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.551 1.157 . . . . 63.210000000000001 110.385 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 33.3 t -44.3 -30.84 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.505 1.128 . . . . 62.049999999999997 109.97 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 44.2 t -88.59 -37.35 15.72 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.5 1.125 . . . . 71.219999999999999 108.347 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.72 -128.06 1.66 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.546 1.154 . . . . 23.300000000000001 110.993 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.453 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.02 145.35 42.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.477 0.751 . . . . 62.329999999999998 109.983 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.02 148.03 4.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.46 1.1 . . . . 62.020000000000003 109.314 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 29.3 m -172.77 155.23 3.16 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 44.229999999999997 110.013 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.667 HG23 ' CG2' ' A' ' 200' ' ' VAL . 4.9 p -102.65 116.54 46.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.467 1.104 . . . . 41.310000000000002 109.283 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 32.0 t -70.76 -44.89 65.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.505 1.128 . . . . 65.030000000000001 109.951 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.609 ' O ' HG23 ' A' ' 200' ' ' VAL . 50.7 p -165.43 -173.52 2.83 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.541 1.151 . . . . 74.230000000000004 110.006 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -165.4 156.53 14.18 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 63.219999999999999 110.982 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.04 147.84 23.05 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.53 1.144 . . . . 75.120000000000005 109.286 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -99.63 158.93 15.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 65.019999999999996 109.31 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 279' ' ' ARG . 1.3 p -146.44 179.14 7.74 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.517 1.135 . . . . 71.530000000000001 110.386 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -74.57 163.36 27.82 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.522 1.139 . . . . 64.530000000000001 109.324 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.47 -16.41 80.01 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.492 1.12 . . . . 74.219999999999999 111.008 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 276' ' ' VAL . 7.5 p30 -86.29 -43.61 12.78 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.53 0.782 . . . . 63.420000000000002 109.342 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.445 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 3.8 t -43.71 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.571 1.169 . . . . 64.230000000000004 109.285 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -66.95 -42.8 84.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.518 1.136 . . . . 52.549999999999997 111.022 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.51 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.6 OUTLIER -153.21 121.02 6.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.524 1.14 . . . . 64.219999999999999 111.029 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.469 ' HD2' ' CG2' ' A' ' 272' ' ' THR . 40.8 ttt-85 -106.57 137.19 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.515 1.134 . . . . 73.030000000000001 110.334 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.92 158.17 32.62 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 73.040000000000006 110.007 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 0.47 8.88 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.467 1.772 . . . . 72.409999999999997 110.974 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 27.9 t -98.18 13.19 32.05 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.542 1.152 . . . . 72.230000000000004 109.99 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 74.87 37.19 0.51 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 55.5 109.338 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 1.2 t -112.3 152.94 27.93 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 64.230000000000004 109.951 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.457 ' CE1' ' HD2' ' A' ' 279' ' ' ARG . 51.9 m-85 -140.54 158.2 44.35 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 73.109999999999999 111.022 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.473 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -126.08 172.95 9.56 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.498 1.123 . . . . 74.299999999999997 109.281 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.473 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 88.1 m-85 -160.23 114.95 2.26 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 1.099 . . . . 64.329999999999998 111.001 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.426 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 8.0 t0 -115.5 97.04 5.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 64.140000000000001 109.273 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.434 ' O ' HD22 ' A' ' 291' ' ' LEU . 6.8 m-20 -85.83 -39.42 17.08 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.101 . . . . 65.25 109.298 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.476 ' CB ' HG12 ' A' ' 292' ' ' ILE . 4.3 m120 -90.52 9.54 28.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.484 1.115 . . . . 72.510000000000005 109.325 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.549 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.9 mm? 40.06 46.67 1.86 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.5 1.125 . . . . 65.049999999999997 109.305 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.485 HG21 ' O ' ' A' ' 319' ' ' GLY . 48.9 mm -77.28 -28.77 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 73.549999999999997 109.298 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.831 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.7 t-20 -94.54 -22.53 18.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 72.420000000000002 109.312 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 22.9 m -84.52 -64.18 1.21 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.478 1.111 . . . . 53.32 110.395 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 82.5 m-20 -57.47 -17.94 15.97 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.491 1.119 . . . . 74.019999999999996 109.308 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 7.2 t -81.88 -63.95 1.28 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.494 1.121 . . . . 55.240000000000002 108.303 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 293' ' ' ASN . 46.2 t -40.38 -51.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.545 1.153 . . . . 75.439999999999998 109.27 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 167' ' ' CYS . 47.0 mt -57.14 -59.48 5.03 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.457 1.098 . . . . 64.310000000000002 109.296 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -45.22 -34.71 2.92 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.140000000000001 110.378 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -68.06 -43.31 78.93 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 73.109999999999999 109.259 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.738 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.5 m-30 -99.5 35.8 1.89 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.505 1.128 . . . . 73.25 111.006 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 36.2 t -69.41 -43.36 73.59 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.56 1.162 . . . . 64.109999999999999 110.029 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.45 -12.78 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 74.430000000000007 109.315 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.776 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 12.6 mt -60.39 150.28 31.35 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.52 1.137 . . . . 74.209999999999994 109.295 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.6 p -161.48 162.92 30.61 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 54.299999999999997 109.984 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.68 -152.82 52.78 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.519 1.137 . . . . 74.040000000000006 111.018 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 2.1 m -101.64 13.12 35.88 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.292 -1.003 . . . . 64.450000000000003 108.292 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.522 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 12.9 p -129.49 150.01 74.45 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 71.150000000000006 110.009 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.705 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.6 Cg_endo -74.95 147.12 88.51 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.967 -2.514 . . . . 75.540000000000006 111.056 -0.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.465 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -128.71 133.69 25.47 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.531 1.145 . . . . 74.109999999999999 109.992 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.465 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -74.96 -170.27 8.1 Favored 'Cis proline' 0 C--N 1.36 1.168 0 C-N-CA 120.97 -2.512 . . . . 55.109999999999999 111.033 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 152.34 29.43 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.462 1.101 . . . . 71.129999999999995 109.29 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.414 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.512 1.796 . . . . 73.439999999999998 110.996 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -91.4 135.31 33.92 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.148 . . . . 71.219999999999999 109.254 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.7 m -126.59 24.5 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.489 1.118 . . . . 73.129999999999995 109.276 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 318' ' ' CYS . 35.6 t -50.73 -44.12 58.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.349999999999994 109.952 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 45.6 m -39.51 -29.82 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.485 1.116 . . . . 71.25 110.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.431 ' N ' ' O ' ' A' ' 316' ' ' SER . 74.6 m -52.04 -179.22 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.434 1.084 . . . . 64.030000000000001 108.304 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.485 ' O ' HG21 ' A' ' 292' ' ' ILE . . . -178.93 66.25 0.08 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.471 1.107 . . . . 70.519999999999996 110.959 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 8.3 p90 . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.493 0.761 . . . . 74.129999999999995 110.966 179.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.718 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.327 -0.62 . . . . 72.329999999999998 109.327 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.811 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -149.04 106.7 3.66 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.533 1.145 . . . . 54.119999999999997 109.327 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m -81.82 5.65 18.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.329999999999998 109.99 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.3 t -149.35 145.62 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 70.140000000000001 109.302 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.107 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -96.88 142.44 24.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.488 1.117 . . . . 62.549999999999997 109.27 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -32.44 5.42 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.464 1.77 . . . . 63.109999999999999 110.99 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.485 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.49 153.22 22.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.105 . . . . 73.129999999999995 109.3 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.512 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.8 t -51.08 -34.31 14.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.552 1.158 . . . . 74.109999999999999 109.316 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.84 -45.86 5.04 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.48 1.113 . . . . 74.049999999999997 109.32 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.721 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.6 m -73.21 -32.38 64.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.476 1.11 . . . . 64.239999999999995 110.415 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.7 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -61.84 -56.23 21.57 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.504 1.127 . . . . 73.319999999999993 109.295 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.512 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 51.6 m-80 -53.62 -31.37 46.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.472 1.108 . . . . 71.040000000000006 109.288 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.39 -55.22 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.471 1.107 . . . . 73.319999999999993 109.987 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.107 HD12 HD11 ' A' ' 140' ' ' ILE . 92.1 mt -44.4 -42.41 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 72.010000000000005 109.302 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.654 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -72.35 -44.7 62.22 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 1.117 . . . . 75.129999999999995 110.994 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -47.04 -37.32 9.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.512 1.132 . . . . 70.450000000000003 109.262 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.465 ' HB3' ' CG2' ' A' ' 187' ' ' ILE . 60.0 mt-30 -74.94 -55.57 5.63 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 1.139 . . . . 62.299999999999997 110.293 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.699 HD11 HD12 ' A' ' 188' ' ' LEU . 23.4 mt -50.45 -28.0 4.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 54.0 109.308 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.406 ' HD3' ' CE1' ' A' ' 150' ' ' PHE . 0.0 OUTLIER -75.07 -33.71 61.71 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.514 1.134 . . . . 62.140000000000001 109.305 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.3 t-20 -61.59 -15.15 36.41 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 70.010000000000005 109.294 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -85.81 -18.47 32.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 71.209999999999994 110.302 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.0 p -37.93 134.51 0.75 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.508 1.13 . . . . 54.350000000000001 109.977 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.676 ' HB3' HH21 ' A' ' 171' ' ' ARG . 1.3 m -66.18 120.04 12.53 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.461 1.101 . . . . 60.329999999999998 108.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 127.69 -15.82 6.26 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 51.439999999999998 110.99 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.867 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 69.6 p -83.39 161.9 21.2 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 0.758 . . . . 72.310000000000002 110.387 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -93.55 0.12 56.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.467 1.104 . . . . 74.5 109.963 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 162' ' ' THR . 2.9 m -119.45 7.15 11.13 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.516 1.135 . . . . 50.119999999999997 110.355 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.867 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -81.31 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.513 1.133 . . . . 62.119999999999997 109.308 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -162.03 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.52 1.137 . . . . 54.409999999999997 110.014 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.436 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 126.92 3.5 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 70.430000000000007 110.039 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 139.85 64.05 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.948 -2.522 . . . . 74.409999999999997 110.998 0.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.99 178.46 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.1 . . . . 75.540000000000006 108.333 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.949 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.0 mp -86.32 132.95 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 70.209999999999994 109.268 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.565 HG21 ' O ' ' A' ' 301' ' ' PHE . 51.0 p -90.43 75.24 6.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.471 1.107 . . . . 60.439999999999998 110.403 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -81.64 -24.79 36.13 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 62.409999999999997 111.027 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.676 HH21 ' HB3' ' A' ' 158' ' ' CYS . 0.0 OUTLIER -75.97 -1.57 26.28 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.497 1.123 . . . . 73.450000000000003 110.3 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.796 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 25.6 t80 -128.91 67.44 77.93 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.092 . . . . 61.240000000000002 111.012 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.415 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.55 4.32 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.51 1.795 . . . . 50.240000000000002 111.013 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.585 HG21 ' CE1' ' A' ' 172' ' ' TYR . 14.6 t -152.23 -58.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.47 1.107 . . . . 74.329999999999998 109.292 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -138.43 -47.35 0.51 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.484 1.115 . . . . 52.43 109.297 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -39.19 106.46 0.05 OUTLIER Glycine 0 CA--C 1.529 0.938 0 O-C-N 124.526 1.141 . . . . 61.450000000000003 111.044 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.786 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.6 p -143.06 -48.41 0.32 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.307 -0.997 . . . . 52.049999999999997 108.307 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.604 ' HB3' HG11 ' A' ' 219' ' ' VAL . 24.3 p90 -69.99 -33.9 72.64 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.461 1.101 . . . . 74.129999999999995 111.062 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.492 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -62.57 -68.42 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.521 1.138 . . . . 72.140000000000001 109.264 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.669 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -46.38 -44.5 17.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 1.139 . . . . 55.100000000000001 110.32 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.71 -55.47 5.25 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.466 1.104 . . . . 51.329999999999998 109.267 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.88 -35.83 15.66 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.483 1.114 . . . . 72.340000000000003 109.635 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.949 ' CB ' HD11 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -71.47 -50.55 30.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.471 1.107 . . . . 75.420000000000002 109.286 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.555 ' HA ' HG23 ' A' ' 153' ' ' ILE . 5.3 mtm -51.84 -41.2 61.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 62.100000000000001 111.01 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.96 -24.47 58.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.51 1.131 . . . . 63.530000000000001 110.305 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.425 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -69.48 -41.56 75.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.515 1.135 . . . . 72.239999999999995 110.305 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 152' ' ' GLN . 20.8 mm -72.02 -33.0 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.488 1.118 . . . . 74.430000000000007 109.274 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.791 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -59.56 -47.36 85.85 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.455 1.097 . . . . 75.219999999999999 109.332 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.482 ' HG2' HD21 ' A' ' 136' ' ' LEU . 2.4 mtt -54.9 -44.35 74.05 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.123 . . . . 73.150000000000006 111.001 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.0 -53.33 20.43 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.475 1.109 . . . . 74.329999999999998 109.312 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -58.46 -32.88 69.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.476 1.11 . . . . 75.450000000000003 109.308 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 108.78 43.86 1.18 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.53 1.144 . . . . 62.310000000000002 110.973 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.811 ' CD1' ' HB3' ' A' ' 137' ' ' ALA . 68.6 m-85 -144.79 133.31 22.02 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.48 0.753 . . . . 73.319999999999993 111.03 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.718 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.5 OUTLIER -99.71 130.07 45.89 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.538 1.149 . . . . 75.409999999999997 109.31 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.791 ' HB3' HD22 ' A' ' 188' ' ' LEU . 28.5 p -112.25 -179.44 3.68 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.545 1.153 . . . . 72.239999999999995 108.307 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -125.87 177.41 6.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.507 1.129 . . . . 64.209999999999994 110.286 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.654 ' HE2' HG22 ' A' ' 221' ' ' ILE . 16.5 mmtt -108.87 164.27 12.54 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.544 1.152 . . . . 64.150000000000006 109.292 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.486 ' OE1' HD13 ' A' ' 222' ' ' LEU . 30.5 tt0 -151.5 117.49 5.53 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.446 1.091 . . . . 73.409999999999997 110.277 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 219' ' ' VAL . 3.9 m-85 -108.65 129.74 55.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 63.299999999999997 111.056 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.795 HG23 ' HB3' ' A' ' 269' ' ' TYR . 6.3 p -128.49 131.63 68.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 64.230000000000004 109.289 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.4 m-85 -108.01 159.51 16.5 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.517 1.135 . . . . 71.150000000000006 111.053 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 123.48 -173.19 16.38 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.469 1.105 . . . . 51.509999999999998 110.978 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.752 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.5 t-20 -76.3 108.19 9.07 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.483 0.755 . . . . 65.319999999999993 109.321 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.752 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.4 mt -111.13 95.09 5.32 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.488 1.118 . . . . 72.239999999999995 109.305 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 264' ' ' ALA . 0.2 OUTLIER -92.21 158.35 16.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.521 1.138 . . . . 73.540000000000006 109.294 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.493 ' O ' HG22 ' A' ' 213' ' ' VAL . . . -179.12 162.63 1.23 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.13 . . . . 73.319999999999993 109.318 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.0 t -117.75 148.37 42.1 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.52 1.138 . . . . 71.140000000000001 110.013 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.8 p -124.43 -0.92 8.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 74.319999999999993 110.38 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 122.27 115.85 2.33 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.478 1.112 . . . . 64.099999999999994 110.981 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 210' ' ' THR . 0.6 OUTLIER 46.61 24.56 0.33 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.5 0.765 . . . . 71.200000000000003 110.408 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -165.17 157.07 15.19 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 70.430000000000007 108.311 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.455 ' O ' HG13 ' A' ' 213' ' ' VAL . 19.1 m -113.76 176.3 5.09 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.508 1.13 . . . . 65.530000000000001 108.294 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 206' ' ' ALA . 2.4 m -153.03 129.99 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.538 1.149 . . . . 72.519999999999996 109.3 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 205' ' ' LYS . . . -124.42 131.01 53.5 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.433 1.083 . . . . 73.519999999999996 109.279 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.48 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -132.33 134.87 45.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.988 -1.116 . . . . 75.129999999999995 107.988 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 23.8 t -77.36 0.18 23.34 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 61.509999999999998 110.063 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 4.7 p90 -178.15 136.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.507 1.13 . . . . 74.219999999999999 110.978 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.519 ' CB ' HD12 ' A' ' 204' ' ' LEU . 77.6 t60 -129.5 143.31 50.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.528 1.142 . . . . 74.439999999999998 109.61 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.786 HG12 ' SG ' ' A' ' 177' ' ' CYS . 7.4 p -124.47 134.27 67.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.475 1.11 . . . . 73.109999999999999 109.284 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.552 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.35 -152.1 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.458 1.099 . . . . 72.540000000000006 109.371 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.654 HG22 ' HE2' ' A' ' 197' ' ' LYS . 13.1 pt -128.72 123.43 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.525 1.141 . . . . 63.210000000000001 109.29 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.7 tp -89.78 109.06 20.08 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.534 1.146 . . . . 55.229999999999997 109.327 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.7 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.04 148.57 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.52 1.137 . . . . 61.530000000000001 109.301 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.611 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -117.24 121.63 41.72 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 30.239999999999998 109.995 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.0 p90 -136.81 144.95 43.96 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.513 1.133 . . . . 64.010000000000005 111.009 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.439 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.6 mmtp -70.07 133.78 47.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 62.229999999999997 109.322 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -75.46 -159.67 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.522 1.139 . . . . 64.230000000000004 109.305 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.93 0.07 49.36 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 74.150000000000006 109.243 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.01 -8.59 12.46 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.133 . . . . 62.32 110.018 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.41 37.59 8.09 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.478 1.111 . . . . 51.210000000000001 111.039 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.54 138.21 41.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.49 0.759 . . . . 71.540000000000006 109.319 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.439 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 23.9 m -71.58 102.67 2.79 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.544 1.152 . . . . 73.140000000000001 110.408 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.0 mm-40 -101.69 -172.61 2.18 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.094 . . . . 60.310000000000002 110.257 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.652 ' HB3' HD11 ' A' ' 222' ' ' LEU . 17.9 mmtt -126.66 144.91 50.76 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 75.329999999999998 109.257 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.651 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.6 tpt180 -143.43 160.57 40.33 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 72.420000000000002 110.32 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.644 HG21 ' CD1' ' A' ' 252' ' ' TRP . 14.3 mm -116.6 119.15 61.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.482 1.114 . . . . 63.420000000000002 109.313 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.711 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -103.37 44.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 75.219999999999999 109.284 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -101.26 108.5 55.27 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.487 1.117 . . . . 63.32 109.283 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -26.9 10.5 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.486 1.782 . . . . 64.310000000000002 110.966 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.3 OUTLIER -45.92 -25.46 0.54 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.537 1.148 . . . . 73.030000000000001 110.002 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.1 mt -112.97 -60.71 1.84 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 73.329999999999998 109.333 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.596 ' CD1' HG11 ' A' ' 247' ' ' VAL . 85.3 m-85 -106.5 99.58 9.15 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.446 1.091 . . . . 74.239999999999995 110.969 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 52.8 m -85.67 -13.47 48.45 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 43.200000000000003 109.992 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 2.2 m -72.01 -47.85 48.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 72.25 109.944 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.75 -170.97 39.91 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.523 1.14 . . . . 52.340000000000003 111.0 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.448 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -74.99 163.84 34.57 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.495 1.787 . . . . 71.430000000000007 111.007 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.596 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.1 m -147.81 162.13 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 74.030000000000001 109.284 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.453 HG22 ' NH1' ' A' ' 235' ' ' ARG . 31.1 p -63.49 139.22 58.75 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.49 1.119 . . . . 73.519999999999996 110.428 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 249' ' ' ASP . 0.2 OUTLIER -42.45 -28.56 0.22 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.458 1.099 . . . . 64.219999999999999 109.317 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.431 ' N ' ' C ' ' A' ' 248' ' ' THR . 9.1 m -75.93 -62.57 1.55 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.502 1.127 . . . . 55.109999999999999 110.367 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.07 -28.23 6.84 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.504 1.128 . . . . 74.129999999999995 109.311 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.644 ' CD1' HG21 ' A' ' 236' ' ' ILE . 10.2 t90 -63.25 -63.88 1.06 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.499 1.125 . . . . 71.519999999999996 107.989 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.625 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -46.5 -42.24 15.31 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.478 1.111 . . . . 62.409999999999997 110.3 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.781 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -56.28 -51.29 68.71 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.47 1.106 . . . . 63.420000000000002 109.325 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.69 -28.0 53.27 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.509 1.131 . . . . 73.439999999999998 109.276 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.2 m -80.14 -36.89 34.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.519 1.137 . . . . 71.109999999999999 108.309 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.802 HG11 HG23 ' A' ' 266' ' ' VAL . 2.6 m -95.37 22.92 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.49 1.119 . . . . 64.219999999999999 109.299 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -50.7 104.47 0.08 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.11 . . . . 74.129999999999995 109.286 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 262' ' ' GLY . 6.1 p -73.34 -4.22 32.02 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.507 1.129 . . . . 71.400000000000006 110.408 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 32.3 t -51.31 -21.69 2.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.474 1.109 . . . . 43.140000000000001 110.004 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . 0.429 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 5.0 m -96.51 -27.3 14.93 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.541 1.151 . . . . 73.430000000000007 108.297 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 156.51 -128.21 2.15 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.436 1.085 . . . . 73.519999999999996 111.025 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.449 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -78.54 141.24 38.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.48 0.753 . . . . 75.200000000000003 110.013 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.585 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -171.38 143.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.479 1.112 . . . . 61.329999999999998 109.316 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.4 t -172.65 161.71 4.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.512 1.132 . . . . 71.420000000000002 109.962 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.802 HG23 HG11 ' A' ' 257' ' ' VAL . 17.5 t -103.57 128.23 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.501 1.126 . . . . 55.310000000000002 109.342 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.9 t -84.77 -39.44 18.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 54.439999999999998 109.991 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 15.6 m -175.0 144.74 0.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.451 1.094 . . . . 74.099999999999994 109.976 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.795 ' HB3' HG23 ' A' ' 200' ' ' VAL . 44.5 p90 -130.48 160.13 35.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.42 1.075 . . . . 64.409999999999997 111.022 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.96 160.45 41.13 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.496 1.123 . . . . 74.439999999999998 109.341 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.43 ' C ' HG23 ' A' ' 272' ' ' THR . 1.2 p-10 -122.7 158.04 30.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.557 1.161 . . . . 71.439999999999998 109.283 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 271' ' ' ASN . 56.0 p -151.95 175.46 12.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 75.200000000000003 110.379 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.759 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -55.36 161.44 1.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.487 1.117 . . . . 70.25 109.373 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.21 -45.38 40.07 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.473 1.108 . . . . 54.100000000000001 110.983 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.51 -37.43 49.18 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.505 0.768 . . . . 52.32 109.286 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.759 HG23 ' HB3' ' A' ' 273' ' ' ALA . 43.1 t -45.86 118.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.555 1.159 . . . . 75.409999999999997 109.277 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 293' ' ' ASN . 6.2 t80 -81.34 -52.09 7.66 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.481 1.113 . . . . 61.119999999999997 110.995 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -135.89 160.08 39.7 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.14 . . . . 71.040000000000006 111.019 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.514 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.8 ttt-85 -131.11 147.48 52.62 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.437 1.085 . . . . 71.510000000000005 110.348 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.92 157.45 52.61 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.461 1.1 . . . . 61.340000000000003 110.0 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 0.31 9.04 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.482 1.78 . . . . 51.420000000000002 111.008 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 11.3 t -99.55 6.21 45.86 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.488 1.118 . . . . 72.230000000000004 110.018 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.4 t-20 76.21 34.67 0.5 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.473 1.108 . . . . 74.140000000000001 109.271 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.3 t -116.49 123.56 47.76 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.125 . . . . 54.399999999999999 110.001 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 13.2 m-30 -104.91 157.6 17.1 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 72.200000000000003 110.987 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.729 HD13 ' H ' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -116.55 171.38 7.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.472 1.107 . . . . 61.520000000000003 109.323 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.729 ' H ' HD13 ' A' ' 286' ' ' LEU . 41.5 m-85 -153.83 115.22 4.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.46 1.1 . . . . 72.239999999999995 110.995 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.441 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 3.8 t0 -115.61 97.84 6.37 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.476 1.11 . . . . 65.5 109.305 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -85.66 -26.96 25.68 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.446 1.091 . . . . 75.430000000000007 109.298 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.472 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -101.74 -1.81 31.63 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.53 1.144 . . . . 62.119999999999997 109.268 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.3 mm? 54.78 46.04 25.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 74.450000000000003 109.295 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.709 HG21 ' O ' ' A' ' 319' ' ' GLY . 16.5 mm -66.69 -42.93 90.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 51.219999999999999 109.27 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.75 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.7 t-20 -90.46 -23.6 20.94 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.503 1.127 . . . . 62.539999999999999 109.304 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.589 HG21 HD12 ' A' ' 291' ' ' LEU . 1.2 m -75.6 -64.21 1.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.532 1.145 . . . . 72.150000000000006 110.426 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 54.3 m-20 -58.1 -25.56 61.49 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 72.430000000000007 109.315 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 27.2 t -76.24 -60.52 2.3 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.481 1.113 . . . . 74.150000000000006 108.305 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.9 t -41.5 -50.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 64.230000000000004 109.298 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.05 -60.02 4.43 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 70.329999999999998 109.328 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -41.68 -37.9 1.29 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.448 1.093 . . . . 74.349999999999994 110.38 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -61.98 -56.67 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.15 . . . . 75.109999999999999 109.314 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.569 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 0.4 OUTLIER -93.16 37.64 1.04 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.506 1.129 . . . . 73.319999999999993 111.035 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.1 t -70.81 -43.89 67.69 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.46 1.1 . . . . 60.219999999999999 110.005 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.657 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -94.28 -12.12 28.76 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.488 1.117 . . . . 72.5 109.292 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.816 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.9 mt -61.08 139.45 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.548 1.155 . . . . 72.340000000000003 109.294 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 71.0 p -149.39 147.17 27.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 72.019999999999996 109.966 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 84.02 -162.0 38.46 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.506 1.128 . . . . 52.030000000000001 110.971 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 4.1 p -91.27 3.67 54.27 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.296 -1.001 . . . . 64.340000000000003 108.296 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 33.9 p -126.09 150.97 71.04 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 71.010000000000005 110.007 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.816 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.96 146.36 86.45 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 121.024 -2.49 . . . . 73.150000000000006 111.024 -0.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.493 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.1 p -133.77 135.42 24.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 34.140000000000001 110.014 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.2 Cg_endo -75.01 -173.19 11.89 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.996 -2.502 . . . . 61.119999999999997 111.004 -0.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.07 154.29 20.62 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.458 1.099 . . . . 41.520000000000003 109.331 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.562 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.1 Cg_endo -75.02 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.489 1.783 . . . . 61.310000000000002 110.994 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -89.75 130.79 35.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.493 1.12 . . . . 70.109999999999999 109.269 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.5 m -121.08 27.45 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 62.229999999999997 109.276 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 318' ' ' CYS . 9.3 t -50.46 -44.47 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.488 1.117 . . . . 74.150000000000006 110.005 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 316' ' ' SER . 80.0 p -38.96 -30.55 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.485 1.116 . . . . 43.520000000000003 109.973 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 316' ' ' SER . 57.4 m -59.65 -173.27 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.445 1.091 . . . . 74.340000000000003 108.324 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.709 ' O ' HG21 ' A' ' 292' ' ' ILE . . . 163.41 80.23 0.04 OUTLIER Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.501 1.126 . . . . 53.210000000000001 111.028 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.636 ' CD2' HD11 ' A' ' 286' ' ' LEU . 8.0 p90 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.523 0.778 . . . . 74.450000000000003 111.042 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.773 HD23 ' HB2' ' A' ' 194' ' ' ASP . 4.5 tp . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.301 -0.629 . . . . 54.119999999999997 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.657 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -152.74 109.64 3.48 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.484 1.115 . . . . 54.219999999999999 109.332 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.4 t -83.11 7.52 15.69 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.536 1.147 . . . . 71.150000000000006 110.011 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.563 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -147.11 148.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.515 1.134 . . . . 74.120000000000005 109.275 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.109 HD11 HD12 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -101.5 143.75 27.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 124.511 1.132 . . . . 74.230000000000004 109.303 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.94 -34.12 4.15 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.504 1.791 . . . . 74.019999999999996 111.035 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.446 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.37 153.29 25.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 74.140000000000001 109.281 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.502 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -49.94 -36.44 11.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.531 1.144 . . . . 71.219999999999999 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.41 -49.27 2.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.507 1.13 . . . . 71.340000000000003 109.335 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.677 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 2.8 m -69.42 -36.88 77.13 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.547 1.155 . . . . 73.340000000000003 110.38 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.678 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -57.16 -57.37 12.89 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.1 . . . . 74.310000000000002 109.323 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.502 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.5 m-80 -52.48 -29.6 25.69 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.509 1.13 . . . . 73.310000000000002 109.329 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -70.27 -56.13 7.53 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 70.319999999999993 110.025 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.109 HD12 HD11 ' A' ' 140' ' ' ILE . 76.1 mt -42.07 -41.93 2.75 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 71.140000000000001 109.329 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.612 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.45 -45.13 60.97 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.533 1.146 . . . . 75.209999999999994 110.99 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -47.41 -36.0 9.19 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.514 1.134 . . . . 63.240000000000002 109.289 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.448 ' NE2' ' OD1' ' A' ' 191' ' ' ASN . 65.0 mt-30 -76.13 -55.49 5.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.481 1.113 . . . . 74.439999999999998 110.272 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.481 HD11 HD12 ' A' ' 188' ' ' LEU . 15.7 mt -50.14 -26.87 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.493 1.121 . . . . 71.319999999999993 109.33 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.65 -34.56 58.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.447 1.092 . . . . 63.030000000000001 109.288 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.7 t-20 -62.33 -14.6 41.13 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 109.259 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -86.44 -17.07 35.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.476 1.11 . . . . 74.420000000000002 110.297 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.1 p -38.71 122.97 1.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.464 1.103 . . . . 71.450000000000003 109.937 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.3 m -54.7 131.12 42.84 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.489 1.118 . . . . 61.43 108.256 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 116.46 -25.1 9.36 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.509 1.131 . . . . 74.030000000000001 110.993 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.815 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 25.3 p -73.52 162.92 28.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.481 0.753 . . . . 73.340000000000003 110.431 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 19.6 m -93.47 -2.45 54.48 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.51 1.131 . . . . 62.310000000000002 110.029 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 162' ' ' THR . 7.5 m -116.79 8.76 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.453 1.096 . . . . 75.430000000000007 110.376 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.815 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.81 138.09 34.09 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.446 1.091 . . . . 62.439999999999998 109.3 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.87 -169.18 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.564 1.165 . . . . 73.540000000000006 110.012 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.437 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 55.7 p -153.54 126.78 4.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.519 1.137 . . . . 71.230000000000004 109.999 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.437 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -74.97 137.48 50.6 Favored 'Cis proline' 0 C--N 1.36 1.142 0 C-N-CA 120.992 -2.503 . . . . 64.219999999999999 111.002 -0.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 24.7 p -73.09 -179.7 3.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 73.219999999999999 108.322 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.722 HG21 ' CB ' ' A' ' 180' ' ' ARG . 3.7 mp -101.93 137.06 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.51 1.131 . . . . 63.340000000000003 109.267 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.512 HG21 ' HB2' ' A' ' 301' ' ' PHE . 34.1 p -74.37 83.66 1.94 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 64.099999999999994 110.381 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.524 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 3.1 m-85 -80.1 -1.07 38.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.477 1.11 . . . . 75.340000000000003 110.991 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.447 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -118.02 14.93 14.18 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.521 1.138 . . . . 72.200000000000003 110.317 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.712 ' OH ' HD13 ' A' ' 304' ' ' LEU . 18.6 t80 -128.86 67.55 77.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 61.409999999999997 111.041 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.438 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.5 Cg_endo -74.97 113.19 3.74 Favored 'Trans proline' 0 C--N 1.361 1.191 0 O-C-N 124.521 1.801 . . . . 72.510000000000005 111.014 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.55 HG21 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.75 -71.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.481 1.113 . . . . 72.219999999999999 109.24 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -133.53 -46.51 0.82 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.507 1.129 . . . . 54.409999999999997 109.31 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.93 100.79 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 42.43 110.988 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.742 ' SG ' HG12 ' A' ' 219' ' ' VAL . 5.2 p -137.56 -48.53 0.58 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.304 -0.998 . . . . 71.430000000000007 108.304 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.602 ' HB3' HG11 ' A' ' 219' ' ' VAL . 27.4 p90 -69.92 -25.21 63.56 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.55 1.156 . . . . 62.130000000000003 111.03 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.35 -65.64 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.476 1.11 . . . . 65.239999999999995 109.37 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.722 ' CB ' HG21 ' A' ' 168' ' ' ILE . 11.4 ptm180 -45.77 -51.86 12.01 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.459 1.099 . . . . 73.430000000000007 110.234 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.489 ' HB1' ' HZ3' ' A' ' 197' ' ' LYS . . . -41.37 -63.0 0.76 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.505 1.128 . . . . 75.439999999999998 109.31 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.656 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.6 OUTLIER -40.74 -38.71 0.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 73.219999999999999 109.583 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.629 ' HB3' HD11 ' A' ' 168' ' ' ILE . 13.3 mmmm -68.47 -59.92 2.81 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.446 1.091 . . . . 71.450000000000003 109.257 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.428 ' SD ' HG21 ' A' ' 153' ' ' ILE . 25.7 mtm -41.4 -30.67 0.2 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.499 1.124 . . . . 62.340000000000003 110.958 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.675 HH21 ' CG ' ' A' ' 275' ' ' ASN . 0.1 OUTLIER -68.25 -47.61 67.28 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.447 1.092 . . . . 53.219999999999999 110.293 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.473 ' HG3' HD13 ' A' ' 187' ' ' ILE . 0.5 OUTLIER -51.4 -33.52 30.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.482 1.114 . . . . 73.319999999999993 110.306 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.473 HD13 ' HG3' ' A' ' 186' ' ' GLN . 16.1 mm -75.7 -34.33 28.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.115 . . . . 63.229999999999997 109.305 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.7 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -60.96 -47.51 86.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.12 . . . . 63.340000000000003 109.253 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 136' ' ' LEU . 4.5 mtt -54.93 -44.29 74.14 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 52.439999999999998 110.996 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -47.25 -52.53 15.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.524 1.14 . . . . 74.230000000000004 109.297 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.448 ' OD1' ' NE2' ' A' ' 152' ' ' GLN . 0.5 OUTLIER -63.32 -36.36 83.43 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 54.109999999999999 109.284 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 111.32 48.71 0.69 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.491 1.12 . . . . 63.439999999999998 110.987 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.677 ' CZ ' HG21 ' A' ' 145' ' ' THR . 64.1 m-85 -149.39 137.37 20.5 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.481 0.754 . . . . 62.25 111.05 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.773 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -103.55 130.31 50.93 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.468 1.105 . . . . 71.430000000000007 109.333 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.7 ' HB3' HD22 ' A' ' 188' ' ' LEU . 26.4 p -107.52 -179.48 3.93 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.478 1.111 . . . . 50.32 108.298 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -127.05 172.62 10.34 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.469 1.106 . . . . 75.430000000000007 110.307 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.646 ' HE2' HG22 ' A' ' 221' ' ' ILE . 15.9 mmtt -104.98 157.29 17.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.438 1.087 . . . . 74.120000000000005 109.321 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.815 ' O ' HG23 ' A' ' 219' ' ' VAL . 20.7 tt0 -146.52 117.76 7.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 65.439999999999998 110.282 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 6.2 m-85 -108.27 128.22 54.54 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 73.5 110.977 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.879 HG13 HG23 ' A' ' 266' ' ' VAL . 1.5 t -120.52 161.05 20.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.532 1.145 . . . . 63.43 109.328 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 2.3 m-85 -138.84 151.22 46.82 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.508 1.13 . . . . 74.109999999999999 111.019 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.14 18.24 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.506 1.129 . . . . 61.409999999999997 111.027 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.787 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.6 t-20 -77.33 111.36 12.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.492 0.76 . . . . 72.530000000000001 109.3 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.0 mt -113.74 94.12 4.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.473 1.108 . . . . 62.509999999999998 109.299 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.7 ' NZ ' ' HB2' ' A' ' 214' ' ' ALA . 1.2 mtpp -92.89 158.31 15.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.51 1.131 . . . . 73.349999999999994 109.294 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -164.89 162.75 20.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.471 1.107 . . . . 71.209999999999994 109.313 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.7 t -141.88 130.68 22.92 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.553 1.158 . . . . 73.030000000000001 110.017 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 25.6 p -90.58 -2.81 57.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 71.310000000000002 110.42 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 110.15 -39.3 2.95 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.516 1.135 . . . . 75.129999999999995 111.003 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.1 p -123.39 7.41 9.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.515 0.773 . . . . 73.430000000000007 110.355 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 7.5 t -157.29 170.34 22.68 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.561 1.163 . . . . 72.120000000000005 108.303 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 52.9 t -133.2 162.35 32.01 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.544 1.153 . . . . 70.219999999999999 108.283 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.901 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -145.08 149.01 17.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.52 1.138 . . . . 64.519999999999996 109.253 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.7 ' HB2' ' NZ ' ' A' ' 205' ' ' LYS . . . -141.79 120.16 12.33 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.539 1.15 . . . . 41.119999999999997 109.291 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -125.46 136.8 53.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.499 1.124 . . . . 73.420000000000002 108.008 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 2.7 p -80.78 1.43 30.46 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 71.510000000000005 110.007 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.454 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 7.9 p90 -178.17 130.8 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 51.229999999999997 111.022 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.504 ' CB ' HD12 ' A' ' 204' ' ' LEU . 80.2 t60 -123.83 166.41 15.67 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.568 1.168 . . . . 75.239999999999995 109.591 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 198' ' ' GLN . 4.8 p -147.94 143.24 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 72.299999999999997 109.264 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.605 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.12 -159.84 1.0 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.452 1.095 . . . . 74.510000000000005 109.348 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.646 HG22 ' HE2' ' A' ' 197' ' ' LYS . 8.2 pt -118.16 125.17 74.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.542 1.151 . . . . 75.140000000000001 109.273 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 234' ' ' LYS . 12.6 tp -89.19 108.97 19.91 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.498 1.124 . . . . 62.5 109.333 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.95 147.41 10.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.484 1.115 . . . . 72.239999999999995 109.32 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.563 ' HB3' HG22 ' A' ' 139' ' ' VAL . 5.1 m -117.1 121.52 41.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.525 1.141 . . . . 62.509999999999998 110.02 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.6 p90 -136.45 143.14 43.73 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.471 1.107 . . . . 73.439999999999998 110.992 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.434 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.0 mmtp -68.73 132.93 47.65 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 51.539999999999999 109.268 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.41 -160.29 0.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.138 . . . . 74.239999999999995 109.349 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.61 0.06 48.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.494 1.121 . . . . 74.439999999999998 109.278 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.8 m -115.15 -7.95 12.41 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 64.519999999999996 110.006 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.97 37.68 8.31 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 72.109999999999999 111.005 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.5 138.02 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.511 0.771 . . . . 72.219999999999999 109.316 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.434 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.0 m -71.72 102.67 2.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.482 1.114 . . . . 74.549999999999997 110.38 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.9 mm-40 -101.55 -172.58 2.18 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.468 1.105 . . . . 75.129999999999995 110.307 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.497 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.9 mmtm -127.29 145.08 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.147 . . . . 74.430000000000007 109.339 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.639 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.7 tpt180 -144.19 161.2 39.47 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.485 1.116 . . . . 75.329999999999998 110.304 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.64 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.6 mm -116.75 120.43 65.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.464 1.102 . . . . 73.439999999999998 109.249 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -104.22 44.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 71.319999999999993 109.279 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -100.32 108.88 54.84 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 43.240000000000002 109.31 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.524 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.2 Cg_endo -75.05 -27.88 9.56 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.506 1.792 . . . . 75.439999999999998 111.019 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.459 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 1.2 t -48.15 -24.2 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.444 1.09 . . . . 75.140000000000001 110.036 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mt -112.11 -57.0 2.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 72.549999999999997 109.277 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.613 ' CE2' HG21 ' A' ' 247' ' ' VAL . 81.7 m-85 -112.46 99.45 7.99 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.5 1.125 . . . . 74.349999999999994 110.996 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 43.0 m -85.92 -9.1 57.49 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.094 . . . . 53.439999999999998 110.021 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.3 p -77.36 -46.26 23.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.488 1.118 . . . . 71.430000000000007 110.004 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.76 -171.59 41.35 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.501 1.126 . . . . 72.200000000000003 110.958 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.438 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.97 163.35 35.55 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.458 1.767 . . . . 71.319999999999993 111.039 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.613 HG21 ' CE2' ' A' ' 242' ' ' PHE . 3.1 m -147.55 160.01 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.502 1.126 . . . . 74.450000000000003 109.265 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.9 p -61.53 141.37 57.78 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 72.430000000000007 110.401 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.445 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 8.9 p30 -44.25 -27.73 0.45 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.456 1.097 . . . . 71.430000000000007 109.302 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 15.8 m -77.53 -61.6 1.94 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.514 1.133 . . . . 74.530000000000001 110.427 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.58 -27.62 7.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 45.020000000000003 109.314 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.64 ' CD1' HG21 ' A' ' 236' ' ' ILE . 9.9 t90 -63.66 -63.14 1.26 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.47 1.106 . . . . 71.239999999999995 108.055 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.569 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -47.17 -42.04 19.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.501 1.126 . . . . 75.239999999999995 110.311 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.814 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.8 m-80 -55.75 -51.57 66.91 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.538 1.149 . . . . 74.340000000000003 109.313 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.25 -24.79 29.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.492 1.12 . . . . 71.219999999999999 109.322 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.458 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.3 m -83.94 -36.5 23.24 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.531 1.144 . . . . 63.140000000000001 108.304 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.814 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.63 22.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 61.539999999999999 109.311 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -49.28 104.85 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.437 1.086 . . . . 74.439999999999998 109.276 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 262' ' ' GLY . 1.8 p -72.33 -4.02 27.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.507 1.13 . . . . 43.109999999999999 110.348 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.2 t -46.32 -27.0 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 61.149999999999999 109.967 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . 0.404 ' CB ' ' HD3' ' A' ' 205' ' ' LYS . 1.7 m -92.11 -35.76 13.71 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.474 1.109 . . . . 74.120000000000005 108.236 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.15 -126.79 1.68 Allowed Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.505 1.128 . . . . 64.540000000000006 110.973 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.5 OUTLIER -69.64 142.21 53.51 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 0.768 . . . . 70.209999999999994 110.002 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.559 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -173.08 140.84 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.496 1.123 . . . . 70.239999999999995 109.279 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 87.8 p -172.09 156.53 4.04 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.161 . . . . 72.329999999999998 109.991 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.879 HG23 HG13 ' A' ' 200' ' ' VAL . 6.0 p -103.78 111.15 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.502 1.126 . . . . 73.120000000000005 109.3 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 201' ' ' TYR . 16.5 t -61.68 -46.9 87.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.516 1.135 . . . . 65.040000000000006 110.013 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.6 m -159.58 -174.21 4.53 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.45 1.094 . . . . 75.010000000000005 110.009 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.586 ' HB3' HG22 ' A' ' 200' ' ' VAL . 45.6 p90 -167.0 157.38 11.51 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.485 1.115 . . . . 75.040000000000006 110.986 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.0 169.44 22.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 61.130000000000003 109.311 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 272' ' ' THR . 1.0 OUTLIER -134.17 160.64 37.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.513 1.133 . . . . 74.200000000000003 109.253 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.743 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.7 p -158.24 -177.93 6.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 74.019999999999996 110.378 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.79 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -60.97 167.22 3.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.483 1.114 . . . . 54.32 109.303 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -81.26 -41.55 10.1 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 110.983 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.675 ' CG ' HH21 ' A' ' 185' ' ' ARG . 0.8 OUTLIER -58.58 -45.2 89.57 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.497 0.763 . . . . 75.439999999999998 109.321 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.79 HG23 ' HB3' ' A' ' 273' ' ' ALA . 91.3 t -43.76 101.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.431 1.082 . . . . 74.109999999999999 109.305 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -52.23 -58.66 5.94 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 62.229999999999997 110.99 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.596 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.9 t80 -139.06 170.17 16.45 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.475 1.109 . . . . 73.120000000000005 110.986 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.743 ' HD2' HG21 ' A' ' 272' ' ' THR . 66.3 ttt-85 -141.59 147.44 37.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 64.200000000000003 110.315 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.61 157.05 43.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.509 1.13 . . . . 75.239999999999995 109.998 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.04 -0.26 9.77 Favored 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.525 1.802 . . . . 64.540000000000006 111.021 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.408 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 8.5 p -96.78 9.08 42.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.453 1.096 . . . . 74.349999999999994 110.011 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.3 t-20 74.98 34.67 0.66 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.54 1.15 . . . . 71.209999999999994 109.294 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 23.2 t -119.72 119.55 34.0 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 70.439999999999998 110.022 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.507 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 9.3 m-30 -99.59 162.22 13.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.200000000000003 110.99 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.3 mm? -116.97 177.57 4.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.517 1.135 . . . . 74.209999999999994 109.312 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.481 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 97.6 m-85 -160.92 115.4 2.1 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.501 1.126 . . . . 73.25 111.03 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 1.016 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.7 OUTLIER -115.31 94.74 4.85 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.108 . . . . 71.209999999999994 109.271 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 290' ' ' ASN . 0.7 OUTLIER -80.27 -42.04 23.88 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.528 1.143 . . . . 74.209999999999994 109.246 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.493 ' N ' ' ND2' ' A' ' 289' ' ' ASN . 11.4 m-20 -95.65 -1.83 49.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 74.209999999999994 109.28 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 1.016 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.0 mm? 52.21 40.34 28.72 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.524 1.14 . . . . 64.340000000000003 109.32 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 16.6 mm -69.8 -25.82 29.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 62.210000000000001 109.264 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.805 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.7 t-20 -92.97 -31.86 14.75 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 74.400000000000006 109.333 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.443 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 18.0 m -81.42 -66.85 0.84 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.515 1.134 . . . . 73.030000000000001 110.408 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.4 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.8 m-20 -47.33 -29.37 2.48 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.494 1.121 . . . . 73.239999999999995 109.306 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.5 t -75.23 -52.91 9.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.554 1.159 . . . . 74.049999999999997 108.328 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 293' ' ' ASN . 4.5 t -46.23 -51.74 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 70.319999999999993 109.307 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 168' ' ' ILE . 20.9 mt -63.47 -52.69 60.29 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.53 1.144 . . . . 75.109999999999999 109.309 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -52.2 -26.54 11.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.463 1.102 . . . . 74.25 110.395 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -76.1 -35.73 59.21 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 75.530000000000001 109.306 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.563 ' CE1' ' HD2' ' A' ' 313' ' ' PRO . 3.1 m-30 -101.83 24.88 9.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 72.439999999999998 111.019 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 14.5 t -57.24 -59.06 5.67 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 72.239999999999995 110.014 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.785 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -74.19 -17.53 60.89 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.441 1.088 . . . . 74.329999999999998 109.315 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.712 HD13 ' OH ' ' A' ' 172' ' ' TYR . 14.8 mt -67.89 134.43 50.83 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.506 1.129 . . . . 75.5 109.317 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.7 p -160.36 135.35 7.79 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 75.310000000000002 110.039 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 109.97 -160.57 13.34 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.477 1.111 . . . . 73.030000000000001 111.02 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 14.9 p -95.08 13.5 24.98 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.295 -1.002 . . . . 64.5 108.295 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 5.6 p -145.91 152.98 49.32 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.521 1.138 . . . . 41.549999999999997 110.043 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.638 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -74.99 145.59 84.34 Favored 'Cis proline' 0 C--N 1.361 1.192 0 C-N-CA 121.016 -2.493 . . . . 73.239999999999995 110.975 0.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.497 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 99.4 p -130.99 134.87 26.48 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.543 1.152 . . . . 71.409999999999997 109.995 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.0 Cg_endo -75.08 -173.19 11.91 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 120.974 -2.511 . . . . 40.130000000000003 110.955 0.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.441 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.76 153.26 22.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 65.219999999999999 109.321 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.563 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.02 -162.38 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.449 1.763 . . . . 70.239999999999995 110.99 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -84.52 137.0 33.58 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 74.409999999999997 109.296 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.57 HG21 HG22 ' A' ' 297' ' ' VAL . 21.3 m -144.6 24.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.105 . . . . 74.129999999999995 109.326 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.404 ' C ' ' N ' ' A' ' 318' ' ' CYS . 28.5 t -69.2 -31.87 70.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.505 1.128 . . . . 74.510000000000005 109.933 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 26.3 m -44.47 -26.49 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 73.209999999999994 109.971 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.404 ' N ' ' C ' ' A' ' 316' ' ' SER . 2.4 m -71.88 -176.02 1.58 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 62.530000000000001 108.293 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 164.89 119.9 0.5 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.504 1.128 . . . . 60.420000000000002 110.972 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 320' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.455 0 O-C-N 124.474 0.749 . . . . 54.229999999999997 110.982 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.841 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.3 tp . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.32 -0.622 . . . . 75.209999999999994 109.32 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.598 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -105.51 108.78 20.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.539 1.149 . . . . 73.400000000000006 109.326 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.0 m -85.7 10.62 12.92 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 73.109999999999999 109.969 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -150.38 144.19 17.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.145 . . . . 35.299999999999997 109.286 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.071 HD11 HD12 ' A' ' 149' ' ' LEU . 1.3 mt -96.31 141.77 23.6 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.477 1.111 . . . . 71.019999999999996 109.286 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.08 -30.26 7.24 Favored 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.467 1.772 . . . . 63.229999999999997 111.015 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.501 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.59 152.28 17.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.12 . . . . 74.129999999999995 109.26 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.509 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.8 t -50.37 -36.0 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 63.009999999999998 109.277 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.05 -47.69 3.15 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.48 1.112 . . . . 74.439999999999998 109.306 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.611 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -71.1 -36.05 72.04 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.489 1.118 . . . . 75.109999999999999 110.411 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.637 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -58.06 -57.08 14.39 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.517 1.136 . . . . 75.099999999999994 109.288 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.509 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.4 m-80 -52.28 -31.36 32.35 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 62.520000000000003 109.281 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.92 -55.03 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 72.319999999999993 109.978 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.071 HD12 HD11 ' A' ' 140' ' ' ILE . 96.2 mt -45.44 -41.88 9.82 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.522 1.139 . . . . 74.209999999999994 109.304 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.672 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -73.54 -43.8 59.09 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.455 1.097 . . . . 72.200000000000003 111.034 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -47.99 -36.4 12.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.127 . . . . 71.010000000000005 109.309 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.489 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 61.6 mt-30 -76.4 -56.07 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.487 1.117 . . . . 71.109999999999999 110.321 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 187' ' ' ILE . 21.6 mt -49.01 -29.41 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 O-C-N 124.461 1.1 . . . . 75.25 109.307 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.97 -37.28 67.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.524 1.14 . . . . 63.409999999999997 109.278 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.9 t-20 -58.26 -17.52 20.02 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.514 1.134 . . . . 74.409999999999997 109.321 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.471 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 21.5 mm-40 -82.18 -25.3 34.4 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.467 1.104 . . . . 74.120000000000005 110.268 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.528 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 15.5 m -42.14 120.86 1.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 71.230000000000004 109.979 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 4.4 m -45.85 131.56 9.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.538 1.149 . . . . 65.150000000000006 108.288 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.41 -15.47 9.24 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.542 1.152 . . . . 72.439999999999998 111.017 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.875 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 14.5 p -89.3 161.15 16.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.426 0.721 . . . . 75.150000000000006 110.381 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.0 m -93.46 -2.03 54.99 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 62.130000000000003 110.031 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 162' ' ' THR . 1.8 m -118.58 8.6 12.02 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.502 1.126 . . . . 73.209999999999994 110.381 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.875 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -81.68 135.78 35.51 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.512 1.133 . . . . 54.32 109.303 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.85 -169.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.47 1.106 . . . . 60.229999999999997 110.024 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.442 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 54.1 p -153.62 127.05 4.25 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 64.420000000000002 109.978 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -75.05 137.88 52.86 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 121.038 -2.484 . . . . 74.109999999999999 110.969 0.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.0 p -72.94 -178.63 2.85 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 43.119999999999997 108.315 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.728 HD11 ' HB2' ' A' ' 183' ' ' LYS . 3.6 mp -86.93 130.76 36.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.310000000000002 109.306 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 12.1 p -95.85 76.11 3.16 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 74.319999999999993 110.432 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 53.8 p90 -76.88 -16.18 59.48 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.515 1.135 . . . . 74.540000000000006 110.994 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -73.46 -3.38 27.16 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 1.133 . . . . 75.439999999999998 110.309 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.613 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -130.96 66.14 78.36 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 111.01 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 115.61 4.34 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.489 1.783 . . . . 73.010000000000005 111.024 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.558 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.8 t -152.04 -60.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.53 1.144 . . . . 62.439999999999998 109.299 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -132.1 -46.79 0.93 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.491 1.12 . . . . 73.150000000000006 109.277 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -49.15 98.21 0.02 OUTLIER Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.545 1.153 . . . . 75.120000000000005 111.011 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.611 ' SG ' HG12 ' A' ' 219' ' ' VAL . 2.5 p -130.09 -46.89 1.11 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.287 -1.005 . . . . 53.399999999999999 108.287 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 31.4 p90 -73.8 -44.2 56.59 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 75.219999999999999 110.992 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -40.91 -68.48 0.18 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.507 1.13 . . . . 44.420000000000002 109.293 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.574 ' HB3' HG23 ' A' ' 168' ' ' ILE . 8.8 ptm180 -48.89 -48.71 42.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.436 1.085 . . . . 74.329999999999998 110.251 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -42.68 -45.93 4.87 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.462 1.101 . . . . 74.200000000000003 109.307 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.694 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -56.98 -41.93 79.28 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 75.310000000000002 109.617 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.728 ' HB2' HD11 ' A' ' 168' ' ' ILE . 15.8 mmmt -71.05 -30.22 66.33 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.122 . . . . 71.0 109.295 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.489 ' HE3' ' HA ' ' A' ' 181' ' ' ALA . 21.7 mtm -66.18 -60.4 2.84 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 73.230000000000004 111.012 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -51.24 -26.88 7.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.504 1.128 . . . . 72.239999999999995 110.279 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.427 ' N ' ' HG3' ' A' ' 185' ' ' ARG . 1.1 tt0 -64.54 -44.28 91.31 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.55 1.156 . . . . 74.549999999999997 110.275 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 190' ' ' ASN . 23.8 mm -66.1 -52.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 72.400000000000006 109.324 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.845 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.3 OUTLIER -40.88 -39.83 1.23 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.543 1.152 . . . . 72.209999999999994 109.31 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.574 ' HG2' HD21 ' A' ' 136' ' ' LEU . 20.3 mtp -66.62 -45.63 78.49 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 73.540000000000006 110.976 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 187' ' ' ILE . 0.3 OUTLIER -46.35 -47.07 18.63 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 70.310000000000002 109.262 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.489 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 35.0 t-20 -66.11 -38.63 88.68 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.458 1.099 . . . . 73.430000000000007 109.282 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.402 ' C ' ' CD2' ' A' ' 193' ' ' TYR . . . 119.85 54.1 0.26 Allowed Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.516 1.135 . . . . 70.239999999999995 110.976 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.611 ' CZ ' HG21 ' A' ' 145' ' ' THR . 91.1 m-85 -158.67 144.73 16.87 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 0.748 . . . . 73.439999999999998 111.026 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.841 ' HB2' HD23 ' A' ' 136' ' ' LEU . 46.8 t0 -110.72 125.91 53.99 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.563 1.165 . . . . 54.109999999999999 109.275 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.845 ' HB3' HD22 ' A' ' 188' ' ' LEU . 29.6 p -103.17 -179.31 3.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.523 1.139 . . . . 63.32 108.29 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 23.1 mp0 -127.33 176.72 7.21 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.446 1.092 . . . . 75.439999999999998 110.336 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.797 ' HE2' HG22 ' A' ' 221' ' ' ILE . 21.3 mmtt -108.57 162.68 13.92 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.102 . . . . 73.430000000000007 109.286 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 23.8 tt0 -155.11 117.62 4.26 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.55 1.156 . . . . 65.439999999999998 110.34 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -109.68 124.61 51.5 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.463 1.102 . . . . 53.200000000000003 110.971 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.666 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.6 p -115.57 150.8 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 62.340000000000003 109.28 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.501 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.7 m-85 -122.13 162.96 20.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.539 1.149 . . . . 73.239999999999995 110.982 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 115.59 -179.43 18.05 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.556 1.16 . . . . 74.129999999999995 110.98 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.72 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.1 t-20 -68.73 109.35 3.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.485 0.756 . . . . 73.140000000000001 109.302 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -113.92 93.42 4.36 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.474 1.109 . . . . 73.310000000000002 109.305 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.568 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 4.5 mttt -93.25 160.3 14.89 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.535 1.147 . . . . 72.239999999999995 109.26 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.803 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -165.78 162.89 18.82 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.441 1.088 . . . . 42.219999999999999 109.269 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.97 136.92 48.97 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.133 . . . . 72.439999999999998 110.02 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.7 p -102.15 -37.06 8.31 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.508 1.13 . . . . 74.219999999999999 110.407 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 138.6 -26.27 2.79 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.519 1.137 . . . . 75.420000000000002 110.994 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.498 HG23 ' SG ' ' A' ' 211' ' ' CYS . 11.9 t -117.93 -9.01 10.69 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.538 0.787 . . . . 72.230000000000004 110.337 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' A' ' 210' ' ' THR . 1.8 p -176.66 153.42 1.1 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.536 1.147 . . . . 54.100000000000001 108.312 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -102.17 148.37 25.5 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.532 1.145 . . . . 62.340000000000003 108.33 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.803 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.3 OUTLIER -109.07 161.58 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.525 1.141 . . . . 65.530000000000001 109.304 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.568 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -146.43 120.48 9.43 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.516 1.135 . . . . 63.140000000000001 109.291 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.45 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.5 m0 -130.41 132.84 45.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.001 -1.111 . . . . 75.319999999999993 108.001 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 54.8 p -79.54 0.61 29.07 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.111 . . . . 54.149999999999999 110.014 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.495 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.1 p90 -170.85 127.82 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.543 1.152 . . . . 62.039999999999999 111.014 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 48.3 t60 -116.47 167.88 10.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 54.030000000000001 109.622 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.611 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.4 p -143.86 145.16 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.127 . . . . 65.310000000000002 109.309 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.598 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -146.38 -169.09 3.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.525 1.14 . . . . 60.329999999999998 109.285 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.797 HG22 ' HE2' ' A' ' 197' ' ' LYS . 13.0 pt -114.38 120.8 65.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.504 1.128 . . . . 71.540000000000006 109.311 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.8 tp -85.33 108.92 18.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.113 . . . . 74.319999999999993 109.314 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.678 HG11 HG13 ' A' ' 237' ' ' ILE . 0.8 OUTLIER -104.9 149.35 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 71.010000000000005 109.292 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 40.2 m -118.26 122.69 43.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.477 1.111 . . . . 61.149999999999999 110.001 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 33.0 p90 -137.37 145.01 42.79 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 71.329999999999998 111.001 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.428 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.1 mmtp -70.72 132.89 46.05 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.51 1.131 . . . . 71.299999999999997 109.285 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.35 -159.86 0.09 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.133 . . . . 61.32 109.294 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.83 -0.4 50.95 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.549 1.156 . . . . 34.539999999999999 109.305 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.78 -7.85 12.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.471 1.107 . . . . 75.310000000000002 110.025 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.96 37.86 8.24 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.509 1.131 . . . . 72.230000000000004 111.0 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.76 137.46 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.452 0.736 . . . . 61.039999999999999 109.261 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.428 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.6 m -71.59 102.47 2.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.472 1.107 . . . . 64.530000000000001 110.355 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.7 mm-40 -102.04 -172.49 2.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.446 1.091 . . . . 73.510000000000005 110.276 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.523 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.8 mmtm -125.66 145.03 50.34 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.48 1.112 . . . . 72.409999999999997 109.314 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.64 ' HB3' HG22 ' A' ' 223' ' ' VAL . 5.8 tpt180 -143.02 159.48 42.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.47 1.106 . . . . 73.340000000000003 110.354 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.0 mm -113.42 117.02 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.118 . . . . 64.200000000000003 109.329 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.2 mm -106.48 46.22 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.505 1.128 . . . . 54.200000000000003 109.307 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -104.6 106.12 53.2 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.488 1.118 . . . . 64.230000000000004 109.291 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 -1.13 10.83 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.533 1.807 . . . . 71.150000000000006 110.995 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 3.1 t -73.21 -4.14 31.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.487 1.117 . . . . 75.239999999999995 110.011 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.485 HD11 ' NE2' ' A' ' 218' ' ' HIS . 5.6 mt -138.15 -49.12 0.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.525 1.141 . . . . 74.140000000000001 109.334 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.89 ' CZ ' ' HB2' ' A' ' 255' ' ' ALA . 83.0 m-85 -113.26 99.35 7.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.548 1.155 . . . . 75.319999999999993 111.014 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 61.5 m -90.63 -5.32 56.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.488 1.118 . . . . 70.450000000000003 109.965 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 12.2 t -83.91 -44.78 13.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.535 1.147 . . . . 53.520000000000003 110.021 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.09 -177.43 46.82 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.518 1.136 . . . . 62.450000000000003 110.985 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.98 165.08 32.08 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.478 1.778 . . . . 64.530000000000001 111.018 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.678 HG11 ' CD2' ' A' ' 242' ' ' PHE . 4.0 m -148.43 167.8 3.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.456 1.098 . . . . 71.239999999999995 109.32 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.442 ' C ' ' N ' ' A' ' 250' ' ' THR . 66.8 p -70.23 137.78 51.14 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 73.420000000000002 110.4 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -41.23 -29.11 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.479 1.112 . . . . 71.239999999999995 109.271 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.442 ' N ' ' C ' ' A' ' 248' ' ' THR . 8.6 m -74.7 -63.8 1.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 1.129 . . . . 73.349999999999994 110.362 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.36 -25.78 6.64 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.52 1.137 . . . . 62.43 109.359 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.598 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.2 t90 -65.79 -65.34 0.69 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.54 1.15 . . . . 74.420000000000002 108.034 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.764 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -42.04 -30.99 0.31 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.518 1.136 . . . . 75.519999999999996 110.303 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.857 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.5 m-80 -67.4 -49.15 65.09 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.51 1.131 . . . . 73.040000000000006 109.268 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.89 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -56.48 -19.36 14.98 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.532 1.145 . . . . 70.129999999999995 109.278 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 205' ' ' LYS . 6.9 m -90.26 -35.75 15.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.509 1.131 . . . . 75.239999999999995 108.331 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.857 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.4 m -93.53 21.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.531 1.144 . . . . 72.329999999999998 109.284 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -50.48 106.44 0.12 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.128 . . . . 72.209999999999994 109.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 262' ' ' GLY . 14.7 p -73.31 -3.34 26.41 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.48 1.113 . . . . 75.340000000000003 110.428 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.72 -30.51 0.96 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.531 1.145 . . . . 73.5 109.963 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.5 t -88.71 -36.96 15.89 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.506 1.129 . . . . 61.299999999999997 108.309 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.87 -128.82 1.78 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.512 1.133 . . . . 71.209999999999994 110.972 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.89 145.69 42.5 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.518 0.775 . . . . 71.150000000000006 109.986 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -167.96 147.61 4.84 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.135 . . . . 72.299999999999997 109.308 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.3 t -172.92 153.61 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.493 1.12 . . . . 73.230000000000004 110.056 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.666 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.9 p -99.42 118.7 46.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.508 1.13 . . . . 74.510000000000005 109.324 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 6.0 t -73.78 -43.82 57.83 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.556 1.16 . . . . 74.319999999999993 110.02 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 200' ' ' VAL . 11.5 p -164.94 -175.15 3.61 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.497 1.123 . . . . 74.230000000000004 109.994 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -164.77 157.14 16.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 71.319999999999993 110.998 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -156.1 160.49 39.99 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.545 1.153 . . . . 72.040000000000006 109.27 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 272' ' ' THR . 1.1 p-10 -118.41 160.65 21.32 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.093 . . . . 50.229999999999997 109.272 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.638 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.1 p -153.47 -178.5 7.04 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.514 1.133 . . . . 72.230000000000004 110.399 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.893 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.75 163.83 13.31 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.437 1.086 . . . . 64.109999999999999 109.326 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.14 -17.07 78.84 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.484 1.115 . . . . 62.119999999999997 110.991 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.457 ' H ' ' ND2' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -85.99 -35.71 20.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 0.778 . . . . 62.200000000000003 109.286 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' A' ' 273' ' ' ALA . 92.8 t -43.81 102.68 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 61.109999999999999 109.291 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 6.0 t80 -59.21 -49.83 76.34 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.506 1.129 . . . . 62.509999999999998 110.968 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.51 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 56.2 t80 -147.9 158.15 43.89 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.529 1.143 . . . . 61.420000000000002 110.955 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.638 ' HD2' HG21 ' A' ' 272' ' ' THR . 73.0 ttt-85 -123.95 147.47 47.71 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.13 . . . . 73.239999999999995 110.277 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.55 154.02 47.8 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.115 . . . . 73.530000000000001 109.958 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 0.21 9.19 Favored 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.468 1.772 . . . . 64.109999999999999 110.997 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 20.6 t -105.64 10.22 32.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.488 1.118 . . . . 74.25 109.991 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.402 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.7 t-20 75.38 39.55 0.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.537 1.148 . . . . 60.310000000000002 109.278 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 18.4 t -119.83 120.28 36.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.496 1.122 . . . . 52.409999999999997 110.002 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -101.86 166.65 10.54 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 65.329999999999998 111.03 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -123.34 177.36 5.64 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.448 1.092 . . . . 64.420000000000002 109.323 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 52.5 m-85 -158.61 115.78 2.82 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.501 1.125 . . . . 73.120000000000005 110.984 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.863 ' HB3' HD13 ' A' ' 291' ' ' LEU . 3.8 m-20 -115.26 99.27 7.28 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.518 1.136 . . . . 74.230000000000004 109.329 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.525 ' H ' ' ND2' ' A' ' 289' ' ' ASN . 0.9 OUTLIER -84.94 -48.54 9.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.51 1.131 . . . . 74.310000000000002 109.34 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.466 ' HB3' HD11 ' A' ' 292' ' ' ILE . 27.0 m-20 -90.33 9.53 28.46 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.503 1.127 . . . . 73.420000000000002 109.354 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.863 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.6 mm? 40.32 45.25 1.78 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 109.299 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.466 HD11 ' HB3' ' A' ' 290' ' ' ASN . 47.6 mm -74.47 -23.79 18.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 71.549999999999997 109.317 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.812 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.7 t-20 -94.5 -29.08 15.11 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.479 1.112 . . . . 63.409999999999997 109.299 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 7.8 m -83.16 -68.11 0.73 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 62.310000000000002 110.419 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 39.8 m-20 -48.43 -24.77 1.36 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 73.25 109.288 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 45.7 t -80.8 -47.9 13.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.533 1.146 . . . . 64.340000000000003 108.297 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.4 t -52.86 -45.47 50.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.521 1.138 . . . . 74.349999999999994 109.3 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.4 mt -65.27 -62.9 1.27 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.454 1.096 . . . . 72.219999999999999 109.331 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -24.67 0.85 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.481 1.113 . . . . 74.400000000000006 110.388 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.816 ' HE2' HG12 ' A' ' 315' ' ' VAL . 16.1 mmmt -73.3 -41.75 63.2 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.517 1.136 . . . . 52.25 109.298 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.753 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.7 m-30 -100.87 36.77 1.87 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 74.209999999999994 111.033 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.72 -44.75 73.2 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.484 1.115 . . . . 75.239999999999995 110.009 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -92.8 -12.09 32.05 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.476 1.11 . . . . 53.399999999999999 109.296 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.785 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.7 mt -68.67 136.69 53.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 71.420000000000002 109.33 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 95.2 p -149.39 156.05 41.43 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.489 1.118 . . . . 62.109999999999999 110.014 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.32 -164.68 54.35 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.475 1.109 . . . . 71.439999999999998 111.01 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 10.56 22.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.272 -1.01 . . . . 42.450000000000003 108.272 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.504 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 13.9 p -131.8 149.45 73.44 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.565 1.166 . . . . 73.25 110.022 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.785 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.92 147.1 88.48 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 75.129999999999995 111.047 -0.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.484 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.9 p -133.51 135.75 25.71 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.551 1.157 . . . . 64.019999999999996 110.005 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.6 Cg_endo -74.94 -173.73 12.81 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 120.98 -2.508 . . . . 71.200000000000003 111.032 -0.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.58 154.32 35.39 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.532 1.145 . . . . 73.450000000000003 109.291 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.455 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.99 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 O-C-N 124.512 1.796 . . . . 73.400000000000006 111.011 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -87.92 135.98 33.17 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.495 1.122 . . . . 71.510000000000005 109.263 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.816 HG12 ' HE2' ' A' ' 300' ' ' LYS . 27.1 m -129.62 23.74 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.488 1.118 . . . . 73.530000000000001 109.303 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 17.0 t -54.61 -32.74 59.31 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.418 1.074 . . . . 62.25 110.039 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 5.2 m -48.76 -25.37 1.8 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.349999999999994 110.002 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.44 170.4 15.99 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.524 1.14 . . . . 54.539999999999999 108.299 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 174.47 110.47 0.25 Allowed Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.478 1.111 . . . . 74.140000000000001 111.03 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.558 ' C ' ' CD1' ' A' ' 320' ' ' PHE . 1.3 p90 . . . . . 0 C--N 1.324 -0.515 0 O-C-N 124.516 0.774 . . . . 62.109999999999999 110.971 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.83 HD23 ' HB3' ' A' ' 194' ' ' ASP . 8.6 tp . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.286 -0.635 . . . . 61.210000000000001 109.286 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -116.03 104.37 11.51 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 75.219999999999999 109.314 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.496 ' CB ' ' OD2' ' A' ' 194' ' ' ASP . 0.6 OUTLIER -80.39 3.91 19.74 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.523 1.14 . . . . 71.420000000000002 109.972 -179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -142.93 147.57 20.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 74.129999999999995 109.308 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.053 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -98.99 142.55 24.81 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.481 1.113 . . . . 72.439999999999998 109.299 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.0 -32.74 5.12 Favored 'Trans proline' 0 C--N 1.36 1.139 0 O-C-N 124.528 1.804 . . . . 43.439999999999998 111.025 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.416 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.21 151.47 19.41 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 74.120000000000005 109.295 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.52 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -48.51 -35.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.464 1.103 . . . . 72.0 109.28 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.56 -46.75 3.66 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.495 1.122 . . . . 73.120000000000005 109.303 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.683 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.9 m -72.25 -34.77 68.51 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.13 . . . . 41.240000000000002 110.425 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.675 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -59.47 -56.76 17.86 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.428 1.08 . . . . 74.540000000000006 109.254 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.52 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.2 m-80 -52.54 -31.85 37.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.544 1.153 . . . . 62.5 109.32 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.18 -56.71 6.82 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.473 1.108 . . . . 62.219999999999999 109.994 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.053 HD12 HD11 ' A' ' 140' ' ' ILE . 60.7 mt -42.97 -42.62 3.83 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.472 1.107 . . . . 73.099999999999994 109.307 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.648 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -71.55 -45.1 63.26 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 1.12 . . . . 73.109999999999999 111.037 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.87 -38.15 7.05 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 75.239999999999995 109.324 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 155' ' ' ASN . 64.6 mt-30 -75.21 -55.31 5.84 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 73.209999999999994 110.353 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.109 HD11 HD12 ' A' ' 188' ' ' LEU . 12.4 mt -49.72 -27.35 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.115 . . . . 63.32 109.306 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -36.07 61.61 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.452 1.095 . . . . 73.329999999999998 109.289 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.3 t-20 -60.75 -15.38 28.85 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 74.430000000000007 109.335 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.665 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 8.9 mm100 -83.09 -21.74 33.62 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.519 1.137 . . . . 74.0 110.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.573 ' OG ' HG23 ' A' ' 160' ' ' THR . 29.8 p -39.09 140.69 0.37 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.534 1.146 . . . . 72.109999999999999 109.99 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.7 m -68.73 -9.76 52.5 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 74.040000000000006 108.274 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -87.87 18.88 36.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.511 1.132 . . . . 60.130000000000003 110.999 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.573 HG23 ' OG ' ' A' ' 157' ' ' SER . 59.2 p -136.27 160.74 37.77 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.495 0.762 . . . . 71.439999999999998 110.398 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 p -93.76 -21.55 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.48 1.112 . . . . 52.200000000000003 109.991 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.6 m -82.57 -3.65 56.39 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.488 1.118 . . . . 64.219999999999999 110.416 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 156' ' ' GLN . . . -69.38 138.37 53.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 72.120000000000005 109.303 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.3 t -59.72 -160.14 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.454 1.097 . . . . 52.109999999999999 109.993 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.448 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -156.45 128.0 3.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.561 1.163 . . . . 72.209999999999994 109.993 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.93 140.7 68.78 Favored 'Cis proline' 0 C--N 1.36 1.132 0 C-N-CA 121.011 -2.495 . . . . 74.430000000000007 111.015 -0.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 23.2 p -72.75 177.44 4.8 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.471 1.107 . . . . 63.450000000000003 108.285 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.612 HD11 ' CB ' ' A' ' 183' ' ' LYS . 2.1 mp -94.51 126.84 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.493 1.121 . . . . 64.5 109.309 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 301' ' ' PHE . 15.4 p -77.56 90.06 3.9 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.493 1.121 . . . . 63.549999999999997 110.389 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -88.59 -30.2 19.43 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.571 1.169 . . . . 71.340000000000003 110.988 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.402 ' C ' ' HD3' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -84.03 9.29 12.82 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.51 1.131 . . . . 72.25 110.297 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.559 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 38.8 t80 -128.56 66.9 75.5 Favored Pre-proline 0 C--N 1.324 -0.506 0 O-C-N 124.494 1.121 . . . . 73.030000000000001 111.004 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.448 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -74.97 109.15 2.87 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.463 1.77 . . . . 71.230000000000004 110.98 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 172' ' ' TYR . 2.7 t -151.66 -71.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.483 1.114 . . . . 74.329999999999998 109.271 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -160.52 129.2 4.75 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.526 1.141 . . . . 74.25 109.273 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 129.07 52.29 0.11 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.505 1.128 . . . . 55.049999999999997 111.011 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 64.4 m -89.14 -18.06 27.93 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.273 -1.01 . . . . 44.520000000000003 108.273 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.622 ' HB3' HG11 ' A' ' 219' ' ' VAL . 34.2 p90 -76.59 -22.62 53.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.527 1.142 . . . . 75.349999999999994 110.955 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.532 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -71.17 -68.35 0.45 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.488 1.117 . . . . 64.340000000000003 109.268 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.579 ' HB3' HG23 ' A' ' 168' ' ' ILE . 7.9 ptm180 -46.15 -48.33 17.44 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.498 1.124 . . . . 75.510000000000005 110.296 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.625 ' C ' ' HZ1' ' A' ' 197' ' ' LYS . . . -40.4 -59.0 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.13 . . . . 61.119999999999997 109.327 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.672 ' N ' ' HZ1' ' A' ' 197' ' ' LYS . 1.1 t60 -48.96 -39.69 27.46 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.528 1.142 . . . . 54.25 109.604 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.674 ' NZ ' HE22 ' A' ' 186' ' ' GLN . 30.6 mmmt -64.61 -61.47 2.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.528 1.142 . . . . 72.340000000000003 109.299 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.43 ' HE3' ' HA ' ' A' ' 181' ' ' ALA . 15.0 mtm -38.9 -38.42 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.533 1.146 . . . . 74.230000000000004 110.987 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -59.36 -49.35 78.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.51 1.131 . . . . 74.150000000000006 110.339 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.674 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -54.75 -34.05 62.01 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.122 . . . . 50.210000000000001 110.271 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 153' ' ' ILE . 31.1 mm -70.3 -43.77 78.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.547 1.155 . . . . 75.019999999999996 109.341 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 1.109 HD12 HD11 ' A' ' 153' ' ' ILE . 0.4 OUTLIER -60.68 -40.77 93.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 73.120000000000005 109.28 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.75 ' HG2' HD21 ' A' ' 136' ' ' LEU . 52.1 mtp -61.57 -36.04 79.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 73.329999999999998 110.994 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.67 -53.63 56.02 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.449 1.093 . . . . 64.430000000000007 109.293 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.51 HD22 HD21 ' A' ' 149' ' ' LEU . 23.6 t30 -62.72 -27.56 69.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.487 1.117 . . . . 63.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 109.04 53.58 0.61 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.508 1.13 . . . . 73.340000000000003 110.988 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.683 ' CZ ' HG21 ' A' ' 145' ' ' THR . 92.9 m-85 -156.89 140.74 16.15 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.45 0.735 . . . . 74.510000000000005 111.015 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.83 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -106.12 124.86 50.24 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 62.020000000000003 109.319 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 1.008 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.1 p -95.92 168.46 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 64.129999999999995 108.3 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -117.06 170.91 8.29 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 54.25 110.295 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.672 ' HZ1' ' N ' ' A' ' 182' ' ' HIS . 17.5 mmtt -100.58 169.34 9.12 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 74.010000000000005 109.287 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 22.8 tt0 -167.28 121.85 1.03 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.442 1.089 . . . . 63.420000000000002 110.27 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -115.9 140.58 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.517 1.135 . . . . 64.510000000000005 111.013 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.697 ' CG2' HG23 ' A' ' 266' ' ' VAL . 14.0 p -131.71 149.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.126 . . . . 74.0 109.346 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 13.8 m-85 -122.72 156.37 34.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.452 1.095 . . . . 72.329999999999998 110.977 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 122.39 -175.83 16.44 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.508 1.13 . . . . 63.210000000000001 111.025 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.751 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.5 t-20 -72.63 110.14 6.78 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.53 0.782 . . . . 65.209999999999994 109.346 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.751 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.2 mt -113.19 95.48 5.41 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 74.450000000000003 109.263 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 256' ' ' CYS . 6.8 mtpt -92.31 165.33 13.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.482 1.114 . . . . 74.450000000000003 109.326 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.867 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -169.23 119.1 0.69 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.512 1.132 . . . . 63.140000000000001 109.26 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 117.56 30.38 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.157 . . . . 71.400000000000006 110.019 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.7 p -88.63 -3.66 58.74 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 62.009999999999998 110.404 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.76 -24.75 16.08 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.541 1.151 . . . . 75.430000000000007 111.024 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.435 ' O ' ' CG2' ' A' ' 210' ' ' THR . 1.1 m -123.38 2.52 9.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.499 0.764 . . . . 75.400000000000006 110.427 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.6 156.26 1.88 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.542 1.151 . . . . 74.409999999999997 108.291 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.71 128.35 55.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 61.009999999999998 108.318 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.867 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.5 m -108.87 155.26 9.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.467 1.104 . . . . 74.219999999999999 109.293 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -147.1 130.05 16.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.524 1.14 . . . . 53.329999999999998 109.315 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.3 135.07 42.55 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.505 1.128 . . . . 74.319999999999993 108.015 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.4 m -80.3 3.52 20.72 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.536 1.147 . . . . 73.299999999999997 109.991 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.458 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.0 p90 -177.79 130.41 0.15 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.459 1.099 . . . . 73.340000000000003 111.023 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.506 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 70.6 t60 -120.17 168.03 11.64 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 73.140000000000001 109.609 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.622 HG11 ' HB3' ' A' ' 178' ' ' TYR . 1.5 p -145.66 146.23 19.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.13 . . . . 63.200000000000003 109.284 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.683 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.0 -165.8 2.2 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 74.219999999999999 109.291 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.475 ' O ' HD13 ' A' ' 236' ' ' ILE . 15.9 pt -117.24 123.79 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.112 . . . . 64.239999999999995 109.273 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.4 tp -86.29 108.85 18.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 75.439999999999998 109.285 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.675 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -102.2 145.5 11.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.54 1.15 . . . . 63.450000000000003 109.323 179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 56.3 m -117.75 117.78 30.26 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.467 1.105 . . . . 53.200000000000003 110.031 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 29.9 p90 -133.9 144.46 48.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.508 1.13 . . . . 74.25 110.969 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.436 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 21.1 mmtp -68.87 135.19 50.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.521 1.138 . . . . 73.540000000000006 109.333 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -76.08 -160.18 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 73.239999999999995 109.315 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.76 -0.38 50.7 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.531 1.144 . . . . 65.120000000000005 109.322 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.19 -7.49 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.491 1.119 . . . . 75.510000000000005 109.959 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 86.86 38.01 8.23 Favored Glycine 0 CA--C 1.529 0.958 0 O-C-N 124.5 1.125 . . . . 44.420000000000002 111.031 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.422 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.34 138.23 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.442 0.731 . . . . 74.540000000000006 109.347 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.436 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 20.4 m -71.93 102.55 2.95 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.498 1.124 . . . . 73.140000000000001 110.394 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 224' ' ' SER . 5.4 mm-40 -101.27 -174.21 2.55 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.567 1.167 . . . . 62.149999999999999 110.302 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.535 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.0 mmtm -127.19 144.82 50.95 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.494 1.121 . . . . 75.319999999999993 109.313 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.592 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -146.7 163.88 34.52 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 71.540000000000006 110.307 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.487 HG21 ' CD1' ' A' ' 252' ' ' TRP . 15.3 mm -117.96 119.11 60.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.51 1.131 . . . . 72.420000000000002 109.328 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.3 mm -103.42 45.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.488 1.118 . . . . 72.439999999999998 109.317 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.41 109.44 61.85 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 54.039999999999999 109.309 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -20.42 16.91 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.448 1.762 . . . . 61.329999999999998 111.011 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.439 ' OG ' ' NH1' ' A' ' 180' ' ' ARG . 3.9 t -51.32 -21.72 2.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.526 1.141 . . . . 73.329999999999998 110.009 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.405 ' CD1' ' SG ' ' A' ' 256' ' ' CYS . 7.7 mt -117.97 -57.85 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.503 1.127 . . . . 64.140000000000001 109.272 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.78 ' CE2' HG21 ' A' ' 247' ' ' VAL . 80.7 m-85 -107.65 99.78 9.24 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.533 1.146 . . . . 74.349999999999994 110.972 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 39.1 m -86.47 -6.5 58.89 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.462 1.101 . . . . 73.230000000000004 109.974 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -82.93 -44.45 15.32 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.474 1.109 . . . . 52.0 110.005 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.28 -173.96 43.26 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.509 1.131 . . . . 64.340000000000003 111.009 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.427 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.5 Cg_endo -74.9 165.42 31.43 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.453 1.765 . . . . 61.409999999999997 111.011 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.78 HG21 ' CE2' ' A' ' 242' ' ' PHE . 4.8 m -147.23 159.26 9.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.463 1.102 . . . . 72.129999999999995 109.309 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.432 ' C ' ' N ' ' A' ' 250' ' ' THR . 33.5 p -61.17 139.38 58.13 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 73.109999999999999 110.413 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -41.63 -29.81 0.19 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.52 1.137 . . . . 71.400000000000006 109.294 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.432 ' N ' ' C ' ' A' ' 248' ' ' THR . 12.6 m -77.26 -61.41 1.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.49 1.118 . . . . 72.329999999999998 110.415 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.74 -24.36 3.36 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.495 1.122 . . . . 43.240000000000002 109.25 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.683 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 9.7 t90 -66.33 -64.5 0.84 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.473 1.108 . . . . 74.400000000000006 108.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.862 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.2 OUTLIER -43.77 -34.8 1.65 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.495 1.122 . . . . 63.049999999999997 110.278 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.884 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.1 m-80 -64.56 -49.4 71.37 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 34.130000000000003 109.347 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.648 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.22 -19.08 12.29 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.45 1.094 . . . . 50.210000000000001 109.299 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 205' ' ' LYS . 10.0 m -92.06 -31.91 15.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.512 1.132 . . . . 55.210000000000001 108.28 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.884 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.5 m -96.9 21.84 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.555 1.16 . . . . 64.519999999999996 109.315 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -49.2 104.67 0.07 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.479 1.112 . . . . 75.219999999999999 109.307 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 262' ' ' GLY . 12.7 p -72.54 -3.89 27.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.138 . . . . 72.129999999999995 110.397 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 41.3 t -48.1 -25.15 1.33 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.502 1.126 . . . . 73.329999999999998 110.026 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 205' ' ' LYS . 5.9 m -90.94 -34.45 15.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.572 1.17 . . . . 73.439999999999998 108.279 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 163.01 -118.41 0.82 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.481 1.113 . . . . 45.299999999999997 110.979 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.45 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -83.31 142.73 30.87 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.522 0.778 . . . . 63.409999999999997 110.02 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -170.97 143.82 2.06 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.554 1.159 . . . . 71.319999999999993 109.296 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.2 t -172.77 159.24 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.55 1.156 . . . . 63.539999999999999 109.983 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.697 HG23 ' CG2' ' A' ' 200' ' ' VAL . 4.0 p -101.91 118.16 48.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 63.009999999999998 109.326 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.1 t -77.28 -44.0 31.26 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.521 1.138 . . . . 54.439999999999998 109.999 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 200' ' ' VAL . 4.1 m -149.25 -175.33 4.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.541 1.151 . . . . 34.5 109.984 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -174.28 152.89 1.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 74.400000000000006 110.958 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -159.73 163.59 34.57 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.455 1.097 . . . . 62.350000000000001 109.312 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.84 160.5 20.74 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.466 1.104 . . . . 74.150000000000006 109.314 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.06 -178.7 6.52 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.508 1.13 . . . . 70.540000000000006 110.412 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.49 ' O ' ' CG ' ' A' ' 197' ' ' LYS . . . -86.01 158.2 19.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 73.239999999999995 109.302 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.83 93.94 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.55 1.156 . . . . 71.319999999999993 110.987 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -46.28 77.78 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.515 0.773 . . . . 73.129999999999995 109.312 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . . . . . . . . . 46.8 t -43.48 127.32 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.516 1.135 . . . . 74.200000000000003 109.293 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.555 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 3.5 t80 -93.33 -40.7 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.473 1.108 . . . . 70.420000000000002 110.988 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.3 OUTLIER -160.33 115.46 2.28 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.529 1.143 . . . . 74.540000000000006 111.025 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.419 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 55.1 ttt-85 -94.96 137.87 33.45 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.525 1.141 . . . . 74.420000000000002 110.281 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.02 157.62 34.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.554 1.159 . . . . 60.43 109.956 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.99 0.02 9.41 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.459 1.768 . . . . 61.32 111.033 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 10.2 t -98.42 7.62 45.94 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.448 1.093 . . . . 63.32 110.016 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 282' ' ' SER . 1.9 t-20 76.02 34.69 0.52 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.528 1.142 . . . . 64.319999999999993 109.25 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.7 t -117.41 120.73 39.05 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.565 1.165 . . . . 61.039999999999999 110.0 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.95 164.33 12.24 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 73.319999999999993 111.009 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.537 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.2 mm? -125.32 176.66 6.63 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.537 1.148 . . . . 75.109999999999999 109.288 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 91.2 m-85 -162.62 124.94 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.125 . . . . 75.109999999999999 110.947 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.948 ' HB3' HD13 ' A' ' 291' ' ' LEU . 2.0 m-20 -114.91 99.01 7.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.109 . . . . 50.409999999999997 109.304 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -79.11 -54.79 5.65 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.457 1.098 . . . . 74.219999999999999 109.332 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.461 ' CB ' HG12 ' A' ' 292' ' ' ILE . 9.5 m-20 -95.1 19.2 10.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 71.040000000000006 109.297 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.948 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.5 mm? 40.29 39.38 0.66 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.497 1.123 . . . . 53.32 109.324 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 50.2 mm -68.63 -31.94 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 73.140000000000001 109.337 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.823 ' O ' HG23 ' A' ' 297' ' ' VAL . 0.1 OUTLIER -88.93 -29.1 19.83 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.555 1.159 . . . . 72.099999999999994 109.302 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.453 ' N ' ' OD1' ' A' ' 288' ' ' ASP . 4.9 m -81.52 -67.81 0.75 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 72.030000000000001 110.412 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -45.52 -31.85 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.483 1.114 . . . . 74.200000000000003 109.306 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 50.2 t -73.85 -55.85 5.69 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.539 1.149 . . . . 61.329999999999998 108.288 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.1 t -40.83 -49.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.5 1.125 . . . . 74.319999999999993 109.267 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 301' ' ' PHE . 29.2 mt -67.76 -57.71 5.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.583 1.177 . . . . 73.239999999999995 109.329 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.3 m -44.74 -27.06 0.45 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 72.340000000000003 110.382 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -72.99 -44.7 60.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.541 1.151 . . . . 73.299999999999997 109.355 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.653 ' HB2' HG21 ' A' ' 169' ' ' THR . 1.9 m-30 -97.65 21.97 9.64 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 73.209999999999994 111.031 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 32.0 t -58.27 -57.95 10.61 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.538 1.149 . . . . 74.420000000000002 109.968 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.747 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -76.36 -15.54 59.94 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.117 . . . . 62.229999999999997 109.254 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.69 HD22 ' CD ' ' A' ' 309' ' ' PRO . 17.9 mt -66.38 148.99 51.06 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.468 1.105 . . . . 74.129999999999995 109.292 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.7 p -168.91 127.2 1.03 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 72.430000000000007 109.964 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 172' ' ' TYR . . . 105.28 -163.66 14.22 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.514 1.134 . . . . 54.240000000000002 111.006 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.62 15.62 12.2 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.341 -0.985 . . . . 74.129999999999995 108.341 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.514 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 84.4 p -139.8 148.27 54.76 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 74.450000000000003 110.033 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.69 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.5 Cg_endo -74.95 147.19 88.68 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 121.057 -2.476 . . . . 64.109999999999999 111.02 -0.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 6.4 p -129.89 135.28 27.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 33.210000000000001 109.99 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.98 -174.49 14.19 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.994 -2.503 . . . . 60.140000000000001 110.987 -0.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.2 156.02 23.02 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.443 1.09 . . . . 50.109999999999999 109.317 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.54 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.165 0 O-C-N 124.512 1.796 . . . . 75.319999999999993 111.044 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.4 136.4 33.08 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 70.400000000000006 109.29 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.22 22.92 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 109.316 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 14.1 t -69.31 -33.27 72.91 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 51.43 109.975 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.8 t -47.55 -24.49 0.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.497 1.123 . . . . 71.140000000000001 110.023 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.408 ' HB2' ' ND2' ' A' ' 293' ' ' ASN . 1.8 m -76.19 -175.66 3.24 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.476 1.11 . . . . 71.010000000000005 108.279 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . 161.49 119.75 0.52 Allowed Glycine 0 CA--C 1.529 0.953 0 O-C-N 124.496 1.123 . . . . 43.229999999999997 111.023 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 320' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.51 0 O-C-N 124.508 0.769 . . . . 75.25 110.989 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.928 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.6 tp . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.324 -0.621 . . . . 50.030000000000001 109.324 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.644 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -104.92 107.69 18.79 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.458 1.099 . . . . 73.349999999999994 109.319 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 t -84.81 9.69 13.5 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 55.039999999999999 109.996 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.25 145.6 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.544 1.152 . . . . 64.540000000000006 109.278 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.031 HD11 HD12 ' A' ' 149' ' ' LEU . 1.2 mt -97.25 142.59 24.77 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 75.450000000000003 109.309 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.4 Cg_endo -74.95 -32.63 5.3 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.497 1.788 . . . . 74.319999999999993 111.0 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.421 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.19 151.26 19.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.528 1.142 . . . . 63.520000000000003 109.318 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.516 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.9 t -48.11 -35.73 5.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.531 1.145 . . . . 74.109999999999999 109.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.33 -47.3 3.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.517 1.136 . . . . 70.239999999999995 109.273 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.67 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.3 m -71.73 -35.35 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.544 1.153 . . . . 75.420000000000002 110.403 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.768 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -58.72 -56.97 15.33 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.503 1.127 . . . . 54.219999999999999 109.32 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.516 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.7 m-80 -52.49 -31.7 36.47 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.534 1.146 . . . . 71.450000000000003 109.348 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.35 -54.05 16.49 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.499 1.124 . . . . 75.540000000000006 109.946 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.031 HD12 HD11 ' A' ' 140' ' ' ILE . 54.0 mt -44.15 -40.67 5.16 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.537 1.148 . . . . 75.099999999999994 109.297 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.611 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.49 -44.34 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.57 1.169 . . . . 70.299999999999997 110.996 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -48.03 -37.25 14.48 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 74.109999999999999 109.296 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.492 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 61.4 mt-30 -75.67 -55.87 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.48 1.112 . . . . 61.039999999999999 110.294 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.957 HD11 HD12 ' A' ' 188' ' ' LEU . 12.1 mt -51.13 -23.75 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.508 1.13 . . . . 75.409999999999997 109.367 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.17 -34.03 43.47 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.488 1.118 . . . . 71.209999999999994 109.305 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.1 t-20 -61.75 -17.63 56.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.483 1.114 . . . . 65.239999999999995 109.335 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.449 ' HG3' ' CD1' ' A' ' 187' ' ' ILE . 4.5 mm100 -84.09 -16.94 41.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.489 1.118 . . . . 75.310000000000002 110.292 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.6 p -37.94 133.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 74.209999999999994 109.958 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -64.32 125.12 23.59 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.501 1.126 . . . . 70.230000000000004 108.288 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.85 -18.06 8.62 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.495 1.122 . . . . 51.509999999999998 110.96 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.823 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 63.5 p -80.81 161.7 24.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.575 0.809 . . . . 71.230000000000004 110.422 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 51.0 p -93.55 -0.8 56.12 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 74.439999999999998 109.998 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 162' ' ' THR . 4.5 m -117.56 7.33 12.63 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 55.219999999999999 110.41 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.823 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -82.7 138.93 33.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.526 1.141 . . . . 60.420000000000002 109.278 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -162.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 75.230000000000004 109.999 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.431 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 41.9 t -156.22 127.47 3.67 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 73.230000000000004 109.982 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.01 139.38 61.44 Favored 'Cis proline' 0 C--N 1.36 1.155 0 C-N-CA 120.991 -2.504 . . . . 73.430000000000007 111.033 -0.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 19.9 p -72.73 179.11 3.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.484 1.115 . . . . 62.140000000000001 108.299 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.841 HG23 ' HG2' ' A' ' 180' ' ' ARG . 2.2 mp -88.9 124.73 41.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 61.329999999999998 109.305 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 301' ' ' PHE . 65.5 p -89.21 83.2 6.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.511 1.132 . . . . 74.140000000000001 110.356 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -88.47 -14.78 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.142 . . . . 75.340000000000003 110.999 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.42 -2.21 24.46 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.533 1.145 . . . . 70.439999999999998 110.302 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.654 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 27.1 t80 -127.98 71.15 78.63 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 63.039999999999999 110.996 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.433 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.01 114.07 3.94 Favored 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.484 1.781 . . . . 74.530000000000001 111.005 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.602 HG21 ' CE1' ' A' ' 172' ' ' TYR . 26.2 t -152.59 -75.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 124.486 1.116 . . . . 63.43 109.246 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -156.51 115.79 3.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.497 1.123 . . . . 65.209999999999994 109.301 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 144.63 55.84 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.525 1.14 . . . . 62.149999999999999 111.043 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 66.8 m -96.68 -0.17 48.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.308 -0.997 . . . . 54.310000000000002 108.308 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.62 ' HE1' HG21 ' A' ' 297' ' ' VAL . 12.8 p90 -85.89 -32.65 21.54 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 73.409999999999997 111.017 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.6 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -70.93 -49.59 43.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 73.219999999999999 109.336 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.841 ' HG2' HG23 ' A' ' 168' ' ' ILE . 6.5 mtp85 -57.69 -47.81 81.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.535 1.147 . . . . 54.530000000000001 110.261 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -44.25 -51.04 8.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.449 1.093 . . . . 63.420000000000002 109.329 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.489 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -56.12 -37.47 69.49 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.506 1.129 . . . . 73.5 109.646 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.77 ' HB3' HD11 ' A' ' 168' ' ' ILE . 27.8 mmmt -63.85 -64.33 0.92 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.564 1.165 . . . . 71.099999999999994 109.271 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.404 ' SD ' HG21 ' A' ' 153' ' ' ILE . 9.4 mtm -38.93 -30.24 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.509 1.131 . . . . 75.019999999999996 111.005 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.449 ' NH2' ' OD1' ' A' ' 194' ' ' ASP . 0.1 OUTLIER -66.32 -51.02 61.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 73.310000000000002 110.289 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.56 ' HG3' HD13 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -52.52 -32.32 39.87 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 73.310000000000002 110.282 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.56 HD13 ' HG3' ' A' ' 186' ' ' GLN . 11.6 mm -80.97 -34.46 13.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 72.519999999999996 109.309 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.957 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -63.33 -44.6 94.44 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.540000000000006 109.298 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.481 ' HG2' HD21 ' A' ' 136' ' ' LEU . 8.5 mtp -60.52 -41.55 94.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.507 1.129 . . . . 44.109999999999999 111.02 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -46.22 -49.53 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 74.109999999999999 109.312 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.492 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 24.5 t-20 -68.05 -27.99 66.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.497 1.123 . . . . 75.120000000000005 109.28 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 105.75 56.66 0.67 Allowed Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.512 1.133 . . . . 64.319999999999993 110.96 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.67 ' CZ ' HG21 ' A' ' 145' ' ' THR . 82.0 m-85 -157.52 142.38 16.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.52 0.776 . . . . 72.409999999999997 111.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.928 ' HB2' HD23 ' A' ' 136' ' ' LEU . 1.2 t0 -110.02 124.77 52.05 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.528 1.143 . . . . 71.510000000000005 109.294 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.79 ' HB3' HD22 ' A' ' 188' ' ' LEU . 17.0 p -100.08 171.17 7.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.444 1.09 . . . . 65.439999999999998 108.296 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -116.42 170.23 8.71 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.086 . . . . 71.519999999999996 110.299 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.421 ' HE2' HG22 ' A' ' 221' ' ' ILE . 6.3 mmtt -96.71 159.66 14.8 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.502 1.126 . . . . 74.519999999999996 109.32 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.633 ' OE1' HD11 ' A' ' 236' ' ' ILE . 18.9 tt0 -151.56 117.47 5.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 73.349999999999994 110.298 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 5.8 m-85 -116.39 128.75 55.78 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.52 1.137 . . . . 73.310000000000002 110.964 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.666 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.6 p -122.74 149.96 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 70.349999999999994 109.311 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 10.0 m-85 -122.88 164.21 18.87 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.539 1.15 . . . . 73.129999999999995 110.99 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.46 -172.9 14.44 Favored Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.516 1.135 . . . . 74.230000000000004 111.009 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.75 ' C ' HD23 ' A' ' 204' ' ' LEU . 52.4 t-20 -74.12 107.67 6.45 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.536 0.786 . . . . 73.349999999999994 109.262 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.5 mt -111.54 96.26 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.494 1.121 . . . . 75.099999999999994 109.334 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 12.7 mtpp -90.85 -179.88 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.505 1.128 . . . . 43.439999999999998 109.328 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 1.012 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -179.46 149.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.544 1.152 . . . . 74.299999999999997 109.321 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.05 133.24 45.52 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.49 1.119 . . . . 75.530000000000001 109.933 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.4 p -113.54 -5.61 13.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.478 1.111 . . . . 73.129999999999995 110.405 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.56 -21.69 31.32 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.482 1.114 . . . . 44.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 t -113.05 -23.47 10.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 0.751 . . . . 71.209999999999994 110.371 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 8.6 p -166.71 148.16 6.21 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 75.140000000000001 108.291 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 213' ' ' VAL . 4.4 t -98.17 162.47 13.18 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 72.319999999999993 108.277 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 1.012 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -138.45 143.43 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 71.140000000000001 109.3 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -137.88 132.58 32.7 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 70.099999999999994 109.271 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.432 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.4 OUTLIER -139.99 136.34 33.65 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.511 1.132 . . . . 75.230000000000004 107.993 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.9 t -80.38 -3.65 50.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.499 1.124 . . . . 65.510000000000005 110.01 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.4 p90 -169.99 127.45 0.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.476 1.11 . . . . 62.310000000000002 111.03 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CE1' ' O ' ' A' ' 219' ' ' VAL . 28.6 t60 -115.62 167.23 11.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.531 1.144 . . . . 73.239999999999995 109.583 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.584 HG11 ' HB3' ' A' ' 178' ' ' TYR . 2.3 p -144.23 140.42 24.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.495 1.122 . . . . 52.439999999999998 109.313 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.658 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -140.73 -167.65 2.4 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.49 1.119 . . . . 73.299999999999997 109.289 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.542 HD11 ' HB ' ' A' ' 237' ' ' ILE . 21.3 pt -115.17 119.33 61.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.545 1.153 . . . . 73.209999999999994 109.267 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' A' ' 234' ' ' LYS . 14.7 tp -84.92 108.82 17.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.557 1.161 . . . . 34.32 109.301 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.768 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -103.02 146.57 10.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.52 1.137 . . . . 71.329999999999998 109.345 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 15.9 m -117.17 119.36 34.99 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.462 1.101 . . . . 72.140000000000001 110.044 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.4 p90 -134.63 145.07 48.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.538 1.149 . . . . 71.120000000000005 110.969 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.421 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 19.0 mmtp -69.86 134.57 48.61 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.515 1.134 . . . . 72.409999999999997 109.259 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -75.5 -159.77 0.11 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 42.520000000000003 109.334 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.97 -0.65 52.38 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.458 1.099 . . . . 64.409999999999997 109.261 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 9.7 m -114.82 -7.88 12.62 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.498 1.123 . . . . 71.349999999999994 109.98 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.43 37.64 8.06 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.517 1.136 . . . . 44.140000000000001 111.036 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.424 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.35 137.38 44.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.468 0.746 . . . . 54.049999999999997 109.298 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.421 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.3 m -71.58 102.73 2.8 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.514 1.134 . . . . 61.25 110.388 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 224' ' ' SER . 4.2 mm-40 -101.44 -172.62 2.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 1.104 . . . . 64.200000000000003 110.266 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.574 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtt -126.86 145.22 50.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.1 . . . . 61.100000000000001 109.331 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.619 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -145.53 162.19 38.0 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.547 1.154 . . . . 75.25 110.286 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.633 HD11 ' OE1' ' A' ' 198' ' ' GLN . 16.6 mm -115.88 119.34 61.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 65.150000000000006 109.311 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.6 mm -105.64 45.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 75.219999999999999 109.248 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.19 108.78 58.28 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 124.518 1.136 . . . . 64.549999999999997 109.329 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.412 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -75.0 -19.26 18.02 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.473 1.775 . . . . 75.549999999999997 110.943 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.433 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.4 OUTLIER -53.06 -20.86 3.95 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.482 1.114 . . . . 64.120000000000005 109.994 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.549 HD13 ' SG ' ' A' ' 256' ' ' CYS . 7.3 mt -120.26 -57.09 1.95 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.558 1.161 . . . . 72.530000000000001 109.271 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.637 ' CD1' HG11 ' A' ' 247' ' ' VAL . 96.7 m-85 -110.06 99.62 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.439999999999998 110.97 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -12.63 42.56 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.502 1.126 . . . . 73.230000000000004 110.034 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.2 p -74.51 -44.83 49.5 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.461 1.101 . . . . 65.319999999999993 110.041 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -175.88 -174.76 42.7 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.537 1.148 . . . . 74.530000000000001 110.978 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.434 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.1 Cg_endo -75.03 166.57 28.9 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.5 1.79 . . . . 74.540000000000006 110.99 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.637 HG11 ' CD1' ' A' ' 242' ' ' PHE . 6.0 m -148.09 161.19 6.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.131 . . . . 72.129999999999995 109.322 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.3 p -65.49 137.32 57.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.498 1.124 . . . . 74.049999999999997 110.458 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.415 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 6.4 p-10 -40.03 -30.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.513 1.133 . . . . 72.230000000000004 109.332 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 7.9 m -76.82 -61.92 1.81 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.496 1.122 . . . . 75.430000000000007 110.394 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.85 -24.01 3.22 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 74.340000000000003 109.315 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.658 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 7.7 t90 -68.02 -62.86 1.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.955 -1.128 . . . . 73.219999999999999 107.955 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.809 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -48.68 -38.51 21.51 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.503 1.127 . . . . 72.349999999999994 110.32 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.898 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.6 m-80 -58.24 -51.62 68.98 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.513 1.133 . . . . 72.129999999999995 109.302 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.605 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -59.87 -17.17 34.77 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.556 1.16 . . . . 74.329999999999998 109.283 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.549 ' SG ' HD13 ' A' ' 241' ' ' LEU . 22.0 m -94.91 -25.81 16.4 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 63.030000000000001 108.28 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.898 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -106.17 24.47 2.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.156 . . . . 44.43 109.3 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 206' ' ' ALA . 1.9 p-10 -53.0 129.19 29.82 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.48 1.113 . . . . 61.219999999999999 109.314 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 262' ' ' GLY . 3.1 p -85.81 -3.86 59.02 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 71.420000000000002 110.403 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.416 ' HB3' ' ND2' ' A' ' 258' ' ' ASN . 0.9 OUTLIER -50.71 -30.72 14.54 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.523 1.139 . . . . 42.119999999999997 109.999 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . 0.407 ' SG ' ' CE ' ' A' ' 205' ' ' LYS . 16.4 t -88.39 -29.29 20.36 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.468 1.105 . . . . 73.230000000000004 108.31 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 259' ' ' THR . . . 156.76 -120.77 1.01 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.454 1.096 . . . . 55.100000000000001 110.978 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -87.5 148.38 24.95 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 0.743 . . . . 73.019999999999996 110.047 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -169.8 147.69 3.44 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.488 1.118 . . . . 74.420000000000002 109.306 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 4.9 m -172.84 156.25 3.37 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 71.430000000000007 109.996 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.666 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.5 118.27 44.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 70.209999999999994 109.322 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 8.8 t -74.99 -44.08 50.23 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.513 1.133 . . . . 63.310000000000002 110.007 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 200' ' ' VAL . 22.2 m -157.06 -170.11 3.17 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.428 1.08 . . . . 61.229999999999997 110.012 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -170.08 157.36 6.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 72.230000000000004 110.982 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -162.26 172.05 16.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.474 1.109 . . . . 73.120000000000005 109.321 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 272' ' ' THR . 0.7 OUTLIER -145.71 160.73 41.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.465 1.103 . . . . 72.040000000000006 109.288 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.476 HG21 ' HD2' ' A' ' 279' ' ' ARG . 2.7 p -151.94 -171.92 4.07 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.526 1.141 . . . . 41.109999999999999 110.387 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.807 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -68.0 154.39 41.73 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.495 1.122 . . . . 65.400000000000006 109.242 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -64.56 -46.72 89.34 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.463 1.102 . . . . 72.209999999999994 110.992 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -50.96 -38.29 49.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 0.776 . . . . 73.239999999999995 109.274 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.807 HG23 ' HB3' ' A' ' 273' ' ' ALA . 33.9 t -46.81 116.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.529 1.143 . . . . 73.540000000000006 109.306 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 2.4 t80 -70.78 -46.52 62.74 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.504 1.128 . . . . 72.120000000000005 110.999 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.573 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 63.4 t80 -154.77 162.2 41.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 111.013 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.573 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 75.2 ttt-85 -128.25 147.48 50.59 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.536 1.148 . . . . 54.109999999999999 110.254 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.33 154.75 47.53 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.536 1.148 . . . . 75.319999999999993 110.012 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.91 0.22 9.12 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.502 1.79 . . . . 73.040000000000006 111.026 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 27.9 t -101.63 3.35 39.78 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.496 1.122 . . . . 52.310000000000002 110.007 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.6 t-20 81.74 36.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.433 1.083 . . . . 73.200000000000003 109.277 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -117.65 119.29 34.52 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.47 1.106 . . . . 64.540000000000006 110.013 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 8.7 m-30 -99.78 160.84 14.0 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.535 1.147 . . . . 74.329999999999998 110.967 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.546 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 0.9 OUTLIER -119.77 176.55 5.34 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 63.149999999999999 109.303 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 86.9 m-85 -162.56 130.22 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.531 1.144 . . . . 64.25 111.0 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.3 m-20 -113.52 111.88 22.64 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 75.099999999999994 109.297 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -85.23 -51.86 6.32 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 72.25 109.319 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.464 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -106.96 18.04 22.32 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 54.329999999999998 109.321 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.77 HD12 HG21 ' A' ' 294' ' ' THR . 1.3 mm? 50.34 39.36 20.11 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.572 1.17 . . . . 74.030000000000001 109.313 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.562 HG22 ' C ' ' A' ' 319' ' ' GLY . 20.0 mm -65.58 -30.63 50.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 74.5 109.27 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.737 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.2 t-20 -93.94 -29.75 15.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 60.119999999999997 109.334 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.77 HG21 HD12 ' A' ' 291' ' ' LEU . 1.3 m -76.64 -66.24 0.84 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 63.149999999999999 110.397 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -51.01 -25.92 5.41 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 74.540000000000006 109.297 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.41 -53.17 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.47 1.106 . . . . 72.319999999999993 108.294 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 293' ' ' ASN . 10.6 t -49.32 -37.62 10.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.128 . . . . 74.430000000000007 109.315 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.626 HD22 ' HA ' ' A' ' 168' ' ' ILE . 65.9 mt -75.43 -59.62 2.67 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.51 1.131 . . . . 73.530000000000001 109.316 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.2 m -51.98 -20.71 2.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.516 1.135 . . . . 74.129999999999995 110.367 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.835 ' HE2' HG12 ' A' ' 315' ' ' VAL . 21.4 mmmt -72.58 -42.38 64.66 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 75.420000000000002 109.316 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.877 ' CD1' HD12 ' A' ' 304' ' ' LEU . 5.1 m-30 -102.44 37.82 1.82 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.481 1.113 . . . . 64.019999999999996 110.984 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 35.6 t -68.66 -44.37 74.23 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.481 1.113 . . . . 73.510000000000005 110.003 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.674 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -95.07 -12.96 25.61 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.481 1.113 . . . . 62.109999999999999 109.296 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.877 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.7 mt -65.57 135.65 55.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.469 1.106 . . . . 61.549999999999997 109.311 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 79.0 p -151.67 152.64 33.07 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.467 1.105 . . . . 52.219999999999999 109.983 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 79.87 -145.58 27.43 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.478 1.111 . . . . 63.219999999999999 111.029 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 59.8 m -109.39 15.41 23.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.341 -0.985 . . . . 74.219999999999999 108.341 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.523 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 97.8 p -132.82 148.6 70.14 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.479 1.112 . . . . 54.229999999999997 110.016 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.768 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.08 146.45 86.59 Favored 'Cis proline' 0 C--N 1.36 1.152 0 C-N-CA 120.959 -2.517 . . . . 43.229999999999997 110.992 0.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.5 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.4 p -128.86 134.46 26.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.498 1.124 . . . . 74.230000000000004 109.957 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.5 Cg_endo -74.96 -172.38 10.67 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.985 -2.506 . . . . 64.019999999999996 111.006 -0.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.16 153.59 24.56 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.521 1.138 . . . . 72.230000000000004 109.286 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.4 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -74.99 -162.22 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.491 1.785 . . . . 75.209999999999994 110.983 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -86.15 131.13 34.32 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.449 1.093 . . . . 72.420000000000002 109.335 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.835 HG12 ' HE2' ' A' ' 300' ' ' LYS . 30.5 m -134.61 14.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.491 1.119 . . . . 75.040000000000006 109.332 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 30.6 t -66.91 -41.4 87.17 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 64.439999999999998 110.014 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 4.0 m -48.1 -24.16 1.04 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.119 . . . . 62.100000000000001 109.968 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 97.0 m -49.84 169.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.128 . . . . 74.019999999999996 108.336 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.562 ' C ' HG22 ' A' ' 292' ' ' ILE . . . -124.98 -174.6 14.01 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.484 1.115 . . . . 65.310000000000002 110.968 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.502 0.766 . . . . 73.239999999999995 110.986 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.804 HD23 ' HB2' ' A' ' 194' ' ' ASP . 12.1 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.277 -0.638 . . . . 61.439999999999998 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.605 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -102.69 104.18 14.5 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.489 1.118 . . . . 63.210000000000001 109.304 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -82.98 7.34 15.85 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.482 1.114 . . . . 55.420000000000002 109.985 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.585 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.4 t -150.38 142.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.485 1.116 . . . . 64.450000000000003 109.319 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.034 HD11 HD12 ' A' ' 149' ' ' LEU . 1.4 mt -92.73 141.76 24.82 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.108 . . . . 74.439999999999998 109.32 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.2 Cg_endo -75.02 -31.57 6.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.513 1.796 . . . . 75.140000000000001 110.973 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.424 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.51 149.63 17.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.476 1.11 . . . . 64.510000000000005 109.348 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.49 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.9 t -46.72 -37.19 3.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.138 . . . . 74.400000000000006 109.248 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.18 -50.05 2.67 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.475 1.11 . . . . 71.420000000000002 109.325 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.74 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -68.95 -37.06 78.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 55.020000000000003 110.393 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.734 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.8 OUTLIER -56.72 -57.5 12.16 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.514 1.134 . . . . 61.420000000000002 109.287 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.49 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.1 m-80 -52.09 -29.9 23.62 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.531 1.144 . . . . 73.230000000000004 109.295 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.8 t -69.14 -50.79 44.66 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 74.510000000000005 109.984 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.034 HD12 HD11 ' A' ' 140' ' ' ILE . 54.9 mt -48.53 -40.03 25.5 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.528 1.142 . . . . 72.219999999999999 109.285 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.61 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -75.16 -42.17 56.6 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 75.230000000000004 110.991 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -48.95 -36.77 18.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 72.109999999999999 109.328 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 155' ' ' ASN . 64.2 mt-30 -75.75 -56.0 5.1 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 73.109999999999999 110.269 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.589 HD11 HD12 ' A' ' 188' ' ' LEU . 13.1 mt -50.71 -26.84 4.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.505 1.128 . . . . 64.510000000000005 109.259 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.06 -34.21 59.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.491 1.119 . . . . 75.129999999999995 109.304 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.0 t-20 -61.62 -15.15 36.84 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 70.200000000000003 109.309 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -85.75 -18.82 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 73.140000000000001 110.29 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.8 p -39.38 136.64 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 73.140000000000001 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.492 ' HB3' HH21 ' A' ' 171' ' ' ARG . 1.3 m -68.33 119.99 13.73 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.463 1.102 . . . . 74.049999999999997 108.28 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 128.13 -18.74 5.83 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.436 1.085 . . . . 45.130000000000003 110.999 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.864 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 82.8 p -80.38 162.33 24.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.434 0.726 . . . . 61.25 110.407 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 52.7 m -93.26 -0.59 56.72 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.46 1.1 . . . . 43.219999999999999 110.001 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 162' ' ' THR . 1.3 m -118.84 6.52 11.46 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.52 1.137 . . . . 62.140000000000001 110.42 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.864 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -79.83 139.27 37.25 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.121 . . . . 72.319999999999993 109.263 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.0 -166.94 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.488 1.118 . . . . 64.019999999999996 110.051 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 60.7 p -152.62 125.84 4.17 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 64.019999999999996 109.976 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.0 140.16 65.77 Favored 'Cis proline' 0 C--N 1.36 1.183 0 C-N-CA 120.976 -2.51 . . . . 71.450000000000003 110.973 0.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.6 p -72.89 -177.82 2.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.544 1.153 . . . . 73.150000000000006 108.313 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.687 HD11 ' CB ' ' A' ' 183' ' ' LYS . 2.3 mp -91.96 131.4 39.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.525 1.141 . . . . 64.400000000000006 109.327 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.458 ' HB ' ' NH1' ' A' ' 171' ' ' ARG . 11.1 p -85.3 85.56 7.44 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.481 1.113 . . . . 74.010000000000005 110.417 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 170' ' ' PHE . 2.2 p90 -88.56 -28.24 20.87 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.539 1.149 . . . . 62.200000000000003 111.013 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.492 HH21 ' HB3' ' A' ' 158' ' ' CYS . 0.0 OUTLIER -74.12 -2.52 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.495 1.122 . . . . 64.219999999999999 110.316 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.749 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 24.9 t80 -128.52 68.89 78.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 72.109999999999999 111.029 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.421 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.1 Cg_endo -75.03 116.08 4.47 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.499 1.789 . . . . 64.109999999999999 110.972 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.585 HG21 ' CE1' ' A' ' 172' ' ' TYR . 12.2 t -152.08 -74.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.542 1.152 . . . . 52.240000000000002 109.315 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.604 ' OD2' ' HB2' ' A' ' 312' ' ' ALA . 2.6 p-10 -123.76 -43.41 2.13 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.491 1.12 . . . . 51.409999999999997 109.336 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -47.64 92.58 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 O-C-N 124.496 1.123 . . . . 74.430000000000007 111.01 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 175' ' ' ASP . 57.3 m -128.17 -46.86 1.35 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.28 -1.007 . . . . 63.210000000000001 108.28 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 21.7 p90 -72.87 -40.95 65.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.141 . . . . 65.430000000000007 111.008 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.633 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -45.66 -68.37 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.134 . . . . 73.530000000000001 109.336 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.705 HH21 ' HG2' ' A' ' 239' ' ' PRO . 9.5 ptm180 -49.94 -47.66 52.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.444 1.09 . . . . 74.239999999999995 110.306 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -39.4 -57.38 1.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.132 . . . . 42.240000000000002 109.318 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -47.79 -44.56 28.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.506 1.128 . . . . 74.140000000000001 109.598 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.687 ' CB ' HD11 ' A' ' 168' ' ' ILE . 14.4 mmmm -58.52 -56.58 20.27 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.438 1.086 . . . . 64.420000000000002 109.281 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.521 ' SD ' HG21 ' A' ' 153' ' ' ILE . 5.2 mtm -40.36 -55.41 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.563 1.164 . . . . 71.239999999999995 111.051 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.446 ' NH1' ' HA ' ' A' ' 194' ' ' ASP . 0.2 OUTLIER -46.28 -44.09 16.21 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 1.121 . . . . 73.439999999999998 110.316 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.497 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -62.76 -33.19 74.64 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 75.120000000000005 110.305 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.497 HD13 ' HG2' ' A' ' 186' ' ' GLN . 16.2 mm -76.05 -34.41 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.474 1.109 . . . . 50.219999999999999 109.315 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.589 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -61.97 -45.66 92.69 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.481 1.113 . . . . 71.120000000000005 109.306 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 7.3 mtt -58.63 -38.58 78.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.437 1.086 . . . . 73.450000000000003 111.029 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.76 -44.22 63.27 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.098 . . . . 70.310000000000002 109.284 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.557 HD22 HD21 ' A' ' 149' ' ' LEU . 41.0 t30 -74.17 -31.96 62.9 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.485 1.116 . . . . 63.409999999999997 109.327 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.57 58.5 0.73 Allowed Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.533 1.146 . . . . 64.519999999999996 110.989 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.74 ' CZ ' HG21 ' A' ' 145' ' ' THR . 68.1 m-85 -153.67 141.42 20.03 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.463 0.743 . . . . 61.119999999999997 110.959 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.804 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -102.89 129.46 49.6 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 74.25 109.329 179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.537 ' HB3' HD22 ' A' ' 188' ' ' LEU . 30.7 p -120.26 -178.58 3.71 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.547 1.154 . . . . 42.049999999999997 108.287 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -131.36 177.5 7.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.457 1.098 . . . . 72.439999999999998 110.248 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.456 ' NZ ' ' C ' ' A' ' 181' ' ' ALA . 21.8 mmtt -105.25 153.13 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.523 1.139 . . . . 73.409999999999997 109.265 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.855 ' OE1' HD11 ' A' ' 236' ' ' ILE . 14.8 tt0 -132.55 117.5 18.06 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.519 1.137 . . . . 74.140000000000001 110.319 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.473 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 2.6 m-85 -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.489 1.118 . . . . 75.319999999999993 111.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 204' ' ' LEU . 8.6 p -131.22 142.81 42.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.45 1.094 . . . . 72.099999999999994 109.265 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 6.3 m-85 -116.32 156.08 27.29 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.542 1.151 . . . . 75.109999999999999 111.028 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 121.53 -173.42 15.67 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.474 1.109 . . . . 75.439999999999998 111.061 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.801 ' C ' HD23 ' A' ' 204' ' ' LEU . 51.7 t-20 -74.4 110.97 9.12 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.454 0.738 . . . . 72.230000000000004 109.252 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.801 HD23 ' C ' ' A' ' 203' ' ' ASN . 4.6 mt -115.13 94.39 4.72 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.46 1.1 . . . . 74.109999999999999 109.293 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.709 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 1.9 mtpm? -92.76 175.12 6.93 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.477 1.111 . . . . 73.319999999999993 109.306 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -176.04 131.16 0.24 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.525 1.141 . . . . 72.439999999999998 109.349 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 42.9 p -112.45 107.39 16.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.497 1.123 . . . . 74.319999999999993 109.972 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.8 p -82.26 -16.85 48.0 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 72.430000000000007 110.387 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 114.34 -50.86 0.75 Allowed Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.464 1.102 . . . . 65.310000000000002 110.963 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.1 m -85.38 -20.06 30.47 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.466 0.745 . . . . 63.340000000000003 110.383 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 1.7 p -176.74 140.05 0.32 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.476 1.11 . . . . 64.120000000000005 108.311 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 206' ' ' ALA . 0.5 OUTLIER -97.69 161.89 13.54 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.516 1.135 . . . . 55.119999999999997 108.313 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.2 OUTLIER -132.97 162.06 40.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.479 1.112 . . . . 72.549999999999997 109.285 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.709 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -142.83 135.18 27.5 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.491 1.119 . . . . 73.319999999999993 109.306 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.446 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.7 OUTLIER -138.25 134.32 34.25 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.526 1.142 . . . . 65.420000000000002 107.998 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 17.9 t -77.03 -0.09 23.25 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.519 1.137 . . . . 64.129999999999995 109.979 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.466 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 7.2 p90 -176.64 129.91 0.19 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.432 1.083 . . . . 64.510000000000005 110.986 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.495 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 63.0 t60 -115.17 168.44 9.94 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.492 1.12 . . . . 63.329999999999998 109.603 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.54 HG11 ' HB3' ' A' ' 178' ' ' TYR . 0.8 OUTLIER -140.38 142.27 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 73.109999999999999 109.266 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.631 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -144.8 -167.14 2.58 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.504 1.128 . . . . 72.230000000000004 109.349 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 30.3 pt -120.01 125.19 74.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 63.130000000000003 109.337 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.598 HD13 ' NE2' ' A' ' 198' ' ' GLN . 17.1 tp -87.58 110.82 20.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.518 1.136 . . . . 72.540000000000006 109.272 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.734 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.57 145.92 13.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.499 1.124 . . . . 62.520000000000003 109.304 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.585 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.1 OUTLIER -117.47 119.53 35.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.5 1.125 . . . . 74.219999999999999 110.009 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -134.64 147.1 50.09 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 64.530000000000001 110.979 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.8 mmtp -71.66 134.0 46.05 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.444 1.09 . . . . 74.209999999999994 109.332 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -74.87 -160.24 0.11 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.535 1.147 . . . . 74.439999999999998 109.309 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.37 48.04 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.442 1.089 . . . . 75.239999999999995 109.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.68 -7.93 12.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.529 1.143 . . . . 61.43 109.978 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.5 37.31 8.18 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.521 1.138 . . . . 64.319999999999993 110.983 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.421 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.02 137.47 43.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.485 0.756 . . . . 71.540000000000006 109.324 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 5.7 m -71.88 102.69 2.95 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.516 1.135 . . . . 65.430000000000007 110.34 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.1 mm-40 -102.23 -172.68 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.551 1.157 . . . . 72.329999999999998 110.284 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.559 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.3 mmtm -126.24 145.68 50.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.447 1.092 . . . . 74.540000000000006 109.347 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.586 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.6 tpt180 -145.7 161.98 38.63 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.514 1.133 . . . . 71.150000000000006 110.32 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.855 HD11 ' OE1' ' A' ' 198' ' ' GLN . 16.1 mm -115.47 116.09 51.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.461 1.1 . . . . 64.319999999999993 109.321 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -102.46 46.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.509 1.131 . . . . 64.409999999999997 109.286 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -110.28 113.66 56.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.545 1.153 . . . . 64.519999999999996 109.232 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.705 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -75.0 -18.13 18.98 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.5 1.79 . . . . 72.530000000000001 111.038 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.482 ' OG ' ' CZ ' ' A' ' 180' ' ' ARG . 1.9 m -45.6 -25.98 0.54 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.484 1.115 . . . . 74.209999999999994 109.976 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.427 ' CD1' ' CD1' ' A' ' 252' ' ' TRP . 4.1 mt -119.61 -60.46 1.72 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 72.329999999999998 109.302 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.6 m-85 -106.15 101.12 10.62 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.531 1.144 . . . . 53.130000000000003 110.998 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.21 -23.27 26.51 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.493 1.12 . . . . 61.140000000000001 109.991 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 59.1 m -64.44 -47.8 77.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 65.299999999999997 110.008 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.39 -176.1 39.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.522 1.139 . . . . 52.32 111.006 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.423 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -75.03 169.78 21.87 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.475 1.776 . . . . 71.430000000000007 110.983 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.714 HG21 ' CE2' ' A' ' 242' ' ' PHE . 6.4 m -150.99 158.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.496 1.123 . . . . 73.219999999999999 109.32 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.415 ' C ' ' N ' ' A' ' 250' ' ' THR . 38.6 p -58.89 141.95 52.05 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.473 1.108 . . . . 60.530000000000001 110.378 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 8.7 p30 -46.02 -26.1 0.67 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.541 1.151 . . . . 72.430000000000007 109.288 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.415 ' N ' ' C ' ' A' ' 248' ' ' THR . 28.1 m -78.96 -62.43 1.7 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.5 1.125 . . . . 74.200000000000003 110.387 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.32 -27.86 6.89 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 71.239999999999995 109.338 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.631 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 14.3 t90 -62.66 -61.43 2.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.505 1.128 . . . . 64.219999999999999 107.971 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.56 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.59 -42.69 16.41 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 73.120000000000005 110.249 -179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.853 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -55.94 -51.02 69.12 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.506 1.129 . . . . 73.109999999999999 109.32 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -57.28 -19.46 22.02 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.527 1.142 . . . . 65.439999999999998 109.3 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -90.0 -35.39 15.55 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.516 1.135 . . . . 74.049999999999997 108.281 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.853 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -94.02 20.91 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.501 1.126 . . . . 51.039999999999999 109.286 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -50.45 106.06 0.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.512 1.132 . . . . 63.450000000000003 109.277 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 262' ' ' GLY . 10.3 p -73.44 -3.2 26.02 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.504 1.127 . . . . 65.409999999999997 110.375 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 23.8 t -44.02 -31.83 1.01 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.525 1.141 . . . . 51.450000000000003 110.002 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 50.6 t -87.52 -37.5 16.86 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 71.219999999999999 108.271 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 170.5 -129.2 1.76 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.497 1.123 . . . . 60.549999999999997 110.961 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -76.37 148.21 37.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.434 0.726 . . . . 75.010000000000005 109.939 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -169.91 146.99 3.24 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.493 1.121 . . . . 70.230000000000004 109.284 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 5.4 t -172.77 152.88 2.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.526 1.142 . . . . 74.409999999999997 109.97 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.683 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.6 p -98.26 114.92 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 51.039999999999999 109.285 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 3.3 t -72.48 -44.77 61.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.511 1.132 . . . . 71.549999999999997 110.052 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 4.0 m -158.59 171.37 20.25 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.535 1.147 . . . . 74.219999999999999 110.003 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -155.62 156.01 34.27 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.46 1.1 . . . . 73.430000000000007 111.018 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -166.75 163.58 16.56 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.438 1.086 . . . . 72.430000000000007 109.288 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.45 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.8 OUTLIER -123.58 160.66 26.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 65.200000000000003 109.296 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.496 HG21 ' CD ' ' A' ' 279' ' ' ARG . 21.4 p -147.5 -175.09 4.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.511 1.132 . . . . 55.130000000000003 110.411 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 276' ' ' VAL . . . -55.86 169.69 0.34 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 74.200000000000003 109.35 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -94.46 -15.96 44.98 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.487 1.117 . . . . 63.229999999999997 111.025 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -94.24 -16.95 23.16 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.517 0.775 . . . . 53.549999999999997 109.294 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.674 HG21 ' CD1' ' A' ' 285' ' ' TYR . 0.3 OUTLIER -67.45 115.66 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.559 1.162 . . . . 65.209999999999994 109.283 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.487 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 16.6 t80 -61.66 -54.76 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.472 1.107 . . . . 74.319999999999993 110.991 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 5.5 t80 -146.54 150.84 36.31 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.489 1.118 . . . . 75.010000000000005 110.996 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.594 ' O ' ' CE1' ' A' ' 278' ' ' TYR . 22.3 ttt-85 -121.7 142.7 49.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.457 1.098 . . . . 65.329999999999998 110.339 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.48 157.87 34.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 61.32 109.96 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 0.76 8.51 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.503 1.791 . . . . 53.25 111.014 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 43.2 t -101.72 5.64 41.44 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.542 1.151 . . . . 70.409999999999997 109.961 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.9 t-20 81.66 22.86 0.28 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.562 1.164 . . . . 72.239999999999995 109.309 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.4 t -103.05 119.08 38.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 61.409999999999997 109.984 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.674 ' CD1' HG21 ' A' ' 276' ' ' VAL . 64.5 m-85 -106.12 156.5 18.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 73.209999999999994 111.007 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.647 HD11 ' CZ ' ' A' ' 320' ' ' PHE . 1.0 OUTLIER -113.76 176.1 5.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.486 1.116 . . . . 62.530000000000001 109.279 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 96.5 m-85 -163.55 115.0 1.42 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.496 1.122 . . . . 75.329999999999998 110.997 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.419 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 11.4 t0 -115.6 95.87 5.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.469 1.105 . . . . 54.420000000000002 109.279 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -85.55 -27.07 25.79 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.486 1.117 . . . . 52.340000000000003 109.349 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.459 ' CB ' HG12 ' A' ' 292' ' ' ILE . 43.7 m-20 -99.12 5.76 46.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.13 . . . . 54.009999999999998 109.306 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.3 48.4 2.33 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 1.128 . . . . 74.510000000000005 109.312 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.459 HG12 ' CB ' ' A' ' 290' ' ' ASN . 39.0 mm -78.32 -29.79 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 64.230000000000004 109.274 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.725 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.6 t-20 -94.63 -19.88 20.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.445 1.09 . . . . 73.400000000000006 109.348 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.487 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 16.3 m -87.68 -69.05 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 75.420000000000002 110.352 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 44.5 m-20 -51.39 -27.03 8.86 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.451 1.094 . . . . 63.420000000000002 109.268 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.424 ' CB ' ' O ' ' A' ' 292' ' ' ILE . 19.4 t -73.23 -68.8 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.527 1.142 . . . . 72.109999999999999 108.323 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 293' ' ' ASN . 56.0 t -40.25 -39.56 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.515 1.135 . . . . 71.230000000000004 109.296 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . . . . . . . . . 89.4 mt -66.44 -56.98 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.434 1.084 . . . . 64.310000000000002 109.273 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.85 -17.95 19.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.497 1.123 . . . . 74.420000000000002 110.403 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.422 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.4 mmmt -77.41 -41.71 38.91 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 72.109999999999999 109.315 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.719 ' CE2' HG13 ' A' ' 297' ' ' VAL . 0.8 OUTLIER -106.08 39.64 1.75 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.521 1.138 . . . . 73.120000000000005 111.0 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.7 t -67.89 -53.22 28.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 74.530000000000001 109.99 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.786 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -83.8 -18.09 38.87 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.486 1.116 . . . . 65.530000000000001 109.281 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.749 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 14.2 mt -55.98 137.35 51.01 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.531 1.144 . . . . 71.329999999999998 109.297 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 78.8 p -148.68 159.87 43.71 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.556 1.16 . . . . 71.109999999999999 110.009 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.8 -149.06 40.88 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.475 1.109 . . . . 32.350000000000001 110.976 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 1.2 m -106.74 14.24 27.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.303 -0.999 . . . . 60.200000000000003 108.303 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -132.06 149.21 72.64 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.433 1.083 . . . . 74.349999999999994 110.003 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.737 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -74.97 147.08 88.41 Favored 'Cis proline' 0 C--N 1.36 1.173 0 C-N-CA 120.983 -2.507 . . . . 74.010000000000005 110.989 -0.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.468 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.6 p -129.99 133.32 24.85 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 109.988 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.04 -167.87 6.01 Favored 'Cis proline' 0 C--N 1.359 1.13 0 C-N-CA 121.033 -2.486 . . . . 70.340000000000003 110.967 0.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.604 ' HB2' ' OD2' ' A' ' 175' ' ' ASP . . . -56.65 153.8 20.09 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 61.409999999999997 109.315 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.52 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.0 -162.36 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.504 1.791 . . . . 73.400000000000006 110.993 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.8 135.09 33.47 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.536 1.148 . . . . 54.439999999999998 109.278 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.422 HG12 ' HE2' ' A' ' 300' ' ' LYS . 17.1 m -127.2 24.73 2.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.504 1.127 . . . . 64.120000000000005 109.274 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 16.5 t -57.04 -18.43 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.151 . . . . 64.439999999999998 109.975 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.4 t -60.28 -26.6 66.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.469 1.106 . . . . 62.229999999999997 109.999 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 3.2 m -70.56 -173.44 0.74 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.515 1.134 . . . . 61.020000000000003 108.286 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 167.4 81.37 0.05 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.513 1.133 . . . . 71.230000000000004 110.963 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.647 ' CZ ' HD11 ' A' ' 286' ' ' LEU . 3.6 p90 . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.46 0.741 . . . . 75.25 110.953 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.779 HD23 ' HB3' ' A' ' 194' ' ' ASP . 7.9 tp . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 109.284 -0.635 . . . . 52.020000000000003 109.284 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.708 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -100.39 111.33 23.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.501 1.126 . . . . 74.530000000000001 109.319 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.9 m -73.29 -43.52 60.83 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.451 1.094 . . . . 75.140000000000001 110.029 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.881 HG23 ' HB3' ' A' ' 224' ' ' SER . 0.4 OUTLIER -112.58 161.22 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 65.099999999999994 109.281 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -101.84 144.75 29.21 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 71.319999999999993 109.316 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.48 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -33.79 4.34 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.493 1.786 . . . . 71.349999999999994 110.994 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.424 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.19 147.43 19.42 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.451 1.094 . . . . 72.129999999999995 109.306 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.567 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -47.29 -35.18 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.472 1.108 . . . . 74.140000000000001 109.294 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.3 -45.86 4.36 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.5 1.125 . . . . 65.510000000000005 109.322 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.782 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -72.85 -34.11 66.56 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.48 1.112 . . . . 73.430000000000007 110.396 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.714 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -59.94 -56.35 22.77 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.486 1.116 . . . . 73.450000000000003 109.31 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.491 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.3 m-80 -53.46 -31.39 45.32 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.495 1.122 . . . . 72.329999999999998 109.3 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.08 -54.08 16.91 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.539 1.149 . . . . 72.319999999999993 109.991 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 140' ' ' ILE . 87.5 mt -45.25 -41.6 8.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.494 1.121 . . . . 74.140000000000001 109.262 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.656 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.42 -44.66 57.82 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.423 1.077 . . . . 74.049999999999997 110.974 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -46.95 -36.2 7.41 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.42 1.075 . . . . 54.420000000000002 109.306 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' ASN . 61.0 mt-30 -77.31 -55.15 5.65 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.456 1.097 . . . . 72.040000000000006 110.303 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.647 HD11 HD12 ' A' ' 188' ' ' LEU . 17.5 mt -50.35 -27.09 4.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 55.420000000000002 109.286 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -37.38 60.72 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 74.219999999999999 109.31 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.4 t-20 -57.74 -17.88 17.97 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 74.340000000000003 109.33 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.452 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.4 mm100 -82.79 -25.72 32.47 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 73.420000000000002 110.291 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 m -40.35 114.27 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.539 1.15 . . . . 71.420000000000002 110.028 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.7 m -42.42 124.4 2.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.513 1.133 . . . . 53.539999999999999 108.3 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.89 -22.04 3.88 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.523 1.14 . . . . 73.439999999999998 111.016 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.709 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 56.8 p -90.09 158.25 17.39 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 0.747 . . . . 65.319999999999993 110.38 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 10.2 t -89.62 -2.52 58.33 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.528 1.143 . . . . 70.349999999999994 109.984 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 162' ' ' THR . 3.2 m -110.27 -1.6 17.2 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.45 1.094 . . . . 75.409999999999997 110.396 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.709 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -74.75 134.51 41.84 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.575 1.172 . . . . 62.140000000000001 109.288 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.423 ' H ' ' NE2' ' A' ' 156' ' ' GLN . 0.5 OUTLIER -55.14 -167.59 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.486 1.116 . . . . 72.329999999999998 109.976 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.46 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.6 t -156.27 128.32 3.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 124.535 1.147 . . . . 75.120000000000005 109.965 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.5 Cg_endo -74.95 136.61 45.98 Favored 'Cis proline' 0 C--N 1.36 1.147 0 C-N-CA 121.031 -2.487 . . . . 73.340000000000003 111.019 -0.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 11.9 p -73.19 -179.42 3.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.532 1.145 . . . . 72.239999999999995 108.269 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.729 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.3 mp -88.28 124.52 41.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.573 1.171 . . . . 74.019999999999996 109.311 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.419 ' HB ' ' NE ' ' A' ' 171' ' ' ARG . 12.4 p -90.13 81.16 6.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 73.140000000000001 110.403 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -80.28 -11.18 59.75 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.506 1.128 . . . . 74.120000000000005 110.995 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.449 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -72.57 -5.2 35.53 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.519 1.137 . . . . 73.230000000000004 110.314 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.747 ' CE2' HD13 ' A' ' 304' ' ' LEU . 26.8 t80 -129.73 69.68 81.64 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.539 1.149 . . . . 75.109999999999999 111.023 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.693 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.4 Cg_endo -74.94 114.19 3.97 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.448 1.762 . . . . 64.329999999999998 111.039 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.566 HG21 ' CE1' ' A' ' 172' ' ' TYR . 22.1 t -153.26 -66.41 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.51 1.131 . . . . 61.130000000000003 109.302 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -163.91 114.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.518 1.136 . . . . 75.530000000000001 109.28 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.57 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 151.64 46.4 0.02 OUTLIER Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.476 1.11 . . . . 72.099999999999994 111.004 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.455 ' HB2' HG13 ' A' ' 219' ' ' VAL . 84.9 m -85.73 -23.12 27.47 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.3 -1.0 . . . . 74.010000000000005 108.3 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.57 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 16.1 p90 -67.13 -35.89 80.71 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.531 1.145 . . . . 74.530000000000001 110.995 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.568 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -68.53 -67.04 0.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.477 1.111 . . . . 44.539999999999999 109.271 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.475 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -44.05 -46.56 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.512 1.133 . . . . 73.230000000000004 110.319 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.531 ' HB1' ' NZ ' ' A' ' 197' ' ' LYS . . . -44.96 -50.45 10.57 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 73.239999999999995 109.285 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.693 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -54.0 -35.39 61.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.528 1.143 . . . . 73.129999999999995 109.579 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.729 ' CB ' HD11 ' A' ' 168' ' ' ILE . 17.4 mmmt -73.43 -32.22 64.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.529 1.143 . . . . 75.230000000000004 109.334 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 20.3 mtm -66.21 -55.95 13.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.47 1.106 . . . . 63.539999999999999 110.99 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.66 HH21 ' N ' ' A' ' 275' ' ' ASN . 0.0 OUTLIER -55.32 -26.86 43.17 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 74.409999999999997 110.364 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.432 ' HG2' HD13 ' A' ' 187' ' ' ILE . 1.2 tt0 -64.05 -43.38 95.69 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 72.329999999999998 110.266 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.432 HD13 ' HG2' ' A' ' 186' ' ' GLN . 21.4 mm -70.48 -38.04 72.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.138 . . . . 72.109999999999999 109.281 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.766 HD22 ' HB3' ' A' ' 195' ' ' CYS . 0.2 OUTLIER -56.43 -31.6 64.09 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 63.340000000000003 109.319 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.525 ' HG2' HD21 ' A' ' 136' ' ' LEU . 35.7 mtp -72.89 -43.64 62.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.573 1.171 . . . . 75.420000000000002 110.973 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -45.32 -53.37 8.56 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.473 1.108 . . . . 64.430000000000007 109.296 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -64.66 -27.86 69.21 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 73.209999999999994 109.314 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 104.08 52.33 0.89 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.545 1.153 . . . . 61.409999999999997 111.002 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.782 ' CZ ' HG21 ' A' ' 145' ' ' THR . 60.2 m-85 -150.83 128.13 11.31 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.537 0.786 . . . . 63.109999999999999 110.981 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.779 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -98.38 131.51 44.61 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.472 1.107 . . . . 61.210000000000001 109.363 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.766 ' HB3' HD22 ' A' ' 188' ' ' LEU . 24.1 p -109.5 -179.3 3.79 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.5 1.125 . . . . 44.119999999999997 108.276 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.71 176.99 5.44 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.55 1.156 . . . . 62.020000000000003 110.305 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.836 ' HE2' HG22 ' A' ' 221' ' ' ILE . 14.2 mmtt -105.7 171.6 7.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.486 1.116 . . . . 75.310000000000002 109.302 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 31.8 tt0 -166.81 121.02 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.526 1.141 . . . . 72.430000000000007 110.288 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 8.8 m-85 -116.37 123.93 48.81 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.466 1.104 . . . . 64.5 110.99 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.659 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.7 p -115.28 152.68 16.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.496 1.122 . . . . 71.209999999999994 109.279 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 5.3 m-85 -124.91 162.75 23.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 73.340000000000003 111.016 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 116.57 -179.88 17.76 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.455 1.097 . . . . 61.399999999999999 111.005 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.721 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.0 t-20 -69.11 109.62 4.12 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.528 0.781 . . . . 64.140000000000001 109.276 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.721 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.9 mt -114.01 93.78 4.52 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.432 1.083 . . . . 73.239999999999995 109.297 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.52 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 7.1 mttt -93.12 167.19 11.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.506 1.129 . . . . 34.25 109.349 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.487 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -175.53 151.86 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.527 1.142 . . . . 61.340000000000003 109.286 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.5 t -124.32 131.99 53.54 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 64.200000000000003 109.962 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 17.3 p -97.29 -14.23 21.47 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 62.109999999999999 110.414 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 117.66 -30.96 5.93 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.503 1.127 . . . . 15.529999999999999 110.998 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.5 t -110.95 -22.48 11.49 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.535 0.785 . . . . 65.530000000000001 110.396 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . 0.482 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -160.98 163.5 31.7 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.122 . . . . 70.430000000000007 108.283 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.482 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.37 143.76 46.4 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 73.310000000000002 108.315 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.693 HG11 ' O ' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -110.28 156.61 11.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 75.409999999999997 109.287 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.52 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -141.34 119.2 11.83 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.52 1.137 . . . . 33.240000000000002 109.348 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -125.11 137.1 54.18 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.01 -1.107 . . . . 75.340000000000003 108.01 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.8 p -81.81 4.6 21.58 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.508 1.13 . . . . 61.539999999999999 110.022 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.505 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 9.3 p90 -177.74 126.87 0.13 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.522 1.139 . . . . 73.319999999999993 110.946 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.514 ' CD2' ' CZ2' ' A' ' 252' ' ' TRP . 40.5 t60 -112.7 168.71 9.45 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 1.106 . . . . 71.120000000000005 109.608 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 218' ' ' HIS . 1.5 p -144.62 142.07 23.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 62.520000000000003 109.314 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -143.76 -165.13 2.03 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.514 1.134 . . . . 52.32 109.304 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.836 HG22 ' HE2' ' A' ' 197' ' ' LYS . 14.2 pt -119.07 124.93 73.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.535 1.147 . . . . 44.340000000000003 109.305 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.3 tp -85.9 108.99 18.42 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 70.109999999999999 109.293 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.714 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -105.61 148.03 10.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.128 . . . . 71.439999999999998 109.301 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.881 ' HB3' HG23 ' A' ' 139' ' ' VAL . 49.7 m -116.89 125.39 51.42 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.495 1.122 . . . . 75.010000000000005 110.03 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 34.8 p90 -139.48 137.47 35.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.54 1.15 . . . . 65.340000000000003 111.009 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 20.1 mmtp -64.6 131.1 46.05 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.568 1.167 . . . . 63.539999999999999 109.347 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.6 OUTLIER -72.06 -160.54 0.06 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 65.230000000000004 109.277 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.8 -0.08 49.56 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.128 . . . . 71.340000000000003 109.324 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.98 -7.85 12.52 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.497 1.123 . . . . 72.239999999999995 110.034 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.42 37.8 8.0 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.495 1.122 . . . . 43.109999999999999 111.001 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.62 43.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.501 0.765 . . . . 72.530000000000001 109.283 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.483 HG23 ' CG2' ' A' ' 139' ' ' VAL . 2.5 m -71.9 102.75 2.98 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.463 1.102 . . . . 75.540000000000006 110.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 224' ' ' SER . 6.8 mm-40 -102.63 -172.58 2.15 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.509 1.131 . . . . 75.409999999999997 110.303 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.519 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.1 mmtm -126.18 145.39 50.39 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 61.420000000000002 109.301 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.636 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.2 tpt180 -143.07 161.44 38.15 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 74.049999999999997 110.31 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.681 HG21 ' CD1' ' A' ' 252' ' ' TRP . 11.2 mm -114.74 116.55 52.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.562 1.163 . . . . 75.25 109.305 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 237' ' ' ILE . 4.0 mm -102.58 45.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.115 . . . . 74.439999999999998 109.298 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.05 109.47 62.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.523 1.139 . . . . 75.439999999999998 109.263 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.2 Cg_endo -75.05 -27.3 10.05 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.477 1.777 . . . . 74.129999999999995 110.966 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.9 OUTLIER -45.21 -26.37 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.471 1.107 . . . . 74.450000000000003 109.992 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.25 -60.39 1.87 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.519 1.137 . . . . 74.409999999999997 109.294 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 255' ' ' ALA . 87.9 m-85 -107.87 99.6 9.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.508 1.13 . . . . 72.109999999999999 111.009 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.96 -6.28 57.36 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 72.019999999999996 110.015 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 4.9 p -80.53 -46.09 16.38 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.539 1.15 . . . . 71.209999999999994 109.97 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.49 -175.76 42.31 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.524 1.14 . . . . 74.120000000000005 111.034 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.449 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.98 163.57 35.1 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.503 1.791 . . . . 65.140000000000001 110.987 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 242' ' ' PHE . 2.4 m -150.35 156.88 6.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.107 . . . . 54.229999999999997 109.278 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.423 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.2 p -60.54 140.49 57.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 72.530000000000001 110.434 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.403 ' HA ' ' CG1' ' A' ' 236' ' ' ILE . 1.1 p-10 -42.97 -28.98 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.526 1.141 . . . . 75.329999999999998 109.281 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.423 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.0 m -71.34 -65.22 0.78 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.485 1.116 . . . . 73.239999999999995 110.421 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.32 13.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.494 1.121 . . . . 64.25 109.31 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.681 ' CD1' HG21 ' A' ' 236' ' ' ILE . 12.5 t90 -59.94 -61.12 2.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.982 -1.118 . . . . 63.240000000000002 107.982 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.566 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -47.42 -41.61 20.52 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 61.119999999999997 110.275 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.826 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.9 m-80 -57.31 -51.11 70.68 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 74.209999999999994 109.3 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.588 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.25 -19.51 14.36 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.464 1.102 . . . . 62.229999999999997 109.297 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.5 m -89.08 -35.81 16.11 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.483 1.114 . . . . 73.439999999999998 108.32 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.826 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.5 m -93.96 21.36 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 74.400000000000006 109.304 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -50.22 106.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.481 1.113 . . . . 64.040000000000006 109.316 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 262' ' ' GLY . 4.6 p -73.48 -3.14 25.74 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.507 1.129 . . . . 72.049999999999997 110.38 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 39.0 t -44.52 -30.76 0.94 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.471 1.107 . . . . 73.349999999999994 110.025 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 41.9 t -88.51 -37.2 15.94 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 62.219999999999999 108.275 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 166.84 -127.95 1.67 Allowed Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.53 1.144 . . . . 41.140000000000001 110.983 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -74.61 144.86 43.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.522 0.778 . . . . 74.150000000000006 109.942 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.21 147.53 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 73.439999999999998 109.304 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 84.1 p -172.95 155.56 3.11 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.125 . . . . 74.450000000000003 109.973 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.659 HG23 ' CG2' ' A' ' 200' ' ' VAL . 3.8 p -101.14 118.86 48.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.145 . . . . 75.349999999999994 109.357 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.3 t -73.22 -43.75 60.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.469 1.105 . . . . 73.140000000000001 110.026 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.564 ' O ' HG23 ' A' ' 200' ' ' VAL . 51.2 p -168.8 -179.35 3.7 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.447 1.092 . . . . 65.25 110.029 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -159.22 157.16 30.19 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.514 1.134 . . . . 73.129999999999995 110.979 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.35 152.22 29.97 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.494 1.121 . . . . 62.439999999999998 109.295 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 272' ' ' THR . 0.8 OUTLIER -112.36 160.71 17.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.493 1.121 . . . . 72.519999999999996 109.344 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.642 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.7 p -153.83 -178.45 7.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.487 1.117 . . . . 61.240000000000002 110.396 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.829 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -68.24 162.15 25.66 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.461 1.101 . . . . 63.420000000000002 109.311 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -72.9 -44.69 36.37 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.515 1.135 . . . . 73.209999999999994 111.015 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.66 ' N ' HH21 ' A' ' 185' ' ' ARG . 1.7 p30 -53.18 -41.01 64.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 0.777 . . . . 72.510000000000005 109.299 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.829 HG23 ' HB3' ' A' ' 273' ' ' ALA . 22.8 t -43.56 120.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 74.540000000000006 109.247 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -82.2 -53.07 6.36 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.523 1.139 . . . . 73.209999999999994 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -136.92 152.83 50.65 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 74.239999999999995 111.002 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.642 ' HD2' HG21 ' A' ' 272' ' ' THR . 78.2 ttt-85 -126.86 147.3 50.06 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.492 1.12 . . . . 73.230000000000004 110.31 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.96 158.14 50.92 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.47 1.106 . . . . 62.420000000000002 109.936 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.04 0.25 9.15 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.465 1.771 . . . . 73.409999999999997 110.952 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 7.1 t -98.98 4.98 47.38 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 72.409999999999997 110.015 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.5 t-20 75.38 41.56 0.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.475 1.109 . . . . 74.349999999999994 109.338 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -120.21 120.39 36.01 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.467 1.104 . . . . 64.049999999999997 109.981 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.46 ' OH ' HG22 ' A' ' 272' ' ' THR . 11.7 m-30 -103.05 160.65 14.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.508 1.13 . . . . 61.399999999999999 111.035 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.671 ' CD1' ' CE2' ' A' ' 320' ' ' PHE . 1.0 OUTLIER -125.42 177.24 6.29 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 54.329999999999998 109.342 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.7 m-85 -161.03 115.84 2.11 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.476 1.11 . . . . 64.540000000000006 111.016 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.43 ' O ' ' NE2' ' A' ' 182' ' ' HIS . 1.0 OUTLIER -115.36 96.78 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.512 1.132 . . . . 74.239999999999995 109.348 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -85.63 -19.11 31.46 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 75.439999999999998 109.253 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.473 ' HB3' HD11 ' A' ' 292' ' ' ILE . 38.6 m-20 -107.65 6.59 27.93 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.461 1.101 . . . . 75.430000000000007 109.297 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.693 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.26 47.22 2.09 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.478 1.112 . . . . 73.209999999999994 109.3 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.703 HG21 ' O ' ' A' ' 319' ' ' GLY . 47.5 mm -76.51 -31.58 20.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 73.310000000000002 109.296 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.78 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.5 t-20 -94.78 -18.51 21.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.478 1.112 . . . . 71.400000000000006 109.27 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.52 HG22 ' HD3' ' A' ' 183' ' ' LYS . 2.0 m -84.76 -66.51 0.89 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.497 1.123 . . . . 60.439999999999998 110.424 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 87.8 m-20 -56.68 -18.71 13.24 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.481 1.113 . . . . 52.399999999999999 109.278 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 4.9 t -80.49 -63.9 1.31 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.504 1.128 . . . . 74.030000000000001 108.308 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 293' ' ' ASN . 65.9 t -46.93 -37.24 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.52 1.138 . . . . 71.040000000000006 109.334 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.663 HD11 ' HG3' ' A' ' 183' ' ' LYS . 85.2 mt -67.69 -57.8 5.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.493 1.12 . . . . 74.129999999999995 109.277 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.85 -20.76 16.65 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.497 1.123 . . . . 73.409999999999997 110.384 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -72.27 -39.2 68.53 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.482 1.114 . . . . 70.340000000000003 109.3 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.943 ' CD1' HD12 ' A' ' 304' ' ' LEU . 3.6 m-30 -101.78 35.09 2.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.498 1.123 . . . . 64.340000000000003 110.987 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.3 t -67.96 -43.85 78.07 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.513 1.133 . . . . 73.150000000000006 110.01 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.785 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -95.62 -17.18 21.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.102 . . . . 54.439999999999998 109.278 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.943 HD12 ' CD1' ' A' ' 301' ' ' PHE . 14.2 mt -56.58 153.43 10.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 63.200000000000003 109.288 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.1 p -165.55 162.17 18.94 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.528 1.142 . . . . 72.0 110.039 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 65.69 -153.1 51.48 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.507 1.13 . . . . 75.019999999999996 110.979 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 3.0 m -99.38 9.77 42.66 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.294 -1.002 . . . . 73.040000000000006 108.294 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.527 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -125.06 148.85 61.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.476 1.11 . . . . 55.009999999999998 109.953 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.735 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -74.96 147.06 88.37 Favored 'Cis proline' 0 C--N 1.36 1.164 0 C-N-CA 120.965 -2.515 . . . . 73.409999999999997 111.014 -0.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.467 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 0.1 OUTLIER -128.83 133.33 25.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 63.140000000000001 110.006 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.99 -168.73 6.72 Favored 'Cis proline' 0 C--N 1.36 1.179 0 C-N-CA 120.974 -2.511 . . . . 73.219999999999999 111.042 -0.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.03 150.3 40.53 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.515 1.135 . . . . 73.219999999999999 109.318 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.98 -162.32 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.525 1.803 . . . . 71.019999999999996 111.03 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.47 127.33 39.07 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.528 1.143 . . . . 73.239999999999995 109.237 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 18.2 m -112.52 27.22 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.526 1.141 . . . . 72.099999999999994 109.297 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 12.5 t -51.72 -35.55 43.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 70.019999999999996 109.993 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 30.8 m -42.3 -28.86 0.22 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.422 1.076 . . . . 73.420000000000002 110.025 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 62.0 m -56.81 -176.43 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.488 1.118 . . . . 73.420000000000002 108.29 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.703 ' O ' HG21 ' A' ' 292' ' ' ILE . . . 179.0 84.31 0.06 OUTLIER Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.527 1.142 . . . . 43.039999999999999 111.001 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.671 ' CE2' ' CD1' ' A' ' 286' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.496 0 O-C-N 124.517 0.775 . . . . 73.319999999999993 110.976 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.967 HD23 ' HB2' ' A' ' 194' ' ' ASP . 12.5 tp . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.316 -0.624 . . . . 71.420000000000002 109.316 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -102.56 106.91 17.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.525 1.141 . . . . 64.430000000000007 109.302 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.2 m -69.33 -42.59 75.12 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.478 1.111 . . . . 61.399999999999999 109.972 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.845 HG23 ' HB3' ' A' ' 224' ' ' SER . 0.4 OUTLIER -112.79 159.75 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 72.340000000000003 109.298 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.866 HD11 HD12 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -98.07 143.83 26.95 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.466 1.104 . . . . 72.150000000000006 109.316 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.464 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.4 Cg_endo -75.02 -33.23 4.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.514 1.797 . . . . 75.349999999999994 110.984 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.41 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.37 146.28 16.83 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.471 1.107 . . . . 61.109999999999999 109.267 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.9 t -45.15 -36.47 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.552 1.158 . . . . 62.240000000000002 109.271 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.83 -47.75 2.96 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.546 1.153 . . . . 63.539999999999999 109.265 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.8 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.11 -36.26 72.09 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.546 1.154 . . . . 34.299999999999997 110.406 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.742 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -57.7 -57.26 13.53 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.493 1.121 . . . . 72.239999999999995 109.32 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.501 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 48.8 m-80 -51.91 -31.93 30.62 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.537 1.148 . . . . 62.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -68.75 -56.66 7.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 62.229999999999997 109.998 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.866 HD12 HD11 ' A' ' 140' ' ' ILE . 22.6 mt -43.05 -41.08 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.506 1.129 . . . . 63.32 109.28 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.763 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.02 -44.48 54.31 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.544 1.153 . . . . 73.219999999999999 111.003 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -48.52 -34.82 11.99 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.135 . . . . 74.120000000000005 109.324 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.438 HE22 ' ND2' ' A' ' 191' ' ' ASN . 54.0 mt-30 -77.69 -51.7 10.17 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.516 1.135 . . . . 72.450000000000003 110.335 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 188' ' ' LEU . 17.6 mt -54.61 -24.74 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.147 . . . . 51.340000000000003 109.327 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 -34.73 49.29 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.531 1.144 . . . . 72.040000000000006 109.26 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -58.64 -20.08 44.65 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.519 1.137 . . . . 62.25 109.295 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.462 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 8.9 mm100 -77.63 -24.1 49.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.119 . . . . 74.409999999999997 110.29 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 160' ' ' THR . 6.3 m -38.99 113.04 0.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.468 1.105 . . . . 70.219999999999999 109.967 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 5.9 m -43.05 129.65 4.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.475 1.109 . . . . 55.32 108.301 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 125.36 -14.24 7.35 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.511 1.132 . . . . 71.010000000000005 110.989 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.676 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 45.1 p -98.47 154.22 18.03 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 0.775 . . . . 52.310000000000002 110.434 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 p -86.4 -3.61 59.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.548 1.155 . . . . 73.319999999999993 109.974 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.8 m -106.92 -3.98 19.63 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.536 1.148 . . . . 71.030000000000001 110.369 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.676 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -76.93 133.6 39.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.51 1.131 . . . . 71.450000000000003 109.285 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -168.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.503 1.127 . . . . 63.439999999999998 109.99 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.464 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 1.1 t -155.91 128.16 4.02 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.479 1.112 . . . . 61.409999999999997 110.002 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.464 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 136.62 46.04 Favored 'Cis proline' 0 C--N 1.361 1.191 0 C-N-CA 120.967 -2.514 . . . . 52.030000000000001 111.03 -0.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 13.2 p -73.01 179.66 3.66 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.536 1.148 . . . . 71.129999999999995 108.3 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.834 HD11 ' CB ' ' A' ' 183' ' ' LYS . 4.4 mp -91.9 135.41 27.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.45 1.094 . . . . 74.140000000000001 109.336 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 13.8 p -96.19 94.53 7.56 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.122 . . . . 54.399999999999999 110.388 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.516 ' CE2' ' HG2' ' A' ' 239' ' ' PRO . 90.2 m-85 -88.48 -15.46 35.3 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.557 1.161 . . . . 72.109999999999999 110.993 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -74.67 -2.02 24.38 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 74.120000000000005 110.285 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.565 ' CD2' ' HB3' ' A' ' 301' ' ' PHE . 30.9 t80 -132.38 67.18 78.45 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 74.040000000000006 111.014 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.416 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.3 Cg_endo -75.03 112.53 3.58 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.471 1.774 . . . . 64.230000000000004 110.991 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.533 HG21 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.95 -72.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 71.400000000000006 109.305 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -152.6 125.12 8.25 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.539 1.15 . . . . 62.210000000000001 109.325 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.467 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 139.34 44.29 0.07 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.467 1.105 . . . . 72.400000000000006 111.02 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 218' ' ' HIS . 6.0 t -81.56 -25.42 35.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.329 -0.989 . . . . 64.150000000000006 108.329 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.467 ' CE2' ' HA2' ' A' ' 176' ' ' GLY . 28.4 p90 -71.47 -28.67 64.11 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.522 1.139 . . . . 74.439999999999998 110.992 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.09 -68.12 0.49 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.423 1.077 . . . . 63.039999999999999 109.307 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.508 HH21 ' HE2' ' A' ' 170' ' ' PHE . 0.1 OUTLIER -45.24 -47.69 12.78 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.47 1.106 . . . . 70.129999999999995 110.298 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.543 ' HB1' ' NZ ' ' A' ' 197' ' ' LYS . . . -43.2 -55.09 4.14 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.465 1.103 . . . . 71.109999999999999 109.28 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.42 -36.61 15.15 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 74.140000000000001 109.582 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.834 ' CB ' HD11 ' A' ' 168' ' ' ILE . 9.4 mmmm -77.07 -32.82 57.04 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.539 1.149 . . . . 72.120000000000005 109.3 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 181' ' ' ALA . 18.3 mtm -63.6 -50.23 70.23 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 71.140000000000001 110.99 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.521 ' CZ ' ' HE3' ' A' ' 189' ' ' MET . 0.0 OUTLIER -64.43 -26.34 68.41 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 72.040000000000006 110.316 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.85 -38.92 90.01 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 73.450000000000003 110.301 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.436 ' CG2' ' CB ' ' A' ' 152' ' ' GLN . 21.2 mm -70.7 -37.68 70.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 64.409999999999997 109.336 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -54.69 -44.08 73.08 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.525 1.141 . . . . 73.310000000000002 109.273 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.521 ' HE3' ' CZ ' ' A' ' 185' ' ' ARG . 13.7 mtt -58.85 -43.59 90.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.517 1.135 . . . . 60.420000000000002 111.047 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -48.08 -51.46 24.35 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.464 1.103 . . . . 75.340000000000003 109.3 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.438 ' ND2' HE22 ' A' ' 152' ' ' GLN . 6.1 t-20 -68.74 -26.06 65.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.451 1.094 . . . . 75.230000000000004 109.257 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 101.15 57.94 0.84 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.495 1.122 . . . . 61.109999999999999 110.982 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.8 ' CZ ' HG21 ' A' ' 145' ' ' THR . 59.6 m-85 -152.13 140.37 20.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.459 0.741 . . . . 75.140000000000001 110.999 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.967 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -105.53 130.8 53.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.118 . . . . 72.230000000000004 109.301 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.915 ' HB3' HD22 ' A' ' 188' ' ' LEU . 11.4 p -109.42 -179.52 3.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.517 1.136 . . . . 65.430000000000007 108.258 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.13 175.65 8.25 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.543 1.152 . . . . 75.200000000000003 110.279 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.595 ' HE2' HG22 ' A' ' 221' ' ' ILE . 15.8 mmtt -108.9 159.32 16.89 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 73.430000000000007 109.306 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 8.3 tt0 -152.4 117.72 5.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.548 1.155 . . . . 74.510000000000005 110.273 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.561 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.0 m-85 -108.94 136.13 48.98 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.496 1.122 . . . . 62.109999999999999 111.047 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.657 HG22 HG23 ' A' ' 266' ' ' VAL . 9.4 p -131.81 143.33 40.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.473 1.108 . . . . 75.349999999999994 109.318 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 201' ' ' TYR . 4.3 m-85 -117.7 161.38 19.77 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.502 1.126 . . . . 71.200000000000003 110.952 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.63 -179.62 17.28 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.502 1.126 . . . . 53.450000000000003 111.023 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.725 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.8 t-20 -69.08 110.22 4.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 0.767 . . . . 73.430000000000007 109.324 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.725 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.8 mt -114.32 93.98 4.59 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 74.120000000000005 109.301 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.655 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 7.0 mttt -93.36 166.14 12.44 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 73.030000000000001 109.297 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 212' ' ' CYS . . . -173.28 148.18 1.61 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.537 1.148 . . . . 75.109999999999999 109.286 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.6 t -123.73 131.23 53.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 63.240000000000002 109.953 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 10.6 p -99.96 -4.35 30.3 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.498 1.124 . . . . 62.409999999999997 110.368 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 105.36 -35.48 5.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.457 1.098 . . . . 30.129999999999999 111.008 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 7.0 t -102.28 -22.42 14.15 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.508 0.769 . . . . 63.030000000000001 110.392 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . 0.481 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -166.2 163.52 17.85 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.512 1.133 . . . . 52.409999999999997 108.286 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.481 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -119.58 148.57 43.16 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.453 1.095 . . . . 64.430000000000007 108.314 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.0 OUTLIER -117.99 157.52 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.482 1.114 . . . . 53.140000000000001 109.27 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.655 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -140.76 120.55 13.47 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 70.530000000000001 109.26 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.444 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m-90 -125.95 135.67 52.13 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 74.549999999999997 107.995 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.6 t -81.14 1.21 32.85 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.25 109.969 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.522 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 11.2 p90 -172.23 125.62 0.53 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.467 1.104 . . . . 74.400000000000006 111.024 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.6 ' CE1' ' SG ' ' A' ' 177' ' ' CYS . 76.4 t60 -125.41 157.7 36.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.47 1.107 . . . . 74.209999999999994 109.568 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 177' ' ' CYS . 1.5 p -131.5 163.99 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.548 1.155 . . . . 54.240000000000002 109.288 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.65 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -156.19 -167.55 2.47 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.517 1.136 . . . . 50.420000000000002 109.292 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.595 HG22 ' HE2' ' A' ' 197' ' ' LYS . 30.6 pt -117.77 119.79 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.515 1.135 . . . . 63.25 109.316 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 234' ' ' LYS . 10.8 tp -83.11 109.86 17.52 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.555 1.159 . . . . 75.140000000000001 109.304 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.742 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.7 OUTLIER -106.15 147.48 11.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.505 1.128 . . . . 71.340000000000003 109.313 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.845 ' HB3' HG23 ' A' ' 139' ' ' VAL . 37.0 m -116.74 125.4 51.6 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 73.099999999999994 109.983 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.572 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.7 p90 -140.52 137.44 33.81 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.54 1.15 . . . . 74.200000000000003 110.977 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.406 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 17.9 mmtp -64.08 132.45 50.55 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.546 1.153 . . . . 53.439999999999998 109.307 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.43 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -72.82 -160.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.496 1.122 . . . . 74.340000000000003 109.311 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.86 0.34 48.02 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.503 1.127 . . . . 72.319999999999993 109.309 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.32 -8.56 12.27 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.505 1.128 . . . . 74.340000000000003 109.997 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.45 37.73 7.44 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.469 1.106 . . . . 75.450000000000003 110.967 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.65 136.97 46.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.535 0.785 . . . . 73.540000000000006 109.28 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.493 HG23 ' CG2' ' A' ' 139' ' ' VAL . 2.5 m -71.23 102.79 2.63 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.502 1.126 . . . . 70.409999999999997 110.389 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.43 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 2.2 mm-40 -102.33 -172.65 2.17 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.512 1.133 . . . . 73.340000000000003 110.32 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.493 ' HB3' HD11 ' A' ' 222' ' ' LEU . 13.8 mmtm -126.1 145.36 50.38 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.468 1.105 . . . . 70.510000000000005 109.283 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.613 ' HB3' HG22 ' A' ' 223' ' ' VAL . 4.7 tpt180 -145.88 160.34 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 62.409999999999997 110.325 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.547 HG21 ' CD1' ' A' ' 252' ' ' TRP . 9.9 mm -114.24 120.89 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 75.519999999999996 109.251 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.763 HD12 ' HB2' ' A' ' 150' ' ' PHE . 5.5 mm -104.29 44.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 74.329999999999998 109.288 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.57 113.62 62.83 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.534 1.146 . . . . 75.040000000000006 109.271 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.516 ' HG2' ' CE2' ' A' ' 170' ' ' PHE . 18.4 Cg_endo -75.03 -26.61 10.71 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.501 1.79 . . . . 71.420000000000002 111.009 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.419 ' HB2' ' NH2' ' A' ' 180' ' ' ARG . 0.1 OUTLIER -41.53 -30.76 0.22 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 74.5 110.049 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.2 mt -110.05 -61.14 1.7 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.457 1.098 . . . . 72.319999999999993 109.317 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.869 ' CE2' HG21 ' A' ' 247' ' ' VAL . 98.3 m-85 -108.78 99.51 8.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 74.329999999999998 111.013 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 69.5 m -86.39 -15.98 38.68 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 64.5 109.998 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 15.8 t -73.92 -40.05 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.515 1.135 . . . . 70.120000000000005 110.011 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.6 -177.54 45.65 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.498 1.124 . . . . 51.119999999999997 111.04 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.437 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.96 170.57 20.12 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.503 1.791 . . . . 74.420000000000002 111.062 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.869 HG21 ' CE2' ' A' ' 242' ' ' PHE . 11.2 m -150.84 158.55 4.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.506 1.129 . . . . 64.209999999999994 109.287 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.404 ' C ' ' N ' ' A' ' 250' ' ' THR . 40.6 p -60.64 141.45 56.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.55 1.157 . . . . 51.100000000000001 110.379 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -46.3 -25.91 0.71 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 71.319999999999993 109.331 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.404 ' N ' ' C ' ' A' ' 248' ' ' THR . 21.4 m -79.37 -61.14 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.529 1.143 . . . . 72.219999999999999 110.439 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -54.42 -22.22 11.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.473 1.108 . . . . 63.210000000000001 109.283 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.65 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 10.6 t90 -66.56 -57.8 6.52 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.513 1.133 . . . . 64.439999999999998 107.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.556 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.0 OUTLIER -49.22 -42.99 42.16 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.503 1.127 . . . . 30.149999999999999 110.33 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.834 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.4 m-80 -56.24 -51.04 69.57 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 75.340000000000003 109.31 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.6 -19.36 10.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.444 1.09 . . . . 73.209999999999994 109.321 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.467 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -89.0 -36.79 15.63 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 73.329999999999998 108.266 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.834 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.4 m -92.73 20.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.492 1.12 . . . . 73.420000000000002 109.315 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -50.18 105.78 0.1 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.467 1.105 . . . . 72.019999999999996 109.266 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.41 -3.26 26.26 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.506 1.129 . . . . 75.430000000000007 110.352 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 t -44.47 -30.13 0.82 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 52.140000000000001 110.01 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 40.8 t -89.01 -37.3 15.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.485 1.115 . . . . 63.509999999999998 108.29 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 168.13 -129.3 1.86 Allowed Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.481 1.113 . . . . 75.439999999999998 111.019 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.8 OUTLIER -73.9 145.18 45.0 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.582 0.813 . . . . 64.209999999999994 110.036 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.16 147.68 4.68 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.513 1.133 . . . . 62.100000000000001 109.281 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 94.7 p -172.9 155.48 3.14 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.477 1.11 . . . . 75.099999999999994 110.035 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.657 HG23 HG22 ' A' ' 200' ' ' VAL . 3.7 p -101.42 117.95 47.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.506 1.129 . . . . 74.230000000000004 109.313 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.2 t -73.89 -44.19 56.11 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.521 1.138 . . . . 74.420000000000002 109.981 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 1.4 m -166.65 172.97 10.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.482 1.114 . . . . 63.340000000000003 110.002 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.408 ' HB3' HG23 ' A' ' 200' ' ' VAL . 30.9 p90 -154.64 156.05 35.79 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 73.230000000000004 111.011 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -154.65 153.34 31.17 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.541 1.151 . . . . 65.209999999999994 109.311 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 272' ' ' THR . 1.0 OUTLIER -113.49 160.7 18.2 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 72.5 109.257 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.542 HG22 ' CZ ' ' A' ' 285' ' ' TYR . 2.5 p -154.37 -179.61 8.1 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.52 1.137 . . . . 75.329999999999998 110.41 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.85 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -66.83 167.76 10.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.449 1.093 . . . . 60.310000000000002 109.307 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -78.9 -41.77 13.97 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.481 1.113 . . . . 74.010000000000005 110.986 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -57.2 -42.59 81.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.509 0.77 . . . . 64.409999999999997 109.373 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.85 HG23 ' HB3' ' A' ' 273' ' ' ALA . 44.1 t -43.86 118.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.488 1.118 . . . . 75.030000000000001 109.297 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.582 ' CD2' ' OD2' ' A' ' 288' ' ' ASP . 18.4 t80 -73.74 -53.46 10.29 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 74.549999999999997 111.003 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.522 ' CZ ' ' O ' ' A' ' 279' ' ' ARG . 31.0 t80 -136.31 166.7 22.83 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.485 1.115 . . . . 70.340000000000003 111.008 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.561 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 76.0 ttt-85 -135.39 147.45 49.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 64.420000000000002 110.283 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.85 158.03 50.94 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.508 1.13 . . . . 61.299999999999997 109.997 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.06 0.32 9.08 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.565 1.823 . . . . 70.349999999999994 111.01 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 42.0 p -98.42 4.23 48.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.465 1.103 . . . . 74.430000000000007 109.993 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 282' ' ' SER . 3.3 t-20 77.21 41.74 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 73.409999999999997 109.304 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.2 t -122.66 131.4 53.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.541 1.151 . . . . 64.430000000000007 109.973 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.552 ' HB3' HG13 ' A' ' 276' ' ' VAL . 16.4 m-30 -111.65 153.13 26.83 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.498 1.124 . . . . 73.0 110.953 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.587 ' C ' ' CD1' ' A' ' 287' ' ' TYR . 0.2 OUTLIER -110.95 177.44 4.67 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.458 1.099 . . . . 73.209999999999994 109.334 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.587 ' CD1' ' C ' ' A' ' 286' ' ' LEU . 84.9 m-85 -160.25 115.79 2.33 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.522 1.139 . . . . 75.319999999999993 111.044 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.582 ' OD2' ' CD2' ' A' ' 277' ' ' TYR . 0.7 OUTLIER -115.43 94.98 4.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.478 1.111 . . . . 70.219999999999999 109.337 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -85.61 -18.34 33.57 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.483 1.115 . . . . 60.299999999999997 109.297 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.44 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.3 m-20 -107.09 3.28 25.66 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.476 1.11 . . . . 73.409999999999997 109.322 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.685 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.56 47.43 2.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.448 1.092 . . . . 73.109999999999999 109.27 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.722 HG22 ' H ' ' A' ' 319' ' ' GLY . 22.5 mm -74.27 -32.63 32.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.513 1.133 . . . . 62.219999999999999 109.276 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.659 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.9 t-20 -90.72 -26.17 19.67 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.476 1.11 . . . . 72.439999999999998 109.291 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.459 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 1.3 m -79.37 -65.35 1.01 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.463 1.102 . . . . 62.299999999999997 110.409 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -54.59 -20.13 7.37 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.514 1.133 . . . . 62.399999999999999 109.272 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 40.4 t -86.32 -62.22 1.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.477 1.111 . . . . 73.430000000000007 108.288 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.9 t -40.29 -41.13 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.11 . . . . 55.340000000000003 109.29 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' A' ' 168' ' ' ILE . 24.3 mt -69.96 -56.13 7.82 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.536 1.148 . . . . 75.329999999999998 109.316 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -55.3 -18.46 6.4 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.478 1.111 . . . . 74.230000000000004 110.449 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.609 ' HE2' HG12 ' A' ' 315' ' ' VAL . 18.6 mmmt -75.38 -45.77 37.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 72.450000000000003 109.302 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.694 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.6 m-30 -99.81 38.87 1.39 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.563 1.165 . . . . 71.209999999999994 111.029 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.1 t -69.5 -45.01 69.94 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.122 . . . . 55.409999999999997 110.029 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.801 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.67 -17.7 22.95 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.481 1.113 . . . . 51.530000000000001 109.277 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.767 HD22 ' CD ' ' A' ' 309' ' ' PRO . 14.8 mt -59.52 144.91 46.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 73.040000000000006 109.34 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.3 p -154.02 158.08 40.04 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 75.420000000000002 110.057 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 70.32 -162.17 53.25 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.505 1.128 . . . . 74.230000000000004 110.969 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 310' ' ' SER . 9.4 p -92.1 13.9 17.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.29 -1.004 . . . . 74.5 108.29 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 3.3 m -132.96 148.1 68.08 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.528 1.142 . . . . 62.439999999999998 110.009 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.767 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 145.42 83.87 Favored 'Cis proline' 0 C--N 1.361 1.196 0 C-N-CA 120.984 -2.507 . . . . 64.099999999999994 111.008 0.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.495 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 1.2 t -131.35 135.6 27.33 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.488 1.117 . . . . 71.310000000000002 109.996 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.97 -174.96 15.03 Favored 'Cis proline' 0 C--N 1.36 1.182 0 C-N-CA 121.016 -2.493 . . . . 72.209999999999994 111.026 -0.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.43 154.96 21.06 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.538 1.149 . . . . 73.319999999999993 109.296 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.425 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.4 Cg_endo -74.97 -162.23 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.498 1.788 . . . . 22.129999999999999 111.011 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -82.96 131.52 35.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.489 1.118 . . . . 72.040000000000006 109.297 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.609 HG12 ' HE2' ' A' ' 300' ' ' LYS . 34.1 m -129.39 26.52 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.512 1.133 . . . . 70.340000000000003 109.305 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 6.9 t -70.76 -33.52 70.88 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.491 1.119 . . . . 54.409999999999997 109.982 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 22.6 p -45.75 -25.71 0.54 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 64.530000000000001 110.01 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.39 -173.83 1.2 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.519 1.137 . . . . 71.439999999999998 108.275 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.722 ' H ' HG22 ' A' ' 292' ' ' ILE . . . -164.4 -135.58 1.85 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.475 1.109 . . . . 72.409999999999997 110.955 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.445 ' CA ' ' HB ' ' A' ' 292' ' ' ILE . 20.5 m-85 . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.516 0.774 . . . . 72.400000000000006 110.977 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.98 HD23 ' HB2' ' A' ' 194' ' ' ASP . 9.0 tp . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.348 -0.612 . . . . 73.310000000000002 109.348 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.553 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -103.88 105.47 15.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.532 1.145 . . . . 73.450000000000003 109.32 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 m -83.64 7.89 16.03 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.469 1.106 . . . . 73.030000000000001 110.002 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 224' ' ' SER . 2.4 t -150.4 145.86 16.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.47 1.106 . . . . 41.439999999999998 109.327 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.044 HD11 HD12 ' A' ' 149' ' ' LEU . 1.6 mt -97.05 141.67 23.4 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.549 1.155 . . . . 60.049999999999997 109.322 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -74.98 -30.54 7.09 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.506 1.793 . . . . 70.25 110.968 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.459 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -161.58 150.25 15.71 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.476 1.11 . . . . 62.210000000000001 109.293 -179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.517 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -48.54 -36.67 7.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 73.25 109.258 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.99 -47.49 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.435 1.084 . . . . 72.129999999999995 109.242 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.733 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.4 m -71.44 -36.19 71.18 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.518 1.136 . . . . 61.350000000000001 110.375 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.728 HD11 HG21 ' A' ' 223' ' ' VAL . 0.7 OUTLIER -58.1 -57.17 14.01 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.449 1.093 . . . . 73.420000000000002 109.278 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.517 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 47.6 m-80 -51.71 -32.34 29.82 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 72.209999999999994 109.332 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.6 t -69.25 -53.83 17.85 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 50.340000000000003 110.007 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.044 HD12 HD11 ' A' ' 140' ' ' ILE . 63.4 mt -45.56 -41.55 10.0 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.53 1.144 . . . . 74.239999999999995 109.291 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.677 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -73.38 -44.7 58.03 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.486 1.116 . . . . 75.239999999999995 110.991 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -47.21 -33.89 5.85 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.483 1.114 . . . . 74.319999999999993 109.319 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.451 ' HB2' ' CG2' ' A' ' 187' ' ' ILE . 62.9 mt-30 -78.53 -53.9 6.73 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.535 1.147 . . . . 71.140000000000001 110.302 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.097 HD11 HD12 ' A' ' 188' ' ' LEU . 24.1 mt -51.28 -28.32 7.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.492 1.12 . . . . 71.209999999999994 109.281 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.22 -38.48 63.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.499 1.124 . . . . 72.109999999999999 109.273 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -58.94 -16.97 20.45 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.536 1.147 . . . . 71.109999999999999 109.283 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.485 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 10.0 mm100 -86.83 -26.55 23.99 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.514 1.134 . . . . 70.129999999999995 110.272 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.2 m -40.04 128.78 2.21 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.494 1.121 . . . . 63.240000000000002 109.979 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 3.8 m -56.71 112.43 1.29 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 75.209999999999994 108.326 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 146.76 -17.47 1.61 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.505 1.128 . . . . 44.5 110.969 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.68 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 37.4 p -95.47 161.1 14.21 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.451 0.736 . . . . 70.510000000000005 110.383 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.64 -7.59 49.59 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.521 1.138 . . . . 54.109999999999999 110.01 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.4 m -103.53 -4.23 24.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.453 1.096 . . . . 64.109999999999999 110.396 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.68 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -71.91 136.32 46.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.537 1.148 . . . . 34.240000000000002 109.291 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.05 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 61.009999999999998 109.985 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.421 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 3.1 m -156.24 127.2 3.57 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.532 1.145 . . . . 72.239999999999995 110.017 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.421 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.3 Cg_endo -75.02 140.06 65.22 Favored 'Cis proline' 0 C--N 1.359 1.127 0 C-N-CA 120.994 -2.503 . . . . 71.340000000000003 111.008 0.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.644 ' O ' HD13 ' A' ' 298' ' ' LEU . 6.6 p -72.78 -178.6 2.77 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 33.539999999999999 108.319 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 183' ' ' LYS . 2.2 mp -83.45 128.51 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 75.239999999999995 109.275 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 51.3 p -96.56 69.15 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.484 1.115 . . . . 73.209999999999994 110.374 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -81.25 -11.36 59.4 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.51 1.131 . . . . 73.340000000000003 111.023 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.456 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.31 -1.82 25.4 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.545 1.153 . . . . 74.450000000000003 110.288 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.793 ' CE2' HD13 ' A' ' 304' ' ' LEU . 18.9 t80 -131.47 64.59 73.7 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.481 1.113 . . . . 74.329999999999998 110.984 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.432 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.95 123.09 7.65 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.444 1.76 . . . . 63.030000000000001 111.024 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 172' ' ' TYR . 10.7 t -152.68 -55.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.513 1.133 . . . . 65.109999999999999 109.324 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 177' ' ' CYS . 5.2 m-20 -147.22 -78.59 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.533 1.146 . . . . 72.299999999999997 109.313 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -37.38 92.9 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.505 1.128 . . . . 63.299999999999997 110.978 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.602 ' SG ' ' CE1' ' A' ' 218' ' ' HIS . 13.4 t -115.36 -16.0 11.49 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.293 -1.002 . . . . 75.519999999999996 108.293 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.612 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 33.1 p90 -74.99 -45.0 44.99 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.482 1.114 . . . . 73.129999999999995 111.02 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.612 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -41.58 -68.39 0.19 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.529 1.143 . . . . 72.439999999999998 109.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.677 ' HB3' HG23 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -47.67 -47.23 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 73.400000000000006 110.333 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 178' ' ' TYR . . . -46.86 -55.86 7.27 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.47 1.106 . . . . 73.099999999999994 109.289 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.701 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -48.1 -30.23 4.31 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.516 1.135 . . . . 70.409999999999997 109.604 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.755 ' HB2' HD11 ' A' ' 168' ' ' ILE . 21.4 mmmt -85.12 -31.99 23.02 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.462 1.101 . . . . 71.030000000000001 109.275 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.57 ' HB3' HD13 ' A' ' 221' ' ' ILE . 31.2 mtm -62.51 -36.7 83.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 53.439999999999998 111.0 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.456 ' CB ' ' SG ' ' A' ' 195' ' ' CYS . 0.0 OUTLIER -78.32 -33.77 49.05 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 64.299999999999997 110.293 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.553 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -53.9 -35.44 61.62 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.522 1.139 . . . . 75.340000000000003 110.303 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.452 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 21.8 mm -74.67 -48.06 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 124.529 1.143 . . . . 72.140000000000001 109.296 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 1.097 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -47.22 -36.87 9.45 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.452 1.095 . . . . 73.150000000000006 109.305 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.403 ' SD ' ' CD ' ' A' ' 185' ' ' ARG . 6.5 mtt -65.72 -46.96 76.97 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 74.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -46.43 -51.31 15.35 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 73.25 109.304 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.408 ' ND2' HE22 ' A' ' 152' ' ' GLN . 7.0 t-20 -65.33 -34.81 79.2 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 74.340000000000003 109.31 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.93 54.19 0.46 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.473 1.108 . . . . 70.109999999999999 110.984 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.733 ' CZ ' HG21 ' A' ' 145' ' ' THR . 78.1 m-85 -152.24 142.18 22.11 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.512 0.772 . . . . 63.450000000000003 110.994 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.98 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.2 OUTLIER -108.13 128.65 54.88 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.494 1.121 . . . . 72.5 109.291 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 1.015 ' HB3' HD22 ' A' ' 188' ' ' LEU . 12.5 p -104.45 178.22 4.62 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.49 1.119 . . . . 61.130000000000003 108.28 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -127.17 173.81 9.42 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.468 1.105 . . . . 72.329999999999998 110.322 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.456 ' NZ ' ' HB1' ' A' ' 181' ' ' ALA . 21.4 mmtt -108.3 153.78 22.74 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.544 1.153 . . . . 73.349999999999994 109.303 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.474 ' NE2' HD13 ' A' ' 222' ' ' LEU . 9.2 tt0 -147.34 117.42 7.27 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.528 1.142 . . . . 72.099999999999994 110.326 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 6.0 m-85 -110.59 123.29 49.69 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.496 1.123 . . . . 70.329999999999998 110.973 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.67 ' CG2' HG23 ' A' ' 266' ' ' VAL . 8.0 p -114.99 151.05 16.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 72.140000000000001 109.313 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.451 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 13.0 m-85 -122.27 161.18 23.77 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 71.150000000000006 111.01 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.6 -178.4 16.72 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.478 1.111 . . . . 50.350000000000001 111.006 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.733 ' C ' HD23 ' A' ' 204' ' ' LEU . 58.8 t-20 -69.96 109.44 4.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.574 0.808 . . . . 62.25 109.328 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.733 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.5 mt -114.26 94.5 4.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.155 . . . . 50.210000000000001 109.329 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.484 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 8.4 mttt -92.96 164.3 13.35 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.135 . . . . 63.240000000000002 109.305 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.748 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -175.69 170.92 2.81 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.113 . . . . 50.509999999999998 109.321 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.24 135.7 54.38 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.109999999999999 110.013 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 8.0 p -118.96 0.86 11.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.438 1.086 . . . . 71.099999999999994 110.37 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 210' ' ' THR . . . 115.3 112.71 2.88 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.496 1.123 . . . . 71.450000000000003 111.026 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 209' ' ' GLY . 14.5 t 50.59 21.68 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 0.759 . . . . 74.040000000000006 110.402 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . 0.512 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.1 OUTLIER -158.42 163.94 36.72 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.543 1.152 . . . . 62.350000000000001 108.319 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.512 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.0 OUTLIER -131.24 138.47 49.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.517 1.135 . . . . 74.5 108.267 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.748 HG23 ' HB3' ' A' ' 206' ' ' ALA . 1.9 m -111.12 128.75 67.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.488 1.118 . . . . 40.130000000000003 109.314 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.484 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -121.67 122.99 40.83 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 63.119999999999997 109.327 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.56 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.3 m0 -128.89 136.93 51.09 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.119 . . . . 65.150000000000006 108.034 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -81.65 -1.31 46.26 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.518 1.136 . . . . 75.010000000000005 110.007 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.501 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.2 p90 -169.8 127.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.495 1.122 . . . . 73.409999999999997 110.977 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.602 ' CE1' ' SG ' ' A' ' 177' ' ' CYS . 85.8 t60 -124.79 149.24 47.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.473 1.108 . . . . 63.350000000000001 109.597 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 220' ' ' ALA . 1.5 p -118.1 164.64 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.467 1.104 . . . . 75.439999999999998 109.292 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.644 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.06 -170.53 2.72 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.13 . . . . 65.200000000000003 109.321 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.648 HD11 ' HB ' ' A' ' 237' ' ' ILE . 21.1 pt -116.44 118.38 58.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.546 1.154 . . . . 71.219999999999999 109.272 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 234' ' ' LYS . 11.8 tp -83.99 108.64 17.07 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.461 1.101 . . . . 73.129999999999995 109.327 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.728 HG21 HD11 ' A' ' 146' ' ' LEU . 0.9 OUTLIER -102.95 143.89 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.522 1.139 . . . . 74.25 109.311 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.615 ' HB2' HG22 ' A' ' 139' ' ' VAL . 0.2 OUTLIER -116.32 116.78 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 52.229999999999997 109.981 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.575 ' CE1' ' HD3' ' A' ' 235' ' ' ARG . 32.5 p90 -131.92 145.83 51.74 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.494 1.121 . . . . 75.510000000000005 111.019 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.426 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -70.76 132.73 45.79 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 64.209999999999994 109.335 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.28 -160.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.54 1.15 . . . . 63.409999999999997 109.283 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.89 -0.06 49.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 73.239999999999995 109.244 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -114.86 -8.51 12.56 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 73.209999999999994 109.984 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.86 37.55 7.86 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.494 1.121 . . . . 71.239999999999995 111.016 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.41 137.95 41.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 71.299999999999997 109.294 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.426 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.0 m -71.87 102.55 2.91 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.513 1.133 . . . . 62.409999999999997 110.368 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 224' ' ' SER . 6.9 mm-40 -102.12 -172.71 2.19 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 62.240000000000002 110.275 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.544 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.8 mmtt -127.3 144.63 51.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 73.140000000000001 109.304 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.577 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.0 tpt180 -143.91 163.31 33.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.554 1.159 . . . . 70.140000000000001 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.577 HG21 ' CD1' ' A' ' 252' ' ' TRP . 22.0 mm -118.82 116.98 52.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 73.430000000000007 109.319 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.4 mm -98.7 50.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.493 1.121 . . . . 65.120000000000005 109.327 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.443 ' OD1' HG22 ' A' ' 236' ' ' ILE . 41.2 p-10 -96.6 109.61 48.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.503 1.127 . . . . 74.150000000000006 109.349 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.477 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -74.98 -50.55 0.13 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.505 1.792 . . . . 71.239999999999995 111.002 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 239' ' ' PRO . 0.3 OUTLIER -36.51 -34.3 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.524 1.14 . . . . 51.229999999999997 110.017 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 241' ' ' LEU . 13.9 mt -97.36 -60.97 1.47 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.144 . . . . 64.209999999999994 109.302 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.732 ' CE2' HG21 ' A' ' 247' ' ' VAL . 97.2 m-85 -112.02 99.68 8.28 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.555 1.16 . . . . 64.439999999999998 111.0 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.22 -22.08 33.24 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.491 1.12 . . . . 73.239999999999995 109.961 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 28.1 m -66.49 -47.26 73.57 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.502 1.126 . . . . 71.219999999999999 109.961 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -176.74 -172.18 41.13 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.486 1.116 . . . . 62.240000000000002 110.977 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.446 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.3 Cg_endo -74.94 170.47 20.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.512 1.796 . . . . 73.549999999999997 111.019 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.732 HG21 ' CE2' ' A' ' 242' ' ' PHE . 14.6 m -147.74 156.3 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.434 1.084 . . . . 73.219999999999999 109.318 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.432 ' N ' ' HE ' ' A' ' 235' ' ' ARG . 41.8 p -59.51 139.01 57.5 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 71.540000000000006 110.398 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.45 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 23.2 p-10 -43.08 -28.19 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.479 1.112 . . . . 64.150000000000006 109.327 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.43 ' N ' ' C ' ' A' ' 248' ' ' THR . 11.5 m -77.12 -62.55 1.62 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.424 1.077 . . . . 73.349999999999994 110.411 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.03 -24.71 4.01 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.491 1.119 . . . . 64.140000000000001 109.325 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.644 ' CZ2' ' CB ' ' A' ' 220' ' ' ALA . 11.1 t90 -66.11 -64.66 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.49 1.119 . . . . 75.349999999999994 108.038 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.886 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.2 OUTLIER -43.06 -33.56 0.87 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.478 1.112 . . . . 73.230000000000004 110.295 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.885 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.5 m-80 -66.25 -48.91 68.97 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.525 1.141 . . . . 71.25 109.325 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -57.45 -18.18 17.0 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.504 1.128 . . . . 64.219999999999999 109.26 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.478 ' O ' ' N ' ' A' ' 205' ' ' LYS . 9.6 m -92.53 -33.98 14.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 72.140000000000001 108.269 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 253' ' ' ARG . 2.9 m -93.79 20.44 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.52 1.138 . . . . 64.040000000000006 109.258 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.412 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 46.4 t30 -44.4 104.63 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.47 1.106 . . . . 65.329999999999998 109.299 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.2 p -74.24 -4.72 37.72 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.518 1.136 . . . . 70.319999999999993 110.408 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.412 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -47.79 -26.66 1.7 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.469 1.106 . . . . 64.230000000000004 110.007 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 18.2 t -91.08 -34.76 14.96 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.452 1.095 . . . . 71.040000000000006 108.316 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 160.73 -129.8 2.23 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 124.517 1.135 . . . . 63.340000000000003 111.038 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.441 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -67.0 145.18 55.67 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.46 0.741 . . . . 74.340000000000003 109.959 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -173.22 142.23 1.01 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.53 1.144 . . . . 55.32 109.298 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.9 p -173.08 153.46 2.53 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 73.129999999999995 109.998 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.67 HG23 ' CG2' ' A' ' 200' ' ' VAL . 2.7 p -98.15 120.71 47.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.501 1.125 . . . . 61.310000000000002 109.293 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 16.9 t -76.12 -43.07 44.84 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.434 1.084 . . . . 64.319999999999993 110.007 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.663 ' O ' HG23 ' A' ' 200' ' ' VAL . 54.6 m -164.56 -172.52 2.7 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 71.329999999999998 109.971 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -166.75 157.27 11.96 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.49 1.119 . . . . 75.420000000000002 111.025 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -155.9 157.55 36.52 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.486 1.116 . . . . 54.310000000000002 109.281 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.485 ' C ' HG23 ' A' ' 272' ' ' THR . 1.5 p-10 -122.92 160.09 26.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 63.109999999999999 109.307 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.582 ' HB ' HG21 ' A' ' 276' ' ' VAL . 48.2 p -154.98 176.94 11.88 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.096 . . . . 71.400000000000006 110.408 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.595 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -57.74 160.91 4.1 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 75.010000000000005 109.291 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -74.1 -21.65 78.81 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.526 1.141 . . . . 74.340000000000003 110.984 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.44 ' OD1' ' HB1' ' A' ' 273' ' ' ALA . 1.5 p-10 -74.19 -35.03 63.93 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 0.759 . . . . 64.140000000000001 109.302 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 273' ' ' ALA . 53.4 t -43.67 101.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.479 1.112 . . . . 62.020000000000003 109.253 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.559 ' CE1' ' OG1' ' A' ' 294' ' ' THR . 4.6 t80 -63.12 -53.63 50.42 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 74.209999999999994 111.029 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -146.85 135.04 21.65 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.538 1.148 . . . . 73.099999999999994 110.988 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.57 ' HB3' ' CD1' ' A' ' 199' ' ' PHE . 72.8 ttt-85 -106.15 147.44 29.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 74.420000000000002 110.294 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.19 157.95 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.439 1.087 . . . . 65.239999999999995 110.006 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -0.65 10.19 Favored 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.434 1.754 . . . . 70.219999999999999 111.004 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 40.5 m -101.12 8.71 42.65 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.457 1.098 . . . . 60.450000000000003 109.959 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 73.03 38.21 0.72 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.563 1.164 . . . . 71.519999999999996 109.297 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.9 t -119.79 119.17 32.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.120000000000005 110.004 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -99.89 167.06 10.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.491 1.12 . . . . 73.140000000000001 111.033 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.562 ' O ' ' CD1' ' A' ' 287' ' ' TYR . 1.1 mm? -125.89 177.49 6.28 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.483 1.114 . . . . 64.430000000000007 109.353 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' A' ' 286' ' ' LEU . 37.8 m-85 -158.34 118.98 3.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.479 1.112 . . . . 73.140000000000001 111.036 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.916 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.9 OUTLIER -115.39 99.49 7.42 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.465 1.103 . . . . 72.310000000000002 109.305 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.413 ' O ' HD22 ' A' ' 291' ' ' LEU . 10.3 m-20 -83.48 -52.82 6.17 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.461 1.101 . . . . 65.209999999999994 109.312 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.472 ' CB ' HG12 ' A' ' 292' ' ' ILE . 24.4 m-20 -88.04 10.63 18.46 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.533 1.146 . . . . 74.540000000000006 109.328 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.916 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.5 mm? 40.45 45.15 1.84 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.483 1.115 . . . . 63.420000000000002 109.287 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.472 HG12 ' CB ' ' A' ' 290' ' ' ASN . 45.5 mm -75.26 -27.26 19.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.506 1.129 . . . . 71.549999999999997 109.307 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.801 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.5 t-20 -92.1 -29.32 16.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.478 1.111 . . . . 75.019999999999996 109.295 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.559 ' OG1' ' CE1' ' A' ' 277' ' ' TYR . 17.9 m -80.02 -68.88 0.63 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.49 1.119 . . . . 73.329999999999998 110.356 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -45.29 -33.64 2.52 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.56 1.162 . . . . 74.299999999999997 109.307 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 53.5 t -72.61 -46.08 55.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.485 1.115 . . . . 71.540000000000006 108.251 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.0 t -55.73 -41.04 63.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 43.130000000000003 109.31 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 167' ' ' CYS . 84.5 mt -66.78 -62.14 1.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.52 1.137 . . . . 72.420000000000002 109.32 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.1 m -51.89 -23.87 5.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.461 1.101 . . . . 71.340000000000003 110.441 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.886 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.7 mmmt -71.19 -40.02 71.45 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.127 . . . . 72.120000000000005 109.318 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.84 ' CD1' HD12 ' A' ' 304' ' ' LEU . 5.2 m-30 -101.5 35.14 2.37 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 62.240000000000002 110.965 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 29.4 t -67.35 -44.83 78.08 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.107 . . . . 75.409999999999997 110.007 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.656 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -93.19 -12.25 30.76 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.516 1.135 . . . . 72.209999999999994 109.301 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.84 HD12 ' CD1' ' A' ' 301' ' ' PHE . 13.2 mt -66.66 141.75 57.68 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.556 1.16 . . . . 71.450000000000003 109.346 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 99.4 p -159.33 157.46 30.47 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.499 1.124 . . . . 44.219999999999999 110.026 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.84 -157.65 50.59 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.525 1.141 . . . . 74.209999999999994 110.986 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 29.4 p -96.01 11.41 34.16 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.286 -1.005 . . . . 64.510000000000005 108.286 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.506 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.4 p -130.07 151.15 77.84 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.466 1.104 . . . . 75.019999999999996 109.98 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.736 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.2 Cg_endo -75.01 148.3 91.39 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.02 -2.491 . . . . 71.310000000000002 110.967 0.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.473 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.2 p -130.05 134.29 25.96 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.523 1.139 . . . . 53.340000000000003 110.017 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -75.08 -172.39 10.72 Favored 'Cis proline' 0 C--N 1.36 1.144 0 C-N-CA 120.994 -2.503 . . . . 65.329999999999998 110.992 0.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -56.63 151.38 30.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.524 1.14 . . . . 44.009999999999998 109.36 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.97 -162.42 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.523 1.802 . . . . 65.5 110.985 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -90.14 135.51 33.62 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 63.039999999999999 109.299 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.886 HG12 ' HE2' ' A' ' 300' ' ' LYS . 24.4 m -137.48 24.6 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.527 1.142 . . . . 74.239999999999995 109.313 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.441 ' C ' ' N ' ' A' ' 318' ' ' CYS . 39.7 t -66.58 -41.07 89.11 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.547 1.154 . . . . 75.140000000000001 110.041 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -39.72 -29.87 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.443 1.089 . . . . 72.109999999999999 109.982 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.441 ' N ' ' C ' ' A' ' 316' ' ' SER . 7.5 m -61.85 -173.9 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.546 1.154 . . . . 63.119999999999997 108.3 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 293' ' ' ASN . . . -160.26 -158.82 9.45 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.508 1.13 . . . . 52.229999999999997 111.001 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 320' ' ' PHE . 4.4 m-85 . . . . . 0 C--N 1.324 -0.504 0 O-C-N 124.503 0.767 . . . . 70.549999999999997 111.018 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.91 HD23 ' HB2' ' A' ' 194' ' ' ASP . 7.4 tp . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.321 -0.622 . . . . 70.109999999999999 109.321 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.433 ' HB3' ' CD2' ' A' ' 193' ' ' TYR . . . -105.17 107.61 18.68 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.551 1.157 . . . . 54.340000000000003 109.304 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.6 m -85.62 10.64 12.73 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.455 1.097 . . . . 71.140000000000001 110.001 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.4 t -150.37 146.82 16.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.499 1.124 . . . . 74.219999999999999 109.283 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.071 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -99.13 143.04 25.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.521 1.138 . . . . 65.439999999999998 109.29 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.5 Cg_endo -75.0 -33.06 4.87 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.489 1.784 . . . . 75.549999999999997 111.053 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.435 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -159.78 152.49 21.43 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 51.200000000000003 109.291 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.506 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -48.98 -35.87 7.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.431 1.082 . . . . 54.409999999999997 109.313 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -41.06 -47.47 3.13 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.489 1.118 . . . . 72.439999999999998 109.285 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.675 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.42 -35.83 71.11 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.469 1.106 . . . . 54.5 110.381 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.686 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.5 OUTLIER -58.2 -57.03 14.65 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.452 1.095 . . . . 72.540000000000006 109.293 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.506 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 50.4 m-80 -52.51 -31.57 36.04 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.478 1.111 . . . . 64.420000000000002 109.291 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.67 -56.83 6.89 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.14 . . . . 74.019999999999996 109.979 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.071 HD12 HD11 ' A' ' 140' ' ' ILE . 81.3 mt -42.35 -40.11 2.38 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.495 1.122 . . . . 54.329999999999998 109.254 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.563 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -74.69 -44.58 49.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 74.450000000000003 110.99 -180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -48.03 -36.8 13.51 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.556 1.16 . . . . 61.509999999999998 109.28 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.465 ' NE2' ' ND2' ' A' ' 191' ' ' ASN . 63.2 mt-30 -76.05 -55.7 5.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.494 1.121 . . . . 70.120000000000005 110.296 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 188' ' ' LEU . 18.3 mt -49.52 -27.34 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.502 1.126 . . . . 64.409999999999997 109.304 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -36.7 61.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 75.099999999999994 109.315 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 152' ' ' GLN . 1.2 t-20 -57.52 -20.08 29.11 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.527 1.142 . . . . 74.209999999999994 109.257 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.468 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 3.0 mm100 -80.53 -25.41 38.7 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.527 1.142 . . . . 75.299999999999997 110.26 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 160' ' ' THR . 19.1 m -39.03 116.94 0.63 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 74.239999999999995 110.019 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 1.6 m -43.39 136.9 2.95 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.491 1.119 . . . . 75.109999999999999 108.328 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.39 -43.36 1.52 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.561 1.163 . . . . 65.150000000000006 110.955 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.746 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 32.2 p -64.84 159.79 21.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.538 0.787 . . . . 62.030000000000001 110.434 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 t -91.56 -4.58 55.22 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.555 1.16 . . . . 63.530000000000001 110.0 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.5 m -108.86 -1.91 18.82 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.487 1.117 . . . . 71.109999999999999 110.423 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.746 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -72.29 133.16 44.86 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.471 1.107 . . . . 64.420000000000002 109.307 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.59 -169.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.528 1.142 . . . . 63.439999999999998 109.971 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.443 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 45.9 p -154.61 127.07 3.97 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 62.119999999999997 110.013 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.443 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -74.95 138.87 58.56 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.009 -2.496 . . . . 70.439999999999998 111.005 -0.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 7.8 p -72.79 -178.99 2.92 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.481 1.113 . . . . 64.120000000000005 108.28 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.803 HD11 ' CB ' ' A' ' 183' ' ' LYS . 3.1 mp -92.82 137.97 21.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.509 1.131 . . . . 54.219999999999999 109.273 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.58 HG21 ' O ' ' A' ' 301' ' ' PHE . 59.7 p -92.03 85.16 5.44 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.515 1.135 . . . . 70.150000000000006 110.414 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.7 ' CZ ' HG21 ' A' ' 168' ' ' ILE . 60.0 m-85 -88.75 -25.2 22.41 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.502 1.126 . . . . 61.039999999999999 110.995 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.471 ' NH1' ' HB ' ' A' ' 169' ' ' THR . 0.0 OUTLIER -75.09 -1.99 25.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.548 1.155 . . . . 75.019999999999996 110.292 179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.785 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.4 t80 -127.25 69.61 74.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 64.450000000000003 111.042 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.431 ' C ' HG23 ' A' ' 174' ' ' VAL . 18.4 Cg_endo -74.94 111.56 3.35 Favored 'Trans proline' 0 C--N 1.361 1.212 0 O-C-N 124.46 1.768 . . . . 70.540000000000006 111.026 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.611 HG21 ' CE1' ' A' ' 172' ' ' TYR . 21.3 t -153.0 -75.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.459 1.099 . . . . 73.219999999999999 109.31 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 312' ' ' ALA . 3.9 m-20 -149.09 131.9 16.05 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.494 1.121 . . . . 61.020000000000003 109.258 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 178' ' ' TYR . . . 121.71 79.26 0.51 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.493 1.121 . . . . 53.020000000000003 111.014 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . . . . . . . . . 1.5 p -119.78 -1.78 10.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.287 -1.005 . . . . 70.109999999999999 108.287 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 29.0 p90 -81.9 -43.91 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.539 1.149 . . . . 73.0 111.002 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.625 ' HB1' ' HA ' ' A' ' 294' ' ' THR . . . -70.09 -45.2 67.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.522 1.139 . . . . 71.409999999999997 109.285 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.509 ' NH2' ' CB ' ' A' ' 240' ' ' SER . 7.3 mtm180 -49.76 -58.76 4.7 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 70.219999999999999 110.325 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -43.02 -52.49 5.25 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 61.409999999999997 109.303 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.655 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 0.3 OUTLIER -46.91 -39.51 12.35 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.505 1.128 . . . . 74.109999999999999 109.62 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.803 ' CB ' HD11 ' A' ' 168' ' ' ILE . 19.0 mmmt -72.92 -33.3 65.88 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.516 1.135 . . . . 65.310000000000002 109.281 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.585 ' HE1' ' OD1' ' A' ' 238' ' ' ASP . 17.6 mtm -65.99 -59.21 4.05 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.509 1.13 . . . . 72.140000000000001 110.997 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.98 -26.07 14.05 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.508 1.13 . . . . 63.409999999999997 110.318 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.414 ' HG2' HD13 ' A' ' 187' ' ' ILE . 0.9 OUTLIER -64.86 -43.42 93.03 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.463 1.102 . . . . 65.530000000000001 110.274 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.424 ' HB ' ' CG1' ' A' ' 153' ' ' ILE . 22.6 mm -69.86 -38.21 75.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 74.120000000000005 109.269 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.832 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -54.57 -35.54 63.4 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.495 1.122 . . . . 71.109999999999999 109.318 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.574 ' HG2' HD21 ' A' ' 136' ' ' LEU . 17.0 mtp -70.12 -42.79 72.15 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.54 1.15 . . . . 74.239999999999995 111.055 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -44.77 -47.12 10.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.474 1.109 . . . . 72.010000000000005 109.283 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.465 ' ND2' ' NE2' ' A' ' 152' ' ' GLN . 23.8 t-20 -67.81 -34.57 77.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.491 1.119 . . . . 75.150000000000006 109.295 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 189' ' ' MET . . . 113.59 55.29 0.42 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.496 1.123 . . . . 73.439999999999998 110.972 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.675 ' CZ ' HG21 ' A' ' 145' ' ' THR . 83.7 m-85 -153.61 141.51 20.19 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 0.738 . . . . 75.439999999999998 111.009 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.91 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -108.71 122.87 48.03 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.49 1.119 . . . . 73.319999999999993 109.308 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.817 ' HB3' HD22 ' A' ' 188' ' ' LEU . 27.5 p -106.41 -179.28 3.89 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 72.129999999999995 108.301 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -126.77 176.89 6.93 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.489 1.118 . . . . 53.420000000000002 110.317 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.708 ' HE2' HG22 ' A' ' 221' ' ' ILE . 13.9 mmtt -107.83 164.05 12.59 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.556 1.16 . . . . 73.150000000000006 109.299 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 30.4 tt0 -151.2 117.36 5.6 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 71.030000000000001 110.305 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -109.18 125.94 52.74 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.461 1.101 . . . . 73.5 111.041 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.789 HG23 ' HB3' ' A' ' 269' ' ' TYR . 8.6 p -122.35 121.32 63.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 71.549999999999997 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.447 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 56.2 m-85 -93.9 151.77 19.34 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.486 1.116 . . . . 72.299999999999997 111.001 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 128.42 -172.56 19.3 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.493 1.12 . . . . 62.32 111.021 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.817 ' C ' HD23 ' A' ' 204' ' ' LEU . 55.4 t-20 -78.25 111.19 13.96 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.476 0.751 . . . . 74.129999999999995 109.281 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.817 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.5 mt -115.33 94.25 4.64 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.48 1.113 . . . . 64.120000000000005 109.359 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.851 ' HE3' ' HB2' ' A' ' 214' ' ' ALA . 5.3 mtpt -93.21 170.52 9.57 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.501 1.125 . . . . 63.439999999999998 109.297 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.766 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -172.58 129.65 0.54 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.513 1.133 . . . . 64.040000000000006 109.338 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.6 t -117.89 127.09 53.52 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.486 1.116 . . . . 75.120000000000005 110.007 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 56.4 p -93.28 -26.83 17.16 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.498 1.124 . . . . 33.43 110.408 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 143.03 -63.39 0.5 Allowed Glycine 0 CA--C 1.531 1.046 0 O-C-N 124.518 1.136 . . . . 65.109999999999999 110.991 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 53.2 p -99.24 8.07 45.11 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.546 0.792 . . . . 72.209999999999994 110.433 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -173.23 160.95 4.15 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.522 1.139 . . . . 73.230000000000004 108.288 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.466 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -134.19 -175.64 3.93 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.482 1.114 . . . . 72.120000000000005 108.314 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.766 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -153.59 147.95 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.451 1.095 . . . . 73.310000000000002 109.314 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.851 ' HB2' ' HE3' ' A' ' 205' ' ' LYS . . . -133.46 128.43 35.42 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.555 1.159 . . . . 62.32 109.33 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.454 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.1 m0 -134.39 131.72 38.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 1.137 . . . . 61.409999999999997 107.999 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 15.0 m -74.59 -2.54 26.45 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.498 1.124 . . . . 53.020000000000003 109.976 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.43 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 6.1 p90 -173.74 132.9 0.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.472 1.108 . . . . 72.310000000000002 111.008 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.469 ' N ' HD12 ' A' ' 204' ' ' LEU . 84.6 t60 -121.61 154.68 36.44 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.517 1.135 . . . . 65.420000000000002 109.581 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 198' ' ' GLN . 1.6 p -130.61 130.81 64.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.522 1.139 . . . . 65.349999999999994 109.349 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.647 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.4 -164.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.499 1.124 . . . . 24.41 109.268 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.708 HG22 ' HE2' ' A' ' 197' ' ' LYS . 39.1 pt -122.31 120.26 60.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.474 1.109 . . . . 72.299999999999997 109.296 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 234' ' ' LYS . 15.0 tp -84.49 109.0 17.58 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.476 1.11 . . . . 71.349999999999994 109.282 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.686 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -103.04 147.99 8.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.462 1.101 . . . . 70.310000000000002 109.267 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 51.6 m -118.15 121.27 40.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.481 1.113 . . . . 64.299999999999997 110.021 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.498 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 31.3 p90 -136.41 144.24 44.4 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.545 1.153 . . . . 75.530000000000001 110.983 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.438 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 20.8 mmtp -69.49 133.06 47.25 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.525 1.141 . . . . 65.0 109.263 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -74.55 -159.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.516 1.135 . . . . 74.25 109.293 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.91 0.15 48.94 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.499 1.124 . . . . 72.340000000000003 109.345 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.7 m -115.22 -8.07 12.37 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.546 1.153 . . . . 43.399999999999999 110.027 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.14 37.58 8.26 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.471 1.107 . . . . 45.450000000000003 111.05 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.419 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.52 137.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.46 0.741 . . . . 70.239999999999995 109.3 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.438 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 19.3 m -71.79 102.58 2.88 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 61.049999999999997 110.365 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.9 mm-40 -101.42 -172.54 2.18 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.491 1.119 . . . . 74.420000000000002 110.31 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.52 ' HB3' HD11 ' A' ' 222' ' ' LEU . 10.2 mmtm -127.0 145.11 50.83 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.491 1.119 . . . . 75.5 109.311 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.63 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.9 tpt180 -144.54 160.84 40.46 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 72.230000000000004 110.311 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 252' ' ' TRP . 16.6 mm -115.13 121.73 67.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.529 1.143 . . . . 75.219999999999999 109.317 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.1 mm -108.09 44.54 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.529 1.143 . . . . 73.400000000000006 109.285 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.585 ' OD1' ' HE1' ' A' ' 184' ' ' MET . 0.7 OUTLIER -104.98 107.76 59.55 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.493 1.12 . . . . 74.030000000000001 109.276 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.562 ' HG2' ' CE1' ' A' ' 170' ' ' PHE . 18.3 Cg_endo -75.01 -2.11 12.11 Favored 'Trans proline' 0 C--N 1.36 1.184 0 O-C-N 124.549 1.816 . . . . 62.109999999999999 111.018 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.509 ' CB ' ' NH2' ' A' ' 180' ' ' ARG . 0.2 OUTLIER -61.3 -22.66 65.08 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.497 1.123 . . . . 74.129999999999995 109.992 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.74 -50.21 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.501 1.126 . . . . 70.420000000000002 109.272 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.613 ' CD1' HG11 ' A' ' 247' ' ' VAL . 97.4 m-85 -112.18 99.5 8.09 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.464 1.103 . . . . 74.040000000000006 111.025 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 71.0 m -90.14 -8.44 51.27 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.495 1.122 . . . . 72.219999999999999 109.987 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 30.6 p -77.75 -46.44 21.71 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.543 1.152 . . . . 63.399999999999999 110.008 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.11 -174.79 40.45 Favored Glycine 0 CA--C 1.529 0.965 0 O-C-N 124.445 1.091 . . . . 62.299999999999997 111.036 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.448 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.2 Cg_endo -75.0 164.68 32.87 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.477 1.777 . . . . 74.319999999999993 110.99 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.613 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.5 m -147.82 164.97 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 61.210000000000001 109.317 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.417 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.7 p -65.93 141.36 58.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.455 1.097 . . . . 62.439999999999998 110.445 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.437 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 1.3 p30 -45.2 -26.55 0.5 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.491 1.119 . . . . 74.329999999999998 109.338 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.417 ' N ' ' C ' ' A' ' 248' ' ' THR . 10.7 m -77.41 -62.95 1.49 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.469 1.106 . . . . 64.209999999999994 110.423 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.69 -27.98 8.1 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.465 1.103 . . . . 25.52 109.303 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.68 ' CD1' HG21 ' A' ' 236' ' ' ILE . 11.0 t90 -63.28 -61.82 2.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 75.430000000000007 107.997 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.599 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.63 -41.87 15.34 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 63.409999999999997 110.309 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.789 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.3 m-80 -57.24 -50.8 71.75 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.476 1.11 . . . . 42.439999999999998 109.298 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.577 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -56.87 -24.41 51.45 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.525 1.141 . . . . 33.530000000000001 109.317 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -83.42 -36.43 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.5 1.125 . . . . 71.310000000000002 108.304 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.789 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.61 21.47 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.475 1.109 . . . . 72.510000000000005 109.303 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.441 ' ND2' ' CB ' ' A' ' 260' ' ' SER . 38.7 t30 -54.41 109.14 0.45 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 71.129999999999995 109.287 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 262' ' ' GLY . 3.3 p -73.79 -2.77 24.92 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.519 1.137 . . . . 74.129999999999995 110.386 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.441 ' CB ' ' ND2' ' A' ' 258' ' ' ASN . 33.7 t -44.0 -27.0 0.33 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.098 . . . . 72.010000000000005 109.979 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . 0.417 ' N ' ' C ' ' A' ' 259' ' ' THR . 48.5 t -94.27 -37.01 11.73 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 61.0 108.3 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 171.09 -128.33 1.59 Allowed Glycine 0 CA--C 1.531 1.061 0 O-C-N 124.493 1.121 . . . . 70.219999999999999 110.968 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -79.86 149.42 30.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.527 0.78 . . . . 74.140000000000001 110.017 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.573 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -170.69 146.35 2.64 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.501 1.125 . . . . 40.450000000000003 109.324 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 24.3 m -173.08 151.99 2.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.449 1.093 . . . . 63.5 109.99 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.595 HG23 HG11 ' A' ' 257' ' ' VAL . 2.3 t -97.84 122.35 49.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.504 1.127 . . . . 75.519999999999996 109.281 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . 0.407 ' C ' ' OG ' ' A' ' 268' ' ' SER . 31.1 t -83.81 -34.21 24.77 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.507 1.13 . . . . 74.430000000000007 109.999 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.407 ' OG ' ' C ' ' A' ' 267' ' ' SER . 0.7 OUTLIER -174.78 159.32 2.77 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 74.109999999999999 109.978 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.789 ' HB3' HG23 ' A' ' 200' ' ' VAL . 52.9 p90 -147.5 154.66 41.04 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.447 1.092 . . . . 54.219999999999999 110.985 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -152.32 165.7 34.14 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.475 1.109 . . . . 70.329999999999998 109.32 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.468 ' C ' HG23 ' A' ' 272' ' ' THR . 1.4 p-10 -122.68 160.73 25.23 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 62.329999999999998 109.296 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.468 HG23 ' C ' ' A' ' 271' ' ' ASN . 45.1 p -154.09 179.43 8.94 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.483 1.114 . . . . 61.130000000000003 110.419 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.833 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -57.5 166.98 1.11 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.504 1.127 . . . . 42.240000000000002 109.253 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -83.49 -18.67 63.65 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.52 1.137 . . . . 50.130000000000003 111.012 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.448 ' H ' ' ND2' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -83.98 -19.0 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.513 0.773 . . . . 62.229999999999997 109.287 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.833 HG23 ' HB3' ' A' ' 273' ' ' ALA . 12.9 t -60.48 101.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.533 1.145 . . . . 71.510000000000005 109.301 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.415 ' OH ' ' CE1' ' A' ' 178' ' ' TYR . 15.1 t80 -64.41 -44.45 91.2 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.559 1.162 . . . . 64.549999999999997 111.007 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -144.54 155.78 43.84 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.542 1.151 . . . . 73.099999999999994 110.989 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.447 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 68.0 ttt-85 -124.97 147.45 48.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.515 1.134 . . . . 74.409999999999997 110.318 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.77 154.07 44.92 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.467 1.104 . . . . 71.540000000000006 110.006 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -0.03 9.45 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.496 1.787 . . . . 74.019999999999996 111.011 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 6.1 t -104.58 10.6 34.92 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 44.439999999999998 109.969 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 282' ' ' SER . 2.0 t-20 76.21 38.5 0.32 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.54 1.15 . . . . 72.329999999999998 109.341 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.2 t -117.9 121.03 39.64 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.536 1.148 . . . . 63.530000000000001 110.001 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.524 ' HB3' HG13 ' A' ' 276' ' ' VAL . 12.5 m-30 -103.86 158.38 16.44 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 74.25 110.987 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.742 HD11 ' CZ ' ' A' ' 320' ' ' PHE . 1.0 OUTLIER -118.35 177.64 4.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.135 . . . . 73.519999999999996 109.3 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.0 m-85 -161.84 115.79 1.89 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.479 1.112 . . . . 65.120000000000005 111.045 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.3 96.76 5.82 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.507 1.129 . . . . 62.119999999999997 109.346 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -85.62 -15.47 42.4 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.479 1.112 . . . . 64.329999999999998 109.307 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.422 ' CB ' HG12 ' A' ' 292' ' ' ILE . 47.6 m-20 -109.88 2.26 19.72 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.529 1.143 . . . . 73.420000000000002 109.302 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.655 ' CD1' ' CD2' ' A' ' 182' ' ' HIS . 2.7 mm? 40.91 47.07 2.51 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 45.329999999999998 109.293 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.422 HG12 ' CB ' ' A' ' 290' ' ' ASN . 20.4 mm -73.28 -31.74 35.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.12 . . . . 65.140000000000001 109.315 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.418 ' ND2' ' HB2' ' A' ' 318' ' ' CYS . 1.6 t-20 -93.08 -28.41 16.37 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.523 1.139 . . . . 74.329999999999998 109.27 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.625 ' HA ' ' HB1' ' A' ' 179' ' ' ALA . 1.8 m -77.07 -65.69 0.92 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.563 1.164 . . . . 73.439999999999998 110.407 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.419 ' O ' ' CG ' ' A' ' 166' ' ' PRO . 57.3 m-20 -54.61 -20.07 7.29 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.471 1.107 . . . . 53.329999999999998 109.296 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 297' ' ' VAL . 25.0 t -83.99 -66.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.452 1.095 . . . . 42.399999999999999 108.278 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.523 HG21 ' OH ' ' A' ' 178' ' ' TYR . 3.2 t -40.27 -39.54 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.493 1.121 . . . . 72.200000000000003 109.296 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.685 HD22 ' HA ' ' A' ' 168' ' ' ILE . 20.4 mt -70.23 -57.2 5.16 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.528 1.142 . . . . 73.239999999999995 109.267 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -51.0 -22.78 2.47 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.454 1.096 . . . . 75.040000000000006 110.358 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -71.32 -48.58 49.66 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.473 1.108 . . . . 75.540000000000006 109.311 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.58 ' O ' HG21 ' A' ' 169' ' ' THR . 0.7 OUTLIER -98.43 38.81 1.3 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.503 1.127 . . . . 61.130000000000003 111.005 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 34.0 t -70.07 -48.54 57.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.509 1.13 . . . . 44.210000000000001 109.971 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -88.18 -11.36 47.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 41.340000000000003 109.284 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.785 HD13 ' CZ ' ' A' ' 172' ' ' TYR . 15.1 mt -63.93 142.55 58.37 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.134 . . . . 72.25 109.296 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 66.6 p -157.49 148.43 21.4 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.555 1.16 . . . . 71.430000000000007 109.964 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.05 -152.12 23.46 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.483 1.114 . . . . 41.229999999999997 111.028 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 5.4 p -103.96 12.87 33.73 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.309 -0.997 . . . . 52.219999999999999 108.309 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.521 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 1.3 p -134.99 150.99 74.66 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.506 1.129 . . . . 64.510000000000005 109.992 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.721 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.01 146.52 86.87 Favored 'Cis proline' 0 C--N 1.36 1.176 0 C-N-CA 121.001 -2.5 . . . . 73.439999999999998 110.992 0.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.488 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 3.3 p -130.06 133.46 25.0 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.478 1.111 . . . . 71.120000000000005 109.968 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -75.04 -168.16 6.25 Favored 'Cis proline' 0 C--N 1.36 1.165 0 C-N-CA 121.031 -2.487 . . . . 72.109999999999999 110.967 0.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 175' ' ' ASP . . . -56.89 152.73 26.14 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.47 1.106 . . . . 71.109999999999999 109.24 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.548 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.06 -162.52 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.5 1.79 . . . . 64.340000000000003 110.932 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.65 130.72 35.15 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.5 1.125 . . . . 72.329999999999998 109.275 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.486 HG11 ' CZ ' ' A' ' 301' ' ' PHE . 35.4 m -128.85 24.71 2.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.476 1.11 . . . . 73.140000000000001 109.28 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.2 t -68.38 -27.06 65.9 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.5 1.125 . . . . 63.43 110.015 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.5 t -47.19 -24.66 0.74 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.502 1.126 . . . . 74.530000000000001 109.961 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.418 ' HB2' ' ND2' ' A' ' 293' ' ' ASN . 1.7 m -76.89 -173.35 2.64 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 74.340000000000003 108.275 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 171.12 83.62 0.06 OUTLIER Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.453 1.095 . . . . 74.099999999999994 110.971 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.742 ' CZ ' HD11 ' A' ' 286' ' ' LEU . 2.9 p90 . . . . . 0 C--N 1.325 -0.499 0 O-C-N 124.469 0.747 . . . . 63.219999999999999 110.969 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.756 HD23 ' HB3' ' A' ' 194' ' ' ASP . 4.8 tp . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.295 -0.631 . . . . 73.120000000000005 109.295 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.67 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -146.99 108.02 4.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.536 1.148 . . . . 51.420000000000002 109.291 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.75 2.74 28.53 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.516 1.135 . . . . 71.540000000000006 110.026 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 224' ' ' SER . 2.4 t -142.23 150.31 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.474 1.109 . . . . 72.349999999999994 109.243 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.056 HD11 HD12 ' A' ' 149' ' ' LEU . 1.0 OUTLIER -102.94 143.31 26.35 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.476 1.11 . . . . 61.100000000000001 109.312 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -33.76 4.33 Favored 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.485 1.782 . . . . 71.129999999999995 111.014 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.44 ' O ' ' CG2' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -157.7 151.23 23.75 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.449 1.093 . . . . 75.519999999999996 109.288 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.497 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 1.7 t -49.52 -34.81 8.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.485 1.115 . . . . 75.409999999999997 109.277 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -42.48 -46.6 4.84 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.489 1.118 . . . . 61.350000000000001 109.255 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.702 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.0 m -72.1 -33.22 67.69 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.54 1.15 . . . . 72.099999999999994 110.36 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.4 OUTLIER -60.91 -56.44 21.14 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.511 1.132 . . . . 64.540000000000006 109.308 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.497 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 53.6 m-80 -54.05 -30.77 49.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.434 1.084 . . . . 72.549999999999997 109.29 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -56.59 7.35 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.497 1.123 . . . . 63.350000000000001 110.032 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.056 HD12 HD11 ' A' ' 140' ' ' ILE . 84.1 mt -42.18 -42.43 3.0 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.47 1.106 . . . . 52.030000000000001 109.318 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.506 ' HB2' HD12 ' A' ' 237' ' ' ILE . 0.8 OUTLIER -71.17 -44.88 64.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.513 1.133 . . . . 72.450000000000003 111.012 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -45.43 -39.06 6.64 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 73.420000000000002 109.298 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 155' ' ' ASN . 57.1 mt-30 -75.82 -55.51 5.56 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 74.439999999999998 110.271 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.891 HD11 HD12 ' A' ' 188' ' ' LEU . 14.3 mt -51.05 -24.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.489 1.118 . . . . 73.430000000000007 109.368 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 243' ' ' SER . 0.0 OUTLIER -78.74 -33.98 46.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.499 1.124 . . . . 75.450000000000003 109.327 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 152' ' ' GLN . 2.4 t-20 -61.73 -14.99 37.02 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 62.329999999999998 109.286 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 157' ' ' SER . 3.2 mm100 -84.08 -18.19 37.75 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.559 1.162 . . . . 72.400000000000006 110.287 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 156' ' ' GLN . 11.0 p -37.37 147.44 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.444 1.09 . . . . 70.409999999999997 110.01 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.4 m -82.28 53.54 2.3 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.49 1.119 . . . . 73.400000000000006 108.335 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -164.34 27.88 0.21 Allowed Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.531 1.145 . . . . 72.450000000000003 111.015 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.716 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 60.7 p -132.7 163.19 29.52 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.481 0.754 . . . . 75.099999999999994 110.398 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 63.0 m -93.62 0.86 56.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.546 1.154 . . . . 62.039999999999999 110.034 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 162' ' ' THR . 3.0 m -116.68 0.44 12.61 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.134 . . . . 74.109999999999999 110.384 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.716 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -69.83 137.99 52.23 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.509 1.13 . . . . 43.109999999999999 109.301 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.51 -164.94 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.512 1.132 . . . . 55.119999999999997 110.028 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.433 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 15.3 p -155.57 127.39 3.82 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 124.476 1.11 . . . . 63.530000000000001 110.023 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.433 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.2 Cg_endo -74.96 139.77 63.61 Favored 'Cis proline' 0 C--N 1.36 1.158 0 C-N-CA 120.988 -2.505 . . . . 52.119999999999997 111.021 -0.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 21.1 p -72.76 -179.53 3.16 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 64.319999999999993 108.312 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.686 ' HA ' HD22 ' A' ' 298' ' ' LEU . 3.1 mp -92.24 123.24 44.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.485 1.116 . . . . 72.409999999999997 109.344 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 25.3 p -89.76 80.71 6.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.496 1.123 . . . . 65.530000000000001 110.395 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -80.75 -14.41 58.12 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.482 1.114 . . . . 73.209999999999994 110.98 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 304' ' ' LEU . 0.0 OUTLIER -75.26 -1.23 22.52 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 71.400000000000006 110.278 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.644 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.7 t80 -130.9 65.54 76.89 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.442 1.089 . . . . 73.129999999999995 111.001 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.439 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.4 Cg_endo -74.97 117.24 4.84 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.486 1.782 . . . . 70.510000000000005 110.997 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.578 HG21 ' CE1' ' A' ' 172' ' ' TYR . 9.6 t -151.92 -72.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 70.319999999999993 109.301 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.37 -44.13 1.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.455 1.097 . . . . 70.540000000000006 109.273 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -53.23 99.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.448 1.093 . . . . 43.340000000000003 111.003 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.63 ' SG ' HG12 ' A' ' 219' ' ' VAL . 3.5 p -134.82 -48.2 0.74 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.278 -1.008 . . . . 54.0 108.278 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.569 ' HB3' HG11 ' A' ' 219' ' ' VAL . 8.4 p90 -69.52 -11.77 61.1 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.528 1.142 . . . . 73.409999999999997 110.973 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.494 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -73.41 -68.12 0.53 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 74.5 109.299 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.828 HH21 ' HG2' ' A' ' 239' ' ' PRO . 11.1 ptm180 -50.64 -49.85 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.157 . . . . 74.25 110.281 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.463 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -39.64 -57.63 1.46 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.523 1.14 . . . . 71.129999999999995 109.338 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.505 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.2 t60 -45.86 -43.9 13.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.486 1.116 . . . . 70.109999999999999 109.618 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 180' ' ' ARG . 17.3 mmmt -60.35 -58.58 7.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 1.125 . . . . 74.530000000000001 109.273 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.48 ' SD ' HG21 ' A' ' 153' ' ' ILE . 5.8 mtm -39.01 -29.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.455 1.097 . . . . 75.109999999999999 111.015 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.443 ' NH1' ' SD ' ' A' ' 189' ' ' MET . 2.1 tmt_? -70.57 -50.18 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.471 1.107 . . . . 71.150000000000006 110.3 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.471 ' HG3' HD13 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -55.29 -33.97 63.71 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.534 1.146 . . . . 62.539999999999999 110.255 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.471 HD13 ' HG3' ' A' ' 186' ' ' GLN . 16.0 mm -77.02 -34.87 22.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 64.120000000000005 109.307 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.891 HD12 HD11 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -64.74 -45.12 87.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.563 1.164 . . . . 63.229999999999997 109.338 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.722 ' HG2' HD21 ' A' ' 136' ' ' LEU . 63.2 mtp -58.28 -37.2 74.51 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.502 1.126 . . . . 71.25 111.064 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -52.29 -52.02 55.27 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.506 1.129 . . . . 54.210000000000001 109.315 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.445 ' HB3' ' CD2' ' A' ' 149' ' ' LEU . 7.9 t-20 -63.82 -28.67 70.02 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.495 1.122 . . . . 71.019999999999996 109.284 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 106.55 44.94 1.27 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.522 1.139 . . . . 62.240000000000002 111.027 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.702 ' CZ ' HG21 ' A' ' 145' ' ' THR . 80.0 m-85 -147.82 130.3 15.8 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.492 0.76 . . . . 64.319999999999993 111.018 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.756 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.4 OUTLIER -97.07 130.78 44.32 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.502 1.127 . . . . 74.219999999999999 109.313 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.839 ' HB3' HD22 ' A' ' 188' ' ' LEU . 30.5 p -104.96 -179.48 3.95 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.483 1.114 . . . . 62.100000000000001 108.311 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -129.54 174.59 9.51 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.464 1.103 . . . . 74.349999999999994 110.32 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.622 ' HE2' HG22 ' A' ' 221' ' ' ILE . 16.4 mmtt -108.17 169.49 8.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.52 1.138 . . . . 64.299999999999997 109.303 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 219' ' ' VAL . 27.7 tt0 -164.11 117.69 1.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.471 1.107 . . . . 73.0 110.299 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.467 ' CE1' HG21 ' A' ' 219' ' ' VAL . 6.0 m-85 -108.28 120.5 42.54 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.511 1.132 . . . . 75.340000000000003 111.006 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.673 ' CG2' HG23 ' A' ' 266' ' ' VAL . 7.5 p -109.77 148.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 74.120000000000005 109.29 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.414 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 23.5 m-85 -119.91 158.28 27.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.49 1.119 . . . . 75.329999999999998 111.002 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 120.63 -179.73 16.36 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.512 1.132 . . . . 61.219999999999999 110.979 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.742 ' C ' HD23 ' A' ' 204' ' ' LEU . 59.3 t-20 -70.39 110.82 5.53 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.537 0.787 . . . . 72.109999999999999 109.304 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 203' ' ' ASN . 5.6 mt -114.93 93.43 4.31 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.466 1.104 . . . . 75.120000000000005 109.267 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 256' ' ' CYS . 5.7 mttp -93.55 166.01 12.46 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.487 1.117 . . . . 64.510000000000005 109.307 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.722 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -169.64 147.98 3.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 34.399999999999999 109.298 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 58.2 p -120.84 112.86 19.33 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.509 1.13 . . . . 63.439999999999998 109.93 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 27.5 p -82.52 -13.13 57.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.494 1.121 . . . . 72.319999999999993 110.393 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 114.83 -48.15 0.97 Allowed Glycine 0 CA--C 1.53 1.03 0 O-C-N 124.48 1.113 . . . . 60.030000000000001 111.013 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 12.7 t -95.65 -12.55 25.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.494 0.761 . . . . 72.200000000000003 110.372 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 212' ' ' CYS . 0.0 OUTLIER -170.43 163.36 8.53 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 55.5 108.325 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.479 ' N ' ' SG ' ' A' ' 211' ' ' CYS . 0.5 OUTLIER -118.67 144.05 46.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.51 1.131 . . . . 65.109999999999999 108.312 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.722 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.1 OUTLIER -109.83 155.69 10.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.464 1.103 . . . . 70.340000000000003 109.303 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -139.68 119.26 13.1 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 61.5 109.295 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.434 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -128.39 133.1 48.54 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 64.310000000000002 107.958 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.3 m -79.61 2.5 22.18 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.507 1.129 . . . . 61.0 109.985 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.481 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 8.9 p90 -174.17 128.51 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.498 1.124 . . . . 74.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.502 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 71.2 t60 -116.36 167.6 10.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.511 1.132 . . . . 73.310000000000002 109.612 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.63 HG12 ' SG ' ' A' ' 177' ' ' CYS . 2.6 p -144.79 137.61 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 72.120000000000005 109.296 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.667 ' HB3' ' CZ2' ' A' ' 252' ' ' TRP . . . -137.89 -165.7 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 62.119999999999997 109.286 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.622 HG22 ' HE2' ' A' ' 197' ' ' LYS . 15.9 pt -115.42 123.54 71.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 74.219999999999999 109.295 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.7 tp -87.91 108.83 19.37 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 73.409999999999997 109.276 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.718 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.89 146.98 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.482 1.114 . . . . 71.030000000000001 109.275 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 140' ' ' ILE . 75.4 m -117.09 120.18 37.55 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.434 1.084 . . . . 65.299999999999997 110.025 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 32.9 p90 -134.96 143.22 46.74 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.482 1.114 . . . . 74.230000000000004 111.007 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.422 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.6 mmtp -68.85 132.38 46.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.519 1.137 . . . . 63.530000000000001 109.315 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.36 0.08 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.507 1.13 . . . . 75.340000000000003 109.323 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.66 0.18 48.04 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.455 1.097 . . . . 71.530000000000001 109.32 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 8.1 m -115.27 -7.89 12.35 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.465 1.103 . . . . 75.349999999999994 110.004 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.12 37.44 8.34 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.471 1.107 . . . . 71.25 111.004 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.3 137.63 43.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.532 0.784 . . . . 74.219999999999999 109.283 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.422 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.1 m -71.82 102.55 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.115 . . . . 74.140000000000001 110.369 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.6 mm-40 -101.79 -172.59 2.18 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.5 1.125 . . . . 71.299999999999997 110.321 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.523 ' HB3' HD11 ' A' ' 222' ' ' LEU . 12.3 mmtm -127.13 144.73 50.96 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.561 1.163 . . . . 74.519999999999996 109.305 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.629 ' HB3' HG22 ' A' ' 223' ' ' VAL . 0.9 OUTLIER -142.72 163.95 31.42 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 75.530000000000001 110.252 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.717 HG21 ' CD1' ' A' ' 252' ' ' TRP . 26.6 mm -119.01 117.86 55.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.493 1.121 . . . . 74.200000000000003 109.294 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.0 mm -102.63 47.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.509 1.131 . . . . 75.129999999999995 109.302 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.669 ' OD1' HD12 ' A' ' 241' ' ' LEU . 20.7 p-10 -94.73 111.53 54.56 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.504 1.128 . . . . 74.010000000000005 109.286 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.828 ' HG2' HH21 ' A' ' 180' ' ' ARG . 18.3 Cg_endo -75.06 -40.28 0.93 Allowed 'Trans proline' 0 C--N 1.36 1.175 0 O-C-N 124.463 1.77 . . . . 51.520000000000003 111.01 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 180' ' ' ARG . 0.6 OUTLIER -41.59 -39.09 1.51 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.551 1.157 . . . . 51.420000000000002 110.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.669 HD12 ' OD1' ' A' ' 238' ' ' ASP . 10.5 mt -95.78 -58.34 2.13 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.517 1.136 . . . . 74.409999999999997 109.324 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.658 ' CD2' HG11 ' A' ' 247' ' ' VAL . 91.6 m-85 -117.15 99.2 6.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.449 1.093 . . . . 74.319999999999993 110.99 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . 0.418 ' O ' ' CE ' ' A' ' 154' ' ' LYS . 35.4 m -90.68 -5.81 55.31 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.531 1.144 . . . . 73.310000000000002 110.0 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 25.3 m -79.42 -47.08 16.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.466 1.104 . . . . 75.209999999999994 109.98 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.13 -175.76 39.84 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.478 1.112 . . . . 75.209999999999994 110.992 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.518 ' CG ' HD21 ' A' ' 146' ' ' LEU . 18.4 Cg_endo -74.97 161.7 38.42 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.506 1.793 . . . . 74.030000000000001 110.991 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.658 HG11 ' CD2' ' A' ' 242' ' ' PHE . 3.4 m -144.7 157.35 14.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.516 1.135 . . . . 71.209999999999994 109.314 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.444 ' C ' ' N ' ' A' ' 250' ' ' THR . 28.6 p -64.93 137.63 57.87 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.492 1.12 . . . . 74.400000000000006 110.392 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 248' ' ' THR . 0.1 OUTLIER -39.78 -31.12 0.1 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 73.319999999999993 109.302 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.444 ' N ' ' C ' ' A' ' 248' ' ' THR . 4.6 m -71.35 -64.31 0.94 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 62.020000000000003 110.402 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -52.42 -24.74 8.33 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.475 1.11 . . . . 72.109999999999999 109.282 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.717 ' CD1' HG21 ' A' ' 236' ' ' ILE . 8.8 t90 -67.33 -59.92 3.01 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.478 1.111 . . . . 73.209999999999994 108.012 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.578 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -51.95 -41.25 61.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.497 1.123 . . . . 73.450000000000003 110.314 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.804 ' HA ' HG22 ' A' ' 257' ' ' VAL . 2.3 m-80 -54.83 -52.49 62.56 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.459 1.099 . . . . 72.439999999999998 109.314 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -55.2 -26.18 37.63 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 62.229999999999997 109.287 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.9 m -81.82 -36.36 28.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.482 1.114 . . . . 55.329999999999998 108.306 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.804 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.0 m -94.69 22.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.52 1.137 . . . . 62.450000000000003 109.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -52.23 109.21 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 74.299999999999997 109.305 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 262' ' ' GLY . 17.1 p -73.77 -3.09 26.39 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.153 . . . . 71.319999999999993 110.408 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 18.4 t -43.82 -31.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.521 1.138 . . . . 72.239999999999995 110.001 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.8 -37.7 15.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.527 1.142 . . . . 52.229999999999997 108.301 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 167.46 -126.97 1.49 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.515 1.134 . . . . 63.299999999999997 110.997 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.452 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.9 OUTLIER -75.6 145.03 41.47 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.513 0.772 . . . . 74.439999999999998 109.98 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -168.2 147.72 4.66 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.487 1.117 . . . . 64.120000000000005 109.324 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 92.2 p -172.87 156.8 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.537 1.148 . . . . 60.439999999999998 110.004 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.673 HG23 ' CG2' ' A' ' 200' ' ' VAL . 5.2 p -103.12 117.4 48.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.449 1.093 . . . . 75.239999999999995 109.3 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 21.0 t -72.05 -44.7 62.93 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 63.030000000000001 109.965 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 200' ' ' VAL . 3.4 m -166.66 -174.67 2.87 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.52 1.137 . . . . 74.219999999999999 110.011 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -163.09 156.6 19.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.521 1.138 . . . . 74.25 110.968 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 198' ' ' GLN . . . -154.85 149.57 26.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.48 1.113 . . . . 75.400000000000006 109.269 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -107.68 157.81 17.79 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.441 1.088 . . . . 73.140000000000001 109.282 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.582 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.4 p -148.82 179.11 8.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.562 1.164 . . . . 71.319999999999993 110.411 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.619 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -64.95 164.44 12.65 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.49 1.118 . . . . 73.519999999999996 109.279 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -79.31 -12.0 84.36 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.557 1.16 . . . . 71.420000000000002 111.0 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 275' ' ' ASN . 0.2 OUTLIER -84.23 -37.1 22.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.468 0.746 . . . . 74.109999999999999 109.347 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.619 HG23 ' HB3' ' A' ' 273' ' ' ALA . 21.1 t -43.73 108.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 65.530000000000001 109.265 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.545 ' CE2' ' HB3' ' A' ' 293' ' ' ASN . 1.6 t80 -72.01 -41.33 67.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 73.099999999999994 110.978 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.565 ' C ' ' CD1' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -162.85 115.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.438 1.086 . . . . 72.510000000000005 111.011 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.582 ' HD2' HG21 ' A' ' 272' ' ' THR . 62.8 ttt-85 -95.82 141.53 29.17 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.459 1.099 . . . . 65.0 110.297 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.73 158.02 37.76 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.548 1.155 . . . . 64.010000000000005 110.009 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 0.17 9.24 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 43.130000000000003 111.026 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.414 ' O ' ' CB ' ' A' ' 283' ' ' ASN . 46.3 t -97.51 9.23 42.98 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 71.010000000000005 109.989 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 282' ' ' SER . 0.9 OUTLIER 75.37 27.96 1.02 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.484 1.115 . . . . 75.109999999999999 109.334 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 121.51 45.13 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.49 1.119 . . . . 65.219999999999999 109.971 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.561 ' CE1' ' HG3' ' A' ' 279' ' ' ARG . 3.3 m-85 -104.8 162.42 13.32 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.514 1.134 . . . . 64.430000000000007 110.974 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.544 ' CD1' ' CE2' ' A' ' 320' ' ' PHE . 0.7 OUTLIER -121.21 172.12 8.22 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 72.230000000000004 109.276 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.492 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 78.4 m-85 -160.54 127.86 4.37 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.461 1.101 . . . . 73.430000000000007 111.022 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.637 ' HB3' HD13 ' A' ' 291' ' ' LEU . 1.3 m-20 -115.28 114.21 24.89 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.525 1.14 . . . . 74.040000000000006 109.331 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -85.65 -51.24 6.6 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.53 1.144 . . . . 54.0 109.305 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -108.13 14.19 25.3 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.501 1.125 . . . . 71.549999999999997 109.285 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 288' ' ' ASP . 1.2 mm? 54.19 39.06 30.39 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 62.219999999999999 109.296 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 290' ' ' ASN . 18.6 mm -66.77 -28.99 44.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.474 1.109 . . . . 73.0 109.352 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.915 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.7 t-20 -94.81 -29.25 14.84 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.456 1.098 . . . . 73.519999999999996 109.286 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 291' ' ' LEU . 1.9 m -79.03 -65.61 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.5 1.125 . . . . 71.109999999999999 110.381 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -49.13 -34.04 13.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.48 1.112 . . . . 73.209999999999994 109.298 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 47.8 t -69.06 -49.06 60.77 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.557 1.161 . . . . 71.219999999999999 108.295 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 293' ' ' ASN . 8.3 t -47.99 -47.85 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.53 1.144 . . . . 63.439999999999998 109.329 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 168' ' ' ILE . 15.6 mt -67.2 -61.99 1.65 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.51 1.131 . . . . 63.25 109.33 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -45.04 -25.6 0.34 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.499 1.124 . . . . 64.430000000000007 110.417 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.646 ' HE2' HG12 ' A' ' 315' ' ' VAL . 19.6 mmmt -72.91 -45.12 59.94 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.45 1.094 . . . . 62.229999999999997 109.314 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.731 ' CD1' HD12 ' A' ' 304' ' ' LEU . 2.0 m-30 -98.91 37.97 1.45 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.524 1.14 . . . . 75.319999999999993 111.009 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 31.1 t -68.97 -44.23 73.36 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.518 1.136 . . . . 63.140000000000001 109.967 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.799 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -93.85 -18.16 22.3 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.493 1.12 . . . . 73.040000000000006 109.274 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.818 HD22 ' CD ' ' A' ' 309' ' ' PRO . 13.9 mt -59.78 142.35 53.48 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.518 1.136 . . . . 74.209999999999994 109.315 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 86.9 p -152.64 160.75 43.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.133 . . . . 61.219999999999999 110.005 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 67.94 -159.05 51.37 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.535 1.147 . . . . 62.509999999999998 110.983 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 27.0 p -95.33 16.52 16.54 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.308 -0.997 . . . . 72.430000000000007 108.308 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.51 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 41.7 p -134.93 148.97 69.18 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.543 1.152 . . . . 33.340000000000003 110.004 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.818 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.0 147.28 88.9 Favored 'Cis proline' 0 C--N 1.359 1.131 0 C-N-CA 120.99 -2.504 . . . . 75.25 110.992 -0.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.48 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.3 p -131.67 135.56 27.04 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.473 1.108 . . . . 62.219999999999999 109.993 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.4 Cg_endo -74.94 -174.31 13.86 Favored 'Cis proline' 0 C--N 1.36 1.141 0 C-N-CA 121.005 -2.498 . . . . 63.530000000000001 111.027 -0.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -58.67 156.03 26.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.491 1.119 . . . . 52.350000000000001 109.327 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.92 -162.3 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.461 1.769 . . . . 34.130000000000003 110.993 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -89.29 135.87 33.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 73.310000000000002 109.315 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.646 HG12 ' HE2' ' A' ' 300' ' ' LYS . 30.0 m -128.16 23.17 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.118 . . . . 74.019999999999996 109.272 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 t -57.61 -35.58 70.64 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.539 1.149 . . . . 60.200000000000003 110.012 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 43.3 t -49.23 -23.54 1.39 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.507 1.13 . . . . 64.439999999999998 109.985 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . . . . . . . . . 1.9 m -81.5 170.42 15.92 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.558 1.161 . . . . 72.099999999999994 108.282 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.427 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . -179.19 104.52 0.19 Allowed Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.459 1.099 . . . . 71.040000000000006 110.985 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.544 ' CE2' ' CD1' ' A' ' 286' ' ' LEU . 5.5 p90 . . . . . 0 C--N 1.325 -0.474 0 O-C-N 124.554 0.796 . . . . 52.350000000000001 110.986 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 194' ' ' ASP . 2.8 tp . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.251 -0.648 . . . . 75.120000000000005 109.251 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.704 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -156.25 106.36 2.37 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 75.340000000000003 109.321 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -5.47 54.92 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.467 1.104 . . . . 63.020000000000003 109.994 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -136.38 149.39 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.529 1.143 . . . . 73.540000000000006 109.338 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -101.96 143.43 26.59 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 124.507 1.129 . . . . 74.540000000000006 109.299 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.0 -33.77 4.33 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.451 1.764 . . . . 74.140000000000001 110.967 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.402 ' H ' HG23 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -160.06 148.0 16.78 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.526 1.142 . . . . 74.349999999999994 109.35 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.519 HG23 ' CD2' ' A' ' 225' ' ' TYR . 1.7 t -43.68 -36.74 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.482 1.114 . . . . 72.340000000000003 109.321 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.5 -49.78 2.91 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 71.200000000000003 109.296 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.787 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.1 m -68.73 -37.06 79.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.536 1.148 . . . . 72.420000000000002 110.415 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.625 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -56.97 -57.33 12.99 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.498 1.124 . . . . 74.129999999999995 109.332 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.492 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 52.2 m-80 -53.12 -29.35 30.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 75.430000000000007 109.297 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.9 t -68.97 -57.55 5.33 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.428 1.08 . . . . 73.5 109.989 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 140' ' ' ILE . 92.7 mt -42.63 -42.77 3.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.548 1.155 . . . . 72.439999999999998 109.29 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.567 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.0 OUTLIER -72.53 -44.81 61.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.415 1.072 . . . . 75.430000000000007 110.982 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -47.06 -38.14 10.64 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.504 1.128 . . . . 72.430000000000007 109.284 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.424 ' CB ' ' CG2' ' A' ' 187' ' ' ILE . 58.7 mt-30 -75.53 -53.37 8.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.491 1.119 . . . . 73.239999999999995 110.293 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.765 HD11 HD12 ' A' ' 188' ' ' LEU . 16.0 mt -51.95 -24.63 5.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 41.140000000000001 109.317 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.41 -35.85 53.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.506 1.128 . . . . 72.219999999999999 109.247 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -61.78 -15.79 44.31 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.400000000000006 109.317 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.478 ' HG3' HD11 ' A' ' 187' ' ' ILE . 6.9 mm100 -84.73 -17.48 38.23 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.522 1.139 . . . . 71.310000000000002 110.316 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.8 p -38.54 133.15 1.06 Allowed 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.455 1.097 . . . . 41.299999999999997 110.022 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 168' ' ' ILE . 1.3 m -62.49 135.33 57.36 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.453 1.096 . . . . 52.210000000000001 108.312 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 112.21 -22.33 18.27 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.515 1.134 . . . . 54.240000000000002 110.987 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.791 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 55.7 p -77.44 161.63 27.82 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.561 0.801 . . . . 73.209999999999994 110.411 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 69.2 m -93.56 -2.56 54.07 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 71.310000000000002 110.003 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 162' ' ' THR . 3.5 m -114.98 7.61 15.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.509 1.13 . . . . 73.420000000000002 110.392 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.791 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -84.19 139.44 32.39 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.46 1.1 . . . . 64.239999999999995 109.3 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.73 -161.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.48 1.113 . . . . 75.310000000000002 109.971 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.434 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 0.9 OUTLIER -156.16 127.64 3.75 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 62.25 110.018 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.1 Cg_endo -75.06 138.25 54.97 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.028 -2.488 . . . . 54.409999999999997 110.968 0.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 15.4 p -73.08 178.88 4.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.553 1.158 . . . . 64.310000000000002 108.269 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.921 HG23 ' HG2' ' A' ' 180' ' ' ARG . 2.1 mp -87.41 124.72 40.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.483 1.114 . . . . 71.010000000000005 109.264 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 29.1 p -92.34 72.58 5.28 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.478 1.111 . . . . 54.399999999999999 110.423 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.433 ' HA ' ' NH1' ' A' ' 180' ' ' ARG . 26.6 p90 -77.75 -14.24 59.66 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.529 1.143 . . . . 61.439999999999998 110.987 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 171' ' ' ARG . 0.0 OUTLIER -75.91 -0.57 21.86 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.464 1.103 . . . . 65.230000000000004 110.283 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.626 ' CZ ' HD13 ' A' ' 304' ' ' LEU . 22.0 t80 -129.37 66.3 76.48 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 74.109999999999999 110.999 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.422 ' C ' ' CG2' ' A' ' 174' ' ' VAL . 18.4 Cg_endo -75.0 117.76 5.02 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.472 1.775 . . . . 74.519999999999996 110.994 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.596 HG21 ' CE1' ' A' ' 172' ' ' TYR . 14.0 t -152.28 -54.19 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.441 1.088 . . . . 54.030000000000001 109.254 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.42 -46.71 0.15 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.526 1.141 . . . . 72.340000000000003 109.346 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -48.18 103.46 0.07 OUTLIER Glycine 0 CA--C 1.529 0.944 0 O-C-N 124.526 1.141 . . . . 45.43 110.983 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.536 ' HB3' HG13 ' A' ' 219' ' ' VAL . 42.1 m -138.74 -48.47 0.51 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.319 -0.993 . . . . 73.340000000000003 108.319 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 13.4 p90 -62.55 -34.52 77.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.499 1.125 . . . . 75.150000000000006 111.01 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.681 ' HB2' HG11 ' A' ' 297' ' ' VAL . . . -60.93 -56.88 15.96 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.46 1.1 . . . . 64.040000000000006 109.3 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.921 ' HG2' HG23 ' A' ' 168' ' ' ILE . 22.9 mtp180 -53.27 -49.13 67.55 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.113 . . . . 74.150000000000006 110.323 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.433 ' C ' ' NZ ' ' A' ' 197' ' ' LYS . . . -41.64 -62.31 0.91 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.491 1.119 . . . . 73.019999999999996 109.347 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.658 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -42.8 -37.02 1.65 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.512 1.133 . . . . 65.120000000000005 109.608 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.647 ' CB ' HD11 ' A' ' 168' ' ' ILE . 28.0 mmmt -70.67 -55.33 8.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.478 1.111 . . . . 74.420000000000002 109.339 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.454 ' HA ' HG23 ' A' ' 153' ' ' ILE . 20.1 mtm -43.99 -28.73 0.5 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.504 1.127 . . . . 71.230000000000004 111.001 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.453 ' NH1' ' HE3' ' A' ' 189' ' ' MET . 0.3 OUTLIER -75.69 -40.49 55.79 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.47 1.106 . . . . 74.209999999999994 110.294 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.647 HE22 ' NZ ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -51.65 -34.14 36.66 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.511 1.132 . . . . 75.230000000000004 110.331 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.506 HD13 ' HG3' ' A' ' 186' ' ' GLN . 10.9 mm -78.46 -35.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.477 1.111 . . . . 73.109999999999999 109.288 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -59.83 -40.5 88.69 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.499 1.124 . . . . 54.229999999999997 109.298 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.453 ' HE3' ' NH1' ' A' ' 185' ' ' ARG . 4.1 mtt -63.75 -42.72 97.78 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 74.040000000000006 110.993 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -47.74 -53.51 14.98 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.543 1.152 . . . . 74.409999999999997 109.289 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -64.18 -37.48 87.61 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.538 1.149 . . . . 64.340000000000003 109.351 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 112.48 40.45 1.12 Allowed Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.517 1.136 . . . . 31.32 111.004 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.787 ' CZ ' HG21 ' A' ' 145' ' ' THR . 50.5 m-85 -137.28 134.01 35.64 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.502 0.766 . . . . 53.229999999999997 110.984 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.635 ' HB2' HD23 ' A' ' 136' ' ' LEU . 0.1 OUTLIER -101.21 144.91 29.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.486 1.116 . . . . 71.329999999999998 109.27 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.61 ' HB3' HD22 ' A' ' 188' ' ' LEU . 28.7 p -128.57 -179.4 5.03 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.531 1.144 . . . . 71.319999999999993 108.282 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 222' ' ' LEU . 19.9 mp0 -125.35 178.09 5.8 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.467 1.105 . . . . 74.340000000000003 110.271 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.499 ' HZ1' ' HA ' ' A' ' 182' ' ' HIS . 19.0 mmtt -106.01 159.3 16.16 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 1.107 . . . . 74.430000000000007 109.259 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.795 ' OE1' HD11 ' A' ' 236' ' ' ILE . 10.2 tt0 -145.18 117.59 8.51 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.559 1.162 . . . . 51.109999999999999 110.312 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.562 ' CD2' ' HB3' ' A' ' 279' ' ' ARG . 3.4 m-85 -116.89 128.02 54.83 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.53 1.144 . . . . 73.129999999999995 110.98 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.678 ' CG2' HG23 ' A' ' 266' ' ' VAL . 12.3 p -117.37 162.8 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 O-C-N 124.477 1.111 . . . . 74.25 109.281 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.442 ' OH ' ' NH1' ' A' ' 279' ' ' ARG . 76.3 m-85 -133.07 157.97 43.93 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.468 1.105 . . . . 73.140000000000001 110.99 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 118.26 -177.19 16.42 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.492 1.12 . . . . 50.109999999999999 111.043 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.686 ' C ' HD23 ' A' ' 204' ' ' LEU . 62.3 t-20 -70.64 109.77 5.09 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.479 0.753 . . . . 73.030000000000001 109.29 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.686 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.3 mt -113.31 95.74 5.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.486 1.116 . . . . 73.040000000000006 109.266 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 256' ' ' CYS . 0.4 OUTLIER -92.09 165.61 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.545 1.153 . . . . 64.049999999999997 109.315 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.873 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -174.63 151.6 1.51 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.522 1.139 . . . . 62.509999999999998 109.302 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.4 t -118.1 142.44 47.41 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.537 1.148 . . . . 75.430000000000007 110.027 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 7.7 p -129.93 5.43 4.98 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 53.140000000000001 110.411 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.751 ' O ' HG22 ' A' ' 210' ' ' THR . . . 108.8 114.41 3.73 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 124.492 1.12 . . . . 73.019999999999996 110.992 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.751 HG22 ' O ' ' A' ' 209' ' ' GLY . 14.7 t 50.48 21.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.502 0.766 . . . . 61.409999999999997 110.413 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 7.5 t -152.37 170.3 20.43 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 70.030000000000001 108.291 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 12.0 m -154.23 133.29 12.45 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.133 . . . . 72.310000000000002 108.298 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.873 HG23 ' HB3' ' A' ' 206' ' ' ALA . 0.4 OUTLIER -109.24 139.29 32.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.509 1.131 . . . . 72.25 109.306 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -133.02 126.14 31.23 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.491 1.12 . . . . 71.140000000000001 109.293 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.451 ' NE1' ' O ' ' A' ' 174' ' ' VAL . 0.8 OUTLIER -132.43 147.8 52.39 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 74.209999999999994 108.024 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 8.3 t -91.59 4.44 52.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.514 1.134 . . . . 71.340000000000003 110.007 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.507 ' O ' ' CG ' ' A' ' 217' ' ' TYR . 26.5 p90 -175.66 122.77 0.2 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.54 1.15 . . . . 72.219999999999999 110.981 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.544 ' NE2' HD11 ' A' ' 241' ' ' LEU . 52.1 t60 -106.56 165.69 11.11 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 62.210000000000001 109.595 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 177' ' ' CYS . 2.1 p -137.2 155.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.55 1.156 . . . . 74.430000000000007 109.245 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.652 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -161.18 -163.24 0.99 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 60.030000000000001 109.265 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.5 HD11 ' HB ' ' A' ' 237' ' ' ILE . 27.2 pt -123.86 122.48 64.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.53 1.144 . . . . 74.310000000000002 109.288 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.547 HD11 ' HB3' ' A' ' 234' ' ' LYS . 13.1 tp -86.36 108.85 18.63 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.542 1.151 . . . . 70.239999999999995 109.294 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.642 HG11 HG13 ' A' ' 237' ' ' ILE . 0.9 OUTLIER -101.03 166.68 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.576 1.173 . . . . 50.240000000000002 109.313 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 140' ' ' ILE . 64.0 m -137.14 118.95 15.13 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.511 1.132 . . . . 64.409999999999997 109.977 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.519 ' CD2' HG23 ' A' ' 143' ' ' VAL . 33.0 p90 -135.46 143.43 45.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.476 1.11 . . . . 72.310000000000002 110.959 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -68.49 131.73 45.78 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.511 1.132 . . . . 73.239999999999995 109.316 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.428 ' OD1' ' CG ' ' A' ' 233' ' ' GLU . 0.6 OUTLIER -71.68 -160.21 0.05 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.507 1.129 . . . . 72.409999999999997 109.318 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -84.26 -0.58 52.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.485 1.115 . . . . 63.030000000000001 109.254 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 4.1 m -114.65 -8.17 12.7 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.514 1.133 . . . . 54.009999999999998 109.977 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 88.21 37.78 7.55 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.51 1.131 . . . . 73.019999999999996 111.028 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.425 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.49 138.31 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.512 0.772 . . . . 74.239999999999995 109.256 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.9 m -72.06 102.71 3.06 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.539 1.149 . . . . 74.340000000000003 110.413 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.428 ' CG ' ' OD1' ' A' ' 227' ' ' ASN . 5.4 mm-40 -101.54 -172.62 2.19 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.459 1.099 . . . . 71.230000000000004 110.278 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.547 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.4 mmtm -128.12 145.11 51.11 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.466 1.104 . . . . 44.299999999999997 109.294 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.495 ' HB3' HG22 ' A' ' 223' ' ' VAL . 1.9 tpt180 -143.86 161.79 37.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.502 1.126 . . . . 75.329999999999998 110.331 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.795 HD11 ' OE1' ' A' ' 198' ' ' GLN . 17.5 mm -114.47 119.13 60.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.516 1.135 . . . . 72.519999999999996 109.359 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.2 mm -105.95 45.57 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 44.409999999999997 109.299 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.434 ' HA ' ' HE1' ' A' ' 184' ' ' MET . 12.6 t0 -105.9 107.72 60.14 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.484 1.115 . . . . 64.219999999999999 109.347 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 -0.42 9.95 Favored 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.51 1.795 . . . . 72.439999999999998 110.965 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.6 t -72.81 -4.53 32.17 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.504 1.128 . . . . 73.420000000000002 110.013 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.544 HD11 ' NE2' ' A' ' 218' ' ' HIS . 10.3 mt -136.21 -47.02 0.64 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.529 1.143 . . . . 71.200000000000003 109.264 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 247' ' ' VAL . 96.5 m-85 -123.23 101.45 7.39 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.549 1.156 . . . . 73.120000000000005 110.968 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.21 -22.11 28.84 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.481 1.113 . . . . 32.229999999999997 110.034 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 69.1 m -62.02 -49.56 75.55 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.516 1.135 . . . . 72.019999999999996 110.014 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.04 -170.77 37.77 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.478 1.111 . . . . 45.219999999999999 110.996 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.444 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.4 Cg_endo -74.99 164.18 33.89 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.506 1.793 . . . . 72.409999999999997 110.987 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.594 HG11 ' CD1' ' A' ' 242' ' ' PHE . 3.0 m -148.36 160.08 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.554 1.159 . . . . 71.340000000000003 109.281 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.443 ' C ' ' N ' ' A' ' 250' ' ' THR . 34.4 p -64.81 137.6 57.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.504 1.127 . . . . 74.150000000000006 110.392 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 248' ' ' THR . 5.8 p-10 -40.19 -30.29 0.09 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 74.120000000000005 109.33 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.443 ' N ' ' C ' ' A' ' 248' ' ' THR . 5.3 m -71.47 -64.5 0.91 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.526 1.141 . . . . 74.109999999999999 110.413 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.98 -26.11 9.85 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.532 1.145 . . . . 74.549999999999997 109.281 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.681 ' CD1' HG21 ' A' ' 236' ' ' ILE . 10.7 t90 -65.11 -57.87 7.48 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.512 1.133 . . . . 74.25 107.993 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.572 ' HD3' ' CE3' ' A' ' 252' ' ' TRP . 0.1 OUTLIER -52.89 -42.12 65.01 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.517 1.136 . . . . 72.430000000000007 110.293 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.858 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.3 m-80 -55.14 -50.63 68.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.496 1.122 . . . . 70.030000000000001 109.323 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 242' ' ' PHE . . . -54.86 -26.59 36.5 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.515 1.134 . . . . 52.329999999999998 109.312 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 205' ' ' LYS . 3.4 m -82.56 -37.83 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.472 1.108 . . . . 62.530000000000001 108.33 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.858 HG22 ' HA ' ' A' ' 254' ' ' ASN . 3.1 m -92.77 22.69 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 74.329999999999998 109.364 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 260' ' ' SER . 47.7 t30 -50.38 104.53 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.528 1.143 . . . . 41.020000000000003 109.328 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 262' ' ' GLY . 16.7 p -75.01 -4.03 35.88 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.457 1.098 . . . . 73.099999999999994 110.37 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.414 ' HB2' ' ND2' ' A' ' 258' ' ' ASN . 1.4 m -50.74 -22.26 2.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.549 1.156 . . . . 72.420000000000002 110.042 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 5.9 m -93.96 -29.47 15.24 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.457 1.098 . . . . 71.430000000000007 108.255 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 159.9 -122.18 1.1 Allowed Glycine 0 CA--C 1.531 1.055 0 O-C-N 124.483 1.114 . . . . 71.450000000000003 111.004 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.448 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.3 OUTLIER -83.86 140.12 32.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.572 0.807 . . . . 44.020000000000003 110.007 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.543 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -169.21 146.37 3.55 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.486 1.116 . . . . 71.150000000000006 109.288 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 1.7 t -172.87 164.02 5.04 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.504 1.127 . . . . 75.519999999999996 110.002 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.678 HG23 ' CG2' ' A' ' 200' ' ' VAL . 6.6 p -105.53 120.54 56.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.51 1.131 . . . . 73.530000000000001 109.305 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 1.4 t -80.05 -43.14 22.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.483 1.114 . . . . 75.040000000000006 109.984 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 49.0 m -156.88 176.73 12.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.443 1.089 . . . . 75.109999999999999 109.997 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.21 158.77 27.89 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.574 1.171 . . . . 75.510000000000005 110.953 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -172.88 155.37 3.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 65.019999999999996 109.345 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.524 ' C ' ' ND2' ' A' ' 271' ' ' ASN . 0.1 OUTLIER -122.22 159.34 27.48 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.514 1.134 . . . . 73.340000000000003 109.344 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.527 HG21 ' HD2' ' A' ' 279' ' ' ARG . 41.5 p -144.68 167.31 22.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.459 1.1 . . . . 75.450000000000003 110.386 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.696 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -45.71 158.17 0.09 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 1.14 . . . . 63.140000000000001 109.289 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -70.24 -46.58 49.26 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.489 1.118 . . . . 73.430000000000007 111.026 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -49.5 -37.54 26.88 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 0.752 . . . . 71.120000000000005 109.301 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.696 HG23 ' HB3' ' A' ' 273' ' ' ALA . 98.4 t -45.61 120.22 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 72.109999999999999 109.289 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' A' ' 277' ' ' TYR . 1.0 OUTLIER -75.78 -48.74 20.47 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.512 1.133 . . . . 74.349999999999994 110.983 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.468 ' CE1' ' O ' ' A' ' 279' ' ' ARG . 23.6 t80 -151.39 154.98 37.7 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.551 1.157 . . . . 51.009999999999998 111.032 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.562 ' HB3' ' CD2' ' A' ' 199' ' ' PHE . 71.1 ttt-85 -118.52 147.53 43.56 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.539 1.149 . . . . 73.349999999999994 110.269 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.82 157.4 46.37 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.505 1.128 . . . . 75.25 109.966 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.02 0.27 9.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.5 1.79 . . . . 55.43 110.983 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 11.6 t -105.46 9.13 33.69 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.466 1.104 . . . . 74.400000000000006 110.003 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 74.23 40.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.493 1.121 . . . . 71.209999999999994 109.306 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -119.23 119.81 35.2 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.506 1.129 . . . . 70.109999999999999 109.968 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -100.07 157.96 16.18 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.455 1.097 . . . . 71.439999999999998 111.009 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 287' ' ' TYR . 1.0 OUTLIER -118.04 177.64 4.71 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 1.148 . . . . 63.299999999999997 109.244 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 98.2 m-85 -162.82 132.23 4.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.524 1.14 . . . . 73.430000000000007 110.98 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.888 ' HB3' HD13 ' A' ' 291' ' ' LEU . 0.6 OUTLIER -113.84 112.08 22.8 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.515 1.134 . . . . 72.409999999999997 109.334 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.24 -52.17 8.5 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.461 1.101 . . . . 72.319999999999993 109.296 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 292' ' ' ILE . 0.1 OUTLIER -115.05 25.08 11.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.518 1.136 . . . . 63.439999999999998 109.331 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.888 HD13 ' HB3' ' A' ' 288' ' ' ASP . 1.9 mm? 48.87 36.59 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.473 1.108 . . . . 65.120000000000005 109.278 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.493 ' CG2' ' O ' ' A' ' 319' ' ' GLY . 18.6 mm -66.04 -30.05 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.562 1.164 . . . . 54.310000000000002 109.317 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.886 ' O ' HG23 ' A' ' 297' ' ' VAL . 1.5 t-20 -94.5 -31.35 13.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.528 1.143 . . . . 73.430000000000007 109.245 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.474 ' CG2' ' HD3' ' A' ' 183' ' ' LYS . 7.6 m -77.19 -65.89 0.9 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.44 1.087 . . . . 74.319999999999993 110.434 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 70.7 m-20 -48.23 -33.17 8.18 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.542 1.151 . . . . 74.409999999999997 109.286 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 42.4 t -72.72 -40.26 66.27 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.508 1.13 . . . . 64.349999999999994 108.283 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.9 t -59.61 -42.85 89.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 63.210000000000001 109.327 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.626 HD11 ' HG3' ' A' ' 183' ' ' LYS . 77.1 mt -71.18 -62.42 1.4 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.473 1.108 . . . . 70.510000000000005 109.311 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -43.82 -26.38 0.25 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.477 1.111 . . . . 73.530000000000001 110.343 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.722 ' HE2' HG12 ' A' ' 315' ' ' VAL . 17.1 mmmt -67.74 -46.77 71.19 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.51 1.131 . . . . 64.420000000000002 109.255 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.708 ' CD1' HD12 ' A' ' 304' ' ' LEU . 1.8 m-30 -97.35 36.61 1.44 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.517 1.136 . . . . 71.25 111.003 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 30.0 t -67.03 -46.84 73.24 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.469 1.106 . . . . 62.219999999999999 109.978 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.796 ' C ' HD22 ' A' ' 303' ' ' LEU . 0.0 OUTLIER -92.13 -18.15 23.95 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.53 1.144 . . . . 73.129999999999995 109.327 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.793 HD22 ' CD ' ' A' ' 309' ' ' PRO . 15.2 mt -59.51 134.17 56.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.493 1.121 . . . . 71.209999999999994 109.303 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 77.3 p -149.67 150.55 32.31 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.463 1.102 . . . . 74.329999999999998 109.994 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.6 -162.94 45.79 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 124.496 1.123 . . . . 73.25 110.986 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 4.6 p -90.17 9.92 26.52 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.295 -1.002 . . . . 61.210000000000001 108.295 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.513 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 2.2 p -132.56 150.77 76.75 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 74.109999999999999 109.968 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.793 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.4 Cg_endo -74.92 146.42 86.63 Favored 'Cis proline' 0 C--N 1.36 1.181 0 C-N-CA 120.984 -2.506 . . . . 73.209999999999994 111.046 -0.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.505 ' HA ' ' C ' ' A' ' 311' ' ' PRO . 2.4 p -131.82 136.05 27.74 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.507 1.129 . . . . 71.420000000000002 110.02 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.505 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.3 Cg_endo -74.97 -174.81 14.78 Favored 'Cis proline' 0 C--N 1.36 1.17 0 C-N-CA 121.036 -2.485 . . . . 50.399999999999999 111.023 0.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.59 158.2 32.37 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.463 1.102 . . . . 62.119999999999997 109.324 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.3 Cg_endo -75.01 -162.4 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.48 1.779 . . . . 55.109999999999999 110.976 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -91.79 136.24 33.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 74.329999999999998 109.279 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.722 HG12 ' HE2' ' A' ' 300' ' ' LYS . 17.6 m -130.43 17.58 2.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.51 1.131 . . . . 64.109999999999999 109.325 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 318' ' ' CYS . 12.4 t -64.9 -33.01 74.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.541 1.151 . . . . 72.420000000000002 110.014 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -48.33 -23.92 1.06 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.518 1.136 . . . . 62.350000000000001 110.0 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 316' ' ' SER . 1.6 m -79.51 166.51 21.88 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.47 1.106 . . . . 73.129999999999995 108.308 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 292' ' ' ILE . . . -163.15 101.59 0.19 Allowed Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 64.340000000000003 111.009 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 23.9 p90 . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.538 0.787 . . . . 73.519999999999996 110.939 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.792 HD23 ' HB2' ' A' ' 194' ' ' ASP . 5.0 tp . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.273 -0.639 . . . . 74.319999999999993 109.273 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HB3' ' CD1' ' A' ' 193' ' ' TYR . . . -150.06 105.31 3.37 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.512 1.133 . . . . 64.530000000000001 109.306 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.3 t -81.77 5.62 18.03 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 51.030000000000001 109.992 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -146.35 147.52 17.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.502 1.126 . . . . 74.219999999999999 109.302 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.019 HD11 HD12 ' A' ' 149' ' ' LEU . 1.1 mt -100.1 142.54 24.8 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 62.520000000000003 109.315 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 140' ' ' ILE . 18.3 Cg_endo -75.01 -32.73 5.12 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.434 1.755 . . . . 73.109999999999999 110.972 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.31 147.7 16.17 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.477 1.111 . . . . 64.140000000000001 109.266 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.507 ' CG1' ' ND2' ' A' ' 147' ' ' ASN . 2.0 t -45.45 -36.16 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.498 1.124 . . . . 75.200000000000003 109.262 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -40.98 -47.42 3.02 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.476 1.11 . . . . 62.240000000000002 109.297 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.777 HG21 ' CZ ' ' A' ' 193' ' ' TYR . 3.2 m -71.38 -36.16 71.33 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.146 . . . . 53.140000000000001 110.395 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.727 ' CD1' HG21 ' A' ' 223' ' ' VAL . 0.6 OUTLIER -57.91 -56.97 15.12 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.462 1.101 . . . . 74.040000000000006 109.303 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.507 ' ND2' ' CG1' ' A' ' 143' ' ' VAL . 49.3 m-80 -52.44 -31.69 35.74 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.521 1.138 . . . . 75.549999999999997 109.299 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 1.7 t -69.13 -56.13 8.61 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 73.040000000000006 109.98 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 140' ' ' ILE . 45.2 mt -44.08 -42.28 6.12 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.504 1.128 . . . . 74.540000000000006 109.269 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.672 ' HB2' HD12 ' A' ' 237' ' ' ILE . 1.1 t80 -72.44 -44.64 62.11 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.494 1.121 . . . . 73.129999999999995 111.037 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -47.05 -34.5 5.86 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.546 1.154 . . . . 63.43 109.291 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.502 HE22 ' ND2' ' A' ' 191' ' ' ASN . 55.1 mt-30 -79.35 -50.85 10.23 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.493 1.121 . . . . 60.240000000000002 110.281 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 1.132 HD11 HD12 ' A' ' 188' ' ' LEU . 12.7 mt -54.91 -23.19 12.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 64.25 109.282 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.69 -38.55 38.96 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.55 1.156 . . . . 74.340000000000003 109.259 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.21 -17.44 19.04 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.472 1.107 . . . . 63.100000000000001 109.323 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.49 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 12.5 mm-40 -82.94 -25.37 32.43 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.5 1.125 . . . . 74.109999999999999 110.327 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.574 ' HB3' ' CE2' ' A' ' 170' ' ' PHE . 17.4 m -39.87 126.5 2.02 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 55.140000000000001 109.997 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 10.2 m -58.11 109.88 0.83 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.487 1.117 . . . . 63.219999999999999 108.307 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.71 -18.97 1.13 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.483 1.114 . . . . 61.240000000000002 111.007 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.731 ' OG1' ' HB2' ' A' ' 163' ' ' ALA . 59.4 p -93.25 159.84 15.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.496 0.762 . . . . 70.140000000000001 110.387 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.93 -3.51 58.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.47 1.106 . . . . 64.420000000000002 110.014 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.7 m -110.15 -1.16 17.58 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.511 1.132 . . . . 71.349999999999994 110.42 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.731 ' HB2' ' OG1' ' A' ' 160' ' ' THR . . . -73.31 132.82 43.54 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.511 1.132 . . . . 72.450000000000003 109.294 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -173.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.475 1.109 . . . . 75.109999999999999 109.989 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.42 ' HA ' ' C ' ' A' ' 166' ' ' PRO . 53.3 p -152.65 126.94 4.5 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.49 1.118 . . . . 62.009999999999998 109.985 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . 0.42 ' C ' ' HA ' ' A' ' 165' ' ' SER . 18.4 Cg_endo -75.0 137.88 52.9 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 121.021 -2.491 . . . . 70.129999999999995 110.979 -0.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . . . . . . . . . 9.1 p -72.66 -173.85 1.27 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.501 1.125 . . . . 63.539999999999999 108.256 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.94 ' HA ' HD22 ' A' ' 298' ' ' LEU . 3.3 mp -100.82 134.17 41.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.485 1.116 . . . . 75.200000000000003 109.351 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.501 HG21 ' HB2' ' A' ' 301' ' ' PHE . 36.2 p -81.42 86.67 6.26 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.13 . . . . 74.219999999999999 110.377 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 157' ' ' SER . 1.6 p90 -88.9 -1.99 58.37 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.472 1.107 . . . . 73.319999999999993 111.007 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.405 HH12 HG22 ' A' ' 169' ' ' THR . 0.1 OUTLIER -110.6 9.88 23.0 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.481 1.113 . . . . 55.219999999999999 110.258 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.706 ' OH ' HD13 ' A' ' 304' ' ' LEU . 18.0 t80 -129.51 68.09 79.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.476 1.11 . . . . 75.450000000000003 110.989 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.611 ' O ' HG11 ' A' ' 213' ' ' VAL . 18.3 Cg_endo -75.03 117.08 4.78 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.528 1.804 . . . . 51.310000000000002 111.012 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.637 HG13 ' HB2' ' A' ' 310' ' ' SER . 2.6 t -151.78 -55.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.496 1.122 . . . . 71.310000000000002 109.262 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.36 -46.77 0.15 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.506 1.129 . . . . 73.450000000000003 109.281 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -38.2 121.22 1.02 Allowed Glycine 0 CA--C 1.529 0.966 0 O-C-N 124.47 1.106 . . . . 55.109999999999999 111.004 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.598 ' SG ' HG12 ' A' ' 219' ' ' VAL . 4.3 p -153.02 -47.63 0.1 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.361 -0.978 . . . . 73.150000000000006 108.361 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 179' ' ' ALA . 47.0 p90 -67.53 -44.47 78.27 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.468 1.105 . . . . 74.230000000000004 111.048 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.567 ' N ' ' CD1' ' A' ' 178' ' ' TYR . . . -54.21 -66.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.472 1.107 . . . . 72.219999999999999 109.281 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.529 ' CB ' HG21 ' A' ' 168' ' ' ILE . 2.0 ptm85 -42.02 -46.96 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 1.155 . . . . 72.420000000000002 110.26 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 184' ' ' MET . . . -50.36 -58.96 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.518 1.137 . . . . 72.230000000000004 109.268 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.592 ' CD2' ' CD1' ' A' ' 291' ' ' LEU . 1.6 t60 -46.35 -28.19 1.26 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.113 . . . . 73.349999999999994 109.613 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.843 ' HB3' HD11 ' A' ' 168' ' ' ILE . 24.4 mmmt -81.03 -40.03 24.88 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.534 1.146 . . . . 64.150000000000006 109.32 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.553 ' HB3' HD13 ' A' ' 221' ' ' ILE . 9.8 mtm -60.35 -46.64 89.21 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.484 1.115 . . . . 70.150000000000006 111.005 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.549 ' NH1' ' HE3' ' A' ' 189' ' ' MET . 0.0 OUTLIER -65.85 -30.67 71.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.535 1.147 . . . . 64.120000000000005 110.303 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.445 ' HG2' ' N ' ' A' ' 187' ' ' ILE . 0.0 OUTLIER -59.85 -33.12 71.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.532 1.145 . . . . 74.120000000000005 110.323 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.445 ' N ' ' HG2' ' A' ' 186' ' ' GLN . 25.1 mm -78.5 -50.84 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 52.350000000000001 109.259 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LEU . . . . . 1.132 HD12 HD11 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -43.62 -36.89 2.31 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.454 1.096 . . . . 70.519999999999996 109.307 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.69 ' HG2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -68.54 -46.29 69.93 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.476 1.11 . . . . 62.509999999999998 111.0 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.97 -53.5 12.21 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.53 1.144 . . . . 70.040000000000006 109.251 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . 0.502 ' ND2' HE22 ' A' ' 152' ' ' GLN . 6.3 t-20 -62.29 -37.47 85.67 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 62.5 109.31 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 117.95 51.37 0.33 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.534 1.146 . . . . 70.010000000000005 111.002 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.777 ' CZ ' HG21 ' A' ' 145' ' ' THR . 74.0 m-85 -151.43 136.92 17.75 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.486 0.757 . . . . 72.219999999999999 111.028 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.792 ' HB2' HD23 ' A' ' 136' ' ' LEU . 2.8 t70 -102.74 131.47 49.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.498 1.123 . . . . 61.329999999999998 109.284 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 1.012 ' HB3' HD22 ' A' ' 188' ' ' LEU . 12.8 p -108.38 -179.27 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.495 1.122 . . . . 64.109999999999999 108.323 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER -129.39 177.35 7.25 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 74.049999999999997 110.301 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.653 ' HE2' HG22 ' A' ' 221' ' ' ILE . 13.6 mmtt -109.54 171.67 7.3 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.504 1.128 . . . . 73.409999999999997 109.306 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.429 ' NE2' HD13 ' A' ' 222' ' ' LEU . 9.9 tt0 -168.72 117.4 0.69 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 71.109999999999999 110.324 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 279' ' ' ARG . 7.4 m-85 -109.09 137.81 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.53 1.144 . . . . 64.310000000000002 111.014 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.884 HG23 ' HB3' ' A' ' 269' ' ' TYR . 9.9 p -129.98 125.59 60.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.506 1.129 . . . . 75.129999999999995 109.289 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -95.97 151.14 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.481 1.113 . . . . 72.049999999999997 110.956 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 129.44 -171.07 20.21 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.506 1.129 . . . . 71.310000000000002 110.995 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . 0.837 ' C ' HD23 ' A' ' 204' ' ' LEU . 56.1 t-20 -79.15 111.47 15.4 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.537 0.787 . . . . 73.209999999999994 109.302 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.837 HD23 ' C ' ' A' ' 203' ' ' ASN . 3.3 mt -116.53 94.61 4.69 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.49 1.119 . . . . 52.109999999999999 109.331 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.777 ' HE2' ' HB2' ' A' ' 214' ' ' ALA . 9.3 mttt -93.08 168.18 11.29 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.472 1.107 . . . . 65.430000000000007 109.336 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.586 ' HB3' HG23 ' A' ' 213' ' ' VAL . . . -167.56 125.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.458 1.099 . . . . 50.450000000000003 109.296 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.3 t -116.99 127.05 53.79 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.443 1.09 . . . . 71.340000000000003 109.966 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 11.0 p -93.7 -17.8 22.82 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.486 1.116 . . . . 62.520000000000003 110.4 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 126.25 -48.52 0.96 Allowed Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.509 1.131 . . . . 73.299999999999997 111.024 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.2 m -96.61 -20.34 18.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.502 0.766 . . . . 74.109999999999999 110.392 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' CYS . . . . . . . . . . . . . 5.9 t -156.94 167.61 29.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.523 1.139 . . . . 74.510000000000005 108.343 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.424 ' O ' HG13 ' A' ' 213' ' ' VAL . 0.5 OUTLIER -135.76 178.21 7.23 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.527 1.142 . . . . 70.409999999999997 108.302 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.611 HG11 ' O ' ' A' ' 173' ' ' PRO . 0.1 OUTLIER -153.34 149.19 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.125 . . . . 60.409999999999997 109.295 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.777 ' HB2' ' HE2' ' A' ' 205' ' ' LYS . . . -129.46 133.37 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.535 1.147 . . . . 72.349999999999994 109.313 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' TRP . . . . . 0.469 ' CD1' ' O ' ' A' ' 174' ' ' VAL . 1.2 m0 -134.31 132.01 39.06 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.534 1.146 . . . . 74.040000000000006 108.009 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 16.5 p -73.66 -3.59 29.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.528 1.142 . . . . 63.32 109.988 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 200' ' ' VAL . 6.8 p90 -173.95 137.46 0.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 72.209999999999994 111.013 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CG ' ' N ' ' A' ' 219' ' ' VAL . 60.2 t60 -125.9 168.83 13.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.537 1.148 . . . . 75.340000000000003 109.546 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.598 HG12 ' SG ' ' A' ' 177' ' ' CYS . 1.8 p -147.44 133.63 12.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.51 1.131 . . . . 74.439999999999998 109.327 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.632 ' CB ' ' CZ2' ' A' ' 252' ' ' TRP . . . -128.22 -165.03 1.44 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.469 1.106 . . . . 73.219999999999999 109.25 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.653 HG22 ' HE2' ' A' ' 197' ' ' LYS . 18.5 pt -116.99 117.66 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.494 1.122 . . . . 71.25 109.251 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 234' ' ' LYS . 14.0 tp -81.83 109.05 15.85 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 74.239999999999995 109.277 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.727 HG21 ' CD1' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -104.85 147.86 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.507 1.129 . . . . 71.319999999999993 109.284 179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 233' ' ' GLU . 67.2 m -117.62 121.74 41.72 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 74.019999999999996 109.991 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.528 ' CE1' ' HB2' ' A' ' 235' ' ' ARG . 31.7 p90 -136.64 143.23 43.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 73.200000000000003 111.028 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.427 ' CE ' ' OG1' ' A' ' 232' ' ' THR . 18.7 mmtp -69.17 132.28 46.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.529 1.143 . . . . 72.409999999999997 109.315 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 231' ' ' VAL . 0.5 OUTLIER -73.47 -160.17 0.08 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.476 1.11 . . . . 74.319999999999993 109.317 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -83.68 -0.2 49.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.512 1.132 . . . . 73.040000000000006 109.337 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.7 m -114.79 -8.14 12.62 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.44 1.087 . . . . 73.209999999999994 110.052 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 87.25 37.87 8.06 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.511 1.132 . . . . 54.299999999999997 111.001 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.418 ' O ' ' OD1' ' A' ' 227' ' ' ASN . 2.5 t -111.8 137.33 44.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.511 0.771 . . . . 53.509999999999998 109.305 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.427 ' OG1' ' CE ' ' A' ' 226' ' ' LYS . 4.3 m -71.45 102.54 2.69 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.463 1.102 . . . . 54.450000000000003 110.428 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 224' ' ' SER . 2.7 mm-40 -101.8 -172.58 2.18 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.454 1.096 . . . . 74.209999999999994 110.272 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.497 ' HB3' HD11 ' A' ' 222' ' ' LEU . 11.5 mmtm -126.51 144.89 50.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.482 1.114 . . . . 75.310000000000002 109.3 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.627 ' HB3' HG22 ' A' ' 223' ' ' VAL . 2.1 tpt180 -144.17 161.59 38.48 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 75.140000000000001 110.327 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 252' ' ' TRP . 17.8 mm -115.85 116.32 52.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 O-C-N 124.518 1.136 . . . . 74.420000000000002 109.287 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 237' ' ' ILE . 3.5 mm -100.42 46.17 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.502 1.127 . . . . 53.439999999999998 109.293 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.419 ' OD1' ' CE ' ' A' ' 184' ' ' MET . 3.1 m-20 -100.1 110.38 59.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 75.439999999999998 109.343 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 242' ' ' PHE . 18.3 Cg_endo -74.99 -42.99 0.43 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.465 1.771 . . . . 73.129999999999995 110.987 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 180' ' ' ARG . 26.5 p -39.28 -29.86 0.05 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.5 1.125 . . . . 73.519999999999996 109.998 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.442 ' N ' ' C ' ' A' ' 239' ' ' PRO . 30.0 mt -101.92 -59.49 1.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.518 1.136 . . . . 74.230000000000004 109.288 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.604 ' CD1' HG11 ' A' ' 247' ' ' VAL . 79.7 m-85 -112.29 99.39 7.98 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.512 1.132 . . . . 63.049999999999997 111.025 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 58.5 m -86.2 -5.18 59.24 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.514 1.134 . . . . 64.549999999999997 109.968 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 5.3 m -82.65 -45.28 14.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.504 1.128 . . . . 62.32 109.999 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -179.74 -173.77 45.1 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.512 1.133 . . . . 73.239999999999995 110.993 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.441 ' HB2' ' CG ' ' A' ' 235' ' ' ARG . 18.5 Cg_endo -74.95 162.73 36.74 Favored 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.501 1.79 . . . . 50.530000000000001 111.034 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.604 HG11 ' CD1' ' A' ' 242' ' ' PHE . 2.7 m -148.18 159.19 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.503 1.127 . . . . 73.420000000000002 109.329 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.435 ' C ' ' N ' ' A' ' 250' ' ' THR . 30.2 p -62.23 139.93 58.48 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.527 1.142 . . . . 71.409999999999997 110.418 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.407 ' O ' ' NE ' ' A' ' 253' ' ' ARG . 2.5 p-10 -42.95 -28.13 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.496 1.123 . . . . 63.119999999999997 109.328 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.435 ' N ' ' C ' ' A' ' 248' ' ' THR . 17.1 m -72.45 -65.0 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.513 1.133 . . . . 74.439999999999998 110.387 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -50.66 -30.94 14.85 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.447 1.092 . . . . 70.120000000000005 109.29 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' TRP . . . . . 0.686 ' CD1' HG21 ' A' ' 236' ' ' ILE . 11.9 t90 -59.47 -66.17 0.55 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.953 -1.129 . . . . 70.420000000000002 107.953 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.799 ' O ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -41.67 -39.18 1.59 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.508 1.13 . . . . 75.420000000000002 110.254 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASN . . . . . 0.876 ' HA ' HG22 ' A' ' 257' ' ' VAL . 3.1 m-80 -60.12 -50.37 73.95 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.51 1.131 . . . . 53.329999999999998 109.297 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.597 ' HB2' ' CE2' ' A' ' 242' ' ' PHE . . . -55.1 -28.89 55.89 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.523 1.139 . . . . 73.409999999999997 109.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 205' ' ' LYS . 7.6 m -81.39 -33.52 32.24 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.505 1.128 . . . . 73.030000000000001 108.309 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.876 HG22 ' HA ' ' A' ' 254' ' ' ASN . 2.4 m -98.14 24.18 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.473 1.108 . . . . 72.439999999999998 109.338 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -56.87 110.93 0.89 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.509 1.131 . . . . 71.200000000000003 109.271 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 262' ' ' GLY . 2.8 p -73.32 -3.04 24.61 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.527 1.142 . . . . 74.299999999999997 110.402 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 47.2 t -44.34 -26.66 0.35 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.153 . . . . 73.439999999999998 109.954 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.83 -36.58 11.61 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.447 1.092 . . . . 75.209999999999994 108.253 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 259' ' ' THR . . . 169.96 -126.55 1.36 Allowed Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.485 1.116 . . . . 71.540000000000006 111.028 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.454 ' O ' ' ND2' ' A' ' 203' ' ' ASN . 0.7 OUTLIER -81.24 150.33 28.63 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.491 0.759 . . . . 74.340000000000003 110.001 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.566 ' HB1' ' HA ' ' A' ' 257' ' ' VAL . . . -172.28 144.68 1.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.482 1.114 . . . . 61.520000000000003 109.276 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 41.6 p -172.84 153.14 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.515 1.134 . . . . 74.329999999999998 109.992 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.687 HG23 HG11 ' A' ' 257' ' ' VAL . 3.1 t -99.75 125.47 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.476 1.11 . . . . 70.349999999999994 109.295 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 2.4 t -85.87 -29.35 23.76 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.499 1.124 . . . . 72.430000000000007 109.966 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.6 m 178.58 155.64 0.42 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.134 . . . . 54.439999999999998 109.969 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.884 ' HB3' HG23 ' A' ' 200' ' ' VAL . 30.2 p90 -144.14 155.94 44.13 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 75.319999999999993 111.014 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -147.79 154.33 40.34 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.556 1.16 . . . . 62.119999999999997 109.293 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.426 ' ND2' ' C ' ' A' ' 271' ' ' ASN . 1.0 OUTLIER -107.62 157.71 17.85 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 1.133 . . . . 54.420000000000002 109.323 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.705 HG21 ' HD2' ' A' ' 279' ' ' ARG . 1.8 p -149.47 178.39 8.85 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.462 1.101 . . . . 64.329999999999998 110.364 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ALA . . . . . 0.634 ' HB3' HG23 ' A' ' 276' ' ' VAL . . . -67.91 165.93 16.67 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.425 1.078 . . . . 73.319999999999993 109.303 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . -75.38 -42.69 27.15 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.545 1.153 . . . . 74.329999999999998 110.995 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -55.26 -39.93 70.36 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.504 0.767 . . . . 72.120000000000005 109.273 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' VAL . . . . . 0.634 HG23 ' HB3' ' A' ' 273' ' ' ALA . 76.6 t -43.57 101.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.526 1.141 . . . . 74.310000000000002 109.295 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.43 -47.34 84.49 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.531 1.144 . . . . 74.439999999999998 110.978 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -152.12 138.51 18.51 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.48 1.112 . . . . 62.009999999999998 111.036 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.705 ' HD2' HG21 ' A' ' 272' ' ' THR . 67.4 ttt-85 -106.84 147.42 29.75 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 54.43 110.345 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.71 158.12 48.23 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.493 1.121 . . . . 63.439999999999998 110.011 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 0.25 9.14 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.469 1.773 . . . . 65.140000000000001 111.009 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 28.7 t -103.09 7.4 38.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.464 1.103 . . . . 53.450000000000003 109.996 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 73.93 41.91 0.39 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 72.450000000000003 109.3 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.4 t -123.5 121.51 35.85 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.495 1.122 . . . . 74.239999999999995 110.04 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' TYR . . . . . 0.465 ' OH ' HG22 ' A' ' 272' ' ' THR . 11.5 m-30 -101.27 165.82 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.511 1.132 . . . . 75.099999999999994 110.989 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LEU . . . . . 0.656 HD11 ' CE2' ' A' ' 320' ' ' PHE . 1.1 mm? -124.62 177.37 5.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.482 1.114 . . . . 65.519999999999996 109.328 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' A' ' 286' ' ' LEU . 84.5 m-85 -160.32 123.21 3.39 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.489 1.118 . . . . 71.430000000000007 110.98 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.917 ' HB3' HD13 ' A' ' 291' ' ' LEU . 2.2 m-20 -115.07 104.01 11.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.459 1.099 . . . . 73.409999999999997 109.302 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.415 ' O ' HD22 ' A' ' 291' ' ' LEU . 3.3 m-80 -85.54 -53.81 4.95 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.542 1.151 . . . . 73.329999999999998 109.32 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ASN . . . . . 0.463 ' CB ' HG12 ' A' ' 292' ' ' ILE . 17.0 m-20 -93.04 15.65 14.6 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.558 1.161 . . . . 63.439999999999998 109.318 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.917 HD13 ' HB3' ' A' ' 288' ' ' ASP . 2.4 mm? 40.27 42.99 1.33 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.532 1.145 . . . . 72.439999999999998 109.308 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . 0.463 HG12 ' CB ' ' A' ' 290' ' ' ASN . 26.6 mm -74.04 -28.38 23.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.542 1.151 . . . . 73.439999999999998 109.318 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.865 ' O ' HG23 ' A' ' 297' ' ' VAL . 2.4 t-20 -94.64 -26.91 16.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.446 1.091 . . . . 71.340000000000003 109.313 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 297' ' ' VAL . 23.7 m -82.3 -68.96 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.508 1.13 . . . . 75.329999999999998 110.424 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 291' ' ' LEU . 56.6 m-20 -47.52 -29.86 3.09 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.534 1.146 . . . . 74.439999999999998 109.315 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' CYS . . . . . . . . . . . . . 51.0 t -74.69 -43.06 57.05 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 1.094 . . . . 53.329999999999998 108.333 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.865 HG23 ' O ' ' A' ' 293' ' ' ASN . 3.1 t -56.46 -50.59 71.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.521 1.138 . . . . 74.129999999999995 109.256 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' LEU . . . . . 0.94 HD22 ' HA ' ' A' ' 168' ' ' ILE . 10.4 mt -61.85 -63.1 1.37 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.469 1.106 . . . . 71.239999999999995 109.283 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -41.96 -42.45 2.8 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.496 1.122 . . . . 61.130000000000003 110.425 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.564 ' HE2' HG12 ' A' ' 315' ' ' VAL . 14.9 mmmt -53.34 -44.66 68.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.513 1.133 . . . . 55.130000000000003 109.305 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.562 ' HB3' ' CD2' ' A' ' 172' ' ' TYR . 2.5 m-30 -100.42 29.87 4.18 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.541 1.15 . . . . 74.409999999999997 110.979 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' SER . . . . . . . . . . . . . 27.2 t -62.04 -52.35 64.29 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.521 1.138 . . . . 52.100000000000001 109.989 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' LEU . . . . . 0.626 HD13 ' H ' ' A' ' 303' ' ' LEU . 0.0 OUTLIER -84.05 -10.46 57.84 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.524 1.14 . . . . 72.409999999999997 109.281 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.706 HD13 ' OH ' ' A' ' 172' ' ' TYR . 17.7 mt -73.82 137.18 43.66 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.141 . . . . 71.219999999999999 109.288 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 62.9 p -160.7 137.12 8.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 64.140000000000001 110.009 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 105.89 -158.77 15.53 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.565 1.166 . . . . 64.120000000000005 111.019 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 8.4 p -95.76 8.7 42.75 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.347 -0.983 . . . . 71.219999999999999 108.347 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' SER . . . . . 0.507 ' HA ' ' C ' ' A' ' 309' ' ' PRO . 4.0 p -139.14 152.11 69.1 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 73.040000000000006 109.985 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' PRO . . . . . 0.592 ' CD ' HD22 ' A' ' 304' ' ' LEU . 18.3 Cg_endo -75.02 146.64 87.2 Favored 'Cis proline' 0 C--N 1.36 1.178 0 C-N-CA 121.002 -2.499 . . . . 61.450000000000003 111.028 0.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.637 ' HB2' HG13 ' A' ' 174' ' ' VAL . 6.1 t -132.79 135.15 25.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.485 1.115 . . . . 74.329999999999998 109.999 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 310' ' ' SER . 18.1 Cg_endo -75.01 -173.64 12.7 Favored 'Cis proline' 0 C--N 1.36 1.161 0 C-N-CA 120.986 -2.506 . . . . 72.129999999999995 111.0 0.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.477 ' HB1' ' CZ ' ' A' ' 301' ' ' PHE . . . -56.99 152.99 25.44 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.473 1.108 . . . . 61.219999999999999 109.313 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' PRO . . . . . 0.557 ' HD2' ' CE1' ' A' ' 301' ' ' PHE . 18.2 Cg_endo -75.01 -162.41 0.15 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.491 1.785 . . . . 64.299999999999997 110.988 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -81.96 133.05 35.27 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.532 1.145 . . . . 71.109999999999999 109.264 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.564 HG12 ' HE2' ' A' ' 300' ' ' LYS . 27.1 m -136.19 16.98 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.447 1.092 . . . . 63.020000000000003 109.27 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.439 ' C ' ' N ' ' A' ' 318' ' ' CYS . 1.7 t -64.04 -40.2 95.77 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 75.299999999999997 109.955 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 3.1 t -39.5 -29.83 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.463 1.102 . . . . 73.109999999999999 110.01 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' CYS . . . . . 0.439 ' N ' ' C ' ' A' ' 316' ' ' SER . 5.2 m -64.84 -174.31 0.14 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.541 1.151 . . . . 74.219999999999999 108.287 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.554 ' N ' HD22 ' A' ' 293' ' ' ASN . . . -175.61 167.69 39.7 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.503 1.127 . . . . 54.43 111.046 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 286' ' ' LEU . 1.1 p90 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.533 0.784 . . . . 70.430000000000007 110.985 -179.957 . . . . . . . . 1 1 . 1 stop_ save_